PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Amtul, Z; Uhrig, M; Rozmahel, RF; Beyreuther, K				Amtul, Zareen; Uhrig, Markus; Rozmahel, Richard F.; Beyreuther, Konrad			Structural Insight into the Differential Effects of Omega-3 and Omega-6 Fatty Acids on the Production of A beta Peptides and Amyloid Plaques	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EICOSAPENTAENOIC ACID; ALZHEIMERS-DISEASE; ARACHIDONIC-ACID; CORTICAL-NEURONS; GENE-EXPRESSION; TRANSGENIC MICE; INFUSED RATS; CHOLESTEROL; METABOLISM; PROTEIN	Several studies have shown the protective effects of dietary enrichment of various lipids in several late-onset animal models of Alzheimer Disease (AD); however, none of the studies has determined which structure within a lipid determines its detrimental or beneficial effects on AD. High-sensitivity enzyme-linked immunosorbent assay (ELISA) shows that saturated fatty acids (SFAs), upstream omega-3 FAs, and arachidonic acid (AA) resulted in significantly higher secretion of both A beta 40 and 42 peptides compared with long chain downstream omega-3 and monounsaturated FAs (MUFA). Their distinct detrimental action is believed to be due to a structural template found in their fatty acyl chains that lack SFAs, upstream omega-3 FAs, and AA. Immunoblotting experiments and use of APP-C99-transfected COS-7 cells suggest that FA-driven altered production of A beta is mediated through gamma-secretase cleavage of APP. An early-onset AD transgenic mouse model expressing the double-mutant form of human amyloid precursor protein (APP); Swedish (K670N/M671L) and Indiana (V717F), corroborated in vitro findings by showing lower levels of A beta and amyloid plaques in the brain, when they were fed a low fat diet enriched in DHA. Our work contributes to the clarification of aspects of structure-activity relationships.	[Amtul, Zareen; Uhrig, Markus] Heidelberg Univ, ZMBH, Heidelberg, Germany; [Beyreuther, Konrad] Heidelberg Univ, NAR, Heidelberg, Germany; [Rozmahel, Richard F.] Univ Western Ontario, Dept Biochem, London, ON N6A 4L6, Canada	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Western University (University of Western Ontario)	Amtul, Z (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.	zamtul@uwo.ca	AMTUL, ZAREEN/Y-6364-2019		FP5 framework LipiDiet project [QLK-2002-172]; FP7 project LipiDiDiet [211696]; London and Middlesex Alzheimer Association; Canadian Institutes of Health Research [MOP49546]; Alexander von Humboldt; Ontario Mental Health Foundation	FP5 framework LipiDiet project; FP7 project LipiDiDiet; London and Middlesex Alzheimer Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alexander von Humboldt(Alexander von Humboldt Foundation); Ontario Mental Health Foundation	Grants from the FP5 framework LipiDiet project QLK-2002-172, the FP7 project LipiDiDiet 211696, London and Middlesex Alzheimer Association (Marion and Chester Fish Alzheimer Disease Research Grant), the Canadian Institutes of Health Research (MOP49546) (to R. F. R.), and the Alexander von Humboldt and Ontario Mental Health Foundation Awards (to Z. A.) funded this research.	AGREN JJ, 1995, LIPIDS, V30, P365, DOI 10.1007/BF02536047; Amtul Z., 2010, OLEIC IN PRESS  1005, DOI [10.1111/j.1750-3639.2010.00449, DOI 10.1111/J.1750-3639.2010.00449]; Amtul Z, 2010, NEUROSCI LETT, V481, P73, DOI 10.1016/j.neulet.2010.06.046; BIRCH EE, 1992, INVEST OPHTH VIS SCI, V33, P3242; Calder PC, 2002, P NUTR SOC, V61, P345, DOI 10.1079/PNS2002166; Carta G, 2002, PROSTAG LEUKOTR ESS, V67, P187, DOI 10.1054/plef.2002.0417; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chiu LCM, 2000, INT J ONCOL, V17, P789; Colin A, 2003, ENCEPHALE, V29, P49; DAVIS PJ, 1992, BIOCHEM CELL BIOL, V70, P1313, DOI 10.1139/o92-178; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Hartmann T, 1996, J BIOL CHEM, V271, P13208, DOI 10.1074/jbc.271.22.13208; Hashimoto M, 2005, BBA-MOL CELL BIOL L, V1738, P91, DOI 10.1016/j.bbalip.2005.11.011; Hashimoto M, 2005, J NUTR, V135, P549, DOI 10.1093/jn/135.3.549; HOMAN R, 1991, J LIPID RES, V32, P231; Horrobin DF, 2002, PROSTAG LEUKOTR ESS, V66, P83, DOI 10.1054/plef.2001.0338; Huber T, 2002, J AM CHEM SOC, V124, P298, DOI 10.1021/ja011383j; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Iizuka T, 1996, BIOCHEM BIOPH RES CO, V218, P238, DOI 10.1006/bbrc.1996.0042; Jensen M, 2000, MOL MED, V6, P291, DOI 10.1007/BF03401938; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; KUEHL FA, 1980, SCIENCE, V210, P978, DOI 10.1126/science.6254151; KULKARNI PS, 1987, J OCUL PHARMACOL, V3, P349, DOI 10.1089/jop.1987.3.349; KULKARNI PS, 1986, PROSTAGLANDINS, V31, P1159, DOI 10.1016/0090-6980(86)90217-0; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lichtenthaler SF, 2002, P NATL ACAD SCI USA, V99, P1365, DOI 10.1073/pnas.032395699; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Oda M, 2002, BIOCHEM J, V367, P329, DOI 10.1042/BJ20021089; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Patil S, 2005, NEUROSCI LETT, V384, P288, DOI 10.1016/j.neulet.2005.05.003; Patil S, 2006, NEUROSCI LETT, V406, P55, DOI 10.1016/j.neulet.2006.07.015; Pitman MC, 2004, BIOCHEMISTRY-US, V43, P15318, DOI 10.1021/bi048231w; Price PT, 2000, CURR OPIN LIPIDOL, V11, P3, DOI 10.1097/00041433-200002000-00002; SANDERS TAB, 1981, BRIT J NUTR, V45, P613, DOI 10.1079/BJN19810139; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; St George-Hyslop PH, 2000, SCI AM, V283, P76, DOI 10.1038/scientificamerican1200-76; STUBBS CD, 1990, BIOCHEM SOC T, V18, P779, DOI 10.1042/bst0180779; TAGAWA K, 1992, ANN NY ACAD SCI, V674, P129, DOI 10.1111/j.1749-6632.1992.tb27482.x; Watanabe S, 2003, PROSTAG LEUKOTR ESS, V69, P51, DOI 10.1016/S0952-3278(03)00056-5; YAGALOFF KA, 1995, PROSTAG LEUKOTR ESS, V52, P293, DOI 10.1016/0952-3278(95)90029-2	49	28	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6100	6107		10.1074/jbc.M110.183608	http://dx.doi.org/10.1074/jbc.M110.183608			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	20971855	hybrid, Green Published			2022-12-25	WOS:000287476400019
J	Chan, SW; Lim, CJ; Huang, C; Chong, YF; Gunaratne, HJ; Hogue, KA; Blackstock, WP; Harvey, KF; Hong, W				Chan, S. W.; Lim, C. J.; Huang, C.; Chong, Y. F.; Gunaratne, H. J.; Hogue, K. A.; Blackstock, W. P.; Harvey, K. F.; Hong, W.			WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ	ONCOGENE			English	Article						TAZ; Wbp2; Hippo pathway; cancer; transcription factors	YES-ASSOCIATED PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR PATHWAY; CELL CONTACT INHIBITION; ORGAN SIZE CONTROL; HIPPO PATHWAY; BREAST-CANCER; TRANSCRIPTIONAL OUTPUT; BANTAM MICRORNA; GROWTH-CONTROL	The transcriptional co-activators YAP and TAZ are downstream targets inhibited by the Hippo tumor suppressor pathway. YAP and TAZ both possess WW domains, which are important protein-protein interaction modules that mediate interaction with proline-rich motifs, most commonly PPXY. The WW domains of YAP have complex regulatory roles as exemplified by recent reports showing that they can positively or negatively influence YAP activity in a cell and context-specific manner. In this study, we show that the WW domain of TAZ is important for it to transform both MCF10A and NIH3T3 cells and to activate transcription of ITGB2 but not CTGF, as introducing point mutations into the WW domain of TAZ (WWm) abolished its transforming and transcription-promoting ability. Using a proteomic approach, we discovered potential regulatory proteins that interact with TAZ WW domain and identified Wbp2. The interaction of Wbp2 with TAZ is dependent on the WW domain of TAZ and the PPXY-containing C-terminal region of Wbp2. Knockdown of endogenous Wbp2 suppresses, whereas overexpression of Wbp2 enhances, TAZ-driven transformation. Forced interaction of WWm with Wbp2 by direct C-terminal fusion of full-length Wbp2 or its TAZ-interacting C-terminal domain restored the transforming and transcription-promoting ability of TAZ. These results suggest that the WW domain-mediated interaction with Wbp2 promotes the transforming ability of TAZ. Oncogene (2011) 30, 600-610; doi: 10.1038/onc.2010.438; published online 25 October 2010	[Chan, S. W.; Lim, C. J.; Huang, C.; Chong, Y. F.; Hong, W.] Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore 138673, Singapore; [Gunaratne, H. J.; Hogue, K. A.; Blackstock, W. P.] Inst Mol & Cell Biol, Mass Spectrometry & Syst Biol Lab, Singapore 138673, Singapore; [Harvey, K. F.] Peter MacCallum Canc Ctr, Cell Growth & Proliferat Lab, Melbourne, Vic, Australia; [Harvey, K. F.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Hong, W.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Peter Maccallum Cancer Center; University of Melbourne; National University of Singapore	Hong, W (corresponding author), Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbhwj@imcb.a-star.edu.sg	Harvey, Kieran/AAD-5268-2022; HONG, Wanjin/E-9927-2010	Harvey, Kieran/0000-0001-7845-369X	Agency for Science, Technology, and Research (A*STAR), Singapore	Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work is funded by Agency for Science, Technology, and Research (A*STAR), Singapore.	Bandura JL, 2008, DEV CELL, V14, P315, DOI 10.1016/j.devcel.2008.02.010; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Dhananjayan SC, 2006, MOL ENDOCRINOL, V20, P2343, DOI 10.1210/me.2005-0533; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Einbond A, 1996, FEBS LETT, V384, P1, DOI 10.1016/0014-5793(96)00263-3; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Han W, 2008, GENE CHROMOSOME CANC, V47, P490, DOI 10.1002/gcc.20550; Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lam-Himlin DM, 2006, J GASTROINTEST CANC, V37, P103, DOI 10.1007/s12029-007-0010-8; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Oh H, 2009, ONCOGENE, V28, P1916, DOI 10.1038/onc.2009.43; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang XM, 2009, CANCER RES, V69, P6033, DOI 10.1158/0008-5472.CAN-08-4592; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997	41	80	82	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2011	30	5					600	610		10.1038/onc.2010.438	http://dx.doi.org/10.1038/onc.2010.438			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	715WG	20972459	Green Published, hybrid			2022-12-25	WOS:000286922300008
J	Bayburt, TH; Vishnivetskiy, SA; McLean, MA; Morizumi, T; Huang, CC; Tesmer, JJG; Ernst, OP; Sligar, SG; Gurevich, VV				Bayburt, Timothy H.; Vishnivetskiy, Sergey A.; McLean, Mark A.; Morizumi, Takefumi; Huang, Chih-chin; Tesmer, John J. G.; Ernst, Oliver P.; Sligar, Stephen G.; Gurevich, Vsevolod V.			Monomeric Rhodopsin Is Sufficient for Normal Rhodopsin Kinase (GRK1) Phosphorylation and Arrestin-1 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; PHOSPHOLIPID-BILAYER NANODISCS; VISUAL ARRESTIN; CRYSTAL-STRUCTURE; METARHODOPSIN-II; 48-KDA PROTEIN; MEMBRANE-PROTEINS; FUNCTIONAL UNIT; ACTIVATION; TRANSDUCIN	G-protein-coupled receptor (GPCR) oligomerization has been observed in a wide variety of experimental contexts, but the functional significance of this phenomenon at different stages of the life cycle of class A GPCRs remains to be elucidated. Rhodopsin (Rh), a prototypical class A GPCR of visual transduction, is also capable of forming dimers and higher order oligomers. The recent demonstration that Rh monomer is sufficient to activate its cognate G protein, transducin, prompted us to test whether the same monomeric state is sufficient for rhodopsin phosphorylation and arrestin-1 binding. Here we show that monomeric active rhodopsin is phosphorylated by rhodopsin kinase (GRK1) as efficiently as rhodopsin in the native disc membrane. Monomeric phosphorylated light-activated Rh (P-Rh*) in nanodiscs binds arrestin-1 essentially as well as P-Rh* in native disc membranes. We also measured the affinity of arrestin-1 for P-Rh* in nanodiscs using a fluorescence-based assay and found that arrestin-1 interacts with monomeric P-Rh* with low nanomolar affinity and 1:1 stoichiometry, as previously determined in native disc membranes. Thus, similar to transducin activation, rhodopsin phosphorylation by GRK1 and high affinity arrestin-1 binding only requires a rhodopsin monomer.	[Sligar, Stephen G.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Vishnivetskiy, Sergey A.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Morizumi, Takefumi; Ernst, Oliver P.] Charite, D-10117 Berlin, Germany; [Huang, Chih-chin; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Tesmer, John J. G.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Urbana-Champaign; Vanderbilt University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sligar, SG (corresponding author), Univ Illinois, Dept Biochem, 116 Morrill Hall,505 S Goodwin, Urbana, IL 61801 USA.	s-sligar@uiuc.edu; vsevolod.gurevich@vanderbilt.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Gurevich, Vsevolod/A-3236-2008; Morizumi, Takefumi/AAA-2063-2021	Gurevich, Vsevolod/0000-0002-3950-5351; Morizumi, Takefumi/0000-0002-2785-209X; McLean, Mark/0000-0001-9125-293X; Tesmer, John/0000-0003-1125-3727	National Institutes of Health [EY011500, GM081756, GM077561, GM033775, HL071818]; Deutsche Forschungsgemeinschaft [Sfb740, ER 294/1-1]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM033775, R01GM081756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY011500, GM081756, and GM077561 (to V.V.G.), GM033775 (to S.G.S.), and HL071818 (to J.J.T.). This work was also supported by Deutsche Forschungsgemeinschaft Grants Sfb740 and ER 294/1-1 (to O.P.E.).	Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BUCZYLKO J, 1993, METH NEUROSCI, V15, P226; Burns ME, 2006, J NEUROSCI, V26, P1036, DOI 10.1523/JNEUROSCI.3301-05.2006; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gross OP, 2010, J NEUROSCI, V30, P3450, DOI 10.1523/JNEUROSCI.5391-09.2010; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2008, STRUCTURE, V16, P924, DOI 10.1016/j.str.2008.03.006; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; Jastrzebska B, 2009, BIOCHEMISTRY-US, V48, P5159, DOI 10.1021/bi900284x; Jastrzebska B, 2009, FASEB J, V23, P371, DOI 10.1096/fj.07-114835; Kota P, 2006, P NATL ACAD SCI USA, V103, P3054, DOI 10.1073/pnas.0510982103; KOTAKE S, 1991, ARCH BIOCHEM BIOPHYS, V285, P126, DOI 10.1016/0003-9861(91)90338-J; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; LODOLA A, 1978, BIOCHEM J, V169, P577, DOI 10.1042/bj1690577; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; Pascal G, 2005, MOL PHARMACOL, V68, P905, DOI 10.1124/mol.105.013847; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Satoh AK, 2010, NEURON, V67, P997, DOI 10.1016/j.neuron.2010.08.024; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Sommer ME, 2006, J BIOL CHEM, V281, P9407, DOI 10.1074/jbc.M510037200; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Zhang LR, 1997, J BIOL CHEM, V272, P14762, DOI 10.1074/jbc.272.23.14762	80	149	150	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1420	1428		10.1074/jbc.M110.151043	http://dx.doi.org/10.1074/jbc.M110.151043			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20966068	hybrid, Green Published			2022-12-25	WOS:000286005000054
J	Novak, I; Wang, J; Henriksen, KL; Haanes, KA; Krabbe, S; Nitschke, R; Hede, SE				Novak, Ivana; Wang, Jing; Henriksen, Katrine L.; Haanes, Kristian A.; Krabbe, Simon; Nitschke, Roland; Hede, Susanne E.			Pancreatic Bicarbonate Secretion Involves Two Proton Pumps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-K+-ATPASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; APICAL PLASMA-MEMBRANE; NON-GASTRIC H,K-ATPASE; ADENOSINE-TRIPHOSPHATASE; FUNCTIONAL EXPRESSION; FLUID SECRETION; ALPHA-SUBUNIT; CHOLECYSTOKININ-OCTAPEPTIDE; DIFFERENTIAL LOCALIZATION	Pancreas secretes fluid rich in digestive enzymes and bicarbonate. The alkaline secretion is important in buffering of acid chyme entering duodenum and for activation of enzymes. This secretion is formed in pancreatic ducts, and studies to date show that plasma membranes of duct epithelium express H+/HCO3- transporters, which depend on gradients created by the Na+/K+ -ATPase. However, the model cannot fully account for high-bicarbonate concentrations, and other active transporters, i.e. pumps, have not been explored. Here we show that pancreatic ducts express functional gastric and non-gastric H+ -K+ -ATPases. We measured intracellular pH and secretion in small ducts isolated from rat pancreas and showed their sensitivity to H+ -K+ pump inhibitors and ion substitutions. Gastric and non-gastric H+ -K+ pumps were demonstrated on RNA and protein levels, and pumps were localized to the plasma membranes of pancreatic ducts. Quantitative analysis of H+/HCO3- and fluid transport shows that the H+ -K+ pumps can contribute to pancreatic secretion in several species. Our results call for revision of the bicarbonate transport physiology in pancreas, and most likely other epithelia. Furthermore, because pancreatic ducts play a central role in several pancreatic diseases, it is of high relevance to understand the role of H+ -K+ pumps in pathophysiology.	[Novak, Ivana; Wang, Jing; Henriksen, Katrine L.; Haanes, Kristian A.; Krabbe, Simon; Hede, Susanne E.] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen O, Denmark; [Nitschke, Roland] Univ Freiburg, Life Imaging Ctr Biol Anal, D-79104 Freiburg, Germany; [Nitschke, Roland] Univ Freiburg, Ctr Biol Signaling Studies, D-79104 Freiburg, Germany	University of Copenhagen; University of Freiburg; University of Freiburg	Novak, I (corresponding author), Univ Copenhagen, Dept Biol, August Krogh Bldg,Univ Parken 13, DK-2100 Copenhagen O, Denmark.	inovak@bio.ku.dk	Haanes, Kristian Agmund/I-5881-2013; Nitschke, Roland/F-9525-2010; Novak, Ivana/M-2791-2014	Haanes, Kristian Agmund/0000-0001-5182-8957; Nitschke, Roland/0000-0002-9397-8475; Novak, Ivana/0000-0002-8917-8010	Danish Natural Science Research Council [09-059772, 272-05-0420, 21-03-0558]; Lundbeck Foundation [R17-A1366, 68/04]; Lundbeck Foundation [R17-2007-1366] Funding Source: researchfish	Danish Natural Science Research Council(Danish Natural Science Research Council); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was funded by grants from the Danish Natural Science Research Council (09-059772, 272-05-0420, 21-03-0558). The Lundbeck Foundation has granted Ph.D. stipends (to J. W. and K. A. H.) (R17-A1366) and postdoctoral fellowship (to S. E. H.) (68/04).	ALI AE, 1990, PANCREAS, V5, P314, DOI 10.1097/00006676-199005000-00011; BASTANI B, 1995, J AM SOC NEPHROL, V5, P1476; Bouwens L, 1998, DIABETOLOGIA, V41, P629, DOI 10.1007/s001250050960; BRORASMUSSEN F, 1956, ACTA PHYSIOL SCAND, V37, P97, DOI 10.1111/j.1748-1716.1956.tb01346.x; Burghardt B, 2003, GUT, V52, P1008, DOI 10.1136/gut.52.7.1008; Caplan MJ, 2007, J CLIN GASTROENTEROL, V41, pS217, DOI 10.1097/MCG.0b013e31803233da; CASE RM, 1969, J PHYSIOL-LONDON, V201, P335, DOI 10.1113/jphysiol.1969.sp008759; CASE RM, 1968, J PHYSIOL-LONDON, V196, P133, DOI 10.1113/jphysiol.1968.sp008499; CHEY WY, 1979, J PHYSIOL-LONDON, V293, P435, DOI 10.1113/jphysiol.1979.sp012898; Codina J, 1998, J BIOL CHEM, V273, P7894, DOI 10.1074/jbc.273.14.7894; Crambert G, 2002, AM J PHYSIOL-CELL PH, V283, pC305, DOI 10.1152/ajpcell.00590.2001; DeOndarza J, 1997, AM J PHYSIOL-GASTR L, V272, pG124, DOI 10.1152/ajpgi.1997.272.1.G124; DOMSCHKE S, 1976, GASTROENTEROLOGY, V70, P533; Dunbar LA, 2000, J CELL BIOL, V148, P769, DOI 10.1083/jcb.148.4.769; Dunbar LA, 2001, J BIOL CHEM, V276, P29617, DOI 10.1074/jbc.R100023200; Fernandez-Salazar MP, 2004, J PHYSIOL-LONDON, V556, P415, DOI 10.1113/jphysiol.2004.061762; GITHENS S, 1980, J CELL BIOL, V85, P122, DOI 10.1083/jcb.85.1.122; GITHENS S, 1988, J PEDIATR GASTR NUTR, V7, P486, DOI 10.1097/00005176-198807000-00004; GRAY MA, 1988, J MEMBRANE BIOL, V105, P131, DOI 10.1007/BF02009166; Grishin AV, 1996, AM J PHYSIOL-RENAL, V271, pF539, DOI 10.1152/ajprenal.1996.271.3.F539; GROTMOL T, 1985, ACTA PHYSIOL SCAND, V124, P71, DOI 10.1111/j.1748-1716.1985.tb07633.x; Haanes KA, 2010, BIOCHEM J, V429, P303, DOI 10.1042/BJ20091337; Hede SE, 1999, J BIOL CHEM, V274, P31784, DOI 10.1074/jbc.274.45.31784; Herrmann M, 2007, SCAND J GASTROENTERO, V42, P1275, DOI 10.1080/00365520701405579; Hyde K, 1997, GASTROENTEROLOGY, V113, P914, DOI 10.1016/S0016-5085(97)70187-2; Ishiguro H, 1998, J PHYSIOL-LONDON, V511, P407, DOI 10.1111/j.1469-7793.1998.407bh.x; Jaisser F, 1999, AM J PHYSIOL-RENAL, V276, pF812, DOI 10.1152/ajprenal.1999.276.6.F812; KODAMA T, 1983, ACTA PATHOL JAPON, V33, P297; Kone BC, 1998, J BIOL CHEM, V273, P2543, DOI 10.1074/jbc.273.5.2543; Kraut JA, 2001, AM J PHYSIOL-RENAL, V281, pF763, DOI 10.1152/ajprenal.2001.281.4.F763; KUMPULAINEN T, 1981, GASTROENTEROLOGY, V80, P796; Lee JK, 2007, WORLD J GASTROENTERO, V13, P6296, DOI 10.3748/wjg.13.6296; LEE JS, 1995, J CLIN INVEST, V96, P2002, DOI 10.1172/JCI118247; Lee MG, 2000, J CLIN INVEST, V105, P1651, DOI 10.1172/JCI9207; Lerner M, 2006, CELL PHYSIOL BIOCHEM, V18, P75, DOI 10.1159/000095169; Li DM, 2009, APPL BIOCHEM BIOTECH, V158, P253, DOI 10.1007/s12010-008-8391-0; MARINO CR, 1991, J CLIN INVEST, V88, P712, DOI 10.1172/JCI115358; Novak I, 2008, PURINERG SIGNAL, V4, P237, DOI 10.1007/s11302-007-9087-6; NOVAK I, 1988, PFLUG ARCH EUR J PHY, V411, P58, DOI 10.1007/BF00581647; NOVAK I, 1991, PFLUG ARCH EUR J PHY, V419, P76, DOI 10.1007/BF00373750; NOVAK I, 1988, PFLUG ARCH EUR J PHY, V411, P546, DOI 10.1007/BF00582376; Novak I, 2001, PFLUG ARCH EUR J PHY, V441, P761, DOI 10.1007/s004240000472; PADFIELD PJ, 1989, PANCREAS, V4, P204, DOI 10.1097/00006676-198904000-00009; Pestov NB, 1998, FEBS LETT, V440, P320, DOI 10.1016/S0014-5793(98)01483-5; Pestov NB, 2002, AM J PHYSIOL-CELL PH, V282, pC907, DOI 10.1152/ajpcell.00258.2001; Pestov NB, 2006, AM J PHYSIOL-CELL PH, V291, pC366, DOI 10.1152/ajpcell.00042.2006; Rajendran VM, 1998, AM J PHYSIOL-GASTR L, V274, pG424, DOI 10.1152/ajpgi.1998.274.2.G424; Reinhardt J, 2000, AM J PHYSIOL-RENAL, V279, pF417, DOI 10.1152/ajprenal.2000.279.3.F417; Sachs G, 2007, J CLIN GASTROENTEROL, V41, pS226, DOI 10.1097/MCG.0b013e31803233b7; SEOW KTFP, 1991, PANCREAS, V6, P385, DOI 10.1097/00006676-199107000-00002; SEWELL WA, 1975, J PHYSIOL-LONDON, V252, P379, DOI 10.1113/jphysiol.1975.sp011149; Shaheen NJ, 2006, AM J GASTROENTEROL, V101, P2128, DOI 10.1111/j.1572-0241.2006.00723.x; Shibata T, 2006, AM J PHYSIOL-CELL PH, V291, pC1038, DOI 10.1152/ajpcell.00266.2006; Shumaker H, 1999, AM J PHYSIOL-CELL PH, V276, pC16, DOI 10.1152/ajpcell.1999.276.1.C16; Silver RB, 1999, AM J PHYSIOL-RENAL, V276, pF799, DOI 10.1152/ajprenal.1999.276.6.F799; Sorensen CE, 2003, J PHYSIOL-LONDON, V551, P881, DOI 10.1113/jphysiol.2003.049411; Steward MC, 2005, ANNU REV PHYSIOL, V67, P377, DOI 10.1146/annurev.physiol.67.031103.153247; Swarts HGP, 2005, J BIOL CHEM, V280, P33115, DOI 10.1074/jbc.M504535200; Szalmay G, 2001, J PHYSIOL-LONDON, V535, P795, DOI 10.1111/j.1469-7793.2001.00795.x; VILLANGER O, 1995, GASTROENTEROLOGY, V108, P850, DOI 10.1016/0016-5085(95)90460-3; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007; Wood CM, 2010, J EXP BIOL, V213, P2681, DOI 10.1242/jeb.039164; ZHAO H, 1994, J GEN PHYSIOL, V104, P57, DOI 10.1085/jgp.104.1.57	63	40	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					280	289		10.1074/jbc.M110.136382	http://dx.doi.org/10.1074/jbc.M110.136382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978133	Green Published, hybrid			2022-12-25	WOS:000285782800031
J	Porter, MY; Xie, KQ; Pozharski, E; Koelle, MR; Martemyanov, KA				Porter, Morwenna Y.; Xie, Keqiang; Pozharski, Edwin; Koelle, Michael R.; Martemyanov, Kirill A.			A Conserved Protein Interaction Interface on the Type 5 G Protein beta Subunit Controls Proteolytic Stability and Activity of R7 Family Regulator of G Protein Signaling Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RGS PROTEINS; CRYSTAL-STRUCTURE; GAMMA DIMER; MEMBRANE ANCHOR; DEP DOMAIN; EXPRESSION; COMPLEXES; PHOTORECEPTORS; LOCALIZATION; SELECTIVITY	Regulators of G protein signaling (RGS) proteins of the R7 subfamily limit signaling by neurotransmitters in the brain and by light in the retina. They form obligate complexes with the G beta 5 protein that are subject to proteolysis to control their abundance and alter signaling. The mechanisms that regulate this proteolysis, however, remain unclear. We used genetic screens to find mutations in G beta 5 that selectively destabilize one of the R7 RGS proteins in Caenorhabditis elegans. These mutations cluster at the binding interface between G beta 5 and the N terminus of R7 RGS proteins. Equivalent mutations within mammalian G beta 5 allowed the interface to still bind the N-terminal DEP domain of R7 RGS proteins, and mutant G beta 5-R7 RGS complexes initially formed in cells but were then rapidly degraded by proteolysis. Molecular dynamics simulations suggest the mutations weaken the G beta 5-DEP interface, thus promoting dynamic opening of the complex to expose determinants of proteolysis known to exist on the DEP domain. We propose that conformational rearrangements at the G beta 5-DEP interface are key to controlling the stability of R7 RGS protein complexes.	[Porter, Morwenna Y.; Koelle, Michael R.] Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA; [Xie, Keqiang; Martemyanov, Kirill A.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Pozharski, Edwin] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Yale University; University of Minnesota System; University of Minnesota Twin Cities; University System of Maryland; University of Maryland Baltimore	Koelle, MR (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	michael.koelle@yale.edu; martemyanov@umn.edu	Xie, Keqiang/D-4437-2015; Pozharski, Edwin/AAM-7692-2020; Xie, Keqiang/J-9668-2012	Pozharski, Edwin/0000-0001-7012-5376; 	National Institutes of Health [EY018139, DA021743, DA026405, NS036918, MH082201]; McKnight Land Grant Professorship; NATIONAL EYE INSTITUTE [R01EY018139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH082201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021743, K02DA026405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Land Grant Professorship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants EY018139 (to K. A. M.), DA021743 (to K. A. M.), DA026405 (to K. A. M.), NS036918 (to M. R. K.), and MH082201 (to M. R. K.). This work was also supported by the McKnight Land Grant Professorship (to K. A. M.).	Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Anderson GR, 2009, MOL CELL BIOL, V29, P3033, DOI 10.1128/MCB.01449-08; Bany I. A., 2004, GENETIC CELLULAR ANA; Bastiani Carol, 2006, WormBook, P1; Benzing T, 1999, NAT MED, V5, P913, DOI 10.1038/11354; Benzing T, 2002, J BIOL CHEM, V277, P32954, DOI 10.1074/jbc.M200859200; BRENNER S, 1974, GENETICS, V77, P71; Burchett SA, 1998, J NEUROCHEM, V70, P2216; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Chase DL, 2004, METHOD ENZYMOL, V389, P305; Chase DL, 2001, CURR BIOL, V11, P222, DOI 10.1016/S0960-9822(01)00071-9; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Howlett AC, 2009, J BIOL CHEM, V284, P16386, DOI 10.1074/jbc.M900800200; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Jedema HP, 2008, EUR J NEUROSCI, V27, P2433, DOI 10.1111/j.1460-9568.2008.06208.x; Jones MB, 2004, MOL INTERV, V4, P200, DOI 10.1124/mi.4.4.4; Jose AM, 2007, GENETICS, V175, P93, DOI 10.1534/genetics.106.065516; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Narayanan V, 2007, BIOCHEMISTRY-US, V46, P6859, DOI 10.1021/bi700524w; Porter MY, 2009, PROG MOL BIOL TRANSL, V86, P15, DOI 10.1016/S1877-1173(09)86002-X; Porter MY, 2010, MOL BIOL CELL, V21, P232, DOI 10.1091/mbc.E09-07-0642; Posokhova E, 2010, J PROTEOME RES, V9, P1510, DOI 10.1021/pr901022m; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Robatzek M, 2000, GENETICS, V156, P1069; Robatzek M, 2001, CURR BIOL, V11, P288, DOI 10.1016/S0960-9822(01)00074-4; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Singh RK, 2007, J PHARMACOL EXP THER, V322, P133, DOI 10.1124/jpet.107.120386; Skiba NP, 2001, J BIOL CHEM, V276, P37365, DOI 10.1074/jbc.M106431200; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Sondek J, 2001, BIOCHEM PHARMACOL, V61, P1329, DOI 10.1016/S0006-2952(01)00633-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Tekumalla PK, 2001, BIOL PSYCHIAT, V50, P813, DOI 10.1016/S0006-3223(01)01234-3; Traynor JR, 2009, TRENDS PHARMACOL SCI, V30, P105, DOI 10.1016/j.tips.2008.11.006; van der Linden AM, 2001, GENETICS, V158, P221; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wilkie TM, 2000, CURR BIOL, V10, pR853, DOI 10.1016/S0960-9822(00)00823-X; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100	57	14	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41100	41112		10.1074/jbc.M110.163600	http://dx.doi.org/10.1074/jbc.M110.163600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959458	hybrid, Green Published			2022-12-25	WOS:000285414400072
J	Chuchana, P; Holzmuller, P; Vezilier, F; Berthier, D; Chantal, I; Severac, D; Lemesre, JL; Cuny, G; Nirde, P; Bucheton, B				Chuchana, Paul; Holzmuller, Philippe; Vezilier, Frederic; Berthier, David; Chantal, Isabelle; Severac, Dany; Lemesre, Jean Loup; Cuny, Gerard; Nirde, Philippe; Bucheton, Bruno			Intertwining Threshold Settings, Biological Data and Database Knowledge to Optimize the Selection of Differentially Expressed Genes from Microarray	PLOS ONE			English	Article							SAMPLE-SIZE; CELL DIFFERENTIATION; RECEPTOR; LIPOPOLYSACCHARIDE; CYTOKINE; METALLOTHIONEIN; INFLAMMATION; MACROPHAGES; ACTIVATION; INNATE	Background: Many tools used to analyze microarrays in different conditions have been described. However, the integration of deregulated genes within coherent metabolic pathways is lacking. Currently no objective selection criterion based on biological functions exists to determine a threshold demonstrating that a gene is indeed differentially expressed. Methodology/Principal Findings: To improve transcriptomic analysis of microarrays, we propose a new statistical approach that takes into account biological parameters. We present an iterative method to optimise the selection of differentially expressed genes in two experimental conditions. The stringency level of gene selection was associated simultaneously with the p-value of expression variation and the occurrence rate parameter associated with the percentage of donors whose transcriptomic profile is similar. Our method intertwines stringency level settings, biological data and a knowledge database to highlight molecular interactions using networks and pathways. Analysis performed during iterations helped us to select the optimal threshold required for the most pertinent selection of differentially expressed genes. Conclusions/Significance: We have applied this approach to the well documented mechanism of human macrophage response to lipopolysaccharide stimulation. We thus verified that our method was able to determine with the highest degree of accuracy the best threshold for selecting genes that are truly differentially expressed.	[Chuchana, Paul] INSERM, U844, Montpellier, France; [Chuchana, Paul; Holzmuller, Philippe; Vezilier, Frederic; Berthier, David; Chantal, Isabelle; Lemesre, Jean Loup; Cuny, Gerard; Bucheton, Bruno] Ctr CIRAD 177, UMR IRD, Montpellier, France; [Severac, Dany] Montpellier GenomiX, Inst Genom Fonct, Montpellier, France; [Nirde, Philippe] Univ Montpellier I, Inst Rech Cancerol Montpellier, INSERM, U896, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Chuchana, P (corresponding author), INSERM, U844, Montpellier, France.	paul.chuchana@inserm.fr	Holzmuller, Philippe/F-7231-2019	Holzmuller, Philippe/0000-0002-8919-9081; Isabelle, CHANTAL/0000-0002-3429-484X; David, BERTHIER/0000-0002-3283-6588	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Centre de cooperation internationale en recherche agronomique pour le developpement (CIRAD); Institut National de la Sante Et de la Recherche Medicale (INSERM); EU [223341]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut de Recherche pour le Developpement (IRD); Centre de cooperation internationale en recherche agronomique pour le developpement (CIRAD); Institut National de la Sante Et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); EU(European Commission)	This study was co-supported by the Centre National de la Recherche Scientifique (CNRS), Institut de Recherche pour le Developpement (IRD), Centre de cooperation internationale en recherche agronomique pour le developpement (CIRAD), Institut National de la Sante Et de la Recherche Medicale (INSERM) and by EU (RAPSODI project, FP7), grant N<SUP>o</SUP>223341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bin LH, 2003, J IMMUNOL, V171, P924, DOI 10.4049/jimmunol.171.2.924; Bock-Axelsen J, 2007, P NATL ACAD SCI USA, V104, P13122, DOI 10.1073/pnas.0705824104; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Chinetti G, 2000, CIRCULATION, V101, P2411, DOI 10.1161/01.CIR.101.20.2411; Chiu CY, 2006, CLIN INFECT DIS, V43, pE71, DOI 10.1086/507896; Chuchana P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm093; Davis KE, 2004, J BIOL CHEM, V279, P42453, DOI 10.1074/jbc.M402197200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Febbo PG, 2006, CLIN CANCER RES, V12, P152, DOI 10.1158/1078-0432.CCR-05-1652; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Genolet Raphael, 2004, Current Drug Targets - Inflammation and Allergy, V3, P361, DOI 10.2174/1568010042634578; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Inoue K, 2005, FASEB J, V19, P533, DOI 10.1096/fj.05-3864fje; Inoue K, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/215935; Jimenez F, 2010, J IMMUNOL, V184, P5571, DOI 10.4049/jimmunol.0803494; Laukens D, 2009, CRIT REV EUKAR GENE, V19, P301, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.40; Lee MLT, 2002, STAT MED, V21, P3543, DOI 10.1002/sim.1335; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Luo YQ, 2006, STEM CELLS, V24, P865, DOI 10.1634/stemcells.2005-0392; Mayburd AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005921; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Muller P, 2004, J AM STAT ASSOC, V99, P990, DOI 10.1198/016214504000001646; Oehler VG, 2009, BLOOD, V114, P3292, DOI 10.1182/blood-2009-03-212969; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pulai JI, 2005, J IMMUNOL, V174, P5781, DOI 10.4049/jimmunol.174.9.5781; Puskas LG, 2002, BIOTECHNIQUES, V32, P1330, DOI 10.2144/02326mt04; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; SIEGENTHALER G, 1994, BIOCHEM J, V302, P363, DOI 10.1042/bj3020363; Stolovitzky GA, 2005, P NATL ACAD SCI USA, V102, P1402, DOI 10.1073/pnas.0406555102; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; Tibshirani R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-106; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; Wang CC, 2008, P NATL ACAD SCI USA, V105, P11661, DOI 10.1073/pnas.0804923105; Warnes GR, 2006, SAMPLE SIZE ESTIMATI; Wei CM, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-87; Yoon YD, 2003, INT IMMUNOPHARMACOL, V3, P1873, DOI 10.1016/j.intimp.2003.09.005; Zapolska-Downar D, 2009, J PHYSIOL PHARMACOL, V60, P123; Zhu LX, 2007, ANTIMICROB AGENTS CH, V51, P3707, DOI 10.1128/AAC.01461-06	50	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13518	10.1371/journal.pone.0013518	http://dx.doi.org/10.1371/journal.pone.0013518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976008	Green Published, Green Submitted, gold			2022-12-25	WOS:000283216400022
J	Yang, RJ; Chen, M; Lee, CH; Yoon, R; Lal, S; Mao, JJ				Yang, Rujing; Chen, Mo; Lee, Chang Hun; Yoon, Richard; Lal, Shan; Mao, Jeremy J.			Clones of Ectopic Stem Cells in the Regeneration of Muscle Defects In Vivo	PLOS ONE			English	Article							SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; DIFFERENTIATION; TRANSPLANTATION; EXPRESSION; TEETH; PAX3; SIZE	Little is known about whether clones of ectopic, non-muscle stem cells contribute to muscle regeneration. Stem/progenitor cells that are isolated for experimental research or therapeutics are typically heterogeneous. Non-myogenic lineages in a heterogeneous population conceptually may compromise tissue repair. In this study, we discovered that clones of mononucleated stem cells of human tooth pulp fused into multinucleated myotubes that robustly expressed myosin heavy chain in vitro with or without co-culture with mouse skeletal myoblasts (C2C12 cells). Cloned cells were sustainably Oct4+, Nanog+ and Stro1+. The fusion indices of myogenic clones were approximately 16-17 folds greater than their parent, heterogeneous stem cells. Upon infusion into cardio-toxin induced tibialis anterior muscle defects, undifferentiated clonal progenies not only engrafted and colonized host muscle, but also expressed human dystrophin and myosin heavy chain more efficaciously than their parent heterogeneous stem cell populations. Strikingly, clonal progenies yielded, 9 times more human myosin heavy chain mRNA in regenerating muscles than those infused with their parent, heterogeneous stem cells. The number of human dystrophin positive cells in regenerating muscles infused with clonal progenies was more than, 3 times greater than muscles infused with heterogeneous stem cells from which clonal progenies were derived. These findings suggest the therapeutic potential of ectopic myogenic clones in muscle regeneration.	[Yang, Rujing; Chen, Mo; Lee, Chang Hun; Yoon, Richard; Lal, Shan; Mao, Jeremy J.] Columbia Univ, Med Ctr, Dept Growth & Dev, TERML, New York, NY 10027 USA; [Lee, Chang Hun; Mao, Jeremy J.] Columbia Univ, Dept Biomed Engn, New York, NY USA	Columbia University; Columbia University	Yang, RJ (corresponding author), Columbia Univ, Med Ctr, Dept Growth & Dev, TERML, New York, NY 10027 USA.	jmao@columbia.edu			NIH [R01DE018248]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018248] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work is supported by NIH grant R01DE018248. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blau HM, 2008, NEW ENGL J MED, V359, P1403, DOI 10.1056/NEJMcibr0805708; Chan J, 2006, STEM CELLS, V24, P1879, DOI 10.1634/stemcells.2005-0564; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Gang EJ, 2008, EXP CELL RES, V314, P1721, DOI 10.1016/j.yexcr.2008.02.016; Goudenege S, 2009, MOL THER, V17, P1064, DOI 10.1038/mt.2009.67; Gutierrez J, 2010, MOL CELL BIOL, V30, P1634, DOI 10.1128/MCB.01164-09; Huard J., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P337; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Rafii S, 2002, SEMIN CELL DEV BIOL, V13, P61, DOI 10.1006/scdb.2001.0285; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wilschut KJ, 2008, J CELL BIOCHEM, V105, P1228, DOI 10.1002/jcb.21921	22	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13547	10.1371/journal.pone.0013547	http://dx.doi.org/10.1371/journal.pone.0013547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975999	Green Published, gold, Green Submitted			2022-12-25	WOS:000283216400030
J	Agrawal, S; Gupta, S; Agrawal, A				Agrawal, Sudhanshu; Gupta, Sudhir; Agrawal, Anshu			Human Dendritic Cells Activated via Dectin-1 Are Efficient at Priming Th17, Cytotoxic CD8 T and B Cell Responses	PLOS ONE			English	Article							PATHOGEN CANDIDA-ALBICANS; INNATE IMMUNE-SYSTEM; BETA-GLUCAN; NLRP3 INFLAMMASOME; HELPER-CELLS; RECOGNITION; RECEPTOR; INDUCTION; INTERLEUKIN-1-BETA; DIFFERENTIATION	Background: Dendritic cells capture antigens through PRRs and modulate adaptive immune responses. The type of adaptive immune T cell response generated is dependent upon the type of PRR activated by the microbes. Dectin-1 is a C-type lectin receptor present on dendritic cells. Methodology/Principal Findings: Here we show that selective dectin-1 agonist Curdlan can activate human DCs and induce the secretion of large amounts of IL-23, IL-1 beta, IL-6 and low levels of IL-12p70 as determined by ELISA. The Curdlan-stimulated DCs are efficient at priming naive CD4 cells to differentiate into Th17 and Th1 cells. Furthermore, these CD4 T cells induce differentiation of B cells to secrete IgG and IgA. In addition, Curdlan-stimulated DCs promote the expansion and differentiation of Granzyme and perforin expressing cytotoxic T lymphocyte that display high cytolytic activity against target tumor cells in vitro. Conclusions/Significance: These data demonstrate that DCs stimulated through Dectin-1 can generate efficient Th, CTL and B cell responses and can therefore be used as effective mucosal and systemic adjuvants in humans.	[Agrawal, Sudhanshu; Gupta, Sudhir; Agrawal, Anshu] Univ Calif Irvine, Dept Med, Div Basic & Clin Immunol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Agrawal, S (corresponding author), Univ Calif Irvine, Dept Med, Div Basic & Clin Immunol, Irvine, CA 92717 USA.	aagrawal@uci.edu	Agrawal, Anshu/AAU-6341-2021		Ellison Medical Foundation	Ellison Medical Foundation(Lawrence Ellison Foundation)	This study is supported by a New Scholar grant from the Ellison Medical Foundation (www.ellisonfoundation.org.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Agrawal A, 2007, J IMMUNOL, V178, P6912, DOI 10.4049/jimmunol.178.11.6912; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Baran J, 2007, FOLIA HISTOCHEM CYTO, V45, P107; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; DEKONING HD, 2010, J INVEST DERMAT 0715; Dhodapkar KM, 2008, BLOOD, V112, P2878, DOI 10.1182/blood-2008-03-143222; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Harnack U, 2009, INT IMMUNOPHARMACOL, V9, P1298, DOI 10.1016/j.intimp.2009.07.013; Higashi Takehiro, 2010, Allergology International, V59, P161, DOI 10.2332/allergolint.09-OA-0103; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jotwani R, 2003, EUR J IMMUNOL, V33, P2980, DOI 10.1002/eji.200324392; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; MORIKAWA K, 1985, CANCER RES, V45, P1496; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Osorio F, 2008, EUR J IMMUNOL, V38, P3274, DOI 10.1002/eji.200838950; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Ragupathi G, 2008, VACCINE, V26, P4860, DOI 10.1016/j.vaccine.2008.06.098; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; SUZUKI I, 1989, INT J IMMUNOPHARMACO, V11, P761, DOI 10.1016/0192-0561(89)90130-6; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; Weitberg AB, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-40; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	48	58	59	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13418	10.1371/journal.pone.0013418	http://dx.doi.org/10.1371/journal.pone.0013418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976143	Green Submitted, Green Published, gold			2022-12-25	WOS:000283045300011
J	Choi, H; Schmidbauer, N; Sundell, J; Hasselgren, M; Spengler, J; Bornehag, CG				Choi, Hyunok; Schmidbauer, Norbert; Sundell, Jan; Hasselgren, Mikael; Spengler, John; Bornehag, Carl-Gustaf			Common Household Chemicals and the Allergy Risks in Pre-School Age Children	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; GLYCOL MONOMETHYL ETHER; WATER-BASED PAINTS; BUILDING CHARACTERISTICS; SURFACE MATERIALS; AIRWAY SYMPTOMS; YOUNG-CHILDREN; LUNG-FUNCTION; EXPOSURE; ASTHMA	Background: The risk of indoor exposure to volatile organic compounds (VOCs) on allergic airway diseases in children remains unknown. Objective: We examined the residential concentrations of VOCs, emitted from building materials, paints, furniture, and other lifestyle practices and the risks of multiple allergic diseases as well as the IgE-sensitization in pre-school age children in Sweden. Methods: In a case-control investigation (198 case children with asthma and allergy and 202 healthy controls), air samples were collected in the room where the child slept. The air samples were analyzed for the levels of eight classes of VOCs. Results: A natural-log unit of summed propylene glycol and glycol ethers (PGEs) in bedroom air (equal to interquartile range, or 3.43 -15.65 mu g/m(3)) was associated with 1.5-fold greater likelihood of being a case (95% CI, 1.1 - 2.1), 1.5-fold greater likelihood of asthma (95% CI, 1.0 - 2.3), 2.8-fold greater likelihood of rhinitis (95% CI, 1.6 - 4.7), and 1.6-fold greater likelihood of eczema (95% CI, 1.1 - 2.3), accounting for gender, secondhand smoke, allergies in both parents, wet cleaning with chemical agents, construction period of the building, limonene, cat and dog allergens, butyl benzyl phthalate (BBzP), and di(2-ethylhexyl) phthalate (DEHP). When the analysis was restricted to the cases, the same unit concentration was associated with 1.8-fold greater likelihood of IgE-sensitization (95% CI, 1.1 - 2.8) compared to the non-IgE sensitized cases. No similar associations were found for the other classes of VOCs. Conclusion: We propose a novel hypothesis that PGEs in indoor air exacerbate and/or induce the multiple allergic symptoms, asthma, rhinitis and eczema, as well as IgE sensitization respectively.	[Choi, Hyunok; Spengler, John] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Schmidbauer, Norbert] Norwegian Inst Air Res, Kjeller, Norway; [Sundell, Jan] Tsinghua Univ, Sch Architecture, Dept Bldg Sci, Beijing 100084, Peoples R China; [Hasselgren, Mikael] Cty Council Varmland, Primary Care Res Unit, Karlstad, Sweden; [Bornehag, Carl-Gustaf] Karlstad Univ, Karlstad, Sweden; [Bornehag, Carl-Gustaf] SP Tech Res Inst Sweden, Boras, Sweden	Harvard University; Harvard T.H. Chan School of Public Health; Norwegian Institute for Air Research; Tsinghua University; Karlstad University; SP Technical Research Institute of Sweden	Choi, H (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	carl-gustaf.bornehag@kau.se	Sundell, Jan H/B-2857-2012	Bornehag, Carl-Gustaf/0000-0003-0417-1686	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Swedish Asthma and Allergy Association's Research Foundation; Swedish Foundation for Health Care Sciences and Allergy Research; Norwegian Research Council; U.S. National Research Service [T32 ES 07069]; County Council of Varmland, Sweden; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007069] Funding Source: NIH RePORTER	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish Asthma and Allergy Association's Research Foundation; Swedish Foundation for Health Care Sciences and Allergy Research; Norwegian Research Council(Research Council of NorwayEuropean Commission); U.S. National Research Service; County Council of Varmland, Sweden; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study has been supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), Swedish Asthma and Allergy Association's Research Foundation, the Swedish Foundation for Health Care Sciences and Allergy Research, Norwegian Research Council, the U.S. National Research Service Award (T32 ES 07069), and County Council of Varmland, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYER CW, 1988, J CHROMATOGR SCI, V26, P168, DOI 10.1093/chromsci/26.4.168; Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x; Bornehag CG, 2006, SCAND J PUBLIC HEALT, V34, P534, DOI 10.1080/14034940600607467; Bornehag CG, 2005, INDOOR AIR, V15, P48, DOI 10.1111/j.1600-0668.2005.00306.x; Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Brieger J, 2008, TOXICOL LETT, V177, P138, DOI 10.1016/j.toxlet.2008.01.007; Chalubinski M, 2006, ALLERGY, V61, P1326, DOI 10.1111/j.1398-9995.2006.01135.x; Engman LH, 2007, SCAND J PUBLIC HEALT, V35, P125, DOI 10.1080/14034940600975658; Ernstgard L, 2007, J OCCUP ENVIRON MED, V49, P880, DOI 10.1097/JOM.0b013e3181161ced; HEDEROS CA, 2007, COMP CLIN DIAGNOSED, P135; Helmig D, 1996, J CHROMATOGR A, V732, P414, DOI 10.1016/0021-9673(95)01376-8; Henderson J, 2008, EUR RESPIR J, V31, P547, DOI 10.1183/09031936.00086807; Jaakkola JJK, 1999, AM J PUBLIC HEALTH, V89, P188, DOI 10.2105/AJPH.89.2.188; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P560, DOI 10.2105/AJPH.94.4.560; Jurvelin J, 2001, J ENVIRON MONITOR, V3, P159, DOI 10.1039/b007600g; Kleinbaum D. G., 2002, LOGISTIC REGRESSION; Kleno JG, 2002, ENVIRON SCI TECHNOL, V36, P4121, DOI 10.1021/es025680f; Korinth G, 2003, CONTACT DERMATITIS, V49, P248, DOI 10.1111/j.0105-1873.2003.0242.x; Korinth G, 2007, TOXICOL LETT, V170, P97, DOI 10.1016/j.toxlet.2007.01.013; Kuntasal OO, 2005, J CHROMATOGR A, V1099, P43, DOI 10.1016/j.chroma.2005.08.093; Lemazurier E, 2005, TOXICOL IND HEALTH, V21, P33, DOI 10.1191/0748233705th213oa; Mendell MJ, 2007, INDOOR AIR, V17, P259, DOI 10.1111/j.1600-0668.2007.00478.x; MILLER RR, 1984, TOXICOL APPL PHARM, V75, P521, DOI 10.1016/0041-008X(84)90188-1; Nielsen GD, 2007, INDOOR AIR, V17, P236, DOI 10.1111/j.1600-0668.2006.00468.x; Patel SP, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-57; Pearce N, 2006, INT J TUBERC LUNG D, V10, P125; Rumchev K, 2004, THORAX, V59, P746, DOI 10.1136/thx.2003.013680; Schenker MB, 1996, TUBERCLE LUNG DIS, V77, P4, DOI 10.1016/S0962-8479(96)90069-6; STEWART RD, 1970, ARCH ENVIRON HEALTH, V20, P218, DOI 10.1080/00039896.1970.10665577; Uhde E., 2009, Organic indoor air pollutants: occurrence, measurement, evaluation, P3; Weschler CJ, 2009, ATMOS ENVIRON, V43, P153, DOI 10.1016/j.atmosenv.2008.09.044; Weschler CJ, 2008, ATMOS ENVIRON, V42, P9018, DOI 10.1016/j.atmosenv.2008.09.052; Wieslander G, 2007, INDOOR AIR, V17, P19, DOI 10.1111/j.1600-0668.2006.00441.x; Wieslander G, 1997, INT ARCH OCC ENV HEA, V69, P115; Wieslander G, 1997, ANN OCCUP HYG, V41, P155, DOI 10.1016/S0003-4878(96)00039-7; WIESLANDER G, 1994, INT ARCH OCC ENV HEA, V66, P261, DOI 10.1007/BF00454365; Wieslander G, 2001, OCCUP ENVIRON MED, V58, P649, DOI 10.1136/oem.58.10.649; Wolkoff P, 1998, SCI TOTAL ENVIRON, V215, P135, DOI 10.1016/S0048-9697(98)00110-7; Wu CH, 2004, CHEMOSPHERE, V56, P71, DOI 10.1016/j.chemosphere.2004.02.003	40	108	117	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13423	10.1371/journal.pone.0013423	http://dx.doi.org/10.1371/journal.pone.0013423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976153	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000283045300012
J	Weingartner, O; Pinsdorf, T; Rogacev, KS; Blomer, L; Grenner, Y; Graber, S; Ulrich, C; Girndt, M; Bohm, M; Fliser, D; Laufs, U; Lutjohann, D; Heine, GH				Weingaertner, Oliver; Pinsdorf, Tobias; Rogacev, Kyrill S.; Bloemer, Lutz; Grenner, Yvonne; Graeber, Stefan; Ulrich, Christof; Girndt, Matthias; Boehm, Michael; Fliser, Danilo; Laufs, Ulrich; Luetjohann, Dieter; Heine, Gunnar H.			The Relationships of Markers of Cholesterol Homeostasis with Carotid Intima-Media Thickness	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SERUM PLANT STEROLS; ARTERY-DISEASE; RISK-FACTOR; NONCHOLESTEROL STEROLS; DIETARY-CHOLESTEROL; CARDIOVASCULAR RISK; ABSORPTION; ATHEROSCLEROSIS; HYPERCHOLESTEROLEMIA	Background: The relationship of cholesterol homeostasis and carotid intima-media thickness (cIMT) is unknown. To address this, we assessed markers of cholesterol homeostasis (serum plant sterols and cholesterol precursor concentrations as surrogate measures of cholesterol absorption and synthesis, respectively) and cIMT in a middle-aged, statin-naive population. Methods: In this prospective study of primary prevention cIMT was measured by ultrasound in 583 hospital employees aged 25-60 years without prevalent cardiovascular disease or lipid-modifying medication. The serum concentrations of plant sterols (as markers of cholesterol absorption) were measured by gas-liquid chromatography. Lathosterol serum concentrations were quantitated to assess hepatic cholesterol synthesis. Results: cIMT correlated positively with serum cholesterol (r = 0.22, P<0.0005) and lathosterol-to-cholesterol (r = 0.18, P<0.001). In contrast, plant sterols, as markers of cholesterol absorption, showed a weak negative correlation to cIMT measurements (r = 20.18; P<0.001 for campesterol-to-cholesterol). Stratifying subjects by serum sterol levels, we found that cIMT increased continuously over quintiles of serum cholesterol (P<0.0005) and was positively associated to serum lathosterol-to-cholesterol levels (P = 0.007), on the other hand, plant sterol levels showed a weak negative association to cIMT (P<0.001 for campesterol-to-cholesterol). Conclusions: In this population without prevalent cardiovascular diseases or lipid-modifying medication, markers of increased endogenous cholesterol synthesis correlated positively with cIMT, while markers of cholesterol absorption showed a weakly negative correlation. These data suggest that not only total serum cholesterol levels but also differences in cholesterol homeostasis are associated with cIMT.	[Weingaertner, Oliver; Boehm, Michael; Laufs, Ulrich] Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, Homburg, Germany; [Pinsdorf, Tobias; Luetjohann, Dieter] Univ Klinikum Bonn, Inst Klin Chem & Klin Pharmakol, Bonn, Germany; [Graeber, Stefan] Univ Klinikum Saarlandes, Inst Med Biometrie Epidemiol & Informat, Homburg, Germany; [Grenner, Yvonne] Univ Klinikum Saarlandes, Klin Innere Med 2, Homburg, Germany; [Rogacev, Kyrill S.; Bloemer, Lutz; Ulrich, Christof; Girndt, Matthias; Fliser, Danilo; Heine, Gunnar H.] Univ Klinikum Saarlandes, Klin Innere Med Nephrol & Hochdruckkrankheiten 4, Homburg, Germany	Universitatsklinikum des Saarlandes; University of Bonn; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Weingartner, O (corresponding author), Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, Homburg, Germany.	oweingartner@aol.com	Böhm, Michael/C-3638-2011; Girndt, Matthias/M-1436-2019	Girndt, Matthias/0000-0003-2823-0847; Weingartner, Oliver/0000-0002-0236-206X; Heine, Gunnar/0000-0001-8320-5260	University of the Saarland; Merck Sharp Dohme; Raisio Nutrition Ltd.	University of the Saarland; Merck Sharp Dohme(Merck & Company); Raisio Nutrition Ltd.	University of the Saarland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; O.W. has received minor unrestricted research grants from Merck Sharp & Dohme and Raisio Nutrition Ltd. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Assmann G, 2006, NUTR METAB CARDIOVAS, V16, P13, DOI 10.1016/j.numecd.2005.04.001; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BHATTACHARYYA AK, 1974, J CLIN INVEST, V53, P1033, DOI 10.1172/JCI107640; Center for Disease Control and Prevention, 2012, PREV INS PHYS ACT; Clarenbach JJ, 2006, J LIPID RES, V47, P2820, DOI 10.1194/jlr.P600009-JLR200; del Sol AI, 2002, EUR HEART J, V23, P934, DOI 10.1053/euhj.2001.2965; Fassbender K, 2008, ATHEROSCLEROSIS, V196, P283, DOI 10.1016/j.atherosclerosis.2006.10.032; Filippatos TD, 2009, CURR PHARM DESIGN, V15, P490, DOI 10.2174/138161209787315738; Fleg JL, 2008, J AM COLL CARDIOL, V52, P2198, DOI 10.1016/j.jacc.2008.10.031; GEROULAKOS G, 1994, EUR HEART J, V15, P781, DOI 10.1093/oxfordjournals.eurheartj.a060585; GLUECK CJ, 1991, METABOLISM, V40, P842, DOI 10.1016/0026-0495(91)90013-M; Insull W, 2006, SOUTH MED J, V99, P257, DOI 10.1097/01.smj.0000208120.73327.db; Jakulj L, 2010, J LIPID RES, V51, P755, DOI 10.1194/jlr.M001487; Kalantar-Zadeh K, 2007, CURR OPIN CLIN NUTR, V10, P433, DOI 10.1097/MCO.0b013e3281a30594; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kidambi S, 2008, J CLIN PATHOL, V61, P588, DOI 10.1136/jcp.2007.049775; Knoflach M, 2003, CIRCULATION, V108, P1064, DOI 10.1161/01.CIR.0000085996.95532.FF; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Matthan NR, 2009, J LIPID RES, V50, P1927, DOI 10.1194/jlr.P900039-JLR200; MIETTINEN T A, 1970, Annals of Clinical Research, V2, P300; Miettinen TA, 2005, J AM COLL CARDIOL, V45, P1794, DOI 10.1016/j.jacc.2005.02.063; MIETTINEN TA, 1969, LIFE SCI PT 1 PHYSI, V8, P713, DOI 10.1016/0024-3205(69)90007-1; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Patel MD, 2006, ATHEROSCLEROSIS, V186, P12, DOI 10.1016/j.atherosclerosis.2005.10.026; PEDERSEN TR, 1994, LANCET, V344, P1383; Pinedo S, 2007, J LIPID RES, V48, P139, DOI 10.1194/jlr.M600371-JLR200; Rajaratnam RA, 2000, J AM COLL CARDIOL, V35, P1185, DOI 10.1016/S0735-1097(00)00527-1; Rogacev KS, 2010, EUR HEART J, V31, P369, DOI 10.1093/eurheartj/ehp308; Rosvall M, 2005, ATHEROSCLEROSIS, V179, P325, DOI 10.1016/j.atherosclerosis.2004.10.015; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Silbernagel G, 2009, J LIPID RES, V50, P334, DOI 10.1194/jlr.P800013-JLR200; Simonen P, 2000, AM J CLIN NUTR, V72, P82; Strandberg TE, 2006, J AM COLL CARDIOL, V48, P708, DOI 10.1016/j.jacc.2006.04.081; Strandberg TE, 2010, ATHEROSCLEROSIS, V210, P282, DOI 10.1016/j.atherosclerosis.2009.11.007; Sudhop T, 2002, METABOLISM, V51, P1519, DOI 10.1053/meta.2002.36298; Thelen KM, 2006, J PHARMACOL EXP THER, V316, P1146, DOI 10.1124/jpet.105.094136; TILVIS RS, 1986, AM J CLIN NUTR, V43, P92, DOI 10.1093/ajcn/43.1.92; Wald NJ, 1995, ATHEROSCLEROSIS, V118, pS1, DOI 10.1016/0021-9150(95)90067-5; Weingartner O, 2008, J AM COLL CARDIOL, V51, P1553, DOI 10.1016/j.jacc.2007.09.074; Weingartner O, 2009, EUR HEART J, V30, P404, DOI 10.1093/eurheartj/ehn580; Weingartner O, 2009, CORONARY ARTERY DIS, V20, P376, DOI 10.1097/MCA.0b013e32832fa947	43	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13467	10.1371/journal.pone.0013467	http://dx.doi.org/10.1371/journal.pone.0013467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976107	gold, Green Published, Green Submitted			2022-12-25	WOS:000283045300035
J	Younger, J; Aron, A; Parke, S; Chatterjee, N; Mackey, S				Younger, Jarred; Aron, Arthur; Parke, Sara; Chatterjee, Neil; Mackey, Sean			Viewing Pictures of a Romantic Partner Reduces Experimental Pain: Involvement of Neural Reward Systems	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; ORBITOFRONTAL CORTEX; DECISION-MAKING; CINGULATE CORTEX; BRAIN MECHANISM; LOVE; ADDICTION; ANALGESIA; NUCLEUS; FMRI	The early stages of a new romantic relationship are characterized by intense feelings of euphoria, well-being, and preoccupation with the romantic partner. Neuroimaging research has linked those feelings to activation of reward systems in the human brain. The results of those studies may be relevant to pain management in humans, as basic animal research has shown that pharmacologic activation of reward systems can substantially reduce pain. Indeed, viewing pictures of a romantic partner was recently demonstrated to reduce experimental thermal pain. We hypothesized that pain relief evoked by viewing pictures of a romantic partner would be associated with neural activations in reward-processing centers. In this functional magnetic resonance imaging (fMRI) study, we examined fifteen individuals in the first nine months of a new, romantic relationship. Participants completed three tasks under periods of moderate and high thermal pain: 1) viewing pictures of their romantic partner, 2) viewing pictures of an equally attractive and familiar acquaintance, and 3) a word-association distraction task previously demonstrated to reduce pain. The partner and distraction tasks both significantly reduced self-reported pain, although only the partner task was associated with activation of reward systems. Greater analgesia while viewing pictures of a romantic partner was associated with increased activity in several reward-processing regions, including the caudate head, nucleus accumbens, lateral orbitofrontal cortex, amygdala, and dorsolateral prefrontal cortex - regions not associated with distraction-induced analgesia. The results suggest that the activation of neural reward systems via non-pharmacologic means can reduce the experience of pain.	[Younger, Jarred; Chatterjee, Neil; Mackey, Sean] Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA; [Aron, Arthur] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Parke, Sara] Stanford Univ, Dept Human Biol, Stanford, CA 94305 USA	Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stanford University	Younger, J (corresponding author), Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA.	smackey@pain.stanford.edu	Mackey, Sean/AAF-3314-2019	Mackey, Sean/0000-0001-7744-5348	Arthritis Foundation; Stanford University; National Institutes of Health NINDS [NS053961]; John and Dodie Rosekranz Pain Research Endowment; Chris Redlich Pain Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053961] Funding Source: NIH RePORTER	Arthritis Foundation; Stanford University(Stanford University); National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); John and Dodie Rosekranz Pain Research Endowment; Chris Redlich Pain Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Younger was supported by a postdoctoral fellowship from the Arthritis Foundation. Ms. Parke was supported by a HB-REX (Human Biology Research Exploration) grant from Stanford University. Dr. Mackey was supported by National Institutes of Health NINDS NS053961, the John and Dodie Rosekranz Pain Research Endowment and the Chris Redlich Pain Research Fund. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Altier N, 1998, J PHARMACOL EXP THER, V285, P208; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; Cason AM, 2010, PHYSIOL BEHAV, V100, P419, DOI 10.1016/j.physbeh.2010.03.009; CHEN GB, 1982, ACUPUNCTURE ELECTRO, V7, P255, DOI 10.3727/036012982816952053; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Davis KD, 1997, J NEUROPHYSIOL, V77, P3370, DOI 10.1152/jn.1997.77.6.3370; DICKINSON A, 1977, PSYCHOL BULL, V84, P690, DOI 10.1037/0033-2909.84.4.690; Diekhof EK, 2008, BRAIN RES REV, V59, P164, DOI 10.1016/j.brainresrev.2008.07.004; Ferry AT, 2000, J COMP NEUROL, V425, P447, DOI 10.1002/1096-9861(20000925)425:3<447::AID-CNE9>3.0.CO;2-V; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Fisher H, 2005, J COMP NEUROL, V493, P58, DOI 10.1002/cne.20772; Fisher HE, 1998, HUM NATURE-INT BIOS, V9, P23, DOI 10.1007/s12110-998-1010-5; Fisher HE, 2010, J NEUROPHYSIOL, V104, P51, DOI 10.1152/jn.00784.2009; Frankenstein UN, 2001, NEUROIMAGE, V14, P827, DOI 10.1006/nimg.2001.0883; FRANKLIN KBJ, 1989, NEUROSCI BIOBEHAV R, V13, P149, DOI 10.1016/S0149-7634(89)80024-7; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; HATFIELD E, 1986, J ADOLESCENCE, V9, P383, DOI 10.1016/S0140-1971(86)80043-4; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kim DH, 2002, MAGNET RESON MED, V48, P715, DOI 10.1002/mrm.10267; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; LEMAGNEN J, 1980, PHARMACOL BIOCHEM BE, V12, P729, DOI 10.1016/0091-3057(80)90157-4; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lu HC, 2010, PAIN, V148, P75, DOI 10.1016/j.pain.2009.10.012; Mashek D., 2000, REPRESENTATIVE RES S, V24, P48; Master SL, 2009, PSYCHOL SCI, V20, P1316, DOI 10.1111/j.1467-9280.2009.02444.x; Mesulam MM, 2001, NEUROIMAGE, V13, P1065, DOI 10.1006/nimg.2001.0768; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Ortigue S, 2007, J COGNITIVE NEUROSCI, V19, P1218, DOI 10.1162/jocn.2007.19.7.1218; Qiu YH, 2009, NEUROSCI BULL, V25, P277, DOI 10.1007/s12264-009-0907-2; REYNAUD M, 2010, AM J DRUG ALCOHOL AB; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SELEMON LD, 1985, J NEUROSCI, V5, P776; Seminowicz DA, 2004, PAIN, V112, P48, DOI 10.1016/j.pain.2004.07.027; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Tanaka SC, 2006, NEURAL NETWORKS, V19, P1233, DOI 10.1016/j.neunet.2006.05.039; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Taylor BK, 2003, BRAIN RES, V987, P135, DOI 10.1016/S0006-8993(03)03318-3; Tran TD, 2010, PAIN, V150, P93, DOI 10.1016/j.pain.2010.04.001; Wood PB, 2006, PAIN, V120, P230, DOI 10.1016/j.pain.2005.12.014; XU X, 2010, HUMAN BRAIN MAPPING; Zubieta JK, 2009, ANN NY ACAD SCI, V1156, P198, DOI 10.1111/j.1749-6632.2009.04424.x; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	58	164	169	14	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13309	10.1371/journal.pone.0013309	http://dx.doi.org/10.1371/journal.pone.0013309			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663FZ	20967200	Green Published, gold, Green Submitted			2022-12-25	WOS:000282869800015
J	Shefer, G; Rauner, G; Yablonka-Reuveni, Z; Benayahu, D				Shefer, Gabi; Rauner, Gat; Yablonka-Reuveni, Zipora; Benayahu, Dafna			Reduced Satellite Cell Numbers and Myogenic Capacity in Aging Can Be Alleviated by Endurance Exercise	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; STEM-CELL; TESTOSTERONE CONCENTRATION; ESTROGEN METABOLISM; PHYSICAL-ACTIVITY; OLDER MEN; AGE; HEALTHY; YOUNG; PROLIFERATION	Background: Muscle regeneration depends on satellite cells, myogenic stem cells that reside on the myofiber surface. Reduced numbers and/or decreased myogenic aptitude of these cells may impede proper maintenance and contribute to the age-associated decline in muscle mass and repair capacity. Endurance exercise was shown to improve muscle performance; however, the direct impact on satellite cells in aging was not yet thoroughly determined. Here, we focused on characterizing the effect of moderate-intensity endurance exercise on satellite cell, as possible means to attenuate adverse effects of aging. Young and old rats of both genders underwent 13 weeks of treadmill-running or remained sedentary. Methodology: Gastrocnemius muscles were assessed for the effect of age, gender and exercise on satellite-cell numbers and myogenic capacity. Satellite cells were identified in freshly isolated myofibers based on Pax7 immunostaining (i.e., ex-vivo). The capacity of individual myofiber-associated cells to produce myogenic progeny was determined in clonal assays (in-vitro). We show an age-associated decrease in satellite-cell numbers and in the percent of myogenic clones in old sedentary rats. Upon exercise, there was an increase in myofibers that contain higher numbers of satellite cells in both young and old rats, and an increase in the percent of myogenic clones derived from old rats. Changes at the satellite cell level in old rats were accompanied with positive effects on the lean-to-fat Gast muscle composition and on spontaneous locomotion levels. The significance of these data is that they suggest that the endurance exercise-mediated boost in both satellite numbers and myogenic properties may improve myofiber maintenance in aging.	[Shefer, Gabi; Rauner, Gat; Benayahu, Dafna] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Shefer, Gabi; Yablonka-Reuveni, Zipora] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Washington; University of Washington Seattle	Shefer, G (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel.	gabise@post.tau.ac.il			US-Israel Binational Science Foundation (BSF) [2005132]; Ministry of Health [3-00000-4398]; EU [214706]; National Institute on Aging [5RO1 AG021566]; NATIONAL INSTITUTE ON AGING [R01AG021566] Funding Source: NIH RePORTER	US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Ministry of Health; EU(European Commission); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the US-Israel Binational Science Foundation (BSF, grant number 2005132) to DB and ZYR, from the Ministry of Health (grant number3-00000-4398) and EU-FP7, Excell project 214706 to DB, and by a grant from the National Institute on Aging (5RO1 AG021566) to ZYR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Atkinson C, 2004, CANCER EPIDEM BIOMAR, V13, P868; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bigot A, 2008, BIOL CELL, V100, P189, DOI 10.1042/BC20070085; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Burger HG, 2002, RECENT PROG HORM RES, V57, P257, DOI 10.1210/rp.57.1.257; Burniston JG, 2008, BBA-PROTEINS PROTEOM, V1784, P1077, DOI 10.1016/j.bbapap.2008.04.007; Campbell KL, 2007, CANCER EPIDEM BIOMAR, V16, P731, DOI 10.1158/1055-9965.EPI-06-0784; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Chen Y, 2005, J ENDOCRINOL, V186, P21, DOI 10.1677/joe.1.05976; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cotman CW, 2007, ALZHEIMERS DEMENT, V3, pS30, DOI 10.1016/j.jalz.2007.01.013; Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903; Deschenes MR, 2010, EXP GERONTOL, V45, P389, DOI 10.1016/j.exger.2010.03.007; Enns DL, 2008, ACTA PHYSIOL, V194, P81, DOI 10.1111/j.1748-1716.2008.01861.x; Enns DL, 2008, J APPL PHYSIOL, V104, P347, DOI 10.1152/japplphysiol.00128.2007; Fahrner CL, 1998, INT J SPORTS MED, V19, P12, DOI 10.1055/s-2007-971872; FISER WM, 2010, J GERONTOL A; FRIEDMAN WA, 1992, PHYSIOL BEHAV, V52, P97, DOI 10.1016/0031-9384(92)90438-8; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Grandys M, 2009, INT J SPORTS MED, V30, P489, DOI 10.1055/s-0029-1202340; Grounds MD, 2002, J HISTOCHEM CYTOCHEM, V50, P589, DOI 10.1177/002215540205000501; Haaland DA, 2008, CLIN J SPORT MED, V18, P539, DOI 10.1097/JSM.0b013e3181865eec; Hakkinen K, 1996, J GERONTOL A-BIOL, V51, pB21, DOI 10.1093/gerona/51A.1.B21; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayasaki Hana, 2001, Cellular and Molecular Biology Online Papers, V47, pOL135; Hikida RS, 1998, BASIC APPL MYOL, V8, P419; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kadi F, 2008, BRIT J PHARMACOL, V154, P522, DOI 10.1038/bjp.2008.118; Kadi F, 2004, MUSCLE NERVE, V29, P120, DOI 10.1002/mus.10510; Kargotich S, 2007, INT J SPORTS MED, V28, P211, DOI 10.1055/s-2006-924218; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Kirchengast S, 2009, ANTHROPOL ANZ, V67, P139, DOI 10.1127/0003-5548/2009/0018; KUIPERS H, 1989, INT J SPORTS MED, V10, pS156, DOI 10.1055/s-2007-1024965; Leifke E, 2000, CLIN ENDOCRINOL, V53, P689, DOI 10.1046/j.1365-2265.2000.01159.x; LEXELL J, 1991, ACTA NEUROPATHOL, V81, P377, DOI 10.1007/BF00293457; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Nair KS, 2005, AM J CLIN NUTR, V81, P953; Nakano J, 2009, EXP PHYSIOL, V94, P1005, DOI 10.1113/expphysiol.2009.047738; Nnodim JO, 2000, MECH AGEING DEV, V112, P99, DOI 10.1016/S0047-6374(99)00076-7; Olsen DB, 2005, NEUROLOGY, V64, P1064, DOI 10.1212/01.WNL.0000150584.45055.27; Orngreen MC, 2005, ANN NEUROL, V57, P754, DOI 10.1002/ana.20460; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Paturi S, 2010, MECH AGEING DEV, V131, P202, DOI 10.1016/j.mad.2010.01.008; Ravaglia G, 2001, MECH AGEING DEV, V122, P191, DOI 10.1016/S0047-6374(00)00234-7; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; Rossi CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008523; Roth SM, 2000, ANAT REC, V260, P351, DOI 10.1002/1097-0185(200012)260:4<350::AID-AR30>3.0.CO;2-6; Roubenoff R, 2003, J GERONTOL A-BIOL, V58, P1012; Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sajko S, 2004, J HISTOCHEM CYTOCHEM, V52, P179, DOI 10.1177/002215540405200205; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Shefer G, 2008, J CELL PHYSIOL, V215, P265, DOI 10.1002/jcp.21306; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Shefer G, 2007, CRIT REV EUKAR GENE, V17, P13, DOI 10.1615/CritRevEukarGeneExpr.v17.i1.20; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; Sinha-Hikim I, 2004, J CLIN ENDOCR METAB, V89, P5245, DOI 10.1210/jc.2004-0084; Sinha-Hikim I, 2003, AM J PHYSIOL-ENDOC M, V285, pE197, DOI 10.1152/ajpendo.00370.2002; Sinha-Hikim I, 2006, J CLIN ENDOCR METAB, V91, P3024, DOI 10.1210/jc.2006-0357; SJODIN B, 1992, EUR J APPL PHYSIOL, V65, P150, DOI 10.1007/BF00705073; Smythe GM, 2008, EXP GERONTOL, V43, P550, DOI 10.1016/j.exger.2008.02.005; SNOW MH, 1977, CELL TISSUE RES, V185, P399; Sousa N, 2006, GENES BRAIN BEHAV, V5, P5, DOI 10.1111/j.1601-183X.2006.00228.x; Sveen ML, 2008, BRAIN, V131, P2824, DOI 10.1093/brain/awn189; Taylor-Jones JM, 2002, MECH AGEING DEV, V123, P649, DOI 10.1016/S0047-6374(01)00411-0; TEBOUL L, 1995, J BIOL CHEM, V270, P28183, DOI 10.1074/jbc.270.47.28183; Thompson LV, 2009, EXP GERONTOL, V44, P106, DOI 10.1016/j.exger.2008.05.003; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; van Praag H, 2009, TRENDS NEUROSCI, V32, P283, DOI 10.1016/j.tins.2008.12.007; Vertino AM, 2005, MOL BIOL CELL, V16, P2039, DOI 10.1091/mbc.E04-08-0720; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wasserstrom A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001939; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	90	135	144	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13307	10.1371/journal.pone.0013307	http://dx.doi.org/10.1371/journal.pone.0013307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967266	gold, Green Published, Green Submitted			2022-12-25	WOS:000282807300020
J	Larmarange, J; Wade, AS; Diop, AK; Diop, O; Gueye, K; Marra, A; du Lou, AD				Larmarange, Joseph; Wade, Abdoulaye S.; Diop, Abdou K.; Diop, Oulimata; Gueye, Khady; Marra, Adama; du Lou, Annabel Desgrees		ELIHoS Grp	Men Who Have Sex with Men (MSM) and Factors Associated with Not Using a Condom at Last Sexual Intercourse with a Man and with a Woman in Senegal	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; HIV-INFECTION; RISK BEHAVIOR; PREVALENCE; HEALTH; GAY	Background: Men who have sex with other men (MSM) are a vulnerable population in Africa that has been insufficiently explored. Given the high rate of bisexuality among MSM (73% in the past year), it is important to understand their risktaking behaviors regarding both men and women. Methodology/Principal Findings: A socio-behavioral survey was carried out in 2007 among 501 MSM recruited using the snowball sampling method. We explore in this article why a condom was not used during last sexual intercourse with a man and with a woman, taking into account the respondent's characteristics, type of relationship and the context of the sexual act. In the survey, 489 men reported that they had had sexual intercourse at least once with another man during the previous year, and 358 with a man and with a woman. The main risk factors for not using a condom at last sexual intercourse with another man were having sex in a public place (aOR = 6.26 [95% CI: 2.71-14.46]), non-participation in an MSM prevention program (aOR = 3.47 [95% CI: 2.12-5.69]), a 19 years old or younger partner (aOR = 2.6 [95% CI: 1.23-4.53]), being 24 years or younger (aOR = 2.07 [95% CI: 1.20-3.58]) or being 35 years or over (aOR = 3.08 [95% CI: 1.11-8.53]) and being unemployed (aOR = 0.36 [95% CI: 0.10-1.25]). The last sexual intercourse with the respondent's wife was hardly ever protected (2%). With women, the other factors were a 15 years or younger partner (aOR = 6.45 [95% CI: 2.56-16.28]), being educated (primary: aOR = 0.45 [95% CI: 0.21-0.95], secondary or higher: aOR = 0.26 [95% CI: 0.11-0.62]), being a student (aOR = 2.20 [95% CI: 1.07-4.54]) or unemployed (aOR = 3.72 [95% CI: 1.31-10.61]) and having participated in a MSM prevention program (aOR = 0.57 [95% CI: 0.34-0.93]). Conclusion: Having participated in a prevention program specifically targeting MSM constitutes a major prevention factor. However, these programs targeting MSM must address their heterosexual practices and the specific risks involved.	[Larmarange, Joseph; du Lou, Annabel Desgrees] IRD, CEPED Ctr Populat & Dev Paris Descartes INED UMR, Paris, France; [Wade, Abdoulaye S.; Diop, Abdou K.; Diop, Oulimata; Gueye, Khady] Inst Hyg Sociale, Div SIDA IST, Dakar, Senegal; [Marra, Adama] IRD, US009, Dakar, Senegal; Hop Dantec, Virol Lab, Dakar, Senegal; [ELIHoS Grp] Univ Cheikh Anta Diop, Dakar, Senegal	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar	Larmarange, J (corresponding author), IRD, CEPED Ctr Populat & Dev Paris Descartes INED UMR, Paris, France.	joseph.larmarange@ceped.org	Larmarange, Joseph/I-5889-2015	Larmarange, Joseph/0000-0001-7097-700X; Desgrees du Lou, annabel/0000-0002-2223-5316	Agence Nationale de Recherche sur le SIDA [ANRS-12139]	Agence Nationale de Recherche sur le SIDA(ANRSFrench National Research Agency (ANR))	The study was funded by the Agence Nationale de Recherche sur le SIDA (ANRS-12139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; BLOOR MJ, 1992, AIDS CARE, V4, P131, DOI 10.1080/09540129208253084; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burrell E, 2010, SEX HEALTH, V7, P149, DOI 10.1071/SH09090; Caceres CF, 2008, SEX TRANSM INFECT, V84, pI49, DOI 10.1136/sti.2008.030569; CHIN J, 1988, AIDS, V2, pS247, DOI 10.1097/00002030-198800001-00038; Crowder M., 1959, PAGANS POLITICIANS; EKSTRAND ML, 1992, AIDS, V6, P875, DOI 10.1097/00002030-199208000-00017; Enel C., 2009, AUTREPART, V49, P103; Henry E, 2010, SEX TRANSM INFECT, V86, P136, DOI 10.1136/sti.2009.036939; Kajubi P, 2008, AIDS BEHAV, V12, P492, DOI 10.1007/s10461-007-9323-7; LANE T, 2009, AIDS BEHAV, V15, P626, DOI DOI 10.1007/S10461-009-9598-Y]; Lane T, 2008, AIDS BEHAV, V12, pS78, DOI 10.1007/s10461-008-9389-x; Larmarange J, 2009, POPULATION, V64, P723, DOI 10.3917/popu.904.0723; Murray S. O., 1998, BOY WIVES FEMALE HUS; Ndiaye S, 2006, ENQUETE DEMOGRAPHIQU; Niang CI, 2003, CULT HEALTH SEX, V5, P499, DOI 10.1080/1369105031000152715; Ottosson Daniel, 2009, STATE SPONSORED HOMO; SAAVEDRA J, 2008, INT AIDS C MEX 2008; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; SAPPE R, 2003, SIDA RAPPORTS SEXUEL; Schiltz MA, 2000, SOC SCI MED, V50, P1571, DOI 10.1016/S0277-9536(99)00466-9; Teunis N., 1996, INT J SEXUALITY GEND, V1, P153; Teunis N., 2001, AIDS BEHAV, V5, P173, DOI DOI 10.1023/A:1011335129358; van Griensven F, 2007, AIDS, V21, P1361, DOI 10.1097/QAD.0b013e328017f868; Wade AS, 2010, AIDS CARE, V22, P409, DOI 10.1080/09540120903253973; Wade AS, 2005, AIDS, V19, P2133, DOI 10.1097/01.aids.0000194128.97640.07; Weiss E, 2000, SEX RELATIONSHIP THE, V153, P233, DOI DOI 10.1080/14681990050109836; WIGHT D, 1992, AIDS CARE, V4, P11, DOI 10.1080/09540129208251616	33	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13189	10.1371/journal.pone.0013189	http://dx.doi.org/10.1371/journal.pone.0013189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	658RC	20957157	gold, Green Published, Green Submitted			2022-12-25	WOS:000282506100014
J	Zadjali, F; Pike, ACW; Vesterlund, M; Sun, JM; Wu, CG; Li, SSC; Ronnstrand, L; Knapp, S; Bullock, AN; Flores-Morales, A				Zadjali, Fahad; Pike, Ashley C. W.; Vesterlund, Mattias; Sun, Jianmin; Wu, Chenggang; Li, Shawn S. C.; Ronnstrand, Lars; Knapp, Stefan; Bullock, Alex N.; Flores-Morales, Amilcar			Structural Basis for c-KIT Inhibition by the Suppressor of Cytokine Signaling 6 (SOCS6) Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OF-FUNCTION MUTATIONS; COMPLEX REVEALS; KINASE-ACTIVITY; ACTIVATION; BOX; PROTEIN; PHOSPHORYLATION; AUTOINHIBITION; TRANSFORMATION; SPECIFICITY	The c-KIT receptor tyrosine kinase mediates the cellular response to stem cell factor (SCF). Whereas c-KIT activity is important for the proliferation of hematopoietic cells, melanocytes and germ cells, uncontrolled c-KIT activity contributes to the growth of diverse human tumors. Suppressor of cytokine signaling 6 (SOCS6) is a member of the SOCS family of E3 ubiquitin ligases that can interact with c-KIT and suppress c-KIT-dependent pathways. Here, we analyzed the molecular mechanisms that determine SOCS6 substrate recognition. Our results show that the SH2 domain of SOCS6 is essential for its interaction with c-KIT pY568. The 1.45-angstrom crystal structure of SOCS6 SH2 domain bound to the c-KIT substrate peptide (c-KIT residues 564-574) revealed a highly complementary and specific interface giving rise to a high affinity interaction (K-d = 0.3 mu M). Interestingly, the SH2 binding pocket extends to substrate residue position pY + 6 and envelopes the c-KIT phosphopeptide with a large BG loop insertion that contributes significantly to substrate interaction. We demonstrate that SOCS6 has ubiquitin ligase activity toward c-KIT and regulates c-KIT protein turnover in cells. Our data support a role of SOCS6 as a feedback inhibitor of SCF-dependent signaling and provides molecular data to account for target specificity within the SOCS family of ubiquitin ligases.	[Pike, Ashley C. W.; Knapp, Stefan; Bullock, Alex N.] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7DQ, England; [Zadjali, Fahad; Vesterlund, Mattias] Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden; [Zadjali, Fahad] Sultan Qaboos Univ, Coll Med & Hlth Sci, Alkoudh 123, Oman; [Sun, Jianmin; Ronnstrand, Lars] Lund Univ, Skane Univ Hosp, Dept Lab Med, Wallenberg Lab, S-20502 Malmo, Sweden; [Wu, Chenggang; Li, Shawn S. C.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [Wu, Chenggang; Li, Shawn S. C.] Univ Western Ontario, Siebens Drake Med Res Inst, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England; [Flores-Morales, Amilcar] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn, Ctr Prot Res, DK-2200 Copenhagen, Denmark	University of Oxford; Karolinska Institutet; Lund University; Skane University Hospital; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Oxford; Novo Nordisk Foundation; University of Copenhagen	Bullock, AN (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7DQ, England.	alex.bullock@sgc.ox.ac.uk; amilcar.flores@cpr.ku.dk	Knapp, Stefan/AAG-2347-2019; ZADJALI, FAHAD/B-5091-2019; Vesterlund, Mattias/AAX-8014-2021; Sun, Jianmin/AAX-5094-2021	Knapp, Stefan/0000-0001-5995-6494; ZADJALI, FAHAD/0000-0001-5891-4700; Sun, Jianmin/0000-0003-2327-4285; Ronnstrand, Lars/0000-0003-1275-5809; Vesterlund, Mattias/0000-0001-9471-6592	Novo Nordisk Foundation Center for Protein Research; Swedish Research Council; Cancer-fonden; Sultan Qaboos University; Swedish Cancer Society; Swedish Childrens Cancer Society; Gunnar Nilsson Cancer Society; Alfred Osterlund Foundation; Skane University Hospital; Skane University Hospital Cancer Foundation; Canadian Cancer Society; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Novo Nordisk Foundation Center for Protein Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer-fonden(Swedish Cancer Society); Sultan Qaboos University; Swedish Cancer Society(Swedish Cancer Society); Swedish Childrens Cancer Society; Gunnar Nilsson Cancer Society; Alfred Osterlund Foundation; Skane University Hospital; Skane University Hospital Cancer Foundation; Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust)	This work was funded by a grant from the Novo Nordisk Foundation Center for Protein Research, the Swedish Research Council, and Cancer-fonden (to A. F. M.).; Supported by a fellowship from Sultan Qaboos University.; Supported through grants from the Swedish Cancer Society, the Swedish Research Council and the Swedish Childrens Cancer Society, Gunnar Nilsson Cancer Society, Alfred Osterlund Foundation, Skane University Hospital Funds, and Skane University Hospital Cancer Foundation.; Supported through grants from the Canadian Cancer Society.; We thank Pavel Savitsky for cloning, Chitra Bhatia for initial peptide screening, and Frank von Delft, Ewa Pilka, and the staff at the Swiss Light Source for help with diffraction data collection. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; Babon JJ, 2006, MOL CELL, V22, P205, DOI 10.1016/j.molcel.2006.03.024; Bayle J, 2004, J BIOL CHEM, V279, P12249, DOI 10.1074/jbc.M313381200; Bergamin E, 2006, STRUCTURE, V14, P1285, DOI 10.1016/j.str.2006.06.011; Bullock AN, 2007, STRUCTURE, V15, P1493, DOI 10.1016/j.str.2007.09.016; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Choi YB, 2010, J BIOL CHEM, V285, P7271, DOI 10.1074/jbc.M109.073726; Dibb NJ, 2004, NAT REV CANCER, V4, P718, DOI 10.1038/nrc1434; DiNitto JP, 2010, J BIOCHEM, V147, P601, DOI 10.1093/jb/mvq015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frantsve J, 2001, MOL CELL BIOL, V21, P3547, DOI 10.1128/MCB.21.10.3547-3557.2001; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Hwang MN, 2007, BIOCHEM BIOPH RES CO, V360, P333, DOI 10.1016/j.bbrc.2007.06.062; Isozaki K, 2006, CURR GENOMICS, V7, P469, DOI 10.2174/138920206779315755; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Lai R. H., CANC LETT, V288, P75; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Munugalavadla V, 2007, BLOOD, V110, P1612, DOI 10.1182/blood-2006-10-053058; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Ning ZQ, 2001, BLOOD, V97, P3559, DOI 10.1182/blood.V97.11.3559; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Rottapel R, 2002, ONCOGENE, V21, P4351, DOI 10.1038/sj.onc.1205537; Sun JM, 2008, J BIOL CHEM, V283, P27444, DOI 10.1074/jbc.M709703200; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498	41	46	49	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					480	490		10.1074/jbc.M110.173526	http://dx.doi.org/10.1074/jbc.M110.173526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21030588	hybrid, Green Published			2022-12-25	WOS:000285782800051
J	Li, JK; Wu, J; Rundassa, DB; Song, FF; Zheng, AJ; Fang, Y				Li, Jianke; Wu, Jing; Rundassa, Desalegn Begna; Song, Feifei; Zheng, Aijuan; Fang, Yu			Differential Protein Expression in Honeybee (Apis mellifera L.) Larvae: Underlying Caste Differentiation	PLOS ONE			English	Article							GENE-EXPRESSION; BEE; POLYMORPHISM; STORAGE; WORKERS; REPRODUCTION; EVOLUTION; QUEENS; ACTIN	Honeybee (Apis mellifera) exhibits divisions in both morphology and reproduction. The queen is larger in size and fully developed sexually, while the worker bees are smaller in size and nearly infertile. To better understand the specific time and underlying molecular mechanisms of caste differentiation, the proteomic profiles of larvae intended to grow into queen and worker castes were compared at 72 and 120 hours using two dimensional electrophoresis (2-DE), network, enrichment and quantitative PCR analysis. There were significant differences in protein expression between the two larvae castes at 72 and 120 hours, suggesting the queen and the worker larvae have already decided their fate before 72 hours. Specifically, at 72 hours, queen intended larvae over-expressed transketolase, aldehyde reductase, and enolase proteins which are involved in carbohydrate metabolism and energy production, imaginal disc growth factor 4 which is a developmental related protein, long-chain-fatty-acid CoA ligase and proteasome subunit alpha type 5 which metabolize fatty and amino acids, while worker intended larvae over-expressed ATP synthase beta subunit, aldehyde dehydrogenase, thioredoxin peroxidase 1 and peroxiredoxin 2540, lethal (2) 37 and 14-3-3 protein epsilon, fatty acid binding protein, and translational controlled tumor protein. This differential protein expression between the two caste intended larvae was more pronounced at 120 hours, with particular significant differences in proteins associated with carbohydrate metabolism and energy production. Functional enrichment analysis suggests that carbohydrate metabolism and energy production and anti-oxidation proteins play major roles in the formation of caste divergence. The constructed network and validated gene expression identified target proteins for further functional study. This new finding is in contrast to the existing notion that 72 hour old larvae has bipotential and can develop into either queen or worker based on epigenetics and can help us to gain new insight into the time of departure as well as caste trajectory influencing elements at the molecular level.	[Li, Jianke; Wu, Jing; Rundassa, Desalegn Begna; Song, Feifei; Zheng, Aijuan; Fang, Yu] Chinese Acad Agr Sci, Inst Apicultural Res, Dept Beekeeping & Biotechnol, Key Lab Pollinating Insect Biol,Minist Agr, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs	Li, JK (corresponding author), Chinese Acad Agr Sci, Inst Apicultural Res, Dept Beekeeping & Biotechnol, Key Lab Pollinating Insect Biol,Minist Agr, Beijing, Peoples R China.	freky@163.com	Li, Jianke/K-8139-2013		technical production system of national beekeeping industry [NYCYTX-43]; National Natural Science Foundation of China [30972148]	technical production system of national beekeeping industry; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by a special fund of technical production system of the national beekeeping industry (NYCYTX-43); National Natural Science Foundation of China (No. 30972148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Amdam GV, 2005, AGEING RES REV, V4, P398, DOI 10.1016/j.arr.2005.03.007; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Baer B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r67; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Barchuk Angel Roberto, 2002, Journal of Insect Science (Tucson), V2, P1; Barchuk AR, 2004, INSECT MOL BIOL, V13, P459, DOI 10.1111/j.0962-1075.2004.00506.x; Beye M, 2002, INSECT MOL BIOL, V11, P527, DOI 10.1046/j.1365-2583.2002.00361.x; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Capella ICS, 2002, CELL TISSUE RES, V307, P265, DOI 10.1007/s00441-001-0490-y; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chan QWT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r156; Corona M, 1999, J EXP BIOL, V202, P929; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Corona M, 2005, MECH AGEING DEV, V126, P1230, DOI 10.1016/j.mad.2005.07.004; Cristino AS, 2006, INSECT MOL BIOL, V15, P703, DOI 10.1111/j.1365-2583.2006.00696.x; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Evans JD, 2001, GENOME BIOL, V2; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Evans JD, 2001, BIOESSAYS, V23, P62, DOI 10.1002/1521-1878(200101)23:1&lt;62::AID-BIES1008&gt;3.0.CO;2-7; Feng M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-645; Gadagkar R, 1997, J GENET, V76, P167, DOI 10.1007/BF02932215; Groh C, 2008, ARTHROPOD STRUCT DEV, V37, P459, DOI 10.1016/j.asd.2008.04.001; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; Hasegawa M, 2009, INSECT BIOCHEM MOLEC, V39, P661, DOI 10.1016/j.ibmb.2009.08.001; Haunerland NH, 1996, INSECT BIOCHEM MOLEC, V26, P755, DOI 10.1016/S0965-1748(96)00035-5; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HEPPERLE C, 2000, DIFFERENTIAL DISPLAY; ISHAY J, 1976, STUDY HONEYBEE CASTE, P23; Jacinto A, 2002, CURR BIOL, V12, P1245, DOI 10.1016/S0960-9822(02)00955-7; Kucharski R, 1998, GENE, V211, P343, DOI 10.1016/S0378-1119(98)00114-0; Li J, 2009, INSECT MOL BIOL, V18, P1, DOI 10.1111/j.1365-2583.2008.00849.x; Li JK, 2008, J PROTEOME RES, V7, P3339, DOI 10.1021/pr8002276; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; OMHOLT SW, 2004, SCI AGING KNOWLEDGE, pPE28; Randolt K, 2008, ARCH INSECT BIOCHEM, V69, P155, DOI 10.1002/arch.20269; Rueppell O, 2007, EXP GERONTOL, V42, P1020, DOI 10.1016/j.exger.2007.06.002; Scharlaken B, 2007, ARCH INSECT BIOCHEM, V65, P223, DOI 10.1002/arch.20179; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seehuus SC, 2006, EXP GERONTOL, V41, P1117, DOI 10.1016/j.exger.2006.08.004; SEVERSON DW, 1989, INSECT BIOCHEM, V19, P215, DOI 10.1016/0020-1790(89)90094-2; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; SMITH DF, 1981, CELL, V23, P441, DOI 10.1016/0092-8674(81)90139-2; Strauss K, 2008, BEHAV ECOL SOCIOBIOL, V62, P1523, DOI 10.1007/s00265-008-0581-9; WINSTON ML, 1987, BIOL HONEY BEE, P316	47	40	43	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13455	10.1371/journal.pone.0013455	http://dx.doi.org/10.1371/journal.pone.0013455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975997	Green Published, gold			2022-12-25	WOS:000283216400008
J	Classen, AT; Norby, RJ; Campany, CE; Sides, KE; Weltzin, JF				Classen, Aimee T.; Norby, Richard J.; Campany, Courtney E.; Sides, Katherine E.; Weltzin, Jake F.			Climate Change Alters Seedling Emergence and Establishment in an Old-Field Ecosystem	PLOS ONE			English	Article							ELEVATED CO2; TREE ESTABLISHMENT; ATMOSPHERIC CO2; PLANT COMMUNITY; SOIL-MOISTURE; FOREST; RESPONSES; REGENERATION; TEMPERATURE; GROWTH	Background: Ecological succession drives large-scale changes in ecosystem composition over time, but the mechanisms whereby climatic change might alter succession remain unresolved. Here, we asked if the effects of atmospheric and climatic change would alter tree seedling emergence and establishment in an old-field ecosystem, recognizing that small shifts in rates of seedling emergence and establishment of different species may have long-term repercussions on the transition of fields to forests in the future. Methodology/Principal Findings: We introduced seeds from three early successional tree species into constructed old-field plant communities that had been subjected for 4 years to altered temperature, precipitation, and atmospheric CO2 regimes in an experimental facility. Our experiment revealed that different combinations of atmospheric CO2 concentration, air temperature, and soil moisture altered seedling emergence and establishment. Treatments directly and indirectly affected soil moisture, which was the best predictor of seedling establishment, though treatment effects differed among species. Conclusions: The observed impacts, coupled with variations in the timing of seed arrival, are demonstrated as predictors of seedling emergence and establishment in ecosystems under global change.	[Classen, Aimee T.; Campany, Courtney E.; Weltzin, Jake F.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Classen, Aimee T.; Norby, Richard J.; Sides, Katherine E.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Weltzin, Jake F.] USA Natl Phenol Network, Tucson, AZ USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory	Classen, AT (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	aclassen@utk.edu	Classen, Aimee/AAM-5671-2021; Classen, Aimee T/C-4035-2008; Norby, Richard J/C-1773-2012; Classen, Aimee/X-2984-2019	Classen, Aimee T/0000-0002-6741-3470; Norby, Richard J/0000-0002-0238-9828; Whitacre, Katherine/0000-0002-7573-6448; Campany, Courtney/0000-0003-2986-434X	US Department of Energy, Office of Science, Biological and Environmental [DE-FG02-02ER63366]; U. S. Department of Energy [DE-AC05-00OR22725]	US Department of Energy, Office of Science, Biological and Environmental(United States Department of Energy (DOE)); U. S. Department of Energy(United States Department of Energy (DOE))	Research was sponsored by the US Department of Energy, Office of Science, Biological and Environmental Research Program, Grant No. DE-FG02-02ER63366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank SK Chapman, GM Crutsinger, W Godsoe, PJ Hanson, CM Iversen, JA Langley, and NJ Sanders, and two reviewers for very helpful comments on the manuscript. Work was conducted at Oak Ridge National Laboratory, which is managed by UT Battelle, LLC, for the U. S. Department of Energy under Contract DE-AC05-00OR22725.	Abe M, 2008, ECOL RES, V23, P681, DOI 10.1007/s11284-007-0428-2; Albani M, 2006, GLOBAL CHANGE BIOL, V12, P2370, DOI 10.1111/j.1365-2486.2006.01254.x; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; BROSI GB, NEW PHYTOLO IN PRESS; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; *CCSP, 2007, 1 STAT CARB CYCL REP, P242; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Christie DA, 2003, J ECOL, V91, P776, DOI 10.1046/j.1365-2745.2003.00813.x; Cleland EE, 2006, P NATL ACAD SCI USA, V103, P13740, DOI 10.1073/pnas.0600815103; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Cuesta B, 2010, J ECOL, V98, P687, DOI 10.1111/j.1365-2745.2010.01655.x; Davis MA, 2007, GLOBAL CHANGE BIOL, V13, P2308, DOI 10.1111/j.1365-2486.2007.01444.x; DEDEY, 2008, ECOL LETT, V11, P516; Dermody O, 2007, PLANT SOIL, V301, P255, DOI 10.1007/s11104-007-9443-x; DESTEVEN D, 1991, ECOLOGY, V72, P1066, DOI 10.2307/1940606; Dickie IA, 2007, J ECOL, V95, P309, DOI 10.1111/j.1365-2745.2006.01202.x; Engel EC, 2009, J PLANT ECOL, V2, P1, DOI 10.1093/jpe/rtn026; Engelkes T, 2008, NATURE, V456, P946, DOI 10.1038/nature07474; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Garten CT, 2008, ECOSYSTEMS, V11, P125, DOI 10.1007/s10021-007-9112-1; Garten CT, 2009, PLANT SOIL, V319, P85, DOI 10.1007/s11104-008-9851-6; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Harper J. L., 1977, Population biology of plants.; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Hovenden MJ, 2008, NEW PHYTOL, V180, P143, DOI 10.1111/j.1469-8137.2008.02563.x; Hurtt GC, 1998, GLOBAL CHANGE BIOL, V4, P581, DOI 10.1046/j.1365-2486.1998.t01-1-00203.x; Ibanez I, 2007, ECOL MONOGR, V77, P163, DOI 10.1890/06-1097; Kardol P, 2010, GLOBAL CHANGE BIOL, V16, P2676, DOI 10.1111/j.1365-2486.2010.02162.x; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Liang SY, 2002, ECOLOGY, V83, P212, DOI 10.1890/0012-9658(2002)083[0212:BAMEOR]2.0.CO;2; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mohan JE, 2007, ECOL APPL, V17, P1198, DOI 10.1890/05-1690; Nepstad DC, 1996, OIKOS, V76, P25, DOI 10.2307/3545745; Norby RJ, 2004, P NATL ACAD SCI USA, V101, P9689, DOI 10.1073/pnas.0403491101; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pendall E, 2004, NEW PHYTOL, V162, P311, DOI 10.1111/j.1469-8137.2004.01053.x; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Rudgers JA, 2007, ECOLOGY, V88, P18, DOI 10.1890/0012-9658(2007)88[18:FSSBAI]2.0.CO;2; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Seiwa K, 1998, J ECOL, V86, P219, DOI 10.1046/j.1365-2745.1998.00245.x; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; van der Waal C, 2009, J ECOL, V97, P430, DOI 10.1111/j.1365-2745.2009.01498.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wan SQ, 2004, NEW PHYTOL, V162, P437, DOI 10.1111/j.1469-8137.2004.01034.x	54	35	36	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13476	10.1371/journal.pone.0013476	http://dx.doi.org/10.1371/journal.pone.0013476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976104	Green Published, Green Submitted, gold			2022-12-25	WOS:000283045300038
J	Lee, JK; Lu, SY; Madhukar, A				Lee, Jae Kyoo; Lu, Siyuan; Madhukar, Anupam			Real-Time Dynamics of Ca2+, Caspase-3/7, and Morphological Changes in Retinal Ganglion Cell Apoptosis under Elevated Pressure	PLOS ONE			English	Article							DIFFERENTIATED RGC-5 CELLS; HYDROSTATIC-PRESSURE; CYTOCHROME-C; INTRACELLULAR CA2+; DEATH; CALCIUM; LINE; OSCILLATIONS; GLAUCOMA; MODEL	Quantitative information on the dynamics of multiple molecular processes in individual live cells under controlled stress is central to the understanding of the cell behavior of interest and the establishment of reliable models. Here, the dynamics of the apoptosis regulator intracellular Ca2+, apoptosis effector caspase-3/7, and morphological changes, as well as temporal correlation between them at the single cell level, are examined in retinal gangling cell line (differentiated RGC-5 cells) undergoing apoptosis at elevated hydrostatic pressure using a custom-designed imaging platform that allows long-term real-time simultaneous imaging of morphological and molecular-level physiological changes in large numbers of live cells (beyond the field-of-view of typical microscopy) under controlled hydrostatic pressure. This examination revealed intracellular Ca2+ elevation with transient single or multiple peaks of less than 0.5 hour duration appearing at the early stages (typically less than 5 hours after the onset of 100 mmHg pressure) followed by gradual caspase-3/7 activation at late stages (typically later than 5 hours). The data reveal a strong temporal correlation between the Ca2+ peak occurrence and morphological changes of neurite retraction and cell body shrinkage. This suggests that Ca2+ elevation, through its impact on ion channel activity and water efflux, is likely responsible for the onset of apoptotic morphological changes. Moreover, the data show a significant cell-to-cell variation in the onset of caspase-3/7 activation, an inevitable consequence of the stochastic nature of the underlying biochemical reactions not captured by conventional assays based on population-averaged cellular responses. This real-time imaging study provides, for the first time, statistically significant data on simultaneous multiple molecular level changes to enable refinements and testing of models of the dynamics of mitochondria-mediated apoptosis. Further, the platform developed and the approach has direct significance to the study of a variety of signaling pathway phenomena.	[Lee, Jae Kyoo; Madhukar, Anupam] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Lu, Siyuan; Madhukar, Anupam] Univ So Calif, Dept Phys, Los Angeles, CA USA; [Lu, Siyuan] Univ So Calif, Dept Ophthalmol, Los Angeles, CA USA; [Madhukar, Anupam] Univ So Calif, Dept Mat Sci, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lee, JK (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	madhukar@usc.edu	Lee, Jae Kyoo/AAL-6850-2021	Lee, Jae Kyoo/0000-0002-1257-8737	Defense Advanced Research Projects Agency (DARPA) [F49620-01-1-0474]; Air Force Office of Scientific Research (AFOSR) [F49620-01-1-0474]; Kenneth Norris Chair Endowment; National Science Foundation (NSF) [NSF EEC-0310723]; Whittier Foundation	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Kenneth Norris Chair Endowment; National Science Foundation (NSF)(National Science Foundation (NSF)); Whittier Foundation	This research has benefited from the Defense Advanced Research Projects Agency (DARPA, http://www.darpa.mil)/Air Force Office of Scientific Research (AFOSR, http://www.wpafb.af.mil) funded Defense University Research Initiative in Nanotechnology (DURINT) program grant no. F49620-01-1-0474, the Kenneth Norris Chair Endowment, the National Science Foundation (NSF, http://www.nsf.gov) sponsored Biomimetics Microelectronics Systems ( BMES) Engineering Research Center at the University of Southern California grant no. NSF EEC-0310723, and the Whittier Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar A, 2006, BRAIN RES, V1086, P191, DOI 10.1016/j.brainres.2006.02.061; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Campbell A.K, 1983, INTRACELLULAR CALCIU; Cellerino A, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-16-j0002.2000; Das A, 2006, BRAIN RES, V1084, P146, DOI 10.1016/j.brainres.2006.02.051; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Falcke M, 2004, ADV PHYS, V53, P255, DOI 10.1080/00018730410001703159; Florea AM, 2005, CELL CALCIUM, V37, P251, DOI 10.1016/j.ceca.2004.10.005; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; FRIEL DD, 1995, BIOPHYS J, V68, P1752, DOI 10.1016/S0006-3495(95)80352-8; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P768, DOI 10.1038/77589; Gerasimenko JV, 2002, J CELL SCI, V115, P485; Gross Ronald L, 2003, Trans Am Ophthalmol Soc, V101, P163; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; IGLEWICZ B, 1993, DETECT HANDLE OUTLIE, P32; Ju WK, 2007, INVEST OPHTH VIS SCI, V48, P2145, DOI 10.1167/iovs.06-0573; Ju WK, 2009, MOL VIS, V15, P120; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Krick S, 2001, AM J PHYSIOL-CELL PH, V280, pC970, DOI 10.1152/ajpcell.2001.280.4.C970; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Lee DA, 2005, AM J HEALTH-SYST PH, V62, P691, DOI 10.1093/ajhp/62.7.691; LI YX, 1995, AM J PHYSIOL-CELL PH, V269, pC1079, DOI 10.1152/ajpcell.1995.269.5.C1079; Liu Q, 2007, INVEST OPHTH VIS SCI, V48, P4580, DOI 10.1167/iovs.07-0170; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Moorhouse AJ, 2004, BRAIN RES, V1003, P205, DOI 10.1016/j.brainres.2004.01.027; Nietsch HH, 2000, J BIOL CHEM, V275, P20556, DOI 10.1074/jbc.M002535200; NIITTYKOSKI M, 2010, INVEST OPHTHALMOL VI; Oshimi S, 1996, J PHYSIOL-LONDON, V495, P319, DOI 10.1113/jphysiol.1996.sp021596; Paulsson JF, 2008, EXP DIABETES RES, DOI 10.1155/2008/865850; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Raychaudhuri S, 2008, BIOPHYS J, V95, P3559, DOI 10.1529/biophysj.108.135483; ROSNER B, 2006, FUNDAMENTALS BIOSTAT, P328; Sappington RM, 2009, INVEST OPHTH VIS SCI, V50, P717, DOI 10.1167/iovs.08-2321; SHEN P, 1995, CELL CALCIUM, V17, P225, DOI 10.1016/0143-4160(95)90037-3; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Zhou LL, 2005, APOPTOSIS, V10, P289, DOI 10.1007/s10495-005-0803-9	43	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13437	10.1371/journal.pone.0013437	http://dx.doi.org/10.1371/journal.pone.0013437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976135	Green Submitted, Green Published, gold			2022-12-25	WOS:000283045300018
J	Dominguez, F; Simon, C; Quinonero, A; Ramirez, MA; Gonzalez-Munoz, E; Burghardt, H; Cervero, A; Martinez, S; Pellicer, A; Palacin, M; Sanchez-Madrid, F; Yanez-Mo, M				Dominguez, Francisco; Simon, Carlos; Quinonero, Alicia; Angel Ramirez, Miguel; Gonzalez-Munoz, Elena; Burghardt, Hans; Cervero, Ana; Martinez, Sebastian; Pellicer, Antonio; Palacin, Manuel; Sanchez-Madrid, Francisco; Yanez-Mo, Maria			Human Endometrial CD98 Is Essential for Blastocyst Adhesion	PLOS ONE			English	Article							AMINO-ACID TRANSPORTERS; INTEGRIN ALPHA-6-BETA-1; EMBRYO IMPLANTATION; EPITHELIAL-CELLS; GENE-EXPRESSION; MENSTRUAL-CYCLE; MICE LACKING; IN-VITRO; ASSOCIATION; FERTILIZATION	Background: Understanding the molecular basis of embryonic implantation is of great clinical and biological relevance. Little is currently known about the adhesion receptors that determine endometrial receptivity for embryonic implantation in humans. Methods and Principal Findings: Using two human endometrial cell lines characterized by low and high receptivity, we identified the membrane receptor CD98 as a novel molecule selectively and significantly associated with the receptive phenotype. In human endometrial samples, CD98 was the only molecule studied whose expression was restricted to the implantation window in human endometrial tissue. CD98 expression was restricted to the apical surface and included in tetraspanin-enriched microdomains of primary endometrial epithelial cells, as demonstrated by the biochemical association between CD98 and tetraspanin CD9. CD98 expression was induced in vitro by treatment of primary endometrial epithelial cells with human chorionic gonadotropin, 17-beta-estradiol, LIF or EGF. Endometrial overexpression of CD98 or tetraspanin CD9 greatly enhanced mouse blastocyst adhesion, while their siRNA-mediated depletion reduced the blastocyst adhesion rate. Conclusions: These results indicate that CD98, a component of tetraspanin-enriched microdomains, appears to be an important determinant of human endometrial receptivity during the implantation window.	[Dominguez, Francisco; Simon, Carlos; Quinonero, Alicia; Cervero, Ana; Martinez, Sebastian; Pellicer, Antonio] Univ Valencia, Inst Univ IVI, Fdn IVI, Valencia, Spain; [Simon, Carlos] Ctr Invest Principe Felipe, Valencia, Spain; [Angel Ramirez, Miguel] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Anim Reprod, Madrid, Spain; [Gonzalez-Munoz, Elena; Burghardt, Hans; Palacin, Manuel] Univ Barcelona, Fac Biol, Inst Res Biomed, CIBER Enfermedades Raras, Barcelona, Spain; [Gonzalez-Munoz, Elena; Burghardt, Hans; Palacin, Manuel] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain; [Sanchez-Madrid, Francisco; Yanez-Mo, Maria] Hosp Princesa, Inst Invest Sanitaria Princesa IP, Serv Inmunol, Madrid, Spain; [Sanchez-Madrid, Francisco; Yanez-Mo, Maria] Ctr Nacl Invest Cardiovasc, Madrid, Spain	University of Valencia; Prince Felipe Research Center; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona; Hospital de La Princesa; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Dominguez, F (corresponding author), Univ Valencia, Inst Univ IVI, Fdn IVI, Valencia, Spain.	myanez.hlpr@salud.madrid.org	Pellicer, Antonio/AAA-6005-2020; Yáñez-Mó, María/K-8577-2014; YÃÃez-MÃ, Maria/AAI-4544-2020; Dominguez, Francisco/AAA-7260-2020; Gonzalez-Munoz, Elena/AAY-4658-2020; Ramirez de Paz, Miguel Angel/H-3171-2015; Sanchez-Madrid, Francisco/M-7889-2016	Pellicer, Antonio/0000-0002-8254-863X; Yáñez-Mó, María/0000-0001-7484-2866; YÃÃez-MÃ, Maria/0000-0001-7484-2866; Dominguez, Francisco/0000-0002-7620-8081; Gonzalez-Munoz, Elena/0000-0001-8291-1518; Ramirez de Paz, Miguel Angel/0000-0002-5868-2134; Palacin, Manuel/0000-0002-8670-293X; Sanchez-Madrid, Francisco/0000-0001-5303-0762	Instituto de Salud Carlos III [Contrato-Investigador FIS 0019, PI080794]; Comunidad de Madrid [SAF2008-02635, INSINET-0159/2006]; Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares [RD06/0014-0030]; Genoma Espana; Generalitat Valenciana [GV05/178, BFU2006-14600]; La Marata -TV3;  [SAF 2004-0024];  [SAF 2008-0248];  [PROMETEO/2008/163]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares; Genoma Espana; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); La Marata -TV3; ; ; 	This work was supported by grants Contrato-Investigador FIS 0019 and PI080794 from Instituto de Salud Carlos III to M.Y.-M.; SAF2008-02635, INSINET-0159/2006 from Comunidad de Madrid, RD06/0014-0030 from Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares, and Genoma Espana to F. S. M.; Generalitat Valenciana GV05/178 to F. D.; BFU2006-14600 and La Marata -TV3 to M. P.; SAF 2004-0024, SAF 2008-0248 and PROMETEO/2008/163 to C. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Bentin-Ley U, 2000, HUM REPROD, V15, P67; BENTINLEY U, 1994, J REPROD FERTIL, V101, P327; Borthwick JM, 2003, MOL HUM REPROD, V9, P19, DOI 10.1093/molehr/gag004; BULLETTI C, 1988, FERTIL STERIL, V49, P991; Carson DD, 2002, MOL HUM REPROD, V8, P871, DOI 10.1093/molehr/8.9.871; Chen MS, 1999, P NATL ACAD SCI USA, V96, P11830, DOI 10.1073/pnas.96.21.11830; Chillaron J, 2001, AM J PHYSIOL-RENAL, V281, pF995, DOI 10.1152/ajprenal.2001.281.6.F995; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; Dominguez F, 2005, FASEB J, V19, P1056, DOI 10.1096/fj.05-3781hyp; Dong S, 1996, FEBS LETT, V395, P165, DOI 10.1016/0014-5793(96)01031-9; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; Guzelogiu-Kayisli Z, 2009, SEMIN REPROD MED, V27, P62, DOI 10.1055/s-0028-1108011; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; HUSSA RO, 1975, J CLIN ENDOCR METAB, V40, P401, DOI 10.1210/jcem-40-3-401; JOHN NJ, 1993, IN VITRO CELL DEV-AN, V29A, P461, DOI 10.1007/BF02639380; Kuno N, 1998, FEBS LETT, V425, P191, DOI 10.1016/S0014-5793(98)00213-0; Landgren BM, 1996, FERTIL STERIL, V65, P1067, DOI 10.1016/S0015-0282(16)58291-0; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; LESSEY BA, 1992, J CLIN INVEST, V90, P188, DOI 10.1172/JCI115835; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; LINDENBERG S, 1991, DAN MED BULL, V38, P371; LINDENBERG S, 1989, HUM REPROD, V4, P446, DOI 10.1093/oxfordjournals.humrep.a136925; Liu WM, 2007, FERTIL STERIL, V87, P664, DOI 10.1016/j.fertnstert.2006.07.1525; Liu WM, 2006, J MOL ENDOCRINOL, V36, P121, DOI 10.1677/jme.1.01910; Liu X, 2003, J BIOL CHEM, V278, P23672, DOI 10.1074/jbc.M302777200; Martin JC, 2000, BIOL REPROD, V63, P1370, DOI 10.1095/biolreprod63.5.1370; Mercader A, 2006, METHOD ENZYMOL, V420, P3, DOI 10.1016/S0076-6879(06)20001-6; Miller BJ, 2000, J CELL BIOL, V149, P1289, DOI 10.1083/jcb.149.6.1289; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Miyamoto YJ, 2003, MOL IMMUNOL, V39, P739, DOI 10.1016/S0161-5890(02)00255-9; Murphy CR, 2000, J REPROD FERTIL, P23; NAVOT D, 1991, J CLIN ENDOCR METAB, V72, P408, DOI 10.1210/jcem-72-2-408; Nguyen HTT, 2010, J BIOL CHEM, V285, P1479, DOI 10.1074/jbc.M109.057141; Nguyen HTT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003895; Noguchi Y, 2003, J CLIN ENDOCR METAB, V88, P6063, DOI 10.1210/jc.2003-030457; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Palacin M, 2004, PFLUG ARCH EUR J PHY, V447, P490, DOI 10.1007/s00424-003-1062-7; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Park KR, 2000, MOL HUM REPROD, V6, P252, DOI 10.1093/molehr/6.3.252; Riesewijk A, 2003, MOL HUM REPROD, V9, P253, DOI 10.1093/molehr/gag037; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Rubinstein E, 2006, DEV BIOL, V290, P351, DOI 10.1016/j.ydbio.2005.11.031; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Schatz F, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-2; Simon C, 1999, J CLIN ENDOCR METAB, V84, P2638, DOI 10.1210/jc.84.8.2638; THIE M, 1995, EUR J CELL BIOL, V66, P180; Tinel H, 2000, MOL HUM REPROD, V6, P1119, DOI 10.1093/molehr/6.12.1119; Tsumura H, 2003, BIOCHEM BIOPH RES CO, V308, P847, DOI 10.1016/S0006-291X(03)01473-6; Tsurudome M, 2000, CRIT REV IMMUNOL, V20, P167; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; WAY DL, 1983, IN VITRO CELL DEV B, V19, P147; Xiao LJ, 2002, REPRODUCTION, V124, P219, DOI 10.1530/rep.0.1240219; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004	58	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13380	10.1371/journal.pone.0013380	http://dx.doi.org/10.1371/journal.pone.0013380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976164	Green Published, gold, Green Submitted			2022-12-25	WOS:000283043700004
J	Longrich, NR; Horner, JR; Erickson, GM; Currie, PJ				Longrich, Nicholas R.; Horner, John R.; Erickson, Gregory M.; Currie, Philip J.			Cannibalism in Tyrannosaurus rex	PLOS ONE			English	Article							DINOSAUR BONE; TOOTH MARKS; BITE MARKS; THEROPOD; PREDATION; BEHAVIOR; BEARS	Background: Tyrannosaurus rex was one of the largest terrestrial carnivores of all time, and consequently its ecology and diet have been the focus of much discussion. However, there is little direct evidence of diet or feeding habits in this species. Methodology/Principal Findings: Examination of museum collections has revealed four specimens of Tyrannosaurus rex that bear tooth marks made by large, carnivorous dinosaurs. Because Tyrannosaurus is the only large carnivore known from the Late Maastrichtian of western North America, we infer that Tyrannosaurus made these tooth marks. Conclusions/Significance: The marks are interpreted as feeding traces and these fossils therefore record instances of cannibalism. Given that this behavior has a low preservation potential, cannibalism seems to have been a surprisingly common behavior in Tyrannosaurus, and this behavior may have been relatively common in carnivorous dinosaurs.	[Longrich, Nicholas R.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Erickson, Gregory M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Yale University; Montana State University System; Montana State University Bozeman; State University System of Florida; Florida State University; University of Alberta	Longrich, NR (corresponding author), Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA.	nicholas.longrich@yale.edu	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161; Longrich, Nicholas/0000-0002-9586-8907	Alberta Ingenuity; Yale Institute for Biospheric Studies; Natural Sciences and Engineering Research Council Canada	Alberta Ingenuity; Yale Institute for Biospheric Studies; Natural Sciences and Engineering Research Council Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	NRL was supported by an Alberta Ingenuity Graduate Research Fellowship, and a Yale Institute for Biospheric Studies Donnelley Fellowship. PJC was supported by the Natural Sciences and Engineering Research Council Canada, and N. Myrvold supported fieldwork by JRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstrup SC, 2006, POLAR BIOL, V29, P997, DOI 10.1007/s00300-006-0142-5; Auffenberg W., 1981, BEHAV ECOLOGY KOMODO; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Britt BB, 2008, ICHNOS, V15, P59, DOI 10.1080/10420940701193284; Brochu CA, 2002, SOC VERTEBRATE PALEO, V7, P1, DOI DOI 10.2307/3889334; Carpenter Kenneth, 2000, Gaia (Lisboa), V15, P135; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; D'Amore DC, 2009, PALEOBIOLOGY, V35, P525, DOI 10.1666/0094-8373-35.4.525; Eloff F.C., 1984, Koedoe, V27, P249; Erickson GM, 1996, J VERTEBR PALEONTOL, V16, P175, DOI 10.1080/02724634.1996.10011297; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Estes R., 1964, University of California Publications in Geological Sciences, V49, P1; Farlow James O., 1994, Paleontological Society Special Publication, V7, P165; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Gignac PM, 2010, J VERTEBR PALEONTOL, V30, P1169, DOI 10.1080/02724634.2010.483535; Godfrey SJ, 2005, LIFE O PAST, P292; Happ John, 2008, P354; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Holtz Thomas R. Jr, 2008, P370; Horner J.R, 1993, COMPLETE T REX; Jacobsen Aase Roland, 1998, Historical Biology, V13, P17; Kruuk H., 1972, SPOTTED HYENA STUDY; Lambe LM., 1917, GEOL SURV, V83, P1, DOI [10.4095/101672, DOI 10.4095/101672]; Lesowski J., 1963, Journal of Mammalogy, V44, P586, DOI 10.2307/1377154; Longrich NR, 2010, PALAEONTOLOGY, V53, P703, DOI 10.1111/j.1475-4983.2010.00957.x; LONGRICH NR, 2008, UNIQUE ROLE VERTEBRA, P135; MATTSON DJ, 1992, J MAMMAL, V73, P422, DOI 10.2307/1382078; Nesbitt SJ, 2006, BIOL LETT-UK, V2, P611, DOI 10.1098/rsbl.2006.0524; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; Nowak RM, 1991, WALKERS MAMMALS WORL; Osborn HF, 1916, B AM MUS NAT HIST, V35, P733; Paul G., 1988, PREDATORY DINOSAURS; Paul G. S., 2008, TYRANNOSAURUS REX TY, P354; Pooley A.C., 1989, P92; Roberts EM, 2007, J PALEONTOL, V81, P201, DOI 10.1666/0022-3360(2007)81[201:CIBIDB]2.0.CO;2; Rogers RR, 2003, NATURE, V422, P515, DOI 10.1038/nature01532; ROOTES WL, 1993, HERPETOLOGICA, V49, P99; Schubert BW, 2005, ACTA PALAEONTOL POL, V50, P93; SHIPMAN P, 1986, AM ANTHROPOL, V88, P27, DOI 10.1525/aa.1986.88.1.02a00020; Tanke Darren H., 2000, Gaia (Lisboa), V15, P167; THENIUS VE, 1979, ANN NATURHISTORISCHE, V82, P177; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; TIETJE WD, 1986, J MAMMAL, V67, P762, DOI 10.2307/1381144	46	27	28	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13419	10.1371/journal.pone.0013419	http://dx.doi.org/10.1371/journal.pone.0013419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976177	Green Published, gold, Green Submitted			2022-12-25	WOS:000283043700017
J	Nakou, M; Bertsias, G; Stagakis, I; Centola, M; Tassiulas, I; Hatziapostolou, M; Kritikos, I; Goulielmos, G; Boumpas, DT; Iliopoulos, D				Nakou, Magdalene; Bertsias, George; Stagakis, Ilias; Centola, Michael; Tassiulas, Ioannis; Hatziapostolou, Maria; Kritikos, Iraklis; Goulielmos, George; Boumpas, Dimitrios T.; Iliopoulos, Dimitrios			Gene Network Analysis of Bone Marrow Mononuclear Cells Reveals Activation of Multiple Kinase Pathways in Human Systemic Lupus Erythematosus	PLOS ONE			English	Article							NF-KAPPA-B; GRANULOPOIESIS SIGNATURES; T-CELLS; EXPRESSION; INTERFERON; DISEASE; CANCER; BLOOD; ADENOCARCINOMA; INFLAMMATION	Background: Gene profiling studies provide important information for key molecules relevant to a disease but are less informative of protein-protein interactions, post-translational modifications and regulation by targeted subcellular localization. Integration of genomic data and construction of functional gene networks may provide additional insights into complex diseases such as systemic lupus erythematosus (SLE). Methodology/Principal Findings: We analyzed gene expression microarray data of bone marrow mononuclear cells (BMMCs) from 20 SLE patients (11 with active disease) and 10 controls. Gene networks were constructed using the bioinformatic tool Ingenuity Gene Network Analysis. In SLE patients, comparative analysis of BMMCs genes revealed a network with 19 central nodes as major gene regulators including ERK, JNK, and p38 MAP kinases, insulin, Ca(2+) and STAT3. Comparison between active versus inactive SLE identified 30 central nodes associated with immune response, protein synthesis, and post-transcriptional modification. A high degree of identity between networks in active SLE and non-Hodgkin's lymphoma (NHL) patients was found, with overlapping central nodes including kinases (MAPK, ERK, JNK, PKC), transcription factors (NF-kappaB, STAT3), and insulin. In validation studies, western blot analysis in splenic B cells from 5-month-old NZB/NZW F1 lupus mice showed activation of STAT3, ITGB2, HSPB1, ERK, JNK, p38, and p32 kinases, and downregulation of FOXO3 and VDR compared to normal C57Bl/6 mice. Conclusions/Significance: Gene network analysis of lupus BMMCs identified central gene regulators implicated in disease pathogenesis which could represent targets of novel therapies in human SLE. The high similarity between active SLE and NHL networks provides a molecular basis for the reported association of the former with lymphoid malignancies.	[Nakou, Magdalene; Bertsias, George; Stagakis, Ilias; Tassiulas, Ioannis; Kritikos, Iraklis; Goulielmos, George; Boumpas, Dimitrios T.] Univ Crete, Div Rheumatol Clin Immunol & Allergy, Sch Med, Iraklion, Greece; [Bertsias, George; Stagakis, Ilias; Tassiulas, Ioannis; Boumpas, Dimitrios T.] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Centola, Michael] Oklahoma Med Res Fdn, Microarray Res Facil, Oklahoma City, OK 73104 USA; [Hatziapostolou, Maria; Iliopoulos, Dimitrios] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Hatziapostolou, Maria; Iliopoulos, Dimitrios] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Crete; Oklahoma Medical Research Foundation; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Nakou, M (corresponding author), Univ Crete, Div Rheumatol Clin Immunol & Allergy, Sch Med, Iraklion, Greece.	dimitrios_iliopoulos@dfci.harvard.edu	Hatziapostolou, Maria/N-1820-2015; Bertsias, George/AAA-8400-2020; Iliopoulos, Dimitrios/AAE-9106-2019	Hatziapostolou, Maria/0000-0003-2493-7028; Bertsias, George/0000-0001-5299-1406; 	Hellenic Rheumatology Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053483] Funding Source: NIH RePORTER	Hellenic Rheumatology Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work has been supported by Hellenic Rheumatology Society grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bernatsky S, 2005, ANN RHEUM DIS, V64, P1507, DOI 10.1136/ard.2004.034504; Bernatsky S, 2005, ARTHRITIS RHEUM-US, V52, P1481, DOI 10.1002/art.21029; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Courtney PA, 1999, ANN RHEUM DIS, V58, P309, DOI 10.1136/ard.58.5.309; Delys L, 2007, ONCOGENE, V26, P7894, DOI 10.1038/sj.onc.1210588; Doshi BM, 2010, ANN NY ACAD SCI, V1197, P76, DOI 10.1111/j.1749-6632.2010.05191.x; Ellmark P, 2006, MOL CELL PROTEOMICS, V5, P1638, DOI 10.1074/mcp.M600170-MCP200; EMLEN W, 1994, J IMMUNOL, V152, P3685; Glawe JD, 2009, DIABETES, V58, P1292, DOI 10.2337/db08-0804; Goertsches RH, 2008, J NEUROL, V255, P48, DOI 10.1007/s00415-008-6010-1; Hale MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006756; Harada T, 2007, AUTOIMMUNITY, V40, P1, DOI 10.1080/08916930601095148; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jarvis JN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2048; Krishnan S, 2008, J IMMUNOL, V181, P8145, DOI 10.4049/jimmunol.181.11.8145; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Logsdon CD, 2003, CANCER RES, V63, P2649; Molad Y, 2010, ANN RHEUM DIS, V69, P175, DOI 10.1136/ard.2008.102780; Munoz LE, 2009, ARTHRITIS RHEUM-US, V60, P1733, DOI 10.1002/art.24535; Nakou M, 2008, ARTHRITIS RHEUM, V58, P3541, DOI 10.1002/art.23961; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Reddy PS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2541; Sela U, 2006, EUR J IMMUNOL, V36, P2971, DOI 10.1002/eji.200636137; Sluimer JC, 2007, PHYSIOL GENOMICS, V30, P335, DOI 10.1152/physiolgenomics.00076.2007; STYLIANOU K, 2010, NEPHROL DIAL TRANSPL, P11601; Taher TE, 2010, ARTHRITIS RHEUM-US, V62, P2412, DOI 10.1002/art.27505; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Wong CK, 2009, J CLIN IMMUNOL, V29, P738, DOI 10.1007/s10875-009-9318-4; Wu TF, 2007, J CLIN INVEST, V117, P2186, DOI 10.1172/JCI30398	37	28	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13351	10.1371/journal.pone.0013351	http://dx.doi.org/10.1371/journal.pone.0013351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976278	Green Published, gold, Green Submitted			2022-12-25	WOS:000282941000006
J	Smith, ND				Smith, Nathan D.			Phylogenetic Analysis of Pelecaniformes (Aves) Based on Osteological Data: Implications for Waterbird Phylogeny and Fossil Calibration Studies	PLOS ONE			English	Article							SISTER GROUP RELATIONSHIP; HIGHER-LEVEL PHYLOGENY; LENGTH DIFFERENCE TEST; TOOTHED BIRDS AVES; MIDDLE EOCENE; SEQUENCE DATA; PHALACROCORACOIDEA CORMORANTS; MOLECULAR CLOCK; EARLIEST RECORD; EARLY OLIGOCENE	Background: Debate regarding the monophyly and relationships of the avian order Pelecaniformes represents a classic example of discord between morphological and molecular estimates of phylogeny. This lack of consensus hampers interpretation of the group's fossil record, which has major implications for understanding patterns of character evolution (e. g., the evolution of wing-propelled diving) and temporal diversification (e. g., the origins of modern families). Relationships of the Pelecaniformes were inferred through parsimony analyses of an osteological dataset encompassing 59 taxa and 464 characters. The relationships of the Plotopteridae, an extinct family of wing-propelled divers, and several other fossil pelecaniforms (Limnofregata, Prophaethon, Lithoptila, ?Borvocarbo stoeffelensis) were also assessed. The antiquity of these taxa and their purported status as stem members of extant families makes them valuable for studies of higher-level avian diversification. Methodology/Principal Findings: Pelecaniform monophyly is not recovered, with Phaethontidae recovered as distantly related to all other pelecaniforms, which are supported as a monophyletic Steganopodes. Some anatomical partitions of the dataset possess different phylogenetic signals, and partitioned analyses reveal that these discrepancies are localized outside of Steganopodes, and primarily due to a few labile taxa. The Plotopteridae are recovered as the sister taxon to Phalacrocoracoidea, and the relationships of other fossil pelecaniforms representing key calibration points are well supported, including Limnofregata (sister taxon to Fregatidae), Prophaethon and Lithoptila (successive sister taxa to Phaethontidae), and ? Borvocarbo stoeffelensis (sister taxon to Phalacrocoracidae). These relationships are invariant when 'backbone' constraints based on recent avian phylogenies are imposed. Conclusions/Significance: Relationships of extant pelecaniforms inferred from morphology are more congruent with molecular phylogenies than previously assumed, though notable conflicts remain. The phylogenetic position of the Plotopteridae implies that wing-propelled diving evolved independently in plotopterids and penguins, representing a remarkable case of convergent evolution. Despite robust support for the placement of fossil taxa representing key calibration points, the successive outgroup relationships of several "stem fossil + crown family'' clades are variable and poorly supported across recent studies of avian phylogeny. Thus, the impact these fossils have on inferred patterns of temporal diversification depends heavily on the resolution of deep nodes in avian phylogeny.	[Smith, Nathan D.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Smith, Nathan D.] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	University of Chicago; Field Museum of Natural History (Chicago)	Smith, ND (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	smithnd@uchicago.edu			Field Museum of Natural History; National Science Foundation (NSF) [ANT-0838925, DEB-0808250, EAR-0938199, EAR-0719758, DEB-0949897, EAR-0719943, DEB-0949899]; American Museum of Natural History; University of Chicago; University of Chicago, Biological Sciences Division; Division Of Environmental Biology [0808250] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [0838925] Funding Source: National Science Foundation	Field Museum of Natural History; National Science Foundation (NSF)(National Science Foundation (NSF)); American Museum of Natural History; University of Chicago(University of Chicago); University of Chicago, Biological Sciences Division(University of Chicago); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Nathan Smith is supported by the Field Museum of Natural History Brown Family Graduate Fellowship, National Science Foundation (NSF) ANT-0838925, NSF DEB-0808250, American Museum of Natural History Frank M. Chapman Memorial Fund, University of Chicago Hinds Fund, and University of Chicago, Biological Sciences Division Travel Fund. Funding and support for this project were also provided by NSF EAR-0938199, EAR-0719758 and DEB-0949897 to Julia Clarke, NSF EAR-0719943 to Lance Grande, and NSF DEB-0949899 to Dan Ksepka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumel J.J., 1979, P53; BECKER JJ, 1986, AUK, V103, P804, DOI 10.1093/auk/103.4.804; BERGGREN WA, 1985, GEOL SOC AM BULL, V96, P1407, DOI 10.1130/0016-7606(1985)96<1407:CG>2.0.CO;2; Bertelli S, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3525[1:RAPPOT]2.0.CO;2; Bourdon E, 2005, NATURWISSENSCHAFTEN, V92, P586, DOI 10.1007/s00114-005-0047-0; Bourdon E, 2005, J VERTEBR PALEONTOL, V25, P157, DOI 10.1671/0272-4634(2005)025[0157:EANBAN]2.0.CO;2; Bourdon E, 2008, J VERTEBR PALEONTOL, V28, P751, DOI 10.1671/0272-4634(2008)28[751:NSOLAA]2.0.CO;2; Brewer ML, 2007, J MORPHOL, V268, P866, DOI 10.1002/jmor.10555; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Buckley TR, 2002, SYST BIOL, V51, P509, DOI 10.1080/10635150290069922; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; Chandler A. C., 1916, U CALIFORNIA PUBLICA, V13, P243; Chatterjee Sankar, 2002, P125; Clarke JA, 2007, P NATL ACAD SCI USA, V104, P11545, DOI 10.1073/pnas.0611099104; CODDINGTON J, 1994, CLADISTICS, V10, P415; Cooper A, 1997, SCIENCE, V275, P1109, DOI 10.1126/science.275.5303.1109; Cottam PA, 1957, B BRIT MUS NAT HIST, V5, P51; Cracraft J, 2004, ASSEMBLING THE TREE OF LIFE, P468; CRACRAFT J, 1985, AUK, V102, P834; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Darlu P, 2002, MOL BIOL EVOL, V19, P432, DOI 10.1093/oxfordjournals.molbev.a004098; De Pietri VL, 2010, ACTA PALAEONTOL POL, V55, P23, DOI 10.4202/app.2009.0069; DEQUEIROZ A, 1995, ANNU REV ECOL SYST, V26, P657, DOI 10.1146/annurev.es.26.110195.003301; DEQUEIROZ K, 1992, BIOL J LINN SOC, V45, P333, DOI 10.1111/j.1095-8312.1992.tb00648.x; Dolphin K, 2000, MOL PHYLOGENET EVOL, V17, P401, DOI 10.1006/mpev.2000.0845; Dowton M, 2002, SYST BIOL, V51, P19, DOI 10.1080/106351502753475853; Dyke GJ, 2004, ZOOL J LINN SOC-LOND, V141, P153, DOI 10.1111/j.1096-3642.2004.00118.x; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fain MG, 2004, EVOLUTION, V58, P2558; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FEDUCCIA A, 1993, P BIOL SOC WASH, V106, P749; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Friesen VL, 1997, MOL PHYLOGENET EVOL, V7, P252, DOI 10.1006/mpev.1996.0397; Fuarbringer M., 1888, UNTERSUCHUNGEN MORPH, V15; Gatesy J, 1999, CLADISTICS, V15, P271, DOI 10.1111/j.1096-0031.1999.tb00268.x; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; GOEDERT J L, 1988, Proceedings of the California Academy of Sciences, V45, P97; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HARRIS AH, 1977, NATIONAL PARK SERVIC, V3, P1; HARRISON CJO, 1976, ZOOL J LINN SOC-LOND, V59, P323, DOI 10.1111/j.1096-3642.1976.tb01017.x; HARRISON CJO, 1976, B BRIT MUS NAT HIST, V27, P1; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HEDGES SB, 1994, P NATL ACAD SCI USA, V91, P9861, DOI 10.1073/pnas.91.21.9861; Hillis David M., 2000, P1; Hinic-Frlog S, 2010, J EVOLUTION BIOL, V23, P372, DOI 10.1111/j.1420-9101.2009.01909.x; Holland BR, 2010, SYST BIOL, V59, P433, DOI 10.1093/sysbio/syq023; HOWARD H, 1969, CONDOR, V71, P68, DOI 10.2307/1366050; HOWARD HILDEGARDE, 1929, UNIV CALIFORNIA PUBL ZOOL, V32, P301; Hughes J, 2007, SYST BIOL, V56, P232, DOI 10.1080/10635150701311370; Jadwiszczak Piotr, 2006, Polish Polar Research, V27, P3; Kennedy M, 2005, SYST BIOL, V54, P620, DOI 10.1080/106351591007462; Kennedy M, 2004, MOL PHYLOGENET EVOL, V31, P31, DOI 10.1016/j.ympev.2003.07.007; Kennedy M, 1996, ANIM BEHAV, V51, P273, DOI 10.1006/anbe.1996.0028; Kennedy M, 2000, MOL PHYLOGENET EVOL, V17, P345, DOI 10.1006/mpev.2000.0840; Kennedy M, 2009, MOL PHYLOGENET EVOL, V53, P94, DOI 10.1016/j.ympev.2009.06.002; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Ksepka DT, 2006, CLADISTICS, V22, P412, DOI 10.1111/j.1096-0031.2006.00116.x; Lambrecht, 1933, HDB PALAEORNITHOLOGI; Lambrecht K., 1931, Wetenschappelijke Mededeelingen Batavia, Vno. 17, P15; Lambrecht K., 1929, 10 C INT ZOOL STEPH, P1262; Lee MSY, 2001, MOL BIOL EVOL, V18, P676, DOI 10.1093/oxfordjournals.molbev.a003848; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Louchart A, 2011, J ORNITHOL, V152, P15, DOI 10.1007/s10336-010-0537-5; Lydekker R., 1891, CATALOGUE FOSSIL BIR; Manegold A, 2006, ACTA ORNITHOL, V41, P79, DOI 10.3161/068.041.0113; Mayr G, 2005, BIOL REV, V80, P515, DOI 10.1017/S1464793105006779; Mayr G, 2003, CLADISTICS, V19, P527, DOI [10.1016/j.cladistics.2003.10.003, 10.1111/j.1096-0031.2003.tb00387.x]; Mayr G, 2008, J ZOOL SYST EVOL RES, V46, P63, DOI 10.1111/j.1439-0469.2007.00433.x; Mayr G, 2004, J ORNITHOL, V145, P281, DOI 10.1007/s10336-004-0050-9; Mayr G, 2004, ZOOL J LINN SOC-LOND, V140, P157, DOI 10.1111/j.1096-3642.2003.00094.x; Mayr G, 2003, J ZOOL SYST EVOL RES, V41, P233, DOI 10.1046/j.1439-0469.2003.00230.x; Mayr G, 2003, J ORNITHOL, V144, P157, DOI 10.1007/BF02465644; Mayr G, 2002, ACTA PALAEONTOL POL, V47, P507; Mayr G, 2002, J VERTEBR PALEONTOL, V22, P667, DOI 10.1671/0272-4634(2002)022[0667:PLBWAP]2.0.CO;2; Mayr G, 2008, PALAEONTOLOGY, V51, P1107, DOI 10.1111/j.1475-4983.2008.00798.x; Mayr G, 2007, J ORNITHOL, V148, pS455, DOI 10.1007/s10336-007-0159-8; Mayr G, 2007, CONDOR, V109, P929, DOI 10.1650/0010-5422(2007)109[929:ASROTP]2.0.CO;2; Mayr Gerald, 2008, Oryctos, V7, P67; Mayr Gerald, 2001, Senckenbergiana Lethaea, V81, P329; Mayr G, 2010, PALAEONTOLOGY, V53, P365, DOI 10.1111/j.1475-4983.2009.00930.x; Mayr G, 2009, WATERBIRDS, V32, P468, DOI 10.1675/063.032.0315; Mayr G, 2009, PALAEONTOL Z, V83, P247, DOI 10.1007/s12542-009-0019-3; Mayr G, 2009, IBIS, V151, P392, DOI 10.1111/j.1474-919X.2009.00920.x; Mayr Gerald, 2008, Senckenbergiana Lethaea, V88, P195; McCracken KG, 1999, SYST BIOL, V48, P683, DOI 10.1080/106351599259979; Mertz DF, 2007, INT J EARTH SCI, V96, P353, DOI 10.1007/s00531-006-0094-6; Milne-Edwards A., 1867, RECHERCHES ANATOMIQU; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; Mlikovsky Jiri, 2007, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V109A, P19; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Myrcha Andrzej, 2002, Polish Polar Research, V23, P5; NELSON J.B., 1978, SULIDAE GANNETS BOOB; Nunn GB, 1998, MOL BIOL EVOL, V15, P1360, DOI 10.1093/oxfordjournals.molbev.a025864; Olson S.L., 1985, Avian Biology, V8, P79; Olson S.L., 1977, Smithsonian Contr. Paleobiol., VNo. 35, P1; Olson S.L., 1992, Journal of Vertebrate Paleontology, V12, P122; Olson S. L., 1987, SMITHSONIAN CONTRIBU, V63, P1, DOI DOI 10.5479/SI.00810266.63.1; Olson SL, 2005, ZOOTAXA, P1; Olson SL, 1996, J VERTEBR PALEONTOL, V16, P742, DOI 10.1080/02724634.1996.10011362; OLSON SL, 1984, P BIOL SOC WASH, V97, P736; OLSON SL, 1979, SCIENCE, V206, P688, DOI 10.1126/science.206.4419.688; Olson SL, 1980, CONTRIBUTIONS SCI NA, V330, P51; OMLAND KE, 1994, SYST BIOL, V43, P369, DOI 10.2307/2413674; Owre O. T., 1967, ORNITHOL MONOGR, V6, P1, DOI [DOI 10.2307/40166666, 10.2307/40166666]; Panteleyev A.V., 1993, Trudy Zoologicheskogo Instituta, V252, P95; Parham JF, 2008, AM NAT, V171, P132, DOI 10.1086/524198; PRAGER EM, 1988, J MOL EVOL, V27, P326, DOI 10.1007/BF02101195; Prothero DR, 2000, J GEOPHYS RES-SOL EA, V105, P16473, DOI 10.1029/2000JB900063; Rasmussen D.T., 1987, SMITHSON CONTRIB PAL, P1, DOI DOI 10.5479/SI.00810266.62.1; Sadleir RW, 2008, J EVOLUTION BIOL, V21, P1578, DOI 10.1111/j.1420-9101.2008.01602.x; SAIFF E, 1988, J MORPHOL, V196, P107, DOI 10.1002/jmor.1051960108; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sibley CG, 1990, PHYLOGENY CLASSIFICA; SIEGELCAUSEY D, 1988, CONDOR, V90, P885, DOI 10.2307/1368846; Simons AL, 2009, J CANCER RES THER, V5, P2, DOI 10.4103/0973-1482.55133; Slack KE, 2006, MOL BIOL EVOL, V23, P1144, DOI 10.1093/molbev/msj124; Smith AB, 1998, MOL PHYLOGENET EVOL, V9, P437, DOI 10.1006/mpev.1998.0488; Smith AB, 2006, MOL BIOL EVOL, V23, P1832, DOI 10.1093/molbev/msl039; Smith ME, 2010, GEOLOGY, V38, P527, DOI 10.1130/G30630.1; Smith ND, 2005, SYST BIOL, V54, P166, DOI 10.1080/10635150590906000; SORENSON MD, 1999, TREEROT VERSION 2; Stidham Thomas A., 2005, Contributions from the Museum of Paleontology University of Michigan, V31, P179; STORER ROBERT W., 1956, CONDOR, V58, P413, DOI 10.2307/1365096; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; SWOFFORD DL, 1996, MOL SYSTEMATICS, V2, P407; TAMBUSSI C, 1998, JORN ARG PAL VERT NO, P34; Tambussi CP, 2005, GEOBIOS-LYON, V38, P667, DOI 10.1016/j.geobios.2004.02.003; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; TEMPLETON AR, 1983, STATISTICAL ANAL DNA, P151; van Tets G. F., 1965, Ornithological Monographs, VNo. 2, P1; van Tets G.F., 1988, Notornis, V35, P35; VANTETS GF, 1976, P INT ORNITHOL C, V16, P121; VANTUINEN M, 2001, P ROY SOC LOND B BIO, V268, P1; VANTUINEN M, 2006, HIST BIOL, V18, P205; Warheit K.I., 2001, BIOL MARINE BIRDS, P17, DOI [DOI 10.1201/9781420036305.CH2, 10.1201/9781420036305, DOI 10.1201/9781420036305]; Warheit K. I., 1990, THESIS U CALIFORNIA; WARHEIT KI, 1992, PALEOBIOLOGY, V18, P401, DOI 10.1017/S0094837300010976; Wiens JJ, 2003, SYST BIOL, V52, P501, DOI 10.1080/10635150390218222; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	152	61	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13354	10.1371/journal.pone.0013354	http://dx.doi.org/10.1371/journal.pone.0013354			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976229	Green Published, Green Submitted, gold			2022-12-25	WOS:000282941000007
J	Zou, CG; Xu, YF; Liu, WJ; Zhou, W; Tao, N; Tu, HH; Huang, XW; Yang, JK; Zhang, KQ				Zou, Cheng-Gang; Xu, Yong-Fang; Liu, Wen-Jing; Zhou, Wei; Tao, Nan; Tu, Hui-Hui; Huang, Xiao-Wei; Yang, Jin-Kui; Zhang, Ke-Qin			Expression of a Serine Protease Gene prC Is Up-Regulated by Oxidative Stress in the Fungus Clonostachys rosea: Implications for Fungal Survival	PLOS ONE			English	Article							NEMATODE-TRAPPING FUNGUS; TRICHODERMA-ATROVIRIDE; CANDIDA-ALBICANS; TRANSCRIPTION; PURIFICATION; INFECTION; PATTERNS; BINDING; CUTICLE; FAMILY	Background: Soil fungi face a variety of environmental stresses such as UV light, high temperature, and heavy metals. Adaptation of gene expression through transcriptional regulation is a key mechanism in fungal response to environmental stress. In Saccharomyces cerevisiae, the transcription factors Msn2/4 induce stress-mediated gene expression by binding to the stress response element. Previous studies have demonstrated that the expression of extracellular proteases is up-regulated in response to heat shock in fungi. However, the physiological significance of regulation of these extracellular proteases by heat shock remains unclear. The nematophagous fungus Clonostachys rosea can secret an extracellular serine protease PrC during the infection of nematodes. Since the promoter of prC has three copies of the stress response element, we investigated the effect of environmental stress on the expression of prC. Methodology/Principal Findings: Our results demonstrated that the expression of prC was up-regulated by oxidants (H2O2 or menadione) and heat shock, most likely through the stress response element. After oxidant treatment or heat shock, the germination of conidia in the wild type strain was significantly higher than that in the prC mutant strain in the presence of nematode cuticle. Interestingly, the addition of nematode cuticle significantly attenuated the production of reactive oxygen species (ROS) induced by oxidants and heat shock in the wild type strain, but not in prC mutant strain. Moreover, low molecule weight (<3 kD) degradation products of nematode cuticle suppressed the inhibitory effect of conidial germination induced by oxidants and heat shock. Conclusions/Significance: These results indicate that PrC plays a protective role in oxidative stress in C. rosea. PrC degrades the nematode cuticle to produce degradation products, which in turn offer a protective effect against oxidative stress by scavenging ROS. Our study reveals a novel strategy for fungi to adapt to environmental stress.	[Zou, Cheng-Gang; Xu, Yong-Fang; Liu, Wen-Jing; Zhou, Wei; Tao, Nan; Tu, Hui-Hui; Huang, Xiao-Wei; Yang, Jin-Kui; Zhang, Ke-Qin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Yunnan, Peoples R China; [Zou, Cheng-Gang; Xu, Yong-Fang; Liu, Wen-Jing; Zhou, Wei; Tao, Nan; Tu, Hui-Hui; Huang, Xiao-Wei; Yang, Jin-Kui; Zhang, Ke-Qin] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming 650091, Yunnan, Peoples R China; [Xu, Yong-Fang] First Peoples Hosp Yunnan Prov, Ctr Human Reprod, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University	Zou, CG (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Yunnan, Peoples R China.	kqzhang111@yahoo.com.cn	Liu, Wenjing/ACS-5787-2022; zhang, ke/AAH-8217-2019	Yang, Jinkui/0000-0002-3106-2189	National Basic Research Program of China (973 Program) [2007CB411600, 2010CB134503]; National Natural Science Foundation of China [30630003, 30760053]; Department of Science and Technology of Yunnan Province [2007C007Z, 2009CI045]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province	This work was supported in part by a grant (2007CB411600 and 2010CB134503) from National Basic Research Program of China (973 Program), the grants (30630003 and 30760053) from the National Natural Science Foundation of China, and the grants (2007C007Z and 2009CI045) from the Department of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrashev RI, 2008, CAN J MICROBIOL, V54, P977, DOI 10.1139/W08-091; Ahman J, 2002, APPL ENVIRON MICROB, V68, P3408, DOI 10.1128/AEM.68.7.3408-3415.2002; Ahman J, 1996, MICROBIOL-SGM, V142, P1605, DOI 10.1099/13500872-142-7-1605; Ahren D, 2005, MICROBIOL-SGM, V151, P789, DOI 10.1099/mic.0.27485-0; Bose S, 2005, GENETICS, V169, P1215, DOI 10.1534/genetics.104.034603; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Fekete C, 2008, ENVIRON MICROBIOL, V10, P364, DOI 10.1111/j.1462-2920.2007.01457.x; Freimoser FM, 2005, MICROBIOL-SGM, V151, P361, DOI 10.1099/mic.0.27560-0; Freitas FZ, 2004, MOL GENET GENOMICS, V272, P550, DOI 10.1007/s00438-004-1086-5; Galhaup C, 2002, MICROBIOL-SGM, V148, P2159, DOI 10.1099/00221287-148-7-2159; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; LERNER CG, 1993, J GEN MICROBIOL, V139, P1643, DOI 10.1099/00221287-139-7-1643; Li J, 2006, PROCESS BIOCHEM, V41, P925, DOI 10.1016/j.procbio.2005.10.006; Lorito M, 1996, P NATL ACAD SCI USA, V93, P14868, DOI 10.1073/pnas.93.25.14868; Mach RL, 1999, APPL ENVIRON MICROB, V65, P1858; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Nevarez L, 2008, MICROBIOL-SGM, V154, P3752, DOI 10.1099/mic.0.2008/021386-0; Ramesh G, 2009, APPL ENVIRON MICROB, V75, P2266, DOI 10.1128/AEM.02142-08; Reuss O, 2006, MOL MICROBIOL, V60, P795, DOI 10.1111/j.1365-2958.2006.05136.x; Roetzer A, 2008, MOL MICROBIOL, V69, P603, DOI 10.1111/j.1365-2958.2008.06301.x; Seidl V, 2004, FUNGAL GENET BIOL, V41, P1132, DOI 10.1016/j.fgb.2004.09.002; Steen BR, 2002, GENOME RES, V12, P1386, DOI 10.1101/gr.80202; Sugiyama K, 2000, J BIOL CHEM, V275, P15535, DOI 10.1074/jbc.275.20.15535; Yang HL, 2009, MOL CELL PROTEOMICS, V8, P571, DOI 10.1074/mcp.M800297-MCP200; Yang JK, 2007, APPL MICROBIOL BIOT, V75, P557, DOI 10.1007/s00253-007-0839-6; Zou CG, 2003, J BIOL CHEM, V278, P16802, DOI 10.1074/jbc.M212376200; Zou CG, 2010, ENVIRON MICROBIOL, V12, P3243, DOI 10.1111/j.1462-2920.2010.02296.x; Zou CG, 2010, ENVIRON MICROBIOL, V12, P1868, DOI 10.1111/j.1462-2920.2010.02191.x	29	17	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13386	10.1371/journal.pone.0013386	http://dx.doi.org/10.1371/journal.pone.0013386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976223	gold, Green Submitted, Green Published			2022-12-25	WOS:000282941000017
J	Gotoh, K; Kodama, T; Hiyoshi, H; Izutsu, K; Park, KS; Dryselius, R; Akeda, Y; Honda, T; Iida, T				Gotoh, Kazuyoshi; Kodama, Toshio; Hiyoshi, Hirotaka; Izutsu, Kaori; Park, Kwon-Sam; Dryselius, Rikard; Akeda, Yukihiro; Honda, Takeshi; Iida, Tetsuya			Bile Acid-Induced Virulence Gene Expression of Vibrio parahaemolyticus Reveals a Novel Therapeutic Potential for Bile Acid Sequestrants	PLOS ONE			English	Article							THERMOSTABLE DIRECT HEMOLYSIN; III SECRETION SYSTEM; IN-VITRO; PATHOGENICITY ISLAND; CHOLERAE; ENTEROTOXICITY; RESISTANCE; BACTERIA; TOXIN; IDENTIFICATION	Vibrio parahaemolyticus, a bacterial pathogen, causes human gastroenteritis. A type III secretion system (T3SS2) encoded in pathogenicity island (Vp-PAI) is the main contributor to enterotoxicity and expression of Vp-PAI encoded genes is regulated by two transcriptional regulators, VtrA and VtrB. However, a host-derived inducer for the Vp-PAI genes has not been identified. Here, we demonstrate that bile induces production of T3SS2-related proteins under osmotic conditions equivalent to those in the intestinal lumen. We also show that bile induces vtrA-mediated vtrB transcription. Transcriptome analysis of bile-responsive genes revealed that bile strongly induces expression of Vp-PAI genes in a vtrA-dependent manner. The inducing activity of bile was diminished by treatment with bile acid sequestrant cholestyramine. Finally, we demonstrate an in vivo protective effect of cholestyramine on enterotoxicity and show that similar protection is observed in infection with a different type of V. parahaemolyticus or with non-O1/non-O139 V. cholerae strains of vibrios carrying the same kind of T3SS. In summary, these results provide an insight into how bacteria, through the ingenious action of Vp-PAI genes, can take advantage of an otherwise hostile host environment. The results also reveal a new therapeutic potential for widely used bile acid sequestrants in enteric bacterial infections.	[Gotoh, Kazuyoshi; Hiyoshi, Hirotaka; Izutsu, Kaori; Dryselius, Rikard; Iida, Tetsuya] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Genom Res Pathogenic Bacteria, Osaka, Japan; [Kodama, Toshio; Park, Kwon-Sam; Akeda, Yukihiro; Honda, Takeshi] Osaka Univ, Microbial Dis Res Inst, Dept Bacterial Infect, Osaka, Japan; [Park, Kwon-Sam] Kunsan Natl Univ, Coll Ocean Sci & Technol, Dept Food Sci & Bio Technol, Kunsan, South Korea; [Dryselius, Rikard] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Akeda, Yukihiro] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Clin Res Infect Dis, Osaka, Japan	Osaka University; Osaka University; Kunsan National University; Karolinska Institutet; Osaka University	Gotoh, K (corresponding author), Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Genom Res Pathogenic Bacteria, Osaka, Japan.	kodama@biken.osaka-u.ac.jp		Hiyoshi, Hirotaka/0000-0003-3709-2386; Kodama, Toshio/0000-0002-6511-7301	Ministry of Education, Culture, Sports, Science and Technology of Japan [21790419, 18073003, 20390128, 17019058]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Young Scientists (21790419, http://kaken.nii.ac.jp/ja/p/21790419) and Scientific Research on Priority Areas, Matrix of Infection Phenomena (18073003, http://kaken.nii.ac.jp/ja/p/18073003), a Grant-in-Aid for Scientific Research (B) (20390128, http://kaken.nii.ac.jp/ja/p/20390128) and Special Coordination Funds for Promoting Science and Technology (17019058, http://kaken.nii.ac.jp/ja/p/17019058) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker-Austin C, 2008, J FOOD PROTECT, V71, P2552, DOI 10.4315/0362-028X-71.12.2552; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; BERGEN SS, 1959, P SOC EXP BIOL MED, V102, P676, DOI 10.3181/00379727-102-25358; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Charlton-Menys V, 2008, EXP PHYSIOL, V93, P27, DOI 10.1113/expphysiol.2007.035147; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; Chowdhury R, 1996, J BIOSCIENCES, V21, P149, DOI 10.1007/BF02703105; Daramola BA, 2009, INT J ANTIMICROB AG, V34, P499, DOI 10.1016/j.ijantimicag.2009.06.015; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Edwards AD, 2009, VACCINE, V27, P3897, DOI 10.1016/j.vaccine.2009.04.006; Escaich S, 2008, CURR OPIN CHEM BIOL, V12, P400, DOI 10.1016/j.cbpa.2008.06.022; Fabbri A, 1999, INFECT IMMUN, V67, P1139, DOI 10.1128/IAI.67.3.1139-1148.1999; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; GOSHIMA K, 1977, J MOL CELL CARDIOL, V9, P191, DOI 10.1016/0022-2828(77)90029-3; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Gupta S, 1997, INFECT IMMUN, V65, P1131, DOI 10.1128/IAI.65.3.1131-1134.1997; Han F, 2007, APPL ENVIRON MICROB, V73, P7096, DOI 10.1128/AEM.01116-07; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; HONDA T, 1976, INFECT IMMUN, V13, P163, DOI 10.1128/IAI.13.1.163-171.1976; Honda T., 1993, REV MED MICROBIOL, V4, P106, DOI DOI 10.1097/00013542-199304000-00006; HONDA T, 1976, J JPN ASS INFECT DIS, V50, P216; Hung DT, 2005, P NATL ACAD SCI USA, V102, P3028, DOI 10.1073/pnas.0409559102; Izutsu K, 2008, INFECT IMMUN, V76, P1016, DOI 10.1128/IAI.01535-07; Kodama T, 2002, CELL MICROBIOL, V4, P213, DOI 10.1046/j.1462-5822.2002.00176.x; Kodama T, 2007, CELL MICROBIOL, V9, P2598, DOI 10.1111/j.1462-5822.2007.00980.x; Kodama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008678; LIN Z, 1993, J BACTERIOL, V175, P3844, DOI 10.1128/JB.175.12.3844-3855.1993; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Matsushita Shigeru, 2003, Kansenshogaku Zasshi, V77, P195; Miller JH., 1972, EXPT MOL GENETICS; MIYAMOTO Y, 1969, J BACTERIOL, V100, P1147, DOI 10.1128/JB.100.2.1147-1149.1969; MORRIS JG, 1985, NEW ENGL J MED, V312, P343, DOI 10.1056/NEJM198502073120604; Naim R, 2001, FEMS MICROBIOL LETT, V195, P237, DOI 10.1016/S0378-1097(01)00015-5; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Nakano M, 2007, J INFECT DIS, V195, P1353, DOI 10.1086/513275; Neela FA, 2007, J MICROBIOL, V45, P64; NISHIBUCHI M, 1995, INFECT IMMUN, V63, P2093, DOI 10.1128/IAI.63.6.2093-2099.1995; Okada N, 2009, INFECT IMMUN, V77, P904, DOI 10.1128/IAI.01184-08; Olive AJ, 2007, INFECT IMMUN, V75, P2626, DOI 10.1128/IAI.01599-06; Osawa R, 1996, APPL ENVIRON MICROB, V62, P3023, DOI 10.1128/AEM.62.8.3023-3025.1996; Osawa R, 2002, CURR MICROBIOL, V44, P302, DOI 10.1007/s00284-001-0051-3; Pace JL, 1997, APPL ENVIRON MICROB, V63, P2372, DOI 10.1128/AEM.63.6.2372-2377.1997; PARALES RE, 1993, GENE, V133, P23, DOI 10.1016/0378-1119(93)90220-W; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Prouty AM, 2000, INFECT IMMUN, V68, P6763, DOI 10.1128/IAI.68.12.6763-6769.2000; Raimondi F, 2000, INFECT IMMUN, V68, P3180, DOI 10.1128/IAI.68.6.3180-3185.2000; SAKURAI J, 1976, INFECT IMMUN, V13, P876, DOI 10.1128/IAI.13.3.876-883.1976; Schuhmacher DA, 1999, J BACTERIOL, V181, P1508, DOI 10.1128/JB.181.5.1508-1514.1999; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Sugiyama T, 2008, J BACTERIOL, V190, P1835, DOI 10.1128/JB.01293-07; Takahashi A, 2001, J MED MICROBIOL, V50, P870, DOI 10.1099/0022-1317-50-10-870; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; TANG GQ, 1995, FEMS MICROBIOL LETT, V134, P233, DOI 10.1016/0378-1097(95)00411-3; Tang GQ, 1997, FEMS MICROBIOL LETT, V150, P289, DOI 10.1016/S0378-1097(97)00133-X; Waldor MK, 2006, NEW ENGL J MED, V354, P296, DOI 10.1056/NEJMcibr054591; XU M, 1994, INFECT IMMUN, V62, P166, DOI 10.1128/IAI.62.1.166-171.1994	56	90	95	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13365	10.1371/journal.pone.0013365	http://dx.doi.org/10.1371/journal.pone.0013365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967223	gold, Green Submitted, Green Published			2022-12-25	WOS:000282869800042
J	Mandel, AL; des Gachons, CP; Plank, KL; Alarcon, S; Breslin, PAS				Mandel, Abigail L.; des Gachons, Catherine Peyrot; Plank, Kimberly L.; Alarcon, Suzanne; Breslin, Paul A. S.			Individual Differences in AMY1 Gene Copy Number, Salivary alpha-Amylase Levels, and the Perception of Oral Starch	PLOS ONE			English	Article							SENSORY PROPERTIES; MILK-FAT; VISCOSITY; TEXTURE; FLAVOR	Background: The digestion of dietary starch in humans is initiated by salivary alpha-amylase, an endo-enzyme that hydrolyzes starch into maltose, maltotriose and larger oligosaccharides. Salivary amylase accounts for 40 to 50% of protein in human saliva and rapidly alters the physical properties of starch. Importantly, the quantity and enzymatic activity of salivary amylase show significant individual variation. However, linking variation in salivary amylase levels with the oral perception of starch has proven difficult. Furthermore, the relationship between copy number variations (CNVs) in the AMY1 gene, which influence salivary amylase levels, and starch viscosity perception has not been explored. Principal Findings: Here we demonstrate that saliva containing high levels of amylase has sufficient activity to rapidly hydrolyze a viscous starch solution in vitro. Furthermore, we show with time-intensity ratings, which track the digestion of starch during oral manipulation, that individuals with high amylase levels report faster and more significant decreases in perceived starch viscosity than people with low salivary amylase levels. Finally, we demonstrate that AMY1 CNVs predict an individual's amount and activity of salivary amylase and thereby, ultimately determine their perceived rate of oral starch viscosity thinning. Conclusions: By linking genetic variation and its consequent salivary enzymatic differences to the perceptual sequellae of these variations, we show that AMY1 copy number relates to salivary amylase concentration and enzymatic activity level, which, in turn, account for individual variation in the oral perception of starch viscosity. The profound individual differences in salivary amylase levels and salivary activity may contribute significantly to individual differences in dietary starch intake and, consequently, to overall nutritional status.	[Mandel, Abigail L.; des Gachons, Catherine Peyrot; Plank, Kimberly L.; Alarcon, Suzanne; Breslin, Paul A. S.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Alarcon, Suzanne; Breslin, Paul A. S.] Rutgers State Univ, Dept Nutr Sci, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA	Monell Chemical Senses Center; Rutgers State University New Brunswick	Mandel, AL (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	breslin@aesop.rutgers.edu		Breslin, Paul/0000-0001-5988-8401	National Starch Co.; National Institutes of Health [R01 DC 02995]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002995] Funding Source: NIH RePORTER	National Starch Co.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by National Starch Co. (http://www. foodinnovation. com/FoodInnovation/en-US/) and a grant by the National Institutes of Health (R01 DC 02995) to PASB. National Starch contributed to the design of the microviscoamylograph and perceptual studies. The company conducted the perceptual testing for eight of the 73 subjects included in this manuscript. National Starch had no role in analysis, decision to publish, or preparation of the manuscript.	BANK RA, 1992, HUM GENET, V89, P213; Chatterton RT, 1996, CLIN PHYSIOL, V16, P433, DOI 10.1111/j.1475-097X.1996.tb00731.x; de Wijk RA, 2004, PHYSIOL BEHAV, V83, P81, DOI 10.1016/j.physbeh.2004.07.014; Engelen L, 2007, ARCH ORAL BIOL, V52, P518, DOI 10.1016/j.archoralbio.2006.11.007; EVANS ID, 1986, J SCI FOOD AGR, V37, P573, DOI 10.1002/jsfa.2740370611; Ferry AL, 2004, J TEXTURE STUD, V35, P511, DOI 10.1111/j.1745-4603.2004.35503.x; FOGEL MR, 1973, J APPL PHYSIOL, V35, P263, DOI 10.1152/jappl.1973.35.2.263; Granger DA, 2007, ANN NY ACAD SCI, V1098, P122, DOI 10.1196/annals.1384.008; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Hoebler C, 1998, BRIT J NUTR, V80, P429, DOI 10.1017/S0007114598001494; Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501; MACKIE DA, 1990, PHYSIOL BEHAV, V47, P593, DOI 10.1016/0031-9384(90)90131-M; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Navazesh M, 2008, J AM DENT ASSOC, V139, p35S, DOI 10.14219/jada.archive.2008.0353; Noble R E, 2000, J Oral Sci, V42, P83; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Prindiville EA, 1999, J DAIRY SCI, V82, P1425, DOI 10.3168/jds.S0022-0302(99)75369-5; Prindiville EA, 2000, J DAIRY SCI, V83, P2216, DOI 10.3168/jds.S0022-0302(00)75105-8; SQUIRES BT, 1953, J PHYSIOL-LONDON, V119, P153, DOI 10.1113/jphysiol.1953.sp004835; STANLEY NL, 1993, ACTA PSYCHOL, V84, P79, DOI 10.1016/0001-6918(93)90074-2	21	156	160	6	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13352	10.1371/journal.pone.0013352	http://dx.doi.org/10.1371/journal.pone.0013352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967220	gold, Green Published, Green Submitted			2022-12-25	WOS:000282869800036
J	Robin, VV; Sinha, A; Ramakrishnan, U				Robin, V. V.; Sinha, Anindya; Ramakrishnan, Uma			Ancient Geographical Gaps and Paleo-Climate Shape the Phylogeography of an Endemic Bird in the Sky Islands of Southern India	PLOS ONE			English	Article							EASTERN ARC MOUNTAINS; WESTERN-GHATS; GENETIC DIVERSITY; POPULATIONS; MODELS; ORIGIN; DIFFERENTIATION; BIOGEOGRAPHY; DIVERGENCE; DISPERSAL	Background: Sky islands, formed by the highest reaches of mountain tracts physically isolated from one another, represent one of the biodiversity-rich regions of the world. Comparative studies of geographically isolated populations on such islands can provide valuable insights into the biogeography and evolution of species on these islands. The Western Ghats mountains of southern India form a sky island system, where the relationship between the island structure and the evolution of its species remains virtually unknown despite a few population genetic studies. Methods and Principal Findings: We investigated how ancient geographic gaps and glacial cycles have partitioned genetic variation in modern populations of a threatened endemic bird, the White-bellied Shortwing Brachypteryx major, across the montane Shola forests on these islands and also inferred its evolutionary history. We used Bayesian and maximum likelihood-based phylogenetic and population-genetic analyses on data from three mitochondrial markers and one nuclear marker (totally 2594 bp) obtained from 33 White-bellied Shortwing individuals across five islands. Genetic differentiation between populations of the species correlated with the locations of deep valleys in the Western Ghats but not with geographical distance between these populations. All populations revealed demographic histories consistent with population founding and expansion during the Last Glacial Maximum. Given the level of genetic differentiation north and south of the Palghat Gap, we suggest that these populations be considered two different taxonomic species. Conclusions and Significance: Our results show that the physiography and paleo-climate of this region historically resulted in multiple glacial refugia that may have subsequently driven the evolutionary history and current population structure of this bird. The first avian genetic study from this biodiversity hotspot, our results provide insights into processes that may have impacted the speciation and evolution of the endemic fauna of this region.	[Robin, V. V.; Sinha, Anindya] Natl Inst Adv Studies, Bangalore, Karnataka, India; [Robin, V. V.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Sinha, Anindya] Nat Conservat Fdn, Mysore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Robin, VV (corresponding author), Natl Inst Adv Studies, Indian Inst Sci Campus, Bangalore, Karnataka, India.	robinvijayan@gmail.com	Robin, V.V./H-7299-2019	Robin, V.V./0000-0003-3109-5498; Ramakrishnan, Uma/0000-0002-5370-5966	Ministry of Environment and Forests, Government of India; Council of Scientific and Industrial Research, Government of India; National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India; Fulbright Fellowship	Ministry of Environment and Forests, Government of India(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India; Fulbright Fellowship	A part of the fellowship for VVR and a part of the fieldwork were supported by a grant from the Eastern Ghats - Western Ghats Programme of the Ministry of Environment and Forests, Government of India to VVR and AS. A part of VVR's fellowship, all laboratory work and a part of the fieldwork were supported by the Council of Scientific and Industrial Research, Government of India and the National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India and a start up grant to UR from the National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India. V. V. Robin was also supported by a Fulbright Fellowship while writing a part of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, 2000, Methods Mol Biol, V132, P221; Assefa A, 2007, HEREDITY, V99, P133, DOI 10.1038/sj.hdy.6800974; Bahulikar RA, 2004, CURR SCI INDIA, V86, P824; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beresford P, 2004, AUK, V121, P23, DOI 10.1642/0004-8038(2004)121[0023:ANSOAS]2.0.CO;2; BirdLife International, 2001, THREAT BIRDS AS BIRD; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; Bowie RCK, 2004, AUK, V121, P660, DOI 10.1642/0004-8038(2004)121[0660:SABODS]2.0.CO;2; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; Castoe TA, 2004, SYST BIOL, V53, P448, DOI 10.1080/10635150490445797; DANIELS RJR, 1992, J BIOGEOGR, V19, P521, DOI 10.2307/2845771; DeChaine EG, 2005, J BIOGEOGR, V32, P1943, DOI 10.1111/j.1365-2699.2005.01356.x; DeChaine EG, 2005, AM J BOT, V92, P477, DOI 10.3732/ajb.92.3.477; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Deshpande AU, 2001, MOL ECOL, V10, P2397, DOI 10.1046/j.0962-1083.2001.01379.x; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 2002, TRENDS ECOL EVOL, V17, P347, DOI 10.1016/S0169-5347(02)02543-0; EDWARDS SV, 1991, P ROY SOC B-BIOL SCI, V243, P99, DOI 10.1098/rspb.1991.0017; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; Excoffier L, 2006, ARLEQUIN VER 3 01 IN; Field JS, 2007, J ANTHROPOL ARCHAEOL, V26, P88, DOI 10.1016/j.jaa.2006.06.001; Fjeldsa J, 2003, P ROY SOC B-BIOL SCI, V270, pS238, DOI 10.1098/rsbl.2003.0075; Fjeldsa J, 2008, AFR J ECOL, V46, P235, DOI 10.1111/j.1365-2028.2008.00992.x; Gower DJ, 2007, J ZOOL, V272, P266, DOI 10.1111/j.1469-7998.2006.00266.x; Grimmett R., 1999, POCKET GUIDE BIRDS I; Gunnell Y, 2003, EARTH PLANET SC LETT, V215, P187, DOI 10.1016/S0012-821X(03)00380-7; Harshman J., 1996, THESIS U CHICAGO; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Islam M.Z., 2004, IMPORTANT BIRD AREAS, V2nd; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Knowles LL, 2001, MOL ECOL, V10, P691, DOI 10.1046/j.1365-294x.2001.01206.x; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LANYON SM, 1994, EVOLUTION, V48, P679, DOI 10.1111/j.1558-5646.1994.tb01353.x; Manly BFJ, 1997, RANDOMIZATION BOOTST; MANTEL N, 1967, CANCER RES, V27, P209; Marchant R, 2007, AFR J ECOL, V45, P4, DOI 10.1111/j.1365-2028.2006.00707.x; MAYR E, 1976, P NATL ACAD SCI USA, V73, P1765, DOI 10.1073/pnas.73.5.1765; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Omland KE, 2000, P ROY SOC B-BIOL SCI, V267, P2475, DOI 10.1098/rspb.2000.1308; PETERSON A, 1993, CONSERVATION PRIORIT, P33; Petraglia M, 2009, P NATL ACAD SCI USA, V106, P12261, DOI 10.1073/pnas.0810842106; POSADA D, 2003, USING MODELTEST PAUP; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Prabhu CN, 2004, PALAEOGEOGR PALAEOCL, V214, P309, DOI 10.1016/j.palaeo.2004.07.027; RAMESH B, 1997, EN MAPS GEOG, V6; Rasmussen P. C., 2005, Zoologische Mededelingen (Leiden), V79, P137; Rasmussen P.C., 2005, BIRDS S ASIA; Ripley D, 1987, HDB BIRDS INDIA PAKI; Robin VV, 2002, BIRD CONSERV INT, V12, P335, DOI 10.1017/S0959270902002216; Robinson F, 2006, J ROY ASIATIC SOC, V16, P345, DOI 10.1017/S1356186306006419; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; RONQUIST F, 2005, BAYESIAN ANAL MOL EV, P183; Santosh M., 1992, B INDIAN GEOLOGICAL, V25, P1; SLATKIN M, 1991, GENETICS, V129, P555; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; SOMAN K, 1990, J GEOL SOC INDIA, V35, P82; Stanley WT, 2005, J ZOOL, V266, P341, DOI 10.1017/S0952836905007016; STOREY BC, 1995, NATURE, V377, P301, DOI 10.1038/377301a0; Sutherland W. J., 2004, BIRD ECOLOGY CONSERV; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Vidya TNC, 2005, HEREDITY, V94, P71, DOI 10.1038/sj.hdy.6800568; Warshall P., 1994, BIODIVERSITY MANAGEM, P6; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Weir JT, 2006, EVOLUTION, V60, P842; WIKRAMANAYAKE E, 2001, TERRESTRIAL ECOREGIO; Wright S, 1943, GENETICS, V28, P114; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x; Zink RM, 2003, MOL ECOL, V12, P3069, DOI 10.1046/j.1365-294X.2003.01981.x	78	70	79	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13321	10.1371/journal.pone.0013321	http://dx.doi.org/10.1371/journal.pone.0013321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967202	gold, Green Published, Green Submitted			2022-12-25	WOS:000282869800023
J	Chen, SCC; Yeh, JJ; Chang, MH; Liao, YK; Hsiao, LC; Neoh, CA; Tok, TS; Wang, JD				Chen, Solomon Chih-Cheng; Yeh, Jun-Jun; Chang, Mei-Hwei; Liao, Yu-Kuei; Hsiao, Li-Chen; Neoh, Choo-Aun; Tok, Teck-Siang; Wang, Jung-Der			Gender Difference of Alanine Aminotransferase Elevation May Be Associated with Higher Hemoglobin Levels among Male Adolescents	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CHRONIC HEPATITIS-C; INSULIN-RESISTANCE; IRON DEPLETION; CONTROLLED-TRIAL; B-VACCINE; PHLEBOTOMY; CHILDREN; RISK; DETERMINANTS	Background: To explore the gender difference of ALT elevation and its association with high hemoglobin levels. Methods: A cross-sectional study of 3547 adolescents (2005 females, mean age of 16.5?.3 years) who were negative for hepatitis B surface antigen received health checkups in 2006. Body mass index (BMI), levels of hemoglobin, ALT and cholesterol were measured. ALT >42 U/L was defined as elevated ALT. Elevated ALT levels were detected in 112 of the 3547 participants (3.3%), more prevalent in males than in females (5.4% vs. 1.4%, p<0.001). Hemoglobin levels had a significant linear correlation with ALT levels in both genders. Abnormal ALT started to occur if hemoglobin >11 g/dl in females or >13.5 g/dl in males, but the cumulative cases of elevated ALT increased more quickly in males. Proportion of elevated ALT increased as either the BMI or hemoglobin level rise, more apparent in male adolescents. Logistic regression modeling showed odds ratio (95% confidence interval) were 24.7 (15.0-40.6) for BMI >= 27 kg/m(2); 5.5 (2.9-10.4) for BMI 24-27 kg/m(2); 2.7 (1.3-5.5) for Q5 (top 20th percentile) hemoglobin level; and 2.6 (1.6-4.1) for male gender. Further separately fitting the logistic models for two genders, the significance of Q5 hemoglobin level only appeared in the males. Conclusions: High hemoglobin level is a significant risk factor of ALT elevation after control hepatitis B, obesity and gender. Males have greater risk of abnormal liver function which may be associated with higher hemoglobin levels.	[Chen, Solomon Chih-Cheng; Tok, Teck-Siang] Pingtung Christian Hosp, Dept Pediat, Pingtung, Taiwan; [Yeh, Jun-Jun] Pingtung Christian Hosp, Dept Internal Med, Pingtung, Taiwan; [Chang, Mei-Hwei] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Liao, Yu-Kuei; Hsiao, Li-Chen; Neoh, Choo-Aun] Pingtung Christian Hosp, Dept Community Hlth, Pingtung, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Environm & Occupat Med, Tainan 70428, Taiwan; [Wang, Jung-Der] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University	Chen, SCC (corresponding author), Pingtung Christian Hosp, Dept Pediat, Pingtung, Taiwan.	jdwang121@gmail.com		Chen, Solomon/0000-0003-0031-6147; Chang, Mei Hwei/0000-0002-3648-9261; Yeh, Jun-Jun/0000-0002-4368-7880	National Science Council, Taiwan [NSC99-2314-B-475-001]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by a grant (NSC99-2314-B-475-001) from the National Science Council, Taiwan (http://web1.nsc.gov.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedogni G, 2004, ANN HUM BIOL, V31, P570, DOI 10.1080/03014460400001230; Carlo C, 2003, HEPATO-GASTROENTEROL, V50, P1467; Chang JG, 1997, BLOOD, V89, P3492, DOI 10.1182/blood.V89.9.3492; *DEP HLTH, SMOK RAT SEN HIGH SC; Di Bonito P, 2009, METABOLISM, V58, P368, DOI 10.1016/j.metabol.2008.10.010; Eaton JW, 2002, FREE RADICAL BIO MED, V32, P833, DOI 10.1016/S0891-5849(02)00772-4; Franchini M, 2008, HEPATOL INT, V2, P335, DOI 10.1007/s12072-008-9076-z; Fraser A, 2007, GASTROENTEROLOGY, V133, P1814, DOI 10.1053/j.gastro.2007.08.077; Fu CC, 2009, ANN ACAD MED SINGAP, V38, P15; Hsiao TJ, 2004, INT J OBESITY, V28, P167, DOI 10.1038/sj.ijo.0802519; Lai CL, 2007, J VIRAL HEPATITIS, V14, P6, DOI 10.1111/j.1365-2893.2007.00909.x; Li TC, 2004, J GASTROENTEROL, V39, P1170, DOI 10.1007/s00535-004-1467-x; Lin TJ, 2005, WORLD J GASTROENTERO, V11, P3905; Liu CM, 2005, WORLD J GASTROENTERO, V11, P7159, DOI 10.3748/wjg.v11.i45.7159; Lu CY, 2008, J INFECT DIS, V197, P1419, DOI 10.1086/587695; Lu CY, 2004, HEPATOLOGY, V40, P1415, DOI 10.1002/hep.20490; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Park HS, 2005, AM J CLIN NUTR, V82, P1046, DOI 10.1093/ajcn/82.5.1046; Price L, 2009, CAN J GASTROENTEROL, V23, P822, DOI 10.1155/2009/290383; Riquelme A, 2004, DIGEST DIS SCI, V49, P1012, DOI 10.1023/B:DDAS.0000034564.68307.39; Ruhl CE, 2003, GASTROENTEROLOGY, V124, P1821, DOI 10.1016/S0016-5085(03)00395-0; Ruhl CE, 2003, GASTROENTEROLOGY, V124, P71, DOI 10.1053/gast.2003.50004; Sagi R, 2007, ACTA PAEDIATR, V96, P1209, DOI 10.1111/j.1651-2227.2007.00399.x; Sakugawa H, 2004, EUR J CLIN NUTR, V58, P1248, DOI 10.1038/sj.ejcn.1601956; Salazar LIF, 2004, REV ESP ENFERM DIG, V96, P818; Sartori M, 2010, WORLD J GASTROENTERO, V16, P596, DOI 10.3748/wjg.v16.i5.596; Schwimmer JB, 2005, PEDIATRICS, V115, pE561, DOI 10.1542/peds.2004-1832; Shakya R, 2004, ANN PHARMACOTHER, V38, P1074, DOI 10.1345/aph.1D525; Sikorska Katarzyna, 2003, Med Sci Monit, V9 Suppl 3, P64; Sumida Y, 2007, INTERNAL MED, V46, P637, DOI 10.2169/internalmedicine.46.6085; Tsai Ming-Han, 2005, Journal of Microbiology Immunology and Infection, V38, P255; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Yano M, 2004, J GASTROENTEROL, V39, P570, DOI 10.1007/s00535-003-1344-z; YEH PS, 2009, OBES SURG; Yen SL, 2008, INT J OBESITY, V32, P474, DOI 10.1038/sj.ijo.0803753	35	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13269	10.1371/journal.pone.0013269	http://dx.doi.org/10.1371/journal.pone.0013269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967274	Green Published, gold, Green Submitted			2022-12-25	WOS:000282807300011
J	Marques, RB; Thabet, MM; White, SJ; Houwing-Duistermaat, JJ; Bakker, AM; Hendriks, GJ; Zhernakova, A; Huizinga, TW; van der Helm-van Mil, AH; Toes, RE				Marques, Rute B.; Thabet, Mohamed M.; White, Stefan J.; Houwing-Duistermaat, Jeanine J.; Bakker, Aleida M.; Hendriks, Gert-Jan; Zhernakova, Alexandra; Huizinga, Tom W.; van der Helm-van Mil, Annette H.; Toes, Rene E.			Genetic Variation of the Fc Gamma Receptor 3B Gene and Association with Rheumatoid Arthritis	PLOS ONE			English	Article							COPY-NUMBER VARIATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DEPENDENT PROBE AMPLIFICATION; HUMAN GENOME; SEGMENTAL DUPLICATIONS; DISEASE SUSCEPTIBILITY; STRUCTURAL VARIATION; POLYMORPHISMS; REARRANGEMENTS; FCGR3B	Background: Fc gamma receptors (Fc gamma Rs) play a crucial role in immunity by linking IgG antibody-mediated responses with cellular effector and regulatory functions. Genetic variants in these receptors have been previously identified as risk factors for several chronic inflammatory conditions. The present study aimed to investigate the presence of copy number variations (CNVs) in the FCGR3B gene and its potential association with the autoimmune disease rheumatoid arthritis (RA). Methodology/Principal Findings: CNV of the FCGR3B gene was studied using Multiplex Ligation Dependent Probe Amplification (MLPA) in 518 Dutch RA patients and 304 healthy controls. Surprisingly, three independent MLPA probes targeting the FCGR3B promoter measured different CNV frequencies, with probe#1 and #2 measuring 0 to 5 gene copies and probe#3 showing little evidence of CNV. Quantitative-PCR correlated with the copy number results from MLPA probe#2, which detected low copy number (1 copy) in 6.7% and high copy number (>= 3 copies) in 9.4% of the control population. No significant difference was observed between RA patients and the healthy controls, neither in the low copy nor the high copy number groups (p-values = 0.36 and 0.71, respectively). Sequencing of the FCGR3B promoter region revealed an insertion/deletion (indel) that explained the disparate CNV results of MLPA probe#1. Finally, a non-significant trend was found between the novel -256A>TG indel and RA (40.7% in healthy controls versus 35.9% in RA patients; P = 0.08). Conclusions/Significance: The current study highlights the complexity and poor characterization of the FCGR3B gene sequence, indicating that the design and interpretation of genotyping assays based on specific probe sequences must be performed with caution. Nonetheless, we confirmed the presence of CNV and identified novel polymorphisms in the FCGR3B gene in the Dutch population. Although no association was found between RA and FCGR3B CNV, the possible protective effect of the -256A>TG indel polymorphism must be addressed in larger studies.	[Marques, Rute B.; Thabet, Mohamed M.; Bakker, Aleida M.; Hendriks, Gert-Jan; Zhernakova, Alexandra; Huizinga, Tom W.; van der Helm-van Mil, Annette H.; Toes, Rene E.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Thabet, Mohamed M.] Assiut Univ Hosp, Dept Internal Med, Assiut, Egypt; [White, Stefan J.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Houwing-Duistermaat, Jeanine J.] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Egyptian Knowledge Bank (EKB); Assiut University; Murdoch Children's Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Marques, RB (corresponding author), Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands.	r.b.marques@lumc.nl	Houwing-Duistermaat, Jeanne/V-9048-2018; Zhernakova, Alexandra/ABA-9372-2020	Hendriks, Gert-Jan/0000-0001-8798-1443; van der Helm - van Mil, Annette/0000-0001-8572-1437; Toes, Rene/0000-0002-9618-6414; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137; Zhernakova, Alexandra/0000-0002-4574-0841	Dutch Organisation for Scientific Research; Centre for Medical Systems Biology (CMSB); Netherlands Genomics Initiative (NGI); Dutch Arthritis Association; European Union-funded FP7-integrated project Masterswitch [223404]	Dutch Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for Medical Systems Biology (CMSB); Netherlands Genomics Initiative (NGI); Dutch Arthritis Association; European Union-funded FP7-integrated project Masterswitch	The work published in this manuscript was supported through the Dutch Organisation for Scientific Research (VICI grant), the Centre for Medical Systems Biology (CMSB) within the framework of the Netherlands Genomics Initiative (NGI), the Dutch Arthritis Association (Reumafonds grant) and the European Union-funded FP7-integrated project Masterswitch no. 223404. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Aten E, 2008, CYTOGENET GENOME RES, V123, P313, DOI 10.1159/000184723; Bournazos S, 2009, CLIN EXP IMMUNOL, V157, P244, DOI 10.1111/j.1365-2249.2009.03980.x; Brinkman BMN, 1997, BRIT J RHEUMATOL, V36, P516; Carcao MD, 2003, BRIT J HAEMATOL, V120, P135, DOI 10.1046/j.1365-2141.2003.04033.x; Chu ZT, 2004, TISSUE ANTIGENS, V63, P21, DOI 10.1111/j.1399-0039.2004.00142.x; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; de Jong BA, 2002, HUM IMMUNOL, V63, P281, DOI 10.1016/S0198-8859(02)00369-5; Fanciulli M, 2008, CYTOGENET GENOME RES, V123, P161, DOI 10.1159/000184704; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Janssen B, 2005, NEUROGENETICS, V6, P29, DOI 10.1007/s10048-004-0204-1; Kyogoku C, 2002, ARTHRITIS RHEUM, V46, P1242, DOI 10.1002/art.10257; Kyogoku C, 2002, GENES IMMUN, V3, P488, DOI 10.1038/sj.gene.6363921; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lee YH, 2008, J RHEUMATOL, V35, P2129, DOI 10.3899/jrheum.080186; Li LH, 2010, SCAND J RHEUMATOL, V39, P148, DOI 10.3109/03009740903292304; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Mamtani M, 2010, GENES IMMUN, V11, P155, DOI 10.1038/gene.2009.71; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; MCKINNEY C, 2010, ANN RHEUM D IN PRESS; Morgan AW, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1847; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; QIU WQ, 1990, SCIENCE, V248, P732, DOI 10.1126/science.2139735; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rooms L, 2004, HUM MUTAT, V23, P17, DOI 10.1002/humu.10300; Salmon JE, 2001, ARTHRITIS RHEUM, V44, P739; Schaschl H, 2009, CLIN EXP IMMUNOL, V156, P12, DOI 10.1111/j.1365-2249.2008.03865.x; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Su K, 2002, GENES IMMUN, V3, pS51, DOI 10.1038/sj.gene.6363879; Thabet MM, 2009, ANN RHEUM DIS, V68, P1775, DOI 10.1136/ard.2008.099309; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; van Aken J, 2003, CLIN EXP RHEUMATOL, V21, pS100; van Sorge NM, 2003, TISSUE ANTIGENS, V61, P189, DOI 10.1034/j.1399-0039.2003.00037.x; White SJ, 2007, CYTOGENET GENOME RES, V118, P19, DOI 10.1159/000106437; White SJ, 2006, CYTOGENET GENOME RES, V115, P240, DOI 10.1159/000095920; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054; Williams RG, 1998, PEDIATRICS, V101, P779; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Wu YL, 2008, CYTOGENET GENOME RES, V123, P131, DOI 10.1159/000184700; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yuan H, 2009, MOL BIOL REP, V36, P1053, DOI 10.1007/s11033-008-9280-x	57	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13173	10.1371/journal.pone.0013173	http://dx.doi.org/10.1371/journal.pone.0013173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957197	Green Submitted, gold, Green Published			2022-12-25	WOS:000282506100011
J	Yazdanpanah, Y; Sloan, CE; Charlois-Ou, C; Le Vu, S; Semaille, C; Costagliola, D; Pillonel, J; Poullie, AI; Scemama, O; Deuffic-Burban, S; Losina, E; Walensky, RP; Freedberg, KA; Paltiel, AD				Yazdanpanah, Yazdan; Sloan, Caroline E.; Charlois-Ou, Cecile; Le Vu, Stephane; Semaille, Caroline; Costagliola, Dominique; Pillonel, Josiane; Poullie, Anne-Isabelle; Scemama, Olivier; Deuffic-Burban, Sylvie; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.; Paltiel, A. David			Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; UNITED-STATES; OPPORTUNISTIC INFECTIONS; LATE DIAGNOSIS; LIFETIME COST; CONSEQUENCES; TRANSMISSION; CARE; ERA	Background: In France, roughly 40,000 HIV-infected persons are unaware of their HIV infection. Although previous studies have evaluated the cost-effectiveness of routine HIV screening in the United States, differences in both the epidemiology of infection and HIV testing behaviors warrant a setting-specific analysis for France. Methods/Principal Findings: We estimated the life expectancy (LE), cost and cost-effectiveness of alternative HIV screening strategies in the French general population and high-risk sub-populations using a computer model of HIV detection and treatment, coupled with French national clinical and economic data. We compared risk-factor-based HIV testing ("current practice'') to universal routine, voluntary HIV screening in adults aged 18-69. Screening frequencies ranged from once to annually. Input data included mean age (42 years), undiagnosed HIV prevalence (0.10%), annual HIV incidence (0.01%), test acceptance (79%), linkage to care (75%) and cost/test ((sic)43). We performed sensitivity analyses on HIV prevalence and incidence, cost estimates, and the transmission benefits of ART. "Current practice'' produced LEs of 242.82 quality-adjusted life months (QALM) among HIV-infected persons and 268.77 QALM in the general population. Adding a one-time HIV screen increased LE by 0.01 QALM in the general population and increased costs by (sic)50/person, for a cost-effectiveness ratio (CER) of (sic)57,400 per quality-adjusted life year (QALY). More frequent screening in the general population increased survival, costs and CERs. Among injection drug users (prevalence 6.17%; incidence 0.17%/year) and in French Guyana (prevalence 0.41%; incidence 0.35%/year), annual screening compared to every five years produced CERs of (sic)51,200 and (sic)46,500/QALY. Conclusions/Significance: One-time routine HIV screening in France improves survival compared to "current practice'' and compares favorably to other screening interventions recommended in Western Europe. In higher-risk groups, more frequent screening is economically justifiable.	[Yazdanpanah, Yazdan] Ctr Hosp Tourcoing, Serv Univ Malad Infect & Voyageur, Tourcoing, France; [Yazdanpanah, Yazdan] INSERM, U995, Avenir Act Themat & Incitat Programme, F-59045 Lille, France; [Yazdanpanah, Yazdan; Semaille, Caroline] Fac Med Lille, EA 2694, F-59045 Lille, France; [Sloan, Caroline E.; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Charlois-Ou, Cecile] Ctr Natl Rech Sci, CRESGE LEM, UMR8179, Lille, France; [Le Vu, Stephane; Semaille, Caroline; Pillonel, Josiane] Inst Veille Sanitaire, Dept Infect Dis, HIV AIDS STI HCV Unit, St Maurice, France; [Costagliola, Dominique] INSERM, U943, Paris, France; [Costagliola, Dominique] INSERM, UMR S 943, Paris, France; [Costagliola, Dominique] Univ Paris 06, Paris, France; [Costagliola, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Malad Infect & Trop, F-75634 Paris, France; [Poullie, Anne-Isabelle; Scemama, Olivier] Haute Autorite Sante, Econ & Publ Hlth Assessment Dept, St Denis, France; [Deuffic-Burban, Sylvie] INSERM, U995, Fac Med Lille, F-59045 Lille, France; [Losina, Elena; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Losina, Elena; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Paltiel, A. David] Yale Univ, Sch Med, New Haven, CT USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); Institute of Public Health Surveillance; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University	Yazdanpanah, Y (corresponding author), Ctr Hosp Tourcoing, Serv Univ Malad Infect & Voyageur, Tourcoing, France.	yyazdan@yahoo.com	Costagliola, Dominique/H-5849-2011; Deuffic-Burban, Sylvie/O-3293-2017	Costagliola, Dominique/0000-0003-0765-0869; Deuffic-Burban, Sylvie/0000-0003-3241-7647; Le Vu, Stephane/0000-0002-1303-8281; Walensky, Rochelle P./0000-0002-8795-379X; Sloan, Caroline/0000-0003-1611-3846; Losina, ELENA/0000-0002-3424-0892; Paltiel, A. David/0000-0002-4861-3290	Haute Autorite de Sante; Institut de Veille Sanitaire, Sidaction; Agence Nationale de Recherches sur le SIDA et les hepatites virales; National Institute of Allergy and Infectious Diseases [R01 AI042006, K24 AI062476, P30 AI42851]; National Institute of Mental Health [R01 MH65869]; National Institute on Drug Abuse [R01 DA015612]; Boehringer-Ingelheim; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Merck-Sharp Dohme-Chibret; Pfizer; Roche; Schering Plough; Tibotec; Abbott; Janssen-Cilag; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042006, K24AI062476, P30AI042851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	Haute Autorite de Sante; Institut de Veille Sanitaire, Sidaction; Agence Nationale de Recherches sur le SIDA et les hepatites virales(ANRSFrench National Research Agency (ANR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Boehringer-Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Merck-Sharp Dohme-Chibret(Merck & Company); Pfizer(Pfizer); Roche(Roche Holding); Schering Plough(Merck & CompanySchering Plough Corporation); Tibotec; Abbott(Abbott Laboratories); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by the Haute Autorite de Sante, the Institut de Veille Sanitaire, Sidaction, the Agence Nationale de Recherches sur le SIDA et les hepatites virales, the National Institute of Allergy and Infectious Diseases (R01 AI042006, K24 AI062476, P30 AI42851), the National Institute of Mental Health (R01 MH65869), and the National Institute on Drug Abuse (R01 DA015612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; With the exception of Yazdan Yazdanpanah and Dominique Costagliola, none of the authors report any association that might pose a conflict of interest (e. g. pharmaceutical stock ownership, consultancy, advisory board membership, relevant patents, or research funding). Dr. Yazdanpanah has received travel grants, consultancy fees and honoraria for presentation at workshops from Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck-Sharp & Dohme-Chibret, Pfizer, Roche, Schering Plough and Tibotec. Dominique Costagliola has received travel grants, consultancy fees, honoraria and study grants from various pharmaceutical companies including Abbott, Boehringer-Ingelheim, Bristol-Myers-Squibb, Gilead Sciences, Glaxo-SmithKline, Janssen-Cilag, Merck-Sharp & Dohme-Chibret and Roche.	Adams EJ, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.024364; [Anonymous], 1992, FRENCH HOSP DATABASE; [Anonymous], 2009, GUID US ANT AG HIV 1; Arveux P, 2003, EUR J CANCER CARE, V12, P143, DOI 10.1046/j.1365-2354.2003.00373.x; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Borghi V, 2008, JAIDS-J ACQ IMM DEF, V49, P282, DOI 10.1097/QAI.0b013e318186eabc; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; *CAISS NAT ASS MAL, 2008, NOM GEN ACT BIOL MED; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; CAZEIN F, 2008, B EPIDEMIOL HEBD, V45, P434; CAZEIN F, 2009, B EPIDEMIOLOGIQUE HE; Coco A, 2005, ANN FAM MED, V3, P391, DOI 10.1370/afm.375; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Conseil national du sida, 2006, RAPP EV DISP DEP INF; Conseil National du Sida, 2008, EP INF VIH GUYAN PRO; DESENCLOS JC, 2005, BEH, V11, P41; Deuffic-Burban S, 2006, EUR J EPIDEMIOL, V21, P389, DOI 10.1007/s10654-006-9003-3; Dybul M, 2002, J INFECT DIS, V185, P1818, DOI 10.1086/340650; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Girardi E, 2004, JAIDS-J ACQ IMM DEF, V36, P951, DOI 10.1097/00126334-200408010-00009; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Gold R, 1996, COST EFFECTIVENESS H; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Hamers FF, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00584.x; *I NAT STAT ET EC, 2006, TABL 6 POP TOT SEX A; *I NAT STAT ET EC, 2008, EFF PROF SANT; *I RECH DOC EC SAN, 2007, DEP SANT; *I VEILL SAN, 2007, B EPIDEMIOLOGIQUE HE, P46; *I VEILL SANT, 2006, SURV HIV AIDS INF FR; Jauffret Roustide M, 2006, B EPIDEMIOLOGIQUE HE, V33, P244; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Kim JJ, 2005, JNCI-J NATL CANCER I, V97, P888, DOI 10.1093/jnci/dji162; Lanoy E, 2007, ANTIVIR THER, V12, P89; Lejeune C, 2004, INT J TECHNOL ASSESS, V20, P434, DOI 10.1017/S0266462304001321; LEVU S, 2003, 2010 POPULATION BASE; Lewden C, 2006, EPIDEMIOL INFECT, V134, P1345, DOI 10.1017/S095026880600639X; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; MORTIER E, 2002, B EPIDEMIOLOGIQUE HE, V1, P2; Mounier-Jack S, 2008, HIV MED, V9, P13, DOI 10.1111/j.1468-1293.2008.00585.x; NDAWINZ J, 2009, ESTIMATION INC UNPUB; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 1998, MED DECIS MAKING, V18, pS93, DOI 10.1177/0272989X9801800211; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; RICHETMASTAIN L, I NATL STAT ETUDES E; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Sutton AJ, 2008, J VIRAL HEPATITIS, V15, P797, DOI 10.1111/j.1365-2893.2008.01008.x; UNAIDS, UNAIDS REP GLOB AIDS; Weill A, 2006, PRAT ORG SOINS, V37, P173; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008; *WHO, 2005, LIF TABL WHO MEMB ST; World Health Organization, 2001, MACR HLTH INV HLTH E; Yazdanpanah Y, 2002, ANTIVIR THER, V7, P257; Yazdanpanah Y, 2003, CLIN INFECT DIS, V36, P86, DOI 10.1086/344902; Yazdanpanah Y, 2001, INT J EPIDEMIOL, V30, P864, DOI 10.1093/ije/30.4.864; Yeni P, 2008, PRISE CHARGE MED PER; ASSURANCE MALADIE LI	62	83	85	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13132	10.1371/journal.pone.0013132	http://dx.doi.org/10.1371/journal.pone.0013132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20976112	gold, Green Published, Green Submitted			2022-12-25	WOS:000282359300023
J	Dickhout, JG; Lhotak, S; Hilditch, BA; Basseri, S; Colgan, SM; Lynn, EG; Carlisle, RE; Zhou, J; Sood, SK; Ingram, AJ; Austin, RC				Dickhout, Jeffrey G.; Lhotak, Sarka; Hilditch, Brooke A.; Basseri, Sana; Colgan, Stephen M.; Lynn, Edward G.; Carlisle, Rachel E.; Zhou, Ji; Sood, Sudesh K.; Ingram, Alistair J.; Austin, Richard C.			Induction of the unfolded protein response after monocyte to macrophage differentiation augments cell survival in early atherosclerotic lesions	FASEB JOURNAL			English	Article						atherosclerosis; apoptosis; ER stress; GRP78; cellular transformation	ENDOPLASMIC-RETICULUM STRESS; COLONY-STIMULATING FACTOR; APOE-DEFICIENT MICE; ACUTE CORONARY SYNDROME; APOLIPOPROTEIN-E; ACCELERATES ATHEROSCLEROSIS; FOLIC-ACID; ER STRESS; ENHANCED ATHEROSCLEROSIS; QUANTITATIVE ASSESSMENT	Endoplasmic reticulum (ER) stress causes macrophage cell death within advanced atherosclerotic lesions, thereby contributing to necrotic core formation and increasing the risk of atherothrombotic disease. However, unlike in advanced lesions, the appearance of dead/apoptotic macrophages in early lesions is less prominent. Given that activation of the unfolded protein response (UPR) is detected in early lesion-resident macrophages and can enhance cell survival against ER stress, we investigated whether UPR activation occurs after monocyte to macrophage differentiation and confers a cytoprotective advantage to the macrophage. Human peripheral blood monocytes were treated with monocyte colony-stimulating factor to induce macrophage differentiation, as assessed by changes in ultrastructure and scavenger receptor expression. UPR markers, including GRP78, GRP94, and spliced XBP-1, were induced after macrophage differentiation and occurred after a significant increase in de novo protein synthesis. UPR activation after differentiation reduced macrophage cell death by ER stress-inducing agents. Further, GRP78 overexpression in macrophages was sufficient to reduce ER stress-induced cell death. Consistent with these in vitro findings, UPR activation was observed in viable lesion-resident macrophages from human carotid arteries and from the aortas of apoE(-/-) mice. However, no evidence of apoptosis was observed in early lesion-resident macrophages from the aortas of apoE(-/-) mice. Thus, our findings that UPR activation occurs during macrophage differentiation and is cytoprotective against ER stress-inducing agents suggest an important cellular mechanism for macrophage survival within early atherosclerotic lesions.-Dickhout, J. G., Lhotak, S., Hilditch, B. A., Basseri, S., Colgan, S. M., Lynn, E. G., Carlisle, R. E., Zhou, J., Sood, S. K., Ingram, A. J., Austin, R. C. Induction of the unfolded protein response after monocyte to macrophage differentiation augments cell survival in early atherosclerotic lesions. FASEB J. 25, 576-589 (2011). www.fasebj.org	[Austin, Richard C.] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON L8N 4A6, Canada; [Dickhout, Jeffrey G.; Lhotak, Sarka; Basseri, Sana; Lynn, Edward G.; Carlisle, Rachel E.; Sood, Sudesh K.; Ingram, Alistair J.; Austin, Richard C.] St Josephs Healthcare Hamilton, Hamilton, ON L8N 4A6, Canada	McMaster University; McMaster University	Austin, RC (corresponding author), McMaster Univ, Dept Med, Div Nephrol, 50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.	austinr@taari.ca	Dickhout, Jeffrey/R-2606-2019	Lynn, Edward/0000-0002-8011-5558; Carlisle, Rachel/0000-0002-4266-1953	Heart and Stroke Foundation of Ontario [T-6146]; Canadian Institutes of Health Research [MOP-74477]; Ontario Research and Development Challenge Fund; St. Joseph's Healthcare Hamilton; St. Joseph's Healthcare Hamilton Division of Nephrology; Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research and Development Challenge Fund(General Electric); St. Joseph's Healthcare Hamilton; St. Joseph's Healthcare Hamilton Division of Nephrology; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported in part by research grants to R.C.A. from the Heart and Stroke Foundation of Ontario (T-6146), the Canadian Institutes of Health Research (MOP-74477), and the Ontario Research and Development Challenge Fund. Financial support from St. Joseph's Healthcare Hamilton is acknowledged. J.G.D. is supported by the St. Joseph's Healthcare Hamilton Division of Nephrology Junior Research Award. S.B. is supported by a doctoral scholarship from the Heart and Stroke Foundation of Canada. R.C.A. is a Career Investigator of the Heart and Stroke Foundation of Ontario and holds the Amgen Canada Research Chair in the Division of Nephrology at St. Joseph's Healthcare and McMaster University.	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Boesten LSM, 2006, FASEB J, V20, P953, DOI 10.1096/fj.05-4530fje; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Brewer JW, 1997, EMBO J, V16, P7207, DOI 10.1093/emboj/16.23.7207; Cenci S, 2007, FEBS LETT, V581, P3652, DOI 10.1016/j.febslet.2007.04.031; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; CLINTON SK, 1992, AM J PATHOL, V140, P301; Dickhout JG, 2007, ANTIOXID REDOX SIGN, V9, P1863, DOI 10.1089/ars.2007.1780; Dickhout JG, 2007, CIRCULATION, V116, P1214, DOI 10.1161/CIRCULATIONAHA.107.728378; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; GILBERT HS, 1989, BLOOD, V74, P1231; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hegyi L, 1996, J PATHOL, V180, P423, DOI 10.1002/(SICI)1096-9896(199612)180:4<423::AID-PATH677>3.0.CO;2-1; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kawahara K, 2001, FEBS LETT, V506, P135, DOI 10.1016/S0014-5793(01)02898-8; Kockx MM, 1996, AM J PATHOL, V148, P1771; Libby P, 1996, CURR OPIN LIPIDOL, V7, P330, DOI 10.1097/00041433-199610000-00012; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu H, 1998, J BIOL CHEM, V273, P12858, DOI 10.1074/jbc.273.21.12858; Liu J, 2005, ARTERIOSCL THROM VAS, V25, P174, DOI 10.1161/01.ATV.0000148548.47755.22; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Ma YJ, 2003, NAT IMMUNOL, V4, P310, DOI 10.1038/ni0403-310; Misra UK, 2005, J LEUKOCYTE BIOL, V78, P187, DOI 10.1189/jlb.1104685; Miyamoto M, 2000, CELL TRANSPLANT, V9, P681, DOI 10.1177/096368970000900514; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Naito M, 2008, PATHOL INT, V58, P143, DOI 10.1111/j.1440-1827.2007.02203.x; NAKAI A, 1995, CELL STRUCT FUNCT, V20, P33, DOI 10.1247/csf.20.33; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Pang ZJ, 1999, ATHEROSCLEROSIS, V147, P33, DOI 10.1016/S0021-9150(99)00159-8; Plesner A, 2003, J IMMUNOL METHODS, V279, P287, DOI 10.1016/S0022-1759(03)00234-5; Qiao JH, 1997, AM J PATHOL, V150, P1687; Rajavashisth T, 1998, J CLIN INVEST, V101, P2702, DOI 10.1172/JCI119891; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; ROSENFELD ME, 1992, AM J PATHOL, V140, P291; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; Tabas I, 2009, ANN NY ACAD SCI, V1173, pE40, DOI 10.1111/j.1749-6632.2009.04957.x; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; van Vlijmen BJM, 2001, CIRC RES, V88, P780, DOI 10.1161/hh0801.089261; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; Wang YC, 2008, CANCER RES, V68, P2820, DOI 10.1158/0008-5472.CAN-07-1336; Watson LM, 2003, J BIOL CHEM, V278, P17438, DOI 10.1074/jbc.M301006200; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1; Zhou J, 2004, CIRCULATION, V110, P207, DOI 10.1161/01.CIR.0000134487.51510.97; Zhou J, 2003, ATHEROSCLEROSIS, V168, P255, DOI 10.1016/S0021-9150(03)00138-2; Zhou J, 2001, ARTERIOSCL THROM VAS, V21, P1470, DOI 10.1161/hq0901.096582; Zhou J, 2008, FASEB J, V22, P2569, DOI 10.1096/fj.07-105353	68	37	37	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					576	589		10.1096/fj.10-159319	http://dx.doi.org/10.1096/fj.10-159319			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20966213				2022-12-25	WOS:000286724800016
J	Latonen, L; Moore, HM; Bai, B; Jaamaa, S; Laiho, M				Latonen, L.; Moore, H. M.; Bai, B.; Jaamaa, S.; Laiho, M.			Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability	ONCOGENE			English	Article						proteasome inhibitor; proteasome; ubiquitin; polyadenylated RNA; nuclear export; aggresome	NUCLEAR EXPORT; RIBOSOMAL-SUBUNITS; DNA-DAMAGE; P53; CRM1; ATAXIN-1; LOCALIZATION; BIOGENESIS; AGGRESOMES; COMPONENT	The ubiquitin-proteasome pathway is essential for most cellular processes, including protein quality control, cell cycle, transcription, signaling, protein transport, DNA repair and stress responses. Hampered proteasome activity leads to the accumulation of polyubiquitylated proteins, endoplastic reticulum (ER) stress and even cell death. The ability of chemical proteasome inhibitors (PIs) to induce apoptosis is utilized in cancer therapy. During PI treatment, misfolded proteins accrue to cytoplasmic aggresomes. The formation of aggresome-like structures in the nucleus has remained obscure. We identify here a nucleolus-associated RNA-protein aggregate (NoA) formed by the inhibition of proteasome activity in mammalian cells. The aggregate forms within the nucleolus and is dependent on nucleolar integrity, yet is a separate structure, lacking nucleolar marker proteins, ribosomal RNA (rRNA) and rRNA synthesis activity. The NoAs contain polyadenylated RNA, conjugated ubiquitin and numerous nucleoplasmic proteasome target proteins. Several of these are key factors in oncogenesis, including transcription factors p53 and retinoblastoma protein (Rb), several cell cycle-regulating cyclins and cyclin-dependent kinases (CDKs), and stress response kinases ataxia-telangiectasia mutated (ATM) and Chk1. The aggregate formation depends on ubiquitin availability, as shown by modulating the levels of ubiquitin and deubiquitinases. Furthermore, inhibition of chromosome region maintenance 1 protein homolog (CRM1) export pathway aggravates the formation of NoAs. Taken together, we identify here a novel nuclear stress body, which forms upon proteasome inactivity within the nucleolus and is detectable in mammalian cell lines and in human tissue. These findings show that the nucleolus controls protein and RNA surveillance and export by the ubiquitin pathway in a previously unidentified manner, and provide mechanistic insight into the cellular effects of PIs. Oncogene (2011) 30, 790-805; doi:10.1038/onc.2010.469; published online 18 October 2010	[Bai, B.; Laiho, M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21231 USA; [Latonen, L.; Moore, H. M.; Jaamaa, S.; Laiho, M.] Univ Helsinki, Mol Canc Biol Program, Helsinki, Finland; [Latonen, L.; Moore, H. M.; Jaamaa, S.; Laiho, M.] Univ Helsinki, Haartman Inst, Helsinki, Finland	Johns Hopkins University; Johns Hopkins Medicine; University of Helsinki; University of Helsinki	Laiho, M (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Radiat Oncol & Mol Radiat Sci, 1550 Orleans St,CRB 2,Room 444, Baltimore, MD 21231 USA.	mlaiho1@jhmi.edu	Latonen, Leena/C-8787-2016; Bai, Baoyan/A-8584-2012	Latonen, Leena/0000-0003-4502-2193; 	Academy of Finland [129699, 108828]; Biocentrum Helsinki; Helsinki Biomedical Graduate School	Academy of Finland(Academy of Finland); Biocentrum Helsinki; Helsinki Biomedical Graduate School	We thank Drs M Olson, A Miyawaki, I Dikic, B Vogelstein and A Salminen for providing reagents and cell lines. M Salo and H Liu are thanked for excellent technical assistance. Members of Laiho lab at Helsinki and Hopkins, O Matilainen and C Holmberg are thanked for helpful discussions. University of Helsinki Molecular Imaging Unit is thanked for assistance in image acquisition. University of Helsinki Advanced Imaging Unit is thanked for assistance in TEM imaging and sample preparation. This work was supported by Academy of Finland (ML Grant No. 129699, LL Grant No. 108828), Biocentrum Helsinki and Helsinki Biomedical Graduate School (HMM).	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2004, MOL CELL, V16, P777, DOI 10.1016/j.molcel.2004.11.013; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Daelemans D, 2005, MOL CELL BIOL, V25, P728, DOI 10.1128/MCB.25.2.728-739.2005; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Ernoult-Lange M, 2009, MOL BIOL CELL, V20, P176, DOI 10.1091/mbc.E08-09-0904; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hallstrom TMKA, 2007, P NATL ACAD SCI USA, V104, P7211, DOI 10.1073/pnas.0609299104; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Holmberg CI, 2000, CELL STRESS CHAPERON, V5, P219, DOI 10.1379/1466-1268(2000)005<0219:FONHGV>2.0.CO;2; Hong S, 2002, MOL CELL NEUROSCI, V20, P298, DOI 10.1006/mcne.2002.1103; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Karni-Schmidt O, 2007, ONCOGENE, V26, P3878, DOI 10.1038/sj.onc.1210162; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Klibanov SA, 2001, J CELL SCI, V114, P1867; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kurki S, 2004, CELL CYCLE, V3, P976; Lafontaine DLJ, 2001, NAT REV MOL CELL BIO, V2, P514, DOI 10.1038/35080045; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Latonen L, 2003, CELL SIGNAL, V15, P95, DOI 10.1016/S0898-6568(02)00044-X; Leary DJ, 2001, FEBS LETT, V509, P145, DOI 10.1016/S0014-5793(01)03143-X; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Matafora V, 2009, MOL CELL PROTEOMICS, V8, P2243, DOI 10.1074/mcp.M900079-MCP200; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Mattsson K, 2001, P NATL ACAD SCI USA, V98, P1012, DOI 10.1073/pnas.031566998; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Navon A, 2009, J BIOL CHEM, V284, P33713, DOI 10.1074/jbc.R109.018481; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Stavreva DA, 2006, MOL CELL BIOL, V26, P5131, DOI 10.1128/MCB.02227-05; SUDHA T, 1995, CHROMOSOME RES, V3, P115, DOI 10.1007/BF00710672; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Thomsen R, 2008, RNA, V14, P706, DOI 10.1261/rna.718708; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wojcik C, 1996, EUR J CELL BIOL, V71, P311; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25	63	89	92	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	7					790	805		10.1038/onc.2010.469	http://dx.doi.org/10.1038/onc.2010.469			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	722OT	20956947				2022-12-25	WOS:000287444600004
J	Qiu, JJ; Chu, H; Lu, X; Jiang, X; Dong, S				Qiu, J. J.; Chu, H.; Lu, X.; Jiang, X.; Dong, S.			The reduced and altered activities of PAX5 are linked to the protein-protein interaction motif (coiled-coil domain) of the PAX5-PML fusion protein in t(9;15)-associated acute lymphocytic leukemia	ONCOGENE			English	Article						PAX5; PAX5-PML; dimerization; FRAP; acute lymphocytic leukemia (ALL)	ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; TRANSCRIPTION FACTOR PAX5; B-CELL DIFFERENTIATION; PML-RAR-ALPHA; INTRANUCLEAR MOBILITY; DECREASED MOBILITY; RECEPTOR-ALPHA; GENES; DIMERIZATION	The paired box domain of PAX5 was reported to fuse with the sequence of promyelocytic leukemia (PML) to produce PAX5-PML chimeric protein in two patients with B-cell acute lymphoblastic leukemia. In the present studies, we found, by gel shift assays, that PAX5-PML bound to a panel of PAX5-consensus sequence acts as a homodimer with reduction of its DNA-binding affinities in comparison with wild-type PAX5. In transient transfection assays using 293T and HeLa cells, and retrovirus transduction of murine hematopoietic stem/progenitor cells together with quantitative real-time polymerase chain reaction analysis, PAX5-PML inhibited wild-type PAX5 target gene transcriptional activity. Studies comparing PAX5-PML with PAX5-PML(Delta CC) demonstrated that the coiled-coil (CC) protein interaction domain located within the PML moiety was required for PAX5-PML homodimer complex formation and partial transcriptional repression of genes controlled by PAX5. Fluorescent microscopic examination of transiently expressed YFP-tagged proteins in HeLa and 293T cells demonstrated that YFP-PAX5-PML and YFP-PAX5-PML(Delta CC) exhibited a diffuse granular pattern within the nucleus, similar to PAX5 but not PML. By fluorescent recovery after photobleach (FRAP), we have shown that PAX5-PML fusion protein has reduced intranuclear mobility compared with wild-type PAX5. Furthermore, the dimerization domain (CC) of PML was responsible for the reduced intranuclear mobility of PAX5-PML. These results indicate that the CC domain of PAX5-PML is important for each of the known activities of PAX5-PML fusion proteins. Oncogene (2011) 30, 967-977; doi:10.1038/onc.2010.473; published online 25 October 2010	[Dong, S.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Dong, S (corresponding author), Baylor Coll Med, Dept Med, 1 Baylor Plaza,BCM 286,Room N1317-03, Houston, TX 77030 USA.	jqiu@bcm.edu; sdong@bcm.edu			Albert and Margaret alkek Foundation; Leukemia Research Foundation (LRF)	Albert and Margaret alkek Foundation; Leukemia Research Foundation (LRF)	We thank Dr M Busslinger (Research Institute of Molecular Pathology, Vienna, Austria) for the CD19-luciferase and PAX5 expression vectors, Dr AS Belmont (University of Illinois Champagne-Urbana) for the A03_1 cell line, and Dr CWE So (King's College London, London, UK) for critical reading of the manuscript. This work was supported in part, by funds from the Albert and Margaret alkek Foundation and Leukemia Research Foundation (LRF).	ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dong S, 2004, MOL CELL BIOL, V24, P4465, DOI 10.1128/MCB.24.10.4465-4475.2004; Dong S, 2003, ONCOGENE, V22, P858, DOI 10.1038/sj.onc.1206182; Grignani F, 1999, ONCOGENE, V18, P6313, DOI 10.1038/sj.onc.1203029; Huang Y, 2008, BIOCHEM BIOPH RES CO, V365, P258, DOI 10.1016/j.bbrc.2007.10.184; Kawamata N, 2008, P NATL ACAD SCI USA, V105, P11921, DOI 10.1073/pnas.0711039105; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Kwok C, 2009, P NATL ACAD SCI USA, V106, P2853, DOI 10.1073/pnas.0810558106; Lauring J, 1999, MOL CELL BIOL, V19, P2601; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nebral K, 2009, LEUKEMIA, V23, P134, DOI 10.1038/leu.2008.306; Nebral K, 2007, BRIT J HAEMATOL, V139, P269, DOI 10.1111/j.1365-2141.2007.06731.x; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pridans C, 2008, J IMMUNOL, V180, P1719, DOI 10.4049/jimmunol.180.3.1719; Qiu J, 2006, ONCOGENE, V25, P3982, DOI 10.1038/sj.onc.1209431; Qiu J, 2003, LEUKEMIA, V17, P1891, DOI 10.1038/sj.leu.2403073; Qiu J, 2007, MOL BIOL CELL, V18, P3941, DOI 10.1091/mbc.E07-03-0245; Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81; Qiu JHJ, 2010, BLOOD, V115, P643, DOI 10.1182/blood-2009-07-232652; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; So CW, 2004, BLOOD, V104, P919, DOI 10.1182/blood-2004-03-0992; So CW, 2003, CANCER CELL, V4, P99, DOI 10.1016/S1535-6108(03)00188-0; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Zeisig BB, 2007, CANCER CELL, V12, P36, DOI 10.1016/j.ccr.2007.06.006	35	14	14	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	8					967	977		10.1038/onc.2010.473	http://dx.doi.org/10.1038/onc.2010.473			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	726CJ	20972455				2022-12-25	WOS:000287695900008
J	Gaspar, ML; Hofbauer, HF; Kohlwein, SD; Henry, SA				Gaspar, Maria L.; Hofbauer, Harald F.; Kohlwein, Sepp D.; Henry, Susan A.			Coordination of Storage Lipid Synthesis and Membrane Biogenesis EVIDENCE FOR CROSS-TALK BETWEEN TRIACYLGLYCEROL METABOLISM AND PHOSPHATIDYLINOSITOL SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID BIOSYNTHESIS; PLASMA-MEMBRANE; GENE-EXPRESSION; INOSITOL; SPHINGOLIPIDS; PARTICLES; CHOLESTEROL; LIPOLYSIS; TURNOVER	Despite the importance of triacylglycerols (TAG) and steryl esters (SE) in phospholipid synthesis in cells transitioning from stationary-phase into active growth, there is no direct evidence for their requirement in synthesis of phosphatidylinositol (PI) or other membrane phospholipids in logarithmically growing yeast cells. We report that the dga1 Delta lro1 Delta are1 Delta are2 Delta strain, which lacks the ability to synthesize both TAG and SE, is not able to sustain normal growth in the absence of inositol (Ino(-) phenotype) at 37 degrees C especially when choline is present. Un-like many other strains exhibiting an Ino(-) phenotype, the dga1 Delta lro1 Delta are1 Delta are2 Delta strain does not display a defect in INO1 expression. However, the mutant exhibits slow recovery of PI content compared with wild type cells upon reintroduction of inositol into logarithmically growing cultures. The tgl3 Delta tgl4 Delta tgl5 Delta strain, which is able to synthesize TAG but unable to mobilize it, also exhibits attenuated PI formation under these conditions. However, unlike dga1 Delta lro1 Delta are1 Delta are2 Delta, the tgl3 Delta tgl4 Delta tgl5 Delta strain does not display an Ino(-) phenotype, indicating that failure to mobilize TAG is not fully responsible for the growth defect of the dga1 Delta lro1 Delta are1 Delta are2 Delta strain in the absence of inositol. Moreover, synthesis of phospholipids, especially PI, is dramatically reduced in the dga1 Delta lro1 Delta are1 Delta are2 Delta strain even when it is grown continuously in the presence of inositol. The mutant also utilizes a greater proportion of newly synthesized PI than wild type for the synthesis of inositol-containing sphingolipids, especially in the absence of inositol. Thus, we conclude that storage lipid synthesis actively influences membrane phospholipid metabolism in logarithmically growing cells.	[Gaspar, Maria L.; Henry, Susan A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Hofbauer, Harald F.; Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	Cornell University; University of Graz	Henry, SA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 249 Biotechnol Bldg, Ithaca, NY 14853 USA.	sah42@cornell.edu	Henry, Susan/K-5464-2014	Kohlwein, Sepp Dieter/0000-0002-1030-0598; Hofbauer, Harald F./0000-0003-2617-5901	National Institutes of Health [GM-19629]; Austrian Science Fund FWF [Lipotox F3005]; Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF) [F 3005, W 901] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019629, R01GM019629, F32GM019629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-19629 (to S.A.H.). This work was also supported by grants from the Austrian Science Fund FWF (Project Lipotox F3005) and the Austrian Federal Ministry for Science and Research (Project GOLD (Genomics of Lipid-associated Disorders)) in the framework of the Austrian Genomics Program (GEN-AU) (to S.D.K.).	Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; Brachmann CB, 1998, YEAST, V14, P115; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Christie W.W., 2003, LIPID ANAL ISOLATION, P105; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; GAYNOR PM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P326, DOI 10.1016/0167-4781(91)90197-T; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Greenberg ML, 1996, MICROBIOL REV, V60, P1; HECHTBERGER P, 1994, EUR J BIOCHEM, V225, P641, DOI 10.1111/j.1432-1033.1994.00641.x; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Jensen-Pergakes K, 2001, J BACTERIOL, V183, P4950, DOI 10.1128/JB.183.17.4950-4957.2001; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LANGE Y, 1989, J BIOL CHEM, V264, P3786; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mullner H, 2004, ACTA BIOCHIM POL, V51, P323; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; NOMURA S, 1972, J BIOCHEM-TOKYO, V71, P783, DOI 10.1093/oxfordjournals.jbchem.a129827; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; PATTON JL, 1991, J BACTERIOL, V173, P3101, DOI 10.1128/JB.173.10.3101-3108.1991; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rajakumari S, 2010, BBA-MOL CELL BIOL L, V1801, P1314, DOI 10.1016/j.bbalip.2010.08.004; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sandager L, 2000, BIOCHEM SOC T, V28, P700; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; STEINER MR, 1972, BIOCHIM BIOPHYS ACTA, V260, P222, DOI 10.1016/0005-2760(72)90035-5; Stock SD, 2000, ANTIMICROB AGENTS CH, V44, P1174, DOI 10.1128/AAC.44.5.1174-1180.2000; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Weerheim AM, 2002, ANAL BIOCHEM, V302, P191, DOI 10.1006/abio.2001.5552; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200	53	50	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1696	1708		10.1074/jbc.M110.172296	http://dx.doi.org/10.1074/jbc.M110.172296			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	20972264	Green Published, hybrid			2022-12-25	WOS:000286191500009
J	Piguet, J; Schreiter, C; Segura, JM; Vogel, H; Hovius, R				Piguet, Joachim; Schreiter, Christoph; Segura, Jean-Manuel; Vogel, Horst; Hovius, Ruud			Acetylcholine Receptor Organization in Membrane Domains in Muscle Cells EVIDENCE FOR RAPSYN-INDEPENDENT AND RAPSYN-DEPENDENT MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-PARTICLE TRACKING; TETRATRICOPEPTIDE REPEAT DOMAINS; NEUROMUSCULAR-JUNCTION; LIVE CELLS; MOLECULE TRACKING; PLASMA-MEMBRANE; MYASTHENIC SYNDROME; MOUSE MUSCLE; PROTEIN; AGRIN	Nicotinic acetylcholine receptors (nAChR) in muscle fibers are densely packed in the postsynaptic region at the neuromuscular junction. Rapsyn plays a central role in directing and clustering nAChR during cellular differentiation and neuromuscular junction formation; however, it has not been demonstrated whether rapsyn is the only cause of receptor immobilization. Here, we used single-molecule tracking methods to investigate nAChR mobility in plasma membranes of myoblast cells during their differentiation to myotubes in the presence and absence of rapsyn. We found that in myoblasts the majority of nAChR were immobile and that similar to 20% of the receptors showed restricted diffusion in small domains of similar to 50 nm. In myoblasts devoid of rapsyn, the fraction of mobile nAChR was considerably increased, accompanied by a 3-fold decrease in the immobile population of nAChR with respect to rapsyn-expressing cells. Half of the mobile receptors were confined to domains of similar to 120 nm. Measurements performed in heterologously transfected HEK cells confirmed the direct immobilization of nAChR by rapsyn. However, irrespective of the presence of rapsyn, about one-third of nAChR were confined in 300-nm domains. Our results show (i) that rapsyn efficiently immobilizes nAChR independently of other postsynaptic scaffold components; (ii) nAChR is constrained in confined membrane domains independently of rapsyn; and (iii) in the presence of rapsyn, the size of these domains is strongly reduced.	[Piguet, Joachim; Schreiter, Christoph; Segura, Jean-Manuel; Vogel, Horst; Hovius, Ruud] Ecole Polytech Fed Lausanne, Lab Chim Phys Polymeres & Membranes, CH-1015 Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne	Vogel, H (corresponding author), Ecole Polytech Fed Lausanne, Lab Chim Phys Polymeres & Membranes, CH-1015 Lausanne, Switzerland.	horst.vogel@epfl.ch; ruud.hovius@epfl.ch	Piguet, Joachim/E-2329-2011; Vogel, Horst/AAJ-5490-2021; Hovius, Ruud/B-5647-2009	Piguet, Joachim/0000-0002-4762-4887; Hovius, Ruud/0000-0001-9258-6587	CTI Innovation Promotion Agency [580903]; Swiss National Science Foundation [31003A-118148]; Ecole Polytechnique Federale de Lausanne	CTI Innovation Promotion Agency; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne	This work was supported by CTI Innovation Promotion Agency Grant 580903, Swiss National Science Foundation Grant 31003A-118148, and internal funds from the Ecole Polytechnique Federale de Lausanne.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Antolik C, 2007, NEUROSCIENCE, V145, P56, DOI 10.1016/j.neuroscience.2006.11.047; Antolik C, 2006, NEUROSCIENCE, V141, P87, DOI 10.1016/j.neuroscience.2006.03.035; Barrantes FJ, 2010, J MOL NEUROSCI, V40, P87, DOI 10.1007/s12031-009-9262-z; Bromann PA, 2004, NEUROSCIENCE, V125, P417, DOI 10.1016/j.neuroscience.2003.12.031; Bruneau E, 2007, J BIOL CHEM, V282, P9932, DOI 10.1074/jbc.M608714200; BURDEN SJ, 1985, P NATL ACAD SCI USA, V82, P8270, DOI 10.1073/pnas.82.23.8270; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Dobbins GC, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-18; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Ewers H, 2005, P NATL ACAD SCI USA, V102, P15110, DOI 10.1073/pnas.0504407102; Ferrari R, 2001, PHYSICA D, V154, P111, DOI 10.1016/S0167-2789(01)00234-2; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; FRAIL DE, 1989, NEURON, V2, P1077, DOI 10.1016/0896-6273(89)90232-8; Fuhrer C, 1999, J NEUROSCI, V19, P6405; Gajsek N, 2008, CHEM-BIOL INTERACT, V175, P50, DOI 10.1016/j.cbi.2008.05.027; Gervasio OL, 2005, J PHYSIOL-LONDON, V562, P673, DOI 10.1113/jphysiol.2004.077685; Guignet EG, 2007, CHEMPHYSCHEM, V8, P1221, DOI 10.1002/cphc.200700065; Henriquez JP, 2008, P NATL ACAD SCI USA, V105, P18812, DOI 10.1073/pnas.0806300105; Hezel M, 2010, MOL BIOL CELL, V21, P302, DOI 10.1091/mbc.E09-05-0381; Kasai Y, 2005, NUCLEIC ACIDS RES, V33, pD550; Kellner RR, 2007, NEUROSCIENCE, V144, P135, DOI 10.1016/j.neuroscience.2006.08.071; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lee Y, 2008, NEUROSCIENCE, V153, P997, DOI 10.1016/j.neuroscience.2008.03.009; Lee Y, 2009, NEUROSCIENCE, V163, P222, DOI 10.1016/j.neuroscience.2009.05.057; Lommerse PHM, 2005, J CELL SCI, V118, P1799, DOI 10.1242/jcs.02300; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Muller JS, 2006, BRAIN, V129, P2784, DOI 10.1093/brain/awl188; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; Pato C, 2008, CHEM-BIOL INTERACT, V175, P64, DOI 10.1016/j.cbi.2008.03.020; PHILLIPS WD, 1991, J CELL BIOL, V115, P1713, DOI 10.1083/jcb.115.6.1713; Ramarao MK, 2001, J BIOL CHEM, V276, P7475, DOI 10.1074/jbc.M009888200; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schreiter C, 2005, CHEMBIOCHEM, V6, P2187, DOI 10.1002/cbic.200500216; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; SOBEL A, 1977, EUR J BIOCHEM, V80, P215, DOI 10.1111/j.1432-1033.1977.tb11874.x; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang J, 2008, J BIOL CHEM, V283, P21668, DOI 10.1074/jbc.M709939200; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007	50	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					363	369		10.1074/jbc.M110.139782	http://dx.doi.org/10.1074/jbc.M110.139782			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978122	Green Published, hybrid			2022-12-25	WOS:000285782800039
J	Chen, ZH; Schilde, C; Schaap, P				Chen, Zhi-hui; Schilde, Christina; Schaap, Pauline			Functional Dissection of Adenylate Cyclase R, an Inducer of Spore Encapsulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL RESPONSE REGULATORS; HISTIDINE-KINASE; ESCHERICHIA-COLI; DICTYOSTELIUM-DISCOIDEUM; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; OSMOSENSOR ENVZ; RECEIVER DOMAIN	Cyclic AMP acting on protein kinase A controls sporulation and encystation in social and solitary amoebas. In Dictyostelium discoideum, adenylate cyclase R (ACR), is essential for spore encapsulation. In addition to its cyclase (AC) domain, ACR harbors seven transmembrane helices, a histidine kinase domain, and two receiver domains. We investigated the role of these domains in the regulation of AC activity. Expression of an ACR-YFP fusion protein in acr(-) cells rescued their sporulation defective phenotype and revealed that ACR is associated with the nuclear envelope and endoplasmic reticulum. Loss of the transmembrane helices (Delta TM) caused a 60% reduction of AC activity, but Delta TM-ACR still rescued the acr(-) phenotype. The isolated AC domain was properly expressed but inactive. Mutation of three essential ATP-binding residues in the histidine kinase domain did not affect the AC activity or phenotypic rescue. Mutation of the essential phosphoryl-accepting aspartate in receivers 1, 2, or both had only modest effects on AC activity and did not affect phenotypic rescue, indicating that AC activity is not critically regulated by phosphorelay. Remarkably, the dimerizing histidine phosphoacceptor subdomain, which in ACR lacks the canonical histidine for autophosphorylation, was essential for AC activity. Transformation of wild-type cells with an ACR allele (Delta CRA) that is truncated after this domain inhibited AC activity of endogenous ACR and replicated the acr(-) phenotype. Combined with the observation that the isolated AC domain was inactive, the dominant- negative effect of Delta CRA strongly suggests that the defunct phosphoacceptor domain acquired a novel role in enforcing dimerization of the AC domain.	[Chen, Zhi-hui; Schilde, Christina; Schaap, Pauline] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Schaap, P (corresponding author), MSI WTB JBC Complex,Dow St, Dundee DD1 5EH, Scotland.	p.schaap@dundee.ac.uk	Schaap, Pauline/A-3682-2009; Schaap, Pauline/M-5355-2019	Schaap, Pauline/0000-0003-4500-2555; Schaap, Pauline/0000-0003-4500-2555	Wellcome Trust [076618]; Biotechnology and Biological Sciences Research Council [BB/G020426/1, BB/D013453/1] Funding Source: researchfish; BBSRC [BB/G020426/1, BB/D013453/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grant 076618 (to P. S.).	Alvarez-Curto E, 2007, DEVELOPMENT, V134, P959, DOI 10.1242/dev.02775; Anjard C., 2005, DICTYOSKLIUM GENOMIC, P59; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; Baker DA, 2004, TRENDS PARASITOL, V20, P227, DOI 10.1016/j.pt.2004.02.007; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; Birck C, 1999, STRUCTURE, V7, P1505, DOI 10.1016/S0969-2126(00)88341-0; BUTLER JR, 1992, BIOCHEM CELL BIOL, V70, P169, DOI 10.1139/o92-025; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Cooper DMF, 2006, TRENDS PHARMACOL SCI, V27, P426, DOI 10.1016/j.tips.2006.06.002; Dutta R, 2000, J BIOL CHEM, V275, P38645, DOI 10.1074/jbc.M005872200; Dutta R, 1996, J BIOL CHEM, V271, P1424, DOI 10.1074/jbc.271.3.1424; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gooi P, 2008, CORNEA, V27, P246, DOI 10.1097/ICO.0b013e31815b82a2; Hastings CA, 2003, BIOCHEMISTRY-US, V42, P9081, DOI 10.1021/bi0273866; Hirschman A, 2001, BIOCHEMISTRY-US, V40, P13876, DOI 10.1021/bi0113622; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; Kasahara M, 1999, J BIOL CHEM, V274, P15167, DOI 10.1074/jbc.274.21.15167; Kawabe Y, 2009, P NATL ACAD SCI USA, V106, P7089, DOI 10.1073/pnas.0901617106; Kim HJ, 1998, J BIOL CHEM, V273, P30859, DOI 10.1074/jbc.273.47.30859; Kriebel PW, 2004, IUBMB LIFE, V56, P541, DOI 10.1080/15216540400013887; Lee SY, 2001, NAT STRUCT BIOL, V8, P52; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Linder JU, 2008, CURR OPIN STRUC BIOL, V18, P667, DOI 10.1016/j.sbi.2008.11.008; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meima ME, 2002, MOL BIOL CELL, V13, P3870, DOI 10.1091/mbc.E02-05-0285; Meima ME, 1999, DEV BIOL, V212, P182, DOI 10.1006/dbio.1999.9352; Misono KS, 2005, PEPTIDES, V26, P957, DOI 10.1016/j.peptides.2004.12.021; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; Okamoto S, 2004, PHOTOCHEM PHOTOBIOL, V80, P429, DOI 10.1562/0031-8655(2004)080&lt;0429:APPATT&gt;2.0.CO;2; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; Ritchie AV, 2008, MOL BIOL EVOL, V25, P2109, DOI 10.1093/molbev/msn156; Saran S, 2004, MOL BIOL CELL, V15, P1479, DOI 10.1091/mbc.E03-08-0622; Saran S, 2002, J MUSCLE RES CELL M, V23, P793, DOI 10.1023/A:1024483829878; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; SHELDEN E, 1995, J CELL SCI, V108, P1105; Soderbom F, 1999, DEVELOPMENT, V126, P5463; Stewart RC, 1998, BIOCHEMISTRY-US, V37, P12269, DOI 10.1021/bi980970n; Tanaka T, 1998, NATURE, V396, P88, DOI 10.1038/23968; Tomomori C, 1999, NAT STRUCT BIOL, V6, P729; Turner NA, 2000, J ANTIMICROB CHEMOTH, V46, P27, DOI 10.1093/jac/46.1.27; vanEs S, 1996, J BIOL CHEM, V271, P23623, DOI 10.1074/jbc.271.39.23623; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Yan D, 1999, P NATL ACAD SCI USA, V96, P14789, DOI 10.1073/pnas.96.26.14789; Zhao XD, 2008, J MOL BIOL, V375, P1141, DOI 10.1016/j.jmb.2007.11.045; Zhu Y, 2002, MOL MICROBIOL, V45, P653, DOI 10.1046/j.1365-2958.2002.03061.x	51	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41724	41731		10.1074/jbc.M110.156380	http://dx.doi.org/10.1074/jbc.M110.156380			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20966074	Green Published, hybrid			2022-12-25	WOS:000285622600059
J	Huang, QQ; Szebenyi, DME				Huang, Qingqiu; Szebenyi, Doletha M. E.			Structural Basis for the Interaction between the Growth Factor-binding Protein GRB 10 and the E3 Ubiquitin Ligase NEDD4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN; INSULIN-RECEPTOR; SH2 DOMAIN; GLUCOSE-HOMEOSTASIS; C2 DOMAINS; GENE; DISRUPTION; REGULATOR	In addition to inhibiting insulin receptor and IGF1R kinase activity by directly binding to the receptors, GRB10 can also negatively regulate insulin and IGF1 signaling by mediating insulin receptor and IGF1R degradation through ubiquitination. It has been shown that GRB10 can interact with the C2 domain of the E3 ubiquitin ligase NEDD4 through its Src homology 2 (SH2) domain. Therefore, GRB10 might act as a connector, bringing NEDD4 close to IGF1R to facilitate the ubiquitination of IGF1R by NEDD4. This is the first case in which it has been found that an SH2 domain could colocalize a ubiquitin ligase and its substrate. Here we report the crystal structure of the NEDD4 C2-GRB10 SH2 complex at 2.0A. The structure shows that there are three interaction interfaces between NEDD4 C2 and GRB10 SH2. The main interface centers on an antiparallel beta-sheet composed of the F beta-strand of GRB10 SH2 and the C beta-strand of NEDD4 C2. NEDD4 C2 binds at nonclassical sites on the SH2 domain surface, far from the classical phosphotyrosine-binding pocket. Hence, this interaction is phosphotyrosine-independent, and GRB10 SH2 can bind the C2 domain of NEDD4 and the kinase domain of IGF1R simultaneously. Based on these results, a model of how NEDD4 interacts with IGF1R through GRB10 has been proposed. This report provides further evidence that SH2 domains can participate in important signaling interactions beyond the classical recognition of phosphotyrosine.	[Huang, Qingqiu; Szebenyi, Doletha M. E.] Cornell Univ, MacCHESS, Ithaca, NY 14853 USA	Cornell University	Huang, QQ (corresponding author), Cornell Univ, MacCHESS, Ithaca, NY 14853 USA.	qh24@cornell.edu	Szebenyi, Marian/GMX-2709-2022		National Institutes of Health, NCRR [RR-01646]; National Science Foundation [DMR 0225180]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health, NCRR, Grant RR-01646. This work is based upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation under Award DMR 0225180.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Cariou B, 2004, FASEB J, V18, P965, DOI 10.1096/fj.03-0824fje; Ceccarelli DFJ, 2009, NAT STRUCT MOL BIOL, V16, P803, DOI 10.1038/nsmb0809-803; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Corbalan-Garcia S, 2010, BIOFACTORS, V36, P1, DOI 10.1002/biof.68; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Paola R, 2010, J INTERN MED, V267, P132, DOI 10.1111/j.1365-2796.2009.02089.x; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Giorgetti-Peraldi S, 2001, ONCOGENE, V20, P3959, DOI 10.1038/sj.onc.1204520; Han DC, 2002, J BIOL CHEM, V277, P45655, DOI 10.1074/jbc.M203165200; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; He WM, 1998, J BIOL CHEM, V273, P6860, DOI 10.1074/jbc.273.12.6860; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Holt LJ, 2009, MOL ENDOCRINOL, V23, P1406, DOI 10.1210/me.2008-0386; Hu JJ, 2003, MOL CELL, V12, P1379, DOI 10.1016/S1097-2765(03)00487-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min L, 2009, P NATL ACAD SCI USA, V106, P21143, DOI 10.1073/pnas.0911309106; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Morrione A, 2003, J CELL PHYSIOL, V197, P307, DOI 10.1002/jcp.10363; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Ramos FJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1262, DOI 10.1152/ajpendo.00609.2005; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Sawyer TK, 1998, BIOPOLYMERS, V47, P243, DOI 10.1002/(SICI)1097-0282(1998)47:3<243::AID-BIP4>3.0.CO;2-P; Shen TL, 2004, FRONT BIOSCI-LANDMRK, V9, P192, DOI 10.2741/1229; Shiura H, 2005, BIOCHEM BIOPH RES CO, V329, P909, DOI 10.1016/j.bbrc.2005.02.047; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Sondermann H, 2005, CELL, V121, P158, DOI 10.1016/j.cell.2005.04.001; Stein EG, 2003, J BIOL CHEM, V278, P13257, DOI 10.1074/jbc.M212026200; Stein EG, 2001, FEBS LETT, V493, P106, DOI 10.1016/S0014-5793(01)02282-7; Tezuka N, 2007, BIOCHEM BIOPH RES CO, V356, P648, DOI 10.1016/j.bbrc.2007.03.019; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Waksman Gabriel, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007331; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07	48	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42130	42139		10.1074/jbc.M110.143412	http://dx.doi.org/10.1074/jbc.M110.143412			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20980250	Green Published, hybrid			2022-12-25	WOS:000285622600097
J	Chang, SH; Chung, Y; Dong, C				Chang, Seon Hee; Chung, Yeonseok; Dong, Chen			Vitamin D Suppresses Th17 Cytokine Production by Inducing C/EBP Homologous Protein (CHOP) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,25-DIHYDROXYVITAMIN D-3; T-CELLS; 25-HYDROXYVITAMIN D; ROR-GAMMA; DIFFERENTIATION; PROGRAM	Vitamin D has been shown to have immunomodulatory function, but the molecular basis for it has not been well understood. In this study, we found that vitamin D receptor expression was induced in a CD4+ effector T cell lineage, Th17 cells, which required the transcription factors, ROR alpha, ROR gamma t, and STAT3. Treatment of mice with an active ligand of vitamin D receptor (VDR), 1,25-dihydroxyvitamin D-3 (1,25D3), ameliorated experimental autoimmune encephalomyelitis, accompanied with reduced IL-17 and IL-17F expression. In vitro, treatment of CD4+ T cells with the physiological doses of 1,25D3 preferentially inhibited cytokine production by Th17 cells, in a VDR-dependent manner, without affecting the expression of transcription factors or surface molecules. Moreover, at these concentrations, cytokine expression was suppressed only at protein but not at mRNA levels. Stimulation of Th17 cells with 1,25D3, in a concentration-dependent manner, induced the expression of C/EBP homologous protein (CHOP), a molecule involved in endoplasmic reticulum stress and translational inhibition. In addition, overexpression of CHOP in developing Th17 cells suppressed their cytokine production. Our results suggest a novel, post-transcriptional mechanism whereby Th17 cytokines are inhibited by VDR, which may underscore future therapeutic usage of vitamin D in treatment of autoimmune diseases.	[Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; Univ Texas MD Anderson Canc Ctr, Ctr Inflammat & Canc, Houston, TX 77054 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Dong, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA.	cdong@mdanderson.org	Chang, Seon Hee/AAQ-9521-2020; dong, chen/B-3181-2009	Chang, Seon Hee/0000-0002-9389-508X; dong, chen/0000-0002-0084-9130; Chung, Yeonseok/0000-0001-5780-4841	National Institutes of Health [5R01AR050772-09]; Research Trust Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Trust Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01AR050772-09 (to C.D.) and a Research Trust Fellowship (to C.D.).	Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Holick MF, 1996, J NUTR, V126, pS1159, DOI 10.1093/jn/126.suppl_4.1159S; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Mahon BD, 2003, J CELL BIOCHEM, V89, P922, DOI 10.1002/jcb.10580; MORA JR, 2008, NAT REV IMMUNOL; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pedersen LB, 2007, J NEUROSCI RES, V85, P2480, DOI 10.1002/jnr.21382; Penna G, 2006, J IMMUNOL, V177, P8504, DOI 10.4049/jimmunol.177.12.8504; Platz EA, 2000, CANCER EPIDEM BIOMAR, V9, P1059; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Tavera-Mendoza L, 2006, EMBO REP, V7, P180, DOI 10.1038/sj.embor.7400594; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001	23	140	147	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38751	38755		10.1074/jbc.C110.185777	http://dx.doi.org/10.1074/jbc.C110.185777			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20974859	Green Published, hybrid			2022-12-25	WOS:000284941300003
J	Sharp, TM; Guix, S; Katayama, K; Crawford, SE; Estes, MK				Sharp, Tyler M.; Guix, Susana; Katayama, Kazuhiko; Crawford, Sue E.; Estes, Mary K.			Inhibition of Cellular Protein Secretion by Norwalk Virus Nonstructural Protein p22 Requires a Mimic of an Endoplasmic Reticulum Export Signal	PLOS ONE			English	Article							POLIOVIRUS 3A; TRANSPORT; COPII; REPLICATION; NOROVIRUS; ER; COMPLEX; RNA; GASTROENTERITIS; TRAFFICKING	Protein trafficking between the endoplasmic reticulum ( ER) and Golgi apparatus is central to cellular homeostasis. ER export signals are utilized by a subset of proteins to rapidly exit the ER by direct uptake into COPII vesicles for transport to the Golgi. Norwalk virus nonstructural protein p22 contains a YX Phi ESDG motif that mimics a di-acidic ER export signal in both sequence and function. However, unlike normal ER export signals, the ER export signal mimic of p22 is necessary for apparent inhibition of normal COPII vesicle trafficking, which leads to Golgi disassembly and antagonism of Golgi-dependent cellular protein secretion. This is the first reported function for p22. Disassembly of the Golgi apparatus was also observed in cells replicating Norwalk virus, which may contribute to pathogenesis by interfering with cellular processes that are dependent on an intact secretory pathway. These results indicate that the ER export signal mimic is critical to the antagonistic function of p22, shown herein to be a novel antagonist of ER/Golgi trafficking. This unique and well-conserved human norovirus motif is therefore an appealing target for antiviral drug development.	[Sharp, Tyler M.; Guix, Susana; Katayama, Kazuhiko; Crawford, Sue E.; Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Katayama, Kazuhiko] Natl Inst Infect Dis, Tokyo, Japan	Baylor College of Medicine; National Institute of Infectious Diseases (NIID)	Sharp, TM (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	mestes@bcm.edu	Guix, Susana/D-4318-2014	Guix, Susana/0000-0002-1588-3198; Katayama, Kazuhiko/0000-0002-7692-1151	National Institutes of Health (NIH) [P01 AI057788, T32 AI04741, S10RR024574, AI036211]; National Science Foundation [7316]; John S. Dunn Gulf Coast Consortium for Chemical Genomics; SCCPR [U54 HD-007495, P30 DK-56338, P30 CA-125123]; Dan L. Duncan Cancer Center of Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057788, P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); John S. Dunn Gulf Coast Consortium for Chemical Genomics; SCCPR; Dan L. Duncan Cancer Center of Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Public Health Service grants from the National Institutes of Health (NIH) P01 AI057788 (MKE) and T32 AI04741 (TMS), and by the East Asia and Pacific Summer Institute grant 7316 (TMS) from the National Science Foundation. Microscopy equipment support was from the John S. Dunn Gulf Coast Consortium for Chemical Genomics (MA Mancini). Additional funding for imaging was provided by SCCPR U54 HD-007495 (BW O'Malley), P30 DK-56338 (MKE), P30 CA-125123 (CK Osborne), and the Dan L. Duncan Cancer Center of Baylor College of Medicine. This project was supported by the BCM Cytometry and Cell Sorting Core with funding from the NIH (National Center for Research Resources grant S10RR024574 and National Institute of Allergy and Infectious Diseases AI036211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Bailey D, 2010, J GEN VIROL, V91, P739, DOI 10.1099/vir.0.016279-0; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; BERG L, 1988, CHEM ENG COMMUN, V66, P1, DOI 10.1080/00986448808940257; Beske O, 2007, J CELL SCI, V120, P3207, DOI 10.1242/jcs.03483; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Chang KO, 2007, J VIROL, V81, P12111, DOI 10.1128/JVI.00560-07; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Choe SS, 2005, VIROLOGY, V337, P18, DOI 10.1016/j.virol.2005.03.036; Cornell CT, 2006, J VIROL, V80, P6637, DOI 10.1128/JVI.02572-05; Deitz SB, 2000, P NATL ACAD SCI USA, V97, P13790, DOI 10.1073/pnas.250483097; Dodd DA, 2001, J VIROL, V75, P8158, DOI 10.1128/JVI.75.17.8158-8165.2001; Doedens JR, 1997, J VIROL, V71, P9054, DOI 10.1128/JVI.71.12.9054-9064.1997; DOEDENS JR, 1995, EMBO J, V14, P894, DOI 10.1002/j.1460-2075.1995.tb07071.x; Estes MK, 2006, CURR OPIN INFECT DIS, V19, P467, DOI 10.1097/01.qco.0000244053.69253.3d; Ettayebi K, 2003, J VIROL, V77, P11790, DOI 10.1128/JVI.77.21.11790-11797.2003; Fernandez-Vega V, 2004, J VIROL, V78, P4827, DOI 10.1128/JVI.78.9.4827-4837.2004; Fujita K, 2007, BIOCHEMISTRY-US, V46, P5185, DOI 10.1021/bi6024758; Gilpatrick SG, 2000, J VIROL METHODS, V90, P69, DOI 10.1016/S0166-0934(00)00220-2; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; GLASS RI, 2009, NEW ENGL J MED, V361, P50; Green K, 2007, FIELDS VIROLOGY, P949; Green KY, 2002, J VIROL, V76, P8582, DOI 10.1128/JVI.76.17.8582-8595.2002; Guix S, 2009, CELLULAR SIGNALING AND INNATE IMMUNE RESPONSES TO RNA VIRUS INFECTIONS, P389; Guix S, 2007, J VIROL, V81, P12238, DOI 10.1128/JVI.01489-07; Hardy ME, 2005, FEMS MICROBIOL LETT, V253, P1, DOI 10.1016/j.femsle.2005.08.031; Hyde JL, 2009, J VIROL, V83, P9709, DOI 10.1128/JVI.00600-09; Kim J, 2007, CELL HOST MICROBE, V2, P160, DOI 10.1016/j.chom.2007.07.010; Konan KV, 2003, J VIROL, V77, P7843, DOI 10.1128/JVI.77.14.7843-7855.2003; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; MATSUI SM, 1991, J CLIN INVEST, V87, P1456, DOI 10.1172/JCI115152; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mukherjee S, 2007, TRAFFIC, V8, P369, DOI 10.1111/j.1600-0854.2007.00542.x; Nakamura N, 1998, MOL BIOL CELL, V9, P3493, DOI 10.1091/mbc.9.12.3493; Neznanov N, 2001, J VIROL, V75, P10409, DOI 10.1128/JVI.75.21.10409-10420.2001; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Paulhe F, 2004, J BIOL CHEM, V279, P55545, DOI 10.1074/jbc.M407813200; Persico A, 2009, FEBS LETT, V583, P3857, DOI 10.1016/j.febslet.2009.10.077; Polishchuk RS, 2009, FEBS LETT, V583, P3847, DOI 10.1016/j.febslet.2009.10.031; Rismanchi N, 2009, TRAFFIC, V10, P201, DOI 10.1111/j.1600-0854.2008.00856.x; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Saraste J, 2009, FEBS LETT, V583, P3804, DOI 10.1016/j.febslet.2009.10.084; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; SCHEKMAN R, 1994, FASEB J, V8, pA1379; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Siebenga JJ, 2007, EMERG INFECT DIS, V13, P144; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Tang BL, 2005, BBA-MOL CELL RES, V1744, P293, DOI 10.1016/j.bbamcr.2005.02.007; Teterina NL, 1997, VIROLOGY, V237, P66, DOI 10.1006/viro.1997.8775; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Wessels E, 2007, J VIROL, V81, P5238, DOI 10.1128/JVI.02680-06; Wessels E, 2006, J VIROL, V80, P11852, DOI 10.1128/JVI.01225-06; Wessels E, 2006, DEV CELL, V11, P191, DOI 10.1016/j.devcel.2006.06.005; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	60	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13130	10.1371/journal.pone.0013130	http://dx.doi.org/10.1371/journal.pone.0013130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976190	Green Published, Green Submitted, gold			2022-12-25	WOS:000283045300003
J	Sotnikova, TD; Beaulieu, JM; Espinoza, S; Masri, B; Zhang, XD; Salahpour, A; Barak, LS; Caron, MG; Gainetdinov, RR				Sotnikova, Tatyana D.; Beaulieu, Jean-Martin; Espinoza, Stefano; Masri, Bernard; Zhang, Xiaodong; Salahpour, Ali; Barak, Larry S.; Caron, Marc G.; Gainetdinov, Raul R.			The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; MONOAMINE-OXIDASE; PARKINSONS-DISEASE; IN-VIVO; PHARMACOLOGICAL CHARACTERIZATION; TRACE AMINES; RAT-BRAIN; AMPHETAMINE; RELEASE; RECEPTORS	Dopamine (3-hydroxytyramine) is a well-known catecholamine neurotransmitter involved in multiple physiological functions including movement control. Here we report that the major extracellular metabolite of dopamine, 3-methoxytyramine (3-MT), can induce behavioral effects in a dopamine-independent manner and these effects are partially mediated by the trace amine associated receptor 1 (TAAR1). Unbiased in vivo screening of putative trace amine receptor ligands for potential effects on the movement control revealed that 3-MT infused in the brain is able to induce a complex set of abnormal involuntary movements in mice acutely depleted of dopamine. In normal mice, the central administration of 3-MT caused a temporary mild hyperactivity with a concomitant set of abnormal movements. Furthermore, 3-MT induced significant ERK and CREB phosphorylation in the mouse striatum, signaling events generally related to PKA-mediated cAMP accumulation. In mice lacking TAAR1, both behavioral and signaling effects of 3-MT were partially attenuated, consistent with the ability of 3-MT to activate TAAR1 receptors and cause cAMP accumulation as well as ERK and CREB phosphorylation in cellular assays. Thus, 3-MT is not just an inactive metabolite of DA, but a novel neuromodulator that in certain situations may be involved in movement control. Further characterization of the physiological functions mediated by 3-MT may advance understanding of the pathophysiology and pharmacology of brain disorders involving abnormal dopaminergic transmission, such as Parkinson's disease, dyskinesia and schizophrenia.	[Sotnikova, Tatyana D.; Espinoza, Stefano; Gainetdinov, Raul R.] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy; [Sotnikova, Tatyana D.; Masri, Bernard; Salahpour, Ali; Barak, Larry S.; Caron, Marc G.; Gainetdinov, Raul R.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Beaulieu, Jean-Martin] CRULRG Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Masri, Bernard] Fac Med Toulouse, INSERM, I2MR U858, F-31073 Toulouse, France; [Zhang, Xiaodong] Duke Natl Univ Singapore, Grad Sch Med, Neurosci & Behav Disorders Program, Singapore, Singapore; [Salahpour, Ali] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	Istituto Italiano di Tecnologia - IIT; Duke University; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm); National University of Singapore; University of Toronto	Sotnikova, TD (corresponding author), Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy.	raul.gainetdinov@iit.it	Masri, Bernard/N-9856-2018; Gainetdinov, Raul R/G-5875-2011; Sotnikova, Tatyana D/T-9992-2017; Beaulieu, Jean-Martin/A-7598-2008	Masri, Bernard/0000-0002-4027-2604; Gainetdinov, Raul R/0000-0003-2951-6038; Beaulieu, Jean-Martin/0000-0002-0446-7447; Espinoza, Stefano/0000-0002-3048-4822	National Institutes of Health [NS-19576, 1UO1-DA022950]; Michael J. Fox Foundation for Parkinson's Research; Natural Sciences and Engineering Research Council of Canada (NSERC); NARSAD; Singapore Ministry of Education [T208A3126]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA022950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation for Parkinson's Research; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NARSAD(NARSAD); Singapore Ministry of Education(Ministry of Education, Singapore); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported in part by National Institutes of Health grants NS-19576 and 1UO1-DA022950 to Marc G. Caron and research grants from the Michael J. Fox Foundation for Parkinson's Research to Raul R. Gainetdinov. Jean-Martin Beaulieu is supported by a discovery grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) and he is NARSAD Vital Projects Fund, Inc. Investigator and holds a Canada research Chair in Molecular Psychiatry. Xiaodong Zhang is supported by NARSAD Young Investigator Award and Singapore Ministry of Education T208A3126 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alachkar A, 2010, NEUROSCI RES, V67, P245, DOI 10.1016/j.neures.2010.03.008; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Antkiewicz-Michaluk L, 2008, EUR J PHARMACOL, V599, P32, DOI 10.1016/j.ejphar.2008.09.033; Apud JA, 2007, CNS DRUGS, V21, P535, DOI 10.2165/00023210-200721070-00002; BAKER WW, 1976, ARCH INT PHARMACOD T, V223, P271; Barak LS, 2008, MOL PHARMACOL, V74, P585, DOI 10.1124/mol.108.048884; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2006, J BIOL CHEM, V281, P32072, DOI 10.1074/jbc.M606062200; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; BROWN EE, 1991, J NEUROCHEM, V57, P701, DOI 10.1111/j.1471-4159.1991.tb03802.x; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; CARLSSON A, 1958, SCIENCE, V127, P471, DOI 10.1126/science.127.3296.471; CARLSSON A, 1972, ACTA NEUROL SCAND, V48, P11; Charlton CG, 2000, LIFE SCI, V66, P2159, DOI 10.1016/S0024-3205(00)00543-9; D'Souza UM, 2008, PROG BRAIN RES, V172, P73, DOI 10.1016/S0079-6123(08)00904-7; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; DILL RE, 1973, RES COMMUN CHEM PATH, V6, P975; Elverfors A, 1997, J NEUROCHEM, V69, P1684; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; GARRIS PA, 1995, SYNAPSE, V20, P269, DOI 10.1002/syn.890200311; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Grandy DK, 2007, PHARMACOL THERAPEUT, V116, P355, DOI 10.1016/j.pharmthera.2007.06.007; Haavik J, 2008, HUM MUTAT, V29, P891, DOI 10.1002/humu.20700; Hu LYA, 2009, BIOCHEM J, V424, P39, DOI 10.1042/BJ20090998; JONAS W, 1969, ARCH INT PHARMACOD T, V177, P379; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; KATO T, 1986, J NEUROCHEM, V46, P1277, DOI 10.1111/j.1471-4159.1986.tb00650.x; KEHR W, 1981, J NEURAL TRANSM, V50, P165, DOI 10.1007/BF01249138; Lenders JWM, 1996, J CLIN INVEST, V97, P1010, DOI 10.1172/JCI118492; Lindemann L, 2005, TRENDS PHARMACOL SCI, V26, P274, DOI 10.1016/j.tips.2005.03.007; Mannisto PT, 1999, PHARMACOL REV, V51, P593; MANNISTO PT, 1992, BRIT J PHARMACOL, V105, P569; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MOLINOFF PB, 1971, ANNU REV BIOCHEM, V40, P465, DOI 10.1146/annurev.bi.40.070171.002341; Mori S, 2003, J CEREBR BLOOD F MET, V23, P432, DOI 10.1097/01.WCB.0000050062.57184.75; MUSKIET FAJ, 1979, CLIN CHEM, V25, P453; Nakazato T, 2002, EUR J PHARMACOL, V442, P73, DOI 10.1016/S0014-2999(02)01495-4; Nakazato T, 2002, BRAIN RES, V930, P134, DOI 10.1016/S0006-8993(02)02238-2; NAPOLITANO A, 1995, EUR J PHARMACOL, V273, P215, DOI 10.1016/0014-2999(94)00682-W; Osborne RH, 1996, PHARMACOL THERAPEUT, V69, P117, DOI 10.1016/0163-7258(95)02054-3; Rajput AH, 2004, PARKINSONISM RELAT D, V10, P221, DOI 10.1016/j.parkreldis.2004.01.004; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; Shih JC, 1999, AM J HUM GENET, V65, P593, DOI 10.1086/302562; SIIRTOLA T, 1975, CLIN NEUROL NEUROSUR, V78, P77, DOI 10.1016/S0303-8467(75)80014-X; Sotnikova TD, 2006, NEUROLOGY, V67, pS12, DOI 10.1212/WNL.67.7_suppl_2.S12; Sotnikova TD, 2009, MOL PHARMACOL, V76, P229, DOI 10.1124/mol.109.055970; Sotnikova Tatyana D, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS99, DOI 10.1016/j.parkreldis.2008.04.006; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; VULTO AG, 1986, J NEUROCHEM, V47, P1387, DOI 10.1111/j.1471-4159.1986.tb00769.x; Wainscott DB, 2007, J PHARMACOL EXP THER, V320, P475, DOI 10.1124/jpet.106.112532; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; WESTERINK BHC, 1982, J NEUROCHEM, V38, P342, DOI 10.1111/j.1471-4159.1982.tb08634.x; WESTERINK BHC, 1982, J NEUROCHEM, V38, P680, DOI 10.1111/j.1471-4159.1982.tb08685.x; WOLINSKY TD, 2006, GENES BRAIN BEHAV; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	64	64	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13452	10.1371/journal.pone.0013452	http://dx.doi.org/10.1371/journal.pone.0013452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976142	Green Published, Green Submitted, gold			2022-12-25	WOS:000283045300024
J	Bandaranayake, D; Huang, QS; Bissielo, A; Wood, T; Mackereth, G; Baker, MG; Beasley, R; Reid, S; Roberts, S; Hope, V				Bandaranayake, Don; Huang, Q. Sue; Bissielo, Ange; Wood, Tim; Mackereth, Graham; Baker, Michael G.; Beasley, Richard; Reid, Stewart; Roberts, Sally; Hope, Virginia		2009 H1N1 Serosurvey Invest Team	Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic	PLOS ONE			English	Article							A H1N1; ANTIBODY; VIRUS; INFECTION; VACCINE; VOLUNTEERS; PROTECTION; CHALLENGE; SERUM	Background: Understanding immunity, incidence and risk factors of the 2009 influenza A(H1N1) pandemic (2009 H1N1) through a national seroprevalence study is necessary for informing public health interventions and disease modelling. Methods and Findings: We collected 1687 serum samples and individual risk factor data between November-2009 to March-2010, three months after the end of the 2009 H1N1 wave in New Zealand. Participants were randomly sampled from selected general practices countrywide and hospitals in the Auckland region. Baseline immunity was measured from 521 sera collected during 2004 to April-2009. Haemagglutination inhibition (HI) antibody titres of >= 1:40 against 2009 H1N1 were considered seroprotective as well as seropositive. The overall community seroprevalence was 26.7% (CI: 22.6-29.4). The seroprevalence varied across age and ethnicity. Children aged 5-19 years had the highest seroprevalence (46.7%; CI: 38.3-55.0), a significant increase from the baseline (14%; CI: 7.2-20.8). Older adults aged >= 60 had no significant difference in seroprevalence between the serosurvey (24.8%; CI: 18.7-30.9) and baseline (22.6%; CI: 15.3-30.0). Pacific peoples had the highest seroprevalence (49.5%; CI: 35.1-64.0). There was no significant difference in seroprevalence between both primary (29.6%; CI: 22.6-36.5) and secondary healthcare workers (25.3%; CI: 20.8-29.8) and community participants. No significant regional variation was observed. Multivariate analysis indicated age as the most important risk factor followed by ethnicity. Previous seasonal influenza vaccination was associated with higher HI titres. Approximately 45.2% of seropositive individuals reported no symptoms. Conclusions: Based on age and ethnicity standardisation to the New Zealand Population, about 29.5% of New Zealanders had antibody titers at a level consistent with immunity to 2009 H1N1. Around 18.3% of New Zealanders were infected with the virus during the first wave including about one child in every three. Older people were protected due to pre-existing immunity. Age was the most important factor associated with infection followed by ethnicity. Healthcare workers did not appear to have an increased risk of infection compared with the general population.	[Bandaranayake, Don; Huang, Q. Sue; Bissielo, Ange; Wood, Tim; Hope, Virginia] Natl Ctr Biosecur & Infect Dis, Inst Environm Sci & Res, Upper Hutt, New Zealand; [Mackereth, Graham] Minist Hlth, Wellington, New Zealand; [Baker, Michael G.] Univ Otago, Wellington Sch Med, Wellington, New Zealand; [Beasley, Richard] Wellington Hosp, Med Res Inst New Zealand, Wellington, New Zealand; [Reid, Stewart] Ropata Med Ctr, Lower Hutt, New Zealand; [Roberts, Sally] Auckland Dist Hlth Board, Dept Microbiol, Auckland, New Zealand	Institute of Environmental Science & Research (ESR) - New Zealand; University of Otago; Medical Research Institute Of New Zealand; Auckland District Health Board	Bandaranayake, D (corresponding author), Natl Ctr Biosecur & Infect Dis, Inst Environm Sci & Res, Upper Hutt, New Zealand.	sue.huang@esr.cri.nz	Beasley, Richard/AAH-3908-2019	Beasley, Richard/0000-0003-0337-406X; Best, Emma/0000-0002-2667-5458; Huang, Q. Sue/0000-0002-3923-5195; Barr, Ian/0000-0002-7351-418X; Peacey, Matthew/0000-0002-4312-8085	New Zealand Ministry of Health	New Zealand Ministry of Health	This study was funded by the New Zealand Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker J, 2009, WIRES NANOMED NANOBI, V1, P1, DOI 10.1002/wnan.32; *CDC, 2009, MMWR-MORBID MORTAL W, V58, P435; CHAN M, 2009, SWINE INFLUENZA STAT; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; GREENBERG SB, 1974, AM J EPIDEMIOL, V100, P209, DOI 10.1093/oxfordjournals.aje.a112029; Grills N, 2010, AUST NZ J PUBL HEAL, V34, P228, DOI 10.1111/j.1753-6405.2010.00518.x; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Huang Q. S., 2009, Morbidity and Mortality Weekly Report, V58, P918; Iuliano AD, 2009, CLIN INFECT DIS, V49, P1811, DOI 10.1086/649555; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Kendal AP, 1982, CONCEPTS PROCEDURES; La Ruche G, 2009, EURO SURVEILL, V14; LARSON HE, 1978, J HYG-CAMBRIDGE, V80, P243, DOI 10.1017/S0022172400053596; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; LOPEZ L, INFL NZ 2009; MILLER E, 2010, LANCET, P62126, DOI DOI 10.1016/S0140-6736(09); Paine S, 2010, EURO SURVEILL, V15; PEREIRA MS, 1972, BMJ-BRIT MED J, V4, P701, DOI 10.1136/bmj.4.5842.701; POTTER CW, 1977, J INFECT DIS, V135, P423, DOI 10.1093/infdis/135.3.423; POTTER CW, 1977, J HYG-CAMBRIDGE, V79, P321, DOI 10.1017/S0022172400053158; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; ROSS T, 2010, PLOS CURR INFLUENZA; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; *WHO, WHO SWIN INFL UPD 3; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	31	82	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13211	10.1371/journal.pone.0013211	http://dx.doi.org/10.1371/journal.pone.0013211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976224	Green Published, Green Submitted, gold			2022-12-25	WOS:000282941000001
J	Williams, R; Khan, IM; Richardson, K; Nelson, L; McCarthy, HE; Analbelsi, T; Singhrao, SK; Dowthwaite, GP; Jones, RE; Baird, DM; Lewis, H; Roberts, S; Shaw, HM; Dudhia, J; Fairclough, J; Briggs, T; Archer, CW				Williams, Rebecca; Khan, Ilyas M.; Richardson, Kirsty; Nelson, Larissa; McCarthy, Helen E.; Analbelsi, Talal; Singhrao, Sim K.; Dowthwaite, Gary P.; Jones, Rhiannon E.; Baird, Duncan M.; Lewis, Holly; Roberts, Selwyn; Shaw, Hannah M.; Dudhia, Jayesh; Fairclough, John; Briggs, Timothy; Archer, Charles W.			Identification and Clonal Characterisation of a Progenitor Cell Sub-Population in Normal Human Articular Cartilage	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; IN-VITRO CHONDROGENESIS; HUMAN BONE-MARROW; STROMAL CELLS; MONOLAYER-CULTURE; TELOMERE LENGTH; SURFACE-MARKERS; GENE-EXPRESSION; TISSUE	Background: Articular cartilage displays a poor repair capacity. The aim of cell-based therapies for cartilage defects is to repair damaged joint surfaces with a functional replacement tissue. Currently, chondrocytes removed from a healthy region of the cartilage are used but they are unable to retain their phenotype in expanded culture. The resulting repair tissue is fibrocartilaginous rather than hyaline, potentially compromising long-term repair. Mesenchymal stem cells, particularly bone marrow stromal cells (BMSC), are of interest for cartilage repair due to their inherent replicative potential. However, chondrocyte differentiated BMSCs display an endochondral phenotype, that is, can terminally differentiate and form a calcified matrix, leading to failure in long-term defect repair. Here, we investigate the isolation and characterisation of a human cartilage progenitor population that is resident within permanent adult articular cartilage. Methods and Findings: Human articular cartilage samples were digested and clonal populations isolated using a differential adhesion assay to fibronectin. Clonal cell lines were expanded in growth media to high population doublings and karyotype analysis performed. We present data to show that this cell population demonstrates a restricted differential potential during chondrogenic induction in a 3D pellet culture system. Furthermore, evidence of high telomerase activity and maintenance of telomere length, characteristic of a mesenchymal stem cell population, were observed in this clonal cell population. Lastly, as proof of principle, we carried out a pilot repair study in a goat in vivo model demonstrating the ability of goat cartilage progenitors to form a cartilage-like repair tissue in a chondral defect. Conclusions: In conclusion, we propose that we have identified and characterised a novel cartilage progenitor population resident in human articular cartilage which will greatly benefit future cell-based cartilage repair therapies due to its ability to maintain chondrogenicity upon extensive expansion unlike full-depth chondrocytes that lose this ability at only seven population doublings.	[Williams, Rebecca; Khan, Ilyas M.; Richardson, Kirsty; Nelson, Larissa; McCarthy, Helen E.; Analbelsi, Talal; Singhrao, Sim K.; Dowthwaite, Gary P.; Shaw, Hannah M.; Archer, Charles W.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Lewis, Holly; Roberts, Selwyn] Univ Wales Hosp, Dept Cytogenet, Cardiff CF4 4XW, S Glam, Wales; [Jones, Rhiannon E.; Baird, Duncan M.] Cardiff Univ, Dept Pathol, Cardiff, S Glam, Wales; [Dudhia, Jayesh] Royal Vet Coll, Dept Vet Clin Sci, N Mymms, England; [Fairclough, John] Univ Wales Hosp, Dept Orthopaed, Cardiff CF4 4XW, S Glam, Wales; [Briggs, Timothy] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England	Cardiff University; Cardiff University; Cardiff University; University of London; University of London Royal Veterinary College; Cardiff University; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Williams, R (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales.	archer@cf.ac.uk	Baird, Duncan M/C-9671-2011; Williams, Richard/B-8344-2011	Baird, Duncan M/0000-0001-8408-5467; Williams, Richard/0000-0001-8847-3213; Dudhia, Jayesh/0000-0002-2503-697X; Williams, Rebecca/0000-0003-2168-7369; Khan, Ilyas/0000-0002-3886-1987	Arthritis Research Council [17642]; AO Foundation, Davos, Switzerland	Arthritis Research Council; AO Foundation, Davos, Switzerland	The grant was funded by the Arthritis Research Council (www.arc.org.uk) Project Grant 17642. The caprine in vitro studies were funded by the AO Foundation, Davos, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ND, 2009, BBA-MOL BASIS DIS, V1792, P324, DOI 10.1016/j.bbadis.2009.02.004; Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; ARCHER CW, 1994, J ANAT, V184, P447; ARCHER CW, 1982, CELL DIFFER DEV, V11, P245, DOI 10.1016/0045-6039(82)90072-0; Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BOYLE T, 2001, HUMAN CYTOGENETICS C, P55; Brittberg M., 1998, ICRS NEWSLETTER, V1; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Connelly JT, 2008, OSTEOARTHR CARTILAGE, V16, P1092, DOI 10.1016/j.joca.2008.01.004; Cournil-Henrionnet C, 2008, BIORHEOLOGY, V45, P513, DOI 10.3233/BIR-2008-0487; CRAIG FM, 1987, DEVELOPMENT, V99, P383; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; de la Fuente R, 2004, EXP CELL RES, V297, P313, DOI 10.1016/j.yexcr.2004.02.026; Dell'Accio F, 2001, ARTHRITIS RHEUM-US, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T; Diaz-Romero J, 2005, J CELL PHYSIOL, V202, P731, DOI 10.1002/jcp.20164; Diaz-Romero J, 2008, J CELL PHYSIOL, V214, P75, DOI 10.1002/jcp.21161; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93; Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719; Grogan SP, 2007, ARTHRITIS RHEUM-US, V56, P586, DOI 10.1002/art.22408; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hayes AJ, 2001, ANAT EMBRYOL, V203, P469, DOI 10.1007/s004290100178; Hiraoka K, 2006, BIORHEOLOGY, V43, P447; Ichinose S, 2005, CELL TISSUE RES, V322, P217, DOI 10.1007/s00441-005-1140-6; Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Karlsson C, 2008, CELLS TISSUES ORGANS, V187, P275, DOI 10.1159/000113409; Khan IM, 2007, CURR TOP DEV BIOL, V79, P1, DOI 10.1016/S0070-2153(06)79001-9; Khan IM, 2009, OSTEOARTHR CARTILAGE, V17, P518, DOI 10.1016/j.joca.2008.08.002; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; KOLETTAS E, 1995, J CELL SCI, V108, P1991; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Li Y, 2004, TISSUE ENG, V10, P575, DOI 10.1089/107632704323061933; Mareddy S, 2007, TISSUE ENG, V13, P819, DOI 10.1089/ten.2006.0180; Martin JA, 2002, J GERONTOL A-BIOL, V57, pB48, DOI 10.1093/gerona/57.2.B48; Martin JA, 2001, J GERONTOL A-BIOL, V56, pB172, DOI 10.1093/gerona/56.4.B172; Montesinos JJ, 2009, CYTOTHERAPY, V11, P163, DOI 10.1080/14653240802582075; Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Peterson L, 2000, CLIN ORTHOP RELAT R, P212, DOI 10.1097/00003086-200005000-00020; RADA T, 2009, TISSUE ENG B; Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613; ROONEY G, 2009, TISSUE ENG A    0331; Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482; SEABRIGHT M, 1972, CHROMOSOMA, V36, P204; SINGHRAO S, 2009, IMMUNOFLUORESCENCE M; TIGLI RS, 2009, J TISSUE ENG REGEN M; Tuan RS, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2310; Tuli R, 2003, ARTHRITIS RES THER, V5, P235, DOI 10.1186/ar991; Vidal MA, 2008, VET SURG, V37, P713, DOI 10.1111/j.1532-950X.2008.00462.x; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Waddington RJ, 2009, CELLS TISSUES ORGANS, V189, P268, DOI 10.1159/000151447; WATT FM, 1988, DIFFERENTIATION, V38, P140, DOI 10.1111/j.1432-0436.1988.tb00208.x; Wolf F, 2008, EUR CELLS MATER, V16, P92, DOI 10.22203/eCM.v016a10; Yang R, 2003, Eur Cell Mater, V6, P57; Yang XC, 2007, J TISSUE ENG REGEN M, V1, P128, DOI 10.1002/term.13	61	191	200	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13246	10.1371/journal.pone.0013246	http://dx.doi.org/10.1371/journal.pone.0013246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976230	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000282941000003
J	Fasseu, M; Treton, X; Guichard, C; Pedruzzi, E; Cazals-Hatem, D; Richard, C; Aparicio, T; Daniel, F; Soule, JC; Moreau, R; Bouhnik, Y; Laburthe, M; Groyer, A; Ogier-Denis, E				Fasseu, Magali; Treton, Xavier; Guichard, Cecile; Pedruzzi, Eric; Cazals-Hatem, Dominique; Richard, Christophe; Aparicio, Thomas; Daniel, Fanny; Soule, Jean-Claude; Moreau, Richard; Bouhnik, Yoram; Laburthe, Marc; Groyer, Andre; Ogier-Denis, Eric			Identification of Restricted Subsets of Mature microRNA Abnormally Expressed in Inactive Colonic Mucosa of Patients with Inflammatory Bowel Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; REAL-TIME PCR; ULCERATIVE-COLITIS; GENE-EXPRESSION; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; SEQUENCE VARIANTS; CANCER; PROFILES; ONSET	Background: Ulcerative Colitis (UC) and Crohn's Disease (CD) are two chronic Inflammatory Bowel Diseases (IBD) affecting the intestinal mucosa. Current understanding of IBD pathogenesis points out the interplay of genetic events and environmental cues in the dysregulated immune response. We hypothesized that dysregulated microRNA (miRNA) expression may contribute to IBD pathogenesis. miRNAs are small, non-coding RNAs which prevent protein synthesis through translational suppression or mRNAs degradation, and regulate several physiological processes. Methodology/Findings: Expression of mature miRNAs was studied by Q-PCR in inactive colonic mucosa of patients with UC (8), CD (8) and expressed relative to that observed in healthy controls (10). Only miRNAs with highly altered expression (. 5 or,0.2 -fold relative to control) were considered when Q-PCR data were analyzed. Two subsets of 14 (UC) and 23 (CD) miRNAs with highly altered expression (5.2->100 -fold and 0.05-0.19 -fold for over-and under-expression, respectively; 0.001<p<0.05) were identified in quiescent colonic mucosa, 8 being commonly dysregulated in non-inflamed UC and CD (mir-26a,-29a,-29b,-30c,-126*,-127-3p,-196a,-324-3p). Several miRNA genes with dysregulated expression co-localize with acknowledged IBD-susceptibility loci while others, (eg. clustered on 14q32.31), map on chromosomal regions not previously recognized as IBD-susceptibility loci. In addition, in silico clustering analysis identified 5 miRNAs (mir-26a,-29b,-126*,-127-3p,- 324-3p) that share coordinated dysregulation of expression both in quiescent and in inflamed colonic mucosa of IBD patients. Six miRNAs displayed significantly distinct alteration of expression in non-inflamed colonic biopsies of UC and CD patients (mir-196b,-199a-3p,-199b-5p,-320a,-150,-223). Conclusions/Significance: Our study supports miRNAs as crucial players in the onset and/or relapse of inflammation from quiescent mucosal tissues in IBD patients. It allows speculating a role for miRNAs as contributors to IBD susceptibility and suggests that some of the miRNA with altered expression in the quiescent mucosa of IBD patients may define miRNA signatures for UC and CD and help develop new diagnostic biomarkers.	[Fasseu, Magali; Treton, Xavier; Guichard, Cecile; Pedruzzi, Eric; Cazals-Hatem, Dominique; Richard, Christophe; Aparicio, Thomas; Daniel, Fanny; Soule, Jean-Claude; Moreau, Richard; Bouhnik, Yoram; Laburthe, Marc; Groyer, Andre; Ogier-Denis, Eric] Ctr Rech Biomed Bichat Beaujon, INSERM U773, Paris, France; [Fasseu, Magali; Treton, Xavier; Guichard, Cecile; Pedruzzi, Eric; Cazals-Hatem, Dominique; Richard, Christophe; Aparicio, Thomas; Daniel, Fanny; Soule, Jean-Claude; Moreau, Richard; Bouhnik, Yoram; Laburthe, Marc; Groyer, Andre; Ogier-Denis, Eric] Univ Paris 07, Paris, France; [Treton, Xavier; Bouhnik, Yoram] Hop Beaujon, Serv Gastroenterol & Assistance Nutr, Clichy, France; [Cazals-Hatem, Dominique] Hop Beaujon, Serv Anat Pathol, Clichy, France; [Aparicio, Thomas; Soule, Jean-Claude] Hopital Xavier Bichat, Serv Gastroenterol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Fasseu, M (corresponding author), Ctr Rech Biomed Bichat Beaujon, INSERM U773, Paris, France.	andre.groyer@inserm.fr	Moreau, Richard/N-2197-2017; Ogier-Denis, Eric/E-5030-2016; LABURTHE, Marc/C-1875-2012; Moreau, Richard/S-1300-2019; pedruzzi, eric/B-6050-2017	Moreau, Richard/0000-0003-0862-403X; Moreau, Richard/0000-0003-0862-403X; Ogier-Denis, Eric/0000-0002-0057-7593; treton, xavier/0000-0001-8123-9213	Institut National de la Sante et de la Recherche Medicale (Inserm); Association Francois Aupetit AFA; Assistance Publique-Hopitaux de Paris; Ferring Laboratories; Ipsen Laboratories; Societe Nationale Francaise de Gastro-enterologie (SNFGE); Association Francaise pour l'etude du foie (AFEF); Programme National de Recherche en Hepato-Gastroenterologie	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francois Aupetit AFA; Assistance Publique-Hopitaux de Paris; Ferring Laboratories(Ferring Pharmaceuticals); Ipsen Laboratories(Ipsen); Societe Nationale Francaise de Gastro-enterologie (SNFGE); Association Francaise pour l'etude du foie (AFEF); Programme National de Recherche en Hepato-Gastroenterologie	Institut National de la Sante et de la Recherche Medicale (Inserm) and in parts by grants from Association Francois Aupetit AFA, Assistance Publique-Hopitaux de Paris, Ferring Laboratories, Ipsen Laboratories, Societe Nationale Francaise de Gastro-enterologie (SNFGE), Association Francaise pour l'etude du foie (AFEF), and Programme National de Recherche en Hepato-Gastroenterologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding by Ipsen Laboratories was only a small part of the doctoral fellowships dedicated to Xavier Treton. It did not interfere with the study reported in the manuscript and does not alter the authors' adherence to all the PLoS ONE policies.	Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413; Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Bonen DK, 2003, GASTROENTEROLOGY, V124, P521, DOI 10.1053/gast.2003.50045; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Broeckel U, 2006, PEDIATR CLIN N AM, V53, P807, DOI 10.1016/j.pcl.2006.08.007; Burns M, 2008, EUR FOOD RES TECHNOL, V226, P1513, DOI 10.1007/s00217-007-0683-z; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dooley TP, 2004, INFLAMM BOWEL DIS, V10, P1, DOI 10.1097/00054725-200401000-00001; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; FARMER RG, 1993, DIGEST DIS SCI, V38, P1137, DOI 10.1007/BF01295733; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Flavin R, 2009, INT J GYNECOL CANCER, V19, P641, DOI 10.1111/IGC.0b013e3181a48cf9; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; GOMES P, 1986, GUT, V27, P92, DOI 10.1136/gut.27.1.92; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; HARVEY RF, 1980, LANCET, V1, P514; Hollander D, 1999, Curr Gastroenterol Rep, V1, P410, DOI 10.1007/s11894-999-0023-5; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Liu L, 2008, CURR ISSUES MOL BIOL, V10, P25, DOI 10.21775/cimb.010.025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Olsen J, 2009, INFLAMM BOWEL DIS, V15, P1032, DOI 10.1002/ibd.20879; Paavola-Sakki P, 2003, EUR J HUM GENET, V11, P112, DOI 10.1038/sj.ejhg.5200936; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RUTGEERTS P, 1990, GASTROENTEROLOGY, V99, P956, DOI 10.1016/0016-5085(90)90613-6; Sander S, 2009, CELL CYCLE, V8, P556, DOI 10.4161/cc.8.4.7599; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; Sonkoly E, 2009, J CELL MOL MED, V13, P24, DOI 10.1111/j.1582-4934.2008.00534.x; TUKEY JW, 1977, BOX AND WHISKER PLOT, P39; Van Limbergen J, 2007, AM J GASTROENTEROL, V102, P2820, DOI 10.1111/j.1572-0241.2007.01527.x; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Vermeire S, 2005, GENES IMMUN, V6, P637, DOI 10.1038/sj.gene.6364257; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Von Stein P, 2008, GASTROENTEROLOGY, V134, P1869, DOI 10.1053/j.gastro.2008.02.083; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xiao Li Feng, 2002, Curr Gastroenterol Rep, V4, P490, DOI 10.1007/s11894-002-0025-z; Xu H, 2009, CANCER RES, V69, P6275, DOI 10.1158/0008-5472.CAN-08-4517; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zhou QQ, 2010, GUT, V59, P775, DOI 10.1136/gut.2009.181834	78	174	184	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13160	10.1371/journal.pone.0013160	http://dx.doi.org/10.1371/journal.pone.0013160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957151	gold, Green Published			2022-12-25	WOS:000282506100006
J	Bachetti, T; Di Paolo, D; Di Lascio, S; Mirisola, V; Brignole, C; Bellotti, M; Caffa, I; Ferraris, C; Fiore, M; Fornasari, D; Chiarle, R; Borghini, S; Pfeffer, U; Ponzoni, M; Ceccherini, I; Perri, P				Bachetti, Tiziana; Di Paolo, Daniela; Di Lascio, Simona; Mirisola, Valentina; Brignole, Chiara; Bellotti, Marta; Caffa, Irene; Ferraris, Chiara; Fiore, Michele; Fornasari, Diego; Chiarle, Roberto; Borghini, Silvia; Pfeffer, Ulrich; Ponzoni, Mirco; Ceccherini, Isabella; Perri, Patrizia			PHOX2B-Mediated Regulation of ALK Expression: In Vitro Identification of a Functional Relationship between Two Genes Involved in Neuroblastoma	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; CENTRAL HYPOVENTILATION SYNDROME; N-MYC AMPLIFICATION; NEURO-BLASTOMA; HOMEOBOX GENE; CELL-LINES; FAMILIAL NEUROBLASTOMA; ACTIVATING MUTATIONS; TRANSCRIPTION FACTOR; GERMLINE MUTATIONS	Background: Neuroblastoma (NB) is a severe pediatric tumor originating from neural crest derivatives and accounting for 15% of childhood cancer mortality. The heterogeneous and complex genetic etiology has been confirmed with the identification of mutations in two genes, encoding for the receptor tyrosine kinase Anaplastic Lymphoma Kinase (ALK) and the transcription factor Paired-like Homeobox 2B (PHOX2B), in a limited proportion of NB patients. Interestingly, these two genes are overexpressed in the great majority of primary NB samples and cell lines. These observations led us to test the hypothesis of a regulatory or functional relationship between ALK and PHOX2B underlying NB pathogenesis. Methodology/Principal Findings: Following this possibility, we first confirmed a striking correlation between the transcription levels of ALK, PHOX2B and its direct target PHOX2A in a panel of NB cell lines. Then, we manipulated their expression in NB cell lines by siRNA-mediated knock-down and forced over-expression of each gene under analysis. Surprisingly, PHOX2B- and PHOX2A-directed siRNAs efficiently downregulated each other as well as ALK gene and, consistently, the enhanced expression of PHOX2B in NB cells yielded an increment of ALK protein. We finally demonstrated that PHOX2B drives ALK gene transcription by directly binding its promoter, which therefore represents a novel PHOX2B target. Conclusions/Significance: These findings provide a compelling explanation of the concurrent involvement of these two genes in NB pathogenesis and are going to foster a better understanding of molecular interactions at the base of the disease. Moreover, this work opens new perspectives for NBs refractory to conventional therapies that may benefit from the design of novel therapeutic RNAi-based approaches for multiple gene targets.	[Bachetti, Tiziana; Brignole, Chiara; Bellotti, Marta; Borghini, Silvia; Ceccherini, Isabella] G Gaslini Childrens Hosp, Mol Genet Lab, Genoa, Italy; [Di Paolo, Daniela; Brignole, Chiara; Caffa, Irene; Ponzoni, Mirco; Perri, Patrizia] G Gaslini Childrens Hosp, Lab Oncol, Expt Therapy Unit, Genoa, Italy; [Chiarle, Roberto] Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy; [Mirisola, Valentina; Bellotti, Marta; Pfeffer, Ulrich] Natl Inst Canc Res, Genoa, Italy; [Di Lascio, Simona; Fornasari, Diego] Univ Milan, Sch Med, Dept Pharmacol, I-20122 Milan, Italy; [Di Lascio, Simona; Fornasari, Diego] CNR, Inst Neurosci, I-20133 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; University of Turin; University of Genoa; IRCCS AOU San Martino IST; University of Milan; Consiglio Nazionale delle Ricerche (CNR)	Bachetti, T (corresponding author), G Gaslini Childrens Hosp, Mol Genet Lab, Genoa, Italy.	isa.c@unige.it	Perri, Patrizia/AFV-5794-2022; borghini, silvia/C-8335-2012; Ponzoni, Mirco/J-7713-2016; Bachetti, Tiziana/AAB-4516-2021; Di Paolo, Daniela/J-7681-2016; Brignole, Chiara/H-9986-2018; Ceccherini, Isabella/P-8195-2014; Caffa, Irene/J-9835-2016; Bachetti, Tiziana/K-6405-2016; Pfeffer, Ulrich/J-7064-2016; Fiore, Michele/ABE-1026-2020; Perri, Patrizia/I-8124-2018	Perri, Patrizia/0000-0003-2538-8278; Ponzoni, Mirco/0000-0002-6164-4286; Di Paolo, Daniela/0000-0001-7264-6888; Brignole, Chiara/0000-0002-2563-6991; Ceccherini, Isabella/0000-0001-8732-1955; Caffa, Irene/0000-0003-1111-9915; Bachetti, Tiziana/0000-0002-9456-8945; Pfeffer, Ulrich/0000-0003-0872-4671; Fiore, Michele/0000-0002-6489-2648; Perri, Patrizia/0000-0003-2538-8278; Fornasari, Diego/0000-0002-9668-3103; DI LASCIO, SIMONA/0000-0002-5971-1515; CHIARLE, Roberto/0000-0003-1564-8531	Fondazione Pierfranco e Luisa Mariani; Fondazione Italiana Ricerca Cancro (FIRC); Associazione Italiana Ricerca Cancro (AIRC); Fondazione Mariani [08/69]; Ministry of Health	Fondazione Pierfranco e Luisa Mariani; Fondazione Italiana Ricerca Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Mariani; Ministry of Health	T. Bachetti has been supported by Fondazione Pierfranco e Luisa Mariani. D. Di Paolo is a recipient of a Fondazione Italiana Ricerca Cancro (FIRC) fellowship. The financial support of Associazione Italiana Ricerca Cancro (AIRC) (to M. P.), Fondazione Mariani (grant# 08/69 to I. Ceccherini) and of Ministry of Health (Progetti Finalizzato 2006 and Strategico 2009 to I. Ceccherini and Finalizzato 2007 to M. P.) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2000, DNA CELL BIOL, V19, P539, DOI 10.1089/104454900439773; Alam G, 2009, AM J PATHOL, V175, P856, DOI 10.2353/ajpath.2009.090019; Bachetti T, 2005, GENE EXPRESSION, V12, P137, DOI 10.3727/000000005783992106; Bachetti T, 2005, HUM MOL GENET, V14, P1815, DOI 10.1093/hmg/ddi188; BARNES EN, 1981, IN VITRO CELL DEV B, V17, P619, DOI 10.1007/BF02618461; Benfante R, 2007, J BIOL CHEM, V282, P13290, DOI 10.1074/jbc.M608616200; BIEDLER JL, 1973, CANCER RES, V33, P2643; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bogenmann E, 1996, INT J CANCER, V67, P379, DOI 10.1002/(SICI)1097-0215(19960729)67:3<379::AID-IJC12>3.0.CO;2-3; Borghini S, 2006, BIOCHEM J, V395, P355, DOI 10.1042/BJ20051386; Bourdeaut F, 2005, CANCER LETT, V228, P51, DOI 10.1016/j.canlet.2005.01.055; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Cargnin F, 2005, J BIOL CHEM, V280, P37439, DOI 10.1074/jbc.M508368200; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung IY, 2008, CLIN CANCER RES, V14, P7020, DOI 10.1158/1078-0432.CCR-08-0541; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; CORNAGLIAFERRARIS P, 1990, INT J CANCER, V45, P578, DOI 10.1002/ijc.2910450334; Flora A, 2001, J NEUROSCI, V21, P7037, DOI 10.1523/JNEUROSCI.21-18-07037.2001; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; GROSS N, 1992, INT J CANCER, V52, P85, DOI 10.1002/ijc.2910520116; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; Longo L, 2008, INT J ONCOL, V33, P985, DOI 10.3892/ijo_00000086; LONGO L, 1988, J CANCER RES CLIN, V114, P636, DOI 10.1007/BF00398190; Longo L, 2007, HUM HERED, V63, P205, DOI 10.1159/000099997; McConville C, 2006, AM J MED GENET A, V140A, P1297, DOI 10.1002/ajmg.a.31278; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2009, CLIN CANCER RES, V15, P5609, DOI 10.1158/1078-0432.CCR-08-2762; Mosse YP, 2004, AM J HUM GENET, V75, P727, DOI 10.1086/424530; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Pagnan G, 2000, J NATL CANCER I, V92, P253, DOI 10.1093/jnci/92.3.253; Pagnan G, 2009, CLIN CANCER RES, V15, P1199, DOI 10.1158/1078-0432.CCR-08-2477; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Passoni L, 2009, CANCER RES, V69, P7338, DOI 10.1158/0008-5472.CAN-08-4419; Pastorino F, 2008, CLIN CANCER RES, V14, P7320, DOI 10.1158/1078-0432.CCR-08-0804; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Perri P, 2005, ONCOGENE, V24, P3050, DOI 10.1038/sj.onc.1208532; Raabe EH, 2008, ONCOGENE, V27, P469, DOI 10.1038/sj.onc.1210659; Reiff T, 2010, J NEUROSCI, V30, P905, DOI 10.1523/JNEUROSCI.5368-09.2010; Revet I, 2008, EXP CELL RES, V314, P707, DOI 10.1016/j.yexcr.2007.12.008; Rozen S, 2000, Methods Mol Biol, V132, P365; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SEEGER RC, 1977, CANCER RES, V37, P1364; SEEGER RC, 1982, ANN INTERN MED, V97, P873, DOI 10.7326/0003-4819-97-6-873; Stutterheim J, 2008, J CLIN ONCOL, V26, P5443, DOI 10.1200/JCO.2007.13.6531; Trochet D, 2005, AM J HUM GENET, V76, P421, DOI 10.1086/428366; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; van Limpt V, 2004, ONCOGENE, V23, P9280, DOI 10.1038/sj.onc.1208157; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Webb TR, 2009, EXPERT REV ANTICANC, V9, P331, DOI 10.1586/14737140.9.3.331; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520	54	32	33	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13108	10.1371/journal.pone.0013108	http://dx.doi.org/10.1371/journal.pone.0013108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957039	Green Published, gold			2022-12-25	WOS:000282359300012
J	Cordani, N; Pozzi, S; Martynova, E; Fanoni, D; Borrelli, S; Alotto, D; Castagnoli, C; Berti, E; Vigano, MA; Mantovani, R				Cordani, N.; Pozzi, S.; Martynova, E.; Fanoni, D.; Borrelli, S.; Alotto, D.; Castagnoli, C.; Berti, E.; Vigano, M. A.; Mantovani, R.			Mutant p53 subverts p63 control over KLF4 expression in keratinocytes	ONCOGENE			English	Article						KLF4; p63; mutant p53; keratinocytes	KRUPPEL-LIKE FACTOR-4; SQUAMOUS-CELL CARCINOMA; INDUCED DNA-DAMAGE; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; SKIN-CANCER; STEM-CELL; TRANSCRIPTIONAL CONTROL; CYCLE REGULATION; BREAST-CANCER	Genetic experiments established that p63 is crucial for the development and maintenance of pluri-stratified epithelia and KLF4 for the barrier function of the skin. KLF4 is one of the factors that reprogram differentiated cells to iPS. We investigated the relationship between p63 and KLF4 using RNA interference, overexpression, chromatin immunoprecipitation and transient transfections with reporter constructs. We find that p63 directly represses KLF4 in normal keratinocytes (KCs) by binding to upstream promoter sites. Unlike p63, KLF4 levels are high in the upper layers of human skin and increase upon differentiation of KCs in vitro. In HaCaT KCs, which harbor two mutant alleles of p53, inactivation of p63 and of mutant p53 leads to KLF4 repression. p63 and p53 mutants are bound to sites in the KLF4 core promoter. Importantly, expression of the H179Y and R282Q p53 mutants in primary KCs is sufficient to activate endogenous KLF4. Finally, immunohistochemical analysis of tissue arrays confirms increased coexpression of KLF4 and mutant p53 in squamous cell carcinomas. Our data indicate that suppression of KLF4 is part of the growth-promoting strategy of p63 in the lower layers of normal epidermis, and that tumor-predisposing p53 mutations hijack p63 to a different location on the promoter, turning it into an activator of this reprogramming factor. Oncogene (2011) 30, 922-932; doi:10.1038/onc.2010.474; published online 25 October 2010	[Cordani, N.; Pozzi, S.; Martynova, E.; Borrelli, S.; Vigano, M. A.; Mantovani, R.] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; [Fanoni, D.; Berti, E.] Univ Milan, Ist Sci Dermatol, IRCCS Fdn Osped Maggiore Policlin, I-20133 Milan, Italy; [Alotto, D.; Castagnoli, C.] Osped CTO, Dipartimento Chirurg Plast, Banca Cute, Turin, Italy; [Berti, E.] Univ Milano Bicocca, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milano-Bicocca	Mantovani, R (corresponding author), Univ Milan, Dipartimento Sci Biomol & Biotecnol, Via Celoria 26, I-20133 Milan, Italy.	mantor@unimi.it	Cordani, Nicoletta/AAC-1978-2022; Berti, Emilio/F-5256-2012; Cordani, Nicoletta/ABG-8636-2020	Cordani, Nicoletta/0000-0002-3227-8280; Berti, Emilio/0000-0001-6753-4910; vigano, maria alessandra/0000-0003-2009-0384	European Union [EPISTEM LSHB-CT-2005-019067]; MIUR; Associazione Italiana per la Ricerca sul Cancro	European Union(European Commission); MIUR(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We thank V Yang (Emory University, USA) and C Ishioka (Tohoru U Jp) for gift of the KLF4-Luciferase vector and mutant p53 vectors, respectively. We thank K Vousden and P Muller (Beatson I, UK) for information on the p53 siRNA oligonucleotide. This work was supported by grants from the European Union (EPISTEM LSHB-CT-2005-019067), MIUR and Associazione Italiana per la Ricerca sul Cancro (to RM).	Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Boukamp P, 1997, GENE CHROMOSOME CANC, V19, P201, DOI 10.1002/(SICI)1098-2264(199708)19:4<201::AID-GCC1>3.0.CO;2-0; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Carroll DK, 2007, CELL CYCLE, V6, P255, DOI 10.4161/cc.6.3.3799; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Chen YJ, 2008, CANCER BIOL THER, V7, P777, DOI 10.4161/cbt.7.5.5768; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; Dang DT, 2002, NUCLEIC ACIDS RES, V30, P2736, DOI 10.1093/nar/gkf400; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Davison TS, 1999, J BIOL CHEM, V274, P18709, DOI 10.1074/jbc.274.26.18709; de Gruijl FR, 2008, PHOTOCHEM PHOTOBIOL, V84, P382, DOI 10.1111/j.1751-1097.2007.00275.x; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Donzelli S, 2008, CURR GENOMICS, V9, P200, DOI 10.2174/138920208784340713; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang CC, 2005, CANCER BIOL THER, V4, P1401, DOI 10.4161/cbt.4.12.2355; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; Jiang WD, 1999, ONCOGENE, V18, P4247, DOI 10.1038/sj.onc.1202789; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Koster MI, 2004, DIFFERENTIATION, V72, P364, DOI 10.1111/j.1432-0436.2004.07208002.x; Li G, 1998, J INVEST DERMATOL, V110, P72, DOI 10.1046/j.1523-1747.1998.00090.x; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Ortt K, 2006, FEBS LETT, V580, P4544, DOI 10.1016/j.febslet.2006.07.004; Perez CA, 2007, CELL CYCLE, V6, P246, DOI 10.4161/cc.6.3.3801; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Pozzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005008; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinne T, 2006, AM J MED GENET A, V140A, P1396, DOI 10.1002/ajmg.a.31271; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Smith C, 2004, BIOCHEM J, V380, P757, DOI 10.1042/BJ20040077; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Swamynathan SK, 2008, INVEST OPHTH VIS SCI, V49, P3360, DOI 10.1167/iovs.08-1811; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Testoni B, 2006, CELL CYCLE, V5, P2805, DOI 10.4161/cc.5.23.3525; Tsai KY, 2004, AM J MED GENET C, V131C, P82, DOI 10.1002/ajmg.c.30037; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vigano MA, 2007, CELL CYCLE, V6, P233, DOI 10.4161/cc.6.3.3802; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Whitney EM, 2006, GENE EXPRESSION, V13, P85, DOI 10.3727/000000006783991908; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yoon HS, 2005, ONCOGENE, V24, P4017, DOI 10.1038/sj.onc.1208576; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yoon HS, 2003, J BIOL CHEM, V278, P2101, DOI 10.1074/jbc.M211027200; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhou QB, 2009, CANCER RES, V69, P8284, DOI 10.1158/0008-5472.CAN-09-1345; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	72	28	28	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	8					922	932		10.1038/onc.2010.474	http://dx.doi.org/10.1038/onc.2010.474			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	726CJ	20972454				2022-12-25	WOS:000287695900004
J	Martinez-Barriocanal, A; Comas-Casellas, E; Schwartz, S; Martin, M; Sayos, J				Martinez-Barriocanal, Agueda; Comas-Casellas, Emma; Schwartz, Simo, Jr.; Martin, Margarita; Sayos, Joan			CD300 Heterocomplexes, a New and Family-restricted Mechanism for Myeloid Cell Signaling Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR IRP60 CD300A; INHIBITORY RECEPTOR; FUNCTIONAL-CHARACTERIZATION; IMMUNOGLOBULIN SUPERFAMILY; 3-DIMENSIONAL STRUCTURE; EXTRACELLULAR DOMAIN; ACTIVATING RECEPTORS; ADAPTER PROTEINS; IMMUNE-RESPONSES; CUTTING EDGE	The CD300 family of myeloid immunoglobulin receptors includes activating (CD300b, CD300e) and inhibitory members (CD300a, CD300f), as well as molecules of uncertain function presenting a negative charge within their transmembrane domain (CD300c, CD300d). In this paper, we establish that CD300c is a functional immune receptor able to deliver activating signals upon ligation in RBL-2H3 mast cells. CD300c signaling is partially mediated by a direct association with the immune receptor tyrosine-based activation motif-bearing adaptor Fc epsilon R gamma. The existence of complementary transmembrane- charged residues in certain CD300 receptors suggested the formation of heterodimers within this family. Indeed, we proved the interaction between CD300b and CD300c in transfected COS-7 cells and demonstrated that it has important functional consequences. Unexpectedly, dimmer formation was dependent on the immunoglobulin domains rather than the charged transmembrane residues. Concordantly, all CD300 members were found to interact with each other, even with themselves, forming both homo-and heterodimers. We found that the combination of CD300 receptors in a complex differentially modulates the signaling outcome, strongly suggesting a new mechanism by which CD300 complexes could regulate the activation of myeloid cells upon interaction with their natural ligands.	[Sayos, Joan] Univ Autonoma Barcelona, Inst Recerca VHIR, Hosp Univ Vall dHebron, CIBBIM Nanomed Program,Immunobiol Grp, Barcelona 08035, Spain; [Schwartz, Simo, Jr.] Univ Autonoma Barcelona, Inst Recerca VHIR, Hosp Univ Vall dHebron, CIBBIM Nanomed Program,Drug Delivery & Targeting, Barcelona 08035, Spain; [Martinez-Barriocanal, Agueda; Comas-Casellas, Emma; Schwartz, Simo, Jr.; Sayos, Joan] Inst Salud Carlos III, Networking Res Ctr Bioengn Biomat & Nanomed CIBBE, Barcelona 08035, Spain; [Martin, Margarita] Univ Barcelona, Fac Med, Inst Invest Biomed August Pi i Sunyer, Biochem Unit, Barcelona 08036, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS		agmartinez@ir.vhebron.net; jsayos@ir.vhebron.net	Schwartz, Simo/H-7776-2012; Martinez, Agueda/AAB-7186-2019; Andorra, Margarita Martin/H-2025-2015; Sayos, Joan/B-6119-2009	Martinez, Agueda/0000-0002-8809-160X; Andorra, Margarita Martin/0000-0002-9245-4899; Sayos, Joan/0000-0002-4664-3461; Comas-Casellas, Emma/0000-0002-8567-6848; Schwartz, Simo/0000-0001-8297-7971	Plan Nacional I + D [SAF2004-00972, SAF2009-07548]; Fondo de Investigaciones Sanitarias [PI080366]; Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya (AGAUR) [2009 SGR 493]; Ministerio de Ciencia e Inovacion; Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III [CP06/00058]	Plan Nacional I + D; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Ministerio de Ciencia e Inovacion(Spanish Government); Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III	This work was supported in part by Plan Nacional I + D Grants SAF2004-00972 and SAF2009-07548, Fondo de Investigaciones Sanitarias Grant PI080366, and Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya (AGAUR) (2009 SGR 493).; Supported by a fellowship from the Ministerio de Ciencia e Inovacion. To whom correspondence may be addressed. E-mail: agmartinez@ir.vhebron.net.; Supported by a contract from the Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III (CP06/00058).	Aguilar H, 2004, J IMMUNOL, V173, P6703, DOI 10.4049/jimmunol.173.11.6703; Alvarez Y, 2008, MOL IMMUNOL, V45, P253, DOI 10.1016/j.molimm.2007.05.006; Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Alvarez-Errico D, 2007, J IMMUNOL, V178, P808, DOI 10.4049/jimmunol.178.2.808; Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brckalo T, 2010, EUR J IMMUNOL, V40, P722, DOI 10.1002/eji.200939468; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Cantoni C, 2003, STRUCTURE, V11, P725, DOI 10.1016/S0969-2126(03)00095-9; Chang CW, 1999, J IMMUNOL, V163, P4651; Chiesa S, 2005, MOL IMMUNOL, V42, P477, DOI 10.1016/j.molimm.2004.07.030; Clark GJ, 2009, IMMUNOBIOLOGY, V214, P730, DOI 10.1016/j.imbio.2009.06.004; Clark GJ, 2000, TISSUE ANTIGENS, V55, P101, DOI 10.1034/j.1399-0039.2000.550201.x; Clark GJ, 2001, TISSUE ANTIGENS, V57, P415, DOI 10.1034/j.1399-0039.2001.057005415.x; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; Dietrich J, 2000, MICROBES INFECT, V2, P323, DOI 10.1016/S1286-4579(00)00294-X; Dimasi N, 2007, ACTA CRYSTALLOGR F, V63, P204, DOI 10.1107/S1744309107004903; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fujimoto M, 2006, INT IMMUNOL, V18, P1499, DOI 10.1093/intimm/dxl083; Geng LP, 2001, P NATL ACAD SCI USA, V98, P11527, DOI 10.1073/pnas.191378198; Hedin KE, 1997, J IMMUNOL, V159, P5431; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2009, J IMMUNOL, V183, P925, DOI 10.4049/jimmunol.0900552; JACKSON DG, 1992, EUR J IMMUNOL, V22, P1157, DOI 10.1002/eji.1830220508; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Marquez JA, 2007, J MOL BIOL, V367, P310, DOI 10.1016/j.jmb.2007.01.011; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Martinez-Barriocanal A, 2006, J IMMUNOL, V177, P2819, DOI 10.4049/jimmunol.177.5.2819; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Munitz A, 2006, BLOOD, V107, P1996, DOI 10.1182/blood-2005-07-2926; Nakajima T, 2002, BLOOD, V100, P3861, DOI 10.1182/blood-2002-02-0602; Nakano T, 2008, MOL IMMUNOL, V45, P289, DOI 10.1016/j.molimm.2007.04.011; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; Sayos J, 2001, BLOOD, V97, P3867, DOI 10.1182/blood.V97.12.3867; Shields MJ, 1998, J IMMUNOL, V160, P2297; Smith KM, 1998, J IMMUNOL, V161, P7; Speckman RA, 2003, HUM GENET, V112, P34, DOI 10.1007/s00439-002-0851-y; Springer TA, 2004, ADV PROTEIN CHEM, V68, P29; Tomasello E, 2000, SEMIN IMMUNOL, V12, P139, DOI 10.1006/smim.2000.0216; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Wienands J, 2000, CURR TOP MICROBIOL, V245, P53; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Zamoyska R, 1998, CURR OPIN IMMUNOL, V10, P82, DOI 10.1016/S0952-7915(98)80036-8	54	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41781	41794		10.1074/jbc.M110.140889	http://dx.doi.org/10.1074/jbc.M110.140889			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959446	Green Published, hybrid			2022-12-25	WOS:000285622600066
J	Li, YH; Chen, MHC; Gong, HY; Hu, SY; Li, YW; Lin, GH; Lin, CC; Liu, W; Wu, JL				Li, Yen-Hsing; Chen, Mark Hung-Chih; Gong, Hong-Yi; Hu, Shao-Yang; Li, Ya-Wen; Lin, Gen-Hwa; Lin, Ching-Chun; Liu, Wangta; Wu, Jen-Leih			Progranulin A-mediated MET Signaling Is Essential for Liver Morphogenesis in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULIN-EPITHELIN PRECURSOR; HEPATOCYTE GROWTH-FACTOR; HUMAN HEPATOCELLULAR-CARCINOMA; PROMOTES TUMOR-GROWTH; BREAST-CANCER CELLS; C-MET; GENE-EXPRESSION; DEFICIENT MICE; MESSENGER-RNA; BETA-CATENIN	The mechanism that regulates embryonic liver morphogenesis remains elusive. Progranulin (PGRN) is postulated to play a critical role in regulating pathological liver growth. Nevertheless, the exact regulatory mechanism of PGRN in relation to its functional role in embryonic liver development remains to be elucidated. In our study, the knockdown of progranulin A (GrnA), an orthologue of mammalian PGRN, using antisense morpholinos resulted in impaired liver morphogenesis in zebrafish (Danio rerio). The vital role of GrnA in hepatic outgrowth and not in liver bud formation was further confirmed using whole-mount in situ hybridization markers. In addition, a GrnA deficiency was also found to be associated with the deregulation of MET-related genes in the neonatal liver using a microarray analysis. In contrast, the decrease in liver size that was observed in grnA morphants was avoided when ectopic MET expression was produced by co-injecting met mRNA and grnA morpholinos. This phenomenon suggests that GrnA might play a role in liver growth regulation via MET signaling. Furthermore, our study has shown that GrnA positively modulates hepatic MET expression both in vivo and in vitro. Therefore, our data have indicated that GrnA plays a vital role in embryonic liver morphogenesis in zebrafish. As a result, a novel link between PGRN and MET signaling is proposed.	[Wu, Jen-Leih] Natl Chung Hsing Univ, Taiwan Int Grad Program, Mol & Biol Agr Sci Program, Taipei 115, Taiwan; [Li, Yen-Hsing; Li, Ya-Wen; Lin, Gen-Hwa; Lin, Ching-Chun; Liu, Wangta; Wu, Jen-Leih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Li, Yen-Hsing; Wu, Jen-Leih] Natl Chung Hsing Univ, Grad Inst Biochem, Taichung 402, Taiwan; [Li, Yen-Hsing; Wu, Jen-Leih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Chen, Mark Hung-Chih] Hungkuang Univ, Biotechnol Res Inst, Dept Biotechnol, Bioluminescence Life Image Lab, Taichung 433, Taiwan; [Gong, Hong-Yi] Natl Taiwan Ocean Univ, Coll Life Sci, Dept Aquaculture, Chilung 202, Taiwan; Natl Pingtung Univ Sci & Technol, Dept Life Sci, Pingtung 912, Taiwan	National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University; National Chung Hsing University; Hungkuang University; National Taiwan Ocean University; National Pingtung University Science & Technology	Wu, JL (corresponding author), Acad Sinica, ICOB, 128,Sec 2, Taipei 11529, Taiwan.	jlwu@gate.sinica.edu.tw	Chen, Mark/B-2750-2011; Gong, Hong-Yi/ABE-2571-2020	Gong, Hong-Yi/0000-0002-6240-0582	National Science Council of Taiwan; National Science Council [97-2317-B-001-002, 97-2313-B-241-001-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council 97-2317-B-001-002 Grant (to J.-L. W.) and National Science Council 97-2313-B-241-001-MY3 Grant (to M. H.-C. C. and J.-L. W.) from the National Science Council of Taiwan.	Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Apte U, 2007, AM J PHYSIOL-GASTR L, V292, pG1578, DOI 10.1152/ajpgi.00359.2006; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Boon EMJ, 2002, CANCER RES, V62, P5126; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Cadieux B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-156; Campbell DB, 2008, AUTISM RES, V1, P159, DOI 10.1002/aur.27; Chen MHC, 2007, GEN COMP ENDOCR, V150, P212, DOI 10.1016/j.ygcen.2006.08.005; Cheung ST, 2004, CLIN CANCER RES, V10, P7629, DOI 10.1158/1078-0432.CCR-04-0960; Chou MY, 2008, J EXP BIOL, V211, P3077, DOI 10.1242/jeb.019950; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; Danilkovitch-Miagkova A, 2001, MOL CELL BIOL, V21, P5857, DOI 10.1128/MCB.21.17.5857-5868.2001; Duncan SA, 2003, MECH DEVELOP, V120, P19, DOI 10.1016/S0925-4773(02)00328-3; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Gambarotta G, 1996, ONCOGENE, V13, P1911; Grisendi S, 2001, J BIOL CHEM, V276, P46632, DOI 10.1074/jbc.M104323200; Haines L, 2004, DEVELOPMENT, V131, P4857, DOI 10.1242/dev.01374; He ZH, 1999, CANCER RES, V59, P3222; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2002, CANCER RES, V62, P5590; Her GM, 2003, DEV DYNAM, V227, P347, DOI 10.1002/dvdy.10324; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Hu MC, 2007, BIOCHEM BIOPH RES CO, V359, P778, DOI 10.1016/j.bbrc.2007.05.183; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; Kim WE, 2006, CLIN CANCER RES, V12, P4192, DOI 10.1158/1078-0432.CCR-05-2663; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Latimer AJ, 2008, DEV DYNAM, V237, P3904, DOI 10.1002/dvdy.21794; Liu YH, 1998, EXP CELL RES, V242, P174, DOI 10.1006/excr.1998.4107; Maina F, 2001, MOL CELL, V7, P1293, DOI 10.1016/S1097-2765(01)00261-1; Miyata Y, 2009, HUM PATHOL, V40, P496, DOI 10.1016/j.humpath.2008.09.011; Nakaigawa N, 2006, CANCER RES, V66, P3699, DOI 10.1158/0008-5472.CAN-05-0617; Nikopoulos GN, 2008, BIOTECHNIQUES, V44, P547, DOI 10.2144/000112725; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275; PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pizarro GO, 2007, INT J CANCER, V120, P2339, DOI 10.1002/ijc.22559; Ren Y, 2006, ONCOGENE, V25, P3501, DOI 10.1038/sj.onc.1209395; Rudolph D, 2000, GENE DEV, V14, P854; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Shepard JL, 2004, METHOD CELL BIOL, V76, P109; SUZUKI K, 1994, HEPATOLOGY, V20, P1231; Tangkeangsirisin W, 2004, CANCER RES, V64, P1737, DOI 10.1158/0008-5472.CAN-03-2364; Tavian D, 2000, INT J CANCER, V87, P644, DOI 10.1002/1097-0215(20000901)87:5<644::AID-IJC4>3.3.CO;2-N; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Ueki T, 1997, HEPATOLOGY, V25, P619, DOI 10.1002/hep.510250321; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Watanabe T, 2006, MOL CANCER RES, V4, P499, DOI 10.1158/1541-7786.MCR-05-0141; Xia XM, 1998, BIOCHEM BIOPH RES CO, V245, P539, DOI 10.1006/bbrc.1998.8498; YIN F, 2010, FASEB J IN PRESS; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	60	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41001	41009		10.1074/jbc.M110.138743	http://dx.doi.org/10.1074/jbc.M110.138743			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20961855	Green Published, hybrid			2022-12-25	WOS:000285414400063
J	Yang, SH; Peng, QA; Zhang, Q; Zou, LF; Li, Y; Robert, C; Pritchard, L; Liu, H; Hovey, R; Wang, Q; Birch, P; Toth, IK; Yang, CH				Yang, Shihui; Peng, Quan; Zhang, Qiu; Zou, Lifang; Li, Yan; Robert, Christelle; Pritchard, Leighton; Liu, Hui; Hovey, Raymond; Wang, Qi; Birch, Paul; Toth, Ian K.; Yang, Ching-Hong			Genome-Wide Identification of HrpL-Regulated Genes in the Necrotrophic Phytopathogen Dickeya dadantii 3937	PLOS ONE			English	Article							III SECRETION SYSTEM; EFFECTOR PROTEINS; ADENYLATE-CYCLASE; ERWINIA-AMYLOVORA; TRANSLOCATION; VIRULENCE; EXPRESSION; ERWINIA-CHRYSANTHEMI-3937; PATHOGENICITY; PECTINOLYSIS	Background: Dickeya dadantii is a necrotrophic pathogen causing disease in many plants. Previous studies have demonstrated that the type III secretion system (T3SS) of D. dadantii is required for full virulence. HrpL is an alternative sigma factor that binds to the hrp box promoter sequence of T3SS genes to up-regulate their expression. Methodology/Principal Findings: To explore the inventory of HrpL-regulated genes of D. dadantii 3937 (3937), transcriptome profiles of wild-type 3937 and a hrpL mutant grown in a T3SS-inducing medium were examined. Using a cutoff value of 1.5, significant differential expression was observed in sixty-three genes, which are involved in various cellular functions such as type III secretion, chemotaxis, metabolism, regulation, and stress response. A hidden Markov model (HMM) was used to predict candidate hrp box binding sites in the intergenic regions of 3937, including the promoter regions of HrpL-regulated genes identified in the microarray assay. In contrast to biotrophic phytopathgens such as Pseudomonas syringae, among the HrpL up-regulated genes in 3937 only those within the T3SS were found to contain a hrp box sequence. Moreover, direct binding of purified HrpL protein to the hrp box was demonstrated for hrp box-containing DNA fragments of hrpA and hrpN using the electrophoretic mobility shift assay (EMSA). In this study, a putative T3SS effector DspA/E was also identified as a HrpL-upregulated gene, and shown to be translocated into plant cells in a T3SS-dependent manner. Conclusion/Significances: We provide the genome-wide study of HrpL-regulated genes in a necrotrophic phytopathogen (D. dadantii 3937) through a combination of transcriptomics and bioinformatics, which led to identification of several effectors. Our study indicates the extent of differences for T3SS effector protein inventory requirements between necrotrophic and biotrophic pathogens, and may allow the development of different strategies for disease control for these different groups of pathogens.	[Yang, Shihui; Peng, Quan; Zhang, Qiu; Zou, Lifang; Li, Yan; Hovey, Raymond; Yang, Ching-Hong] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Li, Yan; Wang, Qi] China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China; [Robert, Christelle; Pritchard, Leighton; Liu, Hui; Birch, Paul; Toth, Ian K.] Scottish Crop Res Inst, Dundee DD2 5DA, Scotland	University of Wisconsin System; University of Wisconsin Milwaukee; China Agricultural University; James Hutton Institute	Yang, SH (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA.	Ian.Toth@scri.ac.uk; chyang@uwm.edu	Pritchard, Leighton/A-7331-2008; YANG, SHIHUI/A-6526-2008; Yang, Shihui/AAE-4100-2020; Birch, Paul/F-7681-2012	Pritchard, Leighton/0000-0002-8392-2822; YANG, SHIHUI/0000-0002-9394-9148; Yang, Shihui/0000-0002-9394-9148; Birch, Paul/0000-0002-6559-3746	National Science Foundation [EF-0332163]; Research Growth Initiative of the University of Wisconsin-Milwaukee; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); China Scholarship Council	National Science Foundation(National Science Foundation (NSF)); Research Growth Initiative of the University of Wisconsin-Milwaukee; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); China Scholarship Council(China Scholarship Council)	This project is supported by grants from the National Science Foundation (award no. EF-0332163), the Research Growth Initiative of the University of Wisconsin-Milwaukee, the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD), and the State Scholarship Fund of the China Scholarship Council awarded to Yan Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; BAUER DW, 1994, MOL PLANT MICROBE IN, V7, P573, DOI 10.1094/MPMI-7-0573; BAUER DW, 1995, MOL PLANT MICROBE IN, V8, P484, DOI 10.1094/MPMI-8-0484; Bocsanczy AM, 2008, MOL PLANT PATHOL, V9, P425, DOI 10.1111/J.1364-3703.2008.00471.X; Bogdanove AJ, 1998, P NATL ACAD SCI USA, V95, P1325, DOI 10.1073/pnas.95.3.1325; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Brencic A, 2005, MICROBIOL MOL BIOL R, V69, P155, DOI 10.1128/MMBR.69.1.155-194.2005; Buttner D, 2006, CURR OPIN MICROBIOL, V9, P193, DOI 10.1016/j.mib.2006.02.006; Cambronne ED, 2006, TRAFFIC, V7, P929, DOI 10.1111/j.1600-0854.2006.00446.x; Casper-Lindley C, 2002, P NATL ACAD SCI USA, V99, P8336, DOI 10.1073/pnas.122220299; Chatterjee A, 2002, MOL PLANT MICROBE IN, V15, P971, DOI 10.1094/MPMI.2002.15.9.971; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Fouts DE, 2002, P NATL ACAD SCI USA, V99, P2275, DOI 10.1073/pnas.032514099; Francis MS, 2002, CURR OPIN MICROBIOL, V5, P166, DOI 10.1016/S1369-5274(02)00301-6; Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x; Franza T, 2002, MOL PLANT MICROBE IN, V15, P1181, DOI 10.1094/MPMI.2002.15.11.1181; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Holeva MC, 2004, MOL PLANT MICROBE IN, V17, P943, DOI 10.1094/MPMI.2004.17.9.943; Hovey R, 2005, MOL GENET GENOMICS, V273, P225, DOI 10.1007/s00438-005-1126-9; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Jafra S, 1999, MOL PLANT MICROBE IN, V12, P845, DOI 10.1094/MPMI.1999.12.10.845; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Login FH, 2006, J BIOL CHEM, V281, P33152, DOI 10.1074/jbc.M606245200; Lopez-Solanilla E, 2001, MOL PLANT MICROBE IN, V14, P386, DOI 10.1094/MPMI.2001.14.3.386; Mota LJ, 2005, FEMS MICROBIOL LETT, V252, P1, DOI 10.1016/j.femsle.2005.08.036; Peng Q, 2006, MOL PLANT MICROBE IN, V19, P451, DOI 10.1094/MPMI-19-0451; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Tang XY, 2006, MOL PLANT MICROBE IN, V19, P1159, DOI 10.1094/MPMI-19-1159; Toth IK, 2005, CURR OPIN PLANT BIOL, V8, P424, DOI 10.1016/j.pbi.2005.04.001; Toth IK, 2003, MOL PLANT PATHOL, V4, P17, DOI 10.1046/j.1364-3703.2003.00149.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venkatesh B, 2006, J BACTERIOL, V188, P3088, DOI 10.1128/JB.188.8.3088-3098.2006; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber E, 2005, J BACTERIOL, V187, P6175, DOI 10.1128/JB.187.17.6175-6186.2005; Yang CH, 2002, MOL PLANT MICROBE IN, V15, P472, DOI 10.1094/MPMI.2002.15.5.472; Yang SH, 2004, MOL PLANT MICROBE IN, V17, P999, DOI 10.1094/MPMI.2004.17.9.999; Yang SH, 2008, MOL PLANT MICROBE IN, V21, P133, DOI 10.1094/MPMI-21-1-0133; Yang SH, 2007, APPL ENVIRON MICROB, V73, P1079, DOI 10.1128/AEM.01770-06; Yang SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002973; Yap MN, 2005, J BACTERIOL, V187, P639, DOI 10.1128/JB.187.2.639-648.2005	49	23	23	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13472	10.1371/journal.pone.0013472	http://dx.doi.org/10.1371/journal.pone.0013472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976052	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000283114700009
J	Ji, W; Zhang, W; Xiao, WH				Ji, Wei; Zhang, Wei; Xiao, Wuhan			E2F-1 Directly Regulates Thrombospondin 1 Expression	PLOS ONE			English	Article							RB/E2F PATHWAY; MLL; LEUKEMIA; GENE; ANGIOGENESIS; ACTIVATION; MECHANISMS; APOPTOSIS; BINDING; CD36	Thrombospondin 1 (TSP1) has been shown to play a critical role in inhibiting angiogenesis, resulting in inhibition of tumor growth and metastases. To figure out TSP1's regulators will lead to reveal its biological function mechanistically. In this study, we show that E2F-1 could activate the transcription of TSP1 by both promoter assays and Northern blot. Analysis of various TSP1 promoter mutant constructs showed that a sequence located -144/-137 up-stream of the transcriptional initiation site, related to the consensus E2F-responsive sequence, is necessary for the activation. In consistence with up-regulation of TSP-1 activity by over-expression of E2F-1, the knockdown of endogenous E2F-1 inhibited TSP-1 promoter activity significantly, implying that E2F-1 mediated regulation of TSP-1 is relevant in vivo. In addition, E2F-1 could also directly bind to the TSP1 promoter region covering -144/-137 region as revealed by ChIP assays. Furthermore, the E2F-1-induced activation of TSP1 gene transcription is suppressed by pRB1 in a dose-dependent manner. Taken together, the results demonstrate that TSP1 is a novel target for E2F1, which might imply that E2F-1 can affect angiogenesis by modulating TSP1 expression.	[Ji, Wei; Zhang, Wei; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Ji, W (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan, Peoples R China.	w-xiao@ihb.ac.cn	Zhang, Wei/I-1481-2017; Xiao, Wuhan/GLU-7352-2022		"973'' grant [2010CB126306, 2007CB815705, 2006CB504102]; Natural Science Foundation of China (NSFC) [31071211, 30971667, 30890113]; National Transgene Project [2009ZX08010-021B]	"973'' grant(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Transgene Project	W.X. is supported by "973'' grant 2010CB126306, 2007CB815705, 2006CB504102, Natural Science Foundation of China (NSFC) grant 31071211, 30971667, 30890113 and National Transgene Project 2009ZX08010-021B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bein K, 2000, J BIOL CHEM, V275, P32167, DOI 10.1074/jbc.M003834200; Brechot N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003950; Bruel A, 2005, ANTICANCER RES, V25, P757; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; DiMartino JF, 2000, BLOOD, V96, P3887, DOI 10.1182/blood.V96.12.3887.h8003887_3887_3893; DiPietro LA, 1996, AM J PATHOL, V148, P1851; Eguchi M, 2005, INT J HEMATOL, V82, P9, DOI 10.1532/IJH97.05042; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Isenberg JS, 2006, J BIOL CHEM, V281, P26069, DOI 10.1074/jbc.M605040200; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Krutzsch HC, 1999, J BIOL CHEM, V274, P24080, DOI 10.1074/jbc.274.34.24080; Kyriakides TR, 2009, J CELL COMMUN SIGNAL, V3, P215, DOI 10.1007/s12079-009-0077-z; Lawler J, 2001, AM J PATHOL, V159, P1949, DOI 10.1016/S0002-9440(10)63042-8; Li K, 2003, INT J MOL MED, V12, P995; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Liu H, 2008, CELL CYCLE, V7, P428, DOI 10.4161/cc.7.4.5426; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu P, 2003, LEUKEMIA RES, V27, P701, DOI 10.1016/S0145-2126(02)00346-6; Moodley Y, 2003, AM J PATHOL, V162, P771, DOI 10.1016/S0002-9440(10)63874-6; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Oganesian A, 2008, MOL BIOL CELL, V19, P563, DOI 10.1091/mbc.E07-07-0649; Pallero MA, 2008, FASEB J, V22, P3968, DOI 10.1096/fj.07-104802; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Sheibani N, 1996, CANCER LETT, V107, P45, DOI 10.1016/0304-3835(96)04341-8; Streit M, 2000, EMBO J, V19, P3272, DOI 10.1093/emboj/19.13.3272; THIRMAN MJ, 1994, P NATL ACAD SCI USA, V91, P12110, DOI 10.1073/pnas.91.25.12110; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wang SJ, 2003, DEV DYNAM, V228, P630, DOI 10.1002/dvdy.10412; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; XU J, NAT NEUROSCI, V13, P22; Zhou JG, 2009, J BIOL CHEM, V284, P19142, DOI 10.1074/jbc.M109.010439	47	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13442	10.1371/journal.pone.0013442	http://dx.doi.org/10.1371/journal.pone.0013442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976175	Green Published, Green Submitted, gold			2022-12-25	WOS:000283043700027
J	Urao, N; Razvi, M; Oshikawa, J; McKinney, RD; Chavda, R; Bahou, WF; Fukai, T; Ushio-Fukai, M				Urao, Norifumi; Razvi, Masooma; Oshikawa, Jin; McKinney, Ronald D.; Chavda, Rupal; Bahou, Wadie F.; Fukai, Tohru; Ushio-Fukai, Masuko			IQGAP1 Is Involved in Post-Ischemic Neovascularization by Regulating Angiogenesis and Macrophage Infiltration	PLOS ONE			English	Article							SKELETAL-MUSCLE REGENERATION; HINDLIMB ISCHEMIA; NADPH OXIDASE; ENDOTHELIAL-CELLS; PROTEIN-KINASE; LIMB ISCHEMIA; MICE LACKING; BONE-MARROW; MOUSE MODEL; MIGRATION	Background: Neovascularization is an important repair mechanism in response to ischemic injury and is dependent on inflammation, angiogenesis and reactive oxygen species (ROS). IQGAP1, an actin-binding scaffold protein, is a key regulator for actin cytoskeleton and motility. We previously demonstrated that IQGAP1 mediates vascular endothelial growth factor (VEGF)-induced ROS production and migration of cultured endothelial cells (ECs); however, its role in post-ischemic neovascularization is unknown. Methodology/Principal Findings: Ischemia was induced by left femoral artery ligation, which resulted in increased IQGAP1 expression in Mac3(+) macrophages and CD31(+) capillary-like ECs in ischemic legs. Mice lacking IQGAP1 exhibited a significant reduction in the post-ischemic neovascularization as evaluated by laser Doppler blood flow, capillary density and a-actin positive arterioles. Furthermore, IQGAP1(-/-) mice showed a decrease in macrophage infiltration and ROS production in ischemic muscles, leading to impaired muscle regeneration and increased necrosis and fibrosis. The numbers of bone marrow (BM)-derived cells in the peripheral blood were not affected in these knockout mice. BM transplantation revealed that IQGAP1 expressed in both BM-derived cells and tissue resident cells, such as ECs, is required for post-ischemic neovascularization. Moreover, thioglycollate-induced peritoneal macrophage recruitment and ROS production were inhibited in IQGAP1(-/-) mice. In vitro, IQGAP1(-/-) BM-derived macrophages showed inhibition of migration and adhesion capacity, which may explain the defective macrophage recruitment into the ischemic tissue in IQGAP1(-/-) mice. Conclusions/Significance: IQGAP1 plays a key role in post-ischemic neovascularization by regulating, not only, ECs-mediated angiogenesis but also macrophage infiltration as well as ROS production. Thus, IQGAP1 is a potential therapeutic target for inflammation-and angiogenesis-dependent ischemic cardiovascular diseases.	[Urao, Norifumi; Razvi, Masooma; Oshikawa, Jin; McKinney, Ronald D.; Chavda, Rupal; Ushio-Fukai, Masuko] Univ Illinois, Cardiovasc Res Ctr, Ctr Lung & Vasc Biol, Dept Pharmacol, Chicago, IL 60680 USA; [Fukai, Tohru] Univ Illinois, Cardiovasc Res Ctr, Dept Med, Chicago, IL USA; [Fukai, Tohru] Univ Illinois, Cardiovasc Res Ctr, Dept Pharmacol, Chicago, IL USA; [Bahou, Wadie F.] SUNY Stony Brook, Dept Med, New York, NY USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Urao, N (corresponding author), Univ Illinois, Cardiovasc Res Ctr, Ctr Lung & Vasc Biol, Dept Pharmacol, Chicago, IL 60680 USA.	mfukai@uic.edu	Urao, Norifumi/O-7313-2015	Urao, Norifumi/0000-0001-9750-8406	National Institutes of Health (NIH) [077524, HL077524-S1, HL070187]; American Heart Association (AHA) [0755805Z, 0970336N, 09POST2250151]; Uehara Memorial Foundation; Naito Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070187, R01HL077524] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by National Institutes of Health (NIH) R01 Heart and Lung (HL) 077524 and HL077524-S1 (to M.U.-F.), HL070187 (to T. F.), American Heart Association (AHA) Grant-In-Aid 0755805Z (to M.U.-F.) and AHA National Center Research Program (NCRP) Innovative Research Grant 0970336N (to M.U.-F), AHA Post-doctoral Fellowship 09POST2250151 (to N.U.), Uehara Memorial Foundation and Naito Foundation (to J.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Bogatkevich GS, 2008, AM J PHYSIOL-LUNG C, V295, pL603, DOI 10.1152/ajplung.00530.2007; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Brechot N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003950; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Fan J, 2002, J BIOL CHEM, V277, P3404, DOI 10.1074/jbc.M110054200; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Heil M, 2006, J CELL MOL MED, V10, P45, DOI 10.1111/j.1582-4934.2006.tb00290.x; Heil M, 2004, CIRC RES, V95, P449, DOI 10.1161/01.RES.0000141145.78900.44; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Mateer SC, 2003, CELL MOTIL CYTOSKEL, V55, P147, DOI 10.1002/cm.10118; Meyer RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003848; Munugalavadla V, 2005, BLOOD, V106, P103, DOI 10.1182/blood-2004-10-4041; Nakhaei-Nejad M, 2010, EUR J IMMUNOL, V40, P204, DOI 10.1002/eji.200839214; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Segal BH, 2002, J LEUKOCYTE BIOL, V71, P410; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shireman PK, 2007, J VASC SURG, V45, p48A, DOI 10.1016/j.jvs.2007.02.030; Shireman PK, 2005, J SURG RES, V129, P242, DOI 10.1016/j.jss.2005.06.013; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Takahashi K, 2006, J CELL PHYSIOL, V208, P213, DOI 10.1002/jcp.20657; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; Urao N, 2008, CIRC RES, V103, P212, DOI 10.1161/CIRCRESAHA.108.176230; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7	41	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13440	10.1371/journal.pone.0013440	http://dx.doi.org/10.1371/journal.pone.0013440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976168	Green Submitted, Green Published, gold			2022-12-25	WOS:000283043700025
J	DeLisle, S; South, B; Anthony, JA; Kalp, E; Gundlapallli, A; Curriero, FC; Glass, GE; Samore, M; Perl, TM				DeLisle, Sylvain; South, Brett; Anthony, Jill A.; Kalp, Ericka; Gundlapallli, Adi; Curriero, Frank C.; Glass, Greg E.; Samore, Matthew; Perl, Trish M.			Combining Free Text and Structured Electronic Medical Record Entries to Detect Acute Respiratory Infections	PLOS ONE			English	Article							PUBLIC-HEALTH SURVEILLANCE; INFLUENZA-LIKE ILLNESS; SYNDROMIC SURVEILLANCE; INTERNATIONAL-CLASSIFICATION; DISCHARGE SUMMARIES; DISEASES; SYSTEM; CATEGORIES; DATABASES; HUMANS	Background: The electronic medical record (EMR) contains a rich source of information that could be harnessed for epidemic surveillance. We asked if structured EMR data could be coupled with computerized processing of free-text clinical entries to enhance detection of acute respiratory infections (ARI). Methodology: A manual review of EMR records related to 15,377 outpatient visits uncovered 280 reference cases of ARI. We used logistic regression with backward elimination to determine which among candidate structured EMR parameters (diagnostic codes, vital signs and orders for tests, imaging and medications) contributed to the detection of those reference cases. We also developed a computerized free-text search to identify clinical notes documenting at least two non-negated ARI symptoms. We then used heuristics to build case-detection algorithms that best combined the retained structured EMR parameters with the results of the text analysis. Principal Findings: An adjusted grouping of diagnostic codes identified reference ARI patients with a sensitivity of 79%, a specificity of 96% and a positive predictive value (PPV) of 32%. Of the 21 additional structured clinical parameters considered, two contributed significantly to ARI detection: new prescriptions for cough remedies and elevations in body temperature to at least 38 degrees C. Together with the diagnostic codes, these parameters increased detection sensitivity to 87%, but specificity and PPV declined to 95% and 25%, respectively. Adding text analysis increased sensitivity to 99%, but PPV dropped further to 14%. Algorithms that required satisfying both a query of structured EMR parameters as well as text analysis disclosed PPVs of 52-68% and retained sensitivities of 69-73%. Conclusion: Structured EMR parameters and free-text analyses can be combined into algorithms that can detect ARI cases with new levels of sensitivity or precision. These results highlight potential paths by which repurposed EMR information could facilitate the discovery of epidemics before they cause mass casualties.	[DeLisle, Sylvain] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD USA; [DeLisle, Sylvain] Univ Maryland, Baltimore, MD 21201 USA; [South, Brett; Gundlapallli, Adi; Samore, Matthew] Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [South, Brett; Gundlapallli, Adi; Samore, Matthew] Univ Utah, Salt Lake City, UT USA; [Anthony, Jill A.; Curriero, Frank C.; Glass, Greg E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kalp, Ericka; Perl, Trish M.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	DeLisle, S (corresponding author), Vet Affairs Maryland Hlth Care Syst, Baltimore, MD USA.	sdelisle@umaryland.edu			Centers for Disease Control and Prevention [R01 CI000098, RFA HK000013, 1 P01HK000069-01]; Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs [IIR 06-119-1]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000098] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported in part by grants R01 CI000098, RFA HK000013 and 1 P01HK000069-01 from the Centers for Disease Control and Prevention, and by grant IIR 06-119-1 from the Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Aguilera JF, 2003, EUR J EPIDEMIOL, V18, P751, DOI 10.1023/A:1025337616327; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Beitel AJ, 2004, PEDIATR EMERG CARE, V20, P355, DOI 10.1097/01.pec.0000133608.96957.b9; Bourgeois FT, 2006, ANN EMERG MED, V47, P265, DOI 10.1016/j.annemergmed.2005.11.022; Bradley Colleen A, 2005, MMWR Suppl, V54, P11; Burkom Howard S, 2005, MMWR Suppl, V54, P55; Chapman WW, 2005, J AM MED INFORM ASSN, V12, P618, DOI 10.1197/jamia.M1841; Chapman WW, 2004, STUD HEALTH TECHNOL, V107, P487; Chapman WW, 2004, J BIOMED INFORM, V37, P120, DOI 10.1016/j.jbi.2004.03.002; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; Chen Jian-Hua, 2005, MMWR Suppl, V54, P31; DARA J, 2007, J BIOMED INFORM; Davison A. C., 1998, BOOTSTRAP METHODS TH; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Day FC, 2004, ANN EMERG MED, V43, P401, DOI 10.1016/S0196-0644(03)00748-0; Espino JU, 2001, J AM MED INFORM ASSN, P164; ESPINO JU, 2004, RODS OPEN SOURCE PRO, P1192; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Friedlin Jeff, 2008, AMIA Annu Symp Proc, P207; Friedman C, 2001, J AM MED INFORM ASSN, P189; Friedman C, 2004, J AM MED INFORM ASSN, V11, P392, DOI 10.1197/jamia.M1552; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Gundlapalli AV, 2007, AM J INFECT CONTROL, V35, P163, DOI 10.1016/j.ajic.2006.08.003; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hripcsak G, 2009, J AM MED INFORM ASSN, V16, P354, DOI 10.1197/jamia.M2922; Hurt-Mullen Kathy J, 2005, MMWR Suppl, V54, P141; Kleinman K, 2004, AM J EPIDEMIOL, V159, P217, DOI 10.1093/aje/kwh029; Lazarus R, 2009, J AM MED INFORM ASSN, V16, P18, DOI 10.1197/jamia.M2848; Leng QB, 2003, NEW ENGL J MED, V349, P709, DOI 10.1056/NEJMc031427; Li Ran, 2005, AMIA Annu Symp Proc, P450; LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945; Lombardo J, 2003, J URBAN HEALTH, V80, pI32; Lombardo Joseph S, 2004, MMWR Suppl, V53, P159; Ma Haobo, 2005, MMWR Suppl, V54, P27; Magruder Steven F, 2004, MMWR Suppl, V53, P117; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; Melton CB, 2005, J AM MED INFORM ASSN, V12, P448, DOI 10.1197/jamia.M1794; Mikosz Christina A, 2004, MMWR Suppl, V53, P101; Nadkarni P, 2001, J AM MED INFORM ASSN, V8, P80, DOI 10.1136/jamia.2001.0080080; Nguyen Trang Quyen, 2007, Am J Public Health, V97 Suppl 1, pS142, DOI 10.2105/AJPH.2006.098996; Ohkusa Yasushi, 2005, MMWR Suppl, V54, P47; Overhage JM, 2008, AM J PUBLIC HEALTH, V98, P344, DOI 10.2105/AJPH.2006.092700; Reingold AL, 1998, EMERG INFECT DIS, V4, P21, DOI 10.3201/eid0401.980104; Smith G, 2007, J PUBLIC HEALTH, V29, P75, DOI 10.1093/pubmed/fdl078; Sokolow Leslie Z, 2005, MMWR Suppl, V54, P133; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Vergu E, 2006, EMERG INFECT DIS, V12, P416, DOI 10.3201/eid1203.050573; Wagner MM, 2003, J AM MED INFORM ASSN, V10, P409, DOI 10.1197/jamia.M1357; Wallstrom GL, 2007, J BIOMED INFORM, V40, P642, DOI 10.1016/j.jbi.2007.03.008; Yih W Katherine, 2004, MMWR Suppl, V53, P43; Zou Qinghua, 2003, AMIA Annu Symp Proc, P763	55	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13377	10.1371/journal.pone.0013377	http://dx.doi.org/10.1371/journal.pone.0013377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976281	Green Published, Green Submitted, gold			2022-12-25	WOS:000282941000014
J	Arkun, Y; Erman, B				Arkun, Yaman; Erman, Burak			Prediction of Optimal Folding Routes of Proteins That Satisfy the Principle of Lowest Entropy Loss: Dynamic Contact Maps and Optimal Control	PLOS ONE			English	Article							CHYMOTRYPSIN INHIBITOR-2; 2-STATE PROTEINS; TRANSITION-STATE; PATHWAYS; MECHANISM; RATES; MODEL	An optimization model is introduced in which proteins try to evade high energy regions of the folding landscape, and prefer low entropy loss routes during folding. We make use of the framework of optimal control whose convenient solution provides practical and useful insight into the sequence of events during folding. We assume that the native state is available. As the protein folds, it makes different set of contacts at different folding steps. The dynamic contact map is constructed from these contacts. The topology of the dynamic contact map changes during the course of folding and this information is utilized in the dynamic optimization model. The solution is obtained using the optimal control theory. We show that the optimal solution can be cast into the form of a Gaussian Network that governs the optimal folding dynamics. Simulation results on three examples (CI2, Sso7d and Villin) show that folding starts by the formation of local clusters. Non-local clusters generally require the formation of several local clusters. Non-local clusters form cooperatively and not sequentially. We also observe that the optimal controller prefers "zipping" or small loop closure steps during folding. The folding routes predicted by the proposed method bear strong resemblance to the results in the literature.	[Arkun, Yaman; Erman, Burak] Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey	Koc University	Arkun, Y (corresponding author), Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey.	yarkun@ku.edu.tr; berman@ku.edu.tr	erman, burak/F-5900-2015	erman, burak/0000-0002-2496-6059				Alm E, 1999, CURR OPIN STRUC BIOL, V9, P189, DOI 10.1016/S0959-440X(99)80027-X; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Callen H.B., 1985, THERMODYNAMICS INTRO; Dill KA, 2005, BIOPHYS J, V88, p355A; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; Doob Michael, 1998, SPECTRA GRAPHS THEOR; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Guner U, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2181976; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Ivarsson Y, 2008, EUR BIOPHYS J BIOPHY, V37, P721, DOI 10.1007/s00249-007-0256-x; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11270, DOI 10.1021/bi00093a002; Kazmirski SL, 2001, P NATL ACAD SCI USA, V98, P4349, DOI 10.1073/pnas.071054398; Kmiecik S, 2006, ACTA BIOCHIM POL, V53, P131; Kwakernaak H., 1972, LINEAR OPTIMAL CONTR; Ladurner AG, 1999, NAT STRUCT BIOL, V6, P28; MERRIS R, 1994, LIN ALGEBRA APPL, V143, P197; Pan YP, 2001, BIOCHEMISTRY-US, V40, P2723, DOI 10.1021/bi0022036; SHAW GL, 1995, BIOCHEMISTRY-US, V34, P2225, DOI 10.1021/bi00007a017; Weikl TR, 2003, J MOL BIOL, V332, P953, DOI 10.1016/S0022-2836(03)00884-2; Weikl TR, 2003, J MOL BIOL, V329, P585, DOI 10.1016/S0022-2836(03)00436-4; Weikl TR, 2002, BIOPHYS J, V82, p302A; WEISSTEIN EW, LAPLACIAN MATRIX MAT	26	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13275	10.1371/journal.pone.0013275	http://dx.doi.org/10.1371/journal.pone.0013275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967269	Green Submitted, Green Published, gold			2022-12-25	WOS:000282807300014
J	Deyde, VM; Sampath, R; Garten, RJ; Blair, PJ; Myers, CA; Massire, C; Matthews, H; Svoboda, P; Reed, MS; Pohl, J; Klimov, AI; Gubareva, LV				Deyde, Varough M.; Sampath, Rangarajan; Garten, Rebecca J.; Blair, Patrick J.; Myers, Christopher A.; Massire, Christian; Matthews, Heather; Svoboda, Pavel; Reed, Matthew S.; Pohl, Jan; Klimov, Alexander I.; Gubareva, Larisa V.			Genomic Signature-Based Identification of Influenza A Viruses Using RT-PCR/Electro-Spray Ionization Mass Spectrometry (ESI-MS) Technology	PLOS ONE			English	Article							AMANTADINE-RESISTANT; NUCLEIC-ACIDS; H1N1 VIRUS; PCR; REASSORTMENT; EVOLUTION; DIAGNOSIS; INFECTION; HUMANS	Background: The emergence and rapid spread of the 2009 H1N1 pandemic influenza A virus (H1N1pdm) in humans highlights the importance of enhancing the capability of existing influenza surveillance systems with tools for rapid identification of emerging and re-emerging viruses. One of the new approaches is the RT-PCR electrospray ionization mass spectrometry (RT-PCR/ESI-MS) technology, which is based on analysis of base composition (BC) of RT-PCR amplicons from influenza "core" genes. Combination of the BC signatures represents a "genomic print" of an influenza A virus. Methodology/Principal Findings: Here, 757 samples collected between 2006 and 2009 were tested, including 302 seasonal H1N1, 171 H3N2, 7 swine triple reassortants, and 277 H1N1pdm viruses. Of the 277 H1N1pdm samples, 209 were clinical specimens (throat, nasal and nasopharyngeal swabs, nasal washes, blood and sputum). BC signatures for the clinical specimen from one of the first cases of the 2009 pandemic, A/California/04/2009, confirmed it as an unusual, previously unrecognized influenza A virus, with "core" genes related to viruses of avian, human and swine origins. Subsequent analysis of additional 276 H1N1pdm samples revealed that they shared the genomic print of A/California/04/2009, which differed from those of North American swine triple reassortant viruses, seasonal H1N1 and H3N2 and other viruses tested. Moreover, this assay allowed distinction between "core" genes of co-circulating groups of seasonal H1N1, such as clades 2B, 2C, and their reassortants with dual antiviral resistance to adamantanes and oseltamivir. Conclusions/Significance: The RT-PCR/ESI-MS assay is a broad range influenza identification tool that can be used directly on clinical specimens for rapid and accurate detection of influenza virus genes. The assay differentiates the H1N1pdm from seasonal and other nonhuman hosts viruses. Although not a diagnostic tool, this assay demonstrates its usefulness and robustness in influenza virus surveillance and detection of novel and unusual viruses with previously unseen genomic prints.	[Deyde, Varough M.; Garten, Rebecca J.; Klimov, Alexander I.; Gubareva, Larisa V.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA; [Blair, Patrick J.; Myers, Christopher A.] USN, Hlth Res Ctr, Naval Resp Dis Lab, San Diego, CA 92152 USA; [Svoboda, Pavel; Reed, Matthew S.; Pohl, Jan] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Sci Resources, Atlanta, GA USA; [Sampath, Rangarajan; Massire, Christian; Matthews, Heather] Ibis Biosci, Genom & Computat Biol, Carlsbad, CA USA	Centers for Disease Control & Prevention - USA; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Centers for Disease Control & Prevention - USA	Deyde, VM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA.	lqg3@cdc.gov			Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was funded by the Centers for Disease Control and Prevention. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the manuscript was cleared for submission to the journal following CDC's standard operating procedures. RS, CM and HM were involved in data analysis and interpretation. RS was also involved in assay design and preparation of manuscript. All three are full time employees of Abbott Molecular Inc. Abbott Molecular Inc. who funds RS, CM, and HM has therefore a role in the study design, data collection and analysis, and manuscript preparation.	Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Buggs RJA, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04469.x; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Cheng PKC, 2010, EMERG INFECT DIS, V16, P155, DOI 10.3201/eid1601.091304; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deyde V, 2009, INFLUENZA OTHER RESP, V3, P297, DOI 10.1111/j.1750-2659.2009.00103.x; Ecker DJ, 2009, METHODS MOL BIOL, V551, P71, DOI 10.1007/978-1-60327-999-4_7; Ellegren H, 2008, MOL ECOL, V17, P1629, DOI 10.1111/j.1365-294X.2008.03699.x; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Furuse Y, 2009, J CLIN MICROBIOL, V47, P841, DOI 10.1128/JCM.01622-08; Gabriel S, 2009, CURRENT PROTOCOLS HU; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hofstadler SA, 2005, INT J MASS SPECTROM, V242, P23, DOI 10.1016/j.ijms.2004.09.014; Hofstadler SA, 2005, MASS SPECTROM REV, V24, P265, DOI 10.1002/mas.20016; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Jiang Y, 2003, ANAL BIOCHEM, V316, P50, DOI 10.1016/S0003-2697(03)00024-1; JULKUNEN I, 1985, J VIROL METHODS, V10, P75, DOI 10.1016/0166-0934(85)90091-6; KHIABANIAN H, 2009, PLOS ONE, V4; Maynard A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4888; Muddiman DC, 1997, ANAL CHEM, V69, P1543, DOI 10.1021/ac961134r; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000133; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Sampath R, 2007, ANN NY ACAD SCI, V1102, P109, DOI 10.1196/annals.1408.008; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; SHEU TG, 2010, J INFEC DIS IN PRESS; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; Treanor J, 2004, NEW ENGL J MED, V350, P218, DOI 10.1056/NEJMp038238; van Elden LJR, 2001, BRIT J GEN PRACT, V51, P630; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; World Health Organization, 2002, WHO MAN AN INFL DIAG; WRIGHT KE, 1995, J CLIN MICROBIOL, V33, P1180, DOI 10.1128/JCM.33.5.1180-1184.1995	45	32	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13293	10.1371/journal.pone.0013293	http://dx.doi.org/10.1371/journal.pone.0013293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967258	Green Published, gold, Green Submitted			2022-12-25	WOS:000282807300018
J	Cui, QH				Cui, Qinghua			A Network of Cancer Genes with Co-Occurring and Anti-Co-Occurring Mutations	PLOS ONE			English	Article							COLORECTAL CANCERS; HUMAN BREAST; SIMILARITY; PATTERNS	Certain cancer genes contribute to tumorigenesis in a manner of either co-occurring or mutually exclusive (anti-co-occurring) mutations; however, the global picture of when, where and how these functional interactions occur remains unclear. This study presents a systems biology approach for this purpose. After applying this method to cancer gene mutation data generated from large-scale and whole genome sequencing of cancer samples, a network of cancer genes with co-occurring and anti-co-occurring mutations was constructed. Analysis of this network revealed that genes with co-occurring mutations prefer direct signaling transductions and that the interaction relations among cancer genes in the network are related with their functional similarity. It was also revealed that genes with co-occurring mutations tend to have similar mutation frequencies, whereas genes with anti-co-occurring mutations tend to have different mutation frequencies. Moreover, genes with more exons tend to have more co-occurring mutations with other genes, and genes having lower local coherent network structures tend to have higher mutation frequency. The network showed two complementary modules that have distinct functions and have different roles in tumorigenesis. This study presented a framework for the analysis of cancer genome sequencing outputs. The presented data and uncovered patterns are helpful for understanding the contribution of gene mutations to tumorigenesis and valuable in the identification of key biomarkers and drug targets for cancer.	Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China	Peking University	Cui, QH (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China.	cuiqinghua@hsc.pku.edu.cn						Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Chng WJ, 2007, SCIENCE, V315, P762; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du ZD, 2009, NUCLEIC ACIDS RES, V37, pW345, DOI 10.1093/nar/gkp463; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hernandez P, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-13; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Kholodenko BN, 2007, NAT CELL BIOL, V9, P247, DOI 10.1038/ncb0307-247; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Lin J, 2007, GENOME RES, V17, P1304, DOI 10.1101/gr.6431107; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; PLEASANCE ED, 2009, NATURE; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Torkamani A, 2009, GENOME RES, V19, P1570, DOI 10.1101/gr.092833.109; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang D, 2010, BIOINFORMATICS, V26, P1644, DOI 10.1093/bioinformatics/btq241; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	26	28	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13180	10.1371/journal.pone.0013180	http://dx.doi.org/10.1371/journal.pone.0013180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957180	Green Submitted, Green Published, gold			2022-12-25	WOS:000282423300016
J	Elson-Schwab, I; Lorentzen, A; Marshall, CJ				Elson-Schwab, Ilan; Lorentzen, Anna; Marshall, Christopher J.			MicroRNA-200 Family Members Differentially Regulate Morphological Plasticity and Mode of Melanoma Cell Invasion	PLOS ONE			English	Article							MIR-200 FAMILY; E-CADHERIN; BREAST-CANCER; MESENCHYMAL TRANSITION; MALIGNANT-MELANOMA; REPRESSORS ZEB1; EXPRESSION; TARGETS; MARCKS; PROTEIN	Background: A functional role of microRNAs (miRNAs or miRs) in neoplasia and metastasis is becoming clear, and the miR-200 family has received much attention for potentially regulating tumor progression. The miRNAs of this family have been shown to suppress epithelial-mesenchymal transition, and their down-regulation in some tumors promotes invasion and metastasis. Interestingly, while miR-200 is down-regulated in some cancers, it is up-regulated in others. Principal Findings: We show that levels of miR-200 are increased in melanoma cell lines compared to normal melanocytes and that miR-200 family members play a role in determining modes of tumor cell migration. Individual tumor cells can invade in either elongated, "mesenchymal-type'' or rounded, "amoeboid-like'' modes and these two modes of invasion are inter-convertible [1]. In melanoma cell lines, expression of miR-200 members does not suppress invasion but rather leads to a switch between modes of invasion. MicroRNA-200c results in a higher proportion of cells adopting the rounded, amoeboid-like mode of invasion, while miR-200a results in a protrusion-associated elongated mode of invasion. Functional target identification studies suggest that the morphological effects of miR-200c may be mediated by reduced expression of MARCKS, which has been linked to formation of cell protrusions. In contrast miR-200a reduces actomyosin contractility, a feature of rounded morphology. Significance: Overall our findings call into question the general role of miR-200 in suppressing invasion and metastasis, and highlight novel distinguishing characteristics of individual miR-200 family members.	[Elson-Schwab, Ilan; Lorentzen, Anna; Marshall, Christopher J.] Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Elson-Schwab, I (corresponding author), Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England.	chris.marshall@icr.ac.uk	Xie, Huangming/B-2260-2012	Lorentzen, Anna/0000-0002-4405-935X	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK. C.J.M. is a Cancer Research UK Gibb Life Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; COCHRANE DR, 2009, MOL CANC THER; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Estrada-Bernal A, 2009, J CELL SCI, V122, P2300, DOI 10.1242/jcs.047860; Fidler IJ, 1999, CANCER CHEMOTH PHARM, V43, pS3, DOI 10.1007/s002800051091; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hurteau GJ, 2006, CELL CYCLE, V5, P1951, DOI 10.4161/cc.5.17.3133; Hurteau GJ, 2009, CELL CYCLE, V8, P2064, DOI 10.4161/cc.8.13.8883; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; JOSEPH CK, 1992, J BIOL CHEM, V267, P1327; Kent OA, 2009, CANCER BIOL THER, V8, P2013, DOI 10.4161/cbt.8.21.9685; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Manenti S, 1998, CANCER RES, V58, P1429; Mees ST, 2010, INT J CANCER, V126, P114, DOI 10.1002/ijc.24695; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Michel S, 2010, MOL CARCINOGEN, V49, P175, DOI 10.1002/mc.20587; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Pogribny IR, 2009, TOXICOL APPL PHARM, V235, P305, DOI 10.1016/j.taap.2008.12.021; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; ZHANG L, 2010, CARCINOGENESIS	44	108	119	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13176	10.1371/journal.pone.0013176	http://dx.doi.org/10.1371/journal.pone.0013176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957176	Green Published, Green Submitted, gold			2022-12-25	WOS:000282423300013
J	Murayama, Y; Yoshioka, M; Masujin, K; Okada, H; Iwamaru, Y; Imamura, M; Matsuura, Y; Fukuda, S; Onoe, S; Yokoyama, T; Mohri, S				Murayama, Yuichi; Yoshioka, Miyako; Masujin, Kentaro; Okada, Hiroyuki; Iwamaru, Yoshifumi; Imamura, Morikazu; Matsuura, Yuichi; Fukuda, Shigeo; Onoe, Sadao; Yokoyama, Takashi; Mohri, Shirou			Sulfated Dextrans Enhance In Vitro Amplification of Bovine Spongiform Encephalopathy PrPSc and Enable Ultrasensitive Detection of Bovine PrPSc	PLOS ONE			English	Article							MISFOLDING CYCLIC AMPLIFICATION; CREUTZFELDT-JAKOB-DISEASE; RESISTANT PRION PROTEIN; CHRONIC WASTING DISEASE; TRANSGENIC MICE; PENTOSAN POLYSULFATE; INFECTIOUS PRIONS; CULTURED-CELLS; VARIANT CJD; SCRAPIE	Background: Prions, infectious agents associated with prion diseases such as Creutzfeldt-Jakob disease in humans, bovine spongiform encephalopathy (BSE) in cattle, and scrapie in sheep and goats, are primarily comprised of PrPSc, a protease-resistant misfolded isoform of the cellular prion protein PrPC. Protein misfolding cyclic amplification (PMCA) is a highly sensitive technique used to detect minute amounts of scrapie PrPSc. However, the current PMCA technique has been unsuccessful in achieving good amplification in cattle. The detailed distribution of PrPSc in BSE-affected cattle therefore remains unknown. Methodology/Principal Findings: We report here that PrPSc derived from BSE-affected cattle can be amplified ultraefficiently by PMCA in the presence of sulfated dextran compounds. This method is capable of amplifying very small amounts of PrPSc from the saliva, palatine tonsils, lymph nodes, ileocecal region, and muscular tissues of BSE-affected cattle. Individual differences in the distribution of PrPSc in spleen and cerebrospinal fluid samples were observed in terminal-stage animals. However, the presence of PrPSc in blood was not substantiated in the BSE-affected cattle examined. Conclusions/Significance: The distribution of PrPSc is not restricted to the nervous system and can spread to peripheral tissues in the terminal disease stage. The finding that PrPSc could be amplified in the saliva of an asymptomatic animal suggests a potential usefulness of this technique for BSE diagnosis. This highly sensitive method also has other practical applications, including safety evaluation or safety assurance of products and byproducts manufactured from bovine source materials.	[Murayama, Yuichi; Yoshioka, Miyako; Masujin, Kentaro; Okada, Hiroyuki; Iwamaru, Yoshifumi; Imamura, Morikazu; Matsuura, Yuichi; Yokoyama, Takashi; Mohri, Shirou] Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan; [Yoshioka, Miyako] Natl Inst Anim Hlth, Safety Res Team, Tsukuba, Ibaraki 305, Japan; [Fukuda, Shigeo; Onoe, Sadao] Hokkaido Anim Res Ctr, Shintoku, Hokkaido 0810038, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Murayama, Y (corresponding author), Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan.	ymura@affrc.go.jp	Matsuura, Yuichi/AAF-3170-2021; Mohri, Shirou/AAK-1281-2020	Matsuura, Yuichi/0000-0003-3383-7918; Fukuda, Shigeo/0000-0001-5964-815X	Ministry of Agriculture, Forestry and Fisheries of Japan	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported by a grant-in-aid from the BSE Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2005, J INFECT DIS, V192, P934, DOI 10.1086/431602; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; FARQUHAR CF, 1986, J GEN VIROL, V67, P463, DOI 10.1099/0022-1317-67-3-463; Fujihara A, 2009, FEBS J, V276, P2841, DOI 10.1111/j.1742-4658.2009.07007.x; Gough KC, 2009, PRION, V3, P236, DOI 10.4161/pri.3.4.10425; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Jones M, 2007, J PATHOL, V213, P21, DOI 10.1002/path.2204; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Maddison BC, 2010, J INFECT DIS, V201, P1672, DOI 10.1086/652457; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Murayama Y, 2006, BIOCHEM BIOPH RES CO, V348, P758, DOI 10.1016/j.bbrc.2006.07.130; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Scott MR, 1997, P NATL ACAD SCI USA, V94, P14279, DOI 10.1073/pnas.94.26.14279; Shimizu Y, 2010, MICROBIOL IMMUNOL, V54, P112, DOI 10.1111/j.1348-0421.2009.00190.x; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Terada T, 2010, ACTA NEUROL SCAND, V121, P127, DOI 10.1111/j.1600-0404.2009.01272.x; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Todd NV, 2005, J INFECTION, V50, P394, DOI 10.1016/j.jinf.2004.07.015; Vascellari M, 2007, J VIROL, V81, P4872, DOI 10.1128/JVI.02148-06; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Wells GAH, 2005, VET REC, V156, P401, DOI 10.1136/vr.156.13.401; WELLS GAH, 1996, 6 INT WORKSH BOV SPO, P28; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; WILESMITH JW, 1988, VET REC, V123, P638; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yokoyama T, 2007, JPN J INFECT DIS, V60, P317	39	45	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13152	10.1371/journal.pone.0013152	http://dx.doi.org/10.1371/journal.pone.0013152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957174	Green Published, Green Submitted, gold			2022-12-25	WOS:000282423300007
J	Chu, HY; Gu, QH; Jin, GZ; Hu, GY; Zhen, XC				Chu, Hong-Yuan; Gu, Qinhua; Jin, Guo-Zhang; Hu, Guo-Yuan; Zhen, Xuechu			Electrophysiological Effects of SKF83959 on Hippocampal CA1 Pyramidal Neurons: Potential Mechanisms for the Drug's Neuroprotective Effects	PLOS ONE			English	Article							OUTWARD POTASSIUM CURRENT; D-1 DOPAMINE AGONISTS; PARKINSONS-DISEASE; VARYING EFFICACIES; STRIATAL NEURONS; CHANNELS; RAT; RECEPTOR; EXCITABILITY; PHARMACOLOGY	Although the potent anti-parkinsonian action of the atypical D(1)-like receptor agonist SKF83959 has been attributed to the selective activation of phosphoinositol(PI)-linked D(1) receptor, whereas the mechanism underlying its potent neuroprotective effect is not fully understood. In the present study, the actions of SKF83959 on neuronal membrane potential and neuronal excitability were investigated in CA1 pyramidal neurons of rat hippocampal slices. SKF83959 (10100 mu M) caused a concentration-dependent depolarization, associated with a reduction of input resistance in CA1 pyramidal neurons. The depolarization was blocked neither by antagonists for D(1), D(2), 5-HT(2A/2C) receptors and alpha(1)-adrenoceptor, nor by intracellular dialysis of GDP-beta-S. However, the specific HCN channel blocker ZD7288 (10 mu M) antagonized both the depolarization and reduction of input resistance caused by SKF83959. In voltage-clamp experiments, SKF83959 (10-100 mu M) caused a concentration-dependent increase of Ih current in CA1 pyramidal neurons, which was independent of D(1) receptor activation. Moreover, SKF83959 (50 mu M) caused a 6 mV positive shift in the activation curve of Ih and significantly accelerated the activation of Ih current. In addition, SKF83959 also reduced the neuronal excitability of CA1 pyramidal neurons, which was manifested by the decrease in the number and amplitude of action potentials evoked by depolarizing currents, and by the increase of firing threshold and rhoebase current. The above results suggest that SKF83959 increased Ih current through a D(1) receptor-independent mechanism, which led to the depolarization of hippocampal CA1 pyramidal neurons. These findings provide a novel mechanism for the drug's neuroprotective effects, which may contributes to its therapeutic benefits in Parkinson's disease.	[Chu, Hong-Yuan] Chinese Acad Sci, State Key Lab Drug Res, Shanghai, Peoples R China; Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 2, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Chu, HY (corresponding author), Chinese Acad Sci, State Key Lab Drug Res, Shanghai, Peoples R China.	xczhen@mail.shcnc.ac.cn	Chu, Hong-yuan/G-2380-2014	Chu, Hong-yuan/0000-0003-0923-683X; zhen, xuechu/0000-0001-7458-2566	Ministry of Science and Technology of China [2007AA02z163, 2009CB522000]; Natural Science Foundation of China [20872153, 30825042]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National 863 and 973 research projects of the Ministry of Science and Technology of China (2007AA02z163, 2009CB522000), grants from Natural Science Foundation of China (20872153, 30825042). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Andringa G, 1999, PSYCHOPHARMACOLOGY, V146, P328, DOI 10.1007/s002130051124; ARNT J, 1992, EUR J PHARMACOL, V213, P259, DOI 10.1016/0014-2999(92)90690-6; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; CALABRESI P, 1993, BRAIN, V116, P433; Chen MT, 2001, EXP NEUROL, V171, P72, DOI 10.1006/exnr.2001.7730; Chen XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005811; Clifford JJ, 1999, NEUROSCIENCE, V93, P1483, DOI 10.1016/S0306-4522(99)00297-3; Cools AR, 2002, NEUROPHARMACOLOGY, V42, P237, DOI 10.1016/S0028-3908(01)00169-1; GNANALINGHAM KK, 1995, PSYCHOPHARMACOLOGY, V117, P287, DOI 10.1007/BF02246103; GNANALINGHAM KK, 1995, PSYCHOPHARMACOLOGY, V117, P275, DOI 10.1007/BF02246102; Jin LQ, 2003, J NEUROCHEM, V85, P378, DOI 10.1046/j.1471-4159.2003.01698.x; Kish LJ, 1999, BRAIN RES, V833, P58, DOI 10.1016/S0006-8993(99)01496-1; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Magee JC, 1998, J NEUROSCI, V18, P7613; Neumeyer JL, 2003, EUR J PHARMACOL, V474, P137, DOI 10.1016/S0014-2999(03)02008-9; Pal S, 2003, J NEUROSCI, V23, P4798; Panchalingam S, 2001, NEUROPHARMACOLOGY, V40, P826, DOI 10.1016/S0028-3908(01)00011-9; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Rosenkranz JA, 2006, J NEUROSCI, V26, P3229, DOI 10.1523/JNEUROSCI.4333-05.2006; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; SCHULTZ W, 1978, EXP BRAIN RES, V33, P159; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yu SP, 1998, NEUROBIOL DIS, V5, P81, DOI 10.1006/nbdi.1998.0186; Yu Y, 2008, J NEUROCHEM, V104, P946, DOI 10.1111/j.1471-4159.2007.05062.x; Yu Y, 2007, ACTA PHARMACOL SIN, V28, P1891, DOI 10.1111/j.1745-7254.2007.00730.x; Zhang H, 2007, NEUROPHARMACOLOGY, V53, P125, DOI 10.1016/j.neuropharm.2007.04.004; Zhen XC, 2005, PHARMACOL BIOCHEM BE, V80, P597, DOI 10.1016/j.pbb.2005.01.016	30	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13118	10.1371/journal.pone.0013118	http://dx.doi.org/10.1371/journal.pone.0013118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957037	Green Submitted, Green Published, gold			2022-12-25	WOS:000282359300016
J	Skrzypczak, M; Goryca, K; Rubel, T; Paziewska, A; Mikula, M; Jarosz, D; Pachlewski, J; Oledzki, J; Ostrowsk, J				Skrzypczak, Magdalena; Goryca, Krzysztof; Rubel, Tymon; Paziewska, Agnieszka; Mikula, Michal; Jarosz, Dorota; Pachlewski, Jacek; Oledzki, Janusz; Ostrowsk, Jerzy			Modeling Oncogenic Signaling in Colon Tumors by Multidirectional Analyses of Microarray Data Directed for Maximization of Analytical Reliability	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; COLORECTAL-CANCER; OLIGONUCLEOTIDE ARRAYS; BIOPSY SPECIMEN; PATTERNS; ADENOMA; NORMALIZATION; PROFILES; CDNA	Background: Clinical progression of colorectal cancers (CRC) may occur in parallel with distinctive signaling alterations. We designed multidirectional analyses integrating microarray-based data with biostatistics and bioinformatics to elucidate the signaling and metabolic alterations underlying CRC development in the adenoma-carcinoma sequence. Methodology/Principal Findings: Studies were performed on normal mucosa, adenoma, and carcinoma samples obtained during surgery or colonoscopy. Collections of cryostat sections prepared from the tissue samples were evaluated by a pathologist to control the relative cell type content. The measurements were done using Affymetrix GeneChip HG-U133plus2, and probe set data was generated using two normalization algorithms: MAS5.0 and GCRMA with least-variant set (LVS). The data was evaluated using pair-wise comparisons and data decomposition into singular value decomposition (SVD) modes. The method selected for the functional analysis used the Kolmogorov-Smirnov test. Expressional profiles obtained in 105 samples of whole tissue sections were used to establish oncogenic signaling alterations in progression of CRC, while those representing 40 microdissected specimens were used to select differences in KEGG pathways between epithelium and mucosa. Based on a consensus of the results obtained by two normalization algorithms, and two probe set sorting criteria, we identified 14 and 17 KEGG signaling and metabolic pathways that are significantly altered between normal and tumor samples and between benign and malignant tumors, respectively. Several of them were also selected from the raw microarray data of 2 recently published studies (GSE4183 and GSE8671). Conclusion/Significance: Although the proposed strategy is computationally complex and labor-intensive, it may reduce the number of false results.	[Skrzypczak, Magdalena; Goryca, Krzysztof; Paziewska, Agnieszka; Jarosz, Dorota; Pachlewski, Jacek; Ostrowsk, Jerzy] Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, Warsaw, Poland; [Rubel, Tymon] Maria Sklodowska Curie Mem Canc Ctr, Lab Bioinformat & Syst Biol, Warsaw, Poland; [Rubel, Tymon; Mikula, Michal; Oledzki, Janusz; Ostrowsk, Jerzy] Inst Oncol, Warsaw, Poland; [Mikula, Michal; Ostrowsk, Jerzy] Maria Sklodowska Curie Mem Canc Ctr, Dept Oncol Genet, Warsaw, Poland; [Oledzki, Janusz] Maria Sklodowska Curie Mem Canc Ctr, Dept Colorectal Canc, Warsaw, Poland	Centre of Postgraduate Medical Education - Poland; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Skrzypczak, M (corresponding author), Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, Warsaw, Poland.	jostrow@warman.com.pl	Rubel, Tymon/L-6861-2017; Skrzypczak, Magdalena/F-2575-2016; Mikula, Michal/G-8276-2011	Rubel, Tymon/0000-0002-1342-414X; Mikula, Michal/0000-0003-3447-7328; Oledzki, Jacek/0000-0002-8622-3218; Skrzypczak, Magdalena/0000-0002-3336-0403; Ostrowski, Jerzy/0000-0003-1363-3766	Polish Ministry of Science and Higher Education [PBZ-MNiI-2/1/2005]; Masovian PhD scholarship	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Masovian PhD scholarship	This work was supported by the Polish Ministry of Science and Higher Education grant PBZ-MNiI-2/1/2005. KG and MS were supported by "Masovian PhD scholarship". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2001, STAT ALG REF GUID; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson JR, 2008, SURG CLIN N AM, V88, P681, DOI 10.1016/j.suc.2008.04.011; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Birkenkamp-Demtroder K, 2002, CANCER RES, V62, P4352; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Calza S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-140; Cardoso J, 2007, BBA-REV CANCER, V1775, P103, DOI 10.1016/j.bbcan.2006.08.004; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; Friederichs J, 2005, INT J COLORECTAL DIS, V20, P391, DOI 10.1007/s00384-004-0722-1; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Galamb O, 2006, WORLD J GASTROENTERO, V12, P6998, DOI 10.3748/wjg.v12.i43.6998; Galamb O, 2009, CELL ONCOL, V31, P19, DOI 10.3233/CLO-2009-0458; Grade M, 2007, CANCER RES, V67, P41, DOI 10.1158/0008-5472.CAN-06-1514; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Groene J, 2006, INT J CANCER, V119, P1829, DOI 10.1002/ijc.22027; Ilyas M, 1999, EUR J CANCER, V35, P335, DOI 10.1016/S0959-8049(98)00431-6; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Kitahara O, 2001, CANCER RES, V61, P3544; Kong W, 2008, BIOTECHNIQUES, V45, P501, DOI 10.2144/000112950; Lechner S, 2003, GUT, V52, P1148, DOI 10.1136/gut.52.8.1148; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lutter D, 2009, J BIOMED INFORM, V42, P605, DOI 10.1016/j.jbi.2009.01.002; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Notterman DA, 2001, CANCER RES, V61, P3124; Ostrowski J, 2007, J MOL MED, V85, P733, DOI 10.1007/s00109-007-0176-3; Ostrowski J, 2006, J MOL MED, V84, P872, DOI 10.1007/s00109-006-0083-z; Ostrowski J, 2009, EXPERT REV MOL DIAGN, V9, P623, DOI 10.1586/ERM.09.41; Peano C, 2006, EXPERT REV MOL DIAGN, V6, P465, DOI 10.1586/14737159.6.3.465; Pearson RD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-164; Ploner A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-80; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Shih W, 2005, ONCOL REP, V13, P517; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Staub E, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-79; Sugiyama Y, 2005, GASTROENTEROLOGY, V128, P480, DOI 10.1053/j.gastro.2004.11.010; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yanagawa R, 2001, NEOPLASIA, V3, P395, DOI 10.1038/sj.neo.7900185; Zhu JS, 2008, WORLD J GASTROENTERO, V14, P5887, DOI 10.3748/wjg.14.5887	49	283	288	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13091	10.1371/journal.pone.0013091	http://dx.doi.org/10.1371/journal.pone.0013091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957034	Green Submitted, Green Published, gold			2022-12-25	WOS:000282359300004
J	Diep, TA; Madsen, AN; Holst, B; Kristiansen, MM; Wellner, N; Hansen, SH; Hansen, HS				Diep, Thi Ai; Madsen, Andreas Nygaard; Holst, Birgitte; Kristiansen, Martin Morch; Wellner, Niels; Hansen, Steen Honore; Hansen, Harald Severin			Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor	FASEB JOURNAL			English	Article						oleoylethanolamide; OEA; linoleoylethanolamide; LEA; high-fat diet; isocaloric diet; food intake	N-ACYL-ETHANOLAMINE; PHOSPHOLIPASE-D; FOOD-INTAKE; MOLECULAR CHARACTERIZATION; OLEOYLETHANOLAMIDE; ANANDAMIDE; BIOSYNTHESIS; ACYLPHOSPHATIDYLETHANOLAMINE; PALMITOYLETHANOLAMIDE; DEGRADATION	This study was undertaken to investigate the link between dietary fat content and intestinal levels of anorectic N-acylethanolamines (NAEs), including oleoylethanolamide (OEA), palmitoylethanolamide (PEA), and linoleoylethanolamide (LEA). Male rats were fed high-fat diets (HFDs) with variable percentages of fat [20-45% of total energy (E%)] for 1-7 d; afterward, the jejunums were isolated, and jejunal NAE levels were measured by liquid-chromatography mass spectrometry. Enzyme activities and mRNA expression levels were measured for two synthesizing enzymes, N-acylphosphatidylethanolamine-specific phospholipase D (NAPE-PLD) and glycerophosphodiesterase (GDE1), and one degrading enzyme, fatty acid amide hydrolase (FAAH). We found a dose-response relation between the quantity/percentage of dietary fat, irrespective of the energy density, and the reduction of intestinal levels of OEA, PEA, and LEA. The reductions were present after 1 d of 45E% HFD. LEA, the major NAE species, was shown to have an anorectic potency slightly less than that of OEA but higher than PEA. Regulation at the enzyme level seems not to explain the changes in NAE levels. The results suggest the presence of a fat sensor, mediating the reduced intestinal NAE levels. The intestinal NAE levels are reduced in a dose- and time-dependent manner in response to dietary fat intake, and this may contribute to the well-known hyperphagic effect of HFDs.-Diep, T. A., Madsen, A. N., Holst, B., Kristiansen, M. M., Wellner, N., Hansen, S. H., Hansen, H. S. Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor. FASEB J. 25, 765-774 (2011). www.fasebj.org	[Diep, Thi Ai; Kristiansen, Martin Morch; Wellner, Niels; Hansen, Harald Severin] Univ Copenhagen, Dept Pharmacol & Pharmacothe, Copenhagen, Denmark; [Hansen, Steen Honore] Univ Copenhagen, Dept Pharmaceut & Analyt Chem, Fac Pharmaceut Sci, Copenhagen, Denmark; [Madsen, Andreas Nygaard; Holst, Birgitte] Univ Copenhagen, Dept Neurosci & Pharmacol, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Hansen, HS (corresponding author), Univ Pk 2, DK-2100 Copenhagen O, Denmark.	hsh@farma.ku.dk	Hansen, Steen Honoré/A-5179-2011	Diep, Thi Ai/0000-0003-2681-1090; Holst, Birgitte/0000-0001-7432-097X; Hansen, Harald S./0000-0001-7360-7418	Augustinus Foundation; Novo Nordisk Foundation; Danish Ministry of Science, Technology, and Innovation	Augustinus Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Ministry of Science, Technology, and Innovation	The authors are grateful to Jytte Palmgren-Salomonsson, Line Olesen, Pernille Lyderik, and Christine Petersen for their excellent technical assistance. This project was supported by the Augustinus Foundation and the Novo Nordisk Foundation, and parts of the study were carried in collaboration with the Rodent Metabolic Phenotype Center [Universitetsforskningens Investerings Kapital (UNIK): Food, Fitness, and Pharma for Health and Diseases; http://www.foodfitnesspharma.ku.dk]. The UNIK project is supported by the Danish Ministry of Science, Technology, and Innovation.	Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Aviello G, 2008, J MOL MED, V86, P413, DOI 10.1007/s00109-008-0305-7; Blondeau N, 2007, CIRC RES, V101, P176, DOI 10.1161/CIRCRESAHA.107.154443; Blondeau N, 2009, NEUROPSYCHOPHARMACOL, V34, P2548, DOI 10.1038/npp.2009.84; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Cluny NL, 2009, NEUROGASTROENT MOTIL, V21, P420, DOI 10.1111/j.1365-2982.2008.01248.x; COCKCROFT S, 1992, BIOCHIM BIOPHYS ACTA, V1113, P135, DOI 10.1016/0304-4157(92)90036-A; Collino M, 2006, FREE RADICAL BIO MED, V41, P1619, DOI 10.1016/j.freeradbiomed.2006.09.013; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; de Vogel-van den Bosch HM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-231; FLEIGE S, MOL ASPECTS MED, V27, P126; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2008, AM J PHYSIOL-REG I, V295, pR45, DOI 10.1152/ajpregu.00126.2008; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Gaetani S, 2003, NEUROPSYCHOPHARMACOL, V28, P1311, DOI 10.1038/sj.npp.1300166; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; GUIJARRO A, 2009, PHARM RES, V61, P27; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Hansen HS, 2010, EXP NEUROL, V224, P48, DOI 10.1016/j.expneurol.2010.03.022; Hansen HS, 2009, BIOCHEM PHARMACOL, V78, P553, DOI 10.1016/j.bcp.2009.04.024; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; Jaggar SI, 1998, PAIN, V76, P189, DOI 10.1016/S0304-3959(98)00041-4; Kehrer JP, 2001, BIOCHEM J, V356, P899, DOI 10.1042/0264-6021:3560899; Khan NA, 2009, BBA-MOL CELL BIOL L, V1791, P149, DOI 10.1016/j.bbalip.2009.01.001; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Little TJ, 2007, AM J CLIN NUTR, V86, P531, DOI 10.1093/ajcn/86.3.531; Liu Q, 2002, CHEM PHYS LIPIDS, V115, P77, DOI 10.1016/S0009-3084(02)00015-4; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Mazzari S, 1996, EUR J PHARMACOL, V300, P227, DOI 10.1016/0014-2999(96)00015-5; MIYAUCHI S, J PHARM SCI, V112, P19; Moesgaard B, 2002, COMP BIOCHEM PHYS B, V131, P475, DOI 10.1016/S1096-4959(02)00003-9; Movahed P, 2005, J BIOL CHEM, V280, P38496, DOI 10.1074/jbc.M507429200; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Petersen G, 2006, BBA-MOL CELL BIOL L, V1761, P143, DOI 10.1016/j.bbalip.2005.12.011; Petersen G, 2009, CHEM PHYS LIPIDS, V162, P53, DOI 10.1016/j.chemphyslip.2009.08.005; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Poppitt SD, 1996, APPETITE, V26, P153, DOI 10.1006/appe.1996.0013; Rodriguez de Fonseca F., 2001, NATURE, V414, P209, DOI DOI 10.1038/35102582; Schmid HHO, 2000, CHEM PHYS LIPIDS, V108, pVII; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Simon GM, 2008, J BIOL CHEM, V283, P9341, DOI 10.1074/jbc.M707807200; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Simon GM, 2010, MOL BIOSYST, V6, P1411, DOI 10.1039/c000237b; Skonberg C, 2010, J LIPID RES, V51, P3062, DOI 10.1194/jlr.D004606; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Tang-Christensen M, 2000, NAT MED, V6, P802, DOI 10.1038/77535; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Wang XB, 2005, J PHYSIOL-LONDON, V564, P541, DOI 10.1113/jphysiol.2004.081844; Wellendorph P, 2009, MOL PHARMACOL, V76, P453, DOI 10.1124/mol.109.055244	52	85	86	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					765	774		10.1096/fj.10-166595	http://dx.doi.org/10.1096/fj.10-166595			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20959516				2022-12-25	WOS:000286724800033
J	Jin, ZN; Johnson, KA				Jin, Zhinan; Johnson, Kenneth A.			Role of a GAG Hinge in the Nucleotide-induced Conformational Change Governing Nucleotide Specificity by T7 DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC MECHANISM; INDUCED-FIT; FINGERS SUBDOMAIN; I KLENOW; REPLICATION; FIDELITY; SIMULATION; FRAGMENT; EXPLORER; PROGRAM	A nucleotide-induced change in DNA polymerase structure governs the kinetics of polymerization by high fidelity DNA polymerases. Mutation of a GAG hinge (G542A/G544A) in T7 DNA polymerase resulted in a 1000-fold slower rate of conformational change, which then limited the rate of correct nucleotide incorporation. Rates of misincorporation were comparable to that seen for wild-type enzyme so that the net effect of the mutation was a large decrease in fidelity. We demonstrate that a presumably modest change from glycine to alanine 20A from the active site can severely restrict the flexibility of the enzyme structure needed to recognize and incorporate correct substrates with high specificity. These results emphasize the importance of the substrate-induced conformational change in governing nucleotide selectivity by accelerating the incorporation of correct base pairs but not mismatches.	[Jin, Zhinan; Johnson, Kenneth A.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Chem & Biochem, 2500 Speedway, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu	jin, zhinan/D-4217-2013		National Institutes of Health [R01 GM 071404]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM 071404 (to K. A. J.). K. A. J. is President of KinTek Corp., which provided the rapid quench-flow instruments and the global data fitting software used in this study.	Bakhtina M, 2007, BIOCHEMISTRY-US, V46, P5463, DOI 10.1021/bi700084w; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Brieba LG, 2005, STRUCTURE, V13, P1653, DOI 10.1016/j.str.2005.07.020; Dolghih E, 2009, J PHYS CHEM A, V113, P4639, DOI 10.1021/jp811395r; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Fersht A. R., 1999, ENZYME STRUCTURE MEC, P370; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; JOHNSON KA, 1978, BIOCHEMISTRY-US, V17, P3432, DOI 10.1021/bi00610a002; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Showalter AK, 2002, BIOCHEMISTRY-US, V41, P10571, DOI 10.1021/bi026021i; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Tsai YC, 2009, ANAL BIOCHEM, V384, P136, DOI 10.1016/j.ab.2008.09.006; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030	27	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1312	1322		10.1074/jbc.M110.156737	http://dx.doi.org/10.1074/jbc.M110.156737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20978284	Green Published, hybrid			2022-12-25	WOS:000286005000043
J	Koharudin, LMI; Furey, W; Gronenborn, AM				Koharudin, Leonardus M. I.; Furey, William; Gronenborn, Angela M.			Novel Fold and Carbohydrate Specificity of the Potent Anti-HIV Cyanobacterial Lectin from Oscillatoria agardhii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HYDROGEN-BOND ACCEPTORS; CYANOVIRIN-N; INACTIVATING PROTEIN; STRUCTURAL BASIS; CULTURED CYANOBACTERIUM; ENVELOPE GLYCOPROTEIN; AROMATIC RINGS; DC-SIGN; BINDING	Oscillatoria agardhii agglutinin (OAA) is a recently discovered cyanobacterial lectin that exhibits potent anti-HIV activity. Up to now, only its primary structure and carbohydrate binding data have been available. To elucidate the structural basis for the antiviral mechanism of OAA, we determined the structure of this lectin by x-ray crystallography at 1.2 angstrom resolution and mapped the specific carbohydrate recognition sites of OAA by NMR spectroscopy. The overall architecture of OAA comprises 10 beta-strands that fold into a single, compact, beta-barrel-like domain, creating a unique topology compared with all known protein structures in the Protein Data Bank. OAA sugar binding was tested against Man-9 and various disaccharide components of Man-9. Two symmetric carbohydrate-binding sites were located on the protein, and a preference for Man alpha(1-6) Man-linked sugars was found. Altogether, our structural results explain the antiviral activity OAA and add to the growing body of knowledge about antiviral lectins.	[Koharudin, Leonardus M. I.; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Furey, William; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Furey, William] Vet Adm Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 5th Ave,BST3,Rm 1050, Pittsburgh, PA 15260 USA.	amg100@pitt.edu		Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [GM080642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080642 (to A.M.G.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bewley CA, 2001, STRUCTURE, V9, P931, DOI 10.1016/S0969-2126(01)00653-0; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bokesch HR, 2003, BIOCHEMISTRY-US, V42, P2578, DOI 10.1021/bi0205698; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Chiba H, 2004, BIOCHEM BIOPH RES CO, V316, P203, DOI 10.1016/j.bbrc.2004.02.036; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koharudin LMI, 2008, STRUCTURE, V16, P570, DOI 10.1016/j.str.2008.01.015; Koharudin LMI, 2009, PROTEINS, V77, P904, DOI 10.1002/prot.22514; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McFeeters RL, 2007, J MOL BIOL, V369, P451, DOI 10.1016/j.jmb.2007.03.030; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PERUTZ MF, 1993, PHILOS T R SOC A, V345, P105, DOI 10.1098/rsta.1993.0122; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Sato T, 2009, FISHERIES SCI, V75, P743, DOI 10.1007/s12562-009-0074-4; Sato Y, 2007, J BIOL CHEM, V282, P11021, DOI 10.1074/jbc.M701252200; SATTLER M, 1995, J BIOMOL NMR, V5, P97, DOI 10.1007/BF00227475; Tanaka H, 2009, P NATL ACAD SCI USA, V106, P15633, DOI 10.1073/pnas.0907572106; Wilkinson D, 1996, CURR BIOL, V6, P1051, DOI 10.1016/S0960-9822(02)70661-1; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Yamaguchi M, 1999, BIOCHEM BIOPH RES CO, V265, P703, DOI 10.1006/bbrc.1999.1749; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	39	49	49	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1588	1597		10.1074/jbc.M110.173278	http://dx.doi.org/10.1074/jbc.M110.173278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20961847	Green Published, hybrid			2022-12-25	WOS:000286005000071
J	Dedieu, A; Gaillard, JC; Pourcher, T; Darrouzet, E; Armengaud, J				Dedieu, Alain; Gaillard, Jean-Charles; Pourcher, Thierry; Darrouzet, Elisabeth; Armengaud, Jean			Revisiting Iodination Sites in Thyroglobulin with an Organ-oriented Shotgun Strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE FORMATION; TANDEM MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; BOVINE THYROGLOBULIN; DEHYDROALANINE RESIDUES; COMPLEMENTARY-DNA; RICH PEPTIDES; CATHEPSIN-B; SEQUENCE; PROTEOMICS	Thyroglobulin (Tg) is secreted by thyroid epithelial cells. It is essential for thyroid hormonogenesis and iodine storage. Although studied for many years, only indirect and partial surveys of its post-translational modifications were reported. Here, we present a direct proteomic approach, used to study the degree of iodination of mouse Tg without any preliminary purification. A comprehensive coverage of Tg was obtained using a combination of different proteases, MS/MS fragmentation procedures with inclusion lists and a hybrid mass high-resolution LTQ-Orbitrap XL mass spectrometer. Although only 16 iodinated sites are currently known for human Tg, we uncovered 37 iodinated tyrosine residues, most of them being mono-or diiodinated. We report the specific isotopic pattern of thyroxine modification, not recognized as a normal peptide pattern. Four hormonogenic sites were detected. Two donor sites were identified through the detection of a pyruvic acid residue in place of the initial tyrosine. Evidence for polypeptide cleavages sites due to the action of cathepsins and dipeptidyl proteases in the thyroid were also detected. This work shows that semi-quantitation of Tg iodination states is feasible for human biopsies and should be of significant medical interest for further characterization of human thyroid pathologies.	[Dedieu, Alain; Gaillard, Jean-Charles; Armengaud, Jean] Commissariat Energie Atom, DSV, iBEB, Lab Biochim Syst Pertubes, F-30207 Bagnols Sur Ceze, France; [Pourcher, Thierry; Darrouzet, Elisabeth] Commissariat Energie Atom, DSV, iBEB, Lab Transporters Imagerie & Radiotherapie Oncol, F-30207 Bagnols Sur Ceze, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Dedieu, A (corresponding author), CEA Marcoule, DSV, iBEB, SBTN,LBSP, F-30207 Bagnols Sur Ceze, France.	alain.dedieu@cea.fr		Pourcher, Thierry/0000-0003-2839-4622; ARMENGAUD, Jean/0000-0003-1589-445X				Armengaud J, 2010, EXPERT REV PROTEOMIC, V7, P65, DOI 10.1586/EPR.09.104; Barker WC, 1999, NUCLEIC ACIDS RES, V27, P39, DOI 10.1093/nar/27.1.39; Baudet M, 2010, MOL CELL PROTEOMICS, V9, P415, DOI 10.1074/mcp.M900359-MCP200; Brix K, 2001, BIOL CHEM, V382, P717, DOI 10.1515/BC.2001.087; de Groot A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000434; Deshpande V, 1999, BBA-PROTEIN STRUCT M, V1430, P157, DOI 10.1016/S0167-4838(99)00015-1; DUNN AD, 1991, J BIOL CHEM, V266, P20198; DUNN AD, 1991, ENDOCRINOLOGY, V128, P3073, DOI 10.1210/endo-128-6-3073; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; Dunn J. T., 1995, EUR J ENDOCRINOL, V132, P603; DUNN JT, 1983, J BIOL CHEM, V258, P9093; Dunn JT, 1999, BIOCHIMIE, V81, P505, DOI 10.1016/S0300-9084(99)80102-3; DUNN JT, 1987, J BIOL CHEM, V262, P16948; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; GAVARET JM, 1981, J BIOL CHEM, V256, P9167; GAVARET JM, 1977, J BIOL CHEM, V252, P3281; GAVARET JM, 1980, J BIOL CHEM, V255, P5281; Gentile F, 1997, J BIOL CHEM, V272, P639; Jensen ON, 2004, CURR OPIN CHEM BIOL, V8, P33, DOI 10.1016/j.cbpa.2003.12.009; Jordans S, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-23; Kersey P, 2000, BIOINFORMATICS, V16, P1048, DOI 10.1093/bioinformatics/16.11.1048; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; KIM PS, 1984, ENDOCRINOLOGY, V114, P369, DOI 10.1210/endo-114-2-369; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; Kuster B, 1998, CURR OPIN STRUC BIOL, V8, P393, DOI 10.1016/S0959-440X(98)80075-4; LAMAS L, 1989, J BIOL CHEM, V264, P13541; LEJEUNE PJ, 1983, FEBS LETT, V156, P77, DOI 10.1016/0014-5793(83)80252-X; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; MALTHIERY Y, 1987, EUR J BIOCHEM, V165, P491, DOI 10.1111/j.1432-1033.1987.tb11466.x; MALTHIERY Y, 1989, BIOCHIMIE, V71, P195, DOI 10.1016/0300-9084(89)90057-6; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; MARRIQ C, 1989, FEBS LETT, V242, P414, DOI 10.1016/0014-5793(89)80513-7; MERCKEN L, 1985, NATURE, V316, P647, DOI 10.1038/316647a0; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; MUSTI AM, 1986, P NATL ACAD SCI USA, V83, P323, DOI 10.1073/pnas.83.2.323; OHMIYA Y, 1990, J BIOL CHEM, V265, P9066; PALUMBO G, 1990, J BIOL CHEM, V265, P8887; Salek M, 2005, PROTEOMICS, V5, P351, DOI 10.1002/pmic.200400949; SENKO MW, 1994, ANAL CHEM, V66, P415, DOI 10.1021/ac00075a016; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Taurog A, 1996, ARCH BIOCHEM BIOPHYS, V330, P24, DOI 10.1006/abbi.1996.0222; Tepel C, 2000, J CELL SCI, V113, P4487; Tharakan R, 2010, PROTEOMICS, V10, P1160, DOI 10.1002/pmic.200900433; TURNER CD, 1983, ARCH BIOCHEM BIOPHYS, V222, P245, DOI 10.1016/0003-9861(83)90522-2; Valkenborg D, 2008, J AM SOC MASS SPECTR, V19, P703, DOI 10.1016/j.jasms.2008.01.009; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Zivanovic Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r70	49	36	36	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					259	269		10.1074/jbc.M110.159483	http://dx.doi.org/10.1074/jbc.M110.159483			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978121	hybrid, Green Published			2022-12-25	WOS:000285782800029
J	Ionel, A; Velazquez-Muriel, JA; Luque, D; Cuervo, A; Caston, JR; Valpuesta, JM; Martin-Benito, J; Carrascosa, JL				Ionel, Alina; Velazquez-Muriel, Javier A.; Luque, Daniel; Cuervo, Ana; Caston, Jose R.; Valpuesta, Jose M.; Martin-Benito, Jaime; Carrascosa, Jose L.			Molecular Rearrangements Involved in the Capsid Shell Maturation of Bacteriophage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-MICROSCOPY; VIRUS MATURATION; COMMON ANCESTRY; NEW-GENERATION; PROTEIN GPD; CRYO-EM; VISUALIZATION; RESOLUTION; MECHANISM; EVOLUTION	Maturation of dsDNA bacteriophages involves assembling the virus prohead from a limited set of structural components followed by rearrangements required for the stability that is necessary for infecting a host under challenging environmental conditions. Here, we determine the mature capsid structure of T7 at 1 nm resolution by cryo-electron microscopy and compare it with the prohead to reveal the molecular basis of T7 shell maturation. The mature capsid presents an expanded and thinner shell, with a drastic rearrangement of the major protein monomers that increases in their interacting surfaces, in turn resulting in a new bonding lattice. The rearrangements include tilting, in-plane rotation, and radial expansion of the subunits, as well as a relative bending of the A-and P-domains of each subunit. The unique features of this shell transformation, which does not employ the accessory proteins, inserted domains, or molecular interactions observed in other phages, suggest a simple capsid assembling strategy that may have appeared early in the evolution of these viruses.	[Martin-Benito, Jaime; Carrascosa, Jose L.] CSIC, Ctr Nacl Biotecnol, Dept Macromol Struct, Madrid 28049, Spain; [Velazquez-Muriel, Javier A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Velazquez-Muriel, Javier A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Carrascosa, JL (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Macromol Struct, Darwin 3, Madrid 28049, Spain.	jlcarras@cnb.csic.es	Valpuesta, Jose M/AAA-6002-2019; Caston, Jose R/L-5896-2014; Valpuesta, José M/T-1977-2017; Luque, Daniel/I-6467-2015; Caston, Jose/AAB-8825-2021	Caston, Jose R/0000-0003-2350-9048; Valpuesta, José M/0000-0001-7468-8053; Luque, Daniel/0000-0002-0151-6020; Caston, Jose/0000-0003-2350-9048; Cuervo, Ana/0000-0001-9414-503X; Martin-Benito Romero, Jaime/0000-0002-8541-4709	National Institutes of Health [R01 GM083960, R01GM54762, PN2 EY016525]; Direccion General de Investigacion of the Ministry of Science and Innovation [BFU2008-02328/BM, CSD2007-00010]; Madrid Government [S-2009/MAT-1507]; Ministry of Science and Innovation [BIO2008-02361]; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083960, R01GM054762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direccion General de Investigacion of the Ministry of Science and Innovation; Madrid Government; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM083960, R01GM54762, and PN2 EY016525 (to A. Sali). This work was also supported by Grants BFU2008-02328/BMC and Consolider CSD2007-00010 from the Direccion General de Investigacion of the Ministry of Science and Innovation (to J. L. C.), S-2009/MAT-1507 from the Direccion General de Univertsidades e Investigacion from the Madrid Government (to J. L. C.), BIO2008-02361 from the Direccion General de Investigacion of the Ministry of Science and Innovation (to J. R. C.).	Ackermann HW, 1999, ADV VIRUS RES, V51, P135; Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Agirrezabala X, 2005, J MOL BIOL, V347, P895, DOI 10.1016/j.jmb.2005.02.005; Agirrezabala X, 2007, STRUCTURE, V15, P461, DOI 10.1016/j.str.2007.03.004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Bamford DH, 2005, CURR OPIN STRUC BIOL, V15, P655, DOI 10.1016/j.sbi.2005.10.012; Belnap DM, 2000, J VIROL, V74, P1342, DOI 10.1128/JVI.74.3.1342-1354.2000; Benson SD, 2004, MOL CELL, V16, P673, DOI 10.1016/j.molcel.2004.11.016; Casjens S, 1997, STRUCTURAL BIOL VIRU, P38; Cerritelli ME, 2003, ADV PROTEIN CHEM, V64, P301; CONWAY JF, 1995, J MOL BIOL, V253, P86, DOI 10.1006/jmbi.1995.0538; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Fokine A, 2005, P NATL ACAD SCI USA, V102, P7163, DOI 10.1073/pnas.0502164102; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fujisawa H, 1997, GENES CELLS, V2, P537, DOI 10.1046/j.1365-2443.1997.1450343.x; Gertsman I, 2009, NATURE, V458, P646, DOI 10.1038/nature07686; Gretes M, 2009, J MOL BIOL, V389, P289, DOI 10.1016/j.jmb.2009.03.058; Helgstrand Charlotte, 2003, Journal of Molecular Biology, V334, P885, DOI 10.1016/j.jmb.2003.09.035; Hendrix RW, 2005, ADV VIRUS RES, V64, P1, DOI 10.1016/S0065-3527(05)64001-8; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665; Johnson JE, 2010, CURR OPIN STRUC BIOL, V20, P210, DOI 10.1016/j.sbi.2010.01.004; KING J, 1997, STRUCTURAL BIOL VIRU, P288; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lander GC, 2008, STRUCTURE, V16, P1399, DOI 10.1016/j.str.2008.05.016; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morais MC, 2005, MOL CELL, V18, P149, DOI 10.1016/j.molcel.2005.03.013; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Parent KN, 2010, STRUCTURE, V18, P390, DOI 10.1016/j.str.2009.12.014; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Saban SD, 2006, J VIROL, V80, P12049, DOI 10.1128/JVI.01652-06; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; STEVEN AC, 1991, J STRUCT BIOL, V106, P221, DOI 10.1016/1047-8477(91)90072-5; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Trus BL, 1996, J MOL BIOL, V263, P447, DOI 10.1016/S0022-2836(96)80018-0; VALPUESTA JM, 1994, Q REV BIOPHYS, V27, P107, DOI 10.1017/S0033583500004510; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Yang F, 2000, NAT STRUCT BIOL, V7, P230	49	46	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					234	242		10.1074/jbc.M110.187211	http://dx.doi.org/10.1074/jbc.M110.187211			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20962334	Green Published, hybrid			2022-12-25	WOS:000285782800026
J	Nygaard, EB; Lagerstedt, JO; Bjerre, G; Shi, BA; Budamagunta, M; Poulsen, KA; Meinild, S; Rigor, RR; Voss, JC; Cala, PM; Pedersen, SF				Nygaard, Eva B.; Lagerstedt, Jens O.; Bjerre, Gabriel; Shi, Biao; Budamagunta, Madhu; Poulsen, Kristian A.; Meinild, Stine; Rigor, Robert R.; Voss, John C.; Cala, Peter M.; Pedersen, Stine F.			Structural Modeling and Electron Paramagnetic Resonance Spectroscopy of the Human Na+/H+ Exchanger Isoform 1, NHE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIN-LABELED PROTEINS; LOOP-GAP RESONATOR; ESCHERICHIA-COLI; T4 LYSOZYME; CONFORMATIONAL-CHANGES; TRANSMEMBRANE DOMAINS; LACTOSE PERMEASE; XENOPUS-OOCYTES; SITE; ANTIPORTER	We previously presented evidence that transmembrane domain (TM) IV and TM X-XI are important for inhibitor binding and ion transport by the human Na+/H+ exchanger, hNHE1 (Pedersen, S. F., King, S. A., Nygaard, E. B., Rigor, R. R., and Cala, P. M. (2007) J. Biol. Chem. 282, 19716-19727). Here, we present a structural model of the transmembrane part of hNHE1 that further supports this conclusion. The hNHE1 model was based on the crystal structure of the Escherichia coli Na+/H+ antiporter, NhaA, and previous cysteine scanning accessibility studies of hNHE1 and was validated by EPR spectroscopy of spin labels in TM IV and TM XI, as well as by functional analysis of hNHE1 mutants. Removal of all endogenous cysteines in hNHE1, introduction of the mutations A173C (TM IV) and/or I461C (TM XI), and expression of the constructs in mammalian cells resulted in functional hNHE1 proteins. The distance between these spin labels was similar to 15 A, confirming that TM IV and TM XI are in close proximity. This distance was decreased both at pH 5.1 and in the presence of the NHE1 inhibitor cariporide. A similar TM IV.TM XI distance and a similar change upon a pH shift were found for the cariporide-insensitive Pleuronectes americanus (pa) NHE1; however, in paNHE1, cariporide had no effect on TM IV.TM XI distance. The central role of the TM IV.TM XI arrangement was confirmed by the partial loss of function upon mutation of Arg(425), which the model predicts stabilizes this arrangement. The data are consistent with a role for TM IV and TM XI rearrangements coincident with ion translocation and inhibitor binding by hNHE1.	[Nygaard, Eva B.; Bjerre, Gabriel; Poulsen, Kristian A.; Meinild, Stine; Cala, Peter M.; Pedersen, Stine F.] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen, Denmark; [Lagerstedt, Jens O.] Lund Univ, Biomed Ctr, Dept Expt Med Sci, Lund, Sweden; [Lagerstedt, Jens O.; Budamagunta, Madhu; Voss, John C.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Shi, Biao; Rigor, Robert R.; Cala, Peter M.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of Copenhagen; Lund University; University of California System; University of California Davis; University of California System; University of California Davis	Cala, PM (corresponding author), Univ Copenhagen, Dept Biol, Univ Parken 13, DK-2100 Copenhagen, Denmark.	sfpedersen@bio.ku.dk; pmcala@ucdavis.edu	Budamagunta, Madhu S/C-4628-2011; Lagerstedt, Jens/AAF-9567-2021; Pedersen, Stine Falsig/O-1133-2019; Pedersen, Stine Falsig/M-8347-2014	Pedersen, Stine Falsig/0000-0002-3044-7714; Pedersen, Stine Falsig/0000-0002-3044-7714; Voss, John/0000-0001-9279-209X; Lagerstedt, Jens/0000-0002-4313-2666; Rigor, Robert/0000-0001-6234-1992	National Institutes of Health [HL-21179]; Danish National Research Council; Swedish Research Council; University of Copenhagen; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021179, R37HL021179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National Research Council(Danmarks Grundforskningsfond); Swedish Research Council(Swedish Research CouncilEuropean Commission); University of Copenhagen; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-21179 (to P. M. C.). This work was also supported by funds from the Danish National Research Council (to S. F. P.) and the Swedish Research Council (to J. O. L.) and a Biocampus Scholarship from University of Copenhagen (to E. B. N.).	Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Bolin KA, 1998, J MAGN RESON, V131, P248, DOI 10.1006/jmre.1998.1365; Columbus L, 2004, BIOCHEMISTRY-US, V43, P7273, DOI 10.1021/bi0497906; Counillon L, 1997, BIOCHEMISTRY-US, V36, P2951, DOI 10.1021/bi9615405; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; CoupayeGerard B, 1996, AM J PHYSIOL-CELL PH, V271, pC1639, DOI 10.1152/ajpcell.1996.271.5.C1639; Deweerd K, 2001, BIOCHEMISTRY-US, V40, P15846, DOI 10.1021/bi011414n; Fajer MI, 2007, J AM CHEM SOC, V129, P13840, DOI 10.1021/ja071404v; FRONCISZ W, 1982, J MAGN RESON, V47, P515, DOI 10.1016/0022-2364(82)90221-9; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Hilger D, 2007, BIOPHYS J, V93, P3675, DOI 10.1529/biophysj.107.109769; HUBBELL WL, 1987, REV SCI INSTRUM, V58, P1879, DOI 10.1063/1.1139536; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Khadilkar A, 2001, J BIOL CHEM, V276, P43792, DOI 10.1074/jbc.M106659200; KOWDLEY GC, 1994, J GEN PHYSIOL, V103, P217, DOI 10.1085/jgp.103.2.217; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Lagerstedt JO, 2004, FEBS LETT, V578, P262, DOI 10.1016/j.febslet.2004.11.012; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Langen R, 2000, BIOCHEMISTRY-US, V39, P8396, DOI 10.1021/bi000604f; LU L, 1990, BIOPHYS J, V57, P1117, DOI 10.1016/S0006-3495(90)82632-1; Mchaourab HS, 1997, BIOCHEMISTRY-US, V36, P307, DOI 10.1021/bi962114m; McLean LA, 1999, AM J PHYSIOL-CELL PH, V276, pC1025, DOI 10.1152/ajpcell.1999.276.5.C1025; Meinild AK, 2009, J BIOL CHEM, V284, P16226, DOI 10.1074/jbc.M109.003137; Moncoq K, 2008, J BIOL CHEM, V283, P4145, DOI 10.1074/jbc.M704844200; Nimigean CM, 2006, NAT PROTOC, V1, P1207, DOI 10.1038/nprot.2006.166; Noel J, 2003, BIOCHEMISTRY-US, V42, P15361, DOI 10.1021/bi035296a; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pedersen SF, 2006, AM J PHYSIOL-REG I, V291, pR1, DOI 10.1152/ajpregu.00782.2005; Pedersen SF, 2003, BIOPHYS J, V84, p151A; Pedersen SF, 2007, J BIOL CHEM, V282, P19716, DOI 10.1074/jbc.M701637200; Pedersen Stine F., 2003, Bulletin of the Mount Desert Island Biological Laboratory, V42, P38; Rasmussen M, 2008, AM J PHYSIOL-CELL PH, V294, pC197, DOI 10.1152/ajpcell.00268.2007; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shrode LD, 1998, AM J PHYSIOL-CELL PH, V275, pC431, DOI 10.1152/ajpcell.1998.275.2.C431; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Touret N, 2001, BIOCHEMISTRY-US, V40, P5095, DOI 10.1021/bi0025464; Voss J, 1996, BIOCHEMISTRY-US, V35, P12915, DOI 10.1021/bi9608774; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WANG DH, 1995, AM J PHYSIOL-CELL PH, V269, pC392, DOI 10.1152/ajpcell.1995.269.2.C392; Zhao M, 1999, BIOCHEMISTRY-US, V38, P7407, DOI 10.1021/bi9906524	48	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					634	648		10.1074/jbc.M110.159202	http://dx.doi.org/10.1074/jbc.M110.159202			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20974853	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000285782800065
J	Xu, D; Fuster, MM; Lawrence, R; Esko, JD				Xu, Ding; Fuster, Mark M.; Lawrence, Roger; Esko, Jeffrey D.			Heparan Sulfate Regulates VEGF(165)- and VEGF(121)-mediated Vascular Hyperpermeability*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; VEGF RECEPTOR; EXTRACELLULAR DOMAIN; NEUROPILIN-1 BINDS; CRYSTAL-STRUCTURE; SOLUBLE RECEPTOR; COMPLEX REVEALS; TERNARY COMPLEX; SRC ACTIVITY; PERMEABILITY	VEGF was first described as vascular permeability factor, a potent inducer of vascular leakage. Genetic evidence indicates that VEGF-stimulated endothelial proliferation in vitro and angiogenesis in vivo depend on heparan sulfate, but a requirement for heparan sulfate in vascular hyperpermeability has not been explored. Here we show that altering endothelial cell heparan sulfate biosynthesis in vivo decreases hyperpermeability induced by both VEGF(165) and VEGF(121). Because VEGF(121) does not bind heparan sulfate, the requirement for heparan sulfate suggested that it interacted with VEGF receptors rather than the ligand. By applying proximity ligation assays to primary brain endothelial cells, we show a direct interaction in situ between heparan sulfate and the VEGF receptor, VEGFR2. Furthermore, the number of heparan sulfate-VEGFR2 complexes increased in response to both VEGF(165) and VEGF(121). Genetic or heparin lyase-mediated alteration of endothelial heparan sulfate attenuated phosphorylation of VEGFR2 in response to VEGF(165) and VEGF(121), suggesting that the functional VEGF receptor complex contains heparan sulfate. Pharmacological blockade of heparan sulfate-protein interactions inhibited hyperpermeability in vivo, suggesting heparan sulfate as a potential target for treating hyperpermeability associated with ischemic disease.	[Xu, Ding; Lawrence, Roger; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Fuster, Mark M.] Univ Calif San Diego, Div Pulm & Crit Care, Dept Med, San Diego, CA 92103 USA; [Fuster, Mark M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	jesko@ucsd.edu	Xu, Ding/B-2493-2009	Xu, Ding/0000-0001-9380-2712	National Institutes of Health [HL57345]; American Heart Association [0825274F]; Veterans Affairs Career Development program; American Cancer Society [RSG-08-153-01-CS]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345, P01HL107150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Veterans Affairs Career Development program; American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL57345 ( to J. D. E.). This work was also supported by Post-doctoral Fellowship 0825274F from the American Heart Association ( to D. X.) as well as support from the Veterans Affairs Career Development program and the American Cancer Society (Grant RSG-08-153-01-CS) ( to M. M. F.).	Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; CHIANG MK, 1995, GROWTH FACTORS, V12, P1, DOI 10.3109/08977199509003208; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Criscuoli ML, 2005, BLOOD, V105, P1508, DOI 10.1182/blood-2004-06-2246; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Dougher AM, 1997, GROWTH FACTORS, V14, P257, DOI 10.3109/08977199709021524; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gengrinovitch S, 1999, J BIOL CHEM, V274, P10816, DOI 10.1074/jbc.274.16.10816; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; GitayGoren H, 1996, J BIOL CHEM, V271, P5519, DOI 10.1074/jbc.271.10.5519; Goerges AL, 2003, J BIOL CHEM, V278, P19518, DOI 10.1074/jbc.M211208200; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Izvolsky KI, 2008, GENESIS, V46, P8, DOI 10.1002/dvg.20355; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kleinig TJ, 2009, CURR OPIN NEUROL, V22, P294, DOI 10.1097/WCO.0b013e32832b4db3; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Matyal R, 2005, INT ANESTHESIOL CLIN, V43, P135, DOI 10.1097/01.aia.0000157499.41843.a3; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Qiao DH, 2003, J BIOL CHEM, V278, P16045, DOI 10.1074/jbc.M211259200; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Robinson CJ, 2001, J CELL SCI, V114, P853; Ruhrberg C, 2003, BIOESSAYS, V25, P1052, DOI 10.1002/bies.10351; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; TESSLER S, 1994, J BIOL CHEM, V269, P12456; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Vander Kooi CW, 2007, P NATL ACAD SCI USA, V104, P6152, DOI 10.1073/pnas.0700043104; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988	60	72	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					737	745		10.1074/jbc.M110.177006	http://dx.doi.org/10.1074/jbc.M110.177006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20974861	Green Published, hybrid			2022-12-25	WOS:000285782800073
J	Lee, JH; Khadka, P; Baek, SH; Chung, IK				Lee, Ji Hoon; Khadka, Prabhat; Baek, Seung Han; Chung, In Kwon			CHIP Promotes Human Telomerase Reverse Transcriptase Degradation and Negatively Regulates Telomerase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; E3 UBIQUITIN LIGASE; NUCLEAR-LOCALIZATION; MAMMALIAN TELOMERES; CATALYTIC SUBUNIT; CELL-LINES; COMPLEX; HSP90; HTERT; P23	The maintenance of eukaryotic telomeres requires telomerase, which is minimally composed of a telomerase reverse transcriptase (TERT) and an associated RNA component. Telomerase activity is tightly regulated by expression of human (h) TERT at both the transcriptional and post-translational levels. The Hsp90 and p23 molecular chaperones have been shown to associate with hTERT for the assembly of active telomerase. Here, we show that CHIP (C terminus of Hsc70-interacting protein) physically associates with hTERT in the cytoplasm and regulates the cellular abundance of hTERT through a ubiquitin-mediated degradation. Overexpression of CHIP prevents nuclear translocation of hTERT and promotes hTERT degradation in the cytoplasm, thereby inhibiting telomerase activity. In contrast, knockdown of endogenous CHIP results in the stabilization of cytoplasmic hTERT. However, it does not affect the level of nuclear hTERT and has no effect on telomerase activity and telomere length. We further show that the binding of CHIP and Hsp70 to hTERT inhibits nuclear translocation of hTERT by dissociating p23. However, Hsp90 binding to hTERT was not affected by CHIP overexpression. These results suggest that CHIP can remodel the hTERT-chaperone complexes. Finally, the amount of hTERT associated with CHIP peaks in G(2)/M phases but decreases during S phase, suggesting a cell cycle-dependent regulation of hTERT. Our data suggest that CHIP represents a new pathway for modulating telomerase activity in cancer.	[Chung, In Kwon] Yonsei Univ, Dept Biol, Seoul 20749, South Korea; Yonsei Univ, Dept Biomed Sci, World Class Univ Program, Grad Sch, Seoul 20749, South Korea	Yonsei University; Yonsei University	Chung, IK (corresponding author), Yonsei Univ, Dept Biol, Seoul 20749, South Korea.	topoviro@yonsei.ac.kr	Lee, Ji Hoon/AAV-5473-2021	Lee, Ji Hoon/0000-0002-7488-3999; Baek, Seung Han/0000-0002-8722-0027	Korean Ministry of Education, Science, and Technology [R31-2009-000-10086-0]; Korea Research Foundation [KRF-M1075604000107N560400110, KRF-20090084897]	Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea)	This work was supported in part by World Class University Fund R31-2009-000-10086-0 from the Korean Ministry of Education, Science, and Technology and by Korea Research Foundation Grants KRF-M1075604000107N560400110 and KRF-20090084897.	Akiyama M, 2003, CANCER RES, V63, P18; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cerone MA, 2005, ONCOGENE, V24, P7893, DOI 10.1038/sj.onc.1208934; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Deng Z, 2007, CURR BIOL, V17, P1989, DOI 10.1016/j.cub.2007.10.054; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Huang Z, 2004, MOL CELL BIOL, V24, P8951, DOI 10.1128/MCB.24.20.8951-8962.2004; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Keppler BR, 2006, J BIOL CHEM, V281, P19840, DOI 10.1074/jbc.M511067200; Kharbanda S, 2000, CURR BIOL, V10, P568, DOI 10.1016/S0960-9822(00)00483-8; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Kim JH, 2003, MOL PHARMACOL, V63, P1117, DOI 10.1124/mol.63.5.1117; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Kimura A, 2004, ONCOGENE, V23, P4505, DOI 10.1038/sj.onc.1207582; Lee GE, 2004, J BIOL CHEM, V279, P34750, DOI 10.1074/jbc.M401843200; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee JH, 2010, CANCER LETT, V290, P76, DOI 10.1016/j.canlet.2009.08.026; Li XN, 2008, J CELL BIOL, V181, P959, DOI 10.1083/jcb.200711044; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sampathi S, 2009, J BIOL CHEM, V284, P3682, DOI 10.1074/jbc.M805362200; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	52	58	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42033	42045		10.1074/jbc.M110.149831	http://dx.doi.org/10.1074/jbc.M110.149831			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959453	Green Published, hybrid			2022-12-25	WOS:000285622600089
J	Wirths, O; Erck, C; Martens, H; Harmeier, A; Geumann, C; Jawhar, S; Kumar, S; Multhaup, G; Walter, J; Ingelsson, M; Degerman-Gunnarsson, M; Kalimo, H; Huitinga, I; Lannfelt, L; Bayer, TA				Wirths, Oliver; Erck, Christian; Martens, Henrik; Harmeier, Anja; Geumann, Constanze; Jawhar, Sadim; Kumar, Sathish; Multhaup, Gerd; Walter, Jochen; Ingelsson, Martin; Degerman-Gunnarsson, Malin; Kalimo, Hannu; Huitinga, Inge; Lannfelt, Lars; Bayer, Thomas A.			Identification of Low Molecular Weight Pyroglutamate A beta Oligomers in Alzheimer Disease A NOVEL TOOL FOR THERAPY AND DIAGNOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; AMYLOID PRECURSOR PROTEIN; MOUSE MODEL; SYNAPTIC PLASTICITY; TRANSGENIC MICE; IN-VIVO; PASSIVE-IMMUNIZATION; GLUTAMINYL CYCLASE; NATURAL OLIGOMERS; PLAQUE-FORMATION	N-terminally truncated A beta peptides starting with pyroglutamate (A beta pE3) represent a major fraction of all A beta peptides in the brain of Alzheimer disease (AD) patients. A beta pE3 has a higher aggregation propensity and stability and shows increased toxicity compared with full-length A beta. In the present work, we generated a novel monoclonal antibody (9D5) that selectively recognizes oligomeric assemblies of A beta pE3 and studied the potential involvement of oligomeric A beta pE3 in vivo using transgenic mouse models as well as human brains from sporadic and familial AD cases. 9D5 showed an unusual staining pattern with almost nondetectable plaques in sporadic AD patients and non-demented controls. Interestingly, in sporadic and familial AD cases prominent intraneuronal and blood vessel staining was observed. Using a novel sandwich ELISA significantly decreased levels of oligomers in plasma samples from patients with AD compared with healthy controls were identified. Moreover, passive immunization of 5XFAD mice with 9D5 significantly reduced overall A beta plaque load and A beta pE3 levels, and normalized behavioral deficits. These data indicate that 9D5 is a therapeutically and diagnostically effective monoclonal antibody targeting low molecular weight A beta pE3 oligomers.	[Bayer, Thomas A.] Univ Med Gottingen, Div Mol Psychiat, Grad Sch, Dept Mol Psychiat & Alzheimer, D-37075 Gottingen, Germany; [Erck, Christian; Martens, Henrik; Geumann, Constanze] Synapt Syst, D-37079 Gottingen, Germany; [Harmeier, Anja; Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Kumar, Sathish; Walter, Jochen] Univ Bonn, Dept Neurol Mol Cell Biol, D-53127 Bonn, Germany; [Ingelsson, Martin; Degerman-Gunnarsson, Malin; Lannfelt, Lars] Uppsala Univ, Dept Publ Hlth, SE-75185 Uppsala, Sweden; [Ingelsson, Martin; Degerman-Gunnarsson, Malin; Lannfelt, Lars] Uppsala Univ, Caring Sci Rudbeck Lab, SE-75185 Uppsala, Sweden; [Kalimo, Hannu] Univ Helsinki, Dept Pathol, FI-00014 Helsinki, Finland; [Huitinga, Inge] Netherlands Inst Neurosci, Netherlands Brain Bank, NL-1105 BA Amsterdam, Netherlands	University of Gottingen; Free University of Berlin; University of Bonn; Uppsala University; Uppsala University; University of Helsinki; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Bayer, TA (corresponding author), Univ Med Gottingen, Div Mol Psychiat, Grad Sch, Dept Mol Psychiat & Alzheimer, Von Siebold Str 5, D-37075 Gottingen, Germany.	tbayer@gwdg.de	Walter, Jochen/B-3677-2014; Kumar, Sathish/L-1367-2019; Wirths, Oliver/C-7342-2019; Wang, Caihong/T-5837-2019	Wirths, Oliver/0000-0002-4115-0334; Wang, Caihong/0000-0002-6808-3709; Kumar, Sathish/0000-0002-2792-7047; Walter, Jochen/0000-0002-4678-2912	German Federal Ministry for Economy; Fritz Thyssen Stiftung	German Federal Ministry for Economy; Fritz Thyssen Stiftung	This work was supported by the German Federal Ministry for Economy (to T. A. B., C. E., and H. M.) and the Fritz Thyssen Stiftung (to O. W.).	Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Buttini M, 2005, J NEUROSCI, V25, P9096, DOI 10.1523/JNEUROSCI.1697-05.2005; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cynis H, 2008, BIOCHEMISTRY-US, V47, P7405, DOI 10.1021/bi800250p; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; GOREVIC PD, 1986, J NEUROPATH EXP NEUR, V45, P647, DOI 10.1097/00005072-198611000-00004; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lord A, 2009, FEBS J, V276, P995, DOI 10.1111/j.1742-4658.2008.06836.x; Marcello A, 2011, NEUROBIOL AGING, V32, P1379, DOI 10.1016/j.neurobiolaging.2009.08.011; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mohajeri MH, 2002, J BIOL CHEM, V277, P33012, DOI 10.1074/jbc.M203193200; MORI H, 1992, J BIOL CHEM, V267, P17082; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Rohrer DC, 1996, CELL TRANSPLANT, V5, P57, DOI 10.1016/0963-6897(95)02023-3; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Tseng Bertrand P., 2004, Current Alzheimer Research, V1, P231, DOI 10.2174/1567205043332045; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Wirths O, 2008, NEUROBIOL AGING, V29, P891, DOI 10.1016/j.neurobiolaging.2006.12.004; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5	50	85	94	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41517	41524		10.1074/jbc.M110.178707	http://dx.doi.org/10.1074/jbc.M110.178707			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20971852	hybrid, Green Published			2022-12-25	WOS:000285622600038
J	Grembecka, J; Belcher, AM; Hartley, T; Cierpicki, T				Grembecka, Jolanta; Belcher, Amalia M.; Hartley, Thomas; Cierpicki, Tomasz			Molecular Basis of the Mixed Lineage Leukemia-Menin Interaction IMPLICATIONS FOR TARGETING MIXED LINEAGE LEUKEMIAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; HOX GENE-EXPRESSION; MLL GENE; NMR-SPECTROSCOPY; INFANT LEUKEMIA; TRANSFORMATION; TRITHORAX; PROTEINS; LEUKEMOGENESIS; ASSIGNMENT	Chromosomal translocations targeting the mixed lineage leukemia (MLL) gene result in MLL fusion proteins that are found in aggressive human acute leukemias. Disruption of MLL by such translocations leads to overexpression of Hox genes, resulting in a blockage of hematopoietic differentiation that ultimately leads to leukemia. Menin, which directly binds MLL, has been identified as an essential oncogenic co-factor required for the leukemogenic activity of MLL fusion proteins. Here, we characterize the molecular basis of the MLL-menin interaction. Using C-13-detected NMR experiments, we have mapped the residues within the intrinsically unstructured fragment of MLL that are required for binding to menin. Interestingly, we found that MLL interacts with menin with a nanomolar affinity (K-d similar to 10 nM) through two motifs, MBM1 and MBM2 (menin binding motifs 1 and 2). These motifs are located within the N-terminal 43-amino acid fragment of MLL, and the MBM1 represents a high affinity binding motif. Using alanine scanning mutagenesis of MBM1, we found that the hydrophobic residues Phe(9), Pro(10), and Pro(13) are most critical for binding. Furthermore, based on exchange-transferred nuclear Overhauser effect measurements, we established that MBM1 binds to menin in an extended conformation. In a series of competition experiments we showed that a peptide corresponding to MBM1 efficiently dissociates the menin-MLL complex. Altogether, our work establishes the molecular basis of the menin interaction with MLL and MLL fusion proteins and provides the necessary foundation for development of small molecule inhibitors targeting this interaction in leukemias with MLL translocations.	[Grembecka, Jolanta; Hartley, Thomas; Cierpicki, Tomasz] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Belcher, Amalia M.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Michigan System; University of Michigan; University of Virginia	Grembecka, J (corresponding author), Univ Michigan, Dept Pathol, 1150 W Med Ctr Dr,MSRB1,Rm 4510, Ann Arbor, MI 48109 USA.	jolantag@umich.edu; tomaszc@umich.edu			Leukemia and Lymphoma Society [6070-09]; University of Virginia Cancer Center; Children's Leukemia Research Foundation; Department of Pathology, University of Michigan	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); University of Virginia Cancer Center; Children's Leukemia Research Foundation; Department of Pathology, University of Michigan(University of Michigan System)	This work was supported by Leukemia and Lymphoma Society TRP Grant 6070-09 (to J.G.), a University of Virginia Cancer Center grant (to J.G. and T.C.), a Children's Leukemia Research Foundation grant (to J.G.), and startup funds provided by the Department of Pathology, University of Michigan (to J.G. and T.C.).	Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; Bermel W, 2005, ANGEW CHEM INT EDIT, V44, P3089, DOI 10.1002/anie.200461794; Bermel W, 2009, J MAGN RESON, V198, P275, DOI 10.1016/j.jmr.2009.02.012; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; Cox MC, 2004, AM J CLIN PATHOL, V122, P298, DOI 10.1309/RX27R8GJQM330C22; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eguchi M, 2003, INT J HEMATOL, V78, P390, DOI 10.1007/BF02983811; Greaves MF, 1996, LEUKEMIA, V10, P372; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hess JL, 2004, CRIT REV EUKAR GENE, V14, P235, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.10; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012; SEDKOV Y, 1994, DEVELOPMENT, V120, P1907; Slany RK, 2005, HEMATOL ONCOL, V23, P1, DOI 10.1002/hon.739; SORENSEN PHB, 1994, J CLIN INVEST, V93, P429, DOI 10.1172/JCI116978; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004	27	62	64	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40690	40698		10.1074/jbc.M110.172783	http://dx.doi.org/10.1074/jbc.M110.172783			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20961854	hybrid, Green Published			2022-12-25	WOS:000285414400032
J	Ju, JH; Naura, AS; Errami, Y; Zerfaoui, M; Kim, H; Kim, JG; Abd Elmageed, ZY; Abdel-Mageed, AB; Giardina, C; Beg, AA; Smulson, ME; Boulares, AH				Ju, Jihang; Naura, Amarjit S.; Errami, Youssef; Zerfaoui, Mourad; Kim, Hogyoung; Kim, Jong G.; Abd Elmageed, Zakaria Y.; Abdel-Mageed, Asim B.; Giardina, Charles; Beg, Amer A.; Smulson, Mark E.; Boulares, A. Hamid			Phosphorylation of p50 NF-kappa B at a Single Serine Residue by DNA-dependent Protein Kinase Is Critical for VCAM-1 Expression upon TNF Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; NECROSIS-FACTOR-ALPHA; ADHESION MOLECULES; IMMUNE-SYSTEM; DAMAGE; ACTIVATION; ATHEROSCLEROSIS; INVOLVEMENT; MODULATION; APOPTOSIS	The DNA binding activity of NF-kappa B is critical for VCAM-1 expression during inflammation. DNA-dependent protein kinase (DNA-PK) is thought to be involved in NF-kappa B activation. Here we show that DNA-PK is required for VCAM-1 expression in response to TNF. The phosphorylation and subsequent degradation of I-kappa B alpha as well as the serine 536 phosphorylation and nuclear translocation of p65 NF-kappa B were insufficient for VCAM-1 expression in response to TNF. The requirement for p50 NF-kappa B in TNF-induced VCAM-1 expression may be associated with its interaction with and phosphorylation by DNA-PK, which appears to be dominant over the requirement for p65 NF-kappa B activation. p50 NF-kappa B binding to its consensus sequence increased its susceptibility to phosphorylation by DNA-PK. Additionally, DNA-PK activity appeared to increase the association between p50/p50 and p50/p65 NF-kappa B dimers upon binding to DNA and after binding of p50 NF-kappa B to the VCAM-1 promoter. Analyses of the p50 NF-kappa B protein sequence revealed that both serine 20 and serine 227 at the amino terminus of the protein are putative sites for phosphorylation by DNA-PK. Mutation of serine 20 completely eliminated phosphorylation of p50 NF-kappa B by DNA-PK, suggesting that serine 20 is the only site in p50 NF-kappa B for phosphorylation by DNA-PK. Re-establishing wildtype p50 NF-kappa B, but not its serine 20/alanine mutant, in p50 NF-kappa B-/- fibroblasts reversed VCAM-1 expression after TNF treatment, demonstrating the importance of the serine 20 phosphorylation site in the induction of VCAM-1 expression. Together, these results elucidate a novel mechanism for the involvement of DNA-PK in the positive regulation of p50 NF-kappa B to drive VCAM-1 expression.	[Ju, Jihang; Naura, Amarjit S.; Errami, Youssef; Zerfaoui, Mourad; Kim, Hogyoung; Kim, Jong G.; Boulares, A. Hamid] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Abd Elmageed, Zakaria Y.; Abdel-Mageed, Asim B.] Tulane Univ Med Ctr Hosp & Clin, Dept Urol, New Orleans, LA 70112 USA; [Giardina, Charles] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Beg, Amer A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Smulson, Mark E.] Georgetown Univ, Sch Med, Dept Biochem, Washington, DC 20057 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University; University of Connecticut; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Georgetown University	Boulares, AH (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	hboulr@lsuhsc.edu	Elmageed, Zakaria Y Abd/O-3456-2018	Elmageed, Zakaria Y Abd/0000-0003-4031-0348; Abdel-Mageed, Asim/0000-0001-8590-783X; Errami, Youssef/0000-0002-0432-4331	National Institutes of Health [HL072889]; American Cancer Society [RSG-116608]; Louisiana Cancer Research Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Louisiana Cancer Research Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL072889 (to A.H.B.). This work was also supported by Grant RSG-116608 from the American Cancer Society and funds from the Louisiana Cancer Research Consortium (to A.H.B.).	Andreassi MG, 2008, J MOL MED, V86, P1033, DOI 10.1007/s00109-008-0358-7; Basu S, 1998, BIOCHEM BIOPH RES CO, V247, P79, DOI 10.1006/bbrc.1998.8741; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Boulares HA, 1999, TOXICOL SCI, V48, P264, DOI 10.1093/toxsci/48.2.264; Braun M, 1999, CARDIOVASC RES, V41, P395, DOI 10.1016/S0008-6363(98)00302-2; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; DAS KC, 1995, MOL CELL BIOCHEM, V148, P45, DOI 10.1007/BF00929502; Ding YB, 2003, WORLD J GASTROENTERO, V9, P1409, DOI 10.3748/wjg.v9.i7.1409; Hughes JM, 2000, MEDIAT INFLAMM, V9, P93, DOI 10.1080/096293500411550; Huo Y, 2001, ACTA PHYSIOL SCAND, V173, P35, DOI 10.1046/j.1365-201X.2001.00882.x; Kasper H.-U., 1996, General and Diagnostic Pathology, V141, P289; Ko L, 2003, J BIOL CHEM, V278, P11471, DOI 10.1074/jbc.M209723200; Lazaar AL, 2005, J ALLERGY CLIN IMMUN, V116, P488, DOI 10.1016/j.jaci.2005.06.030; LAZAAR AL, 1994, J EXP MED, V180, P807, DOI 10.1084/jem.180.3.807; Lee CW, 2006, J CELL PHYSIOL, V207, P174, DOI 10.1002/jcp.20549; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu L, 1998, MOL CELL BIOL, V18, P4221, DOI 10.1128/MCB.18.7.4221; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; Rojas AI, 1999, CRIT REV ORAL BIOL M, V10, P337, DOI 10.1177/10454411990100030601; SATRIANO J, 1994, J CLIN INVEST, V94, P1629, DOI 10.1172/JCI117505; Shin WS, 2002, ATHEROSCLEROSIS, V160, P91, DOI 10.1016/S0021-9150(01)00571-8; Simbulan-Rosenthal CM, 1999, ONCOGENE, V18, P5015, DOI 10.1038/sj.onc.1202900; Smulson ME, 2000, ADV ENZYME REGUL, V40, P183, DOI 10.1016/S0065-2571(99)00024-2; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; ten Hacken NHT, 1998, CLIN EXP ALLERGY, V28, P1518; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wheelhouse NM, 2003, INT J MOL MED, V12, P889; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646	36	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41152	41160		10.1074/jbc.M110.158352	http://dx.doi.org/10.1074/jbc.M110.158352			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20966071	Green Published, hybrid			2022-12-25	WOS:000285414400077
J	Covey, TM; Edes, K; Coombs, GS; Virshup, DM; Fitzpatrick, FA				Covey, Tracy M.; Edes, Kornelia; Coombs, Gary S.; Virshup, David M.; Fitzpatrick, Frank A.			Alkylation of the Tumor Suppressor PTEN Activates Akt and beta-Catenin Signaling: A Mechanism Linking Inflammation and Oxidative Stress with Cancer	PLOS ONE			English	Article							CYCLOPENTENONE PROSTAGLANDINS; COLORECTAL-CANCER; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); COVALENT MODIFICATION; LIPID-PEROXIDATION; CELL; INACTIVATION; RESOLUTION; PROTEIN; GROWTH	PTEN, a phosphoinositide-3-phosphatase, serves dual roles as a tumor suppressor and regulator of cellular anabolic/catabolic metabolism. Adaptation of a redox-sensitive cysteinyl thiol in PTEN for signal transduction by hydrogen peroxide may have superimposed a vulnerability to other mediators of oxidative stress and inflammation, especially reactive carbonyl species, which are commonly occurring by-products of arachidonic acid peroxidation. Using MCF7 and HEK-293 cells, we report that several reactive aldehydes and ketones, e.g. electrophilic alpha,beta-enals (acrolein, 4-hydroxy-2-nonenal) and alpha,beta-enones (prostaglandin A(2), Delta 12-prostaglandin J(2) and 15-deoxy-Delta-12,14-prostaglandin J(2)) covalently modify and inactivate cellular PTEN, with ensuing activation of PKB/Akt kinase; phosphorylation of Akt substrates; increased cell proliferation; and increased nuclear beta-catenin signaling. Alkylation of PTEN by alpha,beta-enals/enones and interference with its restraint of cellular PKB/Akt signaling may accentuate hyperplastic and neoplastic disorders associated with chronic inflammation, oxidative stress, or aging.	[Covey, Tracy M.; Edes, Kornelia; Coombs, Gary S.; Virshup, David M.; Fitzpatrick, Frank A.] Univ Utah, Dept Med Chem, Hlth Sci Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Covey, TM (corresponding author), Duke Natl Univ Singapore Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore.	FFitzpatrick@kcumb.edu	Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X; Coombs, Gary/0000-0002-0711-185X	National Institutes of Health Research [R01 AI 26730, PO1 CA73992, R03 MH082387-01]; NATIONAL CANCER INSTITUTE [P01CA073992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH082387] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by the National Institutes of Health Research Project Grant R01 AI 26730 (Frank A. Fitzpatrick), Research Program Projects PO1 CA73992 Project 4 (David M. Virshup) and Project 5 (Frank A. Fitzpatrick), and Small Grant Program R03 MH082387-01 (Gary S. Coombs, David M. Virshup and Frank A. Fitzpatrick). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carothers AM, 2006, CANCER RES, V66, P6432, DOI 10.1158/0008-5472.CAN-06-0992; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; Chinery R, 1999, CANCER RES, V59, P2739; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Connor KM, 2005, J BIOL CHEM, V280, P16916, DOI 10.1074/jbc.M410690200; Coombs GS, 2008, CURR DRUG TARGETS, V9, P513, DOI 10.2174/138945008784911796; Covey TM, 2007, ONCOGENE, V26, P5784, DOI 10.1038/sj.onc.1210391; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1990, MUTAT RES, V238, P223, DOI 10.1016/0165-1110(90)90014-3; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; Gayarre J, 2005, FEBS LETT, V579, P5803, DOI 10.1016/j.febslet.2005.09.069; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Gilroy DW, 2003, FASEB J, V17, P2269, DOI 10.1096/fj.02-1162fje; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Hays E, 2009, IN VITRO CELL DEV-AN, V45, P361, DOI 10.1007/s11626-009-9189-2; Huang W, 2007, ONCOGENE, V26, P2471, DOI 10.1038/sj.onc.1210033; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Landar A, 2006, BIOCHEM J, V394, P185, DOI 10.1042/BJ20051259; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McCulloch MWB, 2009, BIOORGAN MED CHEM, V17, P2189, DOI 10.1016/j.bmc.2008.10.077; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; NARUMIYA S, 1986, J PHARMACOL EXP THER, V239, P500; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Peek RM, 2005, CANCER RES, V65, P8583, DOI 10.1158/0008-5472.CAN-05-1777; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Piazza GA, 1997, CANCER RES, V57, P2909; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Roncucci L, 2008, CANCER EPIDEM BIOMAR, V17, P2291, DOI 10.1158/1055-9965.EPI-08-0224; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SHAHABI NA, 1987, EXP CELL BIOL, V55, P18; Sheehan KM, 1999, JAMA-J AM MED ASSOC, V282, P1254, DOI 10.1001/jama.282.13.1254; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Shin SY, 2006, CELL SIGNAL, V18, P601, DOI 10.1016/j.cellsig.2005.06.001; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wagner TM, 2006, J BIOL CHEM, V281, P2598, DOI 10.1074/jbc.M509723200; West JD, 2006, CHEM RES TOXICOL, V19, P173, DOI 10.1021/tx050321u; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	59	62	64	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13545	10.1371/journal.pone.0013545	http://dx.doi.org/10.1371/journal.pone.0013545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975834	Green Submitted, Green Published, gold			2022-12-25	WOS:000283293800014
J	Widodo, N; Priyandoko, D; Shah, N; Wadhwa, R; Kaul, SC				Widodo, Nashi; Priyandoko, Didik; Shah, Navjot; Wadhwa, Renu; Kaul, Sunil C.			Selective Killing of Cancer Cells by Ashwagandha Leaf Extract and Its Component Withanone Involves ROS Signaling	PLOS ONE			English	Article							FUNCTION EVOLUTION DATA; MEDIATED MECHANISM; PANCREATIC-CANCER; RIBOZYME LIBRARY; PROTEIN-SEQUENCE; IN-VITRO; DIFFERENTIATION; IDENTIFICATION; SOMNIFERA; APOPTOSIS	Background and Purpose: Ashwagandha is a popular Ayurvedic herb used in Indian traditional home medicine. It has been assigned a variety of health-promoting effects of which the mechanisms remain unknown. We previously reported the selective killing of cancer cells by leaf extract of Ashwagandha (i-Extract) and its purified component Withanone. In the present study, we investigated its mechanism by loss-of-function screening (abrogation of i-Extract induced cancer cell killing) of the cellular targets and gene pathways. Methodology/Principal Findings: Randomized ribozyme library was introduced into cancer cells prior to the treatment with i-Extract. Ribozymes were recovered from cells that survived the i-Extract treatment. Gene targets of the selected ribozymes (as predicted by database search) were analyzed by bioinformatics and pathway analyses. The targets were validated for their role in i-Extract induced selective killing of cancer cells by biochemical and molecular assays. Fifteen gene-targets were identified and were investigated for their role in specific cancer cell killing activity of i-Extract and its two major components (Withaferin A and Withanone) by undertaking the shRNA-mediated gene silencing approach. Bioinformatics on the selected gene-targets revealed the involvement of p53, apoptosis and insulin/IGF signaling pathways linked to the ROS signaling. We examined the involvement of ROS-signaling components (ROS levels, DNA damage, mitochondrial structure and membrane potential) and demonstrate that the selective killing of cancer cells is mediated by induction of oxidative stress. Conclusion: Ashwagandha leaf extract and Withanone cause selective killing of cancer cells by induction of ROS-signaling and hence are potential reagents that could be recruited for ROS-mediated cancer chemotherapy.	[Widodo, Nashi; Priyandoko, Didik; Shah, Navjot; Wadhwa, Renu; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Widodo, Nashi] Brawijaya Univ, Fac Math & Nat Sci, Dept Biol, Malang, Indonesia; [Priyandoko, Didik; Shah, Navjot] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Brawijaya University; University of Tsukuba	Widodo, N (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan.	renu-wadhwa@aist.go.jp; s-kaul@aist.go.jp	widodo, nashi/X-4595-2019; Priyandoko, Didik/GNP-1593-2022; Kaul, Sunil C/L-8671-2018; Wadhwa, Renu/L-8898-2018	widodo, nashi/0000-0002-1126-498X; Priyandoko, Didik/0000-0001-8601-9818; Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192	New Energy and Industrial Technology Development Organization (Japan); MEXT, Japan	New Energy and Industrial Technology Development Organization (Japan)(New Energy and Industrial Technology Development Organization (NEDO)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the New Energy and Industrial Technology Development Organization (Japan). N. S. is a recipient of MEXT Scholarship, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibby RA, 2009, J BIOL CHEM, V284, P33177, DOI 10.1074/jbc.M109.032722; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23; Deocaris CC, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-14; Dietrich D, 2009, J HISTOCHEM CYTOCHEM, V57, P477, DOI 10.1369/jhc.2009.953026; Ding HM, 2009, NUTR CANCER, V61, P348, DOI 10.1080/01635580802567158; Furukawa T, 2006, ONCOGENE, V25, P4831, DOI 10.1038/sj.onc.1209494; Ge Y, 2006, BLOOD, V108, P4126, DOI 10.1182/blood-2006-04-017046; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Kim Y, 2003, CANCER GENE THER, V10, P707, DOI 10.1038/sj.cgt.7700623; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Lebedeva IV, 2003, CANCER RES, V63, P8138; Lieber A, 1996, J VIROL, V70, P8782, DOI 10.1128/JVI.70.12.8782-8791.1996; Menendez C, 2009, CURR DRUG TARGETS, V10, P406, DOI 10.2174/138945009788185077; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra L C, 2000, Altern Med Rev, V5, P334; Modak M, 2007, J CLIN BIOCHEM NUTR, V40, P163, DOI 10.3164/jcbn.40.163; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; Piccirillo S, 2009, J BIOL CHEM, V284, P27721, DOI 10.1074/jbc.M109.014837; Rajab A, 2008, HUM MOL GENET, V17, P2150, DOI 10.1093/hmg/ddn114; Scott WG, 2009, BBA-GENE REGUL MECH, V1789, P634, DOI 10.1016/j.bbagrm.2009.09.006; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Shah S, 2009, BIOCHEM CELL BIOL, V87, P117, DOI 10.1139/O08-107; Tanenbaum ME, 2009, CURR BIOL, V19, P1703, DOI 10.1016/j.cub.2009.08.027; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Tohda C, 2008, YAKUGAKU ZASSHI, V128, P1159, DOI 10.1248/yakushi.128.1159; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tuschl T, 1998, EMBO J, V17, P2637, DOI 10.1093/emboj/17.9.2637; Unwalla HJ, 2008, MOL THER, V16, P1113, DOI 10.1038/mt.2008.54; Usman N, 1996, CURR OPIN STRUC BIOL, V6, P527, DOI 10.1016/S0959-440X(96)80119-9; Vlassov AV, 2004, OLIGONUCLEOTIDES, V14, P210, DOI 10.1089/oli.2004.14.210; Wadhwa R, 2004, J BIOL CHEM, V279, P51622, DOI 10.1074/jbc.M407428200; Wadhwa R, 2000, CANCER RES, V60, P6818; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Welch PJ, 2000, GENOMICS, V66, P274, DOI 10.1006/geno.2000.6230; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2009, J GERONTOL A-BIOL, V64, P1031, DOI 10.1093/gerona/glp088; Winters M, 2006, ALTERN MED REV, V11, P269; Wu XJ, 2007, CANCER BIOL THER, V6, P646, DOI 10.4161/cbt.6.5.4092; Xu YM, 2009, BIOORGAN MED CHEM, V17, P2210, DOI 10.1016/j.bmc.2008.10.091; Yen Laising, 2009, V540, P335, DOI 10.1007/978-1-59745-558-9_24; Zhu Z, 2009, HEPATOLOGY, V49, P504, DOI 10.1002/hep.22675	43	101	101	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13536	10.1371/journal.pone.0013536	http://dx.doi.org/10.1371/journal.pone.0013536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975835	Green Submitted, Green Published, gold			2022-12-25	WOS:000283293800010
J	Frommer, F; Waisman, A				Frommer, Friederike; Waisman, Ari			B Cells Participate in Thymic Negative Selection of Murine Auto-reactive CD4(+) T Cells	PLOS ONE			English	Article							DENDRITIC CELLS; POSITIVE SELECTION; SELF-TOLERANCE; RECEPTOR; MICE; RECOGNITION; EXPRESSION; APOPTOSIS; ANTIGENS; DELETION	It is well documented that thymic epithelial cells participate in the process of negative selection in the thymus. In recent years it was reported that also dendritic cells enter the thymus and contribute to this process, thus allowing for the depletion of thymocytes that are specific to peripherally expressed self-antigens. Here we report that also B cells may take part in the elimination of auto-reactive thymocytes. Using a unique mouse model we show that B cells induce negative selection of self-reactive thymocytes in a process that leads to the deletion of these cells whereas regulatory T cells are spared. These findings have direct implication in autoimmunity, as expression of a myelin antigen by B cells in the thymus renders the mice resistant to autoimmune inflammation of the CNS.	[Frommer, Friederike; Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55131 Mainz, Germany	Johannes Gutenberg University of Mainz	Frommer, F (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55131 Mainz, Germany.	waisman@uni-mainz.de	Waisman, Ari/C-7383-2015	Waisman, Ari/0000-0003-4304-8234	DFG [WA 1600/3-1, FOR1336, SFB/TR 52]; Immunology Center; German Ministry for Education and Research (BMBF)	DFG(German Research Foundation (DFG)); Immunology Center; German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	AW is supported by the DFG grants WA 1600/3-1, FOR1336 and SFB/TR 52, by the Immunology Center of Excellence Mainz (FZI) and by the German Ministry for Education and Research (BMBF, Consortium UNDERSTANDMS, as part of the "German Competence Network of MS"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, J IMMUNOL, V164, P5221, DOI 10.4049/jimmunol.164.10.5221; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Doffinger R, 1997, MOL IMMUNOL, V34, P115, DOI 10.1016/S0161-5890(97)00014-X; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Frommer F, 2008, J IMMUNOL, V181, P5748, DOI 10.4049/jimmunol.181.8.5748; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hanahan D, 1998, CURR OPIN IMMUNOL, V10, P656, DOI 10.1016/S0952-7915(98)80085-X; Hare KJ, 2003, J IMMUNOL, V171, P2825, DOI 10.4049/jimmunol.171.6.2825; Hovelmeyer N, 2007, J EXP MED, V204, P2615, DOI 10.1084/jem.20070318; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; JENKINSON EJ, 1994, DEV IMMUNOL, V3, P265, DOI 10.1155/1994/75434; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Kleindienst P, 2000, BLOOD, V95, P2610; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Romagnoli P, 2002, J IMMUNOL, V168, P1644, DOI 10.4049/jimmunol.168.4.1644; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Taylor SRJ, 2007, J IMMUNOL, V178, P3474, DOI 10.4049/jimmunol.178.6.3474; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Volkmann A, 1997, J IMMUNOL, V158, P693	37	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e15372	10.1371/journal.pone.0015372	http://dx.doi.org/10.1371/journal.pone.0015372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976010	Green Published, gold, Green Submitted			2022-12-25	WOS:000283216400031
J	Mills, RF; Valdes, B; Duke, M; Peaston, KA; Lahner, B; Salt, DE; Williams, LE				Mills, Rebecca F.; Valdes, Billy; Duke, Michael; Peaston, Kerry A.; Lahner, Brett; Salt, David E.; Williams, Lorraine E.			Functional Significance of AtHMA4 C-Terminal Domain In Planta	PLOS ONE			English	Article							METAL-BINDING DOMAIN; ARABIDOPSIS-THALIANA; THLASPI-CAERULESCENS; TRANSPORTING ATPASE; ZINC HOMEOSTASIS; P-1B-TYPE ATPASE; CADMIUM; EXPRESSION; HYPERACCUMULATION; BIOFORTIFICATION	Background: Enhancing the upward translocation of heavy metals such as Zn from root to shoot through genetic engineering has potential for biofortification and phytoremediation. This study examined the contribution of the heavy metal-transporting ATPase, AtHMA4, to the shoot ionomic profile of soil-grown plants, and investigated the importance of the C-terminal domain in the functioning of this transporter. Principal Findings: The Arabidopsis hma2 hma4 mutant has a stunted phenotype and a distinctive ionomic profile, with low shoot levels of Zn, Cd, Co, K and Rb, and high shoot Cu. Expression of AtHMA4 (AtHMA4-FL) under the CaMV-35S promoter partially rescued the stunted phenotype of hma2 hma4; rosette diameter returned to wild-type levels in the majority of lines and bolts were also produced, although the average bolt height was not restored completely. AtHMA4-FL expression rescued Co, K, Rb and Cu to wild-type levels, and partially returned Cd and Zn levels (83% and 28% of wild type respectively). In contrast, expression of AtHMA4-trunc (without the C-terminal region) in hma2 hma4 only partially restored the rosette diameter in two of five lines and bolt production was not rescued. There was no significant effect on the shoot ionomic profile, apart from Cd, which was increased to 41% of wild-type levels. When the AtHMA4 C-terminal domain (AtHMA4-C-term) was expressed in hma2 hma4 it had no marked effect. When expressed in yeast, AtHMA4-C-term and AtHMA4-trunc conferred greater Cd and Zn tolerance than AtHMA4-FL. Conclusion: The ionome of the hma2 hma4 mutant differs markedly from wt plants. The functional relevance of domains of AtHMA4 in planta can be explored by complementing this mutant. AtHMA4-FL is more effective in restoring shoot metal accumulation in this mutant than a C-terminally truncated version of the pump, indicating that the C-terminal domain is important in the functioning of AtHMA4 in planta.	[Mills, Rebecca F.; Valdes, Billy; Duke, Michael; Peaston, Kerry A.; Williams, Lorraine E.] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Lahner, Brett; Salt, David E.] Purdue Univ, Ctr Plant Environm Stress Physiol, W Lafayette, IN 47907 USA	University of Southampton; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Mills, RF (corresponding author), Univ Southampton, Sch Biol Sci, Southampton, Hants, England.	lew@soton.ac.uk			European Union [FOOD-CT-2006- 016253]; US National Science Foundation [IBN-0419695, DBI- 0953433]; US National Institutes of Health [R01 GM078536]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536] Funding Source: NIH RePORTER	European Union(European Commission); US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the European Union Framework Programme 6 as part of the Integrated Project Public health impact of long-term, low-level mixed element exposure in susceptible population strata (PHIME) (contract no FOOD-CT-2006- 016253); it reflects only the authors' views. The Community is not liable for any use that may be made of the information contained therein. The authors also acknowledge funding to D. E. S. from the US National Science Foundation (IBN-0419695 & DBI- 0953433) and the US National Institutes of Health (R01 GM078536). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEKGAARD L, J BIOL CHEM IN PRESS; Bernard C, 2004, FEBS LETT, V569, P140, DOI 10.1016/j.febslet.2004.05.036; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Brown KH, 1998, BIBL NUTR DIET, P76; BROWN KH, 2009, PREVENTIVE ZINC SUPP; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Clemens S, 2006, J PLANT PHYSIOL, V163, P319, DOI 10.1016/j.jplph.2005.11.010; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; Genc Y, 2009, PLANT SOIL, V314, P49, DOI 10.1007/s11104-008-9704-3; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; McCormac AC, 1997, MOL BIOTECHNOL, V8, P199, DOI 10.1007/BF02760773; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Papoyan A, 2004, PLANT PHYSIOL, V136, P3814, DOI 10.1104/pp.104.044503; Ramesh SA, 2004, PLANT MOL BIOL, V54, P373, DOI 10.1023/B:PLAN.0000036370.70912.34; ROBINSON NJ, 1993, BIOCHEM J, V295, P1; SIEMIANOWSKI O, 2010, PLANT BIOTE IN PRESS; Sinclair SA, 2007, NEW PHYTOL, V174, P39, DOI 10.1111/j.1469-8137.2007.02030.x; Song WY, 2004, PLANT PHYSIOL, V135, P1027, DOI 10.1104/pp.103.037739; Verret F, 2004, FEBS LETT, V576, P306, DOI 10.1016/j.febslet.2004.09.023; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; Williams L, 2009, CURR OPIN PLANT BIOL, V12, P247, DOI 10.1016/j.pbi.2009.05.009; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Wong CKE, 2009, NEW PHYTOL, V181, P71, DOI 10.1111/j.1469-8137.2008.02638.x; Wong CKE, 2009, NEW PHYTOL, V181, P79, DOI 10.1111/j.1469-8137.2008.02637.x	32	46	49	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13388	10.1371/journal.pone.0013388	http://dx.doi.org/10.1371/journal.pone.0013388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975991	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000283216400003
J	Tao, WJ; Zou, M; Wang, XZ; Gan, XN; Mayden, RL; He, SP				Tao, Wenjing; Zou, Ming; Wang, Xuzhen; Gan, Xiaoni; Mayden, Richard L.; He, Shunping			Phylogenomic Analysis Resolves the Formerly Intractable Adaptive Diversification of the Endemic Clade of East Asian Cyprinidae (Cypriniformes)	PLOS ONE			English	Article							ORDER CYPRINIFORMES; DIVERGENCE TIME; NUCLEAR GENE; MITOCHONDRIAL; EVOLUTIONARY; TELEOSTEI; MODEL; ACTINOPTERYGII; TREE; OSTARIOPHYSI	Despite their great diversity and biological importance, evolutionary relationships among the endemic clade of East Asian Cyprinidae remain ambiguous. Understanding the phylogenetic history of this group involves many challenges. For instance, ecomorphological convergence may confound morphology-based phylogenetic inferences, and previous molecular phylogenetic studies based on single genes have often yielded contradictory and poorly supported trees. We assembled a comprehensive data matrix of 100 nuclear gene segments (similar to 71132 base pairs) for representative species of the endemic East Asian cyprinid fauna and recovered a robust phylogeny from this genome-wide signal supported by multiple analytical methods, including maximum parsimony, maximum likelihood and Bayesian inference. Relaxed molecular clock analyses indicated species radiations of this clade concentrated at approximately 1.9-7.6 MYA. We provide evidence that the bursts of diversification in this fauna are directly linked to major paleoenvironmental events associated with monsoon evolution occurring from late Miocene to Pliocene. Ancestral state reconstruction reveals convergent morphological characters are hypothesized to be independent products of similar selective pressures in ecosystems. Our study is the first comprehensive phylogenetic study of the enigmatic East-Asian cyprinids. The explicit molecular phylogeny provides a valuable framework for future research in genome evolution, adaptation and speciation of cyprinids.	[Tao, Wenjing; Zou, Ming; Wang, Xuzhen; Gan, Xiaoni; He, Shunping] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Tao, Wenjing; Zou, Ming; Wang, Xuzhen; Gan, Xiaoni] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Mayden, Richard L.] St Louis Univ, Dept Biol, Lab Integrated Genom Biodivers & Conservat, St Louis, MO 63103 USA	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Saint Louis University	Tao, WJ (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	clad@ihb.ac.cn	Wang, Xuzhen/L-7892-2019		Major State Basic Research Development Program of China (973 Program) [2007CB411601, 2004CB117400]; United States National Science Foundation (NSF) [EF-0431326]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); United States National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the Major State Basic Research Development Program of China (973 Program), grants number 2007CB411601 and 2004CB117400) to SH and United States National Science Foundation (NSF) grant number EF-0431326 to RLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Angelini DR, 2008, MOL PHYLOGENET EVOL, V46, P127, DOI 10.1016/j.ympev.2007.08.017; Badyaev AV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-3; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Barrier M, 2001, P NATL ACAD SCI USA, V98, P10208, DOI 10.1073/pnas.181257698; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Castresana J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-216; Chen WJ, 2008, GENE, V423, P125, DOI 10.1016/j.gene.2008.07.016; CHEN X, 1984, ACT ZOO SINICA, V9; CHEN YY, 1998, FAUNA SINICA OSTEI 2; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dettai A, 2005, CR BIOL, V328, P674, DOI 10.1016/j.crvi.2005.04.002; Franzosa EA, 2007, TREEROT VERSION 3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; He SP, 2008, MOL PHYLOGENET EVOL, V46, P818, DOI 10.1016/j.ympev.2007.06.001; He SP, 2004, SCI CHINA SER C, V47, P130, DOI 10.1360/03yc0034; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulsey CD, 2008, EVOLUTION, V62, P1587, DOI 10.1111/j.1558-5646.2008.00384.x; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Koblmuller S, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-49; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; *LAB ICHTH, 1976, FISH YANGTZ RIV; Lecointre G, 2005, ZOOL SCR, V34, P101, DOI 10.1111/j.1463-6409.2005.00168.x; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Li JB, 2008, MOL PHYLOGENET EVOL, V47, P472, DOI 10.1016/j.ympev.2007.09.012; Lienau EK, 2009, ACTA BIOTHEOR, V57, P187, DOI 10.1007/s10441-008-9066-5; LIU HSIEN-T'ING, 1962, VERTEBR PALASIAT, V6, P1; Liu HZ, 2003, CAN J ZOOL, V81, P1938, DOI 10.1139/Z03-169; Mayden RL, 2007, J EXP ZOOL PART B, V308B, P642, DOI 10.1002/jez.b.21175; MHAPAH M, 1993, OIKOS, V68, P549; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; NELSON J S, 1976, P416; Page RDM, 2000, MOL PHYLOGENET EVOL, V14, P89, DOI 10.1006/mpev.1999.0676; Peregrin-Alvarez Jose M., 2009, V533, P257, DOI 10.1007/978-1-60327-136-3_12; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Rieppel O, 2003, SYST BIOL, V52, P259, DOI 10.1080/10635150390192762; ROBERT EK, 1995, AM STAT ASS, V90, P773; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; Rutschmann F., 2005, BAYESIAN MOL DATING; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; SAMBROOK E, 1989, MOL CLONING LAB MANU; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Sims GE, 2009, P NATL ACAD SCI USA, V106, P17077, DOI 10.1073/pnas.0909377106; Springer MS, 1999, SYST BIOL, V48, P65, DOI 10.1080/106351599260445; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Syring J, 2005, AM J BOT, V92, P2086, DOI 10.3732/ajb.92.12.2086; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Varona L, 2001, GENET SEL EVOL, V33, P133, DOI 10.1051/gse:2001113; Wang XZ, 2007, MOL PHYLOGENET EVOL, V42, P157, DOI 10.1016/j.ympev.2006.06.014; Wang XZ, 2004, PROG NAT SCI-MATER, V14, P132, DOI 10.1080/10020070412331343261; WILEY EO, 1981, PHYLOGENETICS THEORY; WINFIELD IJ, 1991, BIOL CYPRINIDS; Witek A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-345; Wood RM, 2002, REV FISH BIOL FISHER, V12, P253, DOI 10.1023/A:1025018118339; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	67	25	27	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13508	10.1371/journal.pone.0013508	http://dx.doi.org/10.1371/journal.pone.0013508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976012	gold, Green Published, Green Submitted			2022-12-25	WOS:000283216400015
J	Machida, K; Eschrich, S; Li, J; Bai, Y; Koomen, J; Mayer, BJ; Haura, EB				Machida, Kazuya; Eschrich, Steven; Li, Jiannong; Bai, Yun; Koomen, John; Mayer, Bruce J.; Haura, Eric B.			Characterizing Tyrosine Phosphorylation Signaling in Lung Cancer Using SH2 Profiling	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; C-MET; RECEPTOR GENE; CELL-LINES; IN-VITRO; KINASE; GEFITINIB; SENSITIVITY; EGFR; MUTATIONS	Background: Tyrosine kinases drive the proliferation and survival of many human cancers. Thus profiling the global state of tyrosine phosphorylation of a tumor is likely to provide a wealth of information that can be used to classify tumors for prognosis and prediction. However, the comprehensive analysis of tyrosine phosphorylation of large numbers of human cancer specimens is technically challenging using current methods. Methodology/Principal Findings: We used a phosphoproteomic method termed SH2 profiling to characterize the global state of phosphotyrosine (pTyr) signaling in human lung cancer cell lines. This method quantifies the phosphorylated binding sites for SH2 domains, which are used by cells to respond to changes in pTyr during signaling. Cells could be grouped based on SH2 binding patterns, with some clusters correlated with EGF receptor (EGFR) or K-RAS mutation status. Binding of specific SH2 domains, most prominently RAS pathway activators Grb2 and ShcA, correlated with EGFR mutation and sensitivity to the EGFR inhibitor erlotinib. SH2 binding patterns also reflected MET activation and could identify cells driven by multiple kinases. The pTyr responses of cells treated with kinase inhibitors provided evidence of distinct mechanisms of inhibition. Conclusions/Significance: This study illustrates the potential of modular protein domains and their proteomic binding profiles as powerful molecular diagnostic tools for tumor classification and biomarker identification.	[Machida, Kazuya; Mayer, Bruce J.] Univ Connecticut, Ctr Hlth, Raymond & Beverly Sackler Lab Genet & Mol Med, Dept Genet & Dev Biol, Farmington, CT USA; [Eschrich, Steven] H Lee Moffitt Canc Ctr & Res Inst, Dept Bioinformat, Tampa, FL USA; [Li, Jiannong; Bai, Yun; Haura, Eric B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA; [Koomen, John] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	University of Connecticut; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Machida, K (corresponding author), Univ Connecticut, Ctr Hlth, Raymond & Beverly Sackler Lab Genet & Mol Med, Dept Genet & Dev Biol, Farmington, CT USA.	bmayer@neuron.uchc.edu; Eric.haura@moffitt.org	Eschrich, Steven/K-6848-2013; Koomen, John/D-1844-2013	Eschrich, Steven/0000-0002-9833-2788; 	National Functional Genomics Center [E395859332944CBF8AFBDED2CE39B74A, W81XWH-08-2-0101]; National Institutes of Health [P50-CA119997, R33-CA107785, RC1-CA146843, P30CA076292]; CT Breast Health Initiative, Inc.; NATIONAL CANCER INSTITUTE [P50CA119997, P30CA076292, RC1CA146843, R33CA107785] Funding Source: NIH RePORTER	National Functional Genomics Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CT Breast Health Initiative, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was partially funded by grants from the National Functional Genomics Center (http://nfgc.moffitt.org/nfgc_Site.aspx?spid = E395859332944CBF8AFBDED2CE39B74A) (W81XWH-08-2-0101), the National Institutes of Health (http://grants.nih.gov/grants/oer.htm) (P50-CA119997, R33-CA107785, and RC1-CA146843) and the CT Breast Health Initiative, Inc. (http://ctbhi.org/). This work has been supported in part by a grant from the National Institutes of Health (P30CA076292) to the Molecular Biology Core and Bioinformatics Core Facilities at the H. Lee Moffitt Cancer Center & Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoku S, 2009, J CELL SCI, V122, P4228, DOI 10.1242/jcs.054627; Balko JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-289; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brannan JM, 2009, CLIN CANCER RES, V15, P4423, DOI 10.1158/1078-0432.CCR-09-0473; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chong YP, 2005, GROWTH FACTORS, V23, P233, DOI 10.1080/08977190500178877; Christensen JG, 2003, CANCER RES, V63, P7345; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Dierck K, 2006, NAT METHODS, V3, P737, DOI 10.1038/nmeth917; Dierck Kevin, 2009, V527, P131, DOI 10.1007/978-1-60327-834-8_11; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fischer H, 2008, MOL CANCER THER, V7, P3408, DOI 10.1158/1535-7163.MCT-08-0444; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; Guha U, 2008, P NATL ACAD SCI USA, V105, P14112, DOI 10.1073/pnas.0806158105; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kikuchi T, 2007, RESPIROLOGY, V12, P22, DOI 10.1111/j.1440-1843.2006.00957.x; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Machida K, 2005, BBA-PROTEINS PROTEOM, V1747, P1, DOI 10.1016/j.bbapap.2004.10.005; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; Machida K, 2009, METHODS MOL BIOL, V536, P313, DOI 10.1007/978-1-59745-542-8_34; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Nakamura Y, 2008, CANCER SCI, V99, P14, DOI 10.1111/j.1349-7006.2007.00640.x; Nollau P, 2001, P NATL ACAD SCI USA, V98, P13531, DOI 10.1073/pnas.241215998; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Ptacek J, 2006, TRENDS GENET, V22, P545, DOI 10.1016/j.tig.2006.08.005; Puri N, 2007, CANCER RES, V67, P3529, DOI 10.1158/0008-5472.CAN-06-4416; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Schmezle K, 2006, CURR OPIN BIOTECH, V17, P406, DOI 10.1016/j.copbio.2006.06.004; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957	52	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13470	10.1371/journal.pone.0013470	http://dx.doi.org/10.1371/journal.pone.0013470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976048	Green Published, Green Submitted, gold			2022-12-25	WOS:000283114700008
J	Martignani, E; Eirew, P; Accornero, P; Eaves, CJ; Baratta, M				Martignani, Eugenio; Eirew, Peter; Accornero, Paolo; Eaves, Connie J.; Baratta, Mario			Human Milk Protein Production in Xenografts of Genetically Engineered Bovine Mammary Epithelial Stem Cells	PLOS ONE			English	Article							TEMPLATE DNA STRANDS; ALDEHYDE DEHYDROGENASE; GLAND; MARKER; IDENTIFICATION; EXPRESSION; DIFFERENTIATION; PROLIFERATION; PROGENITORS; POPULATION	Background: In the bovine species milk production is well known to correlate with mammary tissue mass. However, most advances in optimizing milk production relied on improvements of breeding and husbandry practices. A better understanding of the cells that generate bovine mammary tissue could facilitate important advances in milk production and have global economic impact. With this possibility in mind, we show that a mammary stem cell population can be functionally identified and isolated from the bovine mammary gland. We also demonstrate that this stem cell population may be a promising target for manipulating the composition of cow's milk using gene transfer. Methods and Findings: We show that the in vitro colony-forming cell assay for detecting normal primitive bipotent and lineage-restricted human mammary clonogenic progenitors are applicable to bovine mammary cells. Similarly, the ability of normal human mammary stem cells to regenerate functional bilayered structures in collagen gels placed under the kidney capsule of immunodeficient mice is shared by a subset of bovine mammary cells that lack aldehyde dehydrogenase activity. We also find that this activity is a distinguishing feature of luminal-restricted bovine progenitors. The regenerated structures recapitulate the organization of bovine mammary tissue, and milk could be readily detected in these structures when they were assessed by immunohistochemical analysis. Transplantation of the bovine cells transduced with a lentivirus encoding human beta-CASEIN led to expression of the transgene and secretion of the product by their progeny regenerated in vivo. Conclusions: These findings point to a common developmental hierarchy shared by human and bovine mammary glands, providing strong evidence of common mechanisms regulating the maintenance and differentiation of mammary stem cells from both species. These results highlight the potential of novel engineering and transplant strategies for a variety of commercial applications including the production of modified milk components for human consumption.	[Martignani, Eugenio; Eirew, Peter; Accornero, Paolo; Baratta, Mario] Univ Turin, Dept Vet Morphophysiol, Grugliasco, Italy; [Martignani, Eugenio; Eirew, Peter; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	University of Turin; British Columbia Cancer Agency	Baratta, M (corresponding author), Univ Turin, Dept Vet Morphophysiol, Grugliasco, Italy.	mario.baratta@unito.it	Baratta, Mario/ABA-7749-2021; Baratta, Mario/AAP-8882-2021	Baratta, Mario/0000-0003-2537-6429; Eaves, Connie/0000-0002-3452-1926	Canadian Cancer Society; Canadian Bank of Commerce, Regione Piemonte; CRC Foundation; British Columbia Cancer Foundation; University of Turin; United States Department of Defense	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Bank of Commerce, Regione Piemonte(Regione Piemonte); CRC Foundation; British Columbia Cancer Foundation; University of Turin; United States Department of Defense(United States Department of Defense)	This work was supported by grants from the Canadian Cancer Society, the Canadian Bank of Commerce, Regione Piemonte, and the CRC Foundation with core support provided by the British Columbia Cancer Foundation and the University of Turin. Peter Eirew held a United States Department of Defense Breast Cancer Research Program Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Brisken C, 2007, STEM CELL REV, V3, P147, DOI 10.1007/s12015-007-0019-1; Burger PE, 2009, STEM CELLS, V27, P2220, DOI 10.1002/stem.135; Capuco AV, 2007, EXP BIOL MED, V232, P1381, DOI 10.3181/0703-RM-58; Capuco AV, 2002, TISSUE CELL, V34, P143, DOI 10.1016/S0040-8166(02)00024-1; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Ellis S, 2002, TISSUE CELL, V34, P155, DOI 10.1016/S0040-8166(02)00025-3; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hanker L, 2010, BREAST CANCER RES TR, V122, P765, DOI 10.1007/s10549-009-0608-6; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; JEAN E, 2009, J CELL MOL MED; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; RICHARDS SR, 1983, AM J OBSTET GYNECOL, V146, P1; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; SMITH GH, 1988, J CELL SCI, V90, P173; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Stingl J, 2006, CELL CYCLE, V5, P1519, DOI 10.4161/cc.5.14.2983; Storms RW, 2005, BLOOD, V106, P95, DOI 10.1182/blood-2004-09-3652; Tiede BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008035	31	37	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13372	10.1371/journal.pone.0013372	http://dx.doi.org/10.1371/journal.pone.0013372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976049	Green Published, Green Submitted, gold			2022-12-25	WOS:000283114700003
J	Andersson, T; Rahman, S; Sansom, SN; Alsio, JM; Kaneda, M; Smith, J; O'Carroll, D; Tarakhovsky, A; Livesey, FJ				Andersson, Therese; Rahman, Sabhi; Sansom, Stephen N.; Alsioe, Jessica M.; Kaneda, Masahiro; Smith, James; O'Carroll, Donal; Tarakhovsky, Alexander; Livesey, Frederick J.			Reversible Block of Mouse Neural Stem Cell Differentiation in the Absence of Dicer and MicroRNAs	PLOS ONE			English	Article							MICROARRAY ANALYSIS; GENE-EXPRESSION; SELF-RENEWAL; BRAIN; MORPHOGENESIS; NEUROGENESIS; TRANSITION; SURVIVAL; NEURONS; MURINE	Background: To investigate the functions of Dicer and microRNAs in neural stem (NS) cell self-renewal and neurogenesis, we established neural stem cell lines from the embryonic mouse Dicer-null cerebral cortex, producing neural stem cell lines that lacked all microRNAs. Principal Findings: Dicer-null NS cells underwent normal self-renewal and could be maintained in vitro indefinitely, but had subtly altered cell cycle kinetics and abnormal heterochromatin organisation. In the absence of all microRNAs, Dicer-null NS cells were incapable of generating either glial or neuronal progeny and exhibited a marked dependency on exogenous EGF for survival. Dicer-null NS cells assumed complex differences in mRNA and protein expression under self-renewing conditions, upregulating transcripts indicative of self-renewing NS cells and expressing genes characteristic of differentiating neurons and glia. Underlining the growth-factor dependency of Dicer-null NS cells, many regulators of apoptosis were enriched in expression in these cells. Dicer-null NS cells initiate some of the same gene expression changes as wild-type cells under astrocyte differentiating conditions, but also show aberrant expression of large sets of genes and ultimately fail to complete the differentiation programme. Acute replacement of Dicer restored their ability to differentiate to both neurons and glia. Conclusions: The block in differentiation due to loss of Dicer and microRNAs is reversible and the significantly altered phenotype of Dicer-null NS cells does not constitute a permanent transformation. We conclude that Dicer and microRNAs function in this system to maintain the neural stem cell phenotype and to facilitate the completion of differentiation.	[Andersson, Therese; Rahman, Sabhi; Sansom, Stephen N.; Alsioe, Jessica M.; Kaneda, Masahiro; Smith, James; Livesey, Frederick J.] Univ Cambridge, Gurdon Inst, Cambridge, England; [Andersson, Therese; Rahman, Sabhi; Sansom, Stephen N.; Alsioe, Jessica M.; Smith, James; Livesey, Frederick J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [O'Carroll, Donal; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signalling, New York, NY 10021 USA	University of Cambridge; University of Cambridge; Rockefeller University	Andersson, T (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge, England.	rick@gurdon.cam.ac.uk	Kaneda, Masahiro/E-3117-2010; Vasilica, Andrei V/F-2185-2010	Kaneda, Masahiro/0000-0003-0660-7156; O'Carroll, Donal/0000-0002-8626-2217; Smith, James/0000-0001-9131-5849; Livesey, Rick/0000-0001-6128-3372	Wellcome Trust; Wenner-Gren Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Wenner-Gren Foundation	This work was supported by grants from the Wellcome Trust (FJL) and the Wenner-Gren Foundation (TA) and by core support to the Gurdon Institute from Cancer Research UK and the Wellcome Trust (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KM, 1999, EPILEPSY RES, V36, P143, DOI 10.1016/S0920-1211(99)00048-0; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cheng LC, 2005, NEURON, V46, P363, DOI 10.1016/j.neuron.2005.04.027; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Giles KE, 2010, NAT CELL BIOL, V12, P94, DOI 10.1038/ncb2010; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kawase-Koga Y, 2010, J CELL SCI, V123, P586, DOI 10.1242/jcs.059659; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kosik KS, 2005, NEURON, V47, P779, DOI 10.1016/j.neuron.2005.08.019; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Livesey FJ, 2004, P NATL ACAD SCI USA, V101, P1374, DOI 10.1073/pnas.0307014101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stadler BM, 2008, CELL, V132, P563, DOI 10.1016/j.cell.2008.02.005; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Young ARJ, 2007, GENE DEV, V21, P1005, DOI 10.1101/gad.1554707	49	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13453	10.1371/journal.pone.0013453	http://dx.doi.org/10.1371/journal.pone.0013453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976144	Green Published, gold, Green Submitted			2022-12-25	WOS:000283045300025
J	Baek, RC; Broekman, MLD; Leroy, SG; Tierney, LA; Sandberg, MA; d'Azzo, A; Seyfried, TN; Sena-Esteves, M				Baek, Rena C.; Broekman, Marike L. D.; Leroy, Stanley G.; Tierney, Laryssa A.; Sandberg, Michael A.; d'Azzo, Alessandra; Seyfried, Thomas N.; Sena-Esteves, Miguel			AAV-Mediated Gene Delivery in Adult GM1-Gangliosidosis Mice Corrects Lysosomal Storage in CNS and Improves Survival	PLOS ONE			English	Article							ACID BETA-GALACTOSIDASE; SANDHOFF-DISEASE MICE; GM1 GANGLIOSIDOSIS; MOUSE MODEL; ANIMAL-MODEL; NIEMANN-PICK; GENERALIZED GANGLIOSIDOSIS; BRAIN GANGLIOSIDE; RAT-BRAIN; THERAPY	Background: GM1-gangliosidosis is a glycosphingolipid (GSL) lysosomal storage disease caused by a genetic deficiency of acid beta-galactosidase (beta gal), which results in the accumulation of GM1-ganglioside and its asialo-form (GA1) primarily in the CNS. Age of onset ranges from infancy to adulthood, and excessive ganglioside accumulation produces progressive neurodegeneration and psychomotor retardation in humans. Currently, there are no effective therapies for the treatment of GM1-gangliosidosis. Methodology/Principal Findings: In this study we examined the effect of thalamic infusion of AAV2/1-beta gal vector in adult GM1 mice on enzyme distribution, activity, and GSL content in the CNS, motor behavior, and survival. Six to eight week-old GM1 mice received bilateral injections of AAV vector in the thalamus, or thalamus and deep cerebellar nuclei (DCN) with pre-determined endpoints at 1 and 4 months post-injection, and the humane endpoint, or 52 weeks of age. Enzyme activity was elevated throughout the CNS of AAV-treated GM1 mice and GSL storage nearly normalized in most structures analyzed, except in the spinal cord which showed similar to 50% reduction compared to age-matched untreated GM1 mice spinal cord. Survival was significantly longer in AAV-treated GM1 mice (52 wks) than in untreated mice. However the motor performance of AAV-treated GM1 mice declined over time at a rate similar to that observed in untreated GM1 mice. Conclusions/Significance: Our studies show that the AAV-modified thalamus can be used as a 'built-in' central node network for widespread distribution of lysosomal enzymes in the mouse cerebrum. In addition, this study indicates that thalamic delivery of AAV vectors should be combined with additional targets to supply the cerebellum and spinal cord with therapeutic levels of enzyme necessary to achieve complete correction of the neurological phenotype in GM1 mice.	[Baek, Rena C.; Seyfried, Thomas N.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Broekman, Marike L. D.; Leroy, Stanley G.; Tierney, Laryssa A.; Sena-Esteves, Miguel] Massachusetts Gen Hosp, Dept Neurol, Program Neurosci, Charlestown, MA USA; [Broekman, Marike L. D.; Leroy, Stanley G.; Tierney, Laryssa A.; Sena-Esteves, Miguel] Harvard Univ, Sch Med, Charlestown, MA USA; [Broekman, Marike L. D.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Pharmacol & Anat, Utrecht, Netherlands; [Sandberg, Michael A.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA USA; [d'Azzo, Alessandra] St Jude Childrens Hosp, Dept Genet, Memphis, TN 38105 USA	Boston College; Harvard University; Massachusetts General Hospital; Harvard University; Utrecht University; Utrecht University Medical Center; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; St Jude Children's Research Hospital	Baek, RC (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	Miguel.Esteves@umassmed.edu		Seyfried, Thomas/0000-0003-1491-3989	National Institutes of Health/National Institute of Neurological Disorders and Stroke [R21NS053993]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053993] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health/National Institute of Neurological Disorders and Stroke grant R21NS053993 (MSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek RC, 2008, NEUROCHEM INT, V52, P1125, DOI 10.1016/j.neuint.2007.12.001; BIEBER FR, 1986, ARCH NEUROL-CHICAGO, V43, P736, DOI 10.1001/archneur.1986.00520070090027; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Broekman MLD, 2007, MOL THER, V15, P30, DOI 10.1038/sj.mt.6300004; Broekman MLD, 2009, GENE THER, V16, P303, DOI 10.1038/gt.2008.149; Broekman MLD, 2006, NEUROSCIENCE, V138, P501, DOI 10.1016/j.neuroscience.2005.11.057; Cabrera-Salazar MA, 2007, MOL THER, V15, P1782, DOI 10.1038/sj.mt.6300249; Cachon-Gonzalez MB, 2006, P NATL ACAD SCI USA, V103, P10373, DOI 10.1073/pnas.0603765103; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Chang M, 2008, MOL THER; Denny CA, 2006, J NEUROSCI RES, V83, P1028, DOI 10.1002/jnr.20798; Denny CA, 2007, J NEUROCHEM, V101, P1294, DOI 10.1111/j.1471-4159.2007.04525.x; Dickson P, 2007, MOL GENET METAB, V91, P61, DOI 10.1016/j.ymgme.2006.12.012; Dodge JC, 2009, EXP NEUROL, V215, P349, DOI 10.1016/j.expneurol.2008.10.021; Dodge JC, 2005, P NATL ACAD SCI USA, V102, P17822, DOI 10.1073/pnas.0509062102; DODGE JC, 2008, MOL THER; Elliot-Smith E, 2008, MOL GENET METAB, V94, P204, DOI 10.1016/j.ymgme.2008.02.005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Folkerth RD, 2000, PEDIATR DEVEL PATHOL, V3, P73, DOI 10.1007/s100240050010; GOLDSTEIN G, 1984, PLANT CELL ENVIRON, V7, P179; Hahn CN, 1997, HUM MOL GENET, V6, P205, DOI 10.1093/hmg/6.2.205; Hauser EC, 2004, BIOCHEM GENET, V42, P241, DOI 10.1023/B:BIGI.0000034429.55418.71; Hennig AK, 2003, J NEUROSCI, V23, P3302; Husain T, 2009, GENE THER, V16, P927, DOI 10.1038/gt.2009.52; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Jurevics H, 2002, J NEUROCHEM, V82, P126, DOI 10.1046/j.1471-4159.2002.00954.x; KASAMA T, 1986, JPN J EXP MED, V56, P1; Kasperzyk JL, 2004, J NEUROCHEM, V89, P645, DOI 10.1046/j.1471-4159.2004.02381.x; KASPERZYK JL, 2005, J LIPID RES; KAYE EM, 1992, PEDIATR NEUROL, V8, P255, DOI 10.1016/0887-8994(92)90361-2; Kells AP, 2009, P NATL ACAD SCI USA, V106, P2407, DOI 10.1073/pnas.0810682106; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; KUDOH T, 1978, HUM GENET, V44, P287, DOI 10.1007/BF00394293; LATTANZI A, HUM MOL GENET, V19, P2208; Liu GM, 2005, J NEUROSCI, V25, P9321, DOI 10.1523/JNEUROSCI.2936-05.2005; Luca T, 2005, MOL THER, V12, P669, DOI 10.1016/j.ymthe.2005.06.438; Matsuda J, 1997, GLYCOCONJUGATE J, V14, P729, DOI 10.1023/A:1018573518127; MATTHIEU JM, 1973, BRAIN RES, V55, P391, DOI 10.1016/0006-8993(73)90304-1; Morell P., 1999, BASIC NEUROCHEMISTRY, V6th ed.; NORTON WT, 1973, J NEUROCHEM, V21, P759, DOI 10.1111/j.1471-4159.1973.tb07520.x; OBRIEN JS, 1965, AM J DIS CHILD, V109, P338, DOI 10.1001/archpedi.1965.02090020340014; OKADA S, 1968, SCIENCE, V160, P1002, DOI 10.1126/science.160.3831.1002; Passini MA, 2002, J NEUROSCI, V22, P6437; Passini MA, 2007, P NATL ACAD SCI USA, V104, P9505, DOI 10.1073/pnas.0703509104; Sands MS, 2006, MOL THER, V13, P839, DOI 10.1016/j.ymthe.2006.01.006; Sano R, 2005, BLOOD, V106, P2259, DOI 10.1182/blood-2005-03-1189; Sano R, 2009, MOL CELL, V36, P500, DOI 10.1016/j.molcel.2009.10.021; Schuettrumpf J, 2005, BLOOD, V105, P2316, DOI 10.1182/blood-2004-08-2990; SEYFRIED TN, 1982, J NEUROCHEM, V39, P277, DOI 10.1111/j.1471-4159.1982.tb04735.x; SEYFRIED TN, 1984, EXP NEUROL, V84, P590, DOI 10.1016/0014-4886(84)90206-1; SEYFRIED TN, 1980, BIOCHEM GENET, V18, P1229, DOI 10.1007/BF00484350; SUZUKI Y, 2001, ONLINE METABOLIC MOL, P3775; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029; Vite CH, 2005, ANN NEUROL, V57, P355, DOI 10.1002/ana.20392; Watson G, 2006, GENE THER, V13, P917, DOI 10.1038/sj.gt.3302735; WILLIAMS MA, 1980, J NEUROCHEM, V35, P266, DOI 10.1111/j.1471-4159.1980.tb12515.x	57	54	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13468	10.1371/journal.pone.0013468	http://dx.doi.org/10.1371/journal.pone.0013468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976108	gold, Green Published, Green Submitted			2022-12-25	WOS:000283045300036
J	Greninger, AL; Chen, EC; Sittler, T; Scheinerman, A; Roubinian, N; Yu, GX; Kim, E; Pillai, DR; Guyard, C; Mazzulli, T; Isa, P; Arias, CF; Hackett, J; Schochetman, G; Miller, S; Tang, P; Chiu, CY				Greninger, Alexander L.; Chen, Eunice C.; Sittler, Taylor; Scheinerman, Alex; Roubinian, Nareg; Yu, Guixia; Kim, Edward; Pillai, Dylan R.; Guyard, Cyril; Mazzulli, Tony; Isa, Pavel; Arias, Carlos F.; Hackett, John, Jr.; Schochetman, Gerald; Miller, Steve; Tang, Patrick; Chiu, Charles Y.			A Metagenomic Analysis of Pandemic Influenza A (2009 H1N1) Infection in Patients from North America	PLOS ONE			English	Article							FLUCHIP DIAGNOSTIC MICROARRAY; RESPIRATORY-TRACT INFECTIONS; VIRUS; IDENTIFICATION; CORONAVIRUS; HUMANS	Although metagenomics has been previously employed for pathogen discovery, its cost and complexity have prevented its use as a practical front-line diagnostic for unknown infectious diseases. Here we demonstrate the utility of two metagenomics-based strategies, a pan-viral microarray (Virochip) and deep sequencing, for the identification and characterization of 2009 pandemic H1N1 influenza A virus. Using nasopharyngeal swabs collected during the earliest stages of the pandemic in Mexico, Canada, and the United States (n = 17), the Virochip was able to detect a novel virus most closely related to swine influenza viruses without a priori information. Deep sequencing yielded reads corresponding to 2009 H1N1 influenza in each sample ( percentage of aligned sequences corresponding to 2009 H1N1 ranging from 0.0011% to 10.9%), with up to 97% coverage of the influenza genome in one sample. Detection of 2009 H1N1 by deep sequencing was possible even at titers near the limits of detection for specific RT-PCR, and the percentage of sequence reads was linearly correlated with virus titer. Deep sequencing also provided insights into the upper respiratory microbiota and host gene expression in response to 2009 H1N1 infection. An unbiased analysis combining sequence data from all 17 outbreak samples revealed that 90% of the 2009 H1N1 genome could be assembled de novo without the use of any reference sequence, including assembly of several near full-length genomic segments. These results indicate that a streamlined metagenomics detection strategy can potentially replace the multiple conventional diagnostic tests required to investigate an outbreak of a novel pathogen, and provide a blueprint for comprehensive diagnosis of unexplained acute illnesses or outbreaks in clinical and public health settings.	[Greninger, Alexander L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Chen, Eunice C.; Sittler, Taylor; Scheinerman, Alex; Yu, Guixia; Miller, Steve; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Chen, Eunice C.; Sittler, Taylor; Scheinerman, Alex; Yu, Guixia; Miller, Steve; Chiu, Charles Y.] Univ Calif San Francisco, UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA; [Roubinian, Nareg; Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Kim, Edward; Tang, Patrick] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Kim, Edward; Tang, Patrick] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Pillai, Dylan R.; Guyard, Cyril; Mazzulli, Tony] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Pillai, Dylan R.; Guyard, Cyril] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada; [Mazzulli, Tony] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Isa, Pavel; Arias, Carlos F.] Univ Nacl Autonoma Mexico, Inst Biotechnol, Cuernavaca, Morelos, Mexico; [Hackett, John, Jr.; Schochetman, Gerald] Abbott Diagnost, Abbott Pk, IL USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of British Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Universidad Nacional Autonoma de Mexico	Greninger, AL (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	charles.chiu@ucsf.edu	Isa, Pavel/GVU-8303-2022; Arias, Carlos/O-4036-2019	Arias, Carlos/0000-0003-3130-4501; Tang, Patrick/0000-0003-1583-5484; Sittler, Taylor/0000-0001-7495-4147; , cyril/0000-0002-2721-0097; Tripp, Ralph/0000-0002-2924-9956; Greninger, Alexander/0000-0002-7443-0527; Chiu, Charles/0000-0003-2915-2094	National Institutes of Health (NIH) [AI074913]; Kleine-Levin Syndrome Foundation; Abbott Diagnostics, Inc.; Amazon, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI074913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kleine-Levin Syndrome Foundation; Abbott Diagnostics, Inc.(Abbott Laboratories); Amazon, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.Y.C. is supported by National Institutes of Health (NIH) K08 grant AI074913, a grant from the Kleine-Levin Syndrome Foundation, and a viral discovery award from Abbott Diagnostics, Inc. The authors also acknowledge an Amazon Web Services (AWS) grant to T. S., A. G., and C.Y.C. from Amazon, Inc., for high-performance computation on the Elastic Compute Cloud (EC2) platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnulf I, 2008, ANN NEUROL, V63, P482, DOI 10.1002/ana.21333; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Chiu CY, 2008, J PEDIATR-US, V153, P76, DOI 10.1016/j.jpeds.2007.12.035; Chiu CY, 2006, CLIN INFECT DIS, V43, pE71, DOI 10.1086/507896; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DEYDE VM, 2009, ANTIMICROB AGENTS CH; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; DRUMMOND AJ, 2009, GENEIOUS V4 7; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Fischer N, 2010, EMERG INFECT DIS, V16, P1000, DOI 10.3201/eid1606.100066; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Ganev PN, 2010, LITHOSPHERE-US, V2, P33, DOI 10.1130/L51.1; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; *GROUP NHW, 2009, GENOME RES, V19, P2317; HALE BG, 2010, J VIROL; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; Lee CWH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq089; LI L, 2010, J VIROL; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Lu Q, 2009, J CLIN MICROBIOL, V47, P3060, DOI 10.1128/JCM.01243-09; Martinez DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000906; Mehlmann M, 2006, J CLIN MICROBIOL, V44, P2857, DOI 10.1128/JCM.00135-06; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sorber K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003495; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; Thompson B, 2002, PORTAL-LIBR ACAD, V2, P3, DOI 10.1353/pla.2002.0022; Townsend MB, 2006, J CLIN MICROBIOL, V44, P2863, DOI 10.1128/JCM.00134-06; Treanor J, 2004, NEW ENGL J MED, V350, P218, DOI 10.1056/NEJMp038238; Urisman A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r78; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wang Z, 2006, EMERG INFECT DIS, V12, P638, DOI 10.3201/eid1204.051441; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Zhang HW, 2006, INT J MULTISCALE COM, V4, P3, DOI 10.1615/IntJMultCompEng.v4.i1.20	55	133	150	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13381	10.1371/journal.pone.0013381	http://dx.doi.org/10.1371/journal.pone.0013381			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976137	Green Published, gold, Green Submitted			2022-12-25	WOS:000283045300008
J	Meenderink, LM; Ryzhova, LM; Donato, DM; Gochberg, DF; Kaverina, I; Hanks, SK				Meenderink, Leslie M.; Ryzhova, Larisa M.; Donato, Dominique M.; Gochberg, Daniel F.; Kaverina, Irina; Hanks, Steven K.			P130Cas Src-Binding and Substrate Domains Have Distinct Roles in Sustaining Focal Adhesion Disassembly and Promoting Cell Migration	PLOS ONE			English	Article							CRK-ASSOCIATED SUBSTRATE; TYROSINE PHOSPHORYLATION SITES; ADAPTER PROTEIN CAS; TRANSFORMED CELLS; CAS/CRK SCAFFOLD; ACTIN; P130(CAS); PAXILLIN; KINASE; LOCALIZATION	The docking protein p130Cas is a prominent Src substrate found in focal adhesions (FAs) and is implicated in regulating critical aspects of cell motility including FA disassembly and protrusion of the leading edge plasma membrane. To better understand how p130Cas acts to promote these events we examined requirements for established p130Cas signaling motifs including the SH3-binding site of the Src binding domain (SBD) and the tyrosine phosphorylation sites within the substrate domain (SD). Expression of wild type p130Cas in Cas -/- mouse embryo fibroblasts resulted in enhanced cell migration associated with increased leading-edge actin flux, increased rates of FA assembly/disassembly, and uninterrupted FA turnover. Variants lacking either the SD phosphorylation sites or the SBD SH3-binding motif were able to partially restore the migration response, while only a variant lacking both signaling functions was fully defective. Notably, the migration defects associated with p130Cas signaling-deficient variants correlated with longer FA lifetimes resulting from aborted FA disassembly attempts. However the SD mutational variant was fully defective in increasing actin assembly at the protruding leading edge and FA assembly/disassembly rates, indicating that SD phosphorylation is the sole p130Cas signaling function in regulating these processes. Our results provide the first quantitative evidence supporting roles for p130Cas SD tyrosine phosphorylation in promoting both leading edge actin flux and FA turnover during cell migration, while further revealing that the p130Cas SBD has a function in cell migration and sustained FA disassembly that is distinct from its known role of promoting SD tyrosine phosphorylation.	[Meenderink, Leslie M.; Ryzhova, Larisa M.; Donato, Dominique M.; Kaverina, Irina; Hanks, Steven K.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Gochberg, Daniel F.] Vanderbilt Univ, Sch Med, Dept Radiol & Radiol Sci, Nashville, TN 37212 USA; [Gochberg, Daniel F.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37212 USA; [Gochberg, Daniel F.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Meenderink, LM (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA.	steve.hanks@vanderbilt.edu	Donato, Dominique/C-1058-2012	Donato, Dominique/0000-0002-0495-4376; Meenderink, Leslie/0000-0003-3943-4079	National Institutes of Health [R01-GM049882, R01-GM78373, T32-CA09592, T32-GM07347, P30-DK058404]; American Heart Association [0815136E]; NATIONAL CANCER INSTITUTE [T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, R01GM078373, R01GM049882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01-GM049882, R01-GM78373, T32-CA09592, T32-GM07347, and P30-DK058404, and by a predoctoral fellowship 0815136E from the American Heart Association (to L.M.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballestrem C, 2006, J CELL SCI, V119, P866, DOI 10.1242/jcs.02794; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Burnham MR, 2000, MOL CELL BIOL, V20, P5865, DOI 10.1128/MCB.20.16.5865-5878.2000; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Cunningham-Edmondson AC, 2009, BREAST CANCER-TARGET, V1, P39; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Donato DM, 2010, J BIOL CHEM, V285, P20769, DOI 10.1074/jbc.M109.091207; Efimov A, 2008, J CELL SCI, V121, P196, DOI 10.1242/jcs.012666; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Fonseca PM, 2004, CELL SIGNAL, V16, P621, DOI 10.1016/j.cellsig.2003.10.004; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kruchten AE, 2008, AM J PHYSIOL-CELL PH, V295, pC1113, DOI 10.1152/ajpcell.00238.2008; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li EG, 2000, J BIOL CHEM, V275, P14729, DOI 10.1074/jbc.275.19.14729; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Siesser PMF, 2008, CELL MOTIL CYTOSKEL, V65, P25, DOI 10.1002/cm.20241; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Wang Yu-li, 2007, Sci STKE, V2007, ppe10; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	40	40	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13412	10.1371/journal.pone.0013412	http://dx.doi.org/10.1371/journal.pone.0013412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976150	Green Submitted, Green Published, gold			2022-12-25	WOS:000283045300010
J	Reich, HN; Tritchler, D; Cattran, DC; Herzenberg, AM; Eichinger, F; Boucherot, A; Henger, A; Berthier, CC; Nair, V; Cohen, CD; Scholey, JW; Kretzler, M				Reich, Heather N.; Tritchler, David; Cattran, Daniel C.; Herzenberg, Andrew M.; Eichinger, Felix; Boucherot, Anissa; Henger, Anna; Berthier, Celine C.; Nair, Viji; Cohen, Clemens D.; Scholey, James W.; Kretzler, Matthias			A Molecular Signature of Proteinuria in Glomerulonephritis	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; TUBULAR EPITHELIAL-CELLS; GENE-EXPRESSION ANALYSIS; GROWTH-FACTOR-BETA; IGA NEPHROPATHY; RENAL-DISEASE; NATURAL-HISTORY; KIDNEY-DISEASE; TUBULOINTERSTITIAL CHANGES; PROGNOSTIC-SIGNIFICANCE	Proteinuria is the most important predictor of outcome in glomerulonephritis and experimental data suggest that the tubular cell response to proteinuria is an important determinant of progressive fibrosis in the kidney. However, it is unclear whether proteinuria is a marker of disease severity or has a direct effect on tubular cells in the kidneys of patients with glomerulonephritis. Accordingly we studied an in vitro model of proteinuria, and identified 231 "albumin-regulated genes" differentially expressed by primary human kidney tubular epithelial cells exposed to albumin. We translated these findings to human disease by studying mRNA levels of these genes in the tubulo-interstitial compartment of kidney biopsies from patients with IgA nephropathy using microarrays. Biopsies from patients with IgAN (n = 25) could be distinguished from those of control subjects ( n = 6) based solely upon the expression of these 231 "albumin-regulated genes." The expression of an 11-transcript subset related to the degree of proteinuria, and this 11-mRNA subset was also sufficient to distinguish biopsies of subjects with IgAN from control biopsies. We tested if these findings could be extrapolated to other proteinuric diseases beyond IgAN and found that all forms of primary glomerulonephritis ( n = 33) can be distinguished from controls ( n = 21) based solely on the expression levels of these 11 genes derived from our in vitro proteinuria model. Pathway analysis suggests common regulatory elements shared by these 11 transcripts. In conclusion, we have identified an albumin-regulated 11-gene signature shared between all forms of primary glomerulonephritis. Our findings support the hypothesis that albuminuria may directly promote injury in the tubulo-interstitial compartment of the kidney in patients with glomerulonephritis.	[Reich, Heather N.; Cattran, Daniel C.; Scholey, James W.] Univ Toronto, Univ Hlth Network, Div Nephrol, Toronto, ON, Canada; [Reich, Heather N.; Cattran, Daniel C.; Scholey, James W.] Toronto Glomerulonephritis Registry, Toronto, ON, Canada; [Tritchler, David] Ontario Canc Inst, Div Epidemiol & Stat, Toronto, ON M4X 1K9, Canada; [Tritchler, David] Univ Toronto, Univ Hlth Network, Dept Lab Med & Pathol, Toronto, ON, Canada; [Eichinger, Felix; Boucherot, Anissa; Henger, Anna; Berthier, Celine C.; Nair, Viji; Kretzler, Matthias] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Cohen, Clemens D.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Cohen, Clemens D.] Univ Zurich Hosp, Inst Physiol, CH-8091 Zurich, Switzerland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Michigan System; University of Michigan; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Reich, HN (corresponding author), Univ Toronto, Univ Hlth Network, Div Nephrol, Toronto, ON, Canada.	hreich@uhnresearch.on.ca			KRESCENT; Physicians Services Inc. Foundation; KFOC; CIHR; Swiss National Science Foundation [32-122439/1]; Else Kroener-Fresenius Foundation [A62/04]; Mathematics of Information Technology and Complex Systems (MITACS); Natural Sciences and Engineering Research Council of Canada (NSERC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079912] Funding Source: NIH RePORTER	KRESCENT; Physicians Services Inc. Foundation; KFOC; CIHR(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Else Kroener-Fresenius Foundation; Mathematics of Information Technology and Complex Systems (MITACS); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Heather Reich is the recipient of a KRESCENT new investigator award and her work is supported by the Physicians Services Inc. Foundation, with gratitude to the physicians of Ontario. Dr. James Scholey holds the Amgen-CIHR Research Chair at University Health Network/University of Toronto. Funding for this study was also supported by operating grants from the KFOC and CIHR, in addition to the CIHR Genes, Gender, and Glomerulonephritis New Emerging Team grant. Dr. David Tritchler was supported by funding from the Mathematics of Information Technology and Complex Systems (MITACS) and the Natural Sciences and Engineering Research Council of Canada (NSERC). The work was supported by the Swiss National Science Foundation (32-122439/1) and the Else Kroener-Fresenius Foundation (A62/04) to CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2002, KIDNEY INT, V61, P2066, DOI 10.1046/j.1523-1755.2002.00380.x; Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; BOHLE A, 1987, AM J NEPHROL, V7, P421, DOI 10.1159/000167514; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; CAMERON JS, 1990, AM J NEPHROL, V10, P81; Cattran DC, 2008, NEPHROL DIAL TRANSPL, V23, P2247, DOI 10.1093/ndt/gfm919; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Christensen PK, 1999, DIABETIC MED, V16, P388, DOI 10.1046/j.1464-5491.1999.00063.x; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; DAMICO G, 1987, Q J MED, V64, P709; Diwakar R, 2007, AM J PHYSIOL-RENAL, V292, pF1464, DOI 10.1152/ajprenal.00069.2006; Donadelli R, 2000, AM J KIDNEY DIS, V36, P1226, DOI 10.1053/ajkd.2000.19838; Donadio JV, 2002, NEPHROL DIAL TRANSPL, V17, P1197, DOI 10.1093/ndt/17.7.1197; Drummond K, 2002, DIABETES, V51, P1580, DOI 10.2337/diabetes.51.5.1580; Eddy AA, 2004, NEPHROL DIAL TRANSPL, V19, P277, DOI 10.1093/ndt/gfg533; EDDY AA, 1995, KIDNEY INT, V47, P1546, DOI 10.1038/ki.1995.218; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erkan E, 2005, J AM SOC NEPHROL, V16, P398, DOI 10.1681/ASN.2003100861; Erkan E, 2001, AM J PHYSIOL-RENAL, V280, pF1107, DOI 10.1152/ajprenal.2001.280.6.F1107; GALL MA, 1993, DIABETOLOGIA, V36, P1071, DOI 10.1007/BF02374501; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GENTLEMAN R, 2003, BIOCONDUCTOR FAQ; GENTLEMAN R, 2007, USING GO STAT ANAL; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Grandaliano G, 2000, AM J KIDNEY DIS, V35, P726, DOI 10.1016/S0272-6386(00)70022-9; Hamano K, 2002, AM J KIDNEY DIS, V39, P695, DOI 10.1053/ajkd.2002.31986; Henger A, 2004, KIDNEY INT, V65, P904, DOI 10.1111/j.1523-1755.2004.00499.x; Heymann F, 2009, J CLIN INVEST, V119, P1286, DOI 10.1172/JCI38399; IBELS LS, 1994, MEDICINE, V73, P79, DOI 10.1097/00005792-199403000-00002; Iglesias J, 2001, NEPHROL DIAL TRANSPL, V16, P215, DOI 10.1093/ndt/16.2.215; Irizarry R. A., 2003, ANAL GENE EXPRESSION, P102; Ju WJ, 2009, AM J PATHOL, V174, P2073, DOI 10.2353/ajpath.2009.080888; Kamijo A, 2002, KIDNEY INT, V62, P1628, DOI 10.1046/j.1523-1755.2002.00618.x; Katz A, 2002, KIDNEY INT, V61, P2058, DOI 10.1046/j.1523-1755.2002.00370.x; KEESFOLTS D, 1994, KIDNEY INT, V45, P1697, DOI 10.1038/ki.1994.222; KOBAYASHI Y, 1983, NEPHRON, V34, P146, DOI 10.1159/000183000; Kretzler M, 2002, J AM SOC NEPHROL, V13, P1961, DOI 10.1097/01.ASN.0000020390.29418.70; Kriz W, 2001, J AM SOC NEPHROL, V12, P496, DOI 10.1681/ASN.V123496; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Liu HT, 2005, J IMMUNOL, V175, P8337, DOI 10.4049/jimmunol.175.12.8337; Meyer TW, 2003, KIDNEY INT, V63, P774, DOI 10.1046/j.1523-1755.2003.00795.x; MOGENSEN CE, 1976, SCAND J CLIN LAB INV, V36, P383, DOI 10.3109/00365517609055274; MYERS BD, 1995, KIDNEY INT, V47, P1781, DOI 10.1038/ki.1995.246; Nakamura H, 2002, GENE THER, V9, P495, DOI 10.1038/sj.gt.3301681; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Nikolic-Paterson DJ, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_5.3; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Peterson KS, 2004, J CLIN INVEST, V113, P1722, DOI 10.1172/JCI200419139; Philibert D, 2008, NAT CLIN PRACT NEPHR, V4, P550, DOI 10.1038/ncpneph0915; Porubsky S, 2004, AM J PATHOL, V164, P2175, DOI 10.1016/S0002-9440(10)63775-3; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Reich H, 2005, J AM SOC NEPHROL, V16, P1266, DOI 10.1681/ASN.2004030222; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Row P G, 1975, Ateneo Parmense Acta Biomed, V46, P433; Rudnicki M, 2007, KIDNEY INT, V71, P325, DOI 10.1038/sj.ki.5002043; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; Schmid H, 2004, NEPHROL DIAL TRANSPL, V19, P1347, DOI 10.1093/ndt/gfh181; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Sitailo LA, 2006, J BIOL CHEM, V281, P29703, DOI 10.1074/jbc.M607351200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Striker LJ, 2003, J AM SOC NEPHROL, V14, P1096, DOI 10.1097/01.ASN.0000060865.30249.40; Stuart JR, 2005, ONCOGENE, V24, P8085, DOI 10.1038/sj.onc.1208953; Tang S, 2003, J CLIN INVEST, V111, P515, DOI [10.1172/JCI16079, 10.1172/JCI200316079]; Tarshish P, 1997, J AM SOC NEPHROL, V8, P769; Theilig F, 2007, J AM SOC NEPHROL, V18, P1824, DOI 10.1681/ASN.2006111266; Thomas ME, 2002, AM J PHYSIOL-RENAL, V283, pF640, DOI 10.1152/ajprenal.00001.2002; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Timofeeva OA, 2006, ONCOGENE, V25, P7555, DOI 10.1038/sj.onc.1209742; Tritchler D, 2005, COMPUT STAT DATA AN, V49, P63, DOI 10.1016/j.csda.2004.04.010; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Timmeren MM, 2005, NEPHROL DIAL TRANSPL, V20, P2349, DOI 10.1093/ndt/gfh964; Waga I, 2003, KIDNEY INT, V64, P1253, DOI 10.1046/j.1523-1755.2003.00220.x; Wang SN, 2000, KIDNEY INT, V57, P1002, DOI 10.1046/j.1523-1755.2000.00928.x; WETTENHALL J, GENE ONTOLOGIES GENE; Woltman AM, 2007, KIDNEY INT, V71, P1001, DOI 10.1038/sj.ki.5002187; Yamamoto T, 1996, KIDNEY INT, V49, P461, DOI 10.1038/ki.1996.65; Yang-Yen HF, 2006, J BIOMED SCI, V13, P201, DOI 10.1007/s11373-005-9064-4; Zhang GQ, 2003, J AM SOC NEPHROL, V14, P1254, DOI 10.1097/01.ASN.0000064292.37793.FB; Zoja C, 2004, CURR OPIN NEPHROL HY, V13, P31, DOI 10.1097/00041552-200401000-00005; Zoja C, 1998, KIDNEY INT, V53, P1608, DOI 10.1046/j.1523-1755.1998.00905.x; Zoja C, 1995, AM J KIDNEY DIS, V26, P934, DOI 10.1016/0272-6386(95)90058-6	86	52	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13451	10.1371/journal.pone.0013451	http://dx.doi.org/10.1371/journal.pone.0013451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976140	Green Published, gold, Green Submitted			2022-12-25	WOS:000283045300023
J	Huber, G; Heynen, S; Imsand, C; vom Hagen, F; Muehlfriedel, R; Tanimoto, N; Feng, Y; Hammes, HP; Grimm, C; Peichl, L; Seeliger, MW; Beck, SC				Huber, Gesine; Heynen, Severin; Imsand, Coni; vom Hagen, Franziska; Muehlfriedel, Regine; Tanimoto, Naoyuki; Feng, Yuxi; Hammes, Hans-Peter; Grimm, Christian; Peichl, Leo; Seeliger, Mathias W.; Beck, Susanne C.			Novel Rodent Models for Macular Research	PLOS ONE			English	Article							RETINAL DEGENERATION; GANGLION-CELLS; ANIMAL-MODELS; MOUSE MODELS; PHOTORECEPTORS; COEXPRESSION; PATHOGENESIS; ARRANGEMENT; PREVALENCE; PHENOTYPE	Background: Many disabling human retinal disorders involve the central retina, particularly the macula. However, the commonly used rodent models in research, mouse and rat, do not possess a macula. The purpose of this study was to identify small laboratory rodents with a significant central region as potential new models for macular research. Methodology/Principal Findings: Gerbillus perpallidus, Meriones unguiculatus and Phodopus campbelli, laboratory rodents less commonly used in retinal research, were subjected to confocal scanning laser ophthalmoscopy (cSLO), fluorescein and indocyanine green angiography, and spectral-domain optical coherence tomography (SD-OCT) using standard equipment (Heidelberg Engineering HRA1 and Spectralis (TM)) adapted to small rodent eyes. The existence of a visual streak-like pattern was assessed on the basis of vascular topography, retinal thickness, and the topography of retinal ganglion cells and cone photoreceptors. All three species examined showed evidence of a significant horizontal streak-like specialization. cSLO angiography and retinal wholemounts revealed that superficial retinal blood vessels typically ramify and narrow into a sparse capillary net at the border of the respective area located dorsal to the optic nerve. Similar to the macular region, there was an absence of larger blood vessels in the streak region. Furthermore, the thickness of the photoreceptor layer and the population density of neurons in the ganglion cell layer were markedly increased in the visual streak region. Conclusions/Significance: The retinal specializations of Gerbillus perpallidus, Meriones unguiculatus and Phodopus campbelli resemble features of the primate macula. Hence, the rodents reported here may serve to study aspects of macular development and diseases like age-related macular degeneration and diabetic macular edema, and the preclinical assessment of therapeutic strategies.	[Huber, Gesine; Muehlfriedel, Regine; Tanimoto, Naoyuki; Seeliger, Mathias W.; Beck, Susanne C.] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Div Ocular Neurodegenerat, Tubingen, Germany; [Heynen, Severin; Imsand, Coni; Grimm, Christian] Univ Zurich, Dept Ophthalmol, Lab Retinal Cell Biol, Zurich, Switzerland; [vom Hagen, Franziska; Feng, Yuxi; Hammes, Hans-Peter] Heidelberg Univ, Univ Med Mannheim, Dept Med 5, D-6800 Mannheim, Germany; [Peichl, Leo] Max Planck Inst Brain Res, D-60496 Frankfurt, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Zurich; Ruprecht Karls University Heidelberg; Max Planck Society	Huber, G (corresponding author), Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Div Ocular Neurodegenerat, Tubingen, Germany.	Susanne.Beck@med.uni-tuebingen.de		Grimm, Christian/0000-0001-9318-4352; Peichl, Leo/0000-0002-8141-0911	Deutsche Forschungsgemeinschaft (DFG) [Se837/5-2, Se837/6-1, Se837/7-1]; German Ministry of Education and Research (BMBF) [0314106]; European Union [EU HEALTH-F2-2008-200234, EU MEST-CT-2005-020235]; Kerstan Foundation; Swiss National Science Foundation [3100A0-117760, GRK880, Ha 1755/8-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Kerstan Foundation(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft (DFG, grants Se837/5-2, Se837/6-1, Se837/7-1), the German Ministry of Education and Research (BMBF, grant 0314106), and the European Union grants EU HEALTH-F2-2008-200234, EU MEST-CT-2005-020235, Kerstan Foundation, Swiss National Science Foundation Grant 3100A0-117760, GRK880, Ha 1755/8-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the mansucript.	Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; [Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; Bobu C, 2008, VISION RES, V48, P424, DOI 10.1016/j.visres.2007.08.011; Boudard DL, 2010, NEUROSCIENCE, V169, P1815, DOI 10.1016/j.neuroscience.2010.06.037; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; DESCHAEPDRIJVER L, 1989, RES VET SCI, V47, P34; Eppens MC, 2006, DIABETES CARE, V29, P1300, DOI 10.2337/dc05-2470; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gaillard F, 2009, INVEST OPHTH VIS SCI, V50, P5426, DOI 10.1167/iovs.09-3896; Glosmann M, 2002, BRAIN RES, V929, P139, DOI 10.1016/S0006-8993(02)02267-9; Hahn P, 2004, P NATL ACAD SCI USA, V101, P13850, DOI 10.1073/pnas.0405146101; HENKIND P, 1966, EXP EYE RES, V5, P10, DOI 10.1016/S0014-4835(66)80015-5; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Hughes A., 1985, PROGR RETINAL RES, V4, P243; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; LONG KO, 1983, J COMP NEUROL, V221, P329, DOI 10.1002/cne.902210308; Lukats A, 2005, HISTOL HISTOPATHOL, V20, P551, DOI 10.14670/HH-20.551; Lukats A, 2002, INVEST OPHTH VIS SCI, V43, P2468; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; Musser G G, 1993, MAMMAL SPECIES WORLD; Palacios AG, 2010, J COMP NEUROL, V518, P1589, DOI 10.1002/cne.22292; PEICHL L, 1992, J COMP NEUROL, V324, P603, DOI 10.1002/cne.903240412; Rakoczy PE, 2006, EXP EYE RES, V82, P741, DOI 10.1016/j.exer.2005.10.012; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Ramkumar HL, 2010, PROG RETIN EYE RES, V29, P169, DOI 10.1016/j.preteyeres.2010.02.002; RODIECK RW, 1973, VERTEBRATE RETINA PR; Samardzija M, 2006, FASEB J, V20, P2411, DOI 10.1096/fj.06-5895fje; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Singh Ajay, 2009, Int Ophthalmol Clin, V49, P1, DOI 10.1097/IIO.0b013e31819fd164; WASSLE H, 1975, J COMP NEUROL, V159, P419, DOI 10.1002/cne.901590308; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; WOLFENSBERGER TJ, 1998, RETINAL PIGMENT EPIT, P621; Yoshida T, 2005, J CLIN INVEST, V115, P2793, DOI 10.1172/JCI24635; Zeiss CJ, 2010, VET PATHOL, V47, P396, DOI 10.1177/0300985809359598	36	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13403	10.1371/journal.pone.0013403	http://dx.doi.org/10.1371/journal.pone.0013403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976212	gold, Green Published			2022-12-25	WOS:000283043700008
J	Irie, T; Bessho, K; Findlay, HS; Calosi, P				Irie, Takahiro; Bessho, Kazuhiro; Findlay, Helen S.; Calosi, Piero			Increasing Costs Due to Ocean Acidification Drives Phytoplankton to Be More Heavily Calcified: Optimal Growth Strategy of Coccolithophores	PLOS ONE			English	Article							EMILIANIA-HUXLEYI PRYMNESIOPHYCEAE; CARBON-DIOXIDE; BODY-SIZE; CALCIFICATION; CO2; SEAWATER; MODEL; CONSEQUENCES; DIVERSITY; CLIMATE	Ocean acidification is potentially one of the greatest threats to marine ecosystems and global carbon cycling. Amongst calcifying organisms, coccolithophores have received special attention because their calcite precipitation plays a significant role in alkalinity flux to the deep ocean (i.e., inorganic carbon pump). Currently, empirical effort is devoted to evaluating the plastic responses to acidification, but evolutionary considerations are missing from this approach. We thus constructed an optimality model to evaluate the evolutionary response of coccolithophorid life history, assuming that their exoskeleton (coccolith) serves to reduce the instantaneous mortality rates. Our model predicted that natural selection favors constructing more heavily calcified exoskeleton in response to increased acidification-driven costs. This counter-intuitive response occurs because the fitness benefit of choosing a better-defended, slower growth strategy in more acidic conditions, outweighs that of accelerating the cell cycle, as this occurs by producing less calcified exoskeleton. Contrary to the widely held belief, the evolutionarily optimized population can precipitate larger amounts of CaCO3 during the bloom in more acidified seawater, depending on parameter values. These findings suggest that ocean acidification may enhance the calcification rates of marine organisms as an adaptive response, possibly accompanied by higher carbon fixation ability. Our theory also provides a compelling explanation for the multispecific fossil time-series record from similar to 200 years ago to present, in which mean coccolith size has increased along with rising atmospheric CO2 concentration.	[Irie, Takahiro] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Bessho, Kazuhiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Findlay, Helen S.] Plymouth Marine Lab, Plymouth, Devon, England; [Calosi, Piero] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England	University of Amsterdam; Kyushu University; Plymouth Marine Laboratory; University of Plymouth	Irie, T (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	irie@bio-math10.biology.kyushu-u.ac.jp	Irie, Takahiro/A-3621-2012; Irie, Takahiro/AAG-4293-2020	Irie, Takahiro/0000-0001-7730-5556; Calosi, Piero/0000-0003-3378-2603	Japan Society for the Promotion of Science; Plymouth Marine Laboratory; University of Plymouth; NERC [pml010004] Funding Source: UKRI; Natural Environment Research Council [pml010004] Funding Source: researchfish	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Plymouth Marine Laboratory(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Plymouth; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Japan Society for the Promotion of Science to T. I. and K. B. This work was also undertaken while H. S. F. was in receipt of the Lord Kingsland Fellowship at the Plymouth Marine Laboratory and P. C. of a RCUK Fellowship to investigate ocean acidification at the University of Plymouth. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Balch WM, 1996, LIMNOL OCEANOGR, V41, P1669, DOI 10.4319/lo.1996.41.8.1669; Bibby R, 2007, BIOLOGY LETT, V3, P699, DOI 10.1098/rsbl.2007.0457; Brand Larry E., 1994, P39; Buitenhuis ET, 1999, J PHYCOL, V35, P949, DOI 10.1046/j.1529-8817.1999.3550949.x; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Day T, 1997, AM NAT, V149, P381, DOI 10.1086/285995; Day T, 2005, ECOLOGICAL PARADIGMS, P273, DOI DOI 10.1016/B978-012088459-9/50015-7; Delille B, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002318; DEVRINDDEJONG EW, 1994, HAPTOPHYTE ALGAE, P149; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; Engel A, 2005, LIMNOL OCEANOGR, V50, P493, DOI 10.4319/lo.2005.50.2.0493; Erez J, 2003, REV MINERAL GEOCHEM, V54, P115, DOI 10.2113/0540115; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Gibbs SJ, 2006, SCIENCE, V314, P1770, DOI 10.1126/science.1133902; Grelaud M, 2009, BIOGEOSCIENCES, V6, P2025, DOI 10.5194/bg-6-2025-2009; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Halloran PR, 2008, BIOGEOSCIENCES, V5, P1651, DOI 10.5194/bg-5-1651-2008; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; Heinze C, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020613; Houdan A, 2006, AQUAT MICROB ECOL, V44, P291, DOI 10.3354/ame044291; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Iglesias-Rodriguez MD, 2006, J PHYCOL, V42, P526; Irie T, 2005, AM NAT, V165, P238, DOI 10.1086/427157; Irie T, 2003, EVOL ECOL RES, V5, P1133; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KLEYPAS JA, 2006, WORKSH NSF NOAA US G; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Kozlowski J, 1997, AM NAT, V149, P352; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Kuroyanagi A, 2009, MAR MICROPALEONTOL, V73, P190, DOI 10.1016/j.marmicro.2009.09.003; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Lika K, 2000, J MATH BIOL, V41, P361, DOI 10.1007/s002850000049; MALONE TC, 1980, PHYSL ECOLOGY PHYTOP, P433; Marshall DJ, 2008, MAR ENVIRON RES, V66, P422, DOI 10.1016/j.marenvres.2008.07.003; Merico A, 2006, J MARINE SYST, V59, P120, DOI 10.1016/j.jmarsys.2005.11.004; METZ JAJ, 1996, WP9604 IIASA; Miles H, 2007, MAR POLLUT BULL, V54, P89, DOI 10.1016/j.marpolbul.2006.09.021; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; Ridgwell A, 2005, MAR GEOL, V217, P339, DOI 10.1016/j.margeo.2004.10.036; Ridgwell A, 2009, BIOGEOSCIENCES, V6, P2611, DOI 10.5194/bg-6-2611-2009; Ridgwell A, 2010, NAT GEOSCI, V3, P196, DOI 10.1038/NGEO755; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Roff Derek, 2002, pi; Schmidt DN, 2006, EARTH-SCI REV, V78, P239, DOI 10.1016/j.earscirev.2006.05.004; Sciandra A, 2003, MAR ECOL PROG SER, V261, P111, DOI 10.3354/meps261111; SIKES CS, 1994, PHOTOSYNTHETIC CARBO, P217; Stearns S.C., 1992, pi; The Royal Society, 2005, 1205 ROYAL SOC; Triantaphyllou M, 2010, GEOBIOS-LYON, V43, P99, DOI 10.1016/j.geobios.2009.09.002; Twitchett R.J., 2009, BIOGEOSCIENCES DISCU, V6, P2267, DOI [DOI 10.5194/BGD-6-2267-2009, 10.5194/bgd-6-2267-2009]; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Voss KJ, 1998, LIMNOL OCEANOGR, V43, P870, DOI 10.4319/lo.1998.43.5.0870; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Young Jeremy R., 1994, P63; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB; Zondervan I, 2001, GLOBAL BIOGEOCHEM CY, V15, P507, DOI 10.1029/2000GB001321; Zondervan I, 2007, DEEP-SEA RES PT II, V54, P521, DOI 10.1016/j.dsr2.2006.12.004	64	24	25	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13436	10.1371/journal.pone.0013436	http://dx.doi.org/10.1371/journal.pone.0013436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976167	Green Published, gold, Green Submitted			2022-12-25	WOS:000283043700023
J	Grigoryev, YA; Kurian, SM; Avnur, Z; Borie, D; Deng, J; Campbell, D; Sung, J; Nikolcheva, T; Quinn, A; Schulman, H; Peng, SL; Schaffer, R; Fisher, J; Mondala, T; Head, S; Flechner, SM; Kantor, AB; Marsh, C; Salomon, DR				Grigoryev, Yevgeniy A.; Kurian, Sunil M.; Avnur, Zafi; Borie, Dominic; Deng, Jun; Campbell, Daniel; Sung, Joanna; Nikolcheva, Tania; Quinn, Anthony; Schulman, Howard; Peng, Stanford L.; Schaffer, Randolph; Fisher, Jonathan; Mondala, Tony; Head, Steven; Flechner, Stuart M.; Kantor, Aaron B.; Marsh, Christopher; Salomon, Daniel R.			Deconvoluting Post-Transplant Immunity: Cell Subset-Specific Mapping Reveals Pathways for Activation and Expansion of Memory T, Monocytes and B Cells	PLOS ONE			English	Article							ANTITHYMOCYTE GLOBULIN THYMOGLOBULIN(R); RENAL-ALLOGRAFT REJECTION; LONG-TERM; PERIPHERAL-BLOOD; ISCHEMIA/REPERFUSION INJURY; KIDNEY-TRANSPLANTATION; LIVER-TRANSPLANTATION; DE-NOVO; INDUCTION; EXPRESSION	A major challenge for the field of transplantation is the lack of understanding of genomic and molecular drivers of early post-transplant immunity. The early immune response creates a complex milieu that determines the course of ensuing immune events and the ultimate outcome of the transplant. The objective of the current study was to mechanistically deconvolute the early immune response by purifying and profiling the constituent cell subsets of the peripheral blood. We employed genome-wide profiling of whole blood and purified CD4, CD8, B cells and monocytes in tandem with high-throughput laser-scanning cytometry in 10 kidney transplants sampled serially pre-transplant, 1, 2, 4, 8 and 12 weeks. Cytometry confirmed early cell subset depletion by antibody induction and immunosuppression. Multiple markers revealed the activation and proliferative expansion of CD45RO(+)CD62L(-) effector memory CD4/CD8 T cells as well as progressive activation of monocytes and B cells. Next, we mechanistically deconvoluted early post-transplant immunity by serial monitoring of whole blood using DNA microarrays. Parallel analysis of cell subset-specific gene expression revealed a unique spectrum of time-dependent changes and functional pathways. Gene expression profiling results were validated with 157 different probesets matching all 65 antigens detected by cytometry. Thus, serial blood cell monitoring reflects the profound changes in blood cell composition and immune activation early post-transplant. Each cell subset reveals distinct pathways and functional programs. These changes illuminate a complex, early phase of immunity and inflammation that includes activation and proliferative expansion of the memory effector and regulatory cells that may determine the phenotype and outcome of the kidney transplant.	[Grigoryev, Yevgeniy A.; Campbell, Daniel; Mondala, Tony; Head, Steven] Scripps Res Inst, DNA Microarray Core Facil, La Jolla, CA 92037 USA; [Deng, Jun; Schulman, Howard; Kantor, Aaron B.] Pharmaceut Product Dev PPD, Biomarker Discovery Sci, Menlo Pk, CA USA; [Sung, Joanna; Schaffer, Randolph; Fisher, Jonathan; Marsh, Christopher; Salomon, Daniel R.] Scripps Ctr Organ & Cell Transplantat, La Jolla, CA USA; [Avnur, Zafi; Borie, Dominic; Nikolcheva, Tania; Quinn, Anthony; Peng, Stanford L.] Roche, Palo Alto, CA USA; [Flechner, Stuart M.] Cleveland Clin, Glickman Urol Inst, Cleveland, OH 44106 USA	Scripps Research Institute; Scripps Research Institute; Roche Holding; Cleveland Clinic Foundation	Grigoryev, YA (corresponding author), Scripps Res Inst, DNA Microarray Core Facil, La Jolla, CA 92037 USA.	dsalomon@scripps.edu	Peng, Stanford/S-6723-2019; Schaffer, Randolph/S-7432-2019; Salomon, Daniel/E-9380-2012; Kurian, Sunil/C-4493-2008	Kurian, Sunil/0000-0002-7782-7263; Marsh, Christopher/0000-0002-6517-076X	NIH [U19 AI063603]; Molly Baber Research Fund; Verna Harrah Research Fund; Roche Pharmaceuticals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI063603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molly Baber Research Fund; Verna Harrah Research Fund; Roche Pharmaceuticals(Roche Holding); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH U19 AI063603, Molly Baber Research Fund, Verna Harrah Research Fund, service work for high throughput flow cytometry and data analysis by Pharmaceutical Product Development Inc. (PPD) and an unrestricted research grant from Roche Pharmaceuticals. Roche and PPD were involved in the study design as a scientific collaboration and involved in the first half of the data collection and analysis that was performed during the period covered by their unrestricted educational grant. Roche and PPD were not involved in the next stage, where the second half of the samples were analyzed and in all the subsequent data analysis, genomic pathway mapping, final decision to publish, and preparation of the manuscript. The Roche and PPD authors as listed, however, were treated as scientific collaborators and were provided a full copy of the submitted manuscript for their review and approval prior to submission.	Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bloom DD, 2008, AM J TRANSPLANT, V8, P793, DOI 10.1111/j.1600-6143.2007.02134.x; Boros P, 2006, AM J TRANSPLANT, V6, P652, DOI 10.1111/j.1600-6143.2005.01228.x; Chapman JR, 2010, TRANSPLANTATION, V89, P644, DOI 10.1097/TP.0b013e3181d62f1b; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Deeks ED, 2009, DRUGS, V69, P1483, DOI 10.2165/00003495-200969110-00007; Dietz LJ, 1996, CYTOMETRY, V23, P177; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esposito L, 2005, TRANSPL P, V37, P785, DOI 10.1016/j.transproceed.2004.12.200; Flechner SM, 2004, AM J TRANSPLANT, V4, P1475, DOI 10.1111/j.1600-6143.2004.00526.x; Flechner SM, 2004, AM J TRANSPLANT, V4, P1776, DOI 10.1111/j.1600-6143.2004.00627.x; Fox DA, 2001, IMMUNOL INVEST, V30, P67, DOI 10.1081/IMM-100104017; Gaber AO, 2010, DRUGS, V70, P691, DOI 10.2165/11315940-000000000-00000; Gould SJ, 2004, Q REV BIOL, V79, P359, DOI 10.1086/426088; Grigoryev DN, 2006, TRANSPLANT P, V38, P3333, DOI 10.1016/j.transproceed.2006.10.129; Gunther OP, 2009, TRANSPLANTATION, V88, P942, DOI 10.1097/TP.0b013e3181b7ccc6; Hale DA, 2004, CURR OPIN IMMUNOL, V16, P565, DOI 10.1016/j.coi.2004.07.005; Heidenhain C, 2009, ANN TRANSPL, V14, P36; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Kamoun M, 2006, THER DRUG MONIT, V28, P14, DOI 10.1097/01.ftd.0000194499.32398.32; Kantor AB, 2007, J NEUROIMMUNOL, V188, P103, DOI 10.1016/j.jneuroim.2007.05.009; Kantor AB, 2004, BIOTECHNIQUES, V36, P520, DOI 10.2144/04363PF01; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; Kurian SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006212; LANIER LL, 1995, J IMMUNOL, V154, P97; Lopez M, 2006, J AM SOC NEPHROL, V17, P2844, DOI 10.1681/ASN.2006050422; Louis S, 2007, TRANSPLANTATION, V83, P712, DOI 10.1097/01.tp.0000255683.66156.d3; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Neujahr DC, 2006, J IMMUNOL, V176, P4632, DOI 10.4049/jimmunol.176.8.4632; Noris M, 2009, J IMMUNOL, V183, P4249, DOI 10.4049/jimmunol.0803549; Oertel M, 2002, TRANSPL INT, V15, P463, DOI 10.1111/j.1432-2277.2002.tb00201.x; Perco P, 2007, TRANSPL INT, V20, P2, DOI 10.1111/j.1432-2277.2006.00376.x; Ramsey C, 2008, J IMMUNOL, V180, P5320, DOI 10.4049/jimmunol.180.8.5320; Rush D, 1998, J AM SOC NEPHROL, V9, P2129; Serban G, 2009, HUM IMMUNOL, V70, P882, DOI 10.1016/j.humimm.2009.07.027; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Trieb K, 1998, PATHOL RES PRACT, V194, P679, DOI 10.1016/S0344-0338(98)80126-X; Trivedi HL, 2007, TRANSPL P, V39, P647, DOI 10.1016/j.transproceed.2007.01.047; Woodroffe R, 2005, HEALTH TECHNOL ASSES, V9, P1	42	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13358	10.1371/journal.pone.0013358	http://dx.doi.org/10.1371/journal.pone.0013358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976225	Green Published, Green Submitted, gold			2022-12-25	WOS:000282941000009
J	Grigg, O; Grady, CL				Grigg, Omer; Grady, Cheryl L.			Task-Related Effects on the Temporal and Spatial Dynamics of Resting-State Functional Connectivity in the Default Network	PLOS ONE			English	Article							BOLD SIGNAL FLUCTUATIONS; PARTIAL LEAST-SQUARES; HUMAN BRAIN; MODE NETWORK; ALZHEIMERS-DISEASE; CEREBRAL-CORTEX; GLOBAL SIGNAL; BASE-LINE; FMRI; HYPOTHESIS	Recent evidence points to two potentially fundamental aspects of the default network (DN), which have been relatively understudied. One is the temporal nature of the functional interactions among nodes of the network in the resting-state, usually assumed to be static. The second is possible influences of previous brain states on the spatial patterns (i.e., the brain regions involved) of functional connectivity (FC) in the DN at rest. The goal of the current study was to investigate modulations in both the spatial and temporal domains. We compared the resting-state FC of the DN in two runs that were separated by a 45 minute interval containing cognitive task execution. We used partial least squares (PLS), which allowed us to identify FC spatiotemporal patterns in the two runs and to determine differences between them. Our results revealed two primary modes of FC, assessed using a posterior cingulate seed - a robust correlation among DN regions that is stable both spatially and temporally, and a second pattern that is reduced in spatial extent and more variable temporally after cognitive tasks, showing switching between connectivity with certain DN regions and connectivity with other areas, including some task-related regions. Therefore, the DN seems to exhibit two simultaneous FC dynamics at rest. The first is spatially invariant and insensitive to previous brain states, suggesting that the DN maintains some temporally stable functional connections. The second dynamic is more variable and is seen more strongly when the resting-state follows a period of task execution, suggesting an after-effect of the cognitive activity engaged during task that carries over into resting-state periods.	[Grigg, Omer; Grady, Cheryl L.] Rotman Res Inst Baycrest, Toronto, ON, Canada; [Grady, Cheryl L.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Grady, Cheryl L.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto	Grigg, O (corresponding author), Rotman Res Inst Baycrest, Toronto, ON, Canada.	OGrigg@Rotman-Baycrest.on.ca		Orringer, Daniel/0000-0001-6427-8376	Canadian Institutes of Health Research [MOP14036]; Canada Research Chairs; Ontario Research Fund; Canadian Foundation for Innovation; Heart and Stroke Foundation Centre for Stroke Recovery	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs(Canada Research ChairsCGIAR); Ontario Research Fund; Canadian Foundation for Innovation(Canada Foundation for Innovation); Heart and Stroke Foundation Centre for Stroke Recovery(Heart & Stroke Foundation of Canada)	This work was supported by the Canadian Institutes of Health Research (MOP14036 to CLG), the Canada Research Chairs program, the Ontario Research Fund, the Canadian Foundation for Innovation, and the Heart and Stroke Foundation Centre for Stroke Recovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006626; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; GRIGG O, 2010, NEUROPSYCHO IN PRESS; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Lin FH, 2003, NEUROIMAGE, V20, P625, DOI 10.1016/S1053-8119(03)00333-1; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mai JK, 2004, ATLAS HUMAN BRAIN; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McIntosh AR, 1999, MEMORY, V7, P523, DOI 10.1080/096582199387733; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; McIntosh AR, 2004, NEUROINFORMATICS, V2, P175, DOI 10.1385/NI:2:2:175; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Stevens WD, 2010, CEREB CORTEX, V20, P1997, DOI 10.1093/cercor/bhp270; STEVENS WD, 2009, CEREB CORTEX; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	50	92	92	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13311	10.1371/journal.pone.0013311	http://dx.doi.org/10.1371/journal.pone.0013311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663FZ	20967203	Green Published, gold, Green Submitted			2022-12-25	WOS:000282869800016
J	Huang, QX; Cheng, XY; Mao, ZC; Wang, YS; Zhao, LL; Yan, X; Ferris, VR; Xu, RM; Xie, BY				Huang, Qi-Xing; Cheng, Xin-Yue; Mao, Zhen-Chuan; Wang, Yun-Sheng; Zhao, Li-Lin; Yan, Xia; Ferris, Virginia R.; Xu, Ru-Mei; Xie, Bing-Yan			MicroRNA Discovery and Analysis of Pinewood Nematode Bursaphelenchus xylophilus by Deep Sequencing	PLOS ONE			English	Article							MONOCHAMUS-CAROLINENSIS; ANIMAL DEVELOPMENT; C-ELEGANS; EXPRESSION; EVOLUTION; PATHWAYS; 21U-RNAS; ENCODES; COMPLEX; SPREAD	Background: MicroRNAs (miRNAs) are considered to be very important in regulating the growth, development, behavior and stress response in animals and plants in post-transcriptional gene regulation. Pinewood nematode, Bursaphelenchus xylophilus, is an important invasive plant parasitic nematode in Asia. To have a comprehensive knowledge about miRNAs of the nematode is necessary for further in-depth study on roles of miRNAs in the ecological adaptation of the invasive species. Methods and Findings: Five small RNA libraries were constructed and sequenced by Illumina/Solexa deep-sequencing technology. A total of 810 miRNA candidates (49 conserved and 761 novel) were predicted by a computational pipeline, of which 57 miRNAs (20 conserved and 37 novel) encoded by 53 miRNA precursors were identified by experimental methods. Ten novel miRNAs were considered to be species-specific miRNAs of B. xylophilus. Comparison of expression profiles of miRNAs in the five small RNA libraries showed that many miRNAs exhibited obviously different expression levels in the third-stage dispersal juvenile and at a cold-stressed status. Most of the miRNAs exhibited obviously down-regulated expression in the dispersal stage. But differences among the three geographic libraries were not prominent. A total of 979 genes were predicted to be targets of these authentic miRNAs. Among them, seven heat shock protein genes were targeted by 14 miRNAs, and six FMRFamide-like neuropeptides genes were targeted by 17 miRNAs. A real-time quantitative polymerase chain reaction was used to quantify the mRNA expression levels of target genes. Conclusions: Basing on the fact that a negative correlation existed between the expression profiles of miRNAs and the mRNA expression profiles of their target genes (hsp, flp) by comparing those of the nematodes at a cold stressed status and a normal status, we suggested that miRNAs might participate in ecological adaptation and behavior regulation of the nematode. This is the first description of miRNAs in plant parasitic nematodes. The results provide a useful resource for further in-depth study on molecular regulation and evolution of miRNAs in plant parasitic nematodes.	[Huang, Qi-Xing; Cheng, Xin-Yue; Yan, Xia; Xu, Ru-Mei] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Huang, Qi-Xing; Mao, Zhen-Chuan; Wang, Yun-Sheng; Xie, Bing-Yan] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China; [Wang, Yun-Sheng] Hunan Agr Univ, Hunan Prov Key Lab Crop Germplasm Innovat & Utili, Changsha, Hunan, Peoples R China; [Zhao, Li-Lin] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Ferris, Virginia R.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	Beijing Normal University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Hunan Agricultural University; Chinese Academy of Sciences; Institute of Zoology, CAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Huang, QX (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China.	xiebingyan2003@yahoo.com.cn		Wang, Yunsheng/0000-0001-5003-4434	National Basic Research and Development Program [2009CB119200]; National Natural Science Foundation of China [30570288]	National Basic Research and Development Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Basic Research and Development Program (No. 2009CB119200), the National Natural Science Foundation of China (No. 30570288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BOLLA RI, 1993, J NEMATOL, V25, P227; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cheng XY, 2008, HEREDITY, V100, P356, DOI 10.1038/sj.hdy.6801082; de Wit E, 2009, GENOME RES, V19, P2064, DOI 10.1101/gr.093781.109; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Ibanez-Ventoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002818; Iovino N, 2009, DEV CELL, V17, P123, DOI 10.1016/j.devcel.2009.06.008; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kang JS, 2009, GENOMICS, V94, P70, DOI 10.1016/j.ygeno.2009.03.001; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kimber MJ, 2007, FASEB J, V21, P1233, DOI 10.1096/fj.06-7343com; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LI HM, 2008, THESIS GHENT U GHENT; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Liu TW, 2007, J NEUROSCI, V27, P7174, DOI 10.1523/JNEUROSCI.1405-07.2007; Necibi S, 1998, J NEMATOL, V30, P246; Parkinson J, 2004, NUCLEIC ACIDS RES, V32, pD427, DOI 10.1093/nar/gkh018; Pasiecznik N. M., 2005, Bulletin OEPP, V35, P1, DOI 10.1111/j.1365-2338.2005.00815.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poole CB, 2010, MOL BIOCHEM PARASIT, V169, P87, DOI 10.1016/j.molbiopara.2009.10.004; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; *SPSS INC, 2003, SPSS WIND; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P438; WARREN JE, 1993, J NEMATOL, V25, P703; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WINGFIELD MJ, 1983, EUR J FOREST PATHOL, V13, P360; Xie BY, 2009, SCI CHINA SER C, V52, P587, DOI 10.1007/s11427-009-0071-y; Yang, 2003, PINE WILT DIS; Zhao BG., 2008, PINE WILT DIS; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	59	29	33	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13271	10.1371/journal.pone.0013271	http://dx.doi.org/10.1371/journal.pone.0013271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967259	Green Published, gold, Green Submitted			2022-12-25	WOS:000282807300013
J	Shen, H; Harris, G; Chen, WX; Sjostedt, A; Ryden, P; Conlan, W				Shen, Hua; Harris, Gregory; Chen, Wangxue; Sjostedt, Anders; Ryden, Patrik; Conlan, Wayne			Molecular Immune Responses to Aerosol Challenge with Francisella tularensis in Mice Inoculated with Live Vaccine Candidates of Varying Efficacy	PLOS ONE			English	Article							DELTA-T-CELLS; INTERFERON-GAMMA; PROTECTIVE IMMUNITY; TULAREMIA VACCINE; RESPIRATORY CHALLENGE; NATURAL INFECTION; IL-17 PRODUCTION; STRAIN; PATHOGEN; IMMUNIZATION	Background: Francisella tularensis is a facultative intracellular bacterial pathogen and the etiological agent of tularemia. The subspecies F. tularensis tularensis is especially virulent for humans when inhaled and respiratory tularemia is associated with high mortality if not promptly treated. A live vaccine strain (LVS) derived from the less virulent holarctica subspecies confers incomplete protection against aerosol challenge with subsp. tularensis. Moreover, correlates of protection have not been established for LVS. Methodology/Principal Findings: In the present study we compare molecular immune responses elicited by LVS and two defined deletion mutants of clinical subsp. tularensis strain, SCHU S4, that confer enhanced protection in a mouse model. BALB/c mice were immunized intradermally then challenged with an aerosol of SCHU S4 six weeks later. Changes in the levels of a selected panel of cytokines and chemokines were examined in the lungs, spleens, and sera of vaccinated and challenged mice. Mostly, increased cytokine and chemokine levels correlated with increased bacterial burden. However, after adjusting for this variable, immunization with either of the two Schu S4 mutants resulted in higher levels of several pulmonary cytokines, versus those resulting after LVS immunization, including IL-17. Moreover, treatment of mice immunized with Delta clpB with anti-IL-17 antibodies post-challenge enhanced lung infection. Conclusions/Significance: This is the first report characterizing local and systemic cytokine and chemokine responses in mice immunized with vaccines with different efficacies against aerosol challenge with virulent F. tularensis subsp. tularensis. It shows that increases in the levels of most of these immunomodulators, including those known to be critical for protective immunity, do not superficially correlate with protection unless adjusted for the effects of bacterial burden. Additionally, several cytokines were selectively suppressed in the lungs of naive mice, suggesting that one mechanism of vaccine action is to overcome this pathogen-induced immunosuppression.	[Shen, Hua; Harris, Gregory; Chen, Wangxue; Conlan, Wayne] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Sjostedt, Anders] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Ryden, Patrik] Umea Univ, Dept Stat, Computat Life Sci Cluster, Dept Math & Math Stat,Dept Stat, Umea, Sweden	National Research Council Canada; Umea University; Umea University	Shen, H (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	wayne.conlan@nrc-cnrc.gc.ca	Rydén, Patrik/I-4201-2016; Sjöstedt, Anders/AAC-6575-2020	Rydén, Patrik/0000-0002-0577-123X; Sjöstedt, Anders/0000-0002-0768-8405	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [AI60689]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060689] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under grant No. AI60689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Chen WX, 2004, MICROB PATHOGENESIS, V36, P311, DOI 10.1016/j.micpath.2004.02.003; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Conlan JW, 2008, MOL IMMUNOL, V45, P2962, DOI 10.1016/j.molimm.2008.01.022; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; ERICSSON M, 1994, J INFECT DIS, V170, P110, DOI 10.1093/infdis/170.1.110; Fuller CL, 2006, J ALLERGY CLIN IMMUN, V117, P1186, DOI 10.1016/j.jaci.2006.01.044; Fuller CL, 2007, MOL IMMUNOL, V44, P3173, DOI 10.1016/j.molimm.2007.01.037; Green M, 2005, VACCINE, V23, P2680, DOI 10.1016/j.vaccine.2004.03.071; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; KARTTUNEN R, 1987, J CLIN MICROBIOL, V25, P1074, DOI 10.1128/JCM.25.6.1074-1078.1987; Kelchtermans H, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2787; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Markel G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011176; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; McMurry JA, 2007, VACCINE, V25, P3179, DOI 10.1016/j.vaccine.2007.01.039; Paranavitana C, 2010, J INTERF CYTOK RES, V30, P471, DOI 10.1089/jir.2009.0108; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Salerno-Goncalves R, 2009, VACCINE, V28, P195, DOI 10.1016/j.vaccine.2009.09.100; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, AM J MED SCI, V241, P689, DOI 10.1097/00000441-196106000-00001; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; SJOSTEDT A, 1992, IMMUNOLOGY, V76, P584; Sjostedt A, 1996, MICROBIOL-UK, V142, P1369, DOI 10.1099/13500872-142-6-1369; SJOSTEDT A, 1994, INFECT IMMUN, V62, P2779; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; TARNVIK A, 1989, REV INFECT DIS, V11, P440; Velin D, 2009, GASTROENTEROLOGY, V136, P2237, DOI 10.1053/j.gastro.2009.02.077; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07; Wu TH, 2009, VACCINE, V27, P4684, DOI 10.1016/j.vaccine.2009.05.060; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075	40	48	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13349	10.1371/journal.pone.0013349	http://dx.doi.org/10.1371/journal.pone.0013349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967278	gold, Green Published, Green Submitted			2022-12-25	WOS:000282807300027
J	Groussard, M; La Joie, R; Rauchs, G; Landeau, B; Chetelat, G; Viader, F; Desgranges, B; Eustache, F; Platel, H				Groussard, Mathilde; La Joie, Renaud; Rauchs, Geraldine; Landeau, Brigitte; Chetelat, Gael; Viader, Fausto; Desgranges, Beatrice; Eustache, Francis; Platel, Herve			When Music and Long-Term Memory Interact: Effects of Musical Expertise on Functional and Structural Plasticity in the Hippocampus	PLOS ONE			English	Article							EPISODIC MEMORY; SEMANTIC MEMORY; GREY-MATTER; BRAIN; ACTIVATION; FMRI; PERFORMANCE; FAMILIARITY; RETRIEVAL; IMAGERY		[Groussard, Mathilde; La Joie, Renaud; Rauchs, Geraldine; Landeau, Brigitte; Chetelat, Gael; Viader, Fausto; Desgranges, Beatrice; Eustache, Francis; Platel, Herve] Univ Caen Basse Normandie, CHU Cote Nacre, GIP Cyceron, U923,EPHE,Inserm, Caen, France; [Viader, Fausto] CHU Cote Nacre, Dept Neurol, Caen, France	CHU de Caen NORMANDIE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Groussard, M (corresponding author), Univ Caen Basse Normandie, CHU Cote Nacre, GIP Cyceron, U923,EPHE,Inserm, Caen, France.	herve.platel@unicaen.fr	Chetelat, Gael/G-2316-2015; Desgranges, Béatrice/L-7739-2015; RAUCHS, Géraldine/L-7921-2015; Eustache, Francis/J-9465-2015; DESGRANGES, BEATRICE/AAK-4756-2021; Platel, Herve/L-8468-2015; La Joie, Renaud/AAC-8569-2021; Groussard, Mathilde/L-7923-2015	RAUCHS, Géraldine/0000-0001-7128-2189; Eustache, Francis/0000-0003-4460-8686; DESGRANGES, BEATRICE/0000-0002-3657-9996; Platel, Herve/0000-0003-1576-0398; La Joie, Renaud/0000-0003-2581-8100; Gael, Chetelat/0000-0002-4889-7932; GROUSSARD, Mathilde/0000-0002-6749-8611				Altenmueller E, 2008, CLIN MED, V8, P410, DOI 10.7861/clinmedicine.8-4-410; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BAILEY DL, 1991, EUR J NUCL MED, V18, P374, DOI 10.1007/BF02258426; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Burianova H, 2010, NEUROIMAGE, V49, P865, DOI 10.1016/j.neuroimage.2009.08.066; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eustache F, 2008, NEUROPSYCHOL REV, V18, P53, DOI 10.1007/s11065-008-9052-3; Gaser C, 2003, J NEUROSCI, V23, P9240; Gilboa A, 2004, NEUROPSYCHOLOGIA, V42, P1336, DOI 10.1016/j.neuropsychologia.2004.02.014; Groussard M, 2010, NEUROIMAGE, V49, P2764, DOI 10.1016/j.neuroimage.2009.10.039; Hackert VH, 2002, NEUROIMAGE, V17, P1365, DOI 10.1006/nimg.2002.1248; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Herdener M, 2010, J NEUROSCI, V30, P1377, DOI 10.1523/JNEUROSCI.4513-09.2010; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Imfeld A, 2009, NEUROIMAGE, V46, P600, DOI 10.1016/j.neuroimage.2009.02.025; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Janata P, 2009, CEREB CORTEX, V19, P2579, DOI 10.1093/cercor/bhp008; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Luders E, 2004, NEUROIMAGE, V22, P656, DOI 10.1016/j.neuroimage.2004.01.032; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Meister IG, 2004, COGNITIVE BRAIN RES, V19, P219, DOI 10.1016/j.cogbrainres.2003.12.005; MILNER B, 1962, INTERHEMISPHER RELAT, P177; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Peretz I, 2009, ANN NY ACAD SCI, V1169, P256, DOI 10.1111/j.1749-6632.2009.04557.x; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Plailly J, 2007, CEREB CORTEX, V17, P2650, DOI 10.1093/cercor/bhl173; Platel H, 2003, NEUROIMAGE, V20, P244, DOI 10.1016/S1053-8119(03)00287-8; POLINE JB, 1995, J COMPUT ASSIST TOMO, V19, P788, DOI 10.1097/00004728-199509000-00017; Richardson MP, 1997, BRAIN, V120, P1961, DOI 10.1093/brain/120.11.1961; Ryan L, 2008, NEUROPSYCHOLOGIA, V46, P2109, DOI 10.1016/j.neuropsychologia.2008.02.030; Satoh M, 2006, AM J NEURORADIOL, V27, P1101; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schmidt-Wilcke T, 2009, NEUROIMAGE, V47, P1914, DOI 10.1016/j.neuroimage.2009.04.092; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; SCHOENFELD AH, 1982, J EXP PSYCHOL LEARN, V8, P484, DOI 10.1037/0278-7393.8.5.484; Seung Y, 2005, NEUROSCI RES, V52, P323, DOI 10.1016/j.neures.2005.04.011; Skinner EI, 2007, NEUROPSYCHOLOGIA, V45, P2163, DOI 10.1016/j.neuropsychologia.2007.03.007; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tervaniemi M, 2009, ANN NY ACAD SCI, V1169, P151, DOI 10.1111/j.1749-6632.2009.04591.x; Tulving E., 1972, ORG MEMORY, P382, DOI DOI 10.1007/978-1-4419-0463-8_37; Van Laere KJ, 2001, RADIOLOGY, V221, P810, DOI 10.1148/radiol.2213010295; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; VILLAIN V, 2010, J NEUROIMAGING, DOI DOI 10.1111/J.1552-6569.2010.00470.X; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Westmacott R, 2004, NEUROPSYCHOLOGIA, V42, P25, DOI 10.1016/S0028-3932(03)00147-7; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172	61	83	87	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13225	10.1371/journal.pone.0013225	http://dx.doi.org/10.1371/journal.pone.0013225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	658RC	20957158	Green Submitted, Green Published, gold			2022-12-25	WOS:000282506100017
J	Arankalle, VA; Lole, KS; Arya, RP; Tripathy, AS; Ramdasi, AY; Chadha, MS; Sangle, SA; Kadam, DB				Arankalle, Vidya A.; Lole, Kavita S.; Arya, Ravi P.; Tripathy, Anuradha S.; Ramdasi, Ashwini Y.; Chadha, Mandeep S.; Sangle, Shashi A.; Kadam, Deelip B.			Role of Host Immune Response and Viral Load in the Differential Outcome of Pandemic H1N1 (2009) Influenza Virus Infection in Indian Patients	PLOS ONE			English	Article							EXPRESSION; INNATE; IL-10	Background: An unusually high number of severe pneumonia cases with considerable mortality is being observed with the pandemic H1N1 2009 virus infections globally. In India, all mild as well as critically ill cases were admitted and treated in the government hospitals during the initial phase of the pandemic. The present study was undertaken during this early phase of the pandemic. Methodology: The role of viral load and host factors in the pathogenesis were assessed by examining 26 mild (MP), 15 critically ill patients (CIP) and 20 healthy controls from Pune, India. Sequential blood and lung aspirate samples were collected from CIP. Viral load and cytokines/chemokine levels were determined from the plasma and lung aspirates of the patients. TLR levels were determined by staining and FACS analysis. Gene profiling was done for both cells in the lung aspirates and PBMCs using TaqMan Low Density arrays. Antibody titres and isotyping was done using HA protein based ELISAs. Principal Findings: 13/15 critically ill patients expired. All plasma samples were negative for the virus irrespective of the patient's category. Sequential lung samples from CIP showed lower viral loads questioning association of viral replication with the severity. Anti-rpH1N1-09-HA-IgG titres were significantly higher in critically ill patients and both categories circulated exclusively IgG1 isotype. Critically ill patients exhibited increase in TLR-3, 4, 7 and decrease in TLR-2 expressions. The disease severity correlated with increased plasma levels of IL1RA, IL2, IL6, CCL3, CCL4 and IL10. Majority of the immune-function genes were down-regulated in the PBMCs and up-regulated in the cells from lung aspirates of critically ill patients. No distinct pattern differentiating fatal and surviving patients was observed when sequential samples were examined for various parameters. Conclusions: Disease severity was associated with pronounced impairment of host immune response.	[Arankalle, Vidya A.; Lole, Kavita S.; Arya, Ravi P.; Tripathy, Anuradha S.; Ramdasi, Ashwini Y.; Chadha, Mandeep S.] Natl Inst Virol, Pune, Maharashtra, India; [Sangle, Shashi A.; Kadam, Deelip B.] Sassoon Gen Hosp, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Arankalle, VA (corresponding author), Natl Inst Virol, Pune, Maharashtra, India.	varankalle@yahoo.com	ARYA, RAVI/F-7684-2015; ARYA, RAVI/AAF-4108-2020	ARYA, RAVI/0000-0001-9255-610X; ARYA, RAVI/0000-0001-9255-610X; Arankalle, Vidya/0000-0002-9940-3437	Indian Council of Medical Research	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research, www.icmr.org.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARANKALLE VA, 2010, CLIN VACCINE IM 0714; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P431; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Deng R, 2008, J PATHOL, V216, P328, DOI 10.1002/path.2417; Deshmukh TM, 2007, VACCINE, V25, P4350, DOI 10.1016/j.vaccine.2007.03.040; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; KATZE MG, 1984, MOL CELL BIOL, V4, P2198, DOI 10.1128/MCB.4.10.2198; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; QIU Y, 1994, J VIROL, V68, P2425, DOI 10.1128/JVI.68.4.2425-2432.1994; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785	27	54	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13099	10.1371/journal.pone.0013099	http://dx.doi.org/10.1371/journal.pone.0013099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957032	Green Published, Green Submitted, gold			2022-12-25	WOS:000282359300007
J	Burke, SP; Smith, JB				Burke, Stephen P.; Smith, Jeffrey B.			Monomerization of Cytosolic Mature Smac Attenuates Interaction with IAPs and Potentiation of Caspase Activation	PLOS ONE			English	Article							X-LINKED INHIBITOR; UBIQUITIN-PROTEIN LIGASE; STRUCTURAL BASIS; APOPTOSIS; SMAC/DIABLO; DEGRADATION; PROMOTES; BINDING; XIAP; REAPER	The four residues at the amino-terminus of mature Smac/DIABLO are an IAP binding motif (IBM). Upon exit from mitochondria, mature Smac interacts with inhibitor of apoptosis proteins (IAPs), abrogating caspase inhibition. We used the ubiquitin fusion model to express mature Smac in the cytosol. Transiently expressed mature Smac56-239 (called Smac56) and Smac60-239 (called Smac60), which lacks the IBM, interacted with X-linked inhibitor of apoptosis protein (XIAP). However, stable expression produced wild type Smac56 that failed to homodimerize, interact with XIAP, and potentiate caspase activation. Cytosolic Smac60 retained these functions. Cytosolic Smac56 apparently becomes posttranslationally modified at the dimer interface region, which obliterated the epitope for a monoclonal antibody. Cytosolic Smac delta, which has the IBM but lacks amino acids 62-105, homodimerized and weakly interacted with XIAP, but failed to potentiate apoptosis. These findings suggest that the IBM of Smac is a recognition point for a posttranslational modification(s) that blocks homodimerization and IAP interaction, and that amino acids 62-105 are required for the proapoptotic function of Smac.	[Burke, Stephen P.; Smith, Jeffrey B.] Univ Alabama Birmingham, Sch Med & Dent, Dept Pharmacol & Toxicol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Burke, SP (corresponding author), Univ Alabama Birmingham, Sch Med & Dent, Dept Pharmacol & Toxicol, Birmingham, AL USA.	jeff.smith@ccc.uab.edu		Burke, Stephen/0000-0002-8489-6953	National Institutes of Health [GM60383]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM60383 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Burke SP, 2010, J BIOL CHEM, V285, P30061, DOI 10.1074/jbc.M110.125955; Burri L, 2005, MOL BIOL CELL, V16, P2926, DOI 10.1091/mbc.E04-12-1086; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chen L, 2003, MOL PHARMACOL, V64, P334, DOI 10.1124/mol.64.2.334; Claveria C, 2002, EMBO J, V21, P3327, DOI 10.1093/emboj/cdf354; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eckelman BP, 2008, CELL DEATH DIFFER, V15, P920, DOI 10.1038/cdd.2008.6; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Fu J, 2003, J BIOL CHEM, V278, P52660, DOI 10.1074/jbc.M308036200; Goncalves RB, 2008, BIOCHEMISTRY-US, V47, P3832, DOI 10.1021/bi702248n; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang HK, 2000, J BIOL CHEM, V275, P26661; Huang YH, 2003, J BIOL CHEM, V278, P49517, DOI 10.1074/jbc.M310061200; Hunter AM, 2003, J BIOL CHEM, V278, P7494, DOI 10.1074/jbc.C200695200; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Ma L, 2006, CELL DEATH DIFFER, V13, P2079, DOI 10.1038/sj.cdd.4401959; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; Olson MR, 2003, J BIOL CHEM, V278, P44758, DOI 10.1074/jbc.M308055200; Park BD, 2007, BIOCHEM BIOPH RES CO, V361, P994, DOI 10.1016/j.bbrc.2007.07.121; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Roberts DL, 2001, J CELL BIOL, V153, P221, DOI 10.1083/jcb.153.1.221; Sambrook J, 2001, MOL CLONING LAB MANU; Shin H, 2003, BIOCHEM J, V373, P965, DOI 10.1042/BJ20030583; Silke J, 2004, J BIOL CHEM, V279, P4313, DOI 10.1074/jbc.M305661200; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	44	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13094	10.1371/journal.pone.0013094	http://dx.doi.org/10.1371/journal.pone.0013094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957035	gold, Green Published, Green Submitted			2022-12-25	WOS:000282359300005
J	Gnidehou, S; Jessen, L; Gangnard, S; Ermont, C; Triqui, C; Quiviger, M; Guitard, J; Lund, O; Deloron, P; Ndam, NT				Gnidehou, Sedami; Jessen, Leon; Gangnard, Stephane; Ermont, Caroline; Triqui, Choukri; Quiviger, Mickael; Guitard, Juliette; Lund, Ole; Deloron, Philippe; Ndam, Nicaise Tuikue			Insight into Antigenic Diversity of VAR2CSA-DBL5 epsilon Domain from Multiple Plasmodium falciparum Placental Isolates	PLOS ONE			English	Article							PREGNANCY-ASSOCIATED MALARIA; CHONDROITIN SULFATE-A; CSA-BINDING PARASITES; INFECTED ERYTHROCYTES; VAR GENE; VAR2CSA; ADHESION; ANTIBODIES; PFEMP1; WOMEN	Background: Protection against pregnancy associated malaria (PAM) is associated with high levels of anti-VAR2CSA antibodies. This protection is obtained by the parity dependent acquisition of anti-VAR2CSA antibodies. Distinct parity-associated molecular signatures have been identified in VAR2CSA domains. These two observations combined point to the importance of identifying VAR2CSA sequence variation, which facilitate parasitic evasion or subversion of host immune response. Highly conserved domains of VAR2CSA such as DBL5e are likely to contain conserved epitopes, and therefore do constitute attractive targets for vaccine development. Methodology/Principal Findings: VAR2CSA DBL5e-domain sequences obtained from cDNA of 40 placental isolates were analysed by a combination of experimental and in silico methods. Competition ELISA assays on two DBL5e variants, using plasma samples from women from two different areas and specific mice hyperimmune plasma, indicated that DBL5e possess conserved and cross-reactive B cell epitopes. Peptide ELISA identified conserved areas that are recognised by naturally acquired antibodies. Specific antibodies against these peptides labelled the native proteins on the surface of placental parasites. Despite high DBL5e sequence homology among parasite isolates, sequence analyses identified motifs in DBL5e that discriminate parasites according to donor's parity. Moreover, recombinant proteins of two VAR2CSA DBL5e variants displayed diverse recognition patterns by plasma from malaria-exposed women, and diverse proteoglycan binding abilities. Conclusions/Significance: This study provides insights into conserved and exposed B cell epitopes in DBL5e that might be a focus for cross reactivity. The importance of sequence variation in VAR2CSA as a critical challenge for vaccine development is highlighted. VAR2CSA conformation seems to be essential to its functionality. Therefore, identification of sequence variation sites in distinct locations within VAR2CSA, affecting antigenicity and/or binding properties, is critical to the effort of developing an efficient VAR2CSA-based vaccine. Motifs associated with parasite segregation according to parity constitute one such site.	[Gnidehou, Sedami; Ermont, Caroline; Triqui, Choukri; Quiviger, Mickael; Guitard, Juliette; Deloron, Philippe; Ndam, Nicaise Tuikue] Inst Rech Dev, IRD UMR 216, Paris, France; [Jessen, Leon; Lund, Ole] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Gnidehou, Sedami; Ermont, Caroline; Triqui, Choukri; Quiviger, Mickael; Guitard, Juliette; Deloron, Philippe] Univ Paris 05, Paris, France; [Gangnard, Stephane] Inst Pasteur, CNRS, URA2185, Unite Immunol Struct, Paris, France; [Ndam, Nicaise Tuikue] Inst Sci Biomed & Appl, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Technical University of Denmark; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gnidehou, S (corresponding author), Inst Rech Dev, IRD UMR 216, Paris, France.	gcarine@yahoo.com; nicaise.ndam@ird.fr	Lund, Ole/F-4437-2014; Deloron, Philippe/G-6305-2010; Guitard, Juliette/AAE-6344-2019; Jessen, Leon/L-7156-2018	Lund, Ole/0000-0003-1108-0491; Deloron, Philippe/0000-0003-4705-2484; Guitard, Juliette/0000-0002-9782-3577; Jessen, Leon Eyrich/0000-0003-2879-2559; Tuikue Ndam, Nicaise/0000-0003-2646-2513	French National Agency of Research [ANR-05-MIME-009-01]; European Commission [200889]; Copenhagen University	French National Agency of Research(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Copenhagen University	This work was supported by grants from the French National Agency of Research (grant # ANR-05-MIME-009-01), the European Commission, FP7 work program (Grant # 200889), and the Copenhagen University Programme of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akogbeto M., 1992, Parassitologia (Rome), V34, P147; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Bengtsson D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-101; Briand V, 2009, J INFECT DIS, V200, P991, DOI 10.1086/605474; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Flick K, 2001, SCIENCE, V293, P2098, DOI 10.1126/science.1062891; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; GANGNARD S, 2010, MOL BIOCH PARASITOL; Guitard J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-165; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; HOOF I, 2009, THESIS TU DENMARK; Juillerat A, 2010, MOL BIOCHEM PARASIT, V170, P84, DOI 10.1016/j.molbiopara.2009.12.008; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leblond J, 2007, BIOCONJUGATE CHEM, V18, P484, DOI 10.1021/bc060141b; Magistrado P, 2008, J INFECT DIS, V198, P1071, DOI 10.1086/591502; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2004, J INFECT DIS, V190, P2001, DOI 10.1086/425521; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Resende M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-104; Resende M, 2009, INT J PARASITOL, V39, P1195, DOI 10.1016/j.ijpara.2009.02.022; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sander AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006667; Shannon C., 1964, MATH THEORY COMMUNIC; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; STEKETEE RW, 1988, ANN TROP MED PARASIT, V82, P113, DOI 10.1080/00034983.1988.11812217; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83; H2PDB SERVER	41	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13105	10.1371/journal.pone.0013105	http://dx.doi.org/10.1371/journal.pone.0013105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957045	Green Published, Green Submitted, gold			2022-12-25	WOS:000282359300011
J	Kuriwada, T; Hosokawa, T; Kumano, N; Shiromoto, K; Haraguchi, D; Fukatsu, T				Kuriwada, Takashi; Hosokawa, Takahiro; Kumano, Norikuni; Shiromoto, Keiko; Haraguchi, Dai; Fukatsu, Takema			Biological Role of Nardonella Endosymbiont in Its Weevil Host	PLOS ONE			English	Article							SWEET-POTATO WEEVIL; DRYOPHTHORIDAE WEEVILS; GENOME SEQUENCE; EVOLUTIONARY RELATIONSHIPS; BACTERIAL ENDOSYMBIONTS; ARTIFICIAL DIET; COLEOPTERA; SYMBIONT; COSPECIATION; SURVIVAL	Weevils constitute the most species-rich animal group with over 60,000 described species, many of which possess specialized symbiotic organs and harbor bacterial endosymbionts. Among the diverse microbial associates of weevils, Nardonella spp. represent the most ancient and widespread endosymbiont lineage, having co-speciated with the host weevils for over 125 million years. Thus far, however, no empirical work on the role of Nardonella for weevil biology has been reported. Here we investigated the biological role of the Nardonella endosymbiont for the West Indian sweet potato weevil, Euscepes postfasciatus. This insect is an experimentally tractable pest insect that can easily be reared on a natural diet of sweet potato root as well as on an agar-based artificial diet. By larval feeding on an antibiotic-containing artificial diet, Nardonella infection was effectively eliminated from the treated insects. The antibiotic-treated insects exhibited significantly lighter body weight and lower growth rate than the control insects. Then, the antibiotic-treated insects and the control insects were respectively allowed to mate and oviposit on fresh sweet potatoes without the antibiotic. The offspring of the antibiotic-treated insects, which were all Nardonella-negative, exhibited significantly lighter body weight, smaller body size, lower growth rate and paler body color in comparison with the offspring of the control insects, which were all Nardonella-positive. In conclusion, the Nardonella endosymbiont is involved in normal growth and development of the host weevil. The biological role of the endosymbiont probably underlies the long-lasting host-symbiont co-speciation in the evolutionary course of weevils.	[Kuriwada, Takashi; Kumano, Norikuni; Shiromoto, Keiko; Haraguchi, Dai] Okinawa Prefectural Plant Protect Ctr, Naha, Japan; [Hosokawa, Takahiro; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Kuriwada, T (corresponding author), Okinawa Prefectural Plant Protect Ctr, Naha, Japan.	t-fukatsu@aist.go.jp		Hosokawa, Takahiro/0000-0001-7618-1774; Kumano, Norikuni/0000-0003-2803-8660	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), Japan	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), Japan	This research was supported by a funding from the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), Japan, to T. F. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Allen JM, 2007, APPL ENVIRON MICROB, V73, P1659, DOI 10.1128/AEM.01877-06; Baumann P, 1997, ANTON LEEUW INT J G, V72, P39, DOI 10.1023/A:1000239108771; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOURTZIS K, 2008, INSECT SYMBIOSIS, V3, P384; Braendle C, 2003, PLOS BIOL, V1, P70, DOI 10.1371/journal.pbio.0000021; Buchner P, 1965, ENDOSYMBIONTS ANIMAL; Chen XA, 1999, J MOL EVOL, V48, P49, DOI 10.1007/PL00006444; Clark MA, 2000, EVOLUTION, V54, P517, DOI 10.1111/j.0014-3820.2000.tb00054.x; COCHRAN DG, 1985, ANNU REV ENTOMOL, V30, P29, DOI 10.1146/annurev.en.30.010185.000333; Conord C, 2008, MOL BIOL EVOL, V25, P859, DOI 10.1093/molbev/msn027; Costa HS, 1997, J ECON ENTOMOL, V90, P333, DOI 10.1093/jee/90.2.333; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Fukatsu T, 2007, APPL ENVIRON MICROB, V73, P6660, DOI 10.1128/AEM.01131-07; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Heddi A, 2005, SYMBIOSIS, V39, P1; Hosokawa T, 2010, APPL ENTOMOL ZOOL, V45, P115, DOI 10.1303/aez.2010.115; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; HOUK EJ, 1980, ANNU REV ENTOMOL, V25, P161, DOI 10.1146/annurev.en.25.010180.001113; Jansson RK, 1991, SWEET POTATO PEST MA, P1; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Koga R, 2007, FEMS MICROBIOL ECOL, V60, P229, DOI 10.1111/j.1574-6941.2007.00284.x; Kono M, 2008, APPL ENVIRON MICROB, V74, P4175, DOI 10.1128/AEM.00250-08; Kuba H., 2000, PLANT PROT Q, V54, P483; Kuriwada T, 2009, FLA ENTOMOL, V92, P221, DOI 10.1653/024.092.0205; Lefevre C, 2004, MOL BIOL EVOL, V21, P965, DOI 10.1093/molbev/msh063; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; McKenna DD, 2009, P NATL ACAD SCI USA, V106, P7083, DOI 10.1073/pnas.0810618106; Moran NA, 2005, APPL ENVIRON MICROB, V71, P8802, DOI 10.1128/AEM.71.12.8802-8810.2005; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nardon P, 2002, SYMBIOSIS, V33, P227; NOGGE G, 1981, PARASITOLOGY, V82, P101; Oberprieler Rolf G., 2007, Zootaxa, V1668, P491; Ohno S, 2009, APPL ENTOMOL ZOOL, V44, P13, DOI 10.1303/aez.2009.13; Pontes MH, 2006, TRENDS MICROBIOL, V14, P406, DOI 10.1016/j.tim.2006.07.004; Puchta O., 1955, Zeitschrift fuer Parasitenkunde, V17, P1; R Core Team, 2021, R LANG ENV STAT COMP; Raman K.V., 1991, P263; Sabree ZL, 2009, P NATL ACAD SCI USA, V106, P19521, DOI 10.1073/pnas.0907504106; Sauer C, 2000, INT J SYST EVOL MICR, V50, P1877, DOI 10.1099/00207713-50-5-1877; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Shimoji Y, 1996, APPL ENTOMOL ZOOL, V31, P152, DOI 10.1303/aez.31.152; Takiya DM, 2006, MOL ECOL, V15, P4175, DOI 10.1111/j.1365-294X.2006.03071.x; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Toju H, 2010, APPL ENVIRON MICROB, V76, P275, DOI 10.1128/AEM.02154-09; Urasaki K, 2009, JPN J APPL ENTOMOL Z, V53, P1, DOI 10.1303/jjaez.2009.1; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; WICKER C, 1983, COMP BIOCHEM PHYS A, V76, P177, DOI 10.1016/0300-9629(83)90311-0; Woolfe JA., 2008, SWEETPOTATO UNTAPPED; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	55	44	45	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13101	10.1371/journal.pone.0013101	http://dx.doi.org/10.1371/journal.pone.0013101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957033	gold, Green Published, Green Submitted			2022-12-25	WOS:000282359300008
J	Liu, XA; Qin, SZ; Rijpkema, M; Luo, J; Fernandez, G				Liu, Xiao; Qin, Shaozheng; Rijpkema, Mark; Luo, Jing; Fernandez, Guillen			Intermediate Levels of Hippocampal Activity Appear Optimal for Associative Memory Formation	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; PATTERN SEPARATION; DENTATE GYRUS; ITEM; RECOGNITION; CA3; MECHANISMS; STRENGTH; DORSAL; CORTEX	Background: It is well established that hippocampal activity is positively related to effective associative memory formation. However, in biological systems often optimal levels of activity are contrasted by both sub-and supra-optimal levels. Suboptimal levels of hippocampal activity are commonly attributed to unsuccessful memory formation, whereas the supraoptimal levels of hippocampal activity related to unsuccessful memory formation have been rarely studied. It is still unclear under what circumstances such supra-optimal levels of hippocampal activity occur. To clarify this issue, we aimed at creating a condition, in which supra-optimal hippocampal activity is associated with encoding failure. We assumed that such supra-optimal activity occurs when task-relevant information is embedded in task-irrelevant, distracting information, which can be considered as noise. Methodology/Principal Findings: In the present fMRI study, we probed neural correlates of associative memory formation in a full-factorial design with associative memory (subsequently remembered versus forgotten) and noise (induced by high versus low distraction) as factors. Results showed that encoding failure was associated with supra-optimal activity in the high-distraction condition and with sub-optimal activity in the low distraction condition. Thus, we revealed evidence for a bell-shape function relating hippocampal activity with associative encoding success. Conclusions/Significance: Our findings indicate that intermediate levels of hippocampal activity are optimal while both too low and too high levels appear detrimental for associative memory formation. Supra-optimal levels of hippocampal activity seem to occur when task-irrelevant information is added to task-relevant signal. If such task-irrelevant noise is reduced adequately, hippocampal activity is lower and thus optimal for associative memory formation.	[Liu, Xiao; Qin, Shaozheng; Rijpkema, Mark; Fernandez, Guillen] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Liu, Xiao; Luo, Jing] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Liu, Xiao] Chinese Acad Sci, Grad Sch, Beijing 100101, Peoples R China; [Qin, Shaozheng] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Fernandez, Guillen] Radboud Univ Nijmegen, Dept Cognit Neurosci, Donders Inst Brain Cognit & Behav, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Radboud University Nijmegen; Radboud University Nijmegen	Liu, XA (corresponding author), Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	luoj@psych.ac.cn; guillen.fernandez@donders.ru.nl	Rijpkema, Mark/D-1974-2010; Qin, Shaozheng/AAD-2107-2019; Fernandez, Guillen/B-3771-2009	Rijpkema, Mark/0000-0002-8495-4703; Qin, Shaozheng/0000-0002-1859-2150; Fernandez, Guillen/0000-0002-5522-0604	Netherlands Organization for Scientific Research (NWO) [918.66.613]; Royal Netherlands Academy of Arts and Sciences (KNAW); Chinese Academy of Sciences (CAS)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Royal Netherlands Academy of Arts and Sciences (KNAW); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences)	This work is supported by Netherlands Organization for Scientific Research (NWO), grant number: 918.66.613, Royal Netherlands Academy of Arts and Sciences (KNAW) and the Chinese Academy of Sciences (CAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Baldi Elisabetta, 2005, Nonlinearity in Biology Toxicology and Medicine, V3, P9, DOI 10.2201/nonlin.003.01.002; Caplan JB, 2007, CEREB CORTEX, V17, P1650, DOI 10.1093/cercor/bhl076; Cheng DT, 2008, P NATL ACAD SCI USA, V105, P8108, DOI 10.1073/pnas.0800374105; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Forster S, 2009, COGNITION, V111, P345, DOI 10.1016/j.cognition.2009.02.006; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gerwig M, 2007, CEREBELLUM, V6, P38, DOI 10.1080/14734220701225904; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Henson RNA, 1999, J NEUROSCI, V19, P3962; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P955, DOI 10.1002/hipo.20455; Jonides J, 2006, NEUROSCIENCE, V139, P181, DOI 10.1016/j.neuroscience.2005.06.042; Kirwan CB, 2004, HIPPOCAMPUS, V14, P919, DOI 10.1002/hipo.20014; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Luo J, 2005, HIPPOCAMPUS, V15, P141, DOI 10.1002/hipo.20054; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Martinez A, 2006, J COGNITIVE NEUROSCI, V18, P298, DOI 10.1162/089892906775783642; Mayes AR, 2004, HIPPOCAMPUS, V14, P763, DOI 10.1002/hipo.10211; MCNAUGHTON BL, 1989, NEUROSCIENCE CONNECT, P1; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Otten LJ, 2001, CURR BIOL, V11, P1528, DOI 10.1016/S0960-9822(01)00454-7; Piekema C, 2009, LEARN MEMORY, V16, P231, DOI 10.1101/lm.1283109; Qin SZ, 2007, NEUROIMAGE, V38, P212, DOI 10.1016/j.neuroimage.2007.07.020; Qin SZ, 2009, NEUROIMAGE, V46, P874, DOI 10.1016/j.neuroimage.2009.02.039; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ranganath C, 2001, NEURON, V31, P865, DOI 10.1016/S0896-6273(01)00411-1; Rolls ET, 2007, LEARN MEMORY, V14, P714, DOI 10.1101/lm.631207; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shrager Y, 2008, NEURON, V59, P547, DOI 10.1016/j.neuron.2008.07.022; Tseng W, 2004, HIPPOCAMPUS, V14, P58, DOI 10.1002/hipo.10157; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Wagner AD, 2001, CURR BIOL, V11, pR964, DOI 10.1016/S0960-9822(01)00575-9; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Weible AP, 2006, NEUROSCIENCE, V141, P1123, DOI 10.1016/j.neuroscience.2006.04.065; Weis S, 2004, CEREB CORTEX, V14, P256, DOI 10.1093/cercor/bhg125; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	42	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13147	10.1371/journal.pone.0013147	http://dx.doi.org/10.1371/journal.pone.0013147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957209	Green Published, Green Submitted, gold			2022-12-25	WOS:000282359300031
J	Siepmann, M; Kumar, S; Mayer, G; Walter, J				Siepmann, Martin; Kumar, Sathish; Mayer, Guenter; Walter, Jochen			Casein Kinase 2 Dependent Phosphorylation of Neprilysin Regulates Receptor Tyrosine Kinase Signaling to Akt	PLOS ONE			English	Article							EZRIN/RADIXIN/MOESIN ERM PROTEINS; SURFACE-PLASMON RESONANCE; TUMOR-SUPPRESSOR GENE; NEUTRAL ENDOPEPTIDASE-24.11; PROSTATE-CANCER; CD10/NEUTRAL ENDOPEPTIDASE-24.11; MEMBRANE ASSOCIATION; CYTOPLASMIC DOMAIN; CELL CARCINOMAS; HUMAN BRAIN	Neprilysin (NEP) is a type II membrane metalloproteinase that cleaves physiologically active peptides at the cell surface thus regulating the local concentration of these peptides available for receptor binding and signal transduction. In addition, the cytoplasmic N-terminal domain of NEP interacts with the phosphatase and tensin homologue deleted on chromosome 10 (PTEN) thereby regulating intracellular signaling via Akt. Thus, NEP serves dual functions in extracellular and intracellular signal transduction. Here, we show that NEP undergoes phosphorylation at serine residue 6 within the N-terminal cytoplasmic domain. In vitro and cell culture experiments demonstrate that Ser 6 is efficiently phosphorylated by protein kinase CK2. The phosphorylation of the cytoplasmic domain of NEP inhibits its interaction with PTEN. Interestingly, expression of a pseudophosphorylated NEP variant (Ser6Asp) abrogates the inhibitory effect of NEP on insulin/insulin-like growth factor-1 (IGF-1) stimulated activation of Akt. Thus, our data demonstrate a regulatory role of CK2 in the interaction of NEP with PTEN and insulin/IGF-1 signaling.	[Siepmann, Martin; Kumar, Sathish; Walter, Jochen] Univ Bonn, Dept Neurol, D-5300 Bonn, Germany; [Mayer, Guenter] Univ Bonn, Chem Biol CO Kekule Inst Organ Chem & Biochem, Limes Inst, D-5300 Bonn, Germany	University of Bonn; University of Bonn	Siepmann, M (corresponding author), Univ Bonn, Dept Neurol, D-5300 Bonn, Germany.	Jochen.Walter@ukb.uni-bonn.de	Wang, Caihong/T-5837-2019; Walter, Jochen/B-3677-2014; Kumar, Sathish/L-1367-2019	Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912; Kumar, Sathish/0000-0002-2792-7047	Deutsche Forschungsgemeinschaft [SFB645, KFo177]; Hans und Ilse Breuer Stiftung; Bundesministerium fur Bildung und Forschung [01GI0708]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans und Ilse Breuer Stiftung; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB645, KFo177), the Hans und Ilse Breuer Stiftung, and the Bundesministerium fur Bildung und Forschung (01GI0708). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura Y, 2004, J BIOL CHEM, V279, P11408, DOI 10.1074/jbc.M309063200; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; DAYAMAKIN M, 1994, CANCER RES, V54, P2262; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145; Ganju RK, 1996, BLOOD, V88, P4159; Guerra B, 1999, PHARMACOL THERAPEUT, V82, P303, DOI 10.1016/S0163-7258(98)00064-3; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Iwase A, 2004, J BIOL CHEM, V279, P11898, DOI 10.1074/jbc.M212737200; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; KENNY J, 1993, BIOCHEM SOC T, V21, P663, DOI 10.1042/bst0210663; Kim SO, 1998, J CELL BIOCHEM, V71, P328, DOI 10.1002/(SICI)1097-4644(19981201)71:3<328::AID-JCB2>3.0.CO;2-U; Koul D, 2008, CANCER BIOL THER, V7, P1321, DOI 10.4161/cbt.7.9.6954; LAFRANCE MH, 1994, BIOCHEM J, V302, P451, DOI 10.1042/bj3020451; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; MARIN O, 1994, BIOCHEM BIOPH RES CO, V198, P898, DOI 10.1006/bbrc.1994.1128; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McKendrick L, 1999, MOL CELL BIOCHEM, V191, P187, DOI 10.1023/A:1006854109926; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Nelson JB, 2000, CANCER INVEST, V18, P87, DOI 10.3109/07357900009023066; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Papandreou CN, 1998, NAT MED, V4, P50, DOI 10.1038/nm0198-050; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Rentmeister A, 2006, RNA, V12, P1650, DOI 10.1261/rna.126306; Roher N, 1998, FEBS LETT, V437, P211, DOI 10.1016/S0014-5793(98)01230-7; Sarno S, 2008, MOL BIOSYST, V4, P889, DOI 10.1039/b805534c; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; SHIPP MA, 1991, P NATL ACAD SCI USA, V88, P10662, DOI 10.1073/pnas.88.23.10662; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; STEWART JR, 1984, BIOCHEM J, V224, P549, DOI 10.1042/bj2240549; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; Terawaki S, 2007, J BIOL CHEM, V282, P19854, DOI 10.1074/jbc.M609232200; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Vazquez F, 2006, CELL CYCLE, V5, P1523, DOI 10.4161/cc.5.14.3005; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Walter J, 1998, BIOCHEMISTRY-US, V37, P5961, DOI 10.1021/bi971763a; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Xu Z, 2002, CELL GROWTH DIFFER, V13, P285; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	56	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13134	10.1371/journal.pone.0013134	http://dx.doi.org/10.1371/journal.pone.0013134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957047	Green Published, Green Submitted, gold			2022-12-25	WOS:000282359300024
J	Smejkalova, H; Erb, TJ; Fuchs, G				Smejkalova, Hana; Erb, Tobias J.; Fuchs, Georg			Methanol Assimilation in Methylobacterium extorquens AM1: Demonstration of All Enzymes and Their Regulation	PLOS ONE			English	Article							MALYL-COENZYME-A; BETA-HYDROXYBUTYRATE BIOSYNTHESIS; METABOLIC-CONTROL ANALYSIS; ETHYLMALONYL-COA PATHWAY; MALATE SYNTHASE ACTIVITY; PSEUDOMONAS AM1; C1 COMPOUNDS; MICROBIAL-METABOLISM; METHYLOTROPHIC METABOLISM; RHODOBACTER-SPHAEROIDES	Background: Methylobacterium extorquens AM1 is an aerobic facultative methylotrophic alpha-proteobacterium that can use reduced one-carbon compounds such as methanol, but also multi-carbon substrates like acetate (C(2)) or succinate (C(4)) as sole carbon and energy source. The organism has gained interest as future biotechnological production platform based on methanol as feedstock. Methodology/Principal Findings: We present a comprehensive study of all postulated enzymes for the assimilation of methanol and their regulation in response to the carbon source. Formaldehyde, which is derived from methanol oxidation, is assimilated via the serine cycle, which starts with glyoxylate and forms acetyl-CoA. Acetyl-CoA is assimilated via the proposed ethylmalonyl-CoA pathway, which thereby regenerates glyoxylate. To further the understanding of the central carbon metabolism we identified and quantified all enzymes of the pathways involved in methanol assimilation. We observed a strict differential regulation of their activity level depending on whether C(1), C(2) or C(4) compounds are used. The enzymes, which are specifically required for the utilization of the individual substrates, were several-fold up-regulated and those not required were down-regulated. The enzymes of the ethylmalonyl-CoA pathway showed specific activities, which were higher than the calculated minimal values that can account for the observed growth rate. Yet, some enzymes of the serine cycle, notably its first and last enzymes serine hydroxymethyl transferase and malate thiokinase, exhibit much lower values and probably are rate limiting during methylotrophic growth. We identified the natural C(1) carrying coenzyme as tetrahydropteroyl-tetraglutamate rather than tetrahydrofolate. Conclusion/Significance: This study provides the first complete picture of the enzymes required for methanol assimilation, the regulation of their activity levels in response to the growth substrate, and the identification of potential growth limiting steps.	[Smejkalova, Hana; Erb, Tobias J.; Fuchs, Georg] Univ Freiburg, Fak Biol, Freiburg, Germany	University of Freiburg	Smejkalova, H (corresponding author), Univ Freiburg, Fak Biol, Freiburg, Germany.	georg.fuchs@biologie.uni-freiburg.de	Erb, Tobias/J-5214-2013	Erb, Tobias/0000-0003-3685-0894	Evonik-Degussa GmbH	Evonik-Degussa GmbH	This work was supported by Evonik-Degussa GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanda-Nkpwatt D, 2006, J EXP BOT, V57, P4025, DOI 10.1093/jxb/erl173; Alber BE, 2006, MOL MICROBIOL, V61, P297, DOI 10.1111/j.1365-2958.2006.05238.x; ANTHONY C, 1964, BIOCHEM J, V92, P614, DOI 10.1042/bj0920614; Anthony C., 1982, BIOCH METHYLOTROPHS; ARPS PJ, 1993, J BACTERIOL, V175, P3776, DOI 10.1128/JB.175.12.3776-3783.1993; Bosch G, 2008, PROTEOMICS, V8, P3494, DOI 10.1002/pmic.200800152; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cascante M, 2002, NAT BIOTECHNOL, V20, P243, DOI 10.1038/nbt0302-243; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; CHISTOSERDOVA LV, 1991, J BACTERIOL, V173, P7228, DOI 10.1128/jb.173.22.7228-7232.1991; CHISTOSERDOVA LV, 1994, J BACTERIOL, V176, P6759, DOI 10.1128/JB.176.21.6759-6762.1994; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; COX RB, 1976, J GEN MICROBIOL, V95, P121, DOI 10.1099/00221287-95-1-121; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; Crowther GJ, 2008, J BACTERIOL, V190, P5057, DOI 10.1128/JB.00228-08; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; DUNSTAN PM, 1973, BIOCHEM J, V132, P797, DOI 10.1042/bj1320797; DUNSTAN PM, 1972, BIOCHEM J, V128, P99, DOI 10.1042/bj1280099; DUNSTAN PM, 1972, BIOCHEM J, V128, P107, DOI 10.1042/bj1280107; Erb TJ, 2009, THESIS A LUDWIGS U F; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2010, J BACTERIOL, V192, P1249, DOI 10.1128/JB.01267-09; Erb TJ, 2009, MOL MICROBIOL, V73, P992, DOI 10.1111/j.1365-2958.2009.06837.x; ESCALANTESEMERENA JC, 1984, J BIOL CHEM, V259, P9447; Garratt LC, 2005, RAPID COMMUN MASS SP, V19, P2390, DOI 10.1002/rcm.2074; Glykys DJ, 2009, BIOTECHNOL BIOENG, V102, P1624, DOI 10.1002/bit.22199; GOODWIN PM, 1990, METHOD ENZYMOL, V188, P361; Gourion B, 2006, P NATL ACAD SCI USA, V103, P13186, DOI 10.1073/pnas.0603530103; Guo XF, 2008, BIOTECHNOL BIOENG, V99, P929, DOI 10.1002/bit.21652; HACKING AJ, 1990, METHOD ENZYMOL, V188, P379; HARDER W, 1971, BIOCHEM J, V121, P753, DOI 10.1042/bj1210753; Hatzimanikatis V, 1996, J THEOR BIOL, V182, P233, DOI 10.1006/jtbi.1996.0160; HEPTINST.J, 1970, BIOCHEM J, V117, P563, DOI 10.1042/bj1170563; HILL B, 1974, J GEN MICROBIOL, V83, P187, DOI 10.1099/00221287-83-1-187; HUENNEKENS FM, 1963, METHOD ENZYMOL, V6, P802, DOI 10.1016/0076-6879(63)06253-4; Kiefer P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007831; Kirstine WV, 2004, J AIR WASTE MANAGE, V54, P1299, DOI 10.1080/10473289.2004.10470990; KISLIUK RL, 1981, MOL CELL BIOCHEM, V39, P331, DOI 10.1007/BF00232583; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Korotkova N, 2002, J BACTERIOL, V184, P6174, DOI 10.1128/JB.184.22.6174-6181.2002; Korotkova N, 2002, J BACTERIOL, V184, P1750, DOI 10.1128/JB.184.6.1750-1758.2002; Korotkova N, 2001, J BACTERIOL, V183, P1038, DOI 10.1128/JB.183.3.1038-1046.2001; KREMA C, 1990, METHOD ENZYMOL, V188, P373; LARGE PJ, 1963, BIOCHEM J, V87, P386, DOI 10.1042/bj0870386; Laukel M, 2004, PROTEOMICS, V4, P1247, DOI 10.1002/pmic.200300713; Lee MC, 2009, EVOLUTION, V63, P2816, DOI 10.1111/j.1558-5646.2009.00757.x; Lefebvre S, 2005, PLANT PHYSIOL, V138, P451, DOI 10.1104/pp.104.055046; Lengeler J. W., 1999, BIOL PROKARYOTES; Madhaiyan M, 2004, BOT BULL ACAD SINICA, V45, P315; Marx CJ, 2005, PLOS BIOL, V3, P244, DOI 10.1371/journal.pbio.0030016; Marx CJ, 2003, J BACTERIOL, V185, P7160, DOI 10.1128/JB.185.23.7160-7168.2003; MCGUIRE JJ, 1981, MOL CELL BIOCHEM, V38, P19, DOI 10.1007/BF00235686; MCNERNEY T, 1980, APPL ENVIRON MICROB, V40, P370, DOI 10.1128/AEM.40.2.370-375.1980; Moreno-Sanchez R, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/597913; Okubo Y, 2007, OMICS, V11, P325, DOI 10.1089/omi.2007.0027; Okubo Y, 2010, J BACTERIOL, V192, P1813, DOI 10.1128/JB.01166-09; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Sage RF, 2002, J EXP BOT, V53, P609, DOI 10.1093/jexbot/53.369.609; SALEM AR, 1973, BIOCHEM J, V136, P89, DOI 10.1042/bj1360089; Schrader J, 2009, TRENDS BIOTECHNOL, V27, P107, DOI 10.1016/j.tibtech.2008.10.009; Schuster S, 1999, METAB ENG, V1, P232, DOI 10.1006/mben.1999.0119; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; Smith LM, 1996, MICROBIOL-UK, V142, P675, DOI 10.1099/13500872-142-3-675; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; Sy A, 2005, APPL ENVIRON MICROB, V71, P7245, DOI 10.1128/AEM.71.11.7245-7252.2005; TAYLOR IJ, 1976, J GEN MICROBIOL, V95, P134, DOI 10.1099/00221287-95-1-134; Thomas AH, 2000, J PHOTOCH PHOTOBIO A, V135, P147, DOI 10.1016/S1010-6030(00)00304-X; Van Dien SJ, 2003, MICROBIOL-SGM, V149, P601, DOI 10.1099/mic.0.25955-0; Van Dien SJ, 2002, BIOTECHNOL BIOENG, V78, P296, DOI 10.1002/bit.10200; Vorholt JA, 2002, ARCH MICROBIOL, V178, P239, DOI 10.1007/s00203-002-0450-2; Vorholt JA, 2000, J BACTERIOL, V182, P6645, DOI 10.1128/JB.182.23.6645-6650.2000; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Williams P, 2006, J MOL BIOL, V357, P151, DOI 10.1016/j.jmb.2005.12.055; WILLIBALD B, 1995, ANAL BIOCHEM, V227, P363, DOI 10.1006/abio.1995.1292; Zarzycki J, 2008, J BACTERIOL, V190, P1366, DOI 10.1128/JB.01621-07	77	81	86	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13001	10.1371/journal.pone.0013001	http://dx.doi.org/10.1371/journal.pone.0013001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957036	Green Published, Green Submitted, gold			2022-12-25	WOS:000282359300002
J	Yu, XB; Hartmann, M; Wang, QA; Poetz, O; Schneiderhan-Marra, N; Stoll, D; Kazmaier, C; Joos, TO				Yu, Xiaobo; Hartmann, Michael; Wang, Quan; Poetz, Oliver; Schneiderhan-Marra, Nicole; Stoll, Dieter; Kazmaier, Cornelia; Joos, Thomas O.			mu FBI: A Microfluidic Bead-Based Immunoassay for Multiplexed Detection of Proteins from a mu L Sample Volume	PLOS ONE			English	Article							BREAST-CANCER; MICROARRAY ANALYSIS; IMMUNOAFFINITY CE; PHOSPHORYLATION; BIOPSIES; ARRAYS; CELLS; TECHNOLOGY; ACTIVATION; PREDICTION	Background: Over the last ten years, miniaturized multiplexed immunoassays have become robust, reliable research tools that enable researchers to simultaneously determine a multitude of parameters. Among the numerous analytical protein arrays available, bead-based assay systems have evolved into a key technology that enables the quantitative protein profiling of biological samples whilst requiring only a minimal amount of sample material. Methodology/Principal Findings: A microfluidic bead-based immunoassay, mu FBI, was developed to perform bead-based multiplexed sandwich immunoassays in a capillary. This setup allows the simultaneous detection of several parameters and only requires 200 ng of tissue lysate in a 1 mu L assay volume. In addition, only 1 mu L of detection antibodies and 1 mu L of the reporter molecule Streptavidin-Phycoerythrin were required. The mu FBI was used to compare the expression of seven receptor tyrosine kinases and their degree of tyrosine phosphorylation in breast cancer tissue and in normal tissue lysates. The total amount of HER-2, as well the degree of tyrosine phosphorylation was much higher in breast cancer tissue than in normal tissue. mu FBI and a standard bead-based assay led to identical protein expression data. Moreover, it was possible to reduce the quantity of sample material required by a factor of 100 and the quantity of reagents by a factor of 30. Conclusions/Significance: The mu FBI, microfluidic bead-based immunoassay, allows the analysis of multiple parameters from a very small amount of sample material, such as tumor biopsies or tissue sections.	[Yu, Xiaobo; Hartmann, Michael; Wang, Quan; Poetz, Oliver; Schneiderhan-Marra, Nicole; Stoll, Dieter; Kazmaier, Cornelia; Joos, Thomas O.] Univ Tubingen, Nat & Med Sci Inst NMI, Reutlingen, Germany; [Hartmann, Michael] Royal Inst Technol, Dept Analyt Chem, Sch Chem Sci & Engn, S-10044 Stockholm, Sweden; [Stoll, Dieter] Hsch Albstadt Sigmaringen, Sigmaringen, Germany; [Joos, Thomas O.] Expt & Diagnost Immunol EDI GmbH, Reutlingen, Germany	Eberhard Karls University of Tubingen; Royal Institute of Technology	Yu, XB (corresponding author), Univ Tubingen, Nat & Med Sci Inst NMI, Reutlingen, Germany.	joos@nmi.de	Yu, Xiaobo/F-5997-2015		Alexander von Humboldt Foundation, Germany [1126997]	Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation)	XY is supported by a Humboldt research fellowship (Alexander von Humboldt Foundation, Germany, fellowship ID: 1126997). No additional current external funding sources were used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamdani MSS, 2009, GENOME MED, V1, DOI 10.1186/gm68; Bainer R, 2003, J MICROBIOL METH, V55, P315, DOI 10.1016/S0167-7012(03)00112-X; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Fan AC, 2009, NAT MED, V15, P566, DOI 10.1038/nm.1903; Frogne T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2230; Hsu HY, 2008, MED ENG PHYS, V30, P976, DOI 10.1016/j.medengphy.2008.01.003; Hu LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-16; Huang RP, 2007, EXPERT REV PROTEOMIC, V4, P299, DOI 10.1586/14789450.4.2.299; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Joos Thomas O, 2007, Expert Rev Proteomics, V4, P347, DOI 10.1586/14789450.4.3.347; Kim JS, 2009, ANAL CHEM, V81, P5426, DOI 10.1021/ac9005827; Knickerbocker T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100167; Korf U, 2009, PROTEOM CLIN APPL, V3, P1140, DOI 10.1002/prca.200780035; Kricka LJ, 2006, ANN CLIN BIOCHEM, V43, P457, DOI 10.1258/000456306778904731; KULASINGAM V, 2007, NATURE CLIN PRACTICE, P588; O'Neill RA, 2006, P NATL ACAD SCI USA, V103, P16153, DOI 10.1073/pnas.0607973103; Paczesny S, 2009, BLOOD, V113, P273, DOI 10.1182/blood-2008-07-167098; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Phillips TM, 2007, ELECTROPHORESIS, V28, P3041, DOI 10.1002/elps.200700193; Phillips TM, 2009, ELECTROPHORESIS, V30, P2307, DOI 10.1002/elps.200900095; Phillips TM, 2004, ELECTROPHORESIS, V25, P1652, DOI 10.1002/elps.200305873; Qiu J, 2009, CLIN LAB MED, V29, P31, DOI 10.1016/j.cll.2009.01.002; Ramachandran N, 2008, NAT METHODS, V5, P535, DOI 10.1038/NMETH.1210; Sauer G, 2008, CLIN CANCER RES, V14, P3345, DOI 10.1158/1078-0432.CCR-07-4802; Schwenk JM, 2007, MOL CELL PROTEOMICS, V6, P125, DOI 10.1074/mcp.T600035-MCP200; Templin MF, 2004, COMB CHEM HIGH T SCR, V7, P223; Thor AD, 2000, J CLIN ONCOL, V18, P3230, DOI 10.1200/JCO.2000.18.18.3230; VanMeter AJ, 2008, MOL CELL PROTEOMICS, V7, P1902, DOI 10.1074/mcp.M800204-MCP200; Wingren C, 2008, CURR OPIN BIOTECH, V19, P55, DOI 10.1016/j.copbio.2007.11.010; Wulfkuhle JD, 2008, J PROTEOME RES, V7, P1508, DOI 10.1021/pr7008127; Yu XB, 2010, CLIN CHEM, V56, P376, DOI 10.1373/clinchem.2009.137158; Yu XB, 2009, METHODS MOL BIOL, V577, P199, DOI 10.1007/978-1-60761-232-2_15; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	35	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13125	10.1371/journal.pone.0013125	http://dx.doi.org/10.1371/journal.pone.0013125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957050	gold, Green Published, Green Submitted			2022-12-25	WOS:000282359300019
J	Kim, MKH; Min, DJ; Rabin, M; Licht, JD				Kim, M. K-H; Min, D. J.; Rabin, M.; Licht, J. D.			Functional characterization of Wilms tumor-suppressor WTX and tumor-associated mutants	ONCOGENE			English	Article						WTX; WT1; microarray; tumor suppressor; G(0)/G(1) arrest; p21	BECKWITH-WIEDEMANN SYNDROME; KIDNEY DEVELOPMENT; BETA-CATENIN; BONE MASS; GENE; MUTATIONS; INDUCTION; FREQUENT; EVENT; TUMORIGENESIS	The WTX, Wilms tumor-associated tumor-suppressor gene, is present on the X chromosome and a single WTX mutation may be sufficient to promote carcinogenesis. Unlike the WT1 tumor suppressor, a transcription factor, WTX lacks conserved functional protein domains. To study the function of WTX, we constructed inducible cell lines expressing WTX and tumor-associated WTX mutants. Induction of WTX inhibited cell growth and caused G(1)/G(0) arrest. In contrast, a short, tumor-associated truncation mutant of WTX358 only slightly inhibited cell growth without a significant cell-cycle arrest, although expression of a longer truncation mutant WTX565 led to the growth inhibition and cell-cycle arrest to a similar extent as wild-type WTX. Like WT1, WTX slowed growth and caused cell-cycle arrest through p21 induction. Gene expression profiling showed that these two tumor-suppressors regulated genes in similar pathways, including those implicated in control of the cellular growth, cell cycle, cell death, cancer and cardiovascular system development. When gene expression changes mediated by wild-type WTX were compared with those affected by mutant forms, WTX565 showed a 55% overlap (228 genes) in differentially regulated genes, whereas WTX358 regulated only two genes affected by wild-type WTX, implying that amino-acid residues 358-561 are critical for WTX function. Oncogene (2011) 30, 832-842; doi:10.1038/onc.2010.452; published online 18 October 2010	[Kim, M. K-H; Min, D. J.; Rabin, M.; Licht, J. D.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Robert H Lurie Comprehens Canc Ctr,Dept Med, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Licht, JD (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Robert H Lurie Comprehens Canc Ctr,Dept Med, Lurie 5-123,303 E Super St, Chicago, IL 60611 USA.	j-licht@northwestern.edu	Licht, Jonathan/L-4239-2019; Licht, Jonathan/AAL-9184-2020	Licht, Jonathan/0000-0002-3942-1369	Northwestern Memorial Foundation; NATIONAL CANCER INSTITUTE [R01CA059998] Funding Source: NIH RePORTER	Northwestern Memorial Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by a grant from the Northwestern Memorial Foundation.	BARDEESY N, 1995, CANCER RES, V55, P215; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Chung NG, 2008, LEUKEMIA LYMPHOMA, V49, P1616, DOI 10.1080/10428190802105082; Englert C, 1997, CANCER RES, V57, P1429; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Huff V, 1998, AM J MED GENET, V79, P260, DOI 10.1002/(SICI)1096-8628(19981002)79:4<260::AID-AJMG6>3.0.CO;2-Q; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Kim MKH, 2009, P NATL ACAD SCI USA, V106, P11154, DOI 10.1073/pnas.0901591106; Koesters R, 1999, CANCER RES, V59, P3880; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Li CM, 2004, AM J PATHOL, V165, P1943, DOI 10.1016/S0002-9440(10)63246-4; Licht JD, 2008, NEOPLASIA, V10, P69, DOI 10.1593/neo.07869; Maiti S, 2000, CANCER RES, V60, P6288; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Morrison DJ, 2008, MOL CANCER RES, V6, P1225, DOI 10.1158/1541-7786.MCR-08-0078; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; Owen C, 2008, HAEMATOLOGICA, V93, P947, DOI 10.3324/haematol.12509; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Perotti D, 2008, ONCOGENE, V27, P4625, DOI 10.1038/onc.2008.93; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2009, P NATL ACAD SCI USA, V106, P8338, DOI 10.1073/pnas.0811349106; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Ruteshouser EC, 2008, GENE CHROMOSOME CANC, V47, P461, DOI 10.1002/gcc.20553; Schmidt-Ott KM, 2007, DEVELOPMENT, V134, P3177, DOI 10.1242/dev.006544; Strathdee CA, 1999, GENE, V229, P21, DOI 10.1016/S0378-1119(99)00045-1; Wegert J, 2009, GENE CHROMOSOME CANC, V48, P1102, DOI 10.1002/gcc.20712; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; Yoo NJ, 2009, DIGEST DIS SCI, V54, P1011, DOI 10.1007/s10620-008-0458-9	30	8	8	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	7					832	842		10.1038/onc.2010.452	http://dx.doi.org/10.1038/onc.2010.452			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	722OT	20956941				2022-12-25	WOS:000287444600007
J	Strub, GM; Paillard, M; Liang, J; Gomez, L; Allegood, JC; Hait, NC; Maceyka, M; Price, MM; Chen, Q; Simpson, DC; Kordula, T; Milstien, S; Lesnefsky, EJ; Spiegel, S				Strub, Graham M.; Paillard, Melanie; Liang, Jie; Gomez, Ludovic; Allegood, Jeremy C.; Hait, Nitai C.; Maceyka, Michael; Price, Megan M.; Chen, Qun; Simpson, David C.; Kordula, Tomasz; Milstien, Sheldon; Lesnefsky, Edward J.; Spiegel, Sarah			Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration	FASEB JOURNAL			English	Article						SphK2; oxidative phosphorylation; cytochrome-c oxidase	PROTEIN-COUPLED RECEPTORS; CYTOCHROME-C-OXIDASE; CELL-PROLIFERATION; CRISTAE MORPHOGENESIS; ELECTRON-TRANSPORT; MEMBRANE; APOPTOSIS; STRESS; GROWTH; ROLES	The potent lipid mediator sphingosine-1-phosphate (S1P) regulates diverse physiological processes by binding to 5 specific GPCRs, although it also has intracellular targets. Here, we demonstrate that S1P, produced in the mitochondria mainly by sphingosine kinase 2 (SphK2), binds with high affinity and specificity to prohibitin 2 (PHB2), a highly conserved protein that regulates mitochondrial assembly and function. In contrast, S1P did not bind to the closely related protein PHB1, which forms large, multimeric complexes with PHB2. In mitochondria from SphK2-null mice, a new aberrant band of cytochrome-c oxidase was detected by blue native PAGE, and interaction between subunit IV of cytochrome-c oxidase and PHB2 was greatly reduced. Moreover, depletion of SphK2 or PHB2 led to a dysfunction in mitochondrial respiration through cytochrome-c oxidase. Our data point to a new action of S1P in mitochondria and suggest that interaction of S1P with homomeric PHB2 is important for cytochrome-c oxidase assembly and mitochondrial respiration.-Strub, G. M., Paillard, M., Liang, J., Gomez, L., Allegood, J. C., Hait, N. C., Maceyka, M., Price, M. M., Chen, Q., Simpson, D. C., Kordula, T., Milstien, S., Lesnefsky, E. J., Spiegel, S. Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. FASEB J. 25, 600-612 (2011). www.fasebj.org	[Strub, Graham M.; Liang, Jie; Allegood, Jeremy C.; Hait, Nitai C.; Maceyka, Michael; Price, Megan M.; Kordula, Tomasz; Milstien, Sheldon; Lesnefsky, Edward J.; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA; [Paillard, Melanie; Gomez, Ludovic; Chen, Qun; Lesnefsky, Edward J.] Virginia Commonwealth Univ, Dept Med, Sch Med, Richmond, VA 23298 USA; [Simpson, David C.] Virginia Commonwealth Univ, Dept Chem, Sch Med, Richmond, VA 23298 USA; [Strub, Graham M.; Liang, Jie; Allegood, Jeremy C.; Hait, Nitai C.; Maceyka, Michael; Price, Megan M.; Kordula, Tomasz; Spiegel, Sarah] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA; [Chen, Qun; Lesnefsky, Edward J.] McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Paillard, Melanie; Gomez, Ludovic] Univ Lyon 1, Inst Natl Sante & Rech Med INSERM, U886, F-69365 Lyon, France	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Paillard, Mélanie/ABF-7686-2020; Maceyka, Michael/B-9277-2008; Gomez, Ludovic/O-6807-2017; Chen, Qun/HGD-0868-2022; Simpson, David/D-4677-2009	Gomez, Ludovic/0000-0001-8509-4955; Simpson, David/0000-0002-1189-0833; Paillard, Melanie/0000-0002-4912-4915	U.S. National Institutes of Health (NIH) [R37GM043880]; Medical Research Service Department of Veterans Affairs; National Research Service [F30NS058008]; NIH-National Cancer Institute Cancer Center [5P30CA016059];  [P01AG15885];  [EXPLORA'DOC 2009];  [5P30 NS047463]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS058008, P30NS047463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015885] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service Department of Veterans Affairs(US Department of Veterans Affairs); National Research Service; NIH-National Cancer Institute Cancer Center; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institutes of Health (NIH) grant R37GM043880 (S.S.) and, in part, by P01AG15885 and a Medical Research Service Department of Veterans Affairs Merit Review grant (E.J.L.). G.S. was supported by National Research Service Award F30NS058008. M.P. was supported by French grant EXPLORA'DOC 2009. The authors thank Dr. Richard Proia (NIH, Bethesda, MD, USA) for a generous gift of SphK antibodies and the Lipidomics/Metabolomics facility for lipid analyses. Microscopy was performed at the Virginia Commonwealth University Microscopy Facility, supported, in part, by grant 5P30 NS047463 and NIH-National Cancer Institute Cancer Center Core grant 5P30CA016059.	Ahn CS, 2006, PLANT J, V46, P658, DOI 10.1111/j.1365-313X.2006.02726.x; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Berger KH, 1998, MOL CELL BIOL, V18, P4043, DOI 10.1128/MCB.18.7.4043; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Da Cruz S, 2008, BBA-MOL CELL RES, V1783, P904, DOI 10.1016/j.bbamcr.2008.02.006; Ding G, 2007, J BIOL CHEM, V282, P27493, DOI 10.1074/jbc.M701641200; DOWHAN W, 1985, EMBO J, V4, P179, DOI 10.1002/j.1460-2075.1985.tb02334.x; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2; GHOSH TK, 1994, J BIOL CHEM, V269, P22628; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; Heringdorf DMZ, 2003, FEBS LETT, V554, P443, DOI 10.1016/S0014-5793(03)01219-5; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Kuramori C, 2009, BIOCHEM BIOPH RES CO, V379, P519, DOI 10.1016/j.bbrc.2008.12.103; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Matas J, 2009, J MOL CELL CARDIOL, V46, P420, DOI 10.1016/j.yjmcc.2008.10.020; MATTIE M, 1994, J BIOL CHEM, V269, P3181; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; Olivera A, 2006, J BIOL CHEM, V281, P2515, DOI 10.1074/jbc.M508931200; Olivera A, 2003, J BIOL CHEM, V278, P46452, DOI 10.1074/jbc.M308749200; Olivera A, 2007, IMMUNITY, V26, P287, DOI 10.1016/j.immuni.2007.02.008; Oskouian B, 2004, SEMIN CELL DEV BIOL, V15, P529, DOI 10.1016/j.semcdb.2004.05.009; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Paillard M, 2009, J MOL CELL CARDIOL, V46, P902, DOI 10.1016/j.yjmcc.2009.02.017; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Sankala HM, 2007, CANCER RES, V67, P10466, DOI 10.1158/0008-5472.CAN-07-2090; Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200; Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072; Skrzypek MS, 1999, J BACTERIOL, V181, P1134, DOI 10.1128/JB.181.4.1134-1140.1999; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Tsutsumi T, 2009, HEPATOLOGY, V50, P378, DOI 10.1002/hep.22998; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	51	242	248	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					600	612		10.1096/fj.10-167502	http://dx.doi.org/10.1096/fj.10-167502			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20959514	Green Published			2022-12-25	WOS:000286724800018
J	Jones, AK; Rayes, D; Al-Diwani, A; Maynard, TPR; Jones, R; Hernando, G; Buckingham, SD; Bouzat, C; Sattelle, DB				Jones, Andrew K.; Rayes, Diego; Al-Diwani, Adam; Maynard, Thomas P. R.; Jones, Rachel; Hernando, Guillermina; Buckingham, Steven D.; Bouzat, Cecilia; Sattelle, David B.			A Cys-loop Mutation in the Caenorhabditis elegans Nicotinic Receptor Subunit UNC-63 Impairs but Does Not Abolish Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MYASTHENIC SYNDROMES; ACETYLCHOLINE-RECEPTORS; AGONIST BINDING; GENE ENCODES; NEMATODE; INVERTEBRATE; FAMILY; MUSCLE	The nematode Caenorhabditis elegans is an established model organism for studying neurobiology. UNC-63 is a C. elegans nicotinic acetylcholine receptor (nAChR) alpha-subunit. It is an essential component of the levamisole-sensitive muscle nAChR (L-nAChR) and therefore plays an important role in cholinergic transmission at the nematode neuromuscular junction. Here, we show that worms with the unc-63(x26) allele, with its alpha C151Y mutation disrupting the Cys-loop, have deficient muscle function reflected by impaired swimming (thrashing). Single-channel recordings from cultured muscle cells from the mutant strain showed a 100-fold reduced frequency of opening events and shorter channel openings of L-nAChRs compared with those of wild-type worms. Anti-UNC-63 antibody staining in both cultured adult muscle and embryonic cells showed that L-nAChRs were expressed at similar levels in the mutant and wild-type cells, suggesting that the functional changes in the receptor, rather than changes in expression, are the predominant effect of the mutation. The kinetic changes mimic those reported in patients with fast-channel congenital myasthenic syndromes. We show that pyridostigmine bromide and 3,4-diaminopyridine, which are drugs used to treat fast-channel congenital myasthenic syndromes, partially rescued the motility defect seen in unc-63(x26). The C. elegans unc-63(x26) mutant may therefore offer a useful model to assist in the development of therapies for syndromes produced by altered function of human nAChRs.	[Rayes, Diego; Hernando, Guillermina; Bouzat, Cecilia] Univ Nacl Sur, Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Bahia Blanca, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Jones, Andrew K.; Al-Diwani, Adam; Maynard, Thomas P. R.; Jones, Rachel; Buckingham, Steven D.] Univ Oxford, Dept Physiol Anat & Genet, Funct Genom Unit, MRC, Oxford OX1 3QX, England; [Sattelle, David B.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; University of Oxford; University of Manchester	Bouzat, C (corresponding author), Univ Nacl Sur, Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Bahia Blanca, B-8000FWB, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	inbouzat@criba.edu.ar; david.sattelle@dpag.ox.ac.uk	, Diego/AAH-4523-2020	Jones, Andrew/0000-0002-7835-0890; Hernando, Guillermina/0000-0002-8411-5467; Al-Diwani, Adam/0000-0001-6596-7579	Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad Nacional del Sur; Fundacion F. Fiorini; Fondo para la Investigacion Cientifica y Tecnologica; Agencia Nacional de Promocion Cientifica y Tecnologica; Medical Research Council; Royal Society; Medical Research Council [MC_U137761447] Funding Source: researchfish; MRC [MC_U137761447] Funding Source: UKRI	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional del Sur; Fundacion F. Fiorini; Fondo para la Investigacion Cientifica y Tecnologica; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, the Universidad Nacional del Sur, the Fundacion F. Fiorini, and Fondo para la Investigacion Cientifica y Tecnologica, Agencia Nacional de Promocion Cientifica y Tecnologica (to C.B.); the Medical Research Council (to S.D.B., A.A.-D., A.K.J., T.P.R.M., and R.J.); and a Royal Society International Joint Project Award (to C.B. and D.B.S.).	Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Bartos M, 2009, MOL NEUROBIOL, V40, P236, DOI 10.1007/s12035-009-8084-x; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Bouzat C, 2000, J GEN PHYSIOL, V115, P663, DOI 10.1085/jgp.115.5.663; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; BRENNER S, 1974, GENETICS, V77, P71; Buckingham SD, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-84; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; Culetto E, 2000, HUM MOL GENET, V9, P869, DOI 10.1093/hmg/9.6.869; Duerr Janet S, 2006, WormBook, P1; Eimer S, 2007, EMBO J, V26, P4313, DOI 10.1038/sj.emboj.7601858; Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fleming JT, 1997, J NEUROSCI, V17, P5843; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Francis MM, 2003, TRENDS NEUROSCI, V26, P90, DOI 10.1016/S0166-2236(02)00041-3; Green WN, 1997, J BIOL CHEM, V272, P20945, DOI 10.1074/jbc.272.33.20945; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harris TW, 2004, NUCLEIC ACIDS RES, V32, pD411, DOI 10.1093/nar/gkh066; Jones AK, 2004, BIOESSAYS, V26, P39, DOI 10.1002/bies.10377; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P129, DOI 10.1007/s10158-007-0049-z; Kaas B, 2010, INVERTEBR NEUROSCI, V10, P17, DOI 10.1007/s10158-010-0101-2; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; KAO PN, 1986, J BIOL CHEM, V261, P8085; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Milone M, 1998, ANN NY ACAD SCI, V841, P184, DOI 10.1111/j.1749-6632.1998.tb10925.x; Mueller Juliane S., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000427; Rand James B, 2007, WormBook, P1; Rayes D, 2007, MOL PHARMACOL, V71, P1407, DOI 10.1124/mol.106.033514; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Salkoff L, 2005, WormBook, P1; Sattelle David B., 2006, Invertebrate Neuroscience, V6, P1, DOI 10.1007/s10158-005-0014-7; Segalat L, 2007, ACS CHEM BIOL, V2, P231, DOI 10.1021/cb700009m; Shen XM, 2003, J CLIN INVEST, V111, P497, DOI 10.1172/JC1200316997; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Towers PR, 2005, J NEUROCHEM, V93, P1, DOI 10.1111/j.1471-4159.2004.02951.x; Vincent A, 2000, EUR J BIOCHEM, V267, P6717, DOI 10.1046/j.1432-1327.2000.01785.x; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	43	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2550	2558		10.1074/jbc.M110.177238	http://dx.doi.org/10.1074/jbc.M110.177238			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	20966081	Green Published, hybrid			2022-12-25	WOS:000286464300020
J	Kuehn, HS; Jung, MY; Beaven, MA; Metcalfe, DD; Gilfillan, AM				Kuehn, Hye Sun; Jung, Mi-Yeon; Beaven, Michael A.; Metcalfe, Dean D.; Gilfillan, Alasdair M.			Prostaglandin E-2 Activates and Utilizes mTORC2 as a Central Signaling Locus for the Regulation of Mast Cell Chemotaxis and Mediator Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; NF-KAPPA-B; REACTIVE OXYGEN; RAC ACTIVATION; PROTEIN-KINASE; RESPONSES; RECEPTORS; DEGRANULATION; PATHWAYS; PHOSPHORYLATION	Prostaglandin (PG) E-2, a potent mediator produced in inflamed tissues, can substantially influence mast cell responses including adhesion to basement membrane proteins, chemotaxis, and chemokine production. However, the signaling pathways by which PGE(2) induces mast cell chemotaxis and chemokine production remains undefined. In this study, we identified the downstream target of phosphatidylinositol 3-kinase, mammalian target of rapamycin (mTOR), as a key regulator of these responses. In mouse bone marrow-derived mast cells, PGE(2) was found to induce activation of mTORC1 (mTOR complexed to raptor) as indicated by increased p70S6K and 4E-BP1 phosphorylation, and activation of mTORC2 (mTOR complexed to rictor), as indicated by increased phosphorylation of AKT at position Ser(473). Selective inhibition of the mTORC1 cascade by rapamycin or by the use of raptor-targeted shRNA failed to decrease PGE(2)-mediated chemotaxis or chemokine generation. However, inhibition of the mTORC2 cascade through the dual mTORC1/mTORC2 inhibitor Torin, or through rictor-targeted shRNA, resulted in a significant attenuation in PGE2-mediated chemotaxis, which was associated with a comparable decrease in actin polymerization. Furthermore, mTORC2 down-regulation decreased PGE(2)-induced production of the chemokine monocyte chemoattractant protein-1 (CCL2), which was linked to a significant reduction in ROS production. These findings are consistent with the conclusion that activation of mTORC2, downstream of PI3K, represents a critical signaling locus for chemotaxis and chemokine release from PGE(2)-activated mast cells.	[Gilfillan, Alasdair M.] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Beaven, Michael A.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gilfillan, AM (corresponding author), NIAID, Lab Allerg Dis, NIH, Bldg 10,Rm 11C206,10 Ctr Dr,MSC 1881, Bethesda, MD 20892 USA.	agilfillan@niaid.nih.gov			NIAID; NHLBI within the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000965] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI within the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by the Division of Intramural Research of NIAID and NHLBI within the National Institutes of Health.	Ali K, 2008, J IMMUNOL, V180, P2538, DOI 10.4049/jimmunol.180.4.2538; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; Beaven MA, 2009, EUR J IMMUNOL, V39, P11, DOI 10.1002/eji.200838899; Bonazzi A, 2000, AM J RESP CRIT CARE, V162, P2272, DOI 10.1164/ajrccm.162.6.2003127; CHUNG KF, 2005, SCI STKE, pPE47; Cloutier A, 2007, J LEUKOCYTE BIOL, V81, P567, DOI 10.1189/jlb.0806536; DELPRETE G, 1992, ALLERGY, V47, P450; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Faour WH, 2001, J BIOL CHEM, V276, P31720, DOI 10.1074/jbc.M104036200; Feng CL, 2006, BLOOD, V107, P3243, DOI 10.1182/blood-2005-07-2772; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gomi K, 2000, J IMMUNOL, V165, P6545, DOI 10.4049/jimmunol.165.11.6545; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; HIRASAWA N, 1995, J IMMUNOL, V154, P5391; Hogaboam G, 1998, J IMMUNOL, V160, P6166; HUMES JL, 1977, NATURE, V269, P149, DOI 10.1038/269149a0; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kay LJ, 2006, BRIT J PHARMACOL, V147, P707, DOI 10.1038/sj.bjp.0706664; Kim MS, 2008, TRENDS IMMUNOL, V29, P493, DOI 10.1016/j.it.2008.07.004; Kim MS, 2008, J IMMUNOL, V180, P4586, DOI 10.4049/jimmunol.180.7.4586; Kirshenbaum Arnold S, 2006, Methods Mol Biol, V315, P105; Kitaura J, 2000, J EXP MED, V192, P729, DOI 10.1084/jem.192.5.729; Kraft S, 2004, INT ARCH ALLERGY IMM, V135, P62, DOI 10.1159/000080231; Kuehn HS, 2008, CELL SIGNAL, V20, P625, DOI 10.1016/j.cellsig.2007.11.016; Kuehn HS, 2007, IMMUNOL LETT, V113, P59, DOI 10.1016/j.imlet.2007.08.007; Kuehn HS, 2010, J CELL SCI, V123, P2576, DOI 10.1242/jcs.071043; Kuehn HS, 2008, J IMMUNOL, V181, P7706, DOI 10.4049/jimmunol.181.11.7706; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MADDEN KB, 1991, J IMMUNOL, V147, P1387; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; MEININGER CJ, 1992, BLOOD, V79, P958; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Nakayama T, 2006, J LEUKOCYTE BIOL, V79, P95, DOI 10.1189/jlb.0405226; Nguyen MT, 2002, J IMMUNOL, V169, P4586, DOI 10.4049/jimmunol.169.8.4586; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sakanaka M, 2008, AM J PHYSIOL-CELL PH, V295, pC1427, DOI 10.1152/ajpcell.00218.2008; Samayawardhena LA, 2007, BLOOD, V109, P3679, DOI 10.1182/blood-2006-11-057315; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Swindle EJ, 2007, J IMMUNOL, V179, P7059, DOI 10.4049/jimmunol.179.10.7059; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tkaczyk C, 2003, J BIOL CHEM, V278, P48474, DOI 10.1074/jbc.M301350200; Tkaczyk C, 2002, J IMMUNOL METHODS, V268, P239, DOI 10.1016/S0022-1759(02)00210-7; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Weller CL, 2007, P NATL ACAD SCI USA, V104, P11712, DOI 10.1073/pnas.0701700104; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	54	57	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					391	402		10.1074/jbc.M110.164772	http://dx.doi.org/10.1074/jbc.M110.164772			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980255	hybrid, Green Published			2022-12-25	WOS:000285782800042
J	Voss, I; Goss, T; Murozuka, E; Altmann, B; McLean, KJ; Rigby, SEJ; Munro, AW; Scheibe, R; Hase, T; Hanke, GT				Voss, Ingo; Goss, Tatjana; Murozuka, Emiko; Altmann, Bianca; McLean, Kirsty J.; Rigby, Stephen E. J.; Munro, Andrew W.; Scheibe, Renate; Hase, Toshiharu; Hanke, Guy T.			FdC1, a Novel Ferredoxin Protein Capable of Alternative Electron Partitioning, Increases in Conditions of Acceptor Limitation at Photosystem I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUNDLE-SHEATH-CELLS; ARABIDOPSIS-THALIANA; FUNCTIONAL INTERACTION; NITRITE REDUCTASE; QUANTUM YIELD; REDOX SIGNALS; NUCLEAR GENES; EXPRESSION; SPINACH; CHLOROPLAST	In higher plants, [2Fe-2S] ferredoxin (Fd) proteins are the unique electron acceptors from photosystem I (PSI). Fds are soluble, and distribute electrons to many enzymes, including Fd: NADP(H) reductase (FNR), for the photoreduction of NADP(+). In addition to well studied [2Fe-2S] Fd proteins, higher plants also possess genes for significantly different, as yet uncharacterized Fd proteins, with extended C termini (FdCs). Whether these FdC proteins function as photosynthetic electron transfer proteins is not known. We examined whether these proteins play a role as alternative electron acceptors at PSI, using quantitative RT-PCR to follow how their expression changes in response to acceptor limitation at PSI, in mutant Arabidopsis plants lacking 90-95% of photosynthetic [2Fe-2S] Fd. Expression of the gene encoding one FdC protein, FdC1, was identified as being strongly up-regulated. We confirmed that this protein was chloroplast localized and increased in abundance on PSI acceptor limitation. We purified the recombinant FdC1 protein, which exhibited a UV-visible spectrum consistent with a [2Fe-2S] cluster, confirmed by EPR analysis. Measurements of electron transfer show that FdC1 is capable of accepting electrons from PSI, but cannot support photoreduction of NADP(+). Whereas FdC1 was capable of electron transfer with FNR, redox potentiometry showed that it had a more positive redox potential than photosynthetic Fds by around 220 mV. These results indicate that FdC1 electron donation to FNR is prevented because it is thermodynamically unfavorable. Based on our data, we speculate that FdC1 has a specific function in conditions of acceptor limitation at PSI, and channels electrons away from NADP(+) photoreduction.	[Voss, Ingo; Goss, Tatjana; Altmann, Bianca; Scheibe, Renate; Hanke, Guy T.] Univ Osnabruck, Dept Plant Physiol, D-49076 Osnabruck, Germany; [Murozuka, Emiko; Hase, Toshiharu] Osaka Univ, Lab Regulat Biol React, Inst Prot Res, Suita, Osaka 5650871, Japan; [McLean, Kirsty J.; Rigby, Stephen E. J.; Munro, Andrew W.] Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, Manchester M1 7DN, Lancs, England	University Osnabruck; Osaka University; University of Manchester	Hanke, GT (corresponding author), Univ Osnabruck, Dept Plant Physiol, Barbara Str 11, D-49076 Osnabruck, Germany.	Guy.Hanke@biologie.uni-osnabrueck.DE	Hase, Toshiharu/H-9271-2013; McLean, Kirsty J/GXI-2853-2022; Munro, Andrew/G-5639-2019	Munro, Andrew/0000-0002-4642-180X; Hanke, Guy/0000-0002-6167-926X; McLean, Kirsty/0000-0002-7193-5044	Deutsche Forschungsgemeinschaft [HA5921/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant HA5921/1-1.	ALIVERTI A, 1995, FEBS LETT, V368, P220, DOI 10.1016/0014-5793(95)00648-S; ARNON DI, 1963, SCIENCE, V140, P378, DOI 10.1126/science.140.3565.378; Asada K, 2000, PHILOS T ROY SOC B, V355, P1419, DOI 10.1098/rstb.2000.0703; Backhausen JE, 2000, PHOTOSYNTH RES, V64, P1, DOI 10.1023/A:1026523809147; Backhausen JE, 1998, PLANTA, V207, P105, DOI 10.1007/s004250050461; Becker B, 2006, PLANTA, V224, P380, DOI 10.1007/s00425-006-0222-3; Dal Bosco C, 2004, J BIOL CHEM, V279, P1060, DOI 10.1074/jbc.M308435200; DEMMIG B, 1987, PLANT PHYSIOL, V84, P218, DOI 10.1104/pp.84.2.218; Dunford AJ, 2007, BIOCHEMISTRY-US, V46, P5018, DOI 10.1021/bi7001339; Dutton P L, 1978, Methods Enzymol, V54, P411; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; ESCOUBAS JM, 1995, P NATL ACAD SCI USA, V92, P10237, DOI 10.1073/pnas.92.22.10237; Fey V, 2005, J BIOL CHEM, V280, P5318, DOI 10.1074/jbc.M406358200; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gou P, 2006, BIOCHEMISTRY-US, V45, P14389, DOI 10.1021/bi061779d; Hanke GT, 2004, PLANT PHYSIOL, V134, P255, DOI 10.1104/pp.103.032755; Hanke GT, 2008, PLANT CELL ENVIRON, V31, P1017, DOI 10.1111/j.1365-3040.2008.01814.x; Hanke GT, 2008, PHOTOCHEM PHOTOBIOL, V84, P1302, DOI 10.1111/j.1751-1097.2008.00411.x; HASE T, 1991, PLANT PHYSIOL, V96, P77, DOI 10.1104/pp.96.1.77; HEDERSTEDT L, 1985, J BIOL CHEM, V260, P5554; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Holtgrefe S, 2003, PLANT PHYSIOL, V133, P1768, DOI 10.1104/pp.103.026013; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; HOSLER JP, 1985, BIOCHIM BIOPHYS ACTA, V808, P21, DOI 10.1016/0005-2728(85)90023-4; Jacobs J, 2009, FEBS LETT, V583, P325, DOI 10.1016/j.febslet.2008.12.018; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; Kanervo E, 2005, PHOTOCH PHOTOBIO SCI, V4, P1072, DOI 10.1039/b507866k; KIMATA Y, 1989, PLANT PHYSIOL, V89, P1193, DOI 10.1104/pp.89.4.1193; Kimata-Ariga Y, 2000, EMBO J, V19, P5041, DOI 10.1038/sj.emboj.7593319; KLUGHAMMER C, 1994, PLANTA, V192, P261, DOI 10.1007/BF01089043; Knaff D. B., 1996, ADV PHOTOSYNTHESIS O, P333; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; LELONG C, 1994, J BIOL CHEM, V269, P10034; Matsumura T, 1999, PLANT PHYSIOL, V119, P481, DOI 10.1104/pp.119.2.481; MCSWAIN BD, 1968, P NATL ACAD SCI USA, V61, P989, DOI 10.1073/pnas.61.3.989; MIYAKE C, 1994, PLANT CELL PHYSIOL, V35, P539, DOI 10.1093/oxfordjournals.pcp.a078628; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Nakamura K, 2006, J BIOL CHEM, V281, P36758, DOI 10.1074/jbc.M606797200; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; PARDO MB, 1990, ARCH MICROBIOL, V153, P528, DOI 10.1007/BF00245260; Pfannschmidt T, 2001, J BIOL CHEM, V276, P36125, DOI 10.1074/jbc.M105701200; Piippo M, 2006, PHYSIOL GENOMICS, V25, P142, DOI 10.1152/physiolgenomics.00256.2005; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHMITZ S, 1995, BBA-BIOENERGETICS, V1231, P335, DOI 10.1016/0005-2728(95)00097-3; Seidel T, 2004, J BIOTECHNOL, V112, P165, DOI 10.1016/j.jbiotec.2004.04.027; SHIN M, 1965, J BIOL CHEM, V240, P1405; Snyrychova I, 2006, PHOTOCH PHOTOBIO SCI, V5, P472, DOI 10.1039/b514394b; SUZUKI A, 1985, PLANT PHYSIOL, V78, P374, DOI 10.1104/pp.78.2.374; TERASHIMA I, 1985, PLANT CELL PHYSIOL, V26, P63; VANCAMP W, 1994, BIO-TECHNOL, V12, P165, DOI 10.1038/nbt0294-165; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; VIDAKOVIC M, 1995, BIOCHEMISTRY-US, V34, P13906, DOI 10.1021/bi00042a023; VORST O, 1993, PLANT J, V3, P793, DOI 10.1111/j.1365-313X.1993.00793.x; Voss I, 2008, PHYSIOL PLANTARUM, V133, P584, DOI 10.1111/j.1399-3054.2008.01112.x; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	59	39	45	1	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					50	59		10.1074/jbc.M110.161562	http://dx.doi.org/10.1074/jbc.M110.161562			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20966083	hybrid, Green Published			2022-12-25	WOS:000285782800006
J	Wang, AP; Liu, ML; Liu, XL; Dong, LQ; Glickman, RD; Slaga, TJ; Zhou, ZG; Liu, F				Wang, Anping; Liu, Meilian; Liu, Xianling; Dong, Lily Q.; Glickman, Randolph D.; Slaga, Thomas J.; Zhou, Zhiguang; Liu, Feng			Up-regulation of Adiponectin by Resveratrol THE ESSENTIAL ROLES OF THE Akt/FOXO1 AND AMP-ACTIVATED PROTEIN KINASE SIGNALING PATHWAYS AND DsbA-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR FOXO1; DSBA-L; GENE-EXPRESSION; ADIPOSE-TISSUE; SIRT1; MICE; MECHANISM; CELLS; PHOSPHORYLATION	The natural polyphenol resveratrol (RSV) displays a wide spectrum of health beneficial activities, yet the precise mechanisms remain to be fully elucidated. Here we show that RSV promotes the multimerization and cellular levels of adiponectin in 3T3-L1 adipocytes. The stimulatory effect of RSV was not affected by knocking out Sirt1, but was diminished by suppressing the expression levels of DsbA-L, a recently identified adiponectin-interactive protein that promotes adiponectin multimerization. Suppression of the Akt signaling pathway resulted in an increase in the expression levels of DsbA-L and adiponectin. On the other hand, knocking out FOXO1 or suppressing the activity or expression levels of the AMP-activated protein kinase (AMPK) down-regulated DsbA-L and adiponectin. The stimulatory effect of RSV on adiponectin and DsbA-L expression was completely diminished in FOXO1-suppressed and AMPK-inactivated 3T3-L1 adipocytes. Taken together, our results demonstrate that RSV promotes adiponectin multimerization in 3T3-L1 adipocytes via a Sirt1-independent mechanism. In addition, we show that the stimulatory effect of RSV is regulated by both the Akt/FOXO1 and the AMPK signaling pathways. Last, we show that DsbA-L plays a critical role in the promoting effect of RSV on adiponectin multimerization and cellular levels.	[Wang, Anping; Liu, Meilian; Slaga, Thomas J.; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Glickman, Randolph D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Zhou, Zhiguang; Liu, Feng] Cent S Univ, Metab Syndrome Res Ctr, Xiangya Hosp 2, Xiangya 410011, Hunan, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Central South University	Liu, ML (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.	lium2@uthscsa.edu; liuf@uthscsa.edu	Liu, Feng/CAG-8962-2022	Zhou, Zhiguang/0000-0002-0374-1838	National Institutes of Health [RO1 DK76902, DK69930]; San Antonio Life Sciences Institute (SALSI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076902, R56DK069930, R01DK069930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); San Antonio Life Sciences Institute (SALSI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK76902 (to F.L.) and DK69930 (to L.Q.D.) and a Research Award from the San Antonio Life Sciences Institute (SALSI) (to T.J.S., R.D.G., and F.L.).	Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Chen HY, 2008, VISION RES, V48, P690, DOI 10.1016/j.visres.2007.10.014; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Fisher FM, 2005, DIABETOLOGIA, V48, P1084, DOI 10.1007/s00125-005-1758-7; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lim MA, 2003, P NATL ACAD SCI USA, V100, P14006, DOI 10.1073/pnas.2335486100; Liu ML, 2010, J BIOL CHEM, V285, P36387, DOI 10.1074/jbc.M110.169284; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Mader I, 2010, FASEB J, V24, P1997, DOI 10.1096/fj.09-142943; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mustafi SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008719; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Riojas RA, 2006, J BIOL CHEM, V281, P21588, DOI 10.1074/jbc.M600393200; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Srivastava RK, 2010, MOL CELL BIOCHEM, V337, P201, DOI 10.1007/s11010-009-0300-5; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang ZV, 2008, P NATL ACAD SCI USA, V105, P18077, DOI 10.1073/pnas.0810027105; Zang MW, 2006, DIABETES, V55, pA13; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412	40	69	79	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					60	66		10.1074/jbc.M110.188144	http://dx.doi.org/10.1074/jbc.M110.188144			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980258	Green Published, hybrid			2022-12-25	WOS:000285782800007
J	Walther, C; Nagel, S; Gimenez, LE; Morl, K; Gurevich, VV; Beck-Sickinger, AG				Walther, Cornelia; Nagel, Stefanie; Gimenez, Luis E.; Moerl, Karin; Gurevich, Vsevolod V.; Beck-Sickinger, Annette G.			Ligand-induced Internalization and Recycling of the Human Neuropeptide Y-2 Receptor Is Regulated by Its Carboxyl-terminal Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; RESONANCE ENERGY-TRANSFER; MUSCARINIC ACETYLCHOLINE-RECEPTOR; ACIDIC AMINO-ACIDS; BETA-ARRESTIN; Y-RECEPTORS; C-TERMINUS; PHOSPHORYLATION SITES; DIFFERENTIAL DISTRIBUTION; THREONINE RESIDUES	Agonist-induced internalization of G protein-coupled receptors plays an important role in signal regulation. The underlying mechanisms of the internalization of the human neuropeptide Y-2 receptor (hY(2)R), as well as its desensitization, endocytosis, and resensitization are mainly unknown. In the present study we have investigated the role of carboxyl-terminal (C-terminal) Ser/Thr residues and acidic amino acids in regulating receptor internalization, arrestin interaction, and recycling by fluorescence microscopy, cell surface enzyme-linked immunosorbent assay, and bioluminescence resonance energy transfer in several cell lines. Strikingly, C-terminal truncation mutants revealed two different internalization motifs. Whereas a distal motif (DSXTEXT379)-D-373 was found to be the primary regulatory internalization sequence acting in concert with arrestin-3, the proximal motif (DXXXSEX)-D-347-SXT356 promoted ligand-induced internalization in an arrestin-3-independent manner. Moreover, we identified a regulatory sequence located between these internalization motifs ((357)FKAKKNLEVRKN(368)), which serves as an inhibitory element. We found that hY(2)R recycling is also governed by structural determinants within the proximal internalization motif. In conclusion, these results indicate that the hY(2)R C terminus is involved in multiple molecular events that regulate internalization, interaction with arrestin-3, and receptor resensitization. Our findings provide novel insights into complex mechanisms of controlled internalization of hY(2)R, which is likely applicable to other GPCRs.	[Walther, Cornelia; Nagel, Stefanie; Moerl, Karin; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany; [Gimenez, Luis E.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Leipzig University; Vanderbilt University	Beck-Sickinger, AG (corresponding author), Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, Bruderstr 34, D-04103 Leipzig, Germany.	beck-sickinger@uni-leipzig.de	Gurevich, Vsevolod/A-3236-2008; Gimenez, Luis E Diaz/D-9291-2011	Gurevich, Vsevolod/0000-0002-3950-5351; Diaz Gimenez, Luis Eduardo/0000-0002-0110-2135	National Institutes of Health [GM081756]; Deutsche Forschungsgemeinschaft [SFB-610/TP-A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081756 (to V.V.G.) and Deutsche Forschungsgemeinschaft (AGB-S) Grant SFB-610/TP-A1.	BECKSICKINGER AG, 1994, EUR J BIOCHEM, V225, P947, DOI 10.1111/j.1432-1033.1994.0947b.x; Berglund MM, 2003, J PHARMACOL EXP THER, V306, P147, DOI 10.1124/jpet.103.051227; Bohme I, 2008, CELL SIGNAL, V20, P1740, DOI 10.1016/j.cellsig.2008.05.017; Bohme I, 2007, PEPTIDES, V28, P226, DOI 10.1016/j.peptides.2006.08.042; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Cabrele C, 2000, J PEPT SCI, V6, P97, DOI 10.1002/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Dinger MC, 2003, J BIOL CHEM, V278, P10562, DOI 10.1074/jbc.M205747200; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; DUMONT Y, 1990, EUR J PHARMACOL, V191, P501, DOI 10.1016/0014-2999(90)94189-5; El Bahh B, 2005, EUR J NEUROSCI, V22, P1417, DOI 10.1111/j.1460-9568.2005.04338.x; FLOOD JF, 1989, PEPTIDES, V10, P963, DOI 10.1016/0196-9781(89)90176-9; Gicquiaux H, 2002, J BIOL CHEM, V277, P6645, DOI 10.1074/jbc.M107224200; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Haack M, 2009, CHEM BIOL DRUG DES, V73, P573, DOI 10.1111/j.1747-0285.2009.00823.x; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Herzog H, 2003, EUR J PHARMACOL, V480, P21, DOI 10.1016/j.ejphar.2003.08.089; Hofliger MM, 2003, J RECEPT SIG TRANSD, V23, P351, DOI 10.1081/RRS-120026974; Holliday ND, 2005, MOL PHARMACOL, V67, P655, DOI 10.1124/mol.104.006114; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Jones BW, 2007, J BIOL CHEM, V282, P12893, DOI 10.1074/jbc.M610854200; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Karoor V, 1998, J BIOL CHEM, V273, P33035, DOI 10.1074/jbc.273.49.33035; Karra E, 2009, J PHYSIOL-LONDON, V587, P19, DOI 10.1113/jphysiol.2008.164269; Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kilpatrick LE, 2010, BRIT J PHARMACOL, V160, P892, DOI 10.1111/j.1476-5381.2010.00676.x; Kocan M, 2009, METHODS MOL BIOL, V552, P305, DOI 10.1007/978-1-60327-317-6_22; Korner M, 2007, PEPTIDES, V28, P419, DOI 10.1016/j.peptides.2006.08.037; Krueger KM, 1997, J BIOL CHEM, V272, P5; Kule CE, 2004, REGUL PEPTIDES, V120, P141, DOI 10.1016/j.regpep.2004.03.001; Kuravi S, 2010, BIOPHYS J, V98, P2391, DOI 10.1016/j.bpj.2010.02.004; Lee KB, 2000, J BIOL CHEM, V275, P35767, DOI 10.1074/jbc.M002225200; Lee KB, 2000, J BIOL CHEM, V275, P9284, DOI 10.1074/jbc.275.13.9284; Lindner D, 2008, NUTRITION, V24, P907, DOI 10.1016/j.nut.2008.06.025; Lindner D, 2008, BIOCHEMISTRY-US, V47, P5905, DOI 10.1021/bi800181k; Lindner D, 2009, CELL SIGNAL, V21, P61, DOI 10.1016/j.cellsig.2008.09.007; Liu Q, 2008, MOL PHARMACOL, V73, P292, DOI 10.1124/mol.107.038570; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Merten N, 2007, J BIOL CHEM, V282, P7543, DOI 10.1074/jbc.M608902200; Millar RP, 2010, MOL ENDOCRINOL, V24, P261, DOI 10.1210/me.2009-0473; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mundell SJ, 2010, BRIT J PHARMACOL, V159, P518, DOI 10.1111/j.1476-5381.2009.00598.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; Ouedraogo M, 2008, TRAFFIC, V9, P305, DOI 10.1111/j.1600-0854.2007.00691.x; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Parker E, 2002, EUR J PHARMACOL, V440, P173, DOI 10.1016/S0014-2999(02)01427-9; Parker SL, 2001, EUR J BIOCHEM, V268, P877, DOI 10.1046/j.1432-1327.2001.01966.x; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Potter RM, 2006, J IMMUNOL, V176, P5418, DOI 10.4049/jimmunol.176.9.5418; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P1130, DOI 10.1074/jbc.270.3.1130; Rana BK, 2001, ANNU REV PHARMACOL, V41, P593, DOI 10.1146/annurev.pharmtox.41.1.593; Reiner S, 2009, MOL PHARMACOL, V76, P1162, DOI 10.1124/mol.109.060467; Reubi JC, 2003, ENDOCR REV, V24, P389, DOI 10.1210/er.2002-0007; Reubi JC, 2001, CANCER RES, V61, P4636; Richardson MD, 2003, J NEUROCHEM, V84, P854, DOI 10.1046/j.1471-4159.2003.01577.x; Roy SJ, 2010, EUR J PHARMACOL, V630, P10, DOI 10.1016/j.ejphar.2009.12.022; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; SHEIKH SP, 1989, J BIOL CHEM, V264, P6648; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Smith-White MA, 2001, BRIT J PHARMACOL, V132, P861, DOI 10.1038/sj.bjp.0703879; Spiegel AM, 1996, ANNU REV PHYSIOL, V58, P143, DOI 10.1146/annurev.ph.58.030196.001043; Thomas WG, 1998, MOL ENDOCRINOL, V12, P1513, DOI 10.1210/me.12.10.1513; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Whistler JL, 2001, J BIOL CHEM, V276, P34331, DOI 10.1074/jbc.M104627200; WIDDOWSON PS, 1993, BRAIN RES, V631, P27, DOI 10.1016/0006-8993(93)91182-R; Zhang X, 2005, J NEUROCHEM, V95, P169, DOI 10.1111/j.1471-4159.2005.03352.x	76	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41578	41590		10.1074/jbc.M110.162156	http://dx.doi.org/10.1074/jbc.M110.162156			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959467	Green Published, hybrid			2022-12-25	WOS:000285622600045
J	Eto, K; Noda, Y; Horikawa, S; Uchida, S; Sasaki, S				Eto, Kayoko; Noda, Yumi; Horikawa, Saburo; Uchida, Shinichi; Sasaki, Sei			Phosphorylation of Aquaporin-2 Regulates Its Water Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL AQUAPORIN-2; COLLECTING DUCT; TRAFFICKING; KIDNEY; VESICLES; ACTIN; AQP2; PATHOPHYSIOLOGY; IDENTIFICATION; SERINE-261	Vasopressin-regulated water reabsorption through the water channel aquaporin-2 (AQP2) in renal collecting ducts maintains body water homeostasis. Vasopressin activates PKA, which phosphorylates AQP2, and this phosphorylation event is required to increase the water permeability and water reabsorption of the collecting duct cells. It has been established that the phosphorylation of AQP2 induces its apical membrane insertion, rendering the cell water-permeable. However, whether this phosphorylation regulates the water permeability of this channel still remains unclear. To clarify the role of AQP2 phosphorylation in water permeability, we expressed recombinant human AQP2 in Escherichia coli, purified it, and reconstituted it into proteoliposomes. AQP2 proteins not reconstituted into liposomes were removed by fractionating on density step gradients. AQP2-reconstituted liposomes were then extruded through polycarbonate filters to obtain unilamellar vesicles. PKA phosphorylation significantly increased the osmotic water permeability of AQP2-reconstituted liposomes. We then examined the roles of AQP2 phosphorylation at Ser-256 and Ser-261 in the regulation of water permeability using phosphorylation mutants reconstituted into proteoliposomes. The water permeability of the non-phosphorylation-mimicking mutant S256A-AQP2 and non-phosphorylated WT-AQP2 was similar, and that of the phosphorylation-mimicking mutant S256D-AQP2 and phosphorylated WT-AQP2 was similar. The water permeability of S261A-AQP2 and S261D-AQP2 was similar to that of non-phosphorylated WT-AQP2. This study shows that PKA phosphorylation of AQP2 at Ser-256 enhances its water permeability.	[Noda, Yumi] Tokyo Med & Dent Univ, Dept Nephrol, Bunkyo Ku, Tokyo 1138519, Japan; [Horikawa, Saburo] Tokyo Med & Dent Univ, Div Pathophysiol, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Noda, Y (corresponding author), Tokyo Med & Dent Univ, Dept Nephrol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	ynodmed2@tmd.ac.jp	Uchida, Shinichi/D-1111-2013		Japan Society for the Promotion of Science [17GS0312, 21591053]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid 17GS0312 and 21591053 from the Japan Society for the Promotion of Science.	Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; Christensen BM, 2000, AM J PHYSIOL-RENAL, V278, pF29, DOI 10.1152/ajprenal.2000.278.1.F29; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gunnarson E, 2008, GLIA, V56, P587, DOI 10.1002/glia.20627; Hedfalk K, 2006, CURR OPIN STRUC BIOL, V16, P447, DOI 10.1016/j.sbi.2006.06.009; Higashimoto Y, 2000, J BIOL CHEM, V275, P23199, DOI 10.1074/jbc.M002674200; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2009, J BIOL CHEM, V284, P14683, DOI 10.1074/jbc.R900006200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001; KUWAHARA M, 1995, J BIOL CHEM, V270, P10384, DOI 10.1074/jbc.270.18.10384; Lande MB, 1996, J BIOL CHEM, V271, P5552, DOI 10.1074/jbc.271.10.5552; Li YH, 2009, INT J BIOCHEM CELL B, V41, P2466, DOI 10.1016/j.biocel.2009.07.017; Loonen AJM, 2008, SEMIN NEPHROL, V28, P252, DOI 10.1016/j.semnephrol.2008.03.006; Lu HJ, 2008, AM J PHYSIOL-RENAL, V295, pF290, DOI 10.1152/ajprenal.00072.2008; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Moeller HB, 2009, AM J PHYSIOL-RENAL, V296, pF649, DOI 10.1152/ajprenal.90682.2008; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Nishimoto G, 1999, AM J PHYSIOL-RENAL, V276, pF254, DOI 10.1152/ajprenal.1999.276.2.F254; Noda Y, 2005, BIOCHEM BIOPH RES CO, V330, P1041, DOI 10.1016/j.bbrc.2005.03.079; Noda Y, 2004, BIOCHEM BIOPH RES CO, V322, P740, DOI 10.1016/j.bbrc.2004.07.195; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Noda Y, 2008, J CELL BIOL, V182, P587, DOI 10.1083/jcb.200709177; Noda Y, 2008, PFLUG ARCH EUR J PHY, V456, P737, DOI 10.1007/s00424-007-0404-2; Noda Y, 2006, BBA-BIOMEMBRANES, V1758, P1117, DOI 10.1016/j.bbamem.2006.03.004; Noda Y, 2010, NAT REV NEPHROL, V6, P168, DOI 10.1038/nrneph.2009.231; Nyblom M, 2009, J MOL BIOL, V387, P653, DOI 10.1016/j.jmb.2009.01.065; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Xie LK, 2010, AM J PHYSIOL-RENAL, V298, pF1018, DOI 10.1152/ajprenal.00580.2009; Yamashita Y, 2000, AM J PHYSIOL-RENAL, V278, pF395, DOI 10.1152/ajprenal.2000.278.3.F395; Zelenina M, 2002, AM J PHYSIOL-RENAL, V283, pF309, DOI 10.1152/ajprenal.00260.2001	36	56	57	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40777	40784		10.1074/jbc.M110.151928	http://dx.doi.org/10.1074/jbc.M110.151928			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20971851	Green Published, hybrid			2022-12-25	WOS:000285414400042
J	Aquilini, E; Azevedo, J; Merino, S; Jimenez, N; Tomas, JM; Regue, M				Aquilini, Eleonora; Azevedo, Joana; Merino, Susana; Jimenez, Natalia; Tomas, Juan M.; Regue, Miguel			Three Enzymatic Steps Required for the Galactosamine Incorporation into Core Lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; PROTEUS-MIRABILIS; POLYACRYLAMIDE GELS; REGION; OLIGOSACCHARIDE; BIOSYNTHESIS; GENE; IDENTIFICATION; INFECTION	The core lipopolysaccharides (LPS) of Proteus mirabilis as well as those of Klebsiella pneumoniae and Serratia marcescens are characterized by the presence of a hexosamine-galacturonic acid disaccharide (alpha HexN-(1,4)-alpha GalA) attached by an alpha 1,3 linkage to L-glycero-D-manno-heptopyranose II (L-glycero-alpha-D-manno-heptosepyranose II). In K. pneumoniae, S. marcescens, and some P. mirabilis strains, HexN is D-glucosamine, whereas in other P. mirabilis strains, it corresponds to D-galactosamine. Previously, we have shown that two enzymes are required for the incorporation of D-glucosamine into the core LPS of K. pneumoniae; the WabH enzyme catalyzes the incorporation of GlcNAc from UDP-GlcNAc to outer core LPS, and WabN catalyzes the deacetylation of the incorporated GlcNAc. Here we report the presence of two different HexNAc transferases depending on the nature of the HexN in P. mirabilis core LPS. In vivo and in vitro assays using LPS truncated at the level of galacturonic acid as acceptor show that these two enzymes differ in their specificity for the transfer of GlcNAc or GalNAc. By contrast, only one WabN homologue was found in the studied P. mirabilis strains. Similar assays suggest that the P. mirabilis WabN homologue is able to deacetylate both GlcNAc and GalNAc. We conclude that incorporation of D-galactosamine requires three enzymes: Gne epimerase for the generation of UDP-GalNAc from UDP-GlcNAc, N-acetylgalactosaminyltransferase (WabP), and LPS: HexNAc deacetylase.	[Merino, Susana; Jimenez, Natalia; Tomas, Juan M.] Univ Barcelona, Dept Microbiol, Fac Biol, E-08071 Barcelona, Spain; [Aquilini, Eleonora; Azevedo, Joana; Regue, Miguel] Univ Barcelona, Fac Farm, Dept Microbiol & Parasitol Sanitarias, E-08028 Barcelona, Spain	University of Barcelona; University of Barcelona	Tomas, JM (corresponding author), Univ Barcelona, Dept Microbiol, Fac Biol, E-08071 Barcelona, Spain.	jtomas@ub.edu	Aquilini, Eleonora/AAD-4741-2019; Tomas, Juan M/L-1398-2015; Merino, Susana/D-4342-2014	Aquilini, Eleonora/0000-0001-7545-7863; Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259; Jimenez, Natalia/0000-0002-7057-0426; Marques, Joana/0000-0003-1827-2912	Ministerio de Educacion, Ciencia y Deporte, and Ministerio de Sanidad, Spain; Generalitat de Catalunya (Centre de Referencia en Biotecnologia); Generalitat de Catalunya	Ministerio de Educacion, Ciencia y Deporte, and Ministerio de Sanidad, Spain(Spanish Government); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)(Generalitat de Catalunya); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by Plan Nacional de I + D + i and Fondo de Investigaciones Sanitarias grants (Ministerio de Educacion, Ciencia y Deporte, and Ministerio de Sanidad, Spain) and from Generalitat de Catalunya (Centre de Referencia en Biotecnologia).; Recipient of a predoctoral fellowship from Generalitat de Catalunya.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amor K, 2000, INFECT IMMUN, V68, P1116, DOI 10.1128/IAI.68.3.1116-1124.2000; Aquilini E, 2010, J BACTERIOL, V192, P4413, DOI 10.1128/JB.00494-10; Belas Robert, 1996, P271; BOITEUX S, 1987, EMBO J, V6, P3177, DOI 10.1002/j.1460-2075.1987.tb02629.x; Canals R, 2007, J BACTERIOL, V189, P540, DOI 10.1128/JB.01260-06; Coderch N, 2004, J BACTERIOL, V186, P978, DOI 10.1128/JB.186.4.978-988.2004; FAIRLEY KF, 1971, LANCET, V2, P615; Frirdich E, 2004, J BIOL CHEM, V279, P27928, DOI 10.1074/jbc.M402549200; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Geerlof A, 1999, J BIOL CHEM, V274, P27105, DOI 10.1074/jbc.274.38.27105; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Knirel YA, 1999, POL J CHEM, V73, P895; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LARSSON P, 1984, METHOD MICROBIOL, V14, P187, DOI 10.1016/S0580-9517(08)70451-3; Miller J. H., 1972, EXPT MOL GENETICS, P433; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; Olsthoorn MMA, 1999, J MASS SPECTROM, V34, P622, DOI 10.1002/(SICI)1096-9888(199906)34:6<622::AID-JMS814>3.3.CO;2-M; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; PENNER JL, 1980, J CLIN MICROBIOL, V12, P304, DOI 10.1128/JCM.12.3.304-309.1980; PRADEL E, 1991, J BACTERIOL, V173, P6428, DOI 10.1128/jb.173.20.6428-6431.1991; Rashid T, 2007, CLIN RHEUMATOL, V26, P1036, DOI 10.1007/s10067-006-0491-z; Regue M, 2005, J BIOL CHEM, V280, P36648, DOI 10.1074/jbc.M506278200; Regue M, 2005, J BACTERIOL, V187, P4198, DOI 10.1128/JB.187.12.4198-4206.2005; Regue M, 2001, J BACTERIOL, V183, P3564, DOI 10.1128/JB.183.12.3564-3573.2001; RUBIN RH, 1986, KIDNEY, P1085; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vinogradov E, 2002, AUST J CHEM, V55, P61, DOI 10.1071/CH01184; Vinogradov E, 2001, CARBOHYD RES, V335, P291, DOI 10.1016/S0008-6215(01)00216-6; Wang QA, 2010, APPL ENVIRON MICROB, V76, P5471, DOI 10.1128/AEM.02946-09; WARREN JW, 1991, MED CLIN N AM, V75, P481, DOI 10.1016/S0025-7125(16)30465-5; WARREN JW, 1988, J INFECT DIS, V158, P1341, DOI 10.1093/infdis/158.6.1341; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Zych K, 2000, ADV EXP MED BIOL, V485, P339	38	5	5	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39739	39749		10.1074/jbc.M110.168385	http://dx.doi.org/10.1074/jbc.M110.168385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20959463	hybrid, Green Published			2022-12-25	WOS:000285185500018
J	Reiner, CL; McCullar, JS; Kow, RL; Le, JH; Goodlett, DR; Nathanson, NM				Reiner, Cindy L.; McCullar, Jennifer S.; Kow, Rebecca L.; Le, Joshua H.; Goodlett, David R.; Nathanson, Neil M.			RACK1 Associates with Muscarinic Receptors and Regulates M-2 Receptor Trafficking	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ACETYLCHOLINE-RECEPTOR; MASS-SPECTROMETRY; BETA-ARRESTIN; CELL-SURFACE; LIPID RAFTS; INTERNALIZATION; ENDOCYTOSIS; KINASE; SEQUESTRATION	Receptor internalization from the cell surface occurs through several mechanisms. Some of these mechanisms, such as clathrin coated pits, are well understood. The M-2 muscarinic acetylcholine receptor undergoes internalization via a poorly-defined clathrin-independent mechanism. We used isotope coded affinity tagging and mass spectrometry to identify the scaffolding protein, receptor for activated C kinase (RACK1) as a protein enriched in M-2-immunoprecipitates from M-2-expressing cells over those of non-M-2 expressing cells. Treatment of cells with the agonist carbachol disrupted the interaction of RACK1 with M-2. We further found that RACK1 overexpression inhibits the internalization and subsequent down regulation of the M-2 receptor in a receptor subtype-specific manner. Decreased RACK1 expression increases the rate of agonist internalization of the M-2 receptor, but decreases the extent of subsequent down-regulation. These results suggest that RACK1 may both interfere with agonist-induced sequestration and be required for subsequent targeting of internalized M-2 receptors to the degradative pathway.	[Reiner, Cindy L.; McCullar, Jennifer S.; Kow, Rebecca L.; Le, Joshua H.; Nathanson, Neil M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Goodlett, David R.] Inst Syst Biol, Seattle, WA USA	University of Washington; University of Washington Seattle; Institute for Systems Biology (ISB)	Reiner, CL (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nathanso@u.washington.edu		Nathanson, Neil/0000-0002-9216-121X	American Heart Association; National Institutes of Health [P01-HL44948, T32 GM 07727, R01-ES015594]; National Heart, Lung, and Blood Institute Seattle Proteome Center [N01-HV-8179]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015594] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute Seattle Proteome Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by a Grant-in-Aid from the American Heart Association, and by the National Institutes of Health, under grants P01-HL44948, T32 GM 07727 and R01-ES015594, and in part with Federal funds from the National Heart, Lung, and Blood Institute Seattle Proteome Center (contract No. N01-HV-8179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Erkang, 2009, Communicative & Integrative Biology, V2, P444; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Delaney KA, 2002, J BIOL CHEM, V277, P33439, DOI 10.1074/jbc.M205293200; Dell EJ, 2002, J BIOL CHEM, V277, P49888, DOI 10.1074/jbc.M202755200; GOLDMAN PS, 1994, J BIOL CHEM, V269, P15640; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Jones Kymry T, 2006, J Mol Signal, V1, P7, DOI 10.1186/1750-2187-1-7; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Min L, 2002, J BIOL CHEM, V277, P702, DOI 10.1074/jbc.M106082200; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nikolov EN, 2004, J BIOL CHEM, V279, P23630, DOI 10.1074/jbc.M312861200; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; Parent A, 2008, TRAFFIC, V9, P394, DOI 10.1111/j.1600-0854.2007.00692.x; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Reiner C, 2008, LIFE SCI, V82, P718, DOI 10.1016/j.lfs.2008.01.013; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Roseberry AG, 2001, MOL PHARMACOL, V59, P1256, DOI 10.1124/mol.59.5.1256; Roseberry AG, 2001, J CELL SCI, V114, P739; Sambrook J., 2002, MOL CLONING LAB MANU; Schlador ML, 2000, J BIOL CHEM, V275, P23295, DOI 10.1074/jbc.M002380200; Schlador ML, 1997, J BIOL CHEM, V272, P18882, DOI 10.1074/jbc.272.30.18882; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; van Koppen CJ, 2001, BIOCHEM SOC T, V29, P505, DOI 10.1042/BST0290505; Vogler O, 1998, J BIOL CHEM, V273, P12155, DOI 10.1074/jbc.273.20.12155; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wang W, 2002, INT J BIOCHEM CELL B, V34, P93, DOI 10.1016/S1357-2725(01)00094-2; Yaka R, 2003, J NEUROSCI, V23, P3623; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yi EC, 2003, RAPID COMMUN MASS SP, V17, P2093, DOI 10.1002/rcm.1150; Zhou HL, 2002, NAT BIOTECHNOL, V20, P512, DOI 10.1038/nbt0502-512	34	10	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13517	10.1371/journal.pone.0013517	http://dx.doi.org/10.1371/journal.pone.0013517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976005	Green Published, Green Submitted, gold			2022-12-25	WOS:000283216400021
J	Tjomsland, V; Spangeus, A; Sandstrom, P; Borch, K; Messmer, D; Larsson, M				Tjomsland, Vegard; Spangeus, Anna; Sandstrom, Per; Borch, Kurt; Messmer, Davorka; Larsson, Marie			Semi Mature Blood Dendritic Cells Exist in Patients with Ductal Pancreatic Adenocarcinoma Owing to Inflammatory Factors Released from the Tumor	PLOS ONE			English	Article							EXPRESSION; SUBSETS; MATURATION; ACTIVATION; INDUCTION; CANCER; ABNORMALITIES; DEFICIENCIES; PHENOTYPE; MONOCYTES	Background: Much evidence exists regarding the fact that blood DCs, both myeloid DCs (MDCs) and plasmacytoid DCs (PDCs), are negatively affected in different types of cancer, with both reduced numbers and impaired functionality. Functional impairment of DCs in patients with pancreatic ductal adenocarcinoma (PDAC), may contribute to the poor clinical outcome. The aim of this study was to examine the effects PDAC had on blood DCs and elucidate the underlying mechanism responsible for the DC impairment. Methodology/Principal Findings: We examined the systemic influence PDAC exerted on blood DCs by ex vivo measuring numerous activation and maturation markers expressed on these cells. Furthermore, the effect patient plasma and the inflammatory factors CXCL8 and PGE(2) had on purified MDCs and PDCs from healthy donors was assessed and compared to the DCs existing in PDAC patients. We found a partial maturation of the blood MDCs and PDCs in PDAC patients with significantly enhanced expression of CD83, CD40, B7H3, PDL-1, CCR6, and CCR7 and decreased expression of ICOSL, and DCIR. These changes lead to impairment in their immunostimulatory function. Furthermore, chronic pancreatitis gave rise to DCs with similar semi-mature phenotype as seen in PDAC. Low expression of ICOSL was associated with poor prognosis. We found that the mechanism underlying this semi-maturation of DCs was inflammatory factors existing in the PDAC patients' plasma. Of note, PGE2, which is elevated PDAC patient plasma, was one contributing factor to the changes seen in MDCs and PDCs phenotype. Conclusion/Significance: Our findings point to a role for the systemic inflammation in transforming blood MDCs and PDCs into semi-mature cells in PDAC patients and we show a correlation between maturation status and clinical outcome. Thus, means to preserve a functional blood DC compartment in PDAC patients by diminishing the inflammation could facilitate their ability to control the disease and improve survival.	[Tjomsland, Vegard] Linkoping Univ, Dept Clin & Expt Med, Div Mol Virol, Linkoping, Sweden; [Spangeus, Anna] Linkoping Univ, Dept Endocrinol, Div Internal Med, Linkoping, Sweden; [Spangeus, Anna] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Sandstrom, Per; Borch, Kurt] Linkoping Univ, Div Surg, Linkoping, Sweden; [Messmer, Davorka; Larsson, Marie] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Linkoping University; Linkoping University; Linkoping University; Linkoping University; University of California System; University of California San Diego	Tjomsland, V (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Mol Virol, Linkoping, Sweden.	marie.larsson@liu.se	SandstrÃm, Per/AAF-1841-2019	Larsson, Marie/0000-0002-4524-0177	Swedish Research Council [AI52731]; Swedish International Development Cooperation Agency (SIDA); Swedish Governmental Agency for Innovation Systems (VINNOVA:VINNMER); Medical Research Council of Southeast Sweden; Swedish Society of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052731, R01AI052731] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency (SIDA); Swedish Governmental Agency for Innovation Systems (VINNOVA:VINNMER)(Vinnova); Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Society of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by grants from: ML: The Swedish Research Council AI52731, The Swedish International Development Cooperation Agency (SIDA), The Swedish Governmental Agency for Innovation Systems (VINNOVA:VINNMER), Medical Research Council of Southeast Sweden, and Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam JP, 2008, J ALLERGY CLIN IMMUN, V121, P368, DOI 10.1016/j.jaci.2007.09.045; Almeida M, 2005, AIDS, V19, P261; Bachmann J, 2008, J GASTROINTEST SURG, V12, P1193, DOI 10.1007/s11605-008-0505-z; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Beckebaum S, 2004, CLIN CANCER RES, V10, P7260, DOI 10.1158/1078-0432.CCR-04-0872; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; Breloer M, 2008, TRENDS IMMUNOL, V29, P186, DOI 10.1016/j.it.2008.01.009; Brittingham KC, 2005, J IMMUNOL, V174, P5545, DOI 10.4049/jimmunol.174.9.5545; Cao W, 2007, CURR OPIN IMMUNOL, V19, P24, DOI 10.1016/j.coi.2006.11.004; Charles J, 2010, J INVEST DERMATOL, V130, P1646, DOI 10.1038/jid.2010.24; Chen YW, 2007, EUR J IMMUNOL, V37, P167, DOI 10.1002/eji.200636285; Coates PTH, 2004, KIDNEY INT, V66, P1907, DOI 10.1111/j.1523-1755.2004.00965.x; Della Bella S, 2003, BRIT J CANCER, V89, P1463, DOI 10.1038/sj.bjc.6601243; Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012; Dieu-Nosjean MC, 1999, J LEUKOCYTE BIOL, V66, P252, DOI 10.1002/jlb.66.2.252; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Farrow B, 2004, ANN SURG, V239, P763, DOI 10.1097/01.sla.0000128681.76786.07; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Frick VO, 2008, PANCREATOLOGY, V8, P488, DOI 10.1159/000151776; Fung E, 2010, NAT PROTOC, V5, P357, DOI 10.1038/nprot.2009.246; Hashizume H, 2005, J IMMUNOL, V174, P2396, DOI 10.4049/jimmunol.174.4.2396; Hoffmann TK, 2002, CLIN CANCER RES, V8, P1787; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jongbloed SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1864; Kunitani H, 2002, J HEPATOL, V36, P734, DOI 10.1016/S0168-8278(02)00062-4; Lee AW, 2002, VACCINE, V20, pA8, DOI 10.1016/S0264-410X(02)00382-1; Leitner J, 2009, EUR J IMMUNOL, V39, P1754, DOI 10.1002/eji.200839028; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li M, 2008, CANCER SCI, V99, P733, DOI 10.1111/j.1349-7006.2008.00740.x; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Maecker B, 2006, LEUKEMIA, V20, P645, DOI 10.1038/sj.leu.2404146; Mahnke K, 2007, EUR J IMMUNOL, V37, P2117, DOI 10.1002/eji.200636841; Matsubayashi H, 2007, CANCER BIOL THER, V6, P1569, DOI 10.4161/cbt.6.10.4711; Meier A, 2008, AIDS, V22, P655, DOI 10.1097/QAD.0b013e3282f4de23; Mengshol JA, 2009, GUT, V58, P964, DOI 10.1136/gut.2008.168948; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Mohty M, 2001, BLOOD, V98, P3750, DOI 10.1182/blood.V98.13.3750; Pacanowski J, 2001, BLOOD, V98, P3016, DOI 10.1182/blood.V98.10.3016; Penna G, 2002, HUM IMMUNOL, V63, P1164, DOI 10.1016/S0198-8859(02)00755-3; Pinzon-Charry A, 2007, BRIT J CANCER, V97, P1251, DOI 10.1038/sj.bjc.6604018; Satthaporn S, 2004, CANCER IMMUNOL IMMUN, V53, P510, DOI 10.1007/s00262-003-0485-5; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Sciarra A, 2007, PROSTATE, V67, P1, DOI 10.1002/pros.20431; Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637, DOI 10.4049/jimmunol.170.7.3637; Shodell M, 2002, SCAND J IMMUNOL, V56, P518, DOI 10.1046/j.1365-3083.2002.01148.x; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Takahashi K, 2006, CANCER IMMUNOL IMMUN, V55, P775, DOI 10.1007/s00262-005-0079-5; TJOMSLAND V, 2010, ROLE IL 1ALPHA UNPUB; Tjomsland V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-87; Verslype C, 2007, ANN ONCOL, V18, pVII1, DOI 10.1093/annonc/mdm210; Wigmore SJ, 2002, INT J ONCOL, V21, P881; Yanagimoto H, 2005, CLIN IMMUNOL, V114, P52, DOI 10.1016/j.clim.2004.09.007	55	52	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13441	10.1371/journal.pone.0013441	http://dx.doi.org/10.1371/journal.pone.0013441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976171	Green Published, Green Submitted, gold			2022-12-25	WOS:000283043700026
J	Guo, JB; Zheng, XD; Xu, LP; Liu, ZY; Xu, KH; Li, ST; Wen, TY; Liu, SG; Pang, H				Guo, Jiubiao; Zheng, Xiangdong; Xu, Lipeng; Liu, Zhongyuan; Xu, Kehui; Li, Shentao; Wen, Tingyi; Liu, Siguo; Pang, Hai			Characterization of a Novel Esterase Rv0045c from Mycobacterium tuberculosis	PLOS ONE			English	Article							ALPHA/BETA-HYDROLASE FOLD; GENOME SEQUENCE; PROTEIN; EXPRESSION; SURVIVAL; ENZYMES; FAMILY; LIPASE	Background: It was proposed that there are at least 250 enzymes in M. tuberculosis involved in lipid metabolism. Rv0045c was predicted to be a hydrolase by amino acid sequence similarity, although its precise biochemical characterization and function remained to be defined. Methodology/Principal Findings: We expressed the Rv0045c protein to high levels in E. coli and purified the protein to high purity. We confirmed that the prepared protein was the Rv0045c protein by mass spectrometry analysis. Circular dichroism spectroscopy analysis showed that the protein possessed abundant beta-sheet secondary structure, and confirmed that its conformation was stable in the range pH 6.0-10.0 and at temperatures <= 40 degrees C. Enzyme activity analysis indicated that the Rv0045c protein could efficiently hydrolyze short chain p-nitrophenyl esters (C-2-C-8), and its suitable substrate was p-nitrophenyl caproate (C-6) with optimal catalytic conditions of 39 degrees C and pH 8.0. Conclusions/Significance: Our results demonstrated that the Rv0045c protein is a novel esterase. These experiments will be helpful in understanding ester/lipid metabolism related to M. tuberculosis.	[Guo, Jiubiao; Zheng, Xiangdong; Xu, Lipeng; Liu, Zhongyuan; Xu, Kehui; Pang, Hai] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Guo, Jiubiao; Liu, Siguo] Chinese Acad Agr, Harbin Vet Res Inst, Harbin, Peoples R China; [Li, Shentao] Capital Med Univ, Dept Immunol, Sch Basic Med Sci, Beijing, Peoples R China; [Wen, Tingyi] Chinese Acad Sci, Dept Ind Microbiol & Biotechnol, Inst Microbiol, Beijing, Peoples R China	Tsinghua University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Capital Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Guo, JB (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.	siguo_liu@yahoo.com.cn; pangh@xtal.tsinghua.edu.cn	Zheng, Xiangdong/AAL-4774-2021; Wen, Tingyi/M-6095-2014	Wen, Tingyi/0000-0003-2583-7088; Guo, Jiubiao/0000-0003-2716-1712	Foundation of State Key Laboratory of Veterinary Biotechnology [SKLVBF2009]; Harbin Veterinary Research Institute (HVRI); National Drug Discovery Program [2008ZX09401-05]; National Natural Science Foundation of China [30770439]; Project 973 of the Major State Basic Research Development Program of China [2006CB504400]	Foundation of State Key Laboratory of Veterinary Biotechnology; Harbin Veterinary Research Institute (HVRI); National Drug Discovery Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project 973 of the Major State Basic Research Development Program of China(National Basic Research Program of China)	This work was financially supported by the Foundation of State Key Laboratory of Veterinary Biotechnology (SKLVBF2009), Harbin Veterinary Research Institute (HVRI), the National Drug Discovery Program (Grant 2008ZX09401-05), the National Natural Science Foundation of China (No. 30770439) and Project 973 of the Major State Basic Research Development Program of China (No. 2006CB504400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1882, BERLINER KLIN WOCHEN, V19, P221; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Canaan S, 2004, EUR J BIOCHEM, V271, P3953, DOI 10.1111/j.1432-1033.2004.04335.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Hotelier T, 2004, NUCLEIC ACIDS RES, V32, pD145, DOI 10.1093/nar/gkh141; Iijima N, 1998, FISH PHYSIOL BIOCHEM, V18, P59, DOI 10.1023/A:1007725513389; KIRSTY M, 2009, BIOCHEMISTRY-US, V48, P863; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Levisson M, 2009, EXTREMOPHILES, V13, P567, DOI 10.1007/s00792-009-0260-4; Lopez-Lopez S, 2003, COMP BIOCHEM PHYS B, V135, P337, DOI 10.1016/S1096-4959(03)00087-3; Lun SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/jbc.M700035200; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Park SY, 2007, APPL MICROBIOL BIOT, V77, P107, DOI 10.1007/s00253-007-1134-2; Park SY, 2008, J MOL BIOL, V376, P1426, DOI 10.1016/j.jmb.2007.12.062; Petersen MTN, 2001, J BIOTECHNOL, V85, P115, DOI 10.1016/S0168-1656(00)00360-6; Ryan KJ., 2004, SHERRIS MED MICROBIO; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; SCHARA JD, 1997, METHOD ENZYMOL, V284, P85; Sorrentino N, 2003, ACTA CRYSTALLOGR D, V59, P1846, DOI 10.1107/S0907444903017864; VAUGHAN A, 1995, J BIOL CHEM, V270, P17044, DOI 10.1074/jbc.270.28.17044; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zhang M, 2005, PROTEIN EXPRES PURIF, V42, P59, DOI 10.1016/j.pep.2005.03.022	25	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13143	10.1371/journal.pone.0013143	http://dx.doi.org/10.1371/journal.pone.0013143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957207	gold, Green Published, Green Submitted			2022-12-25	WOS:000282359300029
J	Maier, E; Hebenstreit, D; Posselt, G; Hammerl, P; Duschl, A; Horejs-Hoeck, J				Maier, Elisabeth; Hebenstreit, Daniel; Posselt, Gernot; Hammerl, Peter; Duschl, Albert; Horejs-Hoeck, Jutta			Inhibition of Suppressive T Cell Factor 1 (TCF-1) Isoforms in Naive CD4(+) T Cells Is Mediated by IL-4/STAT6 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DENDRITIC CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; BETA-CATENIN; IN-VIVO; THYMOCYTE DEVELOPMENT; STAT5 ACTIVATION; STEM-CELLS; TH2 CELLS; IL-4	The Wnt pathway transcription factor T cell factor 1 (TCF-1) plays essential roles in the control of several developmental processes, including T cell development in the thymus. Although previously regarded as being required only during early T cell development, recent studies demonstrate an important role for TCF-1 in T helper 2 (Th2) cell polarization. TCF-1 was shown to activate expression of the Th2 transcription factor GATA-binding protein 3 (GATA3) and thus to promote the development of IL-4-producing Th2 cells independent of STAT6 signaling. In this study, we show that TCF-1 is down-regulated in human naive CD4(+) T cells cultured under Th2-polarizing conditions. The down-regulation is largely due to the polarizing cytokine IL-4 because IL-4 alone is sufficient to substantially inhibit TCF-1 expression. The IL-4-induced suppression of TCF-1 is mediated by STAT6, as shown by electrophoretic mobility shift assays, chromatin immunoprecipitation, and STAT6 knockdown experiments. Moreover, we found that IL-4/STAT6 predominantly inhibits the shorter, dominant-negative TCF-1 isoforms, which were reported to inhibit IL-4 transcription. Thus, this study provides a model for an IL-4/STAT6-dependent fine tuning mechanism of TCF-1-driven T helper cell polarization.	[Maier, Elisabeth; Posselt, Gernot; Hammerl, Peter; Duschl, Albert; Horejs-Hoeck, Jutta] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Salzburg University	Horejs-Hoeck, J (corresponding author), Salzburg Univ, Dept Mol Biol, Hellbrunner Str 34, A-5020 Salzburg, Austria.	jutta.horejs_hoeck@sbg.ac.at	Posselt, Gernot/K-1747-2015; Horejs-Hoeck, Jutta/AAF-1735-2019; hebenstreit, daniel/GWZ-2082-2022; Duschl, Albert/E-5872-2011; Horejs-Hoeck, Jutta/E-5010-2011	Posselt, Gernot/0000-0002-0593-6620; Horejs-Hoeck, Jutta/0000-0002-0984-204X; hebenstreit, daniel/0000-0003-0144-6728; Duschl, Albert/0000-0002-7034-9860; Horejs-Hoeck, Jutta/0000-0002-0984-204X	University of Salzburg; Austrian "Fond zur Forderung der Wissenschaftlichen Forschung" [P18409]; Austrian Academy of Sciences at the Department of Molecular Biology, University of Salzburg; MRC [MC_U105161047] Funding Source: UKRI; Medical Research Council [MC_U105161047] Funding Source: researchfish	University of Salzburg; Austrian "Fond zur Forderung der Wissenschaftlichen Forschung"(Austrian Science Fund (FWF)); Austrian Academy of Sciences at the Department of Molecular Biology, University of Salzburg; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the University of Salzburg priority program "BioScience and Health" and by Austrian "Fond zur Forderung der Wissenschaftlichen Forschung" Grant P18409.; Recipient of a DOC-fFORTE fellowship of the Austrian Academy of Sciences at the Department of Molecular Biology, University of Salzburg.	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bennett BL, 1997, J BIOL CHEM, V272, P10212; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Saint-Vis B, 1998, J IMMUNOL, V160, P1666; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Friedrich K, 1999, INT IMMUNOL, V11, P1283, DOI 10.1093/intimm/11.8.1283; Harnaha J, 2006, DIABETES, V55, P158, DOI 10.2337/diabetes.55.01.06.db05-0340; Hebenstreit D, 2003, J IMMUNOL, V171, P5901, DOI 10.4049/jimmunol.171.11.5901; Hebenstreit D, 2008, J BIOL CHEM, V283, P22490, DOI 10.1074/jbc.M804096200; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Hoeck J, 2001, J IMMUNOL, V167, P3216, DOI 10.4049/jimmunol.167.6.3216; Hoeck J, 2001, J IMMUNOL, V166, P4507, DOI 10.4049/jimmunol.166.7.4507; Hossain MB, 2008, IMMUNOLOGY, V125, P377, DOI 10.1111/j.1365-2567.2008.02854.x; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KOHLER I, 1993, EUR J IMMUNOL, V23, P3066, DOI 10.1002/eji.1830231204; Maier E, 2007, HUM IMMUNOL, V68, P986, DOI 10.1016/j.humimm.2007.10.012; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Nguyen VT, 2000, J IMMUNOL, V165, P6235, DOI 10.4049/jimmunol.165.11.6235; Okamoto M, 2009, J IMMUNOL, V183, P2995, DOI 10.4049/jimmunol.0900692; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Rogge L, 1999, J IMMUNOL, V162, P3926; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Scheinman EJ, 2009, J BIOL CHEM, V284, P3037, DOI 10.1074/jbc.M807302200; Schilham MW, 1998, J IMMUNOL, V161, P3984; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Sorg RV, 1998, IMMUNOBIOLOGY, V198, P514, DOI 10.1016/S0171-2985(98)80075-2; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; van Panhuys N, 2008, P NATL ACAD SCI USA, V105, P12423, DOI 10.1073/pnas.0806372105; VANDEWETERING M, 1992, J BIOL CHEM, V267, P8530; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Wirnsberger G, 2006, EUR J IMMUNOL, V36, P1882, DOI 10.1002/eji.200635972; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	53	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					919	928		10.1074/jbc.M110.144949	http://dx.doi.org/10.1074/jbc.M110.144949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20980261	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000286005000003
J	Hwang, YM; Stathopulos, PB; Dimmick, K; Yang, H; Badiei, HR; Tong, MS; Rumfeldt, JAO; Chen, P; Karanassios, V; Meiering, EM				Hwang, Young-Mi; Stathopulos, Peter B.; Dimmick, Kristin; Yang, Hong; Badiei, Hamid R.; Tong, Ming Sze; Rumfeldt, Jessica A. O.; Chen, Pu; Karanassios, Vassili; Meiering, Elizabeth M.			Nonamyloid Aggregates Arising from Mature Copper/Zinc Superoxide Dismutases Resemble Those Observed in Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BODY-LIKE INCLUSIONS; CU,ZN-SUPEROXIDE DISMUTASE; PROTEIN AGGREGATION; FAMILIAL ALS; FIBRIL FORMATION; WILD-TYPE; IN-VITRO; MOLECULAR MECHANISM; SOLUBLE OLIGOMERS; AMYLOID FORMATION	Protein aggregation is a hallmark of many diseases, including amyotrophic lateral sclerosis (ALS) where aggregation of copper/zinc superoxide dismutase (SOD1) is implicated in pathogenesis. We report here that fully metallated (holo) SOD1 under physiologically relevant solution conditions can undergo changes in metallation and/or dimerization over time and form aggregates that do not exhibit classical characteristics of amyloid. The relevance of the observed aggregation to disease is demonstrated by structural and tinctorial analyses, including the novel observation of binding of an anti-SOD1 antibody that specifically recognizes aggregates in ALS patients and mice models. ALS-associated SOD1 mutations can promote aggregation but are not essential. The SOD1 aggregation is characterized by a lag phase, which is diminished by self-or cross-seeding and by heterogeneous nucleation. We interpret these findings in terms of an expanded aggregation mechanism consistent with other in vitro and in vivo findings that point to multiple pathways for the formation of toxic aggregates by different forms of SOD1.	[Meiering, Elizabeth M.] Univ Waterloo, Guelph Waterloo Ctr Grad Studies Chem & Biochem, Dept Biol & Chem, Waterloo, ON N2L 3G1, Canada; [Yang, Hong; Chen, Pu] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada; [Stathopulos, Peter B.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 3H2, Canada; [Stathopulos, Peter B.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5S 3H2, Canada; [Yang, Hong] Univ Hlth Network, Latner Thorac Surg Res Labs, Toronto, ON M5G 1L7, Canada; [Badiei, Hamid R.] MDS Analyt Technol, ICP MS Technol, Concord, ON L4K 4V8, Canada; [Rumfeldt, Jessica A. O.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of Waterloo; University of Waterloo; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Diego	Meiering, EM (corresponding author), Univ Waterloo, Guelph Waterloo Ctr Grad Studies Chem & Biochem, Dept Biol & Chem, 200 Univ Ave, Waterloo, ON N2L 3G1, Canada.	meiering@uwaterloo.ca	Yang, Hong/E-3478-2014; Yang, Hong/AAZ-1061-2020	Yang, Hong/0000-0002-6707-8481; Stathopulos, Peter B./0000-0002-0536-6656	ALS Society of Canada; Muscular Dystrophy Canada; Canadian Institutes of Health Research	ALS Society of Canada; Muscular Dystrophy Canada(Muscular Dystrophy Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the ALS Society of Canada, Muscular Dystrophy Canada, and the Canadian Institutes of Health Research.	Andersen CB, 2009, BIOPHYS J, V96, P1529, DOI 10.1016/j.bpj.2008.11.024; Banci L, 2005, J BIOL CHEM, V280, P35815, DOI 10.1074/jbc.M506637200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2007, BIOCHEMISTRY-US, V46, P9953, DOI 10.1021/bi700620r; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; BEEM KM, 1974, J BIOL CHEM, V249, P7298; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Cao XH, 2008, J BIOL CHEM, V283, P16169, DOI 10.1074/jbc.M801522200; Carullaa N, 2009, P NATL ACAD SCI USA, V106, P7828, DOI 10.1073/pnas.0812227106; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Crow JP, 1997, J NEUROCHEM, V69, P1936; D'Arrigo A, 2010, J MOL NEUROSCI, V41, P404, DOI 10.1007/s12031-010-9332-2; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; FERRONE FA, 1985, J MOL BIOL, V183, P611, DOI 10.1016/0022-2836(85)90175-5; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559; Jaarsma D, 2006, MITOCHONDRION, V6, P48, DOI 10.1016/j.mito.2005.10.005; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kato S, 2001, NEUROPATHOLOGY, V21, P67, DOI 10.1046/j.1440-1789.2001.00359.x; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Khare SD, 2006, P NATL ACAD SCI USA, V103, P3147, DOI 10.1073/pnas.0511266103; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Liu HN, 2009, ANN NEUROL, V66, P75, DOI 10.1002/ana.21704; Lomakin A, 1999, METHOD ENZYMOL, V309, P429; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAILER K, 1989, J INORG BIOCHEM, V37, P151, DOI 10.1016/0162-0134(89)80038-8; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Matsumoto S, 1996, CLIN NEUROPATHOL, V15, P41; Molnar KS, 2009, J BIOL CHEM, V284, P30965, DOI 10.1074/jbc.M109.023945; Morel B, 2006, J MOL BIOL, V356, P453, DOI 10.1016/j.jmb.2005.11.062; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; OKAMOTO K, 1991, NEUROSCI LETT, V129, P233, DOI 10.1016/0304-3940(91)90469-A; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Piazza R, 2006, EUR BIOPHYS J BIOPHY, V35, P439, DOI 10.1007/s00249-006-0051-0; Prudencio M, 2009, J NEUROCHEM, V108, P1009, DOI 10.1111/j.1471-4159.2008.05839.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; Rumfeldt JAO, 2006, J MOL BIOL, V355, P106, DOI 10.1016/j.jmb.2005.10.042; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Sandelin E, 2007, J BIOL CHEM, V282, P21230, DOI 10.1074/jbc.M700765200; Seetharaman SV, 2010, BIOCHEMISTRY-US, V49, P5714, DOI 10.1021/bi100314n; Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; Souillac PO, 2003, BIOCHEMISTRY-US, V42, P8094, DOI 10.1021/bi034652m; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; Stathopulos P., 2005, CHEMISTRY, P133; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Stathopulos PB, 2004, PROTEIN SCI, V13, P3017, DOI 10.1110/ps.04831804; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Valentine JS, 2002, FREE RADICAL BIO MED, V33, P1314, DOI 10.1016/S0891-5849(02)01080-8; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vassall KA, 2006, BIOCHEMISTRY-US, V45, P7366, DOI 10.1021/bi0600953; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394	97	43	43	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41701	41711		10.1074/jbc.M110.113696	http://dx.doi.org/10.1074/jbc.M110.113696			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974846	Green Published, hybrid			2022-12-25	WOS:000285622600057
J	Caolo, V; van den Akker, NMS; Verbruggen, S; Donners, MMPC; Swennen, G; Schulten, H; Waltenberger, J; Post, MJ; Molin, DGM				Caolo, Vincenza; van den Akker, Nynke M. S.; Verbruggen, Sanne; Donners, Marjo M. P. C.; Swennen, Geertje; Schulten, Henny; Waltenberger, Johannes; Post, Mark J.; Molin, Daniel G. M.			Feed-forward Signaling by Membrane-bound Ligand Receptor Circuit THE CASE OF NOTCH DELTA-LIKE 4 LIGAND IN ENDOTHELIAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-GROWTH-FACTOR; STEM-CELL DIFFERENTIATION; VASCULAR DEVELOPMENT; TRANSCRIPTION FACTORS; PROGENITOR CELLS; NOTCH LIGAND; VEGF; ARTERIAL; ANGIOGENESIS; ACTIVATION	The DELTA like-4 ligand (DLL4) belongs to the highly conserved NOTCH family and is specifically expressed in the endothelium. DLL4 regulates crucial processes in vascular growth, including endothelial cell (EC) sprouting and arterial specification. Its expression is increased by VEGF-A. In the present study, we show that VEGF-induced DLL4 expression depends on NOTCH activation. VEGF-induced DLL4 expression was prevented by the blockage of NOTCH signaling with gamma-secretase or ADAM inhibitors in human cardiac microvascular ECs. Similar to VEGF-A, recombinant DLL4 itself stimulated NOTCH signaling and resulted in up-regulation of DLL4, suggesting a positive feed-forward mechanism. These effects were abrogated by NOTCH inhibitors but not by inhibition of VEGF signaling. NOTCH activation alone suffices to induce DLL4 expression as illustrated by the positive effect of NOTCH intracellular domain (NICD)-1 or -4 overexpression. To discriminate between NICD/RBP-J kappa and FOXC2-regulated DLL4 expression, DLL4 promoter activity was assessed in promoter deletion experiments. NICD induced promoter activity was dependent on RBP-J kappa site but independent of the FOXC2 binding site. Accordingly, constitutively active FOXC2 did not affect DLL4 expression. The notion that the positive feed-forward mechanism might propagate NOTCH activation to neighboring ECs was supported by our observation that DLL4-eGFP-transfected ECs induced DLL4 expression in nontransfected cells in their vicinity. In summary, our data provide evidence for a mechanism by which VEGF or ligand-induced NOTCH signaling up-regulates DLL4 through a positive feed-forward mechanism. By this mechanism, DLL4 could propagate its own expression and enable synchronization of NOTCH expression and signaling between ECs.	[Caolo, Vincenza; Verbruggen, Sanne; Swennen, Geertje; Schulten, Henny; Post, Mark J.; Molin, Daniel G. M.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, NL-6229 ER Maastricht, Netherlands; [van den Akker, Nynke M. S.; Waltenberger, Johannes] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, NL-6229 ER Maastricht, Netherlands; [Donners, Marjo M. P. C.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Mol Genet, NL-6229 ER Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Molin, DGM (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Univ Singel 50, NL-6229 ER Maastricht, Netherlands.	d.molin@fys.unimaas.nl	Waltenberger, Johannes/I-1813-2013	Waltenberger, Johannes/0000-0002-2417-9880	Netherlands Heart Foundation [2005B254]; Marie Curie FP6 Early Stage Researcher Training Grant [MEST-CT-2005-020706];  [200T034]	Netherlands Heart Foundation(Netherlands Heart Foundation); Marie Curie FP6 Early Stage Researcher Training Grant; 	This work was supported by The Netherlands Heart Foundation Grant 2005B254 (to M.P.), the Dr. E. Dekker Grant 200T034 (to M.D.), and the Marie Curie FP6 Early Stage Researcher Training Grant MEST-CT-2005-020706 (to Cardiovascular Research Institute Maastricht).	Aranguren XL, 2007, BLOOD, V109, P2634, DOI 10.1182/blood-2006-06-030411; Benedito R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-117; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Delwig A, 2008, CELL MOL LIFE SCI, V65, P2232, DOI 10.1007/s00018-008-8127-x; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Donners MPC, 2010, ARTERIOSCL THROM VAS, V30, P2188, DOI 10.1161/ATVBAHA.110.213124; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; Gerin I, 2009, J BIOL CHEM, V284, P10755, DOI 10.1074/jbc.M809115200; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Iso T, 2006, BIOCHEM BIOPH RES CO, V341, P708, DOI 10.1016/j.bbrc.2006.01.020; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jen WC, 1997, DEVELOPMENT, V124, P1169; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; Kim YH, 2008, DEVELOPMENT, V135, P3755, DOI 10.1242/dev.022475; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Lanner F, 2007, ARTERIOSCL THROM VAS, V27, P487, DOI 10.1161/01.ATV.0000255990.91805.6d; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Melenhorst WBWH, 2008, HYPERTENSION, V52, P987, DOI 10.1161/HYPERTENSIONAHA.108.113860; Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363; Miao HQ, 2006, BIOCHEM BIOPH RES CO, V345, P438, DOI 10.1016/j.bbrc.2006.04.119; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Segarra M, 2008, BLOOD, V112, P1904, DOI 10.1182/blood-2007-11-126045; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shawber CJ, 2003, ANN NY ACAD SCI, V995, P162, DOI 10.1111/j.1749-6632.2003.tb03219.x; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; Trindade A, 2008, BLOOD, V112, P1720, DOI 10.1182/blood-2007-09-112748; van den Akker NMS, 2008, CARDIOVASC RES, V78, P366, DOI 10.1093/cvr/cvm108; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831; Zhang G, 2008, FEBS LETT, V582, P2957, DOI 10.1016/j.febslet.2008.07.031	49	43	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40681	40689		10.1074/jbc.M110.176065	http://dx.doi.org/10.1074/jbc.M110.176065			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959466	Green Published, hybrid			2022-12-25	WOS:000285414400031
J	Issaeva, I; Cohen, AA; Eden, E; Cohen-Saidon, C; Danon, T; Cohen, L; Alon, U				Issaeva, Irina; Cohen, Ariel A.; Eden, Eran; Cohen-Saidon, Cellina; Danon, Tamar; Cohen, Lydia; Alon, Uri			Generation of Double-Labeled Reporter Cell Lines for Studying Co-Dynamics of Endogenous Proteins in Individual Human Cells	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; NF-KAPPA-B; THIOREDOXIN REDUCTASE; GENE-EXPRESSION; ADENOASSOCIATED VIRUS; TRANSCRIPTION FACTOR; REDOX REGULATION; SINGLE CELLS; LIVING CELLS; NUCLEAR THIOREDOXIN-1	Understanding the dynamic relationship between components of a system or pathway at the individual cell level is a current challenge. To address this, we developed an approach that allows simultaneous tracking of several endogenous proteins of choice within individual living human cells. The approach is based on fluorescent tagging of proteins at their native locus by directed gene targeting. A fluorescent tag-encoding DNA is introduced as a new exon into the intronic region of the gene of interest, resulting in expression of a full-length fluorescently tagged protein. We used this approach to establish human cell lines simultaneously expressing two components of a major antioxidant defense system, thioredoxin 1 (Trx) and thioredoxin reductase 1 (TrxR1), labeled with CFP and YFP, respectively. We find that the distributions of both proteins between nuclear and cytoplasmic compartments were highly variable between cells. However, the two proteins did not vary independently of each other: protein levels of Trx and TrxR1 in both the whole cell and the nucleus were substantially correlated. We further find that in response to a stress-inducing drug (CPT), both Trx and TrxR1 accumulated in the nuclei in a manner that was highly temporally correlated. This accumulation considerably reduced cell-to-cell variability in nuclear content of both proteins, suggesting a uniform response of the thioredoxin system to stress. These results indicate that Trx and TrxR1 act in concert in response to stress in regard to both time course and variability. Thus, our approach provides an efficient tool for studying dynamic relationship between components of systems of interest at a single-cell level.	[Issaeva, Irina; Cohen, Ariel A.; Eden, Eran; Cohen-Saidon, Cellina; Danon, Tamar; Cohen, Lydia; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Issaeva, I (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	irina.issaeva@weizmann.ac.il; urialon@weizmann.ac.il			Kahn Family Foundation; European Research Council; Israel Science Foundation	Kahn Family Foundation; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation)	The authors received funding from the Kahn Family Foundation, the European Research Council and the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bai J, 2003, J NEUROSCI, V23, P503, DOI 10.1523/JNEUROSCI.23-02-00503.2003; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Bunz F, 2002, CURR OPIN ONCOL, V14, P73, DOI 10.1097/00001622-200201000-00013; Byrne RH, 2005, MAR CHEM, V97, P1, DOI 10.1016/j.marchem.2005.09.002; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Clyne PJ, 2003, GENETICS, V165, P1433; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cohen AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004901; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Day RN, 2005, MOL CELL ENDOCRINOL, V230, P1, DOI 10.1016/j.mce.2004.10.011; Day RN, 2005, MOL ENDOCRINOL, V19, P1675, DOI 10.1210/me.2005-0028; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Eriksson SE, 2009, FREE RADICAL BIO MED, V47, P1661, DOI 10.1016/j.freeradbiomed.2009.09.016; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fernandez SL, 2007, BIOL PROCED ONLINE, V9, P84, DOI 10.1251/bpo136; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Go YM, 2007, FREE RADICAL BIO MED, V42, P363, DOI 10.1016/j.freeradbiomed.2006.11.005; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Hampton RY, 1996, P NATL ACAD SCI USA, V93, P828, DOI 10.1073/pnas.93.2.828; Hansen JM, 2004, TOXICOL SCI, V82, P308, DOI 10.1093/toxsci/kfh231; Hirata R, 2002, NAT BIOTECHNOL, V20, P735, DOI 10.1038/nbt0702-735; Hirata RK, 2000, J VIROL, V74, P4612, DOI 10.1128/JVI.74.10.4612-4620.2000; Hirota K, 1999, Tanpakushitsu Kakusan Koso, V44, P2414; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Jarvik JW, 1996, BIOTECHNIQUES, V20, P896; Jarvik JW, 2002, BIOTECHNIQUES, V33, P852, DOI 10.2144/02334rr02; Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karimpour S, 2002, ONCOGENE, V21, P6317, DOI 10.1038/sj.onc.1205749; Kim JS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn566; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lalonde S, 2008, PLANT J, V53, P610, DOI 10.1111/j.1365-313X.2007.03332.x; Li XQ, 1999, J BIOL CHEM, V274, P21244, DOI 10.1074/jbc.274.30.21244; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; MELAN MA, 1992, J CELL SCI, V101, P731; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Muzzey D, 2009, ANNU REV CELL DEV BI, V25, P301, DOI 10.1146/annurev.cellbio.042308.113408; Nelson DE, 2004, BIOCHEM SOC T, V32, P1090; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325; Schroeder P, 2007, ARTERIOSCL THROM VAS, V27, P2325, DOI 10.1161/ATVBAHA.107.149419; Sedivy JM, 1999, TRENDS GENET, V15, P88, DOI 10.1016/S0168-9525(98)01689-8; Sen N, 2004, J BIOL CHEM, V279, P52366, DOI 10.1074/jbc.M406705200; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Simizu S, 1998, J BIOL CHEM, V273, P26900, DOI 10.1074/jbc.273.41.26900; Smith DJ, 1997, BIOTECHNIQUES, V23, P116, DOI 10.2144/97231st01; Soini Y, 2001, CLIN CANCER RES, V7, P1750; SPITZ DR, 1987, J CELL PHYSIOL, V131, P364, DOI 10.1002/jcp.1041310308; Topaloglu O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni160; Ueno M, 1999, J BIOL CHEM, V274, P35809, DOI 10.1074/jbc.274.50.35809; Wang ZH, 2009, METHODS MOL BIOL, V567, P87, DOI 10.1007/978-1-60327-414-2_6; Watson WH, 2008, BIOCHEM BIOPH RES CO, V368, P832, DOI 10.1016/j.bbrc.2008.02.006; Wei SJ, 2000, CANCER RES, V60, P6688; Welsh SJ, 2002, CANCER RES, V62, P5089; Wiesel P, 2000, J BIOL CHEM, V275, P24840, DOI 10.1074/jbc.M000835200; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]	73	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13524	10.1371/journal.pone.0013524	http://dx.doi.org/10.1371/journal.pone.0013524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975952	Green Published, Green Submitted, gold			2022-12-25	WOS:000283293800006
J	Anastos, K; Hoover, DR; Burk, RD; Cajigas, A; Shi, QH; Singh, DK; Cohen, MH; Mutimura, E; Sturgis, C; Banzhaf, WC; Castle, PE				Anastos, Kathryn; Hoover, Donald R.; Burk, Robert D.; Cajigas, Antonio; Shi, Qiuhu; Singh, Diljeet K.; Cohen, Mardge H.; Mutimura, Eugene; Sturgis, Charles; Banzhaf, William C.; Castle, Philip E.			Risk Factors for Cervical Precancer and Cancer in HIV-Infected, HPV-Positive Rwandan Women	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; NATURAL-HISTORY; NEOPLASIA; POPULATION; DIAGNOSIS; DNA; BIOPSY	Background: Although cervical cancer is an AIDS-defining condition, infection with human immunodeficiency virus (HIV) may only modestly increase the risk of cervical cancer. There is a paucity of information regarding factors that influence the natural history of human papillomavirus (HPV) in HIV-infected women. We examined factors associated with cervical intraepithelial neoplasia grade 3 or cancer (CIN3+) in Rwandan women infected with both HIV and HPV (HIV+/HPV+). Methods: In 2005, 710 HIV+ Rwandan women >= 25 years enrolled in an observational cohort study; 476 (67%) tested HPV+. Each woman provided sociodemographic data, CD4 count, a cervical cytology specimen and cervicovaginal lavage (CVL), which was tested for >40 HPV genotypes by MY09/MY11 PCR assay. Logistic regression models calculated odds ratios (OR) and 95% confidence intervals (CI) of associations of potential risk factors for CIN3+ among HIV+/HPV+ women. Results: Of the 476 HIV+/HPV+ women 42 (8.8%) were diagnosed with CIN3+. Factors associated with CIN3+ included >= 7 (vs. 0-2) pregnancies, malarial infection in the previous six months (vs. never), and >= 7 (vs. 0-2) lifetime sexual partners. Compared to women infected by non-HPV16 carcinogenic HPV genotypes, HPV16 infection was positively associated and non-carcinogenic HPV infection was inversely associated with CIN3+. CD4 count was significantly associated with CIN3+ only in analyses of women with non-HPV16 carcinogenic HPV (OR = 0.62 per 100 cells/mm(3), CI = 0.40-0.97). Conclusions: In this HIV+/HPV+ population, lower CD4 was significantly associated with CIN3+ only in women infected with carcinogenic non-HPV16. We found a trend for higher risk of CIN3+ in HIV+ women reporting recent malarial infection; this association should be investigated in a larger group of HIV+/HPV+ women.	[Anastos, Kathryn] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA; [Anastos, Kathryn] Montefiore Med Ctr, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat, Piscataway, NJ USA; [Hoover, Donald R.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, Piscataway, NJ USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, Div Genet, Bronx, NY 10467 USA; [Cajigas, Antonio] Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA; [Shi, Qiuhu] New York Med Coll, Dept Epidemiol & Community Hlth, Valhalla, NY 10595 USA; [Singh, Diljeet K.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Cohen, Mardge H.] John Stroger Hosp, Chicago, IL USA; [Cohen, Mardge H.] Rush Univ, Chicago, IL 60612 USA; [Mutimura, Eugene] Womens Equ Access Care & Treatment, Kigali, Rwanda; [Sturgis, Charles] Providence Reg Med Ctr, Everett, WA USA; [Banzhaf, William C.] Univ Chicago, Pritzker Sch Med, Evanston, IL USA; [Castle, Philip E.] NCI, NIH, US Dept HHS, Bethesda, MD 20892 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; New York Medical College; Northwestern University; Feinberg School of Medicine; John H Stroger Junior Hospital Cook County; Rush University; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Anastos, K (corresponding author), Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA.	kanastos@verizon.net	Castle, Philip/AAP-6395-2020; Banzhaf, Wolfgang/A-7992-2008	Castle, Philip/0000-0003-1082-6554; Banzhaf, Wolfgang/0000-0002-6382-3245; Sturgis, Charles/0000-0003-0153-498X	National Institute of Allergy and Infectious Diseases [UO1-AI-35004]; AIDS International Training and Research Program (Fogarty International Center) [NIH D43-TW001403]; National Institutes of Health (NIH) [AI-51519]; National Institute of Diabetes and Digestive and Kidney Disease [DK54615]; NIH, National Cancer Institute; FOGARTY INTERNATIONAL CENTER [D43TW001403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035004, P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054615] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AIDS International Training and Research Program (Fogarty International Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by supplements from the National Institute of Allergy and Infectious Diseases and the National Cancer Institute to the Bronx/Manhattan Women's Interagency HIV Study (WIHS) funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004). This work was also supported in part by the AIDS International Training and Research Program (Fogarty International Center, NIH D43-TW001403) and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519) and by the National Institute of Diabetes and Digestive and Kidney Disease (DK54615). Dr. Castle was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Carreon JD, 2007, INT J GYNECOL PATHOL, V26, P441, DOI 10.1097/pgp.0b013e31805152ab; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Castle PE, 2006, CANCER RES, V66, P1218, DOI 10.1158/0008-5472.CAN-05-3066; Castle PE, 2004, J INFECT DIS, V190, P458, DOI 10.1086/421916; Castle PE, 2002, J MED VIROL, V68, P417, DOI 10.1002/jmv.10220; Castle PE, 2008, OBSTET GYNECOL, V111, P847, DOI 10.1097/AOG.0b013e318168460b; Castle PE, 2007, AM J CLIN PATHOL, V127, P805, DOI 10.1309/PT3PNC1QL2F4D2VL; Castle PE, 2009, OBSTET GYNECOL, V113, P18, DOI 10.1097/AOG.0b013e31818f5008; Clifford GM, 2009, FUTURE ONCOL, V5, P669, DOI [10.2217/fon.09.28, 10.2217/FON.09.28]; Dal Maso L, 2009, BRIT J CANCER, V100, P840, DOI 10.1038/sj.bjc.6604923; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; KOSHIOL J, 2008, AM J EPIDEMIOL; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Pretorius RG, 2004, AM J OBSTET GYNECOL, V191, P430, DOI 10.1016/j.ajog.2004.02.065; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Singh DK, 2009, J INFECT DIS, V199, P1851, DOI 10.1086/599123; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wright TC, 2003, NEW ENGL J MED, V348, P489, DOI 10.1056/NEJMp020178	26	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13525	10.1371/journal.pone.0013525	http://dx.doi.org/10.1371/journal.pone.0013525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976000	Green Published, gold, Green Submitted			2022-12-25	WOS:000283216400027
J	Farzaneh-Far, R; Desir, GV; Na, B; Schiller, NB; Whooley, MA				Farzaneh-Far, Ramin; Desir, Gary V.; Na, Beeya; Schiller, Nelson B.; Whooley, Mary A.			A Functional Polymorphism in Renalase (Glu37Asp) Is Associated with Cardiac Hypertrophy, Dysfunction, and Ischemia: Data from the Heart and Soul Study	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; PROGNOSTIC IMPLICATIONS; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; STABLE ANGINA; BETA-BLOCKERS; ECHOCARDIOGRAPHY; HYPERTENSION	Background: Renalase is a soluble enzyme that metabolizes circulating catecholamines. A common missense polymorphism in the flavin-adenine dinucleotide-binding domain of human renalase (Glu37Asp) has recently been described. The association of this polymorphism with cardiac structure, function, and ischemia has not previously been reported. Methods: We genotyped the rs2296545 single-nucleotide polymorphism (Glu37Asp) in 590 Caucasian individuals and performed resting and stress echocardiography. Logistic regression was used to examine the associations of the Glu37Asp polymorphism (C allele) with cardiac hypertrophy (LV mass>100 g/m(2)), systolic dysfunction (LVEF<50%), diastolic dysfunction, poor treadmill exercise capacity (METS<5) and inducible ischemia. Results: Compared with the 406 participants who had GG or CG genotypes, the 184 participants with the CC genotype had increased odds of left ventricular hypertrophy (OR = 1.43; 95% CI 0.99-2.06), systolic dysfunction (OR = 1.72; 95% CI 1.01-2.94), diastolic dysfunction (OR = 1.75; 95% CI 1.05-2.93), poor exercise capacity (OR = 1.61; 95% CI 1.05-2.47), and inducible ischemia (OR = 1.49, 95% CI 0.99-2.24). The Glu37Asp (CC genotype) caused a 24-fold decrease in affinity for NADH and a 2.3-fold reduction in maximal renalase enzymatic activity. Conclusions: A functional missense polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, ventricular dysfunction, poor exercise capacity, and inducible ischemia in persons with stable coronary artery disease. Further studies investigating the therapeutic implications of this polymorphism should be considered.	[Farzaneh-Far, Ramin] San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA; [Farzaneh-Far, Ramin; Schiller, Nelson B.; Whooley, Mary A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Desir, Gary V.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Na, Beeya; Whooley, Mary A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Farzaneh-Far, R (corresponding author), San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA.	rfarzanehfar@medicine.ucsf.edu			American Heart Association; Department of Veterans Affairs; National Heart, Lung and Blood Institute [R01 HL079235]; Robert Wood Johnson Foundation; American Federation for Aging Research; Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); American Federation for Aging Research; Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Farzaneh-Far is supported by an American Heart Association Fellow-to-Faculty Transition Award. The Heart and Soul study was supported by the Department of Veterans Affairs (Epidemiology Merit Review Program), the National Heart, Lung and Blood Institute (R01 HL079235), the Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program), the American Federation for Aging Research (Paul Beeson Faculty Scholars in Aging Research Program), the Ischemia Research and Education Foundation, and the Nancy Kirwan Heart Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams J, 2005, NEW ENGL J MED, V352, P2524, DOI 10.1056/NEJMcp042317; Abrams J, 2005, CIRCULATION, V112, pE255, DOI 10.1161/CIRCULATIONAHA.104.526699; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Coats AJS, 2009, INT J CARDIOL, V131, P149, DOI 10.1016/j.ijcard.2008.11.048; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; Desir GV, 2008, CURR OPIN NEPHROL HY, V17, P181, DOI 10.1097/MNH.0b013e3282f521ba; Desir GV, 2009, KIDNEY INT, V76, P366, DOI 10.1038/ki.2009.169; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Fonarow GC, 2006, REV CARDIOVASC MED, V7, P1; GHOSH SS, 2008, PEDIAT NEPHROL; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Joles JA, 2004, HYPERTENSION, V43, P699, DOI 10.1161/01.HYP.0000121881.77212.b1; Kopecky SL, 2006, AM J CARDIOL, V98, P1115, DOI 10.1016/j.amjcard.2006.05.039; LEVEY AS, 1990, KIDNEY INT, V38, P167, DOI 10.1038/ki.1990.182; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li G, 2008, CIRCULATION, V117, P1277, DOI 10.1161/CIRCULATIONAHA.107.732032; Lunetta KL, 2008, CIRCULATION, V118, P96, DOI 10.1161/CIRCULATIONAHA.107.700401; MORRIS CK, 1991, AM HEART J, V122, P1423, DOI 10.1016/0002-8703(91)90586-7; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Oh JK, 2006, J AM COLL CARDIOL, V47, P500, DOI 10.1016/j.jacc.2005.09.032; PEART WS, 1977, LANCET, V2, P543; Remme WJ, 1998, EUR HEART J, V19, pF62; Ren XS, 2007, AM J CARDIOL, V99, P1643, DOI 10.1016/j.amjcard.2007.01.041; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SCHILLER NB, 1983, CIRCULATION, V68, P210, DOI 10.1161/01.CIR.68.1.210; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Turakhia MP, 2008, AM J CARDIOL, V102, P1131, DOI 10.1016/j.amjcard.2008.06.036; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Xu JC, 2007, CURR OPIN NEPHROL HY, V16, P373, DOI 10.1097/MNH.0b013e3281bd8877; Zhao Q, 2007, J MOL MED, V85, P877, DOI 10.1007/s00109-006-0151-4	36	55	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13496	10.1371/journal.pone.0013496	http://dx.doi.org/10.1371/journal.pone.0013496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975995	Green Published, gold, Green Submitted			2022-12-25	WOS:000283216400011
J	Metzger, M; Bernstein, C; Hoffmeister, TS; Desouhant, E				Metzger, Marie; Bernstein, Carlos; Hoffmeister, Thomas S.; Desouhant, Emmanuel			Does Kin Recognition and Sib-Mating Avoidance Limit the Risk of Genetic Incompatibility in a Parasitic Wasp?	PLOS ONE			English	Article							COMPLEMENTARY SEX DETERMINATION; MATE CHOICE; INBREEDING DEPRESSION; VENTURIA-CANESCENS; INCEST AVOIDANCE; SOLITARY WASP; DIPLOID MALES; EVOLUTION; INSECT; RELATEDNESS	Background: When some combinations of maternal and paternal alleles have a detrimental effect on offspring fitness, females should be able to choose mates on the basis of their genetic compatibility. In numerous Hymenoptera, the sex of an individual depends of the allelic combination at a specific locus (single-locus Complementary Sex Determination), and in most of these species individuals that are homozygous at this sexual locus develop into diploid males with zero fitness. Methods and Findings: In this paper, we tested the hypothesis of genetic incompatibility avoidance by investigating sib-mating avoidance in the solitary wasp parasitoid, Venturia canescens. In the context of mate choice we show, for the first time in a non-social hymenopteran species, that females can avoid mating with their brothers through kin recognition. In "no-choice'' tests, the probability a female will mate with an unrelated male is twice as high as the chance of her mating with her brothers. In contrast, in choice tests in small test arenas, no kin discrimination effect was observed. Further experiments with male extracts demonstrate that chemical cues emanating from related males influence the acceptance rate of unrelated males. Conclusions: Our results are compatible with the genetic incompatibility hypothesis. They suggest that the female wasps recognize sibs on the basis of a chemical signature carried or emitted by males possibly using a "self-referent phenotype matching'' mechanism.	[Metzger, Marie; Bernstein, Carlos; Desouhant, Emmanuel] Univ Lyon 1, CNRS, Labe Biometrie & Biol Evolut, UMR 5558, Villeurbanne, France; [Metzger, Marie; Hoffmeister, Thomas S.] Univ Bremen, Inst Oekol, Bremen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Bremen	Metzger, M (corresponding author), Univ Lyon 1, CNRS, Labe Biometrie & Biol Evolut, UMR 5558, Villeurbanne, France.	emmanuel.desouhant@univ-lyon1.fr	Hoffmeister, Thomas S./AAH-7796-2020; Hoffmeister, Thomas S/E-2804-2013; DESOUHANT, Emmanuel/A-9537-2013; Metzger, Marie/K-9772-2018	Hoffmeister, Thomas S./0000-0003-2840-7278; Hoffmeister, Thomas S/0000-0003-2840-7278; DESOUHANT, Emmanuel/0000-0003-0317-4463; Metzger, Marie/0000-0003-3597-5409	French Ministry for Research; BEPAR (Behavioural Ecology of Insect Parasitoids; ESF); 'Fondation pour la Recherche sur la Biodiversite', FRB	French Ministry for Research(Ministry of Research, France); BEPAR (Behavioural Ecology of Insect Parasitoids; ESF); 'Fondation pour la Recherche sur la Biodiversite', FRB	This work was funded by a Ph.D. grant from the French Ministry for Research to M.M., and a BEPAR (Behavioural Ecology of Insect Parasitoids; ESF program) visiting grant to M.M. to conduct work at the University of Bremen (Experiment 3). The project was partially financed by 'Fondation pour la Recherche sur la Biodiversite', FRB (Project: 'Vortex'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RD, 1990, ETHOL SOCIOBIOL, V11, P241, DOI 10.1016/0162-3095(90)90012-U; AMAT I, 2004, COEXISTENCE REPROD S, P226; Andersson Malte, 1994; [Anonymous], 2014, PHEROMONES ANIMAL BE; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Beukeboom LW, 2001, NETH J ZOOL, V51, P1, DOI 10.1163/156854201750210805; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Bourdais D, 2009, BEHAV PROCESS, V81, P92, DOI 10.1016/j.beproc.2009.02.015; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Cowan DP, 2004, P NATL ACAD SCI USA, V101, P10374, DOI 10.1073/pnas.0402481101; de Boer JG, 2007, HEREDITY, V99, P288, DOI 10.1038/sj.hdy.6800995; DUCHATEAU MJ, 1995, INSECT SOC, V42, P255, DOI 10.1007/BF01240420; Enigl M, 2004, ENTOMOL EXP APPL, V112, P21, DOI 10.1111/j.0013-8703.2004.00175.x; Facon B, 2006, EVOL ECOL, V20, P395, DOI 10.1007/s10682-006-0009-9; Fellowes MDE, 1998, ECOL ENTOMOL, V23, P223, DOI 10.1046/j.1365-2311.1998.00128.x; Hauber ME, 2000, TRENDS ECOL EVOL, V15, P349, DOI 10.1016/S0169-5347(00)01923-6; Hedrick PW, 2006, TRENDS ECOL EVOL, V21, P55, DOI 10.1016/j.tree.2005.11.014; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Hein S, 2009, ECOL MODEL, V220, P1663, DOI 10.1016/j.ecolmodel.2009.04.001; Henter HJ, 2003, EVOLUTION, V57, P1793, DOI 10.1111/j.0014-3820.2003.tb00587.x; Holmes WG, 2004, ANN ZOOL FENN, V41, P691; HOLMES WG, 1982, AM ZOOL, V22, P491; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Ivy TM, 2005, P ROY SOC B-BIOL SCI, V272, P2475, DOI 10.1098/rspb.2005.3222; KELLER L, 1993, BEHAV ECOL SOCIOBIOL, V33, P191, DOI 10.1007/BF00216600; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; LaSalle J., 1993, HYMENOPTERA BIODIVER; Lihoreau M, 2009, BEHAV ECOL, V20, P46, DOI 10.1093/beheco/arn113; Lihoreau M, 2007, BEHAV ECOL, V18, P880, DOI 10.1093/beheco/arm046; Lize A, 2010, BEHAV ECOL, V21, P633, DOI 10.1093/beheco/arq034; Lize A, 2010, ANIM COGN, V13, P189, DOI 10.1007/s10071-009-0247-7; Marris GC, 1996, ENTOMOL EXP APPL, V78, P167, DOI 10.1007/BF00187513; Mateo JM, 2000, P ROY SOC B-BIOL SCI, V267, P695, DOI 10.1098/rspb.2000.1058; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; METZGER M, 2008, THESIS U LYON 1, P213; Metzger M, 2010, ANIM BEHAV, V79, P1307, DOI 10.1016/j.anbehav.2010.03.003; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Murray TJ, 2010, BIOL CONTROL, V52, P153, DOI 10.1016/j.biocontrol.2009.10.003; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; ODE PJ, 1995, ANIM BEHAV, V49, P1239, DOI 10.1006/anbe.1995.0156; Petrie M, 1999, NATURE, V401, P155, DOI 10.1038/43651; PFENNIG DW, 1989, ETHOLOGY, V80, P1; PFENNIG DW, 1993, EVOLUTION, V47, P700, DOI [10.2307/2410085, 10.1111/j.1558-5646.1993.tb02127.x]; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; R Development Core Team, 2009, R FDN STAT COMP; RIDLEY M, 1993, AM NAT, V142, P893, DOI 10.1086/285579; SALT G, 1976, ECOL ENTOMOL, V1, P63, DOI 10.1111/j.1365-2311.1976.tb01205.x; Shellman-Reeve JS, 2001, ANIM BEHAV, V61, P869, DOI 10.1006/anbe.2000.1674; Sherman Paul W., 1997, P69; SIMMONS LW, 1991, ANIM BEHAV, V41, P493, DOI 10.1016/S0003-3472(05)80852-8; SIMMONS LW, 1989, ANIM BEHAV, V38, P68, DOI 10.1016/S0003-3472(89)80066-1; SMITH BH, 1987, BEHAV ECOL SOCIOBIOL, V20, P313, DOI 10.1007/BF00300676; Tang-Martinez Z, 2001, BEHAV PROCESS, V53, P21, DOI 10.1016/S0376-6357(00)00148-0; Thurin N, 2009, J EVOLUTION BIOL, V22, P2481, DOI 10.1111/j.1420-9101.2009.01864.x; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van Santen Marlies C.P., 2002, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V13, P87; VANWILGENBURG E, 2006, FRONTIERS ZOOLOGY, V3; Villavicencio CP, 2009, ANIM BEHAV, V78, P377, DOI 10.1016/j.anbehav.2009.04.026; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543; Whitehorn PR, 2009, APIDOLOGIE, V40, P627, DOI 10.1051/apido/2009050; Whitehorn PR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-152; Whiting PW, 1943, GENETICS, V28, P365; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	73	31	31	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13505	10.1371/journal.pone.0013505	http://dx.doi.org/10.1371/journal.pone.0013505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976063	gold, Green Submitted, Green Published			2022-12-25	WOS:000283114700024
J	van Mansfeld, R; Jongerden, I; Bootsma, M; Buiting, A; Bonten, M; Willems, R				van Mansfeld, Rosa; Jongerden, Irene; Bootsma, Martin; Buiting, Anton; Bonten, Marc; Willems, Rob			The Population Genetics of Pseudomonas aeruginosa Isolates from Different Patient Populations Exhibits High-Level Host Specificity	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; CYSTIC-FIBROSIS PATIENTS; TANDEM-REPEAT ANALYSIS; TYPING METHODS; STRAIN; INFECTION; DIVERSITY; PATTERNS	Objective: To determine whether highly prevalent P. aeruginosa sequence types (ST) in Dutch cystic fibrosis (CF) patients are specifically linked to CF patients we investigated the population structure of P. aeruginosa from different clinical backgrounds. We first selected the optimal genotyping method by comparing pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST) and multilocus variable number tandem-repeat analysis (MLVA). Methods: Selected P. aeruginosa isolates (n = 60) were genotyped with PFGE, MLST and MLVA to determine the diversity index (DI) and congruence (adjusted Rand and Wallace coefficients). Subsequently, isolates from patients admitted to two different ICUs (n = 205), from CF patients (n = 100) and from non-ICU, non-CF patients (n = 58, of which 19 were community acquired) were genotyped with MLVA to determine distribution of genotypes and genetic diversity. Results: Congruence between the typing methods was >79% and DIs were similar and all >0.963. Based on costs, ease, speed and possibilities to compare results between labs an adapted MLVA scheme called MLVA9-Utrecht was selected as the preferred typing method. In 363 clinical isolates 252 different MLVA types (MTs) were identified, indicating a highly diverse population (DI = 0.995; CI = 0.993-0.997). DI levels were similarly high in the diverse clinical sources (all >0.981) and only eight genotypes were shared. MTs were highly specific (>80%) for the different patient populations, even for similar patient groups (ICU patients) in two distinct geographic regions, with only three of 142 ICU genotypes detected in both ICUs. The two major CF clones were unique to CF patients. Conclusion: The population structure of P. aeruginosa isolates is highly diverse and population specific without evidence for a core lineage in which major CF, hospital or community clones co-cluster. The two genotypes highly prevalent among Dutch CF patients appeared unique to CF patients, suggesting specific adaptation of these clones to the CF lung.	[van Mansfeld, Rosa; Bonten, Marc; Willems, Rob] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Jongerden, Irene] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Bootsma, Martin] Univ Med Ctr Utrecht, Julius Ctr Hlth Res & Primary Care, Utrecht, Netherlands; [Bootsma, Martin] Univ Utrecht, Fac Sci, Dept Math, Utrecht, Netherlands; [Buiting, Anton] St Elizabeth Hosp, Dept Med Microbiol & Immunol, Tilburg, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Elisabeth-TweeSteden Ziekenhuis (ETZ)	van Mansfeld, R (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	r.vanmansfeld@umcutrecht.nl	Willems, Rob JL/E-3681-2010	Willems, Rob JL/0000-0002-7370-0812; Jongerden, Irene/0000-0002-6637-7631	Netherlands Organization for Scientific Research (VICI NWO) [918.76.611]	Netherlands Organization for Scientific Research (VICI NWO)(Netherlands Organization for Scientific Research (NWO))	M.J.M.B. is supported by the Netherlands Organization for Scientific Research (VICI NWO Grant 918.76.611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Alonso A, 1999, ENVIRON MICROBIOL, V1, P421, DOI 10.1046/j.1462-2920.1999.00052.x; [Anonymous], PSEUDOMONAS AERUGINO; Armstrong D, 2003, J CLIN MICROBIOL, V41, P2266, DOI 10.1128/JCM.41.5.2266-2267.2003; Armstrong DS, 2002, AM J RESP CRIT CARE, V166, P983, DOI 10.1164/rccm.200204-269OC; Bradbury RS, 2009, J HOSP INFECT, V73, P151, DOI 10.1016/j.jhin.2009.05.021; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; DENAMUR E, 1993, FEMS MICROBIOL LETT, V110, P275, DOI 10.1111/j.1574-6968.1993.tb06334.x; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Griffiths AL, 2005, AM J RESP CRIT CARE, V171, P1020, DOI 10.1164/rccm.200409-1194OC; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Johnson JK, 2007, J CLIN MICROBIOL, V45, P3707, DOI 10.1128/JCM.00560-07; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jones AM, 2002, LANCET, V359, P527, DOI 10.1016/S0140-6736(02)07648-1; Jones AM, 2002, THORAX, V57, P924, DOI 10.1136/thorax.57.11.924; Lanotte P, 2004, J MED MICROBIOL, V53, P73, DOI 10.1099/jmm.0.05324-0; PICARD B, 1994, J MED MICROBIOL, V40, P313, DOI 10.1099/00222615-40-5-313; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Pirnay JP, 2005, ENVIRON MICROBIOL, V7, P969, DOI 10.1111/j.1462-2920.2005.00776.x; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P898, DOI 10.1046/j.1462-2920.2002.00321.x; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; Speijer H, 1999, J CLIN MICROBIOL, V37, P3654, DOI 10.1128/JCM.37.11.3654-3661.1999; Talon D, 1996, J HOSP INFECT, V32, P135, DOI 10.1016/S0195-6701(96)90055-9; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Van Mansfeld R, 2009, J CLIN MICROBIOL, V47, P4096, DOI 10.1128/JCM.01462-09; Vu-Thien H, 2007, J CLIN MICROBIOL, V45, P3175, DOI 10.1128/JCM.00702-07; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104	31	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13482	10.1371/journal.pone.0013482	http://dx.doi.org/10.1371/journal.pone.0013482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976062	Green Published, gold, Green Submitted			2022-12-25	WOS:000283114700013
J	Sneppen, K; Trusina, A; Jensen, MH; Bornholdt, S				Sneppen, Kim; Trusina, Ala; Jensen, Mogens H.; Bornholdt, Stefan			A Minimal Model for Multiple Epidemics and Immunity Spreading	PLOS ONE			English	Article							INFECTIOUS-DISEASES; VIRUSES; ABUNDANCE; INFLUENZA; BACTERIAL; BACTERIOPHAGES; POPULATIONS; RESISTANCE; DIVERSITY; EVOLUTION	Pathogens and parasites are ubiquitous in the living world, being limited only by availability of suitable hosts. The ability to transmit a particular disease depends on competing infections as well as on the status of host immunity. Multiple diseases compete for the same resource and their fate is coupled to each other. Such couplings have many facets, for example cross-immunization between related influenza strains, mutual inhibition by killing the host, or possible even a mutual catalytic effect if host immunity is impaired. We here introduce a minimal model for an unlimited number of unrelated pathogens whose interaction is simplified to simple mutual exclusion. The model incorporates an ongoing development of host immunity to past diseases, while leaving the system open for emergence of new diseases. The model exhibits a rich dynamical behavior with interacting infection waves, leaving broad trails of immunization in the host population. This obtained immunization pattern depends only on the system size and on the mutation rate that initiates new diseases.	[Sneppen, Kim; Trusina, Ala; Jensen, Mogens H.] Niels Bohr Inst CMOL, Copenhagen, Denmark; [Bornholdt, Stefan] Univ Bremen, Inst Theoret Phys, Bremen, Germany	University of Copenhagen; Niels Bohr Institute; University of Bremen	Sneppen, K (corresponding author), Niels Bohr Inst CMOL, Copenhagen, Denmark.	sneppen@nbi.dk	trusina, ala/H-7312-2012; Trusina, Ala/L-6069-2013; Jensen, Mogens H./U-5510-2017; Trusina, Ala/N-5030-2019	Trusina, Ala/0000-0003-1945-454X; Jensen, Mogens H./0000-0001-8104-4299; Trusina, Ala/0000-0003-1945-454X; Sneppen, Kim/0000-0001-9820-3567	Danish Research council	Danish Research council(Det Frie Forskningsrad (DFF))	The research was funded by Danish Research council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; Ashelford KE, 2003, APPL ENVIRON MICROB, V69, P285, DOI 10.1128/AEM.69.1.285-289.2003; BARKSDALE L, 1974, ANNU REV MICROBIOL, V28, P265, DOI 10.1146/annurev.mi.28.100174.001405; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Burdon JJ., 1987, DIS PLANT POPULATION; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; CHRISTIE GE, 1990, ANNU REV GENET, V24, P465, DOI 10.1146/annurev.ge.24.120190.002341; Comeau AM, 2005, CURR OPIN MICROBIOL, V8, P488, DOI 10.1016/j.mib.2005.06.004; DEBOER J, 1994, PHYS REV LETT, V73, P906, DOI 10.1103/PhysRevLett.73.906; Djordjevic GM, 1997, J BACTERIOL, V179, P6741, DOI 10.1128/jb.179.21.6741-6748.1997; DROSSEL B, 1992, PHYS REV LETT, V69, P1629, DOI 10.1103/PhysRevLett.69.1629; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437; Heilmann S, 2010, J VIROL, V84, P3016, DOI 10.1128/JVI.02326-09; KENDALL DG, 1948, BIOMETRIKA, V35, P6, DOI 10.2307/2332624; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; Kryazhimskiy S, 2007, PLOS COMPUT BIOL, V3, P1513, DOI 10.1371/journal.pcbi.0030159; Levin SA, 2004, MATH BIOSCI, V188, P17, DOI 10.1016/j.mbs.2003.08.010; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Luria SE, 1943, GENETICS, V28, P491; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; PEASE CM, 1987, THEOR POPUL BIOL, V31, P422, DOI 10.1016/0040-5809(87)90014-1; Rohani P, 2003, NATURE, V422, P885, DOI 10.1038/nature01542; Rosvall M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066105; Shapiro OH, 2010, ISME J, V4, P327, DOI 10.1038/ismej.2009.118; SHAW MW, 1994, ANNU REV PHYTOPATHOL, V32, P523, DOI 10.1146/annurev.py.32.090194.002515; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vos M, 2009, SCIENCE, V325, P833, DOI 10.1126/science.1174173; Williamson KE, 2005, APPL ENVIRON MICROB, V71, P3119, DOI 10.1128/AEM.71.6.3119-3125.2005; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	37	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13326	10.1371/journal.pone.0013326	http://dx.doi.org/10.1371/journal.pone.0013326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976185	Green Submitted, Green Published, gold			2022-12-25	WOS:000283045300007
J	Yu, DD; Jia, XY; Zhang, AM; Li, SQ; Zou, Y; Zhang, QJ; Yao, YG				Yu, Dandan; Jia, Xiaoyun; Zhang, A-Mei; Li, Shiqiang; Zou, Yang; Zhang, Qingjiong; Yao, Yong-Gang			Mitochondrial DNA Sequence Variation and Haplogroup Distribution in Chinese Patients with LHON and m.14484T > C	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; CLINICAL EXPRESSION; MTDNA MUTATIONS; DISEASE; FAMILIES; G11778A; IDENTIFICATION; POLYMORPHISMS; DYSFUNCTION; PENETRANCE	Background: Leber hereditary optic neuropathy (LHON, MIM 535000) is one of the most common mitochondrial genetic disorders caused by three primary mtDNA mutations (m. 3460G>A, m. 11778G>A and m. 14484T>C). The clinical expression of LHON is affected by many additional factors, e. g. mtDNA background, nuclear genes, and environmental factors. Hitherto, there is no comprehensive study of Chinese LHON patients with m. 14484T>C. Methodology/Principal Findings: In this study, we analyzed the mtDNA sequence variations and haplogroup distribution pattern of the largest number of Chinese LHON patients with m. 14484T>C to date. We first determined the complete mtDNA sequences in eleven LHON probands with m. 14484T>C, to discern the potentially pathogenic mutations that co-segregate with m. 14484T>C. We then dissected the matrilineal structure of 52 patients with m. 14484T>C (including 14 from unrelated families and 38 sporadic cases) and compared it with the reported Han Chinese from general populations. Complete mtDNA sequencing showed that the eleven matrilines belonged to nine haplogroups including Y2, C4a, M8a, M10a1a, G1a1, G2a1, G2b2, D5a2a1, and D5c. We did not identify putatively pathogenic mutation that was co-segregated with m. 14484T>C in these lineages based on the evolutionary analysis. Compared with the reported Han Chinese from general populations, the LHON patients with m. 14484T>C had significantly higher frequency of haplogroups C, G, M10, and Y, but a lower frequency of haplogroup F. Intriguingly, we also observed a lower prevalence of F lineages in LHON subjects with m. 11778G>A in our previous study, suggesting that this haplogroup may enact similar role during the onset of LHON in the presence of m. 14484T>C or m. 11778G>A. Conclusions/Significance: Our current study provided a comprehensive profile regarding the mtDNA variation and background of Chinese patients with LHON and m. 14484T>C. Matrilineal background might affect the expression of LHON in Chinese patients with m. 14484T>C.	[Yu, Dandan; Zhang, A-Mei; Zou, Yang; Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China; [Jia, Xiaoyun; Li, Shiqiang; Zhang, Qingjiong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, A-Mei; Zou, Yang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Sun Yat Sen University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, DD (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China.	qingjiongzhang@yahoo.com; ygyaozh@gmail.com	Yao, Yong-Gang/AAH-2303-2021; Zhang, Qingjiong/AAR-6331-2021	Yao, Yong-Gang/0000-0002-2955-0693; Zhang, Qingjiong/0000-0001-7508-848X	Yunnan Province [2009CI119]; Guangdong Province [2009B091300150]; Chinese Academy of Sciences; National Natural Science Foundation of China [30925021]	Yunnan Province; Guangdong Province; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Yunnan Province (2009CI119), Guangdong Province (2009B091300150), Chinese Academy of Sciences, and the National Natural Science Foundation of China (30925021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; Bi R, 2010, CLIN CHIM ACTA, V411, P1671, DOI 10.1016/j.cca.2010.06.026; Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922; HOWELL N, 1991, AM J HUM GENET, V49, P939; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; Jacobi FK, 2001, INVEST OPHTH VIS SCI, V42, P1208; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Jia XY, 2006, J HUM GENET, V51, P851, DOI 10.1007/s10038-006-0032-2; JOHNS DR, 1993, BIOCHEM BIOPH RES CO, V196, P810, DOI 10.1006/bbrc.1993.2321; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V181, P1358, DOI 10.1016/0006-291X(91)92088-2; Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; MACKEY D, 1992, AM J HUM GENET, V51, P1218; Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Tharaphan P, 2006, J NEURO-OPHTHALMOL, V26, P264, DOI 10.1097/01.wno.0000249318.88991.c4; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wang HW, 2008, MUTAT RES-FUND MOL M, V643, P48, DOI 10.1016/j.mrfmmm.2008.06.004; Wei YL, 2009, CLIN EXP PHARMACOL P, V36, P933, DOI 10.1111/j.1440-1681.2009.05183.x; Yang JH, 2009, BIOCHEM BIOPH RES CO, V386, P50, DOI 10.1016/j.bbrc.2009.05.127; Yang JH, 2009, MITOCHONDRION, V9, P273, DOI 10.1016/j.mito.2009.04.003; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2003, MOL BIOL EVOL, V20, P214, DOI 10.1093/molbev/msg026; Yao YG, 2007, BLOOD, V109, P756, DOI 10.1182/blood-2006-01-011007; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023; Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002; Yu DD, 2010, NEUROGENETICS, V11, P349, DOI 10.1007/s10048-010-0236-7; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Zhang AM, 2008, BIOCHEM BIOPH RES CO, V376, P221, DOI 10.1016/j.bbrc.2008.08.128; Zhang AM, 2009, BIOCHEM BIOPH RES CO, V386, P392, DOI 10.1016/j.bbrc.2009.06.051; Zou Y, 2010, BIOCHEM BIOPH RES CO, V399, P179, DOI 10.1016/j.bbrc.2010.07.051	42	20	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13426	10.1371/journal.pone.0013426	http://dx.doi.org/10.1371/journal.pone.0013426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976138	gold, Green Published, Green Submitted			2022-12-25	WOS:000283045300013
J	Kim, ML; Jeong, HG; Kasper, CA; Arrieumerlou, C				Kim, Man Lyang; Jeong, Hyun Gyeong; Kasper, Christoph Alexander; Arrieumerlou, Cecile			IKK alpha Contributes to Canonical NF-kappa B Activation Downstream of Nod1-Mediated Peptidoglycan Recognition	PLOS ONE			English	Article							SHIGELLA-FLEXNERI; SIGNALING PATHWAY; ESCHERICHIA-COLI; INNATE IMMUNITY; REGULATOR; NOD1; PATHOGENESIS; INFLAMMATION; EXPRESSION; INHIBITOR	Background: During pathogen infection, innate immunity is initiated via the recognition of microbial products by pattern recognition receptors and the subsequent activation of transcription factors that upregulate proinflammatory genes. By controlling the expression of cytokines, chemokines, anti-bacterial peptides and adhesion molecules, the transcription factor nuclear factor-kappa B (NF-kappa B) has a central function in this process. In a typical model of NF-kappa B activation, the recognition of pathogen associated molecules triggers the canonical NF-kappa B pathway that depends on the phosphorylation of Inhibitor of NF-kappa B (I kappa B) by the catalytic subunit IkB kinase beta (IKK beta), its degradation and the nuclear translocation of NF-kappa B dimers. Methodology: Here, we performed an RNA interference (RNAi) screen on Shigella flexneri-induced NF-kappa B activation to identify new factors involved in the regulation of NF-kappa B following infection of epithelial cells by invasive bacteria. By targeting a subset of the human signaling proteome, we found that the catalytic subunit IKK alpha is also required for complete NF-kappa B activation during infection. Depletion of IKK alpha by RNAi strongly reduces the nuclear translocation of NF-kappa B p65 during S. flexneri infection as well as the expression of the proinflammatory chemokine interleukin-8. Similar to IKK beta, IKK alpha contributes to the phosphorylation of IkBa on serines 32 and 36, and to its degradation. Experiments performed with the synthetic Nod1 ligand L-Ala-D-gamma-Glu-meso-diaminopimelic acid confirmed that IKK alpha is involved in NF-kappa B activation triggered downstream of Nod1-mediated peptidoglycan recognition. Conclusions: Taken together, these results demonstrate the unexpected role of IKK alpha in the canonical NF-kappa B pathway triggered by peptidoglycan recognition during bacterial infection. In addition, they suggest that IKK alpha may be an important drug target for the development of treatments that aim at limiting inflammation in bacterial infection.	[Kim, Man Lyang; Jeong, Hyun Gyeong; Kasper, Christoph Alexander; Arrieumerlou, Cecile] Univ Basel, Biozentrum, Basel, Switzerland	University of Basel	Kim, ML (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	cecile.arrieumerlou@unibas.ch			Swiss National Science Foundation [3100A0-113561]; University of Basel; Werner-Siemens Foundation; SystemsX.ch	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel; Werner-Siemens Foundation; SystemsX.ch	This work was supported by Swiss National Science Foundation (grant 3100A0-113561, www.snf.ch), the University of Basel (www.unibas.ch) and the InfectX grant from SystemsX.ch (www.systemsx.ch). C. Kasper was supported by the Werner-Siemens Foundation (www.wernersiemens-stiftung.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLI M, PLOS ONE, V5, pE9428; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; BLASIUS AL, IMMUNITY, V32, P305; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEHIO C, 1995, EMBO J, V14, P2471, DOI 10.1002/j.1460-2075.1995.tb07244.x; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Inohara N, 2000, J BIOL CHEM, V275, P27823; Islam D, 1997, INFECT IMMUN, V65, P739, DOI 10.1128/IAI.65.2.739-749.1997; Izmailova ES, 2007, ARTHRITIS RHEUM-US, V56, P117, DOI 10.1002/art.22303; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Le Bourhis L, 2007, BIOCHEM SOC T, V35, P1479, DOI 10.1042/BST0351479; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; OGAWA H, CLIN EXP ALLERGY; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Pedron T, 2003, J BIOL CHEM, V278, P33878, DOI 10.1074/jbc.M303749200; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Rasmussen SB, 2009, APMIS, V117, P323, DOI 10.1111/j.1600-0463.2009.02456.x; REIJMERINK NE, ALLERGY, V65, P199; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Weidinger S, 2005, J ALLERGY CLIN IMMUN, V116, P177, DOI 10.1016/j.jaci.2005.02.034; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e15371	10.1371/journal.pone.0015371	http://dx.doi.org/10.1371/journal.pone.0015371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976174	Green Published, Green Submitted, gold			2022-12-25	WOS:000283043700033
J	Conceicao, IC; Aguade, M				Conceicao, Ines C.; Aguade, Montserrat			Odorant Receptor (Or) Genes: Polymorphism and Divergence in the D. melanogaster and D. pseudoobscura Lineages	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; SEQUENCE EVOLUTION; POSITIVE SELECTION; DNA; POPULATION; PATTERNS; HITCHHIKING; SIGNATURE; PROTEINS; AFRICAN	Background: In insects, like in most invertebrates, olfaction is the principal sensory modality, which provides animals with essential information for survival and reproduction. Odorant receptors are involved in this response, mediating interactions between an individual and its environment, as well as between individuals of the same or different species. The adaptive importance of odorant receptors renders them good candidates for having their variation shaped by natural selection. Methodology/Principal Findings: We analyzed nucleotide variation in a subset of eight Or genes located on the 3L chromosomal arm of Drosophila melanogaster in a derived population of this species and also in a population of Drosophila pseudoobscura. Some heterogeneity in the silent polymorphism to divergence ratio was detected in the D. melanogaster/D. simulans comparison, with a single gene (Or67b) contributing similar to 37% to the test statistic. However, no other signals of a very recent selective event were detected at this gene. In contrast, at the speciation timescale, the MK test uncovered the footprint of positive selection driving the evolution of two of the encoded proteins in both D. melanogaster -OR65c and OR67a -and D. pseudoobscura -OR65b1 and OR67c. Conclusions: The powerful polymorphism/divergence approach provided evidence for adaptive evolution at a rather high proportion of the Or genes studied after relatively recent speciation events. It did not provide, however, clear evidence for very recent selective events in either D. melanogaster or D. pseudoobscura.	[Conceicao, Ines C.; Aguade, Montserrat] Univ Barcelona, Dept Genet, Fac Biol, Barcelona, Spain; [Aguade, Montserrat] Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain	University of Barcelona; University of Barcelona	Conceicao, IC (corresponding author), Univ Barcelona, Dept Genet, Fac Biol, Barcelona, Spain.	maguade@ub.edu	Conceiçao, Ines/ABC-6167-2021	Aguade, Montserrat/0000-0002-3884-7800; Conceicao, Ines/0000-0002-1246-3761	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/11107/2002]; Comision Interdepartamental de Ciencia y Tecnologia, Spain [BFU2004-02253, BFU2007-63229]; Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Spain [2005SGR-00166]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Comision Interdepartamental de Ciencia y Tecnologia, Spain; Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Spain(Generalitat de Catalunya)	I.C.C. was supported by predoctoral fellowship SFRH/BD/11107/2002 from Fundacao para a Ciencia e a Tecnologia, Portugal. This work was supported by grants BFU2004-02253 and BFU2007-63229 from Comision Interdepartamental de Ciencia y Tecnologia, Spain, and 2005SGR-00166 from Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Spain, to M. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 1989, DROSOPHILA LAB HDB; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Burland T G, 2000, Methods Mol Biol, V132, P71; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; CONCEICAO IC, 2008, J MOL EVOL; Dean MD, 2003, GENETICS, V165, P1959; DOBZHANSKY T, 1970, GENETICS EVOLUTIONAR, pR9; Fay JC, 2000, GENETICS, V155, P1405; Gallach M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-408; Glinka S, 2003, GENETICS, V165, P1269; Haddrill PR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r67; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Halligan DL, 2004, GENOME RES, V14, P273, DOI 10.1101/gr.1329204; Hamblin MT, 1999, GENETICS, V153, P859; HOLM S, 1979, SCAND J STAT, V6, P65; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kelly JK, 1997, GENETICS, V146, P1197; Kim Y, 2002, GENETICS, V160, P765; Kovacevic M, 2000, GENETICS, V156, P155; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; MADDISON W. P., 2000, MACCLADE 4 ANAL PHYL; McBride CS, 2007, GENETICS, V177, P1395, DOI 10.1534/genetics.107.078683; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Nei M., 1987, MOL EVOLUTIONARY GEN; Orengo DJ, 2004, GENETICS, V167, P1759, DOI 10.1534/genetics.104.028969; Pascual M, 2004, J ZOOL SYST EVOL RES, V42, P33, DOI 10.1046/j.0947-5745.2003.00237.x; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozas J, 2001, GENETICS, V158, P1147; Shapiro JA, 2007, P NATL ACAD SCI USA, V104, P2271, DOI 10.1073/pnas.0610385104; TAJIMA F, 1989, GENETICS, V123, P585; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000681	44	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13389	10.1371/journal.pone.0013389	http://dx.doi.org/10.1371/journal.pone.0013389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967126	Green Published, Green Submitted, gold			2022-12-25	WOS:000282869800049
J	Kandadi, MR; Hua, YN; Ma, H; Li, Q; Kuo, SR; Frankel, AE; Ren, J				Kandadi, Machender R.; Hua, Yinan; Ma, Heng; Li, Qun; Kuo, Shu-ru; Frankel, Arthur E.; Ren, Jun			Anthrax Lethal Toxin Suppresses Murine Cardiomyocyte Contractile Function and Intracellular Ca2+ Handling via a NADPH Oxidase-Dependent Mechanism	PLOS ONE			English	Article							PROTECTIVE ANTIGEN; EDEMA TOXIN; RAT MODEL; MICE; SHOCK; DYSFUNCTION; INFECTION; GROWTH; TOXICITY; SURVIVAL	Objectives: Anthrax infection is associated with devastating cardiovascular sequelae, suggesting unfavorable cardiovascular effects of toxins originated from Bacillus anthracis namely lethal and edema toxins. This study was designed to examine the direct effect of lethal toxins on cardiomyocyte contractile and intracellular Ca2+ properties. Methods: Murine cardiomyocyte contractile function and intracellular Ca2+ handling were evaluated including peak shortening (PS), maximal velocity of shortening/relengthening (+/- dL/dt), time-to-PS (TPS), time-to-90% relengthening (TR90), intracellular Ca2+ rise measured as fura-2 fluorescent intensity (Delta FFI), and intracellular Ca2+ decay rate. Stress signaling and Ca2+ regulatory proteins were assessed using Western blot analysis. Results: In vitro exposure to a lethal toxin (0.05-50 nM) elicited a concentration-dependent depression on cardiomyocyte contractile and intracellular Ca2+ properties (PS, +/- dL/dt, Delta FFI), along with prolonged duration of contraction and intracellular Ca2+ decay, the effects of which were nullified by the NADPH oxidase inhibitor apocynin. The lethal toxin significantly enhanced superoxide production and cell death, which were reversed by apocynin. In vivo lethal toxin exposure exerted similar time-dependent cardiomyocyte mechanical and intracellular Ca2+ responses. Stress signaling cascades including MEK1/2, p38, ERK and JNK were unaffected by in vitro lethal toxins whereas they were significantly altered by in vivo lethal toxins. Ca2+ regulatory proteins SERCA2a and phospholamban were also differentially regulated by in vitro and in vivo lethal toxins. Autophagy was drastically triggered although ER stress was minimally affected following lethal toxin exposure. Conclusions: Our findings indicate that lethal toxins directly compromised murine cardiomyocyte contractile function and intracellular Ca2+ through a NADPH oxidase-dependent mechanism.	[Kandadi, Machender R.; Hua, Yinan; Ma, Heng; Li, Qun; Ren, Jun] Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA; [Kuo, Shu-ru; Frankel, Arthur E.] Scott & White Mem Hosp & Clin, Canc Res Inst, Temple, TX 76508 USA	University of Wyoming; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Kandadi, MR (corresponding author), Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.	jren@uwyo.edu	Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783				Akki A, 2009, J MOL CELL CARDIOL, V47, P15, DOI 10.1016/j.yjmcc.2009.04.004; Behe P, 2007, BIOCHEM SOC T, V35, P1100, DOI 10.1042/BST0351100; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bleeke T, 2004, CIRC RES, V94, P37, DOI 10.1161/01.RES.0000109412.80157.7D; Borio L, 2001, JAMA-J AM MED ASSOC, V286, P2554, DOI 10.1001/jama.286.20.2554; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Cone LA, 2005, J HEART VALVE DIS, V14, P37; Cui XZ, 2007, J INFECT DIS, V195, P572, DOI 10.1086/510856; Cui XZ, 2005, J INFECT DIS, V191, P422, DOI 10.1086/427189; Cui XZ, 2004, AM J PHYSIOL-REG I, V286, pR699, DOI 10.1152/ajpregu.00593.2003; Culley NC, 2005, INFECT IMMUN, V73, P7006, DOI 10.1128/IAI.73.10.7006-7010.2005; Dong F, 2006, HYPERTENSION, V47, P222, DOI 10.1161/01.HYP.0000198555.51645.f1; Edick MJ, 2007, MOL BIOL CELL, V18, P2481, DOI 10.1091/mbc.E06-04-0261; EZZELL JW, 1984, INFECT IMMUN, V45, P761, DOI 10.1128/IAI.45.3.761-767.1984; Firoved AM, 2007, INFECT IMMUN, V75, P2120, DOI 10.1128/IAI.01781-06; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Frankel AE, 2009, FRONT BIOSCI, V14, P4516, DOI 10.2741/3544; Hougee S, 2006, EUR J PHARMACOL, V531, P264, DOI 10.1016/j.ejphar.2005.11.061; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; KLEIN F, 1968, J INFECT DIS, V118, P97, DOI 10.1093/infdis/118.1.97; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Li Q, 2007, REJUV RES, V10, P501, DOI 10.1089/rej.2007.0552; Marcus H, 2004, INFECT IMMUN, V72, P3471, DOI 10.1128/IAI.72.6.3471-3477.2004; MILLER DJ, 1995, J HUM HYPERTENS, V9, P465; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Noh KM, 2000, J NEUROSCI, V20; Privratsky JR, 2003, HYPERTENSION, V42, P206, DOI 10.1161/01.HYP.0000082814.62655.85; Rossi CA, 2008, INFECT IMMUN, V76, P5790, DOI 10.1128/IAI.00520-08; Sapra R, 2006, MICROB PATHOGENESIS, V41, P157, DOI 10.1016/j.micpath.2006.07.002; Watson LE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000466; Watson LE, 2007, FRONT BIOSCI-LANDMRK, V12, P4670, DOI 10.2741/2416	33	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13335	10.1371/journal.pone.0013335	http://dx.doi.org/10.1371/journal.pone.0013335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967205	Green Published, gold, Green Submitted			2022-12-25	WOS:000282869800030
J	Proulx, R; Wirth, C; Voigt, W; Weigelt, A; Roscher, C; Attinger, S; Baade, J; Barnard, RL; Buchmann, N; Buscot, F; Eisenhauer, N; Fischer, M; Gleixner, G; Halle, S; Hildebrandt, A; Kowalski, E; Kuu, A; Lange, M; Milcu, A; Niklaus, PA; Oelmann, Y; Rosenkranz, S; Sabais, A; Scherber, C; Scherer-Lorenzen, M; Scheu, S; Schulze, ED; Schumacher, J; Schwichtenberg, G; Soussana, JF; Temperton, VM; Weisser, WW; Wilcke, W; Schmid, B				Proulx, Raphael; Wirth, Christian; Voigt, Winfried; Weigelt, Alexandra; Roscher, Christiane; Attinger, Sabine; Baade, Jussi; Barnard, Romain L.; Buchmann, Nina; Buscot, Francois; Eisenhauer, Nico; Fischer, Markus; Gleixner, Gerd; Halle, Stefan; Hildebrandt, Anke; Kowalski, Esther; Kuu, Annely; Lange, Markus; Milcu, Alex; Niklaus, Pascal A.; Oelmann, Yvonne; Rosenkranz, Stephan; Sabais, Alexander; Scherber, Christoph; Scherer-Lorenzen, Michael; Scheu, Stefan; Schulze, Ernst-Detlef; Schumacher, Jens; Schwichtenberg, Guido; Soussana, Jean-Francois; Temperton, Vicky M.; Weisser, Wolfgang W.; Wilcke, Wolfgang; Schmid, Bernhard			Diversity Promotes Temporal Stability across Levels of Ecosystem Organization in Experimental Grasslands	PLOS ONE			English	Article							PLANT DIVERSITY; COMPETITIVE COMMUNITIES; COMPENSATORY DYNAMICS; BIODIVERSITY; VARIABILITY; SOIL; PRODUCTIVITY; HYPOTHESIS; POOLS	The diversity-stability hypothesis states that current losses of biodiversity can impair the ability of an ecosystem to dampen the effect of environmental perturbations on its functioning. Using data from a long-term and comprehensive biodiversity experiment, we quantified the temporal stability of 42 variables characterizing twelve ecological functions in managed grassland plots varying in plant species richness. We demonstrate that diversity increases stability i) across trophic levels (producer, consumer), ii) at both the system (community, ecosystem) and the component levels (population, functional group, phylogenetic clade), and iii) primarily for aboveground rather than belowground processes. Temporal synchronization across studied variables was mostly unaffected with increasing species richness. This study provides the strongest empirical support so far that diversity promotes stability across different ecological functions and levels of ecosystem organization in grasslands.	[Proulx, Raphael; Wirth, Christian; Roscher, Christiane; Gleixner, Gerd; Schulze, Ernst-Detlef; Temperton, Vicky M.] Max Planck Inst Biogeochem, Hans Knoll Str, Jena, Germany; [Wirth, Christian; Weigelt, Alexandra] Univ Leipzig, Dept Special Bot & Funct Biodivers Res, Leipzig, Germany; [Voigt, Winfried; Weigelt, Alexandra; Halle, Stefan; Kowalski, Esther; Kuu, Annely; Lange, Markus; Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Jena, Germany; [Attinger, Sabine; Hildebrandt, Anke; Schwichtenberg, Guido] UFZ Helmholtz Ctr Environm Res, Leipzig, Germany; [Baade, Jussi] Univ Jena, Inst Geog, Jena, Germany; [Barnard, Romain L.; Buchmann, Nina; Niklaus, Pascal A.; Scherer-Lorenzen, Michael] ETH, Inst Plant Anim & Agroecosyst Sci, Zurich, Switzerland; [Buscot, Francois] UFZ Helmholtz Ctr Environm Res, Halle, Germany; [Eisenhauer, Nico; Sabais, Alexander] Tech Univ Darmstadt, Inst Zool, Darmstadt, Germany; [Eisenhauer, Nico; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Fischer, Markus] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Kuu, Annely] Tallinn Univ Technol, Tartu Coll, Tartu, Estonia; [Milcu, Alex] Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Silwood Pk, England; [Niklaus, Pascal A.; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Oelmann, Yvonne; Rosenkranz, Stephan] Johannes Gutenberg Univ Mainz, Inst Geog, Mainz, Germany; [Scherber, Christoph] Univ Gottingen, Dept Crop Sci, Gottingen, Germany; [Scherer-Lorenzen, Michael] Univ Freiburg, Fac Biol, Freiburg, Germany; [Soussana, Jean-Francois] INRA, Grassland Ecosystem Res, Clermont Ferrand, France; [Temperton, Vicky M.] Forschungszentrum Julich, Phytosphere Inst ICG 3, D-52425 Julich, Germany; [Wilcke, Wolfgang] Univ Bern, Inst Geog, Bern, Switzerland; [Schumacher, Jens] Univ Jena, Inst Stochast, Jena, Germany	Max Planck Society; Leipzig University; Friedrich Schiller University of Jena; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Friedrich Schiller University of Jena; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Darmstadt; University of Gottingen; University of Bern; University of Potsdam; Tallinn University of Technology; Imperial College London; University of Zurich; Johannes Gutenberg University of Mainz; University of Gottingen; University of Freiburg; INRAE; Helmholtz Association; Research Center Julich; University of Bern; Friedrich Schiller University of Jena	Proulx, R (corresponding author), Max Planck Inst Biogeochem, Hans Knoll Str, Jena, Germany.	rproulx@bgc-jena.mpg.de	Oelmann, Yvonne/J-8730-2016; Soussana, Jean-Francois/P-2094-2016; Buscot, Francois/A-4125-2016; Niklaus, Pascal A/G-5786-2010; Hildebrandt, Anke/J-7062-2012; Schmid, Bernhard/C-8625-2009; Gleixner, Gerd/O-4215-2019; Scheu, Stefan/H-7049-2015; Wirth, Christian/A-4446-2016; Buchmann, Nina/E-6095-2011; Schulze, Ernst-Detlef/K-9627-2014; Eisenhauer, Nico/I-3191-2019; Soussana, Jean-Francois/E-2543-2012; Fischer, Markus/C-6411-2008; Eisenhauer, Nico/I-5932-2012; Kuu, Annely/AAL-4740-2020; Gleixner, Gerd/M-8519-2017; Barnard, Romain L./G-8190-2011; Scherer-Lorenzen, Michael/AGB-4140-2022; Soussana, Jean-Francois/M-2814-2017; Weisser, Wolfgang W/B-9718-2014; Scherber, Christoph/B-6611-2009; Baade, Jussi/D-4281-2013; Wilcke, Wolfgang/P-4620-2016; Milcu, Alexandru/X-6267-2018	Oelmann, Yvonne/0000-0003-3513-6568; Soussana, Jean-Francois/0000-0002-1932-6583; Buscot, Francois/0000-0002-2364-0006; Niklaus, Pascal A/0000-0002-2360-1357; Hildebrandt, Anke/0000-0001-8643-1634; Schmid, Bernhard/0000-0002-8430-3214; Gleixner, Gerd/0000-0002-4616-0953; Buchmann, Nina/0000-0003-0826-2980; Eisenhauer, Nico/0000-0002-0371-6720; Fischer, Markus/0000-0002-5589-5900; Eisenhauer, Nico/0000-0002-0371-6720; Gleixner, Gerd/0000-0002-4616-0953; Barnard, Romain L./0000-0002-6440-1159; Scherer-Lorenzen, Michael/0000-0001-9566-590X; Weisser, Wolfgang W/0000-0002-2757-8959; Scherber, Christoph/0000-0001-7924-8911; Baade, Jussi/0000-0001-9878-7232; Wilcke, Wolfgang/0000-0002-6031-4613; Proulx, Raphael/0000-0002-9188-9225; Milcu, Alexandru/0000-0002-2889-1234; Temperton, Vicky/0000-0003-0543-4521; Kuu, Annely/0000-0002-0335-6243	German Science Foundation [FOR 456]; NERC [cpb010001] Funding Source: UKRI; Natural Environment Research Council [cpb010001] Funding Source: researchfish	German Science Foundation(German Research Foundation (DFG)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Jena Experiment is funded by the German Science Foundation (FOR 456) with additional support from the Max Planck Society and the Friedrich Schiller University Jena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Caldeira MC, 2005, OIKOS, V110, P115, DOI 10.1111/j.0030-1299.2005.13873.x; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Christianou M, 2008, J THEOR BIOL, V253, P162, DOI 10.1016/j.jtbi.2008.03.001; Delta-T Devices, 1999, THET PROB SOIL MOIST; Duelli P, 1999, AGR ECOSYST ENVIRON, V74, P33, DOI 10.1016/S0167-8809(99)00029-8; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Eisenhauer N, 2009, OECOLOGIA, V161, P291, DOI 10.1007/s00442-009-1374-1; Flynn DFB, 2008, J PLANT ECOL, V1, P59, DOI 10.1093/jpe/rtm004; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Ives AR, 1999, SCIENCE, V286, P542, DOI 10.1126/science.286.5439.542; Jiang L, 2009, AM NAT, V174, P651, DOI 10.1086/605961; Kolasa J, 2003, P ROY SOC B-BIOL SCI, V270, pS198, DOI 10.1098/rsbl.2003.0059; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Niklaus PA, 2006, PLANT SOIL, V282, P83, DOI 10.1007/s11104-005-5230-8; Oelmann Y, 2007, SOIL SCI SOC AM J, V71, P720, DOI 10.2136/sssaj2006.0205; Ranta E, 2008, OIKOS, V117, P1907, DOI 10.1111/j.1600-0706.2008.16614.x; Romanuk TN, 2004, ECOSCIENCE, V11, P455, DOI 10.1080/11956860.2004.11682855; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2009, J ECOL, V97, P32, DOI 10.1111/j.1365-2745.2008.01451.x; Roscher C, 2009, ACTA OECOL, V35, P206, DOI 10.1016/j.actao.2008.10.003; Schmid Bernhard, 2009, P14; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Steinbeiss S, 2008, GLOBAL CHANGE BIOL, V14, P2937, DOI 10.1111/j.1365-2486.2008.01697.x; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; TOKESHI M, 1995, RES POPUL ECOL, V37, P43, DOI 10.1007/BF02515760; Weigelt A., 2010, ECOLOGY, V91, P930, DOI DOI 10.1890/09-0863.1; Wootton JT, 2005, ANNU REV ECOL EVOL S, V36, P419, DOI 10.1146/annurev.ecolsys.36.091704.175535; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	37	74	76	4	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13382	10.1371/journal.pone.0013382	http://dx.doi.org/10.1371/journal.pone.0013382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967213	Green Published, Green Submitted, gold			2022-12-25	WOS:000282869800046
J	Peterson, JE; Lenczewski, ME; Scherer, RP				Peterson, Joseph E.; Lenczewski, Melissa E.; Scherer, Reed P.			Influence of Microbial Biofilms on the Preservation of Primary Soft Tissue in Fossil and Extant Archosaurs	PLOS ONE			English	Article							CELLULAR PRESERVATION; BACTERIAL BIOFILMS; TYRANNOSAURUS-REX; PROTEIN SEQUENCES; BONE; MINERALIZATION; FOSSILIZATION; DECAY; ENVIRONMENT; SURVIVAL	Background: Mineralized and permineralized bone is the most common form of fossilization in the vertebrate record. Preservation of gross soft tissues is extremely rare, but recent studies have suggested that primary soft tissues and biomolecules are more commonly preserved within preserved bones than had been presumed. Some of these claims have been challenged, with presentation of evidence suggesting that some of the structures are microbial artifacts, not primary soft tissues. The identification of biomolecules in fossil vertebrate extracts from a specimen of Brachylophosaurus canadensis has shown the interpretation of preserved organic remains as microbial biofilm to be highly unlikely. These discussions also propose a variety of potential mechanisms that would permit the preservation of soft-tissues in vertebrate fossils over geologic time. Methodology/Principal Findings: This study experimentally examines the role of microbial biofilms in soft-tissue preservation in vertebrate fossils by quantitatively establishing the growth and morphology of biofilms on extant archosaur bone. These results are microscopically and morphologically compared with soft-tissue extracts from vertebrate fossils from the Hell Creek Formation of southeastern Montana (Latest Maastrichtian) in order to investigate the potential role of microbial biofilms on the preservation of fossil bone and bound organic matter in a variety of taphonomic settings. Based on these analyses, we highlight a mechanism whereby this bound organic matter may be preserved. Conclusions/Significance: Results of the study indicate that the crystallization of microbial biofilms on decomposing organic matter within vertebrate bone in early taphonomic stages may contribute to the preservation of primary soft tissues deeper in the bone structure.	[Peterson, Joseph E.] Univ Wisconsin, Dept Geol, Oshkosh, WI 54901 USA; [Lenczewski, Melissa E.; Scherer, Reed P.] No Illinois Univ, Dept Geol & Environm Geosci, De Kalb, IL 60115 USA	University of Wisconsin System; Northern Illinois University	Peterson, JE (corresponding author), Univ Wisconsin, Dept Geol, Oshkosh, WI 54901 USA.	jpeterson0204@gmail.com			Northern Illinois University Department of Geology and Environmental Geosciences; American Association for Microbiology	Northern Illinois University Department of Geology and Environmental Geosciences; American Association for Microbiology	Funding was provided by Goldich Fund, Northern Illinois University Department of Geology and Environmental Geosciences; Student Travel Fund, American Association for Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P.A., 1991, FOSSILIZATION PROCES, P120; ALLISON PA, 1988, PALEOBIOLOGY, V14, P139, DOI 10.1017/S009483730001188X; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Behrensmeyer A.K., 1991, TAPHONOMY RELEASING, P291, DOI DOI 10.1007/978-1-4899-5034-5; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Blob RW, 1997, PALAIOS, V12, P151, DOI 10.2307/3515304; BOAZ NT, 1976, AM J PHYS ANTHROPOL, V45, P53, DOI 10.1002/ajpa.1330450107; Briggs DEG, 1997, J GEOL SOC LONDON, V154, P587, DOI 10.1144/gsjgs.154.4.0587; BRIGGS DEG, 1993, J GEOL SOC LONDON, V150, P1035, DOI 10.1144/gsjgs.150.6.1035; Carpenter K, 2005, NEUES JAHRB GEOL P-M, P83; CHILD AM, 1995, J ARCHAEOL SCI, V22, P165, DOI 10.1006/jasc.1995.0018; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Davis J, 1986, STAT DATA ANAL GEOLO; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Dodson P., 1973, U WYOMING CONTRIB GE, V12, P15; EBDON D, 1991, STATITICS GEOGRAPHY; Hof CHJ, 1997, PALAIOS, V12, P420, DOI 10.2307/3515381; Hollocher TC, 2001, PALAIOS, V16, P547, DOI 10.2307/3515628; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; McNamara ME, 2009, PALAIOS, V24, P104, DOI 10.2110/palo.2008.p08-017r; Morris NS, 1999, WORLD J UROL, V17, P345, DOI 10.1007/s003450050159; PERRY E, 1995, GEOLOGY, V23, P17, DOI 10.1130/0091-7613(1995)023<0017:ROCSNY>2.3.CO;2; Perry E, 2009, J HYDROL, V367, P27, DOI 10.1016/j.jhydrol.2008.12.026; Raff EC, 2008, P NATL ACAD SCI USA, V105, P19360, DOI 10.1073/pnas.0810106105; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Trueman CN, 2002, ARCHAEOMETRY, V44, P371, DOI 10.1111/1475-4754.t01-1-00070; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; WOLFF RG, 1973, PALAEOGEOGR PALAEOCL, V13, P91, DOI 10.1016/0031-0182(73)90038-2; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0	32	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13334	10.1371/journal.pone.0013334	http://dx.doi.org/10.1371/journal.pone.0013334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967227	Green Submitted, Green Published, gold			2022-12-25	WOS:000282807300025
J	Loeuillet, C; Lemaire-Vieille, C; Naquet, P; Cesbron-Delauw, MF; Gagnon, J; Cesbron, JY				Loeuillet, Corinne; Lemaire-Vieille, Catherine; Naquet, Philippe; Cesbron-Delauw, Marie-France; Gagnon, Jean; Cesbron, Jean-Yves			Prion Replication in the Hematopoietic Compartment Is Not Required for Neuroinvasion in Scrapie Mouse Model	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; IMMUNE-SYSTEM; BLOOD-TRANSFUSION; PRP EXPRESSION; MICE; PROTEIN; DISEASES; SPLEEN; TRANSMISSION; LYMPHOCYTES	Fatal neurodegenerative prion diseases are caused by the transmissible PrP(Sc) prion agent whose initial replication after peripheral inoculation takes place in follicular dendritic cells present in germinal centers of lymphoid organs. However, prion replication also occurs in lymphoid cells. To assess the role of the hematopoietic compartment in neuroinvasion and prion replication, we generated chimeric mice, on a uniform congenic C57/BL6J background, by bone marrow replacement with hematopoietic cells expressing different levels of PrP protein. Nine different types of chimeric mice were inoculated intraperitoneally either with the lymphotropic Rocky Mountain Laboratory (RML) strain or the non lymphotropic ME-7 scrapie strain, at different doses. Here, we clearly demonstrate that overexpression of PrP by the hematopoietic system, or the lack of PrP expression by the bone marrow derived cells, does not change the incubation time period of the disease, even when the mice are infected at limiting doses. We conclude that the hematopoietic compartment is more or less permissive to prion replication, both for RML and ME-7, but does not play a role in neuroinvasion.	[Loeuillet, Corinne; Lemaire-Vieille, Catherine; Cesbron-Delauw, Marie-France; Gagnon, Jean; Cesbron, Jean-Yves] Univ Grenoble 1, CNRS, UMR 5163, Lab Adaptat & Pathogenie Microorganismes, Grenoble, France; [Naquet, Philippe] Univ Aix Marseille 2, CNRS, INSERM, Ctr Immunol Marseille Luminy, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Loeuillet, C (corresponding author), Univ Grenoble 1, CNRS, UMR 5163, Lab Adaptat & Pathogenie Microorganismes, Grenoble, France.	jean-yves.cesbron@ujf-grenoble.fr	cesbron delauw, marie france/M-6076-2014; Lemaire-Vieille, Catherine/C-1495-2009; loeuillet, corinne/M-6504-2014; Gagnon, Jean/C-3136-2008	loeuillet, corinne/0000-0001-6474-4453; Gagnon, Jean/0000-0002-0177-824X	Centre National de la Recherche Scientifique	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	CL was supported by a non-permanent research position at the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2003, ADV IMMUNOL, V81, P123, DOI 10.1016/S0065-2776(03)81004-0; Aucouturier P, 2002, J LEUKOCYTE BIOL, V72, P1075; Aucouturier P, 2001, J CLIN INVEST, V108, P703, DOI 10.1172/JCI200113155; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Follet J, 2002, J VIROL, V76, P2434, DOI 10.1128/JVI.76.5.2434-2439.2002; Fraser H, 1996, J GEN VIROL, V77, P1935, DOI 10.1099/0022-1317-77-8-1935; Glatzel M, 2000, J GEN VIROL, V81, P2813, DOI 10.1099/0022-1317-81-11-2813; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Jouvin-Marche E, 2006, J IMMUNOL, V176, P3490, DOI 10.4049/jimmunol.176.6.3490; Kaeser PS, 2001, J VIROL, V75, P7097, DOI 10.1128/JVI.75.15.7097-7106.2001; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Lasmezas CI, 1996, J VIROL, V70, P1292; Mabbott NA, 2001, J GEN VIROL, V82, P2307, DOI 10.1099/0022-1317-82-10-2307; Mabbott NA, 2000, J VIROL, V74, P3338, DOI 10.1128/JVI.74.7.3338-3344.2000; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; Raeber AJ, 1999, EMBO J, V18, P2702, DOI 10.1093/emboj/18.10.2702; Raymond CR, 2007, J NEUROIMMUNOL, V187, P114, DOI 10.1016/j.jneuroim.2007.05.006; Thielen C, 2001, Dev Immunol, V8, P259, DOI 10.1155/2001/45454; van Nierop K, 2002, SEMIN IMMUNOL, V14, P251, DOI 10.1016/S1044-5323(02)00057-X; Visscher PM, 1999, GENET RES, V74, P81, DOI 10.1017/S0016672399003857; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Zabel M, 2009, IMMUNOLOGY, V127, P226, DOI 10.1111/j.1365-2567.2008.02944.x; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103	28	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13166	10.1371/journal.pone.0013166	http://dx.doi.org/10.1371/journal.pone.0013166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957200	Green Published, gold, Green Submitted			2022-12-25	WOS:000282506100009
J	Kam, JH; Lenassi, E; Jeffery, G				Kam, Jaimie Hoh; Lenassi, Eva; Jeffery, Glen			Viewing Ageing Eyes: Diverse Sites of Amyloid Beta Accumulation in the Ageing Mouse Retina and the Up-Regulation of Macrophages	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; COMPLEMENT ACTIVATION; SUBRETINAL MICROGLIA; COGNITIVE IMPAIRMENT; ELECTRON-MICROSCOPE; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; PERIPHERAL-NERVE; A-BETA; DRUSEN	Background: Amyloid beta (A beta) accumulates in the ageing central nervous system and is associated with a number of age-related diseases, including age-related macular degeneration (AMD) in the eye. AMD is characterised by accumulation of extracellular deposits called drusen in which A beta is a key constituent. A beta activates the complement cascade and its deposition is associated with activated macrophages. So far, little is known about the quantitative measurements of A beta accumulation and definitions of its relative sites of ocular deposition in the normal ageing mouse. Methodology/Principal Findings: We have traced A beta accumulation quantitatively in the ageing mouse retina using immunohistochemistry and Western blot analysis. We reveal that it is not only deposited at Bruch's membrane and along blood vessels, but unexpectedly, it also coats photoreceptor outer segments. While A beta is present at all sites of deposition from 3 months of age, it increases markedly from 6 months onward. Progressive accumulation of deposits on outer segments was confirmed with scanning electron microscopy, revealing age-related changes in their morphology. Such progress of accumulation of A beta on photoreceptor outer segments with age was also confirmed in human retinae using immunohistochemistry. We also chart the macrophage response to increases in A beta showing up-regulation in their numbers using both confocal laser imaging of the eye in vivo followed by in vitro immunostaining. With age macrophages become bloated with cellular debris including A beta, however, their increasing numbers fail to stop A beta accumulation. Conclusions: Increasing A beta deposition in blood vessels and Bruch's membrane will impact upon retinal perfusion and clearance of cellular waste products from the outer retina, a region of very high metabolic activity. This accumulation of A beta may contribute to the 30% reduction of photoreceptors found throughout life and the shortening of those that remain. The coating of A beta on outer segments may also have an impact upon visual function with age.	[Kam, Jaimie Hoh; Lenassi, Eva; Jeffery, Glen] UCL, Inst Ophthalmol, London, England; [Lenassi, Eva] Univ Med Ctr, Hosp Eye, Ljubljana, Slovenia	University of London; University College London; University Medical Centre Ljubljana	Kam, JH (corresponding author), UCL, Inst Ophthalmol, London, England.	g.jeffery@ucl.ac.uk			Rosetrees Trust	Rosetrees Trust(Rosetrees Trust)	Funding was received from Rosetrees Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Baker D R, 1997, J Am Optom Assoc, V68, P483; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; Boissonneault V, 2009, BRAIN, V132, P1078, DOI 10.1093/brain/awn331; BRESSLER SB, 1990, ARCH OPHTHALMOL-CHIC, V108, P1442, DOI 10.1001/archopht.1990.01070120090035; Bruban J, 2009, AGING CELL, V8, P162, DOI 10.1111/j.1474-9726.2009.00456.x; COIMBRA A, 1971, BRAIN, V94, P199, DOI 10.1093/brain/94.2.199; COIMBRA A, 1971, BRAIN, V94, P207, DOI 10.1093/brain/94.2.207; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Cunea A, 2007, VISUAL NEUROSCI, V24, P151, DOI 10.1017/S0952523807070204; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; DAVIS JB, 1992, BIOCHEM BIOPH RES CO, V189, P1096, DOI 10.1016/0006-291X(92)92317-Q; Dentchev T, 2003, MOL VIS, V9, P184; Dutescu RM, 2009, GRAEF ARCH CLIN EXP, V247, P1213, DOI 10.1007/s00417-009-1060-3; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Gray Douglas A, 2005, Sci Aging Knowledge Environ, V2005, pre1, DOI 10.1126/sageke.2005.5.re1; GRAYMORE CN, 1969, EYE, P601; Green W R, 1999, Mol Vis, V5, P27; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Isas JM, 2010, INVEST OPHTH VIS SCI, V51, P1304, DOI 10.1167/iovs.09-4207; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Jackson GR, 2006, VISION RES, V46, P1422, DOI 10.1016/j.visres.2005.09.003; Jackson GR, 2004, INVEST OPHTH VIS SCI, V45, P3271, DOI 10.1167/iovs.04-0019; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; KATZ B, 1989, SURV OPHTHALMOL, V34, P31, DOI 10.1016/0039-6257(89)90127-6; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Leibowitz H M, 1980, Surv Ophthalmol, V24, P335; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEWIS H, 1986, OPHTHALMOLOGY, V93, P1098; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; MEDA L, 1995, J NEUROIMMUNOL, V59, P29, DOI 10.1016/0165-5728(95)00021-S; MEDRANO CJ, 1995, EXP EYE RES, V61, P273, DOI 10.1016/S0014-4835(05)80122-8; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; PAULEIKHOFF D, 1990, AM J OPHTHALMOL, V109, P38, DOI 10.1016/S0002-9394(14)75576-X; Perez SE, 2009, INVEST OPHTH VIS SCI, V50, P793, DOI 10.1167/iovs.08-2384; Raoul W, 2008, OPHTHAL RES, V40, P115, DOI 10.1159/000119860; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; SADUN AA, 1987, AM J OPHTHALMOL, V104, P113, DOI 10.1016/0002-9394(87)90001-8; SARKS SH, 1980, AUST J OPHTHALMOL, V8, P117, DOI 10.1111/j.1442-9071.1980.tb01670.x; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; SHIRAHAMA T, 1990, LAB INVEST, V62, P61; Takechi R, 2009, HISTOCHEM CELL BIOL, V131, P661, DOI 10.1007/s00418-009-0567-3; Terman A, 1998, APMIS, V106, P265, DOI 10.1111/j.1699-0463.1998.tb01346.x; WRIGHT CE, 1985, DOC OPHTHALMOL, V59, P385, DOI 10.1007/BF00159172; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303	59	94	94	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13127	10.1371/journal.pone.0013127	http://dx.doi.org/10.1371/journal.pone.0013127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957206	gold, Green Submitted, Green Published			2022-12-25	WOS:000282359300021
J	Zaslavsky, E; Bradley, P; Yanover, C				Zaslavsky, Elena; Bradley, Philip; Yanover, Chen			Inferring PDZ Domain Multi-Mutant Binding Preferences from Single-Mutant Data	PLOS ONE			English	Article							PEPTIDE INTERACTIONS	Many important cellular protein interactions are mediated by peptide recognition domains. The ability to predict a domain's binding specificity directly from its primary sequence is essential to understanding the complexity of protein-protein interaction networks. One such recognition domain is the PDZ domain, functioning in scaffold proteins that facilitate formation of signaling networks. Predicting the PDZ domain's binding specificity was a part of the DREAM4 Peptide Recognition Domain challenge, the goal of which was to describe, as position weight matrices, the specificity profiles of five multi-mutant ERBB2IP-1 domains. We developed a method that derives multi-mutant binding preferences by generalizing the effects of single point mutations on the wild type domain's binding specificities. Our approach, trained on publicly available ERBB2IP-1 single-mutant phage display data, combined linear regression-based prediction for ligand positions whose specificity is determined by few PDZ positions, and single-mutant position weight matrix averaging for all other ligand columns. The success of our method as the winning entry of the DREAM4 competition, as well as its superior performance over a general PDZ-ligand binding model, demonstrates the advantages of training a model on a well-selected domain-specific data set.	[Zaslavsky, Elena] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY USA; [Zaslavsky, Elena] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Bradley, Philip; Yanover, Chen] Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98104 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Fred Hutchinson Cancer Center	Zaslavsky, E (corresponding author), Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY USA.	cyanover@fhcrc.org	Yanover, Chen/A-3754-2012	Yanover, Chen/0000-0003-3663-4286; Zaslavsky, Elena/0000-0002-4828-7771	Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; National Institutes of Health, National Institute of Allergy and Infectious Diseases [HHSN266200500021C]	Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been funded in part by institutional support from the Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. E.Z. was supported by National Institutes of Health, National Institute of Allergy and Infectious Diseases Contract No. HHSN266200500021C (http://www3.niaid.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Beltrao P, 2007, PLOS COMPUT BIOL, V3, P258, DOI 10.1371/journal.pcbi.0030025; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Ceol A, 2007, NUCLEIC ACIDS RES, V35, pD557, DOI 10.1093/nar/gkl961; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Ernst A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000416; Habib N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000010; Harris BZ, 2001, J CELL SCI, V114, P3219; Hertz T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S3; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Venkatarajan MS, 2001, J MOL MODEL, V7, P445, DOI 10.1007/s00894-001-0058-5; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048	17	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12787	10.1371/journal.pone.0012787	http://dx.doi.org/10.1371/journal.pone.0012787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20976110	Green Published, Green Submitted, gold			2022-12-25	WOS:000282312600003
J	Nyman, T; Tresaugues, L; Welin, M; Lehtio, L; Flodin, S; Persson, C; Johansson, I; Hammarstrom, M; Nordlund, P				Nyman, Tomas; Tresaugues, Lionel; Welin, Martin; Lehtio, Lari; Flodin, Susanne; Persson, Camilla; Johansson, Ida; Hammarstrom, Martin; Nordlund, Par			The Crystal Structure of the Dachshund Domain of Human SnoN Reveals Flexibility in the Putative Protein Interaction Surface	PLOS ONE			English	Article							SKI ONCOPROTEIN INTERACTS; SMAD PROTEINS; TRANSCRIPTIONAL REPRESSION; STRUCTURE PREDICTION; CDNA-CLONES; SEQUENCE; HOMOLOG; RECEPTOR; CELLS; TRANSFORMATION	The human SnoN is an oncoprotein that interacts with several transcription-regulatory proteins such as the histone-deacetylase, N-CoR containing co-repressor complex and Smad proteins. This study presents the crystal structure of the Dachshund homology domain of human SnoN. The structure reveals a groove composed of conserved residues with characteristic properties of a protein-interaction surface. A comparison of the 12 monomers in the asymmetric unit reveals the presence of two major conformations: an open conformation with a well accessible groove and a tight conformation with a less accessible groove. The variability in the backbone between the open and the tight conformations matches the differences seen in previously determined structures of individual Dachshund homology domains, suggesting a general plasticity within this fold family. The flexibility observed in the putative protein binding groove may enable SnoN to recognize multiple interaction partners.	[Nyman, Tomas; Tresaugues, Lionel; Welin, Martin; Flodin, Susanne; Persson, Camilla; Johansson, Ida; Hammarstrom, Martin; Nordlund, Par] Karolinska Inst, Struct Genom Consortium, Stockholm, Sweden; [Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Lehtio, Lari] Abo Akad Univ, Dept Biosci, Turku, Finland	Karolinska Institutet; Karolinska Institutet; Abo Akademi University	Nyman, T (corresponding author), Karolinska Inst, Struct Genom Consortium, Stockholm, Sweden.	tomas.nyman@ki.se; par.nordlund@ki.se		Lehtio, Lari/0000-0001-7250-832X	Canadian Institutes for Health Research [1097737]; Canada Foundation for Innovation, Genome Canada; Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation, Genome Canada(Genome CanadaCanada Foundation for Innovation); Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet(GlaxoSmithKline); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck Co., Inc.(Ministry of Research and Innovation, OntarioMerck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Arndt S, 2005, LAB INVEST, V85, P1330, DOI 10.1038/labinvest.3700344; Arndt S, 2007, MOL CELL NEUROSCI, V34, P603, DOI 10.1016/j.mcn.2007.01.002; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; BOYER PL, 1993, ONCOGENE, V8, P457; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cohen SB, 1999, NUCLEIC ACIDS RES, V27, P1006, DOI 10.1093/nar/27.4.1006; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; Dahl R, 1998, P NATL ACAD SCI USA, V95, P11187, DOI 10.1073/pnas.95.19.11187; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FUMAGALLI S, 1993, MELANOMA RES, V3, P23, DOI 10.1097/00008390-199304000-00004; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HEYMAN HC, 1994, J BIOL CHEM, V269, P26996; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim SS, 2002, STRUCTURE, V10, P787, DOI 10.1016/S0969-2126(02)00769-4; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; PEARSONWHITE S, 1993, NUCLEIC ACIDS RES, V21, P4632, DOI 10.1093/nar/21.19.4632; Ritter M, 2006, LEUKEMIA, V20, P437, DOI 10.1038/sj.leu.2404093; STAVNEZER E, 1981, J VIROL, V39, P920, DOI 10.1128/JVI.39.3.920-934.1981; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Tokitou F, 1999, J BIOL CHEM, V274, P4485, DOI 10.1074/jbc.274.8.4485; Wilson JJ, 2004, STRUCTURE, V12, P785, DOI 10.1016/S0969-2126(04)00118-2; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Zheng GX, 1997, ONCOGENE, V15, P459, DOI 10.1038/sj.onc.1201205	41	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12907	10.1371/journal.pone.0012907	http://dx.doi.org/10.1371/journal.pone.0012907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20957027	gold, Green Submitted, Green Published			2022-12-25	WOS:000282091100015
J	Chu, Y; Yang, X				Chu, Y.; Yang, X.			SUMO E3 ligase activity of TRIM proteins	ONCOGENE			English	Article						TRIM proteins; SUMO E3 ligase; sumoylation; PML; Mdm2; p53	RET FINGER PROTEIN; REGULATES P53; TUMOR-SUPPRESSOR; FAMILY PROTEINS; NUCLEAR-BODIES; C-JUN; PML; UBIQUITIN; SUMOYLATION; RING	SUMOylation governs numerous cellular processes and is essential to most eukaryotic life. Despite increasing recognition of the importance of this process, an extremely limited number of small ubiquitin-like modifier (SUMO) protein ligases (E3s) have been identified. Here we show that at least some members of the functionally diverse tripartite motif (TRIM) superfamily are SUMO E3s. These TRIM proteins bind both the SUMO-conjugating enzyme Ubc9 and substrates and strongly enhance transfer of SUMOs from Ubc9 to these substrates. Among the substrates of TRIM SUMO E3s are the tumor suppressor p53 and its principal antagonist Mdm2. The E3 activity depends on the TRIM motif, suggesting it to be the first widespread SUMO E3 motif. Given the large number of TRIM proteins, our results may greatly expand the identified SUMO E3s. Furthermore, TRIM E3 activity may be an important contributor to SUMOylation specificity and the versatile functions of TRIM proteins. Oncogene (2011) 30, 1108-1116; doi:10.1038/onc.2010.462; published online 25 October 2010	[Yang, X.] Univ Penn, Sch Med, Dept Canc Biol, 610 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19096 USA; [Yang, X.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19096 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Yang, X (corresponding author), Univ Penn, Sch Med, Dept Canc Biol, 610 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19096 USA.	xyang@mail.med.upenn.edu			NIH [CA088868, GM060911]; NATIONAL CANCER INSTITUTE [R01CA088868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060911] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr PP Pandolfi for providing Pml<SUP>-/-</SUP> MEF cells and Drs V Yu, A-M Herr, F Rauscher III and TC Cox for TRIM-expressing plasmids. We also thank E Fischer and S Slattery for technical assistance and A Stonestrom for help with manuscript preparation. Supported by NIH (CA088868 and GM060911) to XY.	Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Cao TY, 1998, J CELL SCI, V111, P1319; Chen LH, 2003, ONCOGENE, V22, P5348, DOI 10.1038/sj.onc.1206851; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duprez E, 1999, J CELL SCI, V112, P381; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; GILLOT I, 2009, INT J CELL BIOL; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Lee MH, 2006, NAT CELL BIOL, V8, P1424, DOI 10.1038/ncb1512; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Quimby BB, 2006, ONCOGENE, V25, P2999, DOI 10.1038/sj.onc.1209335; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Salomoni P, 2005, BLOOD, V105, P3686, DOI 10.1182/blood-2004-09-3782; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tago K, 2005, P NATL ACAD SCI USA, V102, P7689, DOI 10.1073/pnas.0502978102; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Townson SM, 2006, BIOCHEM BIOPH RES CO, V349, P540, DOI 10.1016/j.bbrc.2006.08.063; Wei XL, 2003, J BIOL CHEM, V278, P29288, DOI 10.1074/jbc.M212215200; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	43	136	141	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	9					1108	1116		10.1038/onc.2010.462	http://dx.doi.org/10.1038/onc.2010.462			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	729PX	20972456	Green Accepted			2022-12-25	WOS:000287964100009
J	Yamada, T; Tani, Y; Nakanishi, H; Taguchi, R; Arita, M; Arai, H				Yamada, Tomohiro; Tani, Yukako; Nakanishi, Hiroki; Taguchi, Ryo; Arita, Makoto; Arai, Hiroyuki			Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice	FASEB JOURNAL			English	Article						anti-inflammation; lipid mediator; lipoxygenase; metabolomics; protectin	DOCOSAHEXAENOIC ACID; LIPID MEDIATORS; INFLAMMATION; PROGRAMS; CELLS; IL-5	Acute inflammation in healthy individuals is self-limiting and has an active termination program. The mechanisms by which acute inflammation is resolved are of interest. In murine zymosan-induced peritonitis, we found that eosinophils are recruited to the inflamed loci during the resolution phase of acute inflammation. In vivo depletion of eosinophils caused a resolution deficit, namely impaired lymphatic drainage with reduced appearance of phagocytes carrying engulfed zymosan in the draining lymph node, and sustained numbers of polymorphonuclear leukocytes in inflamed tissues. Liquid chromatography-tandem mass spectrometry-based lipidomics of the resolving exudates revealed that locally activated eosinophils in the resolution phase produced proresolving mediators, including protectin D1 (PD1) from docosahexaenoic acid. The resolution deficit caused by eosinophil depletion was rescued by eosinophil restoration or the administration of PD1. Eosinophils deficient in 12/15-lipoxygenase could not rescue the resolution phenotype. The present results indicate that mouse eosinophils and eosinophil-derived lipid mediators, including PD1, have a role in promoting the resolution of acute inflammation, expanding the roles of eosinophils in host defense and resolution.-Yamada, T., Tani, Y., Nakanishi, H., Taguchi, R., Arita, M., Arai, H. Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice. FASEB J. 25, 561-568 (2011). www.fasebj.org	[Arita, Makoto] Univ Tokyo, Dept Hlth Chem, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Nakanishi, Hiroki; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Tokyo 1130033, Japan; [Taguchi, Ryo; Arai, Hiroyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Arita, M (corresponding author), Univ Tokyo, Dept Hlth Chem, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	marita@mol.f.u-tokyo.ac.jp		Nakanishi, Hiroki/0000-0002-5108-1598; Arita, Makoto/0000-0001-9902-0463	Japan Science and Technology Agency; Core Research for Evolutional Science and Technology (CREST); Astella Foundation for Research on Metabolic Disorders	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Astella Foundation for Research on Metabolic Disorders	These studies were supported by the Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology (PRESTO; to M.A.) and Core Research for Evolutional Science and Technology (CREST; to H.A. and R.T), and a grant from the Astella Foundation for Research on Metabolic Disorders (to M.A.). The authors thank Dr. Kiyoshi Takatsu (University of Toyama, Toyama, Japan) for kindly providing IL-5 transgenic mice. The authors thank M. Kamiyama and M. Kamio for technical assistance with lipid extraction and sample preparation for LC-MS/MS, and S. Ishikawa and staff for animal care.	Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Blaho VA, 2009, J BIOL CHEM, V284, P21599, DOI 10.1074/jbc.M109.003822; Cotran R. S., 1999, ROBBINS PATHOLOGIC B, V6th; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Jacobsen EA, 2007, J ALLERGY CLIN IMMUN, V119, P1313, DOI 10.1016/j.jaci.2007.03.043; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Takatsu K, 2008, CURR OPIN IMMUNOL, V20, P288, DOI 10.1016/j.coi.2008.04.001; TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737	20	102	103	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					561	568		10.1096/fj.10-170027	http://dx.doi.org/10.1096/fj.10-170027			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20959515				2022-12-25	WOS:000286724800014
J	Koprowski, P; Grajkowski, W; Isacoff, EY; Kubalski, A				Koprowski, Piotr; Grajkowski, Wojciech; Isacoff, Ehud Y.; Kubalski, Andrzej			Genetic Screen for Potassium Leaky Small Mechanosensitive Channels (MscS) in Escherichia coli RECOGNITION OF CYTOPLASMIC beta DOMAIN AS A NEW GATING ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-CONDUCTANCE MSCS; MUTATIONS; PROTEIN; PORE; IDENTIFICATION; MUTAGENESIS; TRANSITION; MECHANISM; TRANSPORT; DYNAMICS	Mechanosensitive membrane channels in bacteria respond to the mechanical stretching of the membrane. They will open when bacteria are subjected to rapid osmotic down shock. MscS is a bacterial mechanosensitive channel of small conductance. It is a heptameric membrane protein whose transmembrane part, including the gate and its kinetics, has been well characterized. MscS has a large cytoplasmic domain of a cage-like shape that changes its conformation upon gating, but its involvement in gating is not understood. We screened MscS for mutations that cause potassium leak in Escherichia coli strains deficient in potassium transport systems. We did a phenotypic analysis of single and multiple mutants and recorded the single channel activities of some of them. After these analyses, we attributed the effects of a number of mutations to particular functional states of the channel. Our screen revealed that MscS leaks potassium in a desensitized and in an inactivated state. It also appeared that the lower part of TM3 (transmembrane, pore-forming helix) and the cytoplasmic beta domain are tightly packed in the inactivated state but are dissociated in the open state. We attribute the TM3-beta interaction to stabilization of the inactivated state in MscS and to the control of tight closure of its membrane pore.	[Koprowski, Piotr; Grajkowski, Wojciech; Kubalski, Andrzej] M Nencki Inst Expt Biol, Dept Cell Biol, PL-02093 Warsaw, Poland; [Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of California System; University of California Berkeley	Kubalski, A (corresponding author), M Nencki Inst Expt Biol, Dept Cell Biol, Pasteur 3, PL-02093 Warsaw, Poland.	a.kubalski@nencki.gov.pl	isacoff, ehud/AAP-1459-2020; Koprowski, Piotr R/R-4088-2016	Koprowski, Piotr R/0000-0002-7571-2446; Isacoff, Ehud Y./0000-0003-4775-9359	National Institutes of Health [R01 NS35549]; Polish Ministry of Education [2P04C0167, NN301338033]; Human Frontier Science Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Education; Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS35549 (to E. Y. I.). This work was also supported by Grants 2P04C0167 and NN301338033 from the Polish Ministry of Education (to A. K., P. K., and W. G.) and by a Human Frontier Science Program Long Term Fellowship (to P. K.).	Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Akitake B, 2007, NAT STRUCT MOL BIOL, V14, P1141, DOI 10.1038/nsmb1341; Akitake B, 2007, BIOPHYS J, V92, P2771, DOI 10.1529/biophysj.106.098715; Anishkin A, 2004, BIOPHYS J, V86, p6A; Anishkin A, 2008, J GEN PHYSIOL, V132, P67, DOI 10.1085/jgp.200810000; Anishkin A, 2008, BIOPHYS J, V94, P1252, DOI 10.1529/biophysj.107.110171; Anishkin A, 2009, J BIOL CHEM, V284, P19153, DOI 10.1074/jbc.R109.009357; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Belyy V, 2010, NAT STRUCT MOL BIOL, V17, P451, DOI 10.1038/nsmb.1775; Buurman ET, 2004, J BACTERIOL, V186, P4238, DOI 10.1128/JB.186.13.4238-4245.2004; DOSCH DC, 1991, J BACTERIOL, V173, P687, DOI 10.1128/jb.173.2.687-696.1991; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Edwards MD, 2004, CURR OPIN MICROBIOL, V7, P163, DOI 10.1016/j.mib.2004.02.006; Grajkowski W, 2005, BIOPHYS J, V88, p289A; Humphrey W., 1996, J MOL GRAPHICS, V14, P37; Irizarry SN, 2002, BIOCHEMISTRY-US, V41, P13653, DOI 10.1021/bi026393r; Koprowski P, 2003, J BIOL CHEM, V278, P11237, DOI 10.1074/jbc.M212073200; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li C, 2007, MOL MICROBIOL, V64, P560, DOI 10.1111/j.1365-2958.2007.05672.x; Machiyama H, 2009, BIOPHYS J, V97, P1048, DOI 10.1016/j.bpj.2009.05.021; Miller S, 2003, J BIOL CHEM, V278, P32246, DOI 10.1074/jbc.M303188200; Miller S, 2003, EMBO J, V22, P36, DOI 10.1093/emboj/cdg011; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Nomura T, 2008, BIOPHYS J, V94, P1638, DOI 10.1529/biophysj.107.114785; Nomura T, 2006, BIOPHYS J, V91, P2874, DOI 10.1529/biophysj.106.084541; Okada K, 2002, J BIOL CHEM, V277, P27682, DOI 10.1074/jbc.M202497200; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Parfenova LV, 2006, J BIOL CHEM, V281, P21131, DOI 10.1074/jbc.M603109200; Paynter JJ, 2008, CHANNELS, V2, P413, DOI 10.4161/chan.2.6.6874; Sotomayor M, 2006, BIOPHYS J, V90, P3496, DOI 10.1529/biophysj.105.080069; Sotomayor M, 2004, BIOPHYS J, V87, P3050, DOI 10.1529/biophysj.104.046045; Sotomayor M, 2007, BIOPHYS J, V92, P886, DOI 10.1529/biophysj.106.095232; Spronk SA, 2006, BIOPHYS J, V90, P3555, DOI 10.1529/biophysj.105.080432; Sun S, 2006, PHYSIOL GENOMICS, V26, P1, DOI 10.1152/physiolgenomics.00026.2006; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Vasquez V, 2008, SCIENCE, V321, P1210, DOI 10.1126/science.1159674; Vasquez V, 2008, J MOL BIOL, V378, P55, DOI 10.1016/j.jmb.2007.10.086; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2; Yoshimura K, 2004, BIOPHYS J, V86, p545A	40	31	33	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					877	888		10.1074/jbc.M110.176131	http://dx.doi.org/10.1074/jbc.M110.176131			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978126	Green Published, hybrid			2022-12-25	WOS:000285782800087
J	Moren, A; Raja, E; Heldin, CH; Moustakas, A				Moren, Anita; Raja, Erna; Heldin, Carl-Henrik; Moustakas, Aristidis			Negative Regulation of TGF beta Signaling by the Kinase LKB1 and the Scaffolding Protein LIP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITIONS; BONE MORPHOGENETIC PROTEIN; TUMOR-SUPPRESSOR SMAD4; CELLS; CANCER; DIFFERENTIATION; ACTIVATION; RECEPTORS; POLYPOSIS	Signal transduction by the Smad pathway elicits critical biological responses to many extracellular polypeptide factors, including TGF beta and bone morphogenetic protein. Regulation of Smad signaling imparts several cytoplasmic and nuclear mechanisms, some of which entail protein phosphorylation. Previous work established a protein complex between Smad4 and the scaffolding protein LKB1-interacting protein 1 (LIP1). LKB1 is a well studied tumor suppressor kinase that regulates cell growth and polarity. Here, we analyzed the LKB1-LIP1 and the Smad4-LIP1 protein complexes and found that LIP1 can self-oligomerize. We further demonstrate that LKB1 is capable of phosphorylating Smad4 on Thr(77) of its DNA-binding domain. LKB1 inhibits Smad4 from binding to either TGF beta- or bone morphogenetic protein-specific promoter sequences, which correlates with the negative regulatory effect LKB1 exerts on Smad4-dependent transcription. Accordingly, LKB1 negatively regulates TGF beta gene responses and epithelial- mesenchymal transition. Thus, LKB1 and LIP1 provide negative control of TGF beta signaling.	[Moren, Anita; Raja, Erna; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Moustakas, Aristidis] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University	Moustakas, A (corresponding author), Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, Box 595, SE-75124 Uppsala, Sweden.	aris.moustakas@licr.uu.se			Ludwig Institute for Cancer Research, Swedish Research Council [K2007-66X-14936-04-3]; European Commission [LSHG-CT-2005-518254]	Ludwig Institute for Cancer Research, Swedish Research Council(Swedish Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Ludwig Institute for Cancer Research, Swedish Research Council Grant K2007-66X-14936-04-3, and the European Commission FP6 Program network of excellence ENFIN with Contract LSHG-CT-2005-518254.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Katoh Y, 2004, MOL CELL ENDOCRINOL, V217, P109, DOI 10.1016/j.mce.2003.10.016; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Londesborough A, 2008, DEVELOPMENT, V135, P2331, DOI 10.1242/dev.017038; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moren A, 2000, ONCOGENE, V19, P4396, DOI 10.1038/sj.onc.1203798; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Roelen BAJ, 2003, AM J PHYSIOL-CELL PH, V285, pC823, DOI 10.1152/ajpcell.00053.2003; Shen Zan, 2005, Zhonghua Yi Xue Za Zhi, V85, P15; Smith DP, 2001, HUM MOL GENET, V10, P2869, DOI 10.1093/hmg/10.25.2869; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Vaahtomeri K, 2008, J CELL SCI, V121, P3531, DOI 10.1242/jcs.032706; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Yakmovych I, 2001, FASEB J, V15, P553; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126	35	39	43	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					341	353		10.1074/jbc.M110.190660	http://dx.doi.org/10.1074/jbc.M110.190660			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20974850	Green Published, hybrid			2022-12-25	WOS:000285782800037
J	Anderson, DR; Duryee, MJ; Anchan, RK; Garvin, RP; Johnston, MD; Porter, TR; Thiele, GM; Klassen, LW				Anderson, Daniel R.; Duryee, Michael J.; Anchan, Rajeev K.; Garvin, Robert P.; Johnston, Michael D.; Porter, Thomas R.; Thiele, Geoffrey M.; Klassen, Lynell W.			Albumin-based Microbubbles Bind Up-regulated Scavenger Receptors following Vascular Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCLINICAL ATHEROSCLEROSIS; RISK; TOLL-LIKE-RECEPTOR-4; COMPLEMENT; EXPRESSION; INFLAMMATION; PERSISTENCE; ADHERENCE; VARIANTS; PLAQUE	We have shown previously that perfluorocarbon-exposed sonicated dextrose albumin (PESDA) microbubbles bind to injured vascular tissue and can be detected with ultrasound imaging techniques. Prior studies have shown that scavenger receptors (SRs) are regulators of innate and adaptive immune responses and are involved in the progression of vascular disease such as atherosclerosis. In this study, we sought to determine the molecular mechanism of PESDA binding to ballooninjured vasculature. RT-PCR analysis of angioplastied aortas demonstrated a significantly (p <= 0.01) increased expression of SRs. Binding to SRs was confirmed using SR-expressing CHO cells, and this binding was blocked by competitive inhibition with the SR-binding ligands oxidized LDL and malondialdehyde-acetaldehyde-modified LDL. Confocal imaging confirmed the co-localization of PESDA microbubbles to CD36, SRB-1, and Toll-like receptor 4, but not to monocytes/macrophages. This study demonstrates that PESDA binds to SRs and that this binding is in major part dependent upon the oxidized nature of PESDA microbubble shell proteins. The extent of SR mRNA expression was increased with injury and associated with microbubble retention as defined by scanning electron microscopy and immunohistochemistry. These findings clarify the mechanisms of how albumin-based microbubbles bind to injured and inflamed vasculature and further support the potential of this imaging technique to detect early vascular innate inflammatory pathophysiologic processes.	[Anderson, Daniel R.; Porter, Thomas R.] Univ Nebraska Med Ctr, Div Cardiol, Dept Internal Med, Omaha, NE 68198 USA; [Duryee, Michael J.; Thiele, Geoffrey M.; Klassen, Lynell W.] Univ Nebraska Med Ctr, Div Rheumatol, Dept Internal Med, Omaha, NE 68198 USA; [Thiele, Geoffrey M.; Klassen, Lynell W.] Univ Nebraska Med Ctr, Dept Pathol Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Anderson, DR (corresponding author), Univ Nebraska Med Ctr, Div Cardiol, Dept Internal Med, 982265 Nebraska Med Ctr, Omaha, NE 68198 USA.	danderso@unmc.edu		Duryee, Michael/0000-0001-9104-2238; Thiele, Geoffrey/0000-0001-5688-8596	National Scientist Development Grant-American Heart Association [07030210N]; National Institutes of Health; Division of Cardiology, Department of Internal Medicine, at the University of Nebraska Medical Center	National Scientist Development Grant-American Heart Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Cardiology, Department of Internal Medicine, at the University of Nebraska Medical Center	This work was supported by National Scientist Development Grant-American Heart Association Grant 07030210N and the National Institutes of Health Student Loan Repayment Program (to D.R.A.) and by the Division of Cardiology, Department of Internal Medicine, at the University of Nebraska Medical Center.	ACTON SL, 1994, J BIOL CHEM, V269, P21003; Anderson DR, 2007, CARDIOVASC RES, V73, P597, DOI 10.1016/j.cardiores.2006.11.029; Boekholdt SM, 2003, CIRCULATION, V107, P2416, DOI 10.1161/01.CIR.0000068311.40161.28; Buono C, 2002, CIRCULATION, V105, P3025, DOI 10.1161/01.CIR.0000019584.04929.83; Edfeldt K, 2004, EUR HEART J, V25, P1447, DOI 10.1016/j.ehj.2004.05.004; Erickson B, 2008, CARDIOL REV, V16, P273, DOI 10.1097/CRD.0b013e3181709fd8; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; Hart ML, 2004, MOL IMMUNOL, V41, P165, DOI 10.1016/j.molimm.2004.03.013; Karim R, 2008, AM J CARDIOL, V102, P825, DOI 10.1016/j.amjcard.2008.05.039; Kataoka H, 2000, J BIOL CHEM, V275, P6573, DOI 10.1074/jbc.275.9.6573; Kathiresan S, 2007, AM J CARDIOL, V99, P310, DOI 10.1016/j.amjcard.2006.08.028; LEE KD, 1992, BIOCHIM BIOPHYS ACTA, V1111, P1, DOI 10.1016/0005-2736(92)90267-P; Li HL, 2007, J CELL MOL MED, V11, P88, DOI 10.1111/j.1582-4934.2007.00011.x; Libby Peter, 2004, Am J Med, V116 Suppl 6A, p9S; Lindner JR, 1998, CIRCULATION, V98, P2187, DOI 10.1161/01.CIR.98.20.2187; Lindner JR, 2000, CIRCULATION, V101, P668, DOI 10.1161/01.CIR.101.6.668; Lindner JR, 2000, CIRCULATION, V102, P2745, DOI 10.1161/01.CIR.102.22.2745; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Nieuwdorp A, 2009, ATHEROSCLEROSIS, V202, P296, DOI 10.1016/j.atherosclerosis.2008.03.024; Otsui K, 2007, HEART VESSELS, V22, P416, DOI 10.1007/s00380-007-1001-1; RASBAND WS, 2001, BIOPHOTONICS INT, V11, P36; Tsutsui JM, 2004, J AM COLL CARDIOL, V44, P1036, DOI 10.1016/j.jacc.2004.05.056; Wickelgren I, 2006, SCIENCE, V312, P184, DOI 10.1126/science.312.5771.184; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	28	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40645	40653		10.1074/jbc.M110.134809	http://dx.doi.org/10.1074/jbc.M110.134809			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20966069	Green Published, hybrid			2022-12-25	WOS:000285414400027
J	Jain, S; Tillinger, A; Mopidevi, B; Pandey, VG; Chauhan, CK; Fiering, SN; Warming, S; Kumar, A				Jain, Sudhir; Tillinger, Andrej; Mopidevi, Brahmaraju; Pandey, Varunkumar G.; Chauhan, Chetankumar K.; Fiering, Steven N.; Warming, Soren; Kumar, Ashok			Transgenic Mice with -6A Haplotype of the Human Angiotensinogen Gene Have Increased Blood Pressure Compared with -6G Haplotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; ESSENTIAL-HYPERTENSION; MOLECULAR-GENETICS; PROMOTER ACTIVITY; HUMAN RENIN; C/EBP BETA; EXPRESSION; TRANSCRIPTION; RAT	Hypertension is a serious risk factor for cardiovascular disease, and the angiotensinogen (AGT) gene locus is associated with human essential hypertension. The human AGT (hAGT) gene has an A/G polymorphism at -6, and the -6A allele is associated with increased blood pressure. However, transgenic mice containing 1.2 kb of the promoter with -6A of the hAGT gene show neither increased plasma AGT level nor increased blood pressure compared with -6G. We have found that the hAGT gene has three additional SNPs (A/G at -1670, C/G at -1562, and T/G at -1561). Variants -1670A, -1562C, and -1561T almost always occur with -6A, and variants -1670G, -1562G, and -1561G almost always occur with -6G. Therefore, the hAGT gene may be subdivided into either -6A or -6G haplotypes. We show that these polymorphisms affect the binding of HNF-1 alpha and glucocorticoid receptor to the promoter, and a reporter construct containing a 1.8-kb hAGT gene promoter with -6A haplotype has 4-fold increased glucocorticoid-induced promoter activity as compared with -6G haplotype. In order to understand the physiological significance of these haplotypes in an in vivo situation, we have generated double transgenic mice containing either the -6A or -6G haplotype of the hAGT gene and the human renin gene. Our ChIP assay shows that HNF-1 alpha and glucocorticoid receptor have stronger affinity for the chromatin obtained from the liver of transgenic mice containing -6A haplotype. Our studies also show that transgenic mice containing -6A haplotype have increased plasma AGT level and increased blood pressure as compared with -6G haplotype. Our studies explain the molecular mechanism involved in association of the -6A allele of the hAGT gene with hypertension.	[Jain, Sudhir; Tillinger, Andrej; Mopidevi, Brahmaraju; Pandey, Varunkumar G.; Chauhan, Chetankumar K.; Kumar, Ashok] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Fiering, Steven N.] Dartmouth Med Sch, Dept Microbiol Immunol & Genet, Hanover, NH 03755 USA; [Warming, Soren] NCI Frederick, Mouse Canc Genet Program, NIH, Frederick, MD 21702 USA	New York Medical College; Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Kumar, A (corresponding author), New York Med Coll, Dept Pathol, Rm 455,Basic Sci Bldg, Valhalla, NY 10595 USA.	ashok_kumar@nymc.edu	Warming, Soren/ABD-5729-2021; Tillinger, Andrej/E-7964-2018; Mopidevi, Brahmaraju/D-6003-2015	Tillinger, Andrej/0000-0003-4643-7040; Mopidevi, Brahmaraju/0000-0003-1231-7796; Warming, Soren/0000-0002-5721-0741	National Institutes of Health [HL081752, HL66296]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105113, R01HL081752, R01HL066296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081752 and HL66296 (to A. K.).	Atzmon G, 2002, HORM METAB RES, V34, P622, DOI 10.1055/s-2002-38250; Aubert J, 1997, BIOCHEM J, V328, P701, DOI 10.1042/bj3280701; Bailly A, 2001, NUCLEIC ACIDS RES, V29, P3495, DOI 10.1093/nar/29.17.3495; BAUMANN H, 1992, J BIOL CHEM, V267, P19744; BEALE EG, 1992, FASEB J, V6, P3330, DOI 10.1096/fasebj.6.15.1281456; BRASIER AR, 1989, MOL ENDOCRINOL, V3, P1022, DOI 10.1210/mend-3-6-1022; BRASIER AR, 1990, MOL ENDOCRINOL, V4, P1921, DOI 10.1210/mend-4-12-1921; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; CAMPBELL DJ, 1986, J CLIN INVEST, V78, P31, DOI 10.1172/JCI112566; Cassuto H, 1997, FEBS LETT, V412, P597, DOI 10.1016/S0014-5793(97)00867-3; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Castellano M, 2003, J HYPERTENS, V21, pS219; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Corvol P, 1997, ENDOCR REV, V18, P662, DOI 10.1210/er.18.5.662; Corvol P, 1997, PATHOL BIOL, V45, P229; Cvetkovic B, 2002, PHYSIOL GENOMICS, V11, P253, DOI 10.1152/physiolgenomics.00076.2002; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Dickson ME, 2006, HYPERTENSION, V48, P14, DOI 10.1161/01.HYP.0000227932.13687.60; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ESPINAS ML, 1995, MOL CELL BIOL, V15, P5346; Gotoh T, 1997, J BIOL CHEM, V272, P3694, DOI 10.1074/jbc.272.6.3694; GOULD AB, 1971, CARDIOVASC RES, V5, P86, DOI 10.1093/cvr/5.1.86; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; IWAI N, 1995, HYPERTENSION, V25, P688, DOI 10.1161/01.HYP.25.4.688; Jain S, 2005, J MOL MED, V83, P121, DOI 10.1007/s00109-004-0621-5; Jain S, 2007, AM J PHYSIOL-CELL PH, V293, pC401, DOI 10.1152/ajpcell.00433.2006; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; KIMURA S, 1992, EMBO J, V11, P821, DOI 10.1002/j.1460-2075.1992.tb05119.x; KLETT C, 1992, ENDOCRINOLOGY, V130, P3660, DOI 10.1210/en.130.6.3660; Klett CPR, 2001, AM J PHYSIOL-REG I, V281, pR1437, DOI 10.1152/ajpregu.2001.281.5.R1437; Kretowski A, 2007, DIABETES, V56, P863, DOI 10.2337/db06-1321; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Litchfield WR, 1998, HYPERTENSION, V31, P569, DOI 10.1161/01.HYP.31.2.569; MACDOUGALD OA, 1994, J BIOL CHEM, V269, P19041; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Matsuno F, 1996, J BIOCHEM-TOKYO, V119, P524; Narayanan CS, 1998, BIOCHEM BIOPH RES CO, V251, P388, DOI 10.1006/bbrc.1998.9430; Nejatizadeh A, 2008, J HYPERTENS, V26, P1094, DOI 10.1097/HJH.0b013e3282fad951; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rasmussen-Torvik LJ, 2005, HYPERTENSION, V46, P1294, DOI 10.1161/01.HYP.0000192653.17209.84; Schmidt H, 2004, STROKE, V35, P2592, DOI 10.1161/01.STR.0000144646.96121.d2; Schmidt H, 2001, STROKE, V32, P405, DOI 10.1161/01.STR.32.2.405; Sethi AS, 2003, ARTERIOSCL THROM VAS, V23, pA17; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Sinn PL, 1999, J BIOL CHEM, V274, P35785, DOI 10.1074/jbc.274.50.35785; Suh DS, 1997, MOL ENDOCRINOL, V11, P1822, DOI 10.1210/me.11.12.1822; Suh DS, 1996, MOL ENDOCRINOL, V10, P1227, DOI 10.1210/me.10.10.1227; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; Walker BR, 1998, HYPERTENSION, V31, P891, DOI 10.1161/01.HYP.31.4.891; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	52	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41172	41186		10.1074/jbc.M110.167585	http://dx.doi.org/10.1074/jbc.M110.167585			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20978123	Green Published, hybrid			2022-12-25	WOS:000285414400079
J	Cui, JM; Qasim, S; Davidson, AL				Cui, Jinming; Qasim, Sabiha; Davidson, Amy L.			Uncoupling Substrate Transport from ATP Hydrolysis in the Escherichia coli Maltose Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; CATALYTIC TRANSITION-STATE; ABC TRANSPORTER; ACTIVE-TRANSPORT; PROTEIN; MECHANISM; STREPTOCOCCUS; RECEPTOR; SYSTEM; MOTION	Members of the ATP-binding cassette superfamily couple the energy from ATP hydrolysis to the active transport of substrates across the membrane. The maltose transporter, a well characterized model system, consists of a periplasmic maltose-binding protein (MBP) and a multisubunit membrane transporter, MalFGK(2). On the basis of the structure of the MBP-MalFGK(2) complex in an outward-facing conformation (Oldham, M. L., Khare, D., Quiocho, F. A., Davidson, A. L., and Chen, J. (2007) Nature 450, 515-521), we identified two mutants in transmembrane domains MalF and MalG that generated futile cycling; although interaction with MBP stimulated the ATPase activity of the transporter, maltose was not transported. Both mutants appeared to disrupt the normal transfer of maltose from MBP to MalFGK(2). In the first case, substitution of aspartate for glycine in the maltose-binding site of MalF likely generated a futile cycle by preventing maltose from binding to MalFGK(2) during the catalytic cycle. In the second case, a four-residue deletion of a periplasmic loop of MalG limited its reach into the maltose-binding pocket of MBP, allowing maltose to remain associated with MBP during the catalytic cycle. Retention of maltose in the MBP binding site in the deletion mutant, as well as insertion of this loop into the binding site in the wild type, was detected by EPR as a change in mobility of a nitroxide spin label positioned near the maltose-binding pocket of MBP.	[Cui, Jinming; Qasim, Sabiha; Davidson, Amy L.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Davidson, AL (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	adavidso@purdue.edu	Cui, Jinming/G-2214-2012		National Institutes of Health [GM49261, GM070515]; Purdue Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049261, R56GM070515, R29GM049261, R01GM070515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM49261 and GM070515. This work was also supported by a Purdue Research Foundation research grant.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; DAVIDSON AL, 1990, J BIOL CHEM, V265, P4254; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DEAN DA, 1989, P NATL ACAD SCI USA, V86, P9134, DOI 10.1073/pnas.86.23.9134; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; Ehrle R, 1996, J BACTERIOL, V178, P2255, DOI 10.1128/jb.178.8.2255-2262.1996; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; FIKES JD, 1987, J BACTERIOL, V169, P2352, DOI 10.1128/jb.169.6.2352-2359.1987; Gould AD, 2010, J BIOL CHEM, V285, P11290, DOI 10.1074/jbc.M109.089078; Gould AD, 2009, BIOCHEMISTRY-US, V48, P8051, DOI 10.1021/bi9007066; Hall JA, 1997, J BIOL CHEM, V272, P17615, DOI 10.1074/jbc.272.28.17615; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Jacso T, 2009, BIOCHEMISTRY-US, V48, P2216, DOI 10.1021/bi801376m; Jones AL, 2000, MOL MICROBIOL, V37, P1444, DOI 10.1046/j.1365-2958.2000.02099.x; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; KNOWLES PF, 1972, MAGNETIC RESONANCE B; Linton KJ, 1998, MOL MICROBIOL, V28, P5, DOI 10.1046/j.1365-2958.1998.00764.x; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1345, DOI 10.1021/bi0267745; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; Sauna ZE, 2008, J BIOL CHEM, V283, P35010, DOI 10.1074/jbc.M806446200; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2006, INFECT IMMUN, V74, P4605, DOI 10.1128/IAI.00477-06; SZMELCMAN S, 1976, EUR J BIOCHEM, V65, P13, DOI 10.1111/j.1432-1033.1976.tb10383.x; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; TREPTOW NA, 1985, J BACTERIOL, V163, P654, DOI 10.1128/JB.163.2.654-660.1985; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503	41	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39986	39993		10.1074/jbc.M110.147819	http://dx.doi.org/10.1074/jbc.M110.147819			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20959448	Green Published, hybrid			2022-12-25	WOS:000285185500043
J	Ikonen, N; Haanpaa, M; Ronkko, E; Lyytikainen, O; Kuusi, M; Ruutu, P; Kallio-Kokko, H; Mannonen, L; Lappalainen, M; Ziegler, T; Julkunen, I				Ikonen, Niina; Haanpaa, Minna; Ronkko, Esa; Lyytikainen, Outi; Kuusi, Markku; Ruutu, Petri; Kallio-Kokko, Hannimari; Mannonen, Laura; Lappalainen, Maija; Ziegler, Thedi; Julkunen, Ilkka			Genetic Diversity of the 2009 Pandemic Influenza A(H1N1) Viruses in Finland	PLOS ONE			English	Article							A H1N1; HEMAGGLUTININ; SUBSTITUTION; ASSOCIATION; DISEASE	Background: In Finland, the first infections caused by the 2009 pandemic influenza A(H1N1) virus were identified on May 10. During the next three months almost all infections were found from patients who had recently traveled abroad. In September 2009 the pandemic virus started to spread in the general population, leading to localized outbreaks and peak epidemic activity was reached during weeks 43-48. Methods/Results: The nucleotide sequences of the hemagglutinin (HA) and neuraminidase (NA) genes from viruses collected from 138 patients were determined. The analyzed viruses represented mild and severe infections and different geographic regions and time periods. Based on HA and NA gene sequences, the Finnish pandemic viruses clustered in four groups. Finnish epidemic viruses and A/California/07/2009 vaccine virus strain varied from 2-8 and 0-5 amino acids in HA and NA molecules, respectively, giving a respective maximal evolution speed of 1.4% and 1.1%. Most amino acid changes in HA and NA molecules accumulated on the surface of the molecule and were partly located in antigenic sites. Three severe infections were detected with a mutation at HA residue 222, in two viruses with a change D222G, and in one virus D222Y. Also viruses with change D222E were identified. All Finnish pandemic viruses were sensitive to oseltamivir having the amino acid histidine at residue 275 of the neuraminidase molecule. Conclusions: The Finnish pandemic viruses were quite closely related to A/California/07/2009 vaccine virus. Neither in the HA nor in the NA were changes identified that may lead to the selection of a virus with increased epidemic potential or exceptionally high virulence. Continued laboratory-based surveillance of the 2009 pandemic influenza A(H1N1) is important in order to rapidly identify drug resistant viruses and/or virus variants with potential ability to cause severe forms of infection and an ability to circumvent vaccine-induced immunity.	[Ikonen, Niina; Haanpaa, Minna; Ronkko, Esa; Ziegler, Thedi; Julkunen, Ilkka] Natl Inst Hlth & Welf THL, Dept Vaccinat & Immune Protect, Viral Infect Unit, Helsinki, Finland; [Lyytikainen, Outi; Kuusi, Markku; Ruutu, Petri] Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Kallio-Kokko, Hannimari; Mannonen, Laura; Lappalainen, Maija] Helsinki Univ Hosp, Lab Serv HUSLAB, Dept Virol, Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Ikonen, N (corresponding author), Natl Inst Hlth & Welf THL, Dept Vaccinat & Immune Protect, Viral Infect Unit, Helsinki, Finland.	niina.ikonen@thl.fi		Ikonen, Niina/0000-0003-0724-8888; Lappalainen, Maija/0000-0001-5400-1250	National Institute for Health and Welfare (THL); Ministry of Social Affairs and Health (Finland); European Commission DG Research [201169]	National Institute for Health and Welfare (THL); Ministry of Social Affairs and Health (Finland); European Commission DG Research(European CommissionEuropean Commission Joint Research Centre)	The study was supported by the funds of the National Institute for Health and Welfare (THL), the Ministry of Social Affairs and Health (Finland) and the Identification of Mechanisms Correlating with Susceptibility for Avian Influenza (IMECS) project (grant no 201169) supported by the European Commission DG Research and the participating member states. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P21; Brownlee GG, 2001, PHILOS T ROY SOC B, V356, P1871, DOI 10.1098/rstb.2001.1001; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; IKONEN N, 2010, EUROSURVEILL, V15; KILANDER A, 2010, EUROSURVEILL, V15; LIU Y, 2010, J VIROL, DOI DOI 10.1128/JVL.01639-10; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; MAURERSTROH S, 2010, PLOS CURR INFLUENZA, pN1162; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	19	41	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13329	10.1371/journal.pone.0013329	http://dx.doi.org/10.1371/journal.pone.0013329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975994	Green Submitted, Green Published, gold			2022-12-25	WOS:000283216400001
J	Ma, XM; Jiang, Y; Wu, AM; Chen, XH; Pi, RB; Liu, M; Liu, YY				Ma, Xiaomeng; Jiang, Ying; Wu, Aimin; Chen, Xiaohong; Pi, Rongbiao; Liu, Mei; Liu, Yingying			Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MATRIX-METALLOPROTEINASE EXPRESSION; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; PLASMINOGEN-ACTIVATOR; TISSUE INHIBITORS; SPINAL-CORD; IN-VITRO; CELLS	Background: Berberine, an isoquinoline derivative alkaloid, has a wide range of pharmacological properties and is considered to have anti-inflammatory and neuroprotective effects. However, there are no reports about the effects and mechanisms of berberine in experimental autoimmune encephalomyelitis (EAE), an established model of multiple sclerosis (MS). Methodology/Principal Findings: Female C57BL/6 mice immunized with myelin oligodendrocyte glycoprotein 35-55 amino acid peptide were treated with berberine at the day of disease onset and medication was administered daily until mice were sacrificed. Blood-brain barrier (BBB) permeability and the alteration of matrix metalloproteinase-2 (MMP-2, 72 kDa) and matrix metalloproteinase-9 (MMP-9, 92 kDa) in the brain and cerebrospinal fluid (CSF) of EAE mice were detected by quantitative measurement for Evan's blue (EB) content, Western blot and gelatin zymography respectively. The results showed that berberine attenuated clinical and pathological parameters of EAE, reduced the permeability of BBB, inhibited the activity and expression of MMP-9 but not MMP-2 in the CSF and brain of EAE mice. Conclusions/Significance: These findings suggest that berberine is effective to attenuate the clinical severity of EAE in C57 BL/6 mice by reducing the permeability of BBB, decreasing the expression and activity of MMP-9, and decreasing the inflammatory infiltration. We think that berberine might be a potential therapeutic agent for MS.	[Ma, Xiaomeng; Jiang, Ying; Wu, Aimin; Chen, Xiaohong; Liu, Mei; Liu, Yingying] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou, Peoples R China; [Pi, Rongbiao] Sun Yat Sen Univ, Dept Pharmacol & Toxicol, Sch Pharmaceut Sci, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Ma, XM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou, Peoples R China.	xiaohongchenzssy@yahoo.com.cn			National Natural Science Foundation of China [81071068, 30870849]; Planned Science and Technology Project of Guangdong Province, China [2009B030801101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Planned Science and Technology Project of Guangdong Province, China	This work was supported by grants (to X Chen) from the National Natural Science Foundation of China (81071068 and 30870849) and from the Planned Science and Technology Project of Guangdong Province, China (2009B030801101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony DC, 1998, J NEUROIMMUNOL, V87, P62, DOI 10.1016/S0165-5728(98)00046-0; Avolio C, 2003, J NEUROIMMUNOL, V136, P46, DOI 10.1016/S0165-5728(03)00006-7; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Brown KA, 2001, INT IMMUNOPHARMACOL, V1, P2043; Chen FL, 2008, ENDOCRINE, V33, P331, DOI 10.1007/s12020-008-9089-3; Chen XH, 2009, J NEUROIMMUNOL, V210, P22, DOI 10.1016/j.jneuroim.2009.02.016; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Cossins JA, 1997, ACTA NEUROPATHOL, V94, P590, DOI 10.1007/s004010050754; Cuzner ML, 1996, J NEUROPATH EXP NEUR, V55, P1194, DOI 10.1097/00005072-199612000-00002; DANIEL PM, 1983, J NEUROL SCI, V60, P367, DOI 10.1016/0022-510X(83)90147-8; DeVries HE, 1997, PHARMACOL REV, V49, P143; Dubois B, 1999, J CLIN INVEST, V104, P1507, DOI 10.1172/JCI6886; Engelhardt B, 1997, BLOOD, V90, P4459, DOI 10.1182/blood.V90.11.4459.4459_4459_4472; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Fabis MJ, 2007, P NATL ACAD SCI USA, V104, P5656, DOI 10.1073/pnas.0701252104; Guo M, 2008, NEUROSCIENCE, V151, P340, DOI 10.1016/j.neuroscience.2007.10.006; Hartung HP, 2000, J NEUROIMMUNOL, V107, P140, DOI 10.1016/S0165-5728(00)00225-3; Ho YT, 2009, CANCER LETT, V279, P155, DOI 10.1016/j.canlet.2009.01.033; HUANG Z, 2009, INT J CARDIOL; HUHTALA P, 1990, J BIOL CHEM, V265, P11077; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; IKRAM M, 1975, PLANTA MED, V28, P353, DOI 10.1055/s-0028-1097869; Kean RB, 2000, J IMMUNOL, V165, P6511, DOI 10.4049/jimmunol.165.11.6511; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; Kim S, 2008, PHYTOMEDICINE, V15, P340, DOI 10.1016/j.phymed.2007.09.011; Kolb SA, 1998, J NEUROIMMUNOL, V84, P143, DOI 10.1016/S0165-5728(97)00247-6; Kozler P, 2003, PHYSIOL RES, V52, P607; Kuerten S, 2007, J NEUROIMMUNOL, V189, P31, DOI 10.1016/j.jneuroim.2007.06.016; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; LASSMANN H, 1983, PROG BRAIN RES, V59, P305; Leib SL, 2000, INFECT IMMUN, V68, P615, DOI 10.1128/IAI.68.2.615-620.2000; Li HY, 2003, BIOL PHARM BULL, V26, P110, DOI 10.1248/bpb.26.110; Liu XJ, 2008, BRAIN RES, V1207, P237, DOI 10.1016/j.brainres.2008.01.106; Mandler RN, 2001, BRAIN, V124, P493, DOI 10.1093/brain/124.3.493; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Mirowska D, 2004, J NEUROIMMUNOL, V146, P171, DOI 10.1016/j.jneuroim.2003.10.046; Mitani N, 2001, CANCER LETT, V165, P35, DOI 10.1016/S0304-3835(00)00710-2; Mun-Bryce S, 1998, AM J PHYSIOL-REG I, V274, pR1203, DOI 10.1152/ajpregu.1998.274.5.R1203; Nagase H, 1997, BIOL CHEM, V378, P151; NISHINO H, 1986, ONCOLOGY, V43, P131, DOI 10.1159/000226349; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; O'Neill EJ, 2006, J NEUROIMMUNOL, V178, P1, DOI 10.1016/j.jneuroim.2006.05.030; Pan LR, 2005, ACTA PHARMACOL SIN, V26, P1334, DOI 10.1111/j.1745-7254.2005.00186.x; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; RACKE MK, 1994, J IMMUNOL, V152, P2051; ROMANIC AM, 1994, J CELL BIOL, V125, P1165, DOI 10.1083/jcb.125.5.1165; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Xu LH, 2005, CELL MOL IMMUNOL, V2, P295; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhou XQ, 2008, NEUROSCI LETT, V447, P31, DOI 10.1016/j.neulet.2008.09.064	55	78	84	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13489	10.1371/journal.pone.0013489	http://dx.doi.org/10.1371/journal.pone.0013489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976070	Green Published, Green Submitted, gold			2022-12-25	WOS:000283114700017
J	Li, RW; MacKeben, M; Chat, SW; Kumar, M; Ngo, C; Levi, DM				Li, Roger W.; MacKeben, Manfred; Chat, Sandy W.; Kumar, Maya; Ngo, Charlie; Levi, Dennis M.			Aging and Visual Counting	PLOS ONE			English	Article							POSITION DISCRIMINATION; CONTRAST SENSITIVITY; SELECTIVE ATTENTION; SPATIAL ENUMERATION; ALZHEIMERS-DISEASE; EYE-MOVEMENTS; LIFE-SPAN; AGE; NUMBER; MEMORY	Background: Much previous work on how normal aging affects visual enumeration has been focused on the response time required to enumerate, with unlimited stimulus duration. There is a fundamental question, not yet addressed, of how many visual items the aging visual system can enumerate in a "single glance", without the confounding influence of eye movements. Methodology/Principal Findings: We recruited 104 observers with normal vision across the age span ( age 21-85). They were briefly ( 200 ms) presented with a number of well- separated black dots against a gray background on a monitor screen, and were asked to judge the number of dots. By limiting the stimulus presentation time, we can determine the maximum number of visual items an observer can correctly enumerate at a criterion level of performance ( counting threshold, defined as the number of visual items at which approximate to 63% correct rate on a psychometric curve), without confounding by eye movements. Our findings reveal a 30% decrease in the mean counting threshold of the oldest group ( age 61-85: similar to 5 dots) when compared with the youngest groups ( age 21-40: 7 dots). Surprisingly, despite decreased counting threshold, on average counting accuracy function ( defined as the mean number of dots reported for each number tested) is largely unaffected by age, reflecting that the threshold loss can be primarily attributed to increased random errors. We further expanded this interesting finding to show that both young and old adults tend to over-count small numbers, but older observers over-count more. Conclusion/Significance: Here we show that age reduces the ability to correctly enumerate in a glance, but the accuracy (veridicality), on average, remains unchanged with advancing age. Control experiments indicate that the degraded performance cannot be explained by optical, retinal or other perceptual factors, but is cortical in origin.	[Li, Roger W.; Chat, Sandy W.; Kumar, Maya; Ngo, Charlie; Levi, Dennis M.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Li, Roger W.; Levi, Dennis M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [MacKeben, Manfred] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; The Smith-Kettlewell Eye Research Institute	Li, RW (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	oroger@berkeley.edu	Kumar, Maya/HDM-9018-2022; Levi, Dennis/J-7836-2019	Levi, Dennis/0000-0002-5350-8639; Li, Roger/0000-0002-1666-0543	National Eye Institute [R01EY01728]; NATIONAL EYE INSTITUTE [R01EY001728] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Eye Institute grant R01EY01728. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak C, 2003, PSYCHOL AGING, V18, P240, DOI 10.1037/0882-7974.18.2.240; Bennett PJ, 2007, VISION RES, V47, P799, DOI 10.1016/j.visres.2007.01.001; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; CURCIO CA, 1993, ANN NEUROL, V33, P248, DOI 10.1002/ana.410330305; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; Del Viva MM, 2007, INVEST OPHTH VIS SCI, V48, P2940, DOI 10.1167/iovs.06-0729; ELLIOTT D, 1990, VISION RES, V30, P541, DOI 10.1016/0042-6989(90)90066-T; ELLIOTT DB, 1995, OPTOMETRY VISION SCI, V72, P186, DOI 10.1097/00006324-199503000-00006; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; Garcia-Suarez L, 2004, VISION RES, V44, P1039, DOI 10.1016/j.visres.2003.11.018; Geary DC, 1998, EXP AGING RES, V24, P101; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hennelly ML, 1998, OPHTHAL PHYSL OPT, V18, P197, DOI 10.1016/S0275-5408(97)00077-X; Irving EL, 2006, INVEST OPHTH VIS SCI, V47, P2478, DOI 10.1167/iovs.05-1311; JEVONS WS, 1871, NATURE, V3, P281, DOI DOI 10.1038/003281A0; KOTARY L, 1995, EXP AGING RES, V21, P159, DOI 10.1080/03610739508254275; LACHENMAYR BJ, 1994, INVEST OPHTH VIS SCI, V35, P2741; Lemaire P, 2007, J GERONTOL B-PSYCHOL, V62, pP305, DOI 10.1093/geronb/62.6.P305; Li RW, 2004, J VISION, V4, P476, DOI 10.1167/4.6.7; Li RW, 2004, NAT NEUROSCI, V7, P178, DOI 10.1038/nn1183; Li RWH, 2000, VISION RES, V40, P3775, DOI 10.1016/S0042-6989(00)00212-1; Lott LA, 2005, OPTOMETRY VISION SCI, V82, P874, DOI 10.1097/01.opx.0000180764.68737.91; Maylor EA, 2008, NEUROPSYCHOLOGIA, V46, P2696, DOI 10.1016/j.neuropsychologia.2008.05.002; McIntosh AR, 1999, CURR BIOL, V9, P1275, DOI 10.1016/S0960-9822(99)80512-0; Nan Y, 2006, NEUROPSYCHOLOGIA, V44, P1103, DOI 10.1016/j.neuropsychologia.2005.10.020; Narasimhan S, 2009, VISION RES, V49, P10, DOI 10.1016/j.visres.2008.09.023; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Pearson PM, 2006, OPTOMETRY VISION SCI, V83, P444, DOI 10.1097/01.opx.0000218432.52508.10; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; PILZ KS, VISION RES, V50, P211; PYLYSHYN Z, 1994, COGNITION, V50, P363, DOI 10.1016/0010-0277(94)90036-1; RABBITT P, 1993, Q J EXP PSYCHOL-A, V46, P385, DOI 10.1080/14640749308401055; Railo H, 2008, COGNITION, V107, P82, DOI 10.1016/j.cognition.2007.08.004; Ross J, 2010, J VISION, V10, DOI 10.1167/10.2.10; Sekuler R, 2005, EXP AGING RES, V31, P1, DOI 10.1080/03610730590882800; Sharma V, 2000, NAT NEUROSCI, V3, P496, DOI 10.1038/74872; Sliwinski M, 1997, PSYCHOL AGING, V12, P38, DOI 10.1037/0882-7974.12.1.38; Spry PGD, 2001, OPTOMETRY VISION SCI, V78, P436, DOI 10.1097/00006324-200106000-00017; Trick LM, 2005, PSYCHON B REV, V12, P675, DOI 10.3758/BF03196757; Trick LM, 1996, DEV PSYCHOL, V32, P925, DOI 10.1037/0012-1649.32.5.925; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Watson DG, 2007, J EXP PSYCHOL HUMAN, V33, P1389, DOI 10.1037/0096-1523.33.6.1389; Watson DG, 2007, J EXP PSYCHOL HUMAN, V33, P549, DOI 10.1037/0096-1523.33.3.549; Watson DG, 2005, Q J EXP PSYCHOL-A, V58, P1119, DOI 10.1080/02724980443000511; Watson DG, 2005, PSYCHOL AGING, V20, P226, DOI 10.1037/0882-7974.20.2.226; Watson DG, 2002, PSYCHOL AGING, V17, P496, DOI 10.1037//0882-7974.17.3.496; WEALE RA, 1961, T ILLUMINATING ENG S, V26, P95, DOI DOI 10.1177/147715356102600204; WHITAKER D, 1992, OPHTHAL PHYSL OPT, V12, P29, DOI 10.1111/j.1475-1313.1992.tb00250.x; WHITAKER D, 1992, DOC OPHTHALMOL, V82, P307, DOI 10.1007/BF00161018; Yang Q, 2002, INVEST OPHTH VIS SCI, V43, P2939; Zaroff CM, 2003, INVEST OPHTH VIS SCI, V44, P891, DOI 10.1167/iovs.02-0361	55	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13434	10.1371/journal.pone.0013434	http://dx.doi.org/10.1371/journal.pone.0013434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	665ON	20976149	Green Submitted, Green Published, gold			2022-12-25	WOS:000283045300016
J	Avargues-Weber, A; de Brito Sanchez, MG; Giurfa, M; Dyer, AG				Avargues-Weber, Aurore; de Brito Sanchez, Maria G.; Giurfa, Martin; Dyer, Adrian G.			Aversive Reinforcement Improves Visual Discrimination Learning in Free-Flying Honeybees	PLOS ONE			English	Article							APIS-MELLIFERA L; COLOR DISCRIMINATION; CONDITIONING PROCEDURE; PATTERN-RECOGNITION; FORAGING SPEED; TRADE-OFF; TASTE; INSECT; DROSOPHILA; RESPONSES	Background: Learning and perception of visual stimuli by free-flying honeybees has been shown to vary dramatically depending on the way insects are trained. Fine color discrimination is achieved when both a target and a distractor are present during training (differential conditioning), whilst if the same target is learnt in isolation (absolute conditioning), discrimination is coarse and limited to perceptually dissimilar alternatives. Another way to potentially enhance discrimination is to increase the penalty associated with the distractor. Here we studied whether coupling the distractor with a highly concentrated quinine solution improves color discrimination of both similar and dissimilar colors by free-flying honeybees. As we assumed that quinine acts as an aversive stimulus, we analyzed whether aversion, if any, is based on an aversive sensory input at the gustatory level or on a post-ingestional malaise following quinine feeding. Methodology/Principal Findings: We show that the presence of a highly concentrated quinine solution (60 mM) acts as an aversive reinforcer promoting rejection of the target associated with it, and improving discrimination of perceptually similar stimuli but not of dissimilar stimuli. Free-flying bees did not use remote cues to detect the presence of quinine solution; the aversive effect exerted by this substance was mediated via a gustatory input, i.e. via a distasteful sensory experience, rather than via a post-ingestional malaise. Conclusion: The present study supports the hypothesis that aversion conditioning is important for understanding how and what animals perceive and learn. By using this form of conditioning coupled with appetitive conditioning in the framework of a differential conditioning procedure, it is possible to uncover discrimination capabilities that may remain otherwise unsuspected. We show, therefore, that visual discrimination is not an absolute phenomenon but can be modulated by experience.	[Avargues-Weber, Aurore; de Brito Sanchez, Maria G.; Giurfa, Martin] Univ Toulouse, Ctr Rech Cognit Anim, UPS, Toulouse, France; [Avargues-Weber, Aurore; de Brito Sanchez, Maria G.; Giurfa, Martin] CNRS, Ctr Rech Cognit Anim, Toulouse, France; [Avargues-Weber, Aurore; Dyer, Adrian G.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Monash University	Avargues-Weber, A (corresponding author), Univ Toulouse, Ctr Rech Cognit Anim, UPS, Toulouse, France.	adrian.dyer@monash.edu	Avargues-Weber, Aurore/V-5795-2019; Giurfa, Martin MG/A-7322-2008; Giurfa, Martin/H-5140-2016; Giurfa, Martin/AAS-4945-2020	Giurfa, Martin/0000-0001-7173-769X; Giurfa, Martin/0000-0001-7173-769X; de Brito Sanchez, Maria Gabriela/0000-0001-6940-8088	French Research Council (CNRS); University Paul Sabatier; Company of Biologists; Alexander von Humboldt Foundation [ARC DP0987989, ARC DP0878968]; National Research Agency (ANR)	French Research Council (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier; Company of Biologists; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Research Agency (ANR)(French National Research Agency (ANR))	A.A.-W, M. G. de B. S and M. G. thank the National Research Agency (ANR) (Project INSAVEL), the French Research Council (CNRS) and the University Paul Sabatier for support. A.A.-W. was supported by a Travelling Fellowship from The Company of Biologists and by the University Paul Sabatier (ATUPS fellowship). A. G. D. acknowledges the Alexander von Humboldt Foundation, ARC DP0987989 and ARC DP0878968 for support. http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avargues-Weber A, 2010, J EXP BIOL, V213, P593, DOI 10.1242/jeb.039263; AVARGUESWEBER A, 2010, ANN REV ENT IN PRESS; AYESTARAN A, 2010, PLOS ONE UNPUB; BACKHAUS W, 1991, VISION RES, V31, P1381, DOI 10.1016/0042-6989(91)90059-E; Benard J, 2006, ANIM COGN, V9, P257, DOI 10.1007/s10071-006-0032-9; Burns JG, 2008, CURR BIOL, V18, pR953, DOI 10.1016/j.cub.2008.08.028; Camlitepe Y, 2010, J EXP BIOL, V213, P72, DOI 10.1242/jeb.037853; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Dacke M, 2008, ANIM COGN, V11, P683, DOI 10.1007/s10071-008-0159-y; de Brito Sanchez M. G., 2008, J COMP PHYSIOL A, V194, P861, DOI DOI 10.1007/S00359-008-0357-8; de Brito Sanchez MG, 2005, EUR J NEUROSCI, V22, P3161, DOI 10.1111/j.1460-9568.2005.04516.x; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Dyer AG, 2008, J EXP BIOL, V211, P1180, DOI 10.1242/jeb.016683; Dyer AG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004086; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; Dyer AG, 2004, J COMP PHYSIOL A, V190, P759, DOI 10.1007/s00359-004-0547-y; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; Gegear RJ, 2007, ECOL LETT, V10, P375, DOI 10.1111/j.1461-0248.2007.01027.x; Giurfa M, 1999, ANIM BEHAV, V57, P315, DOI 10.1006/anbe.1998.0957; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Giurfa M, 2004, NATURWISSENSCHAFTEN, V91, P228, DOI 10.1007/s00114-004-0530-z; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Gross HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004263; HELVERSEN OV, 1972, J COMP PHYSIOL, V80, P439, DOI 10.1007/BF00696438; Hori S, 2007, J COMP PHYSIOL A, V193, P825, DOI 10.1007/s00359-007-0234-x; Hori S, 2006, J COMP PHYSIOL A, V192, P691, DOI 10.1007/s00359-005-0091-4; Horridge A, 2009, J EXP BIOL, V212, P2721, DOI 10.1242/jeb.030916; Horridge A, 2009, J INSECT PHYSIOL, V55, P499, DOI 10.1016/j.jinsphys.2009.03.006; Johnson SD, 2006, ECOLOGY, V87, P2709, DOI 10.1890/0012-9658(2006)87[2709:DBNFAA]2.0.CO;2; JUDD DB, 1964, J OPT SOC AM, V54, P1031, DOI 10.1364/JOSA.54.001031; Liu FL, 2006, BEHAV ECOL SOCIOBIOL, V59, P582, DOI 10.1007/s00265-005-0084-x; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; MENZEL R, 1985, CENTRAL PERIPHERAL M, P211; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Niggebrugge C, 2009, J EXP BIOL, V212, P1344, DOI 10.1242/jeb.021881; NUNEZ JA, 1966, Z VERGL PHYSIOL, V53, P142; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rival C, 2003, NEUROSCI LETT, V336, P65, DOI 10.1016/S0304-3940(02)01246-6; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; SANCHEZ GD, 2007, ARTHROPOD-PLANT INTE, V1, P69; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Stach S, 2004, NATURE, V429, P758, DOI 10.1038/nature02594; VANHATEREN JH, 1990, J COMP PHYSIOL A, V167, P649, DOI 10.1007/BF00192658; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Whitney HM, 2009, SCIENCE, V323, P130, DOI 10.1126/science.1166256; Zhang Shaowu, 2004, P41; Zhang SW, 1996, NEUROBIOL LEARN MEM, V66, P267, DOI 10.1006/nlme.1996.0069; ZHANG SW, 1994, NATURE, V368, P330, DOI 10.1038/368330a0	57	104	105	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e15370	10.1371/journal.pone.0015370	http://dx.doi.org/10.1371/journal.pone.0015370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976170	gold, Green Submitted, Green Published			2022-12-25	WOS:000283043700032
J	Hopkins, WD; Taglialatela, JP; Russell, JL; Nir, TM; Schaeffer, J				Hopkins, William D.; Taglialatela, Jared P.; Russell, Jamie L.; Nir, Talia M.; Schaeffer, Jennifer			Cortical Representation of Lateralized Grasping in Chimpanzees (Pan troglodytes): A Combined MRI and PET Study	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; HAND AREA; PRECENTRAL GYRUS; LEFT-HEMISPHERE; HANDEDNESS; ASYMMETRIES; LOCALIZATION; BRAIN; PREFERENCE; MATTER	Functional imaging studies in humans have localized the motor-hand region to a neuroanatomical landmark call the KNOB within the precentral gyrus. It has also been reported that the KNOB is larger in the hemisphere contralateral to an individual's preferred hand, and therefore may represent the neural substrate for handedness. The KNOB has also been neuronatomically described in chimpanzees and other great apes and is similarly associated with handedness. However, whether the chimpanzee KNOB represents the hand region is unclear from the extant literature. Here, we used PET to quantify neural metabolic activity in chimpanzees when engaged in unilateral reach-and-grasping responses and found significantly lateralized activation of the KNOB region in the hemisphere contralateral to the hand used by the chimpanzees. We subsequently constructed a probabilistic map of the KNOB region in chimpanzees in order to assess the overlap in consistency in the anatomical landmarks of the KNOB with the functional maps generated from the PET analysis. We found significant overlap in the anatomical and functional voxels comprising the KNOB region, suggesting that the KNOB does correspond to the hand region in chimpanzees. Lastly, from the probabilistic maps, we compared right-and left-handed chimpanzees on lateralization in grey and white matter within the KNOB region and found that asymmetries in white matter of the KNOB region were larger in the hemisphere contralateral to the preferred hand. These results suggest that neuroanatomical asymmetries in the KNOB likely reflect changes in connectivity in primary motor cortex that are experience dependent in chimpanzees and possibly humans.	[Hopkins, William D.; Taglialatela, Jared P.; Russell, Jamie L.; Nir, Talia M.; Schaeffer, Jennifer] Yerkes Natl Primate Res Ctr, Div Dev & Cognit Neurosci, Atlanta, GA USA; [Hopkins, William D.] Agnes Scott Coll, Dept Psychol, Decatur, GA 30030 USA; [Taglialatela, Jared P.] Kennesaw State Univ, Dept Biol & Phys, Kennesaw, GA USA	University System of Georgia; Kennesaw State University	Hopkins, WD (corresponding author), Yerkes Natl Primate Res Ctr, Div Dev & Cognit Neurosci, Atlanta, GA USA.	whopkin@emory.edu			National Institutes of Health [NS-42867, NS-36605, HD-38051, HD-56232]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD038051, R01HD056232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042867, R01NS036605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health grants NS-42867, NS-36605, HD-38051 and HD-56232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKADHI H, 2004, AM J NEURORADIOLOGY, V25; Amunts K, 1996, NEUROIMAGE, V4, P216, DOI 10.1006/nimg.1996.0073; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Annett M, 2002, HANDEDNESS BRAIN ASY; Bailey P, 1950, ISOCORTEX CHIMPANZEE; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Boling W, 1999, J NEUROSURG, V91, P903, DOI 10.3171/jns.1999.91.6.0903; Boroojerdi B, 1999, CLIN NEUROPHYSIOL, V110, P699, DOI 10.1016/S1388-2457(98)00027-3; Brown SG, 2004, BRAIN COGNITION, V55, P283, DOI 10.1016/j.bandc.2004.02.010; Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Caulo M, 2007, AM J NEURORADIOL, V28, P1480, DOI 10.3174/ajnr.A0597; CHRISTEL MI, 1994, CURRENT PRIMATOLOGY, V3, P37; Connolly K. J., 1998, PSYCHOBIOLOGY HAND; Corballis MC, 2002, HAND MOUTH ORIGINS L; Corey DM, 2001, NEUROPSY NEUROPSY BE, V14, P144; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Dadda M, 2006, NEUROPSYCHOLOGIA, V44, P2582, DOI 10.1016/j.neuropsychologia.2006.03.037; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; ETTLINGER G, 1988, CORTEX, V24, P389, DOI 10.1016/S0010-9452(88)80002-9; Fragaszy DM, 1998, CLIN DEV MED, P77; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; Gaser C, 2003, J NEUROSCI, V23, P9240; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Hammond G, 2002, NEUROSCI BIOBEHAV R, V26, P285, DOI 10.1016/S0149-7634(02)00003-9; HATTA T, 2006, MAGN RESON MED SCI, V6, P99; HEALEY JM, 1986, CORTEX, V22, P33, DOI 10.1016/S0010-9452(86)80031-4; Hopkins WD, 2004, BEHAV NEUROSCI, V118, P1176, DOI 10.1037/0735-7044.118.6.1176; Hopkins WD, 2004, NEUROPSYCHOLOGIA, V42, P990, DOI 10.1016/j.neuropsychologia.2003.11.017; Hopkins WD, 2002, J EXP PSYCHOL GEN, V131, P412, DOI 10.1037//0096-3445.131.3.412; Hopkins WD, 2001, BEHAV NEUROSCI, V115, P1159, DOI 10.1037//0735-7044.115.5.1159; Hopkins WD, 1998, NEUROREPORT, V9, P2913, DOI 10.1097/00001756-199808240-00043; HOPKINS WD, 2007, EVOLUTION HEMISPHERI, P112; Hopkins WD, 2007, CEREB CORTEX, V17, P1750, DOI 10.1093/cercor/bhl085; Hopkins WD, 2007, CEREB CORTEX, V17, P1757, DOI 10.1093/cercor/bhl086; Hopkins WD, 2007, EUR J NEUROSCI, V25, P2565, DOI 10.1111/j.1460-9568.2007.05502.x; JEANNEROD M, 1998, NEURAL BEHAV ORG GOA; Kaufman JA, 2003, AM J PHYS ANTHROPOL, V121, P369, DOI 10.1002/ajpa.10181; Lacreuse A, 2005, NEUROBIOL AGING, V26, P543, DOI 10.1016/j.neurobiolaging.2004.05.007; LI S, CEREBRAL CO IN PRESS; Lu LH, 2007, CEREB CORTEX, V17, P1092, DOI 10.1093/cercor/bhl019; Marzke MW, 1997, AM J PHYS ANTHROPOL, V102, P91; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Napier J.R., 1980, HANDS; NUDO RJ, 1992, J NEUROSCI, V12, P2918, DOI 10.1523/JNEUROSCI.12-08-02918.1992; Parr LA, 2009, CURR BIOL, V19, P50, DOI 10.1016/j.cub.2008.11.048; Phillips KA, 2005, BEHAV NEUROSCI, V119, P1701, DOI 10.1037/0735-7044.119.6.1701; Phillips KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000792; Phillips KA, 2007, NEUROPSYCHOLOGIA, V45, P2333, DOI 10.1016/j.neuropsychologia.2007.02.010; Pizzella V, 1999, NEUROREPORT, V10, P3809, DOI 10.1097/00001756-199912160-00016; Porac C, 1981, LATERAL PREFERENCES; Rilling JK, 2007, P NATL ACAD SCI USA, V104, P17146, DOI 10.1073/pnas.0705132104; Rilling JK, 1999, J HUM EVOL, V37, P191, DOI 10.1006/jhev.1999.0313; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Sastre-Janer FA, 1998, CEREB CORTEX, V8, P641, DOI 10.1093/cercor/8.7.641; Sherwood CC, 2007, J COMP NEUROL, V503, P525, DOI 10.1002/cne.21399; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Taglialatela JP, 2008, CURR BIOL, V18, P343, DOI 10.1016/j.cub.2008.01.049; Taglialatela JP, 2006, NEUROREPORT, V17, P923, DOI 10.1097/01.wnr.0000221835.26093.5e; Taglialatela JP, 2009, CEREB CORTEX, V19, P1151, DOI 10.1093/cercor/bhn157; TORIGOE T, 1985, Primates, V26, P182, DOI 10.1007/BF02382017; Vilensky JA, 2002, INT J PRIMATOL, V23, P1319, DOI 10.1023/A:1021135122571; WHITE LE, 1994, NATURE, V368, P197, DOI 10.1038/368197a0; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	68	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13383	10.1371/journal.pone.0013383	http://dx.doi.org/10.1371/journal.pone.0013383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967216	Green Published, gold, Green Submitted			2022-12-25	WOS:000282869800047
J	Mrkonjic, M; Roslin, NM; Greenwood, CM; Raptis, S; Pollett, A; Laird, PW; Pethe, VV; Chiang, T; Daftary, D; Dicks, E; Thibodeau, SN; Gallinger, S; Parfrey, PS; Younghusband, HB; Potter, JD; Hudson, TJ; McLaughlin, JR; Green, RC; Zanke, BW; Newcomb, PA; Paterson, AD; Bapat, B				Mrkonjic, Miralem; Roslin, Nicole M.; Greenwood, Celia M.; Raptis, Stavroula; Pollett, Aaron; Laird, Peter W.; Pethe, Vaijayanti V.; Chiang, Theodore; Daftary, Darshana; Dicks, Elizabeth; Thibodeau, Stephen N.; Gallinger, Steven; Parfrey, Patrick S.; Younghusband, H. Banfield; Potter, John D.; Hudson, Thomas J.; McLaughlin, John R.; Green, Roger C.; Zanke, Brent W.; Newcomb, Polly A.; Paterson, Andrew D.; Bapat, Bharati			Specific Variants in the MLH1 Gene Region May Drive DNA Methylation, Loss of Protein Expression, and MSI-H Colorectal Cancer	PLOS ONE			English	Article							MLH1-93G-GREATER-THAN-A PROMOTER POLYMORPHISM; MICROSATELLITE-INSTABILITY; COLON-CANCER; RISK; CHEMOTHERAPY; IMMUNOHISTOCHEMISTRY; PREDISPOSITION; 5-FLUOROURACIL; INACTIVATION; GUIDELINES	Background: We previously identified an association between a mismatch repair gene, MLH1, promoter SNP (rs1800734) and microsatellite unstable (MSI-H) colorectal cancers (CRCs) in two samples. The current study expanded on this finding as we explored the genetic basis of DNA methylation in this region of chromosome 3. We hypothesized that specific polymorphisms in the MLH1 gene region predispose it to DNA methylation, resulting in the loss of MLH1 gene expression, mismatch-repair function, and consequently to genome-wide microsatellite instability. Methodology/Principal Findings: We first tested our hypothesis in one sample from Ontario (901 cases, 1,097 controls) and replicated major findings in two additional samples from Newfoundland and Labrador (479 cases, 336 controls) and from Seattle (591 cases, 629 controls). Logistic regression was used to test for association between SNPs in the region of MLH1 and CRC, MSI-H CRC, MLH1 gene expression in CRC, and DNA methylation in CRC. The association between rs1800734 and MSI-H CRCs, previously reported in Ontario and Newfoundland, was replicated in the Seattle sample. Two additional SNPs, in strong linkage disequilibrium with rs1800734, showed strong associations with MLH1 promoter methylation, loss of MLH1 protein, and MSI-H CRC in all three samples. The logistic regression model of MSI-H CRC that included MLH1-promoter-methylation status and MLH1 immunohisotchemistry status fit most parsimoniously in all three samples combined. When rs1800734 was added to this model, its effect was not statistically significant (P-value = 0.72 vs. 2.3x10(-4) when the SNP was examined alone). Conclusions/Significance: The observed association of rs1800734 with MSI-H CRC occurs through its effect on the MLH1 promoter methylation, MLH1 IHC deficiency, or both.	[Mrkonjic, Miralem; Raptis, Stavroula; Gallinger, Steven; Bapat, Bharati] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mrkonjic, Miralem; Raptis, Stavroula; Pethe, Vaijayanti V.; Gallinger, Steven; McLaughlin, John R.; Bapat, Bharati] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Mrkonjic, Miralem; Raptis, Stavroula; Pollett, Aaron; Bapat, Bharati] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Roslin, Nicole M.; Greenwood, Celia M.; Chiang, Theodore; Paterson, Andrew D.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Greenwood, Celia M.; McLaughlin, John R.; Paterson, Andrew D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Laird, Peter W.] Univ So Calif, Univ So Calif Epigenome Ctr, Los Angeles, CA USA; [Daftary, Darshana; Gallinger, Steven; McLaughlin, John R.; Zanke, Brent W.] Canc Care Ontario, Ontario Familial Colorectal Canc Registry, Toronto, ON, Canada; [Dicks, Elizabeth; Parfrey, Patrick S.] Mem Univ Newfoundland, Clin Epidemiol Unit, St John, NF, Canada; [Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Gallinger, Steven] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Younghusband, H. Banfield; Green, Roger C.] Mem Univ Newfoundland, Discipline Genet, St John, NF, Canada; [Potter, John D.; Newcomb, Polly A.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Zanke, Brent W.] Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Southern California; Cancer Care Ontario; Memorial University Newfoundland; Mayo Clinic; University of Toronto; Memorial University Newfoundland; Fred Hutchinson Cancer Center; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute	Mrkonjic, M (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	bapat@lunenfeld.ca	Gallinger, Steven/E-4575-2013; Bapat, Bharati/B-5839-2014; Pollett, Aaron/AAQ-2540-2021; Laird, Peter W/G-8683-2012; Paterson, Andrew D/A-4088-2011; Pollett, Aaron/J-2308-2016; McLaughlin, John R/E-4577-2013; Paterson, Andrew/AAQ-7511-2020	Pollett, Aaron/0000-0001-5121-8788; Laird, Peter W/0000-0001-9117-3641; Paterson, Andrew D/0000-0002-9169-118X; Pollett, Aaron/0000-0001-5121-8788; Paterson, Andrew/0000-0002-9169-118X; Potter, John/0000-0001-5439-1500; Greenwood, Celia/0000-0002-2427-5696; Roslin, Nicole/0000-0002-4609-8299	Canadian Institutes of Health Research (CIHR) [CRT-43821]; National Cancer Institute, National Institutes of Health [CA-95-011, U01 CA074783, U24 CA074794]; Genome Canada; Ontario Institute for Cancer Research; Ontario Ministry of Research and Innovation; American Institute for Cancer Research [99B055]; National Cancer Institute of Canada [018668]; Samuel Lunenfeld Research Institute; Team in Interdisciplinary Research on Colorectal Cancer; NATIONAL CANCER INSTITUTE [U24CA074794, U01CA074783, U24CA074783, K22CA095011, U01CA074794, R01CA118699] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genome Canada(Genome Canada); Ontario Institute for Cancer Research; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); American Institute for Cancer Research; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Samuel Lunenfeld Research Institute; Team in Interdisciplinary Research on Colorectal Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Team Grant from the Canadian Institutes of Health Research (CIHR grant CRT-43821 to J.M., B. B., J.K., S. G., R. G., P. P. and B.Y.). In addition, this work was supported by the National Cancer Institute, National Institutes of Health under Request For Applications CA-95-011 and through cooperative agreements with members of the colon family registry and Principal Investigators (U01 CA074783 awarded to Ontario Registry for Studies of Familial Colorectal Cancer, and U24 CA074794 awarded to Seattle Colorectal Cancer Family Registry). A. D. P. and N.R. are supported by Genome Canada. A. D. P. holds Canada Research Chair in Genetics of Complex Diseases. B.W.Z. and T.J.H. are recipients of Senior Investigator Awards from the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Research and Innovation. In addition, this work was supported in part by the American Institute for Cancer Research grant 99B055 (B. B. and J.K.). M. M. is a Research Student of the Canadian Cancer Society through an award from the National Cancer Institute of Canada (018668). M. M. was also supported by graduate studentship from the Team in Interdisciplinary Research on Colorectal Cancer with funding from the Canadian Institutes of Health Research (CIHR) and from the Samuel Lunenfeld Research Institute. All authors had full responsibility for the design of the study, the collection of data, the analysis and interpretation of the data, the decision to submit the manuscript for publication, and the writing of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Allan JM, 2008, INT J CANCER, V123, P2456, DOI 10.1002/ijc.23770; Beiner ME, 2006, CANCER EPIDEM BIOMAR, V15, P1636, DOI 10.1158/1055-9965.EPI-06-0257; Boland CR, 1998, CANCER RES, V58, P5248; CAMPBELL PT, 2008, GUT; Cappel WHDN, 2004, INT J CANCER, V109, P468, DOI 10.1002/ijc.11712; Carethers JM, 1999, GASTROENTEROLOGY, V117, P123, DOI 10.1016/S0016-5085(99)70558-5; Carethers JM, 2004, GASTROENTEROLOGY, V126, P394, DOI 10.1053/j.gastro.2003.12.023; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; Cotterchio M, 2000, Chronic Dis Can, V21, P81; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Greene FL, 2002, AJCC CANC STAGING MA; Hampel H, 2006, CANCER RES, V66, P7810, DOI 10.1158/0008-5472.CAN-06-1114; Harley I, 2008, GYNECOL ONCOL, V109, P384, DOI 10.1016/j.ygyno.2007.11.046; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hitchins MP, 2007, CANCER RES, V67, P9107, DOI 10.1158/0008-5472.CAN-07-0869; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Jenkins MA, 2007, GASTROENTEROLOGY, V133, P48, DOI 10.1053/j.gastro.2007.04.044; Jover R, 2006, GUT, V55, P848, DOI 10.1136/gut.2005.073015; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Liu J, 2005, P NATL ACAD SCI USA, V102, P1927, DOI 10.1073/pnas.0409472102; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Mrkonjic M, 2007, CARCINOGENESIS, V28, P2575, DOI 10.1093/carcin/bgm229; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Raptis S, 2007, JNCI-J NATL CANCER I, V99, P463, DOI 10.1093/jnci/djk095; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Samowitz WS, 2008, GENE CHROMOSOME CANC, V47, P835, DOI 10.1002/gcc.20584; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Wang WS, 2006, CELL MOL LIFE SCI, V63, P663, DOI 10.1007/s00018-005-5425-4; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Woods MO, 2005, CLIN CANCER RES, V11, P6853, DOI 10.1158/1078-0432.CCR-05-0726; Worrillow LJ, 2008, J MED GENET, V45, P142, DOI 10.1136/jmg.2007.053850; Yu JH, 2006, AM J GASTROENTEROL, V101, P1313, DOI 10.1111/j.1572-0241.2006.00551.x; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	41	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13314	10.1371/journal.pone.0013314	http://dx.doi.org/10.1371/journal.pone.0013314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967208	gold, Green Published, Green Accepted			2022-12-25	WOS:000282869800019
J	Badadani, M; Nalbandian, A; Watts, GD; Vesa, J; Kitazawa, M; Su, HL; Tanaja, J; Dec, E; Wallace, DC; Mukherjee, J; Caiozzo, V; Warman, M; Kimonis, VE				Badadani, Mallikarjun; Nalbandian, Angele; Watts, Giles D.; Vesa, Jouni; Kitazawa, Masashi; Su, Hailing; Tanaja, Jasmin; Dec, Eric; Wallace, Douglas C.; Mukherjee, Jogeshwar; Caiozzo, Vincent; Warman, Matthew; Kimonis, Virginia E.			VCP Associated Inclusion Body Myopathy and Paget Disease of Bone Knock-In Mouse Model Exhibits Tissue Pathology Typical of Human Disease	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; AAA-ATPASE; ENDOPLASMIC-RETICULUM; FRONTOTEMPORAL DEMENTIA; AUTOPHAGIC VACUOLES; CELL-DEATH; UBIQUITIN; P97; EXPRESSION; VCP/P97	Dominant mutations in the valosin containing protein (VCP) gene cause inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia (IBMPFD). We have generated a knock-in mouse model with the common R155H mutation. Mice demonstrate progressive muscle weakness starting approximately at the age of 6 months. Histology of mutant muscle showed progressive vacuolization of myofibrils and centrally located nuclei, and immunostaining shows progressive cytoplasmic accumulation of TDP-43 and ubiquitin-positive inclusion bodies in quadriceps myofibrils and brain. Increased LC3-II staining of muscle sections representing increased number of autophagosomes suggested impaired autophagy. Increased apoptosis was demonstrated by elevated caspase-3 activity and increased TUNEL-positive nuclei. Xray microtomography (uCT) images show radiolucency of distal femurs and proximal tibiae in knock-in mice and uCT morphometrics shows decreased trabecular pattern and increased cortical wall thickness. Bone histology and bone marrow derived macrophage cultures in these mice revealed increased osteoclastogenesis observed by TRAP staining suggestive of Paget bone disease. The VCP R155H/+ knock-in mice replicate the muscle, bone and brain pathology of inclusion body myopathy, thus representing a useful model for preclinical studies.	[Badadani, Mallikarjun; Nalbandian, Angele; Vesa, Jouni; Su, Hailing; Tanaja, Jasmin; Dec, Eric; Wallace, Douglas C.; Kimonis, Virginia E.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Watts, Giles D.] Harvard Univ, Sch Med, Dept Orthoped Surg, Childrens Hosp Boston, Boston, MA 02115 USA; [Kitazawa, Masashi] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Wallace, Douglas C.] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA USA; [Wallace, Douglas C.] Univ Calif Irvine, Dept Ecol, Irvine, CA USA; [Wallace, Douglas C.] Univ Calif Irvine, Dept Evolutionary Biol, Irvine, CA USA; [Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Mukherjee, Jogeshwar] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Caiozzo, Vincent] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Caiozzo, Vincent] Univ Calif Irvine, Dept Orthoped, Irvine, CA USA; [Warman, Matthew] Harvard Univ, Sch Med, Dept Genet, Childrens Hosp Boston, Boston, MA USA; [Watts, Giles D.] Univ E Anglia, Sch Med Hlth Policy & Practice, Dept Cell Biol & Biochem, Norwich NR4 7TJ, Norfolk, England	University of California System; University of California Irvine; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Harvard University; Boston Children's Hospital; Harvard Medical School; University of East Anglia	Badadani, M (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA.	vkimonis@uci.edu	Kitazawa, Masashi/AAI-1721-2021; Mukherjee, Jogeshwar/O-1320-2013	Kitazawa, Masashi/0000-0003-2165-8197; Mukherjee, Jogeshwar/0000-0003-1009-877X	National Institutes of Health [R01 AR050236, 1K01AR056002-01A2]; MicroCT [S10 RR024546]; Muscular Dystrophy Association; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR056002, R01AR050236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MicroCT; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health [R01 AR050236 to VEK], [S10 RR024546 for MicroCT to JM] and the Muscular Dystrophy Association [Development grant to JV] and NIH 1K01AR056002-01A2 [GW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2000, BRIT J RADIOL, V73, P1078, DOI 10.1259/bjr.73.874.11271900; Arnold SE, 2000, NEUROBIOL AGING, V21, P913, DOI 10.1016/S0197-4580(00)00173-1; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bergamini E, 2007, ANN NY ACAD SCI, V1114, P69, DOI 10.1196/annals.1396.020; Bernardi P, 1999, ITAL J NEUROL SCI, V20, P395; Boya P, 2002, CELL DEATH DIFFER, V9, P465, DOI 10.1038/sj.cdd.4401006; Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; FARBER JL, 1994, ENVIRON HEALTH PERSP, V102, P17, DOI 10.2307/3432207; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Galluzzi L, 2008, CURR MOL MED, V8, P78; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Jarosch E, 2002, TRAFFIC, V3, P530, DOI 10.1034/j.1600-0854.2002.30803.x; JU JS, HUM MOL GENET; Kimonis V., 2007, INCLUSION BODY MYOPA; Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, pS44, DOI 10.1097/01.wad.0000183081.76820.5a; Kimonis VE, 2000, GENET MED, V2, P232, DOI 10.1097/00125817-200007000-00006; Kimonis VE, 2008, BIOCH BIOPHYS ACTA; Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; Leon A, 1999, MOL BIOL CELL, V10, P3825, DOI 10.1091/mbc.10.11.3825; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Muller JMM, 1999, J BIOL CHEM, V274, P10154, DOI 10.1074/jbc.274.15.10154; Mumby DG, 2002, BEHAV BRAIN RES, V132, P215, DOI 10.1016/S0166-4328(01)00444-2; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Nishino Ichizo, 2003, Curr Neurol Neurosci Rep, V3, P64, DOI 10.1007/s11910-003-0040-y; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Okere CO, 2000, BRAIN RES, V877, P85, DOI 10.1016/S0006-8993(00)02656-1; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; SCHNEIDER R, 1979, ORTHOPADE, V8, P79; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Stypmann J, 2006, BASIC RES CARDIOL, V101, P281, DOI 10.1007/s00395-006-0591-6; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Turner RS, 1996, ANN NEUROL, V39, P166, DOI 10.1002/ana.410390205; VANSWIETEN JC, 2007, GENEREVIEWS; Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Watts GDJ, 2003, NEUROMUSCULAR DISORD, V13, P559, DOI 10.1016/S0960-8966(03)00070-1; Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhukareva V, 2001, ANN NEUROL, V49, P165, DOI 10.1002/1531-8249(20010201)49:2<165::AID-ANA36>3.0.CO;2-3; Zwickl P, 1999, NAT CELL BIOL, V1, pE97, DOI 10.1038/12097	64	87	90	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13183	10.1371/journal.pone.0013183	http://dx.doi.org/10.1371/journal.pone.0013183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957154	Green Published, gold, Green Submitted			2022-12-25	WOS:000282506100013
J	Ruangchan, N; Tongsook, C; Sucharitakul, J; Chaiyen, P				Ruangchan, Nantidaporn; Tongsook, Chanakan; Sucharitakul, Jeerus; Chaiyen, Pimchai			pH-dependent Studies Reveal an Efficient Hydroxylation Mechanism of the Oxygenase Component of p-Hydroxyphenylacetate 3-Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHENOL 4-MONOOXYGENASE TFTD; HYDROXYBENZOATE HYDROXYLASE; 4-HYDROXYPHENYLACETATE 3-MONOOXYGENASE; ALKANESULFONATE MONOOXYGENASE; ACINETOBACTER-BAUMANNII; STYRENE MONOOXYGENASE; OXIDOREDUCTASE TFTC; PHENOL HYDROXYLASE; CRYSTAL-STRUCTURES; FLAVIN REDUCTASE	p-Hydroxyphenylacetate (HPA) 3-hydroxylase (HPAH) catalyzes the hydroxylation of HPA at the ortho-position to yield 3,4-dihydroxyphenylacetate. The enzyme is a flavin-dependent two-component monooxygenase that consists of a reductase component and an oxygenase component (C-2). C-2 catalyzes the hydroxylation of HPA using oxygen and reduced FMN as co-substrates. To date, the effects of pH on the oxygenation of the two-component monooxygenases have never been reported. Here, we report the reaction kinetics of C-2 center dot FMNH- with oxygen at various pH values investigated by stopped-flow and rapid quenched-flow techniques. In the absence of HPA, the rate constant for the formation of C4a-hydroperoxy-FMN (similar to 1.1 x 10(6) M(-1)s(-1)) was unaffected at pH 6.2-9.9, which indicated that the pK(a) of the enzyme-bound reduced FMN was less than 6.2. The rate constant for the following H2O2 elimination step increased with higher pH, which is consistent with a pK(a) of >9.4. In the presence of HPA, the rate constants for the formation of C4a-hydroperoxy-FMN (similar to 4.8 x 10(4) M(-1)s(-1)) and the ensuing hydroxylation step (15-17 s(-1)) were not significantly affected by the pH. In contrast, the following steps of C4a-hydroxy-FMN dehydration to form oxidized FMN occurred through two pathways that were dependent on the pH of the reaction. One pathway, dominant at low pH, allowed the detection of a C4a-hydroxy-FMN intermediate, whereas the pathway dominant at high pH produced oxidized FMN without an apparent accumulation of the intermediate. However, both pathways efficiently catalyzed hydroxylation without generating significant amounts of wasteful H2O2 at pH 6.2-9.9. The decreased accumulation of the intermediate at higher pH was due to the greater rates of C4a-hydroxy-FMN decay caused by the abolishment of substrate inhibition in the dehydration step at high pH.	[Ruangchan, Nantidaporn; Tongsook, Chanakan; Chaiyen, Pimchai] Mahidol Univ, Dept Biochem, Bangkok 10400, Thailand; [Ruangchan, Nantidaporn; Tongsook, Chanakan; Chaiyen, Pimchai] Mahidol Univ, Ctr Excellence Prot Struct & Funct, Fac Sci, Bangkok 10400, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Dept Biochem, Fac Sci, Bangkok 10330, Thailand	Mahidol University; Mahidol University; Chulalongkorn University	Chaiyen, P (corresponding author), Mahidol Univ, Dept Biochem, Rama 6 Rd, Bangkok 10400, Thailand.	scpcy@mahidol.ac.th	Chaiyen, Pimchai/R-5052-2019	Chaiyen, Pimchai/0000-0002-8533-1604	Thailand Research Fund [BRG5180002, MRG5380240]; Faculty of Science, Mahidol University; Development and Promotion of Science and Technology Talents Project (Thailand)	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Development and Promotion of Science and Technology Talents Project (Thailand)	This work was supported by Grants BRG5180002 (to P. C.) and MRG5380240 (to J. S.) from the Thailand Research Fund and a grant from the Faculty of Science, Mahidol University (to P. C.).; Supported by the Development and Promotion of Science and Technology Talents Project (Thailand).	Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; ARUNACHALAM U, 1994, J BIOL CHEM, V269, P150; ARUNACHALAM U, 1992, J BIOL CHEM, V267, P25848; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; Chaiyen P, 2004, BIOCHEMISTRY-US, V43, P3933, DOI 10.1021/bi035734d; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P13856, DOI 10.1021/bi9715122; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P8060, DOI 10.1021/bi970089u; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u; Crozier-Reabe KR, 2008, BIOCHEMISTRY-US, V47, P12420, DOI 10.1021/bi8010434; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; EBERLEIN G, 1983, J AM CHEM SOC, V105, P6685, DOI 10.1021/ja00360a024; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007; ENTSCH B, 1991, J BIOL CHEM, V266, P17341; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; EVANS MG, 1949, T FARADAY SOC, V45, P224, DOI 10.1039/tf9494500224; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; GUNSALUSMIGUEL A, 1972, J BIOL CHEM, V247, P398; Heemstra JR, 2008, J AM CHEM SOC, V130, P14024, DOI 10.1021/ja806467a; ISHIMITSU T, 1979, TALANTA, V26, P67, DOI 10.1016/0039-9140(79)80160-5; Kantz A, 2005, ARCH BIOCHEM BIOPHYS, V442, P102, DOI 10.1016/j.abb.2005.07.020; Kim SH, 2007, J BIOL CHEM, V282, P33107, DOI 10.1074/jbc.M703440200; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Koskiniemi H, 2007, J MOL BIOL, V372, P633, DOI 10.1016/j.jmb.2007.06.087; Lin SJ, 2008, J AM CHEM SOC, V130, P6616, DOI 10.1021/ja710601d; Macheroux Peter, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091/6/26; MAEDAYORITA K, 1993, J BIOL CHEM, V268, P4134; MERENYI G, 1991, J AM CHEM SOC, V113, P3146, DOI 10.1021/ja00008a051; Neumann CS, 2010, P NATL ACAD SCI USA, V107, P5798, DOI 10.1073/pnas.1001681107; Okai M, 2006, BIOCHEMISTRY-US, V45, P5103, DOI 10.1021/bi052313i; Ortiz-Maldonado M, 2004, BIOCHEMISTRY-US, V43, P15246, DOI 10.1021/bi048115t; Ortiz-Maldonado M, 1999, BIOCHEMISTRY-US, V38, P8124, DOI 10.1021/bi990560e; Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004; Palfey B. A., 1995, ACTIVE OXYGEN BIOCH, P37, DOI DOI 10.1007/978-94-011-0609-2_2; Palfey B. A., 1998, COMPREHENSIVE BIOL C, VIII, P83; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Pazmino DET, 2008, BIOCHEMISTRY-US, V47, P4082, DOI 10.1021/bi702296k; Perry LL, 2007, J BACTERIOL, V189, P7563, DOI 10.1128/JB.01849-06; POWLOWSKI J, 1989, J BIOL CHEM, V264, P16008; SCHOPFER LM, 1980, J BIOL CHEM, V255, P5355; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Suadee C, 2007, J BIOCHEM, V142, P539, DOI 10.1093/jb/mvm155; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Suske WA, 1999, J BIOL CHEM, V274, P33355, DOI 10.1074/jbc.274.47.33355; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; Tischler D, 2009, J BACTERIOL, V191, P4996, DOI 10.1128/JB.00307-09; Valton J, 2006, J BIOL CHEM, V281, P27, DOI 10.1074/jbc.M506146200; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van Hellemond EW, 2007, APPL ENVIRON MICROB, V73, P5832, DOI 10.1128/AEM.02708-06; VENKATARAM UV, 1984, J CHEM SOC CHEM COMM, P899, DOI 10.1039/c39840000899; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135; Witschel M, 1997, J BACTERIOL, V179, P6937, DOI 10.1128/jb.179.22.6937-6943.1997; Xun LY, 2004, J BIOL CHEM, V279, P6696, DOI 10.1074/jbc.M312072200; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d; Zhan X, 2008, BIOCHEMISTRY-US, V47, P2221, DOI 10.1021/bi701853w	65	40	41	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					223	233		10.1074/jbc.M110.163881	http://dx.doi.org/10.1074/jbc.M110.163881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21030590	hybrid, Green Published			2022-12-25	WOS:000285782800025
J	Gaudy, AM; Clementi, AH; Campbell, JS; Smrcka, AV; Mooney, RA				Gaudy, Allison M.; Clementi, Alicia H.; Campbell, Jean S.; Smrcka, Alan V.; Mooney, Robert A.			Suppressor of Cytokine Signaling-3 Is a Glucagon-inducible Inhibitor of PKA Activity and Gluconeogenic Gene Expression in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-A; SOCS-BOX MOTIF; INSULIN-RESISTANCE; CYCLIC-AMP; HEPATIC GLUCONEOGENESIS; PHOSPHOLIPASE-C; ADIPOSE-TISSUE; FACTOR-ALPHA; TYROSINE PHOSPHORYLATION	SOCS3 is a cytokine-inducible negative regulator of cytokine receptor signaling. Recently, SOCS3 was shown to be induced by a cAMP-dependent pathway involving exchange protein directly activated by cAMP (Epac). We observed in livers of fasted mice that Socs3 mRNA was increased 4-fold compared with refed mice, suggesting a physiologic role for SOCS3 in the fasted state that may involve glucagon and Epac. Treating primary hepatocytes with glucagon resulted in a 4-fold increase in Socs3 mRNA levels. The Epac-selective cAMP analog 8-4-(chlorophenylthio)-2'-O-methyladenosine-3',5'-monophosphate, acetoxymethyl ester (cpTOME) increased Socs3 expression comparably. In gain-of-function studies, adenoviral expression of SOCS3 in primary hepatocytes caused a 50% decrease in 8-br-cAMP-dependent PKA phosphorylation of the transcription factor CREB. Induction of the gluconeogenic genes Ppargc1a, Pck1, and G6pc by glucagon or 8-br-cAMP was suppressed nearly 50%. In loss-of-function studies, hepatocytes from liver-specific SOCS3 knock-out mice responded to 8-br-cAMP with a 200% greater increase in Ppargc1a and Pck1 expression, and a 30% increase in G6pc expression, relative to wild-type cells. Suppression of SOCS3 by shRNA in hepatocytes resulted in a 60% increase in cAMP-dependent G6pc and Pck1 expression relative to control cells. SOCS3 expression also inhibited cAMP-dependent phosphorylation of the IP3 receptor but did not inhibit nuclear localization of the catalytic subunit of PKA. Using an in vitro kinase assay, cAMP-dependent PKA activity was reduced by 80% in hepatocytes expressing ectopic SOCS3. These data indicate that cAMP activates both the PKA and Epac pathways with induction of SOCS3 by the Epac pathway negatively regulating the PKA pathway.	[Clementi, Alicia H.; Mooney, Robert A.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Gaudy, Allison M.; Smrcka, Alan V.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Campbell, Jean S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Rochester; University of Rochester; University of Washington; University of Washington Seattle	Mooney, RA (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, 601 Elmwood Ave, Rochester, NY 14642 USA.	Robert_Mooney@urmc.rochester.edu		Campbell, Jean/0000-0002-9187-2204	American Diabetes Association [7-04-RA-78]; United States Public Health Service [R01-DK060732, R01-GM053536]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a Research Grant from the American Diabetes Association (7-04-RA-78) (to R. A. M.). Additional support was provided by United States Public Health Service Grants R01-DK060732 (to R. A. M.) and R01-GM053536 (to A. V. S.).	Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Aromataris EC, 2006, J PHYSIOL-LONDON, V573, P611, DOI 10.1113/jphysiol.2006.109819; Barradeau S, 2002, TRENDS CARDIOVAS MED, V12, P235, DOI 10.1016/S1050-1738(02)00167-6; Borland G, 2009, J BIOL CHEM, V284, P17391, DOI 10.1074/jbc.M109.015370; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dunphy JL, 1998, MOL CELL ENDOCRINOL, V141, P179, DOI 10.1016/S0303-7207(98)00096-3; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Giacca A, 1997, ENDOCRINOLOGY, V138, P999, DOI 10.1210/en.138.3.999; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GOODMAN MN, 1980, AM J PHYSIOL, V239, pE269; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Ishizuka K, 2007, ENDOCRINOLOGY, V148, P2994, DOI 10.1210/en.2006-1702; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Lewis GF, 1997, AM J PHYSIOL-ENDOC M, V272, pE371, DOI 10.1152/ajpendo.1997.272.3.E371; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lubis Adisaputra Ramadhinara, 2008, Acta Med Indones, V40, P89; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Sands WA, 2006, MOL CELL BIOL, V26, P6333, DOI 10.1128/MCB.00207-06; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Senn JJ, 2002, DIABETES, V51, pA303; Starr R, 1998, INT J BIOCHEM CELL B, V30, P1081, DOI 10.1016/S1357-2725(98)00067-3; Sun XJ, 1999, DIABETES, V48, P1359, DOI 10.2337/diabetes.48.7.1359; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Thoresen GH, 1999, CELL BIOL INT, V23, P13, DOI 10.1006/cbir.1998.0314; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Ueno H, 2001, GENOMICS, V78, P91, DOI 10.1006/geno.2001.6641; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wang ZW, 2001, FASEB J, V15, P108, DOI 10.1096/fj.00-0310com; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Woolson HD, 2009, CELL SIGNAL, V21, P1706, DOI 10.1016/j.cellsig.2009.07.009; Yarwood SJ, 2008, J BIOL CHEM, V283, P6843, DOI 10.1074/jbc.M710342200; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	64	13	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41356	41365		10.1074/jbc.M110.159111	http://dx.doi.org/10.1074/jbc.M110.159111			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20978125	hybrid, Green Published			2022-12-25	WOS:000285622600021
J	Kajimoto, T; Sawamura, S; Tohyama, Y; Mori, Y; Newton, AC				Kajimoto, Taketoshi; Sawamura, Seishiro; Tohyama, Yumi; Mori, Yasuo; Newton, Alexandra C.			Protein Kinase C delta-specific Activity Reporter Reveals Agonist-evoked Nuclear Activity Controlled by Src Family of Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; ENCODED FLUORESCENT REPORTER; ESTER-INDUCED APOPTOSIS; PKC-DELTA; TYROSINE PHOSPHORYLATION; SPATIOTEMPORAL DYNAMICS; GROWTH-FACTOR; ACTIVATION; TRANSLOCATION; DIACYLGLYCEROL	Conventional and novel protein kinase C (PKC) isozymes transduce the abundance of signals mediated by phospholipid hydrolysis; however redundancy in regulatory mechanisms confounds dissecting the unique signaling properties of each of the eight isozymes constituting these two subgroups. Previously, we created a genetically encoded reporter (C kinase activity reporter (CKAR)) to visualize the rate, amplitude, and duration of agonist-evoked PKC signaling at specific locations within the cell. Here we designed a reporter, delta CKAR, that specifically measures the activation signature of one PKC isozyme, PKC delta, in cells, revealing unique spatial and regulatory properties of this isozyme. Specifically, we show two mechanisms of activation: 1) agonist-stimulated activation at the plasma membrane (the site of most robust PKC delta signaling), Golgi, and mitochondria that is independent of Src and can be triggered by phorbol esters and 2) agonist-stimulated activation in the nucleus that requires Src kinase activation and cannot be triggered by phorbol esters. Translocation studies reveal that the G-protein-coupled receptor agonist UTP induces the translocation of PKC delta into the nucleus by a mechanism that depends on the C2 domain and requires Src kinase activity. However, translocation from the cytosol into the nucleus is not required for the Src-dependent regulation of nuclear activity; a construct of PKC delta prelocalized to the nucleus continues to be activated by UTP by a mechanism dependent on Src kinase activity. These data identify the nucleus as a signaling hub for PKC delta that is driven by receptor-mediated signaling pathways (but not phorbol esters) and differs from signaling at plasma membrane and Golgi in that it is controlled by Src family kinases.	[Kajimoto, Taketoshi; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kajimoto, Taketoshi; Sawamura, Seishiro; Mori, Yasuo] Kyoto Univ, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Tohyama, Yumi] Himeji Dokkyo Univ, Div Biochem, Fac Pharmaceut Sci, Himeji, Hyogo 6708524, Japan	University of California System; University of California San Diego; Kyoto University; Himeji Dokkyo University	Newton, AC (corresponding author), 9500 Gilman Dr 0721, La Jolla, CA 92093 USA.	anewton@ucsd.edu			National Institutes of Health [P01 DK54441, GM 43154]; JSPS, Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [20249015] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043154, R01GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS, Uehara Memorial Foundation(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceUehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 DK54441 and GM 43154 (to A.C.N.). This work was also supported by a grant-in-aid for Japan Society for the Promotion of Science (JSPS) Fellows from the JSPS, Uehara Memorial Foundation (to T.K.).	Bailey K, 2005, BBA-MOL CELL BIOL L, V1733, P199, DOI 10.1016/j.bbalip.2004.12.013; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gallegos LL, 2008, IUBMB LIFE, V60, P782, DOI 10.1002/iub.122; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Greene MW, 2006, BIOCHEM BIOPH RES CO, V349, P976, DOI 10.1016/j.bbrc.2006.08.158; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hamaguchi A, 2003, J BIOL CHEM, V278, P41557, DOI 10.1074/jbc.M305294200; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Humphries MJ, 2008, ONCOGENE, V27, P3045, DOI 10.1038/sj.onc.1210967; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Kajimoto T, 2004, J BIOL CHEM, V279, P12668, DOI 10.1074/jbc.M312350200; Kajimoto T, 2001, MOL CELL BIOL, V21, P1769, DOI 10.1128/MCB.21.5.1769-1783.2001; KIELBASSA K, 1995, J BIOL CHEM, V270, P6156, DOI 10.1074/jbc.270.11.6156; Kunkel M. T., 2010, CURR PROT CHEM BIOL, V1, P17; Kunkel MT, 2010, J BIOL CHEM, V285, P22746, DOI 10.1074/jbc.C110.123133; Kunkel MT, 2009, J BIOL CHEM, V284, P24653, DOI 10.1074/jbc.M109.024547; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Lakshmi S, 2006, NEUROSCIENCE, V141, P179, DOI 10.1016/j.neuroscience.2006.03.074; Li LW, 1999, MOL CELL BIOL, V19, P8547; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; MURRAY NR, 1994, J BIOL CHEM, V269, P21385; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Nguyen T, 2008, J BIOL CHEM, V283, P29831, DOI 10.1074/jbc.M801642200; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Peterson TS, 2010, MOL NEUROBIOL, V41, P356, DOI 10.1007/s12035-010-8115-7; Qi X, 2008, J CELL SCI, V121, P804, DOI 10.1242/jcs.024653; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Reyland ME, 2000, CELL DEATH DIFFER, V7, P1200, DOI 10.1038/sj.cdd.4400744; Ryu J, 2002, ARCH BIOCHEM BIOPHYS, V403, P71, DOI 10.1016/S0003-9861(02)00261-8; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Bilbao PS, 2010, ARCH BIOCHEM BIOPHYS, V499, P40, DOI 10.1016/j.abb.2010.05.001; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Violin JD, 2003, IUBMB LIFE, V55, P653, DOI 10.1080/152165401310001642216; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; von Burstin VA, 2010, MOL PHARMACOL, V78, P325, DOI 10.1124/mol.110.064741; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	50	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41896	41910		10.1074/jbc.M110.184028	http://dx.doi.org/10.1074/jbc.M110.184028			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959447	Green Published, hybrid			2022-12-25	WOS:000285622600077
J	Skovierova, H; Larrouy-Maumus, G; Pham, H; Belanova, M; Barilone, N; DasGupta, A; Mikusova, K; Gicquel, B; Gilleron, M; Brennan, PJ; Puzo, G; Nigou, J; Jackson, M				Skovierova, Henrieta; Larrouy-Maumus, Gerald; Pham, Ha; Belanova, Martina; Barilone, Nathalie; DasGupta, Arunava; Mikusova, Katarina; Gicquel, Brigitte; Gilleron, Martine; Brennan, Patrick. J.; Puzo, Germain; Nigou, Jerome; Jackson, Mary			Biosynthetic Origin of the Galactosamine Substituent of Arabinogalactan in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY-ELECTROPHORESIS; CELL-WALL; MYCOTHIOL; SMEGMATIS; GLYCOSYLTRANSFERASES; LIPOPOLYSACCHARIDES; LIPOARABINOMANNANS; IDENTIFICATION; DEACETYLASE; SYNTHASE	The arabinogalactan (AG) of slow growing pathogenic Mycobacterium spp. is characterized by the presence of galactosamine (GalN) modifying some of the interior branched arabinosyl residues. The biosynthetic origin of this substituent and its role(s) in the physiology and/or pathogenicity of mycobacteria are not known. We report on the discovery of a polyprenyl-phospho-N-acetylgalactosaminyl synthase (PpgS) and the glycosyltransferase Rv3779 from Mycobacterium tuberculosis required, respectively, for providing and transferring the GalN substrate for the modification of AG. Disruption of either ppgS (Rv3631) or Rv3779 totally abolished the synthesis of the GalN substituent of AG in M. tuberculosis H37Rv. Conversely, expression of ppgS in Mycobacterium smegmatis conferred upon this species otherwise devoid of ppgS ortholog and any detectable polyprenyl-phospho-N-acetylgalactosaminyl synthase activity the ability to synthesize polyprenyl-phospho-N-acetylgalactosamine (polyprenyl-P-GalNAc) from polyprenyl-P and UDP-GalNAc. Interestingly, this catalytic activity was increased 40-50-fold by co-expressing Rv3632, the encoding gene of a small membrane protein apparently co-transcribed with ppgS in M. tuberculosis H37Rv. The discovery of this novel lipid-linked sugar donor and the involvement of a the glycosyltransferase C-type glycosyltransferase in its transfer onto its final acceptor suggest that pathogenic mycobacteria modify AG on the periplasmic side of the plasma membrane. The availability of a ppgS knock-out mutant of M. tuberculosis provides unique opportunities to investigate the physiological function of the GalN substituent and the potential impact it may have on host-pathogen interactions.	[Larrouy-Maumus, Gerald; Gilleron, Martine; Puzo, Germain; Nigou, Jerome] CNRS, IPBS, Dept Mecanisms Mol Infect Mycobacteriennes, F-31077 Toulouse, France; [Brennan, Patrick. J.] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Larrouy-Maumus, Gerald; Gilleron, Martine; Puzo, Germain; Nigou, Jerome] Univ Toulouse 3, Univ Toulouse, IPBS, F-31077 Toulouse, France; [Belanova, Martina; Mikusova, Katarina] Comenius Univ, Dept Biochem, Fac Nat Sci, Bratislava 84215, Slovakia; [Barilone, Nathalie; DasGupta, Arunava; Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Colorado State University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Comenius University Bratislava; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nigou, J (corresponding author), CNRS, IPBS, Dept Mecanisms Mol Infect Mycobacteriennes, 205 Route Narbonne, F-31077 Toulouse, France.	Jerome.Nigou@ipbs.fr; Mary.Jackson@colostate.edu	Brennan, Patrick J/G-6896-2017; Mikusova, Katarina/I-3622-2014; Nigou, Jérôme/D-6802-2019; Jackson, Mary/D-5345-2017	Nigou, Jérôme/0000-0002-6233-2487; Jackson, Mary/0000-0002-9212-0258; Mikusova, Katarina/0000-0002-0100-4877; GILLERON, Martine/0000-0002-2581-3302; Larrouy-Maumus, Gerald/0000-0001-6614-8698	National Institutes of Health through the NIAID [AI064798, AI018357, R37 AI18357]; AIDS-Fogarty International Research Collaboration Award [TW 006487]; FOGARTY INTERNATIONAL CENTER [R03TW006487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI018357, R01AI064798, R37AI018357, R01AI018357] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AIDS-Fogarty International Research Collaboration Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI064798 and AI018357 through the NIAID. This work was also supported by AIDS-Fogarty International Research Collaboration Award Grant TW 006487 and its parent National Institutes of Health Grant R37 AI18357 through the NIAID.	ACHARYA PVN, 1970, J BACTERIOL, V102, P733, DOI 10.1128/JB.102.3.733-739.1970; Baulard AR, 2003, J BIOL CHEM, V278, P2242, DOI 10.1074/jbc.M207922200; BEER W, 1986, J BASIC MICROB, V26, P201, DOI 10.1002/jobm.3620260405; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Bhamidi S, 2008, J BIOL CHEM, V283, P12992, DOI 10.1074/jbc.M800222200; Buchmeier NA, 2003, MOL MICROBIOL, V47, P1723, DOI 10.1046/j.1365-2958.2003.03416.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHIU TH, 1988, BIOCHIM BIOPHYS ACTA, V963, P359, DOI 10.1016/0005-2760(88)90302-5; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Dinadayala P, 2006, J BIOL CHEM, V281, P20027, DOI 10.1074/jbc.M603395200; DRAPER P, 1971, J GEN MICROBIOL, V69, P313, DOI 10.1099/00221287-69-3-313; Draper P, 1997, BIOCHEM J, V327, P519, DOI 10.1042/bj3270519; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee A, 2006, BIOCHEMISTRY-US, V45, P15817, DOI 10.1021/bi060688d; Ludwiczak P, 2001, ANAL CHEM, V73, P2323, DOI 10.1021/ac001368h; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; Newton GL, 2006, PROTEIN EXPRES PURIF, V47, P542, DOI 10.1016/j.pep.2006.03.003; Newton GL, 2000, J BACTERIOL, V182, P6958, DOI 10.1128/JB.182.24.6958-6963.2000; Nigou J, 2000, J MOL BIOL, V299, P1353, DOI 10.1006/jmbi.2000.3821; Nigou J, 1997, J BIOL CHEM, V272, P23094, DOI 10.1074/jbc.272.37.23094; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; PFANNENSTIEL MA, 1987, J BACTERIOL, V169, P796, DOI 10.1128/jb.169.2.796-801.1987; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Scherman H, 2009, J BACTERIOL, V191, P6769, DOI 10.1128/JB.00431-09; SCHULTZ J, 1974, ARCH BIOCHEM BIOPHYS, V160, P311, DOI 10.1016/S0003-9861(74)80039-1; SONESSON A, 1994, MICROBIOL-SGM, V140, P2663, DOI 10.1099/00221287-140-10-2663; Song F, 2009, BIOCHEMISTRY-US, V48, P1173, DOI 10.1021/bi802212t; Wang XY, 2009, BIOCHEMISTRY-US, V48, P1162, DOI 10.1021/bi802211k; WOLUCKA BA, 1994, J BIOL CHEM, V269, P23328; YOKOYAMA K, 1989, J BIOL CHEM, V264, P21621	34	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41348	41355		10.1074/jbc.M110.188110	http://dx.doi.org/10.1074/jbc.M110.188110			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21030587	hybrid, Green Published			2022-12-25	WOS:000285622600020
J	Brown, K; Doss, MX; Legros, S; Artus, J; Hadjantonakis, AK; Foley, AC				Brown, Kemar; Doss, Michael Xavier; Legros, Stephanie; Artus, Jerome; Hadjantonakis, Anna-Katerina; Foley, Ann C.			eXtraembryonic ENdoderm (XEN) Stem Cells Produce Factors that Activate Heart Formation	PLOS ONE			English	Article							AVIAN PREGASTRULA EPIBLAST; ACID-METABOLIZING ENZYME; RETINOIC-ACID; CARDIOMYOCYTE DIFFERENTIATION; CARDIAC DIFFERENTIATION; EMBRYONIC HEART; OPPOSING FGF; INDUCTION; EXPRESSION; MOUSE	Background: Initial specification of cardiomyocytes in the mouse results from interactions between the extraembryonic anterior visceral endoderm (AVE) and the nascent mesoderm. However the mechanism by which AVE activates cardiogenesis is not well understood, and the identity of specific cardiogenic factors in the endoderm remains elusive. Most mammalian studies of the cardiogenic potential of the endoderm have relied on the use of cell lines that are similar to the heart-inducing AVE. These include the embryonal-carcinoma-derived cell lines, END2 and PYS2. The recent development of protocols to isolate eXtraembryonic ENdoderm (XEN) stem cells, representing the extraembryonic endoderm lineage, from blastocyst stage mouse embryos offers new tools for the genetic dissection of cardiogenesis. Methodology/Principal Findings: Here, we demonstrate that XEN cell-conditioned media (CM) enhances cardiogenesis during Embryoid Body (EB) differentiation of mouse embryonic stem (ES) cells in a manner comparable to PYS2-CM and END2-CM. Addition of CM from each of these three cell lines enhanced the percentage of EBs that formed beating areas, but ultimately, only XEN-CM and PYS2-CM increased the total number of cardiomyocytes that formed. Furthermore, our observations revealed that both contact-independent and contact-dependent factors are required to mediate the full cardiogenic potential of the endoderm. Finally, we used gene array comparison to identify factors in these cell lines that could mediate their cardiogenic potential. Conclusions/Significance: These studies represent the first step in the use of XEN cells as a molecular genetic tool to study cardiomyocyte differentiation. Not only are XEN cells functionally similar to the heart-inducing AVE, but also can be used for the genetic dissection of the cardiogenic potential of AVE, since they can be isolated from both wild type and mutant blastocysts. These studies further demonstrate the importance of both contact-dependent and contact-independent factors in cardiogenesis and identify potential heart-inducing proteins in the endoderm.	[Brown, Kemar; Doss, Michael Xavier; Legros, Stephanie; Foley, Ann C.] Weill Cornell Med Coll, Greenberg Div Cardiol, New York, NY 10065 USA; [Artus, Jerome; Hadjantonakis, Anna-Katerina] Sloan Kettering Inst, Dev Biol Program, New York, NY USA	Cornell University; Memorial Sloan Kettering Cancer Center	Brown, K (corresponding author), Weill Cornell Med Coll, Greenberg Div Cardiol, New York, NY 10065 USA.	acf2002@med.cornell.edu	; Jesudoss, Michael Xavier Doss/D-1983-2015	Artus, Jerome/0000-0003-3423-8634; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124; Jesudoss, Michael Xavier Doss/0000-0001-6339-9782	American Heart Association [0930056N]; Raymond and Beverly Sackler; National Institutes of Health [RO1-HD052115, RO1-DK084391]; New York Stem Cell Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052115] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084391] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Raymond and Beverly Sackler; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work in Ann Foley's laboratory is supported by the American Heart Association (0930056N) and funding from Raymond and Beverly Sackler. Anna-Katerina Hadjantonakis's laboratory is supported by the National Institutes of Health (RO1-HD052115 and RO1-DK084391) and New York Stem Cell Science. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Abu-Abed SS, 1998, J BIOL CHEM, V273, P2409, DOI 10.1074/jbc.273.4.2409; AbuAbed M, 1997, BIOCHEMISTRY-US, V36, P14012, DOI 10.1021/bi971407s; Arai A, 1997, DEV DYNAM, V210, P344, DOI 10.1002/(SICI)1097-0177(199711)210:3<344::AID-AJA13>3.0.CO;2-A; Artus J, 2010, DEVELOPMENT, V137, P3361, DOI 10.1242/dev.050864; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Brown K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012016; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Drysdale TA, 1997, DEV BIOL, V188, P205, DOI 10.1006/dbio.1997.8623; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; Foley AC, 2000, DEVELOPMENT, V127, P3839; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Foley AC, 2001, J ANAT, V199, P35; Foley AC, 2006, ANN NY ACAD SCI, V1080, P85, DOI 10.1196/annals.1380.008; Foley AC, 2007, DEV BIOL, V303, P57, DOI 10.1016/j.ydbio.2006.10.033; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; FULLILOVE SL, 1970, J EXP ZOOL, V175, P323, DOI 10.1002/jez.1401750306; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; GANNON M, 1995, DEVELOPMENT, V121, P2439; GISSEL C, SACHINIDIS METHODS M; Goldbeter A, 2007, DEV DYNAM, V236, P1495, DOI 10.1002/dvdy.21193; GOURDIE RG, 1993, J CELL SCI, V105, P985; Holtzinger A, 2010, DEV BIOL, V337, P63, DOI 10.1016/j.ydbio.2009.10.003; Honda M, 2005, BIOCHEM BIOPH RES CO, V333, P1334, DOI 10.1016/j.bbrc.2005.05.202; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; JACOBSON AG, 1968, J EXP ZOOL, V167, P79, DOI 10.1002/jez.1401670106; JACOBSON AG, 1960, DEV BIOL, V2, P138, DOI 10.1016/0012-1606(60)90003-8; Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kwon GS, 2006, DEV DYNAM, V235, P2549, DOI 10.1002/dvdy.20843; LEHMAN JM, 1974, J CELL PHYSIOL, V84, P13, DOI 10.1002/jcp.1040840103; Liberatore CM, 2000, DEV BIOL, V223, P169, DOI 10.1006/dbio.2000.9748; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Matsui H, 2005, DEV DYNAM, V233, P1419, DOI 10.1002/dvdy.20477; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Mummery C, 2002, J ANAT, V200, P233, DOI 10.1046/j.1469-7580.2002.00031.x; MUMMERY CL, 1991, DIFFERENTIATION, V46, P51, DOI 10.1111/j.1432-0436.1991.tb00865.x; MUMMERY CL, 1985, DEV BIOL, V109, P402, DOI 10.1016/0012-1606(85)90466-X; Nagy A., 2003, MANIPULATING MOUSE E; NASCONE N, 1995, DEVELOPMENT, V121, P515; Nijmeijer RM, 2009, STEM CELL RES, V3, P170, DOI 10.1016/j.scr.2009.06.003; Pal R, 2009, EXP BIOL MED, V234, P1230, DOI 10.3181/0901-RM-38; Park EJ, 2006, DEVELOPMENT, V133, P2419, DOI 10.1242/dev.02367; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Saga Y, 1999, DEVELOPMENT, V126, P3437; SATER AK, 1990, DEVELOPMENT, V108, P461; SATER AK, 1989, DEVELOPMENT, V105, P821; Schneider VA, 1999, CURR BIOL, V9, P800, DOI 10.1016/S0960-9822(99)80363-7; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Sirbu IO, 2008, DEV DYNAM, V237, P1627, DOI 10.1002/dvdy.21570; Stary M, 2005, EXP CELL RES, V310, P331, DOI 10.1016/j.yexcr.2005.07.013; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tam PPL, 1997, DEVELOPMENT, V124, P1631; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849; Wei H, 2005, J CELL MOL MED, V9, P804, DOI 10.1111/j.1582-4934.2005.tb00381.x; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yatskievych TA, 1997, DEVELOPMENT, V124, P2561	73	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13446	10.1371/journal.pone.0013446	http://dx.doi.org/10.1371/journal.pone.0013446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975998	Green Submitted, Green Published, gold			2022-12-25	WOS:000283216400006
J	Keil, JM; Shen, ZX; Briggs, SP; Patrick, GN				Keil, Jeffrey M.; Shen, Zhouxin; Briggs, Steven P.; Patrick, Gentry N.			Regulation of STIM1 and SOCE by the Ubiquitin-Proteasome System (UPS)	PLOS ONE			English	Article							STROMAL INTERACTION MOLECULE-1; CAPACITATIVE CA2+ ENTRY; PLASMA-MEMBRANE; PROTEIN-DEGRADATION; STORE DEPLETION; LIGASE POSH; CHANNELS; PLASTICITY; NEURONS; BRAIN	The ubiquitin proteasome system (UPS) mediates the majority of protein degradation in eukaryotic cells. The UPS has recently emerged as a key degradation pathway involved in synapse development and function. In order to better understand the function of the UPS at synapses we utilized a genetic and proteomic approach to isolate and identify novel candidate UPS substrates from biochemically purified synaptic membrane preparations. Using these methods, we have identified Stromal interacting molecule 1 (STIM1). STIM1 is as an endoplasmic reticulum (ER) calcium sensor that has been shown to regulate store-operated Ca(2+) entry (SOCE). We have characterized STIM1 in neurons, finding STIM1 is expressed throughout development with stable, high expression in mature neurons. As in non-excitable cells, STIM1 is distributed in a membranous and punctate fashion in hippocampal neurons. In addition, a population of STIM1 was found to exist at synapses. Furthermore, using surface biotinylation and live-cell labeling methods, we detect a subpopulation of STIM1 on the surface of hippocampal neurons. The role of STIM1 as a regulator of SOCE has typically been examined in non-excitable cell types. Therefore, we examined the role of the UPS in STIM1 and SOCE function in HEK293 cells. While we find that STIM1 is ubiquitinated, its stability is not altered by proteasome inhibitors in cells under basal conditions or conditions that activate SOCE. However, we find that surface STIM1 levels and thapsigargin (TG)-induced SOCE are significantly increased in cells treated with proteasome inhibitors. Additionally, we find that the overexpression of POSH (Plenty of SH3's), an E3 ubiquitin ligase recently shown to be involved in the regulation of Ca(2+) homeostasis, leads to decreased STIM1 surface levels. Together, these results provide evidence for previously undescribed roles of the UPS in the regulation of STIM1 and SOCE function.	[Keil, Jeffrey M.; Patrick, Gentry N.] Univ Calif San Diego, Dept Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Shen, Zhouxin; Briggs, Steven P.] Univ Calif San Diego, Dept Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Keil, JM (corresponding author), Univ Calif San Diego, Dept Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	gpatrick@ucsd.edu			University of California San Diego (UCSD); Ray Thomas Edward Career Award; UCSD; National Institutes of Health [NS054732]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060847, R21NS054732] Funding Source: NIH RePORTER	University of California San Diego (UCSD); Ray Thomas Edward Career Award; UCSD; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by University of California San Diego (UCSD) Biology departmental funds to J.M.K.; Ray Thomas Edward Career Award, UCSD Startup Funds, and National Institutes of Health funding (NS054732) to G.N.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Baba A, 2003, J NEUROSCI, V23, P7737; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Gasperini R, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-29; Hauser CT, 2007, P NATL ACAD SCI USA, V104, P3693, DOI 10.1073/pnas.0611713104; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; JOHNSTONE LS, J CELL MOL MED; Klejman ME, 2009, NEUROCHEM INT, V54, P49, DOI 10.1016/j.neuint.2008.10.005; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Oritani K, 1996, J CELL BIOL, V134, P771, DOI 10.1083/jcb.134.3.771; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Skibinska-Kijek A, 2009, ACTA NEUROBIOL EXP, V69, P413; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Tang FJ, 2005, J NEUROSCI, V25, P6702, DOI 10.1523/JNEUROSCI.0871-05.2005; Tsirigotis M, 2001, BIOTECHNIQUES, V31, P120, DOI 10.2144/01311rr03; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	41	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13465	10.1371/journal.pone.0013465	http://dx.doi.org/10.1371/journal.pone.0013465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976103	Green Published, gold, Green Submitted			2022-12-25	WOS:000283045300034
J	Shibata, T; Ariki, S; Shinzawa, N; Miyaji, R; Suyama, H; Sako, M; Inomata, N; Koshiba, T; Kanuka, H; Kawabata, S				Shibata, Toshio; Ariki, Shigeru; Shinzawa, Naoaki; Miyaji, Ryuta; Suyama, Haruka; Sako, Miyuki; Inomata, Nobuyuki; Koshiba, Takumi; Kanuka, Hirotaka; Kawabata, Shun-ichiro			Protein Crosslinking by Transglutaminase Controls Cuticle Morphogenesis in Drosophila	PLOS ONE			English	Article							FRESH-WATER CRAYFISH; CUTICULAR PROTEINS; HORSESHOE-CRAB; PACIFASTACUS-LENIUSCULUS; TISSUE TRANSGLUTAMINASE; HEMOLYMPH-PROTEINS; CLOTTABLE PROTEIN; CLOTTING PROTEIN; ACTIVATION; GENE	Transglutaminase (TG) plays important and diverse roles in mammals, such as blood coagulation and formation of the skin barrier, by catalyzing protein crosslinking. In invertebrates, TG is known to be involved in immobilization of invading pathogens at sites of injury. Here we demonstrate that Drosophila TG is an important enzyme for cuticle morphogenesis. Although TG activity was undetectable before the second instar larval stage, it dramatically increased in the third instar larval stage. RNA interference (RNAi) of the TG gene caused a pupal semi-lethal phenotype and abnormal morphology. Furthermore, TG-RNAi flies showed a significantly shorter life span than their counterparts, and approximately 90% of flies died within 30 days after eclosion. Stage-specific TG-RNAi before the third instar larval stage resulted in cuticle abnormality, but the TG-RNAi after the late pupal stage did not, indicating that TG plays a key role at or before the early pupal stage. Immediately following eclosion, acid-extractable protein from wild-type wings was nearly all converted to non-extractable protein due to wing maturation, whereas several proteins remained acid-extractable in the mature wings of TG-RNAi flies. We identified four proteins-two cuticular chitin-binding proteins, larval serum protein 2, and a putative C-type lectin-as TG substrates. RNAi of their corresponding genes caused a lethal phenotype or cuticle abnormality. Our results indicate that TG-dependent protein crosslinking in Drosophila plays a key role in cuticle morphogenesis and sclerotization.	[Shibata, Toshio; Miyaji, Ryuta; Inomata, Nobuyuki; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Ariki, Shigeru; Suyama, Haruka; Sako, Miyuki; Inomata, Nobuyuki; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Shinzawa, Naoaki; Kanuka, Hirotaka] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan	Kyushu University; Kyushu University; Obihiro University of Agriculture & Veterinary Medicine	Shibata, T (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	skawascb@kyudai.jp	Ariki, Shigeru/E-3861-2014; Koshiba, Takumi/A-3996-2013; Shibata, Toshio/AAE-1694-2020	Ariki, Shigeru/0000-0001-5838-499X; Shibata, Toshio/0000-0003-0211-5525; Koshiba, Takumi/0000-0001-8535-5043	Kyushu University [21415]; Japan Foundation for Applied Enzymology; Takeda Science Foundation	Kyushu University; Japan Foundation for Applied Enzymology; Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by the Kyushu University Interdisciplinary Program in Education and Project in Research Development (type E-2 No. 21415 to S. K.), by Grants-in-Aid for graduate students in Kyushu University (to T. S.), by the Japan Foundation for Applied Enzymology (http://www.mt-pharma.co.jp/jfae/index.html) (to S. K.), and by Takeda Science Foundation (http://www.takeda-sci.or.jp/) (to S. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAM ME, 1978, CELL, V13, P215, DOI 10.1016/0092-8674(78)90190-3; AKAM ME, 1978, BIOCHEM GENET, V16, P101, DOI 10.1007/BF00484387; Andersen SO, 1996, COMP BIOCHEM PHYS B, V113, P689, DOI 10.1016/0305-0491(95)02089-6; Baker JD, 2002, J EXP BIOL, V205, P2555; Butler MJ, 2003, DEVELOPMENT, V130, P659, DOI 10.1242/dev.00293; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; FESUS L, 1987, FEBS LETT, V224, P104, DOI 10.1016/0014-5793(87)80430-1; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Iijima M, 2005, FEBS J, V272, P4774, DOI 10.1111/j.1742-4658.2005.04891.x; Kalinin A, 2001, J CELL SCI, V114, P3069; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; Kawasaki H, 2000, J BIOL CHEM, V275, P35297, DOI 10.1074/jbc.M006856200; Kiger JA, 2007, DEV BIOL, V301, P178, DOI 10.1016/j.ydbio.2006.08.011; Kimura KI, 2004, DEVELOPMENT, V131, P1597, DOI 10.1242/dev.01049; KONIG M, 1986, ROUX ARCH DEV BIOL, V195, P296, DOI 10.1007/BF00376062; KOPACEK P, 1993, EUR J BIOCHEM, V213, P591, DOI 10.1111/j.1432-1033.1993.tb17798.x; Kramer KJ, 2001, TETRAHEDRON, V57, P385, DOI 10.1016/S0040-4020(00)00949-2; LEVENBOOK L, 1984, INSECT BIOCHEM, V14, P77, DOI 10.1016/0020-1790(84)90086-6; Lin XH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-58; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LUSTIGMAN S, 1995, ANTIMICROB AGENTS CH, V39, P1913, DOI 10.1128/AAC.39.9.1913; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Matsuda Y, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705854200; Matsuda Y, 2007, J BIOL CHEM, V282, P37316, DOI 10.1074/jbc.M705731200; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; MELINO G, 1994, MOL CELL BIOL, V14, P6584, DOI 10.1128/MCB.14.10.6584; MousseronGrall S, 1997, EUR J BIOCHEM, V245, P191, DOI 10.1111/j.1432-1033.1997.00191.x; Osaki T, 2004, CELL MOL LIFE SCI, V61, P1257, DOI 10.1007/s00018-004-3396-5; Osaki T, 2002, J BIOL CHEM, V277, P40084, DOI 10.1074/jbc.M206773200; Ren N, 2005, GENETICS, V171, P625, DOI 10.1534/genetics.105.043687; ROBERTS DB, 1977, J INSECT PHYSIOL, V23, P871, DOI 10.1016/0022-1910(77)90013-0; Scherfer C, 2004, CURR BIOL, V14, P625, DOI 10.1016/j.cub.2004.03.030; Sugumaran M, 1998, ADV INSECT PHYSIOL, V27, P229, DOI 10.1016/S0065-2806(08)60014-4; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Ueda Y, 2009, J IMMUNOL, V183, P3810, DOI 10.4049/jimmunol.0900430; Wang R, 2001, FISH SHELLFISH IMMUN, V11, P623, DOI 10.1006/fsim.2001.0341; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Willis JH, 1999, AM ZOOL, V39, P600	43	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13477	10.1371/journal.pone.0013477	http://dx.doi.org/10.1371/journal.pone.0013477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976106	Green Submitted, Green Published, gold			2022-12-25	WOS:000283045300039
J	Frentiu, FD; Robinson, J; Young, PR; McGraw, EA; O'Neill, SL				Frentiu, Francesca D.; Robinson, Jodie; Young, Paul R.; McGraw, Elizabeth A.; O'Neill, Scott L.			Wolbachia-Mediated Resistance to Dengue Virus Infection and Death at the Cellular Level	PLOS ONE			English	Article							LIFE-SHORTENING WOLBACHIA; AEDES-AEGYPTI; MOSQUITO; DROSOPHILA; STRAIN; TEMPERATURE; PIPIENTIS; VIRULENT; SYMBIONT; DENSITY	Background: Dengue is currently the most important arthropod-borne viral disease of humans. Recent work has shown dengue virus displays limited replication in its primary vector, the mosquito Aedes aegypti, when the insect harbors the endosymbiotic bacterium Wolbachia pipientis. Wolbachia-mediated inhibition of virus replication may lead to novel methods of arboviral control, yet the functional and cellular mechanisms that underpin it are unknown. Methodology/Principal Findings: Using paired Wolbachia-infected and uninfected Aedes-derived cell lines and dengue virus, we confirm the phenomenon of viral inhibition at the cellular level. Although Wolbachia imposes a fitness cost to cells via reduced proliferation, it also provides a significant degree of protection from virus-induced mortality. The extent of viral inhibition is related to the density of Wolbachia per cell, with highly infected cell lines showing almost complete protection from dengue infection and dramatically reduced virus titers compared to lines not infected with the bacteria. Conclusions/Significance: We have shown that cells infected with Wolbachia display inhibition of dengue virus replication, that the extent of inhibition is related to bacterial density and that Wolbachia infection, although costly, will provide a fitness benefit in some circumstances. Our results parallel findings in mosquitoes and flies, indicating that cell line models will provide useful and experimentally tractable models to study the mechanisms underlying Wolbachia-mediated protection from viruses.	[Frentiu, Francesca D.; McGraw, Elizabeth A.; O'Neill, Scott L.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Robinson, Jodie; Young, Paul R.] Univ Queensland, Sch Chem & Mol Biosci, Ctr Infect Dis Res, Brisbane, Qld, Australia	University of Queensland; University of Queensland	O'Neill, SL (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	scott.oneill@uq.edu.au	Frentiu, Francesca D/K-4561-2012; Young, Paul R/A-6176-2010; O'Neill, Scott/R-9560-2019; McGraw, Elizabeth/GRF-0434-2022; O'Neill, Scott L/B-3568-2009; McGraw, Elizabeth A/A-6658-2012	Young, Paul R/0000-0002-2040-5190; O'Neill, Scott/0000-0002-4131-3615; O'Neill, Scott L/0000-0002-4131-3615; McGraw, Elizabeth A/0000-0001-7973-088X; Frentiu, Francesca/0000-0001-8628-4216	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council of Australia	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by grants from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation and the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368; BROWNSTEIN JS, 1998, J INVERTEBR PATHOL, V84, P24; Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1023/A:1003043814761; Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Dobson SL, 2002, APPL ENVIRON MICROB, V68, P656, DOI 10.1128/AEM.68.2.656-660.2002; Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; IGARASHI A, 1978, J GEN VIROL, V66, P2773; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kroeger A, 2006, LANCET, V368, P2193, DOI 10.1016/S0140-6736(06)69873-5; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Martin CSS, 2009, TRENDS MICROBIOL, V17, P514, DOI 10.1016/j.tim.2009.08.002; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; ONeill SL, 1997, INSECT MOL BIOL, V6, P33, DOI 10.1046/j.1365-2583.1997.00157.x; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; R Core Team, 2022, R LANG ENV STAT COMP; Reynolds KT, 2003, GENETICS, V164, P1027; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678; Texeira L., 2008, PLOS BIOL, V6; Tsai KH, 2006, J MED ENTOMOL, V43, P752, DOI 10.1603/0022-2585(2006)43[752:PIOJEV]2.0.CO;2; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Voronin D, 2010, J APPL MICROBIOL, V108, P2133, DOI 10.1111/j.1365-2672.2009.04621.x; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1	38	147	151	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13398	10.1371/journal.pone.0013398	http://dx.doi.org/10.1371/journal.pone.0013398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976219	gold, Green Published			2022-12-25	WOS:000283043700006
J	Toh, ML; Gonzales, G; Koenders, MI; Tournadre, A; Boyle, D; Lubberts, E; Zhou, YA; Firestein, GS; van den Berg, WB; Miossec, P				Toh, Myew-Ling; Gonzales, Gaelle; Koenders, Marije I.; Tournadre, Anne; Boyle, David; Lubberts, Erik; Zhou, Yuan; Firestein, Gary S.; van den Berg, Wim B.; Miossec, Pierre			Role of Interleukin 17 in Arthritis Chronicity through Survival of Synoviocytes via Regulation of Synoviolin Expression	PLOS ONE			English	Article							OXIDE-INDUCED APOPTOSIS; NECROSIS FACTOR THERAPY; E3 UBIQUITIN LIGASE; RHEUMATOID-ARTHRITIS; NITRIC-OXIDE; CUTTING EDGE; HUMAN HRD1; CELLS; PROTEIN; GENE	Background: The use of TNF inhibitors has been a major progress in the treatment of chronic inflammation. However, not all patients respond. In addition, response will be often lost when treatment is stopped. These clinical aspects indicate that other cytokines might be involved and we focus here on the role of IL-17. In addition, the chronic nature of joint inflammation may contribute to reduced response and enhanced chronicity. Therefore we studied the capacity of IL-17 to regulate synoviolin, an E3 ubiquitin ligase implicated in synovial hyperplasia in human rheumatoid arthritis (RA) FLS and in chronic reactivated streptococcal cell wall (SCW)-induced arthritis. Methodology/Principal Findings: Chronic reactivated SCW-induced arthritis was examined in IL-17R deficient and wild-type mice. Synoviolin expression was analysed by real-time RT-PCR, Western Blot or immunostaining in RA FLS and tissue, and p53 assessed by Western Blot. Apoptosis was detected by annexin V/propidium iodide staining, SS DNA apoptosis ELISA kit or TUNEL staining and proliferation by PCNA staining. IL-17 receptor A (IL-17RA), IL-17 receptor C (IL-17-RC) or synoviolin inhibition were achieved by small interfering RNA (siRNA) or neutralizing antibodies. IL-17 induced sustained synoviolin expression in RA FLS. Sodium nitroprusside (SNP)-induced RA FLS apoptosis was associated with reduced synoviolin expression and was rescued by IL-17 treatment with a corresponding increase in synoviolin expression. IL-17RC or IL-17RA RNA interference increased SNP-induced apoptosis, and decreased IL-17-induced synoviolin. IL-17 rescued RA FLS from apoptosis induced by synoviolin knockdown. IL-17 and TNF had additive effects on synoviolin expression and protection against apoptosis induced by synoviolin knowndown. In IL-17R deficient mice, a decrease in arthritis severity was characterized by increased synovial apoptosis, reduced proliferation and a marked reduction in synoviolin expression. A distinct absence of synoviolin expressing germinal centres in IL-17R deficient mice contrasted with synoviolin positive B cells and Th17 cells in synovial germinal centre-like structures. Conclusion/Significance: IL-17 induction of synoviolin may contribute at least in part to RA chronicity by prolonging the survival of RA FLS and immune cells in germinal centre reactions. These results extend the role of IL-17 to synovial hyperplasia.	[Toh, Myew-Ling; Gonzales, Gaelle; Tournadre, Anne; Zhou, Yuan; Miossec, Pierre] Univ Lyon, Hosp Edouard Herriot, EA 4130, Res Unit Immunogenom & Inflammat, Lyon, France; [Koenders, Marije I.; Lubberts, Erik; van den Berg, Wim B.] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [Boyle, David; Firestein, Gary S.] Univ Calif San Diego, Dept Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA	bioMerieux; CHU Lyon; Radboud University Nijmegen; University of California System; University of California San Diego	Toh, ML (corresponding author), Univ Lyon, Hosp Edouard Herriot, EA 4130, Res Unit Immunogenom & Inflammat, Lyon, France.	pierre.miossec@univ-lyon1.fr	Koenders, Marije I/A-1341-2012; Lubberts, Erik/AAI-4657-2020; van den Berg, W.B./H-8010-2014; Zhou, Yuan/B-1375-2013	Koenders, Marije I/0000-0001-5845-8362; 	Hospices Civils de Lyon; Region Rhone-Alpes; Merieux Institute	Hospices Civils de Lyon; Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Merieux Institute	This work has been supported by research grants from the Hospices Civils de Lyon and the Region Rhone-Alpes and in part by the Merieux Institute. Ling Toh and Yuan Zhou were supported by a post-doctoral fellowship of the Region Rhone-Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Anolik JH, 2008, J IMMUNOL, V180, P688, DOI 10.4049/jimmunol.180.2.688; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Aupperle KR, 1998, AM J PATHOL, V152, P1091; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Borderie D, 1999, OSTEOARTHR CARTILAGE, V7, P203, DOI 10.1053/joca.1998.0209; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chen QQ, 2006, J RHEUMATOL, V33, P1061; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Dufour JM, 2004, GENE THER, V11, P694, DOI 10.1038/sj.gt.3302218; Eizirik DL, 1996, DIABETOLOGIA, V39, P875; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gao BX, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2081; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hwang SY, 2005, MOL CELLS, V19, P180; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Lacey D, 2003, ARTHRITIS RHEUM, V48, P103, DOI 10.1002/art.10733; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Leech M, 2003, ARTHRITIS RHEUM, V48, P1881, DOI 10.1002/art.11165; Lubberts E, 2005, J IMMUNOL, V175, P3360, DOI 10.4049/jimmunol.175.5.3360; Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104; Miossec P, 2007, ARTHRITIS RHEUM-US, V56, P2111, DOI 10.1002/art.22733; Nadav E, 2003, BIOCHEM BIOPH RES CO, V303, P91, DOI 10.1016/S0006-291X(03)00279-1; Nakamura H, 2004, CLIN EXP RHEUMATOL, V22, P151; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Page G, 2004, J PATHOL, V204, P28, DOI 10.1002/path.1607; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; TOH M, 1994, ARTHRITIS RHEUM; Toh ML, 2005, J IMMUNOL, V175, P7687, DOI 10.4049/jimmunol.175.11.7687; Toh ML, 2004, ARTHRITIS RHEUM-US, V50, P3118, DOI 10.1002/art.20580; Toh ML, 2006, ARTHRITIS RHEUM-US, V54, P2109, DOI 10.1002/art.21926; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; You ZB, 2006, CANCER RES, V66, P175, DOI 10.1158/0008-5472.CAN-05-1130; Zrioual S, 2008, J IMMUNOL, V180, P655, DOI 10.4049/jimmunol.180.1.655	44	66	70	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13416	10.1371/journal.pone.0013416	http://dx.doi.org/10.1371/journal.pone.0013416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976214	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000283043700015
J	Cisneros, JC; Cabral, UG; de Beer, F; Damiani, R; Fortier, DC				Cisneros, Juan Carlos; Cabral, Uiara Gomes; de Beer, Frikkie; Damiani, Ross; Fortier, Daniel Costa			Spondarthritis in the Triassic	PLOS ONE			English	Article							OSSEOUS PATHOLOGY; BEAUFORT GROUP; SOUTH-AFRICA; SPONDYLOARTHROPATHY; KAROO	Background: The evidence of several forms of arthritis has been well documented in the fossil record. However, for pre-Cenozoic vertebrates, especially regarding reptiles, this record is rather scarce. In this work we present a case report of spondarthritis found in a vertebral series that belonged to a carnivorous archosaurian reptile from the Lower Triassic (similar to 245 million years old) of the South African Karoo. Methodology/Principal Findings: Neutron tomography confirmed macroscopic data, revealing the ossification of the entire intervertebral disc space (both annulus fibrosus and nucleus pulposus), which supports the diagnosis of spondarthritis. Conclusions/Significance: The presence of spondarthritis in the new specimen represents by far the earliest evidence of any form of arthritis in the fossil record. The present find is nearly 100 million years older than the previous oldest report of this pathology, based on a Late Jurassic dinosaur. Spondarthritis may have indirectly contributed to the death of the animal under study.	[Cisneros, Juan Carlos] Univ Fed Piaui, Ctr Ciencias Nat, Teresina, Brazil; [Cabral, Uiara Gomes] Univ Fed Rio de Janeiro, Dept Geol & Paleontol, Museu Nacl, Rio De Janeiro, Brazil; [de Beer, Frikkie] S African Nucl Energy Corp, Nucl Technol Div, Pretoria, South Africa; [Damiani, Ross] Staatliches Museum Nat Kunde Stuttgart, Stuttgart, Germany; [Fortier, Daniel Costa] Univ Fed Rio Grande do Sul, Dept Paleontol & Estrati, Porto Alegre, RS, Brazil	Universidade Federal do Piaui; Universidade Federal do Rio de Janeiro; The South African Nuclear Energy Corporation SOC Limited (Necsa); Universidade Federal do Rio Grande do Sul	Cisneros, JC (corresponding author), Univ Fed Piaui, Ctr Ciencias Nat, Teresina, Brazil.	juan.cisneros@ufpi.edu.br	De Beer, Frederik/AAA-1724-2020; Fortier, Daniel/R-2895-2017	De Beer, Frederik/0000-0001-9810-6038; Cisneros, Juan Carlos/0000-0001-6159-1981				Belanger T A, 2001, J Am Acad Orthop Surg, V9, P258; Campillo D., 2001, INTRO PALEOPATOLOGIA; de Beer FC, 2005, NUCL INSTRUM METH A, V542, P1, DOI 10.1016/j.nima.2005.01.003; DEBEER FC, 2001, NONDESTRUCT TEST EVA, V16, P163; Ehrenfeld M, 2008, DIAGNOSTIC CRITERIA IN AUTOIMMUNE DISEASES, P195, DOI 10.1007/978-1-60327-285-8_38; FRANCOIS RJ, 1995, ANN RHEUM DIS, V54, P615, DOI 10.1136/ard.54.8.615; GOLDING DN, 1985, J ROY SOC MED, V78, P706, DOI 10.1177/014107688507800902; HANCOX PJ, 1995, S AFR J SCI, V91, P143; Kitching J.W., 1977, Memoirs Bernard Price Inst palaeont Res, VNo. 1, P1; Kompanje E.J.O., 1999, Zoologische Mededelingen (Leiden), V73, P99; Mader R, 2009, RHEUMATOLOGY, V48, P1478, DOI 10.1093/rheumatology/kep308; Neveling J., 2005, Palaeontologia Africana, V41, P81; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Resnick D., 1988, DIAGNOSIS BONE JOINT; RIVERS ML, 2001, GSECARS TOMOGRAPHY P; Rothschild B, 2002, LANCET, V360, P1454, DOI 10.1016/S0140-6736(02)11471-1; Rothschild B.M., 2006, SKELETAL IMPACT DIS; Rothschild BM, 1999, LANCET, V354, P398, DOI 10.1016/S0140-6736(99)01019-3; ROTHSCHILD BM, 1994, J ZOO WILDLIFE MED, V25, P360; Rothschild B, 2010, J HERPETOL, V44, P13, DOI 10.1670/08-243.1; Rothschild B, 2009, APPL HERPETOL, V6, P47, DOI 10.1163/157075409X413842; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Zochling J, 2005, RHEUMATOLOGY, V44, P1483, DOI 10.1093/rheumatology/kei047	23	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13425	10.1371/journal.pone.0013425	http://dx.doi.org/10.1371/journal.pone.0013425			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976231	Green Submitted, Green Published, gold			2022-12-25	WOS:000282941000027
J	Mfonkeu, JBP; Gouado, I; Kuate, HF; Zambou, O; Zollo, PHA; Grau, GER; Combes, V				Mfonkeu, Joel Bertrand Pankoui; Gouado, Inocent; Kuate, Honore Fotso; Zambou, Odile; Zollo, Paul Henri Amvam; Grau, Georges Emile Raymond; Combes, Valery			Elevated Cell-Specific Microparticles Are a Biological Marker for Cerebral Dysfunctions in Human Severe Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; COMATOSE MALAWIAN CHILDREN; BLOOD-BRAIN-BARRIER; ENDOTHELIAL MICROPARTICLES; COMPLICATED MALARIA; CLINICAL-FEATURES; PATHOGENESIS; PANTETHINE; PLATELETS; NEUROPATHOLOGY	Cerebral malaria (CM) and severe anemia (SA) are the most severe complications of Plasmodium falciparum infections. Although increased release of endothelial microparticles (MP) correlates with malaria severity, the full extent of vascular cell vesiculation remains unknown. Here, we characterize the pattern of cell-specific MP in patients with severe malaria. We tested the hypothesis that systemic vascular activation contributes to CM by examining origins and levels of plasma MP in relation to clinical syndromes, disease severity and outcome. Patients recruited in Douala, Cameroon, were assigned to clinical groups following WHO criteria. MP quantitation and phenotyping were carried out using cell-specific markers by flow cytometry using antibodies recognizing cell-specific surface markers. Platelet, erythrocytic, endothelial and leukocytic MP levels were elevated in patients with cerebral dysfunctions and returned to normal by discharge. In CM patients, platelet MP were the most abundant and their levels significantly correlated with coma depth and thrombocytopenia. This study shows for the first time a widespread enhancement of vesiculation in the vascular compartment appears to be a feature of CM but not of SA. Our data underpin the role of MP as a biomarker of neurological involvement in severe malaria. Therefore, intervention to block MP production in severe malaria may provide a new therapeutic pathway.	[Mfonkeu, Joel Bertrand Pankoui; Gouado, Inocent; Zollo, Paul Henri Amvam] Univ Douala, Dept Biochem, Fac Sci, Douala, Cameroon; [Kuate, Honore Fotso] Laquintinie Hosp, Lab Serv, Douala, Cameroon; [Zambou, Odile] Deido Dist Hosp, Serv Pediat, Douala, Cameroon; [Grau, Georges Emile Raymond; Combes, Valery] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia	University of Sydney	Mfonkeu, JBP (corresponding author), Univ Douala, Dept Biochem, Fac Sci, Douala, Cameroon.	valery.combes@sydney.edu.au	Grau, Georges/AGR-7139-2022	Grau, Georges/0000-0002-0442-0462; Combes, Valery/0000-0003-2178-3596	Europena Union [LSHP-CT-2006-037749]; National Health Medical Research Council - European Union [512101]; AL Kerr Bequest, Sydney Medical School	Europena Union; National Health Medical Research Council - European Union; AL Kerr Bequest, Sydney Medical School	This study was supported by the Europena Union-Framework Program 6, #LSHP-CT-2006-037749 and National Health Medical Research Council - European Union collaborative grant/Australia #512101. The support of the AL Kerr Bequest, Sydney Medical School, is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEBAWY M, 2009, LEUKEMIA; Biemba G, 1998, TROP MED INT HEALTH, V3, P60, DOI 10.1046/j.1365-3156.1998.00168.x; Biemba G, 2000, TROP MED INT HEALTH, V5, P9, DOI 10.1046/j.1365-3156.2000.00506.x; Coltel N, 2006, MICROBES INFECT, V8, P2305, DOI 10.1016/j.micinf.2006.04.006; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Combes V, 2005, AM J PATHOL, V166, P295, DOI 10.1016/S0002-9440(10)62253-5; Combes V, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-b; Combes V, 2006, INT J PARASITOL, V36, P541, DOI 10.1016/j.ijpara.2006.02.005; CORONEL F, 1991, AM J NEPHROL, V11, P32, DOI 10.1159/000168269; Faille D, 2009, FASEB J, V23, P3449, DOI 10.1096/fj.09-135822; Freyssinet JM, 2003, J THROMB HAEMOST, V1, P1655, DOI 10.1046/j.1538-7836.2003.00309.x; Gilstad CW, 2003, CURR OPIN HEMATOL, V10, P419, DOI 10.1097/00062752-200311000-00004; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1993, EUR CYTOKINE NETW, V4, P415; Guiducci S, 2008, ARTHRITIS RHEUM-US, V58, P2845, DOI 10.1002/art.23735; Ho M, 1999, AM J PHYSIOL-CELL PH, V276, pC1231, DOI 10.1152/ajpcell.1999.276.6.C1231; Horvath Z, 2009, IDEGGYOGY SZEMLE, V62, P220; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Lackner P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-116; Lou J, 2001, CLIN MICROBIOL REV, V14, P810, DOI 10.1128/CMR.14.4.810-820.2001; Medana IM, 2007, J INFECT DIS, V195, P921, DOI 10.1086/512089; Mfonkeu J B Pankoui, 2008, Pak J Biol Sci, V11, P2401, DOI 10.3923/pjbs.2008.2401.2406; Mishra SK, 2006, J POSTGRAD MED, V52, P281; Mockenhaupt FP, 2004, AM J TROP MED HYG, V71, P167, DOI 10.4269/ajtmh.2004.71.167; MOLYNEUX ME, 1989, Q J MED, V71, P441; Nieuwland R, 1997, CIRCULATION, V96, P3534; Penet MF, 2008, P NATL ACAD SCI USA, V105, P1321, DOI 10.1073/pnas.0706867105; PICCIN A, 2006, CIRCULATING MICROPAR, P11601; Piguet PF, 2002, APOPTOSIS, V7, P91, DOI 10.1023/A:1014341611412; POLDER TW, 1991, J NEUROL SCI, V101, P24, DOI 10.1016/0022-510X(91)90015-Y; PRISCO D, 1987, ANGIOLOGY, V38, P241, DOI 10.1177/000331978703800307; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Seydel KB, 2006, J INFECT DIS, V194, P208, DOI 10.1086/505078; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Xiao HY, 2000, TRANSFUSION, V40, P420, DOI 10.1046/j.1537-2995.2000.40040420.x	37	96	98	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13415	10.1371/journal.pone.0013415	http://dx.doi.org/10.1371/journal.pone.0013415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976232	Green Published, Green Submitted, gold			2022-12-25	WOS:000282941000026
J	Rose, G; Romeo, G; Dato, S; Crocco, P; Bruni, AC; Hervonen, A; Majamaa, K; Sevini, F; Franceschi, C; Passarino, G				Rose, Giuseppina; Romeo, Giuseppe; Dato, Serena; Crocco, Paolina; Bruni, Amalia C.; Hervonen, Antti; Majamaa, Kari; Sevini, Federica; Franceschi, Claudio; Passarino, Giuseppe		GEHA Project Consortium	Somatic Point Mutations in mtDNA Control Region Are Influenced by Genetic Background and Associated with Healthy Aging: A GEHA Study	PLOS ONE			English	Article							DNA HAPLOGROUP-J; MITOCHONDRIAL-DNA; REPLICATION ORIGIN; CENTENARIANS; CELLS; ACCUMULATION; DYSFUNCTION; LEUKOCYTES; MORTALITY; APOPTOSIS	Tissue specific somatic mutations occurring in the mtDNA control region have been proposed to provide a survival advantage. Data on twins and on relatives of long-lived subjects suggested that the occurrence/accumulation of these mutations may be genetically influenced. To further investigate control region somatic heteroplasmy in the elderly, we analyzed the segment surrounding the nt 150 position (previously reported as specific of Leukocytes) in various types of leukocytes obtained from 195 ultra-nonagenarians sib-pairs of Italian or Finnish origin collected in the frame of the GEHA Project. We found a significant correlation of the mtDNA control region heteroplasmy between sibs, confirming a genetic influence on this phenomenon. Furthermore, many subjects showed heteroplasmy due to mutations different from the C150T transition. In these cases heteroplasmy was correlated within sibpairs in Finnish and northern Italian samples, but not in southern Italians. This suggested that the genetic contribution to control region mutations may be population specific. Finally, we observed a possible correlation between heteroplasmy and Hand Grip strength, one of the best markers of physical performance and of mortality risk in the elderly. Our study provides new evidence on the relevance of mtDNA somatic mutations in aging and longevity and confirms that the occurrence of specific point mutations in the mtDNA control region may represent a strategy for the age-related remodelling of organismal functions.	[Rose, Giuseppina; Romeo, Giuseppe; Dato, Serena; Crocco, Paolina; Passarino, Giuseppe] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy; [Bruni, Amalia C.] Reg Ctr NeuroGenet, Lamezia Terme, Italy; [Hervonen, Antti] Tampere Sch Publ Hlth, Gerontol Lab, Tampere, Finland; [Majamaa, Kari] Univ Oulu, Dept Neurol, Oulu, Finland; [Sevini, Federica; Franceschi, Claudio] Univ Bologna, Interdept Ctr Luigi Galvani CIG, Bologna, Italy	University of Calabria; Tampere University; University of Oulu; University of Bologna	Rose, G (corresponding author), Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy.	g.passarino@unical.it	Robine, Jean-Marie/F-5439-2011; Crocco, Paolina/AAX-2695-2020; Slagboom, P. Eline/R-4790-2016; Majamaa, Kari/A-1344-2012; Dato, Serena/AAC-4072-2020; Kristensen, Peter/T-6684-2018; Franceschi, Claudio/L-4484-2017; Bruni, Amalia/K-5038-2016	Robine, Jean-Marie/0000-0002-4111-6195; Slagboom, P. Eline/0000-0002-2875-4723; Dato, Serena/0000-0003-2589-7929; Kristensen, Peter/0000-0001-7205-6853; Franceschi, Claudio/0000-0001-9841-6386; Bruni, Amalia/0000-0003-3471-3343; Rose, Giuseppina/0000-0002-4264-4184; Majamaa, Kari/0000-0002-9070-3791; crocco, paolina/0000-0001-7803-5340; Sikora, Ewa/0000-0002-1111-1748	GEHA (GEnetics of Healthy Ageing) Project; European Union [LSHM-CT-2004-503270]; National Institute for Health Research [NF-SI-0508-10260] Funding Source: researchfish	GEHA (GEnetics of Healthy Ageing) Project; European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by the GEHA (GEnetics of Healthy Ageing) Project. This project is supported through Priority 1 (Life Sciences, Genomics and Biotechnology for Health) of European Union's FP6, Project Number LSHM-CT-2004-503270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Cesari M, 2009, J GERONTOL A-BIOL, V64, P377, DOI 10.1093/gerona/gln031; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278; Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077; Franceschi C, 2007, ANN NY ACAD SCI, V1100, P21, DOI 10.1196/annals.1395.003; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Iwata N, 2007, MITOCHONDRION, V7, P267, DOI 10.1016/j.mito.2007.03.001; Jeune B, 2006, J GERONTOL A-BIOL, V61, P707, DOI 10.1093/gerona/61.7.707; Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635; Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024; Maggio M, 2006, J GERONTOL A-BIOL, V61, P575, DOI 10.1093/gerona/61.6.575; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863; Procaccio V, 2006, MOL DIAGN THER, V10, P381, DOI 10.1007/BF03256215; Rose G, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-293; Shlush LI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003425; Solvioli Stefano, 2008, Biotechnology Journal, V3, P740, DOI 10.1002/biot.200800046; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598; Yao YG, 2007, HUM MOL GENET, V16, P286, DOI 10.1093/hmg/ddl457; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399	28	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13395	10.1371/journal.pone.0013395	http://dx.doi.org/10.1371/journal.pone.0013395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976236	Green Published, gold, Green Submitted			2022-12-25	WOS:000282941000020
J	Shrestha, S; Wiener, HW; Aissani, B; Song, W; Shendre, A; Wilson, CM; Kaslow, RA; Tang, JM				Shrestha, Sadeep; Wiener, Howard W.; Aissani, Brahim; Song, Wei; Shendre, Aditi; Wilson, Craig M.; Kaslow, Richard A.; Tang, Jianming			Interleukin-10 (IL-10) Pathway: Genetic Variants and Outcomes of HIV-1 Infection in African American Adolescents	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LOAD SET-POINT; DISEASE PROGRESSION; HUMAN MONOCYTES; T-CELLS; CYTOKINE PRODUCTION; HUMAN MACROPHAGES; IL10 HAPLOTYPES; BLOOD MONOCYTES; TAT PROTEIN	Background: Immunological and clinical outcomes can vary considerably at the individual and population levels during both treated and untreated HIV-1 infection. Cytokines encoded by the interleukin-10 gene (IL10) family have broad immunomodulatory function in viral persistence, and several SNPs in the IL10 promoter sequence have been reported to influence pathogenesis or acquisition of HIV-1 infection. Methodology/Principal Findings: We examined 104 informative SNPs in IL10, IL19, IL20, IL24, IL10RA and IL10RB among 250 HIV-1 seropositive and 106 high-risk seronegative African American adolescents in the REACH cohort. In subsequent evaluation of five different immunological and virological outcomes related to HIV-1 infection, 25 SNPs were associated with a single outcome and three were associated with two different outcomes. One SNP, rs2243191 in the IL19 open reading frame (Ser to Phe substitution) was associated with CD4(+)T-cell increase during treatment. Another SNP rs2244305 in IL10RB (in strong linkage disequilibrium with rs443498) was associated with an initial decrease in CD4(+)T-cell by 23 +/- 69% and 29 +/- 69% every 3 months (for AA and AG genotypes, respectively, compared with GG) during ART-free period. These associations were reversed during treatment, as CD4(+)T-cell increased by 31 +/- 60.9% and 17 +/- 68% every 3 months for AA and AG genotype, respectively. Conclusions/Significance: In African Americans, variants in IL10 and related genes might influence multiple outcomes of HIV-1 infection, especially immunological response to HAART. Fine mapping coupled with analysis of gene expression and function should help reveal the immunological importance of the IL10 gene family to HIV-1/AIDS.	[Shrestha, Sadeep; Wiener, Howard W.; Aissani, Brahim; Song, Wei; Shendre, Aditi; Wilson, Craig M.; Kaslow, Richard A.] Univ Alabama, Dept Epidemiol, Birmingham, AL 35294 USA; [Wilson, Craig M.; Kaslow, Richard A.; Tang, Jianming] Univ Alabama, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Shrestha, S (corresponding author), Univ Alabama, Dept Epidemiol, Birmingham, AL 35294 USA.	sshresth@uab.edu; jtang@uab.edu	Tang, Jianming "James"/O-4980-2019	Tang, Jianming "James"/0000-0003-0137-7486; Wilson, Craig/0000-0001-6869-1053; Shendre, Aditi/0000-0003-4123-7613	National Institute of Child Health and Human Development [U01-HD32830]; UAB Center for AIDS Research [5P30 AI27767-20]; National Institute of Allergy and Infectious Diseases [AI051173, AI076123]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD032830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767, K02AI076123, R01AI051173] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UAB Center for AIDS Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The REACH study was supported by grant U01-HD32830 from the National Institute of Child Health and Human Development. This work was supported in part by a developmental award from the UAB Center for AIDS Research (5P30 AI27767-20) and two grants (AI051173 and AI076123) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKRIDGE RE, 1994, J IMMUNOL, V153, P5782; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMIN D, 1992, BLOOD, V80, P1289; BERKMAN N, 1995, J IMMUNOL, V155, P4412; Bettaccini AA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-20; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Chatterjee A, 2009, J CLIN IMMUNOL, V29, P71, DOI 10.1007/s10875-008-9220-5; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; DEVRIES JE, 1995, ANN MED, V27, P537, DOI 10.3109/07853899509002465; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Elrefaei M, 2006, J IMMUNOL, V176, P1274, DOI 10.4049/jimmunol.176.2.1274; Erikstrup C, 2007, AIDS, V21, P2283, DOI 10.1097/QAD.0b013e3282f153ed; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gallagher G, 2004, INT IMMUNOPHARMACOL, V4, P615, DOI 10.1016/j.intimp.2004.01.005; GRAZIOSI C, 1994, SCIENCE, V265, P248, DOI 10.1126/science.8023143; Houle M, 1999, INFLAMMATION, V23, P241; Jordan WJ, 2005, EUR J IMMUNOL, V35, P1576, DOI 10.1002/eji.200425317; Kelley CF, 2007, JAIDS-J ACQ IMM DEF, V45, P445, DOI 10.1097/QAI.0b013e318074ef6e; MarfaingKoka A, 1996, INT IMMUNOL, V8, P1587, DOI 10.1093/intimm/8.10.1587; Mei Y, 2008, STAT MED, V27, P121, DOI 10.1002/sim.3038; MONTANER LJ, 1994, J GEN VIROL, V75, P3393, DOI 10.1099/0022-1317-75-12-3393; MOSMANN TR, 1994, ADV IMMUNOL, V56, P1, DOI 10.1016/S0065-2776(08)60449-6; Murphy DA, 2001, AIDS CARE, V13, P27, DOI 10.1080/09540120020018161; Naicker DD, 2009, J INFECT DIS, V200, P448, DOI 10.1086/600072; Oleksyk TK, 2009, GENES IMMUN, V10, P309, DOI 10.1038/gene.2009.9; Ostrowski MA, 2001, J INFECT DIS, V184, P1268, DOI 10.1086/324005; Rogers AS, 1998, J ADOLESCENT HEALTH, V22, P300, DOI 10.1016/S1054-139X(97)00279-6; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; Shrestha S, 2009, AIDS, V23, P673, DOI 10.1097/QAD.0b013e328325d414; Sozzani S, 1998, J EXP MED, V187, P439, DOI 10.1084/jem.187.3.439; TAGA K, 1993, INT IMMUNOL, V5, P1599, DOI 10.1093/intimm/5.12.1599; Tang J, 1999, GENES IMMUN, V1, P20, DOI 10.1038/sj.gene.6363640; Tang JM, 2002, AIDS, V16, P2275, DOI 10.1097/00002030-200211220-00007; Vasilescu A, 2003, GENES IMMUN, V4, P441, DOI 10.1038/sj.gene.6363983; Wilson CM, 2001, J ADOLESCENT HEALTH, V29, P8, DOI 10.1016/S1054-139X(01)00291-9; Wilson JN, 2006, GENES IMMUN, V7, P680, DOI 10.1038/sj.gene.6364336; Zanussi S, 1996, CLIN EXP IMMUNOL, V105, P220, DOI 10.1046/j.1365-2249.1996.d01-746.x	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13384	10.1371/journal.pone.0013384	http://dx.doi.org/10.1371/journal.pone.0013384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976276	gold, Green Published, Green Submitted			2022-12-25	WOS:000282941000015
J	Barraud, Q; Obeid, I; Aubert, I; Barriere, G; Contamin, H; McGuire, S; Ravenscroft, P; Porras, G; Tison, F; Bezard, E; Ghorayeb, I				Barraud, Quentin; Obeid, Ibrahim; Aubert, Incarnation; Barriere, Gregory; Contamin, Hugues; McGuire, Steve; Ravenscroft, Paula; Porras, Gregory; Tison, Francois; Bezard, Erwan; Ghorayeb, Imad			Neuroanatomical Study of the A11 Diencephalospinal Pathway in the Non-Human Primate	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; RAT SPINAL-CORD; AMINO-ACID DECARBOXYLASE; MONOAMINERGIC DESCENDING PATHWAYS; MIDBRAIN DOPAMINERGIC-NEURONS; LEVODOPA-INDUCED DYSKINESIA; IN-SITU HYBRIDIZATION; PARKINSONS-DISEASE; L-DOPA; TYROSINE-HYDROXYLASE	Background: The A11 diencephalospinal pathway is crucial for sensorimotor integration and pain control at the spinal cord level. When disrupted, it is thought to be involved in numerous painful conditions such as restless legs syndrome and migraine. Its anatomical organization, however, remains largely unknown in the non-human primate (NHP). We therefore characterized the anatomy of this pathway in the NHP. Methods and Findings: In situ hybridization of spinal dopamine receptors showed that D1 receptor mRNA is absent while D2 and D5 receptor mRNAs are mainly expressed in the dorsal horn and D3 receptor mRNA in both the dorsal and ventral horns. Unilateral injections of the retrograde tracer Fluoro-Gold (FG) into the cervical spinal enlargement labeled A11 hypothalamic neurons quasi-exclusively among dopamine areas. Detailed immunohistochemical analysis suggested that these FG-labeled A11 neurons are tyrosine hydroxylase-positive but dopa-decarboxylase and dopamine transporter-negative, suggestive of a L-DOPAergic nucleus. Stereological cell count of A11 neurons revealed that this group is composed by 4002 +/- 501 neurons per side. A 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) intoxication with subsequent development of a parkinsonian syndrome produced a 50% neuronal cell loss in the A11 group. Conclusion: The diencephalic A11 area could be the major source of L-DOPA in the NHP spinal cord, where it may play a role in the modulation of sensorimotor integration through D2 and D3 receptors either directly or indirectly via dopamine formation in spinal dopa-decarboxylase-positives cells.	[Barraud, Quentin; Aubert, Incarnation; Barriere, Gregory; Porras, Gregory; Tison, Francois; Bezard, Erwan; Ghorayeb, Imad] Univ Bordeaux 2, CNRS, Bordeaux Inst Neurosci, UMR 5227, F-33076 Bordeaux, France; [Obeid, Ibrahim; Tison, Francois; Ghorayeb, Imad] Ctr Hosp, Bordeaux, France; [Obeid, Ibrahim; Tison, Francois; Ghorayeb, Imad] Univ Bordeaux, Bordeaux, France; [Contamin, Hugues] Cynbiose, Marcy Letoile, France; [McGuire, Steve; Ravenscroft, Paula] Motac Neurosci Ltd, Manchester, Lancs, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Barraud, Q (corresponding author), Univ Bordeaux 2, CNRS, Bordeaux Inst Neurosci, UMR 5227, F-33076 Bordeaux, France.	imad.ghorayeb@u-bordeaux2.fr	Ghorayeb, Imad/B-3473-2012; Bezard, Erwan/A-8173-2008; Ghorayeb, Imad/D-5073-2017; Bezard, Erwan/ABD-5153-2021	Ghorayeb, Imad/0000-0003-1996-8049; Barraud, Quentin/0000-0003-0894-1959; Barriere, Gregory/0000-0002-0704-508X; Bezard, Erwan/0000-0002-0410-4638	Agence Nationale de la Recherche [ANR-08-MNP-018]; GlaxoSmithKline laboratory	Agence Nationale de la Recherche(French National Research Agency (ANR)); GlaxoSmithKline laboratory(GlaxoSmithKline)	IG and QB received research donations from the French Association of Patients with Restless Legs Syndrome and from GlaxoSmithKline Laboratory. This study was also supported by the Agence Nationale de la Recherche, ANR-08-MNP-018, (MCHPRIMAPARK). HC is salaried of Cynbiose. SMC and PR are salaried employees of Motac Neuroscience Ltd. Cynbiose and Motac Neuroscience Ltd had a role in data collection. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.; HC is salaried of Cynbiose. SMC and PR are salaried employees of Motac Neuroscience Ltd. IG received research donation from GlaxoSmithKline laboratory. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Accili D, 1996, P NATL ACAD SCI USA, V93, P1945, DOI 10.1073/pnas.93.5.1945; Akhavan M, 2006, J NEUROSCI METH, V152, P156, DOI 10.1016/j.jneumeth.2005.09.010; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Aubert I, 2005, ANN NEUROL, V57, P17, DOI 10.1002/ana.20296; Aubert I, 2000, J COMP NEUROL, V418, P22; BAKER LL, 1984, EXP NEUROL, V86, P515, DOI 10.1016/0014-4886(84)90086-4; Bara-Jimenez W, 2000, NEUROLOGY, V54, P1609, DOI 10.1212/WNL.54.8.1609; BARASI S, 1987, BRIT J PHARMACOL, V90, P15, DOI 10.1111/j.1476-5381.1987.tb16820.x; Barraud Q, 2009, EXP NEUROL, V219, P574, DOI 10.1016/j.expneurol.2009.07.019; Barriere G, 2004, EUR J NEUROSCI, V19, P1325, DOI 10.1111/j.1460-9568.2004.03210.x; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Bezard E, 1998, PROG NEUROBIOL, V55, P93, DOI 10.1016/S0301-0082(98)00006-9; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Bezard E, 1998, REV NEUROSCIENCE, V9, P71; Bezard E, 1999, EXP NEUROL, V155, P268, DOI 10.1006/exnr.1998.6995; Bezard E, 2006, NEUROBIOL DIS, V23, P77, DOI 10.1016/j.nbd.2006.02.003; BJORKLUND A, 1979, BRAIN RES, V177, P170, DOI 10.1016/0006-8993(79)90927-2; BJORKLUND A, 1973, BRAIN RES, V51, P193, DOI 10.1016/0006-8993(73)90372-7; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; BLESSING WW, 1979, NEUROSCI LETT, V11, P35, DOI 10.1016/0304-3940(79)90052-1; BOURGOIN S, 1993, NEUROPHARMACOLOGY, V32, P633, DOI 10.1016/0028-3908(93)90076-F; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; CARP JS, 1982, BRAIN RES, V242, P247, DOI 10.1016/0006-8993(82)90307-9; Charbit AR, 2009, J NEUROSCI, V29, P12532, DOI 10.1523/JNEUROSCI.2887-09.2009; CHEN PK, J NEUROL NEUROSURG P, V81, P524; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; Clemens S, 2004, J NEUROSCI, V24, P11337, DOI 10.1523/JNEUROSCI.3698-04.2004; Clemens S, 2006, NEUROLOGY, V67, P125, DOI 10.1212/01.wnl.0000223316.53428.c9; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; Cuenca N, 2005, J COMP NEUROL, V493, P261, DOI 10.1002/cne.20761; d'Onofrio F, 2008, NEUROL SCI, V29, pS169, DOI 10.1007/s10072-008-0916-3; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; DEARRY A, 1990, NATURE, V347, P72, DOI 10.1038/347072a0; DUBOIS A, 1986, NEUROSCIENCE, V19, P125, DOI 10.1016/0306-4522(86)90010-2; Emborg ME, 2006, NEUROBIOL DIS, V23, P281, DOI 10.1016/j.nbd.2006.03.010; Ershov PV, 2002, J COMP NEUROL, V446, P114, DOI 10.1002/cne.10173; FLEETWOODWALKER SM, 1988, J PHYSIOL-LONDON, V399, P335; FUXE K, 1965, ACTA PHYSL SCAND S, V247; Gao X, 2001, BRAIN RES BULL, V54, P391, DOI 10.1016/S0361-9230(00)00460-3; Garraway SM, 2001, J NEUROPHYSIOL, V86, P2183, DOI 10.1152/jn.2001.86.5.2183; Gerin C, 1998, BRAIN RES, V794, P169, DOI 10.1016/S0006-8993(98)00278-9; Gerin C, 1995, BRAIN RES, V704, P191, DOI 10.1016/0006-8993(95)01111-0; GIROS B, 1992, MOL PHARMACOL, V42, P383; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; Guigoni C, 2005, EUR J NEUROSCI, V22, P283, DOI 10.1111/j.1460-9568.2005.04196.x; HABER SN, 1995, J COMP NEUROL, V362, P400, DOI 10.1002/cne.903620308; Han P, 2007, J NEUROSCI, V27, P13192, DOI 10.1523/JNEUROSCI.1279-07.2007; Hening W, 1999, SLEEP, V22, P970; HOKFELT T, 1979, ACTA PHYSIOL SCAND, V107, P393, DOI 10.1111/j.1748-1716.1979.tb06491.x; Holstege JC, 1996, J COMP NEUROL, V376, P631, DOI 10.1002/(SICI)1096-9861(19961223)376:4<631::AID-CNE10>3.0.CO;2-P; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Karasawa N, 1995, NEUROSCI RES, V24, P67, DOI 10.1016/0168-0102(95)00976-0; Karasawa N, 2007, ACTA HISTOCHEM CYTOC, V40, P83, DOI 10.1267/ahc.06019; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Kitahama K, 1998, J CHEM NEUROANAT, V16, P43, DOI 10.1016/S0891-0618(98)00060-X; Lapointe NP, 2008, J NEUROPHYSIOL, V100, P160, DOI 10.1152/jn.90339.2008; Lapointe NP, 2009, J PHYSIOL-LONDON, V587, P1499, DOI 10.1113/jphysiol.2008.166314; Levant B, 2001, NEUROSCI LETT, V303, P9, DOI 10.1016/S0304-3940(01)01692-5; Liang CL, 1996, NEURODEGENERATION, V5, P313, DOI 10.1006/neur.1996.0042; LORANG D, 1994, J NEUROSCI, V14, P4903; MARKEY SP, 1984, NATURE, V311, P464, DOI 10.1038/311464a0; McEwen ML, 1997, BEHAV NEUROSCI, V111, P825, DOI 10.1037/0735-7044.111.4.825; Meister B, 1988, J Chem Neuroanat, V1, P59; MEN DS, 1994, BRAIN RES BULL, V33, P625, DOI 10.1016/0361-9230(94)90225-9; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONS N, 1989, SYNAPSE, V4, P99, DOI 10.1002/syn.890040203; Moreau MS, 2002, BRAIN, V125, P2125, DOI 10.1093/brain/awf201; Okura M, 2004, NEUROBIOL DIS, V16, P274, DOI 10.1016/j.nbd.2004.02.008; ONALI P, 1985, MOL PHARMACOL, V28, P138; Ondo WG, 2000, MOVEMENT DISORD, V15, P154, DOI 10.1002/1531-8257(200001)15:1<154::AID-MDS1025>3.0.CO;2-Q; PIFL C, 1991, NEUROSCIENCE, V44, P591, DOI 10.1016/0306-4522(91)90080-8; Qu S, 2006, EXP BRAIN RES, V168, P152, DOI 10.1007/s00221-005-0075-1; Rhode AM, 2007, CEPHALALGIA, V27, P1255, DOI 10.1111/j.1468-2982.2007.01453.x; RIDET JL, 1992, BRAIN RES, V598, P233, DOI 10.1016/0006-8993(92)90188-F; SCHILLING C, MOV DISORD, V25, P1047; Scholz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001589; SKAGERBERG G, 1985, BRAIN RES, V342, P340, DOI 10.1016/0006-8993(85)91134-5; SKAGERBERG G, 1982, BRAIN RES BULL, V9, P237, DOI 10.1016/0361-9230(82)90136-8; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; Spiga S, 2008, ANN NY ACAD SCI, V1139, P299, DOI 10.1196/annals.1432.008; Stiasny-Kolster K, 2004, BRAIN, V127, P773, DOI 10.1093/brain/awh079; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; Tamae A, 2005, J PHYSIOL-LONDON, V568, P243, DOI 10.1113/jphysiol.2005.091843; TISON F, 1991, J NEURAL TRANSM-PARK, V3, P27, DOI 10.1007/BF02251134; TISON F, 1990, HISTOCHEMISTRY, V93, P655, DOI 10.1007/BF00272209; Ugrumov MV, 2009, J CHEM NEUROANAT, V38, P241, DOI 10.1016/j.jchemneu.2009.08.004; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; vanDijken H, 1996, EUR J NEUROSCI, V8, P621; Weihe E, 2006, CELL MOL NEUROBIOL, V26, P659, DOI 10.1007/s10571-006-9053-9; WEILFUGAZZA J, 1993, BRAIN RES BULL, V30, P319, DOI 10.1016/0361-9230(93)90259-E; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WESTLUND KN, 1980, BRAIN RES REV, V2, P235, DOI 10.1016/0165-0173(80)90009-0; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821; Yang HW, 2005, J NEUROPHYSIOL, V94, P961, DOI 10.1152/jn.01324.2004; YOKOYAMA C, 1994, J COMP NEUROL, V344, P121, DOI 10.1002/cne.903440109; Zhao HR, 2007, J NEUROSCI RES, V85, P1065, DOI 10.1002/jnr.21207; Zhu H, 2007, NEUROSCIENCE, V149, P885, DOI 10.1016/j.neuroscience.2007.07.052	98	69	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13306	10.1371/journal.pone.0013306	http://dx.doi.org/10.1371/journal.pone.0013306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967255	Green Published, gold, Green Submitted			2022-12-25	WOS:000282869800014
J	Rapp, JB; Noguchi, C; Das, MM; Wong, LK; Ansbach, AB; Holmes, AM; Arcangioli, B; Noguchi, E				Rapp, Jordan B.; Noguchi, Chiaki; Das, Mukund M.; Wong, Lisa K.; Ansbach, Alison B.; Holmes, Allyson M.; Arcangioli, Benoit; Noguchi, Eishi			Checkpoint-Dependent and -Independent Roles of Swi3 in Replication Fork Recovery and Sister Chromatid Cohesion in Fission Yeast	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE CHECKPOINT; SCHIZOSACCHAROMYCES-POMBE; S-PHASE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; INTERACTING PROTEIN; PROTECTION COMPLEX; RESPONSE PATHWAY; EUKARYOTIC DNA	Multiple genome maintenance processes are coordinated at the replication fork to preserve genomic integrity. How eukaryotic cells accomplish such a coordination is unknown. Swi1 and Swi3 form the replication fork protection complex and are involved in various processes including stabilization of replication forks, activation of the Cds1 checkpoint kinase and establishment of sister chromatid cohesion in fission yeast. However, the mechanisms by which the Swi1-Swi3 complex achieves and coordinates these tasks are not well understood. Here, we describe the identification of separation-of-function mutants of Swi3, aimed at dissecting the molecular pathways that require Swi1-Swi3. Unlike swi3 deletion mutants, the separation-of-function mutants were not sensitive to agents that stall replication forks. However, they were highly sensitive to camptothecin that induces replication fork breakage. In addition, these mutants were defective in replication fork regeneration and sister chromatid cohesion. Interestingly, unlike swi3-deleted cell, the separation-of-functions mutants were proficient in the activation of the replication checkpoint, but their fork regeneration defects were more severe than those of checkpoint mutants including cds1 Delta, chk1 Delta and rad3 Delta. These results suggest that, while Swi3 mediates full activation of the replication checkpoint in response to stalled replication forks, Swi3 activates a checkpoint-independent pathway to facilitate recovery of collapsed replication forks and the establishment of sister chromatid cohesion. Thus, our separation-of-function alleles provide new insight into understanding the multiple roles of Swi1-Swi3 in fork protection during DNA replication, and into understanding how replication forks are maintained in response to different genotoxic agents.	[Rapp, Jordan B.; Noguchi, Chiaki; Das, Mukund M.; Wong, Lisa K.; Ansbach, Alison B.; Noguchi, Eishi] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA; [Holmes, Allyson M.; Arcangioli, Benoit] Inst Pasteur, Unite Dynam Genome, CNRS, URA 1644,Dept Struct & Dynam Genomes, Paris, France	Drexel University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rapp, JB (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA.	enoguchi@drexelmed.edu	Noguchi, Eishi/E-7283-2013; Noguchi, Eishi/AAF-3986-2021	Noguchi, Eishi/0000-0001-5470-5127; Lee, Lisa/0000-0001-5857-9260	Leukemia Research Foundation; National Institutes of Health [GM077604]; American Recovery and Reinvestment Act of 2009 [R01GM077604-S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077604] Funding Source: NIH RePORTER	Leukemia Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act of 2009; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from Leukemia Research Foundation (to E.N.) and National Institutes of Health (GM077604, to E.N.). This work was also supported by The American Recovery and Reinvestment Act of 2009 (R01GM077604-S1, to E.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Alfa C., 1993, EXPT FISSION YEAST; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Ansbach AB, 2008, MOL BIOL CELL, V19, P595, DOI 10.1091/mbc.E07-06-0618; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Branzei D, 2007, DNA REPAIR, V6, P994, DOI 10.1016/j.dnarep.2007.02.018; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Carr AM, 2002, DNA REPAIR, V1, P983, DOI 10.1016/S1568-7864(02)00165-9; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; ICHIHARA Y, 1993, GENE, V130, P153, DOI 10.1016/0378-1119(93)90361-6; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kaykov A, 2004, EMBO J, V23, P930, DOI 10.1038/sj.emboj.7600099; KEENEY JB, 1994, GENETICS, V136, P849; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; Lee BS, 2004, MOL CELL BIOL, V24, P9813, DOI 10.1128/MCB.24.22.9813-9822.2004; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Noguchi C, 2007, GENETICS, V175, P553, DOI 10.1534/genetics.106.065334; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Noguchi Eishi, 2009, V521, P493, DOI [10.1007/978-1-60327-817-5_28, 10.1007/978-1-60327-815-7_28]; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Paciotti V, 2001, MOL CELL BIOL, V21, P3913, DOI 10.1128/MCB.21.12.3913-3925.2001; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Pryce DW, 2009, P NATL ACAD SCI USA, V106, P4770, DOI 10.1073/pnas.0807739106; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; Silverstein RA, 2003, CURR BIOL, V13, P68, DOI 10.1016/S0960-9822(02)01401-X; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sommariva E, 2005, MOL CELL BIOL, V25, P2770, DOI 10.1128/MCB.25.7.2770-2784.2005; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Tatebayashi K, 1998, GENETICS, V148, P49; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; UNSALKACMAZ K, 2007, MOL CELL BIOL; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Wang SW, 2002, J CELL SCI, V115, P587; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Wolkow TD, 2002, MOL BIOL CELL, V13, P480, DOI 10.1091/mbc.01-03-0104; WOODS A, 1989, J CELL SCI, V93, P491; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	66	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13379	10.1371/journal.pone.0013379	http://dx.doi.org/10.1371/journal.pone.0013379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967229	Green Submitted, Green Published, gold			2022-12-25	WOS:000282807300033
J	Guo, ZW; Zhang, L; Li, YM				Guo, Zhongwei; Zhang, Lin; Li, Yiming			Increased Dependence of Humans on Ecosystem Services and Biodiversity	PLOS ONE			English	Article							ENVIRONMENTAL-CHANGE; FOREST CONSERVATION; ECONOMIC INCENTIVES; DIVERSITY; PROSPECTS; IMPACTS; ECOLOGY; SUPPORT	Humans have altered ecosystems more rapidly and extensively than ever, largely to meet rapidly growing demands for resources along with economic development. These demands have been considered important drivers of ecosystem degradation and biodiversity loss. Are humans becoming less dependent on ecosystem services and biodiversity following economic development? Here, we used roundwood production, hydroelectricity generation and tourism investment in 92 biodiversity hotspot and 60 non-hotspot countries as cases to seek the answer. In 1980-2005, annual growth rates of roundwood production, hydroelectricity generation and tourism investment were higher in hotspot countries (5.2, 9.1 and 7.5%) than in non-hotspot countries (3.4, 5.9 and 5.6%), when GDP grew more rapidly in hotspot countries than non-hotspot countries. Annual growth rates of per capita hydropower and per capita tourism investment were higher in hotspot countries (5.3% and 6.1%) than in non-hotspot countries (3.5% and 4.3%); however, the annual growth rate of per capita roundwood production in hotspot countries (1%) was lower than in non-hotspot countries (1.4%). The dependence of humans on cultural services has increased more rapidly than on regulating services, while the dependence on provisioning services has reduced. This pattern is projected to continue during 2005-2020. Our preliminary results show that economic growth has actually made humans more dependent upon ecosystem services and biodiversity. As a consequence, the policies and implementations of both economic development and ecosystems/biodiversity conservation should be formulated and carried out in the context of the increased dependence of humans on ecosystem services along with economic development.	[Guo, Zhongwei; Zhang, Lin; Li, Yiming] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Guo, ZW (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	guozw@ioz.ac.cn			National Natural Science Fund of China [30670369]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	The project was supported by programs of National Natural Science Fund of China (#30670369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2000, ECOL ECON, V35, P63, DOI 10.1016/S0921-8009(00)00168-3; Aide TM, 2004, SCIENCE, V305, P1915, DOI 10.1126/science.1103179; [Anonymous], 2005, EC HUM WELL BEING SY; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Balvanera P, 2001, SCIENCE, V291, P2047, DOI 10.1126/science.291.5511.2047; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Brown C., 2000, GLOBAL OUTLOOK FUTUR; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Costanza R, 2007, ECOL ECON, V61, P478, DOI 10.1016/j.ecolecon.2006.03.021; Cowling RM, 2008, P NATL ACAD SCI USA, V105, P9483, DOI 10.1073/pnas.0706559105; Daily G. C., 2002, NEW EC NATURE QUEST; Daily G C, 1997, NATURES SERVICES SOC, P365; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Goldman RL, 2008, P NATL ACAD SCI USA, V105, P9445, DOI 10.1073/pnas.0800208105; Guo ZW, 2007, ECOL APPL, V17, P1557, DOI 10.1890/06-0840.1; Heal G.M., 2000, NATURE MARKETPLACE C; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Janzen D, 1998, SCIENCE, V279, P1312, DOI 10.1126/science.279.5355.1312; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Kremen C, 2000, SCIENCE, V288, P1828, DOI 10.1126/science.288.5472.1828; Maeler KG, 2008, P NATL ACAD SCI USA, V105, P9501, DOI 10.1073/pnas.0708856105; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; McDaniel CN, 2002, BIOSCIENCE, V52, P929, DOI 10.1641/0006-3568(2002)052[0929:IHEUCB]2.0.CO;2; Milton SJ, 2003, FRONT ECOL ENVIRON, V1, P247, DOI 10.1890/1540-9295(2003)001[0247:EIFRNC]2.0.CO;2; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; Tallis H, 2008, P NATL ACAD SCI USA, V105, P9457, DOI 10.1073/pnas.0705797105; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	33	126	138	7	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13113	10.1371/journal.pone.0013113	http://dx.doi.org/10.1371/journal.pone.0013113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957042	Green Published, Green Submitted, gold			2022-12-25	WOS:000282359300015
J	Robinson, E; Kur, LW; Ndyaba, A; Lado, M; Shafi, J; Kabare, E; McClelland, RS; Kolaczinski, JH				Robinson, Emily; Kur, Lucia W.; Ndyaba, Aggrey; Lado, Mounir; Shafi, Juma; Kabare, Emmanuel; McClelland, R. Scott; Kolaczinski, Jan H.			Trachoma Rapid Assessments in Unity and Northern Bahr-el-Ghazal States, Southern Sudan	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; PREVALENCE; DIAGNOSIS; AZITHROMYCIN; INFECTION; SEVERITY	Background: Trachoma is thought to be endemic over large parts of Southern Sudan, but empirical evidence is limited. While some areas east of the Nile have been identified as highly endemic, few trachoma surveys have been conducted in the remainder of the country. This study aimed to determine whether trachoma constitutes a problem to public health in Northern Bahr-el-Ghazal and Unity State, both located west of the Nile. Methods and Principal Findings: Trachoma rapid assessments (TRA) were conducted between July and September 2009. Seven villages in Northern Bahr-el-Ghazal State and 13 villages in Unity State were surveyed; an average of 50 children (age 1-9 years) and 44 women (age 15 years and above) were examined per village. Samples for analysis using the APTIMA Combo-2 nucleic acid amplification test (NAAT) were collected from participants with active trachoma in eight villages in Unity State. In Northern Bahr-el-Ghazal State, only three children with active trachoma (trachomatous inflammation follicular (TF) and/or trachomatous inflammation intense (TI)) and two women with trichiasis (TT) were found, in two of the seven villages surveyed. In Unity State, trachoma was endemic in all thirteen villages surveyed; the proportion of children with active trachoma ranged from 33% to 75% between villages, while TF in children ranged from 16% to 44%. Between 4% to 51% of examined women showed signs of TT. Samples from active trachoma cases tested using the NAAT were positive for Chlamydia trachomatis infection for 46.6% of children and 19.0% of women. Conclusions: Trachoma presents a major problem to public health Unity State, while the disease is of low priority in Northern-Bahr-el-Ghazal State. Implementation of a population-based prevalence survey is now required in Unity State to generate baseline prevalence data so that trachoma interventions can be initiated and monitored over time.	[Robinson, Emily; Ndyaba, Aggrey; Kolaczinski, Jan H.] Malaria Consortium, Africa Reg Off, Kampala, Uganda; [Kur, Lucia W.; Lado, Mounir] Govt So Sudan, Minist Hlth, Juba, Sudan; [Shafi, Juma; Kabare, Emmanuel] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [McClelland, R. Scott] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Kolaczinski, Jan H.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England	University of Nairobi; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine	Kolaczinski, JH (corresponding author), Malaria Consortium, Africa Reg Off, Kampala, Uganda.	j.kolaczinski@malariaconsortium.org			UK Department for International Development (DFID)	UK Department for International Development (DFID)	The work presented here was funded by the UK Department for International Development (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khatib T. K., 2006, Eastern Mediterranean Health Journal, V12, P566; Assefa T, 2001, TROP DOCT, V31, P202, DOI 10.1177/004947550103100406; Baral K, 1999, B WORLD HEALTH ORGAN, V77, P461; BOBO L, 1991, LANCET, V338, P847, DOI 10.1016/0140-6736(91)91502-L; Brooker S, 2009, PARASITOLOGY, V136, P1707, DOI 10.1017/S0031182009005940; Burton MJ, 2007, BRIT MED BULL, V84, P99, DOI 10.1093/bmb/ldm034; Clements ACA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000799; DESOLE G, 1987, BRIT J OPHTHALMOL, V71, P873, DOI 10.1136/bjo.71.11.873; Diamant J, 2001, Ophthalmic Epidemiol, V8, P109, DOI 10.1076/opep.8.2.109.4156; *GEN PROB INC, 2009, APTIMA COMBO 2 ASSAY; Khanduja S, 2009, OPHTHAL EPIDEMIOL, V16, P206, DOI [10.1080/09286580902999389, 10.3109/09286580902999389]; King JD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000299; Kur LW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000492; Lansingh VC, 2007, SURV OPHTHALMOL, V52, P535, DOI 10.1016/j.survophthal.2007.06.007; Limburg H, 2001, Ophthalmic Epidemiol, V8, P73, DOI 10.1076/opep.8.2.73.4157; Liu HS, 2002, OPHTHALMIC EPIDEMIOL, V9, P97, DOI 10.1076/opep.9.2.97.1521; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Mathew AA, 2009, BRIT J OPHTHALMOL, V93, P866, DOI 10.1136/bjo.2008.151720; Mathew AA, 2009, DRUGS, V69, P953, DOI 10.2165/00003495-200969080-00002; Negrel A D, 1999, Community Eye Health, V12, P51; NEGREL AD, 2001, GUID RAP ASS BLIND T; Ngondi J, 2006, PLOS MED, V3, P2424, DOI 10.1371/journal.pmed.0030478; Ngondi J, 2007, AM J TROP MED HYG, V77, P126, DOI 10.4269/ajtmh.2007.77.126; Ngondi J, 2009, B WORLD HEALTH ORGAN, V87, P143, DOI 10.2471/BLT.07.046326; Paxton A, 2001, Ophthalmic Epidemiol, V8, P87; Polack S, 2005, B WORLD HEALTH ORGAN, V83, P913; Rabiu M M, 2001, Ophthalmic Epidemiol, V8, P263; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rumunu J, 2009, TRENDS PARASITOL, V25, P301, DOI 10.1016/j.pt.2009.03.011; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; SCHACHTER J, 2010, 110 GEN M AM SOC MIC; Solomon AW, 2008, NEW ENGL J MED, V358, P1870, DOI 10.1056/NEJMc0706263; Solomon AW, 2004, CLIN MICROBIOL REV, V17, P982, DOI 10.1128/CMR.17.4.982-1011.2004; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; VICKERY L, 2006, 106 GEN M AM SOC MIC; WHO, 1993, PRIM HLTH CAR LEV MA PRIM HLTH CAR LEV MA; World Health Organization London School of Hygiene and Tropical Medicine International Trachoma Inititative, 2006, TRACH GUID PROGR MAN; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; Wright HR, 2005, BRIT J OPHTHALMOL, V89, P526, DOI 10.1136/bjo.2005.066183; Yang JL, 2007, BRIT J OPHTHALMOL, V91, P293, DOI 10.1136/bjo.2006.099150; Yang JL, 2009, INVEST OPHTH VIS SCI, V50, P90, DOI 10.1167/iovs.08-2247	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13138	10.1371/journal.pone.0013138	http://dx.doi.org/10.1371/journal.pone.0013138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957205	gold, Green Published			2022-12-25	WOS:000282359300027
J	Belloni, E; Veronesi, G; Micucci, C; Javan, S; Minardi, SP; Venturini, E; Maisonneuve, P; Volorio, S; Riboni, M; Bellomi, M; Scanagatta, P; Taliento, G; Pelosi, G; Pece, S; Spaggiari, L; Pelicci, PG				Belloni, E.; Veronesi, G.; Micucci, C.; Javan, S.; Minardi, S. P.; Venturini, E.; Maisonneuve, P.; Volorio, S.; Riboni, M.; Bellomi, M.; Scanagatta, P.; Taliento, G.; Pelosi, G.; Pece, S.; Spaggiari, L.; Pelicci, P. G.			Genomic characterization of asymptomatic CT-detected lung cancers	ONCOGENE			English	Article						whole genome analysis; early diagnosis; cancer	SPIRAL COMPUTED-TOMOGRAPHY; ARYL-HYDROCARBON RECEPTOR; BASE-LINE; INDOLEAMINE 2,3-DIOXYGENASE; MOLECULAR-ORIGINS; ADENOCARCINOMA; EPIDEMIC; SMOKERS; NODULES; DNA	Computed tomography (CT) screening of lung cancer allows the detection of early tumors. The objective of our study was to verify whether initial asymptomatic lung cancers, identified by high-resolution low-dose CT (LD-CT) on a high-risk population, show genetic abnormalities that could be indicative of the early events of lung carcinogenesis. We analyzed 78 tumor samples: 21 (pilot population) from heavy smokers with asymptomatic non-screening detected early-stage lung cancers and 57 from 5203 asymptomatic heavy smoker volunteers, who underwent a LD-CT screening study. During surgical resection of the detected tumors, tissue samples were collected and short-term cultures were started for karyotype evaluation. Samples were classified according to the normal (NK) or aneuploid (AK) karyotype. The NK samples were further analyzed by the Affymetrix single-nucleotide polymorphisms (SNPs) technology. Metaphase spreads were obtained in 73.0% of the selected samples: 80.7% showed an AK. A statistically significant correlation was found between presence of vascular invasion and abnormal karyotype. A total of 10 NK samples were suitable for SNPs analysis. Subtle genomic alterations were found in eight tumors, the remaining two showing no evidence to date of chromosomal aberrations anywhere in the genome. Two common regions of amplification were identified at 5p and 8p11. Mutation analysis by direct sequencing was conducted for the K-RAS, TP53 and EGFR genes, confirming data already described for heavy smokers. We show that: (i) the majority of screening-detected tumors are aneuploid; (ii) early-stage tumors tend to harbor a less abnormal karyotype; (iii) whole genome analysis of NK tumors allows for the detection of common regions of copy number variation (such as amplifications at 5p and 8p11), highlighting genes that might be considered candidate markers of early events in lung carcinogenesis. Oncogene (2011) 30, 1117-1126; doi:10.1038/onc.2010.478; published online 25 October 2010	[Belloni, E.; Micucci, C.; Javan, S.; Volorio, S.; Riboni, M.; Pece, S.; Pelicci, P. G.] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Veronesi, G.; Scanagatta, P.; Taliento, G.; Spaggiari, L.] European Inst Oncol, Div Thorac Surg, I-20141 Milan, Italy; [Minardi, S. P.; Venturini, E.; Volorio, S.; Riboni, M.] Cogentech, Milan, Italy; [Maisonneuve, P.] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [Bellomi, M.] European Inst Oncol, Div Radiol, Milan, Italy; [Pelosi, G.] European Inst Oncol, Div Pathol, Milan, Italy; [Pece, S.; Spaggiari, L.; Pelicci, P. G.] Univ Milan, Milan, Italy	IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); University of Milan	Belloni, E (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	elena.belloni@ifom-ieo-campus.it; giulia.veronesi@ieo.it	Pelicci, Pier Giuseppe/AAL-6572-2020; Maisonneuve, Patrick/U-9789-2018; Pece, Salvatore/B-9609-2013; Bellomi, Massimo/AAM-4352-2020; Scanagatta, Paolo/AAX-3226-2020; belloni, elena/H-9909-2013; Veronesi, Giulia/AAA-6327-2021; Spaggiari, Lorenzo/G-7915-2012; Scanagatta, Paolo/I-1215-2013; Pelosi, Giuseppe/F-5073-2012	Maisonneuve, Patrick/0000-0002-5309-4704; Pece, Salvatore/0000-0003-1764-3929; Scanagatta, Paolo/0000-0002-1619-6453; Veronesi, Giulia/0000-0001-9032-1278; Scanagatta, Paolo/0000-0002-1619-6453; Belloni, Elena/0000-0003-3214-0780; Pelosi, Giuseppe/0000-0003-4725-4692; Minardi, Simone Paolo/0000-0001-7303-3821; Spaggiari, Lorenzo/0000-0002-1068-3541	AIRC (Associazione Italiana per la Ricerca sul Cancro); FUV (Fondazione Umberto Veronesi); Eredita' Benilde Viotti	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); FUV (Fondazione Umberto Veronesi)(Fondazione Umberto Veronesi); Eredita' Benilde Viotti	This study was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro), FUV (Fondazione Umberto Veronesi) and Eredita' Benilde Viotti. We would like to thank Daniela Brambilla, Raffaella Bertolotti and Giovanna Ciambrone for data managing; Antonio De Vito and Loris Bernard for technical assistance; the Real Time PCR Service at the IFOM-IEO campus for TaqMan assays; Marco Bianchi, Giovanna Maria Jodice, Paolo Nuciforo and the Molecular Pathology Unit at IFOM for samples characterization; Elvira Gerbino for samples preparation; the staff of the IEO Thoracic Surgery and Radiology Departments for clinical assistance; Paola Dalton for manuscript editing; Francesca Toffalorio for helpful discussion.	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bianchi F, 2004, CLIN CANCER RES, V10, P6023, DOI 10.1158/1078-0432.CCR-04-0619; Diederich S, 2004, EUR RADIOL, V14, P691, DOI 10.1007/s00330-003-2200-5; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ebi H, 2009, ONCOGENE, V28, P3371, DOI 10.1038/onc.2009.201; Enstrom JE, 1999, EPIDEMIOLOGY, V10, P500, DOI 10.1097/00001648-199909000-00007; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Horner MJ, 2009, SEER CANC STAT REV 1; Humphrey LL, 2004, ANN INTERN MED, V140, P740, DOI 10.7326/0003-4819-140-9-200405040-00015; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitsuuchi Y, 2002, AM J MED GENET, V115, P183, DOI 10.1002/ajmg.10692; Mulshine JL, 2005, NEW ENGL J MED, V352, P2714, DOI 10.1056/NEJMcp042630; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Nguyen-Khac F, 2006, ONCOGENE, V25, P4840, DOI 10.1038/sj.onc.1209503; Patel JD, 2004, JAMA-J AM MED ASSOC, V291, P1763, DOI 10.1001/jama.291.14.1763; Pelosi G, 2008, LUNG CANCER, V62, P202, DOI 10.1016/j.lungcan.2008.03.012; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Puppala D, 2007, CARCINOGENESIS, V28, P639, DOI 10.1093/carcin/bgl169; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Veronesi G, 2008, LUNG CANCER, V61, P340, DOI 10.1016/j.lungcan.2008.01.001; Veronesi G, 2007, ANN THORAC SURG, V84, P959, DOI 10.1016/j.athoracsur.2007.04.058; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	31	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	9					1117	1126		10.1038/onc.2010.478	http://dx.doi.org/10.1038/onc.2010.478			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	729PX	20972464				2022-12-25	WOS:000287964100010
J	Jin, DZ; Guo, H; Bu, SY; Zhang, YY; Hannaford, J; Mashek, DG; Chen, XL				Jin, Daozhong; Guo, Hong; Bu, So Young; Zhang, Yuanyuan; Hannaford, Jennifer; Mashek, Douglas G.; Chen, Xiaoli			Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-gamma activation and function in lipid homeostasis and energy expenditure	FASEB JOURNAL			English	Article						rosiglitazone; brown adipose tissue; thermogenesis; insulin sensitization	BROWN ADIPOCYTE DIFFERENTIATION; INDUCED INSULIN-RESISTANCE; TYPE-2 DIABETIC-PATIENTS; ADIPOSE-TISSUE; THIAZOLIDINEDIONES; ROSIGLITAZONE; PIOGLITAZONE; OBESITY; FAT; GLYCERONEOGENESIS	We have previously identified lipocalin 2 (Lcn2) as a cytokine playing a critical role in the regulation of body fat mass, lipid metabolism, and insulin resistance. Lcn2 deficiency reduces PPAR gamma gene expression in adipocytes. In this study, we investigated the role of Lcn2 in PPAR gamma activation and function via assessing the insulin sensitization and fatty acid (FA) homeostasis of PPAR gamma agonist in high-fat diet (HFD)-induced obesity in Lcn2(-/-) mice. We found that rosiglitazone (Rosi) significantly improved insulin sensitivity in Lcn2(-/-) mice as effectively as in wild-type (WT) mice; unfed-state levels of blood glucose, free FAs, and triglycerides (TGs) were significantly reduced after a 25-d treatment of Rosi in Lcn2(-/-) mice. However, Rosi action on fat deposition and FA homeostasis was altered; Rosi-induced body weight and subcutaneous fat gain and liver lipid accumulation were markedly lessened in Lcn2(-/-) mice. The results of in vivo metabolic labeling showed that Rosi markedly reduced de novo lipogenesis in adipose tissue of Lcn2(-/-) mice. In brown adipose tissue (BAT), the expression of the genes functioning in TG hydrolysis and mitochondrial oxidation was up-regulated more in Lcn2(-/-) than in WT mice. Most strikingly, Rosi stimulated significantly higher levels of uncoupling protein-1 expression in BAT, and completely rescued cold intolerance in Lcn2(-/-) mice. We demonstrate that Lcn2 is a critical selective modulator of PPAR gamma activation and function in lipid homeostasis and energy expenditure.-Jin, D., Guo, H., Bu, Y. S., Zhang, Y., Hannaford, J., Mashek, D. G., Chen, X. Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-gamma activation and function in lipid homeostasis and energy expenditure. FASEB J. 25, 754-764 (2011). www.fasebj.org	[Jin, Daozhong; Guo, Hong; Bu, So Young; Zhang, Yuanyuan; Hannaford, Jennifer; Mashek, Douglas G.; Chen, Xiaoli] Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Chen, XL (corresponding author), Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN 55108 USA.	xlchen@umn.edu	Mashek, Douglas/ABD-6844-2021; Zhang, Yuanyuan/M-9602-2014	Zhang, Yuanyuan/0000-0002-5894-5387; Mashek, Douglas/0000-0001-7033-3386	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK080743]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080743] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project described was supported by grant R01DK080743 (to X. C.) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDDK or the National Institutes of Health. The authors thank Wendy Wright for assistance in mouse breeding and colony maintenance and Dr. David A. Bernlohr (Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota) for providing the critical comments on the manuscript.	Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boden G, 2005, DIABETES, V54, P880, DOI 10.2337/diabetes.54.3.880; Burkey BF, 2000, METABOLISM, V49, P1301, DOI 10.1053/meta.2000.9524; Cadoudal T, 2007, DIABETOLOGIA, V50, P666, DOI 10.1007/s00125-006-0560-5; Camirand A, 1998, ENDOCRINOLOGY, V139, P428, DOI 10.1210/en.139.1.428; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; DIETSCHY JM, 1984, J LIPID RES, V25, P1469; Fukui Y, 2000, DIABETES, V49, P759, DOI 10.2337/diabetes.49.5.759; Gastaldelli A, 2006, J CLIN ENDOCR METAB, V91, P806, DOI 10.1210/jc.2005-1159; Gregoire FM, 2009, MOL ENDOCRINOL, V23, P975, DOI 10.1210/me.2008-0473; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Guo H, 2010, DIABETES, V59, pA370; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kohlroser J, 2000, AM J GASTROENTEROL, V95, P272; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Kramer D, 2001, METABOLISM, V50, P1294, DOI 10.1053/meta.2001.27202; Laplante M, 2006, DIABETES, V55, P2771, DOI 10.2337/db06-0551; Lessard SJ, 2007, DIABETES, V56, P1856, DOI 10.2337/db06-1065; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Matsuda J, 1998, DIABETES, V47, pA431; Miyazaki Y, 2001, DIABETES CARE, V24, P710, DOI 10.2337/diacare.24.4.710; Miyazaki Y, 2001, DIABETOLOGIA, V44, pA37; Mori Y, 1999, DIABETES CARE, V22, P908, DOI 10.2337/diacare.22.6.908; Rabelo R, 1997, ENDOCRINOLOGY, V138, P5325, DOI 10.1210/en.138.12.5325; Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200; Reginato MJ, 1998, J BIOL CHEM, V273, P32679, DOI 10.1074/jbc.273.49.32679; Rennings AJM, 2006, DIABETES CARE, V29, P581, DOI 10.2337/diacare.29.03.06.dc05-01467; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Smith SR, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2004.07.008; Tai TAC, 1996, J BIOL CHEM, V271, P29909, DOI 10.1074/jbc.271.47.29909; Tan BK, 2009, DIABETES CARE, V32, P129, DOI 10.2337/dc08-1236; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; WEBER TM, 1988, INSULIN RECEPTOR; Xiang CC, 2007, DIABETOLOGIA, V50, P1070, DOI 10.1007/s00125-007-0626-z; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420	38	66	68	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					754	764		10.1096/fj.10-165175	http://dx.doi.org/10.1096/fj.10-165175			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20974668	Green Published			2022-12-25	WOS:000286724800032
J	Maldonado-Perez, D; Golightly, E; Denison, FC; Jabbour, HN; Norman, JE				Maldonado-Perez, David; Golightly, Ellen; Denison, Fiona C.; Jabbour, Henry N.; Norman, Jane E.			A role for lipoxin A(4) as anti-inflammatory and proresolution mediator in human parturition	FASEB JOURNAL			English	Article						labor; lipoxin receptor; myometrium; inflammation; proinflammatory cytokines	GENE-EXPRESSION; LIPID MEDIATORS; FETAL MEMBRANES; HUMAN-PREGNANCY; PRETERM LABOR; KAPPA-B; INFLAMMATION; MYOMETRIUM; LEUKOCYTES; RECEPTOR	The purpose of this study was to investigate the role of lipoxin A(4), an anti-inflammatory and proresolution modulator, during human parturition. We measured serum levels of lipoxin A(4) and myometrial protein release using ELISA, quantified lipoxin receptor (FPR2/ALX) mRNA expression using qRT-PCR, and localized protein expression using immuno-histochemstry in myometrial biopsies from pregnant women. In addition, we compared the effects of lipoxin A(4) (100 nM) with vehicle on basal and LPS-stimulated expression of proinflammatory cytokines from samples of myometrium from pregnant women. Mean +/- SE circulating level of lipoxin A(4) was 5.89 +/- 0.63 nM at 24-wk gestation, with a further modest increase during pregnancy (P<0.05), but no differences in gestation matched women before and after labor (P>0.05). Levels of lipoxin A(4) in nonpregnant women were 0.48 +/- 0.04 nM, significantly lower than in pregnant women (P<0.001). FPR2/ALX localized to myocytes and neutrophils, with a 9-fold increase in mRNA expression in labor (P<0.001). Lipoxin A(4) significantly reduced LPS-induced but not basal expression of the proinflammatory cytokines IL-6 and IL-8 in cultured myometrium (P<0.05), compared to vehicle-treated controls. We demonstrate for the first time a potential role for lipoxin A(4) and its receptor in the resolution of the inflammatory events of both physiological and pathological labor.-Maldonado-Perez, D., Golightly, E., Denison, F. C., Jabbour, H. N., Norman, J. E. A role for lipoxin A(4) as anti-inflammatory and proresolution mediator in human parturition. FASEB J. 25, 569-575 (2011). www.fasebj.org	[Norman, Jane E.] Univ Edinburgh, Div Reprod & Dev Sci, Ctr Reprod Biol, Edinburgh EH16 4TJ, Midlothian, Scotland; [Jabbour, Henry N.] Queens Med Res Inst, MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Norman, JE (corresponding author), Univ Edinburgh, Div Reprod & Dev Sci, Ctr Reprod Biol, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	jane.norman@ed.ac.uk	Norman, Jane/B-2347-2010	Norman, Jane/0000-0001-6031-6953; Denison, Fiona/0000-0003-0371-2014	Piggy Bank Kids; Medical Research Council [MC_U127684438, G1002033] Funding Source: researchfish; MRC [G1002033, MC_U127684438] Funding Source: UKRI	Piggy Bank Kids; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Zillah Jones for her help in collecting tissue samples, Linnea Anderson for help in sample preparation, and Ryan Wong for technical support. This work was supported by Piggy Bank Kids.	Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Decker Y, 2009, AM J PHYSIOL-CELL PH, V296, pC1420, DOI 10.1152/ajpcell.00380.2008; Evans J, 2008, ENDOCRINOLOGY, V149, P2877, DOI 10.1210/en.2007-1633; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P822, DOI 10.1016/j.ajog.2006.06.053; Jabbour HN, 2009, REPRODUCTION, V138, P903, DOI 10.1530/REP-09-0247; Jozsef L, 2002, P NATL ACAD SCI USA, V99, P13266, DOI 10.1073/pnas.202296999; Lirussi F, 2008, BIOL REPROD, V78, P497, DOI 10.1095/biolreprod.107.064444; Maderna P, 2010, FASEB J, V24, P4240, DOI 10.1096/fj.10-159913; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Pirianov G, 2009, ENDOCRINOLOGY, V150, P699, DOI 10.1210/en.2008-1178; Reville K, 2006, J IMMUNOL, V176, P1878, DOI 10.4049/jimmunol.176.3.1878; ROMERO R, 1992, AM J OBSTET GYNECOL, V167, P1041, DOI 10.1016/S0002-9378(12)80035-4; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Sales KJ, 2004, MOL ENDOCRINOL, V18, P1533, DOI 10.1210/me.2004-0022; Sehringer B, 2000, J CLIN ENDOCR METAB, V85, P4859, DOI 10.1210/jc.85.12.4859; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P141, DOI 10.1016/j.plefa.2005.05.002; Smith GCS, 2001, MOL HUM REPROD, V7, P587, DOI 10.1093/molehr/7.6.587; Starosta V, 2008, J IMMUNOL, V181, P8688, DOI 10.4049/jimmunol.181.12.8688; Telfer JF, 1997, HUM REPROD, V12, P2306, DOI 10.1093/humrep/12.10.2306; Terrone DA, 2001, OBSTET GYNECOL, V98, P476, DOI 10.1016/S0029-7844(01)01424-7; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Wu SH, 2008, INFLAMM RES, V57, P430, DOI 10.1007/s00011-008-7147-1; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Yuan M, 2009, MOL HUM REPROD, V15, P713, DOI 10.1093/molehr/gap054	26	37	42	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2011	25	2					569	575		10.1096/fj.10-170340	http://dx.doi.org/10.1096/fj.10-170340			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20959513				2022-12-25	WOS:000286724800015
J	Kamada, R; Nomura, T; Anderson, CW; Sakaguchi, K				Kamada, Rui; Nomura, Takao; Anderson, Carl W.; Sakaguchi, Kazuyasu			Cancer-associated p53 Tetramerization Domain Mutants QUANTITATIVE ANALYSIS REVEALS A LOW THRESHOLD FOR TUMOR SUPPRESSOR INACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; OLIGOMERIZATION DOMAIN; MISSENSE MUTATION; CRYSTAL-STRUCTURE; NUCLEAR EXPORT; LI-FRAUMENI; C-TERMINUS; PROTEIN; PHOSPHORYLATION; STABILITY	The tumor suppressor p53, a 393-amino acid transcription factor, induces cell cycle arrest and apoptosis in response to genotoxic stress. Its inactivation via the mutation of its gene is a key step in tumor progression, and tetramer formation is critical for p53 post-translational modification and its ability to activate or repress the transcription of target genes vital in inhibiting tumor growth. About 50% of human tumors have TP53 gene mutations; most are missense ones that presumably lower the tumor suppressor activity of p53. In this study, we explored the effects of known tumor-derived missense mutations on the stability and oligomeric structure of p53; our comprehensive, quantitative analyses encompassed the tetramerization domain peptides representing 49 such substitutions in humans. Their effects on tetrameric structure were broad, and the stability of the mutant peptides varied widely (Delta T-m = 4.8 similar to -46.8 degrees C). Because formation of a tetrameric structure is critical for protein-protein interactions, DNA binding, and the post-translational modification of p53, a small destabilization of the tetrameric structure could result in dysfunction of tumor suppressor activity. We suggest that the threshold for loss of tumor suppressor activity in terms of the disruption of the tetrameric structure of p53 could be extremely low. However, other properties of the tetramerization domain, such as electrostatic surface potential and its ability to bind partner proteins, also may be important.	[Kamada, Rui; Nomura, Takao; Sakaguchi, Kazuyasu] Hokkaido Univ, Fac Sci, Dept Chem, Biol Chem Lab, Sapporo, Hokkaido 0600810, Japan; [Anderson, Carl W.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Hokkaido University; United States Department of Energy (DOE); Brookhaven National Laboratory	Sakaguchi, K (corresponding author), North 10,West 8,Kita Ku, Sapporo, Hokkaido 0600810, Japan.	kazuyasu@sci.hokudai.ac.jp	Kamada, Rui/P-9714-2019	Kamada, Rui/0000-0002-6118-5091	Ministry of Education, Culture, Sports, Science and Technology and Scientific Research [16041202]; Japan Society for the Promotion of Science [21310133, 18310140, 20004981, 19001703]; Brookhaven National Laboratory; U.S. Department of Energy	Ministry of Education, Culture, Sports, Science and Technology and Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Brookhaven National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported in part by Grants-in-aid for Scientific Research on Priority Areas 16041202 from The Ministry of Education, Culture, Sports, Science and Technology and Scientific Research (B) 21310133 and 18310140 from Japan Society for the Promotion of Science (to K. S.), "Molecular and System Life Science" Promotion of Novel Interdisciplinary Fields Based on Nanotechnology and Materials from The Ministry of Education, Culture, Sports, Science and Technology (to K. S.), Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists 20004981 (to R. K.) and 19001703 (to T. N.) from Japan Society for the Promotion of Science, and Program Development funds from the Brookhaven National Laboratory under contract with the U.S. Department of Energy (to C. W. A.).	Atz J, 2000, J CELL BIOCHEM, V76, P572, DOI 10.1002/(SICI)1097-4644(20000315)76:4<572::AID-JCB6>3.0.CO;2-6; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Chene P, 2000, BIOTECHNIQUES, V28, P240; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; CLORE GM, 1995, NAT STRUCT BIOL, V2, P321, DOI 10.1038/nsb0495-321; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Foo RSY, 2007, P NATL ACAD SCI USA, V104, P20826, DOI 10.1073/pnas.0710017104; Hainaut P, 2000, ADV CANCER RES, V77, P81; HALAZONETIS TD, 1993, EMBO J, V12, P5057, DOI 10.1002/j.1460-2075.1993.tb06199.x; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Higashimoto Y, 2006, BIOCHEMISTRY-US, V45, P1608, DOI 10.1021/bi051192j; Imagawa T, 2009, ANAL BIOCHEM, V387, P249, DOI 10.1016/j.ab.2009.01.030; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Itahana Y, 2009, J BIOL CHEM, V284, P5158, DOI 10.1074/jbc.M805696200; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; JOHNSON CR, 1995, BIOCHEMISTRY-US, V34, P5309, DOI 10.1021/bi00016a002; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kawaguchi T, 2005, ONCOGENE, V24, P6976, DOI 10.1038/sj.onc.1208839; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; Maki CG, 1996, CANCER RES, V56, P2649; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Mateu MG, 1998, EMBO J, V17, P2748, DOI 10.1093/emboj/17.10.2748; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Merritt Joshua, 2007, Genomic Med, V1, P113, DOI 10.1007/s11568-007-9011-8; Miller M, 1996, FEBS LETT, V399, P166, DOI 10.1016/S0014-5793(96)01231-8; Nie Y, 2000, MOL CELL BIOL, V20, P741, DOI 10.1128/MCB.20.3.741-748.2000; Nomura T, 2009, BIOPOLYMERS, V91, P78, DOI 10.1002/bip.21084; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Poon GMK, 2007, J MOL BIOL, V365, P1217, DOI 10.1016/j.jmb.2006.10.051; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; Rigacci S, 2008, BIOPHYS J, V94, P3635, DOI 10.1529/biophysj.107.122283; Rollenhagen C, 1998, INT J CANCER, V78, P372, DOI 10.1002/(SICI)1097-0215(19981029)78:3<372::AID-IJC19>3.0.CO;2-8; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Shieh SY, 2000, GENE DEV, V14, P289; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Soussi T, 2005, HUM MUTAT, V25, P6, DOI 10.1002/humu.20114; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; SWANSON JA, 1991, J CELL BIOL, V115, P941, DOI 10.1083/jcb.115.4.941; van Dieck J, 2009, J BIOL CHEM, V284, P13804, DOI 10.1074/jbc.M901351200; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Warnock LJ, 2008, CANCER BIOL THER, V7, P1483, DOI 10.4161/cbt.7.9.6473; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Zambetti GP, 2007, J CELL PHYSIOL, V213, P370, DOI 10.1002/jcp.21217; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	55	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					252	258		10.1074/jbc.M110.174698	http://dx.doi.org/10.1074/jbc.M110.174698			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978130	Green Published, hybrid			2022-12-25	WOS:000285782800028
J	Wang, QY; Wu, HL; Wang, AM; Du, PF; Pei, XL; Li, HF; Yin, XP; Huang, LF; Xiong, XL				Wang, Qiuyan; Wu, Huili; Wang, Anming; Du, Pengfei; Pei, Xiaolin; Li, Haifeng; Yin, Xiaopu; Huang, Lifeng; Xiong, Xiaolong			Prospecting Metagenomic Enzyme Subfamily Genes for DNA Family Shuffling by a Novel PCR-based Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTED EVOLUTION; LIPASE; SEQUENCE; PURIFICATION; DISCOVERY; LIBRARIES	DNA family shuffling is a powerful method for enzyme engineering, which utilizes recombination of naturally occurring functional diversity to accelerate laboratory-directed evolution. However, the use of this technique has been hindered by the scarcity of family genes with the required level of sequence identity in the genome database. We describe here a strategy for collecting metagenomic homologous genes for DNA shuffling from environmental samples by truncated metagenomic gene-specific PCR (TMGS-PCR). Using identified metagenomic gene-specific primers, twenty-three 921-bp truncated lipase gene fragments, which shared 64-99% identity with each other and formed a distinct subfamily of lipases, were retrieved from 60 metagenomic samples. These lipase genes were shuffled, and selected active clones were characterized. The chimeric clones show extensive functional and genetic diversity, as demonstrated by functional characterization and sequence analysis. Our results indicate that homologous sequences of genes captured by TMGS-PCR can be used as suitable genetic material for DNA family shuffling with broad applications in enzyme engineering.	[Wang, Qiuyan; Wu, Huili; Wang, Anming; Du, Pengfei; Pei, Xiaolin; Li, Haifeng; Yin, Xiaopu; Huang, Lifeng] Hangzhou Normal Univ, Ctr Biomed & Hlth, Hangzhou 310012, Zhejiang, Peoples R China; [Xiong, Xiaolong] Hangzhou Normal Univ, Sch Life Sci, Hangzhou 310012, Zhejiang, Peoples R China	Hangzhou Normal University; Hangzhou Normal University	Wang, QY (corresponding author), Hangzhou Normal Univ, Ctr Biomed & Hlth, 222 Wenyi Rd, Hangzhou 310012, Zhejiang, Peoples R China.	qywanghznu@gmail.com	Pei, Xiaolin/ACY-6781-2022		National Natural Science Foundation of China [30900253, 20906016]; Natural Science Foundation of Zhejiang Province [Y4080317]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (30900253, 20906016), and the Natural Science Foundation of Zhejiang Province (Y4080317).	Arnold FH, 1999, CURR OPIN CHEM BIOL, V3, P54, DOI 10.1016/S1367-5931(99)80010-6; Bell PJL, 2002, MICROBIOL-SGM, V148, P2283, DOI 10.1099/00221287-148-8-2283; Bittker JA, 2004, P NATL ACAD SCI USA, V101, P7011, DOI 10.1073/pnas.0402202101; Blow N, 2008, NATURE, V453, P687, DOI 10.1038/453687a; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Chae JC, 2008, FEMS MICROBIOL LETT, V281, P203, DOI 10.1111/j.1574-6968.2008.01106.x; Chang CCJ, 1999, NAT BIOTECHNOL, V17, P793, DOI 10.1038/11737; Chen ZW, 2007, APPL MICROBIOL BIOT, V74, P688, DOI 10.1007/s00253-006-0691-0; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Christians FC, 1999, NAT BIOTECHNOL, V17, P259, DOI 10.1038/7003; Coco WM, 2001, NAT BIOTECHNOL, V19, P354, DOI 10.1038/86744; Cohen N, 2001, TRENDS BIOTECHNOL, V19, P507, DOI 10.1016/S0167-7799(01)01869-8; Cottrell MT, 2005, APPL ENVIRON MICROB, V71, P8506, DOI 10.1128/AEM.71.12.8506-8513.2005; Cowan D, 2005, TRENDS BIOTECHNOL, V23, P321, DOI 10.1016/j.tibtech.2005.04.001; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Ferrer M, 2005, CURR OPIN BIOTECH, V16, P588, DOI 10.1016/j.copbio.2005.09.001; Ferrer M, 2000, J CHEM TECHNOL BIOT, V75, P569, DOI 10.1002/1097-4660(200007)75:7<569::AID-JCTB258>3.0.CO;2-S; Fischer M, 2003, NUCLEIC ACIDS RES, V31, P319, DOI 10.1093/nar/gkg015; Griswold KE, 2005, P NATL ACAD SCI USA, V102, P10082, DOI 10.1073/pnas.0504556102; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Jiang CJ, 2007, BIOCHEM BIOPH RES CO, V357, P421, DOI 10.1016/j.bbrc.2007.03.159; Joern JM, 2002, J MOL BIOL, V316, P643, DOI 10.1006/jmbi.2001.5349; LeCleir GR, 2007, ENVIRON MICROBIOL, V9, P197, DOI 10.1111/j.1462-2920.2006.01128.x; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; Lutz S, 2001, P NATL ACAD SCI USA, V98, P11248, DOI 10.1073/pnas.201413698; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; Ness JE, 1999, NAT BIOTECHNOL, V17, P893, DOI 10.1038/12884; Ostermeier M, 1999, P NATL ACAD SCI USA, V96, P3562, DOI 10.1073/pnas.96.7.3562; Roh C, 2007, LETT APPL MICROBIOL, V44, P475, DOI 10.1111/j.1472-765X.2007.02118.x; Schmidt M, 2005, BIOMOL ENG, V22, P51, DOI 10.1016/j.bioeng.2004.09.004; Sieber V, 2001, NAT BIOTECHNOL, V19, P456, DOI 10.1038/88129; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao HY, 2002, CURR OPIN CHEM BIOL, V6, P858, DOI 10.1016/S1367-5931(02)00396-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tringe SG, 2005, NAT REV GENET, V6, P805, DOI 10.1038/nrg1709; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Wong H, 2002, J LIPID RES, V43, P993, DOI 10.1194/jlr.R200007-JLR200; Yun J, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-8	38	27	30	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41509	41516		10.1074/jbc.M110.139659	http://dx.doi.org/10.1074/jbc.M110.139659			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20962349	hybrid, Green Published			2022-12-25	WOS:000285622600037
J	Albin, JS; LaRue, RS; Weaver, JA; Brown, WL; Shindo, K; Harjes, E; Matsuo, H; Harris, RS				Albin, John S.; LaRue, Rebecca S.; Weaver, Jessalyn A.; Brown, William L.; Shindo, Keisuke; Harjes, Elena; Matsuo, Hiroshi; Harris, Reuben S.			A Single Amino Acid in Human APOBEC3F Alters Susceptibility to HIV-1 Vif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIRETROVIRAL ACTIVITY; RESTRICTION; SENSITIVITY; VARIANTS; HOST; DNA; IDENTIFICATION; DEAMINATION; INHIBITION; REPERTOIRE	Human APOBEC3F (huA3F) potently restricts the infectivity of HIV-1 in the absence of the viral accessory protein virion infectivity factor (Vif). Vif functions to preserve viral infectivity by triggering the degradation of huA3F but not rhesus macaque A3F (rhA3F). Here, we use a combination of deletions, chimeras, and systematic mutagenesis between huA3F and rhA3F to identify Glu(324) as a critical determinant of huA3F susceptibility to HIV-1 Vif-mediated degradation. A structural model of the C-terminal deaminase domain of huA3F indicates that Glu(324) is a surface residue within the alpha 4 helix adjacent to residues corresponding to other known Vif susceptibility determinants in APOBEC3G and APOBEC3H. This structural clustering suggests that Vif may bind a conserved surface present in multiple APOBEC3 proteins.	[Harjes, Elena; Matsuo, Hiroshi; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Albin, John S.; LaRue, Rebecca S.; Weaver, Jessalyn A.; Brown, William L.; Shindo, Keisuke; Harjes, Elena; Matsuo, Hiroshi; Harris, Reuben S.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Albin, John S.; LaRue, Rebecca S.; Weaver, Jessalyn A.; Brown, William L.; Shindo, Keisuke; Harris, Reuben S.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Harris, RS (corresponding author), 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	rsh@umn.edu	Brown, William/GXN-2777-2022	Harjes, Elena/0000-0002-3643-9432; Shindo, Keisuke/0000-0001-8793-8189	National Institutes of Health through the NIAID [R01 AI064046]; National Institute on Drug Abuse [F30 DA026310]; University of Minnesota [T32 GM008244]; Minnesota Agricultural Experiment Station; College of Veterinary Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI073167, R01AI064046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA026310] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); University of Minnesota(University of Minnesota System); Minnesota Agricultural Experiment Station; College of Veterinary Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by the National Institutes of Health Grant R01 AI064046 through the NIAID (to R.S.H.).; Supported by the National Institute on Drug Abuse (F30 DA026310) and the University of Minnesota Medical Scientist Training Program (T32 GM008244).; Supported in part by a studentship from the Minnesota Agricultural Experiment Station and the College of Veterinary Medicine.	Albin JS, 2010, J VIROL, V84, P10209, DOI 10.1128/JVI.00632-10; Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P343, DOI 10.1089/aid.1994.10.343; Hache G, 2008, CURR BIOL, V18, P819, DOI 10.1016/j.cub.2008.04.073; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Henriet S, 2009, MICROBIOL MOL BIOL R, V73, P211, DOI 10.1128/MMBR.00040-08; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Lassen KG, 2010, J BIOL CHEM, V285, P29326, DOI 10.1074/jbc.M110.154054; Lavens D, 2010, NUCLEIC ACIDS RES, V38, P1902, DOI 10.1093/nar/gkp1154; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Romani B, 2009, ARCH VIROL, V154, P1579, DOI 10.1007/s00705-009-0481-y; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Virgen CA, 2007, J VIROL, V81, P13932, DOI 10.1128/JVI.01760-07; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Zennou V, 2006, VIROLOGY, V349, P31, DOI 10.1016/j.virol.2005.12.035; Zhang WY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003963; Zhen AJ, 2010, J VIROL, V84, P1902, DOI 10.1128/JVI.01509-09; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	36	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40785	40792		10.1074/jbc.M110.173161	http://dx.doi.org/10.1074/jbc.M110.173161			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20971849	Green Published, hybrid			2022-12-25	WOS:000285414400043
J	Bakkes, PJ; Jenewein, S; Smits, SHJ; Holland, IB; Schmitt, L				Bakkes, Patrick J.; Jenewein, Stefan; Smits, Sander H. J.; Holland, I. Barry; Schmitt, Lutz			The Rate of Folding Dictates Substrate Secretion by the Escherichia coli Hemolysin Type 1 Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTOSE-BINDING PROTEIN; MEMBRANE TRANSLOCATION; ANTIFOLDING ACTIVITY; SECB CHAPERONE; IN-VIVO; SIGNAL; EXPORT; TRANSPORTER; EXPRESSION; PATHWAY	Secretion of the Escherichia coli toxin hemolysin A (HlyA) is catalyzed by the membrane protein complex HlyB-HlyD-TolC and requires a secretion sequence located within the last 60 amino acids of HlyA. The Hly translocator complex exports a variety of passenger proteins when fused N-terminal to this secretion sequence. However, not all fusions are secreted efficiently. Here, we demonstrate that the maltose binding protein (MalE) lacking its natural export signal and fused to the HlyA secretion signal is poorly secreted by the Hly system. We anticipated that folding kinetics might be limiting secretion, and we therefore introduced the "folding" mutation Y283D. Indeed this mutant fusion protein was secreted at a much higher level. This level was further enhanced by the introduction of a second MalE folding mutation (V8G or A276G). Secretion did not require the molecular chaperone SecB. Folding analysis revealed that all mutations reduced the refolding rate of the substrate, whereas the unfolding rate was unaffected. Thus, the efficiency of secretion by the Hly system is dictated by the folding rate of the substrate. Moreover, we demonstrate that fusion proteins defective in export can be engineered for secretion while still retaining function.	[Bakkes, Patrick J.; Jenewein, Stefan; Smits, Sander H. J.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Holland, I. Barry; Schmitt, Lutz] Univ Paris 11, Inst Genet & Microbiol, UMR Bat 1354 409, F-91405 Orsay, France	Heinrich Heine University Dusseldorf; UDICE-French Research Universities; Universite Paris Saclay	Schmitt, L (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	lutz.schmitt@uni-duesseldorf.de		Bakkes, Patrick/0000-0003-1876-7384	CNRS at the University of Paris-Sud; Heinrich Heine University of Duesseldorf;  [SFB 628]	CNRS at the University of Paris-Sud; Heinrich Heine University of Duesseldorf; 	This work was supported by the CNRS at the University of Paris-Sud (to I. B. H.) and in part by the SFB 628 and the Heinrich Heine University of Duesseldorf (to L. S.).	Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Benabdelhak H, 2003, J MOL BIOL, V327, P1169, DOI 10.1016/S0022-2836(03)00204-3; Bingle WH, 2000, J BACTERIOL, V182, P3298, DOI 10.1128/JB.182.11.3298-3301.2000; BLIGHT MA, 1994, TRENDS BIOTECHNOL, V12, P450, DOI 10.1016/0167-7799(94)90020-5; Blight Mark A., 1994, Current Opinion in Biotechnology, V5, P468, DOI 10.1016/0958-1669(94)90059-0; CHERVAUX C, 1995, MOL GEN GENET, V249, P237, DOI 10.1007/BF00290371; CHUN SY, 1993, J BIOL CHEM, V268, P20855; COLLIER DN, 1989, J BACTERIOL, V171, P4640, DOI 10.1128/jb.171.9.4640-4647.1989; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; COVER WH, 1987, J BACTERIOL, V169, P1794, DOI 10.1128/jb.169.5.1794-1800.1987; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Debarbieux L, 2001, EMBO J, V20, P4657, DOI 10.1093/emboj/20.17.4657; Delepelaire P, 1998, EMBO J, V17, P936, DOI 10.1093/emboj/17.4.936; DIAMOND DL, 1995, PROTEIN SCI, V4, P1118, DOI 10.1002/pro.5560040610; Driessen AJM, 2001, TRENDS MICROBIOL, V9, P193, DOI 10.1016/S0966-842X(01)01980-1; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Fernandez LA, 2000, APPL ENVIRON MICROB, V66, P5024, DOI 10.1128/AEM.66.11.5024-5029.2000; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; GENTSCHEV I, 1990, MOL GEN GENET, V222, P211, DOI 10.1007/BF00633820; Gentschev I, 2002, TRENDS MICROBIOL, V10, P39, DOI 10.1016/S0966-842X(01)02259-4; Gentschev I, 1996, GENE, V179, P133, DOI 10.1016/S0378-1119(96)00424-6; GRAY L, 1986, MOL GEN GENET, V205, P127, DOI 10.1007/BF02428042; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; HESS J, 1990, MOL GEN GENET, V224, P201, DOI 10.1007/BF00271553; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; HOLLAND IB, 1990, J BIOENERG BIOMEMBR, V22, P473, DOI 10.1007/BF00763178; JOBLING MG, 1990, NUCLEIC ACIDS RES, V18, P5315, DOI 10.1093/nar/18.17.5315; Johnson JM, 1999, J MOL BIOL, V287, P695, DOI 10.1006/jmbi.1999.2630; Jones HE, 2002, CELL CALCIUM, V32, P183, DOI 10.1016/S0143416002001537; KENNY B, 1991, MOL MICROBIOL, V5, P2557, DOI 10.1111/j.1365-2958.1991.tb02102.x; KENNY B, 1994, MOL MICROBIOL, V11, P99, DOI 10.1111/j.1365-2958.1994.tb00293.x; KENNY B, 1992, MOL MICROBIOL, V6, P1477, DOI 10.1111/j.1365-2958.1992.tb00868.x; KHISTY VJ, 1995, J BACTERIOL, V177, P3277, DOI 10.1128/jb.177.11.3277-3282.1995; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Labadia ME, 1998, J IMMUNOL, V161, P836; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; LIU G, 1988, J BIOL CHEM, V263, P14790; LIU GP, 1989, P NATL ACAD SCI USA, V86, P9213, DOI 10.1073/pnas.86.23.9213; LUDWIG A, 1988, MOL GEN GENET, V214, P553, DOI 10.1007/BF00330494; MACKMAN N, 1987, EMBO J, V6, P2835, DOI 10.1002/j.1460-2075.1987.tb02580.x; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; NAKANO H, 1992, APPL MICROBIOL BIOT, V37, P765; NICAUD JM, 1986, FEBS LETT, V204, P331, DOI 10.1016/0014-5793(86)80838-9; PARK SH, 1988, SCIENCE, V239, P1033, DOI 10.1126/science.3278378; Prakash S, 2004, TRENDS BIOCHEM SCI, V29, P593, DOI 10.1016/j.tibs.2004.09.011; STANLEY P, 1991, MOL MICROBIOL, V5, P2391, DOI 10.1111/j.1365-2958.1991.tb02085.x; STANLEY P, 1994, SCIENCE, V266, P1992, DOI 10.1126/science.7801126; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Tomikiewicz D, 2008, J MOL BIOL, V377, P83, DOI 10.1016/j.jmb.2008.01.014; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; WEISS JB, 1988, P NATL ACAD SCI USA, V85, P8978, DOI 10.1073/pnas.85.23.8978; WELCH RA, 1981, NATURE, V294, P665, DOI 10.1038/294665a0; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wolff N, 2003, J BIOL CHEM, V278, P38247, DOI 10.1074/jbc.M302322200	58	51	55	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40573	40580		10.1074/jbc.M110.173658	http://dx.doi.org/10.1074/jbc.M110.173658			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20971850	Green Published, hybrid			2022-12-25	WOS:000285414400020
J	Cheng, C; Xia, CH; Huang, QL; Ding, LL; Horwitz, J; Gong, XH				Cheng, Catherine; Xia, Chun-hong; Huang, Qingling; Ding, Linlin; Horwitz, Joseph; Gong, Xiaohua			Altered Chaperone-like Activity of alpha-Crystallins Promotes Cataractogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-D-CRYSTALLIN; A-CRYSTALLIN; B-CRYSTALLIN; MUTATION; MECHANISM; MUTANT; MODEL	Despite the enormous number of studies demonstrating changes in the chaperone-like activity of alpha-crystallins in vitro, little is known about how these changes influence life-long lens transparency in vivo. Using the gamma B-crystallin I4F mutant protein as a target for alpha A-crystallins, we examined how cataract phenotypes are modulated by interactions between alpha-crystallins with altered chaperone-like activities and gamma B-I4F proteins in vivo. Double heterozygous alpha-crystallin knock-out alpha A(+/-) alpha B(+/-) mice with a decreased amount of alpha-crystallins were used to simulate reduced total alpha-crystallin chaperone-like activity in vivo. We found that triple heterozygous alpha A(+/-) alpha B(+/-) gamma B(I4F/+) mice developed more severe whole cataracts than heterozygous gamma B(I4F/+) mice. Thus, total chaperone-like activity of alpha-crystallins is important for maintaining lens transparency. We further tested whether mutant alpha A-crystallin Y118D proteins with increased chaperone-like activity influenced the whole cataract caused by the gamma B-I4F mutation. Unexpectedly, compound alpha A(Y118D/+) gamma B(I4F/+) mutant lenses displayed severe nuclear cataracts, whereas the lens cortex remained unaffected. Thus, the synergistic effect of alpha A-Y118D and gamma B-I4F mutant proteins is detrimental to the transparency only in the lens core. alpha-Crystallins with different chaperone-like activities are likely required in the lens cortex and nucleus for maintaining transparency.	[Gong, Xiaohua] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Gong, Xiaohua] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Huang, Qingling; Ding, Linlin; Horwitz, Joseph] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Los Angeles	Gong, XH (corresponding author), Univ Calif Berkeley, Sch Optometry, 693 Minor Hall, Berkeley, CA 94720 USA.	xgong@berkeley.edu			National Institutes of Health from NEI [EY013849]; NATIONAL EYE INSTITUTE [R01EY013849] Funding Source: NIH RePORTER	National Institutes of Health from NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY013849 (to X.G.) from NEI.	Andley UP, 2008, BIOCHEMISTRY-US, V47, P9697, DOI 10.1021/bi800594t; Benedek GB, 1997, INVEST OPHTH VIS SCI, V38, P1911; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Derham BK, 1999, PROG RETIN EYE RES, V18, P463, DOI 10.1016/S1350-9462(98)00030-5; Duncan M.K., 2004, DEV OCULAR LENS; Ghosh JG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000498; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Gu F, 2008, HUM MUTAT, V29, P769, DOI 10.1002/humu.20724; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Huang QL, 2009, INVEST OPHTH VIS SCI, V50, P2919, DOI 10.1167/iovs.08-3070; Li H, 2008, BBA-MOL BASIS DIS, V1782, P303, DOI 10.1016/j.bbadis.2008.01.011; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Mayer Marcus, 2004, Methods Mol Med, V94, P239; Morozov V, 2006, DEVELOPMENT, V133, P813, DOI 10.1242/dev.02262; Murugesan R, 2007, MOL VIS, V13, P2301; Pande A, 2009, BIOCHEM BIOPH RES CO, V382, P196, DOI 10.1016/j.bbrc.2009.03.007; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Sanderson J, 2000, INVEST OPHTH VIS SCI, V41, P2255; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Shroff NP, 2000, BIOCHEMISTRY-US, V39, P1420, DOI 10.1021/bi991656b; Singh D, 2006, MOL VIS, V12, P1372; Srinivas V, 2003, PROTEIN SCI, V12, P1262, DOI 10.1110/ps.0302003; Wang K, 2007, INVEST OPHTH VIS SCI, V48, P3719, DOI 10.1167/iovs.06-1487; Xi JH, 2008, J BIOL CHEM, V283, P5801, DOI 10.1074/jbc.M708704200; Xia CH, 2006, INVEST OPHTH VIS SCI, V47, P3004, DOI 10.1167/iovs.06-0178	34	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41187	41193		10.1074/jbc.M110.154534	http://dx.doi.org/10.1074/jbc.M110.154534			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959464	Green Published, hybrid			2022-12-25	WOS:000285414400080
J	Gaines, WA; Sehorn, MG; Marcotte, WR				Gaines, William A.; Sehorn, Michael G.; Marcotte, William R., Jr.			Spidroin N-terminal Domain Promotes a pH-dependent Association of Silk Proteins during Self-assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIDER DRAGLINE SILK; NEPHILA-CLAVIPES; FIBER; GLAND; TRANSITION; FLOW	Spider silks are spun from concentrated solutions of spidroin proteins. The appropriate timing of spidroin assembly into organized fibers must be highly regulated to avoid premature fiber formation. Chemical and physical signals presented to the silk proteins as they pass from the ampulle and through the tapered duct include changes in ionic environment and pH as well as the introduction of shear forces. Here, we show that the N-terminal domain of spidroins from the major ampullate gland (MaSp-NTDs) for both Nephila and Latrodectus spiders associate noncovalently as homodimers. The MaSp-NTDs are highly pH-responsive and undergo a structural transition in the physiological pH range of the spider duct. Tryptophan fluorescence of the MaSp-NTDs reveals a change in conformation when pH is decreased, and the pH at which the transition occurs is determined by the amount and type of salt present. Size exclusion chromatography and pull-down assays both indicate that the lower pH conformation is associated with a significantly increased MaSp-NTD homodimer stability. By transducing the duct pH signal into specific protein-protein interactions, this conserved spidroin domain likely contributes significantly to the silk-spinning process. Based on these results, we propose a model of spider silk assembly dynamics as mediated through the MaSp-NTD.	[Marcotte, William R., Jr.] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA; [Marcotte, William R., Jr.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	Clemson University; Clemson University	Marcotte, WR (corresponding author), Clemson Univ, Dept Biochem & Genet, 51 New Cherry Rd,Biosyst Res Complex,Rm 216, Clemson, SC 29634 USA.	marcotw@clemson.edu	Marcotte, William/AAD-8354-2019	Marcotte, William/0000-0003-4580-1939	National Institutes of Health [EB007403]; Sigma Xi; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R15EB007403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigma Xi; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant EB007403 (to W.R.M.). This work was also supported by a Sigma Xi grant-in-aid for research (to W.A.G.). This is Technical Contribution 5829 of the Clemson University Experiment Station.	Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962; Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Breslauer DN, 2009, BIOMACROMOLECULES, V10, P49, DOI 10.1021/bm800752x; Chen X, 2004, CHEM J CHINESE U, V25, P1160; Chen X, 2002, BIOMACROMOLECULES, V3, P644, DOI 10.1021/bm0156126; Dicko C, 2004, BIOCHEMISTRY-US, V43, P14080, DOI 10.1021/bi0483413; Dicko C, 2004, BIOMACROMOLECULES, V5, P704, DOI 10.1021/bm034307c; Eisoldt L, 2010, J STRUCT BIOL, V170, P413, DOI 10.1016/j.jsb.2009.12.027; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883; Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7; Gaines WA, 2008, INSECT MOL BIOL, V17, P465, DOI 10.1111/j.1365-2583.2008.00828.x; Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936; Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y; Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q; Knight DP, 1999, P ROY SOC B-BIOL SCI, V266, P519, DOI 10.1098/rspb.1999.0667; Knight DP, 2001, NATURWISSENSCHAFTEN, V88, P179, DOI 10.1007/s001140100220; Knight DP, 2000, INT J BIOL MACROMOL, V27, P205, DOI 10.1016/S0141-8130(00)00124-0; Lefevre T, 2008, BIOMACROMOLECULES, V9, P2399, DOI 10.1021/bm800390j; Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683; Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Vollrath F, 1998, P ROY SOC B-BIOL SCI, V265, P817, DOI 10.1098/rspb.1998.0365; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120	31	79	86	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40745	40753		10.1074/jbc.M110.163121	http://dx.doi.org/10.1074/jbc.M110.163121			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959449	Green Published, hybrid			2022-12-25	WOS:000285414400038
J	Matthias, LJ; Azimi, I; Tabrett, CA; Hogg, PJ				Matthias, Lisa J.; Azimi, Iman; Tabrett, Catherine A.; Hogg, Philip J.			Reduced Monomeric CD4 Is the Preferred Receptor for HIV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN DISULFIDE-ISOMERASE; CLASS-II MHC; MONOCLONAL-ANTIBODY; MEDIATED FUSION; TYPE-1 ENVELOPE; BINDING-SITE; INFECTION; THIOREDOXIN; ASSOCIATION	CD4 is a co-receptor for binding of T cells to antigen-presenting cells and the primary receptor for the human immunodeficiency virus type 1 (HIV). CD4 exists in three different forms on the cell surface defined by the state of the domain 2 cysteine residues: an oxidized monomer, a reduced monomer, and a covalent dimer linked through the domain 2 cysteines. The disulfide-linked dimer is the preferred immune co-receptor. The form of CD4 that is preferred by HIV was examined in this study. HIV entry and envelope-mediated cell-cell fusion were tested using cells expressing comparable levels of wildtype or disulfide bond mutant CD4 in which the domain 2 cysteines were mutated to alanine. Eliminating the domain 2 disulfide bond increased entry of HIV reporter viruses and enhanced HIV envelope-mediated cell-cell fusion 2-4-fold. These observations suggest that HIV enters susceptible cells preferably through monomeric reduced CD4, whereas dimeric CD4 is the preferred receptor for binding to antigen-presenting cells. Cleavage of the domain 2 disulfide bond is possibly involved in the conformational change in CD4 associated with fusion of the HIV and cell membranes.	[Hogg, Philip J.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Hogg, PJ (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Level 2, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au	Azimi, Iman/E-2043-2011; Hill, Andrew/B-4527-2009	Azimi, Iman/0000-0001-9477-9999; Hill, Andrew/0000-0001-5581-2354; Hogg, Philip/0000-0001-6486-2863	Australian Research Council; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian Research Council and the National Health and Medical Research Council of Australia.	ASHKENAZI A, 1990, P NATL ACAD SCI USA, V87, P7150, DOI 10.1073/pnas.87.18.7150; BACHELDER RE, 1995, J VIROL, V69, P5734, DOI 10.1128/JVI.69.9.5734-5742.1995; Bourgeois R, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-31; Brady RL, 1996, CURR TOP MICROBIOL, V205, P1; BURKLY LC, 1992, J IMMUNOL, V149, P1779; CELADA F, 1990, J EXP MED, V172, P1143, DOI 10.1084/jem.172.4.1143; CLAYTON LK, 1988, NATURE, V335, P363, DOI 10.1038/335363a0; Collet JF, 2002, J BIOL CHEM, V277, P26886, DOI 10.1074/jbc.M203028200; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Einfeld D, 1996, CURR TOP MICROBIOL, V214, P133; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Hu QX, 2000, J VIROL, V74, P11858, DOI 10.1128/JVI.74.24.11858-11872.2000; JAMESON BA, 1988, SCIENCE, V240, P1335, DOI 10.1126/science.2453925; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Lee S, 1997, J VIROL, V71, P6037, DOI 10.1128/JVI.71.8.6037-6043.1997; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; Lynch GW, 2003, EXP DERMATOL, V12, P700, DOI 10.1034/j.1600-0625.2003.00078.x; Maekawa A, 2006, J IMMUNOL, V176, P6873, DOI 10.4049/jimmunol.176.11.6873; Maerz AL, 2001, J VIROL, V75, P6635, DOI 10.1128/JVI.75.14.6635-6644.2001; Marsh M, 1996, CURR TOP MICROBIOL, V205, P107; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; MIZUKAMI T, 1988, P NATL ACAD SCI USA, V85, P9273, DOI 10.1073/pnas.85.23.9273; MOORE JP, 1992, J VIROL, V66, P4784, DOI 10.1128/JVI.66.8.4784-4793.1992; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; PETERSON A, 1988, CELL, V54, P65, DOI 10.1016/0092-8674(88)90180-8; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; ROTHWARF DM, 1992, P NATL ACAD SCI USA, V89, P7944, DOI 10.1073/pnas.89.17.7944; Sanejouand YH, 2004, PROTEINS, V57, P205, DOI 10.1002/prot.20197; SATTENTAU QJ, 1986, SCIENCE, V234, P1120, DOI 10.1126/science.2430333; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schwertassek U., 2007, SCI STKE, pl8; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; TAGAYA Y, 1989, EMBO J, V8, P757, DOI 10.1002/j.1460-2075.1989.tb03436.x; Vandegraaff N, 2001, ANTIMICROB AGENTS CH, V45, P2510, DOI 10.1128/AAC.45.9.2510-2516.2001; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wong J. W., 2010, MOL BIOL EV IN PRESS; Wouters MA, 2004, BIOESSAYS, V26, P73, DOI 10.1002/bies.10413	42	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40793	40799		10.1074/jbc.M110.190579	http://dx.doi.org/10.1074/jbc.M110.190579			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20974843	Green Published, hybrid			2022-12-25	WOS:000285414400044
J	Parent, A; Roy, SJ; Iorio-Morin, C; Lepine, MC; Labrecque, P; Gallant, MA; Slipetz, D; Parent, JL				Parent, Audrey; Roy, Sebastien J.; Iorio-Morin, Christian; Lepine, Marie-Claude; Labrecque, Pascale; Gallant, Maxime A.; Slipetz, Deborah; Parent, Jean-Luc			ANKRD13C Acts as a Molecular Chaperone for G Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOPHILIN HOMOLOG NINAA; PROSTAGLANDIN D-2; ANKYRIN REPEAT; CRTH2; TRANSPORT; DP; TRAFFICKING; ROLES; MOTIF	Although the mechanisms that regulate folding and maturation of newly synthesized G protein-coupled receptors are crucial for their function, they remain poorly characterized. By yeast two-hybrid screening, we have isolated ANKRD13C, a protein of unknown function, as an interacting partner for the DP receptor for prostaglandin D-2. In the present study we report the characterization of this novel protein as a regulator of DP biogenesis and trafficking in the biosynthetic pathway. Co-localization by confocal microscopy with an endoplasmic reticulum (ER) marker, subcellular fractionation experiments, and demonstration of the interaction between ANKRD13C and the cytoplasmic C terminus of DP suggest that ANKRD13C is a protein associated with the cytosolic side of ER membranes. Co-expression of ANKRD13C with DP initially increased receptor protein levels, whereas siRNA-mediated knockdown of endogenous ANKRD13C decreased them. Pulse-chase experiments indicated that ANKRD13C can promote the biogenesis of DP by inhibiting the degradation of newly synthesized receptors. However, a prolonged interaction between ANKRD13C and DP resulted in ER retention of misfolded/unassembled forms of the receptor and to their proteasome-mediated degradation. ANKRD13C also regulated the expression of other GPCRs tested (CRTH2, thromboxane A(2) (TP alpha), and beta 2-adrenergic receptor), whereas it did not affect the expression of green fluorescent protein, GRK2 (G protein-coupled receptor kinase 2), and VSVG (vesicular stomatitis virus glycoprotein), showing specificity toward G protein-coupled receptors. Altogether, these results suggest that ANKRD13C acts as a molecular chaperone for G protein-coupled receptors, regulating their biogenesis and exit from the ER.	[Gallant, Maxime A.; Parent, Jean-Luc] Univ Sherbrooke, Serv Rhumatol, Dept Med, Fac Med & Sci Sante,Ctr Rech Clin Etienne Lebel, Sherbrooke, PQ J1H 5N4, Canada; [Gallant, Maxime A.; Parent, Jean-Luc] Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada; [Slipetz, Deborah] Merck Res Labs, BRIE Program, Boston, MA 02115 USA	University of Sherbrooke; Merck & Company	Parent, JL (corresponding author), Univ Sherbrooke, Serv Rhumatol, Dept Med, Fac Med & Sci Sante,Ctr Rech Clin Etienne Lebel, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	jean-luc.parent@usherbrooke.ca	Iorio-Morin, Christian/I-8696-2019	Iorio-Morin, Christian/0000-0003-2995-7255	Canadian Institutes of Health Research; Natural Science and Engineering Research Council; Fonds de la Recherche en Sante du Quebec; Andre Lussier Research Chair in Rheumatology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Andre Lussier Research Chair in Rheumatology	This work was supported by a grant from the Canadian Institutes of Health Research (to J.-L.P.).; Recipients of studentships from the Natural Science and Engineering Research Council.; Recipients of studentships from the Fonds de la Recherche en Sante du Quebec.; Holds a "Chercheur boursier-Senior" salary award from the Fonds de la Recherche en Sante du Quebec and the Andre Lussier Research Chair in Rheumatology.	Achour L, 2008, TRENDS PHARMACOL SCI, V29, P528, DOI 10.1016/j.tips.2008.07.009; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Bouschet T, 2005, J CELL SCI, V118, P4709, DOI 10.1242/jcs.02598; Brothers SP, 2006, J MOL ENDOCRINOL, V37, P479, DOI 10.1677/jme.1.02142; Buck TM, 2007, SEMIN CELL DEV BIOL, V18, P751, DOI 10.1016/j.semcdb.2007.09.001; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Durand M, 2008, J BONE MINER RES, V23, P1097, DOI [10.1359/jbmr.080228, 10.1359/JBMR.080228]; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Gallant MA, 2005, J BONE MINER RES, V20, P672, DOI 10.1359/JBMR.041211; Gallant MA, 2010, J RHEUMATOL, V37, P644, DOI 10.3899/jrheum.090622; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hayaishi O, 2002, NEUROSCIENTIST, V8, P12, DOI 10.1177/107385840200800105; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; Laroche G, 2005, CELL SIGNAL, V17, P1373, DOI 10.1016/j.cellsig.2005.02.008; LeClerc PC, 2002, ENDOCRINOLOGY, V143, P4702, DOI 10.1210/en.2002-220679; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Oguma Tsuyoshi, 2008, Allergol Int, V57, P307, DOI 10.2332/allergolint.08-RAI-0033; Parent A, 2008, TRAFFIC, V9, P394, DOI 10.1111/j.1600-0854.2007.00692.x; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Pettipher R, 2008, BRIT J PHARMACOL, V153, pS191, DOI 10.1038/sj.bjp.0707488; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Susuki S, 2009, J BIOL CHEM, V284, P8312, DOI 10.1074/jbc.M809354200; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546	35	20	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40838	40851		10.1074/jbc.M110.142257	http://dx.doi.org/10.1074/jbc.M110.142257			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959461	Green Published, hybrid			2022-12-25	WOS:000285414400049
J	Shelton, SN; Dillard, CD; Robertson, JD				Shelton, Shary N.; Dillard, Cindy D.; Robertson, John D.			Activation of Caspase-9, but Not Caspase-2 or Caspase-8, Is Essential for Heat-induced Apoptosis in Jurkat Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; INITIATOR CASPASES; GENOTOXIC STRESS; COMPLEX; DEATH; HYPERTHERMIA; CLEAVAGE; PROTEIN; REQUIREMENT	Exposure of cells to hyperthermia is known to induce apoptosis, although the underlying mechanisms are only partially understood. Here, we examine the molecular requirements necessary for heat-induced apoptosis using genetically modified Jurkat T-lymphocytes. Cells stably overexpressing Bcl-2/Bcl-xL or stably depleted of Apaf-1 were completely resistant to heat-induced apoptosis, implicating the involvement of the mitochondria-mediated pathway. Pretreatment of wild-type cells with the cell-permeable biotinylated general caspase inhibitor b-VAD-fmk (biotin-Val-Ala-Asp(OMe)-CH2F) both inhibited heat-induced apoptosis and affinity-labeled activated initiator caspase-2, -8, and -9. Despite this finding, however, cells engineered to be deficient in caspase-8, caspase-2, or the caspase-2 adaptor protein RAIDD (receptor-interacting protein (RIP)-associated Ich-1/CED homologous protein with death domain) remained susceptible to heat-induced apoptosis. Additionally, b-VAD-fmk failed to label any activated initiator caspase in Apaf-1-deficient cells exposed to hyperthermia. Cells lacking Apaf-1 or the pro-apoptotic BH3-only protein Bid exhibited lower levels of heat-induced Bak activation, cytochrome c release, and loss of mitochondrial membrane potential, although cleavage of Bid to truncated Bid (tBid) occurred downstream of caspase-9 activation. Combined, the data suggest that caspase-9 is the critical initiator caspase activated during heat-induced apoptosis and that tBid may function to promote cytochrome c release during this process as part of a feed-forward amplification loop.	[Robertson, John D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Robertson, JD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jrobertson3@kumc.edu			National Institutes of Health [K22 ES011647, P20 RR016475, P20 RR016443]; IDeA Networks of Biomedical Research Excellence (INBRE) Program of the NCRR; National Center for Research Resources (NCRR);  [T32 ES007079]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES011647, T32ES007079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IDeA Networks of Biomedical Research Excellence (INBRE) Program of the NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants K22 ES011647 (to J. D. R.), P20 RR016475 from the IDeA Networks of Biomedical Research Excellence (INBRE) Program of the NCRR, and T32 ES007079.; We thank Dr. Joyce Slusser for invaluable assistance with flow cytometry, the late Dr. Stanley Korsmeyer for the pSFFV-neo, pSFFV-Bcl-2, and pSFFV-Bcl-xL mammalian expression vectors, and Drs. Shawn Bratton and Wen-Xing Ding for helpful discussion. The Flow Cytometry Core is supported in part by National Institutes of Health Grant P20 RR016443 from the National Center for Research Resources (NCRR).	Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cippitelli M, 2005, J IMMUNOL, V174, P223, DOI 10.4049/jimmunol.174.1.223; Denault JB, 2007, BIOCHEM J, V405, P11, DOI 10.1042/BJ20070288; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; Ito A, 2006, CANCER IMMUNOL IMMUN, V55, P320, DOI 10.1007/s00262-005-0049-y; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kouloulias V, 2005, AM J CLIN ONCOL-CANC, V28, P91, DOI 10.1097/01.coc.0000139939.60056.42; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Milleron RS, 2007, CELL MOL LIFE SCI, V64, P2329, DOI 10.1007/s00018-007-7135-6; Milleron RS, 2006, J BIOL CHEM, V281, P16991, DOI 10.1074/jbc.M512754200; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; PARSELL DA, 1993, PHILOS T R SOC B, V339, P279, DOI 10.1098/rstb.1993.0026; Pissuwan D, 2006, TRENDS BIOTECHNOL, V24, P62, DOI 10.1016/j.tibtech.2005.12.004; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Shawgo ME, 2009, J BIOL CHEM, V284, P33447, DOI 10.1074/jbc.M109.032359; Shawgo ME, 2008, J BIOL CHEM, V283, P35532, DOI 10.1074/jbc.M807656200; Shelton SN, 2009, J BIOL CHEM, V284, P11247, DOI 10.1074/jbc.M809392200; Shi MG, 2009, CELL, V136, P508, DOI 10.1016/j.cell.2008.12.021; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stankiewicz AR, 2009, CELL DEATH DIFFER, V16, P638, DOI 10.1038/cdd.2008.189; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	42	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40525	40533		10.1074/jbc.M110.167635	http://dx.doi.org/10.1074/jbc.M110.167635			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20978129	hybrid, Green Published			2022-12-25	WOS:000285414400015
J	Welzel, O; Tischbirek, CH; Jung, J; Kohler, EM; Svetlitchny, A; Henkel, AW; Kornhuber, J; Groemer, TW				Welzel, Oliver; Tischbirek, Carsten H.; Jung, Jasmin; Kohler, Eva M.; Svetlitchny, Alexei; Henkel, Andreas W.; Kornhuber, Johannes; Groemer, Teja W.			Synapse Clusters Are Preferentially Formed by Synapses with Large Recycling Pool Sizes	PLOS ONE			English	Article							NEUROTRANSMITTER RELEASE; NEURONAL NETWORKS; VESICLES; PROBABILITY; INCREASES; DYNAMICS; VISUALIZATION; INFORMATION; PROPAGATION; ENDOCYTOSIS	Synapses are distributed heterogeneously in neural networks. The relationship between the spatial arrangement of synapses and an individual synapse's structural and functional features remains to be elucidated. Here, we examined the influence of the number of adjacent synapses on individual synaptic recycling pool sizes. When measuring the discharge of the styryl dye FM1-43 from electrically stimulated synapses in rat hippocampal tissue cultures, a strong positive correlation between the number of neighbouring synapses and recycling vesicle pool sizes was observed. Accordingly, vesicle-rich synapses were found to preferentially reside next to neighbours with large recycling pool sizes. Although these synapses with large recycling pool sizes were rare, they were densely arranged and thus exhibited a high amount of release per volume. To consolidate these findings, functional terminals were marked by live-cell antibody staining with anti-synaptotagmin-1-cypHer or overexpression of synaptopHluorin. Analysis of synapse distributions in these systems confirmed the results obtained with FM 1-43. Our findings support the idea that clustering of synapses with large recycling pool sizes is a distinct developmental feature of newly formed neural networks and may contribute to functional plasticity.	[Welzel, Oliver; Tischbirek, Carsten H.; Jung, Jasmin; Kohler, Eva M.; Svetlitchny, Alexei; Henkel, Andreas W.; Kornhuber, Johannes; Groemer, Teja W.] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany	University of Erlangen Nuremberg	Welzel, O (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany.	teja.groemer@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014; Henkel, Andreas/E-9522-2011	Kornhuber, Johannes/0000-0002-8096-3987; Henkel, Andreas/0000-0002-2627-0215; Groemer, Teja/0000-0003-3854-716X; Wenzel, Eva Maria/0000-0002-5561-3344	Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung ELAN [PS-08.09.22.2]; Interdisciplinary Center of Clinical Research (IZKF) in Erlangen [J5]	Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung ELAN; Interdisciplinary Center of Clinical Research (IZKF) in Erlangen	This work was supported by the Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung ELAN Grant, PS-08.09.22.2, and by the Interdisciplinary Center of Clinical Research (IZKF) in Erlangen (Project J5), both to Teja W. Groemer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EJ, 2002, BIOTECHNIQUES, V33, P1152, DOI 10.2144/02335dd10; Aertsen A, 1996, J PHYSIOLOGY-PARIS, V90, P243, DOI 10.1016/S0928-4257(97)81432-5; Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Aradi I, 2004, J NEUROSCI, V24, P9681, DOI 10.1523/JNEUROSCI.2800-04.2004; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Axmacher N, 2004, NEUROIMAGE, V22, P1014, DOI 10.1016/j.neuroimage.2004.02.009; Bak P, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.031912; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Beggs JM, 2003, J NEUROSCI, V23, P11167; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Branco T, 2009, NAT REV NEUROSCI, V10, P373, DOI 10.1038/nrn2634; Brewer GJ, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/014001; Chen X, 2008, J NEUROSCI, V28, P1894, DOI 10.1523/JNEUROSCI.4518-07.2008; Chialvo DR, 1999, NEUROSCIENCE, V90, P1137, DOI 10.1016/S0306-4522(98)00472-2; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Colicos MA, 2004, DEV NEUROSCI-BASEL, V26, P406, DOI 10.1159/000082283; Colicos MA, 2006, J EXP BIOL, V209, P2312, DOI 10.1242/jeb.02163; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; GRAY EG, 1959, J ANAT, V93, P420; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Kaiser M, 2004, NEUROCOMPUTING, V58, P297, DOI 10.1016/j.neucom.2004.01.059; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lauri SE, 2003, MOL CELL NEUROSCI, V22, P107, DOI 10.1016/S1044-7431(02)00012-X; Martens H, 2008, J NEUROSCI, V28, P13125, DOI 10.1523/JNEUROSCI.3887-08.2008; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Minerbi A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000136; Miralles F, 1996, J PHYSIOL-LONDON, V495, P717, DOI 10.1113/jphysiol.1996.sp021628; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nakayama K, 2005, J NEUROSCI, V25, P4040, DOI 10.1523/JNEUROSCI.4115-04.2005; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; Prange O, 1999, J NEUROSCI, V19, P6427; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; Richards DA, 2005, J CELL BIOL, V168, P929, DOI 10.1083/jcb.200407148; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schikorski T, 1997, J NEUROSCI, V17, P5858; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Staras K, 2010, NEURON, V66, P37, DOI 10.1016/j.neuron.2010.03.020; STROEBEL A, 2010, MICROSCOPY RES TECHN; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	66	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13514	10.1371/journal.pone.0013514	http://dx.doi.org/10.1371/journal.pone.0013514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976002	Green Published, Green Submitted, gold			2022-12-25	WOS:000283216400019
J	Zhao, JM; Li, CH; Chen, AQ; Li, LY; Su, XR; Li, TW				Zhao, Jianmin; Li, Chenghua; Chen, Aiqin; Li, Lingyun; Su, Xiurong; Li, Taiwu			Molecular Characterization of a Novel Big Defensin from Clam Venerupis philippinarum	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; GENE; EXPRESSION; FAMILY; PENAEIDINS; PROTEINS; MUSSELS; CRAB	Antimicrobial peptides (AMPs) are important mediators of the primary defense mechanism against microbial invasion. In the present study, a big defensin was identified from Venerupis philippinarum haemocytes (denoted as VpBD) by RACE and EST approaches. The VpBD cDNA contained an open reading frame (ORF) of 285 bp encoding a polypeptide of 94 amino acids. The deduce amino acid sequence of VpBD shared the common features of big defensin including disulfide array organization and helix structure, indicating that VpBD should be a new member of the big defensin family. The mRNA transcript of VpBD was up-regulated significantly during the first 24 hr after Vibrio anguillarum challenge, which was 7.4-fold increase compared to that of the control group. Then the expression decreased gradually from 24 hr to 96 hr, and the lowest expression level was detected at 96 hr post-infection, which was still 3.9-fold higher than that of control. The mature peptide of VpBD was recombined in Escherichia coli and purified for minimum inhibitory concentration (MIC) determination. The rVpBD displayed broad-spectrum inhibitory activity towards all tested bacteria with the highest activity against Staphyloccocus aureus and Pseudomonas putida. These results indicated that VpBD was involved in the host immune response against bacterial infection and might contribute to the clearance of invading bacteria.	[Zhao, Jianmin; Li, Chenghua; Chen, Aiqin] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China; [Li, Chenghua; Su, Xiurong; Li, Taiwu] Ningbo Univ, Fac Life Sci & Biotechnol, Ningbo, Peoples R China; [Li, Lingyun] NE Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Ningbo University; Northeast Agricultural University - China	Zhao, JM (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China.	chli@yic.ac.cn	Li, Chenghua/L-9825-2019	Li, Chenghua/0000-0003-2978-8762	Chinese Academy of Sciences [kzcx2-yw-225]; NSFC [30901115]	Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	The project was supported by Chinese Academy of Sciences Innovation Program (kzcx2-yw-225) and NSFC grant (No. 30901115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; De Zoysa M, 2010, FISH SHELLFISH IMMUN, V28, P261, DOI 10.1016/j.fsi.2009.11.005; Destoumieux D, 2000, J CELL SCI, V113, P461; Destoumieux D, 1997, J BIOL CHEM, V272, P28398, DOI 10.1074/jbc.272.45.28398; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; HANDCOCK REW, 1999, ANTIMICROBIAL AGENTS, V43, P1317; Hubert F, 1996, EUR J BIOCHEM, V240, P302, DOI 10.1111/j.1432-1033.1996.0302h.x; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li CH, 2009, MOLLUSCAN RES, V29, P17; Liu HP, 2006, J VIROL, V80, P10365, DOI 10.1128/JVI.01101-06; Mitta G, 2000, DEV COMP IMMUNOL, V24, P381, DOI 10.1016/S0145-305X(99)00084-1; Mitta G, 2000, FEBS LETT, V486, P185, DOI 10.1016/S0014-5793(00)02192-X; MOR A, 1994, EUR J BIOCHEM, V219, P145, DOI 10.1111/j.1432-1033.1994.tb19924.x; Mu CK, 2010, DEV COMP IMMUNOL, V34, P734, DOI 10.1016/j.dci.2010.02.001; Munoz M, 2002, EUR J BIOCHEM, V269, P2678, DOI 10.1046/j.1432-1033.2002.02934.x; SAITO T, 1995, J BIOCHEM-TOKYO, V117, P1131, DOI 10.1093/oxfordjournals.jbchem.a124818; Sitaram N, 2002, CURR PHARM DESIGN, V8, P727, DOI 10.2174/1381612023395358; Storici P, 1996, EUR J BIOCHEM, V238, P769, DOI 10.1111/j.1432-1033.1996.0769w.x; Supungul P, 2004, DIS AQUAT ORGAN, V61, P123, DOI 10.3354/dao061123; TERRAS FRG, 1993, FEBS LETT, V316, P233, DOI 10.1016/0014-5793(93)81299-F; Yu Y, 2009, FISH SHELLFISH IMMUN, V26, P492, DOI 10.1016/j.fsi.2009.02.005; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang G, 1999, CHINA FISH, V9, P34; Zhao JM, 2007, MOL IMMUNOL, V44, P360, DOI 10.1016/j.molimm.2006.02.025	27	63	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13480	10.1371/journal.pone.0013480	http://dx.doi.org/10.1371/journal.pone.0013480			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975988	Green Published, Green Submitted, gold			2022-12-25	WOS:000283216400009
J	Floyd, S; Molesworth, A; Dube, A; Banda, E; Jahn, A; Mwafulirwa, C; Ngwira, B; Branson, K; Crampin, AC; Zaba, B; Glynn, JR; French, N				Floyd, Sian; Molesworth, Anna; Dube, Albert; Banda, Emmanuel; Jahn, Andreas; Mwafulirwa, Charles; Ngwira, Bagrey; Branson, Keith; Crampin, Amelia C.; Zaba, Basia; Glynn, Judith R.; French, Neil			Population-Level Reduction in Adult Mortality after Extension of Free Anti-Retroviral Therapy Provision into Rural Areas in Northern Malawi	PLOS ONE			English	Article							RAPID SCALE-UP; SOUTH-AFRICA; FOLLOW-UP; TREATMENT PROGRAM; HIV; OUTCOMES; SERVICE; INDIVIDUALS; COMMUNITY	Background: Four studies from sub-Saharan Africa have found a substantial population-level effect of ART provision on adult mortality. It is important to see if the impact changes with time since the start of treatment scale-up, and as treatment moves to smaller clinics. Methods and Findings: During 2002-4 a demographic surveillance site (DSS) was established in Karonga district, northern Malawi. Information on births and deaths is collected monthly, with verbal autopsies conducted for all deaths; migrations are updated annually. We analysed mortality trends by comparing three time periods: pre-ART roll-out in the district (August 2002-June 2005), ART period 1 (July 2005-September 2006) when ART was available only in a town 70 km away, and ART period 2 (October 2006-September 2008), when ART was available at a clinic within the DSS area. HIV prevalence and ART uptake were estimated from a sero-survey conducted in 2007/2008. The all-cause mortality rate among 15-59 year olds was 10.2 per 1000 person-years in the pre-ART period (288 deaths/28285 person-years). It fell by 16% in ART period 1 and by 32% in ART period 2 (95% CI 18%-43%), compared with the pre-ART period. The AIDS mortality rate fell from 6.4 to 4.6 to 2.7 per 1000 person-years in the pre-ART period, period 1 and period 2 respectively (rate ratio for period 2 = 0.43, 95% CI 0.33-0.56). There was little change in non-AIDS mortality. Treatment coverage among individuals eligible to start ART was around 70% in 2008. Conclusions: ART can have a dramatic effect on mortality in a resource-constrained setting in Africa, at least in the early years of treatment provision. Our findings support the decentralised delivery of ART from peripheral health centres with unsophisticated facilities. Continued funding to maintain and further scale-up treatment provision will bring large benefits in terms of saving lives.	[Floyd, Sian; Molesworth, Anna; Jahn, Andreas; Ngwira, Bagrey; Branson, Keith; Crampin, Amelia C.; Zaba, Basia; Glynn, Judith R.; French, Neil] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Molesworth, Anna; Dube, Albert; Banda, Emmanuel; Mwafulirwa, Charles; Ngwira, Bagrey; Crampin, Amelia C.; French, Neil] Karonga Prevent Study, Chilumba, Karonga, Malawi	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit	Floyd, S (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.	sian.floyd@lshtm.ac.uk	Jahn, Andreas/ABB-7796-2020; French, Neil/A-2994-2012	Jahn, Andreas/0000-0003-4645-1600; Crampin, Amelia/0000-0002-1513-4330; French, Neil/0000-0003-4814-8293; Dube, Albert/0000-0002-6392-0475	Wellcome Trust [079828/Z/06/Z]; Government of the Republic of Malawi	Wellcome Trust(Wellcome TrustEuropean Commission); Government of the Republic of Malawi	The study was funded by a Wellcome Trust Programme grant (number 079828/Z/06/Z), URL http://www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Government of the Republic of Malawi for their interest in and support of the Project and the National Health Sciences Research Committee of Malawi for permission to publish the paper.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Crampin AC, 2003, AIDS, V17, P1817, DOI 10.1097/00002030-200308150-00011; Crampin AC, 2002, AIDS, V16, P1545, DOI 10.1097/00002030-200207260-00012; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Global Fund, 2010, GLOB FUND 2010 INN I; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; *INDEPTH NETW, 2003, INDEPTH STAND VERB A; Isingo R, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000299405.06658.a8; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; KAPLAN R, 2009, 5 INT AIDS SOC IAS C; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lowrance DW, 2008, JAIDS-J ACQ IMM DEF, V49, P287, DOI 10.1097/QAI.0b013e3181893ef0; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; McGrath N, 2007, AIDS, V21, pS105, DOI 10.1097/01.aids.0000299417.69432.65; *MIN HLTH ROM, 2006, GUID US ANT THER MAL; Mwagomba B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010452; *PEPFAR, 2010, MAK DIFF FUND; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; TENTHANI L, 2009, 5 INT AIDS SOC IAS C; UNAIDS/WHO, AIDS EP UPD; *WHO, UN ACC SCAL PRIOR HI; World Health Organization, RAP ADV ANT THER HIV; Zaba B, 2007, AIDS, V21, pS87, DOI 10.1097/01.aids.0000299415.67646.26; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	36	53	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13499	10.1371/journal.pone.0013499	http://dx.doi.org/10.1371/journal.pone.0013499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976068	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000283114700019
J	Massey, AJ; Borgognoni, J; Bentley, C; Foloppe, N; Fiumana, A; Walmsley, L				Massey, Andrew J.; Borgognoni, Jenifer; Bentley, Carol; Foloppe, Nicolas; Fiumana, Andrea; Walmsley, Lee			Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; AURORA KINASES; CANCER; CHK1; PF-00477736; THERAPIES; TARGETS	Background: Checkpoint kinase 1 and 2 (Chk1/Chk2), and the Aurora kinases play a critical role in the activation of the DNA damage response and mitotic spindle checkpoints. We have identified a novel inhibitor of these kinases and utilized this molecule to probe the functional interplay between these two checkpoints. Principal Findings: Fragment screening, structure guided design, and kinase cross screening resulted in the identification of a novel, potent small molecule kinase inhibitor (VER-150548) of Chk1 and Chk2 kinases with IC(50)s of 35 and 34 nM as well as the Aurora A and Aurora B kinases with IC(50)s of 101 and 38 nM. The structural rationale for this kinase specificity could be clearly elucidated through the X-ray crystal structure. In human carcinoma cells, VER-150548 induced reduplication and the accumulation of cells with >4N DNA content, inhibited histone H3 phosphorylation and ultimately gave way to cell death after 120 hour exposure; a phenotype consistent with cellular Aurora inhibition. In the presence of DNA damage induced by cytotoxic chemotherapeutic drugs, VER-150548 abrogated DNA damage induced cell cycle checkpoints. Abrogation of these checkpoints correlated with increased DNA damage and rapid cell death in p53 defective HT29 cells. In the presence of DNA damage, reduplication could not be observed. These observations are consistent with the Chk1 and Chk2 inhibitory activity of this molecule. Conclusions: In the presence of DNA damage, we suggest that VER-150548 abrogates the DNA damage induced checkpoints forcing cells to undergo a lethal mitosis. The timing of this premature cell death induced by Chk1 inhibition negates Aurora inhibition thereby preventing re-entry into the cell cycle and subsequent DNA reduplication. This novel kinase inhibitor therefore serves as a useful chemical probe to further understand the temporal relationship between cell cycle checkpoint pathways, chemotherapeutic agent induced DNA damage and cell death.	[Massey, Andrew J.; Borgognoni, Jenifer; Bentley, Carol; Foloppe, Nicolas; Fiumana, Andrea; Walmsley, Lee] Vernalis R&D Ltd, Cambridge, England	Vernalis	Massey, AJ (corresponding author), Vernalis R&D Ltd, Granta Pk, Cambridge, England.	a.massey@vernalis.com	Massey, Andrew J./H-6954-2019	Massey, Andrew J./0000-0002-0276-2573; Walmsley, Lee/0000-0001-8471-5895				Ashwell S, 2008, EXPERT OPIN INV DRUG, V17, P1331, DOI [10.1517/13543784.17.9.1331, 10.1517/13543784.17.9.1331 ]; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bebbington D, 2009, BIOORG MED CHEM LETT, V19, P3586, DOI 10.1016/j.bmcl.2009.04.136; Bekier ME, 2009, MOL CANCER THER, V8, P1646, DOI 10.1158/1535-7163.MCT-08-1084; Blasina A, 2008, MOL CANCER THER, V7, P2394, DOI 10.1158/1535-7163.MCT-07-2391; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Carvajal RD, 2006, CLIN CANCER RES, V12, P6869, DOI 10.1158/1078-0432.CCR-06-1405; Cheung CHA, 2009, EXPERT OPIN INV DRUG, V18, P379, DOI [10.1517/13543780902806392 , 10.1517/13543780902806392]; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Foloppe N, 2005, J MED CHEM, V48, P4332, DOI 10.1021/jm049022c; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Liu QH, 2000, GENE DEV, V14, P1448; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Matthews DJ, 2007, CELL CYCLE, V6, P104, DOI 10.4161/cc.6.1.3699; O'Connor MJ, 2007, ONCOGENE, V26, P7816, DOI 10.1038/sj.onc.1210879; Pascreau Gaetan, 2003, Prog Cell Cycle Res, V5, P369; Scharer CD, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-79; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; VanderPorten EC, 2009, MOL CANCER THER, V8, P930, DOI 10.1158/1535-7163.MCT-08-0754; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zhang C, 2009, CLIN CANCER RES, V15, P4630, DOI 10.1158/1078-0432.CCR-08-3272; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	27	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13123	10.1371/journal.pone.0013123	http://dx.doi.org/10.1371/journal.pone.0013123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976184	gold, Green Published, Green Submitted			2022-12-25	WOS:000283045300002
J	Yang, YJ; Yao, HH; Lu, YM; Wang, C; Buch, S				Yang, Yanjing; Yao, Honghong; Lu, Yaman; Wang, Chao; Buch, Shilpa			Cocaine Potentiates Astrocyte Toxicity Mediated by Human Immunodeficiency Virus (HIV-1) Protein gp120	PLOS ONE			English	Article							OXIDATIVE STRESS; CYTOCHROME-C; IN-VITRO; INFECTION; APOPTOSIS; BRAIN; ACTIVATION; DEGENERATION; MITOCHONDRIA; CULTURES	It is becoming widely accepted that psychoactive drugs, often abused by HIV-I infected individuals, can significantly alter the progression of neuropathological changes observed in HIV-associated neurodegenerative diseases (HAND). The underlying mechanisms mediating these effects however, remain poorly understood. In the current study, we explored whether the psychostimulant drug cocaine could exacerbate toxicity mediated by gp120 in rat primary astrocytes. Exposure to both cocaine and gp120 resulted in increased cell toxicity compared to cells treated with either factor alone. The combinatorial toxicity of cocaine and gp120 was accompanied by an increase in caspase-3 activation. In addition, increased apoptosis of astrocytes in the presence of both the agents was associated with a concomitant increase in the production of intracellular reactive oxygen species and loss of mitochondrial membrane potential. Signaling pathways including c-jun N-teminal kinase (JNK), p38, extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinases (MAPK), and nuclear factor (NF-kappa B) were identified to be major players in cocaine and gp120-mediated apoptosis of astrocytes. Our results demonstrated that cocaine-mediated potentiation of gp120 toxicity involved regulation of oxidative stress, mitochondrial membrane potential and MAPK signaling pathways.	[Yang, Yanjing; Yao, Honghong; Lu, Yaman; Wang, Chao; Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Yang, YJ (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	sbuch@unmc.edu		Buch, Shilpa/0000-0002-3103-6685	National Institutes of Health [MH-068212, DA020392, DA024442]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261, R01MH068212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020392, R01DA024442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants MH-068212, DA020392 and DA024442 from the National Institutes of Health (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MY, 2006, NEUROTOXICOLOGY, V27, P217, DOI 10.1016/j.neuro.2005.10.003; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Andersson S, 2000, SOIL BIOL BIOCHEM, V32, P1, DOI 10.1016/S0038-0717(99)00103-0; Barbin G, 2001, NEUROCHEM RES, V26, P107, DOI 10.1023/A:1011086426652; Benjelloun N, 1998, CELL MOL BIOL, V44, P579; Bodner A, 2004, EXP NEUROL, V188, P246, DOI 10.1016/j.expneurol.2004.04.009; BRENNEMAN DE, 1988, NATURE, V335, P639, DOI 10.1038/335639a0; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Chen YM, 2001, J NEUROCHEM, V77, P1601, DOI 10.1046/j.1471-4159.2001.00374.x; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Cysique LA, 2009, NEUROPSYCHOL REV, V19, P169, DOI 10.1007/s11065-009-9092-3; Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2; Franz G, 2002, J CEREBR BLOOD F MET, V22, P951, DOI 10.1097/00004647-200208000-00006; Gray F, 2001, CLIN NEUROPATHOL, V20, P146; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gurwell JA, 2001, NEUROSCIENCE, V102, P555, DOI 10.1016/S0306-4522(00)00461-9; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; Jiao HY, 2007, J NEUROCHEM, V103, P840, DOI 10.1111/j.1471-4159.2007.04840.x; Kalasinsky KS, 2000, J FORENSIC SCI, V45, P1041; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kroemer G, 1999, BIOCHEM SOC SYMP, V66, P1; LEE SC, 1993, ANN NY ACAD SCI, V693, P314, DOI 10.1111/j.1749-6632.1993.tb26295.x; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Mazzanti M, 2001, NEUROSCIENTIST, V7, P396, DOI 10.1177/107385840100700509; Peng FW, 2008, EUR J NEUROSCI, V28, P1255, DOI 10.1111/j.1460-9568.2008.06444.x; Peng FW, 2008, J NEUROVIROL, V14, P62, DOI 10.1080/13550280701809084; PETITO CK, 1995, AM J PATHOL, V146, P1121; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; RYCHERT J, 2010, AIDS RES HUM RETROVI; Sabri F, 2003, BRAIN PATHOL, V13, P84, DOI 10.1111/j.1750-3639.2003.tb00009.x; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shi B, 1996, J CLIN INVEST, V98, P1979, DOI 10.1172/JCI119002; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Stephens BG, 2004, AM J FOREN MED PATH, V25, P1, DOI 10.1097/01.paf.0000118960.58334.a9; Stewart VC, 1998, J NEUROCHEM, V70, P432; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Szydlowska K, 2006, J NEUROCHEM, V99, P965, DOI 10.1111/j.1471-4159.2006.04136.x; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Thompson KA, 2001, ANN NEUROL, V49, P745, DOI 10.1002/ana.1011; TORNATORE C, 1994, NEUROLOGY, V44, P481, DOI 10.1212/WNL.44.3_Part_1.481; Turchan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-3; VANDYKE C, 1976, SCIENCE, V191, P859, DOI 10.1126/science.56036; Visalli V, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-106; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yao HH, 2009, J NEUROVIROL, V15, P164, DOI 10.1080/13550280902755375	50	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13427	10.1371/journal.pone.0013427	http://dx.doi.org/10.1371/journal.pone.0013427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976166	gold, Green Submitted, Green Published			2022-12-25	WOS:000283043700019
J	Teng, HJ; Cai, WS; Zhou, LL; Zhang, J; Liu, Q; Wang, YQ; Dai, W; Zhao, M; Sun, ZS				Teng, Huajing; Cai, Wanshi; Zhou, LingLin; Zhang, Jing; Liu, Qi; Wang, Yongqing; Dai, Wei; Zhao, Mei; Sun, Zhongsheng			Evolutionary Mode and Functional Divergence of Vertebrate NMDA Receptor Subunit 2 Genes	PLOS ONE			English	Article							WHOLE-GENOME DUPLICATION; EVENTS; MEMORY; DISRUPTION; DIVERSITY; REVEALS; DOMAIN; BRAIN; SITE; LTD	Background: Ionotropic glutamate receptors in the central nervous system play a major role in numerous brain functions including learning and memory in many vertebrate species. NR2 subunits have been regarded as rate-limiting molecules in controlling the optimal N-methyl-D-aspartate (NMDA) receptor's coincidence-detection property and subsequent learning and memory function across multi-species. However, its evolutionary mode among vertebrate species remains unclear. Results: With extensive analysis of phylogeny, exon structure, protein domain, paralogon and synteny, we demonstrated that two-round genome duplication generated quartet GRIN2 genes and the third-round fish-specific genome duplication generated extra copies of fish GRIN2 genes. In addition, in-depth investigation has enabled the identification of three novel genes, GRIN2C_Gg, GRIN2D-1_Ol and GRIN2D-2_Tr in the chicken, medaka and fugu genome, respectively. Furthermore, we showed functional divergence of NR2 genes mostly occurred at the first-round duplication, amino acid residues located at the N-terminal Lig_chan domain were responsible for type I functional divergence between these GRIN2 subfamilies and purifying selection has been the prominent natural pressure operating on these diversified GRIN2 genes. Conclusion and Significance: These findings provide intriguing subjects for testing the 2R and 3R hypothesis and we expect it could provide new insights into the underlying evolution mechanisms of cognition in vertebrate.	[Teng, Huajing; Zhang, Jing; Wang, Yongqing; Dai, Wei; Zhao, Mei; Sun, Zhongsheng] Chinese Acad Sci, Inst Psychol, Behav Genet Ctr, Beijing 100101, Peoples R China; [Cai, Wanshi; Zhou, LingLin; Liu, Qi] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Wenzhou Medical University	Teng, HJ (corresponding author), Chinese Acad Sci, Inst Psychol, Behav Genet Ctr, Beijing 100101, Peoples R China.	sunzs@psych.ac.cn	Sun, Zhongsheng/AAS-4883-2020; Huajing, Teng/AAF-4040-2020	Sun, Zhongsheng/0000-0002-7640-5026; Huajing, Teng/0000-0001-9952-3618	Chinese Academy of Sciences [KSCX2-YW-R-38]; Major State Basic Research Development Program of China [2007CB512302]; National High Technology Research and Development Program of China [2006AA02A304]; National Natural Science Foundation of China [30770786]	Chinese Academy of Sciences(Chinese Academy of Sciences); Major State Basic Research Development Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the Knowledge Innovation Project of The Chinese Academy of Sciences (KSCX2-YW-R-38), Major State Basic Research Development Program of China (2007CB512302), National High Technology Research and Development Program of China (2006AA02A304) and National Natural Science Foundation of China (30770786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Burrell BD, 2001, CURR OPIN NEUROBIOL, V11, P757, DOI 10.1016/S0959-4388(01)00281-1; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Ebralidze AK, 1996, J NEUROSCI, V16, P5014; FALLS WA, 1992, J NEUROSCI, V12, P854; Finn RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000169; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Friedman R, 2003, MOL BIOL EVOL, V20, P154, DOI 10.1093/molbev/msg017; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; HALDANE J. B. S., 1932; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holland PWH, 1999, SEMIN CELL DEV BIOL, V10, P541, DOI 10.1006/scdb.1999.0335; Ito H, 2007, BRAIN BEHAV EVOLUT, V69, P76, DOI 10.1159/000095196; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kadotani H, 1996, J NEUROSCI, V16, P7859; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Niethammer M, 1996, J NEUROSCI, V16, P2157; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; OHNO S., 1970, Evolution by gene duplication.; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; OHTA T, 1989, GENOME, V31, P304, DOI 10.1139/g89-048; Olinski RP, 2006, MOL BIOL EVOL, V23, P10, DOI 10.1093/molbev/msj002; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Ryan TJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-6; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; STERN P, 1992, P ROY SOC B-BIOL SCI, V250, P271, DOI 10.1098/rspb.1992.0159; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; von Schantz M, 2006, J MOL EVOL, V62, P701, DOI 10.1007/s00239-005-0185-1; Wang H, 2008, J MOL EVOL, V67, P29, DOI 10.1007/s00239-008-9121-5; Wang H, 2008, GENOME, V51, P222, DOI 10.1139/G07-098; Wang W, 2007, MOL BIOL EVOL, V24, P784, DOI 10.1093/molbev/msl205; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981	53	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13342	10.1371/journal.pone.0013342	http://dx.doi.org/10.1371/journal.pone.0013342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976280	Green Published, gold, Green Submitted			2022-12-25	WOS:000282941000004
J	Lehner, F; Kulik, U; Klempnauer, J; Borlak, J				Lehner, Frank; Kulik, Ulf; Klempnauer, Juergen; Borlak, Juergen			Inhibition of the Liver Enriched Protein FOXA2 Recovers HNF6 Activity in Human Colon Carcinoma and Liver Hepatoma Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; C/EBP-ALPHA; HEPATOCELLULAR-CARCINOMA; EXPRESSION; COACTIVATOR; BINDING; HEPG2	Recently, we demonstrated that the transcription factors HNF6 and FOXA2 function as key regulators in human colorectal liver metastases. To better understand their proposed inhibitory crosstalk, the consequences of functional knockdown of FOXA2 on HNF6 and C/EBP alpha activity were investigated in the human colon Caco-2 and HepG2 carcinoma cell lines. Specifically, siRNA-mediated gene silencing of FOXA2 repressed transcript expression by >80%. This resulted in a statistically significant 6-, 3-, 4-, and 8-fold increase in mRNA expression of HNF6 and of genes targeted by this transcription factor, e.g., HSP105B, CYP51, and C/EBP alpha, as determined by qRT-PCR. Thus, functional knockdown of FOXA2 recovered HNF6 activity. Furthermore, with nuclear extracts of Caco-2 cells no HNF6 DNA binding was observed, but expression of HNF1 alpha, FOXA2, FOXA3, and HNF4 alpha protein was abundant. We therefore transfected a plasmid encoding HNF6 into Caco-2 cells but also employed a retroviral vector to transfect HNF6 into HepG2 cells. This resulted in HNF6 protein expression with DNA binding activity being recovered as determined by EMSA band shift assays. Furthermore, by flow cytometry the consequences of HNF6 expression on cell cycle regulation in transfected cells was studied. Essentially, HNF6 inhibited cell cycle progression in the G2/M and G1 phase in Caco-2 and HepG2 cell lines, respectively. Here, proliferation was reduced by 80% and 50% in Caco-2 and HepG2 cells, respectively, as determined by the BrdU labeling assay. Therefore functional knockdown of FOXA2 recovered HNF6 activity and inhibited growth of tumor-cells and may possibly represent a novel therapeutic target in primary and secondary liver malignancies.	[Lehner, Frank; Kulik, Ulf; Klempnauer, Juergen] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, D-3000 Hannover, Germany; [Borlak, Juergen] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany	Hannover Medical School; Fraunhofer Gesellschaft; Hannover Medical School	Lehner, F (corresponding author), Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, D-3000 Hannover, Germany.	juergen.borlak@item.fraunhofer.de			Ministry of Science and Culture, Lower Saxony, Germany [25A.5-76251-99-3/00]	Ministry of Science and Culture, Lower Saxony, Germany	The work was funded by Ministry of Science and Culture, Lower Saxony, Germany; Grant number: 25A.5-76251-99-3/00 to Juergen Borlak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Hayashi Y, 1999, J CLIN PATHOL-MOL PA, V52, P19; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kishimoto T, 1998, CELL GROWTH DIFFER, V9, P337; Lampen A, 1998, XENOBIOTICA, V28, P429, DOI 10.1080/004982598239362; Lehner F, 2007, FASEB J, V21, P1445, DOI 10.1096/fj.06-6575com; Lehner F, 2010, WORLD J GASTROENTERO, V16, P3919, DOI 10.3748/wjg.v16.i31.3919; Niehof M, 2001, J BIOL CHEM, V276, P9016, DOI 10.1074/jbc.M009284200; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Poll AV, 2006, DIABETES, V55, P61; Rausa FM, 2004, J BIOL CHEM, V279, P43070, DOI 10.1074/jbc.M407472200; Rausa FM, 2003, MOL CELL BIOL, V23, P437, DOI 10.1128/MCB.23.2.437-449.2003; Rubins NE, 2005, MOL CELL BIOL, V25, P7069, DOI 10.1128/MCB.25.16.7069-7077.2005; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Xu L, 2001, CANCER RES, V61, P3176; Yoshida Y, 2006, HEPATOLOGY, V43, P276, DOI 10.1002/hep.21044	22	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13344	10.1371/journal.pone.0013344	http://dx.doi.org/10.1371/journal.pone.0013344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967225	Green Published, gold			2022-12-25	WOS:000282869800034
J	Park, HK; Wang, H; Zhang, J; Datta, S; Fei, PW				Park, Hwan Ki; Wang, Hong; Zhang, Jun; Datta, Suvamoy; Fei, Peiwen			Convergence of Rad6/Rad18 and Fanconi Anemia Tumor Suppressor Pathways upon DNA Damage	PLOS ONE			English	Article							HUMAN-CELLS; XERODERMA-PIGMENTOSUM; TRANSLESION SYNTHESIS; RESPONSE NETWORK; UBIQUITIN LIGASE; POLYMERASE ETA; BRCA PROTEINS; REPAIR; RAD6; SPECIFICITY	Extremely high cancer incidence associated with patients with Fanconi anemia (FA) suggests the importance of the FA signaling pathway in the suppression of non-FA human tumor development. Indeed, we found that an impaired FA signaling pathway substantially contributes to the development of non-FA human tumors. However, the mechanisms underlying the function of the FA pathway remain less understood. Using RNA interfering approach in combining with cell proliferation and reporter assays, we showed that the function of FA signaling pathway is at least partly mediated through coupling with hRad6/hRad18 signaling (HHR6 pathway). We previously reported that FANCD2 monoubiquitination, a hallmark of the FA pathway activation, can be regulated by HHR6. Here we found that hRad18 can also regulate activation of the FA pathway. More importantly, we found that FANCD2 is capable of modulating activity of DNA translesion synthesis polymerase eta, an effector of HHR6 pathway. These results provide novel insights into how the FA pathway is intertwined with HHR6 pathway to maintain chromosomal stability and suppress the development of human cancer, representing an important conceptual advance in the field of FA cancer research.	[Park, Hwan Ki; Datta, Suvamoy; Fei, Peiwen] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Wang, Hong; Zhang, Jun] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA	University of Minnesota System; Mayo Clinic	Park, HK (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	pfei@hi.umn.edu			National Institutes of Health [CA136532]; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; Hormel Institute, University of Minnesota, Austin, Minnesota; NATIONAL CANCER INSTITUTE [R01CA136532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; Hormel Institute, University of Minnesota, Austin, Minnesota(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is partly supported by National Institutes of Health grant CA136532 to PF, and is also partly supported by the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, and the Hormel Institute, University of Minnesota, Austin, Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avkin S, 2004, J BIOL CHEM, V279, P53298, DOI 10.1074/jbc.M409155200; Avkin S, 2002, MUTAT RES-FUND MOL M, V510, P81, DOI 10.1016/S0027-5107(02)00254-3; Bagby GC, 2003, CURR OPIN HEMATOL, V10, P68, DOI 10.1097/00062752-200301000-00011; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bilsland E, 2005, MUTAGENESIS, V20, P153, DOI 10.1093/mutage/gei031; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fei PW, 2005, CELL CYCLE, V4, P80, DOI 10.4161/cc.4.1.1358; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; HEJNA J, CELL BIOL INT; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Karras G.I., CELL, V141, P255; Kee Y, GENES DEV, V24, P1680; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; MEINDL A, NAT GENET, V42, P410; PACE P, SCIENCE; Plosky BS, 2004, CURR OPIN GENET DEV, V14, P113, DOI 10.1016/j.gde.2004.02.002; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; SWIFT M, 1971, NATURE, V230, P370, DOI 10.1038/230370a0; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; VAZ F, NAT GENET, V42, P406; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Zhang J, 2008, CELL CYCLE, V7, P407, DOI 10.4161/cc.7.3.5156; Zhang J, 2006, CANCER BIOL THER, V5, P1632, DOI 10.4161/cbt.5.12.3351; Zhang J, 2010, J CLIN INVEST, V120, P1524, DOI 10.1172/JCI40908	35	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13313	10.1371/journal.pone.0013313	http://dx.doi.org/10.1371/journal.pone.0013313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967207	Green Submitted, Green Published, gold			2022-12-25	WOS:000282869800018
J	Regueiro, BJ; Varela-Ledo, E; Martinez-Lamas, L; Rodriguez-Calvino, J; Aguilera, A; Santos, A; Gomez-Tato, A; Alvarez-Escudero, J				Regueiro, Benito J.; Varela-Ledo, Eduardo; Martinez-Lamas, Lucia; Rodriguez-Calvino, Javier; Aguilera, Antonio; Santos, Antonio; Gomez-Tato, Antonio; Alvarez-Escudero, Julian			Automated Extraction Improves Multiplex Molecular Detection of Infection in Septic Patients	PLOS ONE			English	Article							INADEQUATE ANTIMICROBIAL TREATMENT; POLYMERASE-CHAIN-REACTION; PCR ASSAY; SEPSIS; DIAGNOSIS; THERAPY; PNEUMONIA; MORTALITY; ICU	Sepsis is one of the leading causes of morbidity and mortality in hospitalized patients worldwide. Molecular technologies for rapid detection of microorganisms in patients with sepsis have only recently become available. LightCycler SeptiFast test M-grade (Roche Diagnostics GmbH) is a multiplex PCR analysis able to detect DNA of the 25 most frequent pathogens in bloodstream infections. The time and labor saved while avoiding excessive laboratory manipulation is the rationale for selecting the automated MagNA Pure compact nucleic acid isolation kit-I (Roche Applied Science, GmbH) as an alternative to conventional SeptiFast extraction. For the purposes of this study, we evaluate extraction in order to demonstrate the feasibility of automation. Finally, a prospective observational study was done using 106 clinical samples obtained from 76 patients in our ICU. Both extraction methods were used in parallel to test the samples. When molecular detection test results using both manual and automated extraction were compared with the data from blood cultures obtained at the same time, the results show that SeptiFast with the alternative MagNA Pure compact extraction not only shortens the complete workflow to 3.57 hrs., but also increases sensitivity of the molecular assay for detecting infection as defined by positive blood culture confirmation.	[Regueiro, Benito J.; Varela-Ledo, Eduardo; Martinez-Lamas, Lucia; Rodriguez-Calvino, Javier; Aguilera, Antonio] Complejo Hosp Univ Santiago, Dept Clin Microbiol, Santiago De Compostela, Spain; [Santos, Antonio] Complejo Hosp Univ Santiago, Dept Intens Care, Hosp Conxo, Santiago De Compostela, Spain; [Gomez-Tato, Antonio] Univ Santiago, Sch Math, Santiago De Compostela, Spain; [Alvarez-Escudero, Julian] Complejo Hosp Univ Santiago, Dept Anesthesiol, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Regueiro, BJ (corresponding author), Complejo Hosp Univ Santiago, Dept Clin Microbiol, Santiago De Compostela, Spain.	benito.regueiro@usc.es	Regueiro, Benito/H-4264-2014; Tato, Antonio Gómez/N-3202-2013; Julian, Alvarez/D-5716-2011; Aguilera, Antonio/L-6586-2018	Regueiro, Benito/0000-0002-4009-7922; Tato, Antonio Gómez/0000-0003-2465-3500; Julian, Alvarez/0000-0001-6806-6944; Aguilera, Antonio/0000-0001-6940-241X; Rodriguez Calvino, Jose Javier/0000-0003-2358-7468; Alvarez, Julian/0000-0002-2518-0891	Spanish Ministerio de Ciencia e Innovacion [MAT2008-06503]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was partially supported by the Spanish Ministerio de Ciencia e Innovacion (MAT2008-06503) which supported Javier Rodriguez Calvino's fellowship.	Abe Al-Soud W, 2000, J CLIN MICROBIOL, V38, P4463; Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P345; Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; ALVAREZ M, 2008, 18 ECCMID 26 ICC 200, pS578; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Baron RM, 2006, AM J RESP CELL MOL, V34, P129, DOI 10.1165/rcmb.F308; CASALTA JP, 2008, EUR J CLIN MICROBIOL; Celard M., 2008, Annales de Cardiologie et d'Angeiologie, V57, P78, DOI 10.1016/j.ancard.2008.02.007; Garnacho-Montero J, 2008, J ANTIMICROB CHEMOTH, V61, P436, DOI 10.1093/jac/dkm460; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Jahan Ali, 2006, Cleve Clin J Med, V73 Suppl 1, pS67; Kollef MH, 2006, NEW ENGL J MED, V355, P2691, DOI 10.1056/NEJMe068231; Kollef MH, 2006, AM J RESP CRIT CARE, V173, P1182, DOI 10.1164/rccm.2603004; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kumar S, 2008, J CLIN MICROBIOL, V46, P3063, DOI 10.1128/JCM.00625-08; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Lehmann LE, 2009, CRIT CARE MED, V37, P3085, DOI 10.1097/CCM.0b013e3181b033d7; Louie RF, 2008, CRIT CARE MED, V36, P1487, DOI 10.1097/CCM.0b013e31816f487c; Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; Morata P, 1998, J CLIN MICROBIOL, V36, P2443, DOI 10.1128/JCM.36.9.2443-2446.1998; Mussap M, 2007, J Chemother, V19 Suppl 2, P31; REGUEIRO B, 2008, SEPS 2008 GRAN CR S5, V12, pS5; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Schrenzel J, 2007, INT J ANTIMICROB AG, V30, pS2, DOI 10.1016/j.ijantimicag.2007.06.030; Stormer M, 2007, CLIN CHEM, V53, P104, DOI 10.1373/clinchem.2006.070987; Uhl JR, 2003, J CLIN MICROBIOL, V41, P242, DOI 10.1128/JCM.41.1.242-249.2003; Vince A, 2008, J MED MICROBIOL, V57, P1306, DOI 10.1099/jmm.0.47797-0	30	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13387	10.1371/journal.pone.0013387	http://dx.doi.org/10.1371/journal.pone.0013387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967222	Green Submitted, gold, Green Published			2022-12-25	WOS:000282869800048
J	Sommerlad, S; Mcrae, AF; McDonald, B; Johnstone, I; Cuttell, L; Seddon, JM; O'Leary, CA				Sommerlad, Susan; McRae, Allan F.; McDonald, Brenda; Johnstone, Isobel; Cuttell, Leigh; Seddon, Jennifer M.; O'Leary, Caroline A.			Congenital Sensorineural Deafness in Australian Stumpy-Tail Cattle Dogs Is an Autosomal Recessive Trait That Maps to CFA10	PLOS ONE			English	Article							AUDITORY-EVOKED RESPONSE; CLINICALLY NORMAL DOG; SEGREGATION ANALYSIS; TRANSCRIPTION-FACTOR; BILATERAL DEAFNESS; MODEL ANALYSIS; COAT COLOR; PIGMENTATION; LINKAGE; ASSOCIATIONS	Background: Congenital sensorineural deafness is an inherited condition found in many dog breeds, including Australian Stumpy-tail Cattle Dogs (ASCD). This deafness is evident in young pups and may affect one ear (unilateral) or both ears (bilateral). The genetic locus/loci involved is unknown for all dog breeds. The aims of this study were to determine incidence, inheritance mechanism, and possible association of congenital sensorineural deafness with coat colour in ASCD and to identify the genetic locus underpinning this disease. Methodology/Principal Findings: A total of 315 ASCD were tested for sensorineural deafness using the brain stem auditory evoked response (BAER) test. Disease penetrance was estimated directly, using the ratio of unilaterally to bilaterally deaf dogs, and segregation analysis was performed using Mendel. A complete genome screen was undertaken using 325 microsatellites spread throughout the genome, on a pedigree of 50 BAER tested ASCD in which deafness was segregating. Fifty-six dogs (17.8%) were deaf, with 17 bilaterally and 39 unilaterally deaf. Unilaterally deaf dogs showed no significant left/right bias (p = 0.19) and no significant difference was observed in frequencies between the sexes (p = 0.18). Penetrance of deafness was estimated as 0.72. Testing the association of red/blue coat colour and deafness without accounting for pedigree structure showed that red dogs were 1.8 times more likely to be deaf (p = 0.045). The within family association between red/blue coat colour and deafness was strongly significant (p = 0.00036), with red coat colour segregating more frequently with deafness (COR = 0.48). The relationship between deafness and coat speckling approached significance (p = 0.07), with the lack of statistical significance possibly due to only four families co-segregating for both deafness and speckling. The deafness phenotype was mapped to CFA10 (maximum linkage peak on CFA10 -log 10 p-value = 3.64), as was both coat colour and speckling. Fine mapping was then performed on 45 of these 50 dogs and a further 48 dogs (n = 93). Sequencing candidate gene Sox10 in 6 hearing ASCD, 2 unilaterally deaf ASCD and 2 bilaterally deaf ASCD did not reveal any disease-associated mutations. Conclusions: Deafness in ASCD is an incompletely penetrant autosomal recessive inherited disease that maps to CFA10.	[Sommerlad, Susan; McDonald, Brenda; Johnstone, Isobel; Cuttell, Leigh; Seddon, Jennifer M.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [O'Leary, Caroline A.] Univ Queensland, Ctr Compan Anim Hlth, Brisbane, Qld, Australia; [McRae, Allan F.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	University of Queensland; University of Queensland; QIMR Berghofer Medical Research Institute	Sommerlad, S (corresponding author), Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.	c.oleary@uq.edu.au	McRae, Allan F/J-2644-2014; Cuttell, Leigh/F-9281-2011; Seddon, Jennifer/A-1402-2010; Seddon, Jennifer/AAM-3827-2021	McRae, Allan F/0000-0001-5286-5485; Seddon, Jennifer/0000-0003-3789-6878; Seddon, Jennifer/0000-0003-3789-6878	Canine Control Council of Queensland	Canine Control Council of Queensland	Funding was provided by The Canine Control Council of Queensland, 7026001 03 475 21 XXXXXX 001748, 429 7155 CCC (http://www.cccq.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Cargill EJ, 2004, GENETICS, V166, P1385, DOI 10.1534/genetics.166.3.1385; Clark NE., 2003, DOG CALLED BLUE, P22; Clark NE., 2003, DOG CALLED BLUE, P5; Coppens AG, 2003, J COMP PATHOL, V128, P67, DOI 10.1053/jcpa.2002.0596; Coppens AG, 2000, J COMP PATHOL, V122, P223, DOI 10.1053/jcpa.1999.0360; Coppens AG, 2001, HEARING RES, V161, P65, DOI 10.1016/S0378-5955(01)00354-9; Famula TR, 2000, AM J VET RES, V61, P550, DOI 10.2460/ajvr.2000.61.550; Famula TR, 1996, MAMM GENOME, V7, P650, DOI 10.1007/s003359900199; Finsterer J, 2005, INT J PEDIATR OTORHI, V69, P621, DOI 10.1016/j.ijporl.2004.12.002; FORGE A, 2000, BRIT MED B, V63, P5; GREIBROKK T, 1994, J AM ANIM HOSP ASSOC, V30, P170; Guyon R, 2003, P NATL ACAD SCI USA, V100, P5296, DOI 10.1073/pnas.0831002100; HIRAIDE F, 1988, Auris Nasus Larynx, V15, P97; Juraschko K, 2003, MAMM GENOME, V14, P547, DOI 10.1007/s00335-002-3033-2; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kerns JA, 2007, GENETICS, V176, P1679, DOI 10.1534/genetics.107.074237; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lange K, 2001, AM J HUM GENET, V69, P504; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOTOHASHI H, 1994, HEARING RES, V80, P10, DOI 10.1016/0378-5955(94)90003-5; Muhle AC, 2002, VET J, V163, P311, DOI 10.1053/tvjl.2001.0661; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Petersen MB, 2006, CLIN GENET, V69, P371, DOI 10.1111/j.1399-0004.2006.00613.x; Platt S, 2006, J VET INTERN MED, V20, P1355, DOI 10.1892/0891-6640(2006)20[1355:POUABD]2.0.CO;2; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; PUTSCH C, 1998, HUM GENET, V103, P115; Rak SG, 2005, VET J, V169, P188, DOI 10.1016/j.tvjl.2004.01.015; Sanderson A., 1981, COMPLETE BOOK AUSTR, P45; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Schmutz SM, 2009, J HERED, V100, pS66, DOI 10.1093/jhered/esp029; SIMS MH, 1984, AM J VET RES, V45, P2019; SIMS MH, 1984, AM J VET RES, V45, P2028; STEEL KP, 1989, DEVELOPMENT, V107, P453; Steel KP, 2002, P NATL ACAD SCI USA, V99, P14613, DOI 10.1073/pnas.232585699; Strain GM, 2004, VET J, V167, P23, DOI 10.1016/S1090-0233(03)00104-7; Strain GM, 1999, VET CLIN N AM-SMALL, V29, P895, DOI 10.1016/S0195-5616(99)50079-X; STRAIN GM, 1992, J VET INTERN MED, V6, P175, DOI 10.1111/j.1939-1676.1992.tb00333.x; STRAIN GM, 2005, GENETICS DEAFNESS DO; Stritzel S, 2009, J ANIM BREED GENET, V126, P59, DOI 10.1111/j.1439-0388.2008.00761.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Yoshida H, 1996, DEVELOPMENT, V122, P1207	43	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13364	10.1371/journal.pone.0013364	http://dx.doi.org/10.1371/journal.pone.0013364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967282	gold, Green Published, Green Submitted			2022-12-25	WOS:000282807300029
J	Labriola, CA; Conte, IL; Medus, ML; Parodi, AJ; Caramelo, JJ				Labriola, Carlos A.; Conte, Ianina L.; Lopez Medus, Maximo; Parodi, Armando J.; Caramelo, Julio J.			Endoplasmic Reticulum Calcium Regulates the Retrotranslocation of Trypanosoma Cruzi Calreticulin to the Cytosol	PLOS ONE			English	Article							PROTEIN-KINASE-C; RECEPTOR MESSENGER-RNA; MAMMALIAN-CELLS; BINDING PROTEIN; NUCLEAR EXPORT; CHAPERONE; IDENTIFICATION; POLYPEPTIDE; 80K-H; ERP57	For most secretory pathway proteins, crossing the endoplasmic reticulum (ER) membrane is an irreversible process. However, in some cases this flow can be reversed. For instance, misfolded proteins retained in the ER are retrotranslocated to the cytosol to be degraded by the proteasome. This mechanism, known as ER associated degradation (ERAD), is exploited by several bacterial toxins to gain access to the cytosol. Interestingly, some ER resident proteins can also be detected in the cytosol or nucleus, calreticulin (CRT) being the most studied. Here we show that in Trypanosoma cruzi a minor fraction of CRT localized to the cytosol. ER calcium depletion, but not increasing cytosolic calcium, triggered the retrotranslocation of CRT in a relatively short period of time. Cytosolic CRT was subsequently degraded by the proteasome. Interestingly, the single disulfide bridge of CRT is reduced when the protein is located in the cytosol. The effect exerted by ER calcium was strictly dependent on the C-terminal domain (CRT-C), since a CRT lacking it was totally retained in the ER, whereas the localization of an unrelated protein fused to CRT-C mirrored that of endogenous CRT. This finding expands the regulatory mechanisms of protein sorting and may represent a new crossroad between diverse physiological processes.	[Labriola, Carlos A.; Conte, Ianina L.; Parodi, Armando J.] Fdn Inst Leloir, Lab Glycobiol, Buenos Aires, DF, Argentina; [Labriola, Carlos A.; Conte, Ianina L.; Lopez Medus, Maximo; Parodi, Armando J.; Caramelo, Julio J.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, RA-1405 Buenos Aires, DF, Argentina; [Lopez Medus, Maximo; Caramelo, Julio J.] Fdn Inst Leloir, Lab Struct Cell Biol, Buenos Aires, DF, Argentina; [Caramelo, Julio J.] Univ Buenos Aires, Sch Sci, Dept Biol Chem, Buenos Aires, DF, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires	Labriola, CA (corresponding author), Fdn Inst Leloir, Lab Glycobiol, Buenos Aires, DF, Argentina.	jcaramelo@leloir.org.ar		Conte, Ianina/0000-0003-0235-8682	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT); University of Buenos Aires; Howard Hughes Medical Institute; National Institutes of Health [GM-44500]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); University of Buenos Aires(University of Buenos Aires); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work reported here was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT), the University of Buenos Aires, the Howard Hughes Medical Institute, and the National Institutes of Health (Grant GM-44500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Andrin C, 1998, BIOCHEMISTRY-US, V37, P10386, DOI 10.1021/bi980595z; Arosa FA, 1999, J BIOL CHEM, V274, P16917, DOI 10.1074/jbc.274.24.16917; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; CANNATA JJB, 1984, MOL BIOCHEM PARASIT, V11, P37, DOI 10.1016/0166-6851(84)90053-7; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; CAZZULO JJ, 1985, MOL BIOCHEM PARASIT, V16, P329, DOI 10.1016/0166-6851(85)90074-X; Chichiarelli S, 2007, J CELL PHYSIOL, V210, P343, DOI 10.1002/jcp.20824; COE H, 2009, J BIOL CHEM; Conte IL, 2007, BIOCHEMISTRY-US, V46, P4671, DOI 10.1021/bi6026456; Conte L, 2003, MOL BIOL CELL, V14, P3529, DOI 10.1091/mbc.E03-04-0228; Coppari S, 2002, J CELL BIOCHEM, V85, P325, DOI 10.1002/jcb.10137; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; Castaneda-Patlan MC, 2010, INT J BIOCHEM CELL B, V42, P120, DOI 10.1016/j.biocel.2009.09.019; Decca MB, 2007, J BIOL CHEM, V282, P8237, DOI 10.1074/jbc.M608559200; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Fraser SA, 2000, J IMMUNOL, V164, P4150, DOI 10.4049/jimmunol.164.8.4150; Furuya T, 2001, J BIOL CHEM, V276, P32437, DOI 10.1074/jbc.M104000200; Ghiran I, 2003, J BIOL CHEM, V278, P21024, DOI 10.1074/jbc.M302306200; GIRALDO AMV, 2009, J BIOL CHEM; Gkika D, 2004, J BIOL CHEM, V279, P26351, DOI 10.1074/jbc.M403801200; Gold LI, 2006, J INVEST DERM SYMP P, V11, P57, DOI 10.1038/sj.jidsymp.5650011; Grillo C, 2006, FREE RADICAL BIO MED, V41, P1113, DOI 10.1016/j.freeradbiomed.2006.06.016; Guo GG, 2002, J INTERF CYTOK RES, V22, P555, DOI 10.1089/10799900252982034; Ribeiro CH, 2009, MOL IMMUNOL, V46, P1092, DOI 10.1016/j.molimm.2008.10.034; HIRAI M, 1990, BIOCHEM J, V270, P583, DOI 10.1042/bj2700583; Hodgkinson CP, 2005, BIOCHEM J, V388, P785, DOI 10.1042/BJ20041845; Holaska JM, 2002, MOL CELL BIOL, V22, P6286, DOI 10.1128/MCB.22.17.6286-6297.2002; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Kawaai K, 2009, J BIOL CHEM, V284, P372, DOI 10.1074/jbc.M805828200; Labriola C, 1999, MOL BIOL CELL, V10, P1381, DOI 10.1091/mbc.10.5.1381; LABRIOLA C, 1995, J CELL BIOL, V130, P771, DOI 10.1083/jcb.130.4.771; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Massey S, 2009, J MOL BIOL, V393, P1083, DOI 10.1016/j.jmb.2009.09.013; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mueller CFH, 2008, BIOCHEM BIOPH RES CO, V370, P669, DOI 10.1016/j.bbrc.2008.04.011; Nanney LB, 2008, AM J PATHOL, V173, P610, DOI 10.2353/ajpath.2008.071027; Nguyen MM, 2009, MOL CELL ENDOCRINOL, V302, P65, DOI 10.1016/j.mce.2008.12.010; Nickenig G, 2002, CIRC RES, V90, P53, DOI 10.1161/hh0102.102503; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; PARODI AJ, 1993, GLYCOBIOLOGY, V3, P193, DOI 10.1093/glycob/3.3.193; Rendon-Huerta E, 1999, BIOCHEM J, V344, P469, DOI 10.1042/0264-6021:3440469; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; ROJIANI MV, 1991, BIOCHEMISTRY-US, V30, P9859, DOI 10.1021/bi00105a008; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; SINGH NK, 1994, P NATL ACAD SCI USA, V91, P12770, DOI 10.1073/pnas.91.26.12770; Souto-Padron T, 2004, HISTOCHEM CELL BIOL, V122, P563, DOI 10.1007/s00418-004-0724-7; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Sprung R, 2005, J PROTEOME RES, V4, P950, DOI 10.1021/pr050033j; Tesniere A, 2008, CURR OPIN IMMUNOL, V20, P504, DOI 10.1016/j.coi.2008.05.007; Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002; Totary-Jain H, 2005, CIRC RES, V97, P1001, DOI 10.1161/01.RES.0000189260.46084.e5; Tsuji N, 1998, MOL BIOCHEM PARASIT, V97, P69, DOI 10.1016/S0166-6851(98)00131-5; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Yu R, 2000, J BIOL CHEM, V275, P23648, DOI 10.1074/jbc.M002684200	60	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13141	10.1371/journal.pone.0013141	http://dx.doi.org/10.1371/journal.pone.0013141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957192	Green Published, Green Submitted, gold			2022-12-25	WOS:000282506100002
J	Deng, R; Tang, J; Ma, JG; Chen, SP; Xia, LP; Zhou, WJ; Li, DD; Feng, GK; Zeng, YX; Zhu, XF				Deng, R.; Tang, J.; Ma, J-G; Chen, S-P; Xia, L-P; Zhou, W-J; Li, D-D; Feng, G-K; Zeng, Y-X; Zhu, X-F			PKB/Akt promotes DSB repair in cancer cells through upregulating Mre11 expression following ionizing radiation	ONCOGENE			English	Article						Akt; Mre11; DSB repair; ionizing radiation	STRAND-BREAK REPAIR; DNA-REPAIR; HISTONE H2AX; SIGNALING PATHWAY; CERVICAL-CANCER; COLON-CANCER; TUMOR-CELLS; KINASE-B; INHIBITION; COMPLEX	An elevated DNA-repair capacity in cancer cells leads to radiation resistance and severely limits the efficacy of radiation therapy. Activation of Akt is tightly associated with resistance to radiotherapy, and Mre11 protein has important role during the repair of DNA double-strand breaks (DSBs). In this report, our results showed that inhibition of Akt activity impaired the repair of DSBs in CNE2 cells, whereas activated Akt promoted the repair of DSBs in HeLa cells. Knockdown of Mre11 also impaired the process of DSB repair in both these two cell lines. More importantly, we found that Akt could regulate Mre11 expression. Inhibition of Akt activity by small interfering RNA or LY294002 efficiently downregulated the Mre11 expression in CNE2 cells, and transfection with myr-Akt plasmid in HeLa cells upregulated the Mre11 expression. In addition, luciferase reporter analysis revealed that Mre11 reporter activity increased after transfection with myr-Akt1 plasmids, and this myr-Akt1-induced transcriptional activity was blocked in the presence of LY294002. Further study showed GSK3 beta/beta-catenin/LEF-1 pathway was involved in this regulation. Knockdown of beta-catenin or LEF-1 led to the downregulation of Mre11, whereas overexpression of beta-catenin led to upregulation of Mre11. The chromatin immuno-precipitation assay assay showed beta-catenin/LEF-1 heterodimer could directly bind to the promoter of Mre11 in vivo. And the luciferase activity of the pGL3-Mre11 and pGL3-Lef increased in HeLa cells following beta-catenin plasmid co-transfected, but was abolished when the LEF-1- binding conserved sequences of Mre11 promoter were mutated. These results together support Akt can upregulate the expression of Mre11 through GSK3 beta/ beta-catenin/LEF pathway to elevate DSB-repair capacity in cancer cells. Oncogene (2011) 30, 944-955; doi:10.1038/onc.2010.467; published online 18 October 2010	[Deng, R.; Tang, J.; Ma, J-G; Chen, S-P; Xia, L-P; Zhou, W-J; Li, D-D; Feng, G-K; Zeng, Y-X; Zhu, X-F] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University	Zhu, XF (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, 651 Dongfeng Rd E, Guangzhou 510060, Guangdong, Peoples R China.	zhuxfeng@mail.sysu.edu.cn			National Significant New Drug Creation [2008ZX09312-002]; 863 program [2006AA02A404]; National Nature Science Foundation of China [81001446]; Medical Scientific Research Foundation of Guangdong province [B2008059]	National Significant New Drug Creation; 863 program(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Foundation of Guangdong province	We thank Professor Bert Vogelstein from the Howard Hughes Medical Institute Research Laboratory Sidney Kimmel Comprehensive Cancer Center for providing us with the beta-catenin plasmid (wild type). This work was supported by grants from Major science and technology project of 'National Significant New Drug Creation' (2008ZX09312-002), 863 program (2006AA02A404), the National Nature Science Foundation of China (81001446), and Medical Scientific Research Foundation of Guangdong province (B2008059).	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Banath JP, 2003, CANCER RES, V63, P4347; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Borde V, 2009, INT J BIOCHEM CELL B, V41, P1249, DOI 10.1016/j.biocel.2008.12.013; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Brognard J, 2001, CANCER RES, V61, P3986; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Deng R, 2006, ONCOGENE, V25, P7070, DOI 10.1038/sj.onc.1209686; Deng R, 2009, MOL CANCER THER, V8, P873, DOI 10.1158/1535-7163.MCT-08-1080; Deng YB, 2009, NATURE, V460, P914, DOI 10.1038/nature08196; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Ding J, 2006, TRENDS PHARMACOL SCI, V27, P338, DOI 10.1016/j.tips.2006.04.007; Gupta AK, 2002, CLIN CANCER RES, V8, P885; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Hadjihannas MV, 2006, P NATL ACAD SCI USA, V103, P10747, DOI 10.1073/pnas.0604206103; HE X, 2007, LETT BIOTECHNOL, V18, P978; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kao GD, 2007, J BIOL CHEM, V282, P21206, DOI 10.1074/jbc.M703042200; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim IA, 2005, CANCER RES, V65, P7902, DOI 10.1158/0008-5472.CAN-05-0513; Kim TJ, 2006, BRIT J CANCER, V94, P1678, DOI 10.1038/sj.bjc.6603180; Lee CM, 2006, CLIN CANCER RES, V12, P250, DOI 10.1158/1078-0432.CCR-05-1084; Li B, 2004, ONCOGENE, V23, P4594, DOI 10.1038/sj.onc.1207602; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Pitts SA, 2001, HUM MOL GENET, V10, P1155, DOI 10.1093/hmg/10.11.1155; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Takahashi-Yanaga F, 2007, J PHARMACOL SCI, V104, P293, DOI 10.1254/jphs.CR0070024; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Toulany M, 2008, MOL CANCER THER, V7, P1772, DOI 10.1158/1535-7163.MCT-07-2200; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Wu Y, 2007, NAT STRUCT MOL BIOL, V14, P832, DOI 10.1038/nsmb1286	42	71	73	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	8					944	955		10.1038/onc.2010.467	http://dx.doi.org/10.1038/onc.2010.467			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	726CJ	20956948				2022-12-25	WOS:000287695900006
J	von Bubnoff, N; Gorantla, SP; Engh, RA; Oliveira, TM; Thone, S; Aberg, E; Peschel, C; Duyster, J				von Bubnoff, N.; Gorantla, S. P.; Engh, R. A.; Oliveira, T. M.; Thoene, S.; Aberg, E.; Peschel, C.; Duyster, J.			The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitro	ONCOGENE			English	Article						myeloid neoplasms; FIP1L1-PDGFRA; signaling therapies; drug resistance	GROWTH-FACTOR-RECEPTOR; GASTROINTESTINAL STROMAL TUMORS; BCR-ABL; HYPEREOSINOPHILIC SYNDROME; EOSINOPHILIC LEUKEMIA; MYELOPROLIFERATIVE DISEASE; NILOTINIB AMN107; T674I MUTATION; C-KIT; IMATINIB	Myeloproliferation with prominent eosinophilia is associated with rearrangements of PDGFR-A or -B. The most common rearrangement is FIP1L1-PDGFRA (FP). The majority of patients with PDGFR-rearranged myeloproliferation respond to treatment with imatinib. In contrast to BCR-ABL-positive chronic myelogenous leukemia, only few cases of imatinib resistance and mutations of the FP kinase domain have been described so far. We hypothesized that the number of critical residues mediating imatinib resistance in FP in contrast to BCR-ABL might be limited. We performed an established systematic and comprehensive in vitro resistance screen to determine the pattern and frequency of possible TKI resistance mutations in FP. We identified 27 different FP kinase domain mutations including 25 novel variants, which attenuated response to imatinib, nilotinib or sorafenib. However, the majority of these exchanges did not confer complete inhibitor resistance. At clinically achievable drug concentrations, FP/T674I predominated with imatinib, whereas with nilotinib and sorafenib, FP/D842V and the compound mutation T674I+T874I became prevalent. Our results suggest that the PDGFR kinase domain contains a limited number of residues where exchanges critically interfere with binding of and inhibition by available PDGFR kinase inhibitors at achievable concentrations, which might explain the low frequency of imatinib resistance in this patient population. In addition, these findings would help to select the appropriate second-line drug in cases of imatinib-resistant disease and may be translated to other neoplasms driven by activated forms of PDGFR-A or -B. Oncogene (2011) 30, 933-943; doi:10.1038/onc.2010.476; published online 25 October 2010	[von Bubnoff, N.; Gorantla, S. P.; Peschel, C.; Duyster, J.] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 3, D-81675 Munich, Bavaria, Germany; [Engh, R. A.; Oliveira, T. M.; Aberg, E.] Univ Tromso, Dept Chem, Norwegian Struct Biol Ctr, Tromso, Norway; [Engh, R. A.; Oliveira, T. M.; Aberg, E.] Univ Tromso, Dept Pharm, Norwegian Struct Biol Ctr, Tromso, Norway; [Thoene, S.] Ctr Comprehens Canc, Inst Expt Canc Res, Ulm, Germany; [Thoene, S.] Univ Hosp Ulm, Ulm, Germany	Technical University of Munich; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Ulm University; Ulm University	von Bubnoff, N (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 3, Ismaningerstr 22, D-81675 Munich, Bavaria, Germany.	n.bubnoff@lrz.tum.de	Thoene, Silvia/P-2687-2018; von Bubnoff, Nikolas/AAG-1845-2021; von Bubnoff, Nikolas/F-2351-2017	Thoene, Silvia/0000-0003-3155-7293; von Bubnoff, Nikolas/0000-0001-9593-8947; Engh, Richard/0000-0002-6207-0560	Bundesministerium fur Bildung und Forschung (NGFNplus); Wilhelm-Sander Stiftung; Deutsche Forschungsgemeinschaft [SFB 684/A11]; Kommission fur Klinische Forschung (KKF), Technische Universitat Munchen	Bundesministerium fur Bildung und Forschung (NGFNplus)(Federal Ministry of Education & Research (BMBF)); Wilhelm-Sander Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kommission fur Klinische Forschung (KKF), Technische Universitat Munchen	This work was supported by a grant to JD and NvB from the Bundesministerium fur Bildung und Forschung (NGFNplus), and from the Wilhelm-Sander Stiftung, by a grant to JD from the Deutsche Forschungsgemeinschaft (SFB 684/A11), and by a grant to NvB by the Kommission fur Klinische Forschung (KKF), Technische Universitat Munchen.	Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Branford S, 2009, BLOOD, V114, P5426, DOI 10.1182/blood-2009-08-215939; Burgess MR, 2005, P NATL ACAD SCI USA, V102, P3395, DOI 10.1073/pnas.0409770102; CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; Cools J, 2003, CANCER CELL, V3, P459, DOI 10.1016/S1535-6108(03)00108-9; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Corless CL, 2008, ANNU REV PATHOL-MECH, V3, P557, DOI 10.1146/annurev.pathmechdis.3.121806.151538; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Cortes J, 2007, BLOOD, V110, P4005, DOI 10.1182/blood-2007-03-080838; Cross NCP, 2008, ACTA HAEMATOL-BASEL, V119, P199, DOI 10.1159/000140631; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; Dewaele B, 2008, CLIN CANCER RES, V14, P5749, DOI 10.1158/1078-0432.CCR-08-0533; Gleich GJ, 2002, LANCET, V359, P1577, DOI 10.1016/S0140-6736(02)08505-7; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gotlib J, 2008, LEUKEMIA, V22, P1999, DOI 10.1038/leu.2008.287; Guida T, 2007, CLIN CANCER RES, V13, P3363, DOI 10.1158/1078-0432.CCR-06-2667; Guo T, 2007, CLIN CANCER RES, V13, P4874, DOI 10.1158/1078-0432.CCR-07-0484; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Hirota S, 2003, GASTROENTEROLOGY, V125, P660, DOI 10.1016/S0016-5085(03)01046-1; Hughes T, 2009, J CLIN ONCOL, V27, P4204, DOI 10.1200/JCO.2009.21.8230; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kindler T, 2005, BLOOD, V105, P335, DOI 10.1182/blood-2004-02-0660; Lahaye T, 2005, CANCER-AM CANCER SOC, V103, P1659, DOI 10.1002/cncr.20922; Lierman E, 2009, LEUKEMIA, V23, P845, DOI 10.1038/leu.2009.2; Lierman E, 2006, BLOOD, V108, P1374, DOI 10.1182/blood-2006-02-004457; Ma YS, 2002, BLOOD, V99, P1741, DOI 10.1182/blood.V99.5.1741; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Nicolini FE, 2007, LEUKEMIA RES, V31, P865, DOI 10.1016/j.leukres.2006.12.003; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Ohnishi H, 2006, BRIT J HAEMATOL, V134, P547, DOI 10.1111/j.1365-2141.2006.06221.x; Peng B, 2004, J CLIN ONCOL, V22, P935, DOI 10.1200/JCO.2004.03.050; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Score J, 2009, LEUKEMIA, V23, P332, DOI 10.1038/leu.2008.309; Simon D, 2008, J ALLERGY CLIN IMMUN, V121, P1054, DOI 10.1016/j.jaci.2007.11.027; Stover EH, 2005, BLOOD, V106, P3206, DOI 10.1182/blood-2005-05-1932; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; von Bubnoff N, 2005, BLOOD, V105, P1652, DOI 10.1182/blood-2004-06-2445; von Bubnoff N, 2005, LEUKEMIA, V19, P286, DOI 10.1038/sj.leu.2403600; von Bubnoff N, 2006, BLOOD, V108, P1328, DOI 10.1182/blood-2005-12-010132; von Bubnoff N, 2006, BLOOD, V107, P4970, DOI 10.1182/blood-2006-01-0285; von Bubnoff N, 2009, CANCER RES, V69, P3032, DOI 10.1158/0008-5472.CAN-08-2923; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisberg E, 2006, GASTROENTEROLOGY, V131, P1734, DOI 10.1053/j.gastro.2006.09.017	48	23	24	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	8					933	943		10.1038/onc.2010.476	http://dx.doi.org/10.1038/onc.2010.476			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	726CJ	20972453				2022-12-25	WOS:000287695900005
J	Li, XP; Grela, P; Krokowski, D; Tchorzewski, M; Tumer, NE				Li, Xiao-Ping; Grela, Przemyslaw; Krokowski, Dawid; Tchorzewski, Marek; Tumer, Nilgun E.			Pentameric Organization of the Ribosomal Stalk Accelerates Recruitment of Ricin A Chain to the Ribosome for Depurination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-G; N-GLYCOSIDASE ACTIVITY; IN-VITRO; P-PROTEINS; INACTIVATING PROTEIN; INTERACTION SITES; STRUCTURAL BASIS; BINDING-SITES; A-CHAIN; TRICHOSANTHIN	Ribosome inactivating proteins (RIPs) depurinate a universally conserved adenine in the alpha-sarcin/ricin loop (SRL) and inhibit protein synthesis at the translation elongation step. We previously showed that ribosomal stalk is required for depurination of the SRL by ricin toxin A chain (RTA). The interaction between RTA and ribosomes was characterized by a two-step binding model, where the stalk structure could be considered as an important interacting element. Here, using purified yeast ribosomal stalk complexes assembled in vivo, we show a direct interaction between RTA and the isolated stalk complex. Detailed kinetic analysis of these interactions in real time using surface plasmon resonance (SPR) indicated that there is only one type of interaction between RTA and the ribosomal stalk, which represents one of the two binding steps of the interaction with ribosomes. Interactions of RTA with the isolated stalk were relatively insensitive to salt, indicating that nonelectrostatic interactions were dominant. We compared the interaction of RTA with the full pentameric stalk complex containing two pairs of P1/P2 proteins with its interaction with the trimeric stalk complexes containing only one pair of P1/P2 and found that the rate of association of RTA with the pentamer was higher than with either trimer. These results demonstrate that the stalk is the main landing platform for RTA on the ribosome and that pentameric organization of the stalk accelerates recruitment of RTA to the ribosome for depurination. Our results suggest that multiple copies of the stalk proteins might also increase the scavenging ability of the ribosome for the translational GTPases.	[Li, Xiao-Ping; Tumer, Nilgun E.] Rutgers State Univ, Sch Environm & Biol Sci, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA; [Grela, Przemyslaw; Krokowski, Dawid; Tchorzewski, Marek] Marie Curie Sklodowska Univ, Dept Mol Biol, PL-20033 Lublin, Poland	Rutgers State University New Brunswick; Maria Curie-Sklodowska University	Tumer, NE (corresponding author), Rutgers State Univ, Sch Environm & Biol Sci, Dept Plant Biol & Pathol, 59 Dudley Rd, New Brunswick, NJ 08901 USA.	tumer@aesop.rutgers.edu		Tchorzewski, Marek/0000-0002-0718-4223; Grela, Przemyslaw/0000-0002-5930-416X	National Institutes of Health [AI072425]; FOGARTY INTERNATIONAL CENTER [R03TW008418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI072425 (to N. E. T.).	Ayub MJ, 2008, BIOCHEM BIOPH RES CO, V369, P314, DOI 10.1016/j.bbrc.2008.01.170; Ballesta JPG, 1996, PROG NUCLEIC ACID RE, V55, P157, DOI 10.1016/S0079-6603(08)60193-2; Bernado P, 2010, BIOPHYS J, V98, P2374, DOI 10.1016/j.bpj.2010.02.012; CAWLEY DB, 1979, BIOCHEMISTRY-US, V18, P2648, DOI 10.1021/bi00579a034; Chan DSB, 2007, NUCLEIC ACIDS RES, V35, P1660, DOI 10.1093/nar/gkm065; Chan SH, 2001, EUR J BIOCHEM, V268, P2107, DOI 10.1046/j.1432-1327.2001.02091.x; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; Clementi N, 2010, NAT CHEM BIOL, V6, P344, DOI 10.1038/nchembio.341; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; ENDO Y, 1988, J BIOL CHEM, V263, P8735; ENDO Y, 1987, J BIOL CHEM, V262, P8128; FERNANDEZPUENTES C, 1976, EUR J BIOCHEM, V64, P437, DOI 10.1111/j.1432-1033.1976.tb10320.x; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Gonzalo P, 2001, J BIOL CHEM, V276, P19762, DOI 10.1074/jbc.M101398200; Grela P, 2008, J BIOCHEM, V143, P169, DOI 10.1093/jb/mvm207; Grela P, 2010, BIOCHEMISTRY-US, V49, P924, DOI 10.1021/bi901811s; Grela P, 2007, BIOCHEMISTRY-US, V46, P1988, DOI 10.1021/bi0616450; Guarinos E, 2003, MOL MICROBIOL, V50, P703, DOI 10.1046/j.1365-2958.2003.03733.x; Guarinos E, 2001, J BIOL CHEM, V276, P32474, DOI 10.1074/jbc.M103229200; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; HOLMBERG L, 1994, BIOCHEMISTRY-US, V33, P15159, DOI 10.1021/bi00254a027; Huang CH, 2010, J MOL BIOL, V399, P145, DOI 10.1016/j.jmb.2010.04.009; Ilag LL, 2005, P NATL ACAD SCI USA, V102, P8192, DOI 10.1073/pnas.0502193102; Korennykh AV, 2007, RNA, V13, P1391, DOI 10.1261/rna.619707; Korennykh AV, 2006, NAT STRUCT MOL BIOL, V13, P436, DOI 10.1038/nsmb1082; Krokowski D, 2006, MOL MICROBIOL, V60, P386, DOI 10.1111/j.1365-2958.2006.05117.x; Krokowski D, 2005, BBA-GEN SUBJECTS, V1724, P59, DOI 10.1016/j.bbagen.2005.03.009; Krokowski D, 2007, BIOCHEM BIOPH RES CO, V355, P575, DOI 10.1016/j.bbrc.2007.02.024; Lalioti VS, 2002, MOL MICROBIOL, V46, P719, DOI 10.1046/j.1365-2958.2002.03179.x; Li XP, 2009, BIOCHEMISTRY-US, V48, P3853, DOI 10.1021/bi802371h; Lord Michael J., 2003, Toxicological Reviews, V22, P53, DOI 10.2165/00139709-200322010-00006; Maki Y, 2007, J BIOL CHEM, V282, P32827, DOI 10.1074/jbc.M705412200; Martinez-Azorin F, 2008, FEBS LETT, V582, P3029, DOI 10.1016/j.febslet.2008.07.039; McCluskey AJ, 2008, J MOL BIOL, V378, P375, DOI 10.1016/j.jmb.2008.02.014; Miyoshi T, 2009, J BIOL CHEM, V284, P85, DOI 10.1074/jbc.M806024200; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Naganuma T, 2010, J BIOL CHEM, V285, P4747, DOI 10.1074/jbc.M109.068098; NOLAN RD, 1976, EUR J BIOCHEM, V64, P69, DOI 10.1111/j.1432-1033.1976.tb10275.x; Nomura T, 2008, J BIOCHEM, V144, P665, DOI 10.1093/jb/mvn113; OLSNES S, 1972, FEBS LETT, V20, P327, DOI 10.1016/0014-5793(72)80098-X; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Shimizu T, 2002, NUCLEIC ACIDS RES, V30, P2620, DOI 10.1093/nar/gkf379; SPERTI S, 1973, BIOCHEM J, V136, P813, DOI 10.1042/bj1360813; Tchorzewski M, 2000, INT J BIOCHEM CELL B, V32, P737, DOI 10.1016/S1357-2725(00)00017-0; Too PHM, 2009, NUCLEIC ACIDS RES, V37, P602, DOI 10.1093/nar/gkn922; VILELLA MD, 1991, EUR J BIOCHEM, V196, P407, DOI 10.1111/j.1432-1033.1991.tb15831.x; WAHL MC, 2002, CURR PROTEIN PEPT SC, V3, pNIL2; Yang YH, 2010, J MOL BIOL, V395, P897, DOI 10.1016/j.jmb.2009.10.051	48	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41463	41471		10.1074/jbc.M110.171793	http://dx.doi.org/10.1074/jbc.M110.171793			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974854	Green Published, hybrid			2022-12-25	WOS:000285622600032
J	Mok, WWK; Patel, NH; Li, YF				Mok, Wendy W. K.; Patel, Nirav H.; Li, Yingfu			Decoding Toxicity DEDUCING THE SEQUENCE REQUIREMENTS OF IbsC, A TYPE I TOXIN IN ESCHERICHIA COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOS-INDUCED TOXIN; SMALL RNAS; GEF GENE; COMPARATIVE GENOMICS; PLASMID MAINTENANCE; ANTITOXIN SYSTEMS; CELL-DEATH; MEMBRANE; INDUCTION; IDENTIFICATION	Bacterial genomes encode a collection of small peptides that are deleterious to their hosts when overexpressed. The physiological relevance of the majority of these peptides is unknown at present, although many of them have been implicated in regulatory processes important for cell survival and adaptability. One peptide that is of particular interest to us is a 19-amino acid proteic toxin, coined IbsC, whose production is repressed by SibC, an RNA antitoxin. Together, IbsC and SibC constitute a type I toxin-antitoxin (TA) pair. To better understand the function of IbsC and to decipher the sequence determinants for its toxic phenotype, we carried out extensive sequence analyses of the peptide. We generated a series of truncation and single amino acid deletion mutants to determine the minimal sequence required for toxicity. We further probed into functionally relevant amino acids with a comprehensive set of IbsC mutants produced using a systematic sequence randomization strategy. We found that IbsC remained toxic in the presence of multiple deletions and single amino acid substitutions, despite being well-conserved in Escherichia coli and across other Gram-negative bacteria. The toxicity of this peptide was determined to be dependent on a stretch of highly hydrophobic residues near its center. Our results defined sequence-function relationship of IbsC and offered additional insights into properties common to membrane-targeting type I toxins in E. coli and related species.	McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University	Li, YF (corresponding author), Hlth Sci Ctr 4H31, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	liying@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC).; An NSERC CGS Doctoral Scholarship recipient.; Supported by the Canada Research Chairs program. To whom correspondence should be addressed: 1200 Main St. West, Health Sciences Centre 4H31, Hamilton, ON L8N 3Z5, Canada. Tel.: 905-525-9140, ext. 22462; Fax: 905-522-9033; E-mail: liying@mcmaster.ca.	Alix E, 2009, MOL MICROBIOL, V72, P5, DOI 10.1111/j.1365-2958.2009.06626.x; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Boulaiz H, 2008, BRIT J DERMATOL, V159, P370, DOI 10.1111/j.1365-2133.2008.08688.x; Boulaiz H, 2003, BRIT J CANCER, V89, P192, DOI 10.1038/sj.bjc.6601064; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; CALAMIA J, 1990, P NATL ACAD SCI USA, V87, P4937, DOI 10.1073/pnas.87.13.4937; Darfeuille F, 2007, MOL CELL, V26, P381, DOI 10.1016/j.molcel.2007.04.003; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gurezka R, 2001, J BIOL CHEM, V276, P45580, DOI 10.1074/jbc.M105362200; Han K, 2010, NUCLEIC ACIDS RES, V38, P5851, DOI 10.1093/nar/gkq292; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Hershberg R, 2003, NUCLEIC ACIDS RES, V31, P1813, DOI 10.1093/nar/gkg297; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Krishnakumar SS, 2007, J MOL BIOL, V374, P671, DOI 10.1016/j.jmb.2007.09.037; Lee S, 2009, P NATL ACAD SCI USA, V106, P14570, DOI 10.1073/pnas.0903619106; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Mok WWK, 2009, CHEMBIOCHEM, V10, P238, DOI 10.1002/cbic.200800591; Papenfort K, 2008, MOL MICROBIOL, V68, P890, DOI 10.1111/j.1365-2958.2008.06189.x; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Prados J, 2008, INT J ONCOL, V33, P121; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000439	35	13	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41627	41636		10.1074/jbc.M110.149179	http://dx.doi.org/10.1074/jbc.M110.149179			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20980267	Green Published, hybrid			2022-12-25	WOS:000285622600050
J	Prunetti, L; Infossi, P; Brugna, M; Ebel, C; Giudici-Orticoni, MT; Guiral, M				Prunetti, Laurence; Infossi, Pascale; Brugna, Myriam; Ebel, Christine; Giudici-Orticoni, Marie-Therese; Guiral, Marianne			New Functional Sulfide Oxidase-Oxygen Reductase Supercomplex in the Membrane of the Hyperthermophilic Bacterium Aquifex aeolicus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; RESPIRATORY-CHAIN; QUINONE REDUCTASE; ELECTRON-TRANSFER; C-OXIDASE; PARACOCCUS-DENITRIFICANS; RHODOBACTER-SPHAEROIDES; NATIVE ELECTROPHORESIS; PROTEIN COMPLEXES; TERMINAL OXIDASE	Aquifex aeolicus, a hyperthermophilic and microaerophilic bacterium, obtains energy for growth from inorganic compounds alone. It was previously proposed that one of the respiratory pathways in this organism consists of the electron transfer from hydrogen sulfide (H2S) to molecular oxygen. H2S is oxidized by the sulfide quinone reductase, a membrane-bound flavoenzyme, which reduces the quinone pool. We have purified and characterized a novel membrane-bound multienzyme supercomplex that brings together all the molecular components involved in this bioenergetic chain. Our results indicate that this purified structure consists of one dimeric bc(1) complex (complex III), one cytochrome c oxidase (complex IV), and one or two sulfide quinone reductases as well as traces of the monoheme cytochrome c(555) and quinone molecules. In addition, this work strongly suggests that the cytochrome c oxidase in the supercomplex is a ba(3)-type enzyme. The supercomplex has a molecular mass of about 350 kDa and is enzymatically functional, reducing O-2 in the presence of the electron donor, H2S. This is the first demonstration of the existence of such a respirasome carrying a sulfide oxidase-oxygen reductase activity. Moreover, the kinetic properties of the sulfide quinone reductase change slightly when integrated in the supercomplex, compared with the free enzyme. We previously purified a complete respirasome involved in hydrogen oxidation and sulfur reduction from Aquifex aeolicus. Thus, two different bioenergetic pathways (sulfur reduction and sulfur oxidation) are organized in this bacterium as supramolecular structures in the membrane. A model for the energetic sulfur metabolism of Aquifex aeolicus is proposed.	[Prunetti, Laurence; Infossi, Pascale; Brugna, Myriam; Giudici-Orticoni, Marie-Therese; Guiral, Marianne] CNRS, IMM IFR88, Lab Bioenerget & Ingn Prot, UPR 9036, F-13402 Marseille 20, France; [Brugna, Myriam] Univ Aix Marseille 1, F-13331 Marseille 3, France; [Ebel, Christine] CEA, IBS, F-38027 Grenoble 1, France; [Ebel, Christine] Univ Grenoble 1, F-3800 Grenoble, France; [Ebel, Christine] CNRS, UMR 5075, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Guiral, M (corresponding author), CNRS, IMM IFR88, Lab Bioenerget & Ingn Prot, UPR 9036, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	guiral@ifr88.cnrs-mrs.fr		BRUGNA, Myriam/0000-0002-4017-3294; Ebel, Christine/0000-0002-6912-500X	CNRS; Region-Provence-Alpes Cote d'Azur; Marseille Metropole	CNRS(Centre National de la Recherche Scientifique (CNRS)); Region-Provence-Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); Marseille Metropole	This work was supported in part by CNRS, Region-Provence-Alpes Cote d'Azur, and Marseille Metropole.	Aubert C, 2001, BIOCHEMISTRY-US, V40, P13690, DOI 10.1021/bi011202q; Baymann F, 2001, BIOCHEMISTRY-US, V40, P13681, DOI 10.1021/bi011201y; BERRY EA, 1985, J BIOL CHEM, V260, P2458; Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827; Brugna-Guiral M, 2003, EXTREMOPHILES, V7, P145, DOI 10.1007/s00792-002-0306-3; Castelle C, 2008, J BIOL CHEM, V283, P25803, DOI 10.1074/jbc.M802496200; Cherney MM, 2010, J MOL BIOL, V398, P292, DOI 10.1016/j.jmb.2010.03.018; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; DEVRIES S, 1979, BIOCHIM BIOPHYS ACTA, V546, P334; DISPIRITO AA, 1986, J BIOL CHEM, V261, P7048; Ebel C., 2007, PROTEIN STRUCTURES M, P229; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010; Farver O, 2006, FEBS LETT, V580, P3417, DOI 10.1016/j.febslet.2006.05.013; FEE JA, 1980, P NATL ACAD SCI-BIOL, V77, P147, DOI 10.1073/pnas.77.1.147; Genova ML, 2008, BBA-BIOENERGETICS, V1777, P740, DOI 10.1016/j.bbabio.2008.04.007; GRIESBECK C, 2000, RRD MICROBIOL 1, V4, P179; Guiral M, 2005, J BIOL CHEM, V280, P42004, DOI 10.1074/jbc.M508034200; Guiral M, 2009, J PROTEOME RES, V8, P1717, DOI 10.1021/pr8007946; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; Huber R., 1999, EMBRYONIC ENCY LIFE; Infossi P, 2010, INT J HYDROGEN ENERG, V35, P10778, DOI 10.1016/j.ijhydene.2010.02.054; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; KEEFE RG, 1993, BIOCHIM BIOPHYS ACTA, V1183, P91, DOI 10.1016/0005-2728(93)90008-4; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Lebreton S, 2003, J BIOL CHEM, V278, P12078, DOI 10.1074/jbc.M213096200; Marcia M, 2010, BBA-BIOMEMBRANES, V1798, P2114, DOI 10.1016/j.bbamem.2010.07.033; Marcia M, 2009, P NATL ACAD SCI USA, V106, P9625, DOI 10.1073/pnas.0904165106; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; MCCURLEY JP, 1990, BIOCHIM BIOPHYS ACTA, V1020, P176, DOI 10.1016/0005-2728(90)90049-A; Megehee JA, 2006, MICROBIOL-SGM, V152, P823, DOI 10.1099/mic.0.28723-0; Montoya G, 1999, EUR J BIOCHEM, V259, P709, DOI 10.1046/j.1432-1327.1999.00094.x; Niebisch A, 2003, J BIOL CHEM, V278, P4339, DOI 10.1074/jbc.M210499200; Nubel T, 2000, ARCH MICROBIOL, V173, P233, DOI 10.1007/s002030000135; Pelletier N, 2008, EXTREMOPHILES, V12, P205, DOI 10.1007/s00792-007-0119-5; SALERNO JC, 1984, J BIOL CHEM, V259, P2331; Salvay AG, 2006, PROG COLL POL SCI S, V131, P74, DOI 10.1007/2882_006; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Scharf B, 1997, BIOCHEMISTRY-US, V36, P4471, DOI 10.1021/bi962312d; Schutz M, 1999, J BACTERIOL, V181, P6516; Schutz M, 1997, J BIOL CHEM, V272, P9890; Schutz M, 2003, BIOCHEMISTRY-US, V42, P10800, DOI 10.1021/bi034452a; SONE N, 1987, J BIOL CHEM, V262, P15386; SONE N, 1984, BIOCHEM J, V223, P809, DOI 10.1042/bj2230809; Sousa FL, 2008, BIOPHYS J, V94, P2434, DOI 10.1529/biophysj.107.122614; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Stuart RA, 2009, METHOD ENZYMOL, V456, P191, DOI 10.1016/S0076-6879(08)04411-X; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; VANGELDE.BF, 1969, BIOCHIM BIOPHYS ACTA, V189, P1, DOI 10.1016/0005-2728(69)90219-9; Vermeglio A, 2002, BBA-BIOENERGETICS, V1555, P60, DOI 10.1016/S0005-2728(02)00255-4; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104	56	29	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41815	41826		10.1074/jbc.M110.167841	http://dx.doi.org/10.1074/jbc.M110.167841			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20971847	hybrid, Green Published			2022-12-25	WOS:000285622600069
J	Zhou, H; Qiao, KJ; Gao, ZZ; Vederas, JC; Tang, Y				Zhou, Hui; Qiao, Kangjian; Gao, Zhizeng; Vederas, John C.; Tang, Yi			Insights into Radicicol Biosynthesis via Heterologous Synthesis of Intermediates and Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESORCYLIC ACID LACTONES; POLYKETIDE SYNTHASE GENES; NATURAL-PRODUCT BIOSYNTHESIS; FLAVIN-DEPENDENT HALOGENASE; GIBBERELLA-ZEAE; 6-DEOXYERYTHRONOLIDE-B SYNTHASE; FUNCTIONAL-CHARACTERIZATION; POCHONIA-CHLAMYDOSPORIA; KETOREDUCTASE DOMAINS; CHAETOMIUM-CHIVERSII	Resorcylic acid lactones are fungal polyketides that display diverse biological activities, with the potent Hsp90 inhibitor radicicol being an important representative member. Two fungal iterative polyketide synthases (IPKSs), Rdc5, the highly reducing IPKS, and Rdc1, the nonreducing IPKS, are required for the biosynthesis of radicicol in Pochonia chlamydosporia. In this study, the complete reconstitution of Rdc5 and Rdc1 activities both in vitro and in Saccharomyces cerevisiae uncovered the earliest resorcylic acid lactone intermediate of the radicicol biosynthetic pathway, (R)-monocillin II. The enzymatic synthesis of (R)-monocillin II confirmed the exquisite timing of the Rdc5 enoyl reductase domain. Using precursor-directed biosynthesis, the chemical modularity of the dual IPKS system was determined. Rdc1 readily accepted an N-acetylcysteamine thioester mimic of the reduced pentaketide product of Rdc5 to synthesize (R)-monocillin II with four additional iterations of polyketide elongation, indicating the C2' ketone group found in (R)-monocillin II is incorporated via the functions of Rdc1 instead of Rdc5. The involvement of the thioesterase domain in Rdc1 in macrolactonization was confirmed through both site-directed mutagenesis and domain deletion. The Rdc1 thioesterase domain was also shown to be tolerant of the opposite stereochemistry of the terminal hydroxyl nucleophile, demonstrated in the precursor-directed synthesis of the enantiomeric (S)-monocillin II. Finally, reconstitution of the halogenase Rdc2 was demonstrated both in vivo and in vitro in the synthesis of pochonin D and a new halogenated analog 6-chloro, 7', 8'-dehydrozearalenol.	[Gao, Zhizeng; Vederas, John C.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Zhou, Hui; Qiao, Kangjian; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of Alberta; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Vederas, JC (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.	john.vederas@ualberta.ca; yitang@ucla.edu	Gao, Zhizeng/E-2963-2019	Gao, Zhizeng/0000-0002-8176-0727; Vederas, John/0000-0002-2996-0326	National Institutes of Health [1R01GM085128, 1R01GM092217]; David and Lucile Packard Fellowship in Science and Engineering; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Bioorganic and Medicinal Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092217, R01GM085128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Fellowship in Science and Engineering(The David & Lucile Packard Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Bioorganic and Medicinal Chemistry(Canada Research Chairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01GM085128 and 1R01GM092217. This work was also supported by a David and Lucile Packard Fellowship in Science and Engineering (to Y.T.) and by the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chair in Bioorganic and Medicinal Chemistry (to J.C.V.).	Agatsuma T, 2002, BIOORGAN MED CHEM, V10, P3445, DOI 10.1016/S0968-0896(02)00260-2; Akey DL, 2010, STRUCTURE, V18, P94, DOI 10.1016/j.str.2009.10.018; Barluenga S, 2008, ANGEW CHEM INT EDIT, V47, P4432, DOI 10.1002/anie.200800233; Barluenga S, 2009, CHEMBIOCHEM, V10, P2753, DOI 10.1002/cbic.200900494; Brase S, 2009, CHEM REV, V109, P3903, DOI 10.1021/cr050001f; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Castonguay R, 2008, J AM CHEM SOC, V130, P11598, DOI 10.1021/ja804453p; Castonguay R, 2007, J AM CHEM SOC, V129, P13758, DOI 10.1021/ja0753290; Chiang YM, 2009, J AM CHEM SOC, V131, P2965, DOI 10.1021/ja8088185; Chooi YH, 2010, CHEM BIOL, V17, P483, DOI 10.1016/j.chembiol.2010.03.015; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Crawford JM, 2008, SCIENCE, V320, P243, DOI 10.1126/science.1154711; Crawford JM, 2006, P NATL ACAD SCI USA, V103, P16728, DOI 10.1073/pnas.0604112103; Dakas PY, 2007, ANGEW CHEM INT EDIT, V46, P6899, DOI 10.1002/anie.200702406; Day JEH, 2010, CHEM-EUR J, V16, P2758, DOI 10.1002/chem.200902766; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; Gaffoor I, 2006, APPL ENVIRON MICROB, V72, P1793, DOI 10.1128/AEM.72.3.1793-1799.2006; Hellwig V, 2003, J NAT PROD, V66, P829, DOI 10.1021/np020556v; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Ikuina Y, 2003, J MED CHEM, V46, P2534, DOI 10.1021/jm030110r; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Kashima T, 2009, BIOSCI BIOTECH BIOCH, V73, P1118, DOI 10.1271/bbb.80878; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; Korman TP, 2010, P NATL ACAD SCI USA, V107, P6246, DOI 10.1073/pnas.0913531107; Lee KKM, 2009, ANAL BIOCHEM, V394, P75, DOI 10.1016/j.ab.2009.07.010; Ma SM, 2007, J AM CHEM SOC, V129, P10642, DOI 10.1021/ja074865p; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Mootz HD, 2002, FEMS MICROBIOL LETT, V213, P51, DOI 10.1016/S0378-1097(02)00760-7; Moulin E, 2005, J AM CHEM SOC, V127, P6999, DOI 10.1021/ja043101w; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; Neumann CS, 2010, P NATL ACAD SCI USA, V107, P5798, DOI 10.1073/pnas.1001681107; O'Hare HM, 2006, CHEM BIOL, V13, P287, DOI 10.1016/j.chembiol.2006.01.003; Reeves CD, 2008, APPL ENVIRON MICROB, V74, P5121, DOI 10.1128/AEM.00478-08; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Soga S, 2003, CURR CANCER DRUG TAR, V3, P359, DOI 10.2174/1568009033481859; Wang CH, 2009, BIOORG MED CHEM LETT, V19, P3836, DOI 10.1016/j.bmcl.2009.04.030; Wang M, 2009, BIOCHEMISTRY-US, V48, P6288, DOI 10.1021/bi9009049; Wang SH, 2008, CHEM BIOL, V15, P1328, DOI 10.1016/j.chembiol.2008.10.006; Watanabe CMH, 2002, CHEM BIOL, V9, P981, DOI 10.1016/S1074-5521(02)00213-2; Wicklow DT, 2009, MYCOL RES, V113, P1433, DOI 10.1016/j.mycres.2009.10.001; Wijeratne EMK, 2006, TETRAHEDRON, V62, P8439, DOI 10.1016/j.tet.2006.06.089; Winssinger N, 2007, CHEM COMMUN, P22, DOI 10.1039/b610344h; Workman P, 2003, CURR CANCER DRUG TAR, V3, P297, DOI 10.2174/1568009033481868; Xie XK, 2009, J AM CHEM SOC, V131, P8388, DOI 10.1021/ja903203g; Yang ZQ, 2004, J AM CHEM SOC, V126, P7881, DOI 10.1021/ja0484348; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Zeng J, 2010, CHEMBIOCHEM, V11, P2119, DOI 10.1002/cbic.201000439; Zhou H, 2008, P NATL ACAD SCI USA, V105, P6249, DOI 10.1073/pnas.0800657105; Zhou H, 2010, J AM CHEM SOC, V132, P4530, DOI 10.1021/ja100060k	55	73	73	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41412	41421		10.1074/jbc.M110.183574	http://dx.doi.org/10.1074/jbc.M110.183574			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20961859	Green Published, hybrid			2022-12-25	WOS:000285622600027
J	Porter, JR; Burg, JS; Espenshade, PJ; Iglesias, PA				Porter, Joshua R.; Burg, John S.; Espenshade, Peter J.; Iglesias, Pablo A.			Ergosterol Regulates Sterol Regulatory Element Binding Protein (SREBP) Cleavage in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SENSING DOMAIN; SCAP; CHOLESTEROL; OXYGEN; INSIG; ER; DEGRADATION; TRANSPORT; MEMBRANES	In fission yeast, the endoplasmic reticulum membrane-bound proteins Sre1 and Scp1, orthologs of mammalian sterol regulatory element binding protein (SREBP) and Scap, monitor sterol synthesis as an indirect measure of oxygen supply. When cellular oxygen levels are low, sterol synthesis is inhibited, and the Sre1-Scp1 complex responds by increasing transcription of genes required for adaptation to hypoxia. Sre1 and Scp1 are believed to detect a blockage in sterol synthesis by monitoring levels of particular sterols, but the evidence concerning which sterol signals this condition is unclear. Here, we demonstrate that Sre1-Scp1 senses ergosterol. Processing experimental data with a mathematical model of Sre1 and Scp1 function reveals a clear quantitative relationship between ergosterol concentration in the endoplasmic reticulum and Sre1 activation. Based on this relationship, we predict that the Sre1-Scp1 complex exists under "active" and "inactive" states and that the transition between these states is cooperatively mediated by ergosterol.	[Burg, John S.; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Iglesias, Pablo A.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu; pi@jhu.edu	Iglesias, Pablo A/A-5202-2008	Iglesias, Pablo A/0000-0002-0840-155X	National Institutes of Health [HL-077588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-077588.	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Burg JS, 2008, CELL METAB, V8, P522, DOI 10.1016/j.cmet.2008.09.004; Chang YC, 2007, MOL MICROBIOL, V64, P614, DOI 10.1111/j.1365-2958.2007.05676.x; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Hughes AL, 2007, J BIOL CHEM, V282, P24388, DOI 10.1074/jbc.M701326200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Hughes BT, 2009, J BIOL CHEM, V284, P20512, DOI 10.1074/jbc.M109.002436; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lee CYS, 2009, EMBO J, V28, P135, DOI 10.1038/emboj.2008.271; Moler C. B., 2004, NUMERICAL COMPUTING, P99; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Sokolov A, 2010, J BIOL CHEM, V285, P29480, DOI 10.1074/jbc.M110.148254; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Tomlin CJ, 2005, P NATL ACAD SCI USA, V102, P4219, DOI 10.1073/pnas.0500276102; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	31	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41051	41061		10.1074/jbc.M110.144337	http://dx.doi.org/10.1074/jbc.M110.144337			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959444	Green Published, hybrid			2022-12-25	WOS:000285414400068
J	Taib, WRW; Smyth, DJ; Merriman, ME; Dalbeth, N; Gow, PJ; Harrison, AA; Highton, J; Jones, PBB; Stamp, L; Steer, S; Todd, JA; Merriman, TR				Taib, Wan R. Wan; Smyth, Deborah J.; Merriman, Marilyn E.; Dalbeth, Nicola; Gow, Peter J.; Harrison, Andrew A.; Highton, John; Jones, Peter B. B.; Stamp, Lisa; Steer, Sophia; Todd, John A.; Merriman, Tony R.			The PTPN22 Locus and Rheumatoid Arthritis: No Evidence for an Effect on Risk Independent of Arg620Trp	PLOS ONE			English	Article							LYMPHOID TYROSINE PHOSPHATASE; GENOME-WIDE ASSOCIATION; OF-FUNCTION VARIANT; PROMOTER POLYMORPHISM; GENETIC-VARIATION; DISEQUILIBRIUM; HAPLOTYPES; GENOTYPES; DISEASES	Objectives: The Trp(620) allotype of PTPN22 confers susceptibility to rheumatoid arthritis (RA) and certain other classical autoimmune diseases. There has been a report of other variants within the PTPN22 locus that alter risk of RA; protective haplotype '5', haplotype group '6-10' and susceptibility haplotype '4', suggesting the possibility of other PTPN22 variants involved in the pathogenesis of RA independent of R620W (rs2476601). Our aim was to further investigate this possibility. Methods: A total of 4,460 RA cases and 4,481 controls, all European, were analysed. Single nucleotide polymorphisms rs3789607, rs12144309, rs3811021 and rs12566340 were genotyped over New Zealand (NZ) and UK samples. Publically-available Wellcome Trust Case Control Consortium (WTCCC) genotype data were used. Results: The protective effect of haplotype 5 was confirmed (rs3789607; (OR = 0.91, P = 0.016), and a second protective effect (possibly of haplotype 6) was observed (rs12144309; OR = 0.90, P = 0.021). The previously reported susceptibility effect of haplotype 4 was not replicated; instead a protective effect was observed (rs3811021; OR = 0.85, P = 1.4 x 10(-5)). Haplotypes defined by rs3789607, rs12144309 and rs3811021 coalesced with the major allele of rs12566340 within the adjacent BFK (B-cell lymphoma 2 (BCL2) family kin) gene. We, therefore, tested rs12566340 for association with RA conditional on rs2476601; there was no evidence for an independent effect at rs12566340 (P = 0.76). Similarly, there was no evidence for an independent effect at rs12566340 in type 1 diabetes (P = 0.85). Conclusions: We have no evidence for a common variant additional to rs2476601 within the PTPN22 locus that influences the risk of RA. Arg620Trp is almost certainly the single common causal variant.	[Taib, Wan R. Wan; Merriman, Marilyn E.; Merriman, Tony R.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Smyth, Deborah J.; Todd, John A.] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Juvenile Diabet Res Fdn Wellcome Trust Diabet & I, Cambridge, England; [Dalbeth, Nicola; Jones, Peter B. B.] Univ Auckland, Dept Med, Auckland, New Zealand; [Gow, Peter J.] Middlemore Hosp, Dept Rheumatol, Auckland 6, New Zealand; [Harrison, Andrew A.] Univ Otago, Dept Med, Wellington, New Zealand; [Highton, John] Univ Otago, Dept Med, Dunedin, New Zealand; [Stamp, Lisa] Univ Otago, Dept Med, Christchurch, New Zealand; [Steer, Sophia] Kings Coll London, Sch Med Guys, Dept Rheumatol, London WC2R 2LS, England	University of Otago; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Auckland; University of Otago; University of Otago; University of Otago; University of London; King's College London	Taib, WRW (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	tony.merriman@otago.ac.nz	Taib, Wan Rohani Wan/N-4183-2017; Todd, John/A-3542-2010	Todd, John/0000-0003-2740-8148; Merriman, Tony/0000-0003-0844-8726; smyth, deborah/0000-0002-6330-2669; Harrison, Andrew/0000-0003-4372-3252; Wan Taib, Wan Rohani/0000-0001-9455-5768	Health Research Council of New Zealand; Arthritis New Zealand; Juvenile Diabetes Research Foundation International; Wellcome Trust [079895, 068545/Z/02, 076113/C/04/Z]; National Institute for Health Research Cambridge Biomedical Centre; Medical Research Council [G0000934]; Wellcome Trust/Juvenile Diabetes Research Foundation [061858]; National Institute of Health Research of England; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI	Health Research Council of New Zealand(Health Research Council of New Zealand); Arthritis New Zealand; Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome Trust); National Institute for Health Research Cambridge Biomedical Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust/Juvenile Diabetes Research Foundation(Juvenile Diabetes Research FoundationWellcome Trust); National Institute of Health Research of England(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Health Research Council of New Zealand, Arthritis New Zealand, the Juvenile Diabetes Research Foundation International, the Wellcome Trust and the National Institute for Health Research Cambridge Biomedical Centre. The Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award (079895). The authors acknowledge use of DNA from the 1958 British Birth Cohort collection, funded by the Medical Research Council (grant G0000934) and the Wellcome Trust (grant 068545/Z/02). The authors acknowledge use of DNA from The UK Blood Services collection of Common Controls (UKBS collection), funded by the Wellcome Trust (grant 076113/C/04/Z), the Wellcome Trust/Juvenile Diabetes Research Foundation (grant 061858) and the National Institute of Health Research of England. The collection was established as part of the Wellcome Trust Case-Control Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlton VEH, 2005, AM J HUM GENET, V77, P567, DOI 10.1086/468189; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Heward JM, 2007, J CLIN ENDOCR METAB, V92, P685, DOI 10.1210/jc.2006-2064; Hinks A, 2007, ANN RHEUM DIS, V66, P683, DOI 10.1136/ard.2006.060459; Kawasaki E, 2006, AM J MED GENET A, V140A, P586, DOI 10.1002/ajmg.a.31124; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Orru V, 2009, HUM MOL GENET, V18, P569, DOI 10.1093/hmg/ddn363; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; RODRIGEUZRODRIG.L, 2010, ARTHR RHEUM IN PRESS; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Smyth DJ, 2008, DIABETES, V57, P1730, DOI 10.2337/db07-1131; STECK AK, GENES IMMUN S, V1, pS21; Steer S, 2007, GENES IMMUN, V8, P57, DOI 10.1038/sj.gene.6364359; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Viken MK, 2007, TISSUE ANTIGENS, V70, P190, DOI 10.1111/j.1399-0039.2007.00871.x; Wesoly J, 2007, RHEUMATOLOGY, V46, P617, DOI 10.1093/rheumatology/kel381; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200	21	13	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13544	10.1371/journal.pone.0013544	http://dx.doi.org/10.1371/journal.pone.0013544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975833	Green Submitted, gold, Green Published			2022-12-25	WOS:000283293800013
J	Fleissner, D; Hansen, W; Geffers, R; Buer, J; Westendorf, AM				Fleissner, Diana; Hansen, Wiebke; Geffers, Robert; Buer, Jan; Westendorf, Astrid M.			Local Induction of Immunosuppressive CD8(+) T Cells in the Gut-Associated Lymphoid Tissues	PLOS ONE			English	Article							DENDRITIC CELLS; REGULATORY PHENOTYPE; LAMINA PROPRIA; CUTTING EDGE; TOLERANCE; INFLAMMATION; SUPPRESSION; LUPUS	Background: In contrast to intestinal CD4(+) regulatory T cells (T-regs), the generation and function of immunomodulatory intestinal CD8(+) T cells is less well defined. To dissect the immunologic mechanisms of CD8(+) T cell function in the mucosa, reactivity against hemagglutinin (HA) expressed in intestinal epithelial cells of mice bearing a MHC class-I-restricted T-cell-receptor specific for HA was studied. Methodology and Principal Findings: HA-specific CD8(+) T cells were isolated from gut-associated tissues and phenotypically and functionally characterized for the expression of Foxp3(+) and their suppressive capacity. We demonstrate that intestinal HA expression led to peripheral induction of HA-specific CD8(+) Foxp3(+) T cells. Antigen-experienced CD8(+) T cells in this transgenic mouse model suppressed the proliferation of CD8(+) and CD4(+) T cells in vitro. Gene expression analysis of suppressive HA-specific CD8(+) T cells revealed a specific up-regulation of CD103, Nrp1, Tnfrsf9 and Pdcd1, molecules also expressed on CD4(+) T-reg subsets. Finally, gut-associated dendritic cells were able to induce HA-specific CD8+ Foxp3(+) T cells. Conclusion and Significance: We demonstrate that gut specific antigen presentation is sufficient to induce CD8(+) T-regs in vivo which may maintain intestinal homeostasis by down-modulating effector functions of T cells.	[Fleissner, Diana; Hansen, Wiebke; Buer, Jan; Westendorf, Astrid M.] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Dept Cell Biol, Braunschweig, Germany	University of Duisburg Essen; Helmholtz Association; Helmholtz-Center for Infection Research	Fleissner, D (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany.	astrid.westendorf@uk-essen.de	Westendorf, Astrid M./AAX-1937-2020	Buer, Jan/0000-0002-7602-1698; Hansen, Wiebke/0000-0002-6020-0886	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allez M, 2002, GASTROENTEROLOGY, V123, P1516, DOI 10.1053/gast.2002.36588; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Brimnes J, 2005, J IMMUNOL, V174, P5814, DOI 10.4049/jimmunol.174.9.5814; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Kang HK, 2005, J IMMUNOL, V174, P3247, DOI 10.4049/jimmunol.174.6.3247; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Menager-Marcq I, 2006, GASTROENTEROLOGY, V131, P1775, DOI 10.1053/j.gastro.2006.09.008; Morgan DJ, 1996, J IMMUNOL, V157, P978; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Reibke R, 2006, P NATL ACAD SCI USA, V103, P15142, DOI 10.1073/pnas.0602622103; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Singh RP, 2007, J IMMUNOL, V178, P7649, DOI 10.4049/jimmunol.178.12.7649; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Uss E, 2006, J IMMUNOL, V177, P2775, DOI 10.4049/jimmunol.177.5.2775; van Driel IR, 2008, J GASTROEN HEPATOL, V23, P171, DOI 10.1111/j.1440-1746.2007.05278.x; von Boehmer H, 2007, J EXP MED, V204, P1737, DOI 10.1084/jem.20071251; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Westendorf AM, 2009, GUT, V58, P211, DOI 10.1136/gut.2008.151720; Westendorf AM, 2005, GUT, V54, P60, DOI 10.1136/gut.2003.037663; Westendorf AM, 2006, ANN NY ACAD SCI, V1072, P401, DOI 10.1196/annals.1326.035; Westendorf AM, 2006, GASTROENTEROLOGY, V131, P510, DOI 10.1053/j.gastro.2006.05.015	29	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e15373	10.1371/journal.pone.0015373	http://dx.doi.org/10.1371/journal.pone.0015373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975955	Green Published, gold, Green Submitted			2022-12-25	WOS:000283216400032
J	Gravano, DM; McLelland, BT; Horiuchi, K; Manilay, JO				Gravano, David M.; McLelland, Bryce T.; Horiuchi, Keisuke; Manilay, Jennifer O.			ADAM17 Deletion in Thymic Epithelial Cells Alters Aire Expression without Affecting T Cell Developmental Progression	PLOS ONE			English	Article							ALPHA-CONVERTING-ENZYME; NECROSIS-FACTOR-ALPHA; AUTOIMMUNE REGULATOR; LINEAGE COMMITMENT; DEFICIENT MICE; CUTTING EDGE; THYMOCYTES; LIGAND; DIFFERENTIATION; INACTIVATION	Background: Cellular interactions between thymocytes and thymic stromal cells are critical for normal T cell development. Thymic epithelial cells (TECs) are important stromal niche cells that provide essential growth factors, cytokines, and present self-antigens to developing thymocytes. The identification of genes that mediate cellular crosstalk in the thymus is ongoing. One candidate gene, Adam17, encodes a metalloprotease that functions by cleaving the ectodomain of several transmembrane proteins and regulates various developmental processes. In conventional Adam17 knockout mice, a non-cell autonomous role for ADAM17 in adult T cell development was reported, which strongly suggested that expression of ADAM17 in TECs was required for normal T cell development. However, knockdown of Adam17 results in multisystem developmental defects and perinatal lethality, which has made study of the role of Adam17 in specific cell types difficult. Here, we examined T cell and thymic epithelial cell development using a conditional knockout approach. Methodology/Principal Findings: We generated an Adam17 conditional knockout mouse in which floxed Adam17 is deleted specifically in TECs by Cre recombinase under the control of the Foxn1 promoter. Normal T cell lineage choice and development through the canonical ab T cell stages was observed. Interestingly, Adam17 deficiency in TECs resulted in reduced expression of the transcription factor Aire. However, no alterations in the patterns of TEC phenotypic marker expression and thymus morphology were noted. Conclusions/Significance: In contrast to expectation, our data clearly shows that absence of Adam17 in TECs is dispensable for normal T cell development. Differentiation of TECs is also unaffected by loss of Adam17 based on phenotypic markers. Surprisingly, we have uncovered a novel genetic link between Adam17 and Aire expression in vivo. The cell type in which ADAM17 mediates its non-cell autonomous impact and the mechanisms by which it regulates intrathymic T cell development remain to be identified.	[Gravano, David M.; McLelland, Bryce T.; Manilay, Jennifer O.] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Antiaging Orthoped Res, Tokyo, Japan	University of California System; University of California Merced; Keio University; Keio University	Gravano, DM (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA.	jmanilay@ucmerced.edu	Horiuchi, Keisuke/L-2277-2013	Horiuchi, Keisuke/0000-0001-7063-9609	University of California; California Institute for Regenerative Medicine [RN1-00054-1]	University of California(University of California System); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was funded by the University of California through faculty start-up funds, a UC Merced faculty development award (www.ucmerced.edu) and California Institute for Regenerative Medicine New Faculty Award RN1-00054-1 to J.O.M. (www.cirm.ca.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson G, 2006, IMMUNOL REV, V209, P10, DOI 10.1111/j.0105-2896.2006.00347.x; Anderson G, 1997, EUR J IMMUNOL, V27, P1200, DOI 10.1002/eji.1830270522; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Contin C, 2003, J BIOL CHEM, V278, P32801, DOI 10.1074/jbc.M209993200; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Dooley J, 2008, J IMMUNOL, V181, P5225, DOI 10.4049/jimmunol.181.8.5225; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Gelling RW, 2008, ENDOCRINOLOGY, V149, P6053, DOI 10.1210/en.2008-0775; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; GRAVANO DM, 2010, IMMUNOL CELL BIOL; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Gray DHD, 2007, J IMMUNOL, V178, P4956, DOI 10.4049/jimmunol.178.8.4956; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Hakozaki A, 2010, J IMMUNOL, V184, P2442, DOI 10.4049/jimmunol.0901188; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hollander G, 2006, IMMUNOL REV, V209, P28, DOI 10.1111/j.0105-2896.2006.00357.x; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2009, J IMMUNOL, V182, P7408, DOI 10.4049/jimmunol.0801931; Horiuchi K, 2009, J IMMUNOL, V182, P2093, DOI 10.4049/jimmunol.0802491; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Kawaguchi N, 2007, J CELL SCI, V120, P943, DOI 10.1242/jcs.03403; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kuroda N, 2005, J IMMUNOL, V174, P1862, DOI 10.4049/jimmunol.174.4.1862; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Li NY, 2007, J IMMUNOL, V178, P4214, DOI 10.4049/jimmunol.178.7.4214; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Nishikawa Y, 2010, J EXP MED, V207, P963, DOI 10.1084/jem.20092144; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Ruan QG, 1999, J AUTOIMMUN, V13, P307, DOI 10.1006/jaut.1999.0326; Seach N, 2008, J IMMUNOL, V180, P5384, DOI 10.4049/jimmunol.180.8.5384; Shi W, 2003, DEV BIOL, V261, P371, DOI 10.1016/S0012-1606(03)00315-4; Shinohara T, 1996, EUR J IMMUNOL, V26, P747, DOI 10.1002/eji.1830260404; Solomon KA, 1999, J IMMUNOL, V163, P4105; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Suniara RK, 2000, J EXP MED, V191, P1051, DOI 10.1084/jem.191.6.1051; Trotter-Mayo RN, 2008, ENDOCRINOLOGY, V149, P5209, DOI 10.1210/en.2008-0476; Varnum-Finney B, 2008, BLOOD, V111, P2615, DOI 10.1182/blood-2007-03-079855; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	59	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13528	10.1371/journal.pone.0013528	http://dx.doi.org/10.1371/journal.pone.0013528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976004	Green Published, gold, Green Submitted			2022-12-25	WOS:000283216400028
J	Nandakumar, KS; Jansson, A; Xu, BZ; Rydell, N; Blom, AM; Holmdahl, R				Nandakumar, Kutty Selva; Jansson, Asa; Xu, Bingze; Rydell, Niclas; Blom, Anna M.; Holmdahl, Rikard			A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; INNATE IMMUNE-SYSTEM; SINGLE-CHAIN FV; C5A RECEPTOR; COMPLEMENT ACTIVATION; EFFECTOR PHASE; RHEUMATOID-ARTHRITIS; C4B-BINDING PROTEIN; JOINT DESTRUCTION; II COLLAGEN	Objectives: To develop and validate a recombinant vaccine to attenuate inflammation in arthritis by sustained neutralization of the anaphylatoxin C5a. Methods: We constructed and expressed fusion protein of C5a and maltose binding protein. Efficacy of specific C5a neutralization was tested using the fusion protein as vaccine in three different arthritis mouse models: collagen induced arthritis (CIA), chronic relapsing CIA and collagen antibody induced arthritis (CAIA). Levels of anti-C5a antibodies and anti-collagen type II were measured by ELISA. C5a neutralization assay was done using a rat basophilic leukemia cell-line transfected with the human C5aR. Complement activity was determined using a hemolytic assay and joint morphology was assessed by histology. Results: Vaccination of mice with MBP-C5a led to significant reduction of arthritis incidence and severity but not anti-collagen antibody synthesis. Histology of the MBP-C5a and control (MBP or PBS) vaccinated mice paws confirmed the vaccination effect. Sera from the vaccinated mice developed C5a-specific neutralizing antibodies, however C5 activation and formation of the membrane attack complex by C5b were not significantly altered. Conclusions: Exploitation of host immune response to generate sustained C5a neutralizing antibodies without significantly compromising C5/C5b activity is a useful strategy for developing an effective vaccine for antibody mediated and C5a dependent inflammatory diseases. Further developing of such a therapeutic vaccine would be more optimal and cost effective to attenuate inflammation without affecting host immunity.	[Nandakumar, Kutty Selva; Holmdahl, Rikard] Lund Univ, Dept Expt Med, Lund, Sweden; [Nandakumar, Kutty Selva; Holmdahl, Rikard] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Jansson, Asa; Xu, Bingze; Rydell, Niclas] Resistentia Pharmaceut AB, Uppsala, Sweden; [Blom, Anna M.] Lund Univ, Sect Med Prot Chem, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden	Lund University; Karolinska Institutet; Lund University; Skane University Hospital	Nandakumar, KS (corresponding author), Lund Univ, Dept Expt Med, Lund, Sweden.	Nandakumar.kutty-selva@ki.se	Blom, Anna/B-9607-2009; Nandakumar, Kutty Selva/D-5438-2011; Blom, Anna/AFS-7369-2022; Holmdahl, Rikard/AAI-7682-2020	Blom, Anna/0000-0002-1348-1734; Nandakumar, Kutty Selva/0000-0001-7790-8197; , Bingze/0000-0002-5341-1722	Swedish Rheumatism Association; King Gustaf V:s 80-Years Foundation; KI Fund (Fobi); Swedish Research Council; Swedish Foundation for Strategic Research; EU [HEALTH-F2-2008-223404]	Swedish Rheumatism Association; King Gustaf V:s 80-Years Foundation; KI Fund (Fobi); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); EU(European Commission)	This work was supported by Alex and Eva Wallstrom, Professor Nanna Svartz, Ake Wieberg, Anne Greta Holger Crafoord, Swedish Rheumatism Association and King Gustaf V:s 80-Years Foundation, KI Fund (Fobi), Swedish Research Council, Swedish Foundation for Strategic Research and the EU project Masterswitch HEALTH-F2-2008-223404. All the above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Resistentia Pharmaceuticals AB supported this study by employing three of the authors of this manuscript, who provided purified proteins and analyzed serum samples for anti-C5a levels and C5a neutralization in vitro in the study, but the company did not have any part in designing, executing and analysis of in vivo experiments in mice. In 2008, Resistentia Pharmaceuticals AB was closed down, and Medical Inflammation Research Division, Karolinska Institute has taken over the project completely, financed mainly by EU Masterswitch HEALTH-F2-2008-223404.	Allegretti M, 2005, CURR MED CHEM, V12, P217, DOI 10.2174/0929867053363379; Andersson U, 2004, J INTERN MED, V255, P344, DOI 10.1111/j.1365-2796.2003.01303.x; Banda NK, 2010, CLIN EXP IMMUNOL, V159, P100, DOI 10.1111/j.1365-2249.2009.04035.x; Banda NK, 2006, J IMMUNOL, V177, P1904, DOI 10.4049/jimmunol.177.3.1904; Blom AM, 2009, ANN RHEUM DIS, V68, P136, DOI 10.1136/ard.2007.085753; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Dzhambazov B, 2006, J IMMUNOL, V176, P1525, DOI 10.4049/jimmunol.176.3.1525; Fischetti F, 2007, ARTHRITIS RHEUM-US, V56, P1187, DOI 10.1002/art.22492; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Grant EP, 2002, J EXP MED, V196, P1461, DOI 10.1084/jem.20020205; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hawlisch H, 2006, MOL IMMUNOL, V43, P13, DOI 10.1016/j.molimm.2005.06.028; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hietala MA, 2004, EUR J IMMUNOL, V34, P1208, DOI 10.1002/eji.200424895; Hoesel LM, 2007, J IMMUNOL, V178, P7902, DOI 10.4049/jimmunol.178.12.7902; HOLMDAHL R, 1986, ARTHRITIS RHEUM, V29, P400, DOI 10.1002/art.1780290314; HOLMDAHL R, 1986, IMMUNOGENETICS, V24, P84, DOI 10.1007/BF00373114; Holmdahl R, 1998, HUMAN GENOME METHODS, P215; Huber-Lang M, 2002, AM J PATHOL, V161, P1849, DOI 10.1016/S0002-9440(10)64461-6; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Huber-Lang MS, 2002, FASEB J, V16, P1567, DOI 10.1096/fj.02-0209com; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Koehl J, 2006, CURR OPIN MOL THER, V8, P529; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Kohl J, 2001, MOL IMMUNOL, V38, P175, DOI 10.1016/S0161-5890(01)00041-4; Konrad S, 2007, J BIOL CHEM, V282, P37906, DOI 10.1074/jbc.M707937200; Konrad S, 2008, J BIOL CHEM, V283, P33296, DOI 10.1074/jbc.M804617200; Lee H, 2006, NAT BIOTECHNOL, V24, P1279, DOI 10.1038/nbt1248; Lindqvist AKB, 2006, J IMMUNOL, V177, P3952, DOI 10.4049/jimmunol.177.6.3952; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Monach PA, 2004, ADV IMMUNOL, V82, P217, DOI 10.1016/S0065-2776(04)82005-4; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Nandakumar KS, 2008, TRENDS IMMUNOL, V29, P173, DOI 10.1016/j.it.2008.01.007; Nandakumar KS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2089; Nandakumar KS, 2010, CELL TISSUE RES, V339, P213, DOI 10.1007/s00441-009-0816-8; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Schulte S, 1998, J BIOL CHEM, V273, P1551, DOI 10.1074/jbc.273.3.1551; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Sprong T, 2003, BLOOD, V102, P3702, DOI 10.1182/blood-2003-03-0703; Thomas TC, 1996, MOL IMMUNOL, V33, P1389, DOI 10.1016/S0161-5890(96)00078-8; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Uysal H, 2009, J EXP MED, V206, P449, DOI 10.1084/jem.20081862; Vergunst CE, 2007, RHEUMATOLOGY, V46, P1773, DOI 10.1093/rheumatology/kem222; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang Y, 2000, J IMMUNOL, V164, P4340, DOI 10.4049/jimmunol.164.8.4340; WARD PA, 1970, J IMMUNOL, V104, P535; WETSEL RA, 1983, J EXP MED, V157, P2029, DOI 10.1084/jem.157.6.2029; Woodruff TM, 2002, ARTHRITIS RHEUM-US, V46, P2476, DOI 10.1002/art.10449; Woodruff TM, 2006, FASEB J, V20, P1407, DOI 10.1096/fj.05-5814com	54	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13511	10.1371/journal.pone.0013511	http://dx.doi.org/10.1371/journal.pone.0013511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975959	Green Published, Green Submitted, gold			2022-12-25	WOS:000283216400017
J	Mediavilla, MG; Di Venanzio, GA; Guibert, EE; Tiribelli, C				Mediavilla, Maria G.; Di Venanzio, Gisela A.; Guibert, Edgardo E.; Tiribelli, Claudio			Heterologous Ferredoxin Reductase and Flavodoxin Protect Cos-7 Cells from Oxidative Stress	PLOS ONE			English	Article							CYTOSOLIC DIHYDROFOLATE-REDUCTASE; IMPORTED MITOCHONDRIAL PROTEIN; COLD-INDUCED APOPTOSIS; 12 AMINO-ACIDS; ESCHERICHIA-COLI; RAT-LIVER; NADP+ OXIDOREDUCTASE; FREE MALONDIALDEHYDE; SOXRS RESPONSE; HYBRID SYSTEM	Background: Ferredoxin-NADP(H) reductase (FNR) from Pisum sativum and Flavodoxin (Fld) from Anabaena PCC 7119 have been reported to protect a variety of cells and organisms from oxidative insults. In this work, these two proteins were expressed in mitochondria of Cos-7 cells and tested for their efficacy to protect these cells from oxidative stress in vitro. Principal Findings: Cos-7/pFNR and Cos-7/pFld cell lines expressing FNR and Fld, respectively, showed a significantly higher resistance to 24 h exposure to 300-600 mu M hydrogen peroxide measured by LDH retention, MTT reduction, malondialdehyde (MDA) levels and lipid peroxide (LPO; FOX assay) levels. However, FNR and Fld did not exhibit any protection at shorter incubation times (2 h and 4 h) to 4 mM hydrogen peroxide or to a 48 h exposure to 300 mM methyl viologen. We found enhanced methyl viologen damage exerted by FNR that may be due to depletion of NADPH pools through NADPH-MV diaphorase activity as previously observed for other overexpressed enzymes. Significance: The results presented are a first report of antioxidant function of these heterologous enzymes of vegetal and cyanobacterial origin in mammalian cells.	[Mediavilla, Maria G.; Di Venanzio, Gisela A.; Guibert, Edgardo E.] Ctr Binac Argentina Italia Invest Criobiol Clin &, Rosario, Argentina; [Mediavilla, Maria G.; Di Venanzio, Gisela A.; Guibert, Edgardo E.] Consejo Nacl Invest Cient & Tecn, Rosario, Argentina; [Guibert, Edgardo E.] Univ Nacl Rosario, Area Biol Mol, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Argentina; [Tiribelli, Claudio] Ctr Studi Fegato, Basovizza, Italy; [Tiribelli, Claudio] Univ Trieste, Dept ACADEM, Trieste, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of Trieste	Mediavilla, MG (corresponding author), Ctr Binac Argentina Italia Invest Criobiol Clin &, Rosario, Argentina.	mmediavi@fbioyf.unr.edu.ar	Di Venanzio, Gisela/GYV-3910-2022; Mediavilla, María Gabriela/L-5445-2016; Tiribelli, Claudio/A-4716-2014	Mediavilla, María Gabriela/0000-0002-1999-7707; Tiribelli, Claudio/0000-0001-6596-7595	StartUp; CONICET/Sistema Cientifico de Trieste; CONICET (National Scientific and Technology Council), Argentina; Italian Liver Foundation [legge26/00]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [703]	StartUp; CONICET/Sistema Cientifico de Trieste(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET (National Scientific and Technology Council), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Italian Liver Foundation; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	This work was supported by StartUp Grant AREA Science Park/Centro Studi Fegato to Dra. Mediavilla and a postdoctoral fellowship CONICET/Sistema Cientifico de Trieste to Dra. Mediavilla. Dra. Mediavilla and Dr. Guibert are members of CONICET (National Scientific and Technology Council), Argentina. Italian Liver Foundation (legge26/00) to Professor Tiribelli. Grant PICT N<SUP>o</SUP> 703 "Prestamo BID" from Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JX, 1999, J BIOL CHEM, V274, P26217, DOI 10.1074/jbc.274.37.26217; Baudhuin P, 1974, Methods Enzymol, V31, P356; Bilzer M, 1999, AM J PHYSIOL-GASTR L, V276, pG1137, DOI 10.1152/ajpgi.1999.276.5.G1137; Carrillo N, 2003, EUR J BIOCHEM, V270, P1900, DOI 10.1046/j.1432-1033.2003.03566.x; CECCARELLI EA, 1991, J BIOL CHEM, V266, P14283; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Davies KJA, 2005, HANDB ENVIRON CHEM, V2, P63, DOI 10.1007/b10146; Doudican NA, 2005, MOL CELL BIOL, V25, P5196, DOI 10.1128/MCB.25.12.5196-5204.2005; ELROYSTEIN O, 1986, EMBO J, V5, P615, DOI 10.1002/j.1460-2075.1986.tb04255.x; Faro M, 2003, EUR J BIOCHEM, V270, P726, DOI 10.1046/j.1432-1033.2003.03433.x; FILLAT MF, 1991, BIOCHEM J, V280, P187, DOI 10.1042/bj2800187; Gaudu P, 2000, J BACTERIOL, V182, P1788, DOI 10.1128/JB.182.7.1788-1793.2000; Girardini JE, 2002, MOL BIOCHEM PARASIT, V124, P37, DOI 10.1016/S0166-6851(02)00158-5; Giro M, 2006, MICROBIOL-SGM, V152, P1119, DOI 10.1099/mic.0.28612-0; Griffiths HR, 2002, MOL ASPECTS MED, V23, P101, DOI 10.1016/S0098-2997(02)00017-1; HERMESLIMA M, 1995, FREE RADICAL BIO MED, V19, P271, DOI 10.1016/0891-5849(95)00020-X; HORWICH AL, 1985, EMBO J, V4, P1129, DOI 10.1002/j.1460-2075.1985.tb03750.x; HURT EC, 1985, EMBO J, V4, P3509, DOI 10.1002/j.1460-2075.1985.tb04110.x; HURT EC, 1985, EMBO J, V4, P2061, DOI 10.1002/j.1460-2075.1985.tb03892.x; HURT EC, 1984, FEBS LETT, V178, P306, DOI 10.1016/0014-5793(84)80622-5; ITOH S, 1995, BBA-GENE STRUCT EXPR, V1264, P159; Jenkins CM, 1998, BIOCHEMISTRY-US, V37, P6106, DOI 10.1021/bi973076p; Joseph B, 2002, GASTROENTEROLOGY, V123, P1677, DOI 10.1053/gast.2002.36592; Kang HJ, 2006, MOL CELLS, V22, P113; Karatas F, 2002, ANAL BIOCHEM, V311, P76, DOI 10.1016/S0003-2697(02)00387-1; Kerkweg U, 2002, HEPATOLOGY, V35, P560, DOI 10.1053/jhep.2002.31869; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Krapp AR, 1997, EUR J BIOCHEM, V249, P556, DOI 10.1111/j.1432-1033.1997.00556.x; Krapp AR, 2002, J BACTERIOL, V184, P1474, DOI 10.1128/JB.184.5.1474-1480.2002; KRAPP AR, 1995, ARCH BIOCHEM BIOPHYS, V317, P215, DOI 10.1006/abbi.1995.1156; LIOCHEV SI, 1994, P NATL ACAD SCI USA, V91, P1328, DOI 10.1073/pnas.91.4.1328; Mamprin ME, 2001, CRYOBIOLOGY, V43, P310, DOI 10.1006/cryo.2001.2364; Mamprin ME, 2000, CRYOBIOLOGY, V40, P270, DOI 10.1006/cryo.2000.2242; Mediavilla MG, 2006, J GENE MED, V8, P306, DOI 10.1002/jgm.847; Mockett RJ, 2003, FREE RADICAL BIO MED, V34, P207, DOI 10.1016/S0891-5849(02)01190-5; MOREL I, 1990, BIOCHEM PHARMACOL, V39, P1647, DOI 10.1016/0006-2952(90)90107-V; NEWMAN BJ, 1988, PLANT MOL BIOL, V10, P511, DOI 10.1007/BF00033606; Nguyen-nhu NT, 2003, FEBS LETT, V544, P148, DOI 10.1016/S0014-5793(03)00493-9; Palatnik JF, 2003, PLANT J, V35, P332, DOI 10.1046/j.1365-313X.2003.01809.x; Palatnik JF, 1997, PLANT PHYSIOL, V115, P1721, DOI 10.1104/pp.115.4.1721; Pomposiello PJ, 2000, J BACTERIOL, V182, P23, DOI 10.1128/JB.182.1.23-29.2000; PORTER TD, 1986, BIOCHEMISTRY-US, V25, P1682, DOI 10.1021/bi00355a036; Rauen U, 1999, FASEB J, V13, P155, DOI 10.1096/fasebj.13.1.155; RODRIGUEZ JV, 1995, CELL TRANSPLANT, V4, P245, DOI 10.1016/0963-6897(95)90036-5; Rodriguez RE, 2007, PLANT PHYSIOL, V143, P639, DOI 10.1104/pp.106.090449; Rodriguez RE, 1998, MICROBIOL-UK, V144, P2375, DOI 10.1099/00221287-144-9-2375; SERRA EC, 1993, PROTEIN EXPRES PURIF, V4, P539, DOI 10.1006/prep.1993.1071; Shimizu K, 2003, BIOCHEM BIOPH RES CO, V304, P766, DOI 10.1016/S0006-291X(03)00657-0; Singh AK, 2004, PHYSIOL PLANTARUM, V120, P27, DOI 10.1111/j.0031-9317.2004.0232.x; Tognetti VB, 2006, PLANT CELL, V18, P2035, DOI 10.1105/tpc.106.042424; Trouet A, 1974, Methods Enzymol, V31, P323; VANLEEUWEN JW, 1983, EUR J BIOCHEM, V135, P601; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Yousef N, 2003, ARCH MICROBIOL, V180, P471, DOI 10.1007/s00203-003-0618-4; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999; Zollner A, 2004, BIOELECTROCHEMISTRY, V63, P61, DOI 10.1016/j.bioelechem.2003.10.014; Zurbriggen MD, 2008, TRENDS BIOTECHNOL, V26, P531, DOI 10.1016/j.tibtech.2008.07.001	57	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13501	10.1371/journal.pone.0013501	http://dx.doi.org/10.1371/journal.pone.0013501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976072	Green Published, gold, Green Submitted			2022-12-25	WOS:000283114700021
J	Yuan, HY; Huang, CJ; Zhang, SL				Yuan, Hongyan; Huang, Changjin; Zhang, Sulin			Virus-Inspired Design Principles of Nanoparticle-Based Bioagents	PLOS ONE			English	Article							MEDIATED ENDOCYTOSIS; CELLULAR UPTAKE; QUANTUM DOTS; SIZE; CELLS; CLATHRIN; EXPRESSION; MECHANICS; VESICLES; ADHESION	The highly effectiveness and robustness of receptor-mediated viral invasion of living cells shed lights on the biomimetic design of nanoparticle(NP)-based therapeutics. Through thermodynamic analysis, we elucidate that the mechanisms governing both the endocytic time of a single NP and the cellular uptake can be unified into a general energy-balance framework of NP-membrane adhesion and membrane deformation. Yet the NP-membrane adhesion strength is a globally variable quantity that effectively regulates the NP uptake rate. Our analysis shows that the uptake rate interrelatedly depends on the particle size and ligand density, in contrast to the widely reported size effect. Our model predicts that the optimal radius of NPs for maximal uptake rate falls in the range of 25-30 nm, and optimally several tens of ligands should be coated onto NPs. These findings are supported by both recent experiments and typical viral structures, and serve as fundamental principles for the rational design of NP-based nanomedicine.	[Yuan, Hongyan; Huang, Changjin; Zhang, Sulin] Penn State Univ, Dept Engn Sci & Mech, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Yuan, HY (corresponding author), Penn State Univ, Dept Engn Sci & Mech, 227 Hammond Bldg, University Pk, PA 16802 USA.	suz10@psu.edu	Yuan, Hongyan/C-3816-2011; HUANG, CHANGJIN/G-6318-2011; Zhang, Sulin/X-3617-2019; Zhang, Sulin/E-6457-2010	Yuan, Hongyan/0000-0001-8225-0211; HUANG, CHANGJIN/0000-0002-1941-1200; 	National Science Foundation (NSF) [0754463]; Div Of Civil, Mechanical, & Manufact Inn [0754463] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	SLZ gratefully acknowledges the grant support from the National Science Foundation (NSF) grant under Award No. 0754463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bao G, 2005, P NATL ACAD SCI USA, V102, P9997, DOI 10.1073/pnas.0504555102; Buehler MJ, 2006, NATURE, V439, P307, DOI 10.1038/nature04408; Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536; Cevc G, 1999, ADV DRUG DELIVER REV, V38, P207, DOI 10.1016/S0169-409X(99)00030-7; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Decuzzi P, 2007, BIOMATERIALS, V28, P2915, DOI 10.1016/j.biomaterials.2007.02.013; Desai MP, 1997, PHARMACEUT RES, V14, P1568, DOI 10.1023/A:1012126301290; Deserno M, 2003, EUROPHYS LETT, V62, P767, DOI 10.1209/epl/i2003-00438-4; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Freund LB, 2004, J MECH PHYS SOLIDS, V52, P2455, DOI 10.1016/j.jmps.2004.05.004; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; GAROFF H, 1974, P NATL ACAD SCI USA, V71, P3988, DOI 10.1073/pnas.71.10.3988; Garoff H, 1998, MICROBIOL MOL BIOL R, V62, P1171, DOI 10.1128/MMBR.62.4.1171-1190.1998; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; Jaiswal JK, 2004, NAT METHODS, V1, P73, DOI 10.1038/nmeth1004-73; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Lamblet M, 2008, EUR PHYS J E, V26, P205, DOI 10.1140/epje/i2007-10317-x; LERNER DM, 1993, BIOPHYS J, V65, P73, DOI 10.1016/S0006-3495(93)81071-3; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Nakai T, 2003, J AM CHEM SOC, V125, P8465, DOI 10.1021/ja035636f; Osaki F, 2004, J AM CHEM SOC, V126, P6520, DOI 10.1021/ja048792a; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Prabha S, 2002, INT J PHARM, V244, P105, DOI 10.1016/S0378-5173(02)00315-0; Qaddoumi MG, 2003, MOL VIS, V9, P559; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Shenoy VB, 2005, P NATL ACAD SCI USA, V102, P3213, DOI 10.1073/pnas.0500368102; Shi WD, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061914; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sun SX, 2006, BIOPHYS J, V90, pL10, DOI 10.1529/biophysj.105.074203; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Terdalkar SS, 2010, CHEM PHYS LETT, V494, P218, DOI 10.1016/j.cplett.2010.05.090; Tzlil S, 2004, BIOPHYS J, V86, P2037, DOI 10.1016/S0006-3495(04)74265-4; van Effenterre D, 2003, EUROPHYS LETT, V64, P543, DOI 10.1209/epl/i2003-00268-x; Xing XL, 2005, J NANOSCI NANOTECHNO, V5, P1688, DOI 10.1166/jnn.2005.199; Yuan HY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.138101; Yuan HY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3293303; Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393; Zhang SL, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.094114	43	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13495	10.1371/journal.pone.0013495	http://dx.doi.org/10.1371/journal.pone.0013495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976064	Green Published, Green Submitted, gold			2022-12-25	WOS:000283114700018
J	Gregory, KJ; Zhao, B; Bielenberg, DR; Dridi, S; Wu, J; Jiang, WH; Huang, B; Pirie-Shepherd, S; Fannon, M				Gregory, Kalvin J.; Zhao, Bing; Bielenberg, Diane R.; Dridi, Sami; Wu, Jason; Jiang, Weihua; Huang, Bin; Pirie-Shepherd, Steven; Fannon, Michael			Vitamin D Binding Protein-Macrophage Activating Factor Directly Inhibits Proliferation, Migration, and uPAR Expression of Prostate Cancer Cells	PLOS ONE			English	Article							N-ACETYLGALACTOSAMINIDASE ACTIVITY; SERUM VITAMIN-D-3-BINDING PROTEIN; FACTOR DBP-MAF; TUMOR-GROWTH; CARCINOMA CELLS; FACTOR GCMAF; MEDIATED MIGRATION; ENDOTHELIAL-CELLS; C-MET; IMMUNOTHERAPY	Background: Vitamin D binding protein-macrophage activating factor (DBP-maf) is a potent inhibitor of tumor growth. Its activity, however, has been attributed to indirect mechanisms such as boosting the immune response by activating macrophages and inhibiting the blood vessel growth necessary for the growth of tumors. Methods and Findings: In this study we show for the first time that DBP-maf exhibits a direct and potent effect on prostate tumor cells in the absence of macrophages. DBP-maf demonstrated inhibitory activity in proliferation studies of both LNCaP and PC3 prostate cancer cell lines as well as metastatic clones of these cells. Flow cytometry studies with annexin V and propidium iodide showed that this inhibitory activity is not due to apoptosis or cell death. DBP-maf also had the ability to inhibit migration of prostate cancer cells in vitro. Finally, DBP-maf was shown to cause a reduction in urokinase plasminogen activator receptor (uPAR) expression in prostate tumor cells. There is evidence that activation of this receptor correlates with tumor metastasis. Conclusions: These studies show strong inhibitory activity of DBP-maf on prostate tumor cells independent of its macrophage activation.	[Gregory, Kalvin J.; Zhao, Bing; Dridi, Sami; Wu, Jason; Jiang, Weihua; Fannon, Michael] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; [Bielenberg, Diane R.] Harvard Univ, Sch Med, Dept Surg, Vasc Biol Program,Childrens Hosp, Boston, MA 02115 USA; [Huang, Bin] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Pirie-Shepherd, Steven] CovX, San Diego, CA USA	University of Kentucky; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Kentucky	Gregory, KJ (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA.	michael.fannon@uky.edu	Dridi, Sami/Q-8207-2019	Wu, Jason/0000-0002-9137-0351	Department of Defense (DOD) [PC030286]; Research to Prevent Blindness Challenge Grant	Department of Defense (DOD)(United States Department of Defense); Research to Prevent Blindness Challenge Grant(Research to Prevent Blindness (RPB))	This work was supported by Department of Defense (DOD) grant PC030286 and Research to Prevent Blindness Challenge Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Bajou K, 2001, J CELL BIOL, V152, P777, DOI 10.1083/jcb.152.4.777; Bajou K, 2004, ONCOGENE, V23, P6986, DOI 10.1038/sj.onc.1207859; Bauer TW, 2005, CANCER RES, V65, P7775, DOI 10.1158/0008-5472.CAN-05-0946; Bauer TW, 2005, ANN SURG, V241, P748, DOI 10.1097/01.sla.0000160699.59061.92; Besch R, 2007, CELL DEATH DIFFER, V14, P818, DOI 10.1038/sj.cdd.4402065; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Chang LK, 2004, P NATL ACAD SCI USA, V101, P11658, DOI 10.1073/pnas.0404272101; CONNOLLY DT, 1986, ANAL BIOCHEM, V152, P136, DOI 10.1016/0003-2697(86)90131-4; COOKE NE, 1985, J CLIN INVEST, V76, P2420, DOI 10.1172/JCI112256; Dass CR, 2005, CLIN EXP METASTAS, V22, P643, DOI 10.1007/s10585-006-9004-3; Dong Z, 2008, NEOPLASIA, V10, P439, DOI 10.1593/neo.08106; Fannon M, 2008, J CELL PHYSIOL, V215, P434, DOI 10.1002/jcp.21327; Greco M, 2009, CANCER LETT, V283, P222, DOI 10.1016/j.canlet.2009.04.001; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; HELBERT MR, 1993, IMMUNOL TODAY, V14, P340, DOI 10.1016/0167-5699(93)90232-A; Kanda S, 2002, JNCI-J NATL CANCER I, V94, P1311; KAWAKAMI M, 1981, J CLIN ENDOCR METAB, V53, P1110, DOI 10.1210/jcem-53-6-1110; Kisker O, 2003, NEOPLASIA, V5, P32, DOI 10.1016/S1476-5586(03)80015-5; Kisker O, 2001, CANCER RES, V61, P7669; Koga Y, 1999, P SOC EXP BIOL MED, V220, P20, DOI 10.1046/j.1525-1373.1999.d01-3.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mohamad SB, 2002, COMP BIOCHEM PHYS A, V132, P1, DOI 10.1016/S1095-6433(01)00522-0; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Schneider GB, 2003, CRIT REV EUKAR GENE, V13, P277; Serrati S, 2008, J PATHOL, V214, P545, DOI 10.1002/path.2309; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Trinh L, 2000, BIOSEPARATION, V9, P223, DOI 10.1023/A:1008133914854; Yamamoto N, 1996, CELL IMMUNOL, V170, P161, DOI 10.1006/cimm.1996.0148; Yamamoto N, 2006, AIDS RES HUM RETROV, V22, P262, DOI 10.1089/aid.2006.22.262; Yamamoto N, 1997, CLIN IMMUNOL IMMUNOP, V82, P290, DOI 10.1006/clin.1996.4320; Yamamoto N, 1996, MOL IMMUNOL, V33, P1157, DOI 10.1016/S0161-5890(96)00081-8; YAMAMOTO N, 1995, AIDS RES HUM RETROV, V11, P1373, DOI 10.1089/aid.1995.11.1373; Yamamoto N, 2009, J MED VIROL, V81, P16, DOI 10.1002/jmv.21376; Yamamoto N, 2008, CANCER IMMUNOL IMMUN, V57, P1007, DOI 10.1007/s00262-007-0431-z; Yamamoto N, 2008, INT J CANCER, V122, P461, DOI 10.1002/ijc.23107; Yamamoto N, 2008, TRANSL ONCOL, V1, P65, DOI 10.1593/tlo.08106	37	48	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13428	10.1371/journal.pone.0013428	http://dx.doi.org/10.1371/journal.pone.0013428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976141	Green Published, Green Submitted, gold			2022-12-25	WOS:000283045300014
J	Shen, YF; Tolic, N; Liu, T; Zhao, R; Petritis, BO; Gritsenko, MA; Camp, DG; Moore, RJ; Purvine, SO; Esteva, FJ; Smith, RD				Shen, Yufeng; Tolic, Nikola; Liu, Tao; Zhao, Rui; Petritis, Brianne O.; Gritsenko, Marina A.; Camp, David G.; Moore, Ronald J.; Purvine, Samuel O.; Esteva, Francisco J.; Smith, Richard D.			Blood Peptidome-Degradome Profile of Breast Cancer	PLOS ONE			English	Article							HUMAN PLASMA PROTEOME; MASS-SPECTROMETRY; HEAVY-CHAINS; TUMOR-CELLS; PLASMINOGEN; INHIBITOR; PROTEINS; MARKERS; MICROENVIRONMENT; DEGRADATION	Background: Cancer invasion and metastasis are closely associated with activities within the degradome; however, little is known about whether these activities can be detected in the blood of cancer patients. Methodology and Principal Findings: The peptidome-degradome profiles of pooled blood plasma sampled from 15 breast cancer patients (BCP) and age, race, and menopausal status matched control healthy persons (HP) were globally characterized using advanced comprehensive separations combined with tandem Fourier transform mass spectrometry and new data analysis approaches that facilitated top-down peptidomic analysis. The BCP pool displayed 71 degradome protein substrates that encompassed 839 distinct peptidome peptides. In contrast, the HP 50 degradome substrates found encompassed 425 peptides. We find that the ratios of the peptidome peptide relative abundances can vary as much as >4000 fold between BCP and HP. The experimental results also show differential degradation of substrates in the BCP sample in their functional domains, including the proteolytic and inhibitory sites of the plasmin-antiplasmin and thrombin-antithrombin systems, the main chains of the extracellular matrix protection proteins, the excessive degradation of innate immune system key convertases and membrane attack complex components, as well as several other cancer suppressor proteins. Conclusions: Degradomics-peptidomics profiling of blood plasma is highly sensitive to changes not evidenced by conventional bottom-up proteomics and potentially provides unique signatures of possible diagnostic utility.	[Shen, Yufeng; Liu, Tao; Gritsenko, Marina A.; Camp, David G.; Moore, Ronald J.; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Tolic, Nikola; Zhao, Rui; Purvine, Samuel O.; Smith, Richard D.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Petritis, Brianne O.] Arizona State Univ, Biol Design Interdisciplinary Grad Degree Program, Tempe, AZ USA; [Esteva, Francisco J.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Esteva, Francisco J.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Arizona State University; Arizona State University-Tempe; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shen, YF (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	Yufeng.shen@pnl.gov; rds@pnl.gov	Purvine, Samuel O/O-3358-2017; Liu, Tao/A-9020-2013; Smith, Richard D/J-3664-2012	Purvine, Samuel O/0000-0002-2257-2400; Liu, Tao/0000-0001-9529-6550; Smith, Richard D/0000-0002-2381-2349; Esteva, Francisco J./0000-0003-2437-3920	National Institutes of Health, National Center for Research Resources [RR18522]; DOE [DE-AC05-76RLO-1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by the National Institutes of Health, National Center for Research Resources (RR18522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Work was performed in the Environmental Molecular Science Laboratory, a DOE/BER national scientific user facility located on the campus of Pacific Northwest National Laboratory (PNNL) in Richland, Washington. PNNL is a multi-program national laboratory operated by Battelle Memorial Institute for the DOE under contract DE-AC05-76RLO-1830.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Dieplinger H, 2009, CANCER EPIDEM BIOMAR, V18, P1127, DOI 10.1158/1055-9965.EPI-08-0653; Dong Y, 2002, EXP CELL RES, V276, P328, DOI 10.1006/excr.2002.5534; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Masselon C, 2005, ANAL CHEM, V77, P400, DOI 10.1021/ac049043e; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NICULESCU F, 1992, AM J PATHOL, V140, P1039; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PETERSEN TE, 1990, J BIOL CHEM, V265, P6104; Petricoin EF, 2006, NAT REV CANCER, V6, P961, DOI 10.1038/nrc2011; POTEMPA J, 1988, SCIENCE, V241, P699, DOI 10.1126/science.2456616; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Rickles FR, 2003, CHEST, V124, p58S, DOI 10.1378/chest.124.3_suppl.58S; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; SCHAPIRA DV, 1983, BREAST CANCER RES TR, V3, P221, DOI 10.1007/BF01803564; Shen YF, 2005, ANAL CHEM, V77, P7763, DOI 10.1021/ac051257o; Shen YF, 2004, ANAL CHEM, V76, P1134, DOI 10.1021/ac034869m; Shen YF, 2010, J PROTEOME RES, V9, P4053, DOI 10.1021/pr1002559; Shen YF, 2010, J PROTEOME RES, V9, P2339, DOI 10.1021/pr901083m; SHVYRKOVA IG, 2000, RUSS J BIOORG CHEM+, V26, P317; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Sturgeon CM, 2008, CLIN CHEM, V54, pE11, DOI 10.1373/clinchem.2008.105601; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; WOJTUKIEWICZ MZ, 1993, INT J CANCER, V54, P793, DOI 10.1002/ijc.2910540514	43	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13133	10.1371/journal.pone.0013133	http://dx.doi.org/10.1371/journal.pone.0013133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976186	gold, Green Submitted, Green Published			2022-12-25	WOS:000283045300004
J	Bonomi, M; Barducci, A; Gervasio, FL; Parrinello, M				Bonomi, Massimiliano; Barducci, Alessandro; Gervasio, Francesco L.; Parrinello, Michele			Multiple Routes and Milestones in the Folding of HIV-1 Protease Monomer	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ENERGY LANDSCAPES; DRUG-RESISTANCE; STABILITY; DIMERIZATION; SIMULATIONS; FLEXIBILITY; PROTEINS; INSIGHT; FUNNELS	Proteins fold on a time scale incompatible with a mechanism of random search in conformational space thus indicating that somehow they are guided to the native state through a funneled energetic landscape. At the same time the heterogeneous kinetics suggests the existence of several different folding routes. Here we propose a scenario for the folding mechanism of the monomer of HIV-1 protease in which multiple pathways and milestone events coexist. A variety of computational approaches supports this picture. These include very long all-atom molecular dynamics simulations in explicit solvent, an analysis of the network of clusters found in multiple high-temperature unfolding simulations and a complete characterization of free-energy surfaces carried out using a structure-based potential at atomistic resolution and a combination of metadynamics and parallel tempering. Our results confirm that the monomer in solution is stable toward unfolding and show that at least two unfolding pathways exist. In our scenario, the formation of a hydrophobic core is a milestone in the folding process which must occur along all the routes that lead this protein towards its native state. Furthermore, the ensemble of folding pathways proposed here substantiates a rational drug design strategy based on inhibiting the folding of HIV-1 protease.	[Bonomi, Massimiliano; Barducci, Alessandro; Parrinello, Michele] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Lugano, Switzerland; [Gervasio, Francesco L.] Spanish Natl Res Ctr, Computat Biophys Grp, Struct Biol & Biocomp Programme, Madrid, Spain		Bonomi, M (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Lugano, Switzerland.	mbonomi@ethz.ch	Barducci, Alessandro/K-3510-2013; Gervasio, Francesco Luigi/D-8154-2012; Bonomi, Massimiliano/G-2476-2010; Gervasio, Francesco/AAD-1036-2022; Barducci, Alessandro/AAF-9015-2019	Gervasio, Francesco Luigi/0000-0003-4831-5039; Gervasio, Francesco/0000-0003-4831-5039; Barducci, Alessandro/0000-0002-1911-8039; Bonomi, Massimiliano/0000-0002-7321-0004				Alm E, 1999, P NATL ACAD SCI USA, V96, P11305, DOI 10.1073/pnas.96.20.11305; Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; Bannwarth L, 2007, BIOCHEM SOC T, V35, P551, DOI 10.1042/BST0350551; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Bonomi M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.190601; Bonomi M, 2009, J COMPUT CHEM, V30, P1615, DOI 10.1002/jcc.21305; Bonomi M, 2007, BIOPHYS J, V93, P2813, DOI 10.1529/biophysj.107.106369; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bowman MJ, 2002, BIOPOLYMERS, V66, P126, DOI 10.1002/bip.10232; Brandes U, 2004, MATH VIS, P321; Brandes U, 2007, LECT NOTES COMPUT SC, V4372, P42; Broglia RA, 2008, CURR OPIN STRUC BIOL, V18, P60, DOI 10.1016/j.sbi.2007.10.004; Broglia RA, 2006, PROTEINS, V62, P928, DOI 10.1002/prot.20849; Broglia RA, 2005, PROTEIN SCI, V14, P2668, DOI 10.1110/ps.051670905; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Bussi G, 2006, J AM CHEM SOC, V128, P13435, DOI 10.1021/ja062463w; Cecconi F, 2001, PROTEINS, V43, P365, DOI 10.1002/prot.1049; Chipot C., 2007, SPRINGER SERIES CHEM; Clementi C, 2000, P NATL ACAD SCI USA, V97, P5871, DOI 10.1073/pnas.100547897; Daggett V, 2006, CHEM REV, V106, P1898, DOI 10.1021/cr0404242; Dellago C, 2009, ADV POLYM SCI, V221, P167, DOI 10.1007/12_2008_3; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Ding F, 2008, J AM CHEM SOC, V130, P7184, DOI 10.1021/ja800893d; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Galiano L, 2007, J AM CHEM SOC, V129, P11004, DOI 10.1021/ja073684k; Galzitskaya OV, 1999, P NATL ACAD SCI USA, V96, P11299, DOI 10.1073/pnas.96.20.11299; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ishima R, 2003, J BIOL CHEM, V278, P43311, DOI 10.1074/jbc.M307549200; Ishima R, 2001, J BIOL CHEM, V276, P49110, DOI 10.1074/jbc.M108136200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Kogo H, 2009, BBA-PROTEINS PROTEOM, V1794, P70, DOI 10.1016/j.bbapap.2008.09.022; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Levy Y, 2004, J MOL BIOL, V340, P67, DOI 10.1016/j.jmb.2004.04.028; Levy Y, 2003, J PHYS CHEM B, V107, P3068, DOI 10.1021/jp0219956; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; NICHOLSON LK, 1995, NAT STRUCT BIOL, V2, P274, DOI 10.1038/nsb0495-274; Noel AF, 2009, J MOL BIOL, V387, P1002, DOI 10.1016/j.jmb.2008.12.061; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piana S, 2002, J MOL BIOL, V319, P567, DOI 10.1016/S0022-2836(02)00301-7; Pietrucci F, 2009, J AM CHEM SOC, V131, P11811, DOI 10.1021/ja903045y; Rout MK, 2009, ARCH BIOCHEM BIOPHYS, V482, P33, DOI 10.1016/j.abb.2008.11.022; RUSCONI S, 2007, P INT SCH PHYS ENR F, V165, P293; Settanni G, 2008, BIOPHYS J, V94, P4444, DOI 10.1529/biophysj.107.122606; Shafer RW, 1999, J VIROL, V73, P6197, DOI 10.1128/JVI.73.7.6197-6202.1999; SHAKHNOVICH EI, 1993, P NATL ACAD SCI USA, V90, P7195, DOI 10.1073/pnas.90.15.7195; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Tiana G, 2009, PROTEINS, V76, P895, DOI 10.1002/prot.22395; Tomasselli AG, 2000, BBA-PROTEIN STRUCT M, V1477, P189, DOI 10.1016/S0167-4838(99)00273-3; Vendruscolo M, 1999, PHYS REV LETT, V82, P656, DOI 10.1103/PhysRevLett.82.656; Wallqvist A, 1998, PROTEIN ENG, V11, P999, DOI 10.1093/protein/11.11.999; Weinkam P, 2005, P NATL ACAD SCI USA, V102, P12401, DOI 10.1073/pnas.0505274102; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Wolynes PG, 1997, P NATL ACAD SCI USA, V94, P6170, DOI 10.1073/pnas.94.12.6170; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Xie D, 1999, PROTEIN SCI, V8, P1702, DOI 10.1110/ps.8.8.1702; Yan MC, 2008, PROTEINS, V70, P731, DOI 10.1002/prot.21539	62	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13208	10.1371/journal.pone.0013208	http://dx.doi.org/10.1371/journal.pone.0013208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967249	Green Submitted, Green Published, gold			2022-12-25	WOS:000282869800005
J	Knox, SS; Guo, XX; Zhang, YQ; Weidner, G; Williams, S; Ellison, RC				Knox, Sarah S.; Guo, Xinxin; Zhang, Yuqing; Weidner, G.; Williams, Scott; Ellison, R. Curtis			AGT M235T Genotype/Anxiety Interaction and Gender in the HyperGEN Study	PLOS ONE			English	Article							LONGITUDINAL DATA-ANALYSIS; GENOME-WIDE ASSOCIATION; ESSENTIAL-HYPERTENSION; COMPLEX DISEASE; HEART-RATE; ANGIOTENSINOGEN; ENVIRONMENT; STRESS; GENES; RISK	Background: Both anxiety and elevated heart rate (HR) have been implicated in the development of hypertension. The HyperGen cohort, consisting of siblings with severe and mild hypertension, an age-matched random sample of persons from the same base populations, and unmedicated adult offspring of the hypertensive siblings (N = 1,002 men and 987 women), was analyzed for an association of the angiotenisinogen AGTM235T genotype (TT, MT, MM) with an endophenotype, heart rate (HR) in high and low anxious groups. Methodology: The interaction of AGTM genotype with anxiety, which has been independently associated with hypertension, was investigated adjusting for age, hypertension status, smoking, alcohol consumption, beta blocker medication, body mass index, physical activity and hours of television viewing (sedentary life style). Principal Findings: Although there was no main effect of genotype on HR in men or women, high anxious men with the TT genotype had high HR, whereas high anxious men with the MM genotype had low HR. In women, HR was inversely associated with anxiety but there was no interaction with genotype. Conclusion/Significance: The results suggest that high anxiety in men with the TT genotype may increase risk for hypertension whereas the MM genotype may be protective in high anxious men. This type of gene x environment interaction may be one reason why genome wide association studies sometimes fail to replicate. The locus may be important only in combination with certain environmental factors.	[Knox, Sarah S.] W Virginia Univ, Sch Med, Mary Babb Randolf Canc Ctr, Dept Community Med, Morgantown, WV 26506 USA; [Guo, Xinxin] Outcome Sci Inc, Cambridge, MA USA; [Zhang, Yuqing; Ellison, R. Curtis] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; [Weidner, G.] San Francisco State Univ, Dept Biol, Tiburon, CA USA; [Williams, Scott] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA	West Virginia University; Boston University; California State University System; San Francisco State University; Vanderbilt University	Knox, SS (corresponding author), W Virginia Univ, Sch Med, Mary Babb Randolf Canc Ctr, Dept Community Med, Morgantown, WV 26506 USA.	sknox@hsc.wvu.edu	Williams, Scott/Q-4812-2019; Williams, Scott/B-9491-2012	Williams, Scott/0000-0002-4835-9544; Ellison, Robert Curtis/0000-0002-0582-7467; Knox, Sarah/0000-0002-6286-9997; Zhang, Yuqing/0000-0001-7954-1149	NHLBI [HL544471, HL54472, HL54473, HL54495, HL54496, HL54497, HL54509, HL54515]; National Heart, Lung and Blood Institute (NHLBI) at the U.S. National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL054472, U01HL054509, U10HL054496, U01HL054497, U10HL054515, U01HL054496, U10HL054473, U10HL054497, U10HL054495, U01HL054495, U01HL054473, U10HL054472, U10HL054509] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung and Blood Institute (NHLBI) at the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The HyperGEN network is funded by cooperative agreements (U10) with NHLBI: HL544471 (UT FC), HL54472 (MN Lab), HL54473 (DCC), HL54495 (AL FC), HL54496 (MN FC), HL54497 (MA), HL54509 (NJC), HL54515 (UT DNA Lab). The National Heart, Lung and Blood Institute (NHLBI) at the U.S. National Institutes of Health funded this work and NHLBI scientists were involved in its design together with university scientists. The design, implementation, and preparation of manuscripts from this study was the result of a collaborative effort of investigators from the NHLBI and all institutions involved. Although one of the co-authors, Xinxin Guo, is currently employed by a commercial company, Outcome Sciences, Inc., she was employed by Boston University at the time these analyses were performed. Outcome Sciences had no role in planning this study nor were they involved in any way in the analyses or interpretation of the data. They are completely independent.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DIMSDALE JE, 1990, NEUROPSYCHOPHARMACOL, V3, P237; Gardner M, 2008, AM J MED GENET B, V147B, P1070, DOI 10.1002/ajmg.b.30717; Harter MC, 2003, EUR ARCH PSY CLIN N, V253, P313, DOI 10.1007/s00406-003-0449-y; HOLLENBERG NK, 1981, HYPERTENSION, V3, P11, DOI 10.1161/01.HYP.3.1.11; Iacobas DA, 2010, BIOCHEM BIOPH RES CO, V391, P1769, DOI 10.1016/j.bbrc.2009.12.151; Imumorin IG, 2005, CARDIOVASC TOXICOL, V5, P109, DOI 10.1385/CT:5:2:109; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Jonas BS, 1997, ARCH FAM MED, V6, P43, DOI 10.1001/archfami.6.1.43; Knox SS, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-11; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; Lanz JR, 2005, CLIN CHIM ACTA, V362, P176, DOI 10.1016/j.cccn.2005.06.004; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lin JL, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-9; MARKOVITZ JH, 1993, JAMA-J AM MED ASSOC, V270, P2439; MONDRY A, 2004, BMC NEPHROL, V6, P1; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Musani SK, 2007, HUM HERED, V63, P67, DOI 10.1159/000099179; Pan WH, 2006, GENET EPIDEMIOL, V30, P143, DOI 10.1002/gepi.20136; Sarzani R, 2001, J HYPERTENS, V19, P2171, DOI 10.1097/00004872-200112000-00009; Sethi AA, 2003, ARTERIOSCL THROM VAS, V23, P1269, DOI 10.1161/01.ATV.0000079007.40884.5C; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; SPENCE JD, 1990, AM J HYPERTENS, V3, P859, DOI 10.1093/ajh/3.11.859; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Staessen JA, 1999, J HYPERTENS, V17, P9, DOI 10.1097/00004872-199917010-00003; TJUGEN TB, 2010, CURR HYPERTENS REP; Wilk JB, 2006, ANN HUM GENET, V70, P566, DOI 10.1111/j.1469-1809.2005.00258.x; Williams RR, 2000, ANN EPIDEMIOL, V10, P389, DOI 10.1016/S1047-2797(00)00063-6; Xing SQ, 2009, AM J PHYSIOL-HEART C, V296, pH1907, DOI 10.1152/ajpheart.00681.2008; Yang G, 1996, BIOL SIGNAL, V5, P1; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	31	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13353	10.1371/journal.pone.0013353	http://dx.doi.org/10.1371/journal.pone.0013353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967221	gold, Green Published, Green Submitted			2022-12-25	WOS:000282869800037
J	Satyanarayana, S; Shivashankar, R; Vashist, RP; Chauhan, LS; Chadha, SS; Dewan, PK; Wares, F; Sahu, S; Singh, V; Wilson, NC; Harries, AD				Satyanarayana, Srinath; Shivashankar, Roopa; Vashist, Ram Pal; Chauhan, Lakhbir Singh; Chadha, Sarabjit Singh; Dewan, Puneet Kumar; Wares, Fraser; Sahu, Suvanand; Singh, Varinder; Wilson, Nevin Charles; Harries, Anthony David			Characteristics and Programme-Defined Treatment Outcomes among Childhood Tuberculosis (TB) Patients under the National TB Programme in Delhi	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RESPIRATORY TUBERCULOSIS; PEDIATRIC TUBERCULOSIS; CHILDREN; EPIDEMIOLOGY; TRANSMISSION; DIAGNOSIS	Background: Childhood tuberculosis (TB) patients under India's Revised National TB Control Programme (RNTCP) are managed using diagnostic algorithms and directly observed treatment with intermittent thrice-weekly short-course treatment regimens for 6-8 months. The assignment into pre-treatment weight bands leads to drug doses (milligram per kilogram) that are lower than current World Health Organization (WHO) guidelines for some patients. Objectives: The main aim of our study was to describe the baseline characteristics and treatment outcomes reported under RNTCP for registered childhood (age <15 years) TB patients in Delhi. Additionally, we compared the reported programmatic treatment completion rates between children treated as per WHO recommended anti-TB drug doses with those children treated with anti-TB drug doses below that recommended in WHO guidelines. Methods: For this cross-sectional retrospective study, we reviewed programme records of all 1089 TB patients aged <15 years registered for TB treatment from January to June, 2008 in 6 randomly selected districts of Delhi. WHO disease classification and treatment outcome definitions are used by RNTCP, and these were extracted as reported in programme records. Results and Conclusions: Among 1074 patients with records available, 651 (61%) were females, 122 (11%) were <5 years of age, 1000 (93%) were new cases, and 680 (63%) had extra-pulmonary TB (EP-TB)-most commonly peripheral lymph node disease [310 (46%)]. Among 394 pulmonary TB (PTB) cases, 165 (42%) were sputum smear-positive. The overall reported treatment completion rate was 95%. Similar reported treatment completion rates were found in all subgroups assessed, including those patients whose drug dosages were lower than that currently recommended by WHO. Further studies are needed to assess the reasons for the low proportion of under-5 years of age TB case notifications, address challenges in reaching all childhood TB patients by RNTCP, the accuracy of diagnosis, and the clinical validity of reported programme defined treatment completion.	[Satyanarayana, Srinath; Harries, Anthony David] Int Union TB & Lung Dis Union, Ctr Operat Res, Paris, France; [Satyanarayana, Srinath; Wilson, Nevin Charles] Int Union TB & Lung Dis Union, SE Asia Reg Off, New Delhi, India; [Shivashankar, Roopa] All India Inst Med Sci, Ctr Community Med, New Delhi, India; [Vashist, Ram Pal] Govt Delhi, State TB Off, Delhi, India; [Chauhan, Lakhbir Singh] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India; [Chadha, Sarabjit Singh; Dewan, Puneet Kumar; Wares, Fraser; Sahu, Suvanand] WHO, Off World Hlth Org Representat India, New Delhi, India; [Singh, Varinder] Lady Hardinge Med Coll & Hosp, Dept Paediat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; World Health Organization; Lady Hardinge Medical College & Hospital	Satyanarayana, S (corresponding author), Int Union TB & Lung Dis Union, Ctr Operat Res, Paris, France.	ssrinath@theunion.org		Satyanarayana, Srinath/0000-0002-5420-2551; Wilson, Nevin/0000-0002-0191-8855	Centre for Operational Research; International Union Against Tuberculosis and Lung Disease; Operational Research Unit, Medecins sans Frontieres, Brussels	Centre for Operational Research; International Union Against Tuberculosis and Lung Disease; Operational Research Unit, Medecins sans Frontieres, Brussels	This research was supported through an operational research course, which was jointly developed and run by the Centre for Operational Research, the International Union Against Tuberculosis and Lung Disease, and the Operational Research Unit, Medecins sans Frontieres, Brussels. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Cardona M, 1999, J PAEDIATR CHILD H, V35, P375, DOI 10.1046/j.1440-1754.1999.00385.x; *CENTR TUB DIV, 2006, GUID US PED PAT WIS; *CENTR TUB DIV, 2009, TUB IND 2009 ANN REP; *CENTR TUB DIV, 2005, REV NAT TUB CONTR PR; Central Tuberculosis Division, 2005, STRAT DOC SUP MON RE; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Chauhan L S, 2004, Indian Pediatr, V41, P901; Curtis AB, 1999, NEW ENGL J MED, V341, P1491, DOI 10.1056/NEJM199911113412002; Donabedian P., 2007, RENAISSANCE ARCHITEC, P124; GIE RP, 1995, S AFR MED J, V85, P658; *GOV IND MIN HLTH, 2008, HIV SENT SURV HIV ES; Graham SM, 2006, ANTIMICROB AGENTS CH, V50, P407, DOI 10.1128/AAC.50.2.407-413.2006; Indumathi CK, 2010, INDIAN PEDIATR, V47, P93, DOI 10.1007/s13312-010-0012-7; Kabra S K, 2004, Indian Pediatr, V41, P927; Lodha R, 2008, INDIAN PEDIATR, V45, P852; Marais BJ, 2008, PEDIATR PULM, V43, P322, DOI 10.1002/ppul.20787; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; Marais BJ, 2005, INT J TUBERC LUNG D, V9, P1305; NANI N, 2007, RES PRIORITIES TB CO; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; RABALAIS G, 1991, LANCET, V338, P825, DOI 10.1016/0140-6736(91)90719-6; Schaaf HS, 2005, ARCH DIS CHILD, V90, P614, DOI 10.1136/adc.2004.052175; SCHAAF HS, 1995, PEDIATR INFECT DIS J, V14, P189, DOI 10.1097/00006454-199503000-00004; Sharma S, 2008, INT J TUBERC LUNG D, V12, P74; Sharma Sangeeta, 2010, Indian J Tuberc, V57, P4; Singh V, 2006, PAEDIATR RESPIR REV, V7, pS132, DOI 10.1016/j.prrv.2006.04.222; Starke JR, 2003, TUBERCULOSIS, V83, P208, DOI 10.1016/S1472-9792(02)00088-4; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Swaminathan S, 2008, INDIAN PEDIATR, V45, P743; WHO, 2009, WHO REP GLOB TUB CON; *WHO, 2010, CHILDH TUB; WHO, 2009, DOS INSTR US CURR AV; *WHO, 2009, REP M TB MED CHILDR; World Health Organisation, 2006, GUID NAT TUB PROGR M; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2	36	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13338	10.1371/journal.pone.0013338	http://dx.doi.org/10.1371/journal.pone.0013338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967279	gold, Green Published, Green Submitted			2022-12-25	WOS:000282807300026
J	Liu, XP; Tang, WH; Zhao, XM; Chen, LN				Liu, Xiaoping; Tang, Wei-Hua; Zhao, Xing-Ming; Chen, Luonan			A Network Approach to Predict Pathogenic Genes for Fusarium graminearum	PLOS ONE			English	Article							PROTEIN BETA-SUBUNIT; COMPLEX NETWORKS; CUTINASE GENE; NUCLEUS; KINASES; ROLES	Fusarium graminearum is the pathogenic agent of Fusarium head blight (FHB), which is a destructive disease on wheat and barley, thereby causing huge economic loss and health problems to human by contaminating foods. Identifying pathogenic genes can shed light on pathogenesis underlying the interaction between F. graminearum and its plant host. However, it is difficult to detect pathogenic genes for this destructive pathogen by time-consuming and expensive molecular biological experiments in lab. On the other hand, computational methods provide an alternative way to solve this problem. Since pathogenesis is a complicated procedure that involves complex regulations and interactions, the molecular interaction network of F. graminearum can give clues to potential pathogenic genes. Furthermore, the gene expression data of F. graminearum before and after its invasion into plant host can also provide useful information. In this paper, a novel systems biology approach is presented to predict pathogenic genes of F. graminearum based on molecular interaction network and gene expression data. With a small number of known pathogenic genes as seed genes, a subnetwork that consists of potential pathogenic genes is identified from the protein-protein interaction network (PPIN) of F. graminearum, where the genes in the subnetwork are further required to be differentially expressed before and after the invasion of the pathogenic fungus. Therefore, the candidate genes in the subnetwork are expected to be involved in the same biological processes as seed genes, which imply that they are potential pathogenic genes. The prediction results show that most of the pathogenic genes of F. graminearum are enriched in two important signal transduction pathways, including G protein coupled receptor pathway and MAPK signaling pathway, which are known related to pathogenesis in other fungi. In addition, several pathogenic genes predicted by our method are verified in other pathogenic fungi, which demonstrate the effectiveness of the proposed method. The results presented in this paper not only can provide guidelines for future experimental verification, but also shed light on the pathogenesis of the destructive fungus F. graminearum.	[Liu, Xiaoping; Zhao, Xing-Ming; Chen, Luonan] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Liu, Xiaoping] Shanghai Univ, Sch Commun & Informat Engn, Shanghai, Peoples R China; [Tang, Wei-Hua; Zhao, Xing-Ming] Chinese Acad Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Chen, Luonan] Chinese Acad Sci, Shanghai Inst Biol Sci, SIBS Novo Nordisk Translat Res Ctr PreDiabet, Key Lab Syst Biol, Shanghai, Peoples R China	Shanghai University; Shanghai University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Novo Nordisk	Liu, XP (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	xm_zhao@shu.edu.cn; lnchen@sibs.ac.cn	Tang, Wei-Hua/C-9989-2011; liu, Xiaoping/B-5052-2016	Tang, Wei-Hua/0000-0002-6167-7870; liu, Xiaoping/0000-0002-3246-4227	Ministry of Science and Technology of China [2006CB101901]; National High Technology Research and Development Program of China [2006AA02Z309]; Shanghai Municipal Education Commission [10YZ01]; Innovation Funding of Shanghai University; National Key Laboratory of Plant Molecular Genetics; Shanghai Rising-Star Program [10QA1402700]; Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2009CSP002]; Shanghai Education Committee [B.10-0412-08-001]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Innovation Funding of Shanghai University; National Key Laboratory of Plant Molecular Genetics; Shanghai Rising-Star Program; Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Education Committee	Dr Wei-hua Tang was partly supported by the Ministry of Science and Technology of China (Grant No. 2006CB101901). Dr Xing-Ming Zhao was partly supported by the National High Technology Research and Development Program of China (2006AA02Z309), Innovation Program of Shanghai Municipal Education Commission (10YZ01), Innovation Funding of Shanghai University, Open Funding of National Key Laboratory of Plant Molecular Genetics, Shanghai Rising-Star Program (10QA1402700). Dr Luonan Chen was supported by the Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences with Grant No. 2009CSP002, and supported by the Key Project of Shanghai Education Committee (B.10-0412-08-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bastidas RJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000294; Bickford LC, 2004, CURR OPIN STRUC BIOL, V14, P147, DOI 10.1016/j.sbi.2004.02.002; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bores-Walmsley MI, 2000, TRENDS MICROBIOL, V8, P133, DOI 10.1016/S0966-842X(00)01698-X; CAREY V, 2009, RBGL INTERFACE BOOST; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; ETTINGER WF, 1987, BIOCHEMISTRY-US, V26, P7883, DOI 10.1021/bi00398a052; Garcia-Higuera I, 1998, J BIOL CHEM, V273, P9041, DOI 10.1074/jbc.273.15.9041; Garvey GS, 2008, J BIOL CHEM, V283, P1660, DOI 10.1074/jbc.M705752200; Gioti A, 2006, J MOL BIOL, V358, P372, DOI 10.1016/j.jmb.2006.01.076; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Guidi BW, 2004, J BIOL CHEM, V279, P29114, DOI 10.1074/jbc.M404426200; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Idnurm A, 2001, MOL PLANT PATHOL, V2, P241, DOI 10.1046/j.1464-6722.2001.00070.x; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lenssen E, 2007, EUKARYOT CELL, V6, P2251, DOI 10.1128/EC.00327-06; LEWIN B, 2004, GENES 8; Liebmann B, 2004, INFECT IMMUN, V72, P5193, DOI 10.1128/IAI.72.9.5193-5203.2004; Liu XP, 2007, INT J FOOD MICROBIOL, V119, P223, DOI 10.1016/j.ijfoodmicro.2007.07.054; Liu ZC, 2001, EMBO J, V20, P7209, DOI 10.1093/emboj/20.24.7209; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; Mammoto A, 2000, J BIOL CHEM, V275, P13167, DOI 10.1074/jbc.C000096200; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Miedaner T, 2008, J PHYTOPATHOL, V156, P129, DOI 10.1111/j.1439-0434.2007.01394.x; Munoz I, 2003, YEAST, V20, P157, DOI 10.1002/yea.938; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Nickel W, 1998, SEMIN CELL DEV BIOL, V9, P493, DOI 10.1006/scdb.1998.0256; Nunez A, 2009, MOL BIOL CELL, V20, P3996, DOI 10.1091/mbc.E09-05-0388; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Regenfelder E, 1997, EMBO J, V16, P1934, DOI 10.1093/emboj/16.8.1934; Sinha I, 2007, DEV CELL, V13, P421, DOI 10.1016/j.devcel.2007.06.011; Stergiopoulos I, 2003, PEST MANAG SCI, V59, P1333, DOI 10.1002/ps.766; SWEIGARD JA, 1992, MOL GEN GENET, V232, P174, DOI 10.1007/BF00279994; Tang Z, 2007, BIOCHEM J, V405, P21, DOI 10.1042/BJ20061523; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; WU Z, 2010, BMC SYSTEMS IN PRESS; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200; Zhao XM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-57; Zhao XM, 2009, J PROTEOME RES, V8, P4714, DOI 10.1021/pr900415b; Zhao XM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn145; ZHAO XM, 2008, 2 INT S OPT SYST BIO, P115	46	51	51	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13021	10.1371/journal.pone.0013021	http://dx.doi.org/10.1371/journal.pone.0013021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957229	Green Published, gold			2022-12-25	WOS:000282423300001
J	Wang, T; Yu, QJ; Chen, JA; Deng, B; Qian, LH; Le, YY				Wang, Ting; Yu, Qiujing; Chen, Juan; Deng, Bo; Qian, Lihua; Le, Yingying			PP2A Mediated AMPK Inhibition Promotes HSP70 Expression in Heat Shock Response	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PANCREATIC BETA-CELLS; OKADAIC ACID; CERAMIDE; DEPHOSPHORYLATION; APOPTOSIS; GLUCOSE; 2A; PHOSPHORYLATION; ACCUMULATION	Background: Under stress, AMP-activated protein kinase (AMPK) plays a central role in energy balance, and the heat shock response is a protective mechanism for cell survival. The relationship between AMPK activity and heat shock protein (HSP) expression under stress is unclear. Methodology/Principal Findings: We found that heat stress induced dephosphorylation of AMPK alpha subunit (AMPK alpha) in various cell types from human and rodent. In HepG2 cells, the dephosphorylation of AMPK alpha under heat stress in turn caused dephosphorylation of acetyl-CoA carboxylase and upregulation of phosphoenolpyruvate carboxykinase, two downstream targets of AMPK, confirming the inhibition of AMPK activity by heat stress. Treatment of HepG2 cells with phosphatase 2A (PP2A) inhibitor okadaic acid or inhibition of PP2A expression by RNA interference efficiently reversed heat stress-induced AMPKa dephosphorylation, suggesting that heat stress inhibited AMPK through activation of PP2A. Heat stress-and other HSP inducer (CdCl2, celastrol, MG132)-induced HSP70 expression could be inhibited by AICAR, an AMPK specific activator. Inhibition of AMPKa expression by RNA interference reversed the inhibitory effect of AICAR on HSP70 expression under heat stress. These results indicate that AMPK inhibition under stress contribute to HSP70 expression. Mechanistic studies showed that activation of AMPK by AICAR had no effect on heat stress-induced HSF1 nuclear translocation, phosphorylation and binding with heat response element in the promoter region of HSP70 gene, but significantly decreased HSP70 mRNA stability. Conclusions/Significance: These results demonstrate that during heat shock response, PP2A mediated AMPK inhibition upregulates HSP70 expression at least partially through stabilizing its mRNA, which suggests a novel mechanism for HSP induction under stress.	[Wang, Ting] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Wang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	yyle@sibs.ac.cn	Le, Yingying/L-9785-2017	Le, Yingying/0000-0002-7990-3899; wang, ting/0000-0003-2257-0699	Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [SIBS2008006]	Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (SIBS2008006, Y. Le). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Gimeno-Alcaniz JV, 2003, J MOL BIOL, V333, P201, DOI 10.1016/j.jmb.2003.08.022; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; Jung JH, 2010, J CELL PHYSIOL, V223, P408, DOI 10.1002/jcp.22049; Kefas BA, 2003, DIABETOLOGIA, V46, P250, DOI 10.1007/s00125-002-1030-3; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kondo T, 2000, J BIOL CHEM, V275, P7668, DOI 10.1074/jbc.275.11.7668; Lee JY, 1996, J BIOL CHEM, V271, P13169, DOI 10.1074/jbc.271.22.13169; Li CY, 2010, CURR OPIN PHARMACOL, V10, P111, DOI 10.1016/j.coph.2009.11.009; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; Lin CL, 2007, J LIPID RES, V48, P2334, DOI 10.1194/jlr.M700128-JLR200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Rylander MN, 2005, ANN NY ACAD SCI, V1066, P222, DOI 10.1196/annals.1363.009; Sharma A, 2010, CANCER SCI, V101, P1186, DOI 10.1111/j.1349-7006.2010.01516.x; SISTONEN L, 1994, MOL CELL BIOL, V14, P2087, DOI 10.1128/MCB.14.3.2087; Wang OM, 2008, ENDOCRINOLOGY, V149, P672, DOI 10.1210/en.2007-0106; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200	26	18	20	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13096	10.1371/journal.pone.0013096	http://dx.doi.org/10.1371/journal.pone.0013096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957029	Green Submitted, Green Published, gold			2022-12-25	WOS:000282359300006
J	Weetman, D; Wilding, CS; Steen, K; Morgan, JC; Simard, F; Donnelly, MJ				Weetman, David; Wilding, Craig S.; Steen, Keith; Morgan, John C.; Simard, Frederic; Donnelly, Martin J.			Association Mapping of Insecticide Resistance in Wild Anopheles gambiae Populations: Major Variants Identified in a Low-Linkage Disequilbrium Genome	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; KNOCKDOWN RESISTANCE; MOLECULAR-FORMS; WIDE ASSOCIATION; KDR MUTATION; TREATED NETS; MALARIA; SPECIATION; COMPLEX; AFRICA	Background: Association studies are a promising way to uncover the genetic basis of complex traits in wild populations. Data on population stratification, linkage disequilibrium and distribution of variant effect-sizes for different trait-types are required to predict study success but are lacking for most taxa. We quantified and investigated the impacts of these key variables in a large-scale association study of a strongly selected trait of medical importance: pyrethroid resistance in the African malaria vector Anopheles gambiae. Methodology/Principal Findings: We genotyped approximate to 1500 resistance-phenotyped wild mosquitoes from Ghana and Cameroon using a 1536-SNP array enriched for candidate insecticide resistance gene SNPs. Three factors greatly impacted study power. (1) Population stratification, which was attributable to co-occurrence of molecular forms (M and S), and cryptic within-form stratification necessitating both a partitioned analysis and genomic control. (2) All SNPs of substantial effect (odds ratio, OR. 2) were rare (minor allele frequency, MAF, 0.05). (3) Linkage disequilibrium (LD) was very low throughout most of the genome. Nevertheless, locally high LD, consistent with a recent selective sweep, and uniformly high ORs in each subsample facilitated significant direct and indirect detection of the known insecticide target site mutation kdr L1014F (OR< 6; P, 10 26), but with resistance level modified by local haplotypic background. Conclusion: Primarily as a result of very low LD in wild A. Gambiae, LD-based association mapping is challenging, but is feasible at least for major effect variants, especially where LD is enhanced by selective sweeps. Such variants will be of greatest importance for predictive diagnostic screening.	[Weetman, David; Wilding, Craig S.; Steen, Keith; Morgan, John C.; Donnelly, Martin J.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Simard, Frederic] IRD, UR016, Lab Lutte Insectes Nuisibles LIN, Montpellier, France	Liverpool School of Tropical Medicine; University of Liverpool; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Weetman, D (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	dweetman@liv.ac.uk	SIMARD, Frederic/J-9489-2016; Wilding, Craig S/C-5500-2012; Frederic, SIMARD/AFV-5001-2022; Weetman, David/M-1261-2014	SIMARD, Frederic/0000-0002-2871-5329; Wilding, Craig S/0000-0001-5818-2706; Frederic, SIMARD/0000-0002-2871-5329; steen, keith/0000-0002-8933-8643; Weetman, David/0000-0002-5820-1388; Donnelly, Martin/0000-0001-5218-1497	NIAID NIH HHS [R01 AI082734, R01AI082734-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082734] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cohuet A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-227; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Czeher C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-189; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; Denholm I, 2002, SCIENCE, V297, P2222, DOI 10.1126/science.1077266; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Esnault C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001968; Etang J, 2009, MOL ECOL, V18, P3076, DOI 10.1111/j.1365-294X.2009.04256.x; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Felsenstein J, 2008, PHYLIP PHYLOGENY INF; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Soderlund DM, 2008, PEST MANAG SCI, V64, P610, DOI 10.1002/ps.1574; SOKAL RR, 1994, BIOMETRY; TABERNET PB, 2010, PLOS BIOL, V8; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Van Emden HF, 2004, PEST VECTOR CONTROL; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; White BJ, 2007, AM J TROP MED HYG, V76, P334; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; *WHO, 2008, WHOHTMGMP20081; Wilding CS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-320; Wilding CS, 2009, INSECT SCI, V16, P361, DOI 10.1111/j.1744-7917.2009.01260.x	57	48	50	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13140	10.1371/journal.pone.0013140	http://dx.doi.org/10.1371/journal.pone.0013140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20976111	Green Accepted, Green Published, gold			2022-12-25	WOS:000282359300028
J	Hale, M; Oyler, G; Swaminathan, S; Ahmed, SA				Hale, Martha; Oyler, George; Swaminathan, Subramanyam; Ahmed, S. Ashraf			Basic Tetrapeptides as Potent Intracellular Inhibitors of Type A Botulinum Neurotoxin Protease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; MAP KINASE PATHWAY; LIGHT-CHAIN; INTERNALIZATION MECHANISMS; PROTEOLYTIC ACTIVITY; SNAP-25 SUBSTRATE; PEPTIDE DRUGS; SEROTYPE-A; T-CELLS; IDENTIFICATION	Botulinum neurotoxins (BoNT) are the most potent of all toxins that cause flaccid muscle paralysis leading to death. They are also potential biothreat agents. A systematic investigation of various short peptide inhibitors of the BoNT protease domain with a 17-residue peptide substrate led to arginine-arginine-glycine-cysteine having a basic tetrapeptide structure as the most potent inhibitor. When assayed in the presence of dithiothreitol (DTT), the inhibitory effect was drastically reduced. Replacing the terminal cysteine with one hydrophobic residue eliminated the DTT effect but with two hydrophobic residues made the pentapeptide a poor inhibitor. Replacing the first arginine with cysteine or adding an additional cysteine at the N terminus did not improve inhibition. When assessed using mouse brain lysates, the tetrapeptides also inhibited BoNT/A cleavage of the endogenous SNAP-25. The peptides penetrated the neuronal cell lines, N2A and BE(2)-M17, without adversely affecting metabolic functions as measured by ATP production and P-38 phosphorylation. Biological activity of the peptides persisted within cultured chick motor neurons and rat and mouse cerebellar neurons for more than 40 h and inhibited BoNT/A protease action inside the neurons in a dose- and time-dependent fashion. Our results define a tetrapeptide as the smallest peptide inhibitor in the backdrop of a large substrate protein of 200+ amino acids having multiple interaction regions with its cognate enzyme. The inhibitors should also be valuable candidates for drug development.	USA, Med Res Inst Infect Dis, Dept Biochem & Cell Biol, Integrated Toxicol Div, Ft Detrick, MD 21702 USA; [Oyler, George] Synapt Res LLC, Baltimore, MD 21227 USA; [Swaminathan, Subramanyam] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Ahmed, SA (corresponding author), USAMRIID, Integrated Toxicol Div, 1425 Porter St, Ft Detrick, MD 21702 USA.	syed.ahmed@amedd.army.mil		Hale, Martha/0000-0002-1108-9202	Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense [CBS. MEDBIO.01.10.RD.002, JSTOCBD3.10012_06_RD_B]	Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense Grants CBS. MEDBIO.01.10.RD.002 and JSTOCBD3.10012_06_RD_B (to S.A.A.).	Agarwal R, 2008, J BIOL CHEM, V283, P25944, DOI 10.1074/jbc.M803756200; Ahmed SA, 2004, PROTEIN J, V23, P445; Ahmed SA, 2003, BIOCHEMISTRY-US, V42, P12539, DOI 10.1021/bi030062c; Ahmed SA, 2000, J PROTEIN CHEM, V19, P475, DOI 10.1023/A:1026549431380; Awasthi V, 2000, AM J PHYSIOL-LUNG C, V279, pL942, DOI 10.1152/ajplung.2000.279.5.L942; Ayoub M, 2006, CHIM OGGI, V24, P46; Boldt GE, 2006, ORG LETT, V8, P1729, DOI 10.1021/ol0603211; Boldt GE, 2006, J COMB CHEM, V8, P513, DOI 10.1021/cc060010h; Boldt GE, 2006, CHEM COMMUN, P3063, DOI 10.1039/b603099h; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Burnett JC, 2009, BIOORG MED CHEM LETT, V19, P5811, DOI 10.1016/j.bmcl.2009.01.111; Burnett JC, 2007, J MED CHEM, V50, P2127, DOI 10.1021/jm061446e; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Burnett JC, 2003, BIOCHEM BIOPH RES CO, V310, P84, DOI 10.1016/j.bbrc.2003.08.112; Capkova K, 2007, BIOORG MED CHEM LETT, V17, P6463, DOI 10.1016/j.bmcl.2007.09.103; Capkova K, 2009, TOXICON, V54, P575, DOI 10.1016/j.toxicon.2009.03.016; Doherty DG, 1999, J IMMUNOL, V163, P2314; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; FORAN P, 1994, BIOCHEMISTRY-US, V33, P15365, DOI 10.1021/bi00255a017; Gilsdorf J, 2006, PROTEIN EXPRES PURIF, V46, P256, DOI 10.1016/j.pep.2005.09.024; Goldstein DM, 2005, CURR TOP MED CHEM, V5, P1017, DOI 10.2174/1568026054985939; Gul N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012872; Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003; Jensen MJ, 2003, TOXICON, V41, P691, DOI 10.1016/S0041-0101(03)00042-4; Kumaran D, 2008, J BIOL CHEM, V283, P18883, DOI 10.1074/jbc.M801240200; Kumaran D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000165; Kuo CL, 2010, TOXICON, V55, P619, DOI 10.1016/j.toxicon.2009.10.019; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lee SY, 2005, MOL BRAIN RES, V140, P45, DOI 10.1016/j.molbrainres.2005.07.009; LUDIVICO M, 2006, 43 ANN M INT BOT RES, P67; Ludivico M., 2009, BOTULINUM J, V1, P297; MATHEWS CK, 1990, BIOCHEMISTRY-US, P382; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007730; Pires-Alves M, 2009, TOXICON, V53, P392, DOI 10.1016/j.toxicon.2008.12.016; Rowe B, 2010, ANAL BIOCHEM, V396, P188, DOI 10.1016/j.ab.2009.09.034; Roxas-Duncan V, 2009, ANTIMICROB AGENTS CH, V53, P3478, DOI 10.1128/AAC.00141-09; Saikh KU, 2002, IMMUNOLOGY, V106, P363, DOI 10.1046/j.1365-2567.2002.01446.x; Schmidt JJ, 2005, BIOCHEMISTRY-US, V44, P4067, DOI 10.1021/bi0477642; Schmidt JJ, 1995, J PROTEIN CHEM, V14, P703, DOI 10.1007/BF01886909; Schmidt JJ, 2002, FEBS LETT, V532, P423, DOI 10.1016/S0014-5793(02)03738-9; Schmidt JJ, 1998, FEBS LETT, V435, P61, DOI 10.1016/S0014-5793(98)01041-2; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; Sheridan RE, 1997, TOXICON, V35, P1439, DOI 10.1016/S0041-0101(96)00208-5; SHOEMAKER B, 2009, NIAID FOOD WATERBORN; Sikorra S, 2006, J MOL BIOL, V357, P574, DOI 10.1016/j.jmb.2005.12.075; Silvaggi NR, 2008, BIOCHEMISTRY-US, V47, P5736, DOI 10.1021/bi8001067; Silvaggi NR, 2007, CHEM BIOL, V14, P533, DOI 10.1016/j.chembiol.2007.03.014; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Tang J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000761; Tonello F, 1996, ADV EXP MED BIOL, V389, P251; Toth SI, 2009, J PHARM SCI-US, V98, P3302, DOI 10.1002/jps.21676; Vylkova S, 2007, PURINERG SIGNAL, V3, P91, DOI 10.1007/s11302-006-9040-0; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zuniga JE, 2008, STRUCTURE, V16, P1588, DOI 10.1016/j.str.2008.07.011; 2005, CHEM ENG NEWS, V83, P17	59	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1802	1811		10.1074/jbc.M110.146464	http://dx.doi.org/10.1074/jbc.M110.146464			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	20961849	hybrid, Green Published			2022-12-25	WOS:000286191500020
J	Kim, HJ; Lv, P; Sihn, CR; Yamoah, EN				Kim, Hyo Jeong; Lv, Ping; Sihn, Choong-Ryoul; Yamoah, Ebenezer N.			Cellular and Molecular Mechanisms of Autosomal Dominant Form of Progressive Hearing Loss, DFNA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR CELL; POTASSIUM CHANNELS; KCNQ4 GENE; ROMANO-WARD; PORE-REGION; INNER-EAR; HOT-SPOT; SALICYLATE; MUTATIONS; EXPRESSION	Despite advances in identifying deafness genes, determination of the underlying cellular and functional mechanisms for auditory diseases remains a challenge. Mutations of the human K+ channel hKv7.4 lead to post-lingual progressive hearing loss (DFNA2), which affects world-wide population with diverse racial backgrounds. Here, we have generated the spectrum of point mutations in the hKv7.4 that have been identified as diseased mutants. We report that expression of five point mutations in the pore region, namely L274H, W276S, L281S, G285C, and G296S, as well as the C-terminal mutant G321S in the heterologous expression system, yielded nonfunctional channels because of endoplasmic reticulum retention of the mutant channels. We mimicked the dominant diseased conditions by co-expressing the wild-type and mutant channels. As compared with expression of wild-type channel alone, the blend of wild-type and mutant channel subunits resulted in reduced currents. Moreover, the combinatorial ratios of wild type: mutant and the ensuing current magnitude could not be explained by the predictions of a tetrameric channel and a dominant negative effect of the mutant subunits. The results can be explained by the dependence of cell surface expression of the mutant on the wild-type subunit. Surprisingly, a transmembrane mutation F182L, which has been identified in a pre-lingual progressive hearing loss patient in Taiwan, yielded cell surface expression and functional features that were similar to that of the wild type, suggesting that this mutation may represent redundant polymorphism. Collectively, these findings provide traces of the cellular mechanisms for DFNA2.	[Kim, Hyo Jeong; Lv, Ping; Sihn, Choong-Ryoul; Yamoah, Ebenezer N.] Univ Calif Davis, Dept Anesthesiol & Pain Med, Program Commun Sci, Sch Med, Davis, CA 95618 USA	University of California System; University of California Davis	Yamoah, EN (corresponding author), Univ Calif Davis, Dept Anesthesiol & Pain Med, Program Commun Sci, Sch Med, 1515 Newton Ct, Davis, CA 95618 USA.	enyamoah@ucdavis.edu			National Institutes of Health, NIDCD [DC010386, DC007592]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010386, R01DC007592] Funding Source: NIH RePORTER	National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants through DC010386 and DC007592 the NIDCD (to E.N.Y.).	Abbott GW, 2002, FASEB J, V16, DOI 10.1096/fj.01-0520hyp; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Akita J, 2001, J HUM GENET, V46, P355, DOI 10.1007/s100380170053; Beisel KW, 2005, J NEUROSCI, V25, P9285, DOI 10.1523/JNEUROSCI.2110-05.2005; Campbell CA, 2010, AM J MED GENET A, V152A, P67, DOI 10.1002/ajmg.a.33114; Casimiro MC, 2004, GENOMICS, V84, P555, DOI 10.1016/j.ygeno.2004.06.007; Cazals Y, 2000, PROG NEUROBIOL, V62, P583, DOI 10.1016/S0301-0082(00)00027-7; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; Cooper EC, 2001, EPILEPSIA, V42, P49, DOI 10.1046/j.1528-1157.2001.0420s5049.x; COUCKE P, 1994, NEW ENGL J MED, V331, P425, DOI 10.1056/NEJM199408183310702; Coucke PJ, 1999, HUM MOL GENET, V8, P1321, DOI 10.1093/hmg/8.7.1321; Davis H, 1972, Ann Otol Rhinol Laryngol, V81, P750; Diaz RC, 2007, JARO-J ASSOC RES OTO, V8, P422, DOI 10.1007/s10162-007-0089-4; Ehrlich JR, 2004, J BIOL CHEM, V279, P1233, DOI 10.1074/jbc.M309087200; Guitton MJ, 2003, J NEUROSCI, V23, P3944; Hallworth R, 1997, HEARING RES, V114, P204, DOI 10.1016/S0378-5955(97)00167-6; Holt JR, 2007, J NEUROSCI, V27, P8940, DOI 10.1523/JNEUROSCI.2085-07.2007; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Kakehata S, 1996, J NEUROSCI, V16, P4881; Kamada F, 2006, J HUM GENET, V51, P455, DOI 10.1007/s10038-006-0384-7; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lue AJC, 1999, HEARING RES, V135, P163, DOI 10.1016/S0378-5955(99)00102-1; Lv P, 2010, J BIOL CHEM, V285, P34699, DOI 10.1074/jbc.M110.136192; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Mencia A, 2008, HUM GENET, V123, P41, DOI 10.1007/s00439-007-0447-7; Ohyama H, 2001, PFLUG ARCH EUR J PHY, V442, P329, DOI 10.1007/s004240100547; Oliver D, 2003, J NEUROSCI, V23, P2141; Ruel J, 2008, J NEUROSCI, V28, P7313, DOI 10.1523/JNEUROSCI.5335-07.2008; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Su CC, 2007, AUDIOL NEURO-OTOL, V12, P20, DOI 10.1159/000096154; Talebizadeh Z, 1999, HUM MUTAT, V14, P493, DOI 10.1002/(SICI)1098-1004(199912)14:6<493::AID-HUMU8>3.0.CO;2-P; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Topsakal V, 2005, OTOL NEUROTOL, V26, P52, DOI 10.1097/00129492-200501000-00009; Van Camp G, 2002, HUM MUTAT, V20, P15, DOI 10.1002/humu.10096; Van Hauwe P, 2000, AM J MED GENET, V93, P184, DOI 10.1002/1096-8628(20000731)93:3<184::AID-AJMG4>3.0.CO;2-5; VanCamp G, 1997, GENOMICS, V41, P70, DOI 10.1006/geno.1997.4624; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wu T, 2010, J NEUROPHYSIOL, V103, P1969, DOI 10.1152/jn.01057.2009; Xu TH, 2007, J BIOL CHEM, V282, P23899, DOI 10.1074/jbc.M702108200	43	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1517	1527		10.1074/jbc.M110.179010	http://dx.doi.org/10.1074/jbc.M110.179010			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20966080	hybrid, Green Published			2022-12-25	WOS:000286005000064
J	Zou, XQ; Gao, YG; Ruvolo, VR; Gardner, TL; Ruvolo, PP; Brown, RE				Zou, Xianqiong; Gao, Yongguang; Ruvolo, Vivian R.; Gardner, Tawnya L.; Ruvolo, Peter P.; Brown, Rhoderick E.			Human Glycolipid Transfer Protein Gene (GLTP) Expression Is Regulated by Sp1 and Sp3 INVOLVEMENT OF THE BIOACTIVE SPHINGOLIPID CERAMIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TRANSCRIPTASE PROMOTER; GLUCOSYLCERAMIDE SYNTHASE; DIHYDROFOLATE-REDUCTASE; DOWN-REGULATION; CELL; BINDING; FAMILY; MECHANISMS; GLYCOSPHINGOLIPIDS; AMPLIFICATION	Glycolipid transfer protein (GLTP) accelerates glycolipid intermembrane transfer via a unique lipid transfer/binding fold (GLTP fold) that defines the GLTP superfamily and is the prototype for functional GLTP-like domains in larger proteins, i.e. FAPP2. Human GLTP is encoded by the single-copy GLTP gene on chromosome 12 (12q24.11 locus), but regulation of GLTP gene expression remains completely unexplored. Herein, the ability of glycosphingolipids (and their sphingolipid metabolites) to regulate the transcriptional expression of GLTP via its promoter has been evaluated. Using luciferase and GFP reporters in concert with deletion mutants, the constitutive and basal (225 bp; similar to 78% G + C) human GLTP promoters have been defined along with adjacent regulatory elements. Despite high G + C content, translational regulation was not evident by the mammalian target of rapamycin pathway. Four GC-boxes were shown to be functional Sp1/Sp3 transcription factor binding sites. Mutation of one GC-box was particularly detrimental to GLTP transcriptional activity. Sp1/Sp3 RNA silencing and mithramycin A treatment significantly inhibited GLTP promoter activity. Among tested sphingolipid analogs of glucosylceramide, sulfatide, ganglioside GM1, ceramide 1-phosphate, sphingosine 1-phosphate, dihydroceramide, sphingosine, only ceramide, a nonglycosylated precursor metabolite unable to bind to GLTP protein, induced GLTP promoter activity and raised transcript levels in vivo. Ceramide treatment partially blocked promoter activity decreases induced by Sp1/Sp3 knockdown. Ceramide treatment also altered the in vivo binding affinity of Sp1 and Sp3 for the GLTP promoter and decreased Sp3 acetylation. This study represents the first characterization of any Gltp gene promoter and links human GLTP expression to sphingolipid homeostasis through ceramide.	[Zou, Xianqiong; Gao, Yongguang; Ruvolo, Vivian R.; Gardner, Tawnya L.; Ruvolo, Peter P.; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Brown, RE (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	reb@umn.edu	Gao, Yongguang/B-8546-2012	Gao, Yongguang/0000-0002-9359-4252; Brown, Rhoderick/0000-0002-7337-3604	National Institutes of Health/NIGMS [45928]; National Institutes of Health/NCI [121493]; Hormel Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hormel Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health/NIGMS Grant 45928 and National Institutes of Health/NCI Grant 121493. This work was also supported by The Hormel Foundation.	ABE A, 1995, J LIPID RES, V36, P611; Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; Alesse E, 1998, CELL DEATH DIFFER, V5, P381, DOI 10.1038/sj.cdd.4400358; Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Braun H, 2001, NUCLEIC ACIDS RES, V29, P4994, DOI 10.1093/nar/29.24.4994; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Chakrabarti R, 2001, GENE, V274, P293, DOI 10.1016/S0378-1119(01)00621-7; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Debret R, 2008, BBA-MOL CELL RES, V1783, P1718, DOI 10.1016/j.bbamcr.2008.06.001; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Gross P, 2006, BIOCHEM SOC SYMP, V73, P225; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lin X, 2000, J BIOL CHEM, V275, P5104, DOI 10.1074/jbc.275.7.5104; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomize AL, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-44; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; MARUYAMA K, 1994, GENE, V138, P171; Merrill AH, 2001, ENVIRON HEALTH PERSP, V109, P283, DOI 10.2307/3435020; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Norris KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe76; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Rao CS, 2005, BIOPHYS J, V89, P4017, DOI 10.1529/biophysj.105.070631; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Sparkman L, 2006, AM J PHYSIOL-LUNG C, V290, pL351, DOI 10.1152/ajplung.00275.2005; Stockmann-Juvala H, 2008, HUM EXP TOXICOL, V27, P799, DOI 10.1177/0960327108099525; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Swingler TE, 2010, BIOCHEM J, V427, P391, DOI 10.1042/BJ20091798; Thomas K, 2007, MOL CELL ENDOCRINOL, V270, P1, DOI 10.1016/j.mce.2007.03.001; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Tuuf J., 2007, BIOCHIM BIOPHYS ACTA, V1711, P1353; Uchida Y, 2004, CANCER RES, V64, P6271, DOI 10.1158/0008-5472.CAN-03-1476; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; WANG E, 1991, J BIOL CHEM, V266, P14486; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Wooten LG, 2005, J BIOL CHEM, V280, P28867, DOI 10.1074/jbc.M413444200; Wooten-Blanks LG, 2007, FASEB J, V21, P3386, DOI 10.1096/fj.07-8621com; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhao CT, 2005, DEV GROWTH DIFFER, V47, P201; Zou XQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-72	60	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1301	1311		10.1074/jbc.M110.127837	http://dx.doi.org/10.1074/jbc.M110.127837			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20974858	hybrid, Green Published			2022-12-25	WOS:000286005000042
J	Sathish, N; Zhu, FX; Golub, EE; Liang, QM; Yuan, Y				Sathish, Narayanan; Zhu, Fan Xiu; Golub, Ellis E.; Liang, Qiming; Yuan, Yan			Mechanisms of Autoinhibition of IRF-7 and a Probable Model for Inactivation of IRF-7 by Kaposi's Sarcoma-associated Herpesvirus Protein ORF45	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR-7; POSITIVE FEEDBACK; MEDIATED DEGRADATION; PATTERN-RECOGNITION; CRYSTAL-STRUCTURE; I INTERFERON; DNA-BINDING; INDUCTION; LOCALIZATION; DISTINCT	IRF-7 is the master regulator of type I interferon-dependent immune responses controlling both innate and adaptive immunity. Given the significance of IRF-7 in the induction of immune responses, many viruses have developed strategies to inhibit its activity to evade or antagonize host antiviral responses. We previously demonstrated that ORF45, a KSHV immediate-early protein as well as a tegument protein of virions, interacts with IRF-7 and inhibits virus-mediated type I interferon induction by blocking IRF-7 phosphorylation and nuclear translocation (Zhu, F. X., King, S. M., Smith, E. J., Levy, D. E., and Yuan, Y. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 5573-5578). In this report, we sought to reveal the mechanism underlying the ORF45-mediated inactivation of IRF-7. We found that ORF45 interacts with the inhibitory domain of IRF-7. The most striking feature in the IRF-7 inhibitory domain is two alpha-helices H3 and H4 that contain many hydrophobic residues and two beta-sheets located between the helices that are also very hydrophobic. These hydrophobic subdomains mediate intramolecular interactions that keep the molecule in a closed (inactive) form. Mutagenesis studies confirm the contribution of the hydrophobic helices and sheets to the autoinhibition of IRF-7 in the absence of viral signal. The binding of ORF45 to the critical domain of IRF-7 leads to a hypothesis that ORF45 may maintain the IRF-7 molecule in the closed form and prevent it from being activated in response to viral infection.	[Sathish, Narayanan; Yuan, Yan] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Golub, Ellis E.] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA; [Zhu, Fan Xiu; Liang, Qiming] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	University of Pennsylvania; University of Pennsylvania; State University System of Florida; Florida State University	Yuan, Y (corresponding author), 240 S 40th St, Philadelphia, PA 19104 USA.	yuan2@pobox.upenn.edu			National Institutes of Health [R01CA86839, R01DE016680]; NATIONAL CANCER INSTITUTE [R01CA086839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA86839 (to Y. Y.) and R01DE016680 (to F. X. Z.).	Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hahn AM, 2005, J VIROL, V79, P10040, DOI 10.1128/JVI.79.15.10040-10052.2005; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kumar KP, 2000, MOL CELL BIOL, V20, P4159, DOI 10.1128/MCB.20.11.4159-4168.2000; Lau JF, 2000, P NATL ACAD SCI USA, V97, P7278, DOI 10.1073/pnas.97.13.7278; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Rozen R, 2008, J VIROL, V82, P4742, DOI 10.1128/JVI.02745-07; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Schaper F, 1998, BIOCHEM J, V335, P147, DOI 10.1042/bj3350147; Servant MJ, 2002, J INTERF CYTOK RES, V22, P49, DOI 10.1089/107999002753452656; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; Solis M, 2006, BIOCHEM PHARMACOL, V72, P1469, DOI 10.1016/j.bcp.2006.06.002; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Wu L, 2009, J VIROL, V83, P1140, DOI 10.1128/JVI.00602-08; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhang LW, 2002, J INTERF CYTOK RES, V22, P95, DOI 10.1089/107999002753452700; Zhu FX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010573; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	43	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					746	756		10.1074/jbc.M110.150920	http://dx.doi.org/10.1074/jbc.M110.150920			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980251	hybrid, Green Published			2022-12-25	WOS:000285782800074
J	Wei, RR; Hughes, H; Boucher, S; Bird, JJ; Guziewicz, N; Van Patten, SM; Qiu, HW; Pan, CQ; Edmunds, T				Wei, Ronnie R.; Hughes, Heather; Boucher, Susan; Bird, Julie J.; Guziewicz, Nicholas; Van Patten, Scott M.; Qiu, Huawei; Pan, Clark Qun; Edmunds, Tim			X-ray and Biochemical Analysis of N370S Mutant Human Acid beta-Glucosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; GAUCHER-DISEASE TYPE-1; IMINOSUGAR ISOFAGOMINE; CHEMICAL CHAPERONES; CATALYTIC-ACTIVITY; DEFECTIVE ENZYME; GLUCOCEREBROSIDASE; MUTATIONS; FIBROBLASTS; DEFICIENCY	Gaucher disease is caused by mutations in the enzyme acid beta-glucosidase (GCase), the most common of which is the substitution of serine for asparagine at residue 370 (N370S). To characterize the nature of this mutation, we expressed human N370S GCase in insect cells and compared the x-ray structure and biochemical properties of the purified protein with that of the recombinant human GCase (imiglucerase, Cerezyme (R)). The x-ray structure of N370S mutant acid beta-glucosidase at acidic and neutral pH values indicates that the overall folding of the N370S mutant is identical to that of recombinant GCase. Subtle differences were observed in the conformation of a flexible loop at the active site and in the hydrogen bonding ability of aromatic residues on this loop with residue 370 and the catalytic residues Glu-235 and Glu-340. Circular dichroism spectroscopy showed a pH-dependent change in the environment of tryptophan residues in imiglucerase that is absent in N370S GCase. The mutant protein was catalytically deficient with reduced V-max and increased Km values for the substrate p-nitrophenyl-beta-D-glucopyranoside and reduced sensitivity to competitive inhibitors. N370S GCase was more stable to thermal denaturation and had an increased lysosomal half-life compared with imiglucerase following uptake into macrophages. The competitive inhibitor N-(n-nonyl) deoxynojirimycin increased lysosomal levels of both N370S and imiglucerase 2-3-fold by reducing lysosomal degradation. Overall, these data indicate that the N370S mutation results in a normally folded but less flexible protein with reduced catalytic activity compared with imiglucerase.	[Wei, Ronnie R.; Hughes, Heather; Boucher, Susan; Bird, Julie J.; Guziewicz, Nicholas; Van Patten, Scott M.; Qiu, Huawei; Pan, Clark Qun; Edmunds, Tim] Genzyme Corp, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation	Wei, RR (corresponding author), Genzyme Corp, 1 Mt Rd, Framingham, MA 01701 USA.	ronnie.wei@genzyme.com		Jaworski, Julie/0000-0002-0633-287X				BASU A, 1985, J BIOL CHEM, V260, P3067; BERGMANN JE, 1989, AM J HUM GENET, V44, P741; Beutler E, 2005, BLOOD CELL MOL DIS, V35, P355, DOI 10.1016/j.bcmd.2005.07.005; BLONDER E, 1976, BIOCHIM BIOPHYS ACTA, V431, P45, DOI 10.1016/0005-2760(76)90258-7; BRADY RO, 1966, J CLIN INVEST, V45, P1112, DOI 10.1172/JCI105417; Brumshtein B, 2007, J BIOL CHEM, V282, P29052, DOI 10.1074/jbc.M705005200; Brumshtein B, 2006, ACTA CRYSTALLOGR D, V62, P1458, DOI 10.1107/S0907444906038303; Brumshtein B, 2010, GLYCOBIOLOGY, V20, P24, DOI 10.1093/glycob/cwp138; DALE GL, 1976, BIOCHEM BIOPH RES CO, V71, P1048, DOI 10.1016/0006-291X(76)90760-9; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Grabowski GA, 2006, METABOLIC MOL BASES; GRACE ME, 1990, J BIOL CHEM, V265, P6827; GRACE ME, 1994, J BIOL CHEM, V269, P2283; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Lieberman RL, 2009, BIOCHEMISTRY-US, V48, P4816, DOI 10.1021/bi9002265; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; Liou B, 2009, MOL GENET METAB, V97, P65, DOI 10.1016/j.ymgme.2009.01.006; Michelin K, 2005, CLIN CHIM ACTA, V362, P101, DOI 10.1016/j.cccn.2005.06.010; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHASHI T, 1991, J BIOL CHEM, V266, P3661; PETERS SP, 1977, J BIOL CHEM, V252, P563; Piepenhagen PA, 2010, MICROSC RES TECHNIQ, V73, P694, DOI 10.1002/jemt.20810; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Salvioli R, 2005, BIOCHEM J, V390, P95, DOI 10.1042/BJ20050325; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schmitz M, 2005, INT J BIOCHEM CELL B, V37, P2310, DOI 10.1016/j.biocel.2005.05.008; Shen JS, 2008, BIOCHEM BIOPH RES CO, V369, P1071, DOI 10.1016/j.bbrc.2008.02.125; Steet R, 2007, BIOCHEM PHARMACOL, V73, P1376, DOI 10.1016/j.bcp.2006.12.015; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684	37	51	51	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					299	308		10.1074/jbc.M110.150433	http://dx.doi.org/10.1074/jbc.M110.150433			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980263	hybrid, Green Published			2022-12-25	WOS:000285782800033
J	Zeng, ZH; Cortes-Ledesma, F; El Khamisy, SF; Caldecott, KW				Zeng, Zhihong; Cortes-Ledesma, Felipe; El Khamisy, Sherif F.; Caldecott, Keith W.			TDP2/TTRAP Is the Major 5 '-Tyrosyl DNA Phosphodiesterase Activity in Vertebrate Cells and Is Critical for Cellular Resistance to Topoisomerase II-induced DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED FACTORS; TTRAP; PROTEIN; REPAIR; BREAKS; BETA; CD40	Topoisomerase II (Top2) activity involves an intermediate in which the topoisomerase is covalently bound to a DNA double-strand break via a 5' -phosphotyrosyl bond. Although these intermediates are normally transient, they can be stabilized by antitumor agents that act as Top2 "poisons," resulting in the induction of cytotoxic double-strand breaks, and they are implicated in the formation of site-specific translocations that are commonly associated with cancer. Recently, we revealed that TRAF and TNF receptor-associated protein (TTRAP) is a 5' -tyrosyl DNA phosphodiesterase (5' -TDP) that can cleave 5' -phosphotyrosyl bonds, and we denoted this protein tyrosyl DNA phosphodiesterase-2 (TDP2). Here, we have generated TDP2-deleted DT40 cells, and we show that TDP2 is the major if not the only 5' -TDP activity present in vertebrate cells. We also show that TDP2-deleted DT40 cells are highly sensitive to the anticancer Top2 poison, etoposide, but are not hypersensitive to the Top1 poison camptothecin or the DNA-alkyating agent methyl methanesulfonate. These data identify an important mechanism for resistance to Top2-induced chromosome breakage and raise the possibility that TDP2 is a significant factor in cancer development and treatment.	[Zeng, Zhihong; Cortes-Ledesma, Felipe; El Khamisy, Sherif F.; Caldecott, Keith W.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Cortes-Ledesma, F (corresponding author), Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat, Ave Americo Vespucio S-N, Seville 41092, Spain.	felipe.cortes@cabimer.es; s.f.el-khamisy@sussex.ac.uk; k.w.caldecott@sussex.ac.uk	Ledesma, Felipe Cortés/F-4803-2014; Zeng, Zhihong/HEV-8703-2022; Caldecott, Keith/S-4245-2019	Ledesma, Felipe Cortés/0000-0002-0440-6783; Caldecott, Keith/0000-0003-4255-9016; , Sherif/0000-0003-2721-7763	Medical Research Council [G0600776, G0901606]; Marie Curie IntraEuropean Fellowship [2007-2-1-IEF-221222]; Wellcome Trust [085284]; MRC [G0600776, G0901606] Funding Source: UKRI; Cancer Research UK [13078] Funding Source: researchfish; Medical Research Council [G0801130B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie IntraEuropean Fellowship(European Commission); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Grants G0600776 and G0901606 (to K. W. C.), Marie Curie IntraEuropean Fellowship 2007-2-1-IEF-221222 (to F. C.-L.), and a Wellcome Trust grant (085284) (to S. F. E. K.).	Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Esguerra CV, 2007, DEVELOPMENT, V134, P4381, DOI 10.1242/dev.000026; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Rodrigues-Lima F, 2001, BIOCHEM BIOPH RES CO, V285, P1274, DOI 10.1006/bbrc.2001.5328; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wilson-Sali T, 2002, P NATL ACAD SCI USA, V99, P7974, DOI 10.1073/pnas.122007999; Wilson-Sali T, 2002, J BIOL CHEM, V277, P26865, DOI 10.1074/jbc.M204641200; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169	17	117	121	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					403	409		10.1074/jbc.M110.181016	http://dx.doi.org/10.1074/jbc.M110.181016			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21030584	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000285782800043
J	Frezzetti, D; De Menna, M; Zoppoli, P; Guerra, C; Ferraro, A; Bello, AM; De Luca, P; Calabrese, C; Fusco, A; Ceccarelli, M; Zollo, M; Barbacid, M; Di Lauro, R; De Vita, G				Frezzetti, D.; De Menna, M.; Zoppoli, P.; Guerra, C.; Ferraro, A.; Bello, A. M.; De Luca, P.; Calabrese, C.; Fusco, A.; Ceccarelli, M.; Zollo, M.; Barbacid, M.; Di Lauro, R.; De Vita, G.			Upregulation of miR-21 by Ras in vivo and its role in tumor growth	ONCOGENE			English	Article						microRNA; miR-21; Ras; anaplastic thyroid carcinoma; non-small-cell lung cancer	LUNG-CANCER; MICRORNA GENES; DNA-DAMAGE; CELL-CYCLE; INDUCTION; PROFILES; AP-1; RNA	miR-21 is a microRNA (miRNA) frequently overexpressed in human cancers. Here we show that miR-21 is upregulated both in vitro and in vivo by oncogenic Ras, thus linking this miRNA to one of the most frequently activated oncogenes in human cancers. Ras regulation of miR-21 occurs with a delayed kinetic and requires at least two Ras downstream pathways. A screen of human thyroid cancers and non-small-cell lung cancers for the expression of miR-21 reveals that it is overexpressed mainly in anaplastic thyroid carcinomas, the most aggressive form of thyroid cancer, whereas in lung its overexpression appears to be inversely correlated with tumor progression. We also show that a LNA directed against miR-21 slows down tumor growth in mice. Consistently, a search for mRNAs downregulated by miR-21 shows an enrichment for mRNAs encoding cell cycle checkpoints regulators, suggesting an important role for miR-21 in oncogenic Ras-induced cell proliferation. Oncogene (2011) 30, 275-286; doi:10.1038/onc.2010.416; published online 18 October 2010	[Frezzetti, D.; Fusco, A.; Di Lauro, R.; De Vita, G.] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Frezzetti, D.; Zoppoli, P.; De Luca, P.; Ceccarelli, M.] IRGS Biogem Scarl, Ariano Irpino, Italy; [De Menna, M.] European Sch Mol Med, SEMM, Naples, Italy; [De Menna, M.; Ferraro, A.; Bello, A. M.; Zollo, M.] Ctr Ingn Genet & Biotecnol Avanzate, CEINGE, Naples, Italy; [Zoppoli, P.; Ceccarelli, M.] Univ Sannio, Dept Biol & Environm Studies, Benevento, Italy; [Guerra, C.; Barbacid, M.] CNIO, Mol Oncol Program, Madrid, Spain; [Ferraro, A.; Fusco, A.] Naples Oncogenom Ctr, NOGEC, Naples, Italy; [De Luca, P.] Stn Zool Anton Dohrn, Naples, Italy; [Calabrese, C.] Univ Naples 2, Monaldi Hosp, Dept Cardiothorac & Resp Sci, Naples, Italy; [Fusco, A.] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Zollo, M.] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Sannio; Centro Nacional de Investigaciones Oncologicas (CNIO); Stazione Zoologica Anton Dohrn di Napoli; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	De Vita, G (corresponding author), Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Via Pansini 5, I-80131 Naples, Italy.	rdilauro@unina.it; gdevita@unina.it	Ceccarelli, Michele/AGP-1739-2022; De Luca, Pasquale/AAL-5673-2021; De Vita, Gabriella/H-4422-2011; Zoppoli, Pietro/J-9954-2018; Guerra, Carmen/K-5852-2014; Ferraro, Angelo/A-4172-2014; Frezzetti, Daniela/AAI-2410-2019; Bello, Anna Maria/AAA-9139-2020; Ferraro, Angelo/H-3193-2019; Di Lauro, Roberto/A-2746-2012	De Luca, Pasquale/0000-0003-4289-6784; De Vita, Gabriella/0000-0002-7302-1174; Zoppoli, Pietro/0000-0002-7860-9655; Ferraro, Angelo/0000-0002-2044-7569; Frezzetti, Daniela/0000-0002-7500-5506; Bello, Anna Maria/0000-0001-6975-3340; Ferraro, Angelo/0000-0002-2044-7569; Di Lauro, Roberto/0000-0001-9493-3036; Fusco, Alfredo/0000-0003-3332-5197; Ceccarelli, Michele/0000-0002-4702-6617; Guerra, Carmen/0000-0002-3891-046X; Calabrese, Cecilia/0000-0003-4293-4461; De Menna, Marta/0000-0002-6306-3485	EU [LSHG-CT-2006-037900]; Associazione Italiana per la Ricerca sul Cancro (AIRC); AIRC, EUFP7 Tumic	EU(European Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC, EUFP7 Tumic(Fondazione AIRC per la ricerca sul cancro)	We thank Pietro Carotenuto (CROM, Centro Ricerche Oncologiche Mercogliano, Italy), Ilaria Pedicelli (Department of Cardio-Thoracic and Respiratory Sciences, Second University of Naples, Monaldi Hospital, Naples, Italy) and Nicolina De Rosa (Department of Pathology, Monaldi Hospital, Naples, Italy) for collection and technical help in the analysis of lung cancer samples. This work was supported by EU-Project-SIROCCO (Grant LSHG-CT-2006-037900), Associazione Italiana per la Ricerca sul Cancro (AIRC) to RDL and AIRC, EUFP7 Tumic to MZ.	Abulaiti A, 2006, CANCER RES, V66, P10505, DOI 10.1158/0008-5472.CAN-06-2351; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Knauf JA, 2006, J BIOL CHEM, V281, P3800, DOI 10.1074/jbc.M511690200; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Martinsson-Ahlzen HS, 2008, MOL CELL BIOL, V28, P5698, DOI 10.1128/MCB.01833-07; Miller KA, 2009, CANCER RES, V69, P3689, DOI 10.1158/0008-5472.CAN-09-0024; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	33	105	118	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	3					275	286		10.1038/onc.2010.416	http://dx.doi.org/10.1038/onc.2010.416			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709DY	20956945				2022-12-25	WOS:000286418800003
J	Nunez, A; Franco, A; Soto, T; Vicente, J; Gacto, M; Cansado, J				Nunez, Andres; Franco, Alejandro; Soto, Teresa; Vicente, Jero; Gacto, Mariano; Cansado, Jose			Fission Yeast Receptor of Activated C Kinase (RACK1) Ortholog Cpc2 Regulates Mitotic Commitment through Wee1 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; SCHIZOSACCHAROMYCES-POMBE; CELL-CYCLE; EUKARYOTIC TRANSLATION; NEGATIVE REGULATION; SCAFFOLD PROTEIN; TYROSINE KINASE; MITOSIS; STRESS; PROGRESSION	In the fission yeast Schizosaccharomyces pombe, Wee1-dependent inhibitory phosphorylation of the highly conserved Cdc2/Cdk1 kinase determines the mitotic onset when cells have reached a defined size. The receptor of activated C kinase (RACK1) is a scaffolding protein strongly conserved among eukaryotes which binds to other proteins to regulate multiple processes in mammalian cells, including the modulation of cell cycle progression during G1/S transition. We have recently described that Cpc2, the fission yeast ortholog to RACK1, controls from the ribosome the activation of MAPK cascades and the cellular defense against oxidative stress by positively regulating the translation of specific genes whose products participate in the above processes. Intriguingly, mutants lacking Cpc2 display an increased cell size at division, suggesting the existence of a specific cell cycle defect at the G2/M transition. In this work we show that protein levels of Wee1 mitotic inhibitor are increased in cells devoid of Cpc2, whereas the levels of Cdr2, a Wee1 inhibitor, are down-regulated in the above mutant. On the contrary, the kinetics of G1/S transition was virtually identical both in control and Cpc2-less strains. Thus, our results suggest that in fission yeast Cpc2/RACK1 positively regulates from the ribosome the mitotic onset by modulating both the protein levels and the activity of Wee1. This novel mechanism of translational control of cell cycle progression might be conserved in higher eukaryotes.	[Nunez, Andres; Franco, Alejandro; Soto, Teresa; Vicente, Jero; Gacto, Mariano; Cansado, Jose] Univ Murcia, Yeast Physiol Grp, Dept Genet & Microbiol, Fac Biol, E-30071 Murcia, Spain	University of Murcia	Cansado, J (corresponding author), Univ Murcia, Yeast Physiol Grp, Dept Genet & Microbiol, Fac Biol, E-30071 Murcia, Spain.	jcansado@um.es	Pino, Teresa Soto/AAC-6096-2020; Cansado, Jose/K-5212-2014; Nunez-Hernandez, Andres/AAZ-3900-2020; Franco, Alejandro/ABG-6823-2020; Vicente-Soler, Jerónima/ABF-6293-2020; Cansado, Jose/ABC-6872-2020	Pino, Teresa Soto/0000-0003-2965-318X; Nunez-Hernandez, Andres/0000-0002-0781-0001; Franco, Alejandro/0000-0001-7461-3414; Vicente-Soler, Jerónima/0000-0001-8759-6545; Cansado, Jose/0000-0002-2342-8152	MICINN [BFU2008-01653]; Fundacion Seneca (Region de Murcia), Spain [08725/PI/08]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Seneca (Region de Murcia), Spain(Fundacion Seneca)	This work was supported by MICINN Grants BFU2008-01653 and Fundacion Seneca (Region de Murcia), Spain, Grant 08725/PI/08 (to J. C.).	Alfa C., 1993, EXPT FISSION YEAST; Aligue R, 1997, J BIOL CHEM, V272, P13320, DOI 10.1074/jbc.272.20.13320; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baum S, 2004, BIOCHEM J, V380, P823, DOI 10.1042/BJ20031962; Breeding CS, 1998, MOL BIOL CELL, V9, P3399, DOI 10.1091/mbc.9.12.3399; COLEMAN TR, 1993, CELL, V72, P919, DOI 10.1016/0092-8674(93)90580-J; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; FEATHERSTONE C, 1991, NATURE, V349, P808, DOI 10.1038/349808a0; FEILOTTER H, 1991, GENETICS, V127, P309; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; Grallert B, 2000, J CELL SCI, V113, P1447; He DY, 2010, J BIOL CHEM, V285, P19043, DOI 10.1074/jbc.M110.100693; Ishii K, 1996, EMBO J, V15, P6629, DOI 10.1002/j.1460-2075.1996.tb01053.x; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lopez-Aviles S, 2005, MOL CELL, V17, P49, DOI 10.1016/j.molcel.2004.11.043; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; MacNeil S. A., 1997, MOL CELLULAR BIOL YE, V3, P697; Madrid M, 2004, J BIOL CHEM, V279, P41594, DOI 10.1074/jbc.M405509200; Madrid M, 2007, MOL BIOL CELL, V18, P4405, DOI 10.1091/mbc.E07-05-0484; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Mamidipudi V, 2007, BIOCHEM BIOPH RES CO, V352, P423, DOI 10.1016/j.bbrc.2006.11.034; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McInerny CJ, 1995, NUCLEIC ACIDS RES, V23, P4761; McLeod M, 2000, MOL CELL BIOL, V20, P4016, DOI 10.1128/MCB.20.11.4016-4027.2000; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Nunez A, 2009, MOL BIOL CELL, V20, P3996, DOI 10.1091/mbc.E09-05-0388; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; PARKER LL, 1993, NATURE, V363, P736, DOI 10.1038/363736a0; Paul SK, 2009, FEBS J, V276, P5076, DOI 10.1111/j.1742-4658.2009.07204.x; Petersen J, 2009, BIOCHEM SOC T, V37, P273, DOI 10.1042/BST0370273; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Rothberg KG, 2006, J BIOL CHEM, V281, P9781, DOI 10.1074/jbc.M600133200; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; RUSSELL P, 1987, CELL, V49, P569, DOI 10.1016/0092-8674(87)90459-4; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shor B, 2003, J BIOL CHEM, V278, P49119, DOI 10.1074/jbc.M303968200; Soto T, 2002, EUR J BIOCHEM, V269, P5056, DOI 10.1046/j.1432-1033.2002.03214.x; Soto T, 2010, J BIOL CHEM, V285, P11516, DOI 10.1074/jbc.M109.071027; Suda M, 2000, FEBS LETT, V486, P305, DOI 10.1016/S0014-5793(00)02299-7; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; WU L, 1993, NATURE, V363, P738, DOI 10.1038/363738a0	52	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41366	41373		10.1074/jbc.M110.173815	http://dx.doi.org/10.1074/jbc.M110.173815			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974849	Green Published, hybrid			2022-12-25	WOS:000285622600022
J	Chini, CCS; Escande, C; Nin, V; Chini, EN				Chini, Claudia C. S.; Escande, Carlos; Nin, Veronica; Chini, Eduardo N.			HDAC3 Is Negatively Regulated by the Nuclear Protein DBC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASES; SIRT1; SMRT; TRANSCRIPTION; COREPRESSOR; REPRESSION; DISEASE; CANCER; ROLES	HDAC3 is a member of the class I histone deacetylase family that regulates gene expression by deacetylation of histones and non-histone proteins. HDAC3 activity has been shown to be modulated by interaction with the co-repressors NCoR and SMRT. Here, we present evidence that the nuclear protein DBC1 is an endogenous inhibitor of HDAC3. DBC1 has been previously identified as a regulator of some nuclear receptors, the methyltransferase SUV39H1, and the NAD-dependent deacetylase SIRT1. Furthermore, DBC1 has been shown to influence transcription regulation and apoptosis, and it may also act as a tumor suppressor. We found that DBC1 interacts and specifically inhibits the deacetylase HDAC3. This interaction depends on the N terminus of DBC1 and the C terminus of HDAC3. Expression of DBC1 not only inhibited HDAC3 activity but also altered its subcellular distribution. In addition, knockdown of endogenous DBC1 in cells and knock-out in mouse tissues increased HDAC3 deacetylase activity. Together, these results identify DBC1 as a new regulator of HDAC3 and demonstrate that DBC1 is a negative regulator of two key distinct deacetylases, SIRT1 and HDAC3. These findings may lead to a better understanding of the biological roles of DBC1 and HDAC3 in metabolic diseases and cancer.	[Chini, Claudia C. S.; Escande, Carlos; Nin, Veronica; Chini, Eduardo N.] Mayo Clin, Coll Med, Dept Anesthesiol, Lab Signal Transduct, Rochester, MN 55905 USA	Mayo Clinic	Chini, EN (corresponding author), Mayo Clin, Coll Med, Dept Anesthesiol, 200 1st St SW, Rochester, MN 55902 USA.	chini.eduardo@mayo.edu			National Institutes of Health, NIDDK [DK-084055]; American Federation for Aging Research; Mayo Foundation; Strickland Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084055] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Federation for Aging Research; Mayo Foundation; Strickland Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-084055 from NIDDK. This work was supported by grants from the American Federation for Aging Research and from the Mayo Foundation and by the Strickland Career Development Award.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Fu JJ, 2009, J BIOL CHEM, V284, P6832, DOI 10.1074/jbc.M808988200; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kim EJ, 2008, BMB REP, V41, P751, DOI 10.5483/BMBRep.2008.41.11.751; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim JE, 2009, CELL CYCLE, V8, P2932; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li ZY, 2009, J BIOL CHEM, V284, P10361, DOI 10.1074/jbc.M900956200; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Sundararajan R, 2005, ONCOGENE, V24, P4908, DOI 10.1038/sj.onc.1208681; Trauernicht AM, 2007, MOL ENDOCRINOL, V21, P1526, DOI 10.1210/me.2007-0064; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Wen YD, 2003, J BIOL CHEM, V278, P1841, DOI 10.1074/jbc.M206528200; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	29	64	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40830	40837		10.1074/jbc.M110.153270	http://dx.doi.org/10.1074/jbc.M110.153270			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	21030595	hybrid, Green Published			2022-12-25	WOS:000285414400048
J	Figueiredo, RT; Fernandez, PL; Dutra, FF; Gonzalez, Y; Lopes, LC; Bittencourt, VCB; Sassaki, GL; Barreto-Bergter, E; Bozza, MT				Figueiredo, Rodrigo T.; Fernandez, Patricia L.; Dutra, Fabianno F.; Gonzalez, Yissett; Lopes, Livia Cristina; Bittencourt, Vera Carolina B.; Sassaki, Guilherme L.; Barreto-Bergter, Eliana; Bozza, Marcelo T.			TLR4 Recognizes Pseudallescheria boydii Conidia and Purified Rhamnomannans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASIVE PULMONARY ASPERGILLOSIS; TOLL-LIKE RECEPTOR-2; CANDIDA-ALBICANS; FUNGAL PATHOGENS; HOST-DEFENSE; INFECTIONS; FUMIGATUS; DECTIN-1; ALPHA; SCEDOSPORIUM	Pseudallescheria boydii (Scedosporium apiospermum) is a saprophytic fungus widespread in the environment, and has recently emerged as an agent of localized as well as disseminated infections, particularly mycetoma, in immunocompromised and immunocompetent hosts. We have previously shown that highly purified alpha-glucan from P. boydii activates macrophages through Toll-like receptor TLR2, however, the mechanism of P. boydii recognition by macrophage is largely unknown. In this work, we investigated the role of innate immune receptors in the recognition of P. boydii. Macrophages responded to P. boydii conidia and hyphae with secretion of proinflammatory cytokines. The activation of macrophages by P. boydii conidia required functional MyD88, TLR4, and CD14, whereas stimulation by hyphae was independent of TLR4 and TLR2 signaling. Removal of peptidorhamnomannans from P. boydii conidia abolished induction of cytokines by macrophages. A fraction highly enriched in rhamnomannans was obtained and characterized by NMR, high performance TLC, and GC-MS. Preparation of rhamnomannans derived from P. boydii triggered cytokine release by macrophages, as well as MAPKs phosphorylation and I kappa B alpha degradation. Cytokine release induced by P. boydii-derived rhamnomannans was dependent on TLR4 recognition and required the presence of non-reducing end units of rhamnose of the rhamnomannan, but not O-linked oligosaccharides from the peptidorhamnomannan. These results imply that TLR4 recognizes P. boydii conidia and this recognition is at least in part due to rhamnomannans expressed on the surface of P. boydii.	[Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Imunol, Lab Inflamacao & Imunidade, BR-941902 Rio De Janeiro, Brazil; [Figueiredo, Rodrigo T.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-941902 Rio De Janeiro, Brazil; [Fernandez, Patricia L.; Gonzalez, Yissett] Inst Sci Invest & High Technol Serv, INDICASAT, Ciudad De Panama 84301103, Panama; [Lopes, Livia Cristina; Bittencourt, Vera Carolina B.; Barreto-Bergter, Eliana] Univ Fed Rio de Janeiro, Dept Microbiol Geral, Inst Microbiol, BR-941902 Rio De Janeiro, Brazil; [Bittencourt, Vera Carolina B.] Univ Fed Estado Rio de Janeiro, BR-20211040 Rio De Janeiro, Brazil; [Sassaki, Guilherme L.] Univ Fed Parana, Dept Bioquim, BR-81531990 Curitiba, Parana, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Universidade Federal do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Parana	Bozza, MT (corresponding author), Univ Fed Rio de Janeiro, CCS Bloco 1,Ave Carlos Chagas Filho,373 Cidade Un, BR-21941902 Rio de Janeiro, Brazil.	mbozza@micro.ufrj.br	Bergter, Eliana Barreto/E-2664-2013; Ferreira Dutra, Fabianno/AAE-2895-2022; Sassaki, Guilherme/AAM-1112-2020; Dutra, Fabianno F/C-1387-2015; Bittencourt, Vera CB/A-7921-2019; Figueiredo, Rodrigo/F-5176-2016	Ferreira Dutra, Fabianno/0000-0003-3106-7585; Sassaki, Guilherme/0000-0001-7420-168X; Dutra, Fabianno F/0000-0003-3106-7585; Figueiredo, Rodrigo/0000-0002-7551-8782; Llanes Fernandez, Patricia/0000-0002-0762-0566; Bozza, Marcelo/0000-0003-3683-7550; bittencourt, vera/0000-0002-7403-9747	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa de Nucleos de Excelencia (Pronex); Universidade Federal do Rio de Janeiro	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Nucleos de Excelencia (Pronex)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do Rio de Janeiro	The work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Programa de Nucleos de Excelencia (Pronex), and Universidade Federal do Rio de Janeiro.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Baddley JW, 2001, CLIN INFECT DIS, V32, P1319, DOI 10.1086/319985; Balloy V, 2005, INFECT IMMUN, V73, P5420, DOI 10.1128/IAI.73.9.5420-5425.2005; Barbosa FM, 2007, CLIN VACCINE IMMUNOL, V14, P94, DOI 10.1128/CVI.00296-06; BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247; BELCHER R, 1954, ANALYST, V79, P201, DOI 10.1039/an9547900201; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Gilgado F, 2005, J CLIN MICROBIOL, V43, P4930, DOI 10.1128/JCM.43.10.4930-4942.2005; Gorin P. A. J., 1981, ADV CARBOHYD CHEM BI, VV38, P13, DOI DOI 10.1016/S0065-2318(08)60309-1; Hohl TM, 2006, CURR OPIN IMMUNOL, V18, P465, DOI 10.1016/j.coi.2006.05.003; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; Lopes LCL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000853; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; Netea MG, 2004, EUR J CLIN MICROBIOL, V23, P672, DOI 10.1007/s10096-004-1192-7; Netea MG, 2003, J INFECT DIS, V188, P320, DOI 10.1086/376456; Netea MG, 2002, J INFECT DIS, V185, P1483, DOI 10.1086/340511; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; O'Bryan Thomas A, 2005, Expert Rev Anti Infect Ther, V3, P765, DOI 10.1586/14787210.3.5.765; Peter E, 2002, CLIN INFECT DIS, V35, pE54, DOI 10.1086/341971; Pinto MR, 2001, MICROBIOL-SGM, V147, P1499, DOI 10.1099/00221287-147-6-1499; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Roilides E, 2009, MED MYCOL, V47, P433, DOI 10.1080/13693780902738006; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Shoham S, 2001, J IMMUNOL, V166, P4620, DOI 10.4049/jimmunol.166.7.4620; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Tada H, 2002, MICROBIOL IMMUNOL, V46, P503, DOI 10.1111/j.1348-0421.2002.tb02727.x; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Villamon E, 2004, MICROBES INFECT, V6, P1, DOI 10.1016/j.micinf.2003.09.020; Warris A, 2001, NEW ENGL J MED, V344, P1099, DOI 10.1056/NEJM200104053441415; Wieland CW, 2007, MICROBES INFECT, V9, P134, DOI 10.1016/j.micinf.2006.10.018; Zelante T, 2007, ADV EXP MED BIOL, V590, P209	46	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40714	40723		10.1074/jbc.M110.181255	http://dx.doi.org/10.1074/jbc.M110.181255			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959459	Green Published, hybrid			2022-12-25	WOS:000285414400035
J	Rinaldo-Matthis, A; Wetterholm, A; Molina, DM; Holm, J; Niegowski, D; Ohlson, E; Nordlund, P; Morgenstern, R; Haeggstrom, JZ				Rinaldo-Matthis, Agnes; Wetterholm, Anders; Molina, Daniel Martinez; Holm, Johanna; Niegowski, Damian; Ohlson, Eva; Nordlund, Par; Morgenstern, Ralf; Haeggstrom, Jesper Z.			Arginine 104 Is a Key Catalytic Residue in Leukotriene C-4 Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSOMAL GLUTATHIONE TRANSFERASE; PROSTAGLANDIN-E SYNTHASE-1; THIOLATE ANION; ACTIVE-SITE; OXIDATIVE STRESS; STRUCTURAL BASIS; S-TRANSFERASE; ENZYME; IDENTIFICATION; PURIFICATION	Human leukotriene C-4 synthase (hLTC(4)S) is an integral membrane enzyme that conjugates leukotriene (LT) A(4) with glutathione to form LTC4, a precursor to the cysteinyl leukotrienes (LTC4, LTD4, and LTE4) that are involved in the pathogenesis of human bronchial asthma. From the crystal structure of hLTC(4)S, Arg-104 and Arg-31 have been implicated in the conjugation reaction. Here, we used site-directed mutagenesis, UV spectroscopy, and x-ray crystallography to examine the catalytic role of Arg-104 and Arg-31. Exchange of Arg-104 with Ala, Ser, Thr, or Lys abolished 94.3-99.9% of the specific activity against LTA(4). Steady-state kinetics of R104A and R104S revealed that the K-m for GSH was not significantly affected. UV difference spectra of the binary enzyme-GSH complex indicated that GSH ionization depends on the presence of Arg-104 because no thiolate signal, with lambda(max) at 239 nm, could be detected using R104A or R104S hLTC(4)S. Apparently, the interaction of Arg-104 with the thiol group of GSH reduces its pK(a) to allow formation of a thiolate anion and subsequent nucleophilic attack at C6 of LTA(4). On the other hand, exchange of Arg-31 with Ala or Glu reduced the catalytic activity of hLTC4S by 88 and 70%, respectively, without significantly affecting the k(cat)/K-m values for GSH, and a crystal structure of R31Q hLTC(4)S (2.1 angstrom) revealed a Gln-31 side chain pointing away from the active site. We conclude that Arg-104 plays a critical role in the catalytic mechanism of hLTC(4)S, whereas a functional role of Arg-31 seems more elusive. Because Arg-104 is a conserved residue, our results pertain to other homologous membrane proteins and represent a structure-function paradigm probably common to all microsomal GSH transferases.	[Haeggstrom, Jesper Z.] Karolinska Inst, Div Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Molina, Daniel Martinez; Nordlund, Par] Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Morgenstern, Ralf] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Haeggstrom, JZ (corresponding author), Karolinska Inst, Div Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	jesper.haeggstrom@ki.se	Morgenstern, Ralf/GZH-0158-2022	Holm, Johanna/0000-0002-0220-3288	Swedish Research Council [10350, 80429191, 20854]; CERIC; CIDaT; European Commission [005033, 201668]; Soderbergs Foundation; Vinnova SAMPOST; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); CERIC; CIDaT; European Commission(European CommissionEuropean Commission Joint Research Centre); Soderbergs Foundation; Vinnova SAMPOST(Vinnova); Karolinska Institutet(Karolinska Institutet)	This work was supported by Swedish Research Council Grants 10350, 80429191, and 20854 and Linneus Grant CERIC, the CIDaT, European Commission Projects FP6 and FP7 (Grants 005033 and 201668), Soderbergs Foundation, a Vinnova SAMPOST position (to D.N.), and a Distinguished Professor Award from the Karolinska Institutet (to J.Z.H.).	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; Alander J, 2009, ARCH BIOCHEM BIOPHYS, V487, P42, DOI 10.1016/j.abb.2009.04.009; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Beller TC, 2004, J BIOL CHEM, V279, P46129, DOI 10.1074/jbc.M407057200; Caccuri AM, 2001, J BIOL CHEM, V276, P5427, DOI 10.1074/jbc.M002819200; CHEN WJ, 1988, BIOCHEMISTRY-US, V27, P647, DOI 10.1021/bi00402a023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FORDHUTCHINSON AW, 1994, ANNU REV BIOCHEM, V63, P383, DOI 10.1146/annurev.bi.63.070194.002123; GRAMINSKI GF, 1989, BIOCHEMISTRY-US, V28, P6252, DOI 10.1021/bi00441a017; GRAMINSKI GF, 1989, BIOCHEMISTRY-US, V28, P3562, DOI 10.1021/bi00434a062; Hammarberg T, 2009, J BIOL CHEM, V284, P301, DOI 10.1074/jbc.M808365200; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; IZUMI T, 1988, BIOCHIM BIOPHYS ACTA, V959, P305; Jakobsson PJ, 1997, J BIOL CHEM, V272, P22934, DOI 10.1074/jbc.272.36.22934; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jakobsson PJ, 1997, J LIPID MEDIAT CELL, V17, P15, DOI 10.1016/S0929-7855(97)00013-8; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kim DC, 2006, J IMMUNOL, V176, P4440, DOI 10.4049/jimmunol.176.7.4440; Lam BK, 1997, J BIOL CHEM, V272, P13923, DOI 10.1074/jbc.272.21.13923; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lynch KR, 1999, NATURE, V399, P789; Molina DM, 2008, CURR OPIN STRUC BIOL, V18, P442, DOI 10.1016/j.sbi.2008.04.005; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Morgenstern R, 2001, BIOCHEMISTRY-US, V40, P3378, DOI 10.1021/bi0023394; MORGENSTERN R, 1983, EUR J BIOCHEM, V134, P591, DOI 10.1111/j.1432-1033.1983.tb07607.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Patskovsky YV, 2000, J BIOL CHEM, V275, P3296, DOI 10.1074/jbc.275.5.3296; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rinaldo-Matthis A, 2010, BIOCHIMIE, V92, P676, DOI 10.1016/j.biochi.2010.01.010; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Siritantikorn A, 2007, BIOCHEM BIOPH RES CO, V355, P592, DOI 10.1016/j.bbrc.2007.02.018; Svensson R, 2004, BIOCHEMISTRY-US, V43, P8869, DOI 10.1021/bi0492511; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; YOSHIMOTO T, 1988, J CLIN INVEST, V81, P866, DOI 10.1172/JCI113396	37	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40771	40776		10.1074/jbc.M110.105940	http://dx.doi.org/10.1074/jbc.M110.105940			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20980252	hybrid, Green Published			2022-12-25	WOS:000285414400041
J	Dong, LL; Zhang, XF; Liu, DC; Fan, HJ; Sun, JZ; Zhang, ZJ; Qin, HJ; Li, B; Hao, ST; Li, ZS; Wang, DW; Zhang, AM; Ling, HQ				Dong, Lingli; Zhang, Xiaofei; Liu, Dongcheng; Fan, Huajie; Sun, Jiazhu; Zhang, Zhongjuan; Qin, Huanju; Li, Bin; Hao, Shanting; Li, Zhensheng; Wang, Daowen; Zhang, Aimin; Ling, Hong-Qing			New Insights into the Organization, Recombination, Expression and Functional Mechanism of Low Molecular Weight Glutenin Subunit Genes in Bread Wheat	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; DOUBLED HAPLOID POPULATION; MAKING QUALITY; DURUM-WHEAT; DOUGH PROPERTIES; ALLELIC VARIATION; STORAGE PROTEINS; PROLAMIN GENES; RICH REGIONS; STS MARKERS	The bread-making quality of wheat is strongly influenced by multiple low molecular weight glutenin subunit (LMW-GS) proteins expressed in the seeds. However, the organization, recombination and expression of LMW-GS genes and their functional mechanism in bread-making are not well understood. Here we report a systematic molecular analysis of LMW-GS genes located at the orthologous Glu-3 loci (Glu-A3, B3 and D3) of bread wheat using complementary approaches (genome wide characterization of gene members, expression profiling, proteomic analysis). Fourteen unique LMW-GS genes were identified for Xiaoyan 54 (with superior bread-making quality). Molecular mapping and recombination analyses revealed that the three Glu-3 loci of Xiaoyan 54 harbored dissimilar numbers of LMW-GS genes and covered different genetic distances. The number of expressed LMW-GS in the seeds was higher in Xiaoyan 54 than in Jing 411 (with relatively poor bread-making quality). This correlated with the finding of higher numbers of active LMW-GS genes at the A3 and D3 loci in Xiaoyan 54. Association analysis using recombinant inbred lines suggested that positive interactions, conferred by genetic combinations of the Glu-3 locus alleles with more numerous active LMW-GS genes, were generally important for the recombinant progenies to attain high Zeleny sedimentation value (ZSV), an important indicator of bread-making quality. A higher number of active LMW-GS genes tended to lead to a more elevated ZSV, although this tendency was influenced by genetic background. This work provides substantial new insights into the genomic organization and expression of LMW-GS genes, and molecular genetic evidence suggesting that these genes contribute quantitatively to bread-making quality in hexaploid wheat. Our analysis also indicates that selection for high numbers of active LMW-GS genes can be used for improvement of bread-making quality in wheat breeding.	[Dong, Lingli; Zhang, Xiaofei; Liu, Dongcheng; Fan, Huajie; Sun, Jiazhu; Zhang, Zhongjuan; Qin, Huanju; Li, Bin; Hao, Shanting; Li, Zhensheng; Wang, Daowen; Zhang, Aimin; Ling, Hong-Qing] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Dong, LL (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	dwwang@genetics.ac.cn; amzhang@genetics.ac.cn; hqling@genetics.ac.cn	Ling, Hong-Qing/ABC-9451-2020	wang, dao wen/0000-0002-6230-8735; zhang, xiaofei/0000-0003-4516-9179	Ministry of Science and Technology of China [2006AA100102, 2006AA10A105, 2006AA10Z1B2, 2009CB118300]; National Natural Science Foundation of China [30821061]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support for this work was provided by the Ministry of Science and Technology of China (grants 2006AA100102, 2006AA10A105, 2006AA10Z1B2, 2009CB118300) and the National Natural Science Foundation of China (grant 30821061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appels R, 2001, EUPHYTICA, V119, P49, DOI 10.1023/A:1017542405338; AUTRAN JC, 1987, BIOCHIMIE, V69, P699, DOI 10.1016/0300-9084(87)90191-X; AXFORD DWE, 1979, CEREAL CHEM, V56, P582; Barro F, 1997, NAT BIOTECHNOL, V15, P1295, DOI 10.1038/nbt1197-1295; Bekes F, 2006, EUR J AGRON, V25, P155, DOI 10.1016/j.eja.2006.04.008; Blechl AE, 1996, NAT BIOTECHNOL, V14, P875, DOI 10.1038/nbt0796-875; BRANLARD G, 1992, THEOR APPL GENET, V84, P57, DOI 10.1007/BF00223981; Butow BJ, 2004, THEOR APPL GENET, V109, P1525, DOI 10.1007/s00122-004-1776-8; Cloutier S, 2001, J CEREAL SCI, V33, P143, DOI 10.1006/jcrs.2000.0359; Cornish G. B., 2006, Gliadin and glutenin: the unique balance of wheat quality, P243; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; DOVIDIO R, 1992, J CEREAL SCI, V16, P165, DOI 10.1016/S0733-5210(09)80148-3; Eagles HA, 2006, AUST J AGR RES, V57, P179, DOI 10.1071/AR05242; Eagles HA, 2002, AUST J AGR RES, V53, P367, DOI 10.1071/AR01074; Gao SC, 2007, PLANT MOL BIOL, V65, P189, DOI 10.1007/s11103-007-9208-1; Gill KS, 1996, GENETICS, V144, P1883; Gill KS, 1996, GENETICS, V143, P1001; Groos C, 2007, THEOR APPL GENET, V115, P313, DOI 10.1007/s00122-007-0563-8; GUPTA RB, 1989, THEOR APPL GENET, V77, P57, DOI 10.1007/BF00292316; GUPTA RB, 1990, THEOR APPL GENET, V80, P65, DOI 10.1007/BF00224017; GUPTA RB, 1991, CEREAL CHEM, V68, P328; He Z., 2001, HIST WHEAT BREEDING; He ZH, 2005, CEREAL CHEM, V82, P345, DOI 10.1094/CC-82-0345; Huang XQ, 2008, THEOR APPL GENET, V116, P953, DOI 10.1007/s00122-008-0727-1; Hussain A, 1997, CEREAL CHEM, V74, P791, DOI 10.1094/CCHEM.1997.74.6.791; Ikeda TM, 2006, THEOR APPL GENET, V112, P327, DOI 10.1007/s00122-005-0131-z; Ikeda TM, 2002, THEOR APPL GENET, V104, P680, DOI 10.1007/s001220100756; Jackson E. A., 1996, Journal of Genetics and Breeding, V50, P321; JACKSON EA, 1983, THEOR APPL GENET, V66, P29, DOI 10.1007/BF00281844; Johal J, 2004, THEOR APPL GENET, V109, P1028, DOI 10.1007/s00122-004-1711-z; JOSEPHIDES CM, 1987, CROP SCI, V27, P212, DOI 10.2135/cropsci1987.0011183X002700020016x; KIHARA H, 1944, AGR HORTIC, V19, P889, DOI DOI 10.1016/J.JGG.2011.07.002; Kuchel H, 2006, THEOR APPL GENET, V112, P1487, DOI 10.1007/s00122-006-0252-z; LEW EJL, 1992, CEREAL CHEM, V69, P508; Li Y, 2009, PLANT BREEDING, V128, P235, DOI 10.1111/j.1439-0523.2008.01578.x; Ma W, 2005, THEOR APPL GENET, V111, P410, DOI 10.1007/s00122-005-2001-0; MACRITCHIE F, 1987, J CEREAL SCI, V6, P259, DOI 10.1016/S0733-5210(87)80063-2; Mamone G, 2009, J MASS SPECTROM, V44, P1709, DOI 10.1002/jms.1680; Mann G, 2009, THEOR APPL GENET, V118, P1519, DOI 10.1007/s00122-009-1000-y; MASCI S, 1995, CEREAL CHEM, V72, P100; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; METAKOVSKY EV, 1990, AUST J AGR RES, V41, P289, DOI 10.1071/AR9900289; Nelson JC, 2006, EUPHYTICA, V149, P145, DOI 10.1007/s10681-005-9062-7; Osborne T, 1924, VEGETABLE PROTEINS, P154; Oury FX, 2010, EUPHYTICA, V171, P87, DOI 10.1007/s10681-009-9997-1; Patil RM, 2009, J CEREAL SCI, V49, P378, DOI 10.1016/j.jcs.2009.01.001; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1988, J CEREAL SCI, V7, P229, DOI [10.1016/S0733-5210(88)80004-3, 10.1006/jcrs.1998.0194]; PAYNE PI, 1984, J CEREAL SCI, V2, P73, DOI 10.1016/S0733-5210(84)80020-X; PAYNE PI, 1981, J SCI FOOD AGR, V32, P51, DOI 10.1002/jsfa.2740320109; Pena R. J., 2002, Journal of Crop Production, V5, P1, DOI 10.1300/J144v05n01_02; Perretant MR, 2000, THEOR APPL GENET, V100, P1167, DOI 10.1007/s001220051420; POGNA NE, 1990, J CEREAL SCI, V11, P15, DOI 10.1016/S0733-5210(09)80178-1; Rakszegi M, 2008, J AGR FOOD CHEM, V56, P9750, DOI 10.1021/jf8009359; Raman R, 2009, GENOME, V52, P701, DOI [10.1139/G09-045, 10.1139/g09-045]; RUIZ M, 1993, THEOR APPL GENET, V87, P353, DOI 10.1007/BF01184923; SHEWRY PR, 1995, BIO-TECHNOL, V13, P1185, DOI 10.1038/nbt1195-1185; SINGH NK, 1988, THEOR APPL GENET, V75, P628, DOI 10.1007/BF00289132; SINGH R, 1991, NATL ACAD SCI LETT, V14, P203; Spielmeyer W, 2000, GENETICS, V155, P361; TAO HP, 1989, J EXP BOT, V40, P1015, DOI 10.1093/jxb/40.9.1015; Uthayakumaran S, 1999, CEREAL CHEM, V76, P389, DOI 10.1094/CCHEM.1999.76.3.389; Wang LH, 2009, THEOR APPL GENET, V118, P525, DOI 10.1007/s00122-008-0918-9; Weegels PL, 1996, J CEREAL SCI, V23, P1, DOI 10.1006/jcrs.1996.0001; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Zanetti S., 1999, Genetics and breeding for crop quality and resistance. Proceedings of the XV EUCARPIA Congress, Viterbo, Italy, September 20-25, 1998., P357; Zanetti S, 2001, PLANT BREEDING, V120, P13, DOI 10.1046/j.1439-0523.2001.00552.x; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; Zhang PP, 2007, CEREAL CHEM, V84, P370, DOI 10.1094/CCHEM-84-4-0370; Zhang W, 2004, THEOR APPL GENET, V108, P1409, DOI 10.1007/s00122-003-1558-8; Zhang YL, 2009, CROP PASTURE SCI, V60, P587, DOI 10.1071/CP08392; Zhao XL, 2007, THEOR APPL GENET, V114, P451, DOI 10.1007/s00122-006-0445-5; Zhao XL, 2006, THEOR APPL GENET, V113, P1247, DOI 10.1007/s00122-006-0379-y	74	57	59	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13548	10.1371/journal.pone.0013548	http://dx.doi.org/10.1371/journal.pone.0013548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975830	Green Submitted, Green Published, gold			2022-12-25	WOS:000283293800015
J	Febrer, M; Goicoechea, JL; Wright, J; McKenzie, N; Song, XA; Lin, JK; Collura, K; Wissotski, M; Yu, Y; Ammiraju, JSS; Wolny, E; Idziak, D; Betekhtin, A; Kudrna, D; Hasterok, R; Wing, RA; Bevan, MW				Febrer, Melanie; Goicoechea, Jose Luis; Wright, Jonathan; McKenzie, Neil; Song, Xiang; Lin, Jinke; Collura, Kristi; Wissotski, Marina; Yu, Yeisoo; Ammiraju, Jetty S. S.; Wolny, Elzbieta; Idziak, Dominika; Betekhtin, Alexander; Kudrna, Dave; Hasterok, Robert; Wing, Rod A.; Bevan, Michael W.			An Integrated Physical, Genetic and Cytogenetic Map of Brachypodium distachyon, a Model System for Grass Research	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; BAC LIBRARIES; GENOME; CONSTRUCTION; CHROMOSOMES; ALIGNMENT; RESOURCE; COVERAGE; SEQUENCE; DATABASE	The pooid subfamily of grasses includes some of the most important crop, forage and turf species, such as wheat, barley and Lolium. Developing genomic resources, such as whole-genome physical maps, for analysing the large and complex genomes of these crops and for facilitating biological research in grasses is an important goal in plant biology. We describe a bacterial artificial chromosome (BAC)-based physical map of the wild pooid grass Brachypodium distachyon and integrate this with whole genome shotgun sequence (WGS) assemblies using BAC end sequences (BES). The resulting physical map contains 26 contigs spanning the 272 Mb genome. BES from the physical map were also used to integrate a genetic map. This provides an independent vaildation and confirmation of the published WGS assembly. Mapped BACs were used in Fluorescence In Situ Hybridisation (FISH) experiments to align the integrated physical map and sequence assemblies to chromosomes with high resolution. The physical, genetic and cytogenetic maps, integrated with whole genome shotgun sequence assemblies, enhance the accuracy and durability of this important genome sequence and will directly facilitate gene isolation.	[Febrer, Melanie; Wright, Jonathan; McKenzie, Neil; Bevan, Michael W.] John Innes Ctr, Norwich, Norfolk, England; [Goicoechea, Jose Luis; Song, Xiang; Lin, Jinke; Collura, Kristi; Wissotski, Marina; Yu, Yeisoo; Ammiraju, Jetty S. S.; Kudrna, Dave; Wing, Rod A.] Univ Arizona, Arizona Genom Inst, Sch Plant Sci, Tucson, AZ USA; [Goicoechea, Jose Luis; Song, Xiang; Lin, Jinke; Collura, Kristi; Wissotski, Marina; Yu, Yeisoo; Ammiraju, Jetty S. S.; Kudrna, Dave; Wing, Rod A.] Univ Arizona, Inst Collaborat Res BIO5, Tucson, AZ USA; [Wolny, Elzbieta; Idziak, Dominika; Betekhtin, Alexander; Hasterok, Robert] Univ Silesia, Dept Plant Anat & Cytol, Katowice, Poland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Arizona; University of Arizona; University of Silesia in Katowice	Febrer, M (corresponding author), John Innes Ctr, Norwich, Norfolk, England.	michael.bevan@bbsrc.ac.uk	Betekhtin, Alexander/O-4619-2018; Wing, Rod A/Z-2885-2019; Hasterok, Robert/A-1629-2008; song, xiang/A-2336-2012	Betekhtin, Alexander/0000-0001-6146-1669; Wing, Rod A/0000-0001-6633-6226; Idziak-Helmcke, Dominika/0000-0002-0713-2466; Hasterok, Robert/0000-0001-6667-2721; Yu, Yeisoo/0000-0002-8410-0310; Wolny, Elzbieta/0000-0001-7588-4830	Biological and Biotechnological Sciences Research Council [BB/E004725/1]; John Innes Centre; Polish Ministry of Science and Higher Education [N N303 570738]; UPGOW; European Social Fund; Biotechnology and Biological Sciences Research Council [BB/E004725/1] Funding Source: researchfish; BBSRC [BB/E004725/1] Funding Source: UKRI	Biological and Biotechnological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Centre; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); UPGOW; European Social Fund(European Social Fund (ESF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The Biological and Biotechnological Sciences Research Council Grant BB/E004725/1 to MWB and the John Innes Centre Core Strategic Grant. This work was partially supported by the Polish Ministry of Science and Higher Education Grant N N303 570738 to RH, DI and EW. DI and AB are recipients of a scholarship from the UPGOW project co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammiraju JSS, 2006, GENOME RES, V16, P140, DOI 10.1101/gr.3766306; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Chaparro C, 2007, NUCLEIC ACIDS RES, V35, pD66, DOI 10.1093/nar/gkl780; Garvin D, 2007, MODEL PLANTS CROP IM, P109; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Gu YQ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-496; Hasterok R, 2006, GENETICS, V173, P349, DOI 10.1534/genetics.105.049726; Huo NX, 2006, GENOME, V49, P1099, DOI 10.1139/G06-087; IDZIAK D, 2010, THESIS U SILESIA KAT; Jenkins G, 2007, NAT PROTOC, V2, P88, DOI 10.1038/nprot.2006.490; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim H, 2007, GENETICS, V176, P379, DOI 10.1534/genetics.106.068783; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Luo MZ, 2003, METH MOL B, V236, P3; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; Mun JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-280; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Smit A., REPEATMASKER OPEN 3; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; UNFRIED I, 1990, NUCLEIC ACIDS RES, V18, P4011, DOI 10.1093/nar/18.13.4011; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wolny E, 2009, ANN BOT-LONDON, V104, P873, DOI 10.1093/aob/mcp179; Xu ZY, 2004, GENOMICS, V84, P941, DOI 10.1016/j.ygeno.2004.08.014	35	40	43	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13461	10.1371/journal.pone.0013461	http://dx.doi.org/10.1371/journal.pone.0013461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976139	Green Submitted, Green Published, gold			2022-12-25	WOS:000283045300030
J	Serrano-Sanchez, JA; Delgado-Guerra, S; Olmedillas, H; Guadalupe-Grau, A; Arteaga-Ortiz, R; Sanchis-Moysi, J; Dorado, C; Calbet, JAL				Serrano-Sanchez, Jose A.; Delgado-Guerra, Safira; Olmedillas, Hugo; Guadalupe-Grau, Amelia; Arteaga-Ortiz, Rafael; Sanchis-Moysi, Joaquin; Dorado, Cecilia; Calbet, Jose A. L.			Adiposity and Age Explain Most of the Association between Physical Activity and Fitness in Physically Active Men	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE IPAQ; SKELETAL-MUSCLE; SHORT-FORM; RELIABILITY; VALIDATION; VALIDITY; POPULATION; 7-DAY; MASS; PERFORMANCE	Background: To determine if there is an association between physical activity assessed by the short version of the International Physical Activity Questionnaire (IPAQ) and cardiorespiratory and muscular fitness. Methodology/Principal Findings: One hundred and eighty-two young males (age range: 20-55 years) completed the short form of the IPAQ to assess physical activity. Body composition (dual-energy X-Ray absorptiometry), muscular fitness (static and dynamic muscle force and power, vertical jump height, running speed [ 30 m sprint], anaerobic capacity [ 300 m running test]) and cardiorespiratory fitness (estimated VO(2)max: 20 m shuttle run test) were also determined in all subjects. Activity-related energy expenditure of moderate and vigorous intensity (EEPA(moderate) and EEPA(vigorous), respectively) was inversely associated with indices of adiposity (r = -0.21 to -0.37, P<0.05). Cardiorespiratory fitness (VO(2)max) was positively associated with LogEEPA(moderate) (r = 0.26, P<0.05) and LogEEPA(vigorous) (r = 0.27). However, no association between VO(2)max with LogEEPA(moderate), LogEPPA(vigorous) and LogEEPA(total) was observed after adjusting for the percentage of body fat. Multiple stepwise regression analysis to predict VO(2)max from LogEEPA(walking), LogEEPA(moderate), LogEEPA(vigorous), LogEEPA(total), age and percentage of body fat (%fat) showed that the %fat alone explained 62% of the variance in VO(2)max and that the age added another 10%, while the other variables did not add predictive value to the model [VO(2)max = 129.6-(25.1 x Log %fat) - (34.0 x Log age); SEE: 4.3 ml.kg(-1).min(-1); R-2 = 0.72 (P<0.05)]. No positive association between muscular fitness-related variables and physical activity was observed, even after adjusting for body fat or body fat and age. Conclusions/Significance: Adiposity and age are the strongest predictors of VO(2)max in healthy men. The energy expended in moderate and vigorous physical activities is inversely associated with adiposity. Muscular fitness does not appear to be associated with physical activity as assessed by the IPAQ.	[Serrano-Sanchez, Jose A.; Delgado-Guerra, Safira; Olmedillas, Hugo; Guadalupe-Grau, Amelia; Sanchis-Moysi, Joaquin; Dorado, Cecilia; Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain; [Arteaga-Ortiz, Rafael] Univ Las Palmas Gran Canaria, Dept Phys, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Serrano-Sanchez, JA (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain.	lopezcalbet@gmail.com	Calbet, Jose A L/H-6693-2015; SANCHIS-MOYSI, JOAQUIN/H-7017-2015; Cecilia, Dorado-Garcia/B-4586-2010; Guadalupe-Grau, Amelia/H-4961-2016; Sanchis-Moysi, Joaquin/B-5561-2012; Olmedillas, Hugo/F-4809-2015; Dorado García, Cecilia/ABC-2792-2021; Serrano-Sanchez, Jose A/L-3691-2014	Calbet, Jose A L/0000-0002-9215-6234; SANCHIS-MOYSI, JOAQUIN/0000-0001-6602-7087; Cecilia, Dorado-Garcia/0000-0001-6616-6810; Guadalupe-Grau, Amelia/0000-0003-2573-4572; Olmedillas, Hugo/0000-0003-4625-2759; Serrano-Sanchez, Jose A/0000-0002-4868-8751; antunez, Ariel/0000-0002-2548-7885	Ministerio de Educacion y Ciencia [DEP2006-56076-C06-04/ACTI]; FEDER (Fondo Europeo de Desarrollo Regional or European Regional Development Fund (ERDF)); Consejeria de Educacion, Cultura y Deportes del Gobierno de Canarias [2006/1790001]	Ministerio de Educacion y Ciencia(Spanish Government); FEDER (Fondo Europeo de Desarrollo Regional or European Regional Development Fund (ERDF))(European Commission); Consejeria de Educacion, Cultura y Deportes del Gobierno de Canarias	The study was supported by Ministerio de Educacion y Ciencia (DEP2006-56076-C06-04/ACTI) and FEDER (Fondo Europeo de Desarrollo Regional or European Regional Development Fund (ERDF)), Consejeria de Educacion, Cultura y Deportes del Gobierno de Canarias (2006/1790001 and FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara I, 2004, INT J OBESITY, V28, P1585, DOI 10.1038/sj.ijo.0802754; ARA I, 2010, INT J OBES LOND; Arteaga R, 2000, J SPORT MED PHYS FIT, V40, P26; Bi S, 2005, ENDOCRINOLOGY, V146, P1676, DOI 10.1210/en.2004-1441; Bojsen-Moller J, 2005, J APPL PHYSIOL, V99, P986, DOI 10.1152/japplphysiol.01305.2004; Bonnefoy M, 1996, EUR J APPL PHYSIOL, V74, P528; BOON RM, 2010, BR J SPORTS IN PRESS; Bratteby LE, 1997, EUR J CLIN NUTR, V51, P585, DOI 10.1038/sj.ejcn.1600449; Calbet JAL, 1997, EUR J APPL PHYSIOL O, V76, P308, DOI 10.1007/s004210050253; Calbet JAL, 2008, EUR J APPL PHYSIOL, V104, P587, DOI 10.1007/s00421-008-0774-y; Cao ZB, 2010, MED SCI SPORT EXER, V42, P179, DOI 10.1249/MSS.0b013e3181af238d; Caserotti P, 2008, SCAND J MED SCI SPOR, V18, P773, DOI 10.1111/j.1600-0838.2007.00732.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Duncan GE, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-47; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Fuentes T, 2010, EXP PHYSIOL, V95, P160, DOI 10.1113/expphysiol.2009.049270; Hagner W, 2009, MENOPAUSE, V16, P1009, DOI 10.1097/gme.0b013e31819c0924; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Havlik RJ, 2005, AM HEART J, V150, P270, DOI 10.1016/j.ahj.2004.09.006; Johnson-Kozlow M, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-7; Kaleth AS, 2010, DISABIL REHABIL, V32, P353, DOI 10.3109/09638280903166352; Kawaguchi M, 2005, AM J PHYSIOL-REG I, V288, pR1800, DOI 10.1152/ajpregu.00805.2004; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Leon A S, 1996, J Cardiopulm Rehabil, V16, P183, DOI 10.1097/00008483-199605000-00006; Maddison R, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-62; Mader U, 2006, MED SCI SPORT EXER, V38, P1255, DOI 10.1249/01.mss.0000227310.18902.28; Nokes N, 2009, J SPORT MED PHYS FIT, V49, P136; Paalanne NP, 2009, MED SCI SPORT EXER, V41, P1997, DOI 10.1249/MSS.0b013e3181a7f3a6; PAPATHANASIOU G, 2009, EUR J CARDIOVASC PRE; Papathanasiou George, 2009, Hellenic J Cardiol, V50, P283; PENRY JT, 2010, J STRENGTH COND RES; Perez-Gomez J, 2008, APPL PHYSIOL NUTR ME, V33, P501, DOI 10.1139/H08-026; Philippaerts RM, 1999, INT J SPORTS MED, V20, P284, DOI 10.1055/s-2007-971132; Roeykens J, 1998, MED SCI SPORT EXER, V30, P1071, DOI 10.1097/00005768-199807000-00008; Roman B, 2006, MED SCI SPORT EXER, V38, pS563, DOI 10.1249/00005768-200605001-02341; Rzewnicki R, 2003, PUBLIC HEALTH NUTR, V6, P299, DOI 10.1079/PHN2002427; SALTIN B, 1980, FED PROC, V39, P1506; Sanchis-Moysi J, 2010, SCAND J MED SCI SPOR, V20, P524, DOI 10.1111/j.1600-0838.2009.00969.x; Scheeres K, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-29; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Stofan JR, 1998, AM J PUBLIC HEALTH, V88, P1807, DOI 10.2105/AJPH.88.12.1807; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; TREMBLAY A, 1994, METABOLISM, V43, P814, DOI 10.1016/0026-0495(94)90259-3; Vicente-Rodriguez G, 2003, BONE, V33, P853, DOI 10.1016/j.bone.2003.08.003; WASHBURN RA, 1986, AM J EPIDEMIOL, V123, P563, DOI 10.1093/oxfordjournals.aje.a114277; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2	48	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13435	10.1371/journal.pone.0013435	http://dx.doi.org/10.1371/journal.pone.0013435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976154	Green Published, Green Submitted, gold			2022-12-25	WOS:000283045300017
J	Udekwu, KI				Udekwu, Klas I.			Transcriptional and Post-Transcriptional Regulation of the Escherichia coli luxS mRNA; Involvement of the sRNA MicA	PLOS ONE			English	Article							SMALL NONCODING RNAS; ANTISENSE RNAS; AUTOINDUCER-2 PRODUCTION; DEPENDENT REGULATION; RIBONUCLEASE-III; EXPRESSION; BACTERIA; GENES; TYPHIMURIUM; DEGRADATION	Background: The small RNA (sRNA) MicA has been shown to post-transcriptionally regulate translation of the outer membrane protein A (OmpA) in Escherichia coli. It uses an antisense mechanism to down-regulate OmpA protein synthesis and induce mRNA degradation. MicA is genomically localized between the coding regions of the gshA and luxS genes and is divergently transcribed from its neighbours. Transcription of the luxS gene which originates within or upstream of the MicA sequence would thus be complementary to the sRNA. LuxS regulation is as yet unclear. Methodology/Principal Findings: In this report, I show that the luxS mRNA exists as three long (major) transcripts of sizes that suggest just such interaction. The sRNA MicA's expression affects the abundance of each of these luxS transcripts. The involvement of the ribonuclease, RNase III in the accumulation of the shortest transcript is demonstrated. When MicA accumulates during growth, or is induced to be over-expressed, the cleaved mRNA species is observed to increase in intensity. Using primer extension and 5'-RACE experiments in combination with sRNA overexpression plasmids, I identify the exact origin of two of the three luxS transcripts, one of which is seen to result from a previously unidentified sigma(5) dependent promoter. Conclusions/Significance: The presented data provides strong evidence that MicA functions in cis and in trans, targeting both luxS mRNA as well as the previously established ompA and phoP regulation. The proposed luxS regulation by MicA would be in tandem with another sRNA CyaR, shown recently to be involved in inhibiting translation of the luxS mRNA. Regulation of luxS expression is additionally shown to occur on a transcriptional level via sigma(5) with variable transcript levels in different growth phases unlike what was previously assumed. This is the first known case of an sRNA in E. coli which targets both in cis (luxS mRNA) and in trans (ompA and phoP mRNAs).	[Udekwu, Klas I.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Udekwu, KI (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden.	Klas.udekwu@emory.edu	Udekwu, Klas/I-4764-2012		Swedish Research Council; EU-STREP; Wallenberg consortium North	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU-STREP(European Commission); Wallenberg consortium North	Funding for this project was from a Swedish Research Council (VR) grant to the author and the EU-STREP (Specific Targeted Research or Innovation Project) program (Functions of small RNAs across kingdoms, FOSRAK) as well as the Wallenberg consortium North, all to E. Gerhart H. Wagner in whose lab all experimental work was performed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDEA M, 1990, EMBO J, V9, P3787, DOI 10.1002/j.1460-2075.1990.tb07592.x; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Beeston AL, 2002, J BACTERIOL, V184, P3450, DOI 10.1128/JB.184.13.3450-3456.2002; Bensing BA, 1996, P NATL ACAD SCI USA, V93, P7794, DOI 10.1073/pnas.93.15.7794; BLOMBERG P, 1990, EMBO J, V9, P2331, DOI 10.1002/j.1460-2075.1990.tb07405.x; Bralley P, 2004, J BACTERIOL, V186, P3160, DOI 10.1128/JB.186.10.3160-3172.2004; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Chen S, 2004, J BACTERIOL, V186, P6689, DOI 10.1128/JB.186.20.6689-6697.2004; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COORNAERT A, MOL MICROBIOLOGY, V76, P467; De Keersmaecker SCJ, 2006, TRENDS MICROBIOL, V14, P114, DOI 10.1016/j.tim.2006.01.003; De Lay N, 2009, J BACTERIOL, V191, P461, DOI 10.1128/JB.01157-08; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; KRINKE L, 1990, NUCLEIC ACIDS RES, V18, P4809, DOI 10.1093/nar/18.16.4809; LELONG C, 2007, MOL CELL PROTEOMICS; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mitarai N, 2007, PHYS BIOL, V4, P164, DOI 10.1088/1478-3975/4/3/003; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2006, P NATL ACAD SCI USA, V103, P4858, DOI 10.1073/pnas.0509638103; Papamichail D, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-12; Pertzev AV, 2006, NUCLEIC ACIDS RES, V34, P3708, DOI 10.1093/nar/gkl459; Rasmussen AA, 2005, MOL MICROBIOL, V58, P1421, DOI 10.1111/j.1365-2958.2005.04911.x; ROBERTSON HD, 1982, CELL, V30, P669, DOI 10.1016/0092-8674(82)90270-7; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; UDEKWU KI, 2007, NUCLEIC ACIDS RES; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Wagner EGH, 2002, TRENDS GENET, V18, P223, DOI 10.1016/S0168-9525(02)02658-6; Wagner EGH, 2002, ADV GENET, V46, P361; Wang L, 2005, J BACTERIOL, V187, P8350, DOI 10.1128/JB.187.24.8350-8360.2005; Wassarman KM, 1999, TRENDS MICROBIOL, V7, P37; Winzer K, 2002, MICROBIOL-SGM, V148, P909, DOI 10.1099/00221287-148-4-909; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Zhang M, 2008, MICROBIOL-SGM, V154, P2060, DOI 10.1099/mic.0.2008/017343-0	40	13	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13449	10.1371/journal.pone.0013449	http://dx.doi.org/10.1371/journal.pone.0013449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976191	Green Published, Green Submitted, gold			2022-12-25	WOS:000283045300022
J	Martinsson, K; Skogh, T; Mousavi, SA; Berg, T; Jonsson, JI; Hultman, P				Martinsson, Klara; Skogh, Thomas; Mousavi, Seyed Ali; Berg, Trond; Jonsson, Jan-Ingvar; Hultman, Per			Deficiency of Activating Fc gamma-Receptors Reduces Hepatic Clearance and Deposition of IC and Increases CIC Levels in Mercury-Induced Autoimmunity	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SINUSOIDAL ENDOTHELIAL-CELLS; G-IMMUNE-COMPLEXES; ANTI-FIBRILLARIN AUTOANTIBODIES; RAT-LIVER; MEDIATED ENDOCYTOSIS; HIGH-AFFINITY; TREATED MICE; IN-VIVO; MURINE	Background: Inorganic mercury (Hg) induces a T-cell dependent, systemic autoimmune condition (HgIA) where activating Fc gamma-receptors (Fc gamma Rs) are important for the induction. In this study we examined the influence of activating Fc gamma Rs on circulating levels and organ localization of immune complexes (IC) in HgIA. Methods and Principal Findings: Mercury treated BALB/c wt mice showed a significant but modest increase of circulating IC (CIC) from day 12 until day 18 and day 35 for IgG2a- and IgG1- CIC, respectively. Mercury-treated mice lacking the transmembrane gamma-chain of activating Fc gamma Rs (FcR gamma(-/-)) had significantly higher CIC levels of both IgG1-CIC and IgG2a-CIC than wt mice during the treatment course. The hepatic uptake of preformed CIC was significantly more efficient in wt mice compared to Fc gamma R(-/-) mice, but also development of extrahepatic tissue IC deposits was delayed in FcR gamma(-/-) mice. After 35 days of Hg treatment the proportion of immune deposits, as well as the amounts was significantly reduced in vessel FcR gamma(-/-) mice compared to wt mice. Conclusions: We conclude that mice lacking functional activating Fc gamma Rs respond to Hg with increased levels and altered quality of CIC compared with wt mice. Lack of functional activating Fc gamma Rs delayed the elimination of CIC, but also significantly reduced extrahepatic tissue localization of CIC.	[Martinsson, Klara; Hultman, Per] Linkoping Univ, Dept Clin & Expt Med, Div Mol & Immunol Pathol AIR, Linkoping, Sweden; [Skogh, Thomas] Linkoping Univ, Dept Clin & Expt Med, Rheumatol Unit AIR, Linkoping, Sweden; [Jonsson, Jan-Ingvar] Linkoping Univ, Dept Clin & Expt Med, Expt Hematol Unit, Linkoping, Sweden; [Mousavi, Seyed Ali] Rikshosp Univ Hosp, Dept Med Genet, Med Genet Lab, Oslo, Norway; [Berg, Trond] Univ Oslo, Dept Mol Biosci, Oslo, Norway	Linkoping University; Linkoping University; Linkoping University; University of Oslo; National Hospital Norway; University of Oslo	Martinsson, K (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Dept Pharm & Therapeut, Liverpool L69 3BX, Merseyside, England.	klara.martinsson@liu.se	Skogh, Thomas/C-9692-2009	Skogh, Thomas/0000-0002-0153-9249; Martinsson, Klara/0000-0003-4492-9172; Jonsson, Jan-Ingvar/0000-0003-4814-978X	Swedish Research Council Branch of Medicine [9453]; County Council of Ostergotland; Ingrid Asp foundation	Swedish Research Council Branch of Medicine(Swedish Research Council); County Council of Ostergotland; Ingrid Asp foundation	The project was supported by the Swedish Research Council Branch of Medicine (project no. 9453), funds from the County Council of Ostergotland and Ingrid Asp foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SS, 1995, HEPATOLOGY, V22, P316, DOI 10.1002/hep.1840220143; Allhorn M, 2009, ANN NY ACAD SCI, V1173, P664, DOI 10.1111/j.1749-6632.2009.04739.x; Baudino L, 2006, SPRINGER SEMIN IMMUN, V28, P175, DOI 10.1007/s00281-006-0037-0; Berger SP, 2007, SEMIN IMMUNOPATHOL, V29, P375, DOI 10.1007/s00281-007-0090-3; Bergtold A, 2006, J IMMUNOL, V177, P7287, DOI 10.4049/jimmunol.177.10.7287; BOGERS WMJM, 1991, CLIN EXP IMMUNOL, V86, P328; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; CHIA D, 1979, CLIN EXP IMMUNOL, V37, P399; Clynes R, 2005, CLIN EXP IMMUNOL, V141, P230, DOI 10.1111/j.1365-2249.2005.02847.x; Davies KA, 2002, ARTHRITIS RHEUM-US, V46, P1028, DOI 10.1002/art.10189; ENESTROM S, 1984, EXPERIENTIA, V40, P1234, DOI 10.1007/BF01946653; FENTON KA, AUTOIMMUNITY, V43, P179; Fismen S, 2009, LUPUS, V18, P597, DOI 10.1177/0961203308100512; Havarinasab S, 2006, TOXICOL APPL PHARM, V214, P43, DOI 10.1016/j.taap.2005.12.004; Havarinasab S, 2005, AUTOIMMUN REV, V4, P270, DOI 10.1016/j.autrev.2004.12.001; Hazenbos WLW, 1998, J IMMUNOL, V161, P3026; Heyman B, 2003, IMMUNOL LETT, V88, P157, DOI 10.1016/S0165-2478(03)00078-6; HULTMAN P, 1988, CLIN EXP IMMUNOL, V71, P269; HULTMAN P, 1989, CLIN EXP IMMUNOL, V78, P470; HULTMAN P, 1994, FASEB J, V8, P1183, DOI 10.1096/fasebj.8.14.7958626; HULTMAN P, 1989, J CLIN LAB IMMUNOL, V29, P175; HULTMAN P, 1992, CLIN IMMUNOL IMMUNOP, V65, P98, DOI 10.1016/0090-1229(92)90212-7; HULTMAN P, 1995, CLIN IMMUNOL IMMUNOP, V77, P291, DOI 10.1006/clin.1995.1155; IZUI S, 1979, J EXP MED, V149, P1099, DOI 10.1084/jem.149.5.1099; Johansson AG, 1996, HEPATOLOGY, V24, P169, DOI 10.1053/jhep.1996.v24.pm0008707258; Kain R, 2008, NAT MED, V14, P1088, DOI 10.1038/nm.1874; Kavai M, 2007, AUTOIMMUN REV, V6, P497, DOI 10.1016/j.autrev.2007.01.017; Kleinau S, 2000, J EXP MED, V191, P1611, DOI 10.1084/jem.191.9.1611; Kleinau S, 2003, CURR PHARM DESIGN, V9, P1861, DOI 10.2174/1381612033454414; KOSUGI I, 1992, J HEPATOL, V16, P106, DOI 10.1016/S0168-8278(05)80102-3; Kotnik V, 2003, CROAT MED J, V44, P707; Lovdal T, 2000, J CELL SCI, V113, P3255; Martinsson K, 2006, CLIN EXP IMMUNOL, V144, P309, DOI 10.1111/j.1365-2249.2006.03057.x; Martinsson K, 2008, J AUTOIMMUN, V31, P22, DOI 10.1016/j.jaut.2008.01.002; Mjelle JE, 2007, ANN RHEUM DIS, V66, P1661, DOI 10.1136/ard.2007.070482; Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748; Nangaku Masaomi, 2005, Clin Exp Nephrol, V9, P183, DOI 10.1007/s10157-005-0357-8; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Oates JC, 2002, CURR OPIN RHEUMATOL, V14, P498, DOI 10.1097/00002281-200209000-00003; PITTMAN RC, 1983, BIOCHEM J, V212, P791, DOI 10.1042/bj2120791; RAVETCH J, NATURE IMMUNOLOGY, V11, P183; SASAKI T, 1991, AM J MED, V91, P355, DOI 10.1016/0002-9343(91)90152-N; SKOGH T, 1983, INT ARCH ALLER A IMM, V70, P238, DOI 10.1159/000233330; SKOGH T, 1985, IMMUNOLOGY, V55, P585; SKOGH T, 1983, IMMUNOLOGY, V49, P53; Stokol T, 2004, J EXP MED, V200, P835, DOI 10.1084/jem.20040501; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tuzun E, 2006, J NEUROIMMUNOL, V174, P157, DOI 10.1016/j.jneuroim.2006.01.015; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413; Zabaleta-Lanz M, 2003, LUPUS, V12, P26, DOI 10.1191/0961203303lu259oa; Zabaleta-Lanz ME, 2006, LUPUS, V15, P845, DOI 10.1177/0961203306070002	52	7	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13413	10.1371/journal.pone.0013413	http://dx.doi.org/10.1371/journal.pone.0013413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976163	Green Submitted, gold, Green Published			2022-12-25	WOS:000283043700013
J	Zwart, MP; Dieu, BTM; Hemerik, L; Vlak, JM				Zwart, Mark P.; Dieu, Bui Thi Minh; Hemerik, Lia; Vlak, Just M.			Evolutionary Trajectory of White Spot Syndrome Virus (WSSV) Genome Shrinkage during Spread in Asia	PLOS ONE			English	Article							POPULATION-GENETICS; SHRIMP AQUACULTURE; HEALTH MANAGEMENT; ADAPTATION; DNA; REDUCTION; VIRULENCE; QUANTIFICATION; INFECTION; SELECTION	Background: White spot syndrome virus (WSSV) is the sole member of the novel Nimaviridae family, and the source of major economic problems in shrimp aquaculture. WSSV appears to have rapidly spread worldwide after the first reported outbreak in the early 1990s. Genomic deletions of various sizes occur at two loci in the WSSV genome, the ORF14/15 and ORF23/24 variable regions, and these have been used as molecular markers to study patterns of viral spread over space and time. We describe the dynamics underlying the process of WSSV genome shrinkage using empirical data and a simple mathematical model. Methodology/Principal Findings: We genotyped new WSSV isolates from five Asian countries, and analyzed this information together with published data. Genome size appears to stabilize over time, and deletion size in the ORF23/24 variable region was significantly related to the time of the first WSSV outbreak in a particular country. Parameter estimates derived from fitting a simple mathematical model of genome shrinkage to the data support a geometric progression (k < 1) of the genomic deletions, with k = 0.371 +/- 0.150. Conclusions/Significance: The data suggest that the rate of genome shrinkage decreases over time before attenuating. Bioassay data provided support for a link between genome size and WSSV fitness in an aquaculture setting. Differences in genomic deletions between geographic WSSV isolates suggest that WSSV spread did not follow a smooth pattern of geographic radiation, suggesting spread of WSSV over long distances by commercial activities. We discuss two hypotheses for genome shrinkage, an adaptive and a neutral one. We argue in favor of the adaptive hypothesis, given that there is support for a link between WSSV genome size and fitness.	[Zwart, Mark P.; Dieu, Bui Thi Minh; Vlak, Just M.] Wageningen Univ, Virol Lab, Wageningen, Netherlands; [Zwart, Mark P.] Wageningen Univ, Quantitat Vet Epidemiol Grp, Wageningen, Netherlands; [Zwart, Mark P.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Dieu, Bui Thi Minh] Can Tho Univ, Biotechnol Res & Dev Inst, Can Tho City, Vietnam; [Hemerik, Lia] Wageningen Univ, Biometris, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Can Tho University; Wageningen University & Research	Zwart, MP (corresponding author), Wageningen Univ, Virol Lab, Wageningen, Netherlands.	marzwa@upvnet.upv.es	Zwart, Mark P/B-3408-2018	Zwart, Mark P/0000-0003-4361-7636; Hemerik, Lia/0000-0002-6892-2840	Netherlands Organisation for Scientific Research (NWO); Science for Global Development (NWO WOTRO) [WB 83-207]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Science for Global Development (NWO WOTRO)	MPZ was supported in part by a Rubicon Grant from the Netherlands Organisation for Scientific Research (NWO, www.nwo.nl). BTMD was supported by a Science for Global Development (NWO WOTRO, www.nwo.nl/wotro) PhD scholarship (grant WB 83-207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewick V, 2004, CRIT CARE, V8, P130, DOI 10.1186/cc2836; Bondad-Reantaso MG, 2005, VET PARASITOL, V132, P249, DOI 10.1016/j.vetpar.2005.07.005; Buckling A, 2009, NATURE, V457, P824, DOI 10.1038/nature07892; Bull JJ, 2004, EVOLUTION, V58, P692; Bull JJ, 1997, GENETICS, V147, P1497; Chapman RW, 2004, DIS AQUAT ORGAN, V59, P179, DOI 10.3354/dao059179; Corsin F, 2001, DIS AQUAT ORGAN, V47, P1, DOI 10.3354/dao047001; DEJONG MCM, 1994, VACCINE, V12, P761, DOI 10.1016/0264-410X(94)90229-1; Dieu BTM, 2004, J GEN VIROL, V85, P3607, DOI 10.1099/vir.0.80344-0; DIEU BTM, DIS ASIAN AQUACULTUR, V7; Dieu BTM, 2010, J GEN VIROL, V91, P1164, DOI 10.1099/vir.0.018028-0; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Filee J, 2008, RES MICROBIOL, V159, P325, DOI 10.1016/j.resmic.2008.04.012; Gomez-Valero L, 2007, GENE, V389, P87, DOI 10.1016/j.gene.2006.10.001; Holder KK, 2001, GENETICS, V159, P1393; HUANG AS, 1973, ANNU REV MICROBIOL, V27, P101, DOI 10.1146/annurev.mi.27.100173.000533; KHOA LV, 2000, VIET NAM, P91; Kimura MA, 1985, NEUTRAL THEORY MOL E; KONGKEO H, 1994, INFOFISH INT C AQ 21; Kuo CH, 2009, GENOME RES, V19, P1450, DOI 10.1101/gr.091785.109; Lan YS, 2002, VIRUS RES, V90, P269, DOI 10.1016/S0168-1702(02)00231-9; Laramore SE, 2009, J AQUAT ANIM HEALTH, V21, P82, DOI 10.1577/H08-012.1; Lebel L, 2002, AMBIO, V31, P311, DOI 10.1639/0044-7447(2002)031[0311:ITASAI]2.0.CO;2; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lotz JM, 1997, WORLD J MICROB BIOT, V13, P405, DOI 10.1023/A:1018572132529; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Lynch M, 2006, ANNU REV MICROBIOL, V60, P327, DOI 10.1146/annurev.micro.60.080805.142300; Madhi SA, 2021, SAFETY EFFICACY CHAD, DOI 10.1101/2021.02.10.21251247; Marks H, 2005, J GEN VIROL, V86, P2081, DOI 10.1099/vir.0.80895-0; Marks H, 2005, VIRUS RES, V110, P9, DOI 10.1016/j.virusres.2005.01.002; Marks H, 2004, ARCH VIROL, V149, P673, DOI 10.1007/s00705-003-0248-9; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; Ochman H, 2005, P NATL ACAD SCI USA, V102, P11959, DOI 10.1073/pnas.0505863102; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Park JE, 2009, ARCH VIROL, V154, P1709, DOI 10.1007/s00705-009-0489-3; Pradeep B, 2008, DIS AQUAT ORGAN, V78, P189, DOI 10.3354/dao01878; Pradeep B, 2009, J FISH DIS, V32, P801, DOI 10.1111/j.1365-2761.2009.01053.x; Pradeep B, 2008, VIROLOGY, V376, P24, DOI 10.1016/j.virol.2008.02.037; REGIDOR SE, 2005, CURRENT STATUS TRANS; Schoustra SE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000250; Seok SH, 2004, DIS AQUAT ORGAN, V60, P85, DOI 10.3354/dao060085; Sokal R. R., 2012, BIOMETRY; Soto MA, 2001, J INVERTEBR PATHOL, V78, P9, DOI 10.1006/jipa.2001.5035; SOUR K, 2004, WETLANDS MANAGEMENT, P1; Tan Y, 2009, J FISH DIS, V32, P777, DOI 10.1111/j.1365-2761.2009.01055.x; Tang KFJ, 2000, AQUACULTURE, V189, P11, DOI 10.1016/S0044-8486(00)00367-7; Taylor DR, 2002, P NATL ACAD SCI USA, V99, P3690, DOI 10.1073/pnas.072660299; van Hoek MJA, 2007, MOL BIOL EVOL, V24, P2485, DOI 10.1093/molbev/msm183; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; Vijayan KK, 2005, DIS AQUAT ORGAN, V63, P107, DOI 10.3354/dao063107; VISETH H, 2005, OVERVIEW AQUACULTURE; Vlak JM, 2005, 8 REP INT COMM TAX V, P187; VONMAGNUS P, 1954, ADV VIRUS RES, V2, P59, DOI 10.1016/S0065-3527(08)60529-1; Walker PJ, 2009, REV AQUACULT, V1, P125, DOI 10.1111/j.1753-5131.2009.01007.x; Witteveldt J, 2004, FISH SHELLFISH IMMUN, V16, P571, DOI 10.1016/j.fsi.2003.09.006; Wu JL, 2001, DIS AQUAT ORGAN, V47, P129, DOI 10.3354/dao047129; Xie XX, 2005, VIRUS RES, V108, P63, DOI 10.1016/j.virusres.2004.08.002; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Zwart MP, 2008, J GEN VIROL, V89, P1220, DOI 10.1099/vir.0.83645-0; Zwart MP, 2010, BIOL CONTROL, V52, P77, DOI 10.1016/j.biocontrol.2009.10.002	63	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13400	10.1371/journal.pone.0013400	http://dx.doi.org/10.1371/journal.pone.0013400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976239	Green Published, gold, Green Submitted			2022-12-25	WOS:000282941000022
J	Ndamukong, I; Jones, DR; Lapko, H; Divecha, N; Avramova, Z				Ndamukong, Ivan; Jones, David R.; Lapko, Hanna; Divecha, Nullin; Avramova, Zoya			Phosphatidylinositol 5-Phosphate Links Dehydration Stress to the Activity of ARABIDOPSIS TRITHORAX-LIKE Factor ATX1	PLOS ONE			English	Article							PHD FINGER; SUBSTRATE-SPECIFICITY; MOLECULAR-BASIS; MYOTUBULARIN; IDENTIFICATION; PHOSPHOINOSITIDES; PTDINS5P; HOMOLOG; PATHWAY; PROTEIN	Background: Changes in gene expression enable organisms to respond to environmental stress. Levels of cellular lipid second messengers, such as the phosphoinositide PtdIns5P, change in response to a variety of stresses and can modulate the localization, conformation and activity of a number of intracellular proteins. The plant trithorax factor (ATX1) trimethylates the lysine 4 residue of histone H3 (H3K4me3) at gene coding sequences, which positively correlates with gene transcription. Microarray analysis has identified a target gene (WRKY70) that is regulated by both ATX1 and by the exogenous addition of PtdIns5P in Arabidopsis. Interestingly, ATX1 contains a PtdIns5P interaction domain (PHD finger) and thus, phosphoinositide signaling, may link environmental stress to changes in gene transcription. Principal Findings: Using the plant Arabidopsis as a model system, we demonstrate a link between PtdIns5P and the activity of the chromatin modifier ATX1 in response to dehydration stress. We show for the first time that dehydration leads to an increase in cellular PtdIns5P in Arabidopsis. The Arabidopsis homolog of myotubularin (AtMTM1) is capable of generating PtdIns5P and here, we show that AtMTM1 is essential for the induced increase in PtdIns5P upon dehydration. Furthermore, we demonstrate that the ATX1-dependent gene, WRKY70, is downregulated during dehydration and that lowered transcript levels are accompanied by a drastic reduction in H3K4me3 of its nucleosomes. We follow changes in WRKY70 nucleosomal K4 methylation as a model to study ATX1 activity at chromatin during dehydration stress. We found that during dehydration stress, the physical presence of ATX1 at the WRKY70 locus was diminished and that ATX1 depletion resulted from it being retained in the cytoplasm when PtdIns5P was elevated. The PHD of ATX1 and catalytically active AtMTM1 are required for the cytoplasmic localization of ATX1. Conclusions/Significance: The novelty of the manuscript is in the discovery of a mechanistic link between a chromatin modifying activity (ATX1) and a lipid (PtdIns5P) synthesis in a signaling pathway that ultimately results in altered expression of ATX1 dependent genes downregulated in response to dehydration stress.	[Ndamukong, Ivan; Lapko, Hanna; Avramova, Zoya] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Jones, David R.; Divecha, Nullin] Univ Manchester, Paterson Inst Canc Res, Inositide Lab, Manchester, Lancs, England	University of Nebraska System; University of Nebraska Lincoln; Paterson Institute for Cancer Research; University of Manchester	Ndamukong, I (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	zavramova2@unl.edu		Lapko, Hanna/0000-0002-3490-4126; divecha, nullin/0000-0001-9695-6039	Cancer Research UK [NSF-EPS0701892, NSF-MCB0749504]	Cancer Research UK(Cancer Research UK)	The work was partially supported by (National Science Foundation) NSF-EPS0701892 and NSF-MCB0749504 awards to Z.A. Research at the Paterson Institute for Cancer Research is entirely funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Venegas R, 2006, P NATL ACAD SCI USA, V103, P6049, DOI 10.1073/pnas.0600944103; Alvarez-Venegas R, 2003, CURR BIOL, V13, P627, DOI 10.1016/S0960-9822(03)00243-4; Alvarez-Venegas R, 2007, EPIGENETICS-US, V2, P106, DOI 10.4161/epi.2.2.4404; Alvarez-Venegas R, 2006, PLANT SIGNAL BEHAV, V1, P140, DOI 10.4161/psb.1.3.2997; Avramova ZV, 2002, PLANT PHYSIOL, V129, P40, DOI 10.1104/pp.010981; Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Begley MJ, 2005, CURR OPIN STRUC BIOL, V15, P614, DOI 10.1016/j.sbi.2005.10.016; Bensmihen S, 2004, FEBS LETT, V561, P127, DOI 10.1016/S0014-5793(04)00148-6; Boss Wendy E., 2006, V39, P181; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; Ding Y, 2009, PLANT SIGNAL BEHAV, V4, P1049, DOI 10.4161/psb.4.11.10103; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; Firestein R, 2001, J CELL SCI, V114, P2921; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; HEWLETT JD, 1963, PROTOPLASMA, V57, P381, DOI 10.1007/BF01252067; HOLLANDER, WOLFE NONPARAMETRIC; Jones DR, 2006, MOL CELL, V23, P685, DOI 10.1016/j.molcel.2006.07.014; Jones David R., 2009, V462, P75, DOI 10.1007/978-1-60327-115-8_5; Jones DR, 2004, CURR OPIN GENET DEV, V14, P196, DOI 10.1016/j.gde.2004.02.003; Jones DR, 1999, J BIOL CHEM, V274, P18407, DOI 10.1074/jbc.274.26.18407; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim SA, 2002, J BIOL CHEM, V277, P4526, DOI 10.1074/jbc.M111087200; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; MARTIN B, 1985, J BIOL CHEM, V260, P4932; Meijer HJG, 2001, BIOCHEM J, V360, P491, DOI 10.1042/0264-6021:3600491; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Nandurkar HH, 2003, P NATL ACAD SCI USA, V100, P8660, DOI 10.1073/pnas.1033097100; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Pendaries C, 2005, ADV ENZYME REGUL, V45, P201, DOI 10.1016/j.advenzreg.2005.02.006; PETERMAN KT, 2004, PLANT PHYSIOL, V136, P1; Petruk S, 2001, SCIENCE, V294, P1331, DOI 10.1126/science.1065683; Pical C, 1999, J BIOL CHEM, V274, P38232, DOI 10.1074/jbc.274.53.38232; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Saleh A, 2008, GENE, V423, P43, DOI 10.1016/j.gene.2008.06.022; Saleh A, 2008, NAT PROTOC, V3, P1018, DOI 10.1038/nprot.2008.66; Sbrissa D, 2002, J BIOL CHEM, V277, P47276, DOI 10.1074/jbc.M207576200; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; Ungewickell A, 2005, P NATL ACAD SCI USA, V102, P18854, DOI 10.1073/pnas.0509740102; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	46	52	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13396	10.1371/journal.pone.0013396	http://dx.doi.org/10.1371/journal.pone.0013396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967218	Green Published, gold			2022-12-25	WOS:000282869800051
J	Arbesman, S; Laughlin, G				Arbesman, Samuel; Laughlin, Gregory			A Scientometric Prediction of the Discovery of the First Potentially Habitable Planet with a Mass Similar to Earth	PLOS ONE			English	Article								Background: The search for a habitable extrasolar planet has long interested scientists, but only recently have the tools become available to search for such planets. In the past decades, the number of known extrasolar planets has ballooned into the hundreds, and with it, the expectation that the discovery of the first Earth-like extrasolar planet is not far off. Methodology/Principal Findings: Here, we develop a novel metric of habitability for discovered planets and use this to arrive at a prediction for when the first habitable planet will be discovered. Using a bootstrap analysis of currently discovered exoplanets, we predict the discovery of the first Earth-like planet to be announced in the first half of 2011, with the likeliest date being early May 2011. Conclusions/Significance: Our predictions, using only the properties of previously discovered exoplanets, accord well with external estimates for the discovery of the first potentially habitable extrasolar planet and highlight the the usefulness of predictive scientometric techniques to understand the pace of scientific discovery in many fields.	[Arbesman, Samuel] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Arbesman, Samuel] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Laughlin, Gregory] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA	Harvard University; Harvard Medical School; Harvard University; University of California System; University of California Santa Cruz	Arbesman, S (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	arbesman@hcp.med.harvard.edu						Arbesman S, 2011, SCIENTOMETRICS, V86, P245, DOI 10.1007/s11192-010-0232-6; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; de Solla Price Derek J., 1986, LITTLE SCI BIG SCI; Fridlund M, 2010, ASTROBIOLOGY, V10, P1, DOI [10.1089/ast.2009.0382, 10.1089/ast.2009.0368]; GROSSMAN L, 2004, TIME            1011; KASTING JF, 1993, ICARUS, V101, P108, DOI 10.1006/icar.1993.1010; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Koh H, 2006, TECHNOL FORECAST SOC, V73, P1061, DOI 10.1016/j.techfore.2006.06.001; Landsberger HA, 1958, HAWTHORNE REVISITED; LAUGHLIN G, 2010, SYSTEMIC CHARACTERIZ; MAYOR M, 1995, NATURE, V378, P355, DOI 10.1038/378355a0; Mischna MA, 2000, ICARUS, V145, P546, DOI 10.1006/icar.2000.6380; Moore G., 1965, ELECTRONICS, V38, P114, DOI [DOI 10.1109/N-SSC.2006.4785860, DOI 10.1109/JPROC.1998.658762]; Santos NC, 2005, SCIENCE, V310, P251, DOI 10.1126/science.1100210; Schilling G, 2007, SCIENCE, V316, P528; SURVEY CP, 2010, EXOPLANET ORBIT DATA; Vogel G, 1999, SCIENCE, V286, P70, DOI 10.1126/science.286.5437.70; WORDSWORTH R, 2010, ARXIV10055098	18	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13061	10.1371/journal.pone.0013061	http://dx.doi.org/10.1371/journal.pone.0013061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957226	gold, Green Published, Green Submitted			2022-12-25	WOS:000282423300002
J	Inaguma, S; Kasai, K; Ikeda, H				Inaguma, S.; Kasai, K.; Ikeda, H.			GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin	ONCOGENE			English	Article						GLI1; MUC5AC; E-cadherin; beta-catenin; invasion; pancreatic cancer	GENE-EXPRESSION; MUC5AC MUCIN; HEDGEHOG; PROGNOSIS; TARGET; GROWTH; ASSOCIATION; REQUIREMENT; PROTEIN; CHOLANGIOCARCINOMA	The Kruppel-like zinc-finger protein GLI1 functions as a downstream transcription factor of Hedgehog signaling and plays a pivotal role in the cellular proliferation of many types of tumors, including pancreatic ductal adenocarcinoma (PDA). PDA develops from dysplastic lesions called pancreatic intraepithelial neoplasia (PanIN) through a multistep carcinogenesis process that changes its cellular characteristics, including a mucin expression profile. Increased expression of a gel-forming mucin, MUC5AC, was previously revealed as a major biomarker for the poor prognosis of PDA patients, but the molecular mechanisms responsible for its expression and correlation with poor prognosis are not fully understood. Here we show that MUC5AC is a direct transcriptional target of GLI1 in PDA cells. Overexpression of GLI1 enhanced MUC5AC expression, and a double knockdown of GLI1 and GLI2 suppressed endogenous MUC5AC expression in PDA cells. Luciferase reporter assays revealed that GLI1 and GLI2 can activate the MUC5AC promoter through its conserved CACCC-box-like cis-regulatory elements. We also found that GLI1-upregulated MUC5AC was expressed in the intercellular junction between cultured PDA cells and interfered with the membrane localization of E-cadherin, leading to decreased E-cadherin-dependent cell-cell adhesion and promoting the migration and invasion of PDA cells. Consistently, GLI1 induced the nuclear accumulation and target gene expression of beta-catenin in a MUC5AC-dependent manner. Finally, immunohistochemical analysis revealed that GLI1 expression statistically correlated with MUC5AC expression and also with altered subcellular localization of E-cadherin and beta-catenin in PanIN lesions and PDA. This evidence revealed a new aspect of GLI1 function in modulating E-cadherin/beta-catenin-regulated cancer cell properties through the expression of a gel-forming mucin. Oncogene (2011) 30, 714-723; doi:10.1038/onc.2010.459; published online 25 October 2010	[Inaguma, S.; Kasai, K.; Ikeda, H.] Aichi Med Univ, Dept Pathol, Sch Med, Aichi 4801195, Japan	Aichi Medical University	Kasai, K (corresponding author), Aichi Med Univ, Dept Pathol, Sch Med, 21 Karimata, Aichi 4801195, Japan.	kkasai@aichi-med-u.ac.jp	Kasai, Kenji/K-6382-2019	Kasai, Kenji/0000-0001-6566-9483	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Yukiko Matsubara, Motoyasu Takeuchi and Naoki Igari (Aichi Medical University) for their expert technical assistance. We also thank Dr Akiko Tamakoshi (Aichi Medical University) for advice on statistical analyses and Dr Masahide Takahashi (Nagoya University) for comments on the manuscript. This research was supported in part by a Grant-in-Aid for Scientific Research (C) (to KK) and for Young Scientists (B) (to SI) from the Japan Society for the Promotion of Science.	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Aishima S, 2006, HISTOPATHOLOGY, V49, P35, DOI 10.1111/j.1365-2559.2006.02414.x; Al-Aynati MM, 2004, CLIN CANCER RES, V10, P1235, DOI 10.1158/1078-0432.CCR-03-0087; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Boonla C, 2003, CANCER, V98, P1438, DOI 10.1002/cncr.11652; Briggs CD, 2009, EUR J CANCER, V45, P33, DOI 10.1016/j.ejca.2008.08.024; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Gkretsi V, 2005, J CELL SCI, V118, P697, DOI 10.1242/jcs.01638; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Jepson S, 2002, ONCOGENE, V21, P7524, DOI 10.1038/sj.onc.1205970; Kasai K, 2004, GENES CELLS, V9, P49, DOI 10.1111/j.1356-9597.2004.00701.x; Kasai K, 2008, CANCER RES, V68, P7723, DOI 10.1158/0008-5472.CAN-07-6661; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Lee HS, 2001, CANCER, V92, P1427, DOI 10.1002/1097-0142(20010915)92:6<1427::AID-CNCR1466>3.0.CO;2-L; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Park ET, 2008, INT J CANCER, V122, P1253, DOI 10.1002/ijc.23225; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Senapati S, 2008, HISTOL HISTOPATHOL, V23, P1541, DOI 10.14670/HH-23.1541; Shimokawa T, 2003, CANCER RES, V63, P6116; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Singh AP, 2008, LANCET ONCOL, V9, P1076, DOI 10.1016/S1470-2045(08)70277-8; Takikita M, 2009, CANCER RES, V69, P2950, DOI 10.1158/0008-5472.CAN-08-3879; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Truant S, 2003, INT J CANCER, V104, P683, DOI 10.1002/ijc.11011; Vincent A, 2007, ONCOGENE, V26, P6566, DOI 10.1038/sj.onc.1210479; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Yu CJ, 1996, INT J CANCER, V69, P457, DOI 10.1002/(SICI)1097-0215(19961220)69:6<457::AID-IJC7>3.0.CO;2-3; Yu CJ, 2005, LUNG CANCER, V47, P59, DOI 10.1016/j.lungcan.2004.05.018	35	85	90	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	6					714	723		10.1038/onc.2010.459	http://dx.doi.org/10.1038/onc.2010.459			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	719GY	20972463				2022-12-25	WOS:000287192000008
J	Li, HR; Mapolelo, DT; Dingra, NN; Keller, G; Riggs-Gelasco, PJ; Winge, DR; Johnson, MK; Outten, CE				Li, Haoran; Mapolelo, Daphne T.; Dingra, Nin N.; Keller, Greg; Riggs-Gelasco, Pamela J.; Winge, Dennis R.; Johnson, Michael K.; Outten, Caryn E.			Histidine 103 in Fra2 Is an Iron-Sulfur Cluster Ligand in the [2Fe-2S] Fra2-Grx3 Complex and Is Required for in Vivo Iron Signaling in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-ABSORPTION-SPECTROSCOPY; BOLA-LIKE PROTEIN; SACCHAROMYCES-CEREVISIAE; MONOTHIOL GLUTAREDOXINS; SCAFFOLD PROTEINS; OXIDATIVE STRESS; TRANSCRIPTION; MITOCHONDRIAL; RIESKE; AFT1	The BolA homologue Fra2 and the cytosolic monothiol glutaredoxins Grx3 and Grx4 together play a key role in regulating iron homeostasis in Saccharomyces cerevisiae. Genetic studies indicate that Grx3/4 and Fra2 regulate activity of the iron-responsive transcription factors Aft1 and Aft2 in response to mitochondrial Fe-S cluster biosynthesis. We have previously shown that Fra2 and Grx3/4 form a [2Fe-2S](2+)-bridged heterodimeric complex with iron ligands provided by the active site cysteine of Grx3/4, glutathione, and a histidine residue. To further characterize this unusual Fe-S-binding complex, site-directed mutagenesis was used to identify specific residues in Fra2 that influence Fe-S cluster binding and regulation of Aft1 activity in vivo. Here, we present spectroscopic evidence that His-103 in Fra2 is an Fe-S cluster ligand in the Fra2-Grx3 complex. Replacement of this residue does not abolish Fe-S cluster binding, but it does lead to a change in cluster coordination and destabilization of the [2Fe-2S] cluster. In vivo genetic studies further confirm that Fra2 His-103 is critical for control of Aft1 activity in response to the cellular iron status. Using CD spectroscopy, we find that similar to 1 mol eq of apo-Fra2 binds tightly to the [2Fe-2S] Grx3 homodimer to form the [2Fe-2S] Fra2-Grx3 heterodimer, suggesting a mechanism for formation of the [2Fe-2S] Fra2-Grx3 heterodimer in vivo. Taken together, these results demonstrate that the histidine coordination and stability of the [2Fe-2S] cluster in the Fra2-Grx3 complex are essential for iron regulation in yeast.	[Li, Haoran; Dingra, Nin N.; Outten, Caryn E.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Mapolelo, Daphne T.; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Mapolelo, Daphne T.; Johnson, Michael K.] Univ Georgia, Ctr Metalloenzyme Studies, Athens, GA 30602 USA; [Keller, Greg; Winge, Dennis R.] Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; [Keller, Greg; Winge, Dennis R.] Univ Utah, Dept Med, Salt Lake City, UT 84132 USA; [Riggs-Gelasco, Pamela J.] Coll Charleston, Dept Chem & Biochem, Charleston, SC 29424 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; College of Charleston	Outten, CE (corresponding author), Univ S Carolina, Dept Chem & Biochem, 631 Sumter St, Columbia, SC 29208 USA.	caryn.outten@chem.sc.edu	Outten, Caryn E./I-9433-2019; Li, Haoran/J-6618-2013	Outten, Caryn E./0000-0003-0335-6531; Li, Haoran/0000-0002-6158-2345	National Institutes of Health [ES13780, GM62524, ES03817, P20 RR016461]; Camille and Henry Dreyfus Foundation; United States Department of Energy, Office of Basic Energy Sciences; Department of Energy; National Institutes of Health-NCRR; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817, K22ES013780, R37ES003817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062524, R01GM083292, R01GM062524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Camille and Henry Dreyfus Foundation; United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); National Institutes of Health-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES13780 (to C.E.O.), GM62524 (to M.K.J.), ES03817 (to D. R. W.), and P20 RR016461 (P.J.R.-G.). This work was also supported by The Camille and Henry Dreyfus Foundation Scholar Award (to P.J.R.-G.).; We thank F. Wayne Outten (University of South Carolina) for helpful discussions and Jerry Kaplan (University of Utah) for Fra2 antibodies. The Stanford Synchrotron Radiation Laboratory is a national user facility supported by the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by Department of Energy and the National Institutes of Health-NCRR Biomedical Technology Program.	Bak DW, 2009, BIOCHEMISTRY-US, V48, P10193, DOI 10.1021/bi9016445; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BERTRAND P, 1979, BIOCHIM BIOPHYS ACTA, V579, P107, DOI 10.1016/0005-2795(79)90091-6; BERTRAND P, 1980, BIOCHIM BIOPHYS ACTA, V625, P337, DOI 10.1016/0005-2795(80)90298-6; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Broderick JB, 2000, BIOCHEM BIOPH RES CO, V269, P451, DOI 10.1006/bbrc.2000.2313; Chin KH, 2005, J BIOMOL NMR, V31, P167, DOI 10.1007/s10858-004-7804-9; Clark-Baldwin K, 1998, J AM CHEM SOC, V120, P8401, DOI 10.1021/ja980580o; Cosper MM, 2004, BIOCHEMISTRY-US, V43, P2007, DOI 10.1021/bi0356653; Cosper NJ, 2002, PROTEIN SCI, V11, P2969, DOI 10.1110/ps.0222402; Couturier J, 2009, CELL MOL LIFE SCI, V66, P2539, DOI 10.1007/s00018-009-0054-y; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibson LM, 2008, ACTA CRYSTALLOGR D, V64, P927, DOI 10.1107/S0907444908021641; Huynen MA, 2005, FEBS LETT, V579, P591, DOI 10.1016/j.febslet.2004.11.111; Iwema T, 2009, BIOCHEMISTRY-US, V48, P6041, DOI 10.1021/bi900440m; Kasai T, 2004, PROTEIN SCI, V13, P545, DOI 10.1110/ps.03401004; Kim KD, 2010, BIOCHEM BIOPH RES CO, V392, P467, DOI 10.1016/j.bbrc.2010.01.051; Kounosu A, 2004, J BIOL CHEM, V279, P12519, DOI 10.1074/jbc.M305923200; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Link TA, 1999, ADV INORG CHEM, V47, P83, DOI 10.1016/S0898-8838(08)60077-X; MEYER J, 1994, BIOCHEMISTRY-US, V33, P13642, DOI 10.1021/bi00250a014; Molina MM, 2004, J BIOL CHEM, V279, P51923, DOI 10.1074/jbc.M410219200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Protchenko O, 2001, J BIOL CHEM, V276, P49244, DOI 10.1074/jbc.M109220200; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; TSANG HT, 1989, BIOCHEMISTRY-US, V28, P7233, DOI 10.1021/bi00444a015; Ueta R, 2007, MOL BIOL CELL, V18, P2980, DOI 10.1091/mbc.E06-11-1054; WERTH MT, 1990, P NATL ACAD SCI USA, V87, P8965, DOI 10.1073/pnas.87.22.8965; WERTH MT, 1992, FEBS LETT, V299, P1, DOI 10.1016/0014-5793(92)80086-V; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372	43	89	90	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					867	876		10.1074/jbc.M110.184176	http://dx.doi.org/10.1074/jbc.M110.184176			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978135	hybrid, Green Published			2022-12-25	WOS:000285782800086
J	Zhang, ZY; Lowry, SF; Guarente, L; Haimovich, B				Zhang, Zhiyong; Lowry, Stephen F.; Guarente, Leonard; Haimovich, Beatrice			Roles of SIRT1 in the Acute and Restorative Phases following Induction of Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; HYPOXIA-INDUCIBLE FACTOR-1; UBIQUITIN-PROTEASOME PATHWAY; PERIPHERAL-BLOOD LEUKOCYTES; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; FACTOR 1-ALPHA; FACTOR-I	Endotoxin is a potent inducer of systemic inflammatory responses in human and rodents. Here, we show that in vivo endotoxin triggers a rapid and transient decline in ATP concentration in human peripheral blood leukocytes and murine peripheral blood leukocytes and liver, which is associated with a brief increase in expression of the autophagy indicator LC3-II. In both of these tissues, the ATP concentration reaches a nadir, and autophagy is induced between 2 and 4 h post-endotoxin infusion, and homeostasis is restored within 12 h. Mouse liver SIRT1 and AMP-activated protein kinase (AMPK) protein expression levels decline precipitously within 10 min and remain below detection levels for up to 12 h post-endotoxin administration. In marked contrast, the expression of HIF-1 alpha is induced within 90 min and remains elevated for up to 12 h. The ATP recovery is delayed, and the increases in both HIF-1 alpha expression and autophagy are prolonged in endotoxin-challenged SIRT1 liver knock-out mice. Resveratrol prevents the decline in ATP concentration and SIRT1 expression, as well as the increase in HIF-1 alpha expression and autophagy in liver of endotoxin-challenged wild type mice but not in SIRT1 liver knock-out mice. These results provide novel insight into the state of both cellular bioenergetics and metabolic networks during the acute phase of systemic inflammation and suggest a role for SIRT1 in acute metabolic decline, as well as the restoration of metabolic homeostasis during an inflammatory challenge.	[Haimovich, Beatrice] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08902 USA; [Guarente, Leonard] MIT, Paul F Glenn Lab, Cambridge, MA 02139 USA; [Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Haimovich, B (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, CAB Rm 7018,125 Paterson St, New Brunswick, NJ 08902 USA.	haimovic@umdnj.edu		zhang, zhiyong/0000-0003-4061-7374; ZHANG, ZHIYONG/0000-0001-8576-1607	National Institutes of Health [R21GM079255]; NIGMS [RO1 GM 034695]; NIEHS Center for Excellence [ES005022]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM079255, R01GM034695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS Center for Excellence; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21GM079255 (to B. H.) and RO1 GM 034695 (to S. F. L.) from NIGMS and Grant ES005022 from NIEHS Center for Excellence (to B. H.).	Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Baur JA, 2010, BBA-PROTEINS PROTEOM, V1804, P1626, DOI 10.1016/j.bbapap.2009.10.025; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buryanovskyy L, 2004, BIOCHEMISTRY-US, V43, P11417, DOI 10.1021/bi049162o; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Crouser ED, 2002, CRIT CARE MED, V30, P276, DOI 10.1097/00003246-200202000-00002; Crouser ED, 2006, CRIT CARE MED, V34, P2439, DOI 10.1097/01.CCM.0000230240.02216.21; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Haimovich B, 2010, CRIT CARE, V14, DOI 10.1186/cc9283; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Izaguirre G, 1999, J BIOL CHEM, V274, P37012, DOI 10.1074/jbc.274.52.37012; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kim HY, 2007, EXP CELL RES, V313, P1866, DOI 10.1016/j.yexcr.2007.03.009; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Liu SB, 2002, INFECT IMMUN, V70, P3433, DOI 10.1128/IAI.70.7.3433-3442.2002; Lowry SF, 2005, SHOCK, V24, P94, DOI 10.1097/01.shk.0000191340.23907.a1; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Murias M, 2004, BIOORGAN MED CHEM, V12, P5571, DOI 10.1016/j.bmc.2004.08.008; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Padfield KE, 2005, P NATL ACAD SCI USA, V102, P5368, DOI 10.1073/pnas.0501211102; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sebai H, 2009, ARCH TOXICOL, V83, P335, DOI 10.1007/s00204-008-0348-0; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Singer M, 2007, CRIT CARE MED, V35, pS441, DOI 10.1097/01.CCM.0000278049.48333.78; Talwar S, 2006, PHYSIOL GENOMICS, V25, P203, DOI 10.1152/physiolgenomics.00192.2005; Thiel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000853; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WANG GL, 1995, BIOCHEM BIOPH RES CO, V212, P550, DOI 10.1006/bbrc.1995.2005; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshida K, 2008, INT J HEMATOL, V88, P43, DOI 10.1007/s12185-008-0091-6; Zang MW, 2006, DIABETES, V55, pA13; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	84	77	89	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41391	41401		10.1074/jbc.M110.174482	http://dx.doi.org/10.1074/jbc.M110.174482			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20966076	Green Published, hybrid			2022-12-25	WOS:000285622600025
J	Butler, TM; Mooers, SU; Narayan, SR; Siegman, MJ				Butler, Thomas M.; Mooers, Susan U.; Narayan, Srinivasa R.; Siegman, Marion J.			The N-terminal Region of Twitchin Binds Thick and Thin Contractile Filaments REDUNDANT MECHANISMS OF CATCH FORCE MAINTENANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; INVERTEBRATE SMOOTH-MUSCLE; BYSSUS RETRACTOR MUSCLE; F-ACTIN; PROTEIN-C; PEVK DOMAIN; REGULATORY DOMAIN; MOLLUSCAN MUSCLES; MYTILUS-EDULIS; IN-VITRO	Catch force maintenance in invertebrate smooth muscles is probably mediated by a force-bearing tether other than myosin cross-bridges between thick and thin filaments. The phosphorylation state of the mini-titin twitchin controls catch. The C-terminal phosphorylation site (D2) of twitchin with its flanking Ig domains forms a phosphorylation-sensitive complex with actin and myosin, suggesting that twitchin is the tether (Funabara, D., Osawa, R., Ueda, M., Kanoh, S., Hartshorne, D.J., and Watabe, S. (2009) J. Biol. Chem. 284, 18015-18020). Here we show that a region near the N terminus of twitchin also interacts with thick and thin filaments from Mytilus anterior byssus retractor muscles. Both a recombinant protein, including the D1 and DX phosphorylation sites with flanking 7th and 8th Ig domains, and a protein containing just the linker region bind to thin filaments with about a 1: 1 mol ratio to actin and K-d values of 1 and 15 mu M, respectively. Both proteins show a decrease in binding when phosphorylated. The unphosphorylated proteins increase force in partially activated permeabilized muscles, suggesting that they are sufficient to tether thick and thin filaments. There are two sites of thin filament interaction in this region because both a 52-residue peptide surrounding the DX site and a 47-residue peptide surrounding the D1 site show phosphorylation-dependent binding to thin filaments. The peptides relax catch force, confirming the region's central role in the mechanism of catch. The multiple sites of thin filament interaction in the N terminus of twitchin in addition to those in the C terminus provide an especially secure and redundant mechanical link between thick and thin filaments in catch.	[Butler, Thomas M.; Mooers, Susan U.; Narayan, Srinivasa R.; Siegman, Marion J.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA	Jefferson University	Butler, TM (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Mol Physiol & Biophys, 1020 Locust St, Philadelphia, PA 19107 USA.	thomas.butler@jefferson.edu			National Institutes of Health, NIAMS [R01AR042758]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042758] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Pennsylvania Department of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grant R01AR042758. This project was also supported in part under a grant with the Pennsylvania Department of Health.	Avrova SV, 2010, BIOCHEM BIOPH RES CO, V394, P126, DOI 10.1016/j.bbrc.2010.02.128; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; Bianco P, 2007, BIOPHYS J, V93, P2102, DOI [10.1529/biophysj.107.106153, 10.1529/biophysj.l07.106153]; Butler TM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/725207; Butler TM, 2006, BIOPHYS J, V90, P3193, DOI 10.1529/biophysj.105.077453; Butler TM, 1998, BIOPHYS J, V75, P1904, DOI 10.1016/S0006-3495(98)77631-3; CASTELLANI L, 1987, SCIENCE, V235, P334, DOI 10.1126/science.3026049; COLE RA, 1972, COMP BIOCHEM PHYSIOL, V43, P321, DOI 10.1016/0300-9629(72)90191-0; Erickson FL, 2003, MOL BIOL CELL, V14, P4173, DOI 10.1091/mbc.e02-10-0656; Franke AS, 2007, BIOPHYS J, V93, P554, DOI 10.1529/biophysj.107.105577; Funabara D, 2003, J BIOL CHEM, V278, P29308, DOI 10.1074/jbc.M303272200; Funabara D, 2001, BIOCHEMISTRY-US, V40, P2087, DOI 10.1021/bi0022691; Funabara D, 2007, J EXP BIOL, V210, P4399, DOI 10.1242/jeb.008722; Funabara D, 2009, J BIOL CHEM, V284, P18015, DOI 10.1074/jbc.M109.016485; Galler S, 2005, PFLUG ARCH EUR J PHY, V449, P372, DOI 10.1007/s00424-004-1350-x; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Hatch V, 2001, J CELL BIOL, V154, P611, DOI 10.1083/jcb.200105079; ISHII N, 1989, SCIENCE, V243, P1367, DOI 10.1126/science.2922614; JEWELL BR, 1959, J PHYSIOL-LONDON, V149, P154, DOI 10.1113/jphysiol.1959.sp006332; Kulke M, 2001, CIRC RES, V89, P874, DOI 10.1161/hh2201.099453; LEHMAN W, 1975, J GEN PHYSIOL, V66, P1, DOI 10.1085/jgp.66.1.1; Leonard TR, 2010, AM J PHYSIOL-CELL PH, V299, pC14, DOI 10.1152/ajpcell.00049.2010; Linke WA, 2002, J STRUCT BIOL, V137, P194, DOI 10.1006/jsbi.2002.4468; LOWY J, 1963, PHILOS T ROY SOC B, V246, P105, DOI 10.1098/rstb.1963.0003; Nagy A, 2004, J CELL SCI, V117, P5781, DOI 10.1242/jcs.01501; Rode C, 2009, J THEOR BIOL, V259, P350, DOI 10.1016/j.jtbi.2009.03.015; RUEGG J. C., 1961, PROC ROY SOC SER B BIOL SCI, V154, P224, DOI 10.1098/rspb.1961.0030; RUEGG JC, 1971, PHYSIOL REV, V51, P201, DOI 10.1152/physrev.1971.51.1.201; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Shelud'ko NS, 2004, ARCH BIOCHEM BIOPHYS, V432, P269, DOI 10.1016/j.abb.2004.10.006; Siegman MJ, 1997, J MUSCLE RES CELL M, V18, P655, DOI 10.1023/A:1018683823020; Siegman MJ, 1998, P NATL ACAD SCI USA, V95, P5383, DOI 10.1073/pnas.95.9.5383; Smith L, 1999, J BIOL CHEM, V274, P29433, DOI 10.1074/jbc.274.41.29433; Smith L, 2000, FEBS LETT, V480, P298, DOI 10.1016/S0014-5793(00)01931-1; Smith L, 2002, J BIOL CHEM, V277, P35597, DOI 10.1074/jbc.M206483200; TWAROG BM, 1954, J CELL COMPAR PHYSL, V44, P141, DOI 10.1002/jcp.1030440112; VIBERT P, 1993, J MUSCLE RES CELL M, V14, P598, DOI 10.1007/BF00141557; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; YAMADA A, 1989, J MUSCLE RES CELL M, V10, P124, DOI 10.1007/BF01739968; Yamada A, 2001, P NATL ACAD SCI USA, V98, P6635, DOI 10.1073/pnas.111585098; Yamasaki R, 2001, BIOPHYS J, V81, P2297, DOI 10.1016/S0006-3495(01)75876-6	42	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52								10.1074/jbc.M110.166041	http://dx.doi.org/10.1074/jbc.M110.166041			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20971853	hybrid, Green Published			2022-12-25	WOS:000285414400028
J	Suthammarak, W; Morgan, PG; Sedensky, MM				Suthammarak, Wichit; Morgan, Phil G.; Sedensky, Margaret M.			Mutations in Mitochondrial Complex III Uniquely Affect Complex I in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; CYTOCHROME BC(1) COMPLEX; IRON-SULFUR PROTEIN; CONSERVED CHARGED RESIDUES; BOVINE HEART-MITOCHONDRIA; RESPIRATORY-CHAIN; ESCHERICHIA-COLI; ELECTRON-TRANSPORT; C-OXIDASE; LIFE-SPAN	Mitochondrial supercomplexes containing complexes I, III, and IV of the electron transport chain are now regarded as an established entity. Supercomplex I.III.IV has been theorized to improve respiratory chain function by allowing quinone channeling between complexes I and III. Here, we show that the role of the supercomplexes extends beyond channeling. Mutant analysis in Caenorhabditis elegans reveals that complex III affects supercomplex I.III.IV formation by acting as an assembly or stabilizing factor. Also, a complex III mtDNA mutation, ctb-1, inhibits complex I function by weakening the interaction of complex IV in supercomplex I.III.IV. Other complex III mutations inhibit complex I function either by decreasing the amount of complex I (isp-1), or decreasing the amount of complex I in its most active form, the I.III.IV supercomplex (isp-1; ctb-1). ctb-1 suppresses a nuclear encoded complex III defect, isp-1, without improving complex III function. Allosteric interactions involve all three complexes within the supercomplex and are necessary for maximal enzymatic activities.	Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Morgan, Phil G.; Sedensky, Margaret M.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98101 USA; [Morgan, Phil G.; Sedensky, Margaret M.] Seattle Childrens Res Inst, Seattle, WA 98101 USA; [Suthammarak, Wichit] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Biochem, Bangkok 10700, Thailand	Case Western Reserve University; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Mahidol University	Sedensky, MM (corresponding author), Childrens Res Inst, 1900 9th Ave, Seattle, WA 98101 USA.	margaret.sedensky@seattlechildrens.org			National Institutes of Health [GM58881, AG026273]; American Recovery and Reinvestment Act Supplement [3R01GM58881-12S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act Supplement; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by National Institutes of Health Grants GM58881 and AG026273 and American Recovery and Reinvestment Act Supplement 3R01GM58881-12S1.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Arnold S, 1998, EUR J BIOCHEM, V252, P325, DOI 10.1046/j.1432-1327.1998.2520325.x; BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451; Bianchi C, 2004, J BIOL CHEM, V279, P36562, DOI 10.1074/jbc.M405135200; Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x; Brandt U, 1997, BBA-BIOENERGETICS, V1318, P79, DOI 10.1016/S0005-2728(96)00141-7; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brass EP, 2001, AM J PHYSIOL-HEART C, V280, pH603, DOI 10.1152/ajpheart.2001.280.2.H603; Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018; Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257; CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0; Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; De Meirleir L, 2003, AM J MED GENET A, V121A, P126, DOI 10.1002/ajmg.a.20171; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fernandez-Vizarra E, 2007, HUM MOL GENET, V16, P1241, DOI 10.1093/hmg/ddm072; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; GATTI DL, 1989, J MOL BIOL, V205, P421, DOI 10.1016/0022-2836(89)90352-5; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; HATEFI Y, 1962, J BIOL CHEM, V237, P1676; Higdon R, 2005, OMICS, V9, P364, DOI 10.1089/omi.2005.9.364; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; Kadenbach B, 1997, MOL CELL BIOCHEM, V174, P131, DOI 10.1023/A:1006819416358; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; Kayser EB, 2004, MECH AGEING DEV, V125, P455, DOI 10.1016/j.mad.2004.04.002; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; KORENKE GC, 1990, EUR J PEDIATR, V150, P104, DOI 10.1007/BF02072049; KROGER A, 1973, EUR J BIOCHEM, V39, P313, DOI 10.1111/j.1432-1033.1973.tb03129.x; Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Napiwotzki J, 1998, BIOL CHEM, V379, P335, DOI 10.1515/bchm.1998.379.3.335; NOBREGA FG, 1992, EMBO J, V11, P3821, DOI 10.1002/j.1460-2075.1992.tb05474.x; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schafer E, 2007, BIOCHEMISTRY-US, V46, P12579, DOI 10.1021/bi700983h; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169; Suthammarak W, 2009, J BIOL CHEM, V284, P6425, DOI 10.1074/jbc.M805733200; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071; van Straaten HLM, 2005, NEUROPEDIATRICS, V36, P193, DOI 10.1055/s-2005-865713; Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x	54	43	47	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40724	40731		10.1074/jbc.M110.159608	http://dx.doi.org/10.1074/jbc.M110.159608			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20971856	hybrid, Green Published			2022-12-25	WOS:000285414400036
J	Chun, KS; Lao, HC; Langenbach, R				Chun, Kyung-Soo; Lao, Huei-Chen; Langenbach, Robert			The Prostaglandin E-2 Receptor, EP2, Stimulates Keratinocyte Proliferation in Mouse Skin by G Protein-dependent and beta-Arrestin1-dependent Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; BETA-ADRENERGIC-RECEPTOR; SRC FAMILY KINASES; COUPLED RECEPTORS; EGF RECEPTOR; EPITHELIAL CARCINOGENESIS; PROSTANOID RECEPTORS; TUMOR-DEVELOPMENT; KNOCKOUT MICE; ACTIVATION	The prostaglandin E-2 (PGE2) G protein-coupled receptor (GPCR), EP2, plays important roles in mouse skin tumor development (Chun, K. S., Lao, H. C., Trempus, C. S., Okada, M., and Langenbach, R. (2009) Carcinogenesis 30, 1620-1627). Because keratinocyte proliferation is essential for skin tumor development, EP2-mediated signaling pathways that contribute to keratinocyte proliferation were investigated. A single topical application of the EP2 agonist, butaprost, dose-dependently increased keratinocyte replication via activation of epidermal growth factor receptor (EGFR) and PKA signaling. Because GPCR-mediated activation of EGFR can involve the formation of a GPCR-beta-arrestin-Src signaling complex, the possibility of a beta-arrestin1-Src complex contributing to EP2-mediated signaling in keratinocytes was investigated. Butaprost induced beta-arrestin1-Src complex formation and increased both Src and EGFR activation. A role for beta-arrestin1 in EP2-mediated Src and EGFR activation was demonstrated by the observation that beta-arrestin1 deficiency significantly reduced Src and EGFR activation. In agreement with a beta-arrestin1-Src complex contributing to EGFR activation, Src and EGFR inhibition (PP2 and AG1478, respectively) indicated that Src was upstream of EGFR. Butaprost also induced the activation of Akt, ERK1/2, and STAT3, and both beta-arrestin1 deficiency and EGFR inhibition (AG1478 or gefitinib) decreased their activation. In addition to beta-arrestin1-dependent EGFR activation, butaprost increased PKA activation, as measured by phospho-GSK3 beta (p-GSK3 beta) and p-cAMP-response element-binding protein formation. PKA inhibition (H89 or R-P-adenosine-3',5'-cyclic monophosphorothioate (R-P-cAMPS)) decreased butaprost-induced cAMP-response element-binding protein and ERK activation but did not affect EGFR activation, whereas beta-arrestin1 deficiency decreased EGFR activation but did not affect butaprost-induced PKA activation, thus indicating that they were independent EP2-mediated pathways. Therefore, the results indicate that EP2 contributed to mouse keratinocyte proliferation by G protein-independent, beta-arrestin1- dependent activation of EGFR and G protein-dependent activation of PKA.	[Chun, Kyung-Soo; Lao, Huei-Chen; Langenbach, Robert] NIEHS, NIH, Lab Toxicol & Pharmacol, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Langenbach, R (corresponding author), NIEHS, NIH, Lab Toxicol & Pharmacol, MD C4-09,POB 12233, Res Triangle Pk, NC 27709 USA.	langenb1@niehs.nih.gov			NIEHS/National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102145] Funding Source: NIH RePORTER	NIEHS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the Intramural Research Program of the NIEHS/National Institutes of Health.	Ansari KM, 2007, CARCINOGENESIS, V28, P2063, DOI 10.1093/carcin/bgm011; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Bourcier C, 2006, CANCER RES, V66, P2700, DOI 10.1158/0008-5472.CAN-05-3129; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Chang SH, 2005, PROSTAG OTH LIPID M, V76, P48, DOI 10.1016/j.prostaglandins.2004.12.001; Chang SH, 2005, CANCER RES, V65, P4496, DOI 10.1158/0008-5472.CAN-05-0129; Chun KS, 2007, CANCER RES, V67, P2015, DOI 10.1158/0008-5472.CAN-06-3617; Chun KS, 2009, CARCINOGENESIS, V30, P1620, DOI 10.1093/carcin/bgp168; Conner DA, 1997, CIRC RES, V81, P1021; Dajani OF, 2008, J CELL PHYSIOL, V214, P371, DOI 10.1002/jcp.21205; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Desai S, 2000, MOL PHARMACOL, V58, P1279, DOI 10.1124/mol.58.6.1279; Donnini S, 2007, FASEB J, V21, P2418, DOI 10.1096/fj.06-7581com; Egeblad M, 2001, BIOCHEM BIOPH RES CO, V281, P25, DOI 10.1006/bbrc.2001.4302; El-Abaseri TB, 2005, CANCER RES, V65, P3958, DOI 10.1158/0008-5472.CAN-04-2204; Fischer Susan M., 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P183; Fujino H, 2003, TRENDS PHARMACOL SCI, V24, P335, DOI 10.1016/S0165-6147(03)00162-7; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; Kendall RT, 2009, CELL MOL LIFE SCI, V66, P2953, DOI 10.1007/s00018-009-0088-1; Kim DJ, 2007, MOL CARCINOGEN, V46, P725, DOI 10.1002/mc.20342; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; PENTLAND AP, 1986, J CLIN INVEST, V77, P246, DOI 10.1172/JCI112283; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Seno H, 2002, CANCER RES, V62, P506; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Simeonova PP, 2002, J BIOL CHEM, V277, P2945, DOI 10.1074/jbc.M109136200; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Sung YM, 2006, ONCOGENE, V25, P5507, DOI 10.1038/sj.onc.1209538; Sung YM, 2005, CANCER RES, V65, P9304, DOI 10.1158/0008-5472.CAN-05-1015; Tiano HF, 2002, CANCER RES, V62, P3395; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415	54	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39672	39681		10.1074/jbc.M110.117689	http://dx.doi.org/10.1074/jbc.M110.117689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20959465	hybrid, Green Published			2022-12-25	WOS:000285185500011
J	Balzer, EM; Whipple, RA; Thompson, K; Boggs, AE; Slovic, J; Cho, EH; Matrone, MA; Yoneda, T; Mueller, SC; Martin, SS				Balzer, E. M.; Whipple, R. A.; Thompson, K.; Boggs, A. E.; Slovic, J.; Cho, E. H.; Matrone, M. A.; Yoneda, T.; Mueller, S. C.; Martin, S. S.			c-Src differentially regulates the functions of microtentacles and invadopodia	ONCOGENE			English	Article						microtentacle; invadopodia; Src; breast cancer; microtubule; actin	CANCER-CELLS; EXTRACELLULAR-MATRIX; TUMOR-CELLS; METASTASIS; PODOSOMES; INVASION; DEGRADATION; ADHESION; GROWTH; ACTIN	During metastasis, invading cells produce various actin-based membrane protrusions that promote directional migration and proteolysis of extracellular matrix (ECM). Observations of actin staining within thin, tubulin-based microtentacle (McTN) protrusions in suspended MDA-MB-231 tumor cells, prompted an investigation of whether McTNs are structural or functional analogs of invadopodia. We show here that MDA-MB-231 cells are capable of producing invadopodia and McTNs, both of which contain F-actin. Invadopodium formation was enhanced by the expression of a constitutively active c-Src kinase, and repressed by the expression of dominant-negative, catalytically inactive form of c-Src. In contrast, expression of inactive c-Src significantly increased McTN formation. Direct inhibition of c-Src with the SU6656 inhibitor compound also significantly enhanced McTN formation, but suppressed invadopodia, including the appearance of F-actin cores and phospho-cortactin foci, as well as completely blocking focal degradation of ECM. In addition, silencing of Tks5 in Src-transformed fibroblasts blocked invadopodia without affecting McTNs. Genetic modification of c-Src activity that promoted McTN formation augmented capillary retention of circulating tumor cells in vivo and rapid re-attachment of suspended cells in vitro, even though invadopodia were strongly suppressed. These results indicate that McTNs are capable of enhancing tumor cell reattachment, even in the absence of Tks5 and active Src, and define separate cytoskeletal mechanisms and functions for McTNs and invadopodia. Oncogene (2010) 29, 6402-6408; doi:10.1038/onc.2010.360; published online 18 October 2010	[Balzer, E. M.; Whipple, R. A.; Thompson, K.; Cho, E. H.; Matrone, M. A.; Martin, S. S.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum NCI Canc Ctr, Dept Physiol, Baltimore, MD 21201 USA; [Balzer, E. M.; Boggs, A. E.; Slovic, J.; Cho, E. H.; Matrone, M. A.; Martin, S. S.] Univ Maryland, Sch Med, Program Mol Med, Baltimore, MD 21201 USA; [Yoneda, T.] Osaka Univ, Grad Sch Dent, Dept Biochem, Osaka, Japan; [Mueller, S. C.] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Osaka University; Georgetown University	Martin, SS (corresponding author), Univ Maryland, Sch Med, Marlene & Stewart Greenebaum NCI Canc Ctr, Dept Physiol, 655 W Baltimore St,Room 10-029, Baltimore, MD 21201 USA.	ssmartin@som.umaryland.edu	Cho, Edward/B-3727-2012	Cho, Edward/0000-0002-0278-334X	National Cancer Institute [R01-CA124704]; USA Medical Research and Materiel Command [BC061047]; Susan G Komen investigator-initiated grant [KG100240]; NATIONAL CANCER INSTITUTE [R01CA124704, P30CA134274] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USA Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Susan G Komen investigator-initiated grant(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by R01-CA124704 grant from the National Cancer Institute, Breast Cancer Idea Award from USA Medical Research and Materiel Command (BC061047) and a Susan G Komen investigator-initiated grant (KG100240). We are very grateful to Darren Seals and Sara Courtneidge for generously providing cell lines and reagents to examine the role of Tks5.	Balzer EM, 2010, BREAST CANCER RES TR, V121, P65, DOI 10.1007/s10549-009-0457-3; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Korb T, 2004, EXP CELL RES, V299, P236, DOI 10.1016/j.yexcr.2004.06.001; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mendoza M, 2009, INT J BIOCHEM CELL B, V41, P1452, DOI 10.1016/j.biocel.2009.01.015; Miles FL, 2008, CLIN EXP METASTAS, V25, P305, DOI 10.1007/s10585-007-9098-2; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; Whipple RA, 2007, EXP CELL RES, V313, P1326, DOI 10.1016/j.yexcr.2007.02.001; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	20	53	54	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	48					6402	6408		10.1038/onc.2010.360	http://dx.doi.org/10.1038/onc.2010.360			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	688SW	20956943	Green Accepted			2022-12-25	WOS:000284874700010
J	Pigati, L; Yaddanapudi, SCS; Iyengar, R; Kim, DJ; Hearn, SA; Danforth, D; Hastings, ML; Duelli, DM				Pigati, Lucy; Yaddanapudi, Sree C. S.; Iyengar, Ravi; Kim, Dong-Ja; Hearn, Steven A.; Danforth, David; Hastings, Michelle L.; Duelli, Dominik M.			Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells	PLOS ONE			English	Article							BREAST-CANCER; GENE-EXPRESSION; STEM-CELLS; CIRCULATING MICRORNAS; TAMOXIFEN RESISTANCE; TUMOR INVASION; MIR-200 FAMILY; MESSENGER-RNA; DUCTAL LAVAGE; EXOSOMES	MicroRNAs (miRNAs) in body fluids are candidate diagnostics for a variety of conditions and diseases, including breast cancer. One premise for using extracellular miRNAs to diagnose disease is the notion that the abundance of the miRNAs in body fluids reflects their abundance in the abnormal cells causing the disease. As a result, the search for such diagnostics in body fluids has focused on miRNAs that are abundant in the cells of origin. Here we report that released miRNAs do not necessarily reflect the abundance of miRNA in the cell of origin. We find that release of miRNAs from cells into blood, milk and ductal fluids is selective and that the selection of released miRNAs may correlate with malignancy. In particular, the bulk of miR-451 and miR-1246 produced by malignant mammary epithelial cells was released, but the majority of these miRNAs produced by non-malignant mammary epithelial cells was retained. Our findings suggest the existence of a cellular selection mechanism for miRNA release and indicate that the extracellular and cellular miRNA profiles differ. This selective release of miRNAs is an important consideration for the identification of circulating miRNAs as biomarkers of disease.	[Pigati, Lucy; Iyengar, Ravi; Kim, Dong-Ja; Duelli, Dominik M.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Pathol, N Chicago, IL 60064 USA; [Yaddanapudi, Sree C. S.; Hastings, Michelle L.; Duelli, Dominik M.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL USA; [Yaddanapudi, Sree C. S.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Bligh Canc Res Ctr, N Chicago, IL USA; [Hearn, Steven A.] Cold Spring Harbor Lab, Microscopy Facil, Cold Spring Harbor, NY 11724 USA; [Danforth, David] NCI, Surg Branch, CCR, NIH, Bethesda, MD 20892 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science; Cold Spring Harbor Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pigati, L (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Pathol, N Chicago, IL 60064 USA.	Dominik.Duelli@Rosalindfranklin.edu	Hastings, MICHELLE L./AAK-6627-2021	Hearn, Stephen/0000-0002-2489-2424; Hastings, Michelle L./0000-0002-4253-9261	United States Department of Defense [W81XWH-08-1-0641]; American Cancer Society [08-29]; Rosalind Franklin University of Medicine and Science; Bligh Cancer Research Center; NIH NCRR [S10 RR19325]; HRSA [C76 HF03610-01-00]; NATIONAL CANCER INSTITUTE [ZIASC006663] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019325] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); Rosalind Franklin University of Medicine and Science; Bligh Cancer Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the United States Department of Defense grant W81XWH-08-1-0641, and an American Cancer Society of Illinois Research Grant 08-29 to DMD, Rosalind Franklin University of Medicine and Science start-up funds and support of the Bligh Cancer Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge the Midwest Proteome Center, funded by NIH NCRR S10 RR19325, and HRSA C76 HF03610-01-00 for services rendered.	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Coren LV, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-64; Danforth DN, 2006, J SURG ONCOL, V94, P555, DOI 10.1002/jso.20650; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dua RS, 2006, J CLIN ONCOL, V24, P1209, DOI 10.1200/JCO.2005.04.1830; Duelli DM, 2005, J CELL BIOL, V171, P493, DOI 10.1083/jcb.200507069; Duelli DM, 2000, NAT CELL BIOL, V2, P859, DOI 10.1038/35041112; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; Duelli DM, 2007, CURR BIOL, V17, P431, DOI 10.1016/j.cub.2007.01.049; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Go Attie T. J. J., 2008, V444, P291, DOI 10.1007/978-1-59745-066-9_23; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; HATA T, 2010, BIOCH BIOPHYS RES CO; Heaphy CM, 2009, BREAST CANCER RES TR, V118, P229, DOI 10.1007/s10549-009-0504-0; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Heneghan HM, 2010, J ONCOL, V2010, DOI 10.1155/2010/950201; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang Z, 2009, INT J CANC; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Jackson DB, 2009, P NATL ACAD SCI USA, V106, pE5, DOI 10.1073/pnas.0809999106; JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Khan SA, 2009, CANCER PREV RES, V2, P265, DOI 10.1158/1940-6207.CAPR-08-0119; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Lang Julie E, 2007, Cancer Control, V14, P350; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Loud JT, 2009, CANCER EPIDEM BIOMAR, V18, P1243, DOI 10.1158/1055-9965.EPI-08-0795; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Mathias Rommel A., 2009, V528, P227, DOI 10.1007/978-1-60327-310-7_16; MICHAEL A, 2009, ORAL DIS; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ohgaki K, 1998, GENE CHROMOSOME CANC, V23, P244, DOI 10.1002/(SICI)1098-2264(199811)23:3<244::AID-GCC6>3.3.CO;2-#; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Paweletz CP, 2001, DIS MARKERS, V17, P301, DOI 10.1155/2001/674959; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Staubach S, 2009, PROTEOMICS, V9, P2820, DOI 10.1002/pmic.200800793; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; TOMASETTO C, 1995, GENOMICS, V28, P367, DOI 10.1006/geno.1995.1163; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Varis A, 2002, CANCER RES, V62, P2625; Welsch U, 2007, ANN ANAT, V189, P131, DOI 10.1016/j.aanat.2006.09.010; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; Yamada H, 2008, GENE CHROMOSOME CANC, V47, P810, DOI 10.1002/gcc.20582; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	105	449	482	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13515	10.1371/journal.pone.0013515	http://dx.doi.org/10.1371/journal.pone.0013515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976003	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000283216400020
J	Mcbee, ME; Zeng, Y; Parry, N; Nagler, CR; Tannenbaum, SR; Schauer, DB				Mcbee, Megan E.; Zeng, Yu; Parry, Nicola; Nagler, Cathryn R.; Tannenbaum, Steven R.; Schauer, David B.			Multivariate Modeling Identifies Neutrophil- and Th17-Related Factors as Differential Serum Biomarkers of Chronic Murine Colitis	PLOS ONE			English	Article							ULCERATIVE-COLITIS; CITROBACTER-RODENTIUM; NITRIC-OXIDE; BACTERIAL PATHOGEN; EXPRESSION; MICE; INFLAMMATION; ANTIBODIES; RECEPTOR; INFECTION	Background: Diagnosis of chronic intestinal inflammation, which characterizes inflammatory bowel disease (IBD), along with prediction of disease state is hindered by the availability of predictive serum biomarker. Serum biomarkers predictive of disease state will improve trials for therapeutic intervention, and disease monitoring, particularly in genetically susceptible individuals. Chronic inflammation during IBD is considered distinct from infectious intestinal inflammation thereby requiring biomarkers to provide differential diagnosis. To address whether differential serum biomarkers could be identified in murine models of colitis, immunological profiles from both chronic spontaneous and acute infectious colitis were compared and predictive serum biomarkers identified via multivariate modeling. Methodology/Principal Findings: Discriminatory multivariate modeling of 23 cytokines plus chlorotyrosine and nitrotyrosine (protein adducts from reactive nitrogen species and hypochlorite) in serum and tissue from two murine models of colitis was performed to identify disease-associated biomarkers. Acute C. rodentium-induced colitis in C57BL/6J mice and chronic spontaneous Helicobacter-dependent colitis in TLR4(-/-) x IL-10(-/-) mice were utilized for evaluation. Colon profiles of both colitis models were nearly identical with chemokines, neutrophil-and Th17-related factors highly associated with intestinal disease. In acute colitis, discriminatory disease-associated serum factors were not those identified in the colon. In contrast, the discriminatory predictive serum factors for chronic colitis were neutrophil-and Th17-related factors (KC, IL-12/23p40, IL-17, G-CSF, and chlorotyrosine) that were also elevated in colon tissue. Chronic colitis serum biomarkers were specific to chronic colitis as they were not discriminatory for acute colitis. Conclusions/Significance: Immunological profiling revealed strikingly similar colon profiles, yet distinctly different serum profiles for acute and chronic colitis. Neutrophil-and Th17-related factors were identified as predictive serum biomarkers of chronic colitis, but not acute colitis, despite their presence in colitic tissue of both diseases thereby demonstrating the utility of mathematical modeling for identifying disease-associated serum biomarkers.	[Mcbee, Megan E.; Zeng, Yu; Tannenbaum, Steven R.; Schauer, David B.] MIT, Biol Engn Dept, Cambridge, MA 02139 USA; [Parry, Nicola; Schauer, David B.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Mcbee, Megan E.; Nagler, Cathryn R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Chicago	Mcbee, ME (corresponding author), MIT, Biol Engn Dept, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mmcbee@bsd.uchicago.edu		Parry, Nicola/0000-0002-0446-5249	National Institutes of Health [P01 CA026731, DK 55678]; Singapore-MIT Alliance for Research and Technology-Infectious Diseases; Agilent Technologies; NATIONAL CANCER INSTITUTE [P01CA026731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-MIT Alliance for Research and Technology-Infectious Diseases; Agilent Technologies; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health grants P01 CA026731 (YZ, SRT, DBS), DK 55678 (CRN), and the Singapore-MIT Alliance for Research and Technology-Infectious Diseases (MEM, DBS) supported this work. Additional facilities and instrument support were provided by the United States Army Research Office through the Institute for Soldier Nanotechnologies at Massachusetts Institute of Technology (MIT), the National Institutes of Health for Environmental Health Sciences at MIT, and an equipment loan from Agilent Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RC, 2009, NAT IMMUNOL, V10, P453, DOI 10.1038/ni0509-453; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Borenshtein D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0b013e3282f2b0fb; Carlson M, 2002, GUT, V50, P501, DOI 10.1136/gut.50.4.501; Chaluvadi MR, 2009, DRUG METAB DISPOS, V37, P366, DOI 10.1124/dmd.108.024240; Chin MP, 2008, NITRIC OXIDE-BIOL CH, V19, P266, DOI 10.1016/j.niox.2008.04.025; Costa F, 2005, GUT, V54, P364, DOI 10.1136/gut.2004.043406; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; DOMIGAN NM, 1995, J BIOL CHEM, V270, P16542, DOI 10.1074/jbc.270.28.16542; Dotan I, 2006, GASTROENTEROLOGY, V131, P366, DOI 10.1053/j.gastro.2006.04.030; EASTAFFLEUNG N, 2009, J CLIN IMMUNOL; Erdman SE, 2009, P NATL ACAD SCI USA, V106, P1027, DOI 10.1073/pnas.0812347106; Fina D, 2008, GASTROENTEROLOGY, V134, P1038, DOI 10.1053/j.gastro.2008.01.041; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gibson DL, 2008, CELL MICROBIOL, V10, P388, DOI 10.1111/j.1462-5822.2007.01052.x; Gobert AP, 2004, J IMMUNOL, V173, P2109, DOI 10.4049/jimmunol.173.3.2109; Grimm MC, 1996, GUT, V38, P90, DOI 10.1136/gut.38.1.90; GRIMM MC, 1995, CLIN EXP IMMUNOL, V100, P291, DOI 10.1111/j.1365-2249.1995.tb03667.x; Hanauer SB, 2010, NAT REV GASTRO HEPAT, V7, P63, DOI 10.1038/nrgastro.2009.238; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Joossens S, 2006, GUT, V55, P1667, DOI 10.1136/gut.2005.089623; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Lampinen M, 2008, INT J COLORECTAL DIS, V23, P939, DOI 10.1007/s00384-008-0509-x; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; Leon AJ, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/580450; Li XH, 2008, WORLD J GASTROENTERO, V14, P5115, DOI 10.3748/wjg.14.5115; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Masuda A, 2008, INFECT IMMUN, V76, P1728, DOI 10.1128/IAI.01493-07; Matharu KS, 2009, GASTROENTEROLOGY, V137, P1380, DOI 10.1053/j.gastro.2009.07.004; MATHARU KS, 2009, GASTROENTEROLOGY, V1380, pE1381; Mcbee ME, 2008, INFECT IMMUN, V76, P4851, DOI 10.1128/IAI.00745-08; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; MITSUYAMA K, 1994, CLIN EXP IMMUNOL, V96, P432; Nagamine CM, 2008, INT J CANCER, V122, P832, DOI 10.1002/ijc.23175; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; PELLETIER M, 2009, BLOOD; Reimund JM, 1996, J CLIN IMMUNOL, V16, P144, DOI 10.1007/BF01540912; Rogers AB, 2006, LAB INVEST, V86, P526, DOI 10.1038/labinvest.3700407; Satsangi J, 1998, INFLAMM BOWEL DIS, V4, P18, DOI 10.1097/00054725-199802000-00004; Sendid B, 1998, AM J GASTROENTEROL, V93, P1306, DOI 10.1111/j.1572-0241.1998.00415.x; Simmons CP, 2003, INFECT IMMUN, V71, P5077, DOI 10.1128/IAI.71.9.5077-5086.2003; Simmons CP, 2002, J IMMUNOL, V168, P1804, DOI 10.4049/jimmunol.168.4.1804; Spehlmann ME, 2009, J IMMUNOL, V183, P3332, DOI 10.4049/jimmunol.0900600; Ten Hove T, 2001, GASTROENTEROLOGY, V121, P1372, DOI 10.1053/gast.2001.29579; Tu Z, 2007, CLIN EXP IMMUNOL, V149, P186, DOI 10.1111/j.1365-2249.2007.03415.x; Vallance BA, 2002, INFECT IMMUN, V70, P6424, DOI 10.1128/IAI.70.11.6424-6435.2002; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	56	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13277	10.1371/journal.pone.0013277	http://dx.doi.org/10.1371/journal.pone.0013277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976045	Green Published, gold, Green Submitted			2022-12-25	WOS:000283114700001
J	de Vries, R; Kretzschmar, M; Schellekens, JFP; Versteegh, FGA; Westra, TA; Roord, JJ; Postma, MJ				de Vries, Robin; Kretzschmar, Mirjam; Schellekens, Joop F. P.; Versteegh, Florens G. A.; Westra, Tjalke A.; Roord, John J.; Postma, Maarten J.			Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model	PLOS ONE			English	Article							ECONOMIC-EVALUATION; UNITED-STATES; WHOLE-CELL; ACELLULAR VACCINE; BOOSTER; AGE; STRATEGIES; DIPHTHERIA; BENEFITS; TETANUS	Background: Despite widespread immunization programs, a clear increase in pertussis incidence is apparent in many developed countries during the last decades. Consequently, additional immunization strategies are considered to reduce the burden of disease. The aim of this study is to design an individual-based stochastic dynamic framework to model pertussis transmission in the population in order to predict the epidemiologic and economic consequences of the implementation of universal booster vaccination programs. Using this framework, we estimate the cost-effectiveness of universal adolescent pertussis booster vaccination at the age of 12 years in the Netherlands. Methods/Principal Findings: We designed a discrete event simulation (DES) model to predict the epidemiological and economic consequences of implementing universal adolescent booster vaccination. We used national age-specific notification data over the period 1996-2000-corrected for underreporting-to calibrate the model assuming a steady state situation. Subsequently, booster vaccination was introduced. Input parameters of the model were derived from literature, national data sources (e. g. costing data, incidence and hospitalization data) and expert opinions. As there is no consensus on the duration of immunity acquired by natural infection, we considered two scenarios for this duration of protection (i.e. 8 and 15 years). In both scenarios, total pertussis incidence decreased as a result of adolescent vaccination. From a societal perspective, the cost-effectiveness was estimated at (sic)4418/QALY (range: 3205-6364 (sic) per QALY) and (sic)6371/QALY (range: 4139-9549 (sic) per QALY) for the 8- and 15-year protection scenarios, respectively. Sensitivity analyses revealed that the outcomes are most sensitive to the quality of life weights used for pertussis disease. Conclusions/Significance: To our knowledge we designed the first individual-based dynamic framework to model pertussis transmission in the population. This study indicates that adolescent pertussis vaccination is likely to be a cost-effective intervention for The Netherlands. The model is suited to investigate further pertussis booster vaccination strategies.	[de Vries, Robin; Westra, Tjalke A.; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit Pharmacoepidemiol & Pharmacoecon, Groningen, Netherlands; [Kretzschmar, Mirjam] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Kretzschmar, Mirjam] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Schellekens, Joop F. P.] Infect Dis Lab, Groningen, Netherlands; [Versteegh, Florens G. A.] Groene Hart Ziekenhuis, Dept Pediat, Gouda, Netherlands; [Roord, John J.] Vrije Univ Amsterdam Med Ctr, Dept Pediat, Amsterdam, Netherlands	University of Groningen; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	de Vries, R (corresponding author), Univ Groningen, Dept Pharm, Unit Pharmacoepidemiol & Pharmacoecon, Groningen, Netherlands.	Robin.de.Vries@rug.nl	Datta, Samik/S-3822-2016; Westra, Tjalke/B-3971-2011	Versteegh, Florens G.A./0000-0003-4773-5592; Postma, Maarten/0000-0002-6306-3653; Kretzschmar, Mirjam/0000-0002-4394-7697	GlaxoSmithKline, The Netherlands	GlaxoSmithKline, The Netherlands(Netherlands GovernmentGlaxoSmithKline)	This study was supported by an unrestricted grant from GlaxoSmithKline, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Beutels P, 1999, VACCINE, V17, P2400, DOI 10.1016/S0264-410X(99)00028-6; Bos Jasper M, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P247, DOI 10.1586/14737167.4.3.247; Brisson M, 2003, MED DECIS MAKING, V23, P76, DOI 10.1177/0272989X02239651; Calugar A, 2006, CLIN INFECT DIS, V42, P981, DOI 10.1086/500321; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS75, DOI 10.1097/01.inf.0000160918.72953.51; Caro JJ, 2005, PHARMACOECONOMICS, V23, P323, DOI 10.2165/00019053-200523040-00003; Casey JR, 2005, DRUGS, V65, P1367, DOI 10.2165/00003495-200565100-00005; Coudeville L, 2008, EPIDEMIOL INFECT, V136, P604, DOI 10.1017/S0950268807009041; Crowcroft NS, 2002, ARCH DIS CHILD, V86, P336, DOI 10.1136/adc.86.5.336; de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; DEGREEFF SC, 2003, 128507010 RIVM; deMelker HE, 1997, EMERG INFECT DIS, V3, P175, DOI 10.3201/eid0302.970211; DEMELKER HE, 1997, 128507005 NAT I PUBL; DESERRE, 2000, J INFECT DIS, V182, P174; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Edmunds WJ, 1999, STAT MED, V18, P3263, DOI 10.1002/(SICI)1097-0258(19991215)18:23&lt;3263::AID-SIM315&gt;3.0.CO;2-3; Edmunds WJ, 2002, VACCINE, V20, P1316, DOI 10.1016/S0264-410X(01)00473-X; Ekwueme DU, 2000, ARCH PEDIAT ADOL MED, V154, P797, DOI 10.1001/archpedi.154.8.797; FARRINGTON CP, 1992, INT J EPIDEMIOL, V21, P1014, DOI 10.1093/ije/21.5.1014; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Frampton James E, 2006, Paediatr Drugs, V8, P189, DOI 10.2165/00148581-200608030-00005; GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859; Halperin SA, 2005, PEDIATR INFECT DIS J, V24, pS141, DOI 10.1097/01.inf.0000166163.02135.8b; Hethcote HW, 2004, VACCINE, V22, P2181, DOI 10.1016/j.vaccine.2003.11.053; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; Hethcote HW, 1999, MATH BIOSCI, V158, P47, DOI 10.1016/S0025-5564(99)00004-8; Hinman A R, 1985, Dev Biol Stand, V61, P429; HINMAN AR, 1984, JAMA-J AM MED ASSOC, V251, P3109, DOI 10.1001/jama.251.23.3109; *HLTH CAR INS BOAR, 2006, DUTCH GUID PHARM RES; *HLTH CARE INS BOA, 2008, DUTCH GUID PHARM; *HLTH COUNC NETH, 2004, PUBL HLTH COUNC NETH; Hollingworth W, 2007, ACAD RADIOL, V14, P406, DOI 10.1016/j.acra.2007.01.007; Iskedjian M, 2004, VACCINE, V22, P4215, DOI 10.1016/j.vaccine.2004.04.025; Iskedjian M, 2001, PHARMACOECONOMICS, V19, P551, DOI 10.2165/00019053-200119050-00009; Iskedjian Michael, 2005, Paediatr Drugs, V7, P123, DOI 10.2165/00148581-200507020-00005; Jefferson T, 2003, VACCINE, V21, P2003, DOI 10.1016/S0264-410X(02)00770-3; Karnon J, 2003, HEALTH ECON, V12, P837, DOI 10.1002/hec.770; Kelton W. D., 2004, SIMULATION ARENA; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; KOPLAN JP, 1979, NEW ENGL J MED, V301, P906, DOI 10.1056/NEJM197910253011703; Kowalzik F, 2007, PEDIATR INFECT DIS J, V26, P238, DOI 10.1097/01.inf.0000256750.07118.ee; Lee GM, 2005, PEDIATRICS, V115, P1675, DOI 10.1542/peds.2004-2509; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Lee GM, 2008, VACCINE, V26, P3673, DOI 10.1016/j.vaccine.2008.04.068; Lee GM, 2007, AM J PREV MED, V32, P186, DOI 10.1016/j.amepre.2006.10.016; Lee Grace M, 2005, Health Qual Life Outcomes, V3, P17, DOI 10.1186/1477-7525-3-17; Lee LH, 2000, ARCH FAM MED, V9, P989, DOI 10.1001/archfami.9.10.989; Mylius SD, 2008, VACCINE, V26, P3742, DOI 10.1016/j.vaccine.2008.04.043; Neppelenbroek S.E., 1999, Euro Surveill, V4, P133; OOSTENBRINK JB, 2004, GUIDELINE COSTING RE; Orenstein WA, 1999, CLIN INFECT DIS, V28, pS147, DOI 10.1086/515061; Pichichero ME, 2006, PEDIATRICS, V117, P1084, DOI 10.1542/peds.2005-1759; *PRISM, NAT LMR INF ONL FURT; Purdy KW, 2004, CLIN INFECT DIS, V39, P20, DOI 10.1086/421091; RAMSAY MEB, 1993, EPIDEMIOL INFECT, V111, P41, DOI 10.1017/S095026880005665X; RITECO JA, 1999, GUIDELINES PHARMACOE; Rothstein Edward, 2005, Pediatr Infect Dis J, V24, pS44, DOI 10.1097/01.inf.0000160912.58660.87; Schenk CA, 2005, LECT NOTES APPL COMP, V24, P19; Scuffham PA, 2004, VACCINE, V22, P2953, DOI 10.1016/j.vaccine.2003.11.057; Shaikh R, 1998, PEDIATRICS, V101, P323, DOI 10.1542/peds.101.2.323; Stevenson M, 2002, VACCINE, V20, P1778, DOI 10.1016/S0264-410X(02)00025-7; Tan Tina, 2005, Pediatr Infect Dis J, V24, pS10, DOI 10.1097/01.inf.0000160708.43944.99; Tormans G, 1998, EUR J PEDIATR, V157, P395, DOI 10.1007/s004310050837; van Amersfoorth SCM, 2005, J CLIN MICROBIOL, V43, P2837, DOI 10.1128/JCM.43.6.2837-2843.2005; van Boven M, 2000, MATH BIOSCI, V164, P161, DOI 10.1016/S0025-5564(00)00009-2; van Boven M, 2001, EPIDEMIOL INFECT, V127, P73; Van Rie A, 2004, VACCINE, V22, P3154, DOI 10.1016/j.vaccine.2004.01.067; Versteegh FGA, 2002, ACTA PAEDIATR, V91, P95, DOI 10.1080/080352502753458030; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; ZHANG L, 2010, COCHRANE DB SYST REV, V1; DUTCH NATL IMMUNIZAT	75	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13392	10.1371/journal.pone.0013392	http://dx.doi.org/10.1371/journal.pone.0013392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976213	gold, Green Published			2022-12-25	WOS:000283043700005
J	Shapiro, A; Lu, ZL; Huang, CB; Knight, E; Ennis, R				Shapiro, Arthur; Lu, Zhong-Lin; Huang, Chang-Bing; Knight, Emily; Ennis, Robert			Transitions between Central and Peripheral Vision Create Spatial/Temporal Distortions: A Hypothesis Concerning the Perceived Break of the Curveball	PLOS ONE			English	Article							2ND-ORDER MOTION; VISUAL-MOTION; CORTICAL MAGNIFICATION; STRIATE CORTEX; FULL-WAVE; CONTRAST; PERCEPTION; INTEGRATION; FREQUENCY; SHIFTS	Background: The human visual system does not treat all parts of an image equally: the central segments of an image, which fall on the fovea, are processed with a higher resolution than the segments that fall in the visual periphery. Even though the differences between foveal and peripheral resolution are large, these differences do not usually disrupt our perception of seamless visual space. Here we examine a motion stimulus in which the shift from foveal to peripheral viewing creates a dramatic spatial/temporal discontinuity. Methodology/Principal Findings: The stimulus consists of a descending disk (global motion) with an internal moving grating (local motion). When observers view the disk centrally, they perceive both global and local motion (i.e., observers see the disk's vertical descent and the internal spinning). When observers view the disk peripherally, the internal portion appears stationary, and the disk appears to descend at an angle. The angle of perceived descent increases as the observer views the stimulus from further in the periphery. We examine the first-and second-order information content in the display with the use of a three-dimensional Fourier analysis and show how our results can be used to describe perceived spatial/temporal discontinuities in real-world situations. Conclusions/Significance: The perceived shift of the disk's direction in the periphery is consistent with a model in which foveal processing separates first-and second-order motion information while peripheral processing integrates first-and second-order motion information. We argue that the perceived distortion may influence real-world visual observations. To this end, we present a hypothesis and analysis of the perception of the curveball and rising fastball in the sport of baseball. The curveball is a physically measurable phenomenon: the imbalance of forces created by the ball's spin causes the ball to deviate from a straight line and to follow a smooth parabolic path. However, the curveball is also a perceptual puzzle because batters often report that the flight of the ball undergoes a dramatic and nearly discontinuous shift in position as the ball nears home plate. We suggest that the perception of a discontinuous shift in position results from differences between foveal and peripheral processing.	[Shapiro, Arthur] American Univ, Dept Psychol, Washington, DC 20016 USA; [Lu, Zhong-Lin; Huang, Chang-Bing] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Knight, Emily] Mayo Clin, Rochester, MN USA; [Ennis, Robert] SUNY Coll Optometry, New York, NY 10010 USA	American University; University of Southern California; Mayo Clinic; State University of New York (SUNY) System; SUNY Optometry	Shapiro, A (corresponding author), American Univ, Dept Psychol, Washington, DC 20016 USA.	Arthur.Shapiro@American.edu	HUANG, CHANG-BING/D-3855-2011; Huang, Chang-Bing/AAE-2909-2020	Lauwereyns, Jan/0000-0003-0551-2550; Lu, Zhong-Lin/0000-0002-7295-727X; Knight, Emily/0000-0002-6971-1148; huang, chang bing/0000-0003-4694-0834	National Institutes of Health; US National Eye Institute [EY017491]; NATIONAL EYE INSTITUTE [R01EY017491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health grant to Zhong-Lin Lu. Portions of the work were supported by a grant from the the US National Eye Institute (EY017491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair RK., 2002, PHYS BASEBALL, V3rd; AZZOPARDI P, 1993, NATURE, V361, P719, DOI 10.1038/361719a0; Azzopardi P, 1996, NEUROSCIENCE, V72, P627, DOI 10.1016/0306-4522(95)00589-7; BAHILL T, 2004, BIOMEDICAL ENG PRINC, P257; Bressler DW, 2006, VISION RES, V46, P1120, DOI 10.1016/j.visres.2005.10.012; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P2985, DOI 10.1073/pnas.86.8.2985; Chung STL, 2001, VISION RES, V41, P1833, DOI 10.1016/S0042-6989(01)00071-2; CORMACK R, 1992, VISION RES, V32, P73, DOI 10.1016/0042-6989(92)90114-X; Cropper SJ, 2001, J OPT SOC AM A, V18, P2237, DOI 10.1364/JOSAA.18.002237; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; Falchier A, 2002, J NEUROSCI, V22, P5749; FESTINGER L, 1976, VISION RES, V16, P1377, DOI 10.1016/0042-6989(76)90155-3; GOREA A, 1993, P NATL ACAD SCI USA, V90, P11197, DOI 10.1073/pnas.90.23.11197; JOHNSTON A, 1995, VISION RES, V35, P1771, DOI 10.1016/0042-6989(94)00258-N; JOHNSTON A, 1995, VISION RES, V35, P1109, DOI 10.1016/0042-6989(94)00175-L; KNIGHT EJ, Z L L DRAMATICALLY D; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Levi DM, 2002, J VISION, V2, P167, DOI 10.1167/2.2.3; LEVI DM, 1984, VISION RES, V24, P789, DOI 10.1016/0042-6989(84)90150-0; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; Lu ZL, 1996, J OPT SOC AM A, V13, P2305, DOI 10.1364/JOSAA.13.002305; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; MARKOV NT, 2008, 2151 SOC NEUR; Martin P.R., 2003, VISUAL NEUROSCIENCES, P410; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MCBEATH MK, 1990, PERCEPTION, V19, P545, DOI 10.1068/p190545; Nandy AS, 2007, J VISION, V7, DOI 10.1167/7.2.5; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Rider AT, 2009, J VISION, V9, DOI 10.1167/9.13.8; ROVAMO J, 1984, VISION RES, V24, P283, DOI 10.1016/0042-6989(84)90133-0; SHAPIRO AG, 2008, 8113 SOC NEUR; Smith AT, 1998, VISION RES, V38, P403, DOI 10.1016/S0042-6989(97)00134-X; SOLOMON JA, 1994, VISION RES, V34, P2239, DOI 10.1016/0042-6989(94)90105-8; TAUBER ES, 1977, PERCEPT PSYCHOPHYS, V22, P241, DOI 10.3758/BF03199685; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Tse PU, 2006, VISION RES, V46, P3881, DOI 10.1016/j.visres.2006.06.010; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; Watanabe T, 1998, HIGH LEVEL MOTION PR; WATTS RG, 2000, KEEP YOUR EYE BALL; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; ZHANG J, 1993, VISION RES, V33, P2721, DOI 10.1016/0042-6989(93)90231-K; [No title captured]	44	47	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13296	10.1371/journal.pone.0013296	http://dx.doi.org/10.1371/journal.pone.0013296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967247	Green Published, Green Submitted, gold			2022-12-25	WOS:000282869800013
J	Ji, GX; Gu, AH; Zhou, Y; Shi, XG; Xia, YK; Long, Y; Song, L; Wang, SL; Wang, XR				Ji, Guixiang; Gu, Aihua; Zhou, Yong; Shi, Xiangguo; Xia, Yankai; Long, Yan; Song, Ling; Wang, Shoulin; Wang, Xinru			Interactions between Exposure to Environmental Polycyclic Aromatic Hydrocarbons and DNA Repair Gene Polymorphisms on Bulky DNA Adducts in Human Sperm	PLOS ONE			English	Article							URINARY METABOLITES; EXCISION-REPAIR; DAMAGE; SMOKING; XRCC1; EXPRESSION; FERTILITY; SMOKERS; CELLS; RISK	Background: Nucleotide excision repair (NER) and base excision repair (BER) are the primary mechanisms for repair of bulky adducts caused by chemical agents, such as PAHs. It is expected that polymorphisms in NER or BER genes may modulate individual susceptibility to PAHs exposure. Here, we evaluate the effects of PAHs exposure and polymorphisms in NER and BER pathway, alone or combined, on polycyclic aromatic hydrocarbon-DNA (PAH-DNA) adducts in human sperm. Methodology/Principal Findings: Sperm PAH-DNA adducts were measured by immunofluorescent assay using flow cytometry in a sample of 465 infertile adults. Polymorphisms of XPA, XPD, ERCC1, XPF, and XRCC1 were determined by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) techniques. The PAHs exposure was detected as urinary 1-hydroxypyrene (1-OHP) levels. In multivariate models adjusted for potential confounders, we observed that XRCC1 5'pUTR -T/C, Arg194Trp, Arg399Gln polymorphisms were associated with increased sperm adduct levels. Furthermore, the stratified analysis indicated that adverse effects of XRCC1 Arg194Trp, Arg399Gln polymorphisms on PAH-DNA adducts were detected only in the high PAHs exposure group. Conclusions/Significance: These findings provided the first evidence that polymorphisms of XRCC1 may modify sperm PAH-DNA adduct levels and may be useful biomarkers to identify individuals susceptible to DNA damage resulting from PAHs exposure.	[Ji, Guixiang; Gu, Aihua; Shi, Xiangguo; Xia, Yankai; Long, Yan; Song, Ling; Wang, Shoulin; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, Sch Publ Hlth, Key Lab Reprod Med, Nanjing, Peoples R China; [Zhou, Yong] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA	Nanjing Medical University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Ji, GX (corresponding author), Nanjing Med Univ, Inst Toxicol, Sch Publ Hlth, Key Lab Reprod Med, Nanjing, Peoples R China.	xrwang@njmu.edu.cn			National Basic Research Program of China [2009CB941703]; Key Project of National Natural Science Foundation of China [30930079]; National Science Foundation of China [30901210, 30800927]	National Basic Research Program of China(National Basic Research Program of China); Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by National Basic Research Program of China (973 Program, 2009CB941703); The Key Project of National Natural Science Foundation of China (30930079); The National Science Foundation of China (No. 30901210; No. 30800927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AM, 2008, INT J ANDROL, V31, P74, DOI 10.1111/j.1365-2605.2007.00853.x; Binkova B, 2007, MUTAT RES-FUND MOL M, V620, P49, DOI 10.1016/j.mrfmmm.2007.02.022; Braithwaite E, 1998, CARCINOGENESIS, V19, P1239, DOI 10.1093/carcin/19.7.1239; De Ruyck K, 2007, MUTAT RES-GEN TOX EN, V631, P101, DOI 10.1016/j.mrgentox.2007.03.010; Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756; Gaspari L, 2003, MUTAT RES-GEN TOX EN, V535, P155, DOI 10.1016/S1383-5718(02)00297-8; Georgiadis P, 2001, CARCINOGENESIS, V22, P1447, DOI 10.1093/carcin/22.9.1447; Hauser R, 2005, ENVIRON HEALTH PERSP, V113, P425, DOI 10.1289/ehp.7305; Horak S, 2003, ACTA BIOCHIM POL, V50, P197; Horak Stanislaw, 2007, Folia Histochem Cytobiol, V45 Suppl 1, pS99; Hu Y, 2006, BIOMARKERS, V11, P306, DOI 10.1080/13547500600626883; Ji GX, 2008, REPROD BIOMED ONLINE, V17, P36, DOI 10.1016/S1472-6483(10)60290-8; Ji GX, 2010, TOXICOL SCI, V116, P92, DOI 10.1093/toxsci/kfq112; Kelada SN, 2003, ENVIRON HEALTH PERSP, V111, P1055, DOI 10.1289/ehp.6065; Kuriyama SN, 2005, ENVIRON HEALTH PERSP, V113, P149, DOI 10.1289/ehp.7421; LEROYER A, SCI TOTAL ENV, V408, P1166; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; McCarty KM, 2009, ENVIRON HEALTH PERSP, V117, P552, DOI 10.1289/ehp.0800119; Nia AB, 2000, ENVIRON MOL MUTAGEN, V36, P127, DOI 10.1002/1098-2280(2000)36:2<127::AID-EM7>3.0.CO;2-G; PELTONEN K, 1995, J OCCUP ENVIRON MED, V37, P52, DOI 10.1097/00043764-199501000-00008; Piipari R, 2000, INT J CANCER, V86, P610, DOI 10.1002/(SICI)1097-0215(20000601)86:5<610::AID-IJC2>3.0.CO;2-M; Pratt MM, 2007, MUTAT RES-FUND MOL M, V624, P114, DOI 10.1016/j.mrfmmm.2007.04.008; Romano G, 1999, CANCER EPIDEM BIOMAR, V8, P91; Rundle A, 2000, CARCINOGENESIS, V21, P1281, DOI 10.1093/carcin/21.7.1281; Scherer G, 2000, CANCER EPIDEM BIOMAR, V9, P373; Schoket B, 1999, MUTAT RES-FUND MOL M, V424, P143, DOI 10.1016/S0027-5107(99)00015-9; Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; WALTER CA, 1994, SOMAT CELL MOLEC GEN, V20, P451, DOI 10.1007/BF02255837; Xia YK, 2009, ENVIRON SCI TECHNOL, V43, P4567, DOI 10.1021/es9000642; Xia YK, 2009, HUM REPROD, V24, P1067, DOI 10.1093/humrep/dep006; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006; Zenzes MT, 1999, FERTIL STERIL, V72, P330, DOI 10.1016/S0015-0282(99)00230-7; Zenzes MT, 1999, MOL HUM REPROD, V5, P125, DOI 10.1093/molehr/5.2.125; ZHANG YJ, 1995, CANCER EPIDEM BIOMAR, V4, P133; ZHOU ZQ, 1995, MUTAT RES LETT, V348, P111, DOI 10.1016/0165-7992(95)00053-4; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	38	21	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13145	10.1371/journal.pone.0013145	http://dx.doi.org/10.1371/journal.pone.0013145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957144	Green Published, gold			2022-12-25	WOS:000282506100003
J	Hill, VK; Underhill-Day, N; Krex, D; Robel, K; Sangan, CB; Summersgill, HR; Morris, M; Gentle, D; Chalmers, AD; Maher, ER; Latif, F				Hill, V. K.; Underhill-Day, N.; Krex, D.; Robel, K.; Sangan, C. B.; Summersgill, H. R.; Morris, M.; Gentle, D.; Chalmers, A. D.; Maher, E. R.; Latif, F.			Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis	ONCOGENE			English	Article						gliomas; RASSF10; epigenetics	GLIOBLASTOMA-MULTIFORME; IDH2 MUTATIONS; METHYLATION; GLIOMAS; DIFFERENTIATION; PROTEINS; FAMILY; CANCER; DOMAIN; MGMT	We have recently described the N-terminal RAS association domain family of genes, RASSF7-10. Previously, we cloned the N-terminal RASSF10 gene and demonstrated frequent methylation of the associated 50-CpG island in acute lymphoblastic leukemia. To characterize RASSF10 gene expression, we demonstrate that in developing Xenopus embryos, RASSF10 shows a very striking pattern in the rhombencephalon (hind brain). It is also expressed in other parts of the brain and other organs. Due to the well-defined expression pattern in the brain of Xenopus embryos, we analyzed the methylation status of the RASSF10-associated 5'-CpG island in astrocytic gliomas. RASSF10 was frequently methylated in WHO grade II-III astrocytomas and WHO grade IV primary glioblastomas (67.5%), but was unmethylated in grade I astrocytomas and in DNA from age matched control brain samples. RASSF10 gene expression both at the mRNA and protein levels could be switched back on in methylated glioma cell lines after treatment with 5-aza-2'-deoxycytidine. In secondary glioblastomas (sGBM), RASSF10 methylation was an independent prognostic factor associated with worst progression-free survival and overall survival and occurred at an early stage in their development. In cell culture experiments, overexpression of RASSF10 mediated a reduction in the colony forming ability of two RASSF10-methylated glioma cell lines. Conversely, RNAi-mediated knockdown of RASSF10-stimulated anchorage-independent growth of U87 glioma cells, increased their viability and caused an increase in the cells' proliferative ability. We generated and characterized a RASSF10-specific antibody and demonstrated for the first time that RASSF10 subcellular localization is cell-cycle dependent with RASSF10 colocalizing to centrosomes and associated microtubules during mitosis. This is the first report demonstrating that RASSF10 can act as a tumor suppressor gene and is frequently methylated in gliomas and can potentially be developed into a prognostic marker for sGBM. Oncogene (2011) 30, 978-989; doi:10.1038/onc.2010.471; published online 18 October 2010 Keywords: gliomas; RASSF10; epigenetics	[Latif, F.] Univ Birmingham, Inst Biomed Res, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Krex, D.; Robel, K.] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Klin & Poliklin Neurochirurg, Dresden, Germany; [Sangan, C. B.; Summersgill, H. R.; Chalmers, A. D.] Univ Bath, Ctr Regenerat Med, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Birmingham; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Bath	Latif, F (corresponding author), Univ Birmingham, Inst Biomed Res, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England.	f.latif@bham.ac.uk	Chalmers, Andrew/D-4103-2009; Morris, Mark/C-6413-2008; MAHER, EAMONN R/A-9507-2008; Krex, Dietmar/E-6833-2014	Chalmers, Andrew/0000-0003-4182-6717; MAHER, EAMONN R/0000-0002-6226-6918; Morris, Mark/0000-0002-0700-355X	Breast Cancer Campaign; CRUK; Sport Aiding Medical Research for Kids (SPARKS)	Breast Cancer Campaign; CRUK(Cancer Research UK); Sport Aiding Medical Research for Kids (SPARKS)	We thank Dr Reinhard Dammann for providing the RASSF10 construct. F Latif laboratory funded in part by Breast Cancer Campaign, CRUK and Sport Aiding Medical Research for Kids (SPARKS).	Chalmers AD, 2002, DEV CELL, V2, P171, DOI 10.1016/S1534-5807(02)00113-2; Chen LH, 1998, J BIOL CHEM, V273, P33524, DOI 10.1074/jbc.273.50.33524; Dallol A, 2009, CURR BIOL, V19, P1227, DOI 10.1016/j.cub.2009.05.064; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Hesson Luke B, 2008, Expert Rev Neurother, V8, P1475, DOI 10.1586/14737175.8.10.1475; Hesson LB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-42; Honorio S, 2003, ONCOGENE, V22, P461, DOI 10.1038/sj.onc.1206119; Langton PF, 2009, CURR BIOL, V19, P1969, DOI 10.1016/j.cub.2009.10.027; Lock FE, 2010, ONCOGENE, V29, P4307, DOI 10.1038/onc.2010.192; Martinez R, 2009, EPIGENETICS-US, V4, P255, DOI 10.4161/epi.9130; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Reeves N, 2005, DEV CELL, V8, P413, DOI 10.1016/j.devcel.2005.01.020; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Schagdarsurengin U, 2009, EPIGENETICS-US, V4, P571, DOI 10.4161/epi.4.8.10056; Sherwood V, 2008, MOL BIOL CELL, V19, P1772, DOI 10.1091/mbc.E07-07-0652; Sherwood V, 2010, BIOCHEM J, V425, P303, DOI 10.1042/BJ20091318; Tommasi S, 2005, CANCER RES, V65, P92; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631; Yan H, 2009, CANCER RES, V69, P9157, DOI 10.1158/0008-5472.CAN-09-2650; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	28	42	48	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	8					978	989		10.1038/onc.2010.471	http://dx.doi.org/10.1038/onc.2010.471			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	726CJ	20956940				2022-12-25	WOS:000287695900009
J	Lu, YB; Iandiev, I; Hollborn, M; Korber, N; Ulbricht, E; Hirrlinger, PG; Pannicke, T; Wei, EQ; Bringmann, A; Wolburg, H; Wilhelmsson, U; Pekny, M; Wiedemann, P; Reichenbach, A; Kas, JA				Lu, Yun-Bi; Iandiev, Ianors; Hollborn, Margrit; Koerber, Nicole; Ulbricht, Elke; Hirrlinger, Petra G.; Pannicke, Thomas; Wei, Er-Qing; Bringmann, Andreas; Wolburg, Hartwig; Wilhelmsson, Ulrika; Pekny, Milos; Wiedemann, Peter; Reichenbach, Andreas; Kaes, Josef A.			Reactive glial cells: increased stiffness correlates with increased intermediate filament expression	FASEB JOURNAL			English	Article						biomechanics; elasticity; viscosity; retina; reactive gliosis	FIBRILLARY ACIDIC PROTEIN; MULLER CELLS; VISCOELASTIC PROPERTIES; RAT RETINA; INJURY; MICE; ASTROCYTES; VIMENTIN; BRAIN; REGENERATION	Increased stiffness of reactive glial cells may impede neurite growth and contribute to the poor regenerative capabilities of the mammalian central nervous system. We induced reactive gliosis in rodent retina by ischemia-reperfusion and assessed intermediate filament (IF) expression and the viscoelastic properties of dissociated single glial cells in wild-type mice, mice lacking glial fibrillary acidic protein and vimentin (GFAP(-/-)Vim(-/-)) in which glial cells are consequently devoid of IFs, and normal Long-Evans rats. In response to ischemia-reperfusion, glial cells stiffened significantly in wild-type mice and rats but were unchanged in GFAP(-/-)Vim(-/-) mice. Cell stiffness (elastic modulus) correlated with the density of IFs. These results support the hypothesis that rigid glial scars impair nerve regeneration and that IFs are important determinants of cellular viscoelasticity in reactive glia. Thus, therapeutic suppression of IF up-regulation in reactive glial cells may facilitate neuroregeneration.-Lu, Y.-B., Iandiev, I., Hollborn, M., Korber, N., Ulbricht, E., Hirrlinger, P. G., Pannicke, T., Wei, E.-Q., Bringmann, A., Wolburg, H., Wilhelmsson, U., Pekny, M., Wiedemann, P., Reichenbach, A., Kas, J. A. Reactive glial cells: increased stiffness correlates with increased intermediate filament expression. FASEB J. 25, 624-631 (2011). www.fasebj.org	[Lu, Yun-Bi; Koerber, Nicole; Ulbricht, Elke; Hirrlinger, Petra G.; Pannicke, Thomas; Reichenbach, Andreas] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Lu, Yun-Bi; Kaes, Josef A.] Univ Leipzig, Div Soft Matter Phys, Dept Phys, D-04109 Leipzig, Germany; [Iandiev, Ianors; Hollborn, Margrit; Bringmann, Andreas; Wiedemann, Peter] Univ Leipzig, Dept Ophthalmol, D-04109 Leipzig, Germany; [Lu, Yun-Bi; Wei, Er-Qing] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310003, Zhejiang, Peoples R China; [Koerber, Nicole] Translat Ctr Regenerat Med, Leipzig, Germany; [Wolburg, Hartwig] Univ Tubingen, Inst Pathol, D-7400 Tubingen, Germany; [Wilhelmsson, Ulrika; Pekny, Milos] Univ Gothenburg, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol,Sahlgrenska Acad, Gothenburg, Sweden	Leipzig University; Leipzig University; Leipzig University; Zhejiang University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Gothenburg	Reichenbach, A (corresponding author), Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany.	reia@medizin.uni-leipzig.de	Körber, Nicole/A-5118-2017; Reichenbach, Andreas/B-2510-2017; Pannicke, Thomas/A-5078-2017	Pannicke, Thomas/0000-0001-7435-9540; Wilhelmsson, Ulrika/0000-0003-3227-2687; Kas, Josef A./0000-0003-3158-2480	Deutsche Forschungsgemeinschaft; National Natural Science Foundation of China [30700150]; Deutscher Akademischer Austauschdienst; Zhejiang Provincial Natural Science Foundation of China [Y2080105]; Translational Center for Regenerative Medicine; Center for Biotechnology and Biomedicine (BBZ) at the University of Leipzig; Swedish Medical Research Council [11548]; Torsten and Ragnar Soderberg Foundations; LUA/ALF Goteborg, Hjarnfonden; Frimurare Foundation; Amlov's Foundation;  [SPP1172]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Translational Center for Regenerative Medicine; Center for Biotechnology and Biomedicine (BBZ) at the University of Leipzig; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Torsten and Ragnar Soderberg Foundations; LUA/ALF Goteborg, Hjarnfonden; Frimurare Foundation; Amlov's Foundation; 	This study was supported by grants from the Deutsche Forschungsgemeinschaft: Research Training School Inter-Neuro and BuildMoNa to A.R. and J.K. and SPP1172 to A.R.; the National Natural Science Foundation of China (grant 30700150) to Y.-B.L.; the Deutscher Akademischer Austauschdienst to Y.-B.L.; the Zhejiang Provincial Natural Science Foundation of China (grant Y2080105) to Y.-B.L; the Translational Center for Regenerative Medicine to N.K.; the Center for Biotechnology and Biomedicine (BBZ) at the University of Leipzig to A.R. and J.K.; and the Swedish Medical Research Council (project 11548), the Torsten and Ragnar Soderberg Foundations, LUA/ALF Goteborg, Hjarnfonden, the Frimurare Foundation, and Amlov's Foundation to U.W. and M.P. The authors thank Gabi Frommer-Kastle for expert help with electron microscopy and Jens Grosche for preparing Fig. 1.	Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31; BIGNAMI A, 1979, EXP EYE RES, V28, P63; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Franze K, 2009, BIOPHYS J, V97, P1883, DOI 10.1016/j.bpj.2009.07.033; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880; Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9; Miller G, 2005, SCIENCE, V308, P778, DOI 10.1126/science.308.5723.778; Miller WJ, 2009, J NEUROTRAUM, V26, P789, DOI [10.1089/neu.2008.0727, 10.1089/neu.2008-0727]; Mitz SA, 2009, NEUROSCIENCE, V163, P552, DOI 10.1016/j.neuroscience.2009.06.058; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2004, TRENDS NEUROSCI, V27, P243, DOI 10.1016/j.tins.2004.01.012; Pellerin L, 2008, CURR OPIN CLIN NUTR, V11, P701, DOI 10.1097/MCO.0b013e328312c368; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; REICHENBACH A, 1988, Z MIKROSK ANAT FORSC, V102, P721; Reichenbach A, 2008, SCIENCE, V322, P693, DOI 10.1126/science.1166197; Schiwy N, 2009, EUR J NEUROSCI, V30, P1544, DOI 10.1111/j.1460-9568.2009.06929.x; STEFANSSON E, 1988, INVEST OPHTH VIS SCI, V29, P1050; Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103	33	120	124	1	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					624	631		10.1096/fj.10-163790	http://dx.doi.org/10.1096/fj.10-163790			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20974670				2022-12-25	WOS:000286724800020
J	Kashlan, OB; Adelman, JL; Okumura, S; Blobner, BM; Zuzek, Z; Hughey, RP; Kleyman, TR; Grabe, M				Kashlan, Ossama B.; Adelman, Joshua L.; Okumura, Sora; Blobner, Brandon M.; Zuzek, Zachary; Hughey, Rebecca P.; Kleyman, Thomas R.; Grabe, Michael			Constraint-based, Homology Model of the Extracellular Domain of the Epithelial Na+ Channel alpha Subunit Reveals a Mechanism of Channel Activation by Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE LIQUID VOLUME; STRUCTURE PREDICTION; SODIUM-CHANNELS; ION CHANNELS; 3-DIMENSIONAL STRUCTURES; INHIBITORY DOMAIN; GAMMA-SUBUNIT; ENAC; PEPTIDE; FURIN	The epithelial Na+ channel (ENaC) mediates Na+ transport across high resistance epithelia. This channel is assembled from three homologous subunits with the majority of the protein's mass found in the extracellular domains. Acid-sensing ion channel 1 (ASIC1) is homologous to ENaC, but a key functional domain is highly divergent. Here we present molecular models of the extracellular region of alpha ENaC based on a large data set of mutations that attenuate inhibitory peptide binding in combination with comparative modeling based on the resolved structure of ASIC1. The models successfully rationalized the data from the peptide binding screen. We engineered new mutants that had not been tested based on the models and successfully predict sites where mutations affected peptide binding. Thus, we were able to confirm the overall general fold of our structural models. Further analysis suggested that the alpha subunit-derived inhibitory peptide affects channel gating by constraining motions within two major domains in the extracellular region, the thumb and finger domains.	[Kashlan, Ossama B.; Okumura, Sora; Blobner, Brandon M.; Zuzek, Zachary; Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Adelman, Joshua L.; Grabe, Michael] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Grabe, Michael] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Renal Electrolyte Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu			National Institutes of Health [DK078734, DK051391, DK065161, DK079307]; American Heart Association; National Science Foundation [MCB0845286]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065161, K01DK078734, R37DK051391, R01DK051391, R01DK065161, P30DK079307] Funding Source: NIH RePORTER; Direct For Biological Sciences [0845286] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078734 (to O. B. K.), DK051391 (to T. R. K.), DK065161 (to T. R. K. and R. P. H.), and DK079307 (to the Pittsburgh Center for Kidney Research). This work was also supported by a Scientist Development Grant from the American Heart Association (to O. B. K.) and a National Science Foundation Career Award MCB0845286 (to M. G.).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2010, J GEN PHYSIOL, V135, P563, DOI 10.1085/jgp.200910368; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Baldi P, 1999, BIOINFORMATICS, V15, P937, DOI 10.1093/bioinformatics/15.11.937; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; FUCHS W, 1977, J PHYSIOL-LONDON, V267, P137, DOI 10.1113/jphysiol.1977.sp011805; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kastner C, 2009, AM J PHYSIOL-RENAL, V296, pF902, DOI 10.1152/ajprenal.90451.2008; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Myerburg MM, 2008, AM J PHYSIOL-LUNG C, V294, pL932, DOI 10.1152/ajplung.00437.2007; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Passero CJ, 2010, CURR OPIN NEPHROL HY, V19, P13, DOI 10.1097/MNH.0b013e3283330fb2; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Reddy BVB, 2007, J BIOSCIENCES, V32, P929, DOI 10.1007/s12038-007-0093-1; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng S., 2008, KIDNEY PHYSL PATHOPH, P743; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151	52	55	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					649	660		10.1074/jbc.M110.167098	http://dx.doi.org/10.1074/jbc.M110.167098			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20974852	hybrid, Green Published			2022-12-25	WOS:000285782800066
J	Stenson, BM; Ryden, M; Venteclef, N; Dahlman, I; Pettersson, AML; Mairal, A; Astrom, G; Blomqvist, L; Wang, V; Jocken, JWE; Clement, K; Langin, D; Arner, P; Laurencikiene, J				Stenson, Britta M.; Ryden, Mikael; Venteclef, Nicolas; Dahlman, Ingrid; Pettersson, Annie M. L.; Mairal, Aline; Astrom, Gaby; Blomqvist, Lennart; Wang, Victoria; Jocken, Johan W. E.; Clement, Karine; Langin, Dominique; Arner, Peter; Laurencikiene, Jurga			Liver X Receptor (LXR) Regulates Human Adipocyte Lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; HORMONE-SENSITIVE LIPASE; CHOLESTEROL EFFLUX; TISSUE EXPRESSION; GENE-EXPRESSION; LIPID DROPLETS; PERILIPIN; ALPHA; MOUSE; DIFFERENTIATION	The Liver X receptor (LXR) is an important regulator of carbohydrate and lipid metabolism in humans and mice. We have recently shown that activation of LXR regulates cellular fuel utilization in adipocytes. In contrast, the role of LXR in human adipocyte lipolysis, the major function of human white fat cells, is not clear. In the present study, we stimulated in vitro differentiated human and murine adipocytes with the LXR agonist GW3965 and observed an increase in basal lipolysis. Microarray analysis of human adipocyte mRNA following LXR activation revealed an altered gene expression of several lipolysis- regulating proteins, which was also confirmed by quantitative real-time PCR. We show that expression and intracellular localization of perilipin1 (PLIN1) and hormone-sensitive lipase (HSL) are affected by GW3965. Although LXR activation does not influence phosphorylation status of HSL, HSL activity is required for the lipolytic effect of GW3965. This effect is abolished by PLIN1 knockdown. In addition, we demonstrate that upon activation, LXR binds to the proximal regions of the PLIN1 and HSL promoters. By selective knockdown of either LXR isoform, we show that LXR proportional to is the major isoform mediating the lipolysis-related effects of LXR. In conclusion, the present study demonstrates that activation of LXR proportional to up-regulates basal human adipocyte lipolysis. This is at least partially mediated through LXR binding to the PLIN1 promoter and down-regulation of PLIN1 expression.	[Stenson, Britta M.; Ryden, Mikael; Dahlman, Ingrid; Pettersson, Annie M. L.; Astrom, Gaby; Blomqvist, Lennart; Wang, Victoria; Jocken, Johan W. E.; Arner, Peter; Laurencikiene, Jurga] Karolinska Inst, Dept Med, S-14186 Huddinge, Sweden; [Venteclef, Nicolas; Clement, Karine] INSERM, U872, Nutri Team 7, F-75006 Paris, France; [Venteclef, Nicolas; Clement, Karine] Univ Paris 06, Cordeliers Res Ctr, F-75006 Paris, France; [Clement, Karine] Hop La Pitie Salpetriere, AP HP, F-75013 Paris, France; [Mairal, Aline; Langin, Dominique] INSERM, U858, Lab Rech Obes, F-31432 Toulouse, France; [Mairal, Aline; Langin, Dominique] Univ Toulouse, UPS, IFR150, Inst Med Mol Rangueil, F-31432 Toulouse, France; [Langin, Dominique] CHU Toulouse, Biochim Lab, Inst Federatif Biol Purpan, F-31059 Toulouse, France	Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Laurencikiene, J (corresponding author), Karolinska Inst, Dept Med Huddinge, NVS, Halsovagen 7,4th Floor, S-14186 Stockholm, Sweden.	jurga.laurencikiene@ki.se	Clément, karine/R-1120-2017; Venteclef, Nicolas/K-8484-2017	Arner, Peter/0000-0002-6208-6220; Venteclef, Nicolas/0000-0002-6313-1214; Dahlman, Ingrid/0000-0003-3819-5977; Langin, Dominique/0000-0002-2669-7825; , Jurga/0000-0002-7032-2924	Swedish Research Council; NovoNordisk; Swedish Diabetes Association; Swedish Heart and Lung Foundation; EndoMet; Karolinska Institutet; Ake Wiberg Foundation; Magn Bergvalls Foundation; ADAPT [HEALTH-F2-2008-201100]; NordForsk [SYSDIET-070014]; COST action [BM 0602]; NWO Rubicon [825.07.025]; European Union [HEPADIP] [LSHM-CT-2005-018734]	Swedish Research Council(Swedish Research CouncilEuropean Commission); NovoNordisk(Novo Nordisk); Swedish Diabetes Association; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); EndoMet; Karolinska Institutet(Karolinska Institutet); Ake Wiberg Foundation; Magn Bergvalls Foundation; ADAPT; NordForsk; COST action(European Cooperation in Science and Technology (COST)); NWO Rubicon(Netherlands Organization for Scientific Research (NWO)); European Union [HEPADIP]	This study was supported in part by the Swedish Research Council, NovoNordisk, Swedish Diabetes Association, Swedish Heart and Lung Foundation, EndoMet, Karolinska Institutet, Ake Wiberg Foundation, Magn Bergvalls Foundation, the European Union [HEPADIP (LSHM-CT-2005-018734), ADAPT (HEALTH-F2-2008-201100], NordForsk (SYSDIET-070014), COST action BM 0602, and NWO Rubicon (825.07.025).	Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; Arner P, 2007, CURR OPIN LIPIDOL, V18, P246, DOI 10.1097/MOL.0b013e32811e16fb; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Bezaire V, 2009, FEBS LETT, V583, P3045, DOI 10.1016/j.febslet.2009.08.019; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Commerford SR, 2007, MOL ENDOCRINOL, V21, P3002, DOI 10.1210/me.2007-0156; Dahlman I, 2006, PHARMACOGENET GENOM, V16, P881, DOI 10.1097/01.fpc.0000236334.49422.48; Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Darimont C, 2006, BIOCHIMIE, V88, P309, DOI 10.1016/j.biochi.2005.08.010; Dicker A, 2005, INT J OBESITY, V29, P1413, DOI 10.1038/sj.ijo.0803042; Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029; Gerin I, 2005, J BIOL CHEM, V280, P23024, DOI 10.1074/jbc.M412564200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; HELLMER J, 1989, ANAL BIOCHEM, V177, P132, DOI 10.1016/0003-2697(89)90027-4; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; KRAUSE BR, 1984, J LIPID RES, V25, P97; Krintel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003756; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Laurencikiene J, 2007, J LIPID RES, V48, P1069, DOI 10.1194/jlr.M600471-JLR200; Le Lay S, 2003, J LIPID RES, V44, P1499, DOI 10.1194/jlr.M200466-JLR200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe DB, 2004, BIOORG MED CHEM LETT, V14, P3155, DOI 10.1016/j.bmcl.2004.04.015; Magnusson B, 2008, METABOLISM, V57, P1307, DOI 10.1016/j.metabol.2008.04.028; Mairal A, 2006, DIABETOLOGIA, V49, P1629, DOI 10.1007/s00125-006-0272-x; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Mottagui-Tabar S, 2003, DIABETOLOGIA, V46, P789, DOI 10.1007/s00125-003-1112-x; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; Ryden M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1847, DOI 10.1152/ajpendo.00040.2007; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sekiya M, 2007, J LIPID RES, V48, P1581, DOI 10.1194/jlr.M700033-JLR200; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Shimizu M, 1996, PHARMACOL TOXICOL, V78, P254, DOI 10.1111/j.1600-0773.1996.tb00214.x; Stenson BM, 2009, ENDOCRINOLOGY, V150, P4104, DOI 10.1210/en.2009-0676; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulven SM, 2004, J LIPID RES, V45, P2052, DOI 10.1194/jlr.M400119-JLR200; van Harmelen Vanessa, 2005, Methods Mol Med, V107, P125; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200	48	59	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					370	379		10.1074/jbc.M110.179499	http://dx.doi.org/10.1074/jbc.M110.179499			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21030586	Green Published, hybrid			2022-12-25	WOS:000285782800040
J	Bousquet, SM; Monet, M; Boulay, G				Bousquet, Simon M.; Monet, Michael; Boulay, Guylain			Protein Kinase C-dependent Phosphorylation of Transient Receptor Potential Canonical 6 (TRPC6) on Serine 448 Causes Channel Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-ENTRY; CA2+ OSCILLATIONS; CATION CHANNEL; ACTIVATION; STORE; GENERATION; EXPRESSION; DECREASES; HOMOLOG; CLONING	TRPC6 is a cation channel in the plasma membrane that plays a role in Ca2+ entry following the stimulation of a G(q)-protein coupled or tyrosine kinase receptor. A dysregulation of TRPC6 activity causes abnormal proliferation of smooth muscle cells and glomerulosclerosis. In the present study, we investigated the regulation of TRPC6 activity by protein kinase C (PKC). We showed that inhibiting PKC with GF1 or activating it with phorbol 12-myristate 13-acetate potentiated and inhibited agonist-induced Ca2+ entry, respectively, into cells expressing TRPC6. Similar results were obtained when TRPC6 was directly activated with 1-oleyl-2-acetyl-sn-glycerol. Activation of the cells with carbachol increased the phosphorylation of TRPC6, an effect that was prevented by the inhibition of PKC. The target residue of PKC was identified by an alanine screen of all canonical PKC sites on TRPC6. Unexpectedly, all the mutants, including TRPC6(S768A) (a residue previously proposed to be a target for PKC), displayed PKC-dependent inhibition of channel activity. Phosphorylation prediction software suggested that Ser(448), in a non-canonical PKC consensus sequence, was a potential target for PKC delta. Ba2+ and Ca2+ entry experiments revealed that GF1 did not potentiate TRPC6(S448A) activity. Moreover, activation of PKC did not enhance the phosphorylation state of TRPC6(S448A). Using A7r5 vascular smooth muscle cells, which endogenously express TRPC6, we observed that a novel PKC isoform is involved in the inhibition of the vasopressin-induced Ca2+ entry. Furthermore, knocking down PKC delta in A7r5 cells potentiated vasopressin-induced Ca2+ entry. In summary, we provide evidence that PKC delta exerts a negative feedback effect on TRPC6 through the phosphorylation of Ser(448).	[Boulay, Guylain] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Boulay, G (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, 3001-12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Guylain.Boulay@USherbrooke.ca	Boulay, Guylain/D-9773-2010	MONET, Michael/0000-0002-7864-862X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Quebec Heart & Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Quebec Heart & Stroke Foundation	This work was supported by grants from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Quebec Heart & Stroke Foundation.	Arguin G, 2007, J ENDOCRINOL, V192, P659, DOI 10.1677/JOE-06-0179; AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; Basora N, 2003, J BIOL CHEM, V278, P31709, DOI 10.1074/jbc.M304437200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Caron AZ, 2007, CELL CALCIUM, V42, P323, DOI 10.1016/j.ceca.2007.01.002; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Estacion M, 2004, J BIOL CHEM, V279, P22047, DOI 10.1074/jbc.M402320200; Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jung S, 2002, AM J PHYSIOL-CELL PH, V282, pC347, DOI 10.1152/ajpcell.00283.2001; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kawasaki T, 2010, J BIOL CHEM, V285, P25720, DOI 10.1074/jbc.M109.022996; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Kinoshita H, 2010, CIRC RES, V106, P1849, DOI 10.1161/CIRCRESAHA.109.208314; Koitabashi N, 2010, J MOL CELL CARDIOL, V48, P713, DOI 10.1016/j.yjmcc.2009.11.015; Kwan HY, 2006, J CELL PHYSIOL, V207, P315, DOI 10.1002/jcp.20567; Leitges M, 2002, MOL CELL BIOL, V22, P3970, DOI 10.1128/MCB.22.12.3970-3980.2002; Li MX, 2008, PHARMACOL RES, V58, P308, DOI 10.1016/j.phrs.2008.09.004; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Lussier MP, 2005, J BIOL CHEM, V280, P19393, DOI 10.1074/jbc.M500391200; Mani BK, 2009, CELL CALCIUM, V45, P400, DOI 10.1016/j.ceca.2009.01.004; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Maruyama Y, 2006, CIRC RES, V98, P1520, DOI 10.1161/01.RES.0000226495.34949.28; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nishida M, 2010, J BIOL CHEM, V285, P13244, DOI 10.1074/jbc.M109.074104; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rey O, 2006, J BIOL CHEM, V281, P38730, DOI 10.1074/jbc.M605956200; Saleh SN, 2006, J PHYSIOL-LONDON, V577, P479, DOI 10.1113/jphysiol.2006.119305; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P531, DOI 10.1113/jphysiol.2008.166678; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez-Miranda E, 2010, BIOCHEM BIOPH RES CO, V391, P1714, DOI 10.1016/j.bbrc.2009.12.139; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHILLING WP, 1989, J BIOL CHEM, V264, P12838; Sel S, 2008, CLIN EXP ALLERGY, V38, P1548, DOI 10.1111/j.1365-2222.2008.03043.x; Shi J, 2004, J PHYSIOL-LONDON, V561, P415, DOI 10.1113/jphysiol.2004.075051; Snetkov VA, 2008, HYPERTENSION, V51, P239, DOI 10.1161/HYPERTENSIONAHA.107.104802; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; van Rossum DB, 2009, CELL CALCIUM, V45, P535, DOI 10.1016/j.ceca.2009.02.008; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Wang YJ, 2008, CLIN EXP PHARMACOL P, V35, P1127, DOI 10.1111/j.1440-1681.2008.05018.x; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; Zhang L, 2006, J BIOCHEM, V139, P459, DOI 10.1093/jb/mvj065; Zhu MH, 2005, AM J PHYSIOL-CELL PH, V289, pC591, DOI 10.1152/ajpcell.00440.2004; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	57	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40534	40543		10.1074/jbc.M110.160051	http://dx.doi.org/10.1074/jbc.M110.160051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20961851	hybrid, Green Published			2022-12-25	WOS:000285414400016
J	Okamoto, F; Saeki, K; Sumimoto, H; Yamasaki, S; Yokomizo, T				Okamoto, Fuyuki; Saeki, Kazuko; Sumimoto, Hideki; Yamasaki, Sho; Yokomizo, Takehiko			Leukotriene B-4 Augments and Restores Fc gamma Rs-dependent Phagocytosis in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; BLT1-DEFICIENT MICE; SIGNAL-TRANSDUCTION; ANTAGONIST IL-1RA; HUMAN NEUTROPHILS; CELL RECRUITMENT; BONE-MARROW; ACTIVATION; MECHANISMS; IDENTIFICATION	Phagocytosis by macrophages is essential for host defense, i.e. preventing invasion of pathogens and foreign materials. Macrophages engulf immunoglobulin G (IgG)-opsonized particles through the action of the receptors for the Fc of IgG (Fc gamma Rs). Leukotriene B-4 (LTB4) is a classical lipid chemoattractant derived from arachidonic acid. Leukotriene B-4 receptor 1 (BLT1), a high affinity LTB4 receptor, is expressed in a variety of immune cells such as neutrophils, macrophages, and dendritic cells. Although LTB4 has been shown to enhance macrophage phagocytosis, few studies have investigated the intracellular mechanisms involved in this in detail. Furthermore, there have been no reports of the direct cross-talk between LTB4-BLT1 and IgG-Fc gamma Rs signaling. Here, we show that Fc gamma Rs-dependent phagocytosis was attenuated in BLT1-deficient macrophages as compared with wild-type (WT) cells. Moreover, cross-talk between LTB4-BLT1 and IgG-Fc gamma Rs signaling was identified at the level of phosphatidylinositol 3-OH kinase (PI3K) and Rac, downstream of Syk. In addition, the trimeric G(i) protein (G(i)) was found to be essential for BLT1-dependent phagocytosis. Surprisingly, we found that LTB4-BLT1 signaling restores phagocytosis in the absence of Fc gamma Rs signaling. These data indicate that LTB4-BLT1 signaling plays a pivotal role in macrophage phagocytosis and innate immunity.	[Yokomizo, Takehiko] Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Higashi Ku, Fukuoka 8128582, Japan; [Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, Fukuoka 8128582, Japan; [Yamasaki, Sho] Kyushu Univ, Div Mol Immunol, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; [Yokomizo, Takehiko] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan	Kyushu University; Kyushu University; Kyushu University; Japan Science & Technology Agency (JST)	Yokomizo, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yokomizo@biochem1.med.kyushu-u.ac.jp	Yokomizo, Takehiko/P-5673-2016	Yokomizo, Takehiko/0000-0002-5219-1553	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21390083, 22116001, 22116002, 22790320]; Takeda Science Foundation; Mitsubishi Foundation; Uehara Memorial Foundation; Sankyo Foundation of Life Science; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Sankyo Foundation of Life Science; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for Scientific Research 21390083, 22116001, and 22116002 (to T. Y.) and 22790320 (to K. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and grants from the Takeda Science Foundation, Mitsubishi Foundation, Uehara Memorial Foundation, Sankyo Foundation of Life Science, and Japan Society for the Promotion of Science (Global COE Program) (to T. Y.).; Supported by a research fellowship from the Japan Society for the Promotion of Science for Young Scientists.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ahluwalia N, 2007, J IMMUNOL, V179, P691, DOI 10.4049/jimmunol.179.1.691; AHMADZADEH N, 1991, INFLAMMATION, V15, P497, DOI 10.1007/BF00923346; Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; ANTONELLI M, 1989, INTENS CARE MED, V15, P296, DOI 10.1007/BF00263864; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Christmas P, 2006, J BIOL CHEM, V281, P7189, DOI 10.1074/jbc.M513101200; CONTI P, 1993, CLIN EXP IMMUNOL, V91, P526; CONTI P, 1992, AGENTS ACTIONS, pC93; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Crooks SW, 2000, EUR RESPIR J, V15, P274, DOI 10.1034/j.1399-3003.2000.15b09.x; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Dostert C, 2007, NAT IMMUNOL, V8, P17, DOI 10.1038/ni0107-17; DUELL EA, 1988, J INVEST DERMATOL, V91, P446, DOI 10.1111/1523-1747.ep12476562; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Hackam DJ, 1997, J EXP MED, V186, P955, DOI 10.1084/jem.186.6.955; Heller EA, 2005, CIRCULATION, V112, P578, DOI 10.1161/CIRCULATIONAHA.105.545616; Hida S, 2009, NAT IMMUNOL, V10, P214, DOI 10.1038/ni.1686; Kita Y, 2005, ANAL BIOCHEM, V342, P134, DOI 10.1016/j.ab.2005.03.048; KONSTAN MW, 1993, AM REV RESPIR DIS, V148, P896, DOI 10.1164/ajrccm/148.4_Pt_1.896; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; Montuschi P, 2002, J ALLERGY CLIN IMMUN, V109, P615, DOI 10.1067/mai.2002.122461; NEU I, 1992, ACTA NEUROL SCAND, V86, P586, DOI 10.1111/j.1600-0404.1992.tb05491.x; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Pinto AK, 2007, J VIROL, V81, P12564, DOI 10.1128/JVI.01328-07; Sakurai D, 2004, J IMMUNOL, V172, P2374, DOI 10.4049/jimmunol.172.4.2374; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; SHARON P, 1984, GASTROENTEROLOGY, V86, P453; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tedeschi A, 2004, BIOCHEM PHARMACOL, V67, P385, DOI 10.1016/j.bcp.2003.09.019; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Toda A, 2010, BIOCHIMIE, V92, P682, DOI 10.1016/j.biochi.2009.12.002; Weller CL, 2005, J EXP MED, V201, P1961, DOI 10.1084/jem.20042407; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	47	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41113	41121		10.1074/jbc.M110.175497	http://dx.doi.org/10.1074/jbc.M110.175497			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959460	Green Published, hybrid			2022-12-25	WOS:000285414400073
J	Pence, MG; Choi, JY; Egli, M; Guengerich, FP				Pence, Matthew G.; Choi, Jeong-Yun; Egli, Martin; Guengerich, F. Peter			Structural Basis for Proficient Incorporation of dTTP Opposite O-6-Methylguanine by Human DNA Polymerase i	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATSON-CRICK; PAIRING PROPERTIES; IOTA; REPLICATION; HOOGSTEEN; KINETICS; BYPASS; MUTAGENICITY; ALKYLATION; REFINEMENT	O-6-Methylguanine (O-6-methylG) is highly mutagenic and is commonly found in DNA exposed to methylating agents, even physiological ones (e.g. S-adenosylmethionine). The efficiency of a truncated, catalytic DNA polymerase i core enzyme was determined for nucleoside triphosphate incorporation opposite O-6-methylG, using steady-state kinetic analyses. The results presented here corroborate previous work from this laboratory using full-length pol i, which showed that dTTP incorporation occurs with high efficiency opposite O-6-methylG. Misincorporation of dTTP opposite O-6-methylG occurred with similar to 6-fold higher efficiency than incorporation of dCTP. Crystal structures of the truncated form of pol i with O-6-methylG as the template base and incoming dCTP or dTTP were solved and showed that O-6-methylG is rotated into the syn conformation in the pol i active site and that dTTP misincorporation by pol i is the result of Hoogsteen base pairing with the adduct. Both dCTP and dTTP base paired with the Hoogsteen edge of O-6-methylG. A single, short hydrogen bond formed between the N3 atom of dTTP and the N7 atom of O-6-methylG. Protonation of the N3 atom of dCTP and bifurcation of the N3 hydrogen between the N7 and O-6 atoms of O-6-methylG allow base pairing of the lesion with dCTP. We conclude that differences in the Hoogsteen hydrogen bonding between nucleotides is the main factor in the preferential selectivity of dTTP opposite O-6-methylG by human pol i, in contrast to the mispairing modes observed previously for O-6-methylG in the structures of the model DNA polymerases Sulfolobus solfataricus Dpo4 and Bacillus stearothermophilus DNA polymerase I.	[Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA; [Choi, Jeong-Yun; Guengerich, F. Peter] Ewha Womans Univ, Dept Pharmacol, Sch Med, Seoul 158710, South Korea	Vanderbilt University; Vanderbilt University; Ewha Womans University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Pence, Matthew/J-1379-2012	Pence, Matthew/0000-0003-2271-789X	National Institutes of Health [R01 ES010375, P01 ES005355, P30 ES000267, T32 ES007028]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, P30ES000267, T32ES007028, P01ES005355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 (to F.P.G.), P01 ES005355 (to M.E.), P30 ES000267 (to F.P.G. and M.E.), and T32 ES007028 (to F.P.G. and M.G.P.). Vanderbilt University is a member institution of LS-CAT at the Advanced Photon Source (APS), Argonne, Illinois. Use of the APS was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-06CH11357.	Afonin AV, 2010, MAGN RESON CHEM, V48, P309, DOI 10.1002/mrc.2579; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Carpio RVD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005766; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; DAWSON RMC, 1986, DATA BIOCH RES, P80; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; GAFFNEY BL, 1984, BIOCHEMISTRY-US, V23, P5686, DOI 10.1021/bi00319a004; GAFFNEY BL, 1989, BIOCHEMISTRY-US, V28, P5881, DOI 10.1021/bi00440a026; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GINELL SL, 1990, BIOCHEMISTRY-US, V29, P10461, DOI 10.1021/bi00498a005; GRAY DM, 1984, NUCLEIC ACIDS RES, V12, P7565, DOI 10.1093/nar/12.19.7565; Haracska L, 2000, MOL CELL BIOL, V20, P8001, DOI 10.1128/MCB.20.21.8001-8007.2000; Hwang HS, 2005, BIOCHEMISTRY-US, V44, P4850, DOI 10.1021/bi048244+; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; LOVELESS A, 1969, NATURE, V223, P206, DOI 10.1038/223206a0; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2006, STRUCTURE, V14, P749, DOI 10.1016/j.str.2006.01.010; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATEL DJ, 1986, BIOCHEMISTRY-US, V25, P1027, DOI 10.1021/bi00353a012; PATEL DJ, 1986, BIOCHEMISTRY-US, V25, P1036, DOI 10.1021/bi00353a013; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; SHANK RC, 1987, ARCH TOXICOL, P204; SINGER B, 1989, P NATL ACAD SCI USA, V86, P8271, DOI 10.1073/pnas.86.21.8271; SNOW ET, 1984, J BIOL CHEM, V259, P8095; TAN HB, 1994, BIOCHEMISTRY-US, V33, P5335, DOI 10.1021/bi00183a042; Tissier A, 2000, GENE DEV, V14, P1642; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; WILLIAMS LD, 1987, P NATL ACAD SCI USA, V84, P1779, DOI 10.1073/pnas.84.7.1779; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wolfle WT, 2005, MOL CELL BIOL, V25, P7137, DOI 10.1128/MCB.25.16.7137-7143.2005; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1027, DOI 10.1021/bi011495n; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	44	44	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40666	40672		10.1074/jbc.M110.183665	http://dx.doi.org/10.1074/jbc.M110.183665			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20961860	Green Published, hybrid			2022-12-25	WOS:000285414400029
J	Orozco-Solis, R; Matos, RJB; Guzman-Quevedo, O; de Souza, SL; Bihouee, A; Houlgatte, R; de Castro, RM; Bolanos-Jimenez, F				Orozco-Solis, Ricardo; Matos, Rhowena J. B.; Guzman-Quevedo, Omar; de Souza, Sandra Lopes; Bihouee, Audrey; Houlgatte, Remi; de Castro, Raul Manhaes; Bolanos-Jimenez, Francisco			Nutritional Programming in the Rat Is Linked to Long-Lasting Changes in Nutrient Sensing and Energy Homeostasis in the Hypothalamus	PLOS ONE			English	Article							LOW-PROTEIN DIET; GLYCOGEN-SYNTHASE KINASE-3; K-ATP CHANNEL; METABOLIC SYNDROME; GENE-EXPRESSION; INDUCED OBESITY; FOOD-INTAKE; FUNCTIONAL-ORGANIZATION; CIRCADIAN TRANSCRIPTION; PRENATAL INFLUENCES	Background: Nutrient deficiency during perinatal development is associated with an increased risk to develop obesity, diabetes and hypertension in the adulthood. However, the molecular mechanisms underlying the developmental programming of the metabolic syndrome remain largely unknown. Methodology/Principal Findings: Given the essential role of the hypothalamus in the integration of nutritional, endocrine and neuronal cues, here we have analyzed the profile of the hypothalamus transcriptome in 180 days-old rats born to dams fed either a control (200 g/kg) or a low-protein (80 g/kg) diet through pregnancy and lactation. From a total of 26 209 examined genes, 688 were up-regulated and 309 down-regulated (P<0.003) by early protein restriction. Further bioinformatic analysis of the data revealed that perinatal protein restriction permanently alters the expression of two gene clusters regulating common cellular processes. The first one includes several gate keeper genes regulating insulin signaling and nutrient sensing. The second cluster encompasses a functional network of nuclear receptors and co-regulators of transcription involved in the detection and use of lipid nutrients as fuel which, in addition, link temporal and nutritional cues to metabolism through their tight interaction with the circadian clock. Conclusions/Significance: Collectively, these results indicate that the programming of the hypothalamic circuits regulating energy homeostasis is a key step in the development of obesity associated with malnutrition in early life and provide a valuable resource for further investigating the role of the hypothalamus in the programming of the metabolic syndrome.	[Orozco-Solis, Ricardo; Matos, Rhowena J. B.; Guzman-Quevedo, Omar; Bolanos-Jimenez, Francisco] Univ Nantes, INRA, Nantes Atlantique Univ, Physiol Adaptat Nutr UMR1280, Nantes, France; [de Souza, Sandra Lopes] Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Anat, Recife, PE, Brazil; [Bihouee, Audrey; Houlgatte, Remi] INSERM, Inst Thorax, IFR26, U915, Nantes, France; [de Castro, Raul Manhaes] Univ Fed Pernambuco, Ctr Ciencias Saude, Dept Nutr, Recife, PE, Brazil	INRAE; Nantes Universite; Universidade Federal de Pernambuco; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Universidade Federal de Pernambuco	Orozco-Solis, R (corresponding author), Univ Nantes, INRA, Nantes Atlantique Univ, Physiol Adaptat Nutr UMR1280, Nantes, France.	Francisco.Bolanos@univ-nantes.fr	Bihouée, Audrey/D-4934-2015; Guzman Quevedo, Omar/ABU-5276-2022; de Castro, Raul Manhaes/A-1635-2014; Quevedo, omar Guzman/AAG-6327-2020; Houlgatte, Remi/P-3020-2017	Guzman Quevedo, Omar/0000-0003-1358-1783; Quevedo, omar Guzman/0000-0003-1358-1783; Bihouee, Audrey/0000-0002-8689-2083	INRA; La Region Pays de la Loire; L'Agence National de la Recherche [ANR-05-PNRA-009-02]	INRA; La Region Pays de la Loire(Region Pays de la Loire); L'Agence National de la Recherche(French National Research Agency (ANR))	This work was supported by INRA through a Young Team Action and by L'Agence National de la Recherche (ANR-05-PNRA-009-02). R. Orozco-Solis and O. Guzman-Quevedo are doctoral fellows from the Mexican Consejo Nacional de Ciencia y Tecnologia (CONACYT). S. Lopes de Souza and Rhowena Matos are the recipients of a post-doctoral fellowship from La Region Pays de la Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bellinger L, 2005, CLIN SCI, V109, P413, DOI 10.1042/CS20050127; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; de Freitas MS, 2003, BBA-MOL BASIS DIS, V1639, P8, DOI 10.1016/S0925-4439(03)00096-6; de Souza SL, 2008, EUR J NEUROSCI, V27, P1400, DOI 10.1111/j.1460-9568.2008.06105.x; Desai M, 2007, AM J PHYSIOL-REG I, V293, pR2306, DOI 10.1152/ajpregu.00783.2006; Desai M, 2007, REPROD SCI, V14, P329, DOI 10.1177/1933719107303983; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Guard DB, 2009, AM J PHYSIOL-REG I, V296, pR921, DOI 10.1152/ajpregu.90456.2008; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Ikenasio-Thorpe BA, 2007, J ENDOCRINOL, V193, P31, DOI 10.1677/joe.1.07017; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jensen CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003738; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Krechowec SO, 2006, J ENDOCRINOL, V189, P355, DOI 10.1677/joe.1.06679; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Levin BE, 2001, NAT NEUROSCI, V4, P459, DOI 10.1038/87405; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Man PS, 2008, NEUROPHARMACOLOGY, V55, P1, DOI 10.1016/j.neuropharm.2008.04.008; McMullen S, 2005, AM J PHYSIOL-REG I, V288, pR85, DOI 10.1152/ajpregu.00435.2004; Morrison CD, 2005, AM J PHYSIOL-ENDOC M, V289, pE1051, DOI 10.1152/ajpendo.00094.2005; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Nogueiras R, 2009, PHARMACOL RES, V60, P93, DOI 10.1016/j.phrs.2009.04.004; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Orozco-Solis R, 2009, PHYSIOL BEHAV, V96, P481, DOI 10.1016/j.physbeh.2008.11.016; OROZCOSOLIS R, 2010, INT J OBESI IN PRESS; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Plagemann A, 2000, J NUTR, V130, P2582, DOI 10.1093/jn/130.10.2582; Plagemann A, 1999, REGUL PEPTIDES, V85, P109, DOI 10.1016/S0167-0115(99)00085-3; Plagemann A, 2000, NEUROPEPTIDES, V34, P1, DOI 10.1054/npep.1999.0778; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; SARDINHA FLC, NUTRITION, V22, P1152; Sato T, 2003, BIOCHEM BIOPH RES CO, V300, P167, DOI 10.1016/S0006-291X(02)02774-2; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR1003, DOI 10.1152/ajpregu.00011.2007; Woods SC, 2008, ANNU REV NUTR, V28, P295, DOI 10.1146/annurev.nutr.28.061807.155505; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313	57	59	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13537	10.1371/journal.pone.0013537	http://dx.doi.org/10.1371/journal.pone.0013537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975839	Green Published, Green Submitted, gold			2022-12-25	WOS:000283293800011
J	Cherkas, LF; Harris, JM; Levinson, E; Spector, TD; Prainsack, B				Cherkas, Lynn F.; Harris, Juliette M.; Levinson, Elana; Spector, Tim D.; Prainsack, Barbara			A Survey of UK Public Interest in Internet-Based Personal Genome Testing	PLOS ONE			English	Article							GENETIC RISK-ASSESSMENT; SMOKING-CESSATION; SUSCEPTIBILITY; DISEASE; EXPECTATIONS; BEHAVIORS; ATTITUDES; FEEDBACK; SMOKERS; IMPACT	Background: In view of the increasing availability of commercial internet-based Personal Genome Testing (PGT), this study aimed to explore the reasons why people would consider taking such a test and how they would use the genetic risk information provided. Methodology/Principal Findings: A self-completion questionnaire assessing public awareness and interest in PGT and motivational reasons for undergoing PGT was completed by 4,050 unselected adult volunteers from the UK-based TwinsUK register, aged 17 to 91 (response rate 62%). Only 13% of respondents were aware of the existence of PGT. After reading a brief summary about PGT, one in twenty participants (5%) were potentially interested at current prices (250) pound, however this proportion rose to half (50%) if the test was free of charge. Nearly all respondents who were interested in free PGT reported they would take the test to encourage them to adopt a healthier lifestyle if found to be at high genetic risk of a disease (93%). Around 4 in 5 respondents would have the test to convey genetic risk information to their children and a similar proportion felt that having a PGT would enable their doctor to monitor their health more closely. A TwinsUK research focus group also indicated that consumers would consult their GP to help interpret results of PGT. Conclusions/Significance: This hypothetical study suggests that increasing publicity and decreasing costs of PGT may lead to increased uptake, driven in part by the general public's desire to monitor and improve their health. Although the future extent of the clinical utility of PGT is currently unknown, it is crucial that consumers are well informed about the current limitations of PGT. Our results suggest that health professionals will inevitably be required to respond to individuals who have undergone PGT. This has implications for health service providers regarding both cost and time.	[Cherkas, Lynn F.; Harris, Juliette M.; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Levinson, Elana] Columbia Univ, Med Ctr, Dept Pediat, Div Mol Genet, New York, NY USA; [Prainsack, Barbara] Kings Coll London, Ctr Biomed & Soc CBAS, London WC2R 2LS, England	University of London; King's College London; Columbia University; University of London; King's College London	Cherkas, LF (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England.	lynn.cherkas@kcl.ac.uk	Prainsack, Barbara/AAF-5739-2021	Prainsack, Barbara/0000-0002-6335-1532	Department of Twin Research and Genetic Epidemiology [081878/Z/06/Z]; Wellcome Trust	Department of Twin Research and Genetic Epidemiology; Wellcome Trust(Wellcome TrustEuropean Commission)	Department of Twin Research and Genetic Epidemiology is supported by a grant (081878/Z/06/Z) by The Wellcome Trust (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Arkadianos I, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-29; Audrain J, 1997, ADDICT BEHAV, V22, P741, DOI 10.1016/S0306-4603(97)00060-9; Beery TA, 2007, GENET TEST, V11, P111, DOI 10.1089/gte.2006.0527; Bunnik E, 2009, AM J BIOETHICS, V9, P23, DOI 10.1080/15265160902874429; Caulfield T, 2009, AM J BIOETHICS, V9, P48, DOI 10.1080/15265160902918770; Chao S, 2008, ALZ DIS ASSOC DIS, V22, P94, DOI 10.1097/WAD.0b013e31815a9dcc; Gaskell G, 2000, NAT BIOTECHNOL, V18, P935, DOI 10.1038/79403; GRAVES KD, TESTING BREAST UNPUB; *HARV MED SCH DEP, 2010, PERS GEN ED PROJ 201; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Ioannidis JPA, 2009, ANN INTERN MED, V150, P139, DOI 10.7326/0003-4819-150-2-200901200-00012; Ito H, 2006, PREV MED, V42, P102, DOI 10.1016/j.ypmed.2005.10.006; Khoury MJ, 2009, GENET MED, V11, P559, DOI 10.1097/GIM.0b013e3181b13a6c; Makeeva OA, 2009, PERS MED, V6, P329, DOI [10.2217/pme.09.14, 10.2217/PME.09.14]; McBride CM, 2002, CANCER EPIDEM BIOMAR, V11, P521; McBride CM, 2010, ANNU REV PUBL HEALTH, V31, P89, DOI 10.1146/annurev.publhealth.012809.103532; McBride CM, 2009, GENET MED, V11, P582, DOI 10.1097/GIM.0b013e3181b22c3a; McGowan ML, 2008, AM J BIOETHICS, V8, P18, DOI 10.1080/15265160802248302; McGuire AL, 2009, AM J BIOETHICS, V9, P3, DOI 10.1080/15265160902928209; Ng PC, 2009, NATURE, V461, P724, DOI 10.1038/461724a; *PPPG ESHG, 2010, STAT ESHG DIR TO CON; Sanderson SC, 2010, PUBLIC HEALTH GENOMI, V13, P116, DOI 10.1159/000226595; Sanderson SC, 2008, J HEALTH PSYCHOL, V13, P481, DOI 10.1177/1359105308088519; SIMON RM, 2009, GENDER DIFFERENCES K, DOI DOI 10.1177/0963662509335449; Telner DE, 2008, MED TEACH, V30, P192, DOI 10.1080/01421590701827353; *UK HL SCI TECHN C, 2009, GEN MED; *US SACCHS, 2010, DRAFT REP GEN ED TRA; Wright AJ, 2008, CLIN GENET, V73, P306, DOI 10.1111/j.1399-0004.2008.00964.x	29	83	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13473	10.1371/journal.pone.0013473	http://dx.doi.org/10.1371/journal.pone.0013473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976053	gold, Green Published, Green Submitted			2022-12-25	WOS:000283114700010
J	Dong, XY; Tian, WH; Wang, G; Dong, ZY; Shen, W; Zheng, G; Wu, XB; Xue, JL; Wang, Y; Chen, JZ				Dong, Xiaoyan; Tian, Wenhong; Wang, Gang; Dong, Zheyue; Shen, Wei; Zheng, Gang; Wu, Xiaobing; Xue, Jinglun; Wang, Yue; Chen, Jinzhong			Establishment of an AAV Reverse Infection-Based Array	PLOS ONE			English	Article							VIRUS; TRANSFECTION; VECTORS; SEROTYPES	Background: The development of a convenient high-throughput gene transduction approach is critical for biological screening. Adeno-associated virus (AAV) vectors are broadly used in gene therapy studies, yet their applications in in vitro high-throughput gene transduction are limited. Principal Findings: We established an AAV reverse infection (RI)-based method in which cells were transduced by quantified recombinant AAVs (rAAVs) pre-coated onto 96-well plates. The number of pre-coated rAAV particles and number of cells loaded per well, as well as the temperature stability of the rAAVs on the plates, were evaluated. As the first application of this method, six serotypes or hybrid serotypes of rAAVs (AAV1, AAV2, AAV5/5, AAV8, AAV25 m, AAV28 m) were compared for their transduction efficiencies using various cell lines, including BHK21, HEK293, BEAS-2BS, HeLaS3, Huh7, Hepa1-6, and A549. AAV2 and AAV1 displayed high transduction efficiency; thus, they were deemed to be suitable candidate vectors for the RI-based array. We next evaluated the impact of sodium butyrate (NaB) treatment on rAAV vector-mediated reporter gene expression and found it was significantly enhanced, suggesting that our system reflected the biological response of target cells to specific treatments. Conclusions/Significance: Our study provides a novel method for establishing a highly efficient gene transduction array that may be developed into a platform for cell biological assays.	[Dong, Xiaoyan; Xue, Jinglun; Chen, Jinzhong] Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Dong, Xiaoyan; Dong, Zheyue; Shen, Wei; Zheng, Gang] Beijing Fiveplus Mol Med Inst, Beijing, Peoples R China; [Tian, Wenhong; Wang, Gang; Wang, Yue] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China	Fudan University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Dong, XY (corresponding author), Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	euy-tokyo@umin.ac.jp; kingbellchen@fudan.edu.cn		Wu, Xiaobing/0000-0002-2823-2634	State Key Laboratory for Molecular Virology and Genetic Engineering of China [2008-s-0008]; Beijing FivePlus Molecular Medicine Institute	State Key Laboratory for Molecular Virology and Genetic Engineering of China; Beijing FivePlus Molecular Medicine Institute	This study was supported by the Research Programs of State Key Laboratory for Molecular Virology and Genetic Engineering of China (No. 2008-s-0008), and Beijing FivePlus Molecular Medicine Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett Jeffrey S., 1995, P55, DOI 10.1016/B978-012397570-6/50006-X; Carbone R, 2007, BIOMATERIALS, V28, P2244, DOI 10.1016/j.biomaterials.2006.12.026; Chen H, 2007, MICROSC MICROANAL, V13, P384, DOI 10.1017/S1431927607070808; Chen WY, 1997, P NATL ACAD SCI USA, V94, P5798, DOI 10.1073/pnas.94.11.5798; Choi VW, 2005, CURR GENE THER, V5, P299, DOI 10.2174/1566523054064968; Dong Xiaoyan, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P679; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; HOGGAN MD, 1966, P NATL ACAD SCI USA, V55, P1467, DOI 10.1073/pnas.55.6.1467; Hueffer K, 2003, CURR OPIN MICROBIOL, V6, P392, DOI 10.1016/S1369-5274(03)00083-3; KNIPE DM, 2007, FIELDS VIROLOGY, P2438; Okazaki A, 2007, TISSUE ENG, V13, P245, DOI 10.1089/ten.2006.0185; Paneda A, 2009, HUM GENE THER, V20, P908, DOI 10.1089/hum.2009.031; Rabinowitz JE, 2004, J VIROL, V78, P4421, DOI 10.1128/JVI.78.9.4421-4432.2004; Riviere C, 2006, GENE THER, V13, P1300, DOI 10.1038/sj.gt.3302766; Samulski R.J., 1999, COLD SPRING HARBOR M, P131; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Webb BL, 2003, J BIOMOL SCREEN, V8, P620, DOI 10.1177/1087057103259324; Wu XB, 2001, CHINESE SCI BULL, V46, P485, DOI 10.1007/BF03187263; Wu ZJ, 1999, CHINESE SCI BULL, V44, P715, DOI 10.1007/BF02909710; Zabner J, 2000, J VIROL, V74, P3852, DOI 10.1128/JVI.74.8.3852-3858.2000	20	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13479	10.1371/journal.pone.0013479	http://dx.doi.org/10.1371/journal.pone.0013479			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976058	Green Submitted, Green Published, gold			2022-12-25	WOS:000283114700012
J	Sharma, R; Buras, E; Terashima, T; Serrano, F; Massaad, CA; Hu, LY; Bitner, B; Inoue, T; Chan, L; Pautler, RG				Sharma, Ruchi; Buras, Eric; Terashima, Tomoya; Serrano, Faridis; Massaad, Cynthia A.; Hu, Lingyun; Bitner, Brittany; Inoue, Taeko; Chan, Lawrence; Pautler, Robia G.			Hyperglycemia Induces Oxidative Stress and Impairs Axonal Transport Rates in Mice	PLOS ONE			English	Article							IN-VIVO; SUPEROXIDE-DISMUTASE; ANTIOXIDANT DEFENSE; DIABETIC-NEUROPATHY; PROTEIN; DYSFUNCTION; NEURONS; TAU; OVEREXPRESSION; PROTECTION	Background: While hyperglycemia-induced oxidative stress damages peripheral neurons, technical limitations have, in part, prevented in vivo studies to determine the effect of hyperglycemia on the neurons in the central nervous system (CNS). While olfactory dysfunction is indicated in diabetes, the effect of hyperglycemia on olfactory receptor neurons (ORNs) remains unknown. In this study, we utilized manganese enhanced MRI (MEMRI) to assess the impact of hyperglycemia on axonal transport rates in ORNs. We hypothesize that (i) hyperglycemia induces oxidative stress and is associated with reduced axonal transport rates in the ORNs and (ii) hyperglycemia-induced oxidative stress activates the p38 MAPK pathway in association with phosphorylation of tau protein leading to the axonal transport deficits. Research Design and Methods: T-1-weighted MEMRI imaging was used to determine axonal transport rates post-streptozotocin injection in wildtype (WT) and superoxide dismutase 2 (SOD2) overexpressing C57Bl/6 mice. SOD2 overexpression reduces mitochondrial superoxide load. Dihydroethidium staining was used to quantify the reactive oxygen species (ROS), specifically, superoxide (SO). Protein and gene expression levels were determined using western blotting and Q-PCR analysis, respectively. Results: STZ-treated WT mice exhibited significantly reduced axonal transport rates and significantly higher levels of ROS, phosphorylated p38 MAPK and tau protein as compared to the WT vehicle treated controls and STZ-treated SOD2 mice. The gene expression levels of p38 MAPK and tau remained unchanged. Conclusion: Increased oxidative stress in STZ-treated WT hyperglycemic mice activates the p38 MAPK pathway in association with phosphorylation of tau and attenuates axonal transport rates in the olfactory system. In STZ-treated SOD-overexpressing hyperglycemic mice in which superoxide levels are reduced, these deficits are reversed.	[Sharma, Ruchi; Serrano, Faridis; Massaad, Cynthia A.; Hu, Lingyun; Inoue, Taeko; Pautler, Robia G.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Buras, Eric; Terashima, Tomoya; Chan, Lawrence] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Sharma, R (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	rpautler@bcm.edu			DERC (Diabetes Endocrinology Research Center) [NIDDK-P30DK079638, HL-51586]; NIH/NIA [R01AG029977]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029977] Funding Source: NIH RePORTER	DERC (Diabetes Endocrinology Research Center); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by DERC (Diabetes Endocrinology Research Center), NIDDK-P30DK079638 (LC), HL-51586 (LC), and NIH/NIA R01AG029977 (RGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; BURNETT K R, 1984, Magnetic Resonance Imaging, V2, P307, DOI 10.1016/0730-725X(84)90197-8; Chen HM, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-3; Clodfelder-Miller BJ, 2006, DIABETES, V55, P3320, DOI 10.2337/db06-0485; Cross DJ, 2008, NEUROIMAGE, V39, P915, DOI 10.1016/j.neuroimage.2007.08.036; Dennis JC, 2005, J NEUROCYTOL, V34, P3, DOI 10.1007/s11068-005-5044-x; Ho YS, 1998, AM J RESP CELL MOL, V18, P538, DOI 10.1165/ajrcmb.18.4.2959; HOUGH S, 1982, AM J PHYSIOL, V242, pE451, DOI 10.1152/ajpendo.1982.242.6.E451; Hu DY, 2006, J NEUROSCI, V26, P3933, DOI 10.1523/JNEUROSCI.5566-05.2006; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; Kowluru RA, 2006, FREE RADICAL BIO MED, V41, P1191, DOI 10.1016/j.freeradbiomed.2006.01.012; LEFLOCH JP, 1993, DIABETES CARE, V16, P934, DOI 10.2337/diacare.16.6.934; Levy J, 1999, ENDOCRINE, V10, P1, DOI 10.1385/ENDO:10:1:1; Maragos WF, 2000, BRAIN RES, V878, P218, DOI 10.1016/S0006-8993(00)02707-4; Massaad CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010561; Menne J, 2004, DIABETES, V53, P2101, DOI 10.2337/diabetes.53.8.2101; Munusamy S, 2009, FREE RADICAL BIO MED, V46, P1149, DOI 10.1016/j.freeradbiomed.2009.01.022; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; Oh-Hashi K, 2001, FREE RADICAL BIO MED, V30, P213, DOI 10.1016/S0891-5849(00)00461-5; Pautler RG, 2004, NMR BIOMED, V17, P595, DOI 10.1002/nbm.942; Pautler RG, 2003, MAGNET RESON MED, V50, P33, DOI 10.1002/mrm.10498; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Price SA, 2004, DIABETES, V53, P1851, DOI 10.2337/diabetes.53.7.1851; Purves T, 2001, FASEB J, V15, P2508, DOI 10.1096/fj.01-0253hyp; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; SITHIPORN A, 2002, ANN NY ACAD SCI, V973, P359; SLOOT WN, 1994, BRAIN RES, P657; Smith KDB, 2007, NEUROIMAGE, V35, P1401, DOI 10.1016/j.neuroimage.2007.01.046; Terwel D, 2002, NEUROMOL MED, V2, P151, DOI 10.1385/NMM:2:2:151; Tindemans I, 2003, EUR J NEUROSCI, V18, P3352, DOI 10.1111/j.1460-9568.2003.03056.x; Tomlinson DR, 2008, J PERIPHER NERV SYST, V13, P112, DOI 10.1111/j.1529-8027.2008.00167.x; Vincent AM, 2007, EXP NEUROL, V208, P216, DOI 10.1016/j.expneurol.2007.07.017; Vincent AM, 2009, ANTIOXID REDOX SIGN, V11, P425, DOI 10.1089/ars.2008.2235; WEINSTOCK RS, 1993, PHYSIOL BEHAV, V53, P17, DOI 10.1016/0031-9384(93)90005-Z	35	64	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13463	10.1371/journal.pone.0013463	http://dx.doi.org/10.1371/journal.pone.0013463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976160	gold, Green Submitted, Green Published			2022-12-25	WOS:000283045300032
J	Li, CS; Chen, C; Zheng, P; Liu, Y				Li, Chi-Shan; Chen, Chong; Zheng, Pan; Liu, Yang			Transgenic Expression of P1A Induced Thymic Tumor: A Role for Onco-Fetal Antigens in Tumorigenesis	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; C-MYC; REJECTION ANTIGEN; STEM-CELLS; N-MYC; GENE; MICE; CANCER; PROGENITORS; SECONDARY	P1A is the first known tumor rejection antigen. It is expressed in embryonic stem cells and multiple tumors but is silent in adult tissues except for the testis and placenta. Therefore, P1A represents a prototype for onco-fetal antigens. To test the potential function of P1A in tumorigenesis, we used a transgenic mouse expressing P1A in lymphoid cells. We observed that immunodeficient host P1A transgenic mice developed thymic tumors after 7 months of age and had shorter survival rates compared to control groups. Most of the 7 examined tumors displayed B cell lineage markers. The P1A transgenic bone marrow cells had higher proliferation ability and more potential progenitors compared to control bone marrow cells. To our knowledge, our data provided the first example that onco-fetal antigen can promote tumorigenesis.	[Li, Chi-Shan; Chen, Chong; Zheng, Pan; Liu, Yang] Univ Michigan, Sch Med, Dept Surg, Sect Gen Surg,Div Immunotherapy, Ann Arbor, MI 48109 USA; [Liu, Yang] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI USA; [Zheng, Pan; Liu, Yang] Univ Michigan, Sch Med, Dis & Comprehens Canc Ctr, Program Mol Mech, Ann Arbor, MI USA; [Zheng, Pan] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Li, Chi-Shan] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Toxicol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Li, CS (corresponding author), Univ Michigan, Sch Med, Dept Surg, Sect Gen Surg,Div Immunotherapy, Ann Arbor, MI 48109 USA.	panz@umich.edu; yangl@med.umich.edu	Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091648] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Hadden JW, 2003, INT IMMUNOPHARMACOL, V3, P1061, DOI 10.1016/S1567-5769(03)00060-2; Kawamoto H, 1998, J IMMUNOL, V161, P3799; Magliocca JF, 2006, STEM CELLS DEV, V15, P707, DOI 10.1089/scd.2006.15.707; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MUELLER BU, 1995, J PEDIATR-US, V126, P1, DOI 10.1016/S0022-3476(95)70491-4; PENN I, 1994, CANCER DETECT PREV, V18, P241; RAMARATHINAM L, 1995, J IMMUNOL, V155, P5323; ROSENBAUM H, 1989, EMBO J, V8, P749, DOI 10.1002/j.1460-2075.1989.tb03435.x; ROSENBAUM H, 1990, EMBO J, V9, P897, DOI 10.1002/j.1460-2075.1990.tb08187.x; SAKAGUCHI N, 1988, EMBO J, V7, P3457, DOI 10.1002/j.1460-2075.1988.tb03220.x; Sarma S, 1999, J EXP MED, V189, P811, DOI 10.1084/jem.189.5.811; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; Uyttenhove C, 1997, INT J CANCER, V70, P349, DOI 10.1002/(SICI)1097-0215(19970127)70:3<349::AID-IJC17>3.3.CO;2-Z; UYTTENHOVE C, 1983, J EXP MED, V157, P1040, DOI 10.1084/jem.157.3.1040; VANDENEYNDE B, 1994, EUR J IMMUNOL, V24, P2740, DOI 10.1002/eji.1830241125; VANDENEYNDE B, 1991, J EXP MED, V173, P1373, DOI 10.1084/jem.173.6.1373; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617	24	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13439	10.1371/journal.pone.0013439	http://dx.doi.org/10.1371/journal.pone.0013439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976169	Green Published, Green Submitted, gold			2022-12-25	WOS:000283043700024
J	Xi, CW; Wu, JF				Xi, Chuanwu; Wu, Jianfeng			dATP/ATP, a Multifunctional Nucleotide, Stimulates Bacterial Cell Lysis, Extracellular DNA Release and Biofilm Development	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS; EPITHELIAL-CELLS; IMMUNE-SYSTEM; ATP; ACINETOBACTER; COMMUNICATION; INDUCTION; ADHERENCE	Background: Signaling by extracellular adenosine 59-triphosphase (eATP) is very common for cell-to-cell communication in many basic patho-physiological development processes. Rapid release of ATP into the extracellular environment from distressed or injured eukaryotic cells due to pathogens or other etiological factors can serve as a "danger signal'', activating host innate immunity. However, little is known about how or whether pathogenic bacteria respond to this "danger signal''. Methods and Principal Findings: Here we report that extracellular dATP/ATP can stimulate bacterial adhesion and biofilm formation via increased cell lysis and extracellular DNA (eDNA) release. We demonstrate that extracellular dATP/ATP also stimulates bacterial adherence in vitro to human bronchial epithelial cells. Conclusions and Significance: These data suggest that bacteria may sense extracellular dATP/ATP as a signal of "danger'' and form biofilms to protect them from host innate immunity. This study reveals a very important and unrecognized phenomenon that both bacteria and host cells could respond to a common important signal molecule in a race to adapt to the presence of one another. We propose that extracellular dATP/ATP functions as an "inter-domain'' warning signal that serves to induce protective measures in both Bacterial and Eukaryotic cells.	[Xi, Chuanwu; Wu, Jianfeng] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Xi, CW (corresponding author), Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.	cxi@umich.edu	Xi, Chuanwu/C-7432-2011	Xi, Chuanwu/0000-0002-7554-1915	University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098350] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work is supported by an internal funding to C.X. from the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2000, J PHARMACOL EXP THER, V295, P862; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; Di Virgilio F, 2007, PURINERG SIGNAL, V3, P1, DOI 10.1007/s11302-006-9048-5; Di Virgilio F, 2009, TRENDS NEUROSCI, V32, P79, DOI 10.1016/j.tins.2008.11.003; Flemming HC, 2001, WATER SCI TECHNOL, V43, P9, DOI 10.2166/wst.2001.0328; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Komlosi P, 2005, PHYSIOLOGY, V20, P86, DOI 10.1152/physiol.00002.2005; Komoszynski M, 1996, BBA-MOL CELL RES, V1310, P233, DOI 10.1016/0167-4889(95)00135-2; LaPaglia C, 1997, APPL ENVIRON MICROB, V63, P3158, DOI 10.1128/AEM.63.8.3158-3163.1997; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Neu TR, 1999, METHOD ENZYMOL, V310, P145; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rachid S, 2000, ADV EXP MED BIOL, V485, P159; RAMPHAL R, 1983, INFECT IMMUN, V41, P345, DOI 10.1128/IAI.41.1.345-351.1983; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Spoering AL, 2006, CURR OPIN MICROBIOL, V9, P133, DOI 10.1016/j.mib.2006.02.004; Staudt C, 2004, BIOTECHNOL BIOENG, V88, P585, DOI 10.1002/bit.20241; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wolfaardt GM, 1998, MICROB ECOL, V35, P213, DOI 10.1007/s002489900077; Wu JF, 2009, APPL ENVIRON MICROB, V75, P5390, DOI 10.1128/AEM.00400-09; Xi CW, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2209962; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389	39	29	30	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13355	10.1371/journal.pone.0013355	http://dx.doi.org/10.1371/journal.pone.0013355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976227	gold, Green Published, Green Submitted			2022-12-25	WOS:000282941000008
J	Mailloux, RJ; Adjeitey, CNK; Harper, ME				Mailloux, Ryan J.; Adjeitey, Cyril Nii-Klu; Harper, Mary-Ellen			Genipin-Induced Inhibition of Uncoupling Protein-2 Sensitizes Drug-Resistant Cancer Cells to Cytotoxic Agents	PLOS ONE			English	Article							PROTON LEAK; MITOCHONDRIAL; EXPRESSION; APOPTOSIS; DYSFUNCTION; HEPATOCYTES; GENIPOSIDE; METABOLISM; OXIDATION; MENADIONE	Uncoupling protein-2 (UCP2) is known to suppress mitochondrial reactive oxygen species (ROS) production and is employed by drug-resistant cancer cells to mitigate oxidative stress. Using the drug-sensitive HL-60 cells and the drug-resistant MX2 subline as model systems, we show that genipin, a UCP2 inhibitor, sensitizes drug-resistant cells to cytotoxic agents. Increased MX2 cell death was observed upon co-treatment with genipin and different doses of menadione, doxorubicin, and epirubicin. DCFH-DA fluorimetry revealed that the increase in MX2 cell death was accompanied by enhanced cellular ROS levels. The drug-induced increase in ROS was linked to genipin-mediated inhibition of mitochondrial proton leak. State 4 and resting cellular respiratory rates were higher in the MX2 cells in comparison to the HL-60 cells, and the increased respiration was readily suppressed by genipin in the MX2 cells. UCP2 accounted for a remarkable 37% of the resting cellular oxygen consumption indicating that the MX2 cells are functionally reliant on this protein. Higher amounts of UCP2 protein were detected in the MX2 versus the HL-60 mitochondria. The observed effects of genipin were absent in the HL-60 cells pointing to the selectivity of this natural product for drug-resistant cells. The specificity of genipin for UCP2 was confirmed using CHO cells stably expressing UCP2 in which genipin induced an similar to 22% decrease in state 4 respiration. These effects were absent in empty vector CHO cells expressing no UCP2. Thus, the chemical inhibition of UCP2 with genipin sensitizes multidrug-resistant cancer cells to cytotoxic agents.	[Mailloux, Ryan J.; Adjeitey, Cyril Nii-Klu; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa	Mailloux, RJ (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	mharper@uottawa.ca	Harper, Mary-Ellen/C-3103-2009	Harper, Mary-Ellen/0000-0003-3864-5886; Mailloux, Ryan/0000-0003-3986-9830	Canadian Institutes of Health Research: Institute of Nutrition, Metabolism and Diabetes; Heart and Stroke Foundation of Canada; Molecular Function and Imaging group of the University of Ottawa Heart Institute	Canadian Institutes of Health Research: Institute of Nutrition, Metabolism and Diabetes(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Molecular Function and Imaging group of the University of Ottawa Heart Institute	Funding was provided by the Canadian Institutes of Health Research: Institute of Nutrition, Metabolism and Diabetes for Mary-Ellen Harper, and Dr. Ryan Mailloux is the recipient of a Postdoctoral Fellowship from a Heart and Stroke Foundation of Canada Program Grant, awarded by the Molecular Function and Imaging group of the University of Ottawa Heart Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; AZZU V, BIOCH BIOPHYS ACTA, V74, P5463; Baffy G, 2010, MITOCHONDRION, V10, P243, DOI 10.1016/j.mito.2009.12.143; BARNETT YA, 1995, MUTAT RES-DNAGING G, V338, P115, DOI 10.1016/0921-8734(95)00017-Z; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Carretero MV, 1998, FEBS LETT, V439, P55, DOI 10.1016/S0014-5793(98)01335-0; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chang YC, 2002, CHEM-BIOL INTERACT, V141, P243, DOI 10.1016/S0009-2797(02)00073-X; Collins P, 2002, BRIT J CANCER, V86, P372, DOI 10.1038/sj.bjc.6600074; Collins P, 2005, LIVER INT, V25, P880, DOI 10.1111/j.1478-3231.2005.01104.x; Crazzolara R, 2009, CURR CANCER DRUG TAR, V9, P19, DOI 10.2174/156800909787314057; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Gouaze V, 2001, MOL PHARMACOL, V60, P488; HARKER WG, 1989, CANCER RES, V49, P4542; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Hurtaud C, 2007, CELL MOL LIFE SCI, V64, P1853, DOI 10.1007/s00018-007-7039-5; Kim BC, 2005, BIOCHEM PHARMACOL, V70, P1398, DOI 10.1016/j.bcp.2005.07.025; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; McLeod CJ, 2005, J BIOL CHEM, V280, P33470, DOI 10.1074/jbc.M505258200; Muller I, 1998, INT J MOL MED, V1, P491; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Park YK, 2008, NUTR RES, V28, P83, DOI 10.1016/j.nutres.2007.11.008; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Pilkington GJ, 2008, SEMIN CANCER BIOL, V18, P226, DOI 10.1016/j.semcancer.2007.12.006; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Santandreu FM, 2010, FREE RADICAL BIO MED, V49, P658, DOI 10.1016/j.freeradbiomed.2010.05.031; Santandreu FM, 2009, CELL PHYSIOL BIOCHEM, V24, P379, DOI 10.1159/000257430; Savagner F, 2001, J CLIN ENDOCR METAB, V86, P4920, DOI 10.1210/jc.86.10.4920; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; SHANNON JE, 1978, CRYOBIOLOGY, V15, P239, DOI 10.1016/0011-2240(78)90032-9; Sipos I, 2003, NEUROCHEM RES, V28, P1575, DOI 10.1023/A:1025634728227; SUZUKI YJ, 1992, FREE RADICAL RES COM, V16, P131, DOI 10.3109/10715769209049166; Swift LP, 2006, CANCER RES, V66, P4863, DOI 10.1158/0008-5472.CAN-05-3410; TETEF M, 1995, INVEST NEW DRUG, V13, P157, DOI 10.1007/BF00872865; THOR H, 1982, J BIOL CHEM, V257, P2419; Tortora G, 2007, DRUG RESIST UPDATE, V10, P81, DOI 10.1016/j.drup.2007.03.003; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhou H, 2009, ARCH BIOCHEM BIOPHYS, V486, P88, DOI 10.1016/j.abb.2009.02.017	53	74	77	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13289	10.1371/journal.pone.0013289	http://dx.doi.org/10.1371/journal.pone.0013289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967268	gold, Green Submitted, Green Published			2022-12-25	WOS:000282869800012
J	Whitaker, HC; Kote-Jarai, Z; Ross-Adams, H; Warren, AY; Burge, J; George, A; Bancroft, E; Jhavar, S; Leongamornlert, D; Tymrakiewicz, M; Saunders, E; Page, E; Mitra, A; Mitchell, G; Lindeman, GJ; Evans, DG; Blanco, I; Mercer, C; Rubinstein, WS; Clowes, V; Douglas, F; Hodgson, S; Walker, L; Donaldson, A; Izatt, L; Dorkins, H; Male, A; Tucker, K; Stapleton, A; Lam, J; Kirk, J; Lilja, H; Easton, D; Cooper, C; Eeles, R; Neal, DE				Whitaker, Hayley C.; Kote-Jarai, Zsofia; Ross-Adams, Helen; Warren, Anne Y.; Burge, Johanna; George, Anne; Bancroft, Elizabeth; Jhavar, Sameer; Leongamornlert, Daniel; Tymrakiewicz, Malgorzata; Saunders, Edward; Page, Elizabeth; Mitra, Anita; Mitchell, Gillian; Lindeman, Geoffrey J.; Evans, D. Gareth; Blanco, Ignacio; Mercer, Catherine; Rubinstein, Wendy S.; Clowes, Virginia; Douglas, Fiona; Hodgson, Shirley; Walker, Lisa; Donaldson, Alan; Izatt, Louise; Dorkins, Huw; Male, Alison; Tucker, Kathy; Stapleton, Alan; Lam, Jimmy; Kirk, Judy; Lilja, Hans; Easton, Douglas; Cooper, Colin; Eeles, Rosalind; Neal, David E.		IMPACT Study Steering Comm; IMPACT Study Collaborators; UK GPCS Collaborators	The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine	PLOS ONE			English	Article							94 AMINO-ACIDS; SECRETORY PROTEIN; PSP94 EXPRESSION; RADICAL PROSTATECTOMY; MESSENGER-RNA; MODEL; SUSCEPTIBILITY; ANGIOGENESIS; ASSOCIATION; PROGRESSION	Background: Microseminoprotein-beta (MSMB) regulates apoptosis and using genome-wide association studies the rs10993994 single nucleotide polymorphism in the MSMB promoter has been linked to an increased risk of developing prostate cancer. The promoter location of the risk allele, and its ability to reduce promoter activity, suggested that the rs10993994 risk allele could result in lowered MSMB in benign tissue leading to increased prostate cancer risk. Methodology/Principal Findings: MSMB expression in benign and malignant prostate tissue was examined using immunohistochemistry and compared with the rs10993994 genotype. Urinary MSMB concentrations were determined by ELISA and correlated with urinary PSA, the presence or absence of cancer, rs10993994 genotype and age of onset. MSMB levels in prostate tissue and urine were greatly reduced with tumourigenesis. Urinary MSMB was better than urinary PSA at differentiating men with prostate cancer at all Gleason grades. The high risk allele was associated with heterogeneity of MSMB staining and loss of MSMB in both tissue and urine in benign prostate. Conclusions: These data show that some high risk alleles discovered using genome-wide association studies produce phenotypic effects with potential clinical utility. We provide the first link between a low penetrance polymorphism for prostate cancer and a potential test in human tissue and bodily fluids. There is potential to develop tissue and urinary MSMB for a biomarker of prostate cancer risk, diagnosis and disease monitoring.	[Whitaker, Hayley C.; Ross-Adams, Helen; Burge, Johanna; George, Anne; Neal, David E.] CRUK Cambridge Res Inst, Urooncol Res Grp, Cambridge, England; [Kote-Jarai, Zsofia; Bancroft, Elizabeth; Jhavar, Sameer; Leongamornlert, Daniel; Tymrakiewicz, Malgorzata; Saunders, Edward; Page, Elizabeth; Mitra, Anita; Cooper, Colin; Eeles, Rosalind] Inst Canc Res, Sutton, Surrey, England; [Kote-Jarai, Zsofia; Bancroft, Elizabeth; Jhavar, Sameer; Leongamornlert, Daniel; Tymrakiewicz, Malgorzata; Saunders, Edward; Page, Elizabeth; Mitra, Anita; Cooper, Colin; Eeles, Rosalind] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England; [Warren, Anne Y.] Addenbrookes Hosp, Dept Pathol, Cambridge, England; [Mitchell, Gillian] Peter MacCallum Canc Inst, Melbourne, Vic, Australia; [Lindeman, Geoffrey J.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Evans, D. Gareth] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Blanco, Ignacio] Catalonian Inst Oncol, Barcelona, Spain; [Mercer, Catherine] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Rubinstein, Wendy S.] NorthShore Univ Hlth Syst, Evanston, IL USA; [Clowes, Virginia] Addenbrookes Hosp, Dept Clin Genet, Cambridge, England; [Douglas, Fiona] Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Hodgson, Shirley] St Georges Univ London, London, England; [Walker, Lisa] Churchill Hosp, Oxford Reg Genet Ctr, Oxford OX3 7LJ, England; [Donaldson, Alan] St Michaels Hosp, Bristol, Avon, England; [Izatt, Louise] Guys Hosp, London SE1 9RT, England; [Dorkins, Huw] Northwick Pk Hosp & Clin Res Ctr, Kennedy Galton Ctr, Harrow HA1 3UJ, Middx, England; [Male, Alison] Inst Child Hlth, London, England; [Tucker, Kathy] Prince Wales Hosp, Sydney, NSW, Australia; [Lam, Jimmy] Repatriat Gen Hosp, Adelaide, SA, Australia; [Kirk, Judy] Westmead Hosp, Familial Canc Serv, Westmead, NSW 2145, Australia; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Clin Labs, New York, NY 10021 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Easton, Douglas] Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Cambridge, England	CRUK Cambridge Institute; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Peter Maccallum Cancer Center; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Manchester; Catalan Institute of Oncology; NorthShore University Health System; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Newcastle University - UK; St Georges University London; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; Imperial College London; University of London; University College London; Flinders University South Australia; University of Sydney; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cancer Research UK; University of Cambridge	Whitaker, HC (corresponding author), CRUK Cambridge Res Inst, Urooncol Res Grp, Cambridge, England.	Hayley.Whitaker@cancer.org.uk	Lilja, Hans/S-9703-2019; Blanco, Ignacio/AAN-5426-2021; Tobias, Edward/D-4246-2009; Blanco, Ignacio/D-2565-2013; Evans, D Gareth/AAB-4308-2022	Lilja, Hans/0000-0001-5871-7846; Blanco, Ignacio/0000-0002-7414-7481; Tobias, Edward/0000-0003-2649-7695; Blanco, Ignacio/0000-0002-7414-7481; Evans, D Gareth/0000-0002-8482-5784; Thorne, Heather/0000-0003-3610-2511; Eeles, Rosalind/0000-0002-3698-6241; Saunders, Ed/0000-0003-4343-3570; Bancroft, Elizabeth/0000-0002-5482-5660; Lindeman, Geoffrey/0000-0001-9386-2416; Leongamornlert, Daniel/0000-0002-3486-3168; Ross-Adams, Helen/0000-0003-1338-742X; Neal, David/0000-0002-6033-5086	University of Cambridge, Cancer Research UK [C522/A8072, C5047/A8385]; Institute of Cancer Research; Everyman Campaign; EU; Prostate Cancer Research Foundation; Cambridge Bio-medical Research Centre, Cambridge, UK; Bio-medical Research Centre at The Institute of Cancer Research; Royal Marsden NHS Foundation Trust; Biomedical Research Centre at Central Manchester Foundation Trust; National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT) [G0500966/75466]; Cancer Councils of Victoria and South Australia; Prostate Cancer Foundation of Australia; NorthShore University Health System; Ronald and Rita McAulay Foundation; National Cancer Institute; Swedish Cancer Society [3455]; Swedish Research Council (Medicine) [20095]; NATIONAL CANCER INSTITUTE [R33CA127768] Funding Source: NIH RePORTER; Cancer Research UK [10118] Funding Source: researchfish; Medical Research Council [G0900871] Funding Source: researchfish; MRC [G0900871] Funding Source: UKRI	University of Cambridge, Cancer Research UK(Cancer Research UKUniversity of Cambridge); Institute of Cancer Research; Everyman Campaign; EU(European Commission); Prostate Cancer Research Foundation; Cambridge Bio-medical Research Centre, Cambridge, UK; Bio-medical Research Centre at The Institute of Cancer Research; Royal Marsden NHS Foundation Trust(Royal Society of New ZealandMarsden Fund (NZ)); Biomedical Research Centre at Central Manchester Foundation Trust; National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT); Cancer Councils of Victoria and South Australia(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Prostate Cancer Foundation of Australia; NorthShore University Health System; Ronald and Rita McAulay Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council (Medicine)(Swedish Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to acknowledge the support of The University of Cambridge, Cancer Research UK (grant codes C522/A8072 and C5047/A8385), The Institute of Cancer Research, The Everyman Campaign, The EU FP7 Promark work package and Hutchison Whampoa Limited and The Prostate Cancer Research Foundation. The authors would like to acknowledge the support of the National Institute for Health Research which funds the Cambridge Bio-medical Research Centre, Cambridge, UK, the Bio-medical Research Centre at The Institute of Cancer Research and Royal Marsden NHS Foundation Trust and the Biomedical Research Centre at Central Manchester Foundation Trust. The authors would also like to acknowledge the support of the National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT) collaborative (grant code G0500966/75466) which has funded tissue and urine collections in Cambridge. The authors would also like to acknowledge the support of the Cancer Councils of Victoria and South Australia, the Prostate Cancer Foundation of Australia, the Victorian Cancer Agency, Jack and Judy Baker for their support at NorthShore University Health System and The Ronald and Rita McAulay Foundation which supports the IMPACT study collection. Douglas Easton is a Principal Research Fellow of Cancer Research UK. Hans Lilja is funded by the National Cancer Institute [grant numbers R33-CA127768-02]; Swedish Cancer Society [3455]; and Swedish Research Council (Medicine) [20095]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baijal-Gupta M, 2000, J ENDOCRINOL, V165, P425, DOI 10.1677/joe.0.1650425; Bjartell AS, 2007, CLIN CANCER RES, V13, P4130, DOI 10.1158/1078-0432.CCR-06-3031; Bolduc S, 2007, CUAJ-CAN UROL ASSOC, V1, P377; Chan PSF, 1999, PROSTATE, V41, P99; CHANG BL, 2009, HUM MOL GENET; DOCTOR VM, 1986, BRIT J CANCER, V53, P547, DOI 10.1038/bjc.1986.85; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Foster C, 2007, BRIT J CANCER, V96, P718, DOI 10.1038/sj.bjc.6603610; Gabril M, 2004, UROLOGY, V64, P1233, DOI 10.1016/j.urology.2004.07.034; Gabril MY, 2002, GENE THER, V9, P1589, DOI 10.1038/sj.gt.3301895; Imasato Y, 2000, J UROLOGY, V164, P1819, DOI 10.1016/S0022-5347(05)67113-3; KADER AK, 2009, PROSTATE; Kwong J, 2000, PROSTATE, V42, P219, DOI 10.1002/(SICI)1097-0045(20000215)42:3<219::AID-PROS8>3.0.CO;2-J; Lamy S, 2006, INT J CANCER, V118, P2350, DOI 10.1002/ijc.21615; LILJA H, 1988, PROSTATE, V12, P29, DOI 10.1002/pros.2990120105; Lou H, 2009, P NATL ACAD SCI USA, V106, P7933, DOI 10.1073/pnas.0902104106; Mitra AV, 2007, BJU INT, V99, P1350, DOI 10.1111/j.1464-410X.2007.06759.x; Nam RK, 2006, J UROLOGY, V175, P1291, DOI 10.1016/S0022-5347(05)00695-6; Ploussard G, 2010, NAT REV UROL, V7, P101, DOI 10.1038/nrurol.2009.261; Reeves JR, 2006, CLIN CANCER RES, V12, P6018, DOI 10.1158/1078-0432.CCR-06-0625; Sakai H, 1999, PROSTATE, V38, P278; Shukeir N, 2003, CANCER RES, V63, P2072; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thota A, 2003, J CELL BIOCHEM, V88, P999, DOI 10.1002/jcb.10425; Tsurusaki T, 1998, PROSTATE, V35, P109; Vanaja DK, 2003, CANCER RES, V63, P3877; VONDERKAMMER H, 1990, CLIN CHIM ACTA, V187, P207, DOI 10.1016/0009-8981(90)90106-3; WEIBER H, 1990, AM J PATHOL, V137, P593; WHITAKER HC, 2009, PROSTATE; Xuan JW, 1997, J CELL BIOCHEM, V65, P172, DOI 10.1002/(SICI)1097-4644(199705)65:2<172::AID-JCB4>3.3.CO;2-S; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042	32	60	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13363	10.1371/journal.pone.0013363	http://dx.doi.org/10.1371/journal.pone.0013363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967219	Green Accepted, gold, Green Published			2022-12-25	WOS:000282869800041
J	Rolfo, A; Many, A; Racano, A; Tal, R; Tagliaferro, A; Ietta, F; Wang, JX; Post, M; Caniggia, I				Rolfo, Alessandro; Many, Ariel; Racano, Antonella; Tal, Reshef; Tagliaferro, Andrea; Ietta, Francesca; Wang, Jinxia; Post, Martin; Caniggia, Isabella			Abnormalities in Oxygen Sensing Define Early and Late Onset Preeclampsia as Distinct Pathologies	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE-FACTOR; ENDOTHELIAL GROWTH-FACTOR; MITOCHONDRIAL COMPLEX-III; TUMOR-SUPPRESSOR PROTEIN; HUMAN PLACENTAL HYPOXIA; PROLYL-HYDROXYLASES; FACTOR-I; HIF PROLYL; TROPHOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS	Background: The pathogenesis of preeclampsia, a serious pregnancy disorder, is still elusive and its treatment empirical. Hypoxia Inducible Factor-1 (HIF-1) is crucial for placental development and early detection of aberrant regulatory mechanisms of HIF-1 could impact on the diagnosis and management of preeclampsia. HIF-1 alpha stability is controlled by O-2-sensing enzymes including prolyl hydroxylases (PHDs), Factor Inhibiting HIF (FIH), and E3 ligases Seven In Absentia Homologues (SIAHs). Here we investigated early- (E-PE) and late-onset (L-PE) human preeclamptic placentae and their ability to sense changes in oxygen tension occurring during normal placental development. Methods and Findings: Expression of PHD2, FIH and SIAHs were significantly down-regulated in E-PE compared to control and L-PE placentae, while HIF-1 alpha levels were increased. PHD3 expression was increased due to decreased FIH levels as demonstrated by siRNA FIH knockdown experiments in trophoblastic JEG-3 cells. E-PE tissues had markedly diminished HIF-1 alpha hydroxylation at proline residues 402 and 564 as assessed with monoclonal antibodies raised against hydroxylated HIF-1 alpha P402 or P564, suggesting regulation by PHD2 and not PHD3. Culturing villous explants under varying oxygen tensions revealed that E-PE, but not L-PE, placentae were unable to regulate HIF-1 alpha levels because PHD2, FIH and SIAHs did not sense a hypoxic environment. Conclusion: Disruption of oxygen sensing in E-PE vs. L-PE and control placentae is the first molecular evidence of the existence of two distinct preeclamptic diseases and the unique molecular O-2-sensing signature of E-PE placentae may be of diagnostic value when assessing high risk pregnancies and their severity.	[Rolfo, Alessandro; Many, Ariel; Racano, Antonella; Tal, Reshef; Tagliaferro, Andrea; Ietta, Francesca; Caniggia, Isabella] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Caniggia, Isabella] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Racano, Antonella; Post, Martin; Caniggia, Isabella] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Post, Martin; Caniggia, Isabella] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Wang, Jinxia; Post, Martin] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Rolfo, A (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	caniggia@lunenfeld.ca	Ietta, Francesca/I-5307-2013; Caniggia, Isabella/G-6466-2013; Rolfo, Alessandro/L-1089-2019	Caniggia, Isabella/0000-0001-7340-2359; Rolfo, Alessandro/0000-0001-6730-8067; Tal, Reshef/0000-0002-2500-9904; Ietta, Francesca/0000-0002-2160-8790	Canadian Institutes of Health Research (CIHR) [MOP-14096]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (CIHR) Grant (MOP-14096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2002, OBSTET GYNECOL, V99, P869; Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Ahmed A, 1997, LANCET, V350, P826, DOI 10.1016/S0140-6736(05)62027-2; AHMED A, 1995, GROWTH FACTORS, V12, P235, DOI 10.3109/08977199509036883; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Barber A, 2001, FASEB J, V15, P1158, DOI 10.1096/fj.00-0376com; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2002, SCIENCE, V295, P807, DOI 10.1126/science.1069825; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Burton GJ, 1999, AM J OBSTET GYNECOL, V181, P718, DOI 10.1016/S0002-9378(99)70518-1; Callapina M, 2005, FREE RADICAL BIO MED, V39, P925, DOI 10.1016/j.freeradbiomed.2005.05.009; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Caniggia I, 2002, PLACENTA, V23, pS47, DOI 10.1053/plac.2002.0815; Caniggia I, 2000, PLACENTA, V21, pS25, DOI 10.1053/plac.1999.0522; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen CP, 2004, PLACENTA, V25, P413, DOI 10.1016/j.placenta.2003.10.014; Chen YR, 2006, ACTA BIOCH BIOPH SIN, V38, P423, DOI 10.1111/j.1745-7270.2006.00174.x; CHESLEY LC, 1985, OBSTET GYNECOL, V65, P423; Chung JY, 2004, J CLIN ENDOCR METAB, V89, P2484, DOI 10.1210/jc.2003-031580; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Cui XL, 2006, PLACENTA, V27, P422, DOI 10.1016/j.placenta.2005.04.004; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erez N, 2003, CANCER RES, V63, P8777; Genbacev O, 1996, J CLIN INVEST, V97, P540, DOI 10.1172/JCI118447; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA; Hung TH, 2001, AM J PATHOL, V159, P1031, DOI 10.1016/S0002-9440(10)61778-6; Huppertz B, 2006, AM J OBSTET GYNECOL, V195, P29, DOI 10.1016/j.ajog.2005.07.039; Ietta F, 2006, BIOL REPROD, V75, P112, DOI 10.1095/biolreprod.106.051557; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai A, 2004, ONCOGENE, V23, P7593, DOI 10.1038/sj.onc.1208016; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Kozak KR, 1997, DEV BIOL, V191, P297, DOI 10.1006/dbio.1997.8758; Krebs C, 1996, AM J OBSTET GYNECOL, V175, P1534, DOI 10.1016/S0002-9378(96)70103-5; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li H, 2005, PLACENTA, V26, P210, DOI 10.1016/j.placenta.2004.05.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Lazaro M, 2006, FASEB J, V20, P828, DOI 10.1096/fj.05-5168hyp; Macara L, 1996, PLACENTA, V17, P37, DOI 10.1016/S0143-4004(05)80642-3; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Masson N, 2003, J CELL SCI, V116, P3041, DOI 10.1242/jcs.00655; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; Nakayama K, 2004, CELL CYCLE, V3, P1345, DOI 10.4161/cc.3.11.1207; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pijnenborg R, 1998, PLACENTA, V19, P569; Rajakumar A, 2000, BIOL REPROD, V63, P559, DOI 10.1095/biolreprod63.2.559; Rajakumar A, 2004, PLACENTA, V25, P763, DOI 10.1016/j.placenta.2004.02.011; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tian YM, 2006, BIOCHEM J, V397, P179, DOI 10.1042/BJ20051996; Zamudio S, 2007, AM J PATHOL, V170, P2171, DOI 10.2353/ajpath.2007.061185; Zhou Jie, 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P189, DOI 10.2174/187152506777698344; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	74	80	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13288	10.1371/journal.pone.0013288	http://dx.doi.org/10.1371/journal.pone.0013288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967267	gold, Green Published, Green Submitted			2022-12-25	WOS:000282807300017
J	Nyarko, A; Barbar, E				Nyarko, Afua; Barbar, Elisar			Light Chain-dependent Self-association of Dynein Intermediate Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; CYTOPLASMIC DYNEIN; FUNCTIONAL INTERACTION; RHODAMINE DIMERS; PROTEIN; LC8; FLUORESCENCE; DIMERIZATION; COMPLEX; BINDING	Dynein light chains are bivalent dimers that bind two copies of dynein intermediate chain IC to form a cargo attachment subcomplex. The interaction of light chain LC8 with the natively disordered N-terminal domain of IC induces helix formation at distant IC sites in or near a region predicted to form a coiled-coil. This fostered the hypothesis that LC8 binding promotes IC self-association to form a coiled-coil or other interchain helical structure. However, recent studies show that the predicted coiled-coil sequence partially overlaps the light chain LC7 recognition sequence on IC, raising questions about the apparently contradictory effects of LC8 and LC7. Here, we use NMR and fluorescence quenching to localize IC self-association to residues within the predicted coiled-coil that also correspond to helix 1 of the LC7 recognition sequence. LC8 binding promotes IC self-association of helix 1 from each of two IC chains, whereas LC7 binding reverses self-association by incorporating the same residues into two symmetrical, but distant, helices of the LC7-IC complex. Isothermal titration experiments confirm the distinction of LC8 enhancement of IC self-association and LC7 binding effects. When all three light chains are bound, IC self-association is shifted to another region. Such flexibility in association modes may function in maintaining a stable and versatile light chain-intermediate chain assembly under changing cellular conditions.	[Nyarko, Afua; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Barbar, E (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	barbare@science.oregonstate.edu	Nyarko, Afua/R-9872-2019	Barbar, Elisar/0000-0003-4892-5259	National Institutes of Health [GM 084276]; NIEHS, National Institutes of Health [00210]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 084276.; We thank Clare Woodward and Yujuan Song for valuable discussions and Michael Hare at the mass spectrometry facilities and services core in the Oregon State University Environmental Health Sciences Center (NIEHS, National Institutes of Health Grant 00210.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Ashokkumar B, 2009, AM J PHYSIOL-GASTR L, V297, pG480, DOI 10.1152/ajpgi.00154.2009; Barbar E, 2001, BIOCHEMISTRY-US, V40, P1596, DOI 10.1021/bi002278+; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; Burghardt TP, 1996, BIOPHYS CHEM, V59, P119, DOI 10.1016/0301-4622(95)00118-2; Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhani SU, 2003, J BIOL CHEM, V278, P16262, DOI 10.1074/jbc.M209828200; Grama L, 2001, P NATL ACAD SCI USA, V98, P14362, DOI 10.1073/pnas.191494098; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Hall J, 2008, BIOCHEMISTRY-US, V47, P11940, DOI 10.1021/bi801093k; Hall J, 2010, J BIOL CHEM, V285, P22566, DOI 10.1074/jbc.M110.103861; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Karki S, 2002, MOL BIOL CELL, V13, P1722, DOI 10.1091/mbc.02-02-0011; Kelkar SA, 2004, J VIROL, V78, P10122, DOI 10.1128/JVI.78.18.10122-10132.2004; Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794; Lakowicz JR, 2003, ANAL BIOCHEM, V320, P13, DOI 10.1016/S0003-2697(03)00351-8; Lo KWH, 2006, J BIOL CHEM, V281, P9552, DOI 10.1074/jbc.M511721200; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; VAISBERG EA, 1993, J CELL BIOL, V123, P849, DOI 10.1083/jcb.123.4.849; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wanschers B, 2008, CELL MOTIL CYTOSKEL, V65, P183, DOI 10.1002/cm.20254; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Ye GJ, 2000, J VIROL, V74, P1355, DOI 10.1128/JVI.74.3.1355-1363.2000; Zhuang XW, 2000, P NATL ACAD SCI USA, V97, P14241, DOI 10.1073/pnas.97.26.14241	46	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1556	1566		10.1074/jbc.M110.171686	http://dx.doi.org/10.1074/jbc.M110.171686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20974845	Green Published, hybrid			2022-12-25	WOS:000286005000068
J	Lai, Y; Oslund, RC; Bollinger, JG; Henderson, WR; Santana, LF; Altemeier, WA; Gelb, MH; Hallstrand, TS				Lai, Ying; Oslund, Rob C.; Bollinger, James G.; Henderson, William R., Jr.; Santana, Luis F.; Altemeier, William A.; Gelb, Michael H.; Hallstrand, Teal S.			Eosinophil Cysteinyl Leukotriene Synthesis Mediated by Exogenous Secreted Phospholipase A(2) Group X	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; EXERCISE-INDUCED BRONCHOCONSTRICTION; ARACHIDONIC-ACID METABOLISM; GROUP-V; MAMMALIAN-CELLS; ASTHMA; LYSOPHOSPHATIDYLCHOLINE; TRANSLOCATION; ACTIVATION; INHIBITOR	Secreted phospholipase A(2) group X (sPLA(2)-X) has recently been identified in the airways of patients with asthma and may participate in cysteinyl leukotriene (CysLT; C-4, D-4, and E-4) synthesis. We examined CysLT synthesis and arachidonic acid (AA) and lysophospholipid release by eosinophils mediated by recombinant human sPLA(2)-X. We found that recombinant sPLA(2)-X caused marked AA release and a rapid onset of CysLT synthesis in human eosinophils that was blocked by a selective sPLA(2)-X inhibitor. Exogenous sPLA(2)-X released lysophospholipid species that arise from phospholipids enriched in AA in eosinophils, including phosphatidylcholine, phosphatidylinositol, and phosphatidylethanolamine as well as plasmenyl phosphatidylcholine and phosphatidylethanolamine. CysLT synthesis mediated by sPLA(2)-X but not AA release could be suppressed by inhibition of cPLA(2)alpha. Exogenous sPLA(2)-X initiated Ser(505) phosphorylation of cPLA(2)alpha, an intracellular Ca2+ flux, and translocation of cPLA(2)alpha and 5-lipoxygenase in eosinophils. Synthesis of CysLTs in response to sPLA(2)-X or lysophosphatidylcholine was inhibited by p38 or JNK inhibitors but not by a MEK 1/2 inhibitor. A further increase in CysLT synthesis was induced by the addition of sPLA(2)-X to eosinophils under conditions of N-formyl-methionyl-leucyl-phenylalanine-mediated cPLA(2)alpha activation. These results indicate that sPLA(2)-X participates in AA and lysophospholipid release, resulting in CysLT synthesis in eosinophils through a mechanism involving p38 and JNK MAPK, cPLA(2)alpha, and 5-lipoxygenase activation and resulting in the amplification of CysLT synthesis during cPLA(2)alpha activation. Transactivation of eosinophils by sPLA(2)-X may be an important mechanism leading to CysLT formation in the airways of patients with asthma.	[Oslund, Rob C.; Bollinger, James G.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Lai, Ying; Altemeier, William A.; Hallstrand, Teal S.] Univ Washington, Div Pulm & Crit Care, Seattle, WA 98195 USA; [Henderson, William R., Jr.] Univ Washington, Div Allergy & Infect Dis, Dept Med, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Santana, Luis F.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gelb, MH (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	gelb@chem.washington.edu; tealh@u.washington.edu		gelb, michael/0000-0001-7000-5219; Santana, Luis/0000-0002-4297-8029; Hallstrand, Teal/0000-0002-5059-6872; Altemeier, William/0000-0001-8860-405X	National Institutes of Health [R01HL089215, R01HL50040, R37HL036235]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235, R01HL085870, R01HL086883, R01HL089215, R01HL050040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL089215 (to T.S.H.), R01HL50040 (to M.H.G.), and R37HL036235 (to M.H.G.). Some of the results of this study have been previously reported in abstract form (25).	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; Albert CJ, 2003, J BIOL CHEM, V278, P8942, DOI 10.1074/jbc.M211634200; Balboa MA, 2003, J BIOL CHEM, V278, P48059, DOI 10.1074/jbc.M305904200; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Blom M, 1998, BLOOD, V91, P3037; Bollinger JG, 2010, J LIPID RES, V51, P440, DOI 10.1194/jlr.D000885; Bowton DL, 1997, AM J RESP CRIT CARE, V155, P421, DOI 10.1164/ajrccm.155.2.9032172; Calabrese C, 2000, ALLERGY, V55, P27, DOI 10.1034/j.1398-9995.2000.00504.x; Casas J, 2009, J IMMUNOL, V183, P2767, DOI 10.4049/jimmunol.0901530; CHILTON FH, 1989, J APPL PHYSIOL, V66, P2763, DOI 10.1152/jappl.1989.66.6.2763; Chilton FH, 1996, J EXP MED, V183, P2235, DOI 10.1084/jem.183.5.2235; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Fang XJ, 1997, J BIOL CHEM, V272, P13683, DOI 10.1074/jbc.272.21.13683; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Frasch SC, 2007, J IMMUNOL, V178, P6540, DOI 10.4049/jimmunol.178.10.6540; Geijsen N, 2000, FEBS LETT, V471, P83, DOI 10.1016/S0014-5793(00)01373-9; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; Hallstrand TS, 2009, AM J RESP CRIT CARE, V179; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P586, DOI 10.1016/j.jaci.2005.04.035; Hallstrand TS, 2005, AM J RESP CRIT CARE, V172, P679, DOI 10.1164/rccm.200412-1667OC; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Kim YJ, 2002, J BIOL CHEM, V277, P36479, DOI 10.1074/jbc.M205399200; Lamothe J, 2008, CLIN IMMUNOL, V127, pS89, DOI 10.1016/j.clim.2008.03.250; Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106; MEHTA D, 1990, AM REV RESPIR DIS, V142, P157, DOI 10.1164/ajrccm/142.1.157; Misso NLA, 2008, THORAX, V63, P21, DOI 10.1136/thx.2006.074112; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Munoz NM, 2006, J IMMUNOL, V177, P574, DOI 10.4049/jimmunol.177.1.574; Munoz NM, 2003, J BIOL CHEM, V278, P38813, DOI 10.1074/jbc.M302476200; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Myou S, 2003, J IMMUNOL, V171, P4399, DOI 10.4049/jimmunol.171.8.4399; Nishiyama O, 2004, CLIN EXP PHARMACOL P, V31, P179, DOI 10.1111/j.1440-1681.2004.03973.x; OJIMAUCHIYAMA A, 1988, LIPIDS, V23, P815, DOI 10.1007/BF02536227; Oslund RC, 2008, J MED CHEM, V51, P4708, DOI 10.1021/jm800422v; Pavord ID, 1999, AM J RESP CRIT CARE, V160, P1905, DOI 10.1164/ajrccm.160.6.9903114; Romagnoli M, 2002, EUR RESPIR J, V20, P1370, DOI 10.1183/09031936.02.00029202; Sano A, 2001, AM J PHYSIOL-LUNG C, V281, pL844, DOI 10.1152/ajplung.2001.281.4.L844; Santana LF, 2002, J PHYSIOL-LONDON, V544, P57, DOI 10.1113/jphysiol.2002.020552; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Seno K, 2001, BIOORG MED CHEM LETT, V11, P587, DOI 10.1016/S0960-894X(01)00003-8; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; STADEL JM, 1994, AM J RESP CELL MOL, V11, P108, DOI 10.1165/ajrcmb.11.1.8018333; Triggiani M, 2003, J IMMUNOL, V170, P3279, DOI 10.4049/jimmunol.170.6.3279; Triggiani M, 2009, J ALLERGY CLIN IMMUN, V124, P558, DOI 10.1016/j.jaci.2009.04.035; Xing FY, 2009, J CELL MOL MED, V13, P1136, DOI 10.1111/j.1582-4934.2008.00394.x; Zhu XD, 2001, J IMMUNOL, V167, P461, DOI 10.4049/jimmunol.167.1.461; Zhu XD, 2007, AM J RESP CELL MOL, V36, P585, DOI 10.1165/rcmb.2006-0391OC	53	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41491	41500		10.1074/jbc.M110.153338	http://dx.doi.org/10.1074/jbc.M110.153338			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974857	Green Published, hybrid			2022-12-25	WOS:000285622600035
J	Ye, Y; Yin, DT; Chen, L; Zhou, QS; Shen, RL; He, G; Yan, QT; Tong, ZY; Issekutz, AC; Shapiro, CL; Barsky, SH; Lin, HF; Li, JJ; Gao, JX				Ye, Yin; Yin, De-Tao; Chen, Li; Zhou, Quansheng; Shen, Rulong; He, Gang; Yan, Qingtao; Tong, Zhenyu; Issekutz, Andrew C.; Shapiro, Charles L.; Barsky, Sanford H.; Lin, Haifan; Li, Jian-Jian; Gao, Jian-Xin			Identification of Piwil2-Like (PL2L) Proteins that Promote Tumorigenesis	PLOS ONE			English	Article							PRECANCEROUS STEM-CELLS; HUMAN COLON-CANCER; RNA INTERFERENCE; ARGONAUTE FAMILY; DENDRITIC CELLS; PIWI; MOUSE; GENES; MILI; SPERMATOGENESIS	PIWIL2, a member of PIWI/AGO gene family, is expressed in the germline stem cells (GSCs) of testis for gametogenesis but not in adult somatic and stem cells. It has been implicated to play an important role in tumor development. We have previously reported that precancerous stem cells (pCSCs) constitutively express Piwil2 transcripts to promote their proliferation. Here we show that these transcripts de facto represent Piwil2-like (PL2L) proteins. We have identified several PL2L proteins including PL2L80, PL2L60, PL2L50 and PL2L40, using combined methods of Gene-Exon-Mapping Reverse Transcription Polymerase Chain Reaction (GEM RT-PCR), bioinformatics and a group of novel monoclonal antibodies. Among them, PL2L60 rather than Piwil2 and other PL2L proteins is predominantly expressed in various types of human and mouse tumor cells. It promotes tumor cell survival and proliferation in vitro through up-regulation of Stat3 and Bcl2 gene expressions, the cell cycle entry from G(0/1) into S-phase, and the nuclear expression of NF-kappa B, which contribute to the tumorigenicity of tumor cells in vivo. Consistently, PL2L proteins rather than Piwil2 are predominantly expressed in the cytoplasm or cytoplasm and nucleus of euchromatin-enriched tumor cells in human primary and metastatic cancers, such as breast and cervical cancers. Moreover, nuclear PL2L proteins are always co-expressed with nuclear NF-kappa B. These results reveal that PL2L60 can coordinate with NF-kappa B to promote tumorigenesis and might mediate a common pathway for tumor development without tissue restriction. The identification of PL2L proteins provides a novel insight into the mechanisms of cancer development as well as a novel bridge linking cancer diagnostics and anticancer drug development.	[Ye, Yin; Yin, De-Tao; Chen, Li; Shen, Rulong; He, Gang; Yan, Qingtao; Tong, Zhenyu; Barsky, Sanford H.; Gao, Jian-Xin] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; [Shapiro, Charles L.] Ohio State Univ, Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Shapiro, Charles L.; Barsky, Sanford H.; Gao, Jian-Xin] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Yin, De-Tao] Zhengzhou Univ, Dept Gen Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Zhou, Quansheng] Soochow Univ, Jiangsu Inst Hematol, Affiliated Hosp 1, Cyrus Tang Hematol Ctr, Suzhou, Peoples R China; [Lin, Haifan] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Lin, Haifan] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT USA; [Li, Jian-Jian] Univ Calif Davis, Dept Radiat Oncol, Sacramento, CA 95817 USA; [Issekutz, Andrew C.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Zhengzhou University; Soochow University - China; Yale University; Yale University; University of California System; University of California Davis; Dalhousie University	Ye, Y (corresponding author), Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA.	Jian-Xin.Gao@osumc.edu	Shen, Rulong/E-4079-2011	Li, Jian Jian/0000-0003-3694-9675	Strategy Initiative Grant (SIG); Immunology Program Award 2008; American Cancer Society [IRG-112367]	Strategy Initiative Grant (SIG); Immunology Program Award 2008; American Cancer Society(American Cancer Society)	This work is supported from Strategy Initiative Grant (SIG) 2006/2007 (OSU Medical College), Immunology Program Award 2008 (OSUCCC) and American Cancer Society IRG-112367 (JXG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Becker L, 2008, THESCIENTIFICWORLDJO, V8, P1168, DOI 10.1100/tsw.2008.148; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; BUSSOLATI B, 2008, J CELL MOL MED; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000293; CHIU CC, CORRECTED P IN PRESS; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Damonte P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2104; Dawe RK, 2004, NAT GENET, V36, P1141, DOI 10.1038/ng1104-1141; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Feng DQ, 2009, ONCOL REP, V22, P1129, DOI 10.3892/or_00000545; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Gao JX, 2008, J CELL MOL MED, V12, P67, DOI 10.1111/j.1582-4934.2007.00170.x; Gao JX, 2003, J IMMUNOL, V170, P5927, DOI 10.4049/jimmunol.170.12.5927; Gao JX, 2000, CELL IMMUNOL, V202, P41, DOI 10.1006/cimm.2000.1656; GAO JX, 2010, FIELD CANC BASIC SCI; Gao JX, 2009, DRUG DISCOV TODAY DI, V6, P5; Grandage VL, 2005, LEUKEMIA, V19, P586, DOI 10.1038/sj.leu.2403653; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; He G, 2010, AM J TRANSL RES, V2, P156; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jaronczyk K, 2005, BIOCHEM J, V387, P561, DOI 10.1042/BJ20041822; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Lee JH, 2006, MOL REPROD DEV, V73, P173, DOI 10.1002/mrd.20391; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Li L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-38; Liu JJ, 2010, INT J CLIN EXP PATHO, V3, P328; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; LIU JSR, 2010, INT J CLIN EXP PATHO, V3, P10; MADER RM, 2009, DRUG DISCOV TODAY, V6, P1; Melcher R, 2000, CYTOGENET CELL GENET, V88, P145, DOI 10.1159/000015508; Nikpour P, 2009, CANCER EPIDEMIOL, V33, P271, DOI 10.1016/j.canep.2009.06.011; Preall JB, 2005, CELL, V123, P543, DOI 10.1016/j.cell.2005.11.006; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Shen RL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001652; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sugimoto K, 2007, BIOCHEM BIOPH RES CO, V359, P497, DOI 10.1016/j.bbrc.2007.05.136; Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang JX, 2009, EMBO REP, V10, P1272, DOI 10.1038/embor.2009.197; Werbowetski-Ogilvie TE, 2008, TRENDS MOL MED, V14, P323, DOI 10.1016/j.molmed.2008.06.005; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	62	59	64	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13406	10.1371/journal.pone.0013406	http://dx.doi.org/10.1371/journal.pone.0013406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975993	Green Submitted, Green Published, gold			2022-12-25	WOS:000283216400004
J	Palmadottir, VK; Gudmundsson, H; Hardarson, S; Arnadottir, M; Magnusson, T; Andresdottir, MB				Palmadottir, Vala Kolbrun; Gudmundsson, Hjalti; Hardarson, Sverrir; Arnadottir, Margret; Magnusson, Thorvaldur; Andresdottir, Margret B.			Incidence and Outcome of Acute Phosphate Nephropathy in Iceland	PLOS ONE			English	Article							ORAL SODIUM-PHOSPHATE; RENAL-FAILURE; CARDIOVASCULAR-DISEASE; POLYETHYLENE-GLYCOL; KIDNEY-DISEASE; RISK-FACTOR; BOWEL; ASSOCIATION	Background: Oral sodium phosphate solutions (OSPS) are widely used for bowel cleansing prior to colonoscopy and other procedures. Cases of renal failure due to acute phosphate nephropathy following OSPS ingestion have been documented in recent years, questioning the safety of OSPS. However, the magnitude of the problem remains unknown. Methodology/Principal Findings: We conducted a population based, retrospective analysis of medical records and biopsies of all cases of acute phosphate nephropathy that were diagnosed in our country in the period from January 2005 to October 2008. Utilizing the complete official sales figures of OSPS, we calculated the incidence of acute phosphate nephropathy in our country. Fifteen cases of acute phosphate nephropathy were diagnosed per 17,651 sold doses of OSPS (0.085%). Nine (60%) were women and mean age 69 years (range 56-75 years). Thirteen patients had a history of hypertension (87%) all of whom were treated with either ACE-I or ARB and/or diuretics. One patient had underlying DM type I and an active colitis and one patient had no risk factor for the development of acute phosphate nephropathy. Average baseline creatinine was 81.7 mu mol/L and 180.1 at the discovery of acute renal failure, mean 4.2 months after OSPS ingestion. No patient had a full recovery of renal function, and at the end of follow-up, 26.6 months after the OSPS ingestion, the average creatinine was 184.2 mu mol/L. The average eGFR declined from 73.5 ml/min/1.73 m(2) at baseline to 37.3 ml/min/1.73 m(2) at the end of follow-up. One patient reached end-stage renal disease and one patient died with progressive renal failure. Conclusion/Significance: Acute phosphate nephropathy developed in almost one out of thousand sold doses of OSPS. The consequences for kidney function were detrimental. This information can be used in other populations to estimate the impact of OSPS. Our data suggest that acute phosphate nephropathy may be greatly underreported worldwide.	[Palmadottir, Vala Kolbrun; Gudmundsson, Hjalti] Landspitali Univ Hosp, Dept Internal Med, Reykjavik, Iceland; [Hardarson, Sverrir] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Arnadottir, Margret; Andresdottir, Margret B.] Landspitali Univ Hosp, Div Nephrol, Reykjavik, Iceland; [Magnusson, Thorvaldur] Akranes Hosp, Dept Internal Med, Akranes, Iceland	Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital	Palmadottir, VK (corresponding author), Landspitali Univ Hosp, Dept Internal Med, Reykjavik, Iceland.	mband@landspitali.is	Andrésdóttir, Margrét/L-4178-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007121] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aasebo W, 2007, NEPHROL DIAL TRANSPL, V22, P920, DOI 10.1093/ndt/gfl694; Beyea A, 2007, AM J KIDNEY DIS, V50, P151, DOI 10.1053/j.ajkd.2007.03.005; Brunelli SM, 2007, J AM SOC NEPHROL, V18, P3199, DOI 10.1681/ASN.2007040440; Brunelli SM, 2009, AM J KIDNEY DIS, V53, P448, DOI 10.1053/j.ajkd.2008.09.022; Connor Andrew, 2008, BMJ, V337, pa182, DOI 10.1136/bmj.a182; Demoulin N, 2008, CLIN NEPHROL, V70, P176; Desmeules S, 2003, NEW ENGL J MED, V349, P1006, DOI 10.1056/NEJM200309043491020; Gonlusen G, 2006, ARCH PATHOL LAB MED, V130, P101; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Hurst FP, 2007, J AM SOC NEPHROL, V18, P3192, DOI 10.1681/ASN.2007030349; Kim Han Jo, 2008, Kidney Research and Clinical Practice, V27, P374; KORETZ RL, 2006, GASTROENTEROLOGY, V130, P2242; Koretz Ronald L, 2006, Gastroenterology, V130, P2240, DOI 10.1053/j.gastro.2006.03.057; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Manley P, 2006, NEPHROL DIAL TRANSPL, V21, P2957, DOI 10.1093/ndt/gfl321; Markowitz GS, 2009, KIDNEY INT, V76, P1027, DOI 10.1038/ki.2009.308; Markowitz GS, 2005, J AM SOC NEPHROL, V16, P3389, DOI 10.1681/ASN.2005050496; Markowitz GS, 2005, NEPHROL DIAL TRANSPL, V20, P850, DOI 10.1093/ndt/gfh718; Markowitz GS, 2004, HUM PATHOL, V35, P675, DOI 10.1016/j.humpath.2003.12.005; McCullough PA, 2008, NEPHRON PHYSIOL, V109, pP61, DOI 10.1159/000142938; Ori Y, 2008, AM J MED SCI, V336, P309, DOI 10.1097/MAJ.0b013e318167410c; Rocuts AK, 2009, KIDNEY INT, V75, P987, DOI 10.1038/ki.2008.293; Russmann S, 2008, AM J GASTROENTEROL, V103, P2707, DOI 10.1111/j.1572-0241.2008.02201.x; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1670, DOI 10.1053/j.gastro.2004.09.051; Slee TM, 2008, NETH J MED, V66, P438; Steinman TI, 2008, NEW ENGL J MED, V359, P951, DOI 10.1056/NEJMcpc0804600; VANNER SJ, 1990, AM J GASTROENTEROL, V85, P422; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2	29	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13484	10.1371/journal.pone.0013484	http://dx.doi.org/10.1371/journal.pone.0013484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976065	Green Published, gold, Green Submitted			2022-12-25	WOS:000283114700014
J	Yang, Y; Mohand-Said, S; Leveillard, T; Fontaine, V; Simonutti, M; Sahel, JA				Yang, Ying; Mohand-Said, Saddek; Leveillard, Thierry; Fontaine, Valerie; Simonutti, Manuel; Sahel, Jose-Alain			Transplantation of Photoreceptor and Total Neural Retina Preserves Cone Function in P23H Rhodopsin Transgenic Rat	PLOS ONE			English	Article							SUPERIOR COLLICULUS; FETAL RETINA; SURVIVAL; MODEL; CELLS; ROD; RECONSTRUCTION; PROGENITORS; PROTEIN; RESCUE	Background: Transplantation as a therapeutic strategy for inherited retinal degeneration has been historically viewed to restore vision as a method by replacing the lost retinal cells and attempting to reconstruct the neural circuitry with stem cells, progenitor cells and mature neural retinal cells. Methods and Findings: We present evidence for an alternative strategy aimed at preventing the secondary loss of cones, the most crucial photoreceptors for vision, by transplanting normal photoreceptors cells into the eye of the P23H rat, a model of dominant retinitis pigmentosa. We carried out transplantation of photoreceptors or total neural retina in 3-month-old P23H rats and evaluated the function and cell counts 6 months after surgery. In both groups, cone loss was significantly reduced (10%) in the transplanted eyes where the cone outer segments were found to be considerably longer. This morphological effect correlated with maintenance of the visual function of cones as scored by photopic ERG recording, but more precisely with an increase in the photopic b-wave amplitudes by 100% and 78% for photoreceptor transplantation and whole retinal transplantation respectively. Conclusions: We demonstrate here that the transplanted tissue prevents the loss of cone function, which is further translated into cone survival.	[Yang, Ying; Mohand-Said, Saddek; Leveillard, Thierry; Fontaine, Valerie; Simonutti, Manuel; Sahel, Jose-Alain] INSERM, U968, Paris, France; [Yang, Ying; Mohand-Said, Saddek; Leveillard, Thierry; Fontaine, Valerie; Simonutti, Manuel; Sahel, Jose-Alain] Univ Paris 06, Inst Vis, UM80, Paris, France; [Yang, Ying; Mohand-Said, Saddek; Leveillard, Thierry; Fontaine, Valerie; Simonutti, Manuel; Sahel, Jose-Alain] CNRS, UMR 7210, Paris, France; [Yang, Ying; Mohand-Said, Saddek; Leveillard, Thierry; Fontaine, Valerie; Simonutti, Manuel; Sahel, Jose-Alain] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM DHOS CIC 503, Paris, France; [Sahel, Jose-Alain] UCL, Inst Ophthalmol, London, England; [Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rothschild, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Fondation Adolphe de Rothschild	Yang, Y (corresponding author), INSERM, U968, Paris, France.	mohand@quinze-vingts.fr	Léveillard, Thierry/AAR-1804-2020; Sahel, Jose-Alain/F-3172-2017	Léveillard, Thierry/0000-0001-5692-8770; Sahel, Jose-Alain/0000-0002-4831-1153; YANG, YING/0000-0002-9245-4119	Inserm, EVI-GENORET; Foundation Fighting Blindness (USA)	Inserm, EVI-GENORET(Institut National de la Sante et de la Recherche Medicale (Inserm)); Foundation Fighting Blindness (USA)	This work was supported by Inserm, EVI-GENORET and Foundation Fighting Blindness (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramant RB, 2004, PROG RETIN EYE RES, V23, P475, DOI 10.1016/j.preteyeres.2004.05.003; Aramant RB, 1999, INVEST OPHTH VIS SCI, V40, P1557; Aramant RB, 2002, EXP EYE RES, V75, P115, DOI 10.1006/exer.2002.2001; Chacko DM, 2000, BIOCHEM BIOPH RES CO, V268, P842, DOI 10.1006/bbrc.2000.2153; Chalmel F, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-74; Chrysostomou V, 2008, INVEST OPHTH VIS SCI, V49, P1116, DOI 10.1167/iovs.07-1158; CRONIN T, 2010, CELL DEATH DIFF 0205; Fontaine V, 1998, J NEUROSCI, V18, P9662; Francis PJ, 2009, INVEST OPHTH VIS SCI, V50, P3425, DOI 10.1167/iovs.08-2908; Fridlich R, 2009, MOL CELL PROTEOMICS, V8, P1206, DOI 10.1074/mcp.M800406-MCP200; Gamm DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000338; GELLER AM, 1993, VISION RES, V33, P1509, DOI 10.1016/0042-6989(93)90144-L; GOURAS P, 1992, INVEST OPHTH VIS SCI, V33, P2579; Harvey A R, 1984, Brain Res, V314, P27; HORSBURGH GM, 1993, J COMP NEUROL, V327, P323, DOI 10.1002/cne.903270302; Kwan ASL, 1999, EXP NEUROL, V159, P21, DOI 10.1006/exnr.1999.7157; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; MCLOON SC, 1980, EXP BRAIN RES, V40, P273; MCLOON SC, 1983, J COMP NEUROL, V217, P376, DOI 10.1002/cne.902170403; Mohand-Said S, 2000, ARCH OPHTHALMOL-CHIC, V118, P807, DOI 10.1001/archopht.118.6.807; Mohand-Said S, 1998, P NATL ACAD SCI USA, V95, P8357, DOI 10.1073/pnas.95.14.8357; MohandSaid S, 1997, OPHTHALMIC RES, V29, P290, DOI 10.1159/000268027; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Radtke ND, 1999, AM J OPHTHALMOL, V128, P384, DOI 10.1016/S0002-9394(99)00250-0; Radtke ND, 2008, AM J OPHTHALMOL, V146, P172, DOI 10.1016/j.ajo.2008.04.009; Reh TA, 2006, NATURE, V444, P156, DOI 10.1038/444156a; ROYO PARIS E., 1959, GROWTH, V23, P313; Sauve Y, 2006, VISION RES, V46, P1459, DOI 10.1016/j.visres.2005.11.009; Sauve Y, 2002, NEUROSCIENCE, V114, P389, DOI 10.1016/S0306-4522(02)00271-3; Seiler MJ, 2008, EUR J NEUROSCI, V28, P208, DOI 10.1111/j.1460-9568.2008.06279.x; Seiler Magdalene J, 2005, Semin Ophthalmol, V20, P31, DOI 10.1080/08820530590921873; Seiler MJ, 2009, VET OPHTHALMOL, V12, P158, DOI 10.1111/j.1463-5224.2009.00693.x; SEILER MJ, 1994, DEV BRAIN RES, V80, P81, DOI 10.1016/0165-3806(94)90092-2; SIMONS DJ, 1985, DEV BRAIN RES, V21, P156, DOI 10.1016/0165-3806(85)90036-7; Stone LS, 1930, J EXP ZOOL, V55, P193, DOI 10.1002/jez.1400550112; SZEL A, 1992, EXP EYE RES, V55, P47; Wright AF, 1997, NAT GENET, V17, P132, DOI 10.1038/ng1097-132; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28	42	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13469	10.1371/journal.pone.0013469	http://dx.doi.org/10.1371/journal.pone.0013469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976047	gold, Green Published, Green Submitted			2022-12-25	WOS:000283114700007
J	Sabra-Makke, L; Tourrel-Cuzin, C; Denis, RGP; Moldes, M; Pegorier, JP; Luquet, S; Vasseur-Cognet, M; Bossard, P				Sabra-Makke, Lina; Tourrel-Cuzin, Cecile; Denis, Raphael G. P.; Moldes, Marthe; Pegorier, Jean-Paul; Luquet, Serge; Vasseur-Cognet, Mireille; Bossard, Pascale			The Nutritional Induction of COUP-TFII Gene Expression in Ventromedial Hypothalamic Neurons Is Mediated by the Melanocortin Pathway	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-II; BODY-WEIGHT; FOOD-INTAKE; RECEPTOR AGONISTS; NUCLEAR RECEPTOR; INSULIN ACTION; GLUCOSE; OBESITY; BRAIN; LEPTIN	Background: The nuclear receptor chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) is an important coordinator of glucose homeostasis. We report, for the first time, a unique differential regulation of its expression by the nutritional status in the mouse hypothalamus compared to peripheral tissues. Methodology/Principal Findings: Using hyperinsulinemic-euglycemic clamps and insulinopenic mice, we show that insulin upregulates its expression in the hypothalamus. Immunofluorescence studies demonstrate that COUP-TFII gene expression is restricted to a subpopulation of ventromedial hypothalamic neurons expressing the melanocortin receptor. In GT1-7 hypothalamic cells, the MC4-R agonist MTII leads to a dose dependant increase of COUP-TFII gene expression secondarily to a local increase in cAMP concentrations. Transfection experiments, using a COUP-TFII promoter containing a functional cAMP responsive element, suggest a direct transcriptional activation by cAMP. Finally, we show that the fed state or intracerebroventricular injections of MTII in mice induce an increased hypothalamic COUP-TFII expression associated with a decreased hepatic and pancreatic COUP-TFII expression. Conclusions/Significance: These observations strongly suggest that hypothalamic COUP-TFII gene expression could be a central integrator of insulin and melanocortin signaling pathway within the ventromedial hypothalamus. COUP-TFII could play a crucial role in brain integration of circulating signal of hunger and satiety involved in energy balance regulation.	[Sabra-Makke, Lina; Moldes, Marthe; Pegorier, Jean-Paul; Vasseur-Cognet, Mireille; Bossard, Pascale] Univ Paris 05, Inst Cochin, Dept Endocrinol Metab & Canc, CNRS UMR 8104, Paris, France; [Tourrel-Cuzin, Cecile] Univ Paris 07, Lab Biol & Pathol Pancreas Endocrine, Paris, France; [Sabra-Makke, Lina; Moldes, Marthe; Pegorier, Jean-Paul; Vasseur-Cognet, Mireille; Bossard, Pascale] INSERM, U1016, Paris, France; [Denis, Raphael G. P.; Luquet, Serge] Univ Paris 07, Team HERGE, Unite Funct & Adapt Biol Biol Fonct & Adaptat, CNRS EAC 4413, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Sabra-Makke, L (corresponding author), Univ Paris 05, Inst Cochin, Dept Endocrinol Metab & Canc, CNRS UMR 8104, Paris, France.	mireille.vasseur@inserm.fr; pascale.bossard@inserm.fr	Vasseur, Mireille/L-6958-2017; Bossard, Pascale/O-6680-2017; Luquet, serge/AAT-1809-2021; Moldes-Garnaud, Marthe/E-4817-2017; Denis, Raphael/ABE-1758-2020	Vasseur, Mireille/0000-0001-6963-4114; Luquet, serge/0000-0001-8668-6645; Moldes-Garnaud, Marthe/0000-0002-9950-2267; Denis, Raphael/0000-0002-7677-7460; Tourrel-Cuzin, Cecile/0000-0002-5368-4018	ALFEDIAM-Antadir, France; Paris V University, France; Conseil national de la recherche scientifique du Liban; Fondation pour la Recherche Medicale	ALFEDIAM-Antadir, France; Paris V University, France; Conseil national de la recherche scientifique du Liban; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants from ALFEDIAM-Antadir, France, 2008, and from the BQR (Bonus Qualite Recherche), Paris V University, France, 2007. L. S. M. is the recipient of a doctoral fellowship from the Conseil national de la recherche scientifique du Liban and the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bardoux P, 2005, DIABETES, V54, P1357, DOI 10.2337/diabetes.54.5.1357; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Benoit SC, 2002, J NEUROSCI, V22, P9048; BJORKLUND A, 1987, INTEGRATED SYSTEMS 1; Bobard A, 2005, J BIOL CHEM, V280, P199, DOI 10.1074/jbc.M406522200; Borg MA, 1997, J CLIN INVEST, V99, P361, DOI 10.1172/JCI119165; Bossard P, 1998, DEVELOPMENT, V125, P4909; Cooney AJ, 2001, TRENDS ENDOCRIN MET, V12, P247, DOI 10.1016/S1043-2760(01)00424-6; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Fu LY, 2008, J NEUROSCI, V28, P5433, DOI 10.1523/JNEUROSCI.0749-08.2008; Fuentealba P, 2010, J NEUROSCI, V30, P1595, DOI 10.1523/JNEUROSCI.4199-09.2010; GANTZ I, 1993, J BIOL CHEM, V268, P15174; HETHERINGTON AW, 1983, NUTR REV, V41, P124; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JONK LJC, 1994, MECH DEVELOP, V47, P81, DOI 10.1016/0925-4773(94)90098-1; Khong K, 2001, NEUROENDOCRINOLOGY, V74, P193, DOI 10.1159/000054686; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Kublaoui BM, 2006, ENDOCRINOLOGY, V147, P4542, DOI 10.1210/en.2006-0453; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; Lee CT, 2004, MOL CELL BIOL, V24, P10835, DOI 10.1128/MCB.24.24.10835-10843.2004; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Lou DQ, 1999, J BIOL CHEM, V274, P28385, DOI 10.1074/jbc.274.40.28385; MAGENIS RE, 1994, MAMM GENOME, V5, P503, DOI 10.1007/BF00369320; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Myers SA, 2006, J BIOL CHEM, V281, P24149, DOI 10.1074/jbc.M601941200; Nicholson JR, 2007, J NEUROENDOCRINOL, V19, P974, DOI 10.1111/j.1365-2826.2007.01610.x; Niswender KD, 2004, TRENDS ENDOCRIN MET, V15, P362, DOI 10.1016/j.tem.2004.07.009; Obici S, 2003, ENDOCRINOLOGY, V144, P5172, DOI 10.1210/en.2003-0999; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Perilhou A, 2008, MOL CELL BIOL, V28, P6568, DOI 10.1128/MCB.02211-07; Perilhou A, 2008, MOL CELL BIOL, V28, P4588, DOI 10.1128/MCB.01191-07; Porte D, 2002, NUTR REV, V60, pS20, DOI 10.1301/002966402320634797; PORTE D, 2002, NUTR REV, V20, pS68; Sato I, 2005, J NEUROSCI, V25, P8657, DOI 10.1523/JNEUROSCI.2739-05.2005; Soosaar A, 1996, FEBS LETT, V391, P95, DOI 10.1016/0014-5793(96)00711-9; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Sugiyama T, 2000, J BIOL CHEM, V275, P3446, DOI 10.1074/jbc.275.5.3446; Toda C, 2009, DIABETES, V58, P2757, DOI 10.2337/db09-0638; Tomassy GS, 2010, P NATL ACAD SCI USA, V107, P3576, DOI 10.1073/pnas.0911792107; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Torsoni MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE216, DOI 10.1152/ajpendo.00031.2003; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; VANHOUTEN M, 1979, NATURE, V282, P623, DOI 10.1038/282623a0; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yamamoto M, 1999, MECH DEVELOP, V84, P143, DOI 10.1016/S0925-4773(99)00054-4; Yeo GSH, 2000, QJM-INT J MED, V93, P7, DOI 10.1093/qjmed/93.1.7; Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008	57	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13464	10.1371/journal.pone.0013464	http://dx.doi.org/10.1371/journal.pone.0013464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976162	Green Submitted, Green Published, gold			2022-12-25	WOS:000283045300033
J	Candiani, G; Pezzoli, D; Ciani, L; Chiesa, R; Ristori, S				Candiani, Gabriele; Pezzoli, Daniele; Ciani, Laura; Chiesa, Roberto; Ristori, Sandra			Bioreducible Liposomes for Gene Delivery: From the Formulation to the Mechanism of Action	PLOS ONE			English	Article							MEDIATED DNA-TRANSFECTION; CATIONIC LIPIDS; IN-VITRO; GEMINI SURFACTANTS; VESICLE FORMATION; NONVIRAL VECTORS; OXIDATIVE STRESS; DRUG-DELIVERY; PLASMID DNA; GLUTATHIONE	Background: A promising strategy to create stimuli-responsive gene delivery systems is to exploit the redox gradient between the oxidizing extracellular milieu and the reducing cytoplasm in order to disassemble DNA/cationic lipid complexes (lipoplexes). On these premises, we previously described the synthesis of SS14 redox-sensitive gemini surfactant for gene delivery. Although others have attributed the beneficial effects of intracellular reducing environment to reduced glutathione (GSH), these observations cannot rule out the possible implication of the redox milieu in its whole on transfection efficiency of bioreducible transfectants leaving the determinants of DNA release largely undefined. Methodology/Principal Findings: With the aim of addressing this issue, SS14 was here formulated into binary and ternary 100 nm-extruded liposomes and the effects of the helper lipid composition and of the SS14/helper lipids molar ratio on chemical-physical and structural parameters defining transfection effectiveness were investigated. Among all formulations tested, DOPC/DOPE/SS14 at 25: 50: 25 molar ratio was the most effective in transfection studies owing to the presence of dioleoyl chains and phosphatidylethanolamine head groups in co-lipids. The increase in SS14 content up to 50% along DOPC/DOPE/SS14 liposome series yielded enhanced transfection, up to 2.7-fold higher than that of the benchmark Lipofectamine 2000, without altering cytotoxicity of the corresponding lipoplexes at charge ratio 5. Secondly, we specifically investigated the redox-dependent mechanisms of gene delivery into cells through tailored protocols of transfection in GSH-depleted and repleted vs. increased oxidative stress conditions. Importantly, GSH specifically induced DNA release in batch and in vitro. Conclusions/Significance: The presence of helper lipids carrying unsaturated dioleoyl chains and phosphatidylethanolamine head groups significantly improved transfection efficiencies of DOPC/DOPE/SS14 lipoplexes. Most importantly, this study shows that intracellular GSH levels linearly correlated with transfection efficiency while oxidative stress levels did not, highlighting for the first time the pivotal role of GSH rather than oxidative stress in its whole in transfection of bioreducible vectors.	[Candiani, Gabriele; Pezzoli, Daniele; Chiesa, Roberto] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, I-20133 Milan, Italy; [Ciani, Laura; Ristori, Sandra] Univ Florence, Dept Chem, Florence, Italy; [Ciani, Laura; Ristori, Sandra] Univ Florence, Ctr Colloid & Surface Sci CSGI, Florence, Italy	Polytechnic University of Milan; University of Florence; University of Florence	Candiani, G (corresponding author), Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, I-20133 Milan, Italy.	gabriele.candiani@polimi.it	Candiani, Gabriele/A-9744-2009; Pezzoli, Daniele/J-4308-2012; Chiesa, Roberto/N-2605-2013; Fanjul-Moles, María Luisa/C-8069-2011; Roberto, Chiesa/AAV-6476-2021; Ristori, Sandra/ABC-4731-2020; Ristori, Sandra/J-9887-2014	Candiani, Gabriele/0000-0003-0575-068X; Pezzoli, Daniele/0000-0002-6780-6979; Fanjul-Moles, María Luisa/0000-0003-2927-0154; Ristori, Sandra/0000-0003-0708-3956; Chiesa, Roberto/0000-0002-5317-6849	Politecnico di Milano; Italian Institute of Technology (IIT)	Politecnico di Milano; Italian Institute of Technology (IIT)(Istituto Italiano di Tecnologia - IIT)	We wish to thank Politecnico di Milano (Grant: 5 per Mille Junior) and the Italian Institute of Technology (IIT) for economic support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamy C, 2005, ARCH MAL COEUR VAISS, V98, P906; Adamy C, 2007, J MOL CELL CARDIOL, V43, P344, DOI 10.1016/j.yjmcc.2007.06.010; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Audouy S, 2000, J GENE MED, V2, P465, DOI 10.1002/1521-2254(200011/12)2:6<465::AID-JGM141>3.0.CO;2-Z; Bagnacani V, 2008, ORG LETT, V10, P3953, DOI 10.1021/ol801326d; Bahlis NJ, 2002, CLIN CANCER RES, V8, P3658; Bajaj A, 2007, J MED CHEM, V50, P2432, DOI 10.1021/jm0611253; Bauhuber S, 2009, ADV MATER, V21, P3286, DOI 10.1002/adma.200802453; Bhattacharya S, 1997, CHEM COMMUN, P2287, DOI 10.1039/a704154c; Bhattacharya S, 1999, CHEM-EUR J, V5, P2335, DOI 10.1002/(SICI)1521-3765(19990802)5:8<2335::AID-CHEM2335>3.0.CO;2-U; Blessing T, 1998, P NATL ACAD SCI USA, V95, P1427, DOI 10.1073/pnas.95.4.1427; Bombelli C, 2005, J MED CHEM, V48, P5378, DOI 10.1021/jm050477r; Boomer JA, 2002, PHARMACEUT RES, V19, P1292, DOI 10.1023/A:1020342523694; Candiani G, 2008, J GENE MED, V10, P637, DOI 10.1002/jgm.1186; Candiani G, 2007, CHEMMEDCHEM, V2, P292, DOI 10.1002/cmdc.200600267; Caracciolo G, 2008, J PHYS CHEM B, V112, P11298, DOI 10.1021/jp803077n; Caracciolo G, 2007, BBA-BIOMEMBRANES, V1768, P2280, DOI 10.1016/j.bbamem.2007.06.027; Chen J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-10; Ciani L, 2004, BBA-BIOMEMBRANES, V1664, P70, DOI 10.1016/j.bbamem.2004.04.003; Ciani L, 2010, BIOPHYS CHEM, V151, P81, DOI 10.1016/j.bpc.2010.05.010; Congiu A, 2004, COLLOID SURFACE B, V36, P43, DOI 10.1016/j.colsurfb.2004.04.006; Damy T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004871; Eliyahu H, 2005, MOLECULES, V10, P34, DOI 10.3390/10010034; Ewert K, 2002, J MED CHEM, V45, P5023, DOI 10.1021/jm020233w; FARHOOD H, 1995, BBA-BIOMEMBRANES, V1235, P289, DOI 10.1016/0005-2736(95)80016-9; FELGNER JH, 1994, J BIOL CHEM, V269, P2550; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Gao X, 2007, AAPS J, V9, pE92, DOI 10.1208/aapsj0901009; Gilge JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004015; Giordano C, 2006, J Appl Biomater Biomech, V4, P73; Guo X, 2003, ACCOUNTS CHEM RES, V36, P335, DOI 10.1021/ar9703241; Hui SW, 1996, BIOPHYS J, V71, P590, DOI 10.1016/S0006-3495(96)79309-8; Huynh GH, 2006, J CONTROL RELEASE, V110, P236, DOI 10.1016/j.jconrel.2005.09.053; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jeong JH, 2010, BIOCONJUGATE CHEM, V21, P296, DOI 10.1021/bc9003525; Kim A, 2004, BIOMATERIALS, V25, P305, DOI 10.1016/S0142-9612(03)00534-9; Kirby AJ, 2003, ANGEW CHEM INT EDIT, V42, P1448, DOI 10.1002/anie.200201597; Koynova R, 2005, BBA-BIOMEMBRANES, V1714, P63, DOI 10.1016/j.bbamem.2005.05.009; Kretzschmar M, 1996, EXP TOXICOL PATHOL, V48, P439; Limon-Pacheco JH, 2007, FREE RADICAL BIO MED, V43, P1335, DOI 10.1016/j.freeradbiomed.2007.06.028; LITZINGER DC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P201, DOI 10.1016/0304-4157(92)90039-D; MacKay JA, 2008, MOL THER, V16, P893, DOI 10.1038/mt.2008.36; Manickam DS, 2008, BIOMATERIALS, V29, P2680, DOI 10.1016/j.biomaterials.2008.03.009; Manickam DS, 2010, J CONTROL RELEASE, V141, P77, DOI 10.1016/j.jconrel.2009.08.022; McGregor C, 2001, J AM CHEM SOC, V123, P6215, DOI 10.1021/ja005681c; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Ohashi T, 2002, FEBS LETT, V511, P21, DOI 10.1016/S0014-5793(01)03262-8; PINNADUWAGE P, 1989, BIOCHIM BIOPHYS ACTA, V985, P33, DOI 10.1016/0005-2736(89)90099-0; Ray G, 2000, BREAST CANCER RES TR, V59, P163, DOI 10.1023/A:1006357330486; Read ML, 2003, J GENE MED, V5, P232, DOI 10.1002/jgm.331; Saito G, 2003, ADV DRUG DELIVER REV, V55, P199, DOI 10.1016/S0169-409X(02)00179-5; Samiec PS, 1998, FREE RADICAL BIO MED, V24, P699, DOI 10.1016/S0891-5849(97)00286-4; Shang F, 2003, FREE RADICAL BIO MED, V34, P521, DOI 10.1016/S0891-5849(02)01304-7; Shangguan T, 2000, GENE THER, V7, P769, DOI 10.1038/sj.gt.3301156; Simberg D, 2001, J BIOL CHEM, V276, P47453, DOI 10.1074/jbc.M105588200; Skrzydlewska E, 2003, HEPATO-GASTROENTEROL, V50, P126; Tang FX, 1999, BIOCONJUGATE CHEM, V10, P791, DOI 10.1021/bc990016i; TEW KD, 1994, CANCER RES, V54, P4313; Thierry AR, 1997, GENE THER, V4, P226, DOI 10.1038/sj.gt.3300350; TURANOV AA, 2010, BIOCH J; Walker WE, 2004, J CONTROL RELEASE, V94, P245, DOI 10.1016/j.jconrel.2003.10.003; Wetzer B, 2001, BIOCHEM J, V356, P747, DOI 10.1042/0264-6021:3560747; Yang JP, 1997, GENE THER, V4, P950, DOI 10.1038/sj.gt.3300485; Yao JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009508; Zelphati O, 1996, P NATL ACAD SCI USA, V93, P11493, DOI 10.1073/pnas.93.21.11493	67	59	62	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13430	10.1371/journal.pone.0013430	http://dx.doi.org/10.1371/journal.pone.0013430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976172	Green Published, Green Submitted, gold			2022-12-25	WOS:000283043700021
J	Tian, F; Lin, DD; Wu, JJ; Gao, YA; Zhang, DH; Ji, MJ; Wu, GL				Tian, Fang; Lin, Dandan; Wu, Jingjiao; Gao, Yanan; Zhang, Donghui; Ji, Minjun; Wu, Guanling			Immune Events Associated with High Level Protection against Schistosoma japonicum Infection in Pigs Immunized with UV-Attenuated Cercariae	PLOS ONE			English	Article							IRRADIATED CERCARIAE; CELL RESPONSES; MANSONI; MICE; VACCINATION; CHINA; EXPRESSION; CYTOKINES; ANTIGEN; MODEL	Background: The vaccination of radiation-attenuated Schistosoma japonicum cercariae can induce effective protection in artiodactyl, but the immune events related to protective immunity are not fully understood. To provide a paradigm for a human recombinant antigen vaccine, we have undertaken a vaccination and challenge experiment in pigs, which was recognized as an appropriate animal model in this type of study because of their similarity to human in immunology, and investigated the relative immune events induced by the radiation-attenuated S. japonicum cercariae. Methods and Findings: We found that pigs immunized once with 400 mu w UV-irradiated cercariae exhibited 63.84% and 71.82% reductions in worm burden and hepatic eggs respectively. Protective immunity in vaccinated pigs was associated with high level productions of IgM, total IgG, IgG1 and IgG2; IgG2 was significantly increased in the acute infection. IFN-gamma levels could be elicited by immunization. At week 6 post-infection, IFN-gamma, IL-4 and IL-10 levels also showed a dramatic rise synchronously in vaccinated pigs. Moreover, the granzyme b, nk-lysin, ifn gamma, il4 and il10 mRNA levels in early skin-draining lymph nodes of immunized pigs were higher than those in pigs with non-irradiated cercariae infection. In addition, cytotoxicity-related genes in the mesenteric lymph nodes were significantly upregulated in vaccinated pigs in the acute infection. Conclusion/Significance: Our results demonstrated that IFN-gamma and IgG2 antibody production, as well as genes related to cytotoxicity are associated with the high level protection induced by UV-irradiated Schistosoma japonicum vaccine. These findings indicated that optimal vaccination against S. japonicum required the induction of IFN-gamma, IgG2 antibody related to Th1 responses and cytotoxicity effect.	[Tian, Fang; Lin, Dandan; Wu, Jingjiao; Gao, Yanan; Zhang, Donghui; Ji, Minjun; Wu, Guanling] Nanjing Med Univ, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China; [Zhang, Donghui; Ji, Minjun; Wu, Guanling] Jiangsu Prov Key Lab Modern Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Lin, Dandan] Jiangxi Prov Inst Parasit Dis, Nanchang, Jiangxi, Peoples R China; [Tian, Fang] Yangzhou Univ Med Coll, Dept Pathogen Biol & Immunol, Yangzhou, Jiangsu, Peoples R China	Nanjing Medical University	Tian, F (corresponding author), Nanjing Med Univ, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China.	jiminjun@njmu.edu.cn	Lin, Dandan/GRJ-2233-2022		National Science Foundation of China (NSFC) [30430600]; National Basic Research Program of China (973 Program) [2007CB513106]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Science Foundation of China (NSFC) (Project No. 30430600) and the National Basic Research Program of China (973 Program 2007CB513106). The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Abdel-Hafeez EH, 2009, PARASITOL INT, V58, P36, DOI 10.1016/j.parint.2008.09.004; Bartley PB, 2008, AM J TROP MED HYG, V78, P929, DOI 10.4269/ajtmh.2008.78.929; Bickle QD, 2009, PARASITOLOGY, V136, P1621, DOI 10.1017/S0031182009005848; Bickle QD, 2001, VET PARASITOL, V100, P51, DOI 10.1016/S0304-4017(01)00483-6; Bogh HO, 1996, VET PARASITOL, V65, P21, DOI 10.1016/0304-4017(96)00942-9; Bogh HO, 1997, ACTA VET SCAND, V38, P147; BUTTERWORTH AE, 1994, TROP GEOGR MED, V46, P197; Buzza MS, 2006, BIOL CHEM, V387, P827, DOI 10.1515/BC.2006.106; Chen HG, 2000, VACCINE, V18, P2142, DOI 10.1016/S0264-410X(99)00541-1; COULSON PS, 1993, J IMMUNOL, V151, P3663; Crawley A, 2003, VACCINE, V21, P2911, DOI 10.1016/S0264-410X(03)00142-7; Crawley A, 2003, VET IMMUNOL IMMUNOP, V91, P141, DOI 10.1016/S0165-2427(02)00293-3; de Jesus AR, 2000, INFECT IMMUN, V68, P2797, DOI 10.1128/IAI.68.5.2797-2803.2000; Eberl M, 2001, INFECT IMMUN, V69, P5352, DOI 10.1128/IAI.69.9.5352-5362.2001; Ekkens MJ, 2007, INFECT IMMUN, V75, P2291, DOI 10.1128/IAI.01328-06; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Hewitson JP, 2005, PARASITE IMMUNOL, V27, P271, DOI 10.1111/j.1365-3024.2005.00764.x; HSU SYL, 1984, AM J TROP MED HYG, V33, P891, DOI 10.4269/ajtmh.1984.33.891; Hu SY, 2006, J PATHOGEN BIOL, V1, P181; Johansen MV, 2000, ACTA TROP, V76, P85, DOI 10.1016/S0001-706X(00)00103-0; Kumar P., 1999, Parasitology International, V48, P109, DOI 10.1016/S1383-5769(99)00008-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LU FL, 1995, PARASITE IMMUNOL, V17, P435, DOI 10.1111/j.1365-3024.1995.tb00911.x; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Osada Y, 2001, PARASITE IMMUNOL, V23, P251, DOI 10.1046/j.1365-3024.2001.00379.x; Oswald IP, 2001, PARASITOLOGY, V122, P299, DOI 10.1017/S0031182001007399; PANCRE V, 1994, INFECT IMMUN, V62, P3723, DOI 10.1128/IAI.62.9.3723-3730.1994; RATCLIFFE EC, 1991, PARASITOLOGY, V103, P65, DOI 10.1017/S0031182000059308; RUPPEL A, 1990, PARASITOLOGY, V101, P23, DOI 10.1017/S0031182000079701; Sang YM, 2009, DEV COMP IMMUNOL, V33, P334, DOI 10.1016/j.dci.2008.05.006; Sato H, 1998, PARASITE IMMUNOL, V20, P337, DOI 10.1111/j.1365-3024.1998.158.x; SHI YE, 1990, EXP PARASITOL, V71, P100, DOI 10.1016/0014-4894(90)90012-2; SHI YE, 1993, PARASITOLOGY, V106, P459, DOI 10.1017/S0031182000076745; Techau ME, 2007, VET RES, V38, P25, DOI 10.1051/vetres:2006042; Torben W, 2007, EXP PARASITOL, V115, P121, DOI 10.1016/j.exppara.2006.07.004; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Williams DL, 2001, INFECT IMMUN, V69, P1134, DOI 10.1128/IAI.69.2.1134-1141.2001; Willingham A. L., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P128; Willingham AL, 1998, AM J TROP MED HYG, V58, P248, DOI 10.4269/ajtmh.1998.58.248; Willingham AL, 1996, PARASITOL TODAY, V12, P132, DOI 10.1016/0169-4758(96)20001-8; Wu H, 1993, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V11, P41; WYNN TA, 1994, J IMMUNOL, V153, P5200; YUAN HC, 1993, CHINESE MED J-PEKING, V106, P563; Zhang YB, 1999, PARASITE IMMUNOL, V21, P111, DOI 10.1046/j.1365-3024.1999.00208.x; Zheng Jiang, 2009, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V27, P398; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	46	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13408	10.1371/journal.pone.0013408	http://dx.doi.org/10.1371/journal.pone.0013408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976218	Green Published, gold, Green Submitted			2022-12-25	WOS:000283043700010
J	Wang, QH; Sun, SY; Khuri, F; Curran, WJ; Deng, XM				Wang, Qinhong; Sun, Shi-Yong; Khuri, Fadlo; Curran, Walter J.; Deng, Xingming			Mono- or Double-Site Phosphorylation Distinctly Regulates the Proapoptotic Function of Bax	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; CYTOCHROME-C RELEASE; BCL-X-L; CONFORMATIONAL-CHANGE; CELL-SURVIVAL; BH3 DOMAINS; PROTEIN; APOPTOSIS; ACTIVATION; FAMILY	Bax is the major multidomain proapoptotic molecule that is required for apoptosis. It has been reported that phosphorylation of Bax at serine(S) 163 or S184 activates or inactivates its proapoptotic function, respectively. To uncover the mechanism(s) by which phosphorylation regulates the proapoptotic function of Bax, a series of serine (S)-> alanine/glutamate (A/E) Bax mutants, including S163A, S184A, S163E, S184E, S163E/S184A (EA), S163A/S184E (AE), S163A/S184A (AA) and S163E/S184E (EE), were created to abrogate or mimic, respectively, either single or double-site phosphorylation. The compound Bax mutants (i.e. EA and AE) can flesh out the functional contribution of individual phosphorylation site(s). WT and each of these Bax mutants were overexpressed in Bax(-/-) MEF or lung cancer H157 cells and the proapoptotic activities were compared. Intriguingly, expression of any of Bax mutants containing the mutation S -> A at S184 (i.e. S184A, EA or AA) represents more potent proapoptotic activity as compared to WT Bax in association with increased 6A7 epitope conformational change, mitochondrial localization/insertion and prolonged half-life. In contrast, all Bax mutants containing the mutation S -> E at S184 (i.e. S184E, AE or EE) have a mobility-shift and fail to insert into mitochondrial membranes with decreased protein stability and less apoptotic activity. Unexpectedly, mutation either S -> A or S -> E at S163 site does not significantly affect the proapoptotic activity of Bax. These findings indicate that S184 but not S163 is the major phosphorylation site for functional regulation of Bax's activity. Therefore, manipulation of the phosphorylation status of Bax at S184 may represent a novel strategy for cancer treatment.	[Wang, Qinhong] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Sun, Shi-Yong; Khuri, Fadlo] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA; [Sun, Shi-Yong; Khuri, Fadlo; Curran, Walter J.; Deng, Xingming] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Curran, Walter J.; Deng, Xingming] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA USA	Duke University; Emory University; Emory University; Emory University	Wang, QH (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	xdeng4@emory.edu	Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618	Flight Attendant Medical Research Institute; Stop Children's Cancer, Inc.; Developmental Research Program Award of Emory SPORE in Head/Neck Cancer; Winship's Inaugural Kennedy Seed Grant; National Cancer Institute in National Institutes of Health [R01 CA112183, R01CA136534]; NATIONAL CANCER INSTITUTE [R01CA112183, R01CA136534] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; Stop Children's Cancer, Inc.; Developmental Research Program Award of Emory SPORE in Head/Neck Cancer; Winship's Inaugural Kennedy Seed Grant; National Cancer Institute in National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Flight Attendant Medical Research Institute Clinical Innovator Awards, by an Award from Stop Children's Cancer, Inc., by a Developmental Research Program Award of Emory SPORE in Head/Neck Cancer, by Winship's Inaugural Kennedy Seed Grant, and by National Cancer Institute in National Institutes of Health Grants R01 CA112183 and R01CA136534. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; ARNOLD H, 2008, MOL CELL BIOL, V26, P2832; Cao XF, 2003, BLOOD, V102, P2605, DOI 10.1182/blood-2003-01-0211; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Choi SY, 2006, J BIOL CHEM, V281, P7049, DOI 10.1074/jbc.M512000200; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Czabotar PE, 2009, CELL DEATH DIFFER, V16, P1187, DOI 10.1038/cdd.2009.83; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deng XM, 2004, P NATL ACAD SCI USA, V101, P153, DOI 10.1073/pnas.2533920100; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Ekert PG, 2001, J CELL BIOL, V152, P483, DOI 10.1083/jcb.152.3.483; Esposti MD, 2003, BIOCHEM BIOPH RES CO, V304, P455, DOI 10.1016/S0006-291X(03)00617-X; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; IKONEN E, 1995, FEBS LETT, V358, P273, DOI 10.1016/0014-5793(94)01444-6; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Krajewska M, 1997, CANCER RES, V57, P1605; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Sharpe JC, 2004, BBA-MOL CELL RES, V1644, P107, DOI 10.1016/j.bbamcr.2003.10.016; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200; Yamaguchi H, 2002, J BIOL CHEM, V277, P41604, DOI 10.1074/jbc.M207516200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao JF, 2009, MOL CANCER RES, V7, P1954, DOI 10.1158/1541-7786.MCR-09-0304	48	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13393	10.1371/journal.pone.0013393	http://dx.doi.org/10.1371/journal.pone.0013393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976235	Green Published, Green Submitted, gold			2022-12-25	WOS:000282941000018
J	Kano, S; Xiao, JH; Osorio, J; Ekker, M; Hadzhiev, Y; Muller, F; Casane, D; Magdelenat, G; Retaux, S				Kano, Shungo; Xiao, Jin-Hua; Osorio, Joana; Ekker, Marc; Hadzhiev, Yavor; Mueller, Ferenc; Casane, Didier; Magdelenat, Ghislaine; Retaux, Sylvie			Two Lamprey Hedgehog Genes Share Non-Coding Regulatory Sequences and Expression Patterns with Gnathostome Hedgehogs	PLOS ONE			English	Article							SONIC-HEDGEHOG; MULTIPLE ALIGNMENT; FLOOR PLATE; EVOLUTION; CONSERVATION; FOREBRAIN; ENHANCERS; ELEMENTS; DNA; ORGANIZATION	Hedgehog (Hh) genes play major roles in animal development and studies of their evolution, expression and function point to major differences among chordates. Here we focused on Hh genes in lampreys in order to characterize the evolution of Hh signalling at the emergence of vertebrates. Screening of a cosmid library of the river lamprey Lampetra fluviatilis and searching the preliminary genome assembly of the sea lamprey Petromyzon marinus indicate that lampreys have two Hh genes, named Hha and Hhb. Phylogenetic analyses suggest that Hha and Hhb are lamprey-specific paralogs closely related to Sonic/Indian Hh genes. Expression analysis indicates that Hha and Hhb are expressed in a Sonic Hh-like pattern. The two transcripts are expressed in largely overlapping but not identical domains in the lamprey embryonic brain, including a newly-described expression domain in the nasohypophyseal placode. Global alignments of genomic sequences and local alignment with known gnathostome regulatory motifs show that lamprey Hhs share conserved non-coding elements (CNE) with gnathostome Hhs albeit with sequences that have significantly diverged and dispersed. Functional assays using zebrafish embryos demonstrate gnathostome-like midline enhancer activity for CNEs contained in intron2. We conclude that lamprey Hh genes are gnathostome Shh-like in terms of expression and regulation. In addition, they show some lamprey-specific features, including duplication and structural (but not functional) changes in the intronic/regulatory sequences.	[Kano, Shungo; Xiao, Jin-Hua; Osorio, Joana; Ekker, Marc; Hadzhiev, Yavor; Mueller, Ferenc; Casane, Didier; Magdelenat, Ghislaine; Retaux, Sylvie] CNRS, Inst Alfred Fessard, UPR3294, Lab Neurobiol & Dev, Gif Sur Yvette, France; [Ekker, Marc] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Hadzhiev, Yavor; Mueller, Ferenc] Univ Birmingham, Dept Med & Mol Genet, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Casane, Didier] Univ Paris 07, Paris, France; [Casane, Didier] CNRS, Lab Evolut Genomes & Speciat, UPR9034, Gif Sur Yvette, France; [Magdelenat, Ghislaine] CEA, Inst Genom, Evry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Ottawa; University of Birmingham; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Kano, S (corresponding author), CNRS, Inst Alfred Fessard, UPR3294, Lab Neurobiol & Dev, Gif Sur Yvette, France.	retaux@inaf.cnrs-gif.fr	Muller, Ferenc/C-6426-2009	Hadzhiev, Yavor/0000-0002-1134-4904; mueller, ferenc/0000-0002-0996-774X; Osorio, Joana/0000-0003-2713-5370	ANR (Agence Nationale de la Recherche); GIS (Groupement d'Interet Scientifique) Genomique Marine; University of Ottawa (ME); CNRS (Centre National de la Recherche Scientifique); Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education; EMBO (European Molecular Biology Organisation)	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); GIS (Groupement d'Interet Scientifique) Genomique Marine; University of Ottawa (ME); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education; EMBO (European Molecular Biology Organisation)(European Molecular Biology Organization (EMBO))	Work supported by ANR (Agence Nationale de la Recherche)[MIDLINE] to SR, a GIS (Groupement d'Interet Scientifique) Genomique Marine to SR and DC, and by a collaborative student exchange grant between the University of Ottawa (ME) and the CNRS (Centre National de la Recherche Scientifique)(SR). JHX and SK were ANR postdoctoral fellows. JO was supported by a doctoral scholarship from the Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education, and a short-term scholarship from EMBO (European Molecular Biology Organisation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Blin M, 2008, MOL CELL NEUROSCI, V39, P592, DOI 10.1016/j.mcn.2008.08.006; Brudno M, 2004, NUCLEIC ACIDS RES, V32, pW41, DOI 10.1093/nar/gkh361; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; BULLOCK TH, 1984, NEUROSCI LETT, V48, P145, DOI 10.1016/0304-3940(84)90010-7; Carr JL, 1998, J EXP ZOOL, V280, P73, DOI 10.1002/(SICI)1097-010X(19980101)280:1<73::AID-JEZ9>3.0.CO;2-E; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Elgar G, 2008, TRENDS GENET, V24, P344, DOI 10.1016/j.tig.2008.04.005; Epstein DJ, 1999, DEVELOPMENT, V126, P281; Ertzer R, 2007, DEV BIOL, V301, P578, DOI 10.1016/j.ydbio.2006.11.004; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Germot A, 2001, MOL BIOL EVOL, V18, P1668, DOI 10.1093/oxfordjournals.molbev.a003955; Guerin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005374; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hadzhiev Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hufton AL, 2009, GENOME RES, V19, P2036, DOI 10.1101/gr.093237.109; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Irvine SQ, 2002, J EXP ZOOL, V294, P47, DOI 10.1002/jez.10090; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Kuraku S, 1999, J MOL EVOL, V49, P729, DOI 10.1007/PL00006595; KURAKU S, 2010, INTEGRATIVE IN PRESS; KURAKU S, 2008, MOL BIOL EVOLUTION; Kuraku S, 2006, ZOOL SCI, V23, P1053, DOI 10.2108/zsj.23.1053; LANG M, CONSERVATION S UNPUB; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemos B, 2004, GENOMICS, V84, P511, DOI 10.1016/j.ygeno.2004.05.009; Mallatt J, 2007, MOL PHYLOGENET EVOL, V43, P1005, DOI 10.1016/j.ympev.2006.11.023; Marti E, 2002, TRENDS NEUROSCI, V25, P89, DOI 10.1016/S0166-2236(02)02062-3; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; McEwen GK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000762; Muller F, 1999, DEVELOPMENT, V126, P2103; NEAR TJ, 2009, J EXP ZOOLOG B; Noonan JP, 2004, GENOME RES, V14, P2397, DOI 10.1101/gr.2972804; Ohno S., 1970, P1; Osorio J, 2005, DEV BIOL, V288, P100, DOI 10.1016/j.ydbio.2005.08.042; Osorio J, 2008, DEV GENES EVOL, V218, P221, DOI 10.1007/s00427-008-0208-1; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Retaux S, 2010, INTEGR COMP BIOL, V50, P98, DOI 10.1093/icb/icq032; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Sabarinadh C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-75; Shimeld SM, 1999, DEV GENES EVOL, V209, P40, DOI 10.1007/s004270050225; Sower SA, 2009, GEN COMP ENDOCR, V161, P20, DOI 10.1016/j.ygcen.2008.11.023; Suda Y, 2009, DEV BIOL, V325, P282, DOI 10.1016/j.ydbio.2008.09.018; Takatori N, 2002, MECH DEVELOP, V116, P235, DOI 10.1016/S0925-4773(02)00150-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uchida K, 2003, J EXP ZOOL PART B, V300B, P32, DOI 10.1002/jez.b.00044; Vavouri T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r15; Venkatesh B, 2005, CURR BIOL, V15, pR82, DOI 10.1016/j.cub.2005.01.021; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; WOOLFE A, 2008, ORG CONSERVED ELEMEN, P307; Woolfe A, 2008, ADV GENET, V61, P307, DOI 10.1016/S0065-2660(07)00012-0; Zardoya R, 1996, TRENDS GENET, V12, P496, DOI 10.1016/S0168-9525(96)20014-9	58	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13332	10.1371/journal.pone.0013332	http://dx.doi.org/10.1371/journal.pone.0013332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967201	Green Published, Green Submitted, gold			2022-12-25	WOS:000282869800029
J	Helbing, D; Johansson, A				Helbing, Dirk; Johansson, Anders			Cooperation, Norms, and Revolutions: A Unified Game-Theoretical Approach	PLOS ONE			English	Article							SOCIAL NORMS; EVOLUTIONARY GAMES; MATHEMATICAL-MODEL; RANDOM REPLICATORS; COLLECTIVE ACTION; DYNAMICS; PUNISHMENT; ENFORCEMENT; STABILITY; EMERGENCE	Background: Cooperation is of utmost importance to society as a whole, but is often challenged by individual self-interests. While game theory has studied this problem extensively, there is little work on interactions within and across groups with different preferences or beliefs. Yet, people from different social or cultural backgrounds often meet and interact. This can yield conflict, since behavior that is considered cooperative by one population might be perceived as non-cooperative from the viewpoint of another. Methodology and Principal Findings: To understand the dynamics and outcome of the competitive interactions within and between groups, we study game-dynamical replicator equations for multiple populations with incompatible interests and different power (be this due to different population sizes, material resources, social capital, or other factors). These equations allow us to address various important questions: For example, can cooperation in the prisoner's dilemma be promoted, when two interacting groups have different preferences? Under what conditions can costly punishment, or other mechanisms, foster the evolution of norms? When does cooperation fail, leading to antagonistic behavior, conflict, or even revolutions? And what incentives are needed to reach peaceful agreements between groups with conflicting interests? Conclusions and Significance: Our detailed quantitative analysis reveals a large variety of interesting results, which are relevant for society, law and economics, and have implications for the evolution of language and culture as well.	[Helbing, Dirk; Johansson, Anders] ETH, Zurich, Switzerland; [Helbing, Dirk] Santa Fe Inst, Santa Fe, NM 87501 USA; [Helbing, Dirk] Collegium Budapest Inst Adv Study, Budapest, Hungary; [Johansson, Anders] UCL, Ctr Adv Spatial Anal, London, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; The Santa Fe Institute; University of London; University College London	Helbing, D (corresponding author), ETH, Zurich, Switzerland.	dhelbing@ethz.ch	Johansson, Anders F/C-5551-2009		European Commission [231200]; ETH Competence Center [CH1-01 08-2]	European Commission(European CommissionEuropean Commission Joint Research Centre); ETH Competence Center	Partial support was provided by the Future and Emerging Technologies programme FP7-COSI-ICT of the European Commission through the project QLectives (grant no.: 231200) and the ETH Competence Center "Coping with Crises in Complex Socio-Economic Systems" (CCSS) through ETH Research Grant CH1-01 08-2 (Eidgenoessische Technische Hochschule/Swiss Federal Institute of Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, EVOLUTIONARY GAME TH; ARTHUR WB, 1989, ECON J, V99, P116, DOI 10.2307/2234208; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bacharach M, 1997, GAME ECON BEHAV, V19, P1, DOI 10.1006/game.1997.0546; Bacharach M, 2000, GAME ECON BEHAV, V32, P220, DOI 10.1006/game.2000.0796; Bacharach M., 2006, INDIVIDUAL CHOICE; Banfield E.C., 1967, MORAL BASIS BACKWARD; Baronchelli A, 2008, INT J MOD PHYS C, V19, P785, DOI 10.1142/S0129183108012522; Ben Jacob E, 2004, TRENDS MICROBIOL, V12, P366, DOI 10.1016/j.tim.2004.06.006; Bendor J, 2001, AM J SOCIOL, V106, P1493, DOI 10.1086/321298; BENDOR J, 1990, J LAW ECON ORGAN, V6, P33; Bicchieri C., 2006, GRAMMAR SOC; BICCHIERI C, 2009, DYNAMICS NORMS; BINMORE K, 1994, J INST THEOR ECON, V150, P45; Binmore K, 2005, NATURAL JUSTICE; Blume A, 1998, GAME ECON BEHAV, V22, P171, DOI 10.1006/game.1997.0598; Bohnet I, 2001, AM POLIT SCI REV, V95, P131, DOI 10.1017/S0003055401000211; BONNER T, 1980, EVOLUTION CULTURE AN; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1994, J INST THEOR ECON, V150, P72; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R, 2005, ORIGIN EVOLUTION CUL; Buskens V., 2002, SOCIAL NETWORKS TRUS, V30; Castelfranchi C., 1998, J ARTIFICIAL SOC SOC, V1; Castello X, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/12/308; Centola D, 2005, AM J SOCIOL, V110, P1009, DOI 10.1086/427321; Chalub FACC, 2006, J THEOR BIOL, V241, P233, DOI 10.1016/j.jtbi.2005.11.028; Cialdini R.B., 1998, HDB SOCIAL PSYCHOL 4, P151; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Coleman J.S., 1990, FDN SOCIAL THEORY, P761; Conte R, 1995, ARTIFICIAL SOCIETIES, P252; Conte R., 1999, Artificial Intelligence and Law, V7, P1, DOI 10.1023/A:1008397328506; Cressman R, 2003, ECON LEARN SOC EVOL, P1; CRESSMAN R, 1995, GAME ECON BEHAV, V11, P237, DOI 10.1006/game.1995.1050; CRESSMAN R, 1986, J MATH BIOL, V23, P221, DOI 10.1007/BF00276958; Cressman R, 2001, J THEOR BIOL, V211, P1, DOI 10.1006/jtbi.2001.2321; Cressman R, 1996, THEOR POPUL BIOL, V49, P189, DOI 10.1006/tpbi.1996.0011; DAVID PA, 1985, AM ECON REV, V75, P332; de Oliveira VM, 2000, PHYS REV LETT, V85, P4984, DOI 10.1103/PhysRevLett.85.4984; de Oliveira VM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.148101; DIEDERICH S, 1989, PHYS REV A, V39, P4333, DOI 10.1103/PhysRevA.39.4333; Dignum F., 1999, Artificial Intelligence and Law, V7, P69, DOI 10.1023/A:1008315530323; Ehrlich PR, 2005, PLOS BIOL, V3, P943, DOI 10.1371/journal.pbio.0030194; ELLICKSON RC, 2001, SOCIAL NORMS, P35; Ellickson RC, 1991, ORDER LAW; ELSTER J, 1989, J ECON PERSPECT, V3, P99, DOI 10.1257/jep.3.4.99; Elster J., 1989, CEMENT SOC; Epstein J. M., 2001, Computational Economics, V18, P9, DOI 10.1023/A:1013810410243; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fent T, 2007, ADV COMPLEX SYST, V10, P271, DOI 10.1142/S0219525907000970; Flache A, 2001, JASSS-J ARTIF SOC S, V4; Flentge F, 2001, JASSS-J ARTIF SOC S, V4; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Galan JM, 2005, JASSS-J ARTIF SOC S, V8; Galla T, 2006, J PHYS A-MATH GEN, V39, P3853, DOI 10.1088/0305-4470/39/15/001; Gintis H., 2000, GAME THEORY EVOLVING; Gintis Herbert, 2009, BOUNDS REASON GAME T; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Harsanyi J. C., 1988, GEN THEORY EQUILIBRI; HECHTER M, SOCIAL NORMS; HECKATHORN DD, 1990, AM SOCIOL REV, V55, P366, DOI 10.2307/2095762; Helbing D, 1996, THEOR DECIS, V40, P149, DOI 10.1007/BF00133171; HELBING D, 1991, BEHAV SCI, V36, P298, DOI 10.1002/bs.3830360405; HELBING D, 1994, J MATH SOCIOL, V19, P189, DOI 10.1080/0022250X.1994.9990143; HELBING D, 1992, LECT NOTES ECON MATH, V395, P330; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057102; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016112; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Hofbauer J., INT GAME THEORY REV, V4, P17; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Homans G.C., 1974, SOCIAL BEHAV ITS ELE; HORNE C, 2001, SOCIAL NORMS, P305; Horne C, 2008, RATION SOC, V20, P147, DOI 10.1177/1043463108089543; Horne Christine, 2001, SOCIAL NORMS; Kanazawa T, 2007, IEEE T SYST MAN CY A, V37, P132, DOI 10.1109/TSMCA.2006.886361; KANDORI M, 1992, REV ECON STUD, V59, P63, DOI 10.2307/2297925; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Kitts JA, 2006, SIMUL MODEL PRACT TH, V14, P407, DOI 10.1016/j.simpat.2005.09.006; Koford K. J., 1991, SOCIAL NORMS EC I; Kuhn, 1962, STRUCTURE SCI REVOLU, P148; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lindbeck A, 1999, Q J ECON, V114, P1, DOI 10.1162/003355399555936; MACAULAY S, 1963, AM SOCIOL REV, V28, P55, DOI 10.2307/2090458; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7229, DOI 10.1073/pnas.092080099; MACY MW, 1998, J ARTIFICIAL SOC SOC, V1; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Moussaid M, 2009, P ROY SOC B-BIOL SCI, V276, P2755, DOI 10.1098/rspb.2009.0405; Nakamaru M, 2004, J THEOR BIOL, V230, P57, DOI 10.1016/j.jtbi.2004.04.028; Neumann M, 2008, JASSS-J ARTIF SOC S, V11; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; OLIVER P, 1980, AM J SOCIOL, V85, P1356, DOI 10.1086/227168; Opp K.-D., 2001, MIND SOC, V3, P101, DOI DOI 10.1007/BF02512077; Opp Karl-Dieter., 2009, THEORIES POLITICAL P; OPP KD, 1979, KYKLOS, V32, P775; OPP KD, 1982, BRIT J SOC PSYCHOL, V21, P139, DOI 10.1111/j.2044-8309.1982.tb00522.x; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Ostrom E., 1990, GOVERNING COMMONS EV; Platteau J.P., 2000, I SOCIAL NORMS EC DE; POPITZ H, 1980, NORMATIVE KONSTRUKTI; Posner Eric A., 2000, LAW SOCIAL NORMS; Posner RA, 1999, INT REV LAW ECON, V19, P369, DOI 10.1016/S0144-8188(99)00013-7; Putnam R.D., 1994, MAKING DEMOCRACY WOR; RAUB W, 1990, AM J SOCIOL, V96, P626, DOI 10.1086/229574; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Saam NJ, 1999, J ARTIFICIAL SOC SOC, V2; SAMUELSON L, 1998, EVOLUTIONARY GAMES E, pCH5; Sato Y, 2005, PHYSICA D, V210, P21, DOI 10.1016/j.physd.2005.06.031; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; SCHUSTER P, 1981, BIOL CYBERN, V40, P17, DOI 10.1007/BF00326677; Sethi R, 1996, AM ECON REV, V86, P766; Skyrms B, 2014, EVOLUTION SOCIAL CON, DOI 10.1017/CBO9781139924825; Skyrms B, 2003, STAG HUNT EVOLUTION; Stouffer SA, 1949, AM SOCIOL REV, V14, P707, DOI 10.2307/2086672; SUGDEN R, 1995, ECON J, V105, P533, DOI 10.2307/2235016; SUGDEN R, 1989, J ECON PERSPECT, V3, P85, DOI 10.1257/jep.3.4.85; Sugden R., 1998, EC VALUES ORG, P73, DOI DOI 10.1017/CB09781139174855.004; SUGDEN R, 1986, EVOLUTION RIGHTS; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Taylor C, 2004, B MATH BIOL, V66, P1621, DOI 10.1016/j.bulm.2004.03.004; Thebaud O, 2001, JASSS, V4, pU40; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; Ullmann-Margalit Edna., 1977, EMERGENCE NORMS; VANDAMME E, 1994, EUR ECON REV, V38, P847, DOI 10.1016/0014-2921(94)90121-X; Voss T., 2001, SOCIAL NORMS, P105; Weidlich W, 2008, J ECON BEHAV ORGAN, V67, P1, DOI 10.1016/j.jebo.2007.02.002; Wilson, 2000, SOCIOBIOLOGY; YOUNG HP, 1993, ECONOMETRICA, V61, P57, DOI 10.2307/2951778; Zeeman E. C., 1977, CATASTROPHE THEORY	138	29	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e12530	10.1371/journal.pone.0012530	http://dx.doi.org/10.1371/journal.pone.0012530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	662KX	20967256	gold, Green Submitted, Green Published			2022-12-25	WOS:000282807300001
J	Nunes, A; Nogueira, PJ; Borrego, MJ; Gomes, JP				Nunes, Alexandra; Nogueira, Paulo J.; Borrego, Maria J.; Gomes, Joao P.			Adaptive Evolution of the Chlamydia trachomatis Dominant Antigen Reveals Distinct Evolutionary Scenarios for B- and T- cell Epitopes: Worldwide Survey	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; CODON USAGE; NUCLEOTIDE SUBSTITUTIONS; GENE-EXPRESSION; INFECTED HUMANS; TISSUE TROPISM; HOST-CELL; SEROVAR; RECOMBINATION	Background: Chlamydia trachomatis is one of the most disseminated human pathogens, for which no vaccine is available yet. Understanding the impact of the host pressure on pathogen antigens is crucial, but so far it was only assessed for highly-restricted geographic areas. We aimed to evaluate the evolutionary picture of the chlamydial key antigen (MOMP), which is one of the leading multi-subunit vaccine candidates, in a worldwide basis. Methodology/Principal Findings: Using genetics, molecular evolution methods and mathematical modelling, we analyzed all MOMP sequences reported worldwide, composed by 5026 strains from 33 geographic regions of five continents. Overall, 35.9% of variants were detected. The evolutionary pattern of MOMP amino acid gains/losses was found to differ from the remaining chromosome, reflecting the demanding constraints of this porin, adhesin and dominant antigen. Amino acid changes were 4.3-fold more frequent in host-interacting domains (P<10(-12)), specifically within B-cell epitopes (P<10(-5)), where 25% of them are at fixation (P<10(-5)). According to the typical pathogen-host arms race, this rampant B-cell antigenic variation likely represents neutralization escape mutants, as some mutations were previously shown to abrogate neutralization of chlamydial infectivity in vitro. In contrast, T-cell clusters of diverse HLA specificities are under purifying selection, suggesting a strategy that may lead to immune subversion. Moreover, several silent mutations are at fixation, generating preferential codons that may influence expression, and may also reflect recombination-derived `hitchhikingeffect' from favourable nonsilent changes. Interestingly, the most prevalent C. trachomatis genotypes, E and F, showed a mutation rate 22.3-fold lower than that of the remainder (P<10(-20)), suggesting more fitted antigenic profiles. Conclusions/Significance: Globally, the adaptive evolution of the C. trachomatis dominant antigen is likely driven by its complex pathogenesis-related function and reflects distinct evolutionary antigenic scenarios that may benefit the pathogen, and thus should be taking into account in the development of a MOMP-based vaccine.	[Nunes, Alexandra; Borrego, Maria J.; Gomes, Joao P.] Natl Inst Hlth, Dept Infect Dis, Lisbon, Portugal; [Nogueira, Paulo J.] Natl Inst Hlth, Dept Epidemiol, Lisbon, Portugal		Nunes, A (corresponding author), Natl Inst Hlth, Dept Infect Dis, Lisbon, Portugal.	j.paulo.gomes@insa.min-saude.pt	Nogueira, Paulo/HDL-7482-2022; Nunes, Alexandra/ABE-3699-2020; Nogueira, Paulo Jorge/AAR-5605-2020	Nogueira, Paulo Jorge/0000-0001-8316-5035; Gomes, Joao Paulo/0000-0002-2697-2399; Nunes, Alexandra/0000-0001-6449-8053; Borrego, Maria Jose/0000-0002-8604-8800	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/BIA-BCM/71117/2006]; FCT [SFRH/BD/25651/2005]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by Fundacao para a Ciencia e a Tecnologia (FCT) grant to JPG (PTDC/BIA-BCM/71117/2006). AN is the recipient of the PhD Grant SFRH/BD/25651/2005 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Arno JN, 1998, J INFECT DIS, V178, P1713, DOI 10.1086/314478; Batteiger BE, 1996, INFECT IMMUN, V64, P2839, DOI 10.1128/IAI.64.7.2839-2841.1996; Batteiger BE, 1996, INFECT IMMUN, V64, P542, DOI 10.1128/IAI.64.2.542-547.1996; BRUNHAM R, 1994, J CLIN INVEST, V94, P458, DOI 10.1172/JCI117347; BRUNHAM RC, 1992, J INFECT DIS, V165, P1076, DOI 10.1093/infdis/165.6.1076; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Cambray G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000256; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Ciurea A, 2000, P NATL ACAD SCI USA, V97, P2749, DOI 10.1073/pnas.040558797; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; de la Maza Luis M, 2002, Curr Opin Investig Drugs, V3, P980; Gao WW, 1997, MOL MICROBIOL, V25, P707, DOI 10.1046/j.1365-2958.1997.5081871.x; Giles TN, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-166; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Gomes JP, 2006, MICROBES INFECT, V8, P16, DOI 10.1016/j.micinf.2005.05.014; Gomes JP, 2006, J BACTERIOL, V188, P275, DOI 10.1128/JB.188.1.275-286.2006; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hatch TP, 1996, J BACTERIOL, V178, P1; HAYES LJ, 1990, J GEN MICROBIOL, V136, P1559, DOI 10.1099/00221287-136-8-1559; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Igietseme Joseph U, 2003, Expert Rev Vaccines, V2, P129, DOI 10.1586/14760584.2.1.129; Igietseme Joseph U, 2004, Expert Rev Vaccines, V3, P23; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; KAPLAN NL, 1989, GENETICS, V123, P887; Kari L, 2009, J IMMUNOL, V182, P8063, DOI 10.4049/jimmunol.0804375; Kim SK, 1999, J IMMUNOL, V162, P6855; Kim SK, 2001, CURR OPIN IMMUNOL, V13, P429, DOI 10.1016/S0952-7915(00)00237-5; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lesnik T, 2000, J THEOR BIOL, V202, P175, DOI 10.1006/jtbi.1999.1047; Lu H, 2005, ACTA BIOCH BIOPH SIN, V37, P1, DOI 10.1093/abbs/37.1.1; Millman KL, 2001, J BACTERIOL, V183, P5997, DOI 10.1128/JB.183.20.5997-6008.2001; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nunes A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r153; Nunes A, 2009, J BACTERIOL, V191, P7182, DOI 10.1128/JB.00895-09; Ortiz L, 2000, INFECT IMMUN, V68, P1719, DOI 10.1128/IAI.68.3.1719-1723.2000; Ortiz L, 1996, J IMMUNOL, V157, P4554; PETERSON EM, 1988, J BACTERIOL, V170, P1389, DOI 10.1128/jb.170.3.1389-1392.1988; Resnikoff S, 2001, B WORLD HEALTH ORGAN, V79, P222; Rodriguez-Maranon MJ, 2002, PROTEIN SCI, V11, P1854, DOI 10.1110/ps.3650102; Seth-Smith HMB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-239; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; Stephens R. S., 2002, CHLAMYDIAL INFECT; SU H, 1990, INFECT IMMUN, V58, P1017, DOI 10.1128/IAI.58.4.1017-1025.1990; Sun G, 2007, J BACTERIOL, V189, P6222, DOI 10.1128/JB.00552-07; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Wang Y, 2006, PROTEIN SCI, V15, P122, DOI 10.1110/ps.051616206; YUAN Y, 1989, INFECT IMMUN, V57, P1040, DOI 10.1128/IAI.57.4.1040-1049.1989; Zar J. H., 1996, BIOSTATISTICAL ANAL; ZHANG YX, 1989, INFECT IMMUN, V57, P636, DOI 10.1128/IAI.57.2.636-638.1989; ZHONG GM, 1991, INFECT IMMUN, V59, P1141, DOI 10.1128/IAI.59.3.1141-1147.1991; ZHONG GM, 1990, INFECT IMMUN, V58, P1450, DOI 10.1128/IAI.58.5.1450-1455.1990	57	36	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13171	10.1371/journal.pone.0013171	http://dx.doi.org/10.1371/journal.pone.0013171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957150	Green Published, Green Submitted, gold			2022-12-25	WOS:000282506100010
J	Feller, M; Adam, M; Zwahlen, M; Brazzola, P; Niggli, F; Kuehni, C				Feller, Martin; Adam, Martin; Zwahlen, Marcel; Brazzola, Pierluigi; Niggli, Felix; Kuehni, Claudia		SPOG; SNC	Family Characteristics as Risk Factors for Childhood Acute Lymphoblastic Leukemia: A Population-Based Case-Control Study	PLOS ONE			English	Article							PARENTAL AGE; BIRTH CHARACTERISTICS; CANCER; COHORT; ASSOCIATION; PREGNANCY; ETIOLOGY; SWEDEN	Background: To date, few risk factors for childhood acute lymphoblastic leukemia (ALL) have been confirmed and the scientific literature is full of controversial "evidence." We examined if family characteristics, particularly maternal and paternal age and number of older siblings, were risk factors for childhood acute lymphoblastic leukemia (ALL). Methodology/Principal Findings: In this population-based nationwide matched case-control study, patients 0-14 years of age with ALL diagnosed 1991-2006 and registered in the Swiss Childhood Cancer Registry were linked with their census records of 1990 and 2000. Eight controls per case were selected from the census. The association between family characteristics and ALL was analyzed by conditional logistic regressions. We found that increasing maternal age was associated with incidence of ALL in the offspring (OR per 5-year increase in maternal age 1.18, 95% CI 1.05-1.31; p = 0.004), remaining stable (trend OR 1.14, 95% CI 0.99-1.31; p = 0.060) after adjustment for other risk factors. The association with paternal age was weaker (OR per 5-year increase 1.14, 95% CI 1.01-1.28, p = 0.032) and disappeared after adjustments. Number of older siblings was not associated with risk of ALL in the overall group of children aged 0-14 years at diagnosis. However, we found a negative trend between number of older siblings and ALL diagnosed at age 0-4 years (OR per sibling 0.85, 95% CI 0.68-1.06; p = 0.141) and a positive trend for ALL diagnosed at age 5-9 (OR 1.34, 95% CI 1.05-1.72; p = 0.019), with some evidence for an effect modification (p-value for interaction = 0.040). Conclusions: As in other studies, increasing maternal, but not paternal age was associated with risk of ALL. We found only a weak association with the number of older siblings, suggesting a delay in disease manifestation rather than a decrease in incidence.	[Feller, Martin; Adam, Martin; Zwahlen, Marcel; Kuehni, Claudia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Adam, Martin] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Adam, Martin] Univ Basel, Basel, Switzerland; [Brazzola, Pierluigi] Osped Reg Bellinzona & Valli Bellinzona, Bellinzona, Switzerland; [Niggli, Felix] Univ Childrens Hosp Zurich, Pediat Oncol Unit, Zurich, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Regional Hospital of Bellinzona & Valleys, San Giovanni; University Children's Hospital Zurich	Feller, M (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	kuehni@ispm.unibe.ch	Zwahlen, Marcel/AFF-8559-2022; Niggli, Felix/L-6547-2017; Feller, Martin/I-7852-2016	Zwahlen, Marcel/0000-0002-6772-6346; Niggli, Felix/0000-0002-7553-3712; Feller, Martin/0000-0003-2519-836X; Kuehni, Claudia E./0000-0001-8957-2002	Swiss Cancer League [OCS-01869-02-2006]; University of Bern; Swiss Pediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur Krebskranke Kinder Regio Basiliensis	Swiss Cancer League; University of Bern; Swiss Pediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur Krebskranke Kinder Regio Basiliensis	This study was funded by the Swiss Cancer League (OCS-01869-02-2006) and the University of Bern. The Childhood Cancer Registry is supported by the Swiss Pediatric Oncology Group, Kinderkrebshilfe Schweiz, Stiftung fur Krebskranke Kinder Regio Basiliensis, and numerous other sponsors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOPP M, 2008, INT J EPIDEMIOL; Brown RC, 2007, INT J EPIDEMIOL, V36, P724, DOI 10.1093/ije/dyl299; CNATTINGIUS S, 1995, J NATL CANCER I, V87, P908, DOI 10.1093/jnci/87.12.908; Dockerty JD, 2001, INT J EPIDEMIOL, V30, P1428, DOI 10.1093/ije/30.6.1428; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Greaves MF, 1997, LANCET, V349, P344, DOI 10.1016/S0140-6736(96)09412-3; GREAVES MF, 1988, LEUKEMIA, V2, P120; Hemminki K, 1999, EPIDEMIOLOGY, V10, P271, DOI 10.1097/00001648-199905000-00014; Hjalgrim LL, 2004, JNCI-J NATL CANCER I, V96, P1549, DOI 10.1093/jnci/djh287; Johnson KJ, 2009, EPIDEMIOLOGY, V20, P475, DOI 10.1097/EDE.0b013e3181a5a332; Johnson KJ, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-7; KAYE SA, 1991, CANCER-AM CANCER SOC, V68, P1351, DOI 10.1002/1097-0142(19910915)68:6<1351::AID-CNCR2820680627>3.0.CO;2-J; Law GR, 2002, BRIT J CANCER, V86, P350, DOI 10.1038/sj/bjc/6600092; Ma XM, 2005, CANCER CAUSE CONTROL, V16, P1075, DOI 10.1007/s10552-005-0356-9; Maule MM, 2007, INT J EPIDEMIOL, V36, P691, DOI 10.1093/ije/dym115; Michel G, 2007, SWISS MED WKLY, V137, P502; Murray L, 2002, BRIT J CANCER, V86, P356, DOI 10.1038/sj.bjc.6600012; Reynolds P, 2002, AM J EPIDEMIOL, V155, P603, DOI 10.1093/aje/155.7.603; Schuz J, 1999, INT J EPIDEMIOL, V28, P631, DOI 10.1093/ije/28.4.631; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Stiller CA, 2008, BRIT J CANCER, V98, P1006, DOI 10.1038/sj.bjc.6604237; Stiller CA, 2004, ONCOGENE, V23, P6429, DOI 10.1038/sj.onc.1207717; Westergaard T, 1997, J NATL CANCER I, V89, P939, DOI 10.1093/jnci/89.13.939; Wong Donny I M, 2006, BMC Blood Disord, V6, P5, DOI 10.1186/1471-2326-6-5; Yip BH, 2006, INT J EPIDEMIOL, V35, P1495, DOI 10.1093/ije/dyl177	25	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13156	10.1371/journal.pone.0013156	http://dx.doi.org/10.1371/journal.pone.0013156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957179	Green Submitted, Green Published, gold			2022-12-25	WOS:000282423300008
J	Moschetti, R; Dimitri, P; Caizzi, R; Junakovic, N				Moschetti, Roberta; Dimitri, Patrizio; Caizzi, Ruggiero; Junakovic, Nikolaj			Genomic Instability of I Elements of Drosophila melanogaster in Absence of Dysgenic Crosses	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; TRANSGENES; REACTIVITY; IDENTIFICATION	Retrotranspostion of I factors in the female germline of Drosophila melanogaster is responsible for the so called I-R hybrid dysgenesis, a phenomenon that produces a broad spectrum of genetic abnormalities including reduced fertility, increased frequency of mutations and chromosome loss. Transposition of I factor depends on cellular conditions that are established in the oocytes of the reactive females and transmitted to their daughters. The so-called reactivity is a cellular state that may exhibit variable levels of expression and represents a permissive condition for I transposition at high levels. Defective I elements have been proposed to be the genetic determinants of reactivity and, through their differential expression, to modulate transposition of active copies in somatic and/or germ line cells. Recently, control of transposable element activity in the germ line has been found to depend on pi-RNAs, small repressive RNAs interacting with Piwi-family proteins and derived from larger transposable elements (TE)-derived primary transcripts. In particular, maternally transmitted I-element piRNAs originating from the 42AB region of polytene chromosomes were found to be involved in control of I element mobility. In the present work, we use a combination of cytological and molecular approaches to study the activity of I elements in three sublines of the inducer y; cn bw; sp isogenic strain and in dysgenic and non-dysgenic genetic backgrounds. Overall, the results of FISH and Southern blotting experiments clearly show that I elements are highly unstable in the Montpellier subline in the absence of classical dysgenic conditions. Such instability appears to be correlated to the amount of 5' and 3' I element transcripts detected by quantitative and real-time RT-PCR. The results of this study indicate that I elements can be highly active in the absence of a dysgenic crosses. Moreover, in the light of our results caution should be taken to assimilate the genomic annotation data on transposable elements to all y; cn bw sp sublines.	[Moschetti, Roberta; Caizzi, Ruggiero] Univ Bari Aldo Moro, Dipartimento Genet & Microbiol, Bari, Italy; [Dimitri, Patrizio] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; [Junakovic, Nikolaj] CNR, Ist Biol & Patol Mol, Rome, Italy	Universita degli Studi di Bari Aldo Moro; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Moschetti, R (corresponding author), Univ Bari Aldo Moro, Dipartimento Genet & Microbiol, Bari, Italy.	patrizio.dimitri@uniroma1.it		Caizzi, Ruggiero/0000-0002-4360-2808; Moschetti, Roberta/0000-0003-3035-1090	National Institutes of Health (NIH); Istituto Pasteur-Fondazione Cenci Bolognetti	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This work was supported by grants from the National Institutes of Health (NIH) and Istituto Pasteur-Fondazione Cenci Bolognetti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BIEMONT C, 1994, J MOL EVOL, V39, P466, DOI 10.1007/BF00173415; BRENNECKE J, 2008, P NATL ACAD SCI USA, V105, P14964; BRENNECKE J, 2007, CELL; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; BROWN AJL, 1987, GENET RES, V49, P121, DOI 10.1017/S0016672300026914; BUCHETON A, 1978, HEREDITY, V40, P207, DOI 10.1038/hdy.1978.22; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; BUCHETON A, 1992, GENETICA, V86, P175, DOI 10.1007/BF00133719; BUSSEAU I, 1994, GENETICA, V93, P101, DOI 10.1007/BF01435243; Chaboissier MC, 1998, P NATL ACAD SCI USA, V95, P11781, DOI 10.1073/pnas.95.20.11781; Chambeyron S, 2005, CYTOGENET GENOME RES, V110, P215, DOI 10.1159/000084955; CHAMBEYRON S, 2008, PIRNA MEDIATED NUCL; DIFRANCO C, 1992, GENETICA, V86, P1; Dimitri P, 2005, CYTOGENET GENOME RES, V110, P160, DOI 10.1159/000084948; *FLYB, 2010, DAT DROS GEN GEN; Gauthier E, 2000, GENETICS, V156, P1867; GUERREIRO MPG, 1995, CHANGES CHROMOSOMAL; JENSEN S, 1995, MOL GEN GENET, V248, P381, DOI 10.1007/BF02191637; Jensen S, 2002, GENETICS, V162, P1197; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; Junakovic N, 2004, METH MOL B, V260, P41, DOI 10.1385/1-59259-755-6:041; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malinsky S, 2000, GENETICS, V156, P1147; Pardue ML, 1986, DROSOPHILA PRACTICAL, P111; PASYUKOVA EG, 1993, MOL GEN GENET, V240, P302, DOI 10.1007/BF00277071; PIMPINELLI S, 1995, P NATL ACAD SCI USA, V92, P3804, DOI 10.1073/pnas.92.9.3804; Robin S, 2003, GENETICS, V164, P521; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; VAURY C, 1989, CHROMOSOMA, V98, P215, DOI 10.1007/BF00329686; Zakharenko LP, 2007, HEREDITY, V99, P525, DOI 10.1038/sj.hdy.6801029	31	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13142	10.1371/journal.pone.0013142	http://dx.doi.org/10.1371/journal.pone.0013142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957225	Green Submitted, Green Published, gold			2022-12-25	WOS:000282423300005
J	Cheng, JC; Auersperg, N; Leung, PCK				Cheng, J-C; Auersperg, N.; Leung, P. C. K.			Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin	ONCOGENE			English	Article						serous borderline ovarian tumors; p53; ovarian cancer; invasion; E-cadherin	EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN CANCERS; PIK3CA GENE; LOW-GRADE; EXPRESSION; MUTATIONS; TRANSCRIPTION; INVASIVENESS; CARCINOMAS; KINASE	Serous borderline ovarian tumors (SBOTs) are slow-growing, non-invasive ovarian epithelial neoplasms. SBOTs are considered to be distinct entities that give rise to invasive low-grade serous carcinomas (LGCs), which have a relatively poor prognosis and are unrelated to high-grade serous carcinomas (HGCs). The mechanisms underlying the progression of non-invasive SBOTs to invasive epithelial ovarian carcinomas are not understood. We recently established short-term cultures of SBOT cells from tumor biopsies and showed that inactivation of p53, retinoblastoma (Rb) and/or PP2A by the simian virus 40 (SV40) large (LT) and small T antigens extends the life span of the cells and endows them with the ability to invade Matrigel-coated transwells. In this study, we show that concurrent inhibition of p53 and Rb by the SV40 LT produces cells (referred to as SBOT4-LT) with increased life span and cell invasion. To distinguish the roles of p53 and Rb in the progression from SBOTs to invasive ovarian carcinomas, we performed small interfering RNA-mediated knockdown of endogenous p53 in a spontaneously immortalized SBOT cell line, SBOT3.1, which increased cell invasion. This increased invasive activity was associated with the transcriptional downregulation of E-cadherin, correlated with an increase in PIK3CA levels and the increased activation of Akt. Conversely, in invasive LGC-derived MPSC1 cells, enhancing the levels of p53 decreased cell invasion and diminished the phosphatidylinositol 3-kinase (PI3K)/Akt-mediated downregulation of E-cadherin. Inhibition of Rb also enhanced invasiveness, but did not affect the levels of PIK3CA and E-cadherin in SBOT3.1 cells, suggesting that it functions by a different pathway. To our knowledge, this study is the first to show that p53 has an important role in the progression from SBOTs to invasive carcinomas. In addition, our findings suggest that downregulation of E-cadherin by the PI3K/Akt pathway contributes to this progression. Oncogene (2011) 30, 1020-1031; doi:10.1038/onc.2010.486; published online 25 October 2010	[Cheng, J-C; Auersperg, N.; Leung, P. C. K.] Univ British Columbia, Dept Obstet & Gynecol, Child & Family Res Inst, Vancouver, BC V6H 3V5, Canada	Child & Family Research Institute; University of British Columbia	Leung, PCK (corresponding author), Univ British Columbia, Dept Obstet & Gynaecol, Room 2H-30,4490 Oak St, Vancouver, BC V6H 3V5, Canada.	peleung@interchange.ubc.ca	Cheng, Jung-Chien/T-4258-2019	Cheng, Jung-Chien/0000-0002-5399-9327; Leung, Peter/0000-0003-3152-3800	National Cancer Institute of Canada; Canadian Cancer Society; Canadian Institutes of Health Research	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the National Cancer Institute of Canada, with funds from the Canadian Cancer Society to NA and Canadian Institutes of Health Research to PCKL. We thank Dr David Huntsman and Winnie Yang (Centre for Translational and Applied Genomics, BC Cancer Agency) for providing the sequence data. We thank Dr Ie-Ming Shih (Department of Pathology, Johns Hopkins Medical Institutions) for providing the MPSC1 cells. We greatly appreciate the advice and help of Drs Christian Klausen and Michelle Woo.	Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Darai E, 1997, HUM PATHOL, V28, P922, DOI 10.1016/S0046-8177(97)90007-1; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Gershenson DM, 1998, CANCER, V83, P2157, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2157::AID-CNCR14>3.0.CO;2-D; Grille SJ, 2003, CANCER RES, V63, P2172; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Ho CL, 2004, CANCER RES, V64, P6915, DOI 10.1158/0008-5472.CAN-04-2067; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Parker RL, 2004, INT J GYNECOL PATHOL, V23, P265, DOI 10.1097/01.pgp.0000130049.19643.f6; Pohl G, 2005, CANCER RES, V65, P1994, DOI 10.1158/0008-5472.CAN-04-3625; Roger L, 2010, J CELL SCI, V123, P1295, DOI 10.1242/jcs.061002; Roymans D, 2001, EUR J BIOCHEM, V268, P487, DOI 10.1046/j.1432-1327.2001.01936.x; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schuijer M, 2003, HUM MUTAT, V21, P285, DOI 10.1002/humu.10181; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shih IM, 2005, CLIN CANCER RES, V11, P7273, DOI 10.1158/1078-0432.CCR-05-0755; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; VEATCH AL, 1994, INT J CANCER, V58, P393, DOI 10.1002/ijc.2910580315; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Woo MMM, 2008, INT J GYNECOL CANCER, V18, P1234, DOI 10.1111/j.1525-1438.2007.01171.x; Woo MM, 2008, GYNECOL ONCOL, V111, P125, DOI 10.1016/j.ygyno.2008.06.021; Woo MMM, 2007, IN VITRO CELL DEV-AN, V43, P7, DOI 10.1007/s11626-006-9002-4; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhao RB, 2000, GENE DEV, V14, P981	35	29	31	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	9					1020	1031		10.1038/onc.2010.486	http://dx.doi.org/10.1038/onc.2010.486			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	729PX	20972462				2022-12-25	WOS:000287964100002
J	Giulivi, C; Ross-Inta, C; Omanska-Klusek, A; Napoli, E; Sakaguchi, D; Barrientos, G; Allen, PD; Pessah, IN				Giulivi, Cecilia; Ross-Inta, Catherine; Omanska-Klusek, Alicja; Napoli, Eleonora; Sakaguchi, Danielle; Barrientos, Genaro; Allen, Paul D.; Pessah, Isaac N.			Basal Bioenergetic Abnormalities in Skeletal Muscle from Ryanodine Receptor Malignant Hyperthermia-susceptible R163C Knock-in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-CORE DISEASE; ACTIVATED PROTEIN-KINASE; SATURATED FATTY-ACIDS; RAT SKELETAL; OXIDATIVE-PHOSPHORYLATION; GENE-EXPRESSION; FIBER-TYPE; SUBCELLULAR-FRACTIONS; CALCIUM-HOMEOSTASIS; DIABETES-MELLITUS	Malignant hyperthermia (MH) and central core disease in humans have been associated with mutations in the skeletal ryanodine receptor (RyR1). Heterozygous mice expressing the human MH/central core disease RyR1 R163C mutation exhibit MH when exposed to halothane or heat stress. Considering that many MH symptoms resemble those that could ensue from a mitochondrial dysfunction (e.g. metabolic acidosis and hyperthermia) and that MH-susceptible mice or humans have a higher than normal cytoplasmic Ca2+ concentration at rest, we evaluated the role of mitochondria in skeletal muscle from R163C compared with wild type mice under basal (untriggered) conditions. R163C skeletal muscle exhibited a significant increase in matrix Ca2+, increased reactive oxygen species production, lower expression of mitochondrial proteins, and higher mtDNA copy number. These changes, in conjunction with lower myoglobin and glycogen contents, Myh4 and GAPDH transcript levels, GAPDH activity, and lower glucose utilization suggested a switch to a compromised bioenergetic state characterized by both low oxidative phosphorylation and glycolysis. The shift in bioenergetic state was accompanied by a dysregulation of Ca2+-esponsive signaling pathways regulated by calcineurin and ERK1/2. Chronically elevated resting Ca2+ in R163C skeletal muscle elicited the maintenance of a fast-twitch fiber program and the development of insulin resistance-like phenotype as part of a metabolic adaptation to the R163C RyR1 mutation.	[Giulivi, Cecilia; Ross-Inta, Catherine; Omanska-Klusek, Alicja; Napoli, Eleonora; Sakaguchi, Danielle; Barrientos, Genaro; Pessah, Isaac N.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Allen, Paul D.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA	University of California System; University of California Davis; Harvard University; Brigham & Women's Hospital	Giulivi, C (corresponding author), Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, 1120 Haring Hall,1 Shields Ave, Davis, CA 95616 USA.	cgiulivi@ucdavis.edu	Giulivi, Cecilia/AAV-6774-2021; Pessah, Isaac N/K-7985-2017; Giulivi, Cecilia/ABB-7809-2020; Napoli, Eleonora/AAQ-6079-2021; Barrientos, Genaro/I-2778-2013	Pessah, Isaac N/0000-0002-8149-588X; Giulivi, Cecilia/0000-0003-1033-7435; Napoli, Eleonora/0000-0001-8808-4242; 	National Institutes of Health [012691, RC1DK087307]; NIEHS;  [2R0 AR043140];  [1P01 AR052354]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043140, P01AR052354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 012691 (to C. G.) and RC1DK087307 (to C. G.) from NIEHS and 2R0 AR043140 and 1P01 AR052354.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Aleman M, 2004, MUSCLE NERVE, V30, P356, DOI 10.1002/mus.20084; ALMARAZ L, 1989, FEBS LETT, V244, P417, DOI 10.1016/0014-5793(89)80575-7; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andrienko T, 2003, J EXP BIOL, V206, P2059, DOI 10.1242/jeb.00242; Argaud L, 2008, AM J PHYSIOL-HEART C, V294, pH386, DOI 10.1152/ajpheart.01035.2007; Ashcroft S. J. H., 2002, Biochemical Society Transactions, V30, pA114; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Bina S, 2006, ANESTHESIOLOGY, V104, P90, DOI 10.1097/00000542-200601000-00015; Bizeau ME, 1998, J APPL PHYSIOL, V85, P1279, DOI 10.1152/jappl.1998.85.4.1279; BOCEK RM, 1966, AM J PHYSIOL, V210, P1108, DOI 10.1152/ajplegacy.1966.210.5.1108; BOCEK RM, 1966, AM J PHYSIOL, V210, P1101, DOI 10.1152/ajplegacy.1966.210.5.1101; BOCEK RM, 1966, J HISTOCHEM CYTOCHEM, V14, P549, DOI 10.1177/14.7.549; BOLENDER RP, 1978, J CELL BIOL, V77, P565, DOI 10.1083/jcb.77.2.565; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; BOOKELMAN H, 1978, BIOCHEM MED METAB B, V20, P404, DOI 10.1016/0006-2944(78)90090-X; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Britt B. A., 1973, INT S MALIGNANT HYPE, P387; BRITT BA, 1973, CAN ANAESTH SOC J, V20, P431, DOI 10.1007/BF03026208; Bruton JD, 1999, P NATL ACAD SCI USA, V96, P3281, DOI 10.1073/pnas.96.6.3281; Buck ED, 1997, J BIOL CHEM, V272, P7360, DOI 10.1074/jbc.272.11.7360; BULLOCK GR, 1973, BIOCHIM BIOPHYS ACTA, V292, P350, DOI 10.1016/0005-2728(73)90041-8; BYRNE E, 1985, J NEUROL SCI, V69, P319, DOI 10.1016/0022-510X(85)90143-1; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; CAMPBELL IT, 1981, ANESTHESIOLOGY, V55, P46, DOI 10.1097/00000542-198107000-00010; Mulero M, 2007, BBA-MOL CELL RES, V1773, P330, DOI 10.1016/j.bbamcr.2006.12.007; Carpenter D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-104; CHANCE B, 1955, NATURE, V175, P1120, DOI 10.1038/1751120a0; CHANCE B, 1959, CIBA F S REGULATION, P91; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Cross HR, 2002, J MOL CELL CARDIOL, V34, P361, DOI 10.1006/jmcc.2001.1518; Crossthwaite AJ, 2002, J NEUROCHEM, V80, P24, DOI 10.1046/j.0022-3042.2001.00637.x; Davis MR, 2003, NEUROMUSCULAR DISORD, V13, P151, DOI 10.1016/S0960-8966(02)00218-3; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; DENBOROUGH MA, 1962, BRIT J ANAESTH, V34, P395, DOI 10.1093/bja/34.6.395; DENBOROUGH MA, 1970, LANCET, V1, P1137; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DUBOWITZ V, 1960, LANCET, V2, P23; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Edmondson RD, 2002, MOL CELL PROTEOMICS, V1, P421, DOI 10.1074/mcp.M100036-MCP200; Elfering SL, 2004, AM J PHYSIOL-HEART C, V286, pH22, DOI 10.1152/ajpheart.00766.2003; ELLIS FR, 1973, P ROY SOC MED, V66, P66, DOI 10.1177/00359157730661P132; Engstrom I, 1996, SCAND J CLIN LAB INV, V56, P345, DOI 10.3109/00365519609090586; Espinosa A, 2004, J ENDOCRINOL, V182, P339, DOI 10.1677/joe.0.1820339; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; EVERTS ME, 1993, ACTA PHYSIOL SCAND, V147, P357, DOI 10.1111/j.1748-1716.1993.tb09512.x; FENG L, 1992, CELL CALCIUM, V13, P79, DOI 10.1016/0143-4160(92)90001-9; FENOGLIO JJ, 1977, AM J PATHOL, V89, P51; FERNANDEZ JL, 1980, BIOCHIM BIOPHYS ACTA, V599, P552, DOI 10.1016/0005-2736(80)90199-6; FOSTER PS, 1989, MUSCLE NERVE, V12, P390, DOI 10.1002/mus.880120509; Fujisawa Y, 2009, BIOCHEM J, V423, P219, DOI 10.1042/BJ20090594; GAZZOTTI P, 1985, BIOCHEM BIOPH RES CO, V127, P358, DOI 10.1016/S0006-291X(85)80167-4; Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; GIULIVI C, 2003, SIGNAL TRANSDUCTION, P311; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hancock CR, 2005, AM J PHYSIOL-CELL PH, V288, pC1287, DOI 10.1152/ajpcell.00567.2004; Hannken T, 2000, J AM SOC NEPHROL, V11, P1387, DOI 10.1681/ASN.V1181387; HARIGAYA S, 1968, J BIOCHEM-TOKYO, V63, P324; Hatefi Y, 1978, Methods Enzymol, V53, P21; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; HEDMAN R, 1962, BIOCHEM BIOPH RES CO, V8, P314, DOI 10.1016/0006-291X(62)90285-1; Hollander AS, 2003, PEDIATRICS, V111, P1447, DOI 10.1542/peds.111.6.1447; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Imai K, 2006, BIOCHEM BIOPH RES CO, V351, P595, DOI 10.1016/j.bbrc.2006.10.056; Jungbluth H, 2005, NEUROLOGY, V65, P1930, DOI 10.1212/01.wnl.0000188870.37076.f2; Jungbluth Heinz, 2004, Neuromuscul Disord, V14, P754, DOI 10.1016/j.nmd.2004.07.007; Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D; Kilbane BJ, 2006, PEDIATR CRIT CARE ME, V7, P169, DOI 10.1097/01.PCC.0000192340.09136.82; Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; LEBARON FN, 1959, J NEUROCHEM, V4, P1, DOI 10.1111/j.1471-4159.1959.tb13168.x; Leblondel G, 2001, BIOL TRACE ELEM RES, V83, P191, DOI 10.1385/BTER:83:3:191; LEBLONDEL G, 1988, BIOL TRACE ELEM RES, V16, P115, DOI 10.1007/BF02797096; Lin HY, 2003, FREE RADICAL BIO MED, V35, P528, DOI 10.1016/S0891-5849(03)00358-7; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; Long YC, 2007, J BIOL CHEM, V282, P1607, DOI 10.1074/jbc.M609208200; Lopez JR, 2005, AM J PHYSIOL-CELL PH, V288, pC606, DOI 10.1152/ajpcell.00297.2004; MANNESCHI L, 1995, J NEUROL SCI, V128, P151, DOI 10.1016/0022-510X(94)00227-F; MARBAN E, 1980, NATURE, V286, P845, DOI 10.1038/286845a0; MAX SR, 1972, ANAL BIOCHEM, V46, P576, DOI 10.1016/0003-2697(72)90328-4; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; Mezin P, 1997, BRIT J ANAESTH, V79, P327, DOI 10.1093/bja/79.3.327; MEZON BJ, 1974, CAN J BIOCHEM CELL B, V52, P1024, DOI 10.1139/o74-143; MICKELSON JR, 1980, ANAL BIOCHEM, V109, P255, DOI 10.1016/0003-2697(80)90645-4; Missihoun C, 2009, MOL CELL BIOCHEM, V321, P45, DOI 10.1007/s11010-008-9908-0; Monnier N, 2001, HUM MOL GENET, V10, P2581, DOI 10.1093/hmg/10.22.2581; Monnier N, 2003, HUM MOL GENET, V12, P1171, DOI 10.1093/hmg/ddg121; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mu XD, 2007, PHYSIOL GENOMICS, V30, P300, DOI 10.1152/physiolgenomics.00286.2006; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; NISHIYAMA A, 1966, ACTA MED OKAYAMA, V20, P137; OBRIEN PJ, 1990, RES VET SCI, V48, P124, DOI 10.1016/S0034-5288(18)31522-4; OBRIEN PJ, 1990, CAN J VET RES, V54, P83; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; PAYEN JF, 1993, ANESTHESIOLOGY, V78, P848, DOI 10.1097/00000542-199305000-00007; PAYEN JF, 1991, LANCET, V337, P1550, DOI 10.1016/0140-6736(91)93247-7; PETER JB, 1967, BIOCHEM BIOPH RES CO, V29, P430, DOI 10.1016/0006-291X(67)90475-5; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51; Rasmussen HN, 1997, ANAL BIOCHEM, V252, P153, DOI 10.1006/abio.1997.2304; Rasmussen HN, 1997, MOL CELL BIOCHEM, V174, P55, DOI 10.1023/A:1006851705996; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; Riva A, 2005, AM J PHYSIOL-HEART C, V289, pH868, DOI 10.1152/ajpheart.00866.2004; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Robinson RL, 2002, HUM MUTAT, V20, P88, DOI 10.1002/humu.10098; Ross-Inta C, 2008, BIOSCIENCE REP, V28, P239, DOI 10.1042/BSR20080090; Rueffert H, 2004, AM J MED GENET A, V124A, P248, DOI 10.1002/ajmg.a.20404; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sahlin K, 2002, J PHYSIOL-LONDON, V541, P569, DOI 10.1113/jphysiol.2002.016683; Sambuughin N, 2001, AM J HUM GENET, V69, P204, DOI 10.1086/321270; Sarkela TM, 2001, J BIOL CHEM, V276, P6945, DOI 10.1074/jbc.M007625200; SCHILLER HH, 1974, J NEUROL SCI, V21, P93, DOI 10.1016/0022-510X(74)90109-9; SCHWERZMANN K, 1986, J CELL BIOL, V102, P97, DOI 10.1083/jcb.102.1.97; Shi H, 2007, AM J PHYSIOL-CELL PH, V292, pC1681, DOI 10.1152/ajpcell.00466.2006; Shi H, 2008, FASEB J, V22, P2990, DOI 10.1096/fj.07-097600; SHUAIB A, 1987, MEDICINE, V66, P389, DOI 10.1097/00005792-198709000-00004; SHY GM, 1956, BRAIN, V79, P610, DOI 10.1093/brain/79.4.610; SMITH MJH, 1956, BIOCHEM J, V63, P524, DOI 10.1042/bj0630524; Szalai G, 2000, J BIOL CHEM, V275, P15305, DOI 10.1074/jbc.275.20.15305; TAYLOR WM, 1980, BIOCHEM J, V188, P443, DOI 10.1042/bj1880443; Tilgen N, 2001, HUM MOL GENET, V10, P2879, DOI 10.1093/hmg/10.25.2879; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Treves S, 2008, CURR OPIN PHARMACOL, V8, P319, DOI 10.1016/j.coph.2008.01.005; VALLIERES J, 1975, ARCH BIOCHEM BIOPHYS, V170, P659, DOI 10.1016/0003-9861(75)90162-9; Venkatraman R., 2006, Indian Journal of Pediatrics, V73, P55, DOI 10.1007/BF02758261; WANG JK, 1969, ANESTHESIOLOGY, V30, P439, DOI 10.1097/00000542-196904000-00015; Wappler F, 2001, EUR J ANAESTH, V18, P632, DOI 10.1046/j.1365-2346.2001.00888.x; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; WILLIAMS RS, 1987, J BIOL CHEM, V262, P2764; WILSON RD, 1971, SOUTHERN MED J, V64, P411, DOI 10.1097/00007611-197104000-00006; Wright DC, 2004, LIFE SCI, V74, P815, DOI 10.1016/j.lfs.2003.06.041; WROGEMANN K, 1973, ARCH BIOCHEM BIOPHYS, V159, P267, DOI 10.1016/0003-9861(73)90453-0; Wu SW, 2006, BRAIN, V129, P1470, DOI 10.1093/brain/awl077; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200; Yoshida M, 2006, AM J PHYSIOL-REG I, V290, pR449, DOI 10.1152/ajpregu.00684.2004; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46; Zhao P, 2008, EXP BIOL MED, V233, P1289, DOI 10.3181/0803-RM-84; ZHENG XX, 1990, BIOCHIM BIOPHYS ACTA, V1019, P1, DOI 10.1016/0005-2728(90)90118-N; Zimmermann P, 2000, LIFE SCI, V67, P949, DOI 10.1016/S0024-3205(00)00688-3	160	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					99	113		10.1074/jbc.M110.153247	http://dx.doi.org/10.1074/jbc.M110.153247			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978128	hybrid, Green Published			2022-12-25	WOS:000285782800011
J	Lin, DYW; Diao, JB; Zhou, DG; Chen, J				Lin, David Yin-wei; Diao, Jianbo; Zhou, Daoguo; Chen, Jue			Biochemical and Structural Studies of a HECT-like Ubiquitin Ligase from Escherichia coli O157:H7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION EFFECTORS; PROTEIN-KINASE; HOST; INSIGHTS; MECHANISMS; VIRULENCE; FAMILY; ENZYME	Many microbial pathogens deliver effector proteins via the type III secretion system into infected host cells. Elucidating the function of these effectors is essential for our understanding of pathogenesis. Here, we describe biochemical and structural characterization of an effector protein (NleL) from Escherichia coli O157:H7, a widespread pathogen causing severe foodborne diseases. We show that NleL functionally and structurally mimics eukaryotic HECT E3 ligases and catalyzes formation of unanchored polyubiquitin chains using Lys(6) and Lys(48) linkage. The catalytic cysteine residue forms a thioester intermediate with ubiquitin. The structure of NleL contains two domains, a beta-helix domain formed by pentapeptide repeats and a bilobed catalytic domain reminiscent of the N- and C-lobe architecture of HECT E3s. Six structures of NleL observed in two crystal forms revealed a large range of different positions of the C-lobe relative to the N-lobe, indicating that the helix linking the two lobes is extremely flexible. Comparing the structure of NleL with that of the Salmonella homolog SopA showed that the orientation of the C-lobes differ by as much as 108, suggesting that large movements of the C-lobe may be required to facilitate the transfer of ubiquitin from E2 to the substrate. These results provide critical knowledge toward understanding the molecular mechanism by which pathogens utilize the host ubiquitination system during infection.	[Lin, David Yin-wei; Zhou, Daoguo; Chen, Jue] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Chen, Jue] Howard Hughes Med Inst, W Lafayette, IN 47907 USA; [Diao, Jianbo] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Howard Hughes Medical Institute; Fudan University	Chen, J (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	chenjue@purdue.edu		Lin, David/0000-0001-6149-5236	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Howard Hughes Medical Institute.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 1998, PROTEIN SCI, V7, P1477, DOI 10.1002/pro.5560070625; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collins CA, 2010, TRENDS CELL BIOL, V20, P205, DOI 10.1016/j.tcb.2010.01.002; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng WY, 2010, J BIOL CHEM, V285, P6790, DOI 10.1074/jbc.M109.086603; Diao J, 2008, NAT STRUCT MOL BIOL, V15, P65, DOI 10.1038/nsmb1346; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Hicks SW, 2010, CURR OPIN MICROBIOL, V13, P41, DOI 10.1016/j.mib.2009.11.008; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munro P, 2007, CURR OPIN MICROBIOL, V10, P39, DOI 10.1016/j.mib.2006.11.002; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Porwollik S, 2003, MICROBES INFECT, V5, P977, DOI 10.1016/S1286-4579(03)00186-2; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Spallek T, 2009, CELL MICROBIOL, V11, P1425, DOI 10.1111/j.1462-5822.2009.01346.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Vetting MW, 2006, BIOCHEMISTRY-US, V45, P1, DOI 10.1021/bi052130w; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Zhang Y, 2006, ACTA CRYSTALLOGR E, V62, pM490, DOI 10.1107/S1600536806004442; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	44	56	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					441	449		10.1074/jbc.M110.167643	http://dx.doi.org/10.1074/jbc.M110.167643			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980253	hybrid, Green Published			2022-12-25	WOS:000285782800047
J	Shi, YJ; Frost, P; Hoang, B; Benavides, A; Gera, J; Lichtenstein, A				Shi, Yijiang; Frost, Patrick; Hoang, Bao; Benavides, Angelica; Gera, Joseph; Lichtenstein, Alan			IL-6-induced Enhancement of c-Myc Translation in Multiple Myeloma Cells CRITICAL ROLE OF CYTOPLASMIC LOCALIZATION OF THE RNA-BINDING PROTEIN hnRNP A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERNAL RIBOSOME ENTRY; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN-A1; TRANS-ACTING FACTOR; HNRNP A1; SITE FUNCTION; PROTEINS; RELOCALIZATION; ACTIVATION; INITIATION; EXPRESSION	Prior work indicates that IL-6 can stimulate c-Myc expression in multiple myeloma (MM) cells, which is independent of effects on transcription and due to enhanced translation mediated by an internal ribosome entry site in the 5'-UTR of the c-Myc RNA. The RNA-binding protein hnRNP A1 (A1) was also critical to IL-6-stimulated translation. Because A1 shuttles between nucleus and cytoplasm, we investigated whether the ability of IL-6 to enhance Myc translation was mediated by stimulation of A1 shuttling. In MM cell lines and primary specimens, IL-6 increased A1 cytoplasmic localization. In contrast, there was no effect on the total cellular levels of A1. Use of a dominant negative A1 construct, which prevents endogenous A1 from nucleus-to-cytoplasm transit, prevented the ability of IL-6 to enhance Myc internal ribosome entry site activity, Myc protein expression, and MM cell growth. IL-6-stimulated cytoplasmic localization was mediated by alterations in the C-terminal M9 peptide of A1, and this correlated with the ability of IL-6 to induce serine phosphorylation of this domain. A p38 kinase inhibitor prevented IL-6-induced A1 phosphorylation. Thus, IL-6 activates c-Myc translation in MM cells by inducing A1 phosphorylation and cytoplasmic localization in a p38-dependent fashion. These data suggest A1 as a potential therapeutic target in MM.	[Shi, Yijiang; Frost, Patrick; Hoang, Bao; Benavides, Angelica; Gera, Joseph; Lichtenstein, Alan] Univ Calif Los Angeles, Div Hematol Oncol, Greater Los Angeles Vet Affairs Healthcare Ctr, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90073 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Lichtenstein, A (corresponding author), W Los Angeles VA Hosp, W111H,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	alan.lichtenstein@med.va.gov		Frost, Patrick/0000-0003-3348-5983; Gera, Joseph/0000-0002-2908-6894	National Institutes of Health [RO1 CA109312, RO1 CA111448]; Department of Defense; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA111448, R01CA109312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA109312 and RO1 CA111448. This work was also supported by research funds from the Department of Defense and the Department of Veterans Affairs.	Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Avet-Loiseau H, 2001, BLOOD, V98, P3082, DOI 10.1182/blood.V98.10.3082; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Bergsagel PL, 2001, ONCOGENE, V20, P5611, DOI 10.1038/sj.onc.1204641; BIAMONTI G, 1993, J MOL BIOL, V230, P77, DOI 10.1006/jmbi.1993.1127; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Chappell SA, 2000, ONCOGENE, V19, P4437, DOI 10.1038/sj.onc.1203791; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Cheung WC, 2002, LEUKEMIA, V16, P1182, DOI 10.1038/sj.leu.2402481; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Greco C, 2006, INT J IMMUNOPATH PH, V19, P67; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; MELAMED D, 1993, MOL CELL BIOL, V13, P5255, DOI 10.1128/MCB.13.9.5255; MICHAEL WM, 1995, CELL, V83, P415; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Patry C, 2004, MOL CANCER THER, V3, P1193; Patry C, 2003, CANCER RES, V63, P7679; Paulin FEM, 1996, ONCOGENE, V13, P505; Shi YJ, 2008, CANCER RES, V68, P10215, DOI 10.1158/0008-5472.CAN-08-1066; Shi YY, 2002, J BIOL CHEM, V277, P15712, DOI 10.1074/jbc.M200043200; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Subkhankulova T, 2001, BIOCHEM J, V359, P183, DOI 10.1042/0264-6021:3590183; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Vincent T, 2004, LEUKEMIA, V18, P967, DOI 10.1038/sj.leu.2403333; Zhang J, 2009, CANCER RES, V69, P5082, DOI 10.1158/0008-5472.CAN-08-4603; Zinszner H, 1997, J CELL SCI, V110, P1741	38	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					67	78		10.1074/jbc.M110.153221	http://dx.doi.org/10.1074/jbc.M110.153221			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20974848	Green Published, hybrid			2022-12-25	WOS:000285782800008
J	Swenerton, RK; Zhang, SY; Sajid, M; Medzihradszky, KF; Craik, CS; Kelly, BL; McKerrow, JH				Swenerton, Ryan K.; Zhang, Shuyi; Sajid, Mohammed; Medzihradszky, Katalin F.; Craik, Charles S.; Kelly, Ben L.; McKerrow, James H.			The Oligopeptidase B of Leishmania Regulates Parasite Enolase and Immune Evasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED GENE DELETION; CYSTEINE PROTEASES; TRYPANOSOMA-CRUZI; MOLECULAR-CLONING; CELL INVASION; PLASMINOGEN; IDENTIFICATION; PROMASTIGOTES; INHIBITORS; PEPTIDASE	Proteases are a ubiquitous group of enzymes that play key roles in the life cycle of parasites, in the host-parasite relationship, and in the pathogenesis of parasitic diseases. Furthermore, proteases are targets for the development of new antiparasitic therapy. Protozoan parasites like Leishmania predominantly express Clan CA cysteine proteases for key life cycle functions. It was therefore unexpected to find a high level of serine protease activity expressed by Leishmania donovani. Purification of this activity followed by mass spectrometry identified oligopeptidase B (OPB; Clan SC, family S9A) as the responsible enzyme. This was confirmed by gene knock-out of OPB, which resulted in the disappearance of the detected serine protease activity of Leishmania extracts. To delineate the specific role of OPB in parasite physiology, proteomic analysis was carried out on OPB(-/-) versus wild type parasites. Four protein species were significantly elevated in OPB(-/-) parasites, and all four were identified by mass spectrometry as enolase. This increased enolase was enzymatically inactive and associated with the parasite membrane. Aside from its classic role in carbohydrate metabolism, enolase was recently found to localize to membranes, where it binds host plasminogen and functions as a virulence factor for several pathogens. As expected, there was a striking alteration in macrophage responses to Leishmania when OPB was deleted. Whereas wild type parasites elicited little, if any, response from infected macrophages, OPB(-/-) parasites induced a massive up-regulation in gene transcription. Additionally, these OPB(-/-) parasites displayed decreased virulence in the murine footpad infection model.	[Swenerton, Ryan K.; Zhang, Shuyi; Sajid, Mohammed; Kelly, Ben L.; McKerrow, James H.] Univ Calif San Francisco, Dept Pathol, Sandler Ctr Drug Discovery, San Francisco, CA 94158 USA; [Medzihradszky, Katalin F.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Sajid, Mohammed] Leiden Univ, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Kelly, Ben L.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol, New Orleans, LA 70112 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	McKerrow, JH (corresponding author), 1700 4th St,Box 2550,UCSF QB3, San Francisco, CA 94158 USA.	James.McKerrow@ucsf.edu		Swenerton, Ryan/0000-0002-0994-752X	National Institutes of Health (NIH) [AI35707]; National Science Foundation; Sandler Foundation; NIH National Center for Research Resources (NCRR), NIH NCRR [P41RR001614, RR012961]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR012961, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035707] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Sandler Foundation; NIH National Center for Research Resources (NCRR), NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant AI35707. This work was also supported by a National Science Foundation graduate research fellowship and the Sandler Foundation. Mass spectrometry analysis was provided by the Bio-Organic Biomedical Mass Spectrometry Resource at the University of California (San Francisco, CA) (A. L. Burlingame, Director), supported by the Biomedical Research Technology Program of the NIH National Center for Research Resources (NCRR), NIH NCRR Grant P41RR001614, and NIH NCRR Grant RR012961.	Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Avilan L, 2000, MOL BIOCHEM PARASIT, V110, P183, DOI 10.1016/S0166-6851(00)00269-3; Bal G, 2003, BIOORG MED CHEM LETT, V13, P2875, DOI 10.1016/S0960-894X(03)00579-1; Bogdan C, 1998, INT J PARASITOL, V28, P121, DOI 10.1016/S0020-7519(97)00169-0; Burleigh BA, 1997, J CELL BIOL, V136, P609, DOI 10.1083/jcb.136.3.609; BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Guedes HLD, 2007, PARASITOL RES, V101, P853, DOI [10.1007/s00436-007-0552-5, 10.1007/s00436-007-0630-8]; DOYLE PS, 1991, EXP PARASITOL, V73, P326, DOI 10.1016/0014-4894(91)90104-5; Ferguson DJP, 2002, INT J PARASITOL, V32, P1399, DOI 10.1016/S0020-7519(02)00129-7; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; Guedes HLM, 2007, Z NATURFORSCH C, V62, P373; Hansell E, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000262; Hide M, 2008, PARASITOL RES, V103, P989, DOI 10.1007/s00436-008-1062-9; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Joshi PB, 1998, MOL MICROBIOL, V27, P519, DOI 10.1046/j.1365-2958.1998.00689.x; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; LACALLE RA, 1989, GENE, V79, P375, DOI 10.1016/0378-1119(89)90220-5; Maldonado J, 2006, EXP MOL PATHOL, V80, P289, DOI 10.1016/j.yexmp.2005.06.005; MANIATIS T, 1982, MOL CLONING LAB MANU; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; McKerrow JH, 2008, CURR OPIN INFECT DIS, V21, P668, DOI 10.1097/QCO.0b013e328315cca9; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Morty RE, 1999, J BIOL CHEM, V274, P26149, DOI 10.1074/jbc.274.37.26149; Morty RE, 1999, MOL BIOCHEM PARASIT, V102, P145, DOI 10.1016/S0166-6851(99)00097-3; Morty RE, 2005, J BIOL CHEM, V280, P10925, DOI 10.1074/jbc.M410066200; Morty RE, 1998, FEBS LETT, V433, P251, DOI 10.1016/S0014-5793(98)00914-4; Mottram JC, 2004, CURR OPIN MICROBIOL, V7, P375, DOI 10.1016/j.mib.2004.06.010; O'Brien TC, 2008, J BIOL CHEM, V283, P28934, DOI 10.1074/jbc.M805824200; Pal-Bhowmick I, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-45; Polgar L, 1997, PROTEINS, V28, P375; Que XC, 2000, CLIN MICROBIOL REV, V13, P196, DOI 10.1128/CMR.13.2.196-206.2000; Quinones W, 2007, EXP PARASITOL, V116, P241, DOI 10.1016/j.exppara.2007.01.008; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; SACKS DL, 1985, J IMMUNOL, V135, P564; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Silva-Lopez RE, 2007, PARASITOL RES, V101, P1627, DOI 10.1007/s00436-007-0706-5; Vanegas G, 2007, PARASITOL RES, V101, P1511, DOI 10.1007/s00436-007-0668-7; WALLIS AE, 1987, J EXP MED, V166, P1814, DOI 10.1084/jem.166.6.1814; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; Zhang SY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000648	44	69	70	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					429	440		10.1074/jbc.M110.138313	http://dx.doi.org/10.1074/jbc.M110.138313			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20961853	hybrid, Green Published			2022-12-25	WOS:000285782800046
J	Abdul-Sater, AA; Said-Sadier, N; Lam, VM; Singh, B; Pettengill, MA; Soares, F; Tattoli, I; Lipinski, S; Girardin, SE; Rosenstiel, P; Ojcius, DM				Abdul-Sater, Ali A.; Said-Sadier, Najwane; Lam, Verissa M.; Singh, Bhavni; Pettengill, Matthew A.; Soares, Fraser; Tattoli, Ivan; Lipinski, Simone; Girardin, Stephen E.; Rosenstiel, Philip; Ojcius, David M.			Enhancement of Reactive Oxygen Species Production and Chlamydial Infection by the Mitochondrial Nod-like Family Member NLRX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE; TRACHOMATIS INCLUSION; MURIDARUM INFECTION; ACTIVATION; PNEUMONIAE; RECEPTOR; CELLS; MEMBRANE; PATHWAYS; SURVIVAL	Chlamydia trachomatis infections cause severe and irreversible damage that can lead to infertility and blindness in both males and females. Following infection of epithelial cells, Chlamydia induces production of reactive oxygen species (ROS). Unconventionally, Chlamydiae use ROS to their advantage by activating caspase-1, which contributes to chlamydial growth. NLRX1, a member of the Nod-like receptor family that translocates to the mitochondria, can augment ROS production from the mitochondria following Shigella flexneri infections. However, in general, ROS can also be produced by membrane-bound NADPH oxidases. Given the importance of ROS-induced caspase-1 activation in growth of the chlamydial vacuole, we investigated the sources of ROS production in epithelial cells following infection with C. trachomatis. In this study, we provide evidence that basal levels of ROS are generated during chlamydial infection by NADPH oxidase, but ROS levels, regardless of their source, are enhanced by an NLRX1-dependent mechanism. Significantly, the presence of NLRX1 is required for optimal chlamydial growth.	[Abdul-Sater, Ali A.; Said-Sadier, Najwane; Lam, Verissa M.; Singh, Bhavni; Pettengill, Matthew A.; Ojcius, David M.] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA; [Abdul-Sater, Ali A.; Said-Sadier, Najwane; Lam, Verissa M.; Singh, Bhavni; Pettengill, Matthew A.; Ojcius, David M.] Univ Calif, Hlth Sci Res Inst, Merced, CA 95343 USA; [Soares, Fraser; Tattoli, Ivan; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Lipinski, Simone; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	University of California System; University of California Merced; University of California System; University of California Merced; University of Toronto; University of Kiel	Ojcius, DM (corresponding author), Univ Calif, Sch Nat Sci, 5200 N Lake Rd, Merced, CA 95343 USA.	david.ojcius@gmail.com	Ojcius, David/ABE-6557-2020; Rosenstiel, Philip/A-5137-2009; Lipinski, Simone/L-9818-2017; Lipinski, Simone/HHY-9238-2022; Tattoli, Ivan/H-2600-2017	Rosenstiel, Philip/0000-0002-9692-8828; Lipinski, Simone/0000-0002-9322-7372; Tattoli, Ivan/0000-0001-7925-4609; Pettengill, Matthew/0000-0002-4579-0187; Ojcius, David/0000-0003-1461-4495	NIAID NIH HHS [R01 AI079004] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079004] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Azenabor AA, 2005, MED MICROBIOL IMMUN, V194, P91, DOI 10.1007/s00430-004-0223-4; Bavoil PM, 2000, MICROBIOL-UK, V146, P2723, DOI 10.1099/00221287-146-11-2723; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; Buchholz KR, 2008, INFECT IMMUN, V76, P3150, DOI 10.1128/IAI.00104-08; Buss C, 2010, J IMMUNOL, V184, P3072, DOI 10.4049/jimmunol.0902947; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Derbigny WA, 2005, J IMMUNOL, V175, P6065, DOI 10.4049/jimmunol.175.9.6065; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Gerbase AC, 1998, LANCET, V351, P2, DOI 10.1016/S0140-6736(98)90001-0; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Kalvegren H, 2005, THROMB HAEMOSTASIS, V94, P327, DOI 10.1160/TH04-06-0360; Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; McClarty Grant, 1994, Trends in Microbiology, V2, P157, DOI 10.1016/0966-842X(94)90665-3; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Novo E, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-5; Ojcius DM, 1996, RES IMMUNOL, V147, P175, DOI 10.1016/0923-2494(96)83169-5; Ojcius DM, 1998, J BIOL CHEM, V273, P7052, DOI 10.1074/jbc.273.12.7052; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Perfettini JL, 2003, J BIOL CHEM, V278, P9496, DOI 10.1074/jbc.M211275200; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Scidmore MA, 2001, MOL MICROBIOL, V39, P1638, DOI 10.1046/j.1365-2958.2001.02355.x; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shinohara M, 2010, J BIOL CHEM, V285, P4481, DOI 10.1074/jbc.M109.071779; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Takeya R, 2006, METHOD ENZYMOL, V406, P456, DOI 10.1016/S0076-6879(06)06034-4; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	40	102	106	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41637	41645		10.1074/jbc.M110.137885	http://dx.doi.org/10.1074/jbc.M110.137885			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959452	hybrid, Green Published			2022-12-25	WOS:000285622600051
J	Bolourani, P; Spiegelman, G; Weeks, G				Bolourani, Parvin; Spiegelman, George; Weeks, Gerald			Determinants of RasC Specificity during Dictyostelium Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RELAY; ACTIVATION; TRANSFORMATION; CHEMOTAXIS; DISCOIDEUM; EXPRESSION; KINASE	RasC is required for optimum activation of adenylyl cyclase A and for aggregate stream formation during the early differentiation of Dictyostelium discoideum. RasG is unable to substitute for this requirement despite its sequence similarity to RasC. A critical question is which amino acids in RasC are required for its specific function. Each of the amino acids within the switch 1 and 2 domains in the N-terminal portion of RasG was changed to the corresponding amino acid from RasC, and the ability of the mutated RasG protein to reverse the phenotype of rasC(-) cells was determined. Only the change from aspartate at position 30 of RasG to alanine (the equivalent position 31 in RasC) resulted in a significant increase in adenylyl cyclase A activation and a partial reversal of the aggregation-deficient phenotype of rasC(-) cells. All other single amino acid changes were without effect. Expression of a chimeric protein, RasG(1-77)-RasC(79-189), also resulted in a partial reversal of the rasC(-) cell phenotype, indicating the importance of the C-terminal portion of RasC. Furthermore, expression of the chimeric protein, with alanine changed to aspartate (RasG(1-77(D30A))-RasC(79-189)), resulted in a full rescue the rasC(-) aggregation-deficient phenotype. Finally, the expression of either a mutated RasC, with the aspartate 31 replaced by alanine, or the chimeric protein, RasC(1-78)-RasG(78-189), only generated a partial rescue. These results emphasize the importance of both the single amino acid at position 31 and the C-terminal sequence for the specific function of RasC during Dictyostelium aggregation.	[Bolourani, Parvin; Spiegelman, George; Weeks, Gerald] Univ British Columbia, Life Sci Ctr, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Weeks, G (corresponding author), Univ British Columbia, Life Sci Ctr, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	gerwee@interchange.ubc.ca			Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institute of Health Research (to G. W.).	Alibaud L, 2003, BIOTECHNIQUES, V35, P78, DOI 10.2144/03351st03; Biou V, 2004, BIOCHEMISTRY-US, V43, P6833, DOI 10.1021/bi049630u; Bolourani P, 2008, J BIOL CHEM, V283, P10232, DOI 10.1074/jbc.M707459200; Bolourani P, 2006, MOL BIOL CELL, V17, P4543, DOI 10.1091/mbc.E05-11-1019; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chubb JR, 2001, BBA-GEN SUBJECTS, V1525, P262, DOI 10.1016/S0304-4165(01)00111-8; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Kae H, 2004, EMBO REP, V5, P602, DOI 10.1038/sj.embor.7400151; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KHOSLA M, 1990, MOL CELL BIOL, V10, P918, DOI 10.1128/MCB.10.3.918; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Lee S, 1999, MOL BIOL CELL, V10, P2829, DOI 10.1091/mbc.10.9.2829; Lim CJ, 2001, EMBO J, V20, P4490, DOI 10.1093/emboj/20.16.4490; MARSHALL MS, 1991, MOL CELL BIOL, V11, P3997, DOI 10.1128/MCB.11.8.3997; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; ROBBINS SM, 1989, P NATL ACAD SCI USA, V86, P938, DOI 10.1073/pnas.86.3.938; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SAMBROOK J, 1989, MOL CLONING LAB MANU, V18, P47; THIERY R, 1992, BIOCHEM CELL BIOL, V70, P1193, DOI 10.1139/o92-165; Tuxworth RI, 1997, J CELL BIOL, V138, P605, DOI 10.1083/jcb.138.3.605; VANHAASTERT PJM, 1984, J GEN MICROBIOL, V130, P2559; Weeks G., 2005, DICTYOSTELIUM GENOMI, P211; White MA, 1996, J BIOL CHEM, V271, P16439, DOI 10.1074/jbc.271.28.16439; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3	27	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41374	41379		10.1074/jbc.M110.181115	http://dx.doi.org/10.1074/jbc.M110.181115			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20971846	hybrid, Green Published			2022-12-25	WOS:000285622600023
J	Ferreira, R; Xapelli, S; Santos, T; Silva, AP; Cristovao, A; Cortes, L; Malva, JO				Ferreira, Raquel; Xapelli, Sara; Santos, Tiago; Silva, Ana Paula; Cristovao, Armando; Cortes, Luisa; Malva, Joao O.			Neuropeptide Y Modulation of Interleukin-1 beta (IL-1 beta)-induced Nitric Oxide Production in Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; MESSENGER-RNA EXPRESSION; TOLL-LIKE RECEPTORS; NF-KAPPA-B; INFLAMMATORY NEURODEGENERATION; GENE-TRANSCRIPTION; BRAIN INFLAMMATION; IL-1-BETA RELEASE; NPY	Given the modulatory role of neuropeptide Y (NPY) in the immune system, we investigated the effect of NPY on the production of NO and IL-1 beta in microglia. Upon LPS stimulation, NPY treatment inhibited NO production as well as the expression of inducible nitric-oxide synthase (iNOS). Pharmacological studies with a selective Y-1 receptor agonist and selective antagonists for Y-1, Y-2, and Y-5 receptors demonstrated that inhibition of NO production and iNOS expression was mediated exclusively through Y-1 receptor activation. Microglial cells stimulated with LPS and ATP responded with a massive release of IL-1 beta, as measured by ELISA. NPY inhibited this effect, suggesting that it can strongly impair the release of IL-1 beta. Furthermore, we observed that IL-1 beta stimulation induced NO production and that the use of a selective IL-1 receptor antagonist prevented NO production upon LPS stimulation. Moreover, NPY acting through Y1 receptor inhibited LPS-stimulated release of IL-1 beta, inhibiting NO synthesis. IL-1 beta activation of NF-kappa B was inhibited by NPY treatment, as observed by confocal microscopy and Western blotting analysis of nuclear translocation of NF-kappa B p65 subunit, leading to the decrease of NO synthesis. Our results showed that upon LPS challenge, microglial cells release IL-1 beta, promoting the production of NO through a NF-kappa B-dependent pathway. Also, NPY was able to strongly inhibit NO synthesis through Y1 receptor activation, which prevents IL-1 beta release and thus inhibits nuclear translocation of NF-kappa B. The role of NPY in key inflammatory events may contribute to unravel novel gateways to modulate inflammation associated with brain pathology.	[Malva, Joao O.] Univ Coimbra, Inst Biochem, Fac Med, P-3004504 Coimbra, Portugal; [Malva, Joao O.] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004504 Coimbra, Portugal; [Silva, Ana Paula] Univ Coimbra, Inst Pharmacol & Expt Therapeut, P-3004504 Coimbra, Portugal; [Silva, Ana Paula] Univ Coimbra, Inst Biomed Res Light & Image, P-3004504 Coimbra, Portugal; [Cristovao, Armando] Univ Coimbra, Dept Life Sci, P-3004504 Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Malva, JO (corresponding author), Univ Coimbra, Inst Biochem, Fac Med, P-3004504 Coimbra, Portugal.	jomalva@fmed.uc.pt	Ferreira, Raquel/AAA-7401-2021; Silva, Ana Paula/L-4184-2014; Cortes, Luisa/F-7349-2014; Cristóvão, Armando J/N-2612-2013; Malva, Joao/L-3557-2014	Ferreira, Raquel/0000-0003-1014-0499; Silva, Ana Paula/0000-0002-7802-8690; Cortes, Luisa/0000-0001-5292-4369; Cristóvão, Armando J/0000-0002-4090-3269; Santos, Tiago/0000-0003-0237-499X; Xapelli, Sara/0000-0001-6854-2509; Malva, Joao/0000-0002-5438-4447	Fundacao para a Ciencia e a Tecnologia Portugal; Fundo-Europeu-De-Desenvolvimento-Regional Grants [PTDC/SAU-NEU/68465/2006, PTDC/SAU-OSM/101469/2008, SFRH/BD/23595/2005]	Fundacao para a Ciencia e a Tecnologia Portugal(Portuguese Foundation for Science and Technology); Fundo-Europeu-De-Desenvolvimento-Regional Grants	This work was supported by the Fundacao para a Ciencia e a Tecnologia Portugal and Fundo-Europeu-De-Desenvolvimento-Regional Grants PTDC/SAU-NEU/68465/2006, PTDC/SAU-OSM/101469/2008 and SFRH/BD/23595/2005.	Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056; Akama KT, 2000, J BIOL CHEM, V275, P7918, DOI 10.1074/jbc.275.11.7918; Allan SM, 2004, METH MOLEC MED, V104, P333; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; AREND WP, 1990, J CLIN INVEST, V85, P1694, DOI 10.1172/JCI114622; Bal-Price A, 2001, J NEUROSCI, V21, P6480; BALL HJ, 1995, J BIOL CHEM, V270, P27272, DOI 10.1074/jbc.270.45.27272; Bedoui S, 2004, TRENDS IMMUNOL, V25, P508, DOI 10.1016/j.it.2004.08.005; Bedoui S, 2003, J NEUROIMMUNOL, V134, P1, DOI 10.1016/S0165-5728(02)00424-1; Bedoui S, 2003, J IMMUNOL, V171, P3451, DOI 10.4049/jimmunol.171.7.3451; Bedoui S, 2007, PEPTIDES, V28, P373, DOI 10.1016/j.peptides.2006.07.029; Bernardino L, 2005, J NEUROSCI, V25, P6734, DOI 10.1523/JNEUROSCI.1510-05.2005; Bernardino Lifiana, 2007, P3; Bernardino L, 2008, J NEUROCHEM, V106, P271, DOI 10.1111/j.1471-4159.2008.05387.x; Bianco F, 2006, J NEUROCHEM, V99, P745, DOI 10.1111/j.1471-4159.2006.04101.x; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brakch N, 2002, J NEUROCHEM, V81, P1166, DOI 10.1046/j.1471-4159.2002.00919.x; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Cervin A, 1999, AM J RESP CRIT CARE, V160, P1724, DOI 10.1164/ajrccm.160.5.9902102; Choi J, 2008, YONSEI MED J, V49, P1, DOI 10.3349/ymj.2008.49.1.1; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; De la Fuente M, 2001, J NEUROIMMUNOL, V116, P156, DOI 10.1016/S0165-5728(01)00297-1; DEQUIDT ME, 1986, NEUROSCIENCE, V18, P527, DOI 10.1016/0306-4522(86)90056-4; DEQUIDT ME, 1986, NEUROSCIENCE, V18, P545, DOI 10.1016/0306-4522(86)90057-6; Dimayuga FO, 2007, J NEUROIMMUNOL, V182, P89, DOI 10.1016/j.jneuroim.2006.10.003; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Ferrari D, 1997, J IMMUNOL, V159, P1451; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI DOI 10.1002/CBER.187901201117; GRIFFITHS RJ, 1995, J IMMUNOL, V154, P2821; Hagberg H, 2005, CURR OPIN NEUROL, V18, P117, DOI 10.1097/01.wco.0000162851.44897.8f; Hassani H, 2005, AM J PHYSIOL-GASTR L, V288, pG550, DOI 10.1152/ajpgi.00182.2004; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; Hernanz A, 2003, REGUL PEPTIDES, V115, P19, DOI 10.1016/S0167-0115(03)00127-7; Howell OW, 2003, J NEUROCHEM, V86, P646, DOI 10.1046/j.1471-4159.2003.01895.x; Hu SX, 1999, J NEUROSCI, V19, P6468; HUYGEN IC, 1970, ANAL CHEM, V42, P407; Inoue K, 1998, PHARMACOL RES, V38, P323, DOI 10.1006/phrs.1998.0382; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Liu B, 2002, ANN NY ACAD SCI, V962, P318, DOI 10.1111/j.1749-6632.2002.tb04077.x; Minghetti L, 2005, BRAIN RES REV, V48, P251, DOI 10.1016/j.brainresrev.2004.12.015; Mollace V, 1997, BIOCHEM BIOPH RES CO, V238, P916, DOI 10.1006/bbrc.1997.7155; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Moss DW, 2001, EUR J NEUROSCI, V13, P529, DOI 10.1046/j.1460-9568.2001.01418.x; Mukaida N, 1996, J LEUKOCYTE BIOL, V59, P145, DOI 10.1002/jlb.59.2.145; Murphy S, 1996, NEUROSCIENTIST, V2, P90, DOI 10.1177/107385849600200210; Musso R, 1997, MOL PHARMACOL, V51, P27, DOI 10.1124/mol.51.1.27; Nave H, 2004, J NEUROIMMUNOL, V155, P1, DOI 10.1016/j.jneuroim.2004.05.009; Naveilhan P, 1998, NEUROSCIENCE, V87, P289, DOI 10.1016/S0306-4522(98)00141-9; Ohtani Y, 2000, NEUROSCI LETT, V293, P72, DOI 10.1016/S0304-3940(00)01478-6; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PETITTO JM, 1994, J NEUROIMMUNOL, V54, P81, DOI 10.1016/0165-5728(94)90234-8; Pinheiro PS, 2005, NEUROCHEM INT, V47, P309, DOI 10.1016/j.neuint.2005.05.007; Pinteaux E, 2009, CYTOKINE, V45, P1, DOI 10.1016/j.cyto.2008.10.008; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Saha RN, 2006, ANTIOXID REDOX SIGN, V8, P929, DOI 10.1089/ars.2006.8.929; Santos AE, 2001, J NEUROSCI RES, V66, P643, DOI 10.1002/jnr.10036; Schroeder RA, 1999, AM J PHYSIOL-CELL PH, V277, pC523, DOI 10.1152/ajpcell.1999.277.3.C523; Silva AP, 2003, FASEB J, V17, P1118, DOI 10.1096/fj.02-0885fje; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Teixeira L, 2009, J CELL BIOCHEM, V107, P908, DOI 10.1002/jcb.22194; Teng XW, 2002, AM J PHYSIOL-CELL PH, V282, pC144, DOI 10.1152/ajpcell.2002.282.1.C144; Thorsell A, 2002, NEUROPEPTIDES, V36, P182, DOI 10.1054/npep.2002.0897; Turrin NP, 2006, MOL NEUROBIOL, V34, P221, DOI 10.1385/MN:34:3:221; Vetvicka V, 1999, CLIN EXP IMMUNOL, V115, P229, DOI 10.1046/j.1365-2249.1999.00800.x; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Watterson DM, 2001, NEUROCHEM INT, V39, P459, DOI 10.1016/S0197-0186(01)00053-5; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Wheway J, 2007, PEPTIDES, V28, P453, DOI 10.1016/j.peptides.2006.09.030; Xapelli S, 2008, EUR J NEUROSCI, V27, P2089, DOI 10.1111/j.1460-9568.2008.06172.x	77	89	92	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41921	41934		10.1074/jbc.M110.164020	http://dx.doi.org/10.1074/jbc.M110.164020			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959451	Green Published, hybrid			2022-12-25	WOS:000285622600079
J	Greene, MW; Burrington, CM; Ruhoff, MS; Johnson, AK; Chongkrairatanakul, T; Kangwanpornsiri, A				Greene, Michael W.; Burrington, Christine M.; Ruhoff, Mary S.; Johnson, Andrew K.; Chongkrairatanakul, Tepsiri; Kangwanpornsiri, Atipon			PKC delta Is Activated in a Dietary Model of Steatohepatitis and Regulates Endoplasmic Reticulum Stress and Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FATTY LIVER-DISEASE; HEPATIC INSULIN-RESISTANCE; CHOLINE-DEFICIENT DIET; NONALCOHOLIC STEATOHEPATITIS; CHEMICAL CHAPERONES; ER STRESS; PHOSPHATIDYLINOSITOL 3-KINASE; RAT HEPATOCYTES; METHIONINE	Hepatic steatosis can progress to the clinical condition of non-alcoholic steatohepatitis (NASH), which is a precursor of more serious liver diseases. The novel PKC isoforms delta and epsilon are activated by lipid metabolites and have been implicated in lipid-induced hepatic disease. Using a methionine-and choline- deficient (MCD) dietary model of NASH, we addressed the question of whether hepatic PKC delta and PKC epsilon are activated. With progression from steatosis to steatohepatitis, there was activation and increased PKC delta protein content coincident with hepatic endoplasmic reticulum (ER) stress parameters. To examine whether similar changes could be induced in vitro, McA-RH 7777 (McA) hepatoma cells were used. We observed that McA cells stored triglyceride and released alanine aminotransferase (ALT) when treated with MCD medium in the presence of fatty acids. Further, MCD medium with palmitic acid, but not oleic or linoleic acids, maximally activated PKC delta and stimulated ER stress. In PKC delta knockdown McA cells, MCD/fatty acid medium-induced ALT release and ER stress induction were completely blocked, but triglyceride storage was not. In addition, a reduction in the uptake of propidium iodide and the number of apoptotic nuclei and a significant increase in cell viability and DNA content were observed in PKC delta knockdown McA cells incubated in MCD medium with palmitic acid. Our studies show that PKC delta activation and protein levels are elevated in an animal model of steatohepatitis, which was recapitulated in a cell model, supporting the conclusion that PKC delta plays a role in ALT release, the ER stress signal, and cell death.	[Greene, Michael W.] Bassett Res Inst, Cooperstown, NY 13326 USA; [Chongkrairatanakul, Tepsiri; Kangwanpornsiri, Atipon] Bassett Healthcare Network, Dept Internal Med, Bassett Med Ctr, Cooperstown, NY 13326 USA		Greene, MW (corresponding author), Bassett Res Inst, 1 Atwell Rd, Cooperstown, NY 13326 USA.	michael.greene@bassett.org	Greene, Michael/L-6174-2019	Greene, Michael/0000-0002-6443-8269	Stephen C.Clark Fund; E.Donnall Thomas Resident Research Fund	Stephen C.Clark Fund; E.Donnall Thomas Resident Research Fund	This work was supported by the Stephen C.Clark Fund (to M. W. G.) and the E.Donnall Thomas Resident Research Fund (to A. K. and T. C.).	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Chang YC, 2010, BIOCHEMISTRY-US, V49, P5086, DOI 10.1021/bi100222h; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Frangioudakis G, 2009, DIABETOLOGIA, V52, P2616, DOI 10.1007/s00125-009-1543-0; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Greene MW, 2006, BIOCHEM BIOPH RES CO, V349, P976, DOI 10.1016/j.bbrc.2006.08.158; Greene MW, 2010, CELL SIGNAL, V22, P274, DOI 10.1016/j.cellsig.2009.09.029; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Hansson PK, 2004, BBA-MOL CELL BIOL L, V1684, P54, DOI 10.1016/j.bbalip.2004.06.005; Henkel AS, 2009, J BIOL CHEM, V284, P31807, DOI 10.1074/jbc.M109.017970; Itani S, 2002, DIABETES, V51, pA300; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kirsch R, 2003, J GASTROEN HEPATOL, V18, P1272, DOI 10.1046/j.1440-1746.2003.03198.x; Kohli R, 2007, J BIOL CHEM, V282, P21327, DOI 10.1074/jbc.M701759200; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lin SL, 2009, PROTEIN SCI, V18, P526, DOI 10.1002/pro.52; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohmori S, 1998, MOL CELL BIOL, V18, P5263, DOI 10.1128/MCB.18.9.5263; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; Pickens MK, 2009, J LIPID RES, V50, P2072, DOI 10.1194/jlr.M900022-JLR200; Qi X, 2007, J MOL CELL CARDIOL, V43, P420, DOI 10.1016/j.yjmcc.2007.07.061; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sahai A, 2006, AM J PHYSIOL-GASTR L, V291, pG55, DOI 10.1152/ajpgi.00360.2005; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; Shepshelovich J, 2005, J CELL SCI, V118, P1577, DOI 10.1242/jcs.02294; Shin OH, 1997, J CELL BIOCHEM, V64, P196, DOI 10.1002/(SICI)1097-4644(199702)64:2<196::AID-JCB3>3.0.CO;2-S; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Su QZ, 2009, HEPATOLOGY, V50, P77, DOI 10.1002/hep.22960; SVEDBERG J, 1990, DIABETES, V39, P570, DOI 10.2337/diabetes.39.5.570; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; Wei Y, 2007, MOL CELL BIOCHEM, V303, P105, DOI 10.1007/s11010-007-9461-2; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wei YR, 2009, MOL CELL BIOCHEM, V331, P31, DOI 10.1007/s11010-009-0142-1; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yen CLE, 2002, J NUTR, V132, P1840, DOI 10.1093/jn/132.7.1840	55	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42115	42129		10.1074/jbc.M110.168575	http://dx.doi.org/10.1074/jbc.M110.168575			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20971848	Green Published, hybrid			2022-12-25	WOS:000285622600096
J	Zhou, Q; Fan, JJ; Ding, XB; Peng, WX; Yu, XQ; Chen, YQ; Nie, J				Zhou, Qin; Fan, Jinjin; Ding, Xuebing; Peng, Wenxing; Yu, Xueqing; Chen, Yueqin; Nie, Jing			TGF-beta-induced MiR-491-5p Expression Promotes Par-3 Degradation in Rat Proximal Tubular Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL TRANSITION; TIGHT JUNCTIONS; MICRORNAS; INHIBITION; MECHANISM; FIBROSIS; POLARITY; RNA; MICROARRAY	Par-3 is a component of Par complex, which is critical for the integrity of tight junction. We previously reported that TGF-beta down-regulated Par-3 expression in rat proximal tubular epithelial cells, but the underlying mechanism remains unknown. In the present study, we demonstrated by a luciferase reporter assay that miR-491-5p down-regulated the luciferase activity through a binding site in the 3' UTR of Par-3. Overexpression of miR-491-5p dramatically decreased the expression of endogenous Par-3, disrupted tight junction, and resulted in decreased transepithelial resistance. Moreover, miR-491-5p expression was induced by TGF-beta 1 through the MEK/p38 MAPK pathway. Importantly, miR-491-5p levels were increased significantly in a rat model of obstructive nephropathy, in parallel with decreased Par-3 levels. Taken together, we conclude that up-regulation of miR-491-5p contributes to TGF-beta-regulated Par-3 expression. Our study uncovered a novel mechanism by which TGF-beta disrupts cell junction.	Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510080, Guangdong, Peoples R China; [Chen, Yueqin] Sun Yat Sen Univ, State Key Lab Biocontrol, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Nie, J (corresponding author), Zhongshan 2nd Rd 58, Guangzhou 510080, Guangdong, Peoples R China.	niejing@mail.sysu.edu.cn		Zhou, Qin/0000-0002-7205-082X	National Science Foundation of China [30871033]; Natural Science Foundation of Guangdong province [8251008901000014]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This work was supported by National Science Foundation of China Grant 30871033 and Natural Science Foundation of Guangdong province Grant 8251008901000014.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brock P, 1999, CYTOMETRY, V35, P353, DOI 10.1002/(SICI)1097-0320(19990401)35:4<353::AID-CYTO8>3.0.CO;2-M; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; Iden S, 2006, EMBO REP, V7, P1239, DOI 10.1038/sj.embor.7400819; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kojima R, 2010, J IMMUNOL, V184, P5253, DOI 10.4049/jimmunol.0901298; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; NAKANO H, 2009, INT J CANCER, V27, P1072; Ooshio' T, 2007, J CELL SCI, V120, P2352, DOI 10.1242/jcs.03470; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vidyasagar A, 2008, AM J PHYSIOL-RENAL, V295, pF707, DOI 10.1152/ajprenal.90240.2008; Wang XY, 2008, BBA-MOL BASIS DIS, V1782, P51, DOI 10.1016/j.bbadis.2007.11.002; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhu FX, 2010, AM J PATHOL, V176, P650, DOI 10.2353/ajpath.2010.090447	36	46	50	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40019	40027		10.1074/jbc.M110.141341	http://dx.doi.org/10.1074/jbc.M110.141341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20966078	hybrid, Green Published			2022-12-25	WOS:000285185500047
J	Pereira, CP; Bachli, EB; Schaer, DJ; Schoedon, G				Pereira, Claudia P.; Bachli, Esther B.; Schaer, Dominik J.; Schoedon, Gabriele			Transcriptome Analysis Revealed Unique Genes as Targets for the Anti-inflammatory Action of Activated Protein C in Human Macrophages	PLOS ONE			English	Article							FACTOR-KAPPA-B; SELENOPROTEIN-P EXPRESSION; HUMAN ENDOTHELIAL-CELLS; ALPHA PRODUCTION; HUMAN MONOCYTES; SEVERE SEPSIS; ANTICOAGULANT; INFLAMMATION; ACETYLATION; RECRUITMENT	Background: Activated protein C (APC) has been introduced as a therapeutic agent for treatment of patients with severe sepsis due to its unique anticoagulant and anti-inflammatory properties in the vascular system. In this study we investigated novel targets for the anti-inflammatory action of APC in human macrophages. Methods: Using a genome-wide approach, effects of APC on the expression profile in inflammatory activated human macrophages were analyzed. Results: We identified, for the first time, genes that are specifically regulated by APC under inflammatory conditions, such as chromatin binding protein 4B (CHMP4B) and p300/CBP-associated factor (PCAF), thus indicating a role of APC in the epigenetic control of gene transcription. A functional assay showed the influence of APC in the acetyltransferase/deacetylase activity of nuclear extracts from inflamed macrophages. Conclusion: Our data sheds new light on APC targets in inflammation and opens new lines of investigation that may be explored in order to further elucidate its unique molecule properties.	[Pereira, Claudia P.; Schaer, Dominik J.; Schoedon, Gabriele] Univ Zurich Hosp, Div Internal Med, Inflammat Res Unit, CH-8091 Zurich, Switzerland; [Pereira, Claudia P.; Schaer, Dominik J.; Schoedon, Gabriele] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Bachli, Esther B.] Uster Hosp, Med Clin, Uster, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Pereira, CP (corresponding author), Univ Zurich Hosp, Div Internal Med, Inflammat Res Unit, CH-8091 Zurich, Switzerland.	klinsog@usz.unizh.ch		Schaer, Dominik J./0000-0002-6468-4013				Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Akamatsu M, 1999, J BIOL CHEM, V274, P35933, DOI 10.1074/jbc.274.50.35933; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; Brown K M, 2001, Public Health Nutr, V4, P593; Cavaillon JM, 2005, CRIT CARE MED, V33, pS506, DOI 10.1097/01.CCM.0000185502.21012.37; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; Cillo C, 2001, J CELL PHYSIOL, V188, P161, DOI 10.1002/jcp.1115; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dreher I, 1997, J BIOL CHEM, V272, P29364, DOI 10.1074/jbc.272.46.29364; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Franscini N, 2004, CIRCULATION, V110, P2903, DOI 10.1161/01.CIR.0000146344.49689.BB; Gabellini D, 2003, EMBO J, V22, P3715, DOI 10.1093/emboj/cdg340; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Keslacy S, 2007, MOL PHARMACOL, V71, P609, DOI 10.1124/mol.106.030171; Kipling D, 1997, TRENDS GENET, V13, P141, DOI 10.1016/S0168-9525(97)01098-6; Lee J.H., 2006, RES J MICROBIOL, V1, P1, DOI DOI 10.1007/S00418-006-0143-Z; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Marino F, 2010, J BIOL CHEM, V285, P19145, DOI 10.1074/jbc.M110.119875; Martens N, 2004, EXP CELL RES, V298, P239, DOI 10.1016/j.yexcr.2004.04.002; MICHAELY P, 1993, J BIOL CHEM, V268, P22703; Mostert V, 2001, BIOFACTORS, V14, P135, DOI 10.1002/biof.5520140118; PEREIRA C, 2007, J THROMB HAEMOST, V5; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712; Rezaie AR, 2010, CURR MED CHEM, V17, P2059, DOI 10.2174/092986710791233706; Schmeck B, 2008, J IMMUNOL, V181, P940, DOI 10.4049/jimmunol.181.2.940; Schmeck B, 2008, CIRC RES, V102, P888, DOI 10.1161/CIRCRESAHA.107.161307; Stephenson DA, 2006, J IMMUNOL, V177, P2115, DOI 10.4049/jimmunol.177.4.2115; Toltl LJ, 2008, THROMB HAEMOSTASIS, V100, P582, DOI 10.1160/TH08-03-0159; Vincent JL, 2005, CRIT CARE MED, V33, P2266, DOI 10.1097/01.CCM.0000181729.46010.83; Weiler H, 2010, CRIT CARE MED, V38, pS18, DOI 10.1097/CCM.0b013e3181c9cbb5; White B, 2000, BRIT J HAEMATOL, V110, P130, DOI 10.1046/j.1365-2141.2000.02128.x; Yuksel M, 2002, THROMB HAEMOSTASIS, V88, P267	40	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e15352	10.1371/journal.pone.0015352	http://dx.doi.org/10.1371/journal.pone.0015352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976180	Green Submitted, Green Published, gold			2022-12-25	WOS:000283043700031
J	Fathallah-Shaykh, HM				Fathallah-Shaykh, Hassan M.			Dynamics of the Drosophila Circadian Clock: Theoretical Anti-Jitter Network and Controlled Chaos	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSOR; MATHEMATICAL-MODEL; LYAPUNOV EXPONENTS; TIM; OSCILLATIONS; REGULATORS; TIMELESS; HOMOLOG; PERIOD; LOOP	Background: Electronic clocks exhibit undesirable jitter or time variations in periodic signals. The circadian clocks of humans, some animals, and plants consist of oscillating molecular networks with peak-to-peak time of approximately 24 hours. Clockwork orange (CWO) is a transcriptional repressor of Drosophila direct target genes. Methodology/Principal Findings: Theory and data from a model of the Drosophila circadian clock support the idea that CWO controls anti-jitter negative circuits that stabilize peak-to-peak time in light-dark cycles (LD). The orbit is confined to chaotic attractors in both LD and dark cycles and is almost periodic in LD; furthermore, CWO diminishes the Euclidean dimension of the chaotic attractor in LD. Light resets the clock each day by restricting each molecular peak to the proximity of a prescribed time. Conclusions/Significance: The theoretical results suggest that chaos plays a central role in the dynamics of the Drosophila circadian clock and that a single molecule, CWO, may sense jitter and repress it by its negative loops.	[Fathallah-Shaykh, Hassan M.] Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama, Dept Math, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama, Dept Biomed & Mech Engn, Birmingham, AL USA; [Fathallah-Shaykh, Hassan M.] UAB Comprehens Neurosci & Canc Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fathallah-Shaykh, HM (corresponding author), Univ Alabama, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA.	hfathall@uab.edu		Fathallah-Shaykh, Hassan/0000-0002-2690-7685				Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DICCI L, 1995, APPL NUMER MATH, V17, P275; Dieci L, 1997, SIAM J NUMER ANAL, V34, P402, DOI 10.1137/S0036142993247311; Fathallah-Shaykh HM, 2009, BIOPHYS J, V97, P2399, DOI 10.1016/j.bpj.2009.08.018; GEIST K, 1990, PROG THEOR PHYS, V83, P875, DOI 10.1143/PTP.83.875; GOLDBERGER AL, 1992, IEEE ENG MED BIOL, V11, P47, DOI 10.1109/51.139036; Goldbeter A, 2001, CHAOS, V11, P247, DOI 10.1063/1.1345727; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Leloup JC, 1999, J THEOR BIOL, V198, P445, DOI 10.1006/jtbi.1999.0924; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Tsumoto K, 2006, J THEOR BIOL, V239, P101, DOI 10.1016/j.jtbi.2005.07.017	17	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e11207	10.1371/journal.pone.0011207	http://dx.doi.org/10.1371/journal.pone.0011207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967246	gold, Green Submitted, Green Published			2022-12-25	WOS:000282869800001
J	Lines, ER; Coomes, DA; Purves, DW				Lines, Emily R.; Coomes, David A.; Purves, Drew W.			Influences of Forest Structure, Climate and Species Composition on Tree Mortality across the Eastern US	PLOS ONE			English	Article							INTERSPECIFIC VARIATION; SIZE DISTRIBUTIONS; METABOLIC ECOLOGY; GROWTH; RESPONSES; MODELS; VARIABILITY; INCREASE; DYNAMICS; SURVIVAL	Few studies have quantified regional variation in tree mortality, or explored whether species compositional changes or within-species variation are responsible for regional patterns, despite the fact that mortality has direct effects on the dynamics of woody biomass, species composition, stand structure, wood production and forest response to climate change. Using Bayesian analysis of over 430,000 tree records from a large eastern US forest database we characterised tree mortality as a function of climate, soils, species and size (stem diameter). We found (1) mortality is U-shaped vs. stem diameter for all 21 species examined; (2) mortality is hump-shaped vs. plot basal area for most species; (3) geographical variation in mortality is substantial, and correlated with several environmental factors; and (4) individual species vary substantially from the combined average in the nature and magnitude of their mortality responses to environmental variation. Regional variation in mortality is therefore the product of variation in species composition combined with highly varied mortality-environment correlations within species. The results imply that variation in mortality is a crucial part of variation in the forest carbon cycle, such that including this variation in models of the global carbon cycle could significantly narrow uncertainty in climate change predictions.	[Lines, Emily R.; Coomes, David A.] Univ Cambridge, Forest Conservat & Ecol Grp, Dept Plant Sci, Cambridge, England; [Purves, Drew W.] Microsoft Res Cambridge, Cambridge, England	University of Cambridge; Microsoft	Lines, ER (corresponding author), Univ Cambridge, Forest Conservat & Ecol Grp, Dept Plant Sci, Cambridge, England.	Emily.Lines@plantsci.cam.ac.uk	Lines, Emily/B-4646-2013; Coomes, David/H-5630-2011	Coomes, David/0000-0002-8261-2582; Lines, Emily/0000-0002-5357-8741	Microsoft Research	Microsoft Research(Microsoft)	Emily Lines was supported by a Microsoft Research studentship awarded to Cambridge University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Batista WB, 2003, J ECOL, V91, P197, DOI 10.1046/j.1365-2745.2003.00754.x; Bonan GB, 2003, GLOBAL CHANGE BIOL, V9, P1543, DOI 10.1046/j.1365-2486.2003.00681.x; BUCHMAN RG, 1983, CAN J FOREST RES, V13, P601, DOI 10.1139/x83-087; Burgi M, 2000, J BIOGEOGR, V27, P1123, DOI 10.1046/j.1365-2699.2000.00484.x; BUSING RT, 1994, FOREST ECOL MANAG, V64, P41, DOI 10.1016/0378-1127(94)90125-2; Caspersen JP, 2001, OIKOS, V92, P160, DOI 10.1034/j.1600-0706.2001.920119.x; Chao KJ, 2008, J ECOL, V96, P281, DOI 10.1111/j.1365-2745.2007.01343.x; Chen HYH, 1998, FOREST ECOL MANAG, V106, P169, DOI 10.1016/S0378-1127(97)00309-5; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; de Graaf NR, 1999, FOREST ECOL MANAG, V124, P123, DOI 10.1016/S0378-1127(99)00057-2; *FIA DB, 2008, FIA DAT US GUID V4 0; FOSTER DR, 1988, J ECOL, V76, P105, DOI 10.2307/2260457; Fuller TL, 1998, ECOSYSTEMS, V1, P76; Esteban LG, 2010, TREES-STRUCT FUNCT, V24, P19, DOI 10.1007/s00468-009-0375-3; Gelman A., 1996, BAYESIAN STAT, V5, P599; Gelman A., 2004, BAYESIAN DATA ANAL; Gomez-Aparicio L, 2008, OIKOS, V117, P1683, DOI 10.1111/j.1600-0706.2008.16814.x; Gratzer G, 2004, CAN J FOREST RES, V34, P1093, DOI [10.1139/x03-281, 10.1139/X03-281]; Hanson PJ, 2001, TREE PHYSIOL, V21, P345, DOI 10.1093/treephys/21.6.345; He HS, 1999, ECOL MODEL, V114, P213, DOI 10.1016/S0304-3800(98)00147-1; Hilborn Ray, 1997, V28; Ibanez I, 2007, ECOL MONOGR, V77, P163, DOI 10.1890/06-1097; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; JOYCE LA, 1995, PRODUCTIVITY AM FORE; KITTEL T, 1995, J BIOGEOGR, V22, P867; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; Kobe RK, 1999, ECOLOGY, V80, P187, DOI 10.1890/0012-9658(1999)080[0187:LGPATT]2.0.CO;2; Kronfuss H, 1999, PHYTON-ANN REI BOT A, V39, P99; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; LIU Y, 1993, AM MIDL NAT, V129, P19, DOI 10.2307/2426431; Loehle C, 1998, J BIOGEOGR, V25, P735, DOI 10.1046/j.1365-2699.1998.2540735.x; Lovett GM, 2006, BIOSCIENCE, V56, P395, DOI 10.1641/0006-3568(2006)056[0395:FERTEP]2.0.CO;2; Matala J, 2005, ECOL MODEL, V181, P173, DOI 10.1016/j.ecolmodel.2004.06.030; McMahon SM, 2010, P NATL ACAD SCI USA, V107, P3611, DOI 10.1073/pnas.0912376107; Miao SL, 2009, AM NAT, V173, P113, DOI 10.1086/593307; MITCHELL K J, 1969, Yale University School of Forestry Bulletin, P1; Monserud RA, 1999, FOREST ECOL MANAG, V113, P109, DOI 10.1016/S0378-1127(98)00419-8; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Motzkin G, 1999, J VEG SCI, V10, P903, DOI 10.2307/3237315; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; PACALA SW, 1994, CAN J FOREST RES, V24, P2172, DOI 10.1139/x94-280; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; Purves DW, 2009, P R SOC B, V276, P1477, DOI 10.1098/rspb.2008.1241; Purves DW, 2004, GLOBAL CHANGE BIOL, V10, P1737, DOI 10.1111/j.1365-2486.2004.00844.x; Rhemtulla JM, 2009, P NATL ACAD SCI USA, V106, P6082, DOI 10.1073/pnas.0810076106; Rizzo DM, 2003, FRONT ECOL ENVIRON, V1, P197, DOI 10.1890/1540-9295(2003)001[0197:SODECA]2.0.CO;2; Rolland C., 1993, Tree-Ring Bulletin, V53, P1; RUSSELL EWB, 1993, J ECOL, V81, P647, DOI 10.2307/2261663; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Smith WB, 2002, ENVIRON POLLUT, V116, pS233, DOI 10.1016/S0269-7491(01)00255-X; Taylor SL, 2007, FOREST ECOL MANAG, V253, P188, DOI 10.1016/j.foreco.2007.07.016; Umeki K, 2002, ECOL RES, V17, P575, DOI 10.1046/j.1440-1703.2002.00516.x; Vaganov EA, 2009, OECOLOGIA, V161, P729, DOI 10.1007/s00442-009-1421-y; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Villela DM, 2006, J BIOGEOGR, V33, P506, DOI 10.1111/j.1365-2699.2005.01453.x; Welker SL, 2008, FOREST SCI, V54, P8; Wunder J, 2006, ECOL MODEL, V197, P196, DOI 10.1016/j.ecolmodel.2006.02.037; Wyckoff PH, 2002, J ECOL, V90, P604, DOI 10.1046/j.1365-2745.2002.00691.x; Yang YQ, 2003, ECOL MODEL, V163, P209, DOI 10.1016/S0304-3800(03)00008-5	66	115	117	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13212	10.1371/journal.pone.0013212	http://dx.doi.org/10.1371/journal.pone.0013212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967250	Green Published, Green Submitted, gold			2022-12-25	WOS:000282869800006
J	Zhukovsky, MA; Basmaciogullari, S; Pacheco, B; Wang, LP; Madani, N; Haim, H; Sodroski, J				Zhukovsky, Mikhail A.; Basmaciogullari, Stephane; Pacheco, Beatriz; Wang, Liping; Madani, Navid; Haim, Hillel; Sodroski, Joseph			Thermal Stability of the Human Immunodeficiency Virus Type 1 (HIV-1) Receptors, CD4 and CXCR4, Reconstituted in Proteoliposomes	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CHEMOKINE RECEPTOR; MEMBRANE-VESICLES; CRYSTAL-STRUCTURE; SMALL-MOLECULE; FUNCTIONAL-ANALYSIS; IMMUNOGLOBULIN-G; MEDIATED FUSION; TYROSINE KINASE; CELLS	Background: The entry of human immunodeficiency virus (HIV-1) into host cells involves the interaction of the viral exterior envelope glycoprotein, gp120, and receptors on the target cell. The HIV-1 receptors are CD4 and one of two chemokine receptors, CCR5 or CXCR4. Methodology/Principal Findings: We created proteoliposomes that contain CD4, the primary HIV-1 receptor, and one of the coreceptors, CXCR4. Antibodies against CD4 and CXCR4 specifically bound the proteoliposomes. CXCL12, the natural ligand for CXCR4, and the small-molecule CXCR4 antagonist, AMD3100, bound the proteoliposomes with affinities close to those associated with the binding of these molecules to cells expressing CXCR4 and CD4. The HIV-1 gp120 exterior envelope glycoprotein bound tightly to proteoliposomes expressing only CD4 and, in the presence of soluble CD4, bound weakly to proteoliposomes expressing only CXCR4. The thermal stability of CD4 and CXCR4 inserted into liposomes was examined. Thermal denaturation of CXCR4 followed second-order kinetics, with an activation energy (E-a) of 269 kJ/mol (64.3 kcal/mol) and an inactivation temperature (T-i) of 56 degrees C. Thermal inactivation of CD4 exhibited a reaction order of 1.3, an E-a of 278 kJ/mol (66.5 kcal/mol), and a T-i of 52.2 degrees C. The second-order denaturation kinetics of CXCR4 is unusual among G protein-coupled receptors, and may result from dimeric interactions between CXCR4 molecules. Conclusions/Significance: Our studies with proteoliposomes containing the native HIV-1 receptors allowed an examination of the binding of biologically important ligands and revealed the higher-order denaturation kinetics of these receptors. CD4/CXCR4-proteoliposomes may be useful for the study of virus-target cell interactions and for the identification of inhibitors.	[Zhukovsky, Mikhail A.; Basmaciogullari, Stephane; Pacheco, Beatriz; Wang, Liping; Madani, Navid; Haim, Hillel; Sodroski, Joseph] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS,Dept Pathol,Div AIDS, Boston, MA 02115 USA; [Zhukovsky, Mikhail A.] Max Planck Inst Biophys Chem, Dept Struct Dynam Biochem Syst, D-37077 Gottingen, Germany; [Sodroski, Joseph] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Max Planck Society; Harvard University; Harvard T.H. Chan School of Public Health	Zhukovsky, MA (corresponding author), Univ Saarland, Chair Biol Expt Phys, D-6600 Saarbrucken, Germany.	joseph_sodroski@dfci.harvard.edu	Pacheco, Beatriz/Y-5100-2019; Zhukovskiy, Mikhail/Q-5386-2018	Pacheco, Beatriz/0000-0003-0057-1973; Haim, Hillel/0000-0002-6071-5089	National Institutes of Health [AI24755, AI42848]; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042848, T32AI007387, R37AI024755, R01AI024755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by two grants (AI24755 and AI42848) from the National Institutes of Health (http://www.nih.gov), by a gift from the late William F. McCarty-Cooper, and by funds from the International AIDS Vaccine Initiative (http://www.iavi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 2007, EUR J MED RES, V12, P375; Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Aymard C, 2000, ENZYME MICROB TECH, V27, P612, DOI 10.1016/S0141-0229(00)00258-1; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Babcock GJ, 2001, J BIOL CHEM, V276, P38433, DOI 10.1074/jbc.M106229200; Bailey A, 2005, ARCH BIOCHEM BIOPHYS, V439, P211, DOI 10.1016/j.abb.2005.05.010; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Basmaciogullari S, 2006, VIROLOGY, V353, P52, DOI 10.1016/j.virol.2006.05.027; Bee MS, 2007, J BIOL CHEM, V282, P32471, DOI 10.1074/jbc.M703909200; Benitez-Cardoza CG, 2001, BIOCHEMISTRY-US, V40, P9049, DOI 10.1021/bi010528w; BERMAN AL, 1981, VISION RES, V21, P731, DOI 10.1016/0042-6989(81)90082-1; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bourgeois R, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-31; Brelot A, 1999, J VIROL, V73, P2576, DOI 10.1128/JVI.73.4.2576-2586.1999; BROUILLETTE CG, 1989, PROTEINS, V5, P38, DOI 10.1002/prot.340050106; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Byun JS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-47; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Cao JS, 2007, FOOD AGR IMMUNOL, V18, P17, DOI 10.1080/09540100701220267; Carnec X, 2005, J VIROL, V79, P1930, DOI 10.1128/JVI.79.3.1930-1933.2005; Castile JD, 1999, INT J PHARM, V188, P87, DOI 10.1016/S0378-5173(99)00207-0; Chen CC, 2000, J FOOD SCI, V65, P188, DOI 10.1111/j.1365-2621.2000.tb15977.x; Cioci F, 1998, BIOTECHNOL TECH, V12, P855, DOI 10.1023/A:1008839912640; Claeysen S, 2001, EMBO REP, V2, P61, DOI 10.1093/embo-reports/kve003; CUDD A, 1990, J ACQ IMMUN DEF SYND, V3, P109; DANNENBERG F, 1988, J FOOD SCI, V53, P258, DOI 10.1111/j.1365-2621.1988.tb10223.x; De Clercq E, 2009, BIOCHEM PHARMACOL, V77, P1655, DOI 10.1016/j.bcp.2008.12.014; Devesa F, 2002, EUR J BIOCHEM, V269, P5163, DOI 10.1046/j.1432-1033.2002.03213.x; DEVRIJ W, 1989, EUR J BIOCHEM, V178, P763; Dominguez E, 2001, J DAIRY RES, V68, P511, DOI 10.1017/S0022029901004927; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; El-Loly M. M., 2007, International Journal of Dairy Science, V2, P292; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; FLASHER D, 1994, BBA-BIOMEMBRANES, V1194, P185, DOI 10.1016/0005-2736(94)90219-4; Fotopoulos G, 2002, P NATL ACAD SCI USA, V99, P9410, DOI 10.1073/pnas.142586899; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Haque ME, 2001, BIOCHEMISTRY-US, V40, P4340, DOI 10.1021/bi002030k; HEALEY D, 1990, J EXP MED, V172, P1233, DOI 10.1084/jem.172.4.1233; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; HILL CG, 1977, INTRO CHEM ENG KINET, P24; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Hogaboam CM, 2005, PHARMACOL THERAPEUT, V107, P314, DOI 10.1016/j.pharmthera.2005.02.006; Huang ZW, 1997, BIOPOLYMERS, V43, P367, DOI 10.1002/(SICI)1097-0282(1997)43:5<367::AID-BIP3>3.0.CO;2-T; HUBBARD R, 1958, J GEN PHYSIOL, V42, P259, DOI 10.1085/jgp.42.2.259; Jacobs A, 2008, VACCINE, V26, P3026, DOI 10.1016/j.vaccine.2007.12.026; Jeremic A, 2004, CELL BIOL INT, V28, P19, DOI 10.1016/j.cellbi.2003.11.004; Juarez J, 2004, CURR PHARM DESIGN, V10, P1245, DOI 10.2174/1381612043452640; Karlsson GB, 1997, J VIROL, V71, P4218, DOI 10.1128/JVI.71.6.4218-4225.1997; KASAHARA M, 1977, J BIOL CHEM, V252, P7384; Kawai T, 2009, CURR OPIN HEMATOL, V16, P20, DOI 10.1097/MOH.0b013e32831ac557; Klasse PJ, 1999, J VIROL, V73, P7453, DOI 10.1128/JVI.73.9.7453-7466.1999; KNAPP W, 1989, LEUCOCYTE TYPING, V4; Kolena J, 2002, EXP CLIN ENDOCR DIAB, V110, P77, DOI 10.1055/s-2002-23490; Lassalle MW, 1998, BIOCHEMISTRY-US, V37, P8465, DOI 10.1021/bi9730691; Levi V, 2002, BIOPHYS J, V82, P437, DOI 10.1016/S0006-3495(02)75408-8; Liang XY, 2008, CHEM BIOL DRUG DES, V72, P97, DOI 10.1111/j.1747-0285.2008.00681.x; LICHAN E, 1995, FOOD RES INT, V28, P9, DOI 10.1016/0963-9969(95)93325-O; Lin CT, 1999, J AGR FOOD CHEM, V47, P2944, DOI 10.1021/jf981355t; LING AC, 1978, J FOOD SCI, V43, P1307, DOI 10.1111/j.1365-2621.1978.tb15295.x; Lucisano M., 1994, Italian Journal of Food Science, V6, P185; LUKASHEVA EV, 1991, BIOCHEMISTRY-MOSCOW+, V56, P738; Madani N, 2007, J VIROL, V81, P532, DOI 10.1128/JVI.01079-06; Magerus-Chatinet A, 2007, VIROLOGY, V362, P67, DOI 10.1016/j.virol.2006.11.035; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Mainer G, 1997, J FOOD SCI, V62, P1034, DOI 10.1111/j.1365-2621.1997.tb15032.x; Mastrobattista E, 2002, J BIOL CHEM, V277, P27135, DOI 10.1074/jbc.M200429200; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MENGER FM, 1995, ANGEW CHEM INT EDIT, V34, P2091, DOI 10.1002/anie.199520911; MICELI MC, 1993, ADV IMMUNOL, V53, P59, DOI 10.1016/S0065-2776(08)60498-8; Mines M, 2007, CURR MED CHEM, V14, P2456, DOI 10.2174/092986707782023686; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; Nehete PN, 2002, ANTIVIR RES, V56, P233, DOI 10.1016/S0166-3542(02)00130-4; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; PARR GR, 1976, BIOCHEMISTRY-US, V15, P857, DOI 10.1021/bi00649a020; Pollegioni L, 2003, PROTEIN SCI, V12, P1018, DOI 10.1110/ps.0234603; PURI A, 1992, J ACQ IMMUN DEF SYND, V5, P915; RAMASWAMY HS, 1989, J FOOD SCI, V54, P1322, DOI 10.1111/j.1365-2621.1989.tb05983.x; Rawat SS, 2008, MOL MEMBR BIOL, V25, P83, DOI 10.1080/09687680701613713; Rawat SS, 2006, GLYCOCONJUGATE J, V23, P189, DOI 10.1007/s10719-006-7924-4; Rawat SS, 2004, VIROLOGY, V318, P55, DOI 10.1016/j.virol.2003.08.042; RENOSTO F, 1985, J BIOL CHEM, V260, P1535; Rigaud JL, 2002, BRAZ J MED BIOL RES, V35, P753, DOI 10.1590/S0100-879X2002000700001; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Ryu EK, 2007, PROTEINS, V67, P1193, DOI 10.1002/prot.21350; SADANA A, 1988, J BIOTECHNOL, V7, P95, DOI 10.1016/0168-1656(88)90057-0; SADANA A, 1993, THERMOSTABILITY ENZY, P84; Saito K, 2003, J BIOL CHEM, V278, P14732, DOI 10.1074/jbc.M301086200; SATTENTAU QJ, 1988, AIDS, V2, P101, DOI 10.1097/00002030-198804000-00005; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Seibert C, 2004, CURR PHARM DESIGN, V10, P2041, DOI 10.2174/1381612043384312; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; SHNYROV VL, 1977, VISION RES, V17, P169, DOI 10.1016/0042-6989(77)90079-7; Simm M, 1996, J BIOL CHEM, V271, P28266, DOI 10.1074/jbc.271.45.28266; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Steffens CM, 2004, J VIROL, V78, P9573, DOI 10.1128/JVI.78.17.9573-9578.2004; Stenlund P, 2003, ANAL BIOCHEM, V316, P243, DOI 10.1016/S0003-2697(03)00046-0; STOFOROS NG, 1995, FOOD CONTROL, V6, P81, DOI 10.1016/0956-7135(95)98911-J; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Stromberg A, 2000, P NATL ACAD SCI USA, V97, P7, DOI 10.1073/pnas.97.1.7; Sudo Y, 2003, PHOTOCHEM PHOTOBIOL, V78, P511, DOI 10.1562/0031-8655(2003)078<0511:IONPPS>2.0.CO;2; Tamamura H, 2005, EXPERT OPIN THER TAR, V9, P1267, DOI 10.1517/14728222.9.6.1267; Traikia M, 2000, EUR BIOPHYS J BIOPHY, V29, P184, DOI 10.1007/s002490000077; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Van Broekhoven CL, 2001, IMMUNOL CELL BIOL, V79, P274, DOI 10.1046/j.1440-1711.2001.01010.x; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Viard M, 2003, GLYCOCONJUGATE J, V20, P213, DOI 10.1023/B:GLYC.0000024253.48791.d9; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2009, PROTEIN EXPRES PURIF, V65, P204, DOI 10.1016/j.pep.2009.01.014; Weber J, 2006, AIDS REV, V8, P60; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; ZALE SE, 1984, ANN NY ACAD SCI, V434, P20, DOI 10.1111/j.1749-6632.1984.tb29794.x; Zhukovsky MA, 2007, ARCH BIOCHEM BIOPHYS, V465, P101, DOI 10.1016/j.abb.2007.05.005	126	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13249	10.1371/journal.pone.0013249	http://dx.doi.org/10.1371/journal.pone.0013249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967243	gold, Green Published, Green Submitted			2022-12-25	WOS:000282869800008
J	Liu, J; Lluis, A; Illi, S; Layland, L; Olek, S; von Mutius, E; Schaub, B				Liu, Jing; Lluis, Anna; Illi, Sabina; Layland, Laura; Olek, Sven; von Mutius, Erika; Schaub, Bianca			T Regulatory Cells in Cord Blood-FOXP3 Demethylation as Reliable Quantitative Marker	PLOS ONE			English	Article							DNA METHYLATION ANALYSIS; FUNCTIONAL-CHARACTERIZATION; FOXP3; IMPAIRMENT; EXPRESSION; INDUCTION; ALLERGY; BLOOD	Background: Regulatory T-cells (Tregs), characterized as CD4+CD25(hi) T-cells expressing FOXP3, play a crucial role in controlling healthy immune development during early immune maturation. Recently, FOXP3 demethylation was suggested to be a novel marker for natural Tregs in adults. In cord blood, the role and function of Tregs and its demethylation is poorly understood. We assessed FOXP3 demethylation in cord blood in relation to previously used Treg markers such as CD4(+)CD25(hi), FOXP3 mRNA, protein expression, and suppressive Treg function. Methodology: Cord blood mononuclear cells (CBMC) were isolated from 70 healthy neonates, stimulated for 3 days with the microbial stimulus lipid A (LpA), and allergen Dermatophagoides pteronyssinus (Derp1). Tregs (CD4+CD25(hi), intracellular, mRNA FOXP3 expression, isolated cells), DNA methylation of the FOXP3-locus and suppressive Treg function were assessed. Principal Findings: Demethylation of FOXP3 in whole blood was specific for isolated CD4+CD25(hi) Tregs. Demethylation of FOXP3 was positively correlated with unstimulated and LpA-stimulated FOXP3 mRNA-expression (p <= 0.05), and CD4(+)CD25(hi) T-cells (p <= 0.03). Importantly, increased FOXP3 demethylation correlated with more efficient suppressive capacity of Tregs (r = 0.72, p = 0.005). Furthermore, FOXP3 demethylation was positively correlated with Th2 cytokines (IL-5, IL-13) following LpA-stimulation (p = 0.006/0.04), with Th2 and IL-17 following Derp1+LpA-stimulations (p <= 0.009), but not Th1 cytokines (IFN-gamma). Conclusions: FOXP3 demethylation reliable quantifies Tregs in cord blood. FOXP3 demethylation corresponds well with the suppressive potential of Tregs. The resulting strict correlation with functionally suppressive Tregs and the relative ease of measurement render it into a valuable novel marker for large field studies assessing Tregs as qualitative marker indicative of functional activity.	[Liu, Jing; Lluis, Anna; Illi, Sabina; von Mutius, Erika; Schaub, Bianca] Univ Munich, Univ Childrens Hosp Munich, Dept Pulm & Allergy, Munich, Germany; [Liu, Jing] Ji Lin Univ, Hosp 2, Dept Resp Med, Changchun, Peoples R China; [Layland, Laura] Tech Univ Munich, Inst Med Microbiol, Munich, Germany; [Olek, Sven] Epiontis GmbH, Berlin, Germany	University of Munich; Jilin University; Technical University of Munich; Epiontis GmbH	Liu, J (corresponding author), Univ Munich, Univ Childrens Hosp Munich, Dept Pulm & Allergy, Munich, Germany.	Bianca.Schaub@med.uni-muenchen.de	Schaub, Bianca/B-9935-2019	Schaub, Bianca/0000-0003-1652-8873; von Mutius, Erika/0000-0002-8893-4515	Bayerische Forschungsstiftung; GALTRAIN; Munich University	Bayerische Forschungsstiftung; GALTRAIN; Munich University	Bayerische Forschungsstiftung, GALTRAIN, Munich University Grant (all BS). These funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Additional funding was received through Epiontis (SO). SO is employed by Epiontis GmbH, and has supervised performance of experiments, and contributed analysis tools for these experiments.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Baecher-Allan C, 2004, SEMIN IMMUNOL, V16, P89, DOI 10.1016/j.smim.2003.12.005; Baecher-Allan C, 2002, J IMMUNOL, V169, P6210, DOI 10.4049/jimmunol.169.11.6210; Baron U, 2006, EPIGENETICS-US, V1, P55, DOI 10.4161/epi.1.1.2643; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Cao D, 2003, EUR J IMMUNOL, V33, P215, DOI 10.1002/immu.200390024; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Jartti T, 2007, J ALLERGY CLIN IMMUN, V120, P177, DOI 10.1016/j.jaci.2007.03.008; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kleinewietfeld M, 2009, BLOOD, V113, P827, DOI 10.1182/blood-2008-04-150524; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Pace L, 2006, J IMMUNOL, V176, P3900, DOI 10.4049/jimmunol.176.7.3900; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Prescott SL, 2008, ALLERGY, V63, P1481, DOI 10.1111/j.1398-9995.2008.01778.x; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Schaub B, 2008, ALLERGY, V63, P1438, DOI 10.1111/j.1398-9995.2008.01685.x; Schaub B, 2008, J ALLERGY CLIN IMMUN, V121, P1491, DOI 10.1016/j.jaci.2008.04.010; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Skapenko A, 2005, J IMMUNOL, V175, P6107, DOI 10.4049/jimmunol.175.9.6107; Smith M, 2008, J ALLERGY CLIN IMMUN, V121, P1460, DOI 10.1016/j.jaci.2008.03.025; Umetsu DT, 2006, IMMUNOL REV, V212, P238, DOI 10.1111/j.0105-2896.2006.00413.x; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929	36	42	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13267	10.1371/journal.pone.0013267	http://dx.doi.org/10.1371/journal.pone.0013267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967272	Green Published, gold, Green Submitted			2022-12-25	WOS:000282807300010
J	Dubar, G; Azria, E; Tesniere, A; Dupont, H; Le Ray, C; Baugnon, T; Matheron, S; Luton, D; Richard, JC; Launay, O; Tsatsaris, V; Goffinet, F; Mignon, A				Dubar, Gregory; Azria, Elie; Tesniere, Antoine; Dupont, Herve; Le Ray, Camille; Baugnon, Thomas; Matheron, Sophie; Luton, Dominique; Richard, Jean-Christophe; Launay, Odile; Tsatsaris, Vassilis; Goffinet, Francois; Mignon, Alexandre		French Registry 2009 A H1N1v Pregn	French Experience of 2009 A/H1N1v Influenza in Pregnant Women	PLOS ONE			English	Article							H1N1 INFLUENZA; PANDEMIC INFLUENZA; A H1N1; INFECTION; OUTCOMES	Background: The first reports on the pandemic influenza 2009 A/H1N1v from the USA, Mexico, and Australia indicated that this disease was associated with a high mortality in pregnant women. The aim of this study was to describe and compare the characteristics of severe critically ill and non-severe pregnant women with 2009 A/H1N1v-related illness in France. Methodology/Principal Findings: A national registry was created to screen pregnant women with laboratory-confirmed 2009 A/H1N1v influenza. Three hundred and fifteen patients from 46 French hospitals were included: 40 patients were admitted to intensive care units (severe outcomes), 111 were hospitalized in obstetric or medical wards (moderate outcomes), and 164 were outpatients (mild outcomes). The 2009 A/H1N1v influenza illness occurred during all pregnancy trimesters, but most women (54%), notably the severe patients (70%), were in the third trimester. Among the severe patients, twenty (50%) underwent mechanical ventilation, and eleven (28%) were treated with extracorporeal membrane oxygenation. Three women died from A/H1N1v influenza. We found a strong association between the development of a severe outcome and both coexisting illnesses (adjusted odds ratio [OR], 5.1; 95% confidence interval [CI], 2.2-11.8) and a delay in oseltamivir treatment after the onset of symptoms (. 3 or 5 days) (adjusted OR, 4.8; 95% CI, 1.9-12.1 and 61.2, 95% CI; 14.4-261.3, respectively). Among the 140 deliveries after 22 weeks of gestation known to date, 19 neonates (14%) were admitted to a neonatal intensive care unit, mainly for preterm delivery, and two neonates died. None of these neonates developed 2009 A/H1N1v infection. Conclusions: This series confirms the high incidence of complications in pregnant women infected with pandemic A/H1N1v observed in other countries but depicts a lower overall maternal and neonatal mortality and morbidity than indicated in the USA or Australia. Moreover, our data demonstrate the benefit of early oseltamivir treatment in this specific population.	[Dubar, Gregory; Tesniere, Antoine; Mignon, Alexandre] Univ Paris 05, Hop Cochin, AP HP, Dept Anesthesie Reanimat, Paris, France; [Azria, Elie] Univ Paris Diderot, Hop Bichat, AP HP, Serv Gynecol Obstet, Paris, France; [Dupont, Herve] Univ Amiens, Hop Amiens, Dept Anesthesie Reanimat, Amiens, France; [Le Ray, Camille; Tsatsaris, Vassilis; Goffinet, Francois] Univ Paris 05, Hop Cochin, AP HP, Serv Gynecol Obstet, Paris, France; [Baugnon, Thomas] Univ Paris 05, Hop Necker, AP HP, Dept Anesthesie Reanimat, Paris, France; [Matheron, Sophie] Univ Paris Diderot, Hop Bichat, AP HP, Serv Malad Infect & Trop, Paris, France; [Luton, Dominique] Univ Paris Diderot, Hop Beaujon, AP HP, Serv Gynecol Obstet, Paris, France; [Richard, Jean-Christophe] Univ Rouen, Hop Charles Nicolle, Serv Reanimat Med, Rouen, France; [Launay, Odile] Univ Paris 05, Hop Cochin, AP HP, Ctr Invest Clin Vaccinol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; Universite de Rouen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Dubar, G (corresponding author), Univ Paris 05, Hop Cochin, AP HP, Dept Anesthesie Reanimat, Paris, France.	alexandre.mignon@cch.aphp.fr	Matheron, Sophie/D-7420-2017; Dupont, Herve/D-1259-2010	Matheron, Sophie/0000-0001-7879-6553; Le Ray, Camille/0000-0003-0891-1063; GOFFINET, Francois/0000-0001-9643-0299; Azria, Elie/0000-0002-6159-6253				*CNGOF, 2009, REC PRIS CHARG GRIPP; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Greer LG, 2010, OBSTET GYNECOL, V115, P711, DOI 10.1097/AOG.0b013e3181d44752; HANSLIK T, 2010, PLOS CURR INFLUENZA; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; *INVS, 2009, MOD SURV DECL GRIPP; *INVS, 2009, B EP GRIPP A; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lim ML, 2010, BJOG-INT J OBSTET GY, V117, P551, DOI 10.1111/j.1471-0528.2010.02522.x; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; SANTE MDL, 2009, STRATEGIE NATL PRISE; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	24	66	70	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13112	10.1371/journal.pone.0013112	http://dx.doi.org/10.1371/journal.pone.0013112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957195	Green Published, Green Submitted, gold			2022-12-25	WOS:000282506100001
J	Xu, H; Zheng, L; Dai, H; Zhou, M; Hua, Y; Shen, B				Xu, H.; Zheng, L.; Dai, H.; Zhou, M.; Hua, Y.; Shen, B.			Chemical-induced cancer incidence and underlying mechanisms in Fen1 mutant mice	ONCOGENE			English	Article						FEN1; long-patch base excision repair; methylnitrosourea; tetraploidy; aneuploidy; cancer	BASE EXCISION-REPAIR; DNA-POLYMERASE-BETA; FLAP ENDONUCLEASE-1; LUNG-CANCER; HUMAN-CELLS; DAMAGE; INSTABILITY; GLYCOSYLASES; REPLICATION; STIMULATION	A critical observation in sporadic cancers is that not all individuals are equally prone to developing cancer following exposure to a given environmental carcinogen. Epidemiological studies have suggested that the difference in the timing of cancer onset in response to exogenous DNA damage is likely attributable to genetic variations, such as those associated with base excision repair (BER) genes. To test this long-standing hypothesis and elucidate how a genetic variation in the BER gene flap endonuclease 1 (FEN1) results in susceptibility to environment insults and causes cancer, we established a mutant mouse model carrying a point mutation (E160D) in Fen1. We demonstrate that the E160D mutation impairs the ability of FEN1 to process DNA intermediate structures in long-patch BER using nuclear extracts or reconstituted purified BER proteins. E160D cells were more sensitive to the base-damaging agents methylnitrosourea and hydrogen peroxide, leading to DNA strand breaks, chromosomal breakage and chromosome instabilities in response these DNA insults. We further show that E160D mice are significantly more susceptible to exposure to methylnitrosourea and develop lung adenocarcinoma. Thus, our current study demonstrates that a subtle genetic variation (E160D) in BER genes (FEN1) may cause a functional deficiency in repairing base damage, such that individuals carrying the mutation or similar mutations are predisposed to chemical-induced cancer development. Oncogene (2011) 30, 1072-1081; doi:10.1038/onc.2010.482; published online 25 October 2010	[Xu, H.; Hua, Y.; Shen, B.] Zhejiang Univ, Inst Nucl Agr Sci, Chinese Minist Agr Nucl Agr Sci, Key Lab, Hangzhou 310029, Zhejiang, Peoples R China; [Xu, H.; Zheng, L.; Dai, H.; Zhou, M.; Shen, B.] City Hope Natl Med Ctr, Dept Canc Biol, Duarte, CA 91010 USA; [Xu, H.; Zheng, L.; Dai, H.; Zhou, M.; Shen, B.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA	Zhejiang University; City of Hope; City of Hope; Beckman Research Institute of City of Hope	Shen, B (corresponding author), City Hope Natl Med Ctr, Dept Canc Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	yjhua@zju.edu.cn; bshen@coh.org		Shen, Binghui/0000-0002-4408-407X	NIH [R01 CA073764]; China Scholarship Council (CSC); NATIONAL CANCER INSTITUTE [R01CA073764] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council (CSC)(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the microscopy core facility of City of Hope for technical assistance with immunofluorescence staining of MEF cells. We thank D Finger for technical advice on purification of FEN1 proteins. We thank SR da Costa and K Walker for editorial assistance. All protocols involving animal use were approved by the research animal care committee of City of Hope National Medical Center and Beckman Research Institute in compliance with the Public Health Service Policy on Use of Laboratory Animals. This work was supported by an NIH grant R01 CA073764 to BHS and a scholarship from China Scholarship Council (CSC) to HX.	Asagoshi K, 2010, DNA REPAIR, V9, P109, DOI 10.1016/j.dnarep.2009.11.002; Balakrishnan L, 2009, J BIOL CHEM, V284, P15158, DOI 10.1074/jbc.M109.000505; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Chang JS, 2009, CARCINOGENESIS, V30, P78, DOI 10.1093/carcin/bgn261; Cistulli C, 2004, DNA REPAIR, V3, P581, DOI 10.1016/j.dnarep.2003.09.012; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Donny W, 2004, J BIOL CHEM, V279, P25268, DOI 10.1074/jbc.M400804200; Figueroa JD, 2007, HUM GENET, V121, P233, DOI 10.1007/s00439-006-0294-y; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gary R, 1999, J BIOL CHEM, V274, P4354, DOI 10.1074/jbc.274.7.4354; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guo ZG, 2009, NUCLEIC ACIDS RES, V37, P3431, DOI 10.1093/nar/gkp201; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Krokan HE, 1997, BIOCHEM J, V325, P1; Landi S, 2005, EXP LUNG RES, V31, P223, DOI 10.1080/01902140490495624; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; MING Y, 2009, HUM MUTAT, V30, P1320; Nakamura J, 1998, CANCER RES, V58, P222; Pascucci B, 2005, NUCLEIC ACIDS RES, V33, P280, DOI 10.1093/nar/gki168; Prasad R, 2005, DNA REPAIR, V4, P1347, DOI 10.1016/j.dnarep.2005.08.009; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ranalli TA, 2002, J BIOL CHEM, V277, P41715, DOI 10.1074/jbc.M207207200; Rotman G, 1998, HUM MOL GENET, V7, P1555, DOI 10.1093/hmg/7.10.1555; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; SUN B, 1995, J BIOL CHEM, V270, P19501, DOI 10.1074/jbc.270.33.19501; VAINIO H, 1994, SCAND J WORK ENV HEA, V20, P235, DOI 10.5271/sjweh.1402; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	40	21	21	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	9					1072	1081		10.1038/onc.2010.482	http://dx.doi.org/10.1038/onc.2010.482			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	729PX	20972458	Green Accepted			2022-12-25	WOS:000287964100006
J	Pardo, PS; Mohamed, JS; Lopez, MA; Boriek, AM				Pardo, Patricia S.; Mohamed, Junaith S.; Lopez, Michael A.; Boriek, Aladin M.			Induction of Sirt1 by Mechanical Stretch of Skeletal Muscle through the Early Response Factor EGR1 Triggers an Antioxidative Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; REACTIVE OXYGEN; FREE-RADICALS; EXERCISE; LONGEVITY; PROTEIN; PATHWAY; COMPLEX	Mechanical loading of muscles by intrinsic muscle activity or passive stretch leads to an increase in the production of reactive oxygen species (1, 2). The NAD-dependent protein deacetylase SIRT1 is involved in the protection against oxidative stress by enhancing FOXO-driven Sod2 transcription (3-5). In this report, we unravel a mechanism triggered by mechanical stretch of skeletal muscle cells that leads to an EGR1-dependent transcriptional activation of the Sirt1 gene. The resulting transient increase in SIRT1 expression generates an antioxidative response that contributes to reactive oxygen species scavenging.	[Pardo, Patricia S.; Mohamed, Junaith S.; Lopez, Michael A.; Boriek, Aladin M.] Baylor Coll Med, Dept Med, Div Pulm Crit Care Med & Sleep, Houston, TX 77030 USA	Baylor College of Medicine	Boriek, AM (corresponding author), 1 Baylor Plaza 825E, Houston, TX 77030 USA.	boriek@bcm.edu	Mohamed, Junaith/AAC-4050-2020; Lopez, Michael A./AAT-2145-2021	Lopez, Michael A./0000-0002-3029-0761	National Institutes of Health [HL63134]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL63134. This work was also supported by a grant from the National Science Foundation.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281; Hollander J, 2001, PFLUG ARCH EUR J PHY, V442, P426, DOI 10.1007/s004240100539; Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003; Javesghani D, 2002, AM J RESP CRIT CARE, V165, P412, DOI 10.1164/ajrccm.165.3.2103028; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P150, DOI 10.1016/0003-9861(88)90623-6; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kumar A, 2002, J BIOL CHEM, V277, P46493, DOI 10.1074/jbc.M203654200; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Marfe Gabriella, 2010, BMC Physiology, V10, P7, DOI 10.1186/1472-6793-10-7; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nethery D, 2000, J APPL PHYSIOL, V89, P72, DOI 10.1152/jappl.2000.89.1.72; Pardo PS, 2008, AM J PHYSIOL-CELL PH, V294, pC1056, DOI 10.1152/ajpcell.00270.2007; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; POWERS SK, 1994, AM J PHYSIOL, V266, pR375, DOI 10.1152/ajpregu.1994.266.2.R375; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Reid MB, 2002, ANN NY ACAD SCI, V959, P108, DOI 10.1111/j.1749-6632.2002.tb02087.x; Reid MB, 2008, FREE RADICAL BIO MED, V44, P169, DOI 10.1016/j.freeradbiomed.2007.03.002; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468	35	59	64	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2559	2566		10.1074/jbc.M110.149153	http://dx.doi.org/10.1074/jbc.M110.149153			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	20971845	Green Published, hybrid			2022-12-25	WOS:000286464300021
J	Thompson, D; Whistler, JL				Thompson, Dawn; Whistler, Jennifer L.			Dopamine D-3 Receptors Are Down-regulated following Heterologous Endocytosis by a Specific Interaction with G Protein-coupled Receptor-associated Sorting Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C; D2 RECEPTORS; DIFFERENTIAL REGULATION; BINDING; TRAFFICKING; PHOSPHORYLATION; DESENSITIZATION; SCHIZOPHRENIA; TOLERANCE; DISEASE	The D-3 dopamine receptor is endocytosed through a heterologous mechanism mediated by phorbol esters. Here, we show that following this endocytosis the D-3 dopamine receptors fail to recycle and are instead targeted for degradation through an interaction with the G protein-coupled receptor (GPCR)-associated sorting protein-1 (GASP-1). Furthermore, we identified a specific binding motif in the C terminus common to the D-3 and D-2 that confers GASP-1 binding. shRNA knockdown of GASP-1 delayed post-endocytic degradation of both the D-2 and D-3 dopamine receptors. In addition, mutation of the D-2 and D-3 receptor C termini to resemble the D-4, which does not interact with GASP-1, not only inhibited GASP-1 binding but slowed degradation after endocytosis. Conversely, mutation of the C terminus of the D-4 to resemble that of the D-2 and D-3 facilitated GASP-1 binding and promoted post-endocytic degradation of the mutant D-4 receptor. Thus, we have identified a motif that is both necessary and sufficient to promote GASP-1 binding and receptor degradation. In addition, these data demonstrated that GASP-1 can mediate post-endocytic degradation of dopamine receptors that have been endocytosed not only as a consequence of dopamine activation but also as a consequence of activation by phorbol esters.	[Thompson, Dawn; Whistler, Jennifer L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [Whistler, Jennifer L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	Whistler, JL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, 5858 Horton St,Ste 200, Emeryville, CA 94608 USA.	jwhistler@gallo.ucsf.edu			National Institutes of Health [R01MH068442]; State of California for medical research on alcohol and substance abuse through the University of California, San Francisco; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R01MH068442. This work was also supported by funds provided by the State of California for medical research on alcohol and substance abuse through the University of California, San Francisco (to J.L.W.).	Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Boileau I, 2009, BRAIN, V132, P1366, DOI 10.1093/brain/awn337; Cho DI, 2006, BIOCHEM BIOPH RES CO, V350, P634, DOI 10.1016/j.bbrc.2006.09.090; Cho EY, 2007, MOL ENDOCRINOL, V21, P2242, DOI 10.1210/me.2007-0202; Enquist J, 2007, MOL PHARMACOL, V71, P494, DOI 10.1124/mol.106.030858; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; FRIEDMAN E, 1993, BIOL PSYCHIAT, V33, P520, DOI 10.1016/0006-3223(93)90006-Y; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; HIETALA J, 1994, PSYCHOPHARMACOLOGY, V116, P285, DOI 10.1007/BF02245330; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; Martini L, 2010, NEUROPSYCHOPHARMACOL, V35, P1363, DOI 10.1038/npp.2010.6; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Quik M, 2000, NEUROSCIENCE, V98, P263, DOI 10.1016/S0306-4522(00)00130-5; Rankin ML, 2006, MOL PHARMACOL, V69, P759, DOI 10.1124/mol.105.019901; Seneca N, 2006, SYNAPSE, V59, P260, DOI 10.1002/syn.20238; Skinbjerg M, 2009, SYNAPSE, V63, P621, DOI 10.1002/syn.20636; Strange PG, 2008, TRENDS PHARMACOL SCI, V29, P314, DOI 10.1016/j.tips.2008.03.009; Suhara T, 2002, ARCH GEN PSYCHIAT, V59, P25, DOI 10.1001/archpsyc.59.1.25; Talvik M, 2003, INT J NEUROPSYCHOPH, V6, P361, DOI 10.1017/S1461145703003699; Thompson D, 2007, J BIOL CHEM, V282, P29178, DOI 10.1074/jbc.M704014200; Thompson D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011038; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Tschische P, 2010, TRAFFIC, V11, P660, DOI 10.1111/j.1600-0854.2010.1045.x; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; Volkow ND, 2002, PSYCHIAT RES-NEUROIM, V116, P163, DOI 10.1016/S0925-4927(02)00087-2; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669	33	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1598	1608		10.1074/jbc.M110.158345	http://dx.doi.org/10.1074/jbc.M110.158345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21030592	Green Published, hybrid			2022-12-25	WOS:000286005000072
J	Dupouy, C; Zhang, C; Padilla, A; Pochet, S; Kaminski, PA				Dupouy, Christelle; Zhang, Chi; Padilla, Andre; Pochet, Sylvie; Kaminski, Pierre Alexandre			Probing the Active Site of the Deoxynucleotide N-Hydrolase Rcl Encoded by the Rat Gene c6orf108	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE; MASS-SPECTROMETRY; DNA-DAMAGE; IN-VIVO; METABOLISM; IDENTIFICATION; CELLS; PHOSPHORYLATION; EXPRESSION; ENZYME	Rcl is a potential anti-angiogenic therapeutic target that hydrolyzes the N-glycosidic bond of 2'-deoxyribonucleoside 5'-monophosphate, yielding 2-deoxyribose 5-phosphate and the corresponding base. Its recently elucidated solution structure provided the first insight into the molecular basis for the substrate recognition. To facilitate the development of potent and specific inhibitors of Rcl, the active site was probed by site-directed mutagenesis and by the use of substrate analogs. The nucleobase shows weak interactions with the protein, and the deoxyribose binding pocket includes the catalytic triad Tyr-13, Asp-69, and Glu-93 and the phosphate binding site Ser-87 and Ser-117. The phosphomimetic mutation of Ser-17 to Glu prevents substrate binding and, thus, abolishes the activity of Rcl. The synthetic ligand-based analysis of the Rcl binding site shows that substitutions at positions 2 and 6 of the nucleobase as well as large heterocycles are well tolerated. The phosphate group at position 5 of the (deoxy) ribose moiety is the critical binding determinant. This study provides the roadmap for the design of small molecules inhibitors with pharmacological properties.	[Kaminski, Pierre Alexandre] Inst Pasteur, Unite Chim & Biocatalyse, F-75724 Paris 15, France; [Zhang, Chi; Pochet, Sylvie; Kaminski, Pierre Alexandre] CNRS, URA2128, F-75724 Paris 15, France; [Padilla, Andre] CNRS, Ctr Biochim Struct, UMR5048, F-34090 Montpellier, France; [Padilla, Andre] INSERM, U554, F-34090 Montpellier, France; [Padilla, Andre] Univ Montpellier 1 & 2, IFR3, F-34090 Montpellier, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Kaminski, PA (corresponding author), Inst Pasteur, Unite Chim & Biocatalyse, 28 Rue Dr Roux, F-75724 Paris 15, France.	pierre-alexandre.kaminski@pasteur.fr		Dupouy, Christelle/0000-0002-4508-838X; Kaminski, Pierre Alexandre/0000-0001-9841-6837; PADILLA, ANDRE/0000-0001-9702-4612	Institut Pasteur (Direction des applications de la recherche et des relations industrielles); CNRS	Institut Pasteur (Direction des applications de la recherche et des relations industrielles); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Institut Pasteur (Direction des applications de la recherche et des relations industrielles) and CNRS.	Almon RR, 2007, ENDOCRINOLOGY, V148, P2209, DOI 10.1210/en.2006-0790; Armstrong SR, 1996, STRUCTURE, V4, P97, DOI 10.1016/S0969-2126(96)00013-5; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; BEBENEK K, 1992, J BIOL CHEM, V267, P3589; Brown NS, 1998, BIOCHEM J, V334, P1; Burcham PC, 1999, MUTAT RES-GEN TOX EN, V443, P11, DOI 10.1016/S1383-5742(99)00008-3; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Doddapaneni K, 2009, J MOL BIOL, V394, P423, DOI 10.1016/j.jmb.2009.08.054; Epp JB, 1999, J ORG CHEM, V64, P293, DOI 10.1021/jo981316g; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Fyrberg A, 2007, BIOCHEM BIOPH RES CO, V357, P847, DOI 10.1016/j.bbrc.2007.03.176; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Ghiorghi YK, 2007, J BIOL CHEM, V282, P8150, DOI 10.1074/jbc.M610648200; Gorgun G, 2009, P NATL ACAD SCI USA, V106, P6250, DOI 10.1073/pnas.0901166106; Hah SS, 2007, P NATL ACAD SCI USA, V104, P11203, DOI 10.1073/pnas.0701733104; Hirsch AKH, 2007, ANGEW CHEM INT EDIT, V46, P338, DOI 10.1002/anie.200603420; HOLGUIN J, 1975, EUR J BIOCHEM, V54, P515, DOI 10.1111/j.1432-1033.1975.tb04164.x; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pD80; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Jullig M, 2001, J BIOL CHEM, V276, P24000, DOI 10.1074/jbc.M100435200; Kaminski PA, 2002, J BIOL CHEM, V277, P14400, DOI 10.1074/jbc.M111995200; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Lewis BC, 2000, CANCER RES, V60, P6178; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Loeb LA, 2001, CANCER RES, V61, P3230; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Miki Y, 2005, CANCER LETT, V220, P197, DOI 10.1016/j.canlet.2004.07.024; MIZUNO Y, 1963, J ORG CHEM, V28, P3329, DOI 10.1021/jo01047a012; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Neeley WL, 2006, CHEM RES TOXICOL, V19, P491, DOI 10.1021/tx0600043; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; PORTER DJT, 1995, J BIOL CHEM, V270, P15551, DOI 10.1074/jbc.270.26.15551; Rhodes DR, 2002, CANCER RES, V62, P4427; Shin S, 2008, J CELL BIOCHEM, V105, P866, DOI 10.1002/jcb.21884; Smal C, 2006, J BIOL CHEM, V281, P4887, DOI 10.1074/jbc.M512129200; TENER GM, 1961, J AM CHEM SOC, V83, P159, DOI 10.1021/ja01462a032; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Yang YS, 2009, J MOL BIOL, V394, P435, DOI 10.1016/j.jmb.2009.10.004	43	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41806	41814		10.1074/jbc.M110.181594	http://dx.doi.org/10.1074/jbc.M110.181594			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20962348	Green Published, hybrid			2022-12-25	WOS:000285622600068
J	Kokal, I; Keysers, C				Kokal, Idil; Keysers, Christian			Granger Causality Mapping during Joint Actions Reveals Evidence for Forward Models That Could Overcome Sensory-Motor Delays	PLOS ONE			English	Article							TEMPORAL POLYSENSORY AREA; MIRROR NEURON SYSTEM; REACTION-TIME-TASK; FMRI DATA; SENSITIVE CELLS; CEREBELLUM; MOVEMENT; BRAIN; CORTEX; SYNCHRONIZATION	Studies investigating joint actions have suggested a central role for the putative mirror neuron system (pMNS) because of the close link between perception and action provided by these brain regions [1,2,3]. In contrast, our previous functional magnetic resonance imaging (fMRI) experiment demonstrated that the BOLD response of the pMNS does not suggest that it directly integrates observed and executed actions during joint actions [4]. To test whether the pMNS might contribute indirectly to the integration process by sending information to brain areas responsible for this integration (integration network), here we used Granger causality mapping (GCM) [5]. We explored the directional information flow between the anterior sites of the pMNS and previously identified integrative brain regions. We found that the left BA44 sent more information than it received to both the integration network (left thalamus, right middle occipital gyrus and cerebellum) and more posterior nodes of the pMNS (BA2). Thus, during joint actions, two anatomically separate networks therefore seem effectively connected and the information flow is predominantly from anterior to posterior areas of the brain. These findings suggest that the pMNS is involved indirectly in joint actions by transforming observed and executed actions into a common code and is part of a generative model that could predict the future somatosensory and visual consequences of observed and executed actions in order to overcome otherwise inevitable neural delays.	[Kokal, Idil; Keysers, Christian] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Keysers, Christian] Royal Netherlands Acad Arts & Sci KNAW, Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Kokal, I (corresponding author), Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Dept Neurosci, NL-9713 AV Groningen, Netherlands.	c.keysers@nin.knaw.nl	Keysers, Christian/H-6251-2013	Keysers, Christian/0000-0002-2845-5467	European Commission; N.W.O.	European Commission(European CommissionEuropean Commission Joint Research Centre); N.W.O.(Netherlands Organization for Scientific Research (NWO))	The study was supported by a Marie Curie Excellent Grant of the European Commission and an N.W.O. VIDI grant to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM JJ, 1991, PERCEPT MOTOR SKILL, V73, P863, DOI 10.2466/PMS.73.7.863-866; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Blakemore SJ, 2001, NEUROREPORT, V12, P1879, DOI 10.1097/00001756-200107030-00023; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Del Giudice M, 2009, DEVELOPMENTAL SCI, V12, P350, DOI 10.1111/j.1467-7687.2008.00783.x; Demiris J, 2002, FROM ANIM ANIMAT, P327; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Dum RP, 2003, J NEUROPHYSIOL, V89, P634, DOI 10.1152/jn.00626.2002; Dunlap K, 1910, PSYCHOL REV, V17, P399, DOI 10.1037/h0074736; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Etzel JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003690; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Hietanen JK, 1996, BEHAV BRAIN RES, V76, P155, DOI 10.1016/0166-4328(95)00193-X; HIETANEN JK, 1993, EXP BRAIN RES, V93, P117; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Jabbi M, 2008, EMOTION, V8, P775, DOI 10.1037/a0014194; JOHNSON WS, 1898, STUDIES YALE PSYCHOL, V6, P51; KELLER PE, 2008, COGNITIVE SOCIAL PER, P205; Keller PE, 2007, CONSCIOUS COGN, V16, P102, DOI 10.1016/j.concog.2005.12.004; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; KNOBLICH G, 2002, MIRROR NEURONS EVOLU, P115; Kokal I, 2009, NEUROIMAGE, V47, P2046, DOI 10.1016/j.neuroimage.2009.06.010; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Miall RC, 2003, NEUROREPORT, V14, P2135, DOI 10.1097/00001756-200312020-00001; MICHIE PT, 1976, PHYSIOL BEHAV, V16, P311, DOI 10.1016/0031-9384(76)90138-4; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Miyake I., 1902, STUD YALE PSYCHOL LA, V10, P1; Newman-Norlund RD, 2007, SOC NEUROSCI-UK, V2, P48, DOI 10.1080/17470910701224623; Newman-Norlund RD, 2008, NEUROIMAGE, V41, P169, DOI 10.1016/j.neuroimage.2008.02.026; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Schaal S, 2003, PHILOS T R SOC B, V358, P537, DOI 10.1098/rstb.2002.1258; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; Sebanz N, 2006, J COGNITIVE NEUROSCI, V18, P859, DOI 10.1162/jocn.2006.18.5.859; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; STEIN JF, 1992, PHYSIOL REV, V72, P967, DOI 10.1152/physrev.1992.72.4.967; Szymaszek A, 2006, NEUROSCI LETT, V403, P190, DOI 10.1016/j.neulet.2006.04.062; Thioux M, 2008, CURR BIOL, V18, pR431, DOI 10.1016/j.cub.2008.03.018; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	51	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13507	10.1371/journal.pone.0013507	http://dx.doi.org/10.1371/journal.pone.0013507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975836	gold, Green Published, Green Submitted			2022-12-25	WOS:000283293800004
J	Cheney, KM; McKnight, A				Cheney, Kelly M.; McKnight, Aine			Interferon-Alpha Mediates Restriction of Human Immunodeficiency Virus Type-1 Replication in Primary Human Macrophages at an Early Stage of Replication	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; HIV-1 INFECTION; T-CELLS; ANTIRETROVIRAL THERAPY; POSTENTRY BLOCK; IFN-ALPHA; PROTEIN; MECHANISMS; INHIBITION; MONOCYTES	Type I interferons (IFN alpha and beta) are induced directly in response to viral infection, resulting in an antiviral state for the cell. In vitro studies have shown that IFN alpha is a potent inhibitor of viral replication; however, its role in HIV-1 infection is incompletely understood. In this study we describe the ability of IFN alpha to restrict HIV-1 infection in primary human macrophages in contrast to peripheral blood mononuclear cells and monocyte-derived dendritic cells. Inhibition to HIV-1 replication in cells pretreated with IFN alpha occurred at an early stage in the virus life cycle. Late viral events such as budding and subsequent rounds of infection were not affected by IFN alpha treatment. Analysis of early and late HIV-1 reverse transcripts and integrated proviral DNA confirmed an early post entry role for IFN alpha. First strand cDNA synthesis was slightly reduced but late and integrated products were severely depleted, suggesting that initiation or the nucleic acid intermediates of reverse transcription are targeted. The depletion of integrated provirus is disproportionally greater than that of viral cDNA synthesis suggesting the possibility of a least an additional later target. A role for either cellular protein APOBEC3G or tetherin in this IFN alpha mediated restriction has been excluded. Vpu, previously shown by others to rescue a viral budding restriction by tetherin, could not overcome this IFN alpha induced effect. Determining both the viral determinants and cellular proteins involved may lead to novel therapeutic approaches. Our results add to the understanding of HIV-1 restriction by IFN alpha.	[Cheney, Kelly M.; McKnight, Aine] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England	University of London; Queen Mary University London	Cheney, KM (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, London, England.	a.mcknight@qmul.ac.uk		McKnight, Aine/0000-0002-8113-817X	MRC [G117/547]; Wellcome Trust [WT075853MA]; EU [LSHP-CT-2004-503487]; Medical Research Council [G117/547] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an MRC Senior Non-Clinical Fellowship awarded to AM (G117/547) and a Wellcome Trust grant (WT075853MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Matthias Dittmar for helpful discussions and critical reading of the manuscript. The monoclonal antibodies to p24 (EVA365 and 366) were provided by the EU Programme EVA Centre for AIDS Reagents, NIBSC, UK (AVIP Contract Number LSHP-CT-2004-503487). The following cell lines were obtained through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: ACH-2 and 8E5/LAV from Dr. Thomas Folks, OM-10.1 from Dr. Salvatore Butera.	BACAREGEN L, 1994, J VIROL, V68, P7559, DOI 10.1128/JVI.68.11.7559-7565.1994; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; BUTERA ST, 1994, J VIROL, V68, P2726, DOI 10.1128/JVI.68.4.2726-2730.1994; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; CLOUSE KA, 1989, J IMMUNOL, V142, P431; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; GENDELMAN HE, 1990, J IMMUNOL, V145, P2669; GENDELMAN HE, 1990, AIDS RES HUM RETROV, V6, P1045, DOI 10.1089/aid.1990.6.1045; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Greenwell-Wild T, 2009, BLOOD, V114, P1864, DOI 10.1182/blood-2009-03-211540; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Katabira ET, 1998, SEX TRANSM INFECT, V74, P265, DOI 10.1136/sti.74.4.265; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Krown SE, 2006, JAIDS-J ACQ IMM DEF, V41, P149, DOI 10.1097/01.qai.0000194237.15831.23; Krown SE, 2002, J INTERF CYTOK RES, V22, P295, DOI 10.1089/107999002753675712; LANE HC, 1990, ANN INTERN MED, V112, P805, DOI 10.7326/0003-4819-112-11-805; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Marchant D, 2006, J GEN VIROL, V87, P411, DOI 10.1099/vir.0.81391-0; MCKNIGHT A, 1994, VIROLOGY, V201, P8, DOI 10.1006/viro.1994.1260; MEYLAN PRA, 1993, VIROLOGY, V193, P138, DOI 10.1006/viro.1993.1110; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neumann AU, 2007, AIDS, V21, P1855, DOI 10.1097/QAD.0b013e32825eaba7; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; PITHA PM, 1994, ANTIVIR RES, V24, P205, DOI 10.1016/0166-3542(94)90068-X; Reeves JD, 1999, J VIROL, V73, P7795, DOI 10.1128/JVI.73.9.7795-7804.1999; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; SHIRAZI Y, 1993, VIROLOGY, V193, P303, DOI 10.1006/viro.1993.1126; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stylianou E, 2000, CLIN EXP IMMUNOL, V119, P479, DOI 10.1046/j.1365-2249.2000.01144.x; TSANG J, 2009, AIDS; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; YAMAMOTO JK, 1986, J INTERFERON RES, V6, P143, DOI 10.1089/jir.1986.6.143; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	41	43	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13521	10.1371/journal.pone.0013521	http://dx.doi.org/10.1371/journal.pone.0013521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975956	Green Published, gold, Green Submitted			2022-12-25	WOS:000283216400025
J	Siegel, C; Hallstrom, T; Skerka, C; Eberhardt, H; Uzonyi, B; Beckhaus, T; Karas, M; Wallich, R; Stevenson, B; Zipfel, PF; Kraiczy, P				Siegel, Corinna; Hallstroem, Teresia; Skerka, Christine; Eberhardt, Hannes; Uzonyi, Barbara; Beckhaus, Tobias; Karas, Michael; Wallich, Reinhard; Stevenson, Brian; Zipfel, Peter F.; Kraiczy, Peter			Complement Factor H-Related Proteins CFHR2 and CFHR5 Represent Novel Ligands for the Infection-Associated CRASP Proteins of Borrelia burgdorferi	PLOS ONE			English	Article							ACQUIRING SURFACE PROTEIN-1; LYME-DISEASE SPIROCHETE; REGULATORS FACTOR-H; INHIBITOR FACTOR-H; BINDING-SITES; HUMAN SERUM; C-TERMINUS; FUNCTIONAL-CHARACTERIZATION; FAMILY PROTEINS; IMMUNE EVASION	Background: One virulence property of Borrelia burgdorferi is its resistance to innate immunity, in particular to complement-mediated killing. Serum-resistant B. burgdorferi express up to five distinct complement regulator-acquiring surface proteins (CRASP) which interact with complement regulator factor H (CFH) and factor H-like protein 1 (FHL1) or factor H-related protein 1 (CFHR1). In the present study we elucidate the role of the infection-associated CRASP-3 and CRASP-5 protein to serve as ligands for additional complement regulatory proteins as well as for complement resistance of B. burgdorferi. Methodology/Principal Findings: To elucidate whether CRASP-5 and CRASP-3 interact with various human proteins, both borrelial proteins were immobilized on magnetic beads. Following incubation with human serum, bound proteins were eluted and separated by Glycine-SDS-PAGE. In addition to CFH and CFHR1, complement regulators CFHR2 and CFHR5 were identified as novel ligands for both borrelial proteins by employing MALDI-TOF. To further assess the contributions of CRASP-3 and CRASP-5 to complement resistance, a serum-sensitive B. garinii strain G1 which lacks all CFH-binding proteins was used as a valuable model for functional analyses. Both CRASPs expressed on the B. garinii outer surface bound CFH as well as CFHR1 and CFHR2 in ELISA. In contrast, live B. garinii bound CFHR1, CFHR2, and CFHR5 and only miniscute amounts of CFH as demonstrated by serum adsorption assays and FACS analyses. Further functional analysis revealed that upon NHS incubation, CRASP-3 or CRASP-5 expressing borreliae were killed by complement. Conclusions/Significance: In the absence of CFH and the presence of CFHR1, CFHR2 and CFHR5, assembly and integration of the membrane attack complex was not efficiently inhibited indicating that CFH in co-operation with CFHR1, CFHR2 and CFHR5 supports complement evasion of B. burgdorferi.	[Siegel, Corinna; Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Hallstroem, Teresia; Skerka, Christine; Eberhardt, Hannes; Uzonyi, Barbara; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Beckhaus, Tobias; Karas, Michael] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Frankfurt, Germany; [Wallich, Reinhard] Heidelberg Univ, Inst Immunol, D-6900 Heidelberg, Germany; [Stevenson, Brian] Univ Kentucky, Dept Microbiol Mol Genet & Immunol, Lexington, KY USA; [Zipfel, Peter F.] Univ Jena, Jena, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hans Knoll Institute (HKI); Goethe University Frankfurt; Ruprecht Karls University Heidelberg; University of Kentucky; Friedrich Schiller University of Jena	Siegel, C (corresponding author), Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany.	Kraiczy@em.uni-frankfurt.de	Uzonyi, Barbara/J-3973-2018	Uzonyi, Barbara/0000-0002-9680-1974	Deutsche Forschungsgemeinschaft [Kr3383/1-2]; U.S. National Institutes of Health [AI44254]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in part, by the Deutsche Forschungsgemeinschaft grant Kr3383/1-2 to P. Kraiczy and U.S. National Institutes of Health grant AI44254 to B. Stevenson. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alitalo A, 2005, EUR J IMMUNOL, V35, P3043, DOI 10.1002/eji.200526354; Alitalo A, 2004, J IMMUNOL, V172, P6195, DOI 10.4049/jimmunol.172.10.6195; Alitalo A, 2002, J IMMUNOL, V169, P3847, DOI 10.4049/jimmunol.169.7.3847; Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; Arlaud GJ, 2007, MOL IMMUNOL, V44, P3809, DOI 10.1016/j.molimm.2007.06.147; Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; BreitnerRuddock S, 1997, MED MICROBIOL IMMUN, V185, P253, DOI 10.1007/s004300050038; Brooks CS, 2005, J IMMUNOL, V175, P3299, DOI 10.4049/jimmunol.175.5.3299; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; El-Hage N, 2001, MICROBIOL-SGM, V147, P821, DOI 10.1099/00221287-147-4-821; ESTALLER C, 1991, J IMMUNOL, V146, P3190; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; Foldvari G, 2005, EMERG INFECT DIS, V11, P1794; Frank KL, 2003, J BACTERIOL, V185, P6723, DOI 10.1128/JB.185.22.6723-6727.2003; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Haupt K, 2008, INT J MED MICROBIOL, V298, P287, DOI 10.1016/j.ijmm.2007.11.010; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; Hauser U, 1999, J CLIN MICROBIOL, V37, P2241, DOI 10.1128/JCM.37.7.2241-2247.1999; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; Herzberger P, 2007, INFECT IMMUN, V75, P4817, DOI 10.1128/IAI.00532-07; Hovis KM, 2006, INFECT IMMUN, V74, P1967, DOI 10.1128/IAI.74.3.1967-1972.2006; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Kraiczy P, 2003, EUR J IMMUNOL, V33, P697, DOI 10.1002/eji.200323571; Kraiczy P, 2001, INT IMMUNOPHARMACOL, V1, P393, DOI 10.1016/S1567-5769(00)00041-2; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2001, INFECT IMMUN, V69, P7800, DOI 10.1128/IAI.69.12.7800-7809.2001; KUHN S, 1995, GENE, V162, P225, DOI 10.1016/0378-1119(95)00360-I; KUHN S, 1995, J IMMUNOL, V155, P5663; Mbow ML, 2002, HYBRIDOMA HYBRIDOM, V21, P179, DOI 10.1089/153685902760173890; McDowell JV, 2003, INFECT IMMUN, V71, P3597, DOI 10.1128/IAI.71.6.3597-3602.2003; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; McRae JL, 2001, J BIOL CHEM, V276, P6747, DOI 10.1074/jbc.M007495200; Metts MS, 2003, INFECT IMMUN, V71, P3587, DOI 10.1128/IAI.71.6.3587-3596.2003; Michel H, 2004, MED MICROBIOL IMMUN, V193, P219, DOI 10.1007/s00430-003-0196-8; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Miller JC, 2006, MICROB PATHOGENESIS, V41, P43, DOI 10.1016/j.micpath.2006.04.004; Okemefuna AI, 2009, J MOL BIOL, V391, P119, DOI 10.1016/j.jmb.2009.06.013; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Park CT, 1996, J BIOL CHEM, V271, P18054, DOI 10.1074/jbc.271.30.18054; Park CT, 2000, BLOOD, V95, P198, DOI 10.1182/blood.V95.1.198.001k31_198_204; Prodinger WM, 1998, BIOCHEM J, V331, P41, DOI 10.1042/bj3310041; Richter D, 2004, APPL ENVIRON MICROB, V70, P6414, DOI 10.1128/AEM.70.11.6414-6419.2004; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Samuels D S, 1995, Methods Mol Biol, V47, P253; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; Siegel C, 2008, J BIOL CHEM, V283, P34855, DOI 10.1074/jbc.M805844200; SKERKA C, 1991, J BIOL CHEM, V266, P12015; SKERKA C, 1992, J IMMUNOL, V148, P3313; Skerka C, 2008, VACCINE, V26, pI9, DOI 10.1016/j.vaccine.2008.11.021; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Stevenson B, 2002, INFECT IMMUN, V70, P5307, DOI 10.1128/IAI.70.9.5307-5311.2002; Stevenson B, 1998, INFECT IMMUN, V66, P2648, DOI 10.1128/IAI.66.6.2648-2654.1998; Stevenson B, 2006, WIEN KLIN WOCHENSCHR, V118, P643, DOI 10.1007/s00508-006-0690-2; TIMMANN C, 1991, J IMMUNOL, V146, P1265; VanDam AP, 1997, INFECT IMMUN, V65, P1228, DOI 10.1128/IAI.65.4.1228-1236.1997; von Lackum K, 2005, INFECT IMMUN, V73, P7398, DOI 10.1128/IAI.73.11.7398-7405.2005; Wallich R, 2005, INFECT IMMUN, V73, P2351, DOI 10.1128/IAI.73.4.2351-2359.2005; Wang GQ, 1999, J CLIN MICROBIOL, V37, P3025, DOI 10.1128/JCM.37.9.3025-3028.1999; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	70	51	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13519	10.1371/journal.pone.0013519	http://dx.doi.org/10.1371/journal.pone.0013519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975954	Green Published, gold, Green Submitted			2022-12-25	WOS:000283216400023
J	Wang, F; Fu, XQ; Chen, X; Chen, XB; Zhao, YF				Wang, Fei; Fu, Xueqi; Chen, Xia; Chen, Xinbin; Zhao, Yunfeng			Mitochondrial Uncoupling Inhibits p53 Mitochondrial Translocation in TPA-Challenged Skin Epidermal JB6 Cells	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; PROTON LEAK; CANCER-CELLS; OXIDATIVE STRESS; RESPIRATION RATE; MUTANT P53; PROTEIN-2; ACTIVATION; APOPTOSIS; EXPRESSION	The tumor suppressor p53 is known to be able to trigger apoptosis in response to DNA damage, oncogene activation, and certain chemotherapeutic drugs. In addition to its transcriptional activation, a fraction of p53 translocates to mitochondria at the very early stage of apoptosis, which eventually contributes to the loss of mitochondrial membrane potential, generation of reactive oxygen species (ROS), cytochrome c release, and caspase activation. However, the mitochondrial events that affect p53 translocation are still unclear. Since mitochondrial uncoupling has been suggested to contribute to cancer development, herein, we studied whether p53 mitochondrial translocation and subsequent apoptosis were affected by mitochondrial uncoupling using chemical protonophores, and further verified the results using a siRNA approach in murine skin epidermal JB6 cells. Our results showed that mitochondrial uncoupling blocked p53 mitochondrial translocation induced by 12-O-tetradecanoylphorbol 13-acetate (TPA), a known tumor promoter to induce p53-mediated apoptosis in skin carcinogenesis. This blocking effect, in turn, led to preservation of mitochondrial functions, and eventually suppression of caspase activity and apoptosis. Moreover, uncoupling protein 2 (UCP2), a potential suppressor of ROS in mitochondria, is important for TPA-induced cell transformation in JB6 cells. UCP2 knock down cells showed enhanced p53 mitochondrial translocation, and were less prone to form colonies in soft agar after TPA treatment. Altogether, our data suggest that mitochondrial uncoupling may serve as an important regulator of p53 mitochondrial translocation and p53-mediated apoptosis during early tumor promotion. Therefore, targeting mitochondrial uncoupling may be considered as a novel treatment strategy for cancer.	[Wang, Fei; Zhao, Yunfeng] LSU Hlth Sci Ctr Shreveport, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA USA; [Wang, Fei; Fu, Xueqi; Chen, Xia] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Chen, Xinbin] Univ Calif Davis, Dept Surg & Radiol Sci, Davis, CA 95616 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Jilin University; University of California System; University of California Davis	Wang, F (corresponding author), LSU Hlth Sci Ctr Shreveport, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA USA.	yzhao1@lsuhsc.edu			National Cancer Institute [R03CA128077]; LSUHSC-S; NATIONAL CANCER INSTITUTE [R03CA128077] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); LSUHSC-S; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grant Number R03CA128077 from the National Cancer Institute and LSUHSC-S Start-up Package. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch-Machin MA, 1993, METHODS TOXICOL, V2, P51; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; Brand MD, 1999, INT J OBESITY, V23, pS4, DOI 10.1038/sj.ijo.0800936; BRAND MD, 1990, BIOCHIM BIOPHYS ACTA, V1018, P128, DOI 10.1016/0005-2728(90)90232-S; BROWN GC, 1991, BIOCHIM BIOPHYS ACTA, V1059, P55, DOI 10.1016/S0005-2728(05)80187-2; COLBURN NH, 1978, CANCER RES, V38, P624; COLBURN NH, 1979, NATURE, V281, P589, DOI 10.1038/281589a0; Collins P, 2005, LIVER INT, V25, P880, DOI 10.1111/j.1478-3231.2005.01104.x; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Kowaltowski AJ, 1998, FEBS LETT, V425, P213, DOI 10.1016/S0014-5793(98)00231-2; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu JF, 2008, FEBS LETT, V582, P1319, DOI 10.1016/j.febslet.2008.03.013; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Moll UM, 2001, FEBS LETT, V493, P65, DOI 10.1016/S0014-5793(01)02284-0; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213; Rolfe DFS, 1999, AM J PHYSIOL-CELL PH, V276, pC692, DOI 10.1152/ajpcell.1999.276.3.C692; Samudio I, 2008, CANCER RES, V68, P5198, DOI 10.1158/0008-5472.CAN-08-0555; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; SUN Y, 1993, P NATL ACAD SCI USA, V90, P2827, DOI 10.1073/pnas.90.7.2827; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Yan WS, 2008, CANCER RES, V68, P6789, DOI 10.1158/0008-5472.CAN-08-0810; Zhao YF, 2006, FREE RADICAL BIO MED, V40, P1234, DOI 10.1016/j.freeradbiomed.2005.11.009; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835; Zhao YF, 2005, CANCER RES, V65, P1401, DOI 10.1158/0008-5472.CAN-04-3334; Zhao YF, 2002, ONCOGENE, V21, P3836, DOI 10.1038/sj.onc.1205477; Zhao YF, 2006, CARCINOGENESIS, V27, P1692, DOI 10.1093/carcin/bgl037	40	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13459	10.1371/journal.pone.0013459	http://dx.doi.org/10.1371/journal.pone.0013459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976134	Green Submitted, Green Published, gold			2022-12-25	WOS:000283045300028
J	Fukushima, H; Hirata, S; Ueno, A; Matsuda, G; Fuwa, K; Sugama, K; Kusunoki, K; Hirai, M; Hiraki, K; Tomonaga, M; Hasegawa, T				Fukushima, Hirokata; Hirata, Satoshi; Ueno, Ari; Matsuda, Goh; Fuwa, Kohki; Sugama, Keiko; Kusunoki, Kiyo; Hirai, Masahiro; Hiraki, Kazuo; Tomonaga, Masaki; Hasegawa, Toshikazu			Neural Correlates of Face and Object Perception in an Awake Chimpanzee (Pan Troglodytes) Examined by Scalp-Surface Event-Related Potentials	PLOS ONE			English	Article							VISUAL EVOKED-POTENTIALS; HUMANS HOMO-SAPIENS; MISMATCH NEGATIVITY; SOCIAL EXPERIENCE; VOCAL PERCEPTION; RECOGNITION; BRAIN; SPECIALIZATION; EXPERTISE; MONKEY	Background: The neural system of our closest living relative, the chimpanzee, is a topic of increasing research interest. However, electrophysiological examinations of neural activity during visual processing in awake chimpanzees are currently lacking. Methodology/Principal Findings: In the present report, skin-surface event-related brain potentials (ERPs) were measured while a fully awake chimpanzee observed photographs of faces and objects in two experiments. In Experiment 1, human faces and stimuli composed of scrambled face images were displayed. In Experiment 2, three types of pictures (faces, flowers, and cars) were presented. The waveforms evoked by face stimuli were distinguished from other stimulus types, as reflected by an enhanced early positivity appearing before 200 ms post stimulus, and an enhanced late negativity after 200 ms, around posterior and occipito-temporal sites. Face-sensitive activity was clearly observed in both experiments. However, in contrast to the robustly observed face-evoked N170 component in humans, we found that faces did not elicit a peak in the latency range of 150-200 ms in either experiment. Conclusions/Significance: Although this pilot study examined a single subject and requires further examination, the observed scalp voltage patterns suggest that selective processing of faces in the chimpanzee brain can be detected by recording surface ERPs. In addition, this non-invasive method for examining an awake chimpanzee can be used to extend our knowledge of the characteristics of visual cognition in other primate species.	[Fukushima, Hirokata; Ueno, Ari; Matsuda, Goh; Hirai, Masahiro; Hiraki, Kazuo; Hasegawa, Toshikazu] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Fukushima, Hirokata; Hirai, Masahiro] Japan Soc Promot Sci, Tokyo, Japan; [Hirata, Satoshi; Fuwa, Kohki; Sugama, Keiko; Kusunoki, Kiyo] Hayashibara Biochemical Labs Inc, Great Ape Res Inst, Tamano, Japan; [Hirai, Masahiro] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Ueno, Ari] Univ Shiga Prefecture, Sch Human Cultures, Dept Human Relat Studies, Hikone, Japan; [Tomonaga, Masaki] Kyoto Univ, Primate Res Inst, Sect Language & Intelligence, Inuyama, Aichi 484, Japan; [Fukushima, Hirokata] Keio Univ, Dept Psychol, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science; Hayashibara Biochemical Laboratories, Inc.; Queens University - Canada; University Shiga Prefecture; Kyoto University; Keio University	Fukushima, H (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.	hirof@ardbeg.c.u-tokyo.ac.jp			Center for Evolutionary Cognitive Science at The University of Tokyo; JSPS [20680015, 18200018, 19300091, 20002001]	Center for Evolutionary Cognitive Science at The University of Tokyo; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Center for Evolutionary Cognitive Science at The University of Tokyo. This study was also financially supported by Grants-in-Aid for Scientific Research (grant numbers 20680015 to SH, 18200018 to HK, 19300091 and 20002001 to MT) from JSPS (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEY WR, 1963, SCIENCE, V141, P832, DOI 10.1126/science.141.3584.932; BARRETT SE, 1988, NEUROPSYCHOLOGIA, V26, P105, DOI 10.1016/0028-3932(88)90034-6; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BERNTSON GG, 1993, DEV PSYCHOBIOL, V26, P305, DOI 10.1002/dev.420260602; BOYSEN ST, 1985, ELECTROEN CLIN NEURO, V62, P150, DOI 10.1016/0168-5597(85)90027-9; Burrows AM, 2006, J ANAT, V208, P153, DOI 10.1111/j.1469-7580.2006.00523.x; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; de Haan M, 2003, INT J PSYCHOPHYSIOL, V51, P45, DOI 10.1016/S0167-8760(03)00152-1; de Haan M, 2002, J COGNITIVE NEUROSCI, V14, P199, DOI 10.1162/089892902317236849; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; Eifuku S, 2004, J NEUROPHYSIOL, V91, P358, DOI 10.1152/jn.00198.2003; Fagot J, 1999, J COMP PSYCHOL, V113, P3, DOI 10.1037/0735-7036.113.1.3; FUJITA K, 1990, INT J PRIMATOL, V11, P553, DOI 10.1007/BF02197057; FUJITA K, 1993, PRIMATES, V34, P141, DOI 10.1007/BF02381385; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; George N, 1996, COGNITIVE BRAIN RES, V4, P65, DOI 10.1016/0926-6410(95)00045-3; Grossmann T, 2007, EUR J NEUROSCI, V25, P909, DOI 10.1111/j.1460-9568.2007.05379.x; Halit H, 2003, NEUROIMAGE, V19, P1180, DOI 10.1016/S1053-8119(03)00076-4; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; Idani G., 2006, PRIMATE PERSPECTIVES, P29; Imura T, 2008, BEHAV PROCESS, V77, P306, DOI 10.1016/j.beproc.2007.07.006; JAVITT DC, 1992, ELECTROEN CLIN NEURO, V83, P87, DOI 10.1016/0013-4694(92)90137-7; Kano F, 2009, P R SOC B, V276, P1949, DOI 10.1098/rspb.2008.1811; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kiani R, 2005, J NEUROPHYSIOL, V94, P1587, DOI 10.1152/jn.00540.2004; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Martin-Malivel J, 2007, BEHAV NEUROSCI, V121, P1145, DOI 10.1037/0735-7044.121.6.1145; Matsuno T, 2004, BEHAV BRAIN RES, V148, P157, DOI 10.1016/S0166-4328(03)00185-2; Matsuno T., 2007, JAPANESE J PSYCHONOM, V25, P281; Parr LA, 1999, NATURE, V399, P647, DOI 10.1038/21345; Parr LA, 2003, ANN NY ACAD SCI, V1000, P56, DOI 10.1196/annals.1280.005; Parr LA, 1998, J COGNITIVE NEUROSCI, V10, P615, DOI 10.1162/089892998563013; Parr LA, 2008, J COMP PSYCHOL, V122, P390, DOI 10.1037/0735-7036.122.4.390; Parr LA, 2006, BRAIN COGNITION, V62, P30, DOI 10.1016/j.bandc.2006.03.006; Parr LA, 2009, CURR BIOL, V19, P50, DOI 10.1016/j.cub.2008.11.048; PERRETT DI, 1988, BEHAV BRAIN RES, V29, P245, DOI 10.1016/0166-4328(88)90029-0; PINEDA JA, 1994, COGNITIVE BRAIN RES, V2, P1, DOI 10.1016/0926-6410(94)90015-9; Rilling JK, 2007, P NATL ACAD SCI USA, V104, P17146, DOI 10.1073/pnas.0705132104; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Sato A, 1997, JPN PSYCHOL RES, V39, P191, DOI 10.1111/1468-5884.00053; SEECK M, 1992, EXP BRAIN RES, V92, P338; Springer SP, 1997, LEFT BRAIN RIGHT BRA; Taglialatela JP, 2008, CURR BIOL, V18, P343, DOI 10.1016/j.cub.2008.01.049; Taglialatela JP, 2009, CEREB CORTEX, V19, P1151, DOI 10.1093/cercor/bhn157; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tanaka M, 2007, ANIM COGN, V10, P169, DOI 10.1007/s10071-006-0056-1; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; Tomonaga M, 2007, PRIMATES, V48, P1, DOI 10.1007/s10329-006-0011-4; UENO A, 2009, BIOL LETT; Ueno A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001442; Umbricht D, 2005, CLIN NEUROPHYSIOL, V116, P353, DOI 10.1016/j.clinph.2004.08.015; Ungerleider L.G., 1982, ANAL VISUAL BEHAV	54	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13366	10.1371/journal.pone.0013366	http://dx.doi.org/10.1371/journal.pone.0013366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967284	Green Published, gold, Green Submitted			2022-12-25	WOS:000282807300030
J	Prigent, J; Mazuet, C; Boquet, D; Lamourette, P; Volland, H; Popoff, MR; Creminon, C; Simon, S				Prigent, Julie; Mazuet, Christelle; Boquet, Didier; Lamourette, Patricia; Volland, Herve; Popoff, Michel R.; Creminon, Christophe; Simon, Stephanie			Production and Characterisation of a Neutralising Chimeric Antibody against Botulinum Neurotoxin A	PLOS ONE			English	Article							TOXIN TYPE-A; MONOCLONAL-ANTIBODIES; HYBRIDOMAS; IDENTIFICATION; ANTITOXIN; STRAINS; GENES; ASSAY	Botulinum neurotoxins, produced by Clostridium botulinum bacteria, are the causative agent of botulism. This disease only affects a few hundred people each year, thus ranking it among the orphan diseases. However, botulinum toxin type A (BoNT/A) is the most potent toxin known to man. Due to their potency and ease of production, these toxins were classified by the Centers for Disease Control and Prevention (CDC) as Category A biothreat agents. For several biothreat agents, like BoNT/A, passive immunotherapy remains the only possible effective treatment allowing in vivo neutralization, despite possible major side effects. Recently, several mouse monoclonal antibodies directed against a recombinant fragment of BoNT/A were produced in our laboratory and most efficiently neutralised the neurotoxin. In the present work, the most powerful one, TA12, was selected for chimerisation. The variable regions of this antibody were thus cloned and fused with the constant counterparts of human IgG1 (kappa light and gamma 1 heavy chains). Chimeric antibody production was evaluated in mammalian myeloma cells (SP2/0-Ag14) and insect cells (Sf9). After purifying the recombinant antibody by affinity chromatography, the biochemical properties of chimeric and mouse antibody were compared. Both have the same very low affinity constant (close to 10 pM) and the chimeric antibody exhibited a similar capacity to its parent counterpart in neutralising the toxin in vivo. Its strong affinity and high neutralising potency make this chimeric antibody interesting for immunotherapy treatment in humans in cases of poisoning, particularly as there is a probable limitation of the immunological side effects observed with classical polyclonal antisera from heterologous species.	[Prigent, Julie; Boquet, Didier; Lamourette, Patricia; Volland, Herve; Creminon, Christophe; Simon, Stephanie] CEA Saclay, Serv Pharmacol & Immunoanal, iBiTec S, CEA, F-91191 Gif Sur Yvette, France; [Mazuet, Christelle; Popoff, Michel R.] Inst Pasteur, Unite Toxines & Bacteries Anaerobies, Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Prigent, J (corresponding author), CEA Saclay, Serv Pharmacol & Immunoanal, iBiTec S, CEA, F-91191 Gif Sur Yvette, France.	stephanie.simon@cea.fr	Mazuet, Christelle/O-7731-2016; Simon, Stephanie/E-4289-2012; Popoff, Michel/O-7719-2016	Mazuet, Christelle/0000-0001-7619-9050; Simon, Stephanie/0000-0002-6071-8255; Popoff, Michel/0000-0001-9305-8989; BOQUET, Didier/0000-0002-4048-7867	CEA (Commissariat a l'Energie Atomique et aux Energies Renouvelables); IMASSA (Institut de Medecine Aerospatiale du Service de Sante des Armees); NRBC (Nuclear Radiological Biological and Chemical Risks)	CEA (Commissariat a l'Energie Atomique et aux Energies Renouvelables)(French Atomic Energy Commission); IMASSA (Institut de Medecine Aerospatiale du Service de Sante des Armees); NRBC (Nuclear Radiological Biological and Chemical Risks)	This study was supported by a grant from the PhD programme of the CEA (Commissariat a l'Energie Atomique et aux Energies Renouvelables) (Julie Prigent) and funded by the IMASSA (Institut de Medecine Aerospatiale du Service de Sante des Armees) and NRBC (Nuclear Radiological Biological and Chemical Risks) programmes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekar SP, 2008, J IMMUNOL METHODS, V333, P156, DOI 10.1016/j.jim.2008.01.015; Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Arnon SS, 2007, PEDIATRICS, V119, P785, DOI 10.1542/peds.2006-0646; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; Boquet D, 2000, ANAL BIOCHEM, V284, P221, DOI 10.1006/abio.2000.4711; BURGEN ASV, 1949, J PHYSIOL-LONDON, V109, P10, DOI 10.1113/jphysiol.1949.sp004364; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Casadevall A, 2002, EMERG INFECT DIS, V8, P833, DOI 10.3201/eid0808.010516; Centers for Disease Control and Prevention, 1998, HDB EP CLIN LAB WORK; Chen F, 1998, INFECT IMMUN, V66, P2420, DOI 10.1128/IAI.66.6.2420-2425.1998; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Dee KU, 1997, BIOTECHNOL PROGR, V13, P14, DOI 10.1021/bp960086t; Dembek ZF, 2007, DISASTER MED PUBLIC, V1, P122, DOI 10.1097/DMP.0b013e318158c5fd; DIGHIERO G, 1983, J IMMUNOL, V131, P2267; Dokmetjian J, 2000, VACCINE, V18, P2698, DOI 10.1016/S0264-410X(00)00066-9; Drake AW, 2004, ANAL BIOCHEM, V328, P35, DOI 10.1016/j.ab.2003.12.025; ELLMAN GL, 1961, J LAB CLIN MED, V57, P813; *EUR PHARM, 2002, BOT ANT; Foran PG, 2003, J BIOL CHEM, V278, P1363, DOI 10.1074/jbc.M209821200; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; HATHEWAY CH, 1984, J INFECT DIS, V150, P407, DOI 10.1093/infdis/150.3.407; Hines HB, 2005, APPL ENVIRON MICROB, V71, P4478, DOI 10.1128/AEM.71.8.4478-4486.2005; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Inoue K, 1996, INFECT IMMUN, V64, P1589, DOI 10.1128/IAI.64.5.1589-1594.1996; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Liang MF, 2001, J IMMUNOL METHODS, V247, P119, DOI 10.1016/S0022-1759(00)00322-7; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; MAZUET C, 2010, CHARACTERISATION BOT; Mowry MC, 2004, PROTEIN EXPRES PURIF, V37, P399, DOI 10.1016/j.pep.2004.06.022; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Popoff MR, 1995, CURR TOP MICROBIOL, V195, P1; Poulain B., 2003, Annales de Readaptation et de Medecine Physique, V46, P265, DOI 10.1016/S0168-6054(03)00114-4; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507; Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003; TACKET CO, 1984, AM J MED, V76, P794, DOI 10.1016/0002-9343(84)90988-4; Tavallaie M, 2004, FEBS LETT, V572, P299, DOI 10.1016/j.febslet.2004.06.094; Volland H, 2008, J IMMUNOL METHODS, V330, P120, DOI 10.1016/j.jim.2007.11.006	46	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13245	10.1371/journal.pone.0013245	http://dx.doi.org/10.1371/journal.pone.0013245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20967241	gold, Green Published, Green Submitted			2022-12-25	WOS:000282676700017
J	Becker, PD; Legrand, N; van Geelen, CMM; Noerder, M; Huntington, ND; Lim, A; Yasuda, E; Diehl, SA; Scheeren, FA; Ott, M; Weijer, K; Wedemeyer, H; Di Santo, JP; Beaumont, T; Guzman, CA; Spits, H				Becker, Pablo D.; Legrand, Nicolas; van Geelen, Caroline M. M.; Noerder, Miriam; Huntington, Nicholas D.; Lim, Annick; Yasuda, Etsuko; Diehl, Sean A.; Scheeren, Ferenc A.; Ott, Michael; Weijer, Kees; Wedemeyer, Heiner; Di Santo, James P.; Beaumont, Tim; Guzman, Carlos A.; Spits, Hergen			Generation of Human Antigen-Specific Monoclonal IgM Antibodies Using Vaccinated "Human Immune System'' Mice	PLOS ONE			English	Article							MEMORY B-CELLS; GERMINAL-CENTER FORMATION; HEMATOPOIETIC STEM-CELLS; RAG2(-/-)GAMMA(-/-)(C) MICE; VIRUS-INFECTION; MOUSE MODEL; HU MICE; IN-VIVO; RESPONSES; DIFFERENTIATION	Background: Passive transfer of antibodies not only provides immediate short-term protection against disease, but also can be exploited as a therapeutic tool. However, the 'humanization' of murine monoclonal antibodies (mAbs) is a time-consuming and expensive process that has the inherent drawback of potentially altering antigenic specificity and/or affinity. The immortalization of human B cells represents an alternative for obtaining human mAbs, but relies on the availability of biological samples from vaccinated individuals or convalescent patients. In this work we describe a novel approach to generate fully human mAbs by combining a humanized mouse model with a new B cell immortalization technique. Methodology/Principal Findings: After transplantation with CD34(+)CD38(-) human hematopoietic progenitor cells, BALB/c Rag2(-/-)IL-2R gamma c(-/-) mice acquire a human immune system and harbor B cells with a diverse IgM repertoire. "Human Immune System'' mice were then immunized with two commercial vaccine antigens, tetanus toxoid and hepatitis B surface antigen. Sorted human CD19(+)CD27(+) B cells were retrovirally transduced with the human B cell lymphoma (BCL)-6 and BCL-XL genes, and subsequently cultured in the presence of CD40-ligand and IL-21. This procedure allows generating stable B cell receptor-positive B cells that secrete immunoglobulins. We recovered stable B cell clones that produced IgM specific for tetanus toxoid and the hepatitis B surface antigen, respectively. Conclusion/Significance: This work provides the proof-of-concept for the usefulness of this novel method based on the immunization of humanized mice for the rapid generation of human mAbs against a wide range of antigens.	[Becker, Pablo D.; Noerder, Miriam; Guzman, Carlos A.] Helmholtz Ctr Infect Res HZI, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Legrand, Nicolas; Diehl, Sean A.; Scheeren, Ferenc A.; Weijer, Kees; Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Ctr Immunol Amsterdam, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [van Geelen, Caroline M. M.; Yasuda, Etsuko; Beaumont, Tim; Spits, Hergen] AIMM Therapeut, Amsterdam, Netherlands; [Huntington, Nicholas D.; Di Santo, James P.] Inst Pasteur, Cytokines & Lymphoid Dev Unit, Paris, France; [Huntington, Nicholas D.; Lim, Annick; Di Santo, James P.] Inst Pasteur, INSERM, U668, F-75724 Paris, France; [Ott, Michael; Wedemeyer, Heiner] Hannover Med Sch, Twincore Ctr Expt & Clin Infect Res, Clin Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; University of Amsterdam; Academic Medical Center Amsterdam; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research	Becker, PD (corresponding author), Helmholtz Ctr Infect Res HZI, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany.	Hergen.Spits@amc.uva.nl	Di Santo, James P/M-4298-2014; Legrand, Nicolas/B-1794-2009; Huntington, NICHOLAS/AAV-4704-2020; Diehl, Sean/C-7166-2008; Diehl, Sean/AAE-2779-2020; Spits, Hergen/N-2581-2019; Legrand, Nicolas/B-1794-2009	Di Santo, James P/0000-0002-7146-1862; Legrand, Nicolas/0000-0002-0236-7653; Huntington, NICHOLAS/0000-0002-5267-7211; Diehl, Sean/0000-0001-9700-235X; Diehl, Sean/0000-0001-9700-235X; Spits, Hergen/0000-0003-3269-8338; Legrand, Nicolas/0000-0002-0900-3051; Becker, Pablo Daniel/0000-0003-1980-1230; Scheeren, Ferenc/0000-0002-8304-9023	Bill and Melinda Gates Foundation; Wijnand M. Pon Foundation; College de France; Fondation pour la Recherche Medicale (FRM); Institut Pasteur; Institut National de la Sante et de la Recherche Medicale (INSERM); Human Frontiers Science Program; National Institutes of Health (NIH-NIAID) [F32 AI063846]; Excellence Cluster "From Regenerative Biology to reconstructive Therapy''; German Research Foundation [EXC 62/1]; AIMM Therapeutic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI063846] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wijnand M. Pon Foundation; College de France; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut Pasteur(European Commission); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Human Frontiers Science Program(Human Frontier Science Program); National Institutes of Health (NIH-NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Excellence Cluster "From Regenerative Biology to reconstructive Therapy''; German Research Foundation(German Research Foundation (DFG)); AIMM Therapeutic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Bill and Melinda Gates Foundation "Grand Challenges in Global Health'' Program (GC4 - "Human Vaccine Consortium''; http://www.hv-consortium.org/), the Wijnand M. Pon Foundation, College de France, Fondation pour la Recherche Medicale (FRM), Institut Pasteur and the Institut National de la Sante et de la Recherche Medicale (INSERM). N.D.H. was supported by the Human Frontiers Science Program. S.A.D. was supported by the National Institutes of Health (NIH-NIAID grant # F32 AI063846). C.A. G. was supported by a grant from the Excellence Cluster "From Regenerative Biology to reconstructive Therapy'' by the German Research Foundation (EXC 62/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also in part financially supported by AIMM Therapeutic who did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 2000, IMMUNOL TODAY, V21, P204, DOI 10.1016/S0167-5699(00)01605-4; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Baker M, 2005, NAT BIOTECHNOL, V23, P1065, DOI 10.1038/nbt0905-1065; Carballido JM, 2000, NAT MED, V6, P103, DOI 10.1038/71434; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Ito R, 2008, CURR TOP MICROBIOL, V324, P95; Jackson SM, 2008, ADV IMMUNOL, V98, P151, DOI 10.1016/S0065-2776(08)00405-7; Jakobovits A, 2007, NAT BIOTECHNOL, V25, P1134, DOI 10.1038/nbt1337; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Kuruvilla JG, 2007, VIROLOGY, V369, P143, DOI 10.1016/j.virol.2007.06.005; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Legrand N, 2006, J IMMUNOL, V176, P2053, DOI 10.4049/jimmunol.176.4.2053; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Legrand Nicolas, 2008, V415, P65, DOI 10.1007/978-1-59745-570-1_4; Lim A, 2008, INT IMMUNOL, V20, P105, DOI 10.1093/intimm/dxm125; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; O'Connell RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012009; Pendley C, 2003, CURR OPIN MOL THER, V5, P172; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; Scheeren FA, 2005, NAT IMMUNOL, V6, P303, DOI 10.1038/ni1172; Scheeren FA, 2008, J EXP MED, V205, P2033, DOI 10.1084/jem.20070447; Scott CT, 2007, NAT BIOTECHNOL, V25, P1075, DOI 10.1038/nbt1007-1075; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tonomura N, 2008, BLOOD, V111, P4293, DOI 10.1182/blood-2007-11-121319; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; van Lent AU, 2009, J IMMUNOL, V183, P7645, DOI 10.4049/jimmunol.0902019; VONBEHRING E, 1991, MOL IMMUNOL, V28, P1319; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Yajima M, 2008, J INFECT DIS, V198, P673, DOI 10.1086/590502; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	45	44	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13137	10.1371/journal.pone.0013137	http://dx.doi.org/10.1371/journal.pone.0013137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957227	Green Published, gold			2022-12-25	WOS:000282423300004
J	O'Donnell, EF; Saili, KS; Koch, DC; Kopparapu, PR; Farrer, D; Bisson, WH; Mathew, LK; Sengupta, S; Kerkvliet, NI; Tanguay, RL; Kolluri, SK				O'Donnell, Edmond F.; Saili, Katerine S.; Koch, Daniel C.; Kopparapu, Prasad R.; Farrer, David; Bisson, William H.; Mathew, Lijoy K.; Sengupta, Sumitra; Kerkvliet, Nancy I.; Tanguay, Robert L.; Kolluri, Siva Kumar			The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							CELL-CYCLE REGULATION; AH DIOXIN RECEPTOR; RETINOBLASTOMA PROTEIN; NUCLEAR TRANSLOCATOR; RHEUMATOID-ARTHRITIS; HEPATOMA-CELLS; IMMUNE-SYSTEM; IN-VITRO; ACTIVATION; EXPRESSION	Background: The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates the toxicity and biological activity of dioxins and related chemicals. The AhR influences a variety of processes involved in cellular growth and differentiation, and recent studies have suggested that the AhR is a potential target for immune-mediated diseases. Methodology/Principal Findings: During a screen for molecules that activate the AhR, leflunomide, an immunomodulatory drug presently used in the clinic for the treatment of rheumatoid arthritis, was identified as an AhR agonist. We aimed to determine whether any biological activity of leflunomide could be attributed to a previously unappreciated interaction with the AhR. The currently established mechanism of action of leflunomide involves its metabolism to A771726, possibly by cytochrome P450 enzymes, followed by inhibition of de novo pyrimidine biosynthesis by A771726. Our results demonstrate that leflunomide, but not its metabolite A771726, caused nuclear translocation of AhR into the nucleus and increased expression of AhR-responsive reporter genes and endogenous AhR target genes in an AhR-dependent manner. In silico Molecular Docking studies employing AhR ligand binding domain revealed favorable binding energy for leflunomide, but not for A771726. Further, leflunomide, but not A771726, inhibited in vivo epimorphic regeneration in a zebrafish model of tissue regeneration in an AhR-dependent manner. However, suppression of lymphocyte proliferation by leflunomide or A771726 was not dependent on AhR. Conclusions: These data reveal that leflunomide, an anti-inflammatory drug, is an agonist of the AhR. Our findings link AhR activation by leflunomide to inhibition of fin regeneration in zebrafish. Identification of alternative AhR agonists is a critical step in evaluating the AhR as a therapeutic target for the treatment of immune disorders.	[O'Donnell, Edmond F.; Koch, Daniel C.; Kopparapu, Prasad R.; Bisson, William H.; Kolluri, Siva Kumar] Oregon State Univ, Environm Hlth Sci Ctr, Canc Res Lab, Corvallis, OR 97331 USA; [O'Donnell, Edmond F.; Saili, Katerine S.; Koch, Daniel C.; Kopparapu, Prasad R.; Farrer, David; Bisson, William H.; Mathew, Lijoy K.; Sengupta, Sumitra; Kerkvliet, Nancy I.; Tanguay, Robert L.; Kolluri, Siva Kumar] Oregon State Univ, Environm Hlth Sci Ctr, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Bisson, William H.] Univ Geneva, Sch Pharmaceut Sci, Pharmaceut Biochem Grp, Geneva, Switzerland	Oregon State University; Oregon State University; University of Geneva	O'Donnell, EF (corresponding author), Oregon State Univ, Environm Hlth Sci Ctr, Canc Res Lab, Corvallis, OR 97331 USA.	Siva.Kolluri@Oregonstate.edu	Sengupta, Sumitra/G-1814-2017	Sengupta, Sumitra/0000-0003-2861-5608; /0000-0001-9516-9690; Saili, Katerine/0000-0001-5759-1006	National Institute of Environmental Health Sciences (NIEHS) [ES016651, T32ES07060]; National Science Foundation [0641409]; Environmental Health Sciences Center, NIEHS [P30 ES00210]; Department of Defense [W81XWH-10-1-0160]; National Cancer Institute [1F31CA144571-01]; NATIONAL CANCER INSTITUTE [F31CA144571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007060, P30ES000210, R01ES016651, P42ES016465] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation(National Science Foundation (NSF)); Environmental Health Sciences Center, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the National Institute of Environmental Health Sciences (NIEHS) grant number ES016651, the National Science Foundation grant number 0641409, and the Aquatic Biomedical Models and the Cell Imaging and Analysis Facility Cores of the Environmental Health Sciences Center, NIEHS grant number P30 ES00210. EFO, KSS, DCK and DF were supported by NIEHS training grant (T32ES07060). EFO is supported by a pre-doctoral fellowship from the Department of Defense Breast Cancer Research Program (W81XWH-10-1-0160), and DCK is supported by the National Research Service Award (1F31CA144571-01) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Beischlag TV, 2004, J BIOL CHEM, V279, P54620, DOI 10.1074/jbc.M410456200; Bisson WH, 2009, J MED CHEM, V52, P5635, DOI 10.1021/jm900199u; Blankenship A, 1997, MOL PHARMACOL, V52, P667, DOI 10.1124/mol.52.4.667; Elferink CJ, 2001, MOL PHARMACOL, V59, P664, DOI 10.1124/mol.59.4.664; FAN Y, CANC RES, V70, P212; Fritz WA, 2007, CARCINOGENESIS, V28, P497, DOI 10.1093/carcin/bgl179; Ftitz WA, 2009, BIOCHEM PHARMACOL, V77, P1151, DOI 10.1016/j.bcp.2008.12.015; Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; Gasiewicz TA, 2008, CRIT REV EUKAR GENE, V18, P279, DOI 10.1615/CritRevEukarGeneExpr.v18.i4.10; Grabar PB, 2009, DRUG METAB DISPOS, V37, P2061, DOI 10.1124/dmd.109.027482; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; HANKINSON O, 1979, P NATL ACAD SCI USA, V76, P373, DOI 10.1073/pnas.76.1.373; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Kalgutkar AS, 2003, DRUG METAB DISPOS, V31, P1240, DOI 10.1124/dmd.31.10.1240; Kerkvliet NI, 2009, IMMUNOTHERAPY-UK, V1, P539, DOI 10.2217/IMT.09.24; Kerkvliet NI, 2009, BIOCHEM PHARMACOL, V77, P746, DOI 10.1016/j.bcp.2008.11.021; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Kolluri SK, 2005, P NATL ACAD SCI USA, V102, P2525, DOI 10.1073/pnas.0409721102; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Ma Q, 1996, MOL CELL BIOL, V16, P2144; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Mathew LK, 2008, FASEB J, V22, P3087, DOI 10.1096/fj.08-109009; Mathew LK, 2006, MOL PHARMACOL, V69, P257, DOI 10.1124/mol.105.018044; Miceli-Richard C, 2003, EXPERT OPIN PHARMACO, V4, P987, DOI 10.1517/14656566.4.6.987; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NumayamaTsuruta K, 1997, EUR J BIOCHEM, V246, P486, DOI 10.1111/j.1432-1033.1997.00486.x; Puga A, 2002, CHEM-BIOL INTERACT, V141, P117, DOI 10.1016/S0009-2797(02)00069-8; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Safe S, 2002, INT J ONCOL, V20, P1123; Safe S, 2001, TOXICOL LETT, V120, P1, DOI 10.1016/S0378-4274(01)00301-0; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Stockinger Brigitta, 2009, Journal of Biology (London), V8, P61, DOI 10.1186/jbiol170; Sy SKB, 2001, EUR J CLIN PHARMACOL, V57, P377, DOI 10.1007/s002280100330; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Weiss C, 2005, ONCOGENE, V24, P4975, DOI 10.1038/sj.onc.1208679; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; Zodrow JM, 2003, TOXICOL SCI, V76, P151, DOI 10.1093/toxsci/kfg205	45	83	88	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13128	10.1371/journal.pone.0013128	http://dx.doi.org/10.1371/journal.pone.0013128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957046	gold, Green Published, Green Submitted			2022-12-25	WOS:000282359300022
J	Keller, CW; Fokken, C; Turville, SG; Lunemann, A; Schmidt, J; Munz, C; Lunemann, JD				Keller, Christian W.; Fokken, Claudia; Turville, Stuart G.; Luenemann, Anna; Schmidt, Jens; Muenz, Christian; Luenemann, Jan D.			TNF-alpha Induces Macroautophagy and Regulates MHC Class II Expression in Human Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOSITIS; NECROSIS-FACTOR-ALPHA; IDIOPATHIC INFLAMMATORY MYOPATHIES; T-CELLS; INDUCED AUTOPHAGY; LIGAND TRAIL; APOPTOSIS; POLYMYOSITIS; DEATH; IMMUNOBIOLOGY	Macroautophagy, a homeostatic process that shuttles cytoplasmic constituents into endosomal and lysosomal compartments, has recently been shown to deliver antigens for presentation on major histocompatibility complex (MHC) class II molecules. Skeletal muscle fibers show a high level of constitutive macroautophagy and express MHC class II molecules upon immune activation. We found that tumor necrosis factor-alpha (TNF-alpha), a monokine overexpressed in inflammatory myopathies, led to a marked up-regulation of macroautophagy in skeletal myocytes. Furthermore, TNF-alpha augmented surface expression of MHC class II molecules in interferon-gamma (IFN-gamma)-treated myoblasts. The synergistic effect of TNF-alpha and IFN-gamma on the induction of MHC class II surface expression was not reflected by higher intracellular human leukocyte antigen (HLA)-DR levels and was reversed by macroautophagy inhibition, suggesting that TNF-alpha facilitates antigen processing via macroautophagy for more efficient MHC class II loading. Muscle biopsies from patients with sporadic inclusion body myositis, a well defined myopathy with chronic inflammation, showed that over 20% of fibers that contained autophagosomes costained for MHC class II molecules and that more than 40% of double-positive muscle fibers had contact with CD4(+) and CD8(+) immune cells. These findings establish a mechanism through which TNF-alpha regulates both macroautophagy and MHC class II expression and suggest that macroautophagy-mediated antigen presentation contributes to the immunological environment of the inflamed human skeletal muscle.	[Luenemann, Anna; Muenz, Christian; Luenemann, Jan D.] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Keller, Christian W.; Luenemann, Anna; Muenz, Christian; Luenemann, Jan D.] Rockefeller Univ, Lab Viral Immunobiol, Christopher H Browne Ctr Immunol & Immune Dis, New York, NY 10065 USA; [Keller, Christian W.; Fokken, Claudia; Schmidt, Jens] Univ Med Ctr, Inst Multiple Sclerosis Res, Dept Neurol, D-37073 Gottingen, Germany; [Keller, Christian W.; Fokken, Claudia; Schmidt, Jens] Univ Med Ctr, Inst Multiple Sclerosis Res, Dept Neuroimmunol, D-37073 Gottingen, Germany; [Keller, Christian W.; Fokken, Claudia; Schmidt, Jens] Univ Med Ctr, Hertie Fdn, D-37073 Gottingen, Germany; [Turville, Stuart G.] Westmead Hosp, Ctr Virus Res, Westmead Millennium Inst, Sydney, NSW 2145, Australia; [Turville, Stuart G.] Univ Sydney, Sydney, NSW 2145, Australia	University of Zurich; Rockefeller University; University of Gottingen; University of Gottingen; University of Gottingen; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Lunemann, JD (corresponding author), Univ Zurich, Inst Expt Immunol, Campus Irchel,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jan.luenemann@usz.ch	Münz, Christian/W-4881-2017; Schmidt, Jens/B-5791-2013; Lunemann, Jan D/G-8729-2011	Lunemann, Jan D/0000-0002-3007-708X; Keller, Christian Wolfgang/0000-0003-2276-0003; Munz, Christian/0000-0001-6419-1940; Turville, Stuart/0000-0003-1918-5343	National Institutes of Health, NCI [R01CA108609, R01CA101741]; Foundation for National Institutes of Health Grand Challenges in Global Health; Boehringer Ingelheim; University of Gottingen; Swiss National Science Foundation [310030_126995]; Deutsche Forschungsgemeinschaft [SCHM 1669/2-1]; Fritz Thyssen Stiftung [Az 10.08.2.168]; Swiss National Research Foundation; Gemeinnutzige Hertie Stiftung; Swiss Multiple Sclerosis Foundation; Betty and David Koetser Foundation; Ernst Schering Foundation; Baxter Research Grant Program; NATIONAL CANCER INSTITUTE [R01CA108609, R01CA101741] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Foundation for National Institutes of Health Grand Challenges in Global Health; Boehringer Ingelheim(Boehringer Ingelheim); University of Gottingen; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz Thyssen Stiftung; Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Gemeinnutzige Hertie Stiftung; Swiss Multiple Sclerosis Foundation; Betty and David Koetser Foundation; Ernst Schering Foundation; Baxter Research Grant Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA108609 and R01CA101741 from NCI and Foundation for National Institutes of Health Grand Challenges in Global Health.; Supported by Boehringer Ingelheim Fonds Travel Allowance and funds from the University of Gottingen.; Supported by the Marie-Heim Vogtlin Program of the Swiss National Science Foundation.; Supported by Deutsche Forschungsgemeinschaft Grant SCHM 1669/2-1 and Fritz Thyssen Stiftung Grant Az 10.08.2.168.; Supported by Swiss National Science Foundation Grant 310030_126995.; Recipient of grant support from Swiss National Research Foundation, Gemeinnutzige Hertie Stiftung, Swiss Multiple Sclerosis Foundation, Betty and David Koetser Foundation, Ernst Schering Foundation, and Baxter Research Grant Program. To whom correspondence should be addressed: Institute of Experimental Immunology, University of Zurich, Campus Irchel, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. Tel.: 41-44-635-3701; Fax: 41-44-635-6883; E-mail: jan.luenemann@usz.ch.	Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Arancibia-Carcamo CV, 2004, EUR J IMMUNOL, V34, P471, DOI 10.1002/eji.200324195; Curnow J, 2001, J NEUROIMMUNOL, V115, P127, DOI 10.1016/S0165-5728(01)00272-7; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; Dalakas MC, 2006, NAT CLIN PRACT RHEUM, V2, P219, DOI 10.1038/ncprheum0140; De Bleecker JL, 1999, NEUROMUSCULAR DISORD, V9, P239, DOI 10.1016/S0960-8966(98)00126-6; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; ENGEL AG, 1984, ANN NEUROL, V16, P209, DOI 10.1002/ana.410160207; Englund P, 2007, ARTHRITIS RHEUM-US, V56, P372, DOI 10.1002/art.22293; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Fyhr IM, 2002, ACTA NEUROL SCAND, V105, P403, DOI 10.1034/j.1600-0404.2002.01198.x; GOEBELS N, 1992, J IMMUNOL, V149, P661; Greenberg SA, 2007, MUSCLE NERVE, V35, P17, DOI 10.1002/mus.20649; Gupta S, 2002, J CLIN IMMUNOL, V22, P185, DOI 10.1023/A:1016089607548; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HOHLFELD R, 1994, IMMUNOL TODAY, V15, P269, DOI 10.1016/0167-5699(94)90006-X; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura N, 2007, PATHOBIOLOGY, V74, P169, DOI 10.1159/000103376; Klein L, 2010, FEBS LETT, V584, P1405, DOI 10.1016/j.febslet.2010.01.008; Kumamoto T, 2004, ACTA NEUROPATHOL, V107, P59, DOI 10.1007/s00401-003-0774-2; Kuru S, 2000, ACTA NEUROPATHOL, V99, P585, DOI 10.1007/s004010051165; Lepidi H, 1998, NEUROPATH APPL NEURO, V24, P73, DOI 10.1046/j.1365-2990.1998.00092.x; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lundberg I, 1995, J NEUROIMMUNOL, V63, P9, DOI 10.1016/0165-5728(95)00122-0; Lunemann JD, 2007, AUTOPHAGY, V3, P384; Lunemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115; Lunemann JD, 2002, J IMMUNOL, V168, P4881, DOI 10.4049/jimmunol.168.10.4881; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; MICHAELIS D, 1993, AM J PATHOL, V143, P1142; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nikcevich KM, 1999, J NEUROIMMUNOL, V99, P195, DOI 10.1016/S0165-5728(99)00117-4; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pandya JM, 2010, ARTHRITIS RHEUM-US, V62, P3457, DOI 10.1002/art.27665; Porter KE, 2004, CARDIOVASC RES, V64, P507, DOI 10.1016/j.cardiores.2004.07.020; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schmidt J, 2004, BRAIN, V127, P1182, DOI 10.1093/brain/awh148; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Thorburn J, 2005, MOL BIOL CELL, V16, P1189, DOI 10.1091/mbc.E04-10-0906; Wang YJ, 2008, J BIOL CHEM, V283, P4766, DOI 10.1074/jbc.M706666200; WARRENS AN, 1994, INT IMMUNOL, V6, P847, DOI 10.1093/intimm/6.6.847; Wiendl H, 2005, TRENDS IMMUNOL, V26, P373, DOI 10.1016/j.it.2005.05.003; Wiendl H, 2003, BRAIN, V126, P176, DOI 10.1093/brain/awg017	51	95	100	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3970	3980		10.1074/jbc.M110.159392	http://dx.doi.org/10.1074/jbc.M110.159392			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	20980264	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000286653200077
J	Garcia-Marcos, M; Jung, BH; Ear, J; Cabrera, B; Carethers, JM; Ghosh, P				Garcia-Marcos, Mikel; Jung, Barbara H.; Ear, Jason; Cabrera, Betty; Carethers, John M.; Ghosh, Pradipta			Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer	FASEB JOURNAL			English	Article						PI3K-Akt; guanine-nucleotide exchange factor; cell migration; growth factor receptors; cytoskeleton; G protein; microsatellite instability	ACTIN-BINDING PROTEIN; G-ALPHA-I; COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; CELL-LINES; CHROMOSOMAL INSTABILITY; AKT; ACTIVATION; GIV; ASSOCIATION	Metastasis accounts for the majority of cancer-related deaths. Accurate prediction of metastatic potential of tumors has been elusive, and the search for clinically useful markers continues. We previously reported that GIV/Girdin triggers tumor cell migration by virtue of a C-terminal guanine-nucleotide exchange factor motif that activates G alpha i. Here we identify GIV as a metastasis-related protein whose full-length transcript (GIV-fl) is expressed exclusively in highly invasive colon, breast, and pancreatic carcinoma cells and not in their poorly invasive counterparts. A prospective, exploratory biomarker study conducted on a cohort of 56 patients with stage II colorectal cancer revealed a significant correlation between GIV-fl expression in tumor epithelium and shortened metastasis-free survival. Survival rate for patients with GIV-fl-positive tumors is significantly reduced compared with the patients with GIV-fl-negative tumors [P<0.0001; hazard ratio=0.076; CI=0.052-0.30 (95%)]. At the 5-yr mark, survival is 100% in the GIV-fl-negative group and 62 +/- 9% (mean +/- SE; P=6X10(-5)) in the GIV-fl-positive group. Furthermore, GIV-fl expression predicts a risk of mortality independent of the microsatellite stability status, a well-established prognosticator of colorectal cancers. We conclude that GIV-fl is a novel metastasis-related protein and an independent adverse prognosticator that may serve as a useful adjunct to traditional staging strategies in colorectal carcinoma.-Garcia-Marcos, M., Jung, B. H., Ear, J., Cabrera, B., Carethers, J. M., Ghosh, P. Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer. FASEB J. 25, 590-599 (2011). www.fasebj.org	[Garcia-Marcos, Mikel; Ghosh, Pradipta] Univ Calif San Diego, Dept Cellular & Mol Med, George E Palade Labs, San Diego, CA 92103 USA; [Jung, Barbara H.; Ear, Jason; Cabrera, Betty; Carethers, John M.; Ghosh, Pradipta] Univ Calif San Diego, Dept Med, Div Gastroenterol, San Diego, CA 92103 USA; [Carethers, John M.; Ghosh, Pradipta] Univ Calif San Diego, Rebecca & John Moores Comprehens Canc Ctr, San Diego, CA 92103 USA; [Jung, Barbara H.; Carethers, John M.; Ghosh, Pradipta] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Ghosh, P (corresponding author), Univ Calif San Diego, Sch Med, George E Palade Labs Cellular & Mol Med, 9500 Gilman Dr,Rm 333, La Jolla, CA 92093 USA.	prghosh@ucsd.edu		Garcia-Marcos, Mikel/0000-0001-9513-4826	Burroughs Wellcome Fund; American Gastroenterology Association; U.S. National Institutes of Health (NIH) [K08-DK-074019, R01-DK-067287]; University of California, San Diego, Digestive Diseases Research Development Center; U.S. Public Health Service [DK-080506]; Basque Government [BFI06.300]; Susan G. Komen [KG080079]; NIH [CA100768]; NATIONAL CANCER INSTITUTE [R01CA100768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, K08DK074019, R01DK067287] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Gastroenterology Association; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego, Digestive Diseases Research Development Center; U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Basque Government(Basque Government); Susan G. Komen(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Marilyn G. Farquhar for scientific mentoring, advice, and thoughtful comments during preparation of this work. The authors thank Samuel B. Ho (University of California, San Diego) for the generous gift of paired tumor tissue samples from patients with Duke's D colorectal cancer with synchronous liver metastases and Michael Lam (University of California, San Diego) for advice and technical help with the real-time quantitative RT-PCR. This work was supported by awards from the Burroughs Wellcome Fund and American Gastroenterology Association to P.G.; U.S. National Institutes of Health (NIH) grants K08-DK-074019 and R01-DK-067287 to B.H.J and J.M.C, respectively; and the University of California, San Diego, Digestive Diseases Research Development Center, U.S. Public Health Service grant DK-080506. M.G.-M. was supported by Basque Government Postdoctoral Fellowship BFI06.300 and Susan G. Komen Postdoctoral Fellowship KG080079. J.E. is a recipient of a McNair Student Research Scholarship. The authors thank Erin P. Forry for help with tissue culture, and she was supported by NIH grant CA100768 to Marilyn Farquhar.	Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; BAND V, 1990, CANCER RES, V50, P7351; Barbara JT, 2006, INT J CANCER, V118, P2509, DOI 10.1002/ijc.21710; Boland CR, 1998, CANCER RES, V58, P5248; BRESALIER RS, 1987, CANCER RES, V47, P1398; Carethers JM, 1998, GASTROENTEROLOGY, V114, P1188, DOI 10.1016/S0016-5085(98)70424-X; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Enomoto A, 2006, ANN NY ACAD SCI, V1086, P169, DOI 10.1196/annals.1377.016; Erlichman C, 1999, J CLIN ONCOL, V17, P1356, DOI 10.1200/JCO.1999.17.5.1356; ESTELLER M, 2007, Patent No. 2007122369; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Flatmark K, 2004, EUR J CANCER, V40, P1593, DOI 10.1016/j.ejca.2004.02.023; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Gervaz P, 2002, SURGERY, V131, P190, DOI 10.1067/msy.2002.119816; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Grzesiak JJ, 2006, BRIT J CANCER, V94, P1311, DOI 10.1038/sj.bjc.6603088; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Jung B, 2004, GASTROENTEROLOGY, V126, P654, DOI 10.1053/j.gastro.2004.01.008; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MILLER L, 2006, Patent No. 2007013671; MILLER L, 2006, Patent No. 20060074565; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; NOH DY, 1994, CANCER, V73, P36, DOI 10.1002/1097-0142(19940101)73:1<36::AID-CNCR2820730108>3.0.CO;2-5; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Qiao M, 2007, CANCER RES, V67, P5293, DOI 10.1158/0008-5472.CAN-07-0877; Saglam O, 2007, CLIN COLORECTAL CANC, V6, P652, DOI 10.3816/CCC.2007.n.034; Simpson F, 2005, TRAFFIC, V6, P442, DOI 10.1111/j.1600-0854.2005.00289.x; Talmadge JE, 2007, CANCER RES, V67, P11471, DOI 10.1158/0008-5472.CAN-07-2496; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; VEZERIDIS MP, 1990, J SURG RES, V48, P51, DOI 10.1016/0022-4804(90)90145-R; Walther A, 2008, GUT, V57, P941, DOI 10.1136/gut.2007.135004; WENG L, CANC SCI, V101, P836	44	58	63	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					590	599		10.1096/fj.10-167304	http://dx.doi.org/10.1096/fj.10-167304			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20974669	Green Published			2022-12-25	WOS:000286724800017
J	Hunter, GA; Ferreira, GC				Hunter, Gregory A.; Ferreira, Gloria C.			Identification and Characterization of an Inhibitory Metal Ion-binding Site in Ferrochelatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS FERROCHELATASE; MITOCHONDRIAL CARRIER PROTEINS; HEME-BIOSYNTHESIS; PRODUCT RELEASE; IRON; FRATAXIN; CHELATION; BUFFERS; ENZYME	Ferrochelatase catalyzes the insertion of ferrous iron into protoporphyrin IX to form heme. The severe metal ion substrate inhibition observed during in vitro studies of the purified enzyme is almost completely eliminated by mutation of an active site histidine residue (His-287, murine ferrochelatase numbering) to leucine and reduced over 2 orders of magnitude by mutation of a nearby conserved phenylalanine residue (Phe-283) to leucine. Elimination of substrate inhibition had no effect on the apparent V-max for Ni2+, but the apparent K-m was increased 100-fold, indicating that the integrity of the inhibitory binding site is important for the enzyme to turn over substrates rapidly at low micromolar metal ion concentrations. The inhibitory site was observed to have a pK(a) value of 8.0, and this value was reduced to 7.5 by the F283L mutation and to 7.4 in a naturally occurring positional variant observed in most bacterial ferrochelatases, murine ferrochelatase H287C. A H287N variant was also found to be substrate-inhibited, but unlike the H287C variant, pH dependence of substrate inhibition was largely eliminated. The data indicate that the inhibitory metal ion-binding site is composed of multiple residues but primarily defined by His-287 and Phe-283 and is crucial for optimal activity at low metal ion concentrations. It is proposed that this binding site may be important for ferrous iron acquisition and desolvation in vivo.	[Hunter, Gregory A.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Hunter, GA (corresponding author), Univ S Florida, Coll Med, Dept Mol Med, MDC 7, Tampa, FL 33612 USA.	ghunter@health.usf.edu; gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	National Institutes of Health [GM080270]; American Heart Association Florida [0655091B]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Florida(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080270 (to G. C. F.). This work was also supported by the American Heart Association Florida Affiliate 0655091B (to G. C. F.).	Al-Karadaghi S, 2006, TRENDS BIOCHEM SCI, V31, P135, DOI 10.1016/j.tibs.2006.01.001; [Anonymous], 2010, HDB PORPHYRIN SCI, V15; Bencze KZ, 2007, CHEM COMMUN, P1798, DOI 10.1039/b703195e; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Cleland W W, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P273; Davidson RE, 2009, J BIOL CHEM, V284, P33795, DOI 10.1074/jbc.M109.030205; FERREIRA GC, 1994, J BIOL CHEM, V269, P4396; FISCHER BE, 1979, EUR J BIOCHEM, V94, P523, DOI 10.1111/j.1432-1033.1979.tb12921.x; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gouya L, 2002, NAT GENET, V30, P27, DOI 10.1038/ng809; Hansson MD, 2007, BIOCHEMISTRY-US, V46, P87, DOI 10.1021/bi061760a; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Hoggins M, 2007, BIOCHEMISTRY-US, V46, P8121, DOI 10.1021/bi602418e; Hunter GA, 2008, J BIOL CHEM, V283, P23685, DOI 10.1074/jbc.M803372200; Kuchar J, 2004, CHEM REV, V104, P509, DOI 10.1021/cr020613p; Lecerof D, 2003, J BIOL INORG CHEM, V8, P452, DOI 10.1007/s00775-002-0436-1; Lecha M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-19; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Mash HE, 2003, ANAL CHEM, V75, P671, DOI 10.1021/ac0261101; Medlock AE, 2007, J MOL BIOL, V373, P1006, DOI 10.1016/j.jmb.2007.08.040; Medlock AE, 2009, J MOL BIOL, V393, P308, DOI 10.1016/j.jmb.2009.08.042; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Wu CK, 2001, NAT STRUCT BIOL, V8, P156, DOI 10.1038/84152; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yu QY, 1997, ANAL BIOCHEM, V253, P50, DOI 10.1006/abio.1997.2349; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200	28	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41836	41842		10.1074/jbc.M110.174243	http://dx.doi.org/10.1074/jbc.M110.174243			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20966079	hybrid, Green Published			2022-12-25	WOS:000285622600071
J	Jesch, SA; Gaspar, ML; Stefan, CJ; Aregullin, MA; Henry, SA				Jesch, Stephen A.; Gaspar, Maria L.; Stefan, Christopher J.; Aregullin, Manuel A.; Henry, Susan A.			Interruption of Inositol Sphingolipid Synthesis Triggers Stt4p-dependent Protein Kinase C Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL INTEGRITY; SAC1 LIPID PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; MAP-KINASE; PHOSPHATIDYLINOSITOL 4-KINASE; PHOSPHOLIPID-METABOLISM; BUDDING YEAST; 1,3-BETA-D-GLUCAN SYNTHASE; ACTIN CYTOSKELETON	The protein kinase C (PKC)-MAPK signaling cascade is activated and is essential for viability when cells are starved for the phospholipid precursor inositol. In this study, we report that inhibiting inositol-containing sphingolipid metabolism, either by inositol starvation or treatment with agents that block sphingolipid synthesis, triggers PKC signaling independent of sphingoid base accumulation. Under these same growth conditions, a fluorescent biosensor that detects the necessary PKC signaling intermediate, phosphatidylinositol (PI)-4-phosphate (PI4P), is enriched on the plasma membrane. The appearance of the PI4P biosensor on the plasma membrane correlates with PKC activation and requires the PI 4-kinase Stt4p. Like other mutations in the PKC-MAPK pathway, mutants defective in Stt4p and the PI4P 5-kinase Mss4p, which generates phosphatidylinositol 4,5-bisphosphate, exhibit inositol auxotrophy, yet fully derepress INO1, encoding inositol-3-phosphate synthase. These observations suggest that inositol-containing sphingolipid metabolism controls PKC signaling by regulating access of the signaling lipids PI4P and phosphatidylinositol 4,5-bisphosphate to effector proteins on the plasma membrane.	[Henry, Susan A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Stefan, Christopher J.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Henry, SA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 249 Biotechnol Bldg, Ithaca, NY 14853 USA.	sah42@cornell.edu	Henry, Susan/K-5464-2014	Stefan, Christopher/0000-0002-4118-5721	National Institutes of Health [GM-19629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019629, F32GM019629, R01GM019629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-19629 (to S.A.H.).	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; Balasubramanian K, 1996, EUR J BIOCHEM, V240, P798, DOI 10.1111/j.1432-1033.1996.0798h.x; BECKER GW, 1977, J BIOL CHEM, V252, P8684; Becker KP, 2005, CELL MOL LIFE SCI, V62, P1448, DOI 10.1007/s00018-005-4531-7; Brachmann CB, 1998, YEAST, V14, P115; Brice SE, 2009, J BIOL CHEM, V284, P7588, DOI 10.1074/jbc.M808325200; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; CERBON J, 1995, BBA-BIOMEMBRANES, V1235, P100, DOI 10.1016/0005-2736(94)00311-C; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Endo M, 1997, ANTIMICROB AGENTS CH, V41, P672, DOI 10.1128/AAC.41.3.672; Faulhammer F, 2005, J CELL BIOL, V168, P185, DOI 10.1083/jcb.200407118; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foti M, 2001, MOL BIOL CELL, V12, P2396, DOI 10.1091/mbc.12.8.2396; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Han GS, 2002, J BIOL CHEM, V277, P47709, DOI 10.1074/jbc.M207996200; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; HANSON BA, 1980, J LIPID RES, V21, P309; HAWKINS PT, 1986, BIOCHEM J, V238, P507, DOI 10.1042/bj2380507; HECHTBERGER P, 1994, EUR J BIOCHEM, V225, P641, DOI 10.1111/j.1432-1033.1994.00641.x; HEIDLER SA, 1995, ANTIMICROB AGENTS CH, V39, P2765, DOI 10.1128/AAC.39.12.2765; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Heung LJ, 2004, J BIOL CHEM, V279, P21144, DOI 10.1074/jbc.M312995200; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Inagaki M, 1999, MOL CELL BIOL, V19, P8344; INOUE SB, 1995, EUR J BIOCHEM, V231, P845, DOI 10.1111/j.1432-1033.1995.tb20770.x; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kobayashi T, 2005, J BIOL CHEM, V280, P18087, DOI 10.1074/jbc.M414138200; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Liu K, 2005, J BIOL CHEM, V280, P22679, DOI 10.1074/jbc.M502972200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Manford A, 2010, EMBO J, V29, P1489, DOI 10.1038/emboj.2010.57; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MAZZONI C, 1993, J CELL BIOL, V123, P1821, DOI 10.1083/jcb.123.6.1821; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; NIKAWA J, 1984, EUR J BIOCHEM, V143, P251, DOI 10.1111/j.1432-1033.1984.tb08366.x; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Ozaki K, 1996, EMBO J, V15, P2196, DOI 10.1002/j.1460-2075.1996.tb00573.x; Parrish WR, 2005, J CELL SCI, V118, P5589, DOI 10.1242/jcs.02649; Parrish WR, 2004, MOL BIOL CELL, V15, P3567, DOI 10.1091/mbc.E04-03-0209; PATTON JL, 1991, J BACTERIOL, V173, P3101, DOI 10.1128/JB.173.10.3101-3108.1991; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; Perera NM, 2004, J BIOL CHEM, V279, P5216, DOI 10.1074/jbc.M305068200; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Qadota H, 1996, SCIENCE, V272, P279, DOI 10.1126/science.272.5259.279; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Sawai H, 1999, CHEM PHYS LIPIDS, V102, P141, DOI 10.1016/S0009-3084(99)00082-1; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Stock SD, 2000, ANTIMICROB AGENTS CH, V44, P1174, DOI 10.1128/AAC.44.5.1174-1180.2000; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Villa-Garcia M., 2011, MOL GENET G IN PRESS; WHITTERS EA, 1993, J CELL BIOL, V122, P79, DOI 10.1083/jcb.122.1.79; YOSHIDA S, 1994, MOL GEN GENET, V242, P631, DOI 10.1007/BF00283416; YOSHIDA S, 1994, J BIOL CHEM, V269, P1166; Zarzov P, 1996, EMBO J, V15, P83, DOI 10.1002/j.1460-2075.1996.tb00336.x	92	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41947	41960		10.1074/jbc.M110.188607	http://dx.doi.org/10.1074/jbc.M110.188607			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20972263	Green Published, hybrid			2022-12-25	WOS:000285622600081
J	Ooms, LS; Kobayashi, T; Dermody, TS; Chappell, JD				Ooms, Laura S.; Kobayashi, Takeshi; Dermody, Terence S.; Chappell, James D.			A Post-entry Step in the Mammalian Orthoreovirus Replication Cycle Is a Determinant of Cell Tropism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE-SENSITIVE MUTANTS; REVERSE GENETICS SYSTEM; DOUBLE-STRANDED-RNA; CORE PROTEIN MU-2; REOVIRUS TYPE 3; M1 GENE; INFLUENZA-VIRUS; TRIPHOSPHATASE ACTIVITIES; INDUCED APOPTOSIS; STRAIN	Mammalian reoviruses replicate in a broad range of hosts, cells, and tissues. These viruses display strain-dependent variation in tropism for different types of cells in vivo and ex vivo. Early steps in the reovirus life cycle, attachment, entry, and disassembly, have been identified as pivotal points of virus-cell interaction that determine the fate of infection, either productive or abortive. However, in studies of the differential capacity of reovirus strains type 1 Lang and type 3 Dearing to replicate in Madin-Darby canine kidney (MDCK) cells, we found that replication efficiency is regulated at a late point in the viral life cycle following primary transcription and translation. Results of genetic studies using recombinant virus strains show that reovirus tropism for MDCK cells is primarily regulated by replication protein mu 2 and further influenced by the viral RNA-dependent RNA polymerase protein, mu 3, depending on the viral genetic background. Furthermore, mu 2 residue 347 is a critical determinant of replication efficiency in MDCK cells. These findings indicate that components of the reovirus replication complex are mediators of cell-selective viral replication capacity at a post-entry step. Thus, reovirus cell tropism may be determined at early and late points in the viral replication program.	[Ooms, Laura S.; Kobayashi, Takeshi; Dermody, Terence S.; Chappell, James D.] Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37232 USA; [Ooms, Laura S.; Chappell, James D.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [Kobayashi, Takeshi; Dermody, Terence S.; Chappell, James D.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Chappell, JD (corresponding author), Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, D7235 MCN, Nashville, TN 37232 USA.	jim.chappell@vanderbilt.edu			United States Public Health Service [K08 AI62862, R01 AI32539]; Vanderbilt Department of Pathology; Naito Foundation; Elizabeth B. Lamb Center for Pediatric Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI062862, R01AI032539] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Vanderbilt Department of Pathology; Naito Foundation(Naito Memorial Foundation); Elizabeth B. Lamb Center for Pediatric Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 AI62862 (to J.D.C.) and R01 AI32539 (to T.S.D.) from the United States Public Health Service. This work was supported by the Vanderbilt Department of Pathology (to L.S.O.), a fellowship from the Naito Foundation (to T.K.), and the Elizabeth B. Lamb Center for Pediatric Research.	ANDERSON N, 1966, J PATHOL BACTERIOL, V92, P433, DOI 10.1002/path.1700920222; Arnold MM, 2008, VIROLOGY, V375, P412, DOI 10.1016/j.virol.2008.02.024; Attoui H, 2001, BIOCHEM BIOPH RES CO, V287, P583, DOI 10.1006/bbrc.2001.5612; Becker MM, 2001, J VIROL, V75, P1459, DOI 10.1128/JVI.75.3.1459-1475.2001; Berry JM, 1999, BIOTECHNOL BIOENG, V62, P12, DOI 10.1002/(SICI)1097-0290(19990105)62:1<12::AID-BIT2>3.0.CO;2-G; Brentano L, 1998, J VIROL, V72, P8354, DOI 10.1128/JVI.72.10.8354-8357.1998; Campbell JA, 2005, J VIROL, V79, P7967, DOI 10.1128/JVI.79.13.7967-7978.2005; Carvalho J, 2007, VIROLOGY, V364, P301, DOI 10.1016/j.virol.2007.03.037; Clarke P, 2005, APOPTOSIS, V10, P513, DOI 10.1007/s10495-005-1881-4; Coombs KM, 1996, J VIROL, V70, P4237, DOI 10.1128/JVI.70.7.4237-4245.1996; Coombs KM, 1998, CURR TOP MICROBIOL, V233, P69; Coombs KM, 1998, VIROLOGY, V243, P218, DOI 10.1006/viro.1998.9061; DALES S, 1965, VIROLOGY, V25, P193, DOI 10.1016/0042-6822(65)90199-6; DERMODY TS, 1990, J VIROL, V64, P5173, DOI 10.1128/JVI.64.10.5173-5176.1990; FIELDS BN, 1971, VIROLOGY, V46, P142, DOI 10.1016/0042-6822(71)90013-4; Forrest JC, 2003, J VIROL, V77, P9109, DOI 10.1128/JVI.77.17.9109-9115.2003; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; GOMATOS PJ, 1962, VIROLOGY, V17, P441, DOI 10.1016/0042-6822(62)90139-3; Guglielmi KM, 2006, CURR TOP MICROBIOL, V309, P1; Ishii K, 2002, VIROLOGY, V302, P433, DOI 10.1006/viro.2002.1622; KAYE KM, 1986, J VIROL, V59, P90, DOI 10.1128/JVI.59.1.90-97.1986; Kim J, 2004, J BIOL CHEM, V279, P4394, DOI 10.1074/jbc.M308637200; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Kobayashi T, 2006, J VIROL, V80, P9053, DOI 10.1128/JVI.00276-06; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; MATOBA Y, 1991, J CLIN INVEST, V87, P1628, DOI 10.1172/JCI115177; MATOBA Y, 1993, J CLIN INVEST, V92, P2883, DOI 10.1172/JCI116910; Mbisa JL, 2000, VIROLOGY, V272, P16, DOI 10.1006/viro.2000.0362; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nibert ML, 1996, J VIROL, V70, P7295, DOI 10.1128/JVI.70.10.7295-7300.1996; Noble S, 1997, J VIROL, V71, P7728, DOI 10.1128/JVI.71.10.7728-7735.1997; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Rodgers SE, 1997, J VIROL, V71, P2540, DOI 10.1128/JVI.71.3.2540-2546.1997; ROSEN L, 1962, ANN NY ACAD SCI, V101, P461, DOI 10.1111/j.1749-6632.1962.tb18886.x; SABIN AB, 1959, SCIENCE, V130, P1387, DOI 10.1126/science.130.3386.1387; SCHIFF LA, 2007, FIELDS VIROLOGY, P1853; SHARPE AH, 1982, VIROLOGY, V120, P399, DOI 10.1016/0042-6822(82)90040-X; SHARPE AH, 1982, VIROLOGY, V122, P381, DOI 10.1016/0042-6822(82)90237-9; Sherry B, 1998, CURR TOP MICROBIOL, V233, P51; SHERRY B, 1994, J VIROL, V68, P8461, DOI 10.1128/JVI.68.12.8461-8465.1994; Sherry B, 2002, VIRAL IMMUNOL, V15, P17, DOI 10.1089/088282402317340206; SHERRY B, 1989, J VIROL, V63, P4840, DOI 10.1128/JVI.63.11.4840-4849.1989; SILVERST.SC, 1970, VIROLOGY, V41, P564, DOI 10.1016/0042-6822(70)90178-9; SILVERSTEIN SC, 1968, J CELL BIOL, V36, P197, DOI 10.1083/jcb.36.1.197; SPENDLOVE RS, 1963, J IMMUNOL, V90, P548; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; TYLER KL, 1986, SCIENCE, V233, P770, DOI 10.1126/science.3016895; VIRGIN HW, 1988, J VIROL, V62, P4594, DOI 10.1128/JVI.62.12.4594-4604.1988; WEINER HL, 1977, P NATL ACAD SCI USA, V74, P5744, DOI 10.1073/pnas.74.12.5744; YIN BY, 1995, FREE RADICAL BIO MED, V18, P1023, DOI 10.1016/0891-5849(95)00003-G; Yin P, 1996, J VIROL, V70, P1223, DOI 10.1128/JVI.70.2.1223-1227.1996; Zhang X, 2003, NAT STRUCT BIOL, V10, P1011, DOI 10.1038/nsb1009; Zou S, 1996, VIROLOGY, V217, P42, DOI 10.1006/viro.1996.0091; Zurney J, 2009, J VIROL, V83, P2178, DOI 10.1128/JVI.01787-08; ZWEERINK HJ, 1970, VIROLOGY, V41, P501, DOI 10.1016/0042-6822(70)90171-6	60	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41604	41613		10.1074/jbc.M110.176255	http://dx.doi.org/10.1074/jbc.M110.176255			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20978124	Green Published, hybrid			2022-12-25	WOS:000285622600048
J	Pohl, M; Kaminski, H; Castrop, H; Bader, M; Himmerkus, N; Bleich, M; Bachmann, S; Theilig, F				Pohl, Marcus; Kaminski, Henriette; Castrop, Hayo; Bader, Michael; Himmerkus, Nina; Bleich, Markus; Bachmann, Sebastian; Theilig, Franziska			Intrarenal Renin Angiotensin System Revisited ROLE OF MEGALIN-DEPENDENT ENDOCYTOSIS ALONG THE PROXIMAL NEPHRON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-KIDNEY; TUBULE TRANSPORT; TRANSGENIC MICE; APICAL SURFACE; BLOOD-PRESSURE; OK CELLS; EXPRESSION; HYPERTENSION; GENE; PROTEIN	The existence of a local renin angiotensin system (RAS) of the kidney has been established. Angiotensinogen (AGT), renin, angiotensin-converting enzyme (ACE), angiotensin receptors, and high concentrations of luminal angiotensin II have been found in the proximal tubule. Although functional data have documented the relevance of a local RAS, the dualism between biosynthesis and endocytotic uptake of its components and their cellular processing has been incompletely understood. To resolve this, we have selectively analyzed their distribution, endocytosis, transcytosis, and biosynthesis in the proximal tubule. The presence of immunoreactive AGT, restricted to the early proximal tubule, was due to its retrieval from the ultrafiltrate and storage in endosomal and lysosomal compartments. Cellular uptake was demonstrated by autoradiography of radiolabeled AGT and depended on intact endocytosis. AGT was identified as a ligand of the multiple ligand-binding repeats of megalin. AGT biosynthesis was restricted to the proximal straight tubule, revealing substantial AGT mRNA expression. Transgenic AGT overexpression under the control of an endogenous promoter was also restricted to the late proximal tubule. Proximal handling of renin largely followed the patterns of AGT, whereas its local biosynthesis was not significant. Transcytotic transport of AGT in a proximal cell line revealed a 5% recovery rate after 1 h. ACE was expressed along late proximal brush-border membrane, whereas ACE2 was present along the entire segment. Surface expression of ACE and ACE2 differed as a function of endocytosis. Our data on the localization and cellular processing of RAS components provide new aspects of the functional concept of a "self-contained" renal RAS.	[Pohl, Marcus; Kaminski, Henriette; Bachmann, Sebastian; Theilig, Franziska] Charite, Inst Anat, D-10115 Berlin, Germany; [Castrop, Hayo] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Bader, Michael] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Himmerkus, Nina; Bleich, Markus] Inst Physiol, D-24118 Kiel, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Regensburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bachmann, S (corresponding author), Charite, Inst Vegetat Anat, Philippstr 12, D-10115 Berlin, Germany.	sbachm@charite.de; franziska.theilig@unifr.ch	Theilig, Franziska/K-9566-2015; Bleich, Markus/A-2812-2010; Bader, Michael/K-2124-2013	Theilig, Franziska/0000-0001-8810-4717; Bleich, Markus/0000-0002-1745-2295; Bader, Michael/0000-0003-4780-4164; Himmerkus, Nina/0000-0002-2910-6728				Akhter S, 2002, AM J PHYSIOL-CELL PH, V283, pC927, DOI 10.1152/ajpcell.00613.2001; Bachmann S, 2004, J AM SOC NEPHROL, V15, P892, DOI 10.1097/01.ASN.0000120389.09938.21; BACHMANN S, 1992, KIDNEY INT, V41, P24, DOI 10.1038/ki.1992.4; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Baum M, 1997, AM J PHYSIOL-RENAL, V273, pF595, DOI 10.1152/ajprenal.1997.273.4.F595; BIBER J, 1981, BIOCHIM BIOPHYS ACTA, V647, P169, DOI 10.1016/0005-2736(81)90243-1; Bohlender J, 1996, HYPERTENSION, V27, P535, DOI 10.1161/01.HYP.27.3.535; BRAAM B, 1993, AM J PHYSIOL, V264, pF891, DOI 10.1152/ajprenal.1993.264.5.F891; Burns KD, 2007, CURR OPIN NEPHROL HY, V16, P116, DOI 10.1097/MNH.0b013e3280123c0e; CHAN JSD, 1992, J AM SOC NEPHROL, V2, P1360; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; Christensen E, 2007, KIDNEY INT, V72, P1192, DOI 10.1038/sj.ki.5002526; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; COGAN MG, 1990, HYPERTENSION, V15, P451, DOI 10.1161/01.HYP.15.5.451; DARBY IA, 1994, KIDNEY INT, V46, P1557, DOI 10.1038/ki.1994.445; EVERETT AD, 1992, HYPERTENSION, V19, P70, DOI 10.1161/01.HYP.19.1.70; GANTEN D, 1992, P NATL ACAD SCI USA, V89, P7806, DOI 10.1073/pnas.89.16.7806; GEIBEL J, 1990, P NATL ACAD SCI USA, V87, P7917, DOI 10.1073/pnas.87.20.7917; Gociman B, 2004, KIDNEY INT, V65, P2153, DOI 10.1111/j.1523-1755.2004.00635.x; Gonzalez-Villalobos R, 2005, AM J PHYSIOL-RENAL, V288, pF420, DOI 10.1152/ajprenal.00243.2004; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; He WZ, 2008, NATURE, V455, P542, DOI 10.1038/nature07255; HILGENFELDT U, 1982, BIOCHIM BIOPHYS ACTA, V708, P335, DOI 10.1016/0167-4838(82)90446-0; IKEMOTO F, 1990, NEPHRON, V55, P3; IWAO H, 1983, J HISTOCHEM CYTOCHEM, V31, P776, DOI 10.1177/31.6.6341461; Kobori H, 2003, HYPERTENSION, V41, P42, DOI 10.1161/01.HYP.0000050102.90932.CF; Kobori H, 2002, KIDNEY INT, V61, P579, DOI 10.1046/j.1523-1755.2002.00155.x; Kobori H, 2001, J AM SOC NEPHROL, V12, P431, DOI 10.1681/ASN.V123431; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Lantelme P, 2002, HYPERTENSION, V39, P1007, DOI 10.1161/01.HYP.0000016177.20565.A0; Le TH, 2008, CURR OPIN NEPHROL HY, V17, P57, DOI 10.1097/MNH.0b013e3282f2fd39; Leheste JR, 2002, FASEB J, V16, P247, DOI 10.1096/fj.02-0578fje; LEYSSAC PP, 1986, KIDNEY INT, V30, P332, DOI 10.1038/ki.1986.189; Marino M, 2001, J AM SOC NEPHROL, V12, P637, DOI 10.1681/ASN.V124637; MOE OW, 1993, J CLIN INVEST, V91, P774, DOI 10.1172/JCI116296; NASJLETTI A, 1971, CAN J PHYSIOL PHARM, V49, P292, DOI 10.1139/y71-032; NAVAR LG, 1994, J AM SOC NEPHROL, V5, P1153; Navar LG, 2002, HYPERTENSION, V39, P316, DOI 10.1161/hy0202.103821; Orlando RA, 1997, P NATL ACAD SCI USA, V94, P2368, DOI 10.1073/pnas.94.6.2368; Park S, 2010, AM J PHYSIOL-RENAL, V298, pF37, DOI 10.1152/ajprenal.00519.2009; Pollock CA, 2007, CURR OPIN NEPHROL HY, V16, P359, DOI 10.1097/MNH.0b013e3281eb9059; Quan A, 1996, J CLIN INVEST, V97, P2878, DOI 10.1172/JCI118745; Quan A, 2000, NEPHRON, V84, P103, DOI 10.1159/000045556; RICHOUX JP, 1983, CELL TISSUE RES, V233, P439; Riquier-Brison ADM, 2010, AM J PHYSIOL-RENAL, V298, pF177, DOI 10.1152/ajprenal.00464.2009; Rohrwasser A, 1999, HYPERTENSION, V34, P1265, DOI 10.1161/01.HYP.34.6.1265; Sachetelli S, 2006, KIDNEY INT, V69, P1016, DOI 10.1038/sj.ki.5000210; Saftig P, 2008, AUTOPHAGY, V4, P510, DOI 10.4161/auto.5724; Saito A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/403272; Satou R, 2008, AM J PHYSIOL-RENAL, V295, pF283, DOI 10.1152/ajprenal.00047.2008; SEIKALY MG, 1990, J CLIN INVEST, V86, P1352, DOI 10.1172/JCI114846; Singh I, 1996, AM J PHYSIOL-RENAL, V270, pF1027, DOI 10.1152/ajprenal.1996.270.6.F1027; TAUGNER R, 1982, HISTOCHEMISTRY, V75, P473; TAUGNER R, 1982, KIDNEY INT, pS33; TERADA Y, 1993, KIDNEY INT, V43, P1251, DOI 10.1038/ki.1993.177; Theilig F, 2001, J AM SOC NEPHROL, V12, P2209, DOI 10.1681/ASN.V12112209; Theilig F, 2007, J AM SOC NEPHROL, V18, P1824, DOI 10.1681/ASN.2006111266; Warner FJ, 2005, J BIOL CHEM, V280, P39353, DOI 10.1074/jbc.M508914200; Willmann JK, 1997, PFLUG ARCH EUR J PHY, V434, P173, DOI 10.1007/s004240050380; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; YANAGAWA N, 1991, KIDNEY INT, V39, P938, DOI 10.1038/ki.1991.117; YANG GY, 1994, J BIOL CHEM, V269, P32497	62	111	113	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41935	41946		10.1074/jbc.M110.150284	http://dx.doi.org/10.1074/jbc.M110.150284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20966072	Green Published, hybrid			2022-12-25	WOS:000285622600080
J	Martens, S; Korucuoglu, O; Smid, HGOM; Nieuwenstein, MR				Martens, Sander; Korucuoglu, Ozlem; Smid, Henderikus G. O. M.; Nieuwenstein, Mark R.			Quick Minds Slowed Down: Effects of Rotation and Stimulus Category on the Attentional Blink	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; RESOURCE DEPLETION; MENTAL ROTATION; TASK; SELECTION; MEMORY; CONJUNCTIONS; WHOLE	Background: Most people show a remarkable deficit to report the second of two targets when presented in close temporal succession, reflecting an attentional restriction known as the 'attentional blink' (AB). However, there are large individual differences in the magnitude of the effect, with some people showing no such attentional restrictions. Methodology/Principal Findings: Here we present behavioral and electrophysiological evidence suggesting that these 'non-blinkers' can use alphanumeric category information to select targets at an early processing stage. When such information was unavailable and target selection could only be based on information that is processed relatively late (rotation), even non-blinkers show a substantial AB. Electrophysiologically, in non-blinkers this resulted in enhanced distractor-related prefrontal brain activity, as well as delayed target-related occipito-parietal activity (P3). Conclusion/Significance: These findings shed new light on possible strategic mechanisms that may underlie individual differences in AB magnitude and provide intriguing clues as to how temporal restrictions as reflected in the AB can be overcome.	[Martens, Sander; Korucuoglu, Ozlem; Smid, Henderikus G. O. M.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Smid, Henderikus G. O. M.] Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen	Martens, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands.	s.martens@med.umcg.nl	Martens, Sander/C-5353-2008	Nieuwenstein, M.R./0000-0002-9602-3463; Martens, Sander/0000-0001-8237-7984				Arend I, 2006, PSYCHON B REV, V13, P600, DOI 10.3758/BF03193969; Dell'Acqua R, 2009, J EXP PSYCHOL HUMAN, V35, P338, DOI 10.1037/a0013555; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; DUNCAN J, 1983, PERCEPT PSYCHOPHYS, V33, P533, DOI 10.3758/BF03202935; Dux PE, 2007, COGNITION, V104, P47, DOI 10.1016/j.cognition.2006.05.004; Dux PE, 2009, PSYCHON B REV, V16, P219, DOI 10.3758/PBR.16.1.219; Dux PE, 2005, PSYCHOL SCI, V16, P775, DOI 10.1111/j.1467-9280.2005.01613.x; DUX PE, 2008, PLOS ONE, V3; Esterman M, 2004, PSYCHON B REV, V11, P681, DOI 10.3758/BF03196620; Hamilton JP, 2006, PSYCHON B REV, V13, P1074, DOI 10.3758/BF03213928; Harris IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002256; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P535, DOI 10.1017/S0048577202020449; ILAN AB, 1994, J EXP PSYCHOL HUMAN, V20, P520, DOI 10.1037/0096-1523.20.3.520; JOLICOEUR P, 1992, J EXP PSYCHOL HUMAN, V18, P371, DOI 10.1037/0096-1523.18.2.371; JONIDES J, 1972, PERCEPT PSYCHOPHYS, V12, P457, DOI 10.3758/BF03210934; Keil A, 2009, PSYCHOPHYSIOLOGY, V46, P718, DOI 10.1111/j.1469-8986.2009.00824.x; KENEMANS JL, 1993, ELECTROEN CLIN NEURO, V88, P51, DOI 10.1016/0168-5597(93)90028-N; Kranczioch C, 2003, COGNITIVE BRAIN RES, V17, P177, DOI 10.1016/S0926-6410(03)00092-2; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Martens S, 2005, MEM COGNITION, V33, P234, DOI 10.3758/BF03195312; Martens S, 2002, J EXP PSYCHOL HUMAN, V28, P1275, DOI 10.1037//0096-1523.28.6.1275; Martens S, 2009, EXP BRAIN RES, V192, P43, DOI 10.1007/s00221-008-1551-1; Martens S, 2006, ACTA PSYCHOL, V123, P204, DOI 10.1016/j.actpsy.2006.01.001; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Martens S, 2009, EXP PSYCHOL, V56, P33, DOI 10.1027/1618-3169.56.1.33; Martens S, 2009, EXP PSYCHOL, V56, P18, DOI 10.1027/1618-3169.56.1.18; Nieuwenstein MR, 2007, ACTA PSYCHOL, V125, P319, DOI 10.1016/j.actpsy.2006.08.006; Nieuwenstein MR, 2006, PSYCHOL SCI, V17, P471, DOI 10.1111/j.1467-9280.2006.01730.x; Nieuwenstein MR, 2009, J EXP PSYCHOL HUMAN, V35, P159, DOI 10.1037/0096-1523.35.1.159; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P1083, DOI 10.1037/0096-1523.32.5.1083; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Passingham R., 1995, FRONTAL LOBES VOLUNT; Potter MC, 2008, J MEM LANG, V58, P907, DOI 10.1016/j.jml.2007.12.002; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Schneider W., 2002, E PRIME USERS GUIDE; Shapiro K, 1997, PSYCHOL SCI, V8, P95, DOI 10.1111/j.1467-9280.1997.tb00689.x; Shapiro KL, 1997, J EXP PSYCHOL HUMAN, V23, P504, DOI 10.1037/0096-1523.23.2.504; Smid HGOM, 1999, PSYCHOPHYSIOLOGY, V36, P264, DOI 10.1017/S0048577299971135; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Wijers AA, 1989, THESIS U GRONINGEN G; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902	45	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13509	10.1371/journal.pone.0013509	http://dx.doi.org/10.1371/journal.pone.0013509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	668TQ	20975838	gold, Green Published, Green Submitted			2022-12-25	WOS:000283293800005
J	Ottoni, C; Primativo, G; Kashani, BH; Achilli, A; Martinez-Labarga, C; Biondi, G; Torroni, A; Rickards, O				Ottoni, Claudio; Primativo, Giuseppina; Kashani, Baharak Hooshiar; Achilli, Alessandro; Martinez-Labarga, Cristina; Biondi, Gianfranco; Torroni, Antonio; Rickards, Olga			Mitochondrial Haplogroup H1 in North Africa: An Early Holocene Arrival from Iberia	PLOS ONE			English	Article							LAST GLACIAL MAXIMUM; HUMAN GENETIC HISTORY; HUMAN MTDNA; DNA; POPULATION; EUROPE; EXPANSION; PERSPECTIVE; SEQUENCES; CLIMATE	The Tuareg of the Fezzan region (Libya) are characterized by an extremely high frequency (61%) of haplogroup H1, a mitochondrial DNA (mtDNA) haplogroup that is common in all Western European populations. To define how and when H1 spread from Europe to North Africa up to the Central Sahara, in Fezzan, we investigated the complete mitochondrial genomes of eleven Libyan Tuareg belonging to H1. Coalescence time estimates suggest an arrival of the European H1 mtDNAs at about 8,000-9,000 years ago, while phylogenetic analyses reveal three novel H1 branches, termed H1v, H1w and H1x, which appear to be specific for North African populations, but whose frequencies can be extremely different even in relatively close Tuareg villages. Overall, these findings support the scenario of an arrival of haplogroup H1 in North Africa from Iberia at the beginning of the Holocene, as a consequence of the improvement in climate conditions after the Younger Dryas cold snap, followed by in situ formation of local H1 sub-haplogroups. This process of autochthonous differentiation continues in the Libyan Tuareg who, probably due to isolation and recent founder events, are characterized by village-specific maternal mtDNA lineages.	[Ottoni, Claudio; Primativo, Giuseppina; Martinez-Labarga, Cristina; Rickards, Olga] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Ottoni, Claudio] Univ Ziekenhuizen, Lab Forens Genet & Mol Archaeol, Leuven, Belgium; [Ottoni, Claudio] Katholieke Univ Leuven, Ctr Archaeol Sci, Leuven, Belgium; [Ottoni, Claudio] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Kashani, Baharak Hooshiar; Achilli, Alessandro; Torroni, Antonio] Univ Pavia, Dipartimento Genet Microbiol, I-27100 Pavia, Italy; [Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Biondi, Gianfranco] Univ Aquila, Dipartimento Sci Ambientali, I-67100 Laquila, Italy	University of Rome Tor Vergata; KU Leuven; KU Leuven; University of Pavia; University of Perugia; University of L'Aquila	Ottoni, C (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	rickards@uniroma2.it	Torroni, Antonio/E-1557-2011; Ottoni, Claudio/AFM-1230-2022; Ottoni, Claudio/AFM-1348-2022; MARTINEZ-LABARGA, CRISTINA M/K-6011-2014; Rickards, Olga/L-7878-2015; Achilli, Alessandro/I-9236-2012	Torroni, Antonio/0000-0002-4163-4478; Ottoni, Claudio/0000-0001-8870-1589; MARTINEZ-LABARGA, CRISTINA M/0000-0003-0439-0379; Rickards, Olga/0000-0003-2880-7466; Achilli, Alessandro/0000-0001-6871-3451	Italian Ministry of the University [2003100945_002, 20073RH73W_001, RBFR08U07M_001]; University of Rome Tor Vergata; University of Rome La Sapienza	Italian Ministry of the University(Ministry of Education, Universities and Research (MIUR)); University of Rome Tor Vergata; University of Rome La Sapienza	This study was supported by grants from the Italian Ministry of the University, Progetti Ricerca Interesse Nazionale "Nomads and sedentary people. Reconstruction of the genetic history of ancient and extant populations from Libya and Western Sahara'' (protocol 2003100945_002 to OR) and "The peopling of the European continent: the mitochondrial DNA and Y chromosome perspectives" (protocol 20073RH73W_001 to AT), FIRB-Futuro in Ricerca 2008 "The parallel genetic history of humans and domesticated animals'' (protocol RBFR08U07M_001 to AA), Fondazione Alma Mater Ticinensis (to AT), the University of Rome Tor Vergata (Ricerche di Ateneo, ex 60% 2003-2004) allotted to OR and Grandi Scavi di Ateneo, University of Rome La Sapienza, entrusted to Prof. Savino di Lernia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Adams JM, 1997, J ARCHAEOL SCI, V24, P623, DOI 10.1006/jasc.1996.0146; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Camps G., 1974, CIVILISATIONS PREHIS; Cherni L, 2009, AM J PHYS ANTHROPOL, V139, P253, DOI 10.1002/ajpa.20979; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Comas D, 2000, HUM GENET, V107, P312, DOI 10.1007/s004390000370; Costa MD, 2009, MECH AGEING DEV, V130, P222, DOI 10.1016/j.mad.2008.12.001; Coudray C, 2009, ANN HUM GENET, V73, P196, DOI 10.1111/j.1469-1809.2008.00493.x; DOLUKHANOV P, 1993, CULTURAL TRANSFORMAT; Ennafaa H, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-8; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gamble C, 2005, CAMB ARCHAEOL J, V15, P193, DOI 10.1017/S0959774305000107; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; GIAZZI F, ETUDE INITIALE RESER; Gonzalez-Perez E, 2010, AM J PHYS ANTHROPOL, V141, P430, DOI 10.1002/ajpa.21161; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; HASSAN FA, 2002, DROUGHTS FOOD CULTUR; HASSAN FA, 1996, 10 C PANAFRICAN ASS, P83; Kayser M, 2010, CURR BIOL, V20, pR194, DOI 10.1016/j.cub.2009.12.004; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Loogvali EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008260; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Majumder PP, 2010, CURR BIOL, V20, pR184, DOI 10.1016/j.cub.2009.11.053; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; METSPALU M, 2006, MITOCHONDRIAL DNA EV, P181; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Ottoni C, 2009, ANN HUM GENET, V73, P438, DOI 10.1111/j.1469-1809.2009.00526.x; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Pereira L, 2010, EUR J HUM GENET, V18, P915, DOI 10.1038/ejhg.2010.21; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; Richards M., 2006, MITOCHONDRIAL DNA EV, P225; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Sadr K, 2004, J AFR HIST, V45, P492, DOI 10.1017/S0021853704229930; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Smith RL, 2003, J WORLD HIST, V14, P459, DOI 10.1353/jwh.2003.0060; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Spain Daphne, 1992, GENDERED SPACES; Tarasov PE, 1999, CLIM DYNAM, V15, P227, DOI 10.1007/s003820050278; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001	48	39	39	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13378	10.1371/journal.pone.0013378	http://dx.doi.org/10.1371/journal.pone.0013378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975840	gold, Green Submitted, Green Published			2022-12-25	WOS:000283293800001
J	Nishiguchi, KM; Kataoka, K; Kachi, S; Komeima, K; Terasaki, H				Nishiguchi, Koji M.; Kataoka, Keiko; Kachi, Shu; Komeima, Keiichi; Terasaki, Hiroko			Regulation of Pathologic Retinal Angiogenesis in Mice and Inhibition of VEGF-VEGFR2 Binding by Soluble Heparan Sulfate	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; EXTRACELLULAR DOMAIN; DIABETIC-RETINOPATHY; AQUEOUS-HUMOR; VEGF RECEPTOR; PROTEOGLYCANS; EXPRESSION; NEOVASCULARIZATION; SYNDECAN-1	Development of the retinal vascular network is strictly confined within the neuronal retina, allowing the intraocular media to be optically transparent. However, in retinal ischemia, pro-angiogenic factors (including vascular endothelial growth factor-A, VEGF-A) induce aberrant guidance of retinal vessels into the vitreous. Here, we show that the soluble heparan sulfate level in murine intraocular fluid is high particularly during ocular development. When the eyes of young mice with retinal ischemia were treated with heparan sulfate-degrading enzyme, the subsequent aberrant angiogenesis was greatly enhanced compared to PBS-injected contralateral eyes; however, increased angiogenesis was completely antagonized by simultaneous injection of heparin. Intraocular injection of heparan sulfate or heparin alone in these eyes resulted in reduced neovascularization. In cell cultures, the porcine ocular fluid suppressed the dose-dependent proliferation of human umbilical vein endothelial cells (HUVECs) mediated by VEGF-A. Ocular fluid and heparin also inhibited the migration and tube formation by these cells. The binding of VEGF-A and HUVECs was reduced under a high concentration of heparin or ocular fluid compared to lower concentrations of heparin. In vitro assays demonstrated that the ocular fluid or soluble heparan sulfate or heparin inhibited the binding of VEGF-A and immobilized heparin or VEGF receptor 2 but not VEGF receptor 1. The recognition that the high concentration of soluble heparan sulfate in the ocular fluid allows it to serve as an endogenous inhibitor of aberrant retinal vascular growth provides a platform for modulating heparan sulfate/heparin levels to regulate angiogenesis.	[Nishiguchi, Koji M.; Kataoka, Keiko; Kachi, Shu; Komeima, Keiichi; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan	Nagoya University	Nishiguchi, KM (corresponding author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan.	kojinish@med.nagoya-u.ac.jp	Kataoka, Keiko/B-2806-2016; Terasaki, Hiroko/M-5054-2014	Kataoka, Keiko/0000-0002-8795-6536; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21791676]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant (B) 21791676, a Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Collen A, 2000, CANCER RES, V60, P6196; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Dougher AM, 1997, GROWTH FACTORS, V14, P257, DOI 10.3109/08977199709021524; Fannon M, 2003, FASEB J, V17, P902, DOI 10.1096/fj.02-0935fje; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Funatsu H, 2005, GRAEF ARCH CLIN EXP, V243, P3, DOI 10.1007/s00417-004-0950-7; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Halfter W, 2000, DEV BIOL, V220, P111, DOI 10.1006/dbio.2000.9649; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Inatani M, 2002, INVEST OPHTH VIS SCI, V43, P1616; Inatani M, 2002, PROG RETIN EYE RES, V21, P429, DOI 10.1016/S1350-9462(02)00009-5; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Koga T, 2003, CURR EYE RES, V27, P75, DOI 10.1076/ceyr.27.2.75.15950; LINDAHL B, 1995, BIOCHEM J, V306, P177, DOI 10.1042/bj3060177; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Ono K, 1999, GLYCOBIOLOGY, V9, P705, DOI 10.1093/glycob/9.7.705; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Qiao DH, 2003, J BIOL CHEM, V278, P16045, DOI 10.1074/jbc.M211259200; Shih SC, 2003, J CLIN INVEST, V112, P50, DOI 10.1172/JCI200317808; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Su G, 2007, J BIOL CHEM, V282, P14906, DOI 10.1074/jbc.M611739200; TESSLER S, 1994, J BIOL CHEM, V269, P12456; Tumova S, 2000, J BIOL CHEM, V275, P9410, DOI 10.1074/jbc.275.13.9410; Vaughan-Thomas A, 2000, INVEST OPHTH VIS SCI, V41, P3299	37	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13493	10.1371/journal.pone.0013493	http://dx.doi.org/10.1371/journal.pone.0013493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975989	Green Published, Green Submitted, gold			2022-12-25	WOS:000283216400010
J	Kakefuda, K; Oyagi, A; Ishisaka, M; Tsuruma, K; Shimazawa, M; Yokota, K; Shirai, Y; Horie, K; Saito, N; Takeda, J; Hara, H				Kakefuda, Kenichi; Oyagi, Atsushi; Ishisaka, Mitsue; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Yokota, Koichi; Shirai, Yasuhito; Horie, Kyoji; Saito, Naoaki; Takeda, Junji; Hara, Hideaki			Diacylglycerol Kinase beta Knockout Mice Exhibit Lithium-Sensitive Behavioral Abnormalities	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; MOLECULAR-CLONING; PREFRONTAL CORTEX; PHOSPHORYLATION; INHIBITION; GSK-3	Background: Diacylglycerol kinase (DGK) is an enzyme that phosphorylates diacylglycerol (DG) to produce phosphatidic acid (PA). DGK beta is widely distributed in the central nervous system, such as the olfactory bulb, cerebral cortex, striatum, and hippocampus. Recent studies reported that the splice variant at the COOH-terminal of DGK beta was related to bipolar disorder, but its detailed mechanism is still unknown. Methodology/Principal Findings: In the present study, we performed behavioral tests using DGK beta knockout (KO) mice to investigate the effects of DGK beta deficits on psychomotor behavior. DGK beta KO mice exhibited some behavioral abnormalities, such as hyperactivity, reduced anxiety, and reduced depression. Additionally, hyperactivity and reduced anxiety were attenuated by the administration of the mood stabilizer, lithium, but not haloperidol, diazepam, or imipramine. Moreover, DGK beta KO mice showed impairment in Akt-glycogen synthesis kinase (GSK) 3 beta signaling and cortical spine formation. Conclusions/Significance: These findings suggest that DGK beta KO mice exhibit lithium-sensitive behavioral abnormalities that are, at least in part, due to the impairment of Akt- GSK3 beta signaling and cortical spine formation.	[Kakefuda, Kenichi; Oyagi, Atsushi; Ishisaka, Mitsue; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan; [Yokota, Koichi] Carna Biosci In, Kobe, Hyogo, Japan; [Shirai, Yasuhito; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 657, Japan; [Horie, Kyoji; Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka, Japan	Gifu Pharmaceutical University; Kobe University; Osaka University	Kakefuda, K (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp	Shirai, Yasuhito/O-3255-2018	Horie, Kyoji/0000-0001-9036-8180	Gifu Pharmaceutical University	Gifu Pharmaceutical University	Funding of this work was provided only by the Gifu Pharmaceutical University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adachi N, 2005, MOL BRAIN RES, V139, P288, DOI 10.1016/j.molbrainres.2005.06.007; Ao MRB, 2008, AUST NZ J PSYCHIAT, V42, P995, DOI 10.1080/00048670802512073; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Caricasole A, 2002, J BIOL CHEM, V277, P4790, DOI 10.1074/jbc.M110249200; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; CORNE SJ, 1967, PSYCHOPHARMACOLOGIA, V11, P65, DOI 10.1007/BF00401509; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; GELENBERG AJ, 1989, NEW ENGL J MED, V321, P1489, DOI 10.1056/NEJM198911303212201; GOTO K, 1993, P NATL ACAD SCI USA, V90, P7598, DOI 10.1073/pnas.90.16.7598; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P2173, DOI 10.1038/sj.npp.1301338; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Hozumi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-99; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kanoh H, 2002, J BIOCHEM, V131, P629, DOI 10.1093/oxfordjournals.jbchem.a003144; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Kimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003540; Liu CH, 2007, J EXP MED, V204, P781, DOI 10.1084/jem.20061856; Liu F, 2006, FEBS LETT, V580, P6269, DOI 10.1016/j.febslet.2006.10.033; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Oyagi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007461; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Pierri JN, 2001, ARCH GEN PSYCHIAT, V58, P466, DOI 10.1001/archpsyc.58.5.466; Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Quiroz JA, 2004, MOL INTERV, V4, P259, DOI 10.1124/mi.4.5.6; Rosoklija G, 2000, ARCH GEN PSYCHIAT, V57, P349, DOI 10.1001/archpsyc.57.4.349; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Schulze TG, 2009, MOL PSYCHIATR, V14, P487, DOI 10.1038/mp.2008.134; Shansky RM, 2009, CEREB CORTEX, V19, P2479, DOI 10.1093/cercor/bhp003; Shirai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011602; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; VEREBEY K, 1981, PSYCHOPHARMACOLOGY, V75, P44, DOI 10.1007/BF00433500; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	40	47	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13447	10.1371/journal.pone.0013447	http://dx.doi.org/10.1371/journal.pone.0013447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976192	Green Published, gold, Green Submitted			2022-12-25	WOS:000283045300021
J	Graebsch, A; Roche, S; Kostrewa, D; Soding, J; Niessing, D				Graebsch, Almut; Roche, Stephane; Kostrewa, Dirk; Soeding, Johannes; Niessing, Dierk			Of Bits and Bugs - On the Use of Bioinformatics and a Bacterial Crystal Structure to Solve a Eukaryotic Repeat-Protein Structure	PLOS ONE			English	Article							PUR-ALPHA; STRUCTURE PREDICTION; SEQUENCE; BINDING; QUALITY; RNA; CRYSTALLIZATION; FAMILIES; SERVER; NMR	Pur-alpha is a nucleic acid-binding protein involved in cell cycle control, transcription, and neuronal function. Initially no prediction of the three-dimensional structure of Pur-alpha was possible. However, recently we solved the X-ray structure of Pur-alpha from the fruitfly Drosophila melanogaster and showed that it contains a so-called PUR domain. Here we explain how we exploited bioinformatics tools in combination with X-ray structure determination of a bacterial homolog to obtain diffracting crystals and the high-resolution structure of Drosophila Pur-alpha. First, we used sensitive methods for remote-homology detection to find three repetitive regions in Pur-alpha. We realized that our lack of understanding how these repeats interact to form a globular domain was a major problem for crystallization and structure determination. With our information on the repeat motifs we then identified a distant bacterial homolog that contains only one repeat. We determined the bacterial crystal structure and found that two of the repeats interact to form a globular domain. Based on this bacterial structure, we calculated a computational model of the eukaryotic protein. The model allowed us to design a crystallizable fragment and to determine the structure of Drosophila Pur-alpha. Key for success was the fact that single repeats of the bacterial protein self-assembled into a globular domain, instructing us on the number and boundaries of repeats to be included for crystallization trials with the eukaryotic protein. This study demonstrates that the simpler structural domain arrangement of a distant prokaryotic protein can guide the design of eukaryotic crystallization constructs. Since many eukaryotic proteins contain multiple repeats or repeating domains, this approach might be instructive for structural studies of a range of proteins.	[Graebsch, Almut; Roche, Stephane; Niessing, Dierk] Helmholtz Zentrum Munchen, Inst Biol Struct, Munich, Germany; [Graebsch, Almut; Roche, Stephane; Kostrewa, Dirk; Soeding, Johannes; Niessing, Dierk] Univ Munich, Dept Biochem, Gene Ctr, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Graebsch, A (corresponding author), Helmholtz Zentrum Munchen, Inst Biol Struct, Munich, Germany.	niessing@helmholtz-muenchen.de	Niessing, Dierk/AAE-4936-2022; Niessing, Dierk/M-4619-2014; Söding, Johannes/A-3341-2013	Niessing, Dierk/0000-0002-5589-369X; Niessing, Dierk/0000-0002-5589-369X; Söding, Johannes/0000-0001-9642-8244	Helmholtz Association [VG-NH 142]; Deutsche Forschungsgemeinschaft [FOR855, SFB646, SFB 646]; Max-Planck Institute for Biochemistry (Martinsried, Germany)	Helmholtz Association(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Institute for Biochemistry (Martinsried, Germany)	This work was supported by the Helmholtz Association (VG-NH 142 to D.N.) and the Deutsche Forschungsgemeinschaft (FOR855 and SFB646 to D.N.; SFB 646 to J.S.). S. R. is a fellow of the Human Frontiers Science Program organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Andrea Hildebrand and Sigrun Jaklin for their help. We acknowledge the support by the crystallization facility of the Max-Planck Institute for Biochemistry (Martinsried, Germany). We thank the European Synchrotron Radiation Facility (ESRF) as well as Swiss Light Source (SLS) for provision of synchrotron radiation facilities. We are grateful to Alan Cheung for data collection at SLS. We are grateful to Stephen K. Burley for his support during early stages of this project.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761; BERGEMANN AD, 1992, MOL CELL BIOL, V12, P5673, DOI 10.1128/MCB.12.12.5673; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Chayen NE, 2008, NAT METHODS, V5, P147, DOI 10.1038/NMETH.F.203; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fischer D, 2006, CURR OPIN STRUC BIOL, V16, P178, DOI 10.1016/j.sbi.2006.03.004; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Gao Xia, 2005, Journal of Structural and Functional Genomics, V6, P129, DOI 10.1007/s10969-005-1918-5; Graebsch A, 2009, P NATL ACAD SCI USA, V106, P18521, DOI 10.1073/pnas.0907990106; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Koehl P, 2002, J MOL BIOL, V323, P551, DOI 10.1016/S0022-2836(02)00971-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldfield CJ, 2005, PROTEINS, V59, P444, DOI 10.1002/prot.20446; Page R, 2005, P NATL ACAD SCI USA, V102, P1901, DOI 10.1073/pnas.0408490102; Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sadreyev RI, 2007, NUCLEIC ACIDS RES, V35, pW653, DOI 10.1093/nar/gkm293; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Savchenko A, 2003, PROTEINS, V50, P392, DOI 10.1002/prot.10282; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whitaker S, 2009, REV MEX ING QUIM, V8, P1; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428	49	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13402	10.1371/journal.pone.0013402	http://dx.doi.org/10.1371/journal.pone.0013402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976240	gold, Green Published, Green Submitted			2022-12-25	WOS:000282941000023
J	Wieczorek, L; Maas, JW; Muglia, LM; Vogt, SK; Muglia, LJ				Wieczorek, Lindsay; Maas, James W., Jr.; Muglia, Lisa M.; Vogt, Sherri K.; Muglia, Louis J.			Temporal and Regional Regulation of Gene Expression by Calcium-Stimulated Adenylyl Cyclase Activity during Fear Memory	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MESSENGER-RNA; RAT-BRAIN; MICE; TYPE-8; LOCALIZATION; ACTIVATION; RECEPTORS	Background: The Ca2+-stimulated adenylyl cyclases (ACs), AC1 and AC8, are key components of long-term memory processing. AC1 and AC8 double knockout mice (Adcy1(-/-) Adcy8(-/-); DKO) display impaired fear memory processing; the mechanism of this impairment is largely unknown. Methodology/Principal Findings: We hypothesize that the Ca2+-stimulated ACs modulate long-lasting transcriptional changes essential for fear memory consolidation and maintenance. Here, we report a genome-wide study of gene expression changes associated with conditioned fear (CF) memory in wild-type and DKO mice to identify AC-dependent gene regulatory changes that occur in the amygdala and hippocampus at baseline and different time points after CF learning. We observed an overall decrease in transcriptional changes in DKO mice across all time points, but most strikingly, at periods when memory consolidation and retention should be occurring. Further, we identified a shared set of transcription factor binding sites in genes upregulated in wild-type mice that were associated with downregulated genes in DKO mice. To prove the temporal and regional importance of AC activity on different stages of memory processing, the tetracycline-off system was used to produce mice with forebrain-specific inducible expression of AC8 on a DKO background. CF behavioral results reveal that adult restoration of AC8 activity in the forebrain is sufficient for intact learning, while cessation of this expression at any time point across learning causes memory deficits. Conclusions/Significance: Overall, these studies demonstrate that the Ca2+-stimulated ACs contribute to the formation and maintenance of fear memory by a network of long-term transcriptional changes.	[Wieczorek, Lindsay; Maas, James W., Jr.; Vogt, Sherri K.] Washington Univ, Dept Pediat & Dev Biol, St Louis, MO 63130 USA; [Muglia, Lisa M.; Muglia, Louis J.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Muglia, Lisa M.; Muglia, Louis J.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Muglia, Lisa M.; Muglia, Louis J.] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN USA	Washington University (WUSTL); Vanderbilt University; Vanderbilt University; Vanderbilt University	Wieczorek, L (corresponding author), Washington Univ, Dept Pediat & Dev Biol, St Louis, MO 63130 USA.	louis.muglia@vanderbilt.edu			National Institutes of Health [F31MH843913, R01AG18876, R01MH079010]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (www.nih.gov) to LW (F31MH843913) and LJM (R01AG18876; R01MH079010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TD, 2000, CURR OPIN NEUROBIOL, V10, P612, DOI 10.1016/S0959-4388(00)00132-X; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; CALI JJ, 1994, J BIOL CHEM, V269, P12190; Carlson ES, 2009, J NUTR, V139, P672, DOI 10.3945/jn.108.096354; Conti AC, 2007, NEUROSCIENCE, V146, P713, DOI 10.1016/j.neuroscience.2007.01.045; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gass P, 2001, PHYSIOL BEHAV, V73, P811, DOI 10.1016/S0031-9384(01)00518-2; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HILL HD, 1988, ANAL BIOCHEM, V170, P203, DOI 10.1016/0003-2697(88)90109-1; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MATSUOKA I, 1992, J NEUROSCI, V12, P3350; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Muglia LM, 1999, J NEUROSCI, V19, P2051; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stork O, 1999, CELL MOL LIFE SCI, V55, P575, DOI 10.1007/s000180050316; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wang HB, 2004, NAT NEUROSCI, V7, P635, DOI 10.1038/nn1248; Wang HB, 2003, J NEUROSCI, V23, P9710; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; Zhang M, 2008, J NEUROSCI, V28, P4736, DOI 10.1523/JNEUROSCI.1177-08.2008	35	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13385	10.1371/journal.pone.0013385	http://dx.doi.org/10.1371/journal.pone.0013385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976279	Green Published, gold, Green Submitted			2022-12-25	WOS:000282941000016
J	Andrade, GS; Serrao, JE; Zanuncio, JC; Zanuncio, TV; Leite, GLD; Polanczyk, RA				Andrade, Gilberto Santos; Serrao, Jose Eduardo; Zanuncio, Jose Cola; Zanuncio, Teresinha Vinha; Demolin Leite, Germano Leao; Polanczyk, Ricardo Antonio			Immunity of an Alternative Host Can Be Overcome by Higher Densities of Its Parasitoids Palmistichus elaeisis and Trichospilus diatraeae	PLOS ONE			English	Article							LASALLE HYMENOPTERA EULOPHIDAE; TRICHOGRAMMA-PRETIOSUM RILEY; PLUTELLA-XYLOSTELLA L.; COTESIA-PLUTELLAE; THERMAL REQUIREMENTS; ENDOPARASITOID WASP; DIAMONDBACK MOTH; LEPIDOPTERA; SUPERPARASITISM; DEFENSE	Interactions of the parasitoids Palmistichus elaeisis Delvare & LaSalle and Trichospilus diatraeae Cherian & Margabandhu (Hymenoptera: Eulophidae) with its alternative host Anticarsia gemmatalis (Hubner) (Lepidoptera: Noctuidae) affect the success or failure of the mass production of these parasitoids for use in integrated pest management programs. The aim of this study was to evaluate changes in the cellular defense and encapsulation ability of A. gemmatalis pupae against P. elaeisis or T. diatraeae in adult parasitoid densities of 1, 3, 5, 7, 9, 11 or 13 parasitoids/pupae. We evaluated the total quantity of circulating hemocytes and the encapsulation rate versus density. Increasing parasitoid density reduced the total number of hemocytes in the hemolymph and the encapsulation rate by parasitized pupae. Furthermore, densities of P. elaeisis above 5 parasitoids/pupae caused higher reduction in total hemocyte numbers. The encapsulation rate fell with increasing parasitoid density. However, parasitic invasion by both species induced generally similar responses. The reduction in defensive capacity of A. gemmatalis is related to the adjustment of the density of these parasitoids to their development in this host. Thus, the role of the density of P. elaeisis or T. diatraeae by pupa is induced suppression of cellular defense and encapsulation of the host, even without them possesses a co-evolutionary history. Furthermore, these findings can predict the success of P. elaeisis and T. diatraeae in the control of insect pests through the use of immunology as a tool for evaluation of natural enemies.	[Andrade, Gilberto Santos; Zanuncio, Jose Cola; Zanuncio, Teresinha Vinha] Univ Fed Vicosa, Dept Biol Anim, BIOAGRO, Vicosa, MG, Brazil; [Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Demolin Leite, Germano Leao] Univ Fed Minas Gerais, Inst Ciencias Agrarias, Montes Claros, Brazil; [Polanczyk, Ricardo Antonio] Univ Estado Sao Paulo, Dept Protecao Plantas, Univ Estadual Paulista Julio Mesquita Filho UNESP, Sao Paulo, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Minas Gerais; Universidade Estadual Paulista	Andrade, GS (corresponding author), Univ Fed Vicosa, Dept Biol Anim, BIOAGRO, Vicosa, MG, Brazil.	zanuncio@ufv.br	Polanczyk, R A/C-4714-2012; Polanczyk, Ricardo Antonio/AAS-6336-2020; Polanczyk, Ricardo A/N-7237-2017; Andrade, Gilberto/I-5892-2013; Serrão, Jose Eduardo/H-2935-2012	Polanczyk, Ricardo Antonio/0000-0003-0769-9902; Polanczyk, Ricardo A/0000-0003-0769-9902; Andrade, Gilberto/0000-0001-7234-2980; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2008, INSECT BIOCHEM MOLEC, V38, P136, DOI 10.1016/j.ibmb.2007.10.001; Amaya KE, 2005, J INSECT PHYSIOL, V51, P505, DOI 10.1016/j.jinsphys.2004.11.019; Andrade GS, 2009, ACTA SCI-AGRON, V31, P569, DOI 10.4025/actasciagron.v31i4.808; Asgari S, 1997, J GEN VIROL, V78, P3061, DOI 10.1099/0022-1317-78-11-3061; Bae S, 2004, COMP BIOCHEM PHYS A, V138, P39, DOI 10.1016/j.cbpb.2004.02.018; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Chapman R.F., 2012, INSECTS STRUCTURE FU; Cheng TC, 2008, DEV COMP IMMUNOL, V32, P464, DOI 10.1016/j.dci.2007.03.010; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; De Souza DJ, 2008, J INSECT PHYSIOL, V54, P828, DOI 10.1016/j.jinsphys.2008.03.001; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; Hoch G, 2004, ENTOMOL EXP APPL, V113, P77, DOI 10.1111/j.0013-8703.2004.00203.x; Ibrahim AMA, 2006, J INSECT PHYSIOL, V52, P943, DOI 10.1016/j.jinsphys.2006.06.001; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Mendel Z, 2007, PHYTOPARASITICA, V35, P330, DOI 10.1007/BF02980694; Moreira MD, 2009, NEOTROP ENTOMOL, V38, P237, DOI 10.1590/S1519-566X2009000200011; Nalini M, 2009, PHYSIOL ENTOMOL, V34, P110, DOI 10.1111/j.1365-3032.2008.00657.x; Narayanan K, 2004, CURR SCI INDIA, V86, P800; Paron M. R., 2000, Scientia Agricola, V57, P355, DOI 10.1590/S0103-90162000000200025; Pech LL, 1996, J CELL SCI, V109, P2053; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pereira FF, 2008, PHYTOPARASITICA, V36, P304, DOI 10.1007/BF02980777; Pereira FF, 2009, BRAZ J BIOL, V69, P865, DOI 10.1590/S1519-69842009000400014; Pereira FF, 2009, NEOTROP ENTOMOL, V38, P660, DOI 10.1590/S1519-566X2009000500016; Pereira FF, 2008, BRAZ ARCH BIOL TECHN, V51, P259, DOI 10.1590/S1516-89132008000200004; Pereira FF, 2004, NEOTROP ENTOMOL, V33, P231, DOI 10.1590/S1519-566X2004000200014; Pratissoli D, 2005, BRAZ ARCH BIOL TECHN, V48, P523, DOI 10.1590/S1516-89132005000500003; Pratissoli D, 2009, REV BRAS ENTOMOL, V53, P151, DOI 10.1590/S0085-56262009000100032; Rantala MJ, 2007, HEREDITY, V98, P329, DOI 10.1038/sj.hdy.6800945; Rantala MJ, 2004, BEHAV ECOL, V15, P187, DOI 10.1093/beheco/arg103; Reed DA, 2007, BIOL CONTROL, V41, P214, DOI 10.1016/j.biocontrol.2007.01.010; Renault S, 2002, J INSECT PHYSIOL, V48, P297, DOI 10.1016/S0022-1910(01)00174-3; Ribeiro C, 2006, J INSECT PHYSIOL, V52, P417, DOI 10.1016/j.jinsphys.2006.01.005; Richards EH, 2000, COMP BIOCHEM PHYS B, V127, P289, DOI 10.1016/S0305-0491(00)00255-8; Shelby KS, 1999, J INSECT PHYSIOL, V45, P507, DOI 10.1016/S0022-1910(98)00144-9; Silva-Torres CSA, 2009, ENTOMOL EXP APPL, V133, P65, DOI 10.1111/j.1570-7458.2009.00903.x; Soares MA, 2009, REV COLOMB ENTOMOL, V35, P62; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2008, INSECT SCI, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Suzuki M, 2007, J INSECT PHYSIOL, V53, P1072, DOI 10.1016/j.jinsphys.2007.06.006; Tena A, 2008, ANIM BEHAV, V76, P789, DOI 10.1016/j.anbehav.2008.05.007; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Uckan F, 2004, ANN ENTOMOL SOC AM, V97, P775, DOI 10.1603/0013-8746(2004)097[0775:DOVCFT]2.0.CO;2; VANALPHEN JJM, 1990, ANNU REV ENTOMOL, V35, P59, DOI 10.1146/annurev.en.35.010190.000423; Wu ML, 2008, J INVERTEBR PATHOL, V99, P186, DOI 10.1016/j.jip.2008.07.005; Yamamoto D, 2007, ECOL ENTOMOL, V32, P221; Zanuncio JC, 2008, COLEOPTS BULL, V62, P64, DOI 10.1649/1015.1	49	26	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13231	10.1371/journal.pone.0013231	http://dx.doi.org/10.1371/journal.pone.0013231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20975929	Green Published, gold			2022-12-25	WOS:000282869800007
J	Deloumeau, A; Bayard, S; Coquerel, Q; Dechelotte, P; Bole-Feysot, C; Carlander, B; De Cock, VC; Fetissov, SO; Dauvilliers, Y				Deloumeau, Aude; Bayard, Sophie; Coquerel, Quentin; Dechelotte, Pierre; Bole-Feysot, Christine; Carlander, Bertrand; De Cock, Valerie Cochen; Fetissov, Serguei O.; Dauvilliers, Yves			Increased Immune Complexes of Hypocretin Autoantibodies in Narcolepsy	PLOS ONE			English	Article							OREXIN; NEUROPEPTIDES; ANTIBODIES; MUTATION; ONSET	Background: Hypocretin peptides participate in the regulation of sleep-wake cycle while deficiency in hypocretin signaling and loss of hypocretin neurons are causative for narcolepsy-cataplexy. However, the mechanism responsible for alteration of the hypocretin system in narcolepsy-cataplexy and its relevance to other central hypersomnias remain unknown. Here we studied whether central hypersomnias can be associated with autoantibodies reacting with hypocretin-1 peptide present as immune complexes. Methodology: Serum levels of free and dissociated (total) autoantibodies reacting with hypocretin-1 peptide were measured by enzyme-linked immunosorbent assay and analyzed with regard to clinical parameters in 82 subjects with narcolepsy-cataplexy, narcolepsy without cataplexy or idiopathic hypersomnia and were compared to 25 healthy controls. Principal Findings: Serum levels of total but not free IgG autoantibodies against hypocretin-1 were increased in narcolepsy-cataplexy. Increased levels of complexed IgG autoantibodies against hypocretin-1 were found in all patients groups with a further increase in narcolepsy-cataplexy. Levels of total IgM hypocretin-1 autoantibodies were also elevated in all groups of patients. Increased levels of anti-idiotypic IgM autoantibodies reacting with hypocretin-1 IgG autoantibodies affinity purified from sera of subjects with narcolepsy-cataplexy were found in all three groups of patients. Disease duration correlated negatively with serum levels of hypocretin-1 IgG and IgM autoantibodies and with anti-idiotypic IgM autoantibodies. Conclusion: Central hypersomnias and particularly narcolepsy-cataplexy are characterized by higher serum levels of autoantibodies directed against hypocretin-1 which are present as immune complexes most likely with anti-idiotypic autoantibodies suggesting their relevance to the mechanism of sleep-wake cycle regulation.	[Deloumeau, Aude; Coquerel, Quentin; Dechelotte, Pierre; Bole-Feysot, Christine; Fetissov, Serguei O.] Univ Rouen, Digest Syst & Nutr Lab ADEN EA 4311, Rouen Inst Med Res & Innovat, Federat Inst Peptide Res IFR23, Rouen, France; [Bayard, Sophie; Carlander, Bertrand; De Cock, Valerie Cochen; Dauvilliers, Yves] Montpellier Univ Hosp Gui de Chauliac, Dept Neurol, Natl Reference Network Narcolepsy, Montpellier, France; [Bayard, Sophie; Dauvilliers, Yves] INSERM, U888, Montpellier, France	Universite de Rouen Normandie; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Deloumeau, A (corresponding author), Univ Rouen, Digest Syst & Nutr Lab ADEN EA 4311, Rouen Inst Med Res & Innovat, Federat Inst Peptide Res IFR23, Rouen, France.	Serguei.Fetissov@univ-rouen.fr; ydauvilliers@yahoo.fr	Fetissov, Sergueï O/H-6023-2016	Fetissov, Sergueï O/0000-0002-2491-4945; Bayard, Sophie/0000-0003-0767-4924; Dauvilliers, yves/0000-0003-0683-6506	NARSAD: The Mental Health Research Association, USA	NARSAD: The Mental Health Research Association, USA(NARSAD)	S.F. was supported by NARSAD: The Mental Health Research Association, USA, 2007 Independent Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; Black JL, 2005, SLEEP, V28, P427, DOI 10.1093/sleep/28.4.427; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cvetkovic-Lopes V, 2010, J CLIN INVEST, V120, P713, DOI 10.1172/JCI41366; Dauvilliers Y, 2003, J NEUROL NEUROSUR PS, V74, P1667, DOI 10.1136/jnnp.74.12.1667; Dauvilliers Y, 2009, NEUROLOGY, V73, P1333, DOI 10.1212/WNL.0b013e3181bd1344; Dauvilliers Y, 2001, NEUROLOGY, V57, P2029, DOI 10.1212/WNL.57.11.2029; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DOGAN I, 2009, NAT IMMUNOL ADV; Fetissov SO, 2008, NUTRITION, V24, P348, DOI 10.1016/j.nut.2007.12.006; GRABAR P, 1975, CLIN IMMUNOL IMMUNOP, V4, P453, DOI 10.1016/0090-1229(75)90087-2; HALLMAYER J, 2009, NAT GENET; Higuchi S, 2002, NEUROSCI LETT, V318, P61, DOI 10.1016/S0304-3940(01)02476-4; Jackson MW, 2008, J NEUROSCI, V28, P13303, DOI 10.1523/JNEUROSCI.4489-08.2008; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Nishino Seiji, 2002, Sleep Med, V3, P377, DOI 10.1016/S1389-9457(02)00078-3; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; Overeem S, 2008, SLEEP MED REV, V12, P95, DOI 10.1016/j.smrv.2007.07.010; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; ROSSI F, 1989, IMMUNOL REV, V110, P135, DOI 10.1111/j.1600-065X.1989.tb00031.x; ROY BF, 1988, ANN NEUROL, V24, P57, DOI 10.1002/ana.410240111; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sinno MH, 2009, PSYCHONEUROENDOCRINO, V34, P140, DOI 10.1016/j.psyneuen.2008.08.021; Smith AJF, 2004, LANCET, V364, P2122, DOI 10.1016/S0140-6736(04)17553-3; Tafuri S, 2009, NEUROPEPTIDES, V43, P73, DOI 10.1016/j.npep.2009.01.003; Tanaka S, 2006, SLEEP, V29, P633, DOI 10.1093/sleep/29.5.633; Tanaka S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009555; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2009, SLEEP, V32, P993, DOI 10.1093/sleep/32.8.993	36	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13320	10.1371/journal.pone.0013320	http://dx.doi.org/10.1371/journal.pone.0013320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967199	Green Published, gold			2022-12-25	WOS:000282869800022
J	Kadono, T; Tran, D; Errakhi, R; Hiramatsu, T; Meimoun, P; Briand, J; Iwaya-Inoue, M; Kawano, T; Bouteau, F				Kadono, Takashi; Tran, Daniel; Errakhi, Rafik; Hiramatsu, Takuya; Meimoun, Patrice; Briand, Joel; Iwaya-Inoue, Mari; Kawano, Tomonori; Bouteau, Francois			Increased Anion Channel Activity Is an Unavoidable Event in Ozone-Induced Programmed Cell Death	PLOS ONE			English	Article							VACUOLAR PROCESSING ENZYME; SALICYLIC-ACID SIGNAL; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; ABSCISIC-ACID; OXIDATIVE BURST; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; ETHYLENE SYNTHESIS; CYTOSOLIC CALCIUM; SUSPENSION CELLS	Background: Ozone is a major secondary air pollutant often reaching high concentrations in urban areas under strong daylight, high temperature and stagnant high-pressure systems. Ozone in the troposphere is a pollutant that is harmful to the plant. Principal Findings: By exposing cells to a strong pulse of ozonized air, an acute cell death was observed in suspension cells of Arabidopsis thaliana used as a model. We demonstrated that O-3 treatment induced the activation of a plasma membrane anion channel that is an early prerequisite of O-3-induced cell death in A. thaliana. Our data further suggest interplay of anion channel activation with well known plant responses to O-3, Ca2+ influx and NADPH-oxidase generated reactive oxygen species (ROS) in mediating the oxidative cell death. This interplay might be fuelled by several mechanisms in addition to the direct ROS generation by O-3; namely, H2O2 generation by salicylic and abscisic acids. Anion channel activation was also shown to promote the accumulation of transcripts encoding vacuolar processing enzymes, a family of proteases previously reported to contribute to the disruption of vacuole integrity observed during programmed cell death. Significance: Collectively, our data indicate that anion efflux is an early key component of morphological and biochemical events leading to O-3-induced programmed cell death. Because ion channels and more specifically anion channels assume a crucial position in cells, an understanding about the underlying role(s) for ion channels in the signalling pathway leading to programmed cell death is a subject that warrants future investigation.	[Kadono, Takashi; Tran, Daniel; Errakhi, Rafik; Meimoun, Patrice; Briand, Joel; Kawano, Tomonori; Bouteau, Francois] Univ Paris 07, Lab Electrophysiol Membranes, Inst Biol Plantes, Orsay, France; [Kadono, Takashi; Iwaya-Inoue, Mari] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 812, Japan; [Hiramatsu, Takuya; Kawano, Tomonori; Bouteau, Francois] Univ Kitakyushu, Grad Sch Environm Engn, Wakamatsu Ku, Kitakyushu, Fukuoka, Japan	UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Kyushu University; University of Kitakyushu	Kadono, T (corresponding author), Univ Paris 07, Lab Electrophysiol Membranes, Inst Biol Plantes, Bat 630, Orsay, France.	daniel.tran@univ-paris-diderot.fr	Tran, Daniel/AAD-9339-2019; Tran, Daniel/I-4422-2012; Kadono, Takashi/N-4561-2015	Tran, Daniel/0000-0002-5669-8618; Kadono, Takashi/0000-0003-1710-9216; Meimoun, Patrice/0000-0002-7027-6075; Kawano, Tomonori/0000-0002-6876-9399; Bouteau, francois/0000-0003-0243-338X	MESR (Ministere de l'Enseignement Superieur et de la Recherche); Japan Society for the Promotion of Science	MESR (Ministere de l'Enseignement Superieur et de la Recherche)(Ministry of Research, France); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The study was supported by MESR (Ministere de l'Enseignement Superieur et de la Recherche) to LEM. Takashi Kadono gratefully acknowledges the financial support from the Japan Society for the Promotion of Science (** http://www.jsps.go.jp/english/e-pd/pddc.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors R, 2009, PLANT J, V58, P1, DOI 10.1111/j.1365-313X.2008.03756.x; AXELOS M, 1992, PLANT PHYSIOL BIOCH, V30, P123; Baier M, 2005, PLANT CELL ENVIRON, V28, P1012, DOI 10.1111/j.1365-3040.2005.01326.x; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Bouizgarne B, 2006, MOL PLANT MICROBE IN, V19, P550, DOI 10.1094/MPMI-19-0550; Brault M, 2004, PLANT PHYSIOL, V135, P231, DOI 10.1104/pp.104.039255; Cessna SG, 2001, PLANTA, V214, P126, DOI 10.1007/s004250100596; Cho MH, 1996, P NATL ACAD SCI USA, V93, P8134, DOI 10.1073/pnas.93.15.8134; Clayton H, 1999, PLANT J, V17, P575, DOI 10.1046/j.1365-313X.1999.00411.x; Colcombet J, 2009, FUNCT PLANT BIOL, V36, P832, DOI 10.1071/FP09096; Dauphin A, 2001, PHYSIOL PLANTARUM, V113, P79, DOI 10.1034/j.1399-3054.2001.1130111.x; De Angeli A, 2007, FEBS LETT, V581, P2367, DOI 10.1016/j.febslet.2007.04.003; Errakhi R, 2008, J EXP BOT, V59, P4259, DOI 10.1093/jxb/ern267; Errakhi R, 2008, J EXP BOT, V59, P3121, DOI 10.1093/jxb/ern166; Evans NH, 2005, PLANT J, V41, P615, DOI 10.1111/j.1365-313X.2004.02325.x; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Gauthier A, 2007, PLANT SIGNAL BEHAV, V2, P86, DOI 10.4161/psb.2.2.4015; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Hara-Nishimura I, 2005, CURR OPIN PLANT BIOL, V8, P404, DOI 10.1016/j.pbi.2005.05.016; Hatsugai N, 2006, APOPTOSIS, V11, P905, DOI 10.1007/s10495-006-6601-1; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Haymes KM, 2004, J AGR FOOD CHEM, V52, P5456, DOI 10.1021/jf0497962; HEDRICH R, 1990, EMBO J, V9, P3889, DOI 10.1002/j.1460-2075.1990.tb07608.x; HENNIG J, 1993, PLANT J, V4, P593, DOI 10.1046/j.1365-313X.1993.04040593.x; Kadono T, 2006, PLANT SIGNAL BEHAV, V1, P312, DOI 10.4161/psb.1.6.3518; Kangasjarvi J, 2005, PLANT CELL ENVIRON, V28, P1021, DOI 10.1111/j.1365-3040.2005.01325.x; KANGASJARVI J, 1994, PLANT CELL ENVIRON, V17, P783, DOI 10.1111/j.1365-3040.1994.tb00173.x; Kawano T, 2000, J EXP BOT, V51, P685, DOI 10.1093/jexbot/51.345.685; Kawano T, 2004, Z NATURFORSCH C, V59, P684; Kawano T, 1998, PLANT CELL PHYSIOL, V39, P721, DOI 10.1093/oxfordjournals.pcp.a029426; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Kinoshita T, 1995, PLANT CELL PHYSIOL, V36, P1555; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Lam E, 2005, TRENDS CELL BIOL, V15, P124, DOI 10.1016/j.tcb.2005.01.001; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lamotte O, 2006, FREE RADICAL BIO MED, V40, P1369, DOI 10.1016/j.freeradbiomed.2005.12.006; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Liu RS, 2007, AM J PHYSIOL-RENAL, V292, pF1867, DOI 10.1152/ajprenal.00515.2006; Meimoun P, 2009, PLANT SIGNAL BEHAV, V4, P830, DOI 10.4161/psb.4.9.9396; Moeder W, 2002, PLANT PHYSIOL, V130, P1918, DOI 10.1104/pp.009712; MOORE R, 1984, Planta (Heidelberg), V162, P342, DOI 10.1007/BF00396746; NAKANO M, 1986, ANAL BIOCHEM, V159, P363, DOI 10.1016/0003-2697(86)90354-4; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; Overmyer K, 2005, PLANT PHYSIOL, V137, P1092, DOI 10.1104/pp.104.055681; Pasqualini S, 2003, PLANT PHYSIOL, V133, P1122, DOI 10.1104/pp.103.026591; Patel S, 2009, FREE RADICAL RES, V43, P514, DOI 10.1080/10715760902887276; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pell EJ, 1997, PHYSIOL PLANTARUM, V100, P264, DOI 10.1034/j.1399-3054.1997.1000207.x; Rao MV, 2001, PLANTA, V213, P682, DOI 10.1007/s004250100618; Rao MV, 2000, PLANT MOL BIOL, V44, P345, DOI 10.1023/A:1026548726807; Reboutier D, 2005, PLANT PHYSIOL BIOCH, V43, P567, DOI 10.1016/j.plaphy.2005.03.003; Reboutier D, 2002, MOL PLANT MICROBE IN, V15, P932, DOI 10.1094/MPMI.2002.15.9.932; Reboutier D, 2007, J CELL SCI, V120, P3271, DOI 10.1242/jcs.011098; Reboutier D, 2008, PLANT SIGNAL BEHAV, V3, P314, DOI 10.4161/psb.3.5.5304; Roberts SK, 2006, NEW PHYTOL, V169, P647, DOI 10.1111/j.1469-8137.2006.01639.x; Roelfsema MRG, 2004, PLANT J, V37, P578, DOI 10.1111/j.1365-313X.2003.01985.x; Sandermann H, 1998, TRENDS PLANT SCI, V3, P47, DOI 10.1016/S1360-1385(97)01162-X; Sandermann H, 2008, BIOCHEM BIOPH RES CO, V366, P271, DOI 10.1016/j.bbrc.2007.12.018; Sano T, 2006, FEBS LETT, V580, P597, DOI 10.1016/j.febslet.2005.12.074; SATOH S, 1980, PLANT CELL PHYSIOL, V21, P939; SCHROEDER JI, 1992, P NATL ACAD SCI USA, V89, P5025, DOI 10.1073/pnas.89.11.5025; Sharma YK, 1997, FREE RADICAL BIO MED, V23, P480, DOI 10.1016/S0891-5849(97)00108-1; Tamaoki M, 2003, PLANTA, V216, P552, DOI 10.1007/s00425-002-0894-2; Tamaoki M, 2008, PLANT SIGNAL BEHAV, V3, P166, DOI 10.4161/psb.3.3.5538; Terta M, 2010, MOL PLANT MICROBE IN, V23, P139, DOI 10.1094/MPMI-23-2-0139; Torsethaugen G, 1999, P NATL ACAD SCI USA, V96, P13577, DOI 10.1073/pnas.96.23.13577; Trouverie J, 2008, PLANT CELL PHYSIOL, V49, P1495, DOI 10.1093/pcp/pcn126; Tuominen H, 2004, PLANT J, V39, P59, DOI 10.1111/j.1365-313X.2004.02107.x; Umemura K, 2009, PLANT J, V57, P463, DOI 10.1111/j.1365-313X.2008.03697.x; Vahala J, 2003, PLANT PHYSIOL, V132, P185, DOI 10.1104/pp.102.018887; VAHISALU T, 2010, PLANT J; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; van Doorn WG, 2005, TRENDS PLANT SCI, V10, P117, DOI 10.1016/j.tplants.2005.01.006; WARD JM, 1995, PLANT CELL, V7, P833, DOI 10.1105/tpc.7.7.833; Wendehenne D, 2002, PLANT CELL, V14, P1937, DOI 10.1105/tpc.002295; Wrzaczek M, 2009, P NATL ACAD SCI USA, V106, P5412, DOI 10.1073/pnas.0808980106; YOKAWA K, 2004, ITE LETT BATTER NEW, V5, P49; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360; YU YB, 1979, ARCH BIOCHEM BIOPHYS, V198, P280, DOI 10.1016/0003-9861(79)90420-X	82	39	43	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13373	10.1371/journal.pone.0013373	http://dx.doi.org/10.1371/journal.pone.0013373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967217	gold, Green Published, Green Submitted			2022-12-25	WOS:000282869800045
J	Xiao, XD; Zhu, ZY; Dankmeyer, JL; Wormald, MM; Fast, RL; Worsham, PL; Cote, CK; Amemiya, K; Dimitrov, DS				Xiao, Xiaodong; Zhu, Zhongyu; Dankmeyer, Jennifer L.; Wormald, Michael M.; Fast, Randy L.; Worsham, Patricia L.; Cote, Christopher K.; Amemiya, Kei; Dimitrov, Dimiter S.			Human Anti-Plague Monoclonal Antibodies Protect Mice from Yersinia pestis in a Bubonic Plague Model	PLOS ONE			English	Article							V-ANTIGEN; PNEUMONIC PLAGUE; FUSION PROTEIN; VIRULENCE; F1; VACCINE; LCRV; RESISTANCE; INFECTION; IMMUNITY	Yersinia pestis is the etiologic agent of plague that has killed more than 200 million people throughout the recorded history of mankind. Antibiotics may provide little immediate relief to patients who have a high bacteremia or to patients infected with an antibiotic resistant strain of plague. Two virulent factors of Y. pestis are the capsid F1 protein and the low-calcium response (Lcr) V-protein or V-antigen that have been proven to be the targets for both active and passive immunization. There are mouse monoclonal antibodies (mAbs) against the F1- and V-antigens that can passively protect mice in a murine model of plague; however, there are no anti-Yersinia pestis monoclonal antibodies available for prophylactic or therapeutic treatment in humans. We identified one anti-F1-specific human mAb (m252) and two anti-V-specific human mAb (m253, m254) by panning a naive phage-displayed Fab library against the F1- and V-antigens. The Fabs were converted to IgG1s and their binding and protective activities were evaluated. M252 bound weakly to peptides located at the F1 N-terminus where a protective mouse anti-F1 mAb also binds. M253 bound strongly to a V-antigen peptide indicating a linear epitope; m254 did not bind to any peptide from a panel of 53 peptides suggesting that its epitope may be conformational. M252 showed better protection than m253 and m254 against a Y, pestis challenge in a plague mouse model. A synergistic effect was observed when the three antibodies were combined. Incomplete to complete protection was achieved when m252 was given at different times post-challenge. These antibodies can be further studied to determine their potential as therapeutics or prophylactics in Y. pestis infection in humans.	[Xiao, Xiaodong; Zhu, Zhongyu; Dimitrov, Dimiter S.] NCI, Prot Interact Grp, Ctr Canc Res Nanobiol Program, NIH, Frederick, MD 21701 USA; [Zhu, Zhongyu] NCI, BSP, Sci Applicat Int Corp Frederick Inc, Frederick, MD 21701 USA; [Dankmeyer, Jennifer L.; Wormald, Michael M.; Fast, Randy L.; Worsham, Patricia L.; Cote, Christopher K.; Amemiya, Kei] USA, Med Res Inst Infect Dis, Bacteriol Div, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Xiao, XD (corresponding author), Medimmune LLC, Gaithersburg, MD USA.	kei.amemiya@us.army.mil; dimiter.dimitrov@nih.gov			National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; National Cancer Institute, NIH [N01-CO-12400]; National Institute of Allergy and Infectious Diseases; Joint Science and Technology Office Defense Threat Reduction Agency (JUSTO/DTRA) [1.1A0018_07_RD_B]; SAIC-Frederick, Inc.; U.S. Government; NATIONAL CANCER INSTITUTE [ZIABC011156] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Joint Science and Technology Office Defense Threat Reduction Agency (JUSTO/DTRA)(United States Department of DefenseDefense Threat Reduction Agency); SAIC-Frederick, Inc.; U.S. Government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research, by federal funds from the National Cancer Institute, NIH, under contract N01-CO-12400, by the National Institute of Allergy and Infectious Diseases Biodefense Program to Dimiter S. Dimitrov and agency Joint Science and Technology Office Defense Threat Reduction Agency (JUSTO/DTRA) proposal no. 1.1A0018_07_RD_B to Kei Amemiya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SAIC-Frederick, Inc., as one of the funders of this study, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SAIC-Fredereick, Inc. is a wholly owned subsidiary of Science Applications International Corporation and operates exclusively under a single, long-term contract to the National Cancer Institute, part of the U.S. National Institutes of Health. All funding is derived from the U.S. Government. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Albrecht MT, 2007, INFECT IMMUN, V75, P5425, DOI 10.1128/IAI.00261-07; Anderson GW, 1998, AM J TROP MED HYG, V58, P793, DOI 10.4269/ajtmh.1998.58.793; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Anderson GW, 1997, AM J TROP MED HYG, V56, P471, DOI 10.4269/ajtmh.1997.56.471; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P130; Broms JE, 2007, J BACTERIOL, V189, P8417, DOI 10.1128/JB.00936-07; Burton DR, 2001, PHAGE DISPLAY LAB MA, V1st; Casadevall A, 2002, EMERG INFECT DIS, V8, P833, DOI 10.3201/eid0808.010516; CAVANAUGH DC, 1959, J IMMUNOL, V83, P348; Cowan C, 2005, INFECT IMMUN, V73, P6127, DOI 10.1128/IAI.73.9.6127-6137.2005; DiMezzo TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006281; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Fields KA, 1999, INFECT IMMUN, V67, P4801, DOI 10.1128/IAI.67.9.4801-4813.1999; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Heath DG, 1998, VACCINE, V16, P1131, DOI 10.1016/S0264-410X(98)80110-2; Hill J, 2003, INFECT IMMUN, V71, P2234, DOI 10.1128/IAI.71.4.2234-2238.2003; Hill J, 1997, INFECT IMMUN, V65, P4476, DOI 10.1128/IAI.65.11.4476-4482.1997; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; LAWTON WD, 1963, J IMMUNOL, V91, P179; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Park JW, 2001, ADV PROTEIN CHEM, V56, P369; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x; Powell BS, 2005, BIOTECHNOL PROGR, V21, P1490, DOI 10.1021/bp050098r; Titball RW, 2004, EXPERT OPIN BIOL TH, V4, P965, DOI 10.1517/14712598.4.6.965; TURNER A, 2001, IMMUNOLOGY, P65; Weeks S, 2002, MICROB PATHOGENESIS, V32, P227, DOI 10.1006/mpat.2002.0498; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Welkos SL, 1995, CONTRIB TO MICROBIOL, V13, P299; Williamson ED, 1999, CLIN EXP IMMUNOL, V116, P107; Williamson ED, 2005, INFECT IMMUN, V73, P3598, DOI 10.1128/IAI.73.6.3598-3608.2005; WILLIAMSON ED, 1995, FEMS IMMUNOL MED MIC, V12, P223, DOI 10.1111/j.1574-695X.1995.tb00196.x; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Xiao Xiaodong, 2007, Recent Pat Antiinfect Drug Discov, V2, P171, DOI 10.2174/157489107782497272; Zhu ZY, 2007, P NATL ACAD SCI USA, V104, P12123, DOI 10.1073/pnas.0701000104; Zilinskas RA, 2006, CRIT REV MICROBIOL, V32, P47, DOI 10.1080/10408410500496896	37	23	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13047	10.1371/journal.pone.0013047	http://dx.doi.org/10.1371/journal.pone.0013047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20976274	Green Submitted, Green Published, gold			2022-12-25	WOS:000282869800002
J	Certel, SJ; Leung, A; Lin, CY; Perez, P; Chiang, AS; Kravitz, EA				Certel, Sarah J.; Leung, Adelaine; Lin, Chih-Yung; Perez, Philip; Chiang, Ann-Shyn; Kravitz, Edward A.			Octopamine Neuromodulatory Effects on a Social Behavior Decision-Making Network in Drosophila Males	PLOS ONE			English	Article							MALE COURTSHIP BEHAVIOR; LOCUS-COERULEUS; NEURAL CIRCUITRY; CEREBRAL-CORTEX; MUSHROOM BODY; FRUIT-FLY; NEURONS; MELANOGASTER; BRAIN; MODULATION	Situations requiring rapid decision-making in response to dynamic environmental demands occur repeatedly in natural environments. Neuromodulation can offer important flexibility to the output of neural networks in coping with changing conditions, but the contribution of individual neuromodulatory neurons in social behavior networks remains relatively unknown. Here we manipulate the Drosophila octopaminergic system and assay changes in adult male decision-making in courtship and aggression paradigms. When the functional state of OA neural circuits is enhanced, males exhibit elevated courtship behavior towards other males in both behavioral contexts. Eliminating the expression of the male form of the neural sex determination factor, Fruitless (Fru(M)), in three OA suboesophageal ganglia (SOG) neurons also leads to increased male-male courtship behavior in these same contexts. We analyzed the fine anatomical structure through confocal examination of labeled single neurons to determine the arborization patterns of each of the three Fru(M)-positive OA SOG neurons. These neurons send processes that display mirror symmetric, widely distributed arbors of endings within brain regions including the ventrolateral protocerebra, the SOG and the peri-esophageal complex. The results suggest that a small subset of OA neurons have the potential to provide male selective modulation of behavior at a single neuron level.	[Certel, Sarah J.; Leung, Adelaine; Perez, Philip; Kravitz, Edward A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Chiang, Ann-Shyn] Natl Tsing Hua Univ, Brain Res Ctr, Hsinchu, Taiwan; [Certel, Sarah J.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Lin, Chih-Yung; Chiang, Ann-Shyn] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan	Harvard University; Harvard Medical School; National Tsing Hua University; University of Montana System; University of Montana; National Tsing Hua University	Certel, SJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	sarah.certel@umontana.edu	Leung, Adelaine/F-4132-2011; Leung, Adelaine/AAV-3357-2021	Leung, Adelaine/0000-0002-2849-4474; 	National Institute of General Medical Sciences [GM-067645, GM-074675]; National Institutes of Health Center of Biomedical Research Excellence [P20RR015583]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067645, R01GM074675] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Center of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants (http://www.nigms.nih.gov/; GM-067645; GM-074675) from the National Institute of General Medical Sciences to EAK and a National Institutes of Health Center of Biomedical Research Excellence grant P20RR015583 to SJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten AFT, 2007, CEREB CORTEX, V17, pI6, DOI 10.1093/cercor/bhm033; Balaban P M, 2008, Neurosci Behav Physiol, V38, P453, DOI 10.1007/s11055-008-9002-9; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; BEAUDET A, 1981, J PHYSIOLOGY PARIS, V77, P193; BEAUDET A, 1978, NEUROSCIENCE, V3, P851, DOI 10.1016/0306-4522(78)90115-X; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Certel SJ, 2007, P NATL ACAD SCI USA, V104, P4706, DOI 10.1073/pnas.0700328104; Certel SJ, 2004, DEVELOPMENT, V131, P5429, DOI 10.1242/dev.01418; Chen J, 2009, J COMP NEUROL, V515, P441, DOI 10.1002/cne.22088; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Chiang AS, 2001, J COMP NEUROL, V440, P1, DOI 10.1002/cne.1365; Cholewa J, 2009, ZOOLOGY, V112, P251, DOI 10.1016/j.zool.2008.10.004; Christiansen AE, 2002, TRENDS GENET, V18, P510, DOI 10.1016/S0168-9525(02)02769-5; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Dacks AM, 2005, J COMP NEUROL, V488, P255, DOI 10.1002/cne.20556; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dierick HA, 2007, NAT PROTOC, V2, P2712, DOI 10.1038/nprot.2007.404; Doernberg SB, 2001, J COMP PHYSIOL A, V187, P91, DOI 10.1007/s003590000178; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Eckhoff P, 2009, J NEUROSCI, V29, P4301, DOI 10.1523/JNEUROSCI.5024-08.2009; Ejima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003246; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Gaudry Q, 2009, NAT NEUROSCI, V12, P1450, DOI 10.1038/nn.2400; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; Hofbauer A, 2009, J NEUROGENET, V23, P78, DOI 10.1080/01677060802471627; HOFFMANN AA, 1987, ANIM BEHAV, V35, P807, DOI 10.1016/S0003-3472(87)80117-3; Homberg U, 2004, NATURWISSENSCHAFTEN, V91, P199, DOI 10.1007/s00114-004-0525-9; HOMBERG U, 1994, J COMP PHYSIOL A, V175, P597, DOI 10.1007/BF00199481; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jones NG, 2003, CURR BIOL, V13, P1064, DOI 10.1016/S0960-9822(03)00380-4; KANZAKI R, 1992, BRAIN RES, V587, P211, DOI 10.1016/0006-8993(92)90999-P; Kim YC, 2007, GENES BRAIN BEHAV, V6, P201, DOI 10.1111/j.1601-183X.2006.00241.x; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Kononenko NL, 2007, CELL TISSUE RES, V330, P179, DOI 10.1007/s00441-007-0425-3; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kristan WB, 2008, CURR BIOL, V18, pR928, DOI 10.1016/j.cub.2008.07.081; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Langer SZ, 2008, NEUROCHEM INT, V52, P26, DOI 10.1016/j.neuint.2007.04.031; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; MAEDA T, 1991, COMP BIOCHEM PHYS C, V98, P193, DOI 10.1016/0742-8413(91)90195-Y; MAEDA T, 1972, BRAIN RES, V36, P19, DOI 10.1016/0006-8993(72)90763-9; Maeda T, 2000, J CHEM NEUROANAT, V18, P57, DOI 10.1016/S0891-0618(99)00051-4; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Middleton CA, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-17; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Monastirioti M, 1996, J NEUROSCI, V16, P3900; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Nadim F, 2008, J NEUROSCI, V28, P11806, DOI 10.1523/JNEUROSCI.3796-08.2008; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; PARNAVELAS JG, 1989, TRENDS NEUROSCI, V12, P315, DOI 10.1016/0166-2236(89)90037-4; Ramos BP, 2006, LEARN MEMORY, V13, P770, DOI 10.1101/lm.298006; Rodriguez-Valentin R, 2006, J CELL PHYSIOL, V209, P183, DOI 10.1002/jcp.20722; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Shea-Brown E, 2008, NEURAL COMPUT, V20, P2863, DOI 10.1162/neco.2008.03-07-487; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; Siwicki KK, 2009, CURR OPIN NEUROBIOL, V19, P200, DOI 10.1016/j.conb.2009.04.001; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; WELBERGEN P, 1987, BEHAVIOUR, V101, P253, DOI 10.1163/156853987X00017; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103; ZHOU C, 2008, NAT NEUROSCI	87	59	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13248	10.1371/journal.pone.0013248	http://dx.doi.org/10.1371/journal.pone.0013248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967276	gold, Green Submitted, Green Published			2022-12-25	WOS:000282807300006
J	Martin, C; Chen, SB; Heilos, D; Sauer, G; Hunt, J; Shaw, AG; Sims, PFG; Jackson, DA; Lovric, J				Martin, Catherine; Chen, Songbi; Heilos, Daniela; Sauer, Guido; Hunt, Jessica; Shaw, Alexander George; Sims, Paul Francis George; Jackson, Dean Andrew; Lovric, Josip			Changed Genome Heterochromatinization Upon Prolonged Activation of the Raf/ERK Signaling Pathway	PLOS ONE			English	Article							NONHISTONE CHROMOSOMAL-PROTEIN; CELL-CYCLE ARREST; TELOMERE LENGTH; GROWTH ARREST; HISTONE H3; REGULATED KINASE; STEM-CELLS; IN-VITRO; LYSINE 9; HP1	The Raf/ERK (Extracellular Signal Regulated Kinase) signal transduction pathway controls numerous cellular processes, including growth, differentiation, cellular transformation and senescence. ERK activation is thought to involve complex spatial and temporal regulation, to achieve a high degree of specificity, though precisely how this is achieved remains to be confirmed. We report here that prolonged activation of a conditional form of c-Raf-1 (BXB-ER) leads to profound changes in the level and distribution of a heterochromatic histone mark. In mouse fibroblasts, the heterochromatic trimethylation of lysine 9 in histone H3 (H3K9Me3) is normally confined to pericentromeric regions. However, following ERK activation a genome-wide redistribution of H3K9Me3 correlates with loss of the histone modification from chromocentres and the appearance of numerous punctuate sites throughout the interphase nucleus. These epigenetic changes during interphase correlate with altered chromosome structure during mitosis, where robust H3K9Me3 signals appear within telomeric heterochromatin. This pattern of heterochromatinization is distinct from previously described oncogene induced senescence associated heterochromatin foci (SAHF), which are excluded from telomeres. The H3K9Me3 histone mark is known to bind the major heterochromatin protein HP1 and we show that the alterations in the distribution of this histone epistate correlate with redistribution of HP1 beta throughout the nucleus. Interestingly while ERK activation is fully reversible, the observed chromatin changes induced by epigenetic modifications are not reversible once established. We describe for the first time a link from prolonged ERK activation to stable changes in genome organization through redistribution of heterochromatic domains involving the telomeres. These epigenetic changes provide a possible mechanism through which prolonged activation of Raf/ERK can lead to growth arrest or the induction of differentiation, senescence and cancer.	[Martin, Catherine; Heilos, Daniela; Hunt, Jessica; Shaw, Alexander George; Sims, Paul Francis George; Jackson, Dean Andrew; Lovric, Josip] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Chen, Songbi] Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Hainan, Peoples R China; [Sauer, Guido] Max Planck Inst Dev Biol, Tubingen, Germany	University of Manchester; Chinese Academy of Tropical Agricultural Sciences; Max Planck Society	Martin, C (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England.	Josip.Lovric@manchester.ac.uk	Hunt, Jessica/GRO-4060-2022; Shaw, Alex/GWC-7464-2022	Shaw, Alex/0000-0002-3166-872X; Lovric, Josip/0000-0002-0338-6581; Lupinek, Daniela/0000-0001-5749-9701	Biotechnology and Biological Science Research Council, UK [D00327X]; PFGS; BBSRC [BB/D00327X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D00327X/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); PFGS; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Science Research Council, UK, project Grant D00327X to DJ, JL and PFGS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Blasco MA, 2005, EMBO J, V24, P1095, DOI 10.1038/sj.emboj.7600598; Brami-Cherrier K, 2009, J NEUROCHEM, V108, P1323, DOI 10.1111/j.1471-4159.2009.05879.x; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Cerda MC, 1999, BIOL CELL, V91, P55, DOI 10.1016/S0248-4900(99)80031-8; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Fanton CP, 2001, J BIOL CHEM, V276, P18871, DOI 10.1074/jbc.M011514200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gilson E, 2007, CELL CYCLE, V6, P2486, DOI 10.4161/cc.6.20.4798; Gorelik G, 2009, AUTOIMMUN REV, V8, P196, DOI 10.1016/j.autrev.2008.07.043; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; HARLEY CB, 2008, NAT REV CANCER, V67, P179; Herbig U, 2006, MECH AGEING DEV, V127, P16, DOI 10.1016/j.mad.2005.09.002; Hingorani SR, 2003, CANCER RES, V63, P5198; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Houben R, 2009, J INVEST DERMATOL, V129, P406, DOI 10.1038/jid.2008.214; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kappei D, 2008, MECH AGEING DEV, V129, P17, DOI 10.1016/j.mad.2007.10.009; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LINDARDOPOULOS S, 1995, CANCER RES, V55, P5168; Lovric J, 1998, J BIOL CHEM, V273, P22848; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin C, 2006, DEV BIOL, V292, P317, DOI 10.1016/j.ydbio.2006.01.009; Martin C, 2009, J CELL SCI, V122, P1551, DOI 10.1242/jcs.046284; Mayr C, 2003, CHROMOSOME RES, V11, P471, DOI 10.1023/A:1024978711705; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Minc E., 2001, Methods in Cell Science, V23, P171, DOI 10.1023/A:1013168323754; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; NIAULT T, 2010, CARCINOGENESIS; Nittis T, 2008, BIOCHIMIE, V90, P5, DOI 10.1016/j.biochi.2007.08.009; O'Connor MS, 2009, BIOTECHNOL PROGR, V25, P1130, DOI 10.1002/btpr.223; O'Neill E, 2004, BRIT J CANCER, V90, P283, DOI 10.1038/sj.bjc.6601488; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Probst AV, 2008, DIFFERENTIATION, V76, P15, DOI 10.1111/j.1432-0436.2007.00220.x; QUELLE DE, 1995, ONCOGENE, V11, P635; Ravi RK, 1999, J CELL BIOCHEM, V72, P458, DOI 10.1002/(SICI)1097-4644(19990315)72:4<458::AID-JCB2>3.0.CO;2-C; Schreck R, 2006, INT J CANCER, V119, P2261, DOI 10.1002/ijc.22144; Schubeler D, 2000, GENE DEV, V14, P940; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Teller K, 2007, P NATL ACAD SCI USA, V104, P14970, DOI 10.1073/pnas.0704285104; Tombes RM, 1998, BIOCHEM J, V330, P1451; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Weng NP, 2001, J LEUKOCYTE BIOL, V70, P861; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-06; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang RG, 2007, CELL CYCLE, V6, P784, DOI 10.4161/cc.6.7.4079; Zhao T, 2001, J BIOL CHEM, V276, P9512, DOI 10.1074/jbc.M010098200; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	77	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13322	10.1371/journal.pone.0013322	http://dx.doi.org/10.1371/journal.pone.0013322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967285	Green Published, Green Submitted, gold			2022-12-25	WOS:000282807300024
J	Hentschke, M; Berneking, L; Campos, CB; Buck, F; Ruckdeschel, K; Aepfelbacher, M				Hentschke, Moritz; Berneking, Laura; Campos, Cristina Belmar; Buck, Friedrich; Ruckdeschel, Klaus; Aepfelbacher, Martin			Yersinia Virulence Factor YopM Induces Sustained RSK Activation by Interfering with Dephosphorylation	PLOS ONE			English	Article							RIBOSOMAL S6 KINASE; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; HUMAN CYTOMEGALOVIRUS-INFECTION; SARCOMA-ASSOCIATED HERPESVIRUS; COFFIN-LOWRY-SYNDROME; PESTIS YOPM; MOTIF PHOSPHORYLATION; RECOMBINANT PROTEINS; EFFECTOR FUNCTIONS; STEP PURIFICATION	Background: Pathogenic yersiniae inject several effector proteins (Yops) into host cells, which subverts immune functions and enables the bacteria to survive within the host organism. YopM, whose deletion in enteropathogenic yersiniae results in a dramatic loss of virulence, has previously been shown to form a complex with and activate the multifunctional kinases PKN2 and RSK1 in transfected cells. Methodology/Principal Findings: In a near physiological approach with double-affinity-tagged YopM being translocated into the macrophage cell line J774A. 1 via the natural type three secretion system of Yersinia we verified the interaction of YopM with PKN2 and RSK1 and detected association with additional PKN and RSK isoforms. In transfected and infected cells YopM induced sustained phosphorylation of RSK at its activation sites serine-380 and serine-221 even in the absence of signalling from its upstream kinase ERK1/2, suggesting inhibition of dephosphorylation. ATP-depletion and in vitro assays using purified components directly confirmed that YopM shields RSK isoforms from phosphatase activity towards serines 380 and 221. Conclusions/Significance: Our study suggests that during Yersinia infection YopM induces sustained activation of RSK by blocking dephosphorylation of its activatory phosphorylation sites. This may represent a novel mode of action of a bacterial virulence factor.	[Hentschke, Moritz; Berneking, Laura; Campos, Cristina Belmar; Ruckdeschel, Klaus; Aepfelbacher, Martin] Univ Med Ctr Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Buck, Friedrich] Univ Med Ctr Eppendorf, Inst Clin Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hentschke, M (corresponding author), Univ Med Ctr Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany.	m.hentschke@uke.de	Berneking, Laura/GNP-5002-2022	Berneking, Laura/0000-0001-9166-2533	Deutsche Forschungsgemeinschaft DFG [HE 5875/1-1]; Werner-Otto-Stiftung [4/72]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Werner-Otto-Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (HE 5875/1-1) and the Werner-Otto-Stiftung (4/72) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aepfelbacher M, 2007, THROMB HAEMOSTASIS, V98, P521, DOI 10.1160/TH07-03-0173; Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Benabdillah R, 2004, MICROB PATHOGENESIS, V36, P247, DOI 10.1016/j.micpath.2003.12.006; Bliska JB, 2006, ACS CHEM BIOL, V1, P349, DOI 10.1021/cb600261k; Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x; Boland A, 1998, MICROB PATHOGENESIS, V25, P343, DOI 10.1006/mpat.1998.0247; Chaturvedi D, 2009, J BIOL CHEM, V284, P23670, DOI 10.1074/jbc.M109.032813; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dettori R, 2009, J BIOL CHEM, V284, P30318, DOI 10.1074/jbc.M109.051151; Doehn U, 2004, BIOCHEM J, V382, P425, DOI 10.1042/BJ20040948; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; Hentschke M, 2003, BIOCHEM BIOPH RES CO, V312, P975, DOI 10.1016/j.bbrc.2003.11.025; Hentschke M, 2002, EUR J BIOCHEM, V269, P4086, DOI 10.1046/j.1432-1033.2002.03102.x; Hetzer C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000151; Heusipp G, 2006, MICROBIOL-SGM, V152, P1327, DOI 10.1099/mic.0.28697-0; Hoffmann R, 2004, CELL MICROBIOL, V6, P377, DOI 10.1111/j.1462-5822.2004.00365.x; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Johnson RA, 2000, J VIROL, V74, P1158, DOI 10.1128/JVI.74.3.1158-1167.2000; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; Koberle M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000551; Kuang E, 2008, J VIROL, V82, P1838, DOI 10.1128/JVI.02119-07; Kuang E, 2009, J BIOL CHEM, V284, P13958, DOI 10.1074/jbc.M900025200; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; McDonald C, 2003, J BIOL CHEM, V278, P18514, DOI 10.1074/jbc.M301226200; MCPHEE JB, INFECT IMMUN; Meriin AB, 1999, MOL CELL BIOL, V19, P2547; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Poirier R, 2007, BEHAV GENET, V37, P31, DOI 10.1007/s10519-006-9116-1; REISNER BS, 1992, INFECT IMMUN, V60, P5242, DOI 10.1128/IAI.60.12.5242-5252.1992; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Richards SA, 2001, MOL CELL BIOL, V21, P7470, DOI 10.1128/MCB.21.21.7470-7480.2001; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodems SM, 1998, J VIROL, V72, P9173, DOI 10.1128/JVI.72.11.9173-9180.1998; Rogers JP, 2006, J MED CHEM, V49, P1658, DOI 10.1021/jm051033y; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ruckdeschel K, 2008, IMMUNOBIOLOGY, V213, P261, DOI 10.1016/j.imbio.2007.11.001; Sauvonnet N, 2002, J BIOL CHEM, V277, P25133, DOI 10.1074/jbc.M203239200; Schmidt A, 2007, EMBO J, V26, P1624, DOI 10.1038/sj.emboj.7601637; Skrzypek E, 2003, INFECT IMMUN, V71, P937, DOI 10.1128/IAI.71.2.937-947.2003; Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x; STOFKOHAHN RE, 1992, FEBS LETT, V302, P274, DOI 10.1016/0014-5793(92)80458-S; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Trulzsch K, 2003, INT J MED MICROBIOL, V293, P167, DOI 10.1078/1438-4221-00251; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Ye Z, 2009, INFECT IMMUN, V77, P3791, DOI 10.1128/IAI.00284-09; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	63	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13165	10.1371/journal.pone.0013165	http://dx.doi.org/10.1371/journal.pone.0013165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957203	Green Submitted, Green Published, gold			2022-12-25	WOS:000282506100008
J	Schlievert, PM; Chuang-Smith, ON; Peterson, ML; Cook, LCC; Dunny, GM				Schlievert, Patrick M.; Chuang-Smith, Olivia N.; Peterson, Marnie L.; Cook, Laura C. C.; Dunny, Gary M.			Enterococcus faecalis Endocarditis Severity in Rabbits Is Reduced by IgG Fabs Interfering with Aggregation Substance	PLOS ONE			English	Article							INFECTIVE ENDOCARDITIS; ENHANCE PATHOGENICITY; TERMINAL DOMAIN; BINDING; VIRULENCE; INTERNALIZATION; ANTIBODIES; CONTRIBUTE; MSCRAMM; MODEL	Background: Enterococcus faecalis is a significant cause of infective endocarditis, an infection of the heart endothelium leading to vegetation formation (microbes, fibrin, platelets, and host cells attached to underlying endothelial tissue). Our previous research determined that enterococcal aggregation substance (AS) is an important virulence factor in causation of endocarditis, although endocarditis may occur in the absence of AS production. Production of AS by E. faecalis causes the organism to form aggregates through AS binding to enterococcal binding substance. In this study, we assessed the ability of IgGs and IgG Fabs against AS to provide protection against AS(+) E. faecalis endocarditis. Methodology/Principal Findings: When challenged with AS(+) E. faecalis, 10 rabbits actively immunized against AS(+) E. faecalis developed more significant vegetations than 9 animals immunized against AS(-) E. faecalis, and 9/10 succumbed compared to 2/9 (p<0.005), suggesting enhanced aggregation by IgG contributes significantly to disease. IgG antibodies against AS also enhanced enterococcal aggregation as tested in vitro. In contrast, Fab fragments of IgG from rabbits immunized against purified AS, when passively administered to rabbits (6/group) immediately before challenge with AS(+) E. faecalis, reduced total vegetation (endocarditis lesion) microbial counts (7.9x10(6) versus 2.0x10(5), p = 0.02) and size (40 mg versus 10, p = 0.05). In vitro, the Fabs prevented enterococcal aggregation. Conclusions/Significance: The data confirm the role of AS in infective endocarditis formation and suggest that use of Fabs against AS will provide partial protection from AS(+) E. faecalis illness.	[Schlievert, Patrick M.; Chuang-Smith, Olivia N.; Peterson, Marnie L.; Cook, Laura C. C.; Dunny, Gary M.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Schlievert, PM (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	schli001@umn.edu	Cook, Laura C/T-7185-2017	Cook, Laura C/0000-0002-7079-9570; Schlievert, Patrick/0000-0001-8314-9369	United States Public Health Service [HL51987]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051987] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by United States Public Health Service grant HL51987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOMSTERHAUTAMAA DA, 1988, METHOD ENZYMOL, V165, P37; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; CHRISTIE PJ, 1988, J BACTERIOL, V170, P5161, DOI 10.1128/jb.170.11.5161-5168.1988; Chuang ON, 2009, INFECT IMMUN, V77, P539, DOI 10.1128/IAI.01034-08; HIRT H, 1993, EUR J BIOCHEM, V211, P711, DOI 10.1111/j.1432-1033.1993.tb17600.x; Hirt H, 2002, INFECT IMMUN, V70, P716, DOI 10.1128/IAI.70.2.716-723.2002; KAYE D, 2004, INFECT DIS, P569; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McCormick JK, 2002, J INFECT DIS, V185, P994, DOI 10.1086/339604; McCormick JK, 2001, INFECT IMMUN, V69, P3305, DOI 10.1128/IAI.69.5.3305-3314.2001; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Rakita RM, 1999, INFECT IMMUN, V67, P6067, DOI 10.1128/IAI.67.11.6067-6075.1999; RICE LB, 1991, REV INFECT DIS, V13, P1; Rivas JM, 2004, CURR OPIN DRUG DISC, V7, P223; Schlievert PM, 1997, ADV EXP MED BIOL, V418, P789; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; Waters CM, 2004, MOL MICROBIOL, V52, P1159, DOI 10.1111/j.1365-2958.2004.04045.x; Waters CM, 2003, INFECT IMMUN, V71, P5682, DOI 10.1128/IAI.71.10.5682-5689.2003; WILSON W, 2007, CIRCULATION	20	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13194	10.1371/journal.pone.0013194	http://dx.doi.org/10.1371/journal.pone.0013194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957231	gold, Green Published, Green Submitted			2022-12-25	WOS:000282423300018
J	Takanashi, T; Nakano, R; Surlykke, A; Tatsuta, H; Tabata, J; Ishikawa, Y; Skals, N				Takanashi, Takuma; Nakano, Ryo; Surlykke, Annemarie; Tatsuta, Haruki; Tabata, Jun; Ishikawa, Yukio; Skals, Niels			Variation in Courtship Ultrasounds of Three Ostrinia Moths with Different Sex Pheromones	PLOS ONE			English	Article							EUROPEAN CORN-BORER; ADZUKI BEAN BORER; REPRODUCTIVE ISOLATION; NUBILALIS LEPIDOPTERA; PYRALIDAE; FURNACALIS; SCAPULALIS; STRAINS; HEARING; SONGS	Moths use ultrasounds as well as pheromones for sexual communication. In closely related moth species, variations in ultrasounds and pheromones are likely to profoundly affect mate recognition, reproductive isolation, and speciation. The European corn borer, Ostrinia nubilalis, and its Asian congeners, Ostrinia furnacalis and Ostrinia scapulalis, exhibit within-species and between-species variation in their pheromone communication. Recently, we reported ultrasound communication in O. furnacalis; however, variations in ultrasounds in the three congeners have not been addressed to date. Here we investigated features of ultrasound production and hearing in O. nubilalis and O. scapulalis, and compared them with those of O. furnacalis. As in O. furnacalis, males of O. nubilalis and O. scapulalis produced ultrasounds during courtship by rubbing specialized scales on the wings against scales on the thorax. The covering of these scales with nail polish muffled the sounds and significantly reduced mating success in O. nubilalis, showing the importance of ultrasound signaling in mating. The ultrasounds produced by O. nubilalis and O. scapulalis were similar, consisting of long trains of pairs of pulses with a main energy at 40 kHz, but distinctly different from the ultrasound produced by O. furnacalis, consisting of groups of pulses peaking at 50 kHz and with substantially more energy up to 80 kHz. Despite overall similarities, temporal features and patterns of amplitude modulation differed significantly among the geographic populations of O. nubilalis and O. scapulalis, which differed in pheromone type. In contrast, no significant difference in hearing was found among the three species with regard to the most sensitive frequencies and hearing threshold levels. The patterns of variations in the songs and pheromones well reflected those of the phylogenetic relationships, implying that ultrasound and pheromone communications have diverged concordantly. Our results suggest that concordant evolution in sexual signals such as courtship ultrasounds and sex pheromones occurs in moths.	[Takanashi, Takuma] Forestry & Forest Prod Res Inst, Ibaraki, Japan; [Nakano, Ryo] Natl Inst Fruit Tree Sci, Ibaraki, Japan; [Surlykke, Annemarie; Skals, Niels] Univ So Denmark, Inst Biol, Odense, Denmark; [Tatsuta, Haruki] Univ Ryukyus, Grad Sch Agr, Okinawa, Japan; [Tabata, Jun] Natl Inst Agroenvironm Sci, Biodivers Div, Ibaraki, Japan; [Ishikawa, Yukio] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	Forestry & Forest Products Research Institute - Japan; National Agriculture & Food Research Organization - Japan; University of Southern Denmark; University of the Ryukyus; National Institute for Agro-Environmental Sciences (NIAES) Japan; University of Tokyo	Takanashi, T (corresponding author), Forestry & Forest Prod Res Inst, Ibaraki, Japan.	takanasi@affrc.go.jp	Nakano, Ryo/C-2342-2011; Ishikawa, Yukio/J-5676-2019	Ishikawa, Yukio/0000-0003-3067-2513; Tabata, Jun/0000-0001-9095-2694; Tatsuta, Haruki/0000-0001-8847-8874	Japan Society for the Promotion of Science; Forestry and Forest Products Research Institute (FFPRI); Encourage Model for Researchers with Family Responsibilities of FFPRI; Danish Natural Science Research Council; Grants-in-Aid for Scientific Research [21780050] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Forestry and Forest Products Research Institute (FFPRI); Encourage Model for Researchers with Family Responsibilities of FFPRI; Danish Natural Science Research Council(Danish Natural Science Research Council); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by research grants from the Japan Society for the Promotion of Science (T.T., R.N., Y.I.), the Forestry and Forest Products Research Institute (FFPRI) (T.T., R.N., Y.I.), Encourage Model for Researchers with Family Responsibilities of FFPRI (TT), and the Danish Natural Science Research Council (A.S., N.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya L, 1998, BEHAV ECOL, V9, P552, DOI 10.1093/beheco/9.6.552; AGEE HR, 1969, ANN ENTOMOL SOC AM, V62, P1364, DOI 10.1093/aesa/62.6.1364; Ando T, 2004, TOP CURR CHEM, V239, P51, DOI 10.1007/b95449; ANDO T, 1980, AGR BIOL CHEM TOKYO, V44, P2643, DOI 10.1080/00021369.1980.10864390; Bengtsson M, 2006, ENVIRON ENTOMOL, V35, P1238, DOI 10.1603/0046-225X(2006)35[1238:FTROZS]2.0.CO;2; Chatfield C., 2004, ANAL TIME SERIES INT; Conner WE, 1999, J EXP BIOL, V202, P1711; Dopman EB, 2010, EVOLUTION, V64, P881, DOI 10.1111/j.1558-5646.2009.00883.x; Frolov AN, 2007, BIOL J LINN SOC, V91, P49, DOI 10.1111/j.1095-8312.2007.00779.x; Greenfield MD, 2002, SIGNALERS RECEIVERS; Greenfield MD, 2009, ETHOLOGY, V115, P1137, DOI 10.1111/j.1439-0310.2009.01700.x; Hoshizaki S, 2008, EUR J ENTOMOL, V105, P545, DOI 10.14411/eje.2008.073; Huang YP, 1997, J CHEM ECOL, V23, P2791, DOI 10.1023/A:1022567111508; Huang YP, 1998, J CHEM ECOL, V24, P2079, DOI 10.1023/A:1020737726636; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1023/A:1003601407578; Jang YW, 1998, EVOLUTION, V52, P1383, DOI [10.2307/2411308, 10.1111/j.1558-5646.1998.tb02020.x]; Kim CG, 1999, APPL ENTOMOL ZOOL, V34, P405, DOI 10.1303/aez.34.405; KLUN JA, 1975, ENVIRON ENTOMOL, V4, P891, DOI 10.1093/ee/4.6.891; KLUN JA, 1973, SCIENCE, V181, P661, DOI 10.1126/science.181.4100.661; Lofstedt C, 1997, INSECT PHEROMONE RESEARCH, P473; Malausa T, 2005, SCIENCE, V308, P258, DOI 10.1126/science.1107577; Marcus LF, 1990, SPECIAL PUBLICATION, V2, P77; MINET J, 2003, LEPIDOPTERA MOTHS BU, V2, P289; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Nakano R, 2009, J EXP BIOL, V212, P4072, DOI 10.1242/jeb.032466; NAKANO R, 2010, BIOL LETT IN PRESS; Nakano R, 2008, P NATL ACAD SCI USA, V105, P11812, DOI 10.1073/pnas.0804056105; Nakano R, 2006, NATURWISSENSCHAFTEN, V93, P292, DOI 10.1007/s00114-006-0100-7; Nakano R, 2010, PHYSIOL ENTOMOL, V35, P76, DOI 10.1111/j.1365-3032.2009.00712.x; Nakano Ryo, 2009, Communicative & Integrative Biology, V2, P123; Pelozuelo L, 2004, J CHEM ECOL, V30, P335, DOI 10.1023/B:JOEC.0000017981.03762.ed; Pelozuelo L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000555; PENA A, 1988, J CHEM ECOL, V14, P1359, DOI 10.1007/BF01020140; R Development Core Team, 2009, R FDN STAT COMP; ROEDER K. D., 1962, ANIMAL BEHAVIOUR, V10, P300, DOI 10.1016/0003-3472(62)90053-2; ROELOFS W, 1987, P NATL ACAD SCI USA, V84, P7585, DOI 10.1073/pnas.84.21.7585; Skals N, 2005, J EXP BIOL, V208, P595, DOI 10.1242/jeb.01400; SPANGLER HG, 1988, ANNU REV ENTOMOL, V33, P59, DOI 10.1146/annurev.en.33.010188.000423; SURLYKKE A, 1989, NATURWISSENSCHAFTEN, V76, P132, DOI 10.1007/BF00366610; Tabata J, 2003, J CHEM ECOL, V29, P2749, DOI 10.1023/B:JOEC.0000008018.52213.65; Takanashi T, 2005, BIOL J LINN SOC, V84, P143, DOI 10.1111/j.1095-8312.2005.00421.x; Thomas Y, 2003, EVOLUTION, V57, P261; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x	44	21	22	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13144	10.1371/journal.pone.0013144	http://dx.doi.org/10.1371/journal.pone.0013144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957230	gold, Green Published, Green Submitted			2022-12-25	WOS:000282423300006
J	Sajid, W; Kulahin, N; Schluckebier, G; Ribel, U; Henderson, HR; Tatar, M; Hansen, BF; Svendsen, AM; Kiselyov, VV; Norgaard, P; Wahlund, PO; Brandt, J; Kohanski, RA; Andersen, AS; De Meyts, P				Sajid, Waseem; Kulahin, Nikolaj; Schluckebier, Gerd; Ribel, Ulla; Henderson, Hope Rosalind; Tatar, Marc; Hansen, Bo Falck; Svendsen, Angela Manegold; Kiselyov, Vladislav V.; Norgaard, Per; Wahlund, Per-Olof; Brandt, Jakob; Kohanski, Ronald A.; Andersen, Asser Sloth; De Meyts, Pierre			Structural and Biological Properties of the Drosophila Insulin-like Peptide 5 Show Evolutionary Conservation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING REGION; NEGATIVE COOPERATIVITY; LIFE-SPAN; GROWTH; PROTEIN; EXPRESSION; AFFINITY; ISOFORM; CELLS; MUTAGENESIS	We report the crystal structure of two variants of Drosophila melanogaster insulin-like peptide 5 (DILP5) at a resolution of 1.85 angstrom. DILP5 shares the basic fold of the insulin peptide family (T conformation) but with a disordered B-chain C terminus. DILP5 dimerizes in the crystal and in solution. The dimer interface is not similar to that observed in vertebrates, i.e. through an anti-parallel beta-sheet involving the B-chain C termini but, in contrast, is formed through an anti-parallel beta-sheet involving the B-chain N termini. DILP5 binds to and activates the human insulin receptor and lowers blood glucose in rats. It also lowers trehalose levels in Drosophila. Reciprocally, human insulin binds to the Drosophila insulin receptor and induces negative cooperativity as in the human receptor. DILP5 also binds to insect insulin-binding proteins. These results show high evolutionary conservation of the insulin receptor binding properties despite divergent insulin dimerization mechanisms.	[Sajid, Waseem; Kulahin, Nikolaj; Svendsen, Angela Manegold; Kiselyov, Vladislav V.; De Meyts, Pierre] Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark; [Schluckebier, Gerd; Ribel, Ulla; Hansen, Bo Falck; Norgaard, Per; Wahlund, Per-Olof; Brandt, Jakob; Andersen, Asser Sloth] Novo Nordisk AS, Diabet Res Unit, DK-2760 Malov, Denmark; [Henderson, Hope Rosalind; Tatar, Marc] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Kohanski, Ronald A.] NIA, NIH, Bethesda, MD 20892 USA	Novo Nordisk; Hagedorn Research Institute; Novo Nordisk; Brown University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sajid, W (corresponding author), Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark.	wsaj@hagedorn.dk	Schluckebier, Gerd/A-5045-2009	Schluckebier, Gerd/0000-0003-0725-4081; Tatar, Marc/0000-0003-3232-6884; De Meyts, Pierre/0000-0001-6214-0824; Henderson, Hope/0000-0002-1373-296X				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Andersen AS, 2000, J BIOL CHEM, V275, P16948, DOI 10.1074/jbc.M001578200; Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Blundell T., 1972, ADV PROTEIN CHEM, V26, P279; Bonnesen C, 2010, CELL BIOL TOXICOL, V26, P293, DOI 10.1007/s10565-009-9142-x; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Chan SJ, 2000, AM ZOOL, V40, P213; Claeys I, 2002, PEPTIDES, V23, P807, DOI 10.1016/S0196-9781(01)00666-0; CUTFIELD JF, 1979, J MOL BIOL, V132, P85, DOI 10.1016/0022-2836(79)90497-2; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; De Meyts P, 1976, METHODS RECEPTOR RES, V1, P301; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DEMEYTS P, 1978, NATURE, V273, P504; DEMEYTS P, 1976, J BIOL CHEM, V251, P1877; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; GARBE JC, 1993, DEVELOPMENT, V119, P1237; Gauguin L., 2008, THESIS U COPENHAGEN; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; Glaser RW, 1925, J GEN PHYSIOL, V7, P599, DOI 10.1085/jgp.7.5.599; Glendorf T., 1995, THESIS DANISH TU LYN; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hernandez-Sanchez C, 2008, MOL BIOL EVOL, V25, P1043, DOI 10.1093/molbev/msn036; HONEGGER B, 2008, J BIOL-LONDON, V7, pNIL1, DOI DOI 10.1186/jbiol72; Hua QX, 2003, GENE DEV, V17, P826, DOI 10.1101/gad.1058003; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; KADOWAKI H, 1990, J BIOL CHEM, V265, P21285; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kjeldsen T, 1996, GENE, V170, P107, DOI 10.1016/0378-1119(95)00822-5; Kjeldsen T, 1998, PROTEIN EXPRES PURIF, V14, P309, DOI 10.1006/prep.1998.0977; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Lawrence MC, 2007, CURR OPIN STRUC BIOL, V17, P699, DOI 10.1016/j.sbi.2007.07.007; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MENESES P, 1975, COMP BIOCHEM PHYS A, V51, P483, DOI 10.1016/0300-9629(75)90398-9; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; MUGGEO M, 1979, DIABETES, V28, P175, DOI 10.2337/diab.28.3.175; MURRAYRUST J, 1992, BIOESSAYS, V14, P325, DOI 10.1002/bies.950140507; NAGATA K, 1995, J MOL BIOL, V253, P749, DOI 10.1006/jmbi.1995.0588; NORMANN TC, 1975, NATURE, V254, P259, DOI 10.1038/254259a0; OSTERBUR DL, 1988, DEV BIOL, V129, P439, DOI 10.1016/0012-1606(88)90391-0; PETRUZZELLI L, 1985, J BIOL CHEM, V260, P6072; Petruzzelli L., 1985, CANC CELLS, P115; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; Renteria ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003667; RUAN YM, 1995, J BIOL CHEM, V270, P4236, DOI 10.1074/jbc.270.9.4236; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sajid W, 2009, BIOCHEMISTRY-US, V48, P11283, DOI 10.1021/bi901269j; Satake S, 1997, COMP BIOCHEM PHYS B, V118, P349, DOI 10.1016/S0305-0491(97)00166-1; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; Wilkinson TN, 2007, ADV EXP MED BIOL, V612, P1; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011	70	43	45	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					661	673		10.1074/jbc.M110.156018	http://dx.doi.org/10.1074/jbc.M110.156018			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20974844	Green Published, hybrid			2022-12-25	WOS:000285782800067
J	Batchelor, R; Windle, CJ; Buchoux, S; Lorch, M				Batchelor, Rebecca; Windle, Christopher J.; Buchoux, Sebastien; Lorch, Mark			Cholesterol and Lipid Phases Influence the Interactions between Serotonin Receptor Agonists and Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; NOESY NMR CROSSPEAKS; ANGLE-SPINNING NMR; SOLID-STATE NMR; HYDROCARBON CHAINS; H-2 NMR; DIPALMITOYL PHOSPHATIDYLCHOLINE; MEMBRANE INTERACTIONS; MOLECULAR DISORDER; ACYL CHAINS	Solid state NMR techniques have been used to investigate the effect that two serotonin receptor 1a agonists (quipazine and LY-165,163) have on the phase behavior of, and interactions within, cholesterol/phosphocholine lipid bilayers. The presence of agonist, and particularly LY-165,163, appears to widen the phase transitions, an effect that is much more pronounced in the presence of cholesterol. It was found that both agonists locate close to the cholesterol, and their interactions with the lipids are modulated by the lipid phases. As the membrane condenses into mixed liquid-ordered/disordered phases, quipazine is pushed up toward the surface of the bilayer, whereas LY-165,163 moves deeper into the lipid chain region. In light of our results, we discuss the role of lipid/drug interactions on drug efficacy.	[Batchelor, Rebecca; Windle, Christopher J.; Lorch, Mark] Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, N Humberside, England; [Buchoux, Sebastien] Univ Picardie Jules Verne, F-80000 Amiens, France	University of Hull; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Lorch, M (corresponding author), Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, N Humberside, England.	M.Lorch@hull.ac.uk	Buchoux, Sébastien/B-1822-2010	Buchoux, Sébastien/0000-0002-1544-2093	Royal Society; Engineering and Physical Sciences Research Council; Research Councils UK; Engineering and Physical Sciences Research Council [EP/C508912/1] Funding Source: researchfish	Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Research Councils UK(UK Research & Innovation (UKRI)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a Royal Society project grant and an Engineering and Physical Sciences Research Council doctoral training account.; Supported by a Research Councils UK academic fellowship. To whom correspondence should be addressed. Tel.: 44-1482-465687; E-mail: M. Lorch@hull.ac.uk.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; AMMANN C, 1982, J MAGN RESON, V46, P319, DOI 10.1016/0022-2364(82)90147-0; Bjork K, 2010, EXP CELL RES, V316, P1351, DOI 10.1016/j.yexcr.2010.02.034; BURNETT LJ, 1971, J CHEM PHYS, V55, P5829, DOI 10.1063/1.1675758; Castanho MARB, 2006, EUR BIOPHYS J BIOPHY, V35, P92, DOI 10.1007/s00249-005-0007-9; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Clarke JA, 2006, BIOPHYS J, V90, P2383, DOI 10.1529/biophysj.104.056499; DAVIS JH, 1979, BIOPHYS J, V27, P339, DOI 10.1016/S0006-3495(79)85222-4; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; Eisensamer B, 2005, J NEUROSCI, V25, P10198, DOI 10.1523/JNEUROSCI.2460-05.2005; Escriba PV, 2008, J CELL MOL MED, V12, P829, DOI 10.1111/j.1582-4934.2008.00281.x; Escriba PV, 2006, TRENDS MOL MED, V12, P34, DOI 10.1016/j.molmed.2005.11.004; Holte LL, 1997, BIOCHEMISTRY-US, V36, P4669, DOI 10.1021/bi9626416; HUANG TH, 1993, BIOCHEMISTRY-US, V32, P13277, DOI 10.1021/bi00211a041; Huster D, 1999, J PHYS CHEM B, V103, P243, DOI 10.1021/jp983428h; Huster D, 1999, J AM CHEM SOC, V121, P1992, DOI 10.1021/ja9838413; Huster D, 1999, BIOPHYS J, V76, pA354; Jones E., 2001, SCIPY OPEN SOURCE SC; Karmakar S, 2005, J PHYS-CONDENS MAT, V17, pS1177, DOI 10.1088/0953-8984/17/14/006; Keller R., 2004, COMPUTER AIDED RESON, V1; Lombardi D, 2009, EUR J PHARM SCI, V38, P533, DOI 10.1016/j.ejps.2009.10.001; Lopez JJ, 2008, J BIOL CHEM, V283, P7813, DOI 10.1074/jbc.M707480200; Lucio M, 2010, CURR MED CHEM, V17, P1795, DOI 10.2174/092986710791111233; McCabe MA, 1997, SOLID STATE NUCL MAG, V10, P53, DOI 10.1016/S0926-2040(97)00024-6; Meyer HH., 1899, ARCH EXP PATH PHARMA, V42, P109, DOI [10.1007/BF01834479, DOI 10.1007/BF01834479]; MILLAN MJ, 1995, J PHARMACOL EXP THER, V273, P1418; OLDFIELD E, 1978, BIOCHEMISTRY-US, V17, P2727, DOI 10.1021/bi00607a006; Paila YD, 2009, BBA-BIOMEMBRANES, V1788, P295, DOI 10.1016/j.bbamem.2008.11.020; PEROUTKA SJ, 1988, EUR J PHARMACOL, V148, P297, DOI 10.1016/0014-2999(88)90579-1; Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9; Polozov IV, 2006, BIOPHYS J, V90, P2051, DOI 10.1529/biophysj.105.070441; REINL H, 1992, BIOPHYS J, V61, P1025, DOI 10.1016/S0006-3495(92)81910-0; SALMON A, 1987, J AM CHEM SOC, V109, P2600, DOI 10.1021/ja00243a010; SANKARAM MB, 1990, BIOCHEMISTRY-US, V29, P10676, DOI 10.1021/bi00499a015; Scheidt HA, 2005, BIOPHYS J, V89, P2504, DOI 10.1529/biophysj.105.062018; Scheidt HA, 2004, BBA-BIOMEMBRANES, V1663, P97, DOI 10.1016/j.bbamem.2004.02.004; SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; Soubias O, 2004, CHEM-EUR J, V10, P6005, DOI 10.1002/chem.200400246; Vauquelin G, 2009, MOL CELL ENDOCRINOL, V311, P1, DOI 10.1016/j.mce.2009.07.022; Veatch SL, 2004, BIOPHYS J, V86, p201A; VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	44	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41402	41411		10.1074/jbc.M110.155176	http://dx.doi.org/10.1074/jbc.M110.155176			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20961857	Green Published, hybrid			2022-12-25	WOS:000285622600026
J	Legiewicz, M; Zolotukhin, AS; Pilkington, GR; Purzycka, KJ; Mitchell, M; Uranishi, H; Bear, J; Pavlakis, GN; Le Grice, SFJ; Felber, BK				Legiewicz, Michal; Zolotukhin, Andrei S.; Pilkington, Guy R.; Purzycka, Katarzyna J.; Mitchell, Michelle; Uranishi, Hiroaki; Bear, Jenifer; Pavlakis, George N.; Le Grice, Stuart F. J.; Felber, Barbara K.			The RNA Transport Element of the Murine musD Retrotransposon Requires Long-range Intramolecular Interactions for Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KISSING-LOOP INTERACTION; SELECTIVE 2'-HYDROXYL ACYLATION; REV PROTEIN; NUCLEAR EXPORT; POSTTRANSCRIPTIONAL CONTROL; MUTATIONAL ANALYSIS; SECONDARY STRUCTURE; TARGET SEQUENCE; VIRUS GENOME; HIV-1	Retrovirus replication requires specialized transport mechanisms to export genomic mRNA from the nucleus to the cytoplasm of the infected cell. This regulation is mediated by a combination of viral and/or cellular factors that interact with cis-acting RNA export elements linking the viral RNA to the cellular CRM1 or NXF1 nuclear export pathways. Endogenous type D murine LTR retrotransposons (musD) were reported to contain an RNA export element located upstream of the 3'-LTR. Although functionally equivalent, the musD export element, termed the musD transport element, is distinct from the other retroviral RNA export elements, such as the constitutive transport element of simian/Mason-Pfizer monkey retroviruses and the RNA transport element found in rodent intracisternal A-particle LTR retrotransposons. We demonstrate here that the minimal RNA transport element (musD transport element) of musD comprises multiple secondary structure elements that presumably serve as recognition signals for the cellular export machinery. We identified two classes of tertiary interactions, namely kissing loops and a pseudoknot. This work constitutes the first example of an RNA transport element requiring such structural motifs to mediate nuclear export.	[Le Grice, Stuart F. J.] NCI, RT Biochem Sect, HIV Drug Resistance Program, Vaccine Branch,Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Zolotukhin, Andrei S.; Pilkington, Guy R.; Bear, Jenifer; Felber, Barbara K.] NCI, Human Retrovirus Pathogenesis Sect, NIH, Frederick, MD 21702 USA; [Uranishi, Hiroaki; Pavlakis, George N.] NCI, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Le Grice, SFJ (corresponding author), NCI, RT Biochem Sect, HIV Drug Resistance Program, Vaccine Branch,Ctr Canc Res,NIH, POB B,Bldg 535,Rm 206, Frederick, MD 21702 USA.	legrices@mail.nih.gov; felberb@mail.nih.gov		Purzycka, Katarzyna J./0000-0002-0271-9161	National Institutes of Health of the NCI Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010749, ZIABC010750, ZIABC010334] Funding Source: NIH RePORTER	National Institutes of Health of the NCI Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NCI Center for Cancer Research.	Badorrek CS, 2006, BIOCHEMISTRY-US, V45, P12664, DOI 10.1021/bi060521k; BARTEL DP, 1991, CELL, V67, P529, DOI 10.1016/0092-8674(91)90527-6; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Brierley I, 2008, BIOCHEM SOC T, V36, P684, DOI 10.1042/BST0360684; Cochrane AW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-18; Concepcion D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000484; COOK KS, 1991, NUCLEIC ACIDS RES, V19, P1577, DOI 10.1093/nar/19.7.1577; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Ernst RK, 1997, RNA, V3, P210; Felber BK, 2007, ADV PHARMACOL, V55, P161, DOI 10.1016/S1054-3589(07)55005-2; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Gago S, 2005, RNA, V11, P1073, DOI 10.1261/rna.2230605; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Haddrick M, 1996, J MOL BIOL, V259, P58, DOI 10.1006/jmbi.1996.0301; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; Hiriart E, 2005, J BIOL CHEM, V280, P36935, DOI 10.1074/jbc.M501725200; HOLLAND SM, 1990, J VIROL, V64, P5966, DOI 10.1128/JVI.64.12.5966-5975.1990; Ishihara H, 2004, J RADIAT RES, V45, P25, DOI 10.1269/jrr.45.25; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kang YB, 1999, VIROLOGY, V262, P200, DOI 10.1006/viro.1999.9906; Legiewicz M, 2008, P NATL ACAD SCI USA, V105, P14365, DOI 10.1073/pnas.0804461105; Lindtner S, 2006, J BIOL CHEM, V281, P36915, DOI 10.1074/jbc.M608745200; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MANS RMW, 1991, EUR J BIOCHEM, V201, P303, DOI 10.1111/j.1432-1033.1991.tb16288.x; MARINO JP, 1995, SCIENCE, V268, P1448, DOI 10.1126/science.7539549; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mitra S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn267; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Nappi F, 2001, J VIROL, V75, P4558, DOI 10.1128/JVI.75.10.4558-4569.2001; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; REUSS FU, 1992, J VIROL, V66, P1915, DOI 10.1128/JVI.66.4.1915-1923.1992; Ribet D, 2004, GENOME RES, V14, P2261, DOI 10.1101/gr.2924904; Ribet D, 2008, GENOME RES, V18, P597, DOI 10.1101/gr.073486.107; Ribet D, 2007, J VIROL, V81, P1888, DOI 10.1128/JVI.02051-06; Seol Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158103; Smulevitch S, 2005, J VIROL, V79, P2356, DOI 10.1128/JVI.79.4.2356-2365.2005; Sung D, 1998, NUCLEIC ACIDS RES, V26, P1369, DOI 10.1093/nar/26.6.1369; Tabernero C, 1997, J VIROL, V71, P95, DOI 10.1128/JVI.71.1.95-101.1997; Tabernero C, 1996, J VIROL, V70, P5998, DOI 10.1128/JVI.70.9.5998-6011.1996; Townsend HL, 2008, RNA BIOL, V5, P263, DOI 10.4161/rna.7165; Tretyakova I, 2005, J BIOL CHEM, V280, P31981, DOI 10.1074/jbc.M502736200; Uranishi H, 2009, J BIOL CHEM, V284, P26106, DOI 10.1074/jbc.M109.040113; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilkinson KA, 2009, RNA, V15, P1314, DOI 10.1261/rna.1536209; Zolotukhin AS, 2008, VIROLOGY, V377, P88, DOI 10.1016/j.virol.2008.04.002; Zolotukhin AS, 2009, NUCLEIC ACIDS RES, V37, P7151, DOI 10.1093/nar/gkp782; Zolotukhin AS, 2001, J VIROL, V75, P5567, DOI 10.1128/JVI.75.12.5567-5575.2001	49	21	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42097	42104		10.1074/jbc.M110.182840	http://dx.doi.org/10.1074/jbc.M110.182840			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20978285	hybrid, Green Published			2022-12-25	WOS:000285622600094
J	Pal, K; Swaminathan, K; Xu, HE; Pioszak, AA				Pal, Kuntal; Swaminathan, Kunchithapadam; Xu, H. Eric; Pioszak, Augen A.			Structural Basis for Hormone Recognition by the Human CRFR2 alpha G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING-FACTOR; 1ST EXTRACELLULAR DOMAIN; MOLECULAR RECOGNITION; PARATHYROID-HORMONE; CRYSTAL-STRUCTURE; HIGH-AFFINITY; SOLUBLE FORM; TUMOR-GROWTH; CRF; UROCORTINS	The mammalian corticotropin releasing factor (CRF)/urocortin (Ucn) peptide hormones include four structurally similar peptides, CRF, Ucn1, Ucn2, and Ucn3, that regulate stress responses, metabolism, and cardiovascular function by activating either of two related class B G protein-coupled receptors, CRFR1 and CRFR2. CRF and Ucn1 activate both receptors, whereas Ucn2 and Ucn3 are CRFR2-selective. The molecular basis for selectivity is unclear. Here, we show that the purified N-terminal extracellular domains (ECDs) of human CRFR1 and the CRFR2 alpha isoform are sufficient to discriminate the peptides, and we present three crystal structures of the CRFR2 alpha ECD bound to each of the Ucn peptides. The CRFR2 alpha ECD forms the same fold observed for the CRFR1 and mouse CRFR2 alpha ECDs but contains a unique N-terminal alpha-helix formed by its pseudo signal peptide. The CRFR2 alpha ECD peptide-binding site architecture is similar to that of CRFR1, and binding of the alpha-helical Ucn peptides closely resembles CRF binding to CRFR1. Comparing the electrostatic surface potentials of the ECDs suggests a charge compatibility mechanism for ligand discrimination involving a single amino acid difference in the receptors (CRFR1 Glu104/CRFR2 alpha Pro-100) at a site proximate to peptide residue 35 (Arg in CRF/Ucn1, Ala in Ucn2/3). CRFR1 Glu-104 acts as a selectivity filter preventing Ucn2/3 binding because the nonpolar Ala-35 is incompatible with the negatively charged Glu-104. The structures explain the mechanisms of ligand recognition and discrimination and provide a molecular template for the rational design of therapeutic agents selectively targeting these receptors.	[Pal, Kuntal; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA	National University of Singapore; Van Andel Institute	Swaminathan, K (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	dbsks@nus.edu.sg; eric.xu@vai.org; augen-pioszak@ouhsc.edu	Pal, Kuntal/W-6348-2019; Xu, H. Eric/ABD-7487-2021; sarkar, sabyasachi/A-9896-2010	sarkar, sabyasachi/0000-0002-8954-4375; Xu, H. Eric/0000-0002-6829-8144; PAL, KUNTAL/0000-0001-7094-2456	Michigan Economic Development Corp; Michigan Technology Tri-Corridor [085P1000817]; National Institutes of Health [GM087413]; Jay and Betty Van Andel Foundation; Ministry of Education, Singapore, and Biomedical Research Council; National University of Singapore; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087413] Funding Source: NIH RePORTER	Michigan Economic Development Corp; Michigan Technology Tri-Corridor; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; Ministry of Education, Singapore, and Biomedical Research Council(Ministry of Education, Singapore); National University of Singapore(National University of Singapore); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Brunzelle for assistance with data collection at sector 21 (LS-CAT) of the Advanced Photon Source, which is partly funded by the Michigan Economic Development Corp. and Michigan Technology Tri-Corridor Grant 085P1000817. Use of the Advanced Photon Source was supported by the Office of Science of the United States Department of Energy.; This work was supported, in whole or in part, by National Institutes of Health Grant GM087413 (to H. E. X. and A. A. P.). This work was also supported in part by the Jay and Betty Van Andel Foundation (to H. E. X., A. A. P., and K. P.), grants from the Ministry of Education, Singapore, and Biomedical Research Council (to K. S.), and a Research Scholarship from the National University of Singapore (to K.P.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bale TL, 2003, TRENDS CARDIOVAS MED, V13, P68, DOI 10.1016/S1050-1738(02)00214-1; Chen A, 2006, P NATL ACAD SCI USA, V103, P16580, DOI 10.1073/pnas.0607337103; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Dautzenberg FM, 1999, J NEUROCHEM, V73, P821, DOI 10.1046/j.1471-4159.1999.0730821.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dieterle T, 2009, HYPERTENSION, V53, P739, DOI 10.1161/HYPERTENSIONAHA.108.125211; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fekete EM, 2007, FRONT NEUROENDOCRIN, V28, P1, DOI 10.1016/j.yfrne.2006.09.002; Grace CRR, 2007, J AM CHEM SOC, V129, P16102, DOI 10.1021/ja0760933; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2010, J BIOL CHEM, V285, P38580, DOI 10.1074/jbc.M110.121897; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; Hao ZR, 2008, P NATL ACAD SCI USA, V105, P3939, DOI 10.1073/pnas.0712366105; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Klose J, 2005, BIOCHEMISTRY-US, V44, P1614, DOI 10.1021/bi049022e; Kuperman Y, 2008, TRENDS ENDOCRIN MET, V19, P122, DOI 10.1016/j.tem.2007.12.002; Kuperman Y, 2010, P NATL ACAD SCI USA, V107, P8393, DOI 10.1073/pnas.1003969107; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Li C, 2007, P NATL ACAD SCI USA, V104, P4206, DOI 10.1073/pnas.0611641104; Mazur AW, 2004, J MED CHEM, V47, P3450, DOI 10.1021/jm049883l; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Perrin MH, 2003, J BIOL CHEM, V278, P15595, DOI 10.1074/jbc.M210476200; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Pioszak AA, 2010, J BIOL CHEM, V285, P12435, DOI 10.1074/jbc.M109.093138; Pioszak AA, 2009, J BIOL CHEM, V284, P28382, DOI 10.1074/jbc.M109.022905; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Wang JJ, 2008, CANCER INVEST, V26, P359, DOI 10.1080/07357900701788106; Yang LZ, 2010, EUR J PHARMACOL, V632, P1, DOI 10.1016/j.ejphar.2010.01.027; Zmijewski MA, 2010, ACTA BIOCHIM POL, V57, P1	44	64	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40351	40361		10.1074/jbc.M110.186072	http://dx.doi.org/10.1074/jbc.M110.186072			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20966082	hybrid, Green Published			2022-12-25	WOS:000285185500078
J	Gamazon, ER; Im, HK; Duan, SW; Lussier, YA; Cox, NJ; Dolan, ME; Zhang, W				Gamazon, Eric R.; Im, Hae-Kyung; Duan, Shiwei; Lussier, Yves A.; Cox, Nancy J.; Dolan, M. Eileen; Zhang, Wei			ExprTarget: An Integrative Approach to Predicting Human MicroRNA Targets	PLOS ONE			English	Article							GENE-EXPRESSION; DATABASE; CANCER	Variation in gene expression has been observed in natural populations and associated with complex traits or phenotypes such as disease susceptibility and drug response. Gene expression itself is controlled by various genetic and non-genetic factors. The binding of a class of small RNA molecules, microRNAs (miRNAs), to mRNA transcript targets has recently been demonstrated to be an important mechanism of gene regulation. Because individual miRNAs may regulate the expression of multiple gene targets, a comprehensive and reliable catalogue of miRNA-regulated targets is critical to understanding gene regulatory networks. Though experimental approaches have been used to identify many miRNA targets, due to cost and efficiency, current miRNA target identification still relies largely on computational algorithms that aim to take advantage of different biochemical/thermodynamic properties of the sequences of miRNAs and their gene targets. A novel approach, ExprTarget, therefore, is proposed here to integrate some of the most frequently invoked methods (miRanda, PicTar, TargetScan) as well as the genome-wide HapMap miRNA and mRNA expression datasets generated in our laboratory. To our knowledge, this dataset constitutes the first miRNA expression profiling in the HapMap lymphoblastoid cell lines. We conducted diagnostic tests of the existing computational solutions using the experimentally supported targets in TarBase as gold standard. To gain insight into the biases that arise from such an analysis, we investigated the effect of the choice of gold standard on the evaluation of the various computational tools. We analyzed the performance of ExprTarget using both ROC curve analysis and cross-validation. We show that ExprTarget greatly improves miRNA target prediction relative to the individual prediction algorithms in terms of sensitivity and specificity. We also developed an online database, ExprTargetDB, of human miRNA targets predicted by our approach that integrates gene expression profiling into a broader framework involving important features of miRNA target site predictions.	[Gamazon, Eric R.; Lussier, Yves A.; Cox, Nancy J.; Dolan, M. Eileen] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Im, Hae-Kyung] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Lussier, Yves A.; Dolan, M. Eileen] Univ Chicago, Comm Clin Pharmacol & Pharmacogenom, Chicago, IL 60637 USA; [Lussier, Yves A.; Dolan, M. Eileen] Univ Chicago, Comprehens Canc Res Ctr, Chicago, IL 60637 USA; [Lussier, Yves A.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Duan, Shiwei] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Zhang, Wei] Univ Illinois, Coll Med, Inst Human Genet, Chicago, IL USA; [Zhang, Wei] Univ Illinois, Coll Med, Dept Pediat, Chicago, IL USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gamazon, ER (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	edolan@medicine.bsd.uchicago.edu; weizhan1@uic.edu	Lussier, Yves/N-4891-2017; Gamazon, Eric/I-6873-2018; Duan, Shiwei/AAA-4782-2022; Duan, Shiwei/J-9633-2012	Lussier, Yves/0000-0001-9854-1005; Gamazon, Eric/0000-0003-4204-8734; Duan, Shiwei/0000-0001-7682-2877; Im, Hae Kyung/0000-0003-0333-5685	Pharmacogenetics of Anticancer Agents Research Group; National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) [U01GM61393]; National Institutes of Health/National Cancer Institute [CA139278, U54 CA121852]; NIH/NCI Breast SPORE [P50 CA125183]; University of Chicago Comprehensive Cancer Research Center; NIH/NIGMS [U01GM61374]; NATIONAL CANCER INSTITUTE [U54CA121852, P50CA125183, R21CA139278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, U01GM061374] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	Pharmacogenetics of Anticancer Agents Research Group; National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI Breast SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Chicago Comprehensive Cancer Research Center; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded through the Pharmacogenetics of Anticancer Agents Research Group (http://www.pharmacogenetics.org/) by the National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) grant U01GM61393, National Institutes of Health/National Cancer Institute grants CA139278 and U54 CA121852, NIH/NCI Breast SPORE P50 CA125183, and the University of Chicago Comprehensive Cancer Research Center Pilot Project Program. Data deposits are supported by the NIH/NIGMS grant U01GM61374 (http://www.pharmgkb.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bacher Ulrike, 2009, Briefings in Functional Genomics & Proteomics, V8, P184, DOI 10.1093/bfgp/elp011; Barringhaus KG, 2009, CIRCULATION, V119, P2217, DOI 10.1161/CIRCULATIONAHA.107.715839; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; R Development Core Team, 2005, R LANG ENV STAT COMP; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Seo D, 2006, J AM COLL CARDIOL, V48, P227, DOI 10.1016/j.jacc.2006.02.070; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Xu B, 2010, BRAIN RES, V1338, P78, DOI 10.1016/j.brainres.2010.03.109; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015; Zhang W, 2009, CURR PHARM DESIGN, V15, P3782, DOI 10.2174/138161209789649475; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	41	59	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13534	10.1371/journal.pone.0013534	http://dx.doi.org/10.1371/journal.pone.0013534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975837	Green Published, Green Submitted, gold			2022-12-25	WOS:000283293800009
J	Ramirez, GP; Martinez, AS; Fernandez, VM; Bielsa, GC; Farina, WM				Ramirez, Gabriela P.; Martinez, Andres S.; Fernandez, Vanesa M.; Corti Bielsa, Gonzalo; Farina, Walter M.			The Influence of Gustatory and Olfactory Experiences on Responsiveness to Reward in the Honeybee	PLOS ONE			English	Article							SUCROSE-RESPONSE THRESHOLDS; DIVISION-OF-LABOR; APIS-MELLIFERA L.; BOMBUS-TERRESTRIS; JUVENILE-HORMONE; SOCIAL INSECT; FLORAL ODORS; TRANSMISSION DYNAMICS; PROBOSCIS EXTENSION; FORAGING BEHAVIOR	Background: Honeybees (Apis mellifera) exhibit an extraordinarily tuned division of labor that depends on age polyethism. This adjustment is generally associated with the fact that individuals of different ages display different response thresholds to given stimuli, which determine specific behaviors. For instance, the sucrose-response threshold (SRT) which largely depends on genetic factors may also be affected by the nectar sugar content. However, it remains unknown whether SRTs in workers of different ages and tasks can differ depending on gustatory and olfactory experiences. Methodology: Groups of worker bees reared either in an artificial environment or else in a queen-right colony, were exposed to different reward conditions at different adult ages. Gustatory response scores (GRSs) and odor-memory retrieval were measured in bees that were previously exposed to changes in food characteristics. Principal Findings: Results show that the gustatory responses of pre-foraging-aged bees are affected by changes in sucrose solution concentration and also to the presence of an odor provided it is presented as scented sucrose solution. In contrast no differences in worker responses were observed when presented with odor only in the rearing environment. Fast modulation of GRSs was observed in older bees (12-16 days of age) which are commonly involved in food processing tasks within the hive, while slower modulation times were observed in younger bees (commonly nurse bees, 6-9 days of age). This suggests that older food-processing bees have a higher plasticity when responding to fluctuations in resource information than younger hive bees. Adjustments in the number of trophallaxis events were also found when scented food circulated inside the nest, and this was positively correlated with the differences in timing observed in gustatory responsiveness and memory retention for hive bees of different age classes. Conclusions: This work demonstrates the accessibility of chemosensory information in the honeybee colonies with respect to incoming nectar. The modulation of the sensory-response systems within the hive can have important effects on the dynamics of food transfer and information propagation.	[Ramirez, Gabriela P.; Martinez, Andres S.; Fernandez, Vanesa M.; Corti Bielsa, Gonzalo; Farina, Walter M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Grp Estudio Insectos Sociales,IFIBYNE CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Ramirez, GP (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Grp Estudio Insectos Sociales,IFIBYNE CONICET, Buenos Aires, DF, Argentina.	walter@fbmc.fcen.uba.ar		Martinez, Andres/0000-0003-4629-4617; Farina, Walter/0000-0001-6411-489X	National Agency for Scientific and Tecnological promotion [PICT 2006 01-1155]; University of Buenos Aires [X077]; National Council on Scientific and Technical Research [PIP 112-200801-00150]; Guggenheim fellowship	National Agency for Scientific and Tecnological promotion; University of Buenos Aires(University of Buenos Aires); National Council on Scientific and Technical Research; Guggenheim fellowship	This study was supported by grants from the National Agency for Scientific and Tecnological promotion (PICT 2006 01-1155), University of Buenos Aires (X077), National Council on Scientific and Technical Research (PIP 112-200801-00150) and Guggenheim fellowship to WMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2009, EUR J NEUROSCI, V30, P1498, DOI 10.1111/j.1460-9568.2009.06940.x; Arenas A, 2008, J COMP PHYSIOL A, V194, P629, DOI 10.1007/s00359-008-0337-z; Arenas A, 2007, NATURWISSENSCHAFTEN, V94, P218, DOI 10.1007/s00114-006-0176-0; Arenas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008046; Ben-Shahar Y, 2001, J COMP PHYSIOL A, V187, P891, DOI 10.1007/s00359-001-0260-z; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Bloch G, 2002, J INSECT PHYSIOL, V48, P1123, DOI 10.1016/S0022-1910(02)00205-6; Breed MD, 2004, INSECT SOC, V51, P12, DOI 10.1007/s00040-003-0698-9; Dornhaus A, 2005, BEHAV ECOL, V16, P661, DOI 10.1093/beheco/ari040; Dornhaus A, 2001, BEHAV ECOL SOCIOBIOL, V50, P570, DOI 10.1007/s002650100395; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; Farina WM, 2007, NATURWISSENSCHAFTEN, V94, P55, DOI 10.1007/s00114-006-0157-3; Farina WM, 2005, P ROY SOC B-BIOL SCI, V272, P1923, DOI 10.1098/rspb.2005.3172; Farina WM, 2000, J COMP PHYSIOL A, V186, P239, DOI 10.1007/s003590050424; Fernandez VM, 2009, J COMP PHYSIOL A, V195, P759, DOI 10.1007/s00359-009-0453-4; Fewell JH, 2003, SCIENCE, V301, P1867, DOI 10.1126/science.1088945; FREE JB, 1969, NATURE, V222, P778, DOI 10.1038/222778a0; Friedrich A, 2004, J NEUROSCI, V24, P4460, DOI 10.1523/JNEUROSCI.0669-04.2004; Gil M, 2005, J EXP BIOL, V208, P671, DOI 10.1242/jeb.01474; Gordon DM, 2007, NATURE, V446, P143, DOI 10.1038/446143a; Goyret J, 2005, NATURWISSENSCHAFTEN, V92, P440, DOI 10.1007/s00114-005-0016-7; Gruter C, 2007, INSECT SOC, V54, P87, DOI 10.1007/s00040-007-0915-z; Gruter C, 2009, TRENDS ECOL EVOL, V24, P242, DOI 10.1016/j.tree.2008.12.007; Gruter C, 2006, BEHAV ECOL SOCIOBIOL, V60, P707, DOI 10.1007/s00265-006-0214-0; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1997, TRENDS NEUROSCI, V20, P245, DOI 10.1016/S0166-2236(96)01019-3; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Jassim O, 2000, J INSECT PHYSIOL, V46, P243, DOI 10.1016/S0022-1910(99)00176-6; KNUDSEN JT, 1993, PHYTOCHEMISTRY, V33, P253, DOI 10.1016/0031-9422(93)85502-I; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; LOGAN FA, 1960, INCENTIVE; Martinez A, 2008, BEHAV ECOL SOCIOBIOL, V62, P529, DOI 10.1007/s00265-007-0477-0; Mc Cabe SI, 2007, J COMP PHYSIOL A, V193, P1089, DOI 10.1007/s00359-007-0260-8; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Molet M, 2009, NATURWISSENSCHAFTEN, V96, P213, DOI 10.1007/s00114-008-0465-x; Mujagic S, 2009, J COMP PHYSIOL A, V195, P325, DOI 10.1007/s00359-008-0409-0; Naug D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1719, DOI 10.1007/s00265-008-0600-x; Naug D, 2007, P ROY SOC B-BIOL SCI, V274, P61, DOI 10.1098/rspb.2006.3695; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NUNEZ JA, 1971, PHYSIS, V81, P869; Pacheco J, 2008, ANIM BEHAV, V76, P1641, DOI 10.1016/j.anbehav.2008.08.001; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pankiw T, 2000, BEHAV ECOL SOCIOBIOL, V47, P265, DOI 10.1007/s002650050664; Pankiw T, 2004, BEHAV ECOL SOCIOBIOL, V55, P286, DOI 10.1007/s00265-003-0714-0; Pankiw T, 2003, J COMP PHYSIOL A, V189, P675, DOI 10.1007/s00359-003-0442-y; Pankiw T, 2001, J COMP PHYSIOL A, V187, P293, DOI 10.1007/s003590100201; Pirez N, 2004, BEHAV ECOL SOCIOBIOL, V55, P574, DOI 10.1007/s00265-003-0749-2; Provecho Y, 2009, J EXP BIOL, V212, P3221, DOI 10.1242/jeb.033506; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; ROCES F, 1990, OECOLOGIA, V83, P261, DOI 10.1007/BF00317762; Rosch G.A, 1925, Z VERGL PHYSIOL, V2, P571; Roussel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004197; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Sokal, 2000, BIOMETRY PRINCIPLES; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; von Frisch K., 1923, ZOOL JBER ABT      3, V40, P1; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Zar JH, 1999, BIOSTATISTICAL ANAL	66	14	14	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13498	10.1371/journal.pone.0013498	http://dx.doi.org/10.1371/journal.pone.0013498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975953	Green Published, gold, Green Submitted			2022-12-25	WOS:000283216400013
J	Marques, RB; Dits, NF; Erkens-Schulze, S; van Weerden, WM; Jenster, G				Marques, Rute B.; Dits, Natasja F.; Erkens-Schulze, Sigrun; van Weerden, Wytske M.; Jenster, Guido			Bypass Mechanisms of the Androgen Receptor Pathway in Therapy-Resistant Prostate Cancer Cell Models	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; TUMOR-GROWTH; VAV FAMILY; CROSS-TALK; METASTATIC PROGRESSION; EXCHANGE FACTOR; UP-REGULATION; TWIST; CYCLIN; AMPLIFICATION	Background: Prostate cancer is initially dependent on androgens for survival and growth, making hormonal therapy the cornerstone treatment for late-stage tumors. However, despite initial remission, the cancer will inevitably recur. The present study was designed to investigate how androgen-dependent prostate cancer cells eventually survive and resume growth under androgen-deprived and antiandrogen supplemented conditions. As model system, we used the androgen-responsive PC346C cell line and its therapy-resistant sublines: PC346DCC, PC346Flu1 and PC346Flu2. Methodology/Principal Findings: Microarray technology was used to analyze differences in gene expression between the androgen-responsive and therapy-resistant PC346 cell lines. Microarray analysis revealed 487 transcripts differentially-expressed between the androgen-responsive and the therapy-resistant cell lines. Most of these genes were common to all three therapy-resistant sublines and only a minority (similar to 5%) was androgen-regulated. Pathway analysis revealed enrichment in functions involving cellular movement, cell growth and cell death, as well as association with cancer and reproductive system disease. PC346DCC expressed residual levels of androgen receptor (AR) and showed significant down-regulation of androgen-regulated genes (p-value = 10(-7)). Up-regulation of VAV3 and TWIST1 oncogenes and repression of the DKK3 tumor-suppressor was observed in PC346DCC, suggesting a potential AR bypass mechanism. Subsequent validation of these three genes in patient samples confirmed that expression was deregulated during prostate cancer progression. Conclusions/Significance: Therapy-resistant growth may result from adaptations in the AR pathway, but androgen-independence may also be achieved by alternative survival mechanisms. Here we identified TWIST1, VAV3 and DKK3 as potential players in the bypassing of the AR pathway, making them good candidates as biomarkers and novel therapeutical targets.	[Marques, Rute B.; Dits, Natasja F.; Erkens-Schulze, Sigrun; van Weerden, Wytske M.; Jenster, Guido] Erasmus MC, Josephine Nefkens Inst, Dept Urol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Marques, RB (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Urol, Rotterdam, Netherlands.	g.jenster@erasmusmc.nl			Netherlands Organization for Scientific Research (NWO), through ZonMW [903-46-187]; Dutch Cancer Society (KWF) [NKB97-1479, DDHK 2001-2455]	Netherlands Organization for Scientific Research (NWO), through ZonMW(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	The work presented in this manuscript was financially supported by the Netherlands Organization for Scientific Research (NWO), through ZonMW grant 903-46-187, and by the Dutch Cancer Society (KWF), through grants NKB97-1479 and DDHK 2001-2455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asim M, 2008, ONCOGENE, V27, P3596, DOI 10.1038/sj.onc.1211016; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Berry PA, 2008, MOL CELL ENDOCRINOL, V288, P30, DOI 10.1016/j.mce.2008.02.024; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Bridges RS, 2009, AM J PATHOL, V175, P2351, DOI 10.2353/ajpath.2009.080954; Brown RSD, 2002, J PATHOL, V198, P237, DOI 10.1002/path.1206; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen Y, 1996, CELL GROWTH DIFFER, V7, P1571; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Cinar B, 2001, CANCER RES, V61, P7310; Colomba A, 2008, ONCOGENE, V27, P2728, DOI 10.1038/sj.onc.1210921; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Culig Z, 1997, DRUG AGING, V10, P50, DOI 10.2165/00002512-199710010-00005; Culig Z, 2004, GROWTH FACTORS, V22, P179, DOI 10.1080/08977190412331279908; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devlin HL, 2009, CANCER LETT, V274, P177, DOI 10.1016/j.canlet.2008.06.007; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Dong JT, 2001, CANCER METAST REV, V20, P173, DOI 10.1023/A:1015575125780; Dong ZY, 2006, MOL ENDOCRINOL, V20, P2315, DOI 10.1210/me.2006-0048; Dupont J, 2001, J BIOL CHEM, V276, P26699, DOI 10.1074/jbc.M102664200; Edamura K, 2007, CANCER GENE THER, V14, P765, DOI 10.1038/sj.cgt.7701071; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Fizazi K, 2007, ANN ONCOL, V18, P1765, DOI 10.1093/annonc/mdm086; Fribourg AF, 2000, CELL GROWTH DIFFER, V11, P361; Gregory CW, 2001, J ANDROL, V22, P537; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Gurumurthy S, 2001, CANCER METAST REV, V20, P225, DOI 10.1023/A:1015583310759; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Hsieh SY, 2004, ONCOGENE, V23, P9183, DOI 10.1038/sj.onc.1208138; Hu L, 2008, CANCER RES, V68, P4296, DOI 10.1158/0008-5472.CAN-08-0067; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jenster G, 1999, SEMIN ONCOL, V26, P407; Kawano Y, 2006, ONCOGENE, V25, P6528, DOI 10.1038/sj.onc.1209661; Koivisto P, 1997, CANCER RES, V57, P314; Kwok WK, 2007, CARCINOGENESIS, V28, P2467, DOI 10.1093/carcin/bgm185; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lee ECY, 2004, ARCH ANDROLOGY, V50, P27, DOI 10.1080/01485010490250498; Linja MJ, 2001, CANCER RES, V61, P3550; Liu Y, 2008, CANCER RES, V68, P6396, DOI 10.1158/0008-5472.CAN-08-0645; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; Lu S, 1997, CANCER RES, V57, P4511; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Marques RB, 2006, EUR UROL, V49, P245, DOI 10.1016/j.eururo.2005.12.035; Marques RB, 2005, INT J CANCER, V117, P221, DOI 10.1002/ijc.21201; MENDIRATTA P, 2009, J CLIN ONCOL; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Petre-Draviam CE, 2003, CANCER RES, V63, P4903; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Saeb-Parsy K, 2008, BRIT J CANCER, V99, P663, DOI 10.1038/sj.bjc.6604513; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; SMYTH GK, 2005, LIMMA LINEAR MODELS, P397; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; Taneja SS, 2002, J CELL BIOCHEM, V84, P188, DOI 10.1002/jcb.1278; Taplin ME, 2003, J CLIN ONCOL, V21, P2673, DOI 10.1200/JCO.2003.11.102; Tararova ND, 2007, PROSTATE, V67, P1801, DOI 10.1002/pros.20662; TATAROV O, 2007, TRANSLATIONAL ONCOGE, V2, P85; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trenkle T, 2000, GENE, V245, P139, DOI 10.1016/S0378-1119(00)00026-3; van der Heul-Nieuwenhuijsen L, 2006, BJU INT, V98, P886, DOI 10.1111/j.1464-410X.2006.06427.x; VANDERKWAST TH, 1991, INT J CANCER, V48, P189, DOI 10.1002/ijc.2910480206; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Veldhoven A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-192; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Verma RS, 1999, CANCER INVEST, V17, P441, DOI 10.3109/07357909909021436; Wang Y, 2007, CURR CANCER DRUG TAR, V7, P591, DOI 10.2174/156800907781662248; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Yuen HF, 2007, HISTOPATHOLOGY, V50, P648, DOI 10.1111/j.1365-2559.2007.02665.x; Zeng LY, 2000, MOL CELL BIOL, V20, P9212, DOI 10.1128/MCB.20.24.9212-9224.2000; Zenzmaier C, 2008, PROSTATE, V68, P540, DOI 10.1002/pros.20711; Zhang YQ, 2007, PATHOLOGY, V39, P470, DOI 10.1080/00313020701570053; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084	80	68	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13500	10.1371/journal.pone.0013500	http://dx.doi.org/10.1371/journal.pone.0013500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976069	Green Submitted, Green Published, gold			2022-12-25	WOS:000283114700020
J	Ramser, EM; Wolters, G; Dityateva, G; Dityatev, A; Schachner, M; Tilling, T				Ramser, Elisa M.; Wolters, Gerrit; Dityateva, Galina; Dityatev, Alexander; Schachner, Melitta; Tilling, Thomas			The 14-3-3 zeta Protein Binds to the Cell Adhesion Molecule L1, Promotes L1 Phosphorylation by CKII and Influences L1-Dependent Neurite Outgrowth	PLOS ONE			English	Article							SERINE PHOSPHORYLATION; NEURONAL MIGRATION; RAF-1 ACTIVATION; KINASE-ACTIVITY; GROWTH CONES; EXOENZYME S; TRAFFICKING; TRANSPORT; EXPRESSION; BRAIN	Background: The cell adhesion molecule L1 is crucial for mammalian nervous system development. L1 acts as a mediator of signaling events through its intracellular domain, which comprises a putative binding site for 14-3-3 proteins. These regulators of diverse cellular processes are abundant in the brain and preferentially expressed by neurons. In this study, we investigated whether L1 interacts with 14-3-3 proteins, how this interaction is mediated, and whether 14-3-3 proteins influence the function of L1. Methodology/Principal Findings: By immunoprecipitation, we demonstrated that 14-3-3 proteins are associated with L1 in mouse brain. The site of 14-3-3 interaction in the L1 intracellular domain (L1ICD), which was identified by site-directed mutagenesis and direct binding assays, is phosphorylated by casein kinase II (CKII), and CKII phosphorylation of the L1ICD enhances binding of the 14-3-3 zeta isoform (14-3-3 zeta). Interestingly, in an in vitro phosphorylation assay, 14-3-3 zeta promoted CKII-dependent phosphorylation of the L1ICD. Given that L1 phosphorylation by CKII has been implicated in L1-triggered axonal elongation, we investigated the influence of 14-3-3 zeta on L1-dependent neurite outgrowth. We found that expression of a mutated form of 14-3-3 zeta, which impairs interactions of 14-3-3 zeta with its binding partners, stimulated neurite elongation from cultured rat hippocampal neurons, supporting a functional connection between L1 and 14-3-3 zeta. Conclusions/Significance: Our results suggest that 14-3-3 zeta, a novel direct binding partner of the L1ICD, promotes L1 phosphorylation by CKII in the central nervous system, and regulates neurite outgrowth, an important biological process triggered by L1.	[Ramser, Elisa M.; Wolters, Gerrit; Dityateva, Galina; Dityatev, Alexander; Schachner, Melitta; Tilling, Thomas] Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Hamburg, Germany; [Dityateva, Galina; Dityatev, Alexander] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Istituto Italiano di Tecnologia - IIT; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Ramser, EM (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Wolters-Eisfeld, Gerrit/H-8333-2019; Dityatev, Alexander/A-4034-2008	Wolters-Eisfeld, Gerrit/0000-0002-2984-6515; Dityatev, Alexander/0000-0002-0472-0553	German Federal Ministry of Education and Research [0311762/8]; New Jersey Commission for Spinal Cord Research	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); New Jersey Commission for Spinal Cord Research	The study was partially supported by the German Federal Ministry of Education and Research, project no. 0311762/8 (to M. S.), and the New Jersey Commission for Spinal Cord Research (to M. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Cavet ME, 2003, J BIOL CHEM, V278, P18376, DOI 10.1074/jbc.M208475200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chen BS, 2009, NEURON, V62, P471, DOI 10.1016/j.neuron.2009.04.015; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; DENT P, 1995, SCIENCE, V268, P1902, DOI 10.1126/science.7604263; Dityateva G, 2003, J NEUROSCI METH, V130, P65, DOI 10.1016/S0165-0270(03)00202-4; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; Goransson O, 2006, J CELL SCI, V119, P4059, DOI 10.1242/jcs.03097; Gutwein P, 2005, CLIN CANCER RES, V11, P2492, DOI 10.1158/1078-0432.CCR-04-1688; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Henriksson ML, 2000, BIOCHEM J, V349, P697, DOI 10.1042/bj3490697; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kamiguchi H, 1998, J NEUROSCI, V18, P3749, DOI 10.1523/jneurosci.18-10-03749.1998; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Ku NO, 2004, J CELL BIOL, V166, P479, DOI 10.1083/jcb.200402051; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Long KE, 2000, J NEUROBIOL, V44, P230, DOI 10.1002/1097-4695(200008)44:2<230::AID-NEU12>3.0.CO;2-W; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MIURA M, 1991, FEBS LETT, V289, P91, DOI 10.1016/0014-5793(91)80915-P; Mohajeri MH, 1996, EUR J NEUROSCI, V8, P1085, DOI 10.1111/j.1460-9568.1996.tb01276.x; Moore B. W., 1967, SPECIFIC ACID PROTEI; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; Nakata A, 2007, J NEUROSCI RES, V85, P723, DOI 10.1002/jnr.21185; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Reuther GW, 1996, VITAM HORM, V52, P149, DOI 10.1016/S0083-6729(08)60410-0; Rong JA, 2007, J BIOL CHEM, V282, P4748, DOI 10.1074/jbc.M609057200; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schmitz D, 2008, GROWTH HORM IGF RES, V18, P245, DOI 10.1016/j.ghir.2007.10.002; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297; Simsek-Duran F, 2004, NAT NEUROSCI, V7, P1296, DOI 10.1038/nn1348; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Sumioka A, 2005, J BIOL CHEM, V280, P42364, DOI 10.1074/jbc.M504278200; Takeda Y, 1996, J NEUROCHEM, V66, P2338; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wong EV, 1996, J NEUROCHEM, V66, P779; Wong EV, 1996, J BIOL CHEM, V271, P18217, DOI 10.1074/jbc.271.30.18217; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	68	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13462	10.1371/journal.pone.0013462	http://dx.doi.org/10.1371/journal.pone.0013462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976158	Green Submitted, Green Published, gold			2022-12-25	WOS:000283045300031
J	Dessing, MC; Butter, LM; Teske, GJ; Claessen, N; van der Loos, CM; Vogl, T; Roth, J; van der Poll, T; Florquin, S; Leemans, JC				Dessing, Mark C.; Butter, Loes M.; Teske, Gwendoline J.; Claessen, Nike; van der Loos, Chris M.; Vogl, Thomas; Roth, Johannes; van der Poll, Tom; Florquin, Sandrine; Leemans, Jaklien C.			S100A8/A9 Is Not Involved in Host Defense against Murine Urinary Tract Infection	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; TOLL-LIKE RECEPTORS; S100 PROTEINS; ANTIMICROBIAL ACTIVITY; PLASMINOGEN-ACTIVATOR; ACUTE PYELONEPHRITIS; UROLOGIC DISEASES; AMERICA PROJECT; KIDNEY-DISEASE; CALPROTECTIN	Background: Inflammation is commonly followed by the release of endogenous proteins called danger associated molecular patterns (DAMPs) that are able to warn the host for eminent danger. S100A8/A9 subunits are DAMPs that belong to the S100 family of calcium binding proteins. S100A8/A9 complexes induce an inflammatory response and their expression correlates with disease severity in several inflammatory disorders. S100A8/A9 promote endotoxin-and Escherichia (E.) coli-induced sepsis showing its contribution in systemic infection. The role of S100A8/A9 during a local infection of the urinary tract system caused by E. coli remains unknown. Methodology/Principal Findings: We investigated the contribution of S100A8/A9 in acute urinary tract infection (UTI) by instilling 2 different doses of uropathogenic E. coli transurethrally in wild type (WT) and S100A9 knockout (KO) mice. Subsequently, we determined bacterial outgrowth, neutrophilic infiltrate and inflammatory mediators in bladder and kidney 24 and 48 hours later. UTI resulted in a substantial increase of S100A8/A9 protein in bladder and kidney tissue of WT mice. S100A9 KO mice displayed similar bacterial load in bladder or kidney homogenate compared to WT mice using 2 different doses at 2 different time points. S100A9 deficiency had little effect on the inflammatory responses to E. Coli-induced UTI infection, as assessed by myeloperoxidase activity in bladder and kidneys, histopathologic analysis, and renal and bladder cytokine concentrations. Conclusions: We show that despite high S100A8/A9 expression in bladder and kidney tissue upon UTI, S100A8/A9 does not contribute to an effective host response against E. Coli in the urinary tract system.	[Dessing, Mark C.; Butter, Loes M.; Teske, Gwendoline J.; Claessen, Nike; van der Loos, Chris M.; Florquin, Sandrine; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Vogl, Thomas; Roth, Johannes] Univ Munster, Inst Immunol, Munster, Germany; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Munster; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Dessing, MC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	m.c.dessing@amc.uva.nl	Leemans, Jaklien/AAM-4958-2020; Florquin, Sandrine/B-8242-2012	Florquin, Sandrine/0000-0002-9676-1722	Dutch Kidney Foundation	Dutch Kidney Foundation	This study has been financially supported by the Dutch Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2007, CURR OPIN NEPHROL HY, V16, P177, DOI 10.1097/MNH.0b013e32803fb767; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; BRANDTZAEG P, 1995, ADV EXP MED BIOL, V371, P201; Cornish CJ, 1996, J CELL PHYSIOL, V166, P427, DOI 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; EDGEWORTH J, 1989, NATURE, V342, P189, DOI 10.1038/342189a0; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Eue I, 2000, INT IMMUNOL, V12, P1593, DOI 10.1093/intimm/12.11.1593; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Freedman AL, 2005, J UROLOGY, V173, P949, DOI 10.1097/01.ju.0000152092.03931.9a; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Litwin MS, 2005, J UROLOGY, V173, P933, DOI 10.1097/01.ju.0000152365.43125.3b; Loomans HJ, 1998, J INFECT DIS, V177, P812, DOI 10.1086/517816; Mambula SS, 2000, INFECT IMMUN, V68, P6257, DOI 10.1128/IAI.68.11.6257-6264.2000; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; MCNAMARA MP, 1988, LANCET, V2, P1163; Newton RA, 1998, J IMMUNOL, V160, P1427; Nisapakultorn K, 2001, INFECT IMMUN, V69, P3692, DOI 10.1128/IAI.69.6.3692-3696.2001; Passey RJ, 1999, J IMMUNOL, V163, P2209; Perez-Alvarez MJ, 2000, REGUL PEPTIDES, V88, P41, DOI 10.1016/S0167-0115(99)00118-4; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Reyes L, 2009, INFECT IMMUN, V77, P4265, DOI 10.1128/IAI.00458-09; Roelofs JJTH, 2006, KIDNEY INT, V70, P1942, DOI 10.1038/sj.ki.5001947; Roelofs JJTH, 2009, NEPHROL DIAL TRANSPL, V24, P801, DOI 10.1093/ndt/gfn562; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Rouschop KMA, 2006, J IMMUNOL, V177, P7225, DOI 10.4049/jimmunol.177.10.7225; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; SANTHANAGOPALAN V, 1995, J INFECT DIS, V171, P1289, DOI 10.1093/infdis/171.5.1289; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; SOHNLE PG, 1991, J INFECT DIS, V163, P187, DOI 10.1093/infdis/163.1.187; Sohnle PG, 1996, J INFECT DIS, V174, P1369, DOI 10.1093/infdis/174.6.1369; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; van der Loos CM, 2008, J HISTOTECHNOL, V31, P119, DOI 10.1179/his.2008.31.3.119; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; van Zoelen MAD, 2009, AM J RESP CRIT CARE, V180, P1098, DOI 10.1164/rccm.200810-1552OC; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638	42	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13394	10.1371/journal.pone.0013394	http://dx.doi.org/10.1371/journal.pone.0013394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976233	gold, Green Published, Green Submitted			2022-12-25	WOS:000282941000019
J	Manoj, KM; Gade, SK; Mathew, L				Manoj, Kelath Murali; Gade, Sudeep Kumar; Mathew, Lazar			Cytochrome P450 Reductase: A Harbinger of Diffusible Reduced Oxygen Species	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; C REDUCTASE; OXIDATION; ACTIVATION; MECHANISM; BINDING; P4502C9	The bi-enzymatic system of cytochrome P450 (CYP, a hemoprotein) and cytochrome P450 reductase (CPR, a diflavoenzyme) mediate the redox metabolism of diverse indigenous and xenobiotic molecules in various cellular and organ systems, using oxygen and NADPH. Curiously, when a 1: 1 ratio is seen to be optimal for metabolism, the ubiquitous CYP: CPR distribution ratio is 10 to 100: 1 or higher. Further, the NADPH equivalents consumed in these in vitro or in situ assemblies usually far exceeded the amount of substrate metabolized. We aimed to find the rationale to explain for these two oddities. We report here that CPR is capable of activating molecular oxygen on its own merit, generating diffusible reduced oxygen species (DROS). Also, in the first instance for a flavoprotein, CPR is shown to deplete peroxide via diffusible radical mediated process, thereby leading to the formation of water (but without significant evolution of oxygen). We also quantitatively demonstrate that the rate of oxygen activation and peroxide depletion by CPR accounts for the major reactivity in the CYP+CPR mixture. We show unambiguously that CPR is able to regulate the concentration of diffusible reduced oxygen species in the reaction milieu. These findings point out that CPR mediated processes are bound to be energetically 'wasteful' and potentially 'hazardous' owing to the unavoidable nature of the CPR to generate and deplete DROS. Hence, we can understand that CPR is distributed at low densities in cells. Some of the activities that were primarily attributed to the heme-center of CYP are now established to be a facet of the flavins of CPR. The current approach of modeling drugs to minimize "uncoupling" on the basis of erstwhile hypothesis stands questionable, considering the ideas brought forth in this work.	[Manoj, Kelath Murali; Gade, Sudeep Kumar; Mathew, Lazar] VIT Univ, Heme Flavin Lab, Sch Bio Sci & Technol, Ctr Biomed Res, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Manoj, KM (corresponding author), VIT Univ, Heme Flavin Lab, Sch Bio Sci & Technol, Ctr Biomed Res, Vellore, Tamil Nadu, India.	muralimanoj@vit.ac.in			Satyamjayatu: The Science Foundation; VIT University	Satyamjayatu: The Science Foundation; VIT University	This research was partially funded by "Satyamjayatu: The Science Foundation" and departmental student research funds from VIT University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUST SD, 1972, BIOCHEM BIOPH RES CO, V47, P1133, DOI 10.1016/0006-291X(72)90952-7; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Francis K, 2005, J BIOL CHEM, V280, P5195, DOI 10.1074/jbc.M411249200; Guengerich FP, 2002, BIOL CHEM, V383, P1553, DOI 10.1515/BC.2002.175; Hayashi Seiko, 2005, Drug Metab Pharmacokinet, V20, P14, DOI 10.2133/dmpk.20.14; JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N; Joo H, 1999, NATURE, V399, P670, DOI 10.1038/21395; KING MM, 1975, J BIOL CHEM, V250, P6496; Manoj KM, 2006, BBA-PROTEINS PROTEOM, V1764, P1325, DOI 10.1016/j.bbapap.2006.05.012; Manoj KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010601; Martinez CA, 2000, CURR ORG CHEM, V4, P263, DOI 10.2174/1385272003376265; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; MIWA GT, 1979, J BIOL CHEM, V254, P5695; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; Narasimhulu S, 2007, BBA-GEN SUBJECTS, V1770, P360, DOI 10.1016/j.bbagen.2006.09.018; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; PEDERSON TC, 1975, BIOCHIM BIOPHYS ACTA, V385, P232, DOI 10.1016/0304-4165(75)90351-7; Petlicki J, 1998, J CHEM SOC FARADAY T, V94, P2763, DOI 10.1039/a804551h; POULOS TL, 1992, FASEB J, V6, P674, DOI 10.1096/fasebj.6.2.1537455; RUTTER R, 1982, J BIOL CHEM, V257, P7958; SAWYER DT, 1981, ACCOUNTS CHEM RES, V14, P393, DOI 10.1021/ar00072a005; SELLERS RM, 1980, ANALYST, V105, P950, DOI 10.1039/an9800500950; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; Testa B, 1995, METABOLISM DRUGS OTH; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Yun CH, 2006, CURR DRUG METAB, V7, P411, DOI 10.2174/138920006776873472; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018	36	29	32	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13272	10.1371/journal.pone.0013272	http://dx.doi.org/10.1371/journal.pone.0013272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967245	Green Published, Green Submitted, gold			2022-12-25	WOS:000282869800009
J	Kumar, A; Xu, J; Brady, S; Gao, H; Yu, DH; Reuben, J; Mehta, K				Kumar, Anupam; Xu, Jia; Brady, Samuel; Gao, Hui; Yu, Dihua; Reuben, James; Mehta, Kapil			Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; CANCER-CELLS; BINDING-PROTEIN; RESPONSE ELEMENT; OVARIAN-CANCER; CROSS-LINKING; ACTIVATION; EXPRESSION; GROWTH; BETA	Recent observations that aberrant expression of tissue transglutaminase (TG2) promotes growth, survival, and metastasis of multiple tumor types is of great significance and could yield novel therapeutic targets for improved patient outcomes. To accomplish this, a clear understanding of how TG2 contributes to these phenotypes is essential. Using mammary epithelial cell lines (MCF10A, MCF12A, MCF7 and MCF7/RT) as a model system, we determined the impact of TG2 expression on cell growth, cell survival, invasion, and differentiation. Our results show that TG2 expression promotes drug resistance and invasive functions by inducing epithelial-mesenchymal transition (EMT). Thus, TG2 expression supported anchorage-independent growth of mammary epithelial cells in soft-agar, disrupted the apical-basal polarity, and resulted in disorganized acini structures when grown in 3D-culture. At molecular level, TG2 expression resulted in loss of E-cadherin and increased the expression of various transcriptional repressors (Snail1, Zeb1, Zeb2 and Twist1). Tumor growth factor-beta (TGF-beta) failed to induce EMT in cells lacking TG2 expression, suggesting that TG2 is a downstream effector of TGF-beta-induced EMT. Moreover, TG2 expression induced stem cell-like phenotype in mammary epithelial cells as revealed by enrichment of CD44(+)/CD24(-/low) cell populations. Overall, our studies show that aberrant expression of TG2 is sufficient for inducing EMT in epithelial cells and establish a strong link between TG2 expression and progression of metastatic breast disease.	[Kumar, Anupam; Brady, Samuel; Mehta, Kapil] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Xu, Jia; Yu, Dihua] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Gao, Hui; Reuben, James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Xu, Jia; Brady, Samuel; Yu, Dihua; Mehta, Kapil] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Kumar, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	kmehta@mdanderson.org	kumar, Anupam/AFM-6318-2022	Yu, Dihua/0000-0001-6231-9381; Xu, Jia/0000-0003-0254-6261	Susan G. Komen for the Cure Foundation [KG080078]	Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation)	This work was supported by a grant (KG080078) from Susan G. Komen for the Cure Foundation (http://ww5.komen.org). The sponsor had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Chandrashekar R, 1998, P NATL ACAD SCI USA, V95, P531, DOI 10.1073/pnas.95.2.531; CHEN WC, 1991, J CELL BIOL, V114, P319, DOI 10.1083/jcb.114.2.319; Chhabra A, 2009, ANTICANCER RES, V29, P1909; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Im MJ, 1997, CELL SIGNAL, V9, P477, DOI 10.1016/S0898-6568(97)00049-1; Jung SA, 2007, INVEST OPHTH VIS SCI, V48, P1952, DOI 10.1167/iovs.06-1164; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kim Y, 2010, MOL IMMUNOL, V47, P1010, DOI 10.1016/j.molimm.2009.11.017; Kotsakis P, 2007, AMINO ACIDS, V33, P373, DOI 10.1007/s00726-007-0516-1; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Micalizzi DS, 2009, FUTURE ONCOL, V5, P1129, DOI 10.2217/FON.09.94; Mishra S, 2004, J BIOL CHEM, V279, P23863, DOI 10.1074/jbc.M311919200; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Quan G, 2005, ARCH DERMATOL RES, V297, P84, DOI 10.1007/s00403-005-0582-8; Ritter SJ, 1998, J BIOL CHEM, V273, P12798, DOI 10.1074/jbc.273.21.12798; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Telci D, 2009, J BIOL CHEM, V284, P29547, DOI 10.1074/jbc.M109.041806; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Verma A, 2007, DRUG RESIST UPDATE, V10, P144, DOI 10.1016/j.drup.2007.06.002; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zemskov EA, 2009, J BIOL CHEM, V284, P16693, DOI 10.1074/jbc.M109.010769	50	85	94	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13390	10.1371/journal.pone.0013390	http://dx.doi.org/10.1371/journal.pone.0013390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967228	Green Published, gold, Green Submitted			2022-12-25	WOS:000282807300034
J	Tchankouo-Nguetcheu, S; Khun, H; Pincet, L; Roux, P; Bahut, M; Huerre, M; Guette, C; Choumet, V				Tchankouo-Nguetcheu, Stephane; Khun, Huot; Pincet, Laurence; Roux, Pascal; Bahut, Muriel; Huerre, Michel; Guette, Catherine; Choumet, Valerie			Differential Protein Modulation in Midguts of Aedes aegypti Infected with Chikungunya and Dengue 2 Viruses	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; DISULFIDE-ISOMERASE; FLAVIVIRUS INFECTIONS; VIRAL INTERACTIONS; OXIDATIVE STRESS; GENOME SEQUENCE; GENE-EXPRESSION; MEMBRANE-FUSION; LIFE-CYCLE; HOST-CELL	Background: Arthropod borne virus infections cause several emerging and resurgent infectious diseases. Among the diseases caused by arboviruses, dengue and chikungunya are responsible for a high rate of severe human diseases worldwide. The midgut of mosquitoes is the first barrier for pathogen transmission and is a target organ where arboviruses must replicate prior to infecting other organs. A proteomic approach was undertaken to characterize the key virus/vector interactions and host protein modifications that happen in the midgut for viral transmission to eventually take place. Methodology and Principal Findings: Using a proteomics differential approach with two-Dimensional Differential in-Gel Electrophoresis (2D-DIGE), we defined the protein modulations in the midgut of Aedes aegypti that were triggered seven days after an oral infection (7 DPI) with dengue 2 (DENV-2) and chikungunya (CHIKV) viruses. Gel profile comparisons showed that the level of 18 proteins was modulated by DENV-2 only and 12 proteins were modulated by CHIKV only. Twenty proteins were regulated by both viruses in either similar or different ways. Both viruses caused an increase of proteins involved in the generation of reactive oxygen species, energy production, and carbohydrate and lipid metabolism. Midgut infection by DENV-2 and CHIKV triggered an antioxidant response. CHIKV infection produced an increase of proteins involved in detoxification. Conclusion/Significance: Our study constitutes the first analysis of the protein response of Aedes aegypti's midgut infected with viruses belonging to different families. It shows that the differentially regulated proteins in response to viral infection include structural, redox, regulatory proteins, and enzymes for several metabolic pathways. Some of these proteins like antioxidant are probably involved in cell protection. On the other hand, we propose that the modulation of other proteins like transferrin, hsp60 and alpha glucosidase, may favour virus survival, replication and transmission, suggesting a subversion of the insect cell metabolism by the arboviruses.	[Tchankouo-Nguetcheu, Stephane; Pincet, Laurence; Choumet, Valerie] Inst Pasteur, Unite Genet Mol Bunyavirus, Paris, France; [Khun, Huot; Huerre, Michel] Inst Pasteur, Unite Rech & Expertise Histotechnol & Pathol, Paris, France; [Bahut, Muriel; Guette, Catherine] Univ Angers, Angers, France; [Guette, Catherine] Ctr Lutte Canc Paul Papin, Lab Oncopharmacol, Angers, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite d'Angers; UNICANCER; Institut de Cancerologie de l'Ouest (ICO)	Tchankouo-Nguetcheu, S (corresponding author), Inst Pasteur, Unite Genet Mol Bunyavirus, Paris, France.	vchoumet@pasteur.fr	Guette, Catherine/L-2519-2015	Guette, Catherine/0000-0003-1779-9931; Pincet, Laurence/0000-0002-2885-5188	ANR Entomochik	ANR Entomochik(French National Research Agency (ANR))	ANR Entomochik. The funders has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bancroft J. D., 1994, MANUAL HISTOLOGICAL; Baron OL, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.4101; Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155; Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9; Blandin S, 2004, M S-MED SCI, V20, P740, DOI 10.1051/medsci/2004208-9740; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Charrier C, 2006, MICROBIOL-SGM, V152, P179, DOI [10.1099/mic.0.28412-0, 10.1099/MIC.0.28412-0]; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000; Darby NJ, 1999, FEBS LETT, V448, P167, DOI 10.1016/S0014-5793(99)00374-9; Dieng H, 2007, MED VET ENTOMOL, V21, P278, DOI 10.1111/j.1365-2915.2007.00693.x; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Fan YJ, 2010, GENETICS, V184, P141, DOI 10.1534/genetics.109.109553; Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001; FINNERTY V, 1979, GENETICS, V91, P695; Friedman DB, 2009, METHOD ENZYMOL, V463, P515, DOI 10.1016/S0076-6879(09)63030-5; Guo XA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-380; Hertel L, 2004, J VIROL, V78, P11988, DOI 10.1128/JVI.78.21.11988-12011.2004; Jacob R, 2004, J BIOL CHEM, V279, P3680, DOI 10.1074/jbc.C300503200; Jaramillo-Gutierrez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-154; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Klappa P, 1997, EUR J BIOCHEM, V248, P37, DOI 10.1111/j.1432-1033.1997.t01-1-00037.x; Lefevre T, 2006, PLOS PATHOG, V2, P633, DOI 10.1371/journal.ppat.0020072; Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018; Mercado-Curiel RF, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-118; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Mohankumar K, 2006, VIRUS RES, V118, P130, DOI 10.1016/j.virusres.2005.12.002; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nichol H, 2002, ANNU REV ENTOMOL, V47, P535, DOI 10.1146/annurev.ento.47.091201.145237; Ogino T, 2001, BIOCHEM BIOPH RES CO, V285, P447, DOI 10.1006/bbrc.2001.5160; Padwad YS, 2009, IMMUNOBIOLOGY, V214, P422, DOI 10.1016/j.imbio.2008.11.010; Popova-Butler A, 2009, J INSECT PHYSIOL, V55, P264, DOI 10.1016/j.jinsphys.2008.12.008; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; REED L. J., 1938, AMER JOUR HYG, V27, P493; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Suresh DR, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-61; Toba G, 2000, GENE, V253, P179, DOI 10.1016/S0378-1119(00)00246-8; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292; Vennestrom J, 2007, EXP PARASITOL, V115, P53, DOI 10.1016/j.exppara.2006.05.008; Wasinpiyamongkol L, 2010, PROTEOMICS, V10, P1906, DOI 10.1002/pmic.200900626; WEAVER SC, 1988, J VIROL, V62, P2083, DOI 10.1128/JVI.62.6.2083-2090.1988; Woodring Jennifer L., 1996, P51; Wu SF, 2002, J VIROL, V76, P3596, DOI 10.1128/JVI.76.8.3596-3604.2002; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Yocupicio-Monroy RME, 2003, J VIROL, V77, P3067, DOI 10.1128/JVI.77.5.3067-3076.2003; Zhao LM, 2009, J MED ENTOMOL, V46, P490, DOI 10.1603/033.046.0312	63	97	99	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13149	10.1371/journal.pone.0013149	http://dx.doi.org/10.1371/journal.pone.0013149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957153	Green Published, gold, Green Submitted			2022-12-25	WOS:000282506100004
J	Criscuolo, F; Font-Sala, C; Bouillaud, F; Poulin, N; Trabalon, M				Criscuolo, Francois; Font-Sala, Candide; Bouillaud, Frederic; Poulin, Nicolas; Trabalon, Marie			Increased ROS Production: A Component of the Longevity Equation in the Male Mygalomorph, Brachypelma albopilosa	PLOS ONE			English	Article							TARANTULAS APHONOPELMA-ANAX; HISTORY TRADE-OFFS; OXIDATIVE STRESS; ENERGY-METABOLISM; LIFE-SPAN; THERAPHOSIDAE; EVOLUTION; ECOLOGY; ARANEAE; GENDER	Background: The diversity of longevities encountered in wildlife is one of the most intriguing problems in biology. Evolutionary biologists have proposed different theories to explain how longevity variability may be driven by bad genes expression in late life or by gene pleiotropic effects. This reflexion has stimulated, in the last ten years, an active research on the proximal mechanisms that can shape lifespan. Reactive oxygen species (ROS), i.e., the by-products of oxidative metabolism, have emerged as the main proximate cause of ageing. Because ROS are mainly produced by the mitochondria, their production is linked to metabolic rate, and this may explain the differences in longevity between large and small species. However, their implication in the sex difference in longevity within a species has never been tested, despite the fact that these differences are widespread in the animal kingdom. Methodology/Principal Findings: Mitochondrial superoxide production of hemolymph immune cells and antioxidant and oxidative damages plasma levels were measured in adult male and female B. albopilosa at different ages. We found that female spiders are producing less mitochondrial superoxide, are better protected against oxidative attack and are then suffering less oxidative damages than males at adulthood. Conclusions/Significance: In tarantulas, once reaching sexual maturity, males have a life expectancy reduced to 1 to 2 years, while females can still live for 20 years, in spite of the fact that females continue to grow and moult. This study evidences an increased exposure of males to oxidative stress due to an increase in mitochondrial superoxide production and a decrease in hemolymph antioxidant defences. Such a phenomenon is likely to be part of the explanation for the sharp reduction of longevity accompanying male tarantula maturity. This opens several fundamental research roads in the future to better understand how reproduction and longevity are linked in an original ageing model.	[Criscuolo, Francois; Poulin, Nicolas; Trabalon, Marie] Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, CNRS UDS, UMR 7178, Strasbourg, France; [Font-Sala, Candide; Bouillaud, Frederic] Univ Paris 05, BIOTRAM, CNRS UPR9078, Fac Med Necker Enfants Malades, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universite Paris Cite	Criscuolo, F (corresponding author), Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, CNRS UDS, UMR 7178, Strasbourg, France.	francois.criscuolo@c-strasbourg.fr	Bouillaud, Frédéric R/L-3238-2017	Bouillaud, Frédéric R/0000-0002-7518-9237; Poulin, Nicolas/0000-0003-2740-7559	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by finding from Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Austad SN, 1997, EXP GERONTOL, V32, P23, DOI 10.1016/S0531-5565(96)00059-9; Beckman KB, 1997, FASEB J, V11, pA1290; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Costantini D, 2007, J EXP BIOL, V210, P1238, DOI 10.1242/jeb.002741; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; Criscuolo F, 2005, AM NAT, V166, P686, DOI 10.1086/497439; Deerenberg C, 1997, P ROY SOC B-BIOL SCI, V264, P1021, DOI 10.1098/rspb.1997.0141; Demetrius L, 2004, J GERONTOL A-BIOL, V59, P902, DOI 10.1093/gerona/59.9.B902; Foelix R. F., 2011, BIOL SPIDERS; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; HARMAN D, 1979, AGE, V2, P109, DOI 10.1007/BF02432216; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Ide T, 2002, ARTERIOSCL THROM VAS, V22, P438, DOI 10.1161/hq0302.104515; Ilmonen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002143; Janowski-Bell ME, 1999, J ARACHNOL, V27, P503; KAWAHARA M, 2009, NAT BIOTECHNOL, V25, P1045; Keller L, 2006, EXP GERONTOL, V41, P553, DOI 10.1016/j.exger.2006.04.002; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Locht A, 1999, J ARACHNOL, V27, P196; Marshall SD, 1996, ETHOLOGY, V102, P32; McKean KA, 2001, P NATL ACAD SCI USA, V98, P7904, DOI 10.1073/pnas.131216398; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Mozo J, 2006, BIOCHEM J, V393, P431, DOI 10.1042/BJ20050494; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Olsson M, 2009, NATURWISSENSCHAFTEN, V96, P25, DOI 10.1007/s00114-008-0444-2; Owens IPF, 1999, TRENDS ECOL EVOL, V14, P170, DOI 10.1016/S0169-5347(98)01580-8; Partridge L, 2006, TRENDS ECOL EVOL, V21, P334, DOI 10.1016/j.tree.2006.02.008; Pereira LS, 2001, EXP PARASITOL, V99, P66, DOI 10.1006/expr.2001.4657; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; PEREZMILES F, 2005, J ARACHNOL, V25, P137; Rattan SIS, 2004, MECH AGEING DEV, V125, P285, DOI 10.1016/j.mad.2004.01.006; Rogowitz GL, 2000, J EXP BIOL, V203, P1131; Rolff J, 2001, CAN J ZOOL, V79, P2176, DOI 10.1139/cjz-79-12-2176; ROSEN GM, 1995, FASEB J, V9, P200, DOI 10.1096/fasebj.9.2.7540156; Shillington C, 2005, COMP BIOCHEM PHYS A, V142, P439, DOI 10.1016/j.cbpa.2005.09.010; Shillington C, 2002, J EXP BIOL, V205, P2909; Shillington C, 2002, CAN J ZOOL, V80, P251, DOI 10.1139/Z01-227; SMITH DWE, 1989, BIOL REV, V64, P1, DOI 10.1111/j.1469-185X.1989.tb00635.x; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; STEARNS SC, 1994, EVOLUTION, V48, P1438, DOI 10.1111/j.1558-5646.1994.tb02186.x; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Terry DF, 2008, J GERONTOL A-BIOL, V63, P809, DOI 10.1093/gerona/63.8.809; VALERIO CE, 1980, REV BIOL TROP, V28, P271; Vieira C, 2000, GENETICS, V154, P213; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; WIERSMA P, 2004, P R SOC LOND B S, V5, pS360; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	52	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13104	10.1371/journal.pone.0013104	http://dx.doi.org/10.1371/journal.pone.0013104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957044	Green Published, gold, Green Submitted			2022-12-25	WOS:000282359300010
J	Garcia-Silva, S; Martinez-Iglesias, O; Ruiz-Llorente, L; Aranda, A				Garcia-Silva, S.; Martinez-Iglesias, O.; Ruiz-Llorente, L.; Aranda, A.			Thyroid hormone receptor beta 1 domains responsible for the antagonism with the ras oncogene: role of corepressors	ONCOGENE			English	Article						thyroid hormone receptor; Ras; transformation; cyclin D1; corepressors; coactivators	TUMOR INVASIVENESS; SMRT COREPRESSOR; LIGAND-BINDING; RETINOIC ACID; MOUSE MODEL; CYCLIN D1; N-COR; TRANSCRIPTION; SUPPRESSOR; PATHWAY	The thyroid hormone receptor (TR) is a suppressor of ras-mediated responses. To characterize the receptor domains involved in this function, we analyzed a panel of TR beta 1 mutants for their ability to interfere with ras-driven cyclin D1 activation, formation of transformation foci and tumor growth in nude mice. Our results show that the domains and mechanisms responsible for the anti-transforming and anti-tumorigenic actions of the receptor are divergent from those operating in classical T3-dependent transcriptional activation. TR beta 1 mutants that do not bind co-activators and do not transactivate retained the capacity of suppressing cellular transformation and tumor growth, whereas selective mutations in the hinge region affecting corepressors recruitment abolished these actions, while preserving ligand-dependent transcription. There was a strict parallelism between anti-transforming activity of the various mutants and their ability to antagonize cyclin D1 stimulation by ras, indicating that transrepression mechanisms may have an important function in suppression of the transforming effects of the oncogene by TR beta 1. The inhibitory action of T3 on transformation was further enhanced after over-expression of corepressors, while corepressor depletion by means of small-interference RNA reversed significantly hormonal action. This shows an important functional role of endogenous corepressors in suppression of ras-mediated transformation and tumorigenesis by TR beta 1 Oncogene (2011) 30, 854-864; doi:10.1038/onc.2010.464; published online 18 October 2010	[Aranda, A.] CSIC, Inst Invest Biomed, Dept Endocrine & Nervous Syst Physiopathol, E-28029 Madrid, Spain; [Aranda, A.] Univ Autonoma Madrid, Madrid 28029, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid	Aranda, A (corresponding author), CSIC, Inst Invest Biomed, Dept Endocrine & Nervous Syst Physiopathol, Arturo Duperier 4, E-28029 Madrid, Spain.	aaranda@iib.uam.es	Aranda, Ana/ABG-8820-2020; Ruiz, Lidia/L-1620-2014; Martínez-Iglesias, Olaia Antía/A-9793-2018; Garcia-Silva, Susana/AAW-8528-2021	Aranda, Ana/0000-0002-8338-9589; Ruiz, Lidia/0000-0003-1430-9618; Martínez-Iglesias, Olaia Antía/0000-0002-7021-6865; Garcia-Silva, Susana/0000-0003-1065-0245	Ministerio de Educacion y Ciencia [BFU2007-62402, RD06/0020/0036]; Fondo de Investigaciones Sanitarias; European Grant CRESCENDO [FP-018652]	Ministerio de Educacion y Ciencia(Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); European Grant CRESCENDO	We are grateful to M Sanchez-Prieto and PA Chavez for technical help and to A Zambrano for TR mutants. This work was supported by Grant BFU2007-62402 from Ministerio de Educacion y Ciencia, RD06/0020/0036 and Accion Transversal de Cancer from the Fondo de Investigaciones Sanitarias and by the European Grant CRESCENDO (FP-018652).	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Aranda A, 2009, TRENDS ENDOCRIN MET, V20, P318, DOI 10.1016/j.tem.2009.03.011; Berghagen H, 2002, J BIOL CHEM, V277, P49517, DOI 10.1074/jbc.M209546200; BOS JL, 1989, CANCER RES, V49, P4682; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Castillo AI, 2004, MOL CELL BIOL, V24, P502, DOI 10.1128/MCB.24.2.502-513.2004; Chan IH, 2006, ONCOGENE, V25, P3576, DOI 10.1038/sj.onc.1209389; DAMM K, 1987, EMBO J, V6, P375, DOI 10.1002/j.1460-2075.1987.tb04765.x; De Bosscher K, 2008, EUR J PHARMACOL, V583, P290, DOI 10.1016/j.ejphar.2007.11.076; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Fernandez-Majada V, 2007, CELL CYCLE, V6, P1748, DOI 10.4161/cc.6.14.4429; FILMUS J, 1994, ONCOGENE, V9, P3627; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Furuya F, 2009, STEROIDS, V74, P628, DOI 10.1016/j.steroids.2008.10.009; Garcia-Silva S, 2004, MOL CELL BIOL, V24, P7514, DOI 10.1128/MCB.24.17.7514-7523.2004; Hong SH, 2001, MOL CELL BIOL, V21, P7172, DOI 10.1128/MCB.21.21.7172-7182.2001; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lazar Mitchell A, 2003, Nucl Recept Signal, V1, pe001; LIU JJ, 1995, MOL CELL BIOL, V15, P3654; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Marimuthu A, 2002, MOL ENDOCRINOL, V16, P271, DOI 10.1210/me.16.2.271; Martinez-Iglesias O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006428; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; MEIER CA, 1992, MOL ENDOCRINOL, V6, P248, DOI 10.1210/me.6.2.248; Mendez-Pertuz M, 2003, EMBO J, V22, P3102, DOI 10.1093/emboj/cdg295; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; Pissios P, 2000, MOL CELL, V6, P245, DOI 10.1016/S1097-2765(00)00026-5; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Robles AI, 1998, GENE DEV, V12, P2469, DOI 10.1101/gad.12.16.2469; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; Safer JD, 1998, J BIOL CHEM, V273, P30175, DOI 10.1074/jbc.273.46.30175; Sanchez-Martinez R, 2006, EMBO REP, V7, P1030, DOI 10.1038/sj.embor.7400776; Song L, 2005, CANCER RES, V65, P4554, DOI 10.1158/0008-5472.CAN-04-4108; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Tagami T, 1997, MOL CELL BIOL, V17, P2642, DOI 10.1128/MCB.17.5.2642; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zhu XG, 2010, ONCOGENE, V29, P1909, DOI 10.1038/onc.2009.476	45	19	21	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	7					854	864		10.1038/onc.2010.464	http://dx.doi.org/10.1038/onc.2010.464			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	722OT	20956942				2022-12-25	WOS:000287444600009
J	Sugano, G; Bernard-Pierrot, I; Lae, M; Battail, C; Allory, Y; Stransky, N; Krumeich, S; Lepage, ML; Maille, P; Donnadieu, MH; Abbou, CC; Benhamou, S; Lebret, T; Sastre-Garau, X; Amigorena, S; Radvanyi, F; Thery, C				Sugano, G.; Bernard-Pierrot, I.; Lae, M.; Battail, C.; Allory, Y.; Stransky, N.; Krumeich, S.; Lepage, M-L; Maille, P.; Donnadieu, M-H; Abbou, C. C.; Benhamou, S.; Lebret, T.; Sastre-Garau, X.; Amigorena, S.; Radvanyi, F.; Thery, C.			Milk fat globule-epidermal growth factor-factor VIII (MFGE8)/lactadherin promotes bladder tumor development	ONCOGENE			English	Article						MFGE8; lactadherin; bladder carcinoma; tumor microenvironment; immune response	DISCOIDIN-DOMAIN PROTEIN; APOPTOTIC CELLS; EGF REPEAT; LACTADHERIN; CANCER; CARCINOGENESIS; MOUSE; PROGRESSION; MODEL; MICE	Milk fat globule-epidermal growth factor-factor VIII (MFGE8), also called lactadherin or SED1, is a secreted integrin-binding protein that promotes elimination of apoptotic cells by phagocytes leading to tolerogenic immune responses, and vascular endothelial growth factor (VEGF)induced angiogenesis: two important processes for cancer development. Here, by transcriptomic analysis of 228 biopsies of bladder carcinomas, we observed overexpression of MFGE8 during tumor development, correlated with expression of genes involved in cell adhesion or migration and in immune responses, but not in VEGF-mediated angiogenesis. To test whether MFGE8 expression was instrumental in bladder tumor development, or a simple consequence of this development, we used genetic ablation in a mouse model of carcinogen-induced bladder carcinoma. We showed that Mfge8 was also upregulated in mouse carcinoma, and that in its absence, Mfge8-deficient animals developed less advanced tumors. Angiogenesis was similar in carcinogen-treated Mfge8-expressing or -deficient bladders, thus ruling out a major role of the proangiogenic function of Mfge8 for its protumoral role. By contrast, the tumor-promoting role of Mfge8 was not observed anymore in mice devoid of adaptive immune system, and human tumors overexpressing MFGE8 where invaded with macrophages and regulatory T cells, thus suggesting that MFGE8/lactadherin favors development of bladder tumors at least partly by an immune system-dependent mechanism. Our observations suggest future use of MFGE8-inhibiting molecules as therapies of bladder carcinomas, and of a limited number of other human cancers, in which our analysis of public databases also revealed overexpression of MFGE8. Oncogene (2011) 30, 642-653; doi:10.1038/onc.2010.446; published online 18 October 2010	[Sugano, G.; Krumeich, S.; Amigorena, S.; Thery, C.] Inst Curie, Res Ctr, INSERM, U932, F-75248 Paris 05, France; [Bernard-Pierrot, I.; Battail, C.; Stransky, N.; Lepage, M-L; Radvanyi, F.] CNRS, UMR144, Paris, France; [Lae, M.; Amigorena, S.] Inst Curie Hosp, Dept Tumor Biol, Paris, France; [Allory, Y.; Abbou, C. C.] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Allory, Y.; Abbou, C. C.] AP HP Henri Mondor Albert Chenevier Grp, Dept Urol, Creteil, France; [Allory, Y.; Maille, P.] AP HP Henri Mondor Albert Chenevier Grp, Dept Pathol, Creteil, France; [Donnadieu, M-H] Inst Curie Hosp, Dept Translat Res, Paris, France; [Abbou, C. C.] Univ Paris 12, Fac Med, Creteil, France; [Benhamou, S.] INSERM, U946, Fdn Jean Dausset, CEPH, Paris, France; [Benhamou, S.] Inst Gustave Roussy, CNRS, FRE 2939, Villejuif, France; [Lebret, T.] Hop Foch, Dept Urol, Suresnes, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Hospital Foch	Thery, C (corresponding author), Inst Curie, Res Ctr, INSERM, U932, 26 Rue Ulm, F-75248 Paris 05, France.	clotilde.thery@curie.fr	Benhamou, Simone/K-6554-2015; Benhamou, Simone/ABD-2590-2020; thery, clotilde/F-6373-2013	thery, clotilde/0000-0001-8294-6884; Sastre-Garau, Xavier/0000-0001-5992-2083; BENHAMOU, Simone/0000-0001-5853-8047; Battail, Christophe/0000-0001-6849-7824; Amigorena, Sebastian/0000-0001-8583-8416; Sugano, Gael/0000-0002-9520-7375; Radvanyi, Francois/0000-0002-5696-6424	Association pour la Recherche Contre le Cancer; La Ligue Nationale Contre le Cancer (FR: equipe labellisee); program 'Carte d'Identite des Tumeurs', initiated, developed; Ligue Nationale Contre le Cancer; Fondation de France 'Impulsion' program (CT)	Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); La Ligue Nationale Contre le Cancer (FR: equipe labellisee); program 'Carte d'Identite des Tumeurs', initiated, developed; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Fondation de France 'Impulsion' program (CT)	We thank Drs A-C Baglin and Y Denoux (Tumorotheque, Service d'Anatomie et Cytologie Pathologiques, CMC Foch, Suresnes, France), Dr M-J Terrier-Lacombe (Service de Pathologie, Institut Gustave Roussy, Villejuif, France), and Professor K Leroy (Plateforme de Ressources Biologiques, Pole de Recherche Clinique, APHP, Hopital Henri Mondor, Creteil, France) for providing tumor samples. Microbiochips SAS (Paris, France) performed and analyzed antibody microarray hybridizations. This work would not have been possible without the expertise of the Animal Facility and of the Nikon Imaging Center at Institut Curie. We thank S Barrafato and F Valenty (mouse histology), K Zemplenyi (ultrasound analyses), E Chapeaublanc (preparation of Supplementary tables), B Asselain and A Savignoni (statistics) for their help, and V Soumelis, H Kitamura and JW Pollard for critical reading of the manuscript. This work was supported by grants from Association pour la Recherche Contre le Cancer and Fondation de France 'Impulsion' program (CT), La Ligue Nationale Contre le Cancer (FR: equipe labellisee), and the program 'Carte d'Identite des Tumeurs', initiated, developed and funded by Ligue Nationale Contre le Cancer. GS was a fellow from Ministere de la Recherche et des Technologies.	Ait-Oufella H, 2007, CIRCULATION, V115, P2168, DOI 10.1161/CIRCULATIONAHA.106.662080; Andersen MH, 2000, BIOCHEMISTRY-US, V39, P6200, DOI 10.1021/bi992221r; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; BECCI PJ, 1981, CANCER RES, V41, P927; Bu HF, 2007, J CLIN INVEST, V117, P3673, DOI 10.1172/JCI31841; CERIANI RL, 1982, P NATL ACAD SCI-BIOL, V79, P5420, DOI 10.1073/pnas.79.17.5420; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; deMedina SGD, 1997, ONCOGENE, V14, P323, DOI 10.1038/sj.onc.1200830; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Eble J, 2004, WHO CLASSIFICATION T; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Ensslin MA, 2007, P NATL ACAD SCI USA, V104, P2715, DOI 10.1073/pnas.0610296104; Fens MHAM, 2008, BLOOD, V111, P4542, DOI 10.1182/blood-2007-06-094763; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Jinushi M, 2008, CANCER RES, V68, P8889, DOI 10.1158/0008-5472.CAN-08-2147; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Komura H, 2009, J IMMUNOL, V182, P581, DOI 10.4049/jimmunol.182.1.581; LAROCCA D, 1991, CANCER RES, V51, P4994; MCCORMICK DL, 1981, CARCINOGENESIS, V2, P251, DOI 10.1093/carcin/2.3.251; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Neutzner M, 2007, CANCER RES, V67, P6777, DOI 10.1158/0008-5472.CAN-07-0165; Oshima K, 2002, EUR J BIOCHEM, V269, P1209, DOI 10.1046/j.1432-1033.2002.02758.x; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Saint F, 2001, BJU INT, V88, P602, DOI 10.1046/j.1464-410X.2001.02394.x; Sharma P, 2007, SEMIN ONCOL, V34, P165, DOI 10.1053/j.seminoncol.2006.12.004; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Taylor MR, 1997, DNA CELL BIOL, V16, P861, DOI 10.1089/dna.1997.16.861; Veron P, 2005, BLOOD CELL MOL DIS, V35, P81, DOI 10.1016/j.bcmd.2005.05.001; Williams PD, 2008, NEOPLASIA, V10, P838, DOI 10.1593/neo.08432; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344	39	37	37	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	6					642	653		10.1038/onc.2010.446	http://dx.doi.org/10.1038/onc.2010.446			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	719GY	20956946				2022-12-25	WOS:000287192000002
J	Daniel, C; Wahlstedt, H; Ohlson, J; Bjork, P; Ohman, M				Daniel, Chammiran; Wahlstedt, Helene; Ohlson, Johan; Bjork, Petra; Ohman, Marie			Adenosine-to-Inosine RNA Editing Affects Trafficking of the gamma-Aminobutyric Acid Type A (GABA(A)) Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT MESSENGER-RNAS; ALPHA-SUBUNITS; RAT-BRAIN; GABA(A)-RECEPTOR SUBTYPES; SYNAPTIC-TRANSMISSION; ENDOPLASMIC-RETICULUM; POSTNATAL-DEVELOPMENT; GLUR-B; EXPRESSION; EPILEPSY	Recoding by adenosine-to-inosine RNA editing plays an important role in diversifying proteins involved in neurotransmission. We have previously shown that the Gabra-3 transcript, coding for the alpha 3 subunit of the GABA(A) receptor is edited in mouse, causing an isoleucine to methionine (I/M) change. Here we show that this editing event is evolutionarily conserved from human to chicken. Analyzing recombinant GABA(A) receptor subunits expressed in HEK293 cells, our results suggest that editing at the I/M site in alpha 3 has functional consequences on receptor expression. We demonstrate that I/M editing reduces the cell surface and the total number of alpha 3 subunits. The reduction in cell surface levels is independent of the subunit combination as it is observed for alpha in combination with either the beta 2 or the beta 3 subunit. Further, an amino acid substitution at the corresponding I/M site in the alpha 1 subunit has a similar effect on cell surface presentation, indicating the importance of this site for receptor trafficking. We show that the I/M editing during brain development is inversely related to the alpha 3 protein abundance. Our results suggest that editing controls trafficking of alpha 3-containing receptors and may therefore facilitate the switch of subunit compositions during development as well as the subcellular distribution of alpha subunits in the adult brain.	[Daniel, Chammiran; Wahlstedt, Helene; Ohlson, Johan; Bjork, Petra; Ohman, Marie] Stockholm Univ, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden	Stockholm University	Ohman, M (corresponding author), Stockholm Univ, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden.	marie.ohman@molbio.su.se	Ãhman, Marie/N-8561-2015	Ãhman, Marie/0000-0002-6636-5841	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council.	ARAKI T, 1992, NEUROSCIENCE, V51, P583, DOI 10.1016/0306-4522(92)90298-G; Aruscavage PJ, 2000, RNA, V6, P257, DOI 10.1017/S1355838200991921; Barberis A, 2007, EUR J NEUROSCI, V25, P2726, DOI 10.1111/j.1460-9568.2007.05530.x; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; BENKE D, 1991, J BIOL CHEM, V266, P4478; Bohme I, 2004, J BIOL CHEM, V279, P35193, DOI 10.1074/jbc.M405653200; Bosman LWJ, 2002, J PHYSIOL-LONDON, V545, P169, DOI 10.1113/jphysiol.2002.026534; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Enstero M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-6; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; FRITSCHY JM, 1994, J NEUROSCI, V14, P5302; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Gallagher MJ, 2004, J NEUROSCI, V24, P5570, DOI 10.1523/JNEUROSCI.1301-04.2004; Gingrich KJ, 1995, J PHYSIOL-LONDON, V489, P529, DOI 10.1113/jphysiol.1995.sp021070; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Guzman JN, 2003, J NEUROSCI, V23, P8931; Henneberger C, 2005, EUR J NEUROSCI, V21, P431, DOI 10.1111/j.1460-9568.2005.03869.x; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Hutcheon B, 2004, EUR J NEUROSCI, V19, P2475, DOI 10.1111/j.0953-816X.2004.03349.x; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; KORPI ER, 1993, MOL PHARMACOL, V44, P87; Kung SS, 2001, FEBS LETT, V509, P277, DOI 10.1016/S0014-5793(01)03183-0; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Liu QL, 2006, BRAIN RES, V1098, P129, DOI 10.1016/j.brainres.2006.05.001; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Nimmich ML, 2009, NEUROSCI RES, V63, P288, DOI 10.1016/j.neures.2009.01.003; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Ortinski PI, 2004, J NEUROPHYSIOL, V92, P1718, DOI 10.1152/jn.00243.2004; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; Ramadan E, 2003, J NEUROPHYSIOL, V89, P128, DOI 10.1152/jn.00700.2002; Rosenthal JJC, 2002, NEURON, V34, P743, DOI 10.1016/S0896-6273(02)00701-8; Rula EY, 2008, J NEUROSCI, V28, P6196, DOI 10.1523/JNEUROSCI.0443-08.2008; Tian N, 2008, RNA, V14, P211, DOI 10.1261/rna.797108; VERDOORN TA, 1994, MOL PHARMACOL, V45, P475; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wu YM, 1996, DNA CELL BIOL, V15, P717, DOI 10.1089/dna.1996.15.717	49	52	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2031	2040		10.1074/jbc.M110.130096	http://dx.doi.org/10.1074/jbc.M110.130096			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21030585	Green Published, hybrid			2022-12-25	WOS:000286191500045
J	Sarell, CJ; Wilkinson, SR; Viles, JH				Sarell, Claire J.; Wilkinson, Shane R.; Viles, John H.			Substoichiometric Levels of Cu2+ Ions Accelerate the Kinetics of Fiber Formation and Promote Cell Toxicity of Amyloid-beta from Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; TRANSGENIC MICE; IN-VIVO; COORDINATION GEOMETRY; COPPER(II) BINDING; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; FIBRILLAR FORMS; PRION PROTEIN; ZINC-BINDING	A role for Cu2+ ions in Alzheimer disease is often disputed, as it is believed that Cu2+ ions only promote nontoxic amorphous aggregates of amyloid-beta (A beta). In contrast with currently held opinion, we show that the presence of substoichiometric levels of Cu2+ ions in fact doubles the rate of production of amyloid fibers, accelerating both the nucleation and elongation of fiber formation. We suggest that binding of Cu2+ ions at a physiological pH causes A beta to approach its isoelectric point, thus inducing self-association and fiber formation. We further show that Cu2+ ions bound to A beta are consistently more toxic to neuronal cells than A beta in the absence of Cu2+ ions, whereas Cu2+ ions in the absence of A beta are not cytotoxic. The degree of Cu-A beta cytotoxicity correlates with the levels of Cu2+ ions that accelerate fiber formation. We note the effect appears to be specific for Cu2+ ions as Zn2+ ions inhibit the formation of fibers. An active role for Cu2+ ions in accelerating fiber formation and promoting cell death suggests impaired copper homeostasis may be a risk factor in Alzheimer disease.	[Sarell, Claire J.; Wilkinson, Shane R.; Viles, John H.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London; Queen Mary University London	Viles, JH (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	j.viles@qmul.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC) [BBD0050271]; Biotechnology and Biological Sciences Research Council [BB/D005027/1] Funding Source: researchfish; Medical Research Council [MC_U117533887] Funding Source: researchfish; BBSRC [BB/D005027/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Project Grant BBD0050271 and a BBSRC quota studentship.	Antzutkin ON, 2004, MAGN RESON CHEM, V42, P231, DOI 10.1002/mrc.1341; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Calabrese MF, 2008, NAT STRUCT MOL BIOL, V15, P965, DOI 10.1038/nsmb.1483; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Crouch PJ, 2007, FEBS J, V274, P3775, DOI 10.1111/j.1742-4658.2007.05918.x; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Damante CA, 2008, INORG CHEM, V47, P9669, DOI 10.1021/ic8006052; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Dorlet P, 2009, ANGEW CHEM INT EDIT, V48, P9273, DOI 10.1002/anie.200904567; Drew SC, 2009, J AM CHEM SOC, V131, P1195, DOI 10.1021/ja808073b; Faller P, 2009, CHEMBIOCHEM, V10, P2837, DOI 10.1002/cbic.200900321; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Guo M, 2005, FEBS LETT, V579, P3574, DOI 10.1016/j.febslet.2005.05.036; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Hou LM, 2006, J AM CHEM SOC, V128, P9260, DOI 10.1021/ja046032u; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Hureau C, 2009, BIOCHIMIE, V91, P1212, DOI 10.1016/j.biochi.2009.03.013; Innocenti M, 2010, J ALZHEIMERS DIS, V19, P1323, DOI 10.3233/JAD-2010-1338; Jun S, 2009, BIOCHEMISTRY-US, V48, P10724, DOI 10.1021/bi9012935; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Karr JW, 2008, BIOCHEMISTRY-US, V47, P5006, DOI 10.1021/bi702423h; Klewpatinond M, 2008, J BIOL CHEM, V283, P1870, DOI 10.1074/jbc.M708472200; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Murray IVJ, 2005, BIOCHEMISTRY-US, V44, P12606, DOI 10.1021/bi050926p; Nadal RC, 2008, BIOCHEMISTRY-US, V47, P11653, DOI 10.1021/bi8011093; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Raman B, 2005, J BIOL CHEM, V280, P16157, DOI 10.1074/jbc.M500309200; Rival T, 2009, EUR J NEUROSCI, V29, P1335, DOI 10.1111/j.1460-9568.2009.06701.x; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sanokawa-Akakura R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008626; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Shin BK, 2008, BIOCHEMISTRY-US, V47, P9117, DOI 10.1021/bi801014x; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100; Streltsov VA, 2008, BIOPHYS J, V95, P3447, DOI 10.1529/biophysj.108.134429; Syme CD, 2006, BBA-PROTEINS PROTEOM, V1764, P246, DOI 10.1016/j.bbapap.2005.09.012; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Talmard C, 2007, CHEMBIOCHEM, V8, P163, DOI 10.1002/cbic.200600319; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Urbanc B, 2002, P NATL ACAD SCI USA, V99, P13990, DOI 10.1073/pnas.222433299; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; VIGOPELFREY C, 1993, J NEUROCHEM, V61, P1965, DOI 10.1111/j.1471-4159.1993.tb09841.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200	66	154	157	1	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41533	41540		10.1074/jbc.M110.171355	http://dx.doi.org/10.1074/jbc.M110.171355			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974842	hybrid, Green Published			2022-12-25	WOS:000285622600040
J	Yang, JH; Wada, A; Yoshida, K; Miyoshi, Y; Sayano, T; Esaki, K; Kinoshita, MO; Tomonaga, S; Azuma, N; Watanabe, M; Hamase, K; Zaitsu, K; Machida, T; Messing, A; Itohara, S; Hirabayashi, Y; Furuya, S				Yang, Jung Hoon; Wada, Akira; Yoshida, Kazuyuki; Miyoshi, Yurika; Sayano, Tomoko; Esaki, Kayoko; Kinoshita, Masami O.; Tomonaga, Shozo; Azuma, Norihiro; Watanabe, Masahiko; Hamase, Kenji; Zaitsu, Kiyoshi; Machida, Takeo; Messing, Albee; Itohara, Shigeyoshi; Hirabayashi, Yoshio; Furuya, Shigeki			Brain-specific Phgdh Deletion Reveals a Pivotal Role for L-Serine Biosynthesis in Controlling the Level of D-Serine, an N-methyl-D-aspartate Receptor Co-agonist, in Adult Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-PHOSPHOGLYCERATE DEHYDROGENASE GENE; CENTRAL-NERVOUS-SYSTEM; ENDOGENOUS D-SERINE; MOUSE-BRAIN; NMDA-RECEPTORS; RAT-BRAIN; AMINO-ACIDS; TARGETED DISRUPTION; RACEMASE; EXPRESSION	In mammalian brain, D-serine is synthesized from L-serine by serine racemase, and it functions as an obligatory co-agonist at the glycine modulatory site of N-methyl-D-aspartate (NMDA)-selective glutamate receptors. Although diminution in D-serine level has been implicated in NMDA receptor hypofunction, which is thought to occur in schizophrenia, the source of the precursor L-serine and its role in D-serine metabolism in adult brain have yet to be determined. We investigated whether L-serine synthesized in brain via the phosphorylated pathway is essential for D-serine synthesis by generating mice with a conditional deletion of D-3-phosphoglycerate dehydrogenase (Phgdh; EC 1.1.1.95). This enzyme catalyzes the first step in L-serine synthesis via the phosphorylated pathway. HPLC analysis of serine enantiomers demonstrated that both L-and D-serine levels were markedly decreased in the cerebral cortex and hippocampus of conditional knock-out mice, whereas the serine deficiency did not alter protein expression levels of serine racemase and NMDA receptor subunits in these regions. The present study provides definitive proof that L-serine-synthesized endogenously via the phosphorylated pathway is a key rate-limiting factor for maintaining steady-state levels of D-serine in adult brain. Furthermore, NMDA-evoked transcription of Arc, an immediate early gene, was diminished in the hippocampus of conditional knock-out mice. Thus, this study demonstrates that in mature neuronal circuits L-serine availability determines the rate of D-serine synthesis in the forebrain and controls NMDA receptor function at least in the hippocampus.	[Furuya, Shigeki] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Yang, Jung Hoon; Wada, Akira; Sayano, Tomoko; Esaki, Kayoko; Furuya, Shigeki] Kyushu Univ, Lab Metab Regulat Res, Bioarchitecture Ctr, Fukuoka 8128581, Japan; [Miyoshi, Yurika; Hamase, Kenji; Zaitsu, Kiyoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 8128581, Japan; [Yoshida, Kazuyuki; Azuma, Norihiro] Utsunomiya Univ, Dept Appl Biochem, Utsunomiya, Tochigi 3218505, Japan; [Yoshida, Kazuyuki; Kinoshita, Masami O.; Itohara, Shigeyoshi; Hirabayashi, Yoshio; Furuya, Shigeki] RIKEN Brain Sci Inst, Wako, Saitama 3510198, Japan; [Kinoshita, Masami O.; Machida, Takeo] Saitama Univ, Dept Regulat Biol, Saitama 3388570, Japan; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Messing, Albee] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Messing, Albee] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53705 USA	Kyushu University; Kyushu University; Kyushu University; Utsunomiya University; RIKEN; Saitama University; Hokkaido University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Furuya, S (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	shigekifur@brs.kyuhsu-u.ac.jp	Itohara, Shigeyoshi/I-8769-2012; Watanabe, Masahiko/S-3614-2019; Tomonaga, Shozo/S-3307-2018; WATANABE, Masahiko/A-4055-2012	Itohara, Shigeyoshi/0000-0002-2410-9989; Watanabe, Masahiko/0000-0001-5037-7138; Tomonaga, Shozo/0000-0003-0888-1407; WATANABE, Masahiko/0000-0001-5037-7138; Hirabayashi, Yoshio/0000-0002-5774-7354; Wada, Akira/0000-0003-4037-5766; Furuya, Shigeki/0000-0001-9020-3597	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18300125, 22380078]; TOYOTA Physical and Chemical Research Institute; Grants-in-Aid for Scientific Research [22780240] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); TOYOTA Physical and Chemical Research Institute(Toyota Physical and Chemical Research Institute); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research Areas (B) 18300125 and 22380078 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. F.) and a grant from the research fund of the TOYOTA Physical and Chemical Research Institute (to S. F.).	Abe M, 2004, J NEUROSCI, V24, P7292, DOI 10.1523/JNEUROSCI.1261-04.2004; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Cho HM, 2000, GENE, V245, P193, DOI 10.1016/S0378-1119(00)00009-3; Coba MP, 2008, J BIOL CHEM, V283, P34101, DOI 10.1074/jbc.M804951200; CONTRERAS PC, 1990, NEUROPHARMACOLOGY, V29, P291, DOI 10.1016/0028-3908(90)90015-J; Cook SP, 2002, J BIOL CHEM, V277, P27782, DOI 10.1074/jbc.M111814200; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Danysz W, 1998, PHARMACOL REV, V50, P597; de Koning TJ, 2006, J INHERIT METAB DIS, V29, P347, DOI 10.1007/s10545-006-0269-0; DE MJ, 2002, P NATL ACAD SCI USA, V99, P14542; Dunlop DS, 1997, BIOCHEM BIOPH RES CO, V235, P26, DOI 10.1006/bbrc.1997.6724; Foltyn VN, 2005, J BIOL CHEM, V280, P1754, DOI 10.1074/jbc.M405726200; Fuchs SA, 2006, ANN NEUROL, V60, P476, DOI 10.1002/ana.20977; Furuya S, 2000, P NATL ACAD SCI USA, V97, P11528, DOI 10.1073/pnas.200364497; Furuya S, 2008, FUNCT INTEGR GENOMIC, V8, P235, DOI 10.1007/s10142-007-0072-5; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; HASHIMOTO A, 1993, J NEUROCHEM, V60, P783, DOI 10.1111/j.1471-4159.1993.tb03219.x; HASHIMOTO A, 1992, FEBS LETT, V296, P33, DOI 10.1016/0014-5793(92)80397-Y; Hashimoto K, 2005, PROG NEURO-PSYCHOPH, V29, P767, DOI 10.1016/j.pnpbp.2005.04.023; Heresco-Levy U, 2005, BIOL PSYCHIAT, V57, P577, DOI 10.1016/j.biopsych.2004.12.037; Hirabayashi Y, 2008, PROG LIPID RES, V47, P188, DOI 10.1016/j.plipres.2008.01.003; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; Kawakami Y, 2009, NEUROSCI RES, V63, P184, DOI 10.1016/j.neures.2008.12.002; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MATSUI T, 1995, J NEUROCHEM, V65, P454; Menniti FS, 2000, NEUROPHARMACOLOGY, V39, P1147, DOI 10.1016/S0028-3908(99)00211-7; Mitoma J, 1998, NEUROSCI RES, V30, P195, DOI 10.1016/S0168-0102(97)00113-2; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Morikawa A, 2003, ANAL BIOCHEM, V312, P66, DOI 10.1016/S0003-2697(02)00432-3; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Neidle A, 2002, NEUROCHEM RES, V27, P1719, DOI 10.1023/A:1021607715824; Nishikawa T, 2005, BIOL PHARM BULL, V28, P1561, DOI 10.1248/bpb.28.1561; OLDENDORF WH, 1971, AM J PHYSIOL, V221, P1629, DOI 10.1152/ajplegacy.1971.221.6.1629; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; Schell MJ, 1997, J NEUROSCI, V17, P1604; SMITH QR, 1987, J NEUROCHEM, V49, P1651, DOI 10.1111/j.1471-4159.1987.tb01039.x; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; Strisovsky K, 2003, FEBS LETT, V535, P44, DOI 10.1016/S0014-5793(02)03855-3; Takasaki C, 2007, BIOMED RES-TOKYO, V28, P61, DOI 10.2220/biomedres.28.61; TANII Y, 1994, J PHARMACOL EXP THER, V269, P1040; Tsai GC, 1998, BIOL PSYCHIAT, V44, P1081, DOI 10.1016/S0006-3223(98)00279-0; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; WOOD PL, 1989, J NEUROCHEM, V53, P979, DOI 10.1111/j.1471-4159.1989.tb11803.x; Yamasaki M, 2001, J NEUROSCI, V21, P7691, DOI 10.1523/JNEUROSCI.21-19-07691.2001; Yoshida K, 2004, J BIOL CHEM, V279, P3573, DOI 10.1074/jbc.C300507200; Yoshikawa M, 2008, J PHARMACOL SCI, V107, P270, DOI 10.1254/jphs.08030FP; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	62	88	89	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41380	41390		10.1074/jbc.M110.187443	http://dx.doi.org/10.1074/jbc.M110.187443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20966073	hybrid, Green Published			2022-12-25	WOS:000285622600024
J	Caceres, A; Shang, F; Wawrousek, E; Liu, Q; Avidan, O; Cvekl, A; Yang, Y; Haririnia, A; Storaska, A; Fushman, D; Kuszak, J; Dudek, E; Smith, D; Taylor, A				Caceres, Andrea; Shang, Fu; Wawrousek, Eric; Liu, Qing; Avidan, Orna; Cvekl, Ales; Yang, Ying; Haririnia, Aydin; Storaska, Andrew; Fushman, David; Kuszak, Jer; Dudek, Edward; Smith, Donald; Taylor, Allen			Perturbing the Ubiquitin Pathway Reveals How Mitosis Is Hijacked to Denucleate and Regulate Cell Proliferation and Differentiation In Vivo	PLOS ONE			English	Article							ALPHA-A-CRYSTALLIN; LENS; DEGRADATION; CHAINS; PROTEINS; NEURODEGENERATION; EXPRESSION; PROTEOMICS; COMPLEX; GROWTH	Background: The eye lens presents a unique opportunity to explore roles for specific molecules in cell proliferation, differentiation and development because cells remain in place throughout life and, like red blood cells and keratinocytes, they go through the most extreme differentiation, including removal of nuclei and cessation of protein synthesis. Ubiquitination controls many critical cellular processes, most of which require specific lysines on ubiquitin (Ub). Of the 7 lysines (K) least is known about effects of modification of K6. Methodology and Principal Findings: We replaced K6 with tryptophan (W) because K6 is the most readily modified K and W is the most structurally similar residue to biotin. The backbone of K6W-Ub is indistinguishable from that of Wt-Ub. K6W-Ub is effectively conjugated and deconjugated but the conjugates are not degraded via the ubiquitin proteasome pathways (UPP). Expression of K6W-ubiquitin in the lens and lens cells results in accumulation of intracellular aggregates and also slows cell proliferation and the differentiation program, including expression of lens specific proteins, differentiation of epithelial cells into fibers, achieving proper fiber cell morphology, and removal of nuclei. The latter is critical for transparency, but the mechanism by which cell nuclei are removed has remained an age old enigma. This was also solved by expressing K6W-Ub. p27(kip), a UPP substrate accumulates in lenses which express K6W-Ub. This precludes phosphorylation of nuclear lamin by the mitotic kinase, a prerequisite for disassembly of the nuclear membrane. Thus the nucleus remains intact and DNAseII beta neither gains entry to the nucleus nor degrades the DNA. These results could not be obtained using chemical proteasome inhibitors that cannot be directed to specific tissues. Conclusions and Significance: K6W-Ub provides a novel, genetic means to study functions of the UPP because it can be targeted to specific cells and tissues. A fully functional UPP is required to execute most stages of lens differentiation, specifically removal of cell nuclei. In the absence of a functional UPP, small aggregate prone, cataractous lenses are formed.	[Caceres, Andrea; Shang, Fu; Liu, Qing; Avidan, Orna; Dudek, Edward; Smith, Donald; Taylor, Allen] Tufts Univ, Lab Nutr & Vis Res, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Wawrousek, Eric] NEI, Mol & Dev Biol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Cvekl, Ales; Yang, Ying] Albert Einstein Coll Med, Dept Ophthalmol, Bronx, NY 10467 USA; [Cvekl, Ales; Yang, Ying] Albert Einstein Coll Med, Dept Visual Sci & Genet, Bronx, NY 10467 USA; [Haririnia, Aydin; Storaska, Andrew; Fushman, David] Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA; [Kuszak, Jer] Rush Univ, Med Ctr, Dept Ophthalmol, Chicago, IL 60612 USA; [Kuszak, Jer] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA	Tufts University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University System of Maryland; University of Maryland College Park; Rush University; Rush University	Caceres, A (corresponding author), Tufts Univ, Lab Nutr & Vis Res, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA.	allen.taylor@tufts.edu	Cvekl, Ales/B-2427-2013; Wawrousek, Eric/A-4547-2008		NIH [GM065334]; American Health Assistant Foundation [RO1 13250]; Johnson and Johnson; NATIONAL EYE INSTITUTE [ZICEY000458, R01EY013250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065334] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistant Foundation; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH grant GM065334 (to D. F.) and to AT NEI RO1 13250, American Health Assistant Foundation, Johnson and Johnson Focused Giving Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Ciechanover A, 2006, ISR J CHEM, V46, P121, DOI 10.1560/380V-VWLX-XDRT-CB7K; De Maria A, 2007, INVEST OPHTH VIS SCI, V48, P5638, DOI 10.1167/iovs.07-0782; Dudek EJ, 2005, FASEB J, V19, P1707, DOI 10.1096/fj.05-4049fje; Duncan MK, 1998, MOL CELL BIOL, V18, P5579, DOI 10.1128/MCB.18.9.5579; Fushman D, 2010, J MOL BIOL, V395, P803, DOI 10.1016/j.jmb.2009.10.039; Gao CY, 1999, EXP EYE RES, V69, P695, DOI 10.1006/exer.1999.0749; Griep AE, 2006, SEMIN CELL DEV BIOL, V17, P686, DOI 10.1016/j.semcdb.2006.10.004; Groothuis TAM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-21; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; JAHNGENHODGE J, 1992, EXP EYE RES, V55, P897, DOI 10.1016/0014-4835(92)90016-L; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Klionsky DJ, 2006, NATURE, V441, P819, DOI 10.1038/441819a; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lippens S, 2009, APOPTOSIS, V14, P549, DOI 10.1007/s10495-009-0324-z; Liu Q, 2006, MOL VIS, V12, P931; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; SHANG F, 1995, BIOCHEM J, V307, P297, DOI 10.1042/bj3070297; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Shi YR, 2009, J CELL SCI, V122, P1607, DOI 10.1242/jcs.045203; Ueda Y, 2002, INVEST OPHTH VIS SCI, V43, P205; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Weber GF, 2005, J BIOL CHEM, V280, P22135, DOI 10.1074/jbc.M414270200; WICKLIFFE K, 2009, CHEM REV; Wolf L, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-88; Wu G, 2007, MOL BIOL CELL, V18, P1018, DOI 10.1091/mbc.E06-09-0809; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; Yang YG, 2006, DNA REPAIR, V5, P885, DOI 10.1016/j.dnarep.2006.05.004; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Yun MH, 2009, BIOCHEM SOC T, V37, P597, DOI 10.1042/BST0370597; Zandy AJ, 2007, INVEST OPHTH VIS SCI, V48, P293, DOI 10.1167/iovs.06-0656; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162	44	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13331	10.1371/journal.pone.0013331	http://dx.doi.org/10.1371/journal.pone.0013331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975996	Green Published, gold, Green Submitted			2022-12-25	WOS:000283216400002
J	Cong, LM; Takeda, M; Hamanaka, Y; Gonda, K; Watanabe, M; Kumasaka, M; Kobayashi, Y; Kobayashi, M; Ohuchi, N				Cong, Liman; Takeda, Motohiro; Hamanaka, Yohei; Gonda, Kohsuke; Watanabe, Mika; Kumasaka, Masutaka; Kobayashi, Yoshio; Kobayashi, Masaki; Ohuchi, Noriaki			Uniform Silica Coated Fluorescent Nanoparticles: Synthetic Method, Improved Light Stability and Application to Visualize Lymph Network Tracer	PLOS ONE			English	Article							NODE BIOPSY; BREAST-CANCER; QUANTUM DOTS; SENTINEL	Background: The sentinel lymph node biopsy (SLNB) was developed as a new modality in the surgical diagnosis of lymph node metastases. Dye and radioisotope are major tracers for the detection of sentinel lymph nodes (SLN). Dye tends to excessively infiltrate into the interstitium due to their small size ( less than several nanometers), resulting in difficulties in maintaining clear surgical fields. Radioisotopes are available in limited number of hospitals. Fluorescent nanoparticles are good candidates for SLN tracer to solve these problems, as we can choose suitable particle size and fluorescence wavelength of near-infrared. However, the use of nanoparticles faces safety issues, and many attempts have been performed by giving insulating coats on nanoparticles. In addition, the preparation of the uniform insulating layer is important to decrease variations in the quality as an SLN tracer. Methodology/Principal Findings: We herein succeeded in coating fluorescent polystyrene nanoparticles of 40 nm with uniform silica layer of 13 nm by the modified Stober method. The light stability of silica coated nanoparticles was 1.3-fold greater than noncoated nanoparticles. The popliteal lymph node could be visualized by the silica coated nanoparticles with injection in the rat feet. Conclusions/Significance: The silica coated nanoparticles in lymph nodes could be observed by transmission electron microscope, suggesting that our silica coating method is useful as a SLN tracer with highly precise distribution of nanoparticles in histological evaluation. We also demonstrated for the first time that a prolonged enhancement of SLN is caused by the phagocytosis of fluorescent nanoparticles by both macrophages and dendritic cells.	[Cong, Liman; Takeda, Motohiro; Gonda, Kohsuke; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Dept Nanomed Sci, Sendai, Miyagi 980, Japan; [Hamanaka, Yohei; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Dept Surg Oncol, Sendai, Miyagi 980, Japan; [Watanabe, Mika; Ohuchi, Noriaki] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan; [Kumasaka, Masutaka; Kobayashi, Masaki] Tohoku Inst Technol, Dept Elect & Intelligent Syst, Sendai, Miyagi 982, Japan; [Kobayashi, Yoshio] Ibaraki Univ, Coll Engn, Dept Biomol Funct Engn, Hitachi, Ibaraki, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku Institute Technology; Ibaraki University	Cong, LM (corresponding author), Tohoku Univ, Grad Sch Med, Dept Nanomed Sci, Sendai, Miyagi 980, Japan.	motot@med.tohoku.ac.jp	Hamanaka, Yohei/GVS-1245-2022; Kobayashi, Yoshio/N-1451-2015	Hamanaka, Yohei/0000-0003-4169-7767; Kobayashi, Yoshio/0000-0002-8540-3962	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Tohoku University Graduate School of Medicine; COE Program; Grants-in-Aid for Scientific Research [22500440] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Tohoku University Graduate School of Medicine; COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research in Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by Grants-in-aid for Research Projects, Promotion of Advanced Medical Technology from the Ministry of Health, Labor and Welfare of Japan. The authors also acknowledge the support of the Biomedical Research Core of Tohoku University Graduate School of Medicine, the 21st Century COE Program "Future Medical Engineering based on Bio-nanotechnology" and the Global COE Program "Global Nano-Biomedical Engineering Education and Research Network Center" committed by the Japan Society for the Promotion of Science, Japan-China Medical Association and Konica Minolta Medical and Graphic, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y; Bonnema J, 2002, ANN ONCOL, V13, P1531, DOI 10.1093/annonc/mdf319; Gonda K, 2010, J BIOL CHEM, V285, P2750, DOI 10.1074/jbc.M109.075374; Gu S., 2005, E-POLYMERS, V64, P1; Josephson Lee, 2003, Mol Imaging, V2, P18, DOI 10.1162/153535003765276255; Keshtgar MRS, 2005, EJSO-EUR J SURG ONC, V31, P134, DOI 10.1016/j.ejso.2004.08.008; Kim K, 2006, LANGMUIR, V22, P8083, DOI 10.1021/la0612015; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Kobayashi M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364600; Kobayashi Y, 2005, J COLLOID INTERF SCI, V283, P392, DOI 10.1016/j.jcis.2004.08.184; Kobayashi Y, 2004, COLLOID SURFACE A, V242, P47, DOI 10.1016/j.colsurfa.2004.04.052; KOBAYASHI Y, 2005, E-POLYMERS, V52, P1; Nakajima M, 2005, CANCER SCI, V96, P353, DOI 10.1111/j.1349-7006.2005.00053.x; Sato K, 2007, J SURG ONCOL, V96, P322, DOI 10.1002/jso.20866; Sato Kazuhiko, 2007, Breast Cancer, V14, P354, DOI 10.2325/jbcs.14.354; Sharma R, 2008, ANN NY ACAD SCI, V1131, P13, DOI 10.1196/annals.1413.002; Shen J, 2007, CANCER-AM CANCER SOC, V109, P1255, DOI 10.1002/cncr.22540; Soltesz EG, 2006, ANN SURG ONCOL, V13, P386, DOI 10.1245/ASO.2006.04.025; Soltesz EG, 2005, ANN THORAC SURG, V79, P269, DOI 10.1016/j.athoracsur.2004.06.055; Takeda M, 2008, BREAST CANCER-TOKYO, V15, P145, DOI 10.1007/s12282-008-0037-0; TANGOKU A, 2006, J MED INVEST, V54, P1; Tuohy JL, 2009, VET COMP ONCOL, V7, P81, DOI 10.1111/j.1476-5829.2009.00183.x; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206	23	22	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13167	10.1371/journal.pone.0013167	http://dx.doi.org/10.1371/journal.pone.0013167			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976187	Green Published, gold, Green Submitted			2022-12-25	WOS:000283045300005
J	Mellor, D; Prieto, E; Mathieson, L; Moscato, P				Mellor, Drew; Prieto, Elena; Mathieson, Luke; Moscato, Pablo			A Kernelisation Approach for Multiple d-Hitting Set and Its Application in Optimal Multi-Drug Therapeutic Combinations	PLOS ONE			English	Article							CANCER; DOCETAXEL; PROTEIN; CHEMOTHERAPY; ARRY-142886; AZD6244; POTENT; TIME	Therapies consisting of a combination of agents are an attractive proposition, especially in the context of diseases such as cancer, which can manifest with a variety of tumor types in a single case. However uncovering usable drug combinations is expensive both financially and temporally. By employing computational methods to identify candidate combinations with a greater likelihood of success we can avoid these problems, even when the amount of data is prohibitively large. HITTING SET is a combinatorial problem that has useful application across many fields, however as it is NP-complete it is traditionally considered hard to solve exactly. We introduce a more general version of the problem (alpha,beta,d)-HITTING SET, which allows more precise control over how and what the hitting set targets. Employing the framework of Parameterized Complexity we show that despite being NP-complete, the (alpha,beta,d) HITTING SET problem is fixed-parameter tractable with a kernel of size O(alpha dk(d)) when we parameterize by the size k of the hitting set and the maximum number alpha of the minimum number of hits, and taking the maximum degree d of the target sets as a constant. We demonstrate the application of this problem to multiple drug selection for cancer therapy, showing the flexibility of the problem in tailoring such drug sets. The fixed-parameter tractability result indicates that for low values of the parameters the problem can be solved quickly using exact methods. We also demonstrate that the problem is indeed practical, with computation times on the order of 5 seconds, as compared to previous Hitting Set applications using the same dataset which exhibited times on the order of 1 day, even with relatively relaxed notions for what constitutes a low value for the parameters. Furthermore the existence of a kernelization for (alpha,beta,d)-HITTING SET indicates that the problem is readily scalable to large datasets.	[Mellor, Drew; Prieto, Elena; Mathieson, Luke; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Newcastle, NSW 2308, Australia; [Mellor, Drew; Prieto, Elena; Mathieson, Luke; Moscato, Pablo] Hunter Med Res Inst, Informat Based Med Program, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Mellor, D (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Newcastle, NSW 2308, Australia.	pablo.moscato@newcastle.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013; Prieto, Elena/G-7614-2013	Prieto, Elena/0000-0002-3814-6692; Moscato, Pablo/0000-0003-2570-5966; Mathieson, Luke/0000-0001-6470-2296	Hunter Medical Research Institute; University of Newcastle; ARC [DP0773279]	Hunter Medical Research Institute; University of Newcastle; ARC(Australian Research Council)	The authors acknowledge the support of the Hunter Medical Research Institute, The University of Newcastle, and ARC Discovery Project DP0773279 (Application of novel exact combinatorial optimisation techniques and metaheuristic methods for problems in cancer research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Khzam FN, 2010, J COMPUT SYST SCI, V76, P524, DOI 10.1016/j.jcss.2009.09.002; ALBAIN KS, 1990, J CLIN ONCOL, V8, P1563, DOI 10.1200/JCO.1990.8.9.1563; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Cotta C, 2003, J COMPUT SYST SCI, V67, P686, DOI 10.1016/S0022-0000(03)00081-3; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Davies S., 1994, P AAAI S RELEVANCE, P41; DEKLEER J, 1992, ARTIF INTELL, V56, P197, DOI 10.1016/0004-3702(92)90027-U; Downey R.G., 1999, MG COMP SCI; Feige U, 1998, J ACM, V45, P634, DOI 10.1145/285055.285059; Fernau H., 2005, PARAMETERIZED ALGORI; FLAMANT F, 1984, CANCER, V54, P1687, DOI 10.1002/1097-0142(19841015)54:8<1687::AID-CNCR2820540833>3.0.CO;2-U; Flum J., 2006, TEXT THEORET COMP S, DOI 10.1007/3-540-29953-X; FU KK, 1979, CANCER TREAT REP, V63, P351; Garey M.R., 1979, COMPUTERS INTRACTABI; Haus UU, 2008, J COMPUT BIOL, V15, P259, DOI 10.1089/cmb.2007.0229; Hvidsten TR, 2003, BIOINFORMATICS, V19, P1116, DOI 10.1093/bioinformatics/btg047; IBM, ILOG CPLEX; Joensuu H, 2009, J CLIN ONCOL, V27, P5685, DOI 10.1200/JCO.2008.21.4577; LEIPINS GE, 1991, HDB GENETIC ALGORITH, P237; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Lyseng-Williamson KA, 2005, DRUGS, V65, P2513, DOI 10.2165/00003495-200565170-00007; Niedermeier R., 2006, INVITATION FIXED PAR; PAZ A, 1981, THEOR COMPUT SCI, V15, P251, DOI 10.1016/0304-3975(81)90081-5; Perez EA, 2010, ANN ONCOL, V21, P269, DOI 10.1093/annonc/mdp512; PEYTON JD, 2009, J CLIN ONCOL, V27, P9027; Polyzos A, 2010, BREAST CANCER RES TR, V119, P95, DOI 10.1007/s10549-009-0468-0; Rao RD, 2006, J CLIN ONCOL, V24, p463S; REITER R, 1987, ARTIF INTELL, V32, P57, DOI 10.1016/0004-3702(87)90062-2; Ruchkys DP, 2002, 14TH SYMPOSIUM ON COMPUTER ARCHITECTURE AND HIGH PERFORMANCE COMPUTING, PROCEEDINGS, P75, DOI 10.1109/CAHPC.2002.1180762; Shin SY, 2010, CANCER LETT, V287, P231, DOI 10.1016/j.canlet.2009.06.019; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Slamon D, 2009, CANCER RES, V69, P62; Sparano JA, 2009, J CLIN ONCOL, V27, P4522, DOI 10.1200/JCO.2008.20.5013; Vazirani V., 2001, APPROXIMATION ALGORI; Vazquez A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-81; Vinterbo SA, 2005, BIOINFORMATICS, V21, P1964, DOI 10.1093/bioinformatics/bti287; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150	38	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13055	10.1371/journal.pone.0013055	http://dx.doi.org/10.1371/journal.pone.0013055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976188	Green Published, gold, Green Submitted			2022-12-25	WOS:000283045300001
J	Momcilovic, O; Knobloch, L; Fornsaglio, J; Varum, S; Easley, C; Schatten, G				Momcilovic, Olga; Knobloch, Leah; Fornsaglio, Jamie; Varum, Sandra; Easley, Charles; Schatten, Gerald			DNA Damage Responses in Human Induced Pluripotent Stem Cells and Embryonic Stem Cells	PLOS ONE			English	Article							STRAND BREAKS; MOUSE; PHOSPHORYLATION; GENERATION; NANOG; APOPTOSIS; CLONING; ARREST; REPAIR; ABSENT	Background: Induced pluripotent stem (iPS) cells have the capability to undergo self-renewal and differentiation into all somatic cell types. Since they can be produced through somatic cell reprogramming, which uses a defined set of transcription factors, iPS cells represent important sources of patient-specific cells for clinical applications. However, before these cells can be used in therapeutic designs, it is essential to understand their genetic stability. Methodology/Principal Findings: Here, we describe DNA damage responses in human iPS cells. We observe hypersensitivity to DNA damaging agents resulting in rapid induction of apoptosis after gamma-irradiation. Expression of pluripotency factors does not appear to be diminished after irradiation in iPS cells. Following irradiation, iPS cells activate checkpoint signaling, evidenced by phosphorylation of ATM, NBS1, CHEK2, and TP53, localization of ATM to the double strand breaks (DSB), and localization of TP53 to the nucleus of NANOG-positive cells. We demonstrate that iPS cells temporary arrest cell cycle progression in the G(2) phase of the cell cycle, displaying a lack of the G(1)/S cell cycle arrest similar to human embryonic stem (ES) cells. Furthermore, both cell types remove DSB within six hours of gamma-irradiation, form RAD51 foci and exhibit sister chromatid exchanges suggesting homologous recombination repair. Finally, we report elevated expression of genes involved in DNA damage signaling, checkpoint function, and repair of various types of DNA lesions in ES and iPS cells relative to their differentiated counterparts. Conclusions/Significance: High degrees of similarity in DNA damage responses between ES and iPS cells were found. Even though reprogramming did not alter checkpoint signaling following DNA damage, dramatic changes in cell cycle structure, including a high percentage of cells in the S phase, increased radiosensitivity and loss of DNA damage-induced G(1)/S cell cycle arrest, were observed in stem cells generated by induced pluripotency.	[Momcilovic, Olga] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Knobloch, Leah; Fornsaglio, Jamie] Seton Hill Univ, Greensburg, PA USA; [Varum, Sandra] Univ Pittsburgh, Pittsburgh Dev Ctr, Pittsburgh, PA USA; [Easley, Charles; Schatten, Gerald] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Momcilovic, O (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.	schattengp@upmc.edu	Schatten, Gerald/B-3253-2009	Schatten, Gerald/0000-0001-5206-7782	National Institute of Child Health and Human Development [1PO1HD047675]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD047675] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the National Institute of Child Health and Human Development, http://www.nichd.nih.gov/, 1PO1HD047675. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banath JP, 2009, EXP CELL RES, V315, P1505, DOI 10.1016/j.yexcr.2008.12.007; Banuelos CA, 2008, DNA REPAIR, V7, P1471, DOI 10.1016/j.dnarep.2008.05.005; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Deng WB, 2009, TRENDS GENET, V25, P425, DOI 10.1016/j.tig.2009.09.004; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; MAYNARD S, 2008, STEM CELLS; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SERRANO L, STEM CELLS DEV; SINGH DK, AGING CELL; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; TICHY ED, STEM CELLS DEV; Tichy ED, 2008, EXP CELL RES, V314, P1929, DOI 10.1016/j.yexcr.2008.02.007; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	122	126	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13410	10.1371/journal.pone.0013410	http://dx.doi.org/10.1371/journal.pone.0013410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976220	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000283043700012
J	Chu, CH; Lo, WC; Wang, HW; Hsu, YC; Hwang, JK; Lyu, PC; Pai, TW; Tang, CY				Chu, Chia-Han; Lo, Wei-Cheng; Wang, Hsin-Wei; Hsu, Yen-Chu; Hwang, Jenn-Kang; Lyu, Ping-Chiang; Pai, Tun-Wen; Tang, Chuan Yi			Detection and Alignment of 3D Domain Swapping Proteins Using Angle-Distance Image-Based Secondary Structural Matching Techniques	PLOS ONE			English	Article							HUMAN CYSTATIN-C; CRYSTAL-STRUCTURE; CIRCULAR PERMUTATION; SIMILARITY SEARCHES; AMYLOID FORMATION; DIMER; MECHANISM; RESOLUTION; TOOL; OLIGOMERIZATION	This work presents a novel detection method for three-dimensional domain swapping (DS), a mechanism for forming protein quaternary structures that can be visualized as if monomers had "opened'' their "closed'' structures and exchanged the opened portion to form intertwined oligomers. Since the first report of DS in the mid 1990s, an increasing number of identified cases has led to the postulation that DS might occur in a protein with an unconstrained terminus under appropriate conditions. DS may play important roles in the molecular evolution and functional regulation of proteins and the formation of depositions in Alzheimer's and prion diseases. Moreover, it is promising for designing auto-assembling biomaterials. Despite the increasing interest in DS, related bioinformatics methods are rarely available. Owing to a dramatic conformational difference between the monomeric/closed and oligomeric/open forms, conventional structural comparison methods are inadequate for detecting DS. Hence, there is also a lack of comprehensive datasets for studying DS. Based on angle-distance (A-D) image transformations of secondary structural elements (SSEs), specific patterns within A-D images can be recognized and classified for structural similarities. In this work, a matching algorithm to extract corresponding SSE pairs from A-D images and a novel DS score have been designed and demonstrated to be applicable to the detection of DS relationships. The Matthews correlation coefficient (MCC) and sensitivity of the proposed DS-detecting method were higher than 0.81 even when the sequence identities of the proteins examined were lower than 10%. On average, the alignment percentage and root-mean-square distance (RMSD) computed by the proposed method were 90% and 1.8 angstrom for a set of 1,211 DS-related pairs of proteins. The performances of structural alignments remain high and stable for DS-related homologs with less than 10% sequence identities. In addition, the quality of its hinge loop determination is comparable to that of manual inspection. This method has been implemented as a web-based tool, which requires two protein structures as the input and then the type and/or existence of DS relationships between the input structures are determined according to the A-D image-based structural alignments and the DS score. The proposed method is expected to trigger large-scale studies of this interesting structural phenomenon and facilitate related applications.	[Chu, Chia-Han; Tang, Chuan Yi] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Lo, Wei-Cheng; Lyu, Ping-Chiang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Lo, Wei-Cheng; Hwang, Jenn-Kang] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Wang, Hsin-Wei; Hsu, Yen-Chu; Pai, Tun-Wen] Natl Taiwan Ocean Univ, Dept Comp Sci & Engn, Chilung, Taiwan; [Tang, Chuan Yi] Providence Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan	National Tsing Hua University; National Tsing Hua University; National Yang Ming Chiao Tung University; National Taiwan Ocean University; Providence University - Taiwan	Chu, CH (corresponding author), Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan.	twp@mail.ntou.edu.tw; cytang@pu.edu.tw	Chu, Chu/T-6038-2019	Lo, Wei-Cheng/0000-0001-8865-5113	National Science Council, Taiwan [99-2745-B-009-001-ASP, 99-2811-M-007-073, 99-3112-B-007-003, 98-2221-E-019-031-MY2, 97-2221-E-007-080-MY3]; Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was funded by the National Science Council, Taiwan (http://www.nsc.gov.tw) with NSC grant number 99-2745-B-009-001-ASP (Academic Summit Program) to Jenn-Kang Hwang; 99-2811-M-007-073 and 99-3112-B-007-003 to Ping-Chiang Lyu; 98-2221-E-019-031-MY2 to Tun-Wen Pai; 97-2221-E-007-080-MY3 to Chuan Yi Tang. The Ministry of Education, Taiwan also funded this study with the Development Plan for World Class University and Research Centers of Excellence (MOU ATU Plan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov NN, 1996, PROTEINS, V25, P354, DOI 10.1002/(SICI)1097-0134(199607)25:3<354::AID-PROT7>3.3.CO;2-W; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barbosa JARG, 2002, P NATL ACAD SCI USA, V99, P1859, DOI 10.1073/pnas.022476199; Bennett MJ, 2004, STRUCTURE, V12, P1339, DOI 10.1016/j.str.2004.07.004; BENNETT MJ, 1994, PROTEIN SCI, V3, P1444, DOI 10.1002/pro.5560030911; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cameron AD, 1997, EMBO J, V16, P3386, DOI 10.1093/emboj/16.12.3386; Chu CH, 2008, J MOL RECOGNIT, V21, P442, DOI 10.1002/jmr.914; Crane BR, 1999, EMBO J, V18, P6271, DOI 10.1093/emboj/18.22.6271; Dehouck Y, 2003, J MOL BIOL, V330, P1215, DOI 10.1016/S0022-2836(03)00614-4; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding F, 2006, STRUCTURE, V14, P5, DOI 10.1016/j.str.2005.09.008; Dundas J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-388; GREEN SM, 1995, NAT STRUCT BIOL, V2, P746, DOI 10.1038/nsb0995-746; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Janowski R, 2004, J MOL BIOL, V341, P151, DOI 10.1016/j.jmb.2004.06.013; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jaskolski M, 2001, ACTA BIOCHIM POL, V48, P807; Jmol, JMOL OP SOURC JAV VI; Jung J, 2000, PROTEIN ENG, V13, P535, DOI 10.1093/protein/13.8.535; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAPATTO R, 1991, J MOL BIOL, V222, P1067, DOI 10.1016/0022-2836(91)90594-V; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Lo WC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r11; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pW545, DOI 10.1093/nar/gkp291; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pD328, DOI 10.1093/nar/gkn679; Lo WC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-307; Lu GG, 2000, J APPL CRYSTALLOGR, V33, P176, DOI 10.1107/S0021889899012339; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Nagarkar RP, 2010, BIOPOLYMERS, V94, P141, DOI 10.1002/bip.21332; Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404; RAAG R, 1995, FASEB J, V9, P73, DOI 10.1096/fasebj.9.1.7821762; Raveh B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000295; Rousseau F, 2001, P NATL ACAD SCI USA, V98, P5596, DOI 10.1073/pnas.101542098; Sauder JM, 2000, PROTEINS, V40, P6, DOI 10.1002/(SICI)1097-0134(20000701)40:1<6::AID-PROT30>3.0.CO;2-7; Schiering N, 2000, BIOCHEMISTRY-US, V39, P13376, DOI 10.1021/bi0012336; Schymkowitz JWH, 2001, NAT STRUCT BIOL, V8, P888, DOI 10.1038/nsb1001-888; Shih ESC, 2004, PROTEINS, V56, P519, DOI 10.1002/prot.20124; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Suhrer SJ, 2007, BIOINFORMATICS, V23, P513, DOI 10.1093/bioinformatics/btl594; TRINKL S, 1994, PROTEIN SCI, V3, P1392, DOI 10.1002/pro.5560030905; Vesterstrom J, 2006, J COMPUT BIOL, V13, P43, DOI 10.1089/cmb.2006.13.43; Yang SC, 2004, P NATL ACAD SCI USA, V101, P13786, DOI 10.1073/pnas.0403724101; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zegers I, 1999, P NATL ACAD SCI USA, V96, P818, DOI 10.1073/pnas.96.3.818; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhu JH, 2005, PROTEINS, V58, P618, DOI 10.1002/prot.20331	60	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13361	10.1371/journal.pone.0013361	http://dx.doi.org/10.1371/journal.pone.0013361			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976204	gold, Green Submitted, Green Published			2022-12-25	WOS:000282941000010
J	Tiberio, P; Cavadini, E; Abolafio, G; Formelli, F; Appierto, V				Tiberio, Paola; Cavadini, Elena; Abolafio, Gabriella; Formelli, Franca; Appierto, Valentina			4-oxo-N-(4-hydroxyphenyl)retinamide: Two Independent Ways to Kill Cancer Cells	PLOS ONE			English	Article							FENRETINIDE-INDUCED APOPTOSIS; OVARIAN-CARCINOMA CELLS; BREAST-CANCER; DEPENDENT MECHANISM; TOPICAL TREATMENT; ACTIVATED GENE-1; RANDOMIZED-TRIAL; ER STRESS; DEATH; 4-OXO-FENRETINIDE	Background: The retinoid 4-oxo-N-(4-hydroxyphenyl) retinamide (4-oxo-4-HPR) is a polar metabolite of fenretinide (4-HPR) very effective in killing cancer cells of different histotypes, able to inhibit 4-HPR-resistant cell growth and to act synergistically in combination with the parent drug. Unlike 4-HPR and other retinoids, 4-oxo-4-HPR inhibits tubulin polymerization, leading to multipolar spindle formation and mitotic arrest. Here we investigated whether 4-oxo-4-HPR, like 4-HPR, triggered cell death also via reactive oxygen species (ROS) generation and whether its antimicrotubule activity was related to a ROS-dependent mechanism in ovarian (A2780), breast (T47D), cervical (HeLa) and neuroblastoma (SK-N-BE) cancer cell lines. Methodology/Principal Findings: We provided evidence that 4-oxo-4-HPR, besides acting as an antimicrotubule agent, induced apoptosis through a signaling cascade starting from ROS generation and involving endoplasmic reticulum (ER) stress response, Jun N-terminal Kinase (JNK) activation, and upregulation of the proapoptotic PLAcental Bone morphogenetic protein (PLAB). Through time-course analysis and inhibition of the ROS-related signaling pathway (upstream by vitamin C and downstream by PLAB silencing), we demonstrated that the antimitotic activity of 4-oxo-4-HPR was independent from the oxidative stress induced by the retinoid. In fact, ROS generation occurred earlier than mitotic arrest (within 30 minutes and 2 hours, respectively) and abrogation of the ROS-related signaling pathway did not prevent the 4-oxo-4-HPR-induced mitotic arrest. Conclusions/Significance: These data indicate that 4-oxo-4-HPR anticancer activity is due to at least two independent mechanisms and provide an explanation of the ability of 4-oxo-4-HPR to be more potent than the parent drug and to be effective also in 4-HPR-resistant cell lines. In addition, the double mechanism of action could allow 4-oxo-4-HPR to efficiently target tumour and to eventually counteract the development of drug resistance.	[Tiberio, Paola; Cavadini, Elena; Abolafio, Gabriella; Formelli, Franca; Appierto, Valentina] Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Fdn IRCCS, I-20133 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan	Tiberio, P (corresponding author), Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Fdn IRCCS, Via Venezian 1, I-20133 Milan, Italy.	paola.tiberio@istitutotumori.mi.it	Appierto, Valentina/B-9325-2017; Abolafio, Gabriella/AAC-2861-2019	Appierto, Valentina/0000-0002-8726-6981; Abolafio, Gabriella/0000-0003-1077-5187	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy(Fondazione AIRC per la ricerca sul cancro)	The study was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (http://www.airc.it), Milan, Italy, through grants and a fellowship (P. Tiberio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre J, 2007, CANCER RES, V67, P3512, DOI 10.1158/0008-5472.CAN-06-3914; Alexandre J, 2006, INT J CANCER, V119, P41, DOI 10.1002/ijc.21685; Appierto V, 2007, ONCOGENE, V26, P3952, DOI 10.1038/sj.onc.1210171; Appierto V, 2004, CELL DEATH DIFFER, V11, P270, DOI 10.1038/sj.cdd.4401349; Appierto V, 2009, MOL CANCER THER, V8, P3360, DOI 10.1158/1535-7163.MCT-09-0798; Appierto V, 2009, CARCINOGENESIS, V30, P824, DOI 10.1093/carcin/bgp067; Bourgarel-Rey V, 2009, BIOCHEM PHARMACOL, V78, P1148, DOI 10.1016/j.bcp.2009.06.025; Chiesa F, 2005, INT J CANCER, V115, P625, DOI 10.1002/ijc.20923; Chua YS, 2010, MOL CANCER THER, V9, P224, DOI 10.1158/1535-7163.MCT-09-1003; De Palo G, 2002, GYNECOL ONCOL, V86, P24, DOI 10.1006/gyno.2002.6663; DELIA D, 1995, BLOOD, V85, P359, DOI 10.1182/blood.V85.2.359.bloodjournal852359; Durrant D, 2008, GYNECOL ONCOL, V110, P110, DOI 10.1016/j.ygyno.2008.02.031; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Jutooru I, 2009, MOL CARCINOGEN, V48, P692, DOI 10.1002/mc.20518; Kang MH, 2008, JNCI-J NATL CANCER I, V100, P580, DOI 10.1093/jnci/djn076; Khawaja NR, 2008, MOL PHARMACOL, V74, P1072, DOI 10.1124/mol.108.048405; Lee SH, 2010, CARCINOGENESIS, V31, P719, DOI 10.1093/carcin/bgq016; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Moglia D, 1996, CANCER LETT, V110, P87, DOI 10.1016/S0304-3835(96)04475-8; Nagy L, 1998, CELL DEATH DIFFER, V5, P11, DOI 10.1038/sj.cdd.4400337; Pignatelli M, 2005, CARCINOGENESIS, V26, P81, DOI 10.1093/carcin/bgh308; Poruchynsky MS, 2001, BIOCHEM PHARMACOL, V62, P1469, DOI 10.1016/S0006-2952(01)00804-8; Reed JC, 1999, J NATL CANCER I, V91, P1099, DOI 10.1093/jnci/91.13.1099; Rubio S, 2010, MOL CARCINOGEN, V49, P32, DOI 10.1002/mc.20574; Sgadari C, 2000, J IMMUNOL, V165, P509, DOI 10.4049/jimmunol.165.1.509; Shim M, 2008, MOL CANCER THER, V7, P961, DOI 10.1158/1535-7163.MCT-07-0470; Ting CM, 2010, BIOCHEM PHARMACOL, V79, P825, DOI 10.1016/j.bcp.2009.10.018; TRADATI N, 1994, CANCER LETT, V76, P109, DOI 10.1016/0304-3835(94)90385-9; Valsecchi M, 2010, J LIPID RES, V51, P1832, DOI 10.1194/jlr.M004010; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Veronesi U, 1999, J NATL CANCER I, V91, P1847, DOI 10.1093/jnci/91.21.1847; Villani MG, 2006, CANCER RES, V66, P3238, DOI 10.1158/0008-5472.CAN-05-3362; Villani MG, 2004, CLIN CANCER RES, V10, P6265, DOI 10.1158/1078-0432.CCR-04-0655; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yoshioka H, 2008, J BIOL CHEM, V283, P33129, DOI 10.1074/jbc.M805248200	35	8	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13362	10.1371/journal.pone.0013362	http://dx.doi.org/10.1371/journal.pone.0013362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976277	Green Published, gold, Green Submitted			2022-12-25	WOS:000282941000011
J	Cowper-Smith, CD; Lau, EYY; Helmick, CA; Eskes, GA; Westwood, DA				Cowper-Smith, Christopher D.; Lau, Esther Y. Y.; Helmick, Carl A.; Eskes, Gail A.; Westwood, David A.			Neural Coding of Movement Direction in the Healthy Human Brain	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; DORSOLATERAL PREFRONTAL CORTEX; CORTICAL REPRESENTATION; NEURONAL-ACTIVITY; FMRI ADAPTATION; ARM MOVEMENTS; TETRAPLEGIA; PREMOTOR; ORGANIZATION; ACTIVATION	Neurophysiological studies in monkeys show that activity of neurons in primary cortex (M1), pre-motor cortex (PMC), and cerebellum varies systematically with the direction of reaching movements. These neurons exhibit preferred direction tuning, where the level of neural activity is highest when movements are made in the preferred direction (PD), and gets progressively lower as movements are made at increasing degrees of offset from the PD. Using a functional magnetic resonance imaging adaptation (fMRI-A) paradigm, we show that PD coding does exist in regions of the human motor system that are homologous to those observed in non-human primates. Consistent with predictions of the PD model, we show adaptation (i.e., a lower level) of the blood oxygen level dependent (BOLD) time-course signal in M1, PMC, SMA, and cerebellum when consecutive wrist movements were made in the same direction (0 degrees offset) relative to movements offset by 90 degrees or 180 degrees. The BOLD signal in dorsolateral prefrontal cortex adapted equally in all movement offset conditions, mitigating against the possibility that the present results are the consequence of differential task complexity or attention to action in each movement offset condition.	[Cowper-Smith, Christopher D.] Dalhousie Univ, Dept Psychol, Halifax, NS, Canada; [Lau, Esther Y. Y.] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Helmick, Carl A.; Eskes, Gail A.] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Westwood, David A.] Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS, Canada	Dalhousie University; University of Hong Kong; Dalhousie University; Dalhousie University	Cowper-Smith, CD (corresponding author), Dalhousie Univ, Dept Psychol, Halifax, NS, Canada.	David.Westwood@DAL.CA		Eskes, Gail/0000-0001-5867-9616; Westwood, David/0000-0003-3317-0447	Nova Scotia Health Research Foundation; Dalhousie Medical Research Foundation; Canadian Institutes of Health Research/Institutes de recherche en sante du Canada (CIHR/IRCS); Nova Scotia Health Research Foundation (NSHRF); Sir Edward Youde Memorial Overseas Fellowship; Dalhousie Faculty of Medicine Clinical Research; CIHR	Nova Scotia Health Research Foundation; Dalhousie Medical Research Foundation; Canadian Institutes of Health Research/Institutes de recherche en sante du Canada (CIHR/IRCS)(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation (NSHRF); Sir Edward Youde Memorial Overseas Fellowship; Dalhousie Faculty of Medicine Clinical Research; CIHR(Canadian Institutes of Health Research (CIHR))	This research was funded by the Nova Scotia Health Research Foundation and the Dalhousie Medical Research Foundation. CCS was supported by studentships from the Canadian Institutes of Health Research/Institutes de recherche en sante du Canada (CIHR/IRCS) and the Nova Scotia Health Research Foundation (NSHRF). This research was previously published as part of CCS' MSc thesis. EL was supported by the Sir Edward Youde Memorial Overseas Fellowship, and GE was supported by a Dalhousie Faculty of Medicine Clinical Research Scholar Award. DW was supported by a CIHR New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirikian B, 2000, NEUROSCI RES, V36, P73, DOI 10.1016/S0168-0102(99)00112-1; Bedard P, 2008, EXP BRAIN RES, V188, P63, DOI 10.1007/s00221-008-1339-3; Binkofski F, 2002, J NEUROPHYSIOL, V88, P514, DOI 10.1152/jn.2002.88.1.514; Bitterman Y, 2008, NATURE, V451, P197, DOI 10.1038/nature06476; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Chouinard PA, 2009, NEUROIMAGE, V48, P696, DOI 10.1016/j.neuroimage.2009.07.020; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; Donoghue JP, 2007, J PHYSIOL-LONDON, V579, P603, DOI 10.1113/jphysiol.2006.127209; Eisenberg M, 2010, J NEUROSCI, V30, P8897, DOI 10.1523/JNEUROSCI.0007-10.2010; FORTIER PA, 1989, J NEUROPHYSIOL, V62, P198, DOI 10.1152/jn.1989.62.1.198; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Horenstein C, 2009, HUM BRAIN MAPP, V30, P1397, DOI 10.1002/hbm.20610; Hoshi E, 2006, NEUROSCI RES, V54, P73, DOI 10.1016/j.neures.2005.10.013; Hoshi E, 2004, J NEUROPHYSIOL, V91, P2707, DOI 10.1152/jn.00904.2003; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kapreli E, 2006, NEUROIMAGE, V32, P1709, DOI 10.1016/j.neuroimage.2006.05.043; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Kroliczak G, 2008, J NEUROPHYSIOL, V100, P2627, DOI 10.1152/jn.01376.2007; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Mushiake H, 2006, NEURON, V50, P631, DOI 10.1016/j.neuron.2006.03.045; Naselaris T, 2006, J NEUROPHYSIOL, V96, P3237, DOI 10.1152/jn.00488.2006; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; SCHWARTZ AB, 1993, J NEUROPHYSIOL, V70, P28, DOI 10.1152/jn.1993.70.1.28; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	36	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13330	10.1371/journal.pone.0013330	http://dx.doi.org/10.1371/journal.pone.0013330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967197	gold, Green Published			2022-12-25	WOS:000282869800028
J	Wang, MH; Marinotti, O; James, AA; Walker, E; Githure, J; Yan, GY				Wang, Mei-Hui; Marinotti, Osvaldo; James, Anthony A.; Walker, Edward; Githure, John; Yan, Guiyun			Genome-Wide Patterns of Gene Expression during Aging in the African Malaria Vector Anopheles gambiae	PLOS ONE			English	Article							DROSOPHILA LIFE-SPAN; AEDES-AEGYPTI DIPTERA; OXIDATIVE STRESS; MOSQUITO AGE; CELL-DEATH; CUTICULAR HYDROCARBONS; MICROARRAY ANALYSIS; C-ELEGANS; MELANOGASTER; CULICIDAE	The primary means of reducing malaria transmission is through reduction in longevity in days of the adult female stage of the Anopheles vector. However, assessing chronological age is limited to crude physiologic methods which categorize the females binomially as either very young (nulliparous) or not very young (parous). Yet the epidemiologically relevant reduction in life span falls within the latter category. Age-grading methods that delineate chronological age, using accurate molecular surrogates based upon gene expression profiles, will allow quantification of the longevity-reducing effects of vector control tools aimed at the adult, female mosquito. In this study, microarray analyses of gene expression profiles in the African malaria vector Anopheles gambiae were conducted during natural senescence of females in laboratory conditions. Results showed that detoxification-related and stress-responsive genes were up-regulated as mosquitoes aged. A total of 276 transcripts had age-dependent expression, independently of blood feeding and egg laying events. Expression of 112 (40.6%) of these transcripts increased or decreased monotonically with increasing chronologic age. Seven candidate genes for practical age assessment were tested by quantitative gene amplification in the An. gambiae G3 strain in a laboratory experiment and the Mbita strain in field enclosures set up in western Kenya under conditions closely resembling natural ones. Results were similar between experiments, indicating that senescence is marked by changes in gene expression and that chronological age can be gauged accurately and repeatedly with this method. These results indicate that the method may be suitable for accurate gauging of the age in days of field-caught, female An. gambiae.	[Wang, Mei-Hui; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92717 USA; [Marinotti, Osvaldo; James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Walker, Edward] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Githure, John] Int Ctr Insect Physiol & Ecol, Div Human Hlth, Nairobi, Kenya	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Michigan State University; International Centre of Insect Physiology & Ecology (ICIPE)	Wang, MH (corresponding author), Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92717 USA.	guiyuny@uci.edu		Marinotti, Osvaldo/0000-0002-7173-7160; James, Anthony/0000-0001-5577-3308	Ellison Medical Foundation; National Institutes of Health [R21 AI078463]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078463] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank three anonymous referees for their constructive comments on the manuscript and the Ellison Medical Foundation sponsors the 2009 Molecular Biology of Aging Summer Course for M-H Wang.; This study was funded by National Institutes of Health, R21 AI078463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL S, 1994, MECH AGEING DEV, V75, P11, DOI 10.1016/0047-6374(94)90024-8; Ahmed AM, 2001, INSECT MOL BIOL, V10, P347, DOI 10.1046/j.0962-1075.2001.00273.x; [Anonymous], 1962, WHO MONOGRAPHIES SER; [Anonymous], 2008, WORLD MAL REP 2008; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103; Dana AN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-119; Desena ML, 1999, J MED ENTOMOL, V36, P811, DOI 10.1093/jmedent/36.6.811; Desena ML, 1999, J MED ENTOMOL, V36, P824, DOI 10.1093/jmedent/36.6.824; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; GIRAUDO M, 2010, GENOMIC INSIGHTS PES, V97, P115; Golden TR, 2006, EXP GERONTOL, V41, P1040, DOI 10.1016/j.exger.2006.06.034; Golden TR, 2004, AGING CELL, V3, P111, DOI 10.1111/j.1474-9728.2004.00095.x; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Gruenewald C, 2009, FREE RADICAL BIO MED, V46, P1668, DOI 10.1016/j.freeradbiomed.2009.03.025; Hastie T., 2009, UNSUPERVISED LEARNIN; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hodjati MH, 1999, B ENTOMOL RES, V89, P329, DOI 10.1017/S0007485399000462; Hugo LE, 2008, J MED ENTOMOL, V45, P353, DOI 10.1603/0022-2585(2008)45[353:EOMAGT]2.0.CO;2; Hugo LE, 2006, AM J TROP MED HYG, V74, P462, DOI 10.4269/ajtmh.2006.74.462; Jensen HR, 2006, INSECT MOL BIOL, V15, P329, DOI 10.1111/j.1365-2583.2006.00648.x; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Kim AJ, 2004, GENE, V343, P79, DOI 10.1016/j.gene.2004.08.031; Knols Bart G.J., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-19; Lai CQ, 2007, MECH AGEING DEV, V128, P237, DOI 10.1016/j.mad.2006.12.003; LANCIANI CA, 1993, J AM MOSQUITO CONTR, V9, P158; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Li B, 2005, GENE, V360, P131, DOI 10.1016/j.gene.2005.07.001; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Liu Y, 2008, INSECT MOL BIOL, V17, P91, DOI 10.1111/j.1365-2583.2007.00785.x; Luckhart S, 2007, DEV COMP IMMUNOL, V31, P647, DOI 10.1016/j.dci.2006.10.005; MACDONALD G, 1968, B WORLD HEALTH ORGAN, V38, P743; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Martin DN, 2007, CELL DEATH DIFFER, V14, P916, DOI 10.1038/sj.cdd.4402098; Martinez-Lara E, 2002, MAR ENVIRON RES, V54, P263, DOI 10.1016/S0141-1136(02)00188-5; Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Minakawa N, 2006, AM J TROP MED HYG, V75, P448, DOI 10.4269/ajtmh.2006.75.448; Morey M, 2003, FEBS LETT, V534, P111, DOI 10.1016/S0014-5793(02)03790-0; Nirmala X, 2005, INSECT MOL BIOL, V14, P95, DOI 10.1111/j.1365-2583.2005.00535.x; Norry FM, 2009, J INSECT PHYSIOL, V55, P1050, DOI 10.1016/j.jinsphys.2009.07.009; Okanda F.M., 2002, Malaria Journal, pUnpaginated, DOI 10.1186/1475-2875-1-10; Okech BA, 2003, J MED ENTOMOL, V40, P657, DOI 10.1603/0022-2585-40.5.657; Pletcher SD, 2005, AGEING RES REV, V4, P451, DOI 10.1016/j.arr.2005.06.007; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Polovodova V., 1949, MED PARASITOL, V28, P352; Ribeiro JMC, 2004, INSECT MOL BIOL, V13, P449, DOI 10.1111/j.0962-1075.2004.00503.x; Semeiks JR, 2005, MECH AGEING DEV, V126, P193, DOI 10.1016/j.mad.2004.09.028; Seroude L, 2002, AGING CELL, V1, P47, DOI 10.1046/j.1474-9728.2002.00007.x; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9; Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5; Yang JS, 2009, J GERONTOL A-BIOL, V64, P828, DOI 10.1093/gerona/glp054; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	59	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13359	10.1371/journal.pone.0013359	http://dx.doi.org/10.1371/journal.pone.0013359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967211	Green Published, gold			2022-12-25	WOS:000282869800039
J	Bygrave, H; Kranzer, K; Hilderbrand, K; Whittal, J; Jouquet, G; Goemaere, E; Vlahakis, N; Trivino, L; Makakole, L; Ford, N				Bygrave, Helen; Kranzer, Katharina; Hilderbrand, Katherine; Whittal, Jonathan; Jouquet, Guillaume; Goemaere, Eric; Vlahakis, Nathalie; Trivino, Laura; Makakole, Lipontso; Ford, Nathan			Trends in Loss to Follow-Up among Migrant Workers on Antiretroviral Therapy in a Community Cohort in Lesotho	PLOS ONE			English	Article							HIV TREATMENT; OUTCOMES	Background: The provision of antiretroviral therapy (ART) to migrant populations raises particular challenges with respect to ensuring adequate treatment support, adherence, and retention in care. We assessed rates of loss to follow-up for migrant workers compared with non-migrant workers in a routine treatment programme in Morjia, Lesotho. Design: All adult patients (>= 18 years) initiating ART between January 1, 2008, and December 31, 2008, and followed up until the end of 2009, were included in the study. We described rates of loss to follow-up according to migrant status by Kaplan-Meier estimates, and used Poisson regression to model associations between migrant status and loss to follow-up controlling for potential confounders identified a priori. Results: Our cohort comprised 1185 people, among whom 12% (148) were migrant workers. Among the migrant workers, median age was 36.1 (29.6-45.9) and the majority (55%) were male. We found no statistically significant differences between baseline characteristics and migrant status. Rates of lost to follow up were similar between migrants and non-migrants in the first 3 months but differences increased thereafter. Between 3 and 6 months after initiating antiretroviral therapy, migrants had a 2.78-fold increased rate of defaulting (95% CI 1.15-6.73); between 6 and 12 months the rate was 2.36 times greater (95% CI 1.18-4.73), whereas after 1 year the rate was 6.69 times greater (95% CI 3.18-14.09). Conclusions: Our study highlights the need for programme implementers to take into account the specific challenges that may influence continuity of antiretroviral treatment and care for migrant populations.	[Bygrave, Helen; Jouquet, Guillaume; Vlahakis, Nathalie; Trivino, Laura] Med Sans Frontieres, Morija, Lesotho; [Kranzer, Katharina] London Sch Hyg & Trop Med, London WC1, England; [Hilderbrand, Katherine; Whittal, Jonathan; Goemaere, Eric; Ford, Nathan] Med Sans Frontieres, Cape Town, South Africa; [Hilderbrand, Katherine; Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Makakole, Lipontso] Scott Hosp, Morija, Lesotho	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Bygrave, H (corresponding author), Med Sans Frontieres, Morija, Lesotho.	helenbygrave@hotmail.com	Kranzer, Katharina/O-8845-2014	Kranzer, Katharina/0000-0001-5691-7270				AIDS and Rights Alliance for Southern Africa, 2008, MIN SECT TUB MIGR LA; AKUGIZIBWE P, 2009, TIMES S AFRICA  0218; [Anonymous], 2007, HIV AIDS STI STRATEG; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Culbert H, 2007, PLOS MED, V4, P794, DOI 10.1371/journal.pmed.0040129; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; FURIN J, 2008, ANN NY ACAD SCI, P12; GENG EH, J ACQUIR IMMUNE DEFI, V53, P405; *INT ORG MIGR, 2010, INT LAB C 99 SESS GE; *INT ORG MIGR, 2002, POS PAP HIV AIDS MIG; KRANZER K, 2010, J ACQUIR IMMUNE 0908; McCarthy K, 2009, INT J STD AIDS, V20, P858, DOI 10.1258/ijsa.2009.009258; *MED SANS FRONT, 2010, PROV NURS DRIV COMM; Meekers D, 2000, INT J STD AIDS, V11, P21, DOI 10.1258/0956462001914850; *MIN HLTH SOC WELF, 2007, LES NAT ART IN PRESS; SADC, 2009, FUNCT MIN STAND NAT; Saether ST, 2007, TROP MED INT HEALTH, V12, P999, DOI 10.1111/j.1365-3156.2007.01879.x; Schopper D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000115; *UN DEV PROGR, 2009, HUM DEV REP 2009; VEAREY J, 2008, ASSESSING NONCITIZEN; 2009, NURSE DRIVEN COMMUNI	22	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13198	10.1371/journal.pone.0013198	http://dx.doi.org/10.1371/journal.pone.0013198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20976289	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000282676700006
J	Wise, JK; Sena, K; Vranizan, K; Pollock, JF; Healy, KE; Hughes, WF; Sumner, DR; Virdi, AS				Wise, Joel K.; Sena, Kotaro; Vranizan, Karen; Pollock, Jacob F.; Healy, Kevin E.; Hughes, W. Frank; Sumner, D. Rick; Virdi, Amarjit S.			Temporal Gene Expression Profiling during Rat Femoral Marrow Ablation-Induced Intramembranous Bone Regeneration	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PHOSPHATE-COATED IMPLANTS; MATRIX METALLOPROTEINASES; LOCAL APPLICATION; TITANIUM IMPLANT; CLUSTER-ANALYSIS; WNT; PATHWAY; SURFACE; THROMBOSPONDIN-2	Enhanced understanding of differential gene expression and biological pathways associated with distinct phases of intramembranous bone regeneration following femoral marrow ablation surgery will improve future advancements regarding osseointegration of joint replacement implants, biomaterials design, and bone tissue engineering. A rat femoral marrow ablation model was performed and genome-wide microarray data were obtained from samples at 1, 3, 5, 7, 10, 14, 28, and 56 days post-ablation, with intact bones serving as controls at Day 0. Bayesian model-based clustering produced eight distinct groups amongst 9,062 significant gene probe sets based on similar temporal expression profiles, which were further categorized into three major temporal classes of increased, variable, and decreased expression. Osteoblastic-and osteoclastic-associated genes were found to be significantly expressed within the increased expression groups. Chondrogenesis was not detected histologically. Adipogenic marker genes were found within variable/decreased expression groups, emphasizing that adipogenesis was inhibited during osteogenesis. Differential biological processes and pathways associated with each major temporal group were identified, and significantly expressed genes involved were visually represented by heat maps. It was determined that the increased expression group exclusively contains genes involved in pathways for matrix metalloproteinases (MMPs), Wnt signaling, TGF-beta signaling, and inflammatory pathways. Only the variable expression group contains genes associated with glycolysis and gluconeogenesis, the notch signaling pathway, natural killer cell mediated cytotoxicity, and the B cell receptor signaling pathway. The decreased group exclusively consists of genes involved in heme biosynthesis, the p53 signaling pathway, and the hematopoietic cell lineage. Significant biological pathways and transcription factors expressed at each time point post-ablation were also identified. These data present the first temporal gene expression profiling analysis of the rat genome during intramembranous bone regeneration induced by femoral marrow ablation.	[Wise, Joel K.; Sena, Kotaro; Hughes, W. Frank; Sumner, D. Rick; Virdi, Amarjit S.] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Vranizan, Karen] Univ Calif Berkeley, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Vranizan, Karen] Univ Calif Berkeley, Funct Genom Lab, Berkeley, CA 94720 USA; [Pollock, Jacob F.; Healy, Kevin E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Healy, Kevin E.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	Rush University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wise, JK (corresponding author), Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA.	amarjit_virdi@rush.edu	Sena, Kotaro/A-8033-2013	Sena, Kotaro/0000-0003-0612-1826; Sumner, Dale/0000-0001-9575-3862	Grainger Foundation; National Institutes of Health (NIH) [T32 AR052272]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR052272] Funding Source: NIH RePORTER	Grainger Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by The Grainger Foundation and a National Institutes of Health (NIH) Institutional Training Grant (T32 AR052272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL S, 1969, ANAT RECORD, V164, P101, DOI 10.1002/ar.1091640107; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAB IA, 1995, BONE, V17, pS437, DOI 10.1016/8756-3282(95)00323-6; Bais M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005393; Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Behonick DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001150; Chen Y, 2009, J CELL BIOCHEM, V106, P353, DOI 10.1002/jcb.22020; Chung EH, 2006, J BIOMED MATER RES A, V79A, P815, DOI 10.1002/jbm.a.30809; De Ranieri A, 2005, BONE, V37, P55, DOI 10.1016/j.bone.2005.03.011; De Ranieri A, 2005, J BIOMED MATER RES B, V74B, P712, DOI 10.1002/jbm.b.30293; De Ranieri A, 2005, BONE, V36, P931, DOI 10.1016/j.bone.2005.01.019; Delany AM, 2009, J CELL COMMUN SIGNAL, V3, P227, DOI 10.1007/s12079-009-0076-0; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Greco JA, 2010, BURNS, V36, P192, DOI 10.1016/j.burns.2009.06.211; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Hankenson KD, 2002, J BONE MINER RES, V17, P415, DOI 10.1359/jbmr.2002.17.3.415; Hara T, 1999, J BONE JOINT SURG BR, V81B, P705, DOI 10.1302/0301-620X.81B4.9138; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishizaka M, 1996, BONE, V19, P589, DOI 10.1016/S8756-3282(96)00303-1; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jeong JA, 2007, STEM CELLS, V25, P994, DOI 10.1634/stemcells.2006-0604; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kashimaa TG, 2009, HUM PATHOL, V40, P226, DOI 10.1016/j.humpath.2008.07.008; Katoh M, 2006, INT J MOL MED, V17, P681; Katoh M, 2006, INT J MOL MED, V18, P517; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Kuroda S, 2005, CALCIFIED TISSUE INT, V77, P212, DOI 10.1007/s00223-004-0267-x; Kuroda S, 2004, J BIOMED MATER RES A, V70A, P66, DOI 10.1002/jbm.a.30062; LIANG CT, 1992, BONE, V13, P435, DOI 10.1016/8756-3282(92)90087-D; Lind M, 1996, J BONE JOINT SURG BR, V78B, P377, DOI 10.1302/0301-620X.78B3.0780377; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Milat F, 2009, MOL CELL ENDOCRINOL, V310, P52, DOI 10.1016/j.mce.2009.06.002; Nah HD, 2000, J BONE MINER RES, V15, P522, DOI 10.1359/jbmr.2000.15.3.522; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PATT HM, 1975, EXP HEMATOL, V3, P135; Pedemonte E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-65; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; Sato H, 1997, THROMB HAEMOSTASIS, V78, P497; Schmidmaier G, 2002, J BIOMED MATER RES, V63, P168, DOI 10.1002/jbm.10130; Sena K, 2010, J BIOMED MATER RES A, V92A, P1210, DOI 10.1002/jbm.a.32461; Simon R, 2007, CANCER INFORM, V3, P11; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Sumner DR, 2001, J ORTHOP RES, V19, P85; SUMNER DR, 2006, JOINT REPLACEMENTS B, P727; SUVA LJ, 1993, J BONE MINER RES, V8, P379; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Velardo MJ, 2004, J NEUROSCI, V24, P8562, DOI 10.1523/JNEUROSCI.3316-04.2004; Wang WB, 2009, MOL BIOTECHNOL, V43, P221, DOI 10.1007/s12033-009-9199-z; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang Q, 2008, TISSUE ENG PT A, V14, P237, DOI 10.1089/tea.2007.0261; Zhong N, 2006, BONE, V39, P5, DOI 10.1016/j.bone.2005.12.008; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	65	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e12987	10.1371/journal.pone.0012987	http://dx.doi.org/10.1371/journal.pone.0012987			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957030	Green Published, gold, Green Submitted			2022-12-25	WOS:000282359300001
J	Moore, F; Naamane, N; Colli, ML; Bouckenooghe, T; Ortis, F; Gurzov, EN; Igoillo-Esteve, M; Mathieu, C; Bontempi, G; Thykjaer, T; Orntoft, TF; Eizirik, DL				Moore, Fabrice; Naamane, Najib; Colli, Maikel L.; Bouckenooghe, Thomas; Ortis, Fernanda; Gurzov, Esteban N.; Igoillo-Esteve, Mariana; Mathieu, Chantal; Bontempi, Gianluca; Thykjaer, Thomas; Orntoft, Torben F.; Eizirik, Decio L.			STAT1 Is a Master Regulator of Pancreatic beta-Cell Apoptosis and Islet Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; INSULIN-PRODUCING CELLS; IFN-GAMMA; DIABETES-MELLITUS; SIGNAL TRANSDUCER; INDUCED GENES; DEATH; TYPE-1; EXPRESSION; ACTIVATION	Cytokines produced by islet-infiltrating immune cells induce beta-cell apoptosis in type 1 diabetes. The IFN-gamma-regulated transcription factors STAT1/IRF-1 have apparently divergent effects on beta-cells. Thus, STAT1 promotes apoptosis and inflammation, whereas IRF-1 down-regulates inflammatory mediators. To understand the molecular basis for these differential outcomes within a single signal transduction pathway, we presently characterized the gene networks regulated by STAT1 and IRF-1 in beta-cells. This was done by using siRNA approaches coupled to microarray analysis of insulin-producing cells exposed or not to IL-1 beta and IFN-gamma. Relevant microarray findings were further studied in INS-1E cells and primary rat beta-cells. STAT1, but not IRF-1, mediates the cytokine-induced loss of the differentiated beta-cell phenotype, as indicated by decreased insulin, Pdx1, MafA, and Glut2. Furthermore, STAT1 regulates cytokine-induced apoptosis via up-regulation of the proapoptotic protein DP5. STAT1 and IRF-1 have opposite effects on cytokine-induced chemokine production, with IRF-1 exerting negative feedback inhibition on STAT1 and downstream chemokine expression. The present study elucidates the transcriptional networks through which the IFN-gamma/STAT1/IRF-1 axis controls beta-cell function/differentiation, demise, and islet inflammation.	[Moore, Fabrice; Naamane, Najib; Colli, Maikel L.; Bouckenooghe, Thomas; Ortis, Fernanda; Gurzov, Esteban N.; Igoillo-Esteve, Mariana; Eizirik, Decio L.] Univ Libre Bruxelles, Expt Med Lab, B-1070 Brussels, Belgium; [Bontempi, Gianluca] Univ Libre Bruxelles, Machine Learning Grp, B-1070 Brussels, Belgium; [Mathieu, Chantal] Katholieke Univ Leuven, LEGENDO, B-3000 Louvain, Belgium; [Thykjaer, Thomas; Orntoft, Torben F.] CMO Aros Appl Biotechnol AS, Aarhus, Denmark; [Orntoft, Torben F.] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark	Universite Libre de Bruxelles; Universite Libre de Bruxelles; KU Leuven; Aarhus University	Moore, F (corresponding author), Univ Libre Bruxelles, Expt Med Lab, Route Lennik 808,CP618, B-1070 Brussels, Belgium.	fmoore@ulb.ac.be	Bontempi, Gianluca/J-7121-2012; mathieu, chantal/ABD-5505-2021; Ortis, Fernanda/K-7917-2014; Bontempi, Gianluca/ABE-4365-2020; Ortis, Fernanda/M-7190-2019	Bontempi, Gianluca/0000-0001-8621-316X; mathieu, chantal/0000-0002-4055-5233; Bontempi, Gianluca/0000-0001-8621-316X; Gurzov, Esteban/0000-0003-4642-0273; Ortis, Fernanda/0000-0002-9551-2839	Fonds National de la Recherche Scientifique (FNRS-FRSM) Belgium; Communaute Francaise de Belgique (Actions de Recherche Concertees); European Union (NAIMIT) [Health F22009-241447]; Fonds National de la Recherche Scientifique, Belgium; European Molecular Biology Organization; Belgian government [IUAP P6/40]	Fonds National de la Recherche Scientifique (FNRS-FRSM) Belgium(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique (Actions de Recherche Concertees); European Union (NAIMIT)(European Commission); Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Belgian government	This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS-FRSM) Belgium, the Communaute Francaise de Belgique (Actions de Recherche Concertees), the European Union (NAIMIT, Health F22009-241447; in the Framework Programme 7 of the European Community) and the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgian government (IUAP P6/40).; Recipient of a postdoctoral fellowship from Fonds National de la Recherche Scientifique, Belgium. To whom correspondence should be addressed: Laboratory of Experimental Medicine, Universite Libre de Bruxelles, Route de Lennik, 808, CP618, B-1070 Brussels, Belgium. E-mail: fmoore@ulb.ac.be.; Supported by a long term fellowship from the European Molecular Biology Organization.	Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Callewaert HI, 2007, DIABETES, V56, P2169, DOI 10.2337/db07-0052; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cardozo AK, 2003, DIABETOLOGIA, V46, P255, DOI 10.1007/s00125-002-1017-0; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Cardozo AK, 2001, DIABETES, V50, P909, DOI 10.2337/diabetes.50.5.909; Chong MMW, 2004, J IMMUNOL, V172, P5714, DOI 10.4049/jimmunol.172.9.5714; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Darville MI, 2006, BIOCHEM BIOPH RES CO, V339, P1063, DOI 10.1016/j.bbrc.2005.11.111; Eizirik DL, 2008, BIOCHEM SOC T, V36, P321, DOI 10.1042/BST0360321; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Flodstrom-Tullberg M, 2003, DIABETES, V52, P2696, DOI 10.2337/diabetes.52.11.2696; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gysemans C, 2009, DIABETOLOGIA, V52, P2374, DOI 10.1007/s00125-009-1514-5; Gysemans CA, 2005, DIABETES, V54, P2396, DOI 10.2337/diabetes.54.8.2396; Gysemans C, 2008, BIOCHEM SOC T, V36, P328, DOI 10.1042/BST0360328; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Imaizumi K, 2004, J NEUROSCI, V24, P3721, DOI 10.1523/JNEUROSCI.5101-03.2004; Imaizumi K, 1997, J BIOL CHEM, V272, P18842, DOI 10.1074/jbc.272.30.18842; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanazawa K, 1998, MOL BRAIN RES, V54, P316, DOI 10.1016/S0169-328X(97)00360-4; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Kim S, 2007, DIABETES, V56, P2561, DOI 10.2337/db06-1372; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Liu L, 2001, BRIT J PHARMACOL, V134, P1629, DOI 10.1038/sj.bjp.0704404; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Magnusson NE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-311; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Ortis F, 2010, DIABETES, V59, P358, DOI 10.2337/db09-1159; Perez-Arana G, 2010, ENDOCRINOLOGY, V151, P2538, DOI 10.1210/en.2009-1113; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Roep BO, 2010, CLIN EXP IMMUNOL, V159, P338, DOI 10.1111/j.1365-2249.2009.04087.x; Saito H, 2000, J IMMUNOL, V164, P5833, DOI 10.4049/jimmunol.164.11.5833; SIBLEY RK, 1985, LAB INVEST, V53, P132; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Tajima K, 2010, J ORTHOP RES, V28, P937, DOI 10.1002/jor.21086; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	50	125	127	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					929	941		10.1074/jbc.M110.162131	http://dx.doi.org/10.1074/jbc.M110.162131			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20980260	Green Published, hybrid			2022-12-25	WOS:000286005000004
J	Eken, C; Martin, PJ; Sadallah, S; Treves, S; Schaller, M; Schifferli, JA				Eken, Ceylan; Martin, Perrine J.; Sadallah, Salima; Treves, Susan; Schaller, Monica; Schifferli, Juerg A.			Ectosomes Released by Polymorphonuclear Neutrophils Induce a MerTK-dependent Anti-inflammatory Pathway in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; APOPTOTIC CELLS; DENDRITIC CELLS; TYROSINE KINASE; TYRO-3 FAMILY; RESPONSES; RECOGNITION; RECEPTORS; MEDIATORS; MICROPARTICLES	At the earliest stage of activation, human polymorphonuclear neutrophils release vesicles derived directly from the cell surface. These vesicles, called ectosomes (PMN-Ect), expose phosphatidylserine in the outer membrane leaflet. They inhibit the inflammatory response of human monocyte-derived macrophages and dendritic cells to zymosan A (ZymA) and LPS and induce TGF-beta 1 release, suggesting a reprogramming toward a tolerogenic phenotype. The receptors and signaling pathways involved have not yet been defined. Here, we demonstrate that PMN-Ect interfered with ZymA activation of macrophages via inhibition of NF kappa B p65 phosphorylation and NF kappa B translocation. The MerTK (Mer receptor tyrosine kinase) and PI3K/Akt pathways played a key role in this immunomodulatory effect as shown using specific MerTK-blocking antibodies and PI3K inhibitors LY294002 and wortmannin. As a result, PMN-Ect reduced the transcription of many proinflammatory genes in ZymA-activated macrophages. In sum, PMN-Ect interacted with the macrophages by activation of the MerTK pathway responsible for down-modulation of the proinflammatory signals generated by ZymA.	[Eken, Ceylan; Martin, Perrine J.; Sadallah, Salima; Schifferli, Juerg A.] Univ Basel Hosp, Immunonephrol Lab, CH-4031 Basel, Switzerland; [Schaller, Monica] Univ Basel Hosp, Clin Immunol Lab, Dept Biomed, CH-4031 Basel, Switzerland; [Schaller, Monica] Univ Basel Hosp, Clin Immunol Lab, Dept Med, CH-4031 Basel, Switzerland; [Treves, Susan] Univ Basel Hosp, Dept Anesthesia, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel	Eken, C (corresponding author), Univ Basel Hosp, Immunonephrol Lab, CH-4031 Basel, Switzerland.	ceylan.eken@unibas.ch	Poubelle, Patrice E/G-6537-2013	Treves, Susan/0000-0002-0007-9631; Schaller, Monica/0000-0002-5002-2238; Eken, Ceylan/0000-0002-9172-6581; Martin, Perrine/0000-0003-4439-5078	Swiss National Science Foundation [32000-116839]; Roche Foundation for Anemia Research (RoFAR); Fondazione per la Ricerca sulla Trasfusione e sui Trapianti; Nora van Meeuwen Stiftung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Foundation for Anemia Research (RoFAR); Fondazione per la Ricerca sulla Trasfusione e sui Trapianti; Nora van Meeuwen Stiftung	This work was supported by Swiss National Science Foundation Grant 32000-116839, the Roche Foundation for Anemia Research (RoFAR), the Fondazione per la Ricerca sulla Trasfusione e sui Trapianti, and the Nora van Meeuwen Stiftung.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bowers-Morrow VM, 2004, BIOL REV, V79, P611, DOI 10.1017/S1464793103006389; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Chen X, 2004, J IMMUNOL, V173, P2985, DOI 10.4049/jimmunol.173.5.2985; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Eken C, 2008, J IMMUNOL, V180, P817, DOI 10.4049/jimmunol.180.2.817; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Gasser O, 2004, BLOOD, V104, P2543, DOI 10.1182/blood-2004-01-0361; Gasser O, 2003, EXP CELL RES, V285, P243, DOI 10.1016/S0014-4827(03)00055-7; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Graham B, 2005, CELL CYCLE, V4, P1342, DOI 10.4161/cc.4.10.2047; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Hess C, 1999, J IMMUNOL, V163, P4564; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Koppler B, 2006, EUR J IMMUNOL, V36, P648, DOI 10.1002/eji.200535435; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; McDonald PP, 1999, J IMMUNOL, V163, P6164; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Pawson T, 2000, GENE DEV, V14, P1027; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Tassiulas I, 2007, HUM IMMUNOL, V68, P156, DOI 10.1016/j.humimm.2006.12.008; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; Wallet MA, 2008, J EXP MED, V205, P219, DOI 10.1084/jem.20062293; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003	35	95	97	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39914	39921		10.1074/jbc.M110.126748	http://dx.doi.org/10.1074/jbc.M110.126748			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20959443	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000285185500036
J	Jong, WSP; ten Hagen-Jongman, CM; Ruijter, E; Orru, RVA; Genevaux, P; Luirink, J				Jong, Wouter S. P.; ten Hagen-Jongman, Corinne M.; Ruijter, Eelco; Orru, Romano V. A.; Genevaux, Pierre; Luirink, Joen			YidC Is Involved in the Biogenesis of the Secreted Autotransporter Hemoglobin Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; ESCHERICHIA-COLI YIDC; MEMBRANE-PROTEIN; CYTOPLASMIC MEMBRANE; PERIPLASMIC DOMAIN; INNER MEMBRANE; TRIGGER FACTOR; DEPENDENT TRANSLOCATION; PRESECRETORY PROTEINS; CRYSTAL-STRUCTURE	Autotransporters (ATs) constitute an important family of virulence factors secreted by Gram-negative bacteria. Following their translocation across the inner membrane (IM), ATs temporarily reside in the periplasmic space after which they are secreted into the extracellular environment. Previous studies have shown that the AT hemoglobin protease (Hbp) of Escherichia coli requires a functional signal recognition particle pathway and Sec translocon for optimal targeting to and translocation across the IM. Here, we analyzed the mode of IM translocation of Hbp in more detail. Using site-directed photocross-linking, we found that the Hbp signal peptide is adjacent to YidC early during biogenesis. Notably, YidC is in part associated with the Sec translocon but has until now primarily been implicated in the biogenesis of IM proteins. In vivo, YidC appeared critical for the biogenesis of the ATs Hbp and EspC. For Hbp, depletion of YidC resulted in the formation of secretion-incompetent intermediates that were sensitive to degradation by the periplasmic protease DegP, indicating that YidC activity affects Hbp biogenesis at a late stage, after translocation across the IM. This is the first demonstration of a role for YidC in the biogenesis of an extracellular protein. We propose that YidC is required for maintenance of the translocation-competent state of certain ATs in the periplasm. The large periplasmic domain of YidC is not critical for this novel functionality as it can be deleted without affecting Hbp biogenesis.	[Jong, Wouter S. P.; ten Hagen-Jongman, Corinne M.; Luirink, Joen] Vrije Univ Amsterdam, Dept Mol Cell Biol, Sect Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [Ruijter, Eelco; Orru, Romano V. A.] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, NL-1081 HV Amsterdam, Netherlands; [Genevaux, Pierre] Univ Toulouse 3, LMGM, CNRS, F-31062 Toulouse, France	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Luirink, J (corresponding author), Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	joen.luirink@falw.vu.nl	Genevaux, Pierre/A-4851-2015; Ruijter, Eelco/A-7613-2011; Luirink, Joen/AAB-8658-2021	Jong, Wouter/0000-0002-4132-4605; Luirink, J./0000-0001-8431-0804; Jong, W.S.P./0000-0002-8907-6954; Orru, Romano V.A./0000-0003-1142-6798; Ruijter, Eelco/0000-0002-1105-3947; GENEVAUX, Pierre/0000-0001-7539-3126	Netherlands Organization for Scientific Research (NWO); FEBS	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); FEBS	This work was supported by an "ALW Open Program" grant from the Netherlands Organization for Scientific Research (NWO) and a FEBS short term fellowship (to W. S. P. J.).	Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; BRUNNER J, 1989, METHOD ENZYMOL, V172, P628; Chevalier N, 2004, J MOL MICROB BIOTECH, V8, P7, DOI 10.1159/000082076; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Desvaux M, 2007, MICROBIOL-SGM, V153, P59, DOI 10.1099/mic.0.29091-0; Desvaux M, 2006, FEMS MICROBIOL LETT, V264, P22, DOI 10.1111/j.1574-6968.2006.00425.x; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Froderberg L, 2004, J BIOL CHEM, V279, P31026, DOI 10.1074/jbc.M403229200; Giacalone MJ, 2006, BIOTECHNIQUES, V40, P355, DOI 10.2144/000112112; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Houben ENG, 2004, EMBO REP, V5, P970, DOI 10.1038/sj.embor.7400261; Houben ENG, 2002, J BIOL CHEM, V277, P35880, DOI 10.1074/jbc.M205556200; Houben ENG, 2000, FEBS LETT, V476, P229, DOI 10.1016/S0014-5793(00)01735-X; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Jong WSP, 2008, BIOCHEM BIOPH RES CO, V368, P522, DOI 10.1016/j.bbrc.2008.01.122; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; KUSTERS R, 1989, J BIOL CHEM, V264, P20827; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Martoglio B, 1996, TRENDS CELL BIOL, V6, P142, DOI 10.1016/0962-8924(96)10001-5; MATSUYAMA S, 1993, EMBO J, V12, P265, DOI 10.1002/j.1460-2075.1993.tb05652.x; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Otto BR, 1998, J EXP MED, V188, P1091, DOI 10.1084/jem.188.6.1091; Peterson JH, 2006, J BIOL CHEM, V281, P9038, DOI 10.1074/jbc.M508681200; Pop OI, 2009, FEBS J, V276, P4891, DOI 10.1111/j.1742-4658.2009.07188.x; Pradel N, 2005, BIOCHIMIE, V87, P191, DOI 10.1016/j.biochi.2004.11.001; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Saaf A, 1998, J BIOL CHEM, V273, P30415, DOI 10.1074/jbc.273.46.30415; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Scotti PA, 1999, J BIOL CHEM, V274, P29883, DOI 10.1074/jbc.274.42.29883; Shimohata N, 2005, J BACTERIOL, V187, P3997, DOI 10.1128/JB.187.12.3997-4004.2005; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; Sijbrandi R, 2003, J BIOL CHEM, V278, P4654, DOI 10.1074/jbc.M211630200; Stein M, 1996, J BACTERIOL, V178, P6546, DOI 10.1128/jb.178.22.6546-6554.1996; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Ullers RS, 2006, J BIOL CHEM, V281, P13999, DOI 10.1074/jbc.M600638200; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; van Bloois E, 2005, J BIOL CHEM, V280, P12996, DOI 10.1074/jbc.M414094200; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van Bloois E, 2007, BIOCHEM BIOPH RES CO, V362, P727, DOI 10.1016/j.bbrc.2007.08.053; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; WAGNER S, 2008, J BIOL CHEM; Wang P, 2010, J BACTERIOL, V192, P2193, DOI 10.1128/JB.00484-09; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Xie K, 2006, BIOCHEMISTRY-US, V45, P13401, DOI 10.1021/bi060826z	52	21	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39682	39690		10.1074/jbc.M110.167650	http://dx.doi.org/10.1074/jbc.M110.167650			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20959450	Green Published, hybrid			2022-12-25	WOS:000285185500012
J	Herrmann, I; Baeuerle, PA; Friedrich, M; Murr, A; Filusch, S; Ruttinger, D; Majdoub, MW; Sharma, S; Kufer, P; Raum, T; Munz, M				Herrmann, Ines; Baeuerle, Patrick A.; Friedrich, Matthias; Murr, Alexander; Filusch, Susanne; Ruettinger, Dominik; Majdoub, Mariam W.; Sharma, Sherven; Kufer, Peter; Raum, Tobias; Muenz, Markus			Highly Efficient Elimination of Colorectal Tumor-Initiating Cells by an EpCAM/CD3-Bispecific Antibody Engaging Human T Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; EP-CAM; IMMUNOTHERAPEUTIC TARGET; BISPECIFIC ANTIBODIES; THERAPEUTIC WINDOW; ANTITUMOR-ACTIVITY; ADHESION MOLECULE; OVARIAN-CANCER; BREAST-CANCER; BITE ANTIBODY	With their resistance to genotoxic and anti-proliferative drugs and potential to grow tumors and metastases from very few cells, cancer stem or tumor-initiating cells (TICs) are a severe limitation for the treatment of cancer by conventional therapies. Here, we explored whether human T cells that are redirected via an EpCAM/CD3-bispecific antibody called MT110 can lyse colorectal TICs and prevent tumor growth from TICs. MT110 recognizes EpCAM, a cell adhesion molecule expressed on TICs from diverse human carcinoma, which was recently shown to promote tumor growth through engagement of elements of the wnt pathway. MT110 was highly potent in mediating complete redirected lysis of KRAS-, PI3 kinase- and BRAF-mutated colorectal TICs, as demonstrated in a soft agar assay. In immunodeficient mice, MT110 prevented growth of tumors from a 5,000-fold excess of a minimally tumorigenic TIC dose. T cells engaged by MT110 may provide a potent therapeutic means to eradicate TICs and bulk tumor cells derived thereof.	[Herrmann, Ines; Baeuerle, Patrick A.; Friedrich, Matthias; Murr, Alexander; Filusch, Susanne; Ruettinger, Dominik; Kufer, Peter; Raum, Tobias; Muenz, Markus] Micromet AG, Munich, Germany; [Baeuerle, Patrick A.] Micromet Inc, Bethesda, MD USA; [Majdoub, Mariam W.] Celprogen Inc, San Pedro, CA USA; [Sharma, Sherven] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Sharma, Sherven] Greater Los Angeles Healthcare Syst, Mol Gene Med Lab, Los Angeles, CA USA	Amgen; Amgen Research Munich GmbH; Micromet AG; University of California System; University of California Los Angeles	Herrmann, I (corresponding author), Micromet AG, Munich, Germany.	Patrick.baeuerle@micromet-inc.com			Micromet	Micromet(Amgen)	Funding of this study has been exclusively supplied by Micromet, a publically listed company. This funder played a role in study design, data collection and analysis, and decision to publish. Celprogen, another company, helped Micromet with preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amann M, 2009, CANCER IMMUNOL IMMUN, V58, P95, DOI 10.1007/s00262-008-0529-y; Amann M, 2008, CANCER RES, V68, P143, DOI 10.1158/0008-5472.CAN-07-2182; Amann M, 2009, J IMMUNOTHER, V32, P452, DOI 10.1097/CJI.0b013e3181a1c097; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Baeuerle PA, 2003, CURR OPIN MOL THER, V5, P413; BAEUERLE PA, 2009, RATIONALE TREATMENT, P179; Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Brischwein K, 2006, MOL IMMUNOL, V43, P1129, DOI 10.1016/j.molimm.2005.07.034; Chaudry MA, 2007, BRIT J CANCER, V96, P1013, DOI 10.1038/sj.bjc.6603505; Chen HC, 2003, CANCER LETT, V201, P97, DOI 10.1016/j.canlet.2003.07.007; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Fong D, 2008, J CLIN PATHOL, V61, P31, DOI 10.1136/jcp.2006.037333; FRIEDRICH M, 2010, AACR 2010; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gastl G, 2000, LANCET, V356, P1981, DOI 10.1016/S0140-6736(00)03312-2; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Haas C, 2009, IMMUNOBIOLOGY, V214, P441, DOI 10.1016/j.imbio.2008.11.014; Heinemann V, 2009, CANCER TREAT REV, V35, P262, DOI 10.1016/j.ctrv.2008.11.005; Hoffmann P, 2005, INT J CANCER, V115, P98, DOI 10.1002/ijc.20908; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Kischel R, 2009, AACR 2009; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; LOUPAKIS F, 2009, J CLIN ONCOL; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Marhaba R, 2008, CURR MOL MED, V8, P784, DOI 10.2174/156652408786733667; McLaughlin PMJ, 2001, CANCER RES, V61, P4105; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Offner S, 2006, MOL IMMUNOL, V43, P763, DOI 10.1016/j.molimm.2005.03.007; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Prince S, 2008, AM J CLIN PATHOL, V129, P424, DOI 10.1309/H8JEEAEB69J3KYND; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schlereth B, 2006, CANCER IMMUNOL IMMUN, V55, P785, DOI 10.1007/s00262-005-0082-x; Schlereth B, 2005, CANCER RES, V65, P2882, DOI 10.1158/0008-5472.CAN-04-2637; Schmelzer E, 2008, FRONT BIOSCI-LANDMRK, V13, P3096, DOI 10.2741/2911; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Spizzo G, 2006, GYNECOL ONCOL, V103, P483, DOI 10.1016/j.ygyno.2006.03.035; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang JCY, 2007, CELL STEM CELL, V1, P497, DOI 10.1016/j.stem.2007.10.005; Wang Y, 2008, CELL STEM CELL, V2, P297, DOI 10.1016/j.stem.2008.03.014; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Wolf E, 2005, DRUG DISCOV TODAY, V10, P1237, DOI 10.1016/S1359-6446(05)03554-3; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013	51	74	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13474	10.1371/journal.pone.0013474	http://dx.doi.org/10.1371/journal.pone.0013474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976159	Green Published, Green Submitted, gold			2022-12-25	WOS:000283045300037
J	Pasquet, A; Messou, E; Gabillard, D; Minga, A; Depoulosky, A; Deuffic-Burban, S; Losina, E; Freedberg, KA; Danel, C; Anglaret, X; Yazdanpanah, Y				Pasquet, Armelle; Messou, Eugene; Gabillard, Delphine; Minga, Albert; Depoulosky, Ayeby; Deuffic-Burban, Sylvie; Losina, Elena; Freedberg, Kenneth A.; Danel, Christine; Anglaret, Xavier; Yazdanpanah, Yazdan			Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Cote d'Ivoire	PLOS ONE			English	Article							RESOURCE-POOR SETTINGS; SUB-SAHARAN AFRICA; HIV-1-INFECTED PATIENTS; INCOME COUNTRIES; SOUTH-AFRICA; SCALING-UP; COHORT; ADHERENCE; DETERMINANTS; MORTALITY	Background: To evaluate the type and frequency of antiretroviral drug stock-outs, and their impact on death and interruption in care among HIV-infected patients in Abidjan, Cote d'Ivoire. Methods and Findings: We conducted a cohort study of patients who initiated combination antiretroviral therapy (cART) in three adult HIV clinics between February 1, 2006 and June 1, 2007. Follow-up ended on February 1, 2008. The primary outcome was cART regimen modification, defined as at least one drug substitution, or discontinuation for at least one month due to drug stock-outs at the clinic pharmacy. The secondary outcome for patients who were on cART for at least six months was interruption in care, or death. A Cox regression model with time-dependent variables was used to assess the impact of antiretroviral drug stock-outs on interruption in care or death. Overall, 1,554 adults initiated cART and were followed for a mean of 13.2 months. During this time, 72 patients discontinued treatment and 98 modified their regimen because of drug stock-outs. Stock-outs involved nevirapine and fixed-dose combination zidovudine/lamivudine in 27% and 51% of cases. Of 1,554 patients, 839 (54%) initiated cART with fixed-dose stavudine/lamivudine/nevirapine and did not face stock-outs during the study period. Among the 975 patients who were on cART for at least six months, stock-out-related cART discontinuations increased the risk of interruption in care or death (adjusted hazard ratio [HR], 2.83; 95%CI, 1.25-6.44) but cART modifications did not (adjusted HR, 1.21; 95%CI, 0.46-3.16). Conclusions: cART stock-outs affected at least 11% of population on treatment. Treatment discontinuations due to stock-outs were frequent and doubled the risk of interruption in care or death. These stock-outs did not involve the most common first-line regimen. As access to cART continues to increase in sub-Saharan Africa, first-line regimens should be standardized to decrease the probability of drug stock-outs.	[Pasquet, Armelle; Yazdanpanah, Yazdan] Ctr Hosp Tourcoing, Serv Univ Malad Infect & Voyageur, Tourcoing, France; [Messou, Eugene; Depoulosky, Ayeby] Programme Aconda, Abidjan, Cote Ivoire; [Gabillard, Delphine; Minga, Albert; Danel, Christine; Anglaret, Xavier] INSERM, U897, Bordeaux, France; [Minga, Albert; Danel, Christine; Anglaret, Xavier] Programme PACCI, Abidjan, Cote Ivoire; [Deuffic-Burban, Sylvie] INSERM, U995, Lille, France; [Deuffic-Burban, Sylvie; Yazdanpanah, Yazdan] Fac Med Lille, EA 2694, Lille, France; [Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Harvard University; Massachusetts General Hospital	Pasquet, A (corresponding author), Ctr Hosp Tourcoing, Serv Univ Malad Infect & Voyageur, Tourcoing, France.	armellepasquet@hotmail.com	Deuffic-Burban, Sylvie/O-3293-2017; Franzeck, Fabian C/B-5055-2011; Anglaret, Xavier/F-7333-2013; Anglaret, Xavier/T-2757-2019	Deuffic-Burban, Sylvie/0000-0003-3241-7647; Anglaret, Xavier/0000-0003-3319-8423; Losina, ELENA/0000-0002-3424-0892	Agence Nationale de Recherches sur le SIDA et les patites virales; National Institute of Allergy and Infectious Diseases [K24 AI062476, R01 AI058736]; Boehringer-Ingelheim; Bristol-Myers Squibb; Gilead Sciences; Glaxo-SmithKline; Merck-Sharp and Dohme-Chibret; Pfizer; Roche; Schering Plough; Tibotec; Janssen-Cilag; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736, K24AI062476] Funding Source: NIH RePORTER	Agence Nationale de Recherches sur le SIDA et les patites virales(ANRS); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Boehringer-Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Glaxo-SmithKline(GlaxoSmithKline); Merck-Sharp and Dohme-Chibret; Pfizer(Pfizer); Roche(Roche Holding); Schering Plough(Merck & CompanySchering Plough Corporation); Tibotec; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Agence Nationale de Recherches sur le SIDA et les patites virales; and the National Institute of Allergy and Infectious Diseases K24 AI062476 and R01 AI058736. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; With the exception of Yazdan Yazdanpanah and Sylvie Deuffic-Burban none of the authors report any association that might pose a conflict of interest. Dr. Yazdanpanah has received travel grants, consultancy fees and honoraria for presentation at workshops from Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Glaxo-SmithKline, Merck-Sharp and Dohme-Chibret, Pfizer, Roche, Schering Plough and Tibotec. Mrs. Deuffic-Burban has received grants from Roche and Janssen-Cilag. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anglaret X, 2004, JAIDS-J ACQ IMM DEF, V35, P320, DOI 10.1097/00126334-200403010-00015; Boulle A, 2007, ANTIVIR THER, V12, P753; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Cesar C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010490; CROW EL, 1959, BIOMETRIKA, V46, P441, DOI 10.2307/2333541; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; De Beaudrap P, 2008, EUR J EPIDEMIOL, V23, P227, DOI 10.1007/s10654-007-9221-3; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Diabate S, 2007, AIDS, V21, P1799, DOI 10.1097/QAD.0b013e3282a5667b; Eholie SP, 2007, JAIDS-J ACQ IMM DEF, V45, P355; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fischer A, 2006, HIV MED, V7, P64, DOI 10.1111/j.1468-1293.2005.00338.x; GAIL MH, 1972, ANN INTERN MED, V76, P815, DOI 10.7326/0003-4819-76-5-815; GEYE A, 2007, STRAT BUILD NAT SCAL; Harries AD, 2007, B WORLD HEALTH ORGAN, V85, P152, DOI 10.2471/BLT.06.032060; Keiser O, 2007, ANTIVIR THER, V12, P1157; Laniece I, 2003, AIDS, V17, pS103, DOI 10.1097/00002030-200317003-00014; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; MARTIN W, 2008, B WORLD HEALTH ORGAN, V86, P497; Messou E, 2010, AIDS, V24, P93, DOI 10.1097/QAD.0b013e32832ec1c3; Minga A, 2007, B WORLD HEALTH ORGAN, V85, P116, DOI 10.2471/BLT.06.032292; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Scott Menard, 1995, APPL LOGISTIC REGRES; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Tuboi SH, 2005, JAIDS-J ACQ IMM DEF, V40, P324, DOI 10.1097/01.qai.0000182627.28595.01; *UNAIDS WHO, 2008, REP GLOB AIDS EP; Walgate R, 2002, B WORLD HEALTH ORGAN, V80, P259; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; World Health Organization, 2009, RAP ADV ANT THER HIV; 2003, LANCET, V361, P1799	38	88	88	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13414	10.1371/journal.pone.0013414	http://dx.doi.org/10.1371/journal.pone.0013414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976211	gold, Green Submitted, Green Published			2022-12-25	WOS:000283043700014
J	Soliman, A; Michelsen, KS; Karahashi, H; Lu, J; Meng, FJ; Qu, XW; Crother, TR; Rabizadeh, S; Chen, SA; Caplan, MS; Arditi, M; Jilling, T				Soliman, Antoine; Michelsen, Kathrin S.; Karahashi, Hisae; Lu, Jing; Meng, Fan Jing; Qu, Xiaowu; Crother, Timothy R.; Rabizadeh, Shervin; Chen, Shuang; Caplan, Michael S.; Arditi, Moshe; Jilling, Tamas			Platelet-Activating Factor Induces TLR4 Expression in Intestinal Epithelial Cells: Implication for the Pathogenesis of Necrotizing Enterocolitis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; FACTOR-KAPPA-B; ISCHEMIC BOWEL NECROSIS; VEIN ENDOTHELIAL-CELLS; FACTOR ACETYLHYDROLASE; BACTERIAL LIPOPOLYSACCHARIDE; GENE-EXPRESSION; UP-REGULATION; CUTTING EDGE; RAT MODEL	Necrotizing enterocolitis (NEC) is a leading cause of morbidity and mortality in neonatal intensive care units, however its pathogenesis is not completely understood. We have previously shown that platelet activating factor (PAF), bacteria and TLR4 are all important factors in the development of NEC. Given that Toll-like receptors (TLRs) are expressed at low levels in enterocytes of the mature gastrointestinal tract, but were shown to be aberrantly over-expressed in enterocytes in experimental NEC, we examined the regulation of TLR4 expression and signaling by PAF in intestinal epithelial cells using human and mouse in vitro cell lines, and the ex vivo rat intestinal loop model. In intestinal epithelial cell (IEC) lines, PAF stimulation yielded upregulation of both TLR4 mRNA and protein expression and led to increased IL-8 secretion following stimulation with LPS (in an otherwise LPS minimally responsive cell line). PAF stimulation resulted in increased human TLR4 promoter activation in a dose dependent manner. Western blotting and immunohistochemical analysis showed PAF induced STAT3 phosphorylation and nuclear translocation in IEC, and PAF-induced TLR4 expression was inhibited by STAT3 and NFkB Inhibitors. Our findings provide evidence for a mechanism by which PAF augments inflammation in the intestinal epithelium through abnormal TLR4 upregulation, thereby contributing to the intestinal injury of NEC.	[Soliman, Antoine; Michelsen, Kathrin S.; Karahashi, Hisae; Crother, Timothy R.; Rabizadeh, Shervin; Chen, Shuang; Arditi, Moshe] Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA; [Lu, Jing; Caplan, Michael S.; Jilling, Tamas] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Lu, Jing; Meng, Fan Jing; Qu, Xiaowu; Caplan, Michael S.; Jilling, Tamas] Evanston NW Healthcare Res Inst, Evanston, IL USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University; Feinberg School of Medicine	Soliman, A (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA.	moshe.arditi@cshs.org	Crother, Timothy R/E-2879-2010	Crother, Timothy R/0000-0001-8465-6127; Jilling, Tamas/0000-0002-6200-3851	National Institutes of Health [R01AI058128, RO1DK062960, T32 HD007549]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007549, R01HD037581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK089076, R01DK062960] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in part by National Institutes of Health R01AI058128 (MA), R01HD037581 (MSC), RO1DK062960 (TJ). AS was supported through a fellowship training grant (NIH T32 HD007549, PI Sherin U. Devaskar, University of California Los Angeles). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; ACKERMAN Z, 1990, SCAND J GASTROENTERO, V25, P925, DOI 10.3109/00365529008997614; Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Amer MD, 2004, BIOL NEONATE, V85, P159, DOI 10.1159/000075306; AUGERON C, 1984, CANCER RES, V44, P3961; BARLOW B, 1974, J PEDIATR SURG, V9, P587, DOI 10.1016/0022-3468(74)90093-1; Benveniste J, 1988, Prog Clin Biol Res, V282, P73; CAPLAN MS, 1990, GASTROENTEROLOGY, V99, P979, DOI 10.1016/0016-5085(90)90616-9; Caplan MS, 1997, PEDIATR RES, V42, P779, DOI 10.1203/00006450-199712000-00010; CAPLAN MS, 1994, CLIN PERINATOL, V21, P235, DOI 10.1016/S0095-5108(18)30343-9; Caplan MS, 1997, J PEDIATR GASTR NUTR, V24, P296, DOI 10.1097/00005176-199703000-00012; CAPLAN MS, 1990, J PEDIATR, V117, P47; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; De Plaen IG, 2000, BRIT J PHARMACOL, V129, P307, DOI 10.1038/sj.bjp.0703055; Deo DD, 2004, J BIOL CHEM, V279, P3497, DOI 10.1074/jbc.M304497200; Deo DD, 2002, J BIOL CHEM, V277, P21237, DOI 10.1074/jbc.M110955200; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; ELIAKIM R, 1988, GASTROENTEROLOGY, V95, P1167, DOI 10.1016/0016-5085(88)90346-0; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Fusunyan RD, 2001, PEDIATR RES, V49, P589, DOI 10.1203/00006450-200104000-00023; GONZALEZCRUSSI F, 1983, AM J PATHOL, V112, P127; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; HSUEH W, 1987, FASEB J, V1, P403, DOI 10.1096/fasebj.1.5.3678700; HSUEH W, 1986, AM J PATHOL, V122, P231; Ishii S, 1997, EMBO J, V16, P133, DOI 10.1093/emboj/16.1.133; Jilling T, 2004, PEDIATR RES, V55, P622, DOI 10.1203/01.PDR.0000113463.70435.74; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Kald B, 1996, DIGESTION, V57, P472, DOI 10.1159/000201376; KLIEGMAN RM, 1990, J PEDIATR S, V117, P2; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Lu J, 2004, AM J PHYSIOL-GASTR L, V286, pG340, DOI 10.1152/ajpgi.00182.2003; Lukashova V, 2001, J BIOL CHEM, V276, P24113, DOI 10.1074/jbc.M100720200; MCINTIRE FC, 1967, BIOCHEMISTRY-US, V6, P2363, DOI 10.1021/bi00860a011; Means TK, 1999, J IMMUNOL, V163, P3920; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Naik S, 2001, J PEDIATR GASTR NUTR, V32, P449, DOI 10.1097/00005176-200104000-00011; Panopoulos AD, 2002, J BIOL CHEM, V277, P19001, DOI 10.1074/jbc.M112271200; Qureshi N, 1995, Prog Clin Biol Res, V392, P151; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Seo KH, 2004, CANCER RES, V64, P6482, DOI 10.1158/0008-5472.CAN-03-2774; Seo KH, 2006, CANCER RES, V66, P4681, DOI 10.1158/0008-5472.CAN-05-3186; Stafforini DM, 1999, J CLIN INVEST, V103, P989, DOI 10.1172/JCI5574; SUN XM, 1988, J CLIN INVEST, V81, P1328, DOI 10.1172/JCI113459; Suzuki M, 2003, INFECT IMMUN, V71, P3503, DOI 10.1128/IAI.71.6.3503-3511.2003; VENABLE ME, 1993, J LIPID RES, V34, P691; Wang H, 1997, BIOCHEM J, V322, P603, DOI 10.1042/bj3220603; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; Zimmerman GA, 2002, CRIT CARE MED, V30, pS294, DOI 10.1097/00003246-200205001-00020	53	46	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e15044	10.1371/journal.pone.0015044	http://dx.doi.org/10.1371/journal.pone.0015044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976181	Green Published, gold, Green Submitted			2022-12-25	WOS:000283043700029
J	Laird, AS; Van Hoecke, A; De Muynck, L; Timmers, M; Van den Bosch, L; Van Damme, P; Robberecht, W				Laird, Angela S.; Van Hoecke, Annelies; De Muynck, Louis; Timmers, Mieke; Van den Bosch, Ludo; Van Damme, Philip; Robberecht, Wim			Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; TARDBP MUTATIONS; INCLUSIONS; DEMENTIA; ALS; FAMILY	Mislocalization, aberrant processing and aggregation of TAR DNA-binding protein 43 (TDP-43) is found in the neurons affected by two related diseases, amyotrophic lateral sclerosis (ALS) and frontotemporal lobe dementia (FTLD). These TDP-43 abnormalities are seen when TDP-43 is mutated, such as in familial ALS, but also in FTLD, caused by null mutations in the progranulin gene. They are also found in many patients with sporadic ALS and FTLD, conditions in which only wild type TDP-43 is present. The common pathological hallmarks and symptomatic cross over between the two diseases suggest that TDP-43 and progranulin may be mechanistically linked. In this study we aimed to address this link by establishing whether overexpression of mutant TDP-43 or knock-down of progranulin in zebrafish embryos results in motor neuron phenotypes and whether human progranulin is neuroprotective against such phenotypes. Mutant TDP-43 (A315T mutation) induced a motor axonopathy characterized by short axonal outgrowth and aberrant branching, similar, but more severe, than that induced by mutant SOD1. Knockdown of the two zebrafish progranulin genes, grna and grnb, produced a substantial decrease in axonal length, with knockdown of grna alone producing a greater decrease in axonal length than grnb. Progranulin overexpression rescued the axonopathy induced by progranulin knockdown. Interestingly, progranulin also rescued the mutant TDP-43 induced axonopathy, whilst it failed to affect the mutant SOD1-induced phenotype. TDP-43 was found to be nuclear in all conditions described. The findings described here demonstrate that progranulin is neuroprotective in vivo and may have therapeutic potential for at least some forms of motor neuron degeneration.	[Laird, Angela S.; Van Hoecke, Annelies; De Muynck, Louis; Timmers, Mieke; Van den Bosch, Ludo; Van Damme, Philip; Robberecht, Wim] Katholieke Univ Leuven, Neurobiol Lab, Dept Expt Neurol, Leuven, Belgium; [Van Damme, Philip; Robberecht, Wim] Katholieke Univ Leuven, Dept Neurol, Leuven, Belgium; [Laird, Angela S.; Van Hoecke, Annelies; De Muynck, Louis; Timmers, Mieke; Van den Bosch, Ludo; Van Damme, Philip; Robberecht, Wim] VIB, Vesalius Res Ctr, Leuven, Belgium	KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB)	Laird, AS (corresponding author), Katholieke Univ Leuven, Neurobiol Lab, Dept Expt Neurol, Leuven, Belgium.	wim.robberecht@uz.kuleuven.be	Van Damme, Philip/A-6464-2009; Van Den Bosch, Ludo/B-7258-2012	Van Damme, Philip/0000-0002-4010-2357; De Muynck, Louis/0000-0003-4432-945X; Van Den Bosch, Ludo/0000-0003-0104-4067; Laird, Angela/0000-0002-6860-9192	K.U. Leuven; E von Behring Chair for Neuromuscular and Neurodegenerative Disorders; Fund of Scientific Research, Flanders (FWO-V); Stichting Alzheimer Onderzoek-Belgium (SAO-FRMA) [08615]; Institute for Science and Technology, Flanders (IWT-V); Belgian Federal Science Policy Office [P6/43]	K.U. Leuven(KU Leuven); E von Behring Chair for Neuromuscular and Neurodegenerative Disorders; Fund of Scientific Research, Flanders (FWO-V)(FWO); Stichting Alzheimer Onderzoek-Belgium (SAO-FRMA); Institute for Science and Technology, Flanders (IWT-V); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office)	This study was supported by grants from the K.U. Leuven. WR is supported through the E von Behring Chair for Neuromuscular and Neurodegenerative Disorders and by the Interuniversity Attraction Pole program P6/43 of the Belgian Federal Science Policy Office. PVD holds a clinical investigatorship from the Fund of Scientific Research, Flanders (FWO-V) and is supported by 'Stichting Alzheimer Onderzoek-Belgium' (SAO-FRMA #08615). AVH and LDM hold PhD grants from the Institute for Science and Technology, Flanders (IWT-V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Benussi L, 2009, NEUROBIOL DIS, V33, P379, DOI 10.1016/j.nbd.2008.11.008; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Krishnan J, 2006, EXP NEUROL, V200, P301, DOI 10.1016/j.expneurol.2006.02.135; Lemmens R, 2009, J NEUROL NEUROSUR PS, V80, P354, DOI 10.1136/jnnp.2008.157677; Lemmens R, 2007, HUM MOL GENET, V16, P2359, DOI 10.1093/hmg/ddm193; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Lomen-Hoerth C, 2004, DEMENT GERIATR COGN, V17, P337, DOI 10.1159/000077167; Luquin N, 2009, NEUROMUSCULAR DISORD, V19, P696, DOI 10.1016/j.nmd.2009.07.005; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mackenzie IRA, 2005, J NEUROPATH EXP NEUR, V64, P730, DOI 10.1097/01.jnen.0000174335.27708.0a; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V118, P605, DOI 10.1007/s00401-009-0581-5; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Suzuki M, 2009, J REPROD DEVELOP, V55, P351, DOI 10.1262/jrd.20249; Tan CF, 2007, ACTA NEUROPATHOL, V113, P535, DOI 10.1007/s00401-007-0206-9; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107	33	104	116	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13368	10.1371/journal.pone.0013368	http://dx.doi.org/10.1371/journal.pone.0013368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967127	Green Published, Green Submitted, gold			2022-12-25	WOS:000282869800043
J	Bauer, CMT; Zavitz, CCJ; Botelho, FM; Lambert, KN; Brown, EG; Mossman, KL; Taylor, JD; Stampfli, MR				Bauer, Carla M. T.; Zavitz, Caleb C. J.; Botelho, Fernando M.; Lambert, Kristen N.; Brown, Earl G.; Mossman, Karen L.; Taylor, John D.; Staempfli, Martin R.			Treating Viral Exacerbations of Chronic Obstructive Pulmonary Disease: Insights from a Mouse Model of Cigarette Smoke and H1N1 Influenza Infection	PLOS ONE			English	Article							COPD EXACERBATIONS; DENDRITIC CELLS; LUNG-DISEASE; VIRUS; MICE; AIRWAY; INFLAMMATION; IMMUNE; VACCINATION; RECEPTORS	Background: Chronic obstructive pulmonary disease is a progressive lung disease that is punctuated by periods of exacerbations (worsening of symptoms) that are attributable to viral infections. While rhinoviruses are most commonly isolated viruses during episodes of exacerbation, influenza viruses have the potential to become even more problematic with the increased likelihood of an epidemic. Methodology and Principal Findings: This study examined the impact of current and potential pharmacological targets namely the systemic corticosteroid dexamethasone and the peroxisome proliferator-activated receptor- gamma agonist pioglitazone on the outcome of infection in smoke-exposed mice. C57BL/6 mice were exposed to room air or cigarette smoke for 4 days and subsequently inoculated with an H1N1 influenza A virus. Interventions were delivered daily during the course of infection. We show that smoke-exposed mice have an exacerbated inflammatory response following infection. While smoke exposure did not compromise viral clearance, precision cut lung slices from smoke-exposed mice showed greater expression of CC (MCP-1, -3), and CXC (KC, MIP-2, GCP-2) chemokines compared to controls when stimulated with a viral mimic or influenza A virus. While dexamethasone treatment partially attenuated the inflammatory response in the broncho-alveolar lavage of smoke-exposed, virally-infected animals, viral-induced neutrophilia was steroid insensitive. In contrast to controls, dexamethasone-treated smoke-exposed influenza-infected mice had a worsened health status. Pioglitazone treatment of virally-infected smoke-exposed mice proved more efficacious than the steroid intervention. Further mechanistic evaluation revealed that a deficiency in CCR2 did not improve the inflammatory outcome in smoke-exposed, virally-infected animals. Conclusions and Significance: This animal model of cigarette smoke and H1N1 influenza infection demonstrates that smoke-exposed animals are differentially primed to respond to viral insult. While providing a platform to test pharmacological interventions, this model demonstrates that treating viral exacerbations with alternative anti-inflammatory drugs, such as PPAR-gamma agonists should be further explored since they showed greater efficacy than systemic corticosteroids.	[Bauer, Carla M. T.] McMaster Univ, Med Sci Grad Program, Hamilton, ON, Canada; [Zavitz, Caleb C. J.; Botelho, Fernando M.; Mossman, Karen L.; Staempfli, Martin R.] McMaster Univ, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON, Canada; [Lambert, Kristen N.] McMaster Univ, Mol Biol Undergrad Program, Hamilton, ON, Canada; [Brown, Earl G.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Mossman, Karen L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Taylor, John D.] AstraZeneca R&D, Lund, Sweden; [Staempfli, Martin R.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; University of Ottawa; McMaster University; AstraZeneca; McMaster University	Bauer, CMT (corresponding author), McMaster Univ, Med Sci Grad Program, Hamilton, ON, Canada.	stampfli@mcmaster.ca	Zavitz, Caleb CJ/D-4659-2009	Zavitz, Caleb CJ/0000-0002-1097-041X; Stampfli, Martin/0000-0003-4918-5889	Canadian Institutes of Health Research; AstraZeneca, Sweden; Canadian Thoracic Society; RxD/CIHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca, Sweden(AstraZeneca); Canadian Thoracic Society; RxD/CIHR(Canadian Institutes of Health Research (CIHR))	The work described herein was in-part funded by the Canadian Institutes of Health Research, and AstraZeneca, Sweden. CMTB holds a Canadian Thoracic Society Studentship, MRS holds a CIHR New Investigator Award, and KLM holds an Rx&D/CIHR Health Sciences Career Award. JDT at AstraZeneca participated in study design and preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bauer CM, 2010, AM J RESP CRIT CARE, V181; Bauer CM, 2010, AM J RESP CRIT CARE, V181; BAUER CM, 2009, EUR RESPIR J, V34, pA178; Belvisi MG, 2008, CHEST, V134, P152, DOI 10.1378/chest.08-0019; Belvisi MG, 2009, BRIT J PHARMACOL, V158, P994, DOI 10.1111/j.1476-5381.2009.00373.x; Bergner A, 2002, J GEN PHYSIOL, V119, P187, DOI 10.1085/jgp.119.2.187; Birrell MA, 2004, EUR RESPIR J, V24, P18, DOI 10.1183/09031936.04.00098303; Botelho FM, 2010, AM J RESP CELL MOL, V42, P394, DOI 10.1165/rcmb.2008-0301OC; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Caschler GJ, 2008, AM J RESP CELL MOL, V38, P218, DOI 10.1165/rcmb.2007-0053OC; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Gaschler GJ, 2009, AM J RESP CRIT CARE, V179, P666, DOI 10.1164/rccm.200808-1306OC; Gold PM, 2009, RESP CARE, V54, P1040; Gorse GJ, 2006, CHEST, V130, P1109, DOI 10.1378/chest.130.4.1109; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Hansel TT, 2009, LANCET, V374, P744, DOI 10.1016/S0140-6736(09)61342-8; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Khan MA, 2007, EUR RESPIR J, V30, P691, DOI 10.1183/09031936.00025907; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu D, 2005, CRIT CARE MED, V33, P2309, DOI 10.1097/01.CCM.0000183161.81503.7D; Mallia Patrick, 2005, Proc Am Thorac Soc, V2, P361, DOI 10.1513/pats.200504-025SR; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Niewoehner DE, 2006, AM J MED, V119, pS38, DOI 10.1016/j.amjmed.2006.08.006; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Robbins CS, 2006, AM J RESP CRIT CARE, V174, P1342, DOI 10.1164/rccm.200604-561OC; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Roque R, 2006, IMMUNOPHARM IMMUNOT, V28, P13, DOI 10.1080/08923970600623541; Shah P, 2010, EXPERT OPIN DRUG SAF, V9, P347, DOI 10.1517/14740331003623218; Sharma R, 2009, PULM PHARMACOL THER, V22, P183, DOI 10.1016/j.pupt.2008.11.011; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Tashkin Donald P, 2010, Int J Chron Obstruct Pulmon Dis, V5, P41; Vlahos R, 2006, PULM PHARMACOL THER, V19, P12, DOI 10.1016/j.pupt.2005.02.006; Wedzicha JA, 2001, AM J RESP CRIT CARE, V164, P1757, DOI 10.1164/ajrccm.164.10.2108049a; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wesseling Geertjan, 2007, Int J Chron Obstruct Pulmon Dis, V2, P5, DOI 10.2147/copd.2007.2.1.5; WILT T, 2005, AHRQ EVIDENCE REPORT; Wongsurakiat P, 2004, CHEST, V125, P2011, DOI 10.1378/chest.125.6.2011; Wright JL, 2002, CHEST, V122, p301S, DOI 10.1378/chest.122.6_suppl.301S; Xu T, 2009, EUR RESPIR J, V33, P852, DOI 10.1183/09031936.00130507	43	69	70	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13251	10.1371/journal.pone.0013251	http://dx.doi.org/10.1371/journal.pone.0013251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967263	gold, Green Published, Green Submitted			2022-12-25	WOS:000282807300007
J	Schmid, A; Gianella, S; von Wyl, V; Metzner, KJ; Scherrer, AU; Niederost, B; Althaus, CF; Rieder, P; Grube, C; Joos, B; Weber, R; Fischer, M; Gunthard, HF				Schmid, Adrian; Gianella, Sara; von Wyl, Viktor; Metzner, Karin J.; Scherrer, Alexandra U.; Niederost, Barbara; Althaus, Claudia F.; Rieder, Philip; Grube, Christina; Joos, Beda; Weber, Rainer; Fischer, Marek; Gunthard, Huldrych F.			Profound Depletion of HIV-1 Transcription in Patients Initiating Antiretroviral Therapy during Acute Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD MONONUCLEAR-CELLS; STRUCTURED TREATMENT INTERRUPTIONS; CD4(+) T-LYMPHOCYTES; PERIPHERAL-BLOOD; GENE-EXPRESSION; PLASMA VIREMIA; VIRAL REPLICATION; IMMUNE-RESPONSES; IN-VIVO	Background: Although combination antiretroviral therapy (cART) initiated in the acute phase of HIV-1 infection may prevent expansion of the latent reservoir, its benefits remain controversial. In the current study, HIV-1 RNA transcription patterns in peripheral blood mononuclear cells (PBMC) were monitored during acute cART to assess the effect of early treatment on cellular viral reservoirs. Methodology/Principal Findings: Acutely HIV-1 infected patients (n = 24) were treated within 3-15 weeks after infection. Patients elected to cease treatment after >= 1 year of therapy. HIV-1 DNA (vDNA), HIV-1 RNA species expressed both in latently and productively infected cells, unspliced (UsRNA), multiply spliced (MsRNA-tatrev; MsRNA-nef), and PBMC-associated extracellular virion RNA (vRex), expressed specifically by productively infected cells, were quantified in PBMC by patient matched real-time PCR prior, during and post cART. In a matched control-group of patients on successful cART started during chronic infection (n = 15), UsRNA in PBMC and vDNA were measured cross-sectionally. In contrast to previous reports, PBMC-associated HIV-1 RNAs declined to predominantly undetectable levels on cART. After cART cessation, UsRNA, vRex, and MsRNA-tatrev rebounded to levels not significantly different to those at baseline (p>0.1). In contrast, MsRNA-nef remained significantly lower as compared to pretreatment (p = 0.015). UsRNA expressed at the highest levels of all viral RNAs, was detectable on cART in 42% of patients with cART initiated during acute infection as opposed to 87% of patients on cART initiated during chronic infection (Fisher's exact test; p = 0.008). Accordingly, UsRNA levels were 105-fold lower in the acute as compared to the chronic group. Conclusion: Early intervention resulted in profound depletion of PBMC expressing HIV-1 RNA. This is contrary to chronically infected patients who predominantly showed continuous UsRNA expression on cART. Thus, antiretroviral treatment initiated during the acute phase of infection prevented establishment or expansion of long-lived transcriptionally active viral cellular reservoirs in peripheral blood.	[Schmid, Adrian; Gianella, Sara; von Wyl, Viktor; Metzner, Karin J.; Scherrer, Alexandra U.; Niederost, Barbara; Althaus, Claudia F.; Rieder, Philip; Grube, Christina; Joos, Beda; Weber, Rainer; Fischer, Marek; Gunthard, Huldrych F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Schmid, A (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	marek.fischer@usz.ch; huldrych.guenthard@usz.ch	Weber, Rainer/D-5175-2012; gunthard, huldrych f/F-1724-2011; Metzner, Karin J/G-5319-2011; Joos, Beda/D-5547-2009	gunthard, huldrych f/0000-0002-1142-6723; Metzner, Karin J/0000-0003-4862-1503; Joos, Beda/0000-0002-3082-8875; von Wyl, Viktor/0000-0002-8754-9797; Gianella, Sara/0000-0002-9927-0849	Swiss National Science Foundation [324730-116035, -130865, 3100A0-112670]; Stiftung fur Wissenschaftliche Forschung an der Universitat Zurich; Olga-Mayenfisch Stiftung; Hartmann-Muller Stiftung; Klaus Hermann Stiftung; Jubilaumsstiftung Swiss Life; Novartis Foundation; Ciba-Geigy Jubilee Foundation; Abbott, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stiftung fur Wissenschaftliche Forschung an der Universitat Zurich; Olga-Mayenfisch Stiftung; Hartmann-Muller Stiftung; Klaus Hermann Stiftung; Jubilaumsstiftung Swiss Life; Novartis Foundation(Novartis); Ciba-Geigy Jubilee Foundation; Abbott, Switzerland(Abbott Laboratories)	This work was supported by the Swiss National Science Foundation (grant # 324730-116035 and -130865 to HFG, grant # 3100A0-112670 to MF and HFG), by grants from the Stiftung fur Wissenschaftliche Forschung an der Universitat Zurich, Olga-Mayenfisch Stiftung, Hartmann-Muller Stiftung, Klaus Hermann Stiftung, and the Jubilaumsstiftung Swiss Life to MF; a fellowship of the Novartis Foundation, formerly Ciba-Geigy Jubilee Foundation to VVW. The SHCS drug resistance database is supported by the SHCS research foundation. The Zurich HIV Transcription study was supported by an unrestricted research grant from Abbott, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Althaus CF, 2010, J VIROL METHODS, V165, P151, DOI 10.1016/j.jviromet.2010.01.012; Anton PA, 2003, AIDS, V17, P53, DOI 10.1097/00002030-200301030-00008; Barber SA, 2006, J INFECT DIS, V193, P963, DOI 10.1086/500983; Christopherson C, 2000, J CLIN MICROBIOL, V38, P630, DOI 10.1128/JCM.38.2.630-634.2000; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Clerc O, 2010, J CLIN VIROL, V47, P376, DOI 10.1016/j.jcv.2010.01.013; COHN ML, 1959, J CLIN INVEST, V38, P1349, DOI 10.1172/JCI103910; Craigo JK, 2004, AIDS RES HUM RETROV, V20, P1196, DOI 10.1089/aid.2004.20.1196; Dahl V, 2010, ANTIVIR RES, V85, P286, DOI 10.1016/j.antiviral.2009.09.016; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Delwart E, 2002, AIDS, V16, P189, DOI 10.1097/00002030-200201250-00007; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Ehrlich P, 1913, LANCET, V2, P445; Elzi L, 2010, ARCH INTERN MED, V170, P57, DOI 10.1001/archinternmed.2009.432; Fagard C, 2003, ARCH INTERN MED, V163, P1220, DOI 10.1001/archinte.163.10.1220; Farnham PG, 2010, APPL HEALTH ECON HEA, V8, P75, DOI 10.2165/11531890-000000000-00000; Feinberg MB, 1996, LANCET, V348, P239, DOI 10.1016/S0140-6736(96)06231-9; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fischer M, 2000, AIDS RES HUM RETROV, V16, P1135, DOI 10.1089/088922200414974; Fischer M, 2004, J INFECT DIS, V190, P1979, DOI 10.1086/425983; Fischer M, 2004, J INFECT DIS, V189, P273, DOI 10.1086/380797; Fischer M, 2003, AIDS, V17, P195, DOI 10.1097/00002030-200301240-00009; Fischer M, 2002, ANTIVIR THER, V7, P91; Fischer M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-107; Fomsgaard A, 2008, AIDS RES HUM RETROV, V24, P463, DOI 10.1089/aid.2006.0294; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; GalettoLacour A, 1996, J INFECT DIS, V173, P1388, DOI 10.1093/infdis/173.6.1388; George MD, 2005, J VIROL, V79, P2709, DOI 10.1128/JVI.79.5.2709-2719.2005; Grossman Z, 1999, NAT MED, V5, P1099, DOI 10.1038/13410; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gunthard HF, 2000, J INFECT DIS, V181, P522, DOI 10.1086/315260; Gunthard HF, 2001, J INFECT DIS, V183, P1318, DOI 10.1086/319864; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Huber M, 2006, PLOS MED, V3, P2078, DOI 10.1371/journal.pmed.0030441; Joos B, 2005, J VIROL, V79, P9026, DOI 10.1128/JVI.79.14.9026-9037.2005; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; Kaiser P, 2007, J VIROL, V81, P9693, DOI 10.1128/JVI.00492-07; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lassen KG, 2004, J VIROL, V78, P9105, DOI 10.1128/JVI.78.17.9105-9114.2004; Lisziewicz J, 1999, NEW ENGL J MED, V340, P1683, DOI 10.1056/NEJM199905273402114; Lowy A, 2005, AIDS CARE, V17, P698, DOI 10.1080/09540120412331336689; Markowitz M, 1999, J INFECT DIS, V179, P527, DOI 10.1086/314628; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Michael NL, 1999, J CLIN MICROBIOL, V37, P2557, DOI 10.1128/JCM.37.8.2557-2563.1999; Nguyen A, 2008, HIV MED, V9, P142, DOI 10.1111/j.1468-1293.2007.00537.x; Opravil M, 2000, J ACQ IMMUN DEF SYND, V23, P17; Otero M, 2003, AIDS RES HUM RETROV, V19, P1097, DOI 10.1089/088922203771881194; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pasternak AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008490; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; RIEDER P, 2010, AIDS; Roscic-Mrkic B, 2003, BLOOD, V102, P1169, DOI 10.1182/blood-2003-02-0488; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Stebbing J, 2004, NEW ENGL J MED, V350, P1872, DOI 10.1056/NEJMra032395; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Streeck H, 2008, J EXP MED, V205, P1789, DOI 10.1084/jem.20080281; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; VONWY, 2007, ARCH INTERN MED, V167, P1782; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Yang OO, 2005, J VIROL, V79, P860, DOI 10.1128/JVI.79.2.860-868.2005; YUKL SGS, 2010, J INFECT DI IN PRESS; Zhang LQ, 2000, J CLIN INVEST, V106, P839, DOI 10.1172/JCI10565	73	75	76	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13310	10.1371/journal.pone.0013310	http://dx.doi.org/10.1371/journal.pone.0013310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967271	gold, Green Published, Green Submitted			2022-12-25	WOS:000282807300021
J	Stierl, M; Stumpf, P; Udwari, D; Gueta, R; Hagedorn, R; Losi, A; Gartner, W; Petereit, L; Efetova, M; Schwarzel, M; Oertner, TG; Nagel, G; Hegemann, P				Stierl, Manuela; Stumpf, Patrick; Udwari, Daniel; Gueta, Ronnie; Hagedorn, Rolf; Losi, Aba; Gaertner, Wolfgang; Petereit, Linda; Efetova, Marina; Schwarzel, Martin; Oertner, Thomas G.; Nagel, Georg; Hegemann, Peter			Light Modulation of Cellular cAMP by a Small Bacterial Photoactivated Adenylyl Cyclase, bPAC, of the Soil Bacterium Beggiatoa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUGLENA-GRACILIS; NEURAL CIRCUITS; IN-VIVO; MAT; PHOTORECEPTOR; TRANSDUCTION; PHOTOTROPIN; ACTIVATION; MECHANISM; BINDING	The recent success of channelrhodopsin in optogenetics has also caused increasing interest in enzymes that are directly activated by light. We have identified in the genome of the bacterium Beggiatoa a DNA sequence encoding an adenylyl cyclase directly linked to a BLUF (blue light receptor using FAD) type light sensor domain. In Escherichia coli and Xenopus oocytes, this photoactivated adenylyl cyclase (bPAC) showed cyclase activity that is low in darkness but increased 300-fold in the light. This enzymatic activity decays thermally within 20 s in parallel with the red-shifted BLUF photointermediate. bPAC is well expressed in pyramidal neurons and, in combination with cyclic nucleotide gated channels, causes efficient light-induced depolarization. In the Drosophila central nervous system, bPAC mediates light-dependent cAMP increase and behavioral changes in freely moving animals. bPAC seems a perfect optogenetic tool for light modulation of cAMP in neuronal cells and tissues and for studying cAMP-dependent processes in live animals.	[Stierl, Manuela; Hagedorn, Rolf; Hegemann, Peter] Humboldt Univ, D-10115 Berlin, Germany; [Stumpf, Patrick; Gueta, Ronnie; Nagel, Georg] Univ Wurzburg, Dept Bot 1, D-97082 Wurzburg, Germany; [Udwari, Daniel; Oertner, Thomas G.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Losi, Aba] Univ Parma, Dept Phys, I-43121 Parma, Italy; [Gaertner, Wolfgang] Max Planck Inst Bioinorgan Chem, D-45410 Mulheim, Germany; [Petereit, Linda; Efetova, Marina; Schwarzel, Martin] Free Univ Berlin, Dept Biol, D-14195 Berlin, Germany	Humboldt University of Berlin; University of Wurzburg; Friedrich Miescher Institute for Biomedical Research; University of Parma; Max Planck Society; Free University of Berlin	Hegemann, P (corresponding author), Humboldt Univ, Invalidenstr 42, D-10115 Berlin, Germany.	Hegemann@rz.hu-berlin.de	Oertner, Thomas/F-2214-2010; Losi, Aba/M-8709-2015; Stumpf, Patrick/AAK-1895-2020	Oertner, Thomas/0000-0002-2312-7528; Losi, Aba/0000-0003-0497-2723; Stumpf, Patrick/0000-0003-0862-0290; Nagel, Georg/0000-0001-8174-8712; Gartner, Wolfgang/0000-0002-6898-7011	National Institutes of Health [RO1-MH-086415-01]; Deutsche Forschungsgemeinschaft [FOR526/1279]; Cluster of Excellence Unifying Concepts in Catalysis [SFB 567, SCHW1410/1-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence Unifying Concepts in Catalysis(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-MH-086415-01 (to M. S.). This work was also supported by Deutsche Forschungsgemeinschaft Grants FOR526/1279 and the Cluster of Excellence Unifying Concepts in Catalysis (to P. H.), Grant SFB 567 (to G. N.), and Grant SCHW1410/1-1 (to M. S.).	Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bonetti C, 2009, BIOCHEMISTRY-US, V48, P11458, DOI 10.1021/bi901196x; Chen CF, 1997, J NEUROSCI, V17, P8687; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Dunn TA, 2008, DEV NEUROBIOL, V68, P835, DOI 10.1002/dneu.20619; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Gorostiza P, 2008, SCIENCE, V322, P395, DOI 10.1126/science.1166022; Hinck S, 2007, APPL ENVIRON MICROB, V73, P7013, DOI 10.1128/AEM.00548-07; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Looser J, 2009, BIOL CHEM, V390, P1105, DOI 10.1515/BC.2009.132; Makhinson M, 1999, J NEUROSCI, V19, P2500; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Matsuoka D, 2005, P NATL ACAD SCI USA, V102, P13337, DOI 10.1073/pnas.0506402102; Miller G, 2006, SCIENCE, V314, P1674, DOI 10.1126/science.314.5806.1674; Mills HJ, 2004, APPL ENVIRON MICROB, V70, P5447, DOI 10.1128/AEM.70.9.5447-5458.2004; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; MOLLER MM, 1985, APPL ENVIRON MICROB, V50, P373; Ntefidou M, 2003, PLANT PHYSIOL, V133, P1517, DOI 10.1104/pp.103.034223; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Schoenenberger P, 2011, EXP PHYSIOL, V96, P34, DOI 10.1113/expphysiol.2009.051219; Schoenenberger P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008185; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Weinreich F, 1997, PFLUG ARCH EUR J PHY, V434, P484, DOI 10.1007/s004240050424; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120	33	250	258	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1181	1188		10.1074/jbc.M110.185496	http://dx.doi.org/10.1074/jbc.M110.185496			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21030594	hybrid, Green Published			2022-12-25	WOS:000286005000029
J	Brameshuber, M; Weghuber, J; Ruprecht, V; Gombos, I; Horvath, I; Vigh, L; Eckerstorfer, P; Kiss, E; Stockinger, H; Schutz, GJ				Brameshuber, Mario; Weghuber, Julian; Ruprecht, Verena; Gombos, Imre; Horvath, Ibolya; Vigh, Laszlo; Eckerstorfer, Paul; Kiss, Endre; Stockinger, Hannes; Schuetz, Gerhard J.			Imaging of Mobile Long-lived Nanoplatforms in the Live Cell Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; HEAT-SHOCK RESPONSE; LIPID RAFTS; DETERGENT RESISTANCE; LATERAL MOBILITY; CHOLESTEROL; MOLECULES; SURFACE; ACTIN; ORGANIZATION	The plasma membrane has been hypothesized to contain nanoscopic lipid platforms, which are discussed in the context of "lipid rafts" or "membrane rafts." Based on biochemical and cell biological studies, rafts are believed to play a crucial role in many signaling processes. However, there is currently not much information on their size, shape, stability, surface density, composition, and heterogeneity. We present here a method that allows for the first time the direct imaging of nanoscopic long-lived platforms with raft-like properties diffusing in the live cell plasma membrane. Our method senses these platforms by their property to assemble a characteristic set of fluorescent marker proteins or lipids on a time scale of seconds. A special photobleaching protocol was used to reduce the surface density of labeled mobile platforms down to the level of well isolated diffraction-limited spots without altering the single spot brightness. The statistical distribution of probe molecules per platform was determined by single molecule brightness analysis. For demonstration, we used the consensus raft marker glycosylphosphatidylinositol-anchored monomeric GFP and the fluorescent lipid analog BODIPY-G(M1), which preferentially partitions into liquid-ordered phases. For both markers, we found cholesterol-dependent homo-association in the plasma membrane of living CHO and Jurkat T cells in the resting state, thereby demonstrating the existence of small, mobile, long-lived platforms containing these probes. We further applied the technology to address structural changes in the plasma membrane during fever-type heat shock: at elevated temperatures, the glycosylphosphatidylinositol- anchored monomeric GFP homo-association disappeared, accompanied by an increase in the expression of the small heat shock protein Hsp27.	[Schuetz, Gerhard J.] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Gombos, Imre; Horvath, Ibolya; Vigh, Laszlo] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Eckerstorfer, Paul; Kiss, Endre; Stockinger, Hannes] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Mol Immunol, A-1090 Vienna, Austria	Johannes Kepler University Linz; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Medical University of Vienna	Schutz, GJ (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	gerhard.schuetz@jku.at	Stockinger, Hannes/E-5173-2011; Schuetz, Gerhard/B-1243-2008; Ruprecht, Verena/H-7563-2017	Stockinger, Hannes/0000-0001-6404-4430; Schuetz, Gerhard/0000-0003-1542-1089; Ruprecht, Verena/0000-0003-4088-8633; Weghuber, Julian/0000-0001-6312-4666; Brameshuber, Mario/0000-0001-8672-2255	Austrian Science Fund [Y250-B03, I301-B12]; Austrian Federal Ministry for Science and Research; European Union [HEALTH-F4-2008-202272]; Hungarian National Scientific Research Foundation [NK 68379, NN 76716]; Austrian Science Fund (FWF) [Y 250, I 300, I 301] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Federal Ministry for Science and Research; European Union(European Commission); Hungarian National Scientific Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Projects Y250-B03 and I301-B12, the GEN-AU Project of the Austrian Federal Ministry for Science and Research and the European Union Project LipidomicNet (HEALTH-F4-2008-202272), and Hungarian National Scientific Research Foundation Grants NK 68379 and NN 76716.	BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Giocondi MC, 2007, J MOL RECOGNIT, V20, P531, DOI 10.1002/jmr.835; Gombos I, 2004, CYTOM PART A, V61A, P117, DOI 10.1002/cyto.a.20080; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Harder T, 2007, CURR OPIN IMMUNOL, V19, P470, DOI 10.1016/j.coi.2007.05.002; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Krishnan J, 2006, EXP NEUROL, V200, P301, DOI 10.1016/j.expneurol.2006.02.135; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lebreton S, 2008, J BIOL CHEM, V283, P29545, DOI 10.1074/jbc.M803819200; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Metzner C, 2008, FASEB J, V22, P2734, DOI 10.1096/fj.08-108217; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Muhammad A, 2009, J IMMUNOL, V182, P7672, DOI 10.4049/jimmunol.0800691; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nagy E, 2007, P NATL ACAD SCI USA, V104, P7945, DOI 10.1073/pnas.0702557104; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Ruprecht V, 2010, SOFT MATTER, V6, P568, DOI 10.1039/b916734j; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Saidi Y, 2009, PLANT CELL, V21, P2829, DOI 10.1105/tpc.108.065318; Schmidt T, 1996, ANAL CHEM, V68, P4397, DOI 10.1021/ac960710g; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Sengupta P, 2008, BBA-BIOMEMBRANES, V1778, P20, DOI 10.1016/j.bbamem.2007.08.028; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Vigh L, 2005, PROG LIPID RES, V44, P303, DOI 10.1016/j.plipres.2005.08.001; von Haller PD, 2001, PROTEOMICS, V1, P1010; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026	48	88	89	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41765	41771		10.1074/jbc.M110.182121	http://dx.doi.org/10.1074/jbc.M110.182121			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20966075	Green Published, hybrid			2022-12-25	WOS:000285622600064
J	Madl, J; Weghuber, J; Fritsch, R; Derler, I; Fahrner, M; Frischauf, I; Lackner, B; Romanin, C; Schutz, GJ				Madl, Josef; Weghuber, Julian; Fritsch, Reinhard; Derler, Isabella; Fahrner, Marc; Frischauf, Irene; Lackner, Barbara; Romanin, Christoph; Schuetz, Gerhard J.			Resting State Orai1 Diffuses as Homotetramer in the Plasma Membrane of Live Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ STORE DEPLETION; ACTIVATES CRAC CHANNELS; CALCIUM-CHANNEL; LIVING CELLS; SINGLE; STOICHIOMETRY; PROTEINS; STIM1; MOLECULES; SUBUNIT	Store-operated calcium entry is essential for many signaling processes in nonexcitable cells. The best studied store-operated calcium current is the calcium release-activated calcium (CRAC) current in T-cells and mast cells, with Orai1 representing the essential pore forming subunit. Although it is known that functional CRAC channels in store-depleted cells are composed of four Orai1 subunits, the stoichiometric composition in quiescent cells is still discussed controversially: both a tetrameric and a dimeric stoichiometry of resting state Orai1 have been reported. We obtained here robust and similar FRET values on labeled tandem repeat constructs of Orai1 before and after store depletion, suggesting an unchanged tetrameric stoichiometry. Moreover, we directly visualized the stoichiometry of mobile Orai1 channels in live cells using a new single molecule recording modality that combines single molecule tracking and brightness analysis. By alternating imaging and photobleaching pulses, we recorded trajectories of single, fluorescently labeled Orai1 channels, with each trajectory consisting of bright and dim segments, corresponding to higher and lower numbers of colocalized active GFP label. The according brightness values were used for global fitting and statistical analysis, yielding a tetrameric subunit composition of mobile Orai1 channels in resting cells.	[Madl, Josef; Weghuber, Julian; Fritsch, Reinhard; Derler, Isabella; Fahrner, Marc; Frischauf, Irene; Lackner, Barbara; Romanin, Christoph; Schuetz, Gerhard J.] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria	Johannes Kepler University Linz	Schutz, GJ (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	gerhard.schuetz@jku.at	Schuetz, Gerhard/B-1243-2008; Fahrner, Marc/AAI-7927-2021; Romanin, Christoph/D-5399-2009; Frischauf, Irene/AAG-2007-2019; Derler, Isabella/B-7871-2019	Schuetz, Gerhard/0000-0003-1542-1089; Romanin, Christoph/0000-0003-3756-4136; Frischauf, Irene/0000-0003-0661-2932; Derler, Isabella/0000-0002-4768-146X; Weghuber, Julian/0000-0001-6312-4666; Fahrner, Marc/0000-0002-2689-0158	Austrian Science Fund [W1201, Y250-B3, P2118, T466-B09]; Austrian Research Promotion Agency; Austrian Academy of Sciences; Austrian Science Fund (FWF) [Y 250] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Research Promotion Agency; Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (Ph.D. Program W1201 "Molecular Bioanalytics" and project Y250-B3 to G. J. S.; Project P2118 to C. R.: and Hertha Firnberg T466-B09 to I. D.) and the GEN-AU project of the Austrian Research Promotion Agency.; Recipient of a DOC-forte scholarship of the Austrian Academy of Sciences.	Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Garcia-Parajo MF, 2000, P NATL ACAD SCI USA, V97, P7237, DOI 10.1073/pnas.97.13.7237; Goulian M, 2000, BIOPHYS J, V79, P2188, DOI 10.1016/S0006-3495(00)76467-8; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hesse J, 2004, ANAL CHEM, V76, P5960, DOI 10.1021/ac049300f; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Maruyama Y, 2009, J BIOL CHEM, V284, P13676, DOI 10.1074/jbc.M900812200; Mashanov GI, 2010, J BIOL CHEM, V285, P3664, DOI 10.1074/jbc.M109.039974; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Mignen O, 2009, J PHYSIOL-LONDON, V587, P4181, DOI 10.1113/jphysiol.2009.174193; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Ruprecht V, 2010, SOFT MATTER, V6, P568, DOI 10.1039/b916734j; Schmidt T, 1996, ANAL CHEM, V68, P4397, DOI 10.1021/ac960710g; Schwarzenbacher M, 2008, NAT METHODS, V5, P1053, DOI 10.1038/nmeth.1268; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Wieser S, 2008, BIOPHYS J, V95, P5988, DOI 10.1529/biophysj.108.141655; Woodard GE, 2008, AM J PHYSIOL-CELL PH, V294, pC1323, DOI 10.1152/ajpcell.00071.2008; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	37	78	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41135	41142		10.1074/jbc.M110.177881	http://dx.doi.org/10.1074/jbc.M110.177881			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20961852	hybrid, Green Published			2022-12-25	WOS:000285414400075
J	Lynch, CJ; Shah, ZH; Allison, SJ; Ahmed, SU; Ford, J; Warnock, LJ; Li, H; Serrano, M; Milner, J				Lynch, Cian J.; Shah, Zahid H.; Allison, Simon J.; Ahmed, Shafiq U.; Ford, Jack; Warnock, Lorna J.; Li, Han; Serrano, Manuel; Milner, Jo			SIRT1 Undergoes Alternative Splicing in a Novel Auto-Regulatory Loop with p53	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; CALORIE RESTRICTION; GENE-EXPRESSION; MESSENGER-RNA; CELL-SURVIVAL; DEACETYLASE ACTIVITY; GENOMIC STABILITY; PROTEIN STABILITY; ARF/P53 PATHWAY; TRANSGENIC MICE	Background: The NAD-dependent deacetylase SIRT1 is a nutrient-sensitive coordinator of stress-tolerance, multiple homeostatic processes and healthspan, while p53 is a stress-responsive transcription factor and our paramount tumour suppressor. Thus, SIRT1-mediated inhibition of p53 has been identified as a key node in the common biology of cancer, metabolism, development and ageing. However, precisely how SIRT1 integrates such diverse processes remains to be elucidated. Methodology/Principal Findings: Here we report that SIRT1 is alternatively spliced in mammals, generating a novel SIRT1 isoform: SIRT1-Delta Exon8. We show that SIRT1-Delta Exon8 is expressed widely throughout normal human and mouse tissues, suggesting evolutionary conservation and critical function. Further studies demonstrate that the SIRT1-Delta Exon8 isoform retains minimal deacetylase activity and exhibits distinct stress sensitivity, RNA/protein stability, and protein-protein interactions compared to classical SIRT1-Full-Length (SIRT1-FL). We also identify an auto-regulatory loop whereby SIRT1-Delta Exon8 can regulate p53, while in reciprocal p53 can influence SIRT1 splice variation. Conclusions/Significance: We characterize the first alternative isoform of SIRT1 and demonstrate its evolutionary conservation in mammalian tissues. The results also reveal a new level of inter-dependency between p53 and SIRT1, two master regulators of multiple phenomena. Thus, previously-attributed SIRT1 functions may in fact be distributed between SIRT1 isoforms, with important implications for SIRT1 functional studies and the current search for SIRT1-activating therapeutics to combat age-related decline.	[Li, Han; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Mol Oncol Program, Tumour Suppress Grp, Madrid, Spain; [Lynch, Cian J.; Shah, Zahid H.; Allison, Simon J.; Ahmed, Shafiq U.; Ford, Jack; Warnock, Lorna J.; Milner, Jo] Univ York, Dept Biol, YCR Res Unit p53, York YO10 5DD, N Yorkshire, England	Centro Nacional de Investigaciones Oncologicas (CNIO); University of York - UK	Lynch, CJ (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Oncol Program, Tumour Suppress Grp, Madrid, Spain.	clynch@cnio.es; ajm24@york.ac.uk	Serrano, Manuel/H-2634-2015; Shah, Zahid/G-9410-2014; Lynch, Cian/AIC-5510-2022; Allison, Simon/AAC-2027-2019; Lynch, Cian J/K-2191-2017	Serrano, Manuel/0000-0001-7177-9312; Shah, Zahid/0000-0001-7165-8780; Lynch, Cian/0000-0003-0187-3527; Lynch, Cian J/0000-0003-0187-3527; Ahmed, Shafiq U/0000-0001-8701-6889; Allison, Simon/0000-0002-5766-2377	Korner International Travelling Fellowship; MICINN; CNIO; MICINN (SAF and CONSOLIDER); Regional Government of Madrid; European Union; European Research Council (ERC); 'Marcelino Botin' Foundation; Yorkshire Cancer Research	Korner International Travelling Fellowship; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); CNIO; MICINN (SAF and CONSOLIDER)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid; European Union(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); 'Marcelino Botin' Foundation; Yorkshire Cancer Research	Grant support: Korner International Travelling Fellowship awarded to C.J.L. Juan de la Cierva Fellowship awarded to H. L. from MICINN. Work in the laboratory of M. S. is funded by the CNIO and by grants from the MICINN (SAF and CONSOLIDER), the Regional Government of Madrid, the European Union, the European Research Council (ERC), and the 'Marcelino Botin' Foundation. Work in the p53 Cancer Research Unit of JM is funded by Yorkshire Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007305; An P, 2007, PLOS BIOL, V5, P263, DOI 10.1371/journal.pbio.0050036; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campisi J, 2008, AGING CELL, V7, P281, DOI 10.1111/j.1474-9726.2008.00383.x; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cheng ZY, 2009, MOL CELL PROTEOMICS, V8, P45, DOI 10.1074/mcp.M800224-MCP200; Choi J, 1999, CELL MOL LIFE SCI, V55, P38, DOI 10.1007/s000180050268; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Gabut M, 2005, MOL CELL BIOL, V25, P3286, DOI 10.1128/MCB.25.8.3286-3294.2005; Galy B, 2001, ONCOGENE, V20, P4613, DOI 10.1038/sj.onc.1204630; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Ghidelli S, 2001, EMBO J, V20, P4522, DOI 10.1093/emboj/20.16.4522; Ghosh HS, 2007, BIOCHEM J, V408, P105, DOI 10.1042/BJ20070817; Ghosh HS, 2008, CURR OPIN INVEST DR, V9, P1095; Gottlieb E, 1997, EMBO J, V16, P1381, DOI 10.1093/emboj/16.6.1381; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang M, 2002, ONCOGENE, V21, P6041, DOI 10.1038/sj.onc.1205878; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Komarova EA, 1997, EMBO J, V16, P1391, DOI 10.1093/emboj/16.6.1391; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Ljungman M, 2001, ONCOGENE, V20, P5964, DOI 10.1038/sj.onc.1204734; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Lynch CJ, 2006, ONCOGENE, V25, P3463, DOI 10.1038/sj.onc.1209387; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Maisse C, 2003, BIOCHEM PHARMACOL, V66, P1555, DOI 10.1016/S0006-2952(03)00511-2; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Miller SJ, 2000, MOL CELL BIOL, V20, P8420, DOI 10.1128/MCB.20.22.8420-8431.2000; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Milner J, 2009, CURR PHARM DESIGN, V15, P39, DOI 10.2174/138161209787185841; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; OBEROSLER P, 1993, EMBO J, V12, P2389, DOI 10.1002/j.1460-2075.1993.tb05893.x; Olovnikov IA, 2009, SEMIN CANCER BIOL, V19, P32, DOI 10.1016/j.semcancer.2008.11.005; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Riley KJL, 2007, BIOCHEMISTRY-US, V46, P2480, DOI 10.1021/bi061480v; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Soussi T, 2005, BIOCHEM BIOPH RES CO, V331, P834, DOI 10.1016/j.bbrc.2005.03.190; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Warnock LJ, 2008, ONCOGENE, V27, P1639, DOI 10.1038/sj.onc.1210787; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Zhang DY, 2009, J BIOL CHEM, V284, P20917, DOI 10.1074/jbc.M109.020073; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	84	38	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13502	10.1371/journal.pone.0013502	http://dx.doi.org/10.1371/journal.pone.0013502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975832	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000283293800003
J	Anderson, HE; Kagansky, A; Wardle, J; Rappsilber, J; Allshire, RC; Whitehall, SK				Anderson, Holly E.; Kagansky, Alexander; Wardle, Josephine; Rappsilber, Juri; Allshire, Robin C.; Whitehall, Simon K.			Silencing Mediated by the Schizosaccharomyces pombe HIRA Complex Is Dependent upon the Hpc2-Like Protein, Hip4	PLOS ONE			English	Article							ASSEMBLY FACTOR-I; FISSION YEAST; HISTONE CHAPERONE; CHROMOSOME SEGREGATION; HETEROCHROMATIN FOCI; DNA-SYNTHESIS; CELL-CYCLE; RNAI; CHROMATIN; TRANSCRIPTION	Background: HIRA (or Hir) proteins are conserved histone chaperones that function in multi-subunit complexes to mediate replication-independent nucleosome assembly. We have previously demonstrated that the Schizosaccharomyces pombe HIRA proteins, Hip1 and Slm9, form a complex with a TPR repeat protein called Hip3. Here we have identified a new subunit of this complex. Methodology/Principal Findings: To identify proteins that interact with the HIRA complex, rapid affinity purifications of Slm9 were performed. Multiple components of the chaperonin containing TCP-1 complex (CCT) and the 19S subunit of the proteasome reproducibly co-purified with Slm9, suggesting that HIRA interacts with these complexes. Slm9 was also found to interact with a previously uncharacterised protein (SPBC947.08c), that we called Hip4. Hip4 contains a HRD domain which is a characteristic of the budding yeast and human HIRA/Hir-binding proteins, Hpc2 and UBN1. Co-precipitation experiments revealed that Hip4 is stably associated with all of the other components of the HIRA complex and deletion of hip4(+) resulted in the characteristic phenotypes of cells lacking HIRA function, such as temperature sensitivity, an elongated cell morphology and hypersensitivity to the spindle poison, thiabendazole. Moreover, loss of Hip4 function alleviated the heterochromatic silencing of reporter genes located in the mating type locus and centromeres and was associated with increased levels of non-coding transcripts derived from centromeric repeat sequences. Hip4 was also found to be required for the distinct form of silencing that controls the expression of Tf2 LTR retrotransposons. Conclusions/Significance: Overall, these results indicate that Hip4 is an integral component of the HIRA complex that is required for transcriptional silencing at multiple loci.	[Anderson, Holly E.; Wardle, Josephine; Whitehall, Simon K.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Kagansky, Alexander; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Kagansky, Alexander; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Inst Cell Biol, Edinburgh, Midlothian, Scotland	Newcastle University - UK; University of Edinburgh; University of Edinburgh	Anderson, HE (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England.	S.K.Whitehall@ncl.ac.uk	Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015; Kagansky, Alexander/B-3137-2011	Rappsilber, Juri/0000-0001-5999-1310; Kagansky, Alexander/0000-0002-6219-6892; Allshire, Robin/0000-0002-8005-3625	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E014445/1]; Medical Research Council [G0301153]; EC [084229/Z/07/Z]; Wellcome Trust [084229/Z/07/Z, 065061/Z]; BBSRC [BB/E014445/1] Funding Source: UKRI; MRC [G0301153] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E014445/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EC(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral Training Grant to H. E. A, a BBSRC Project Grant (BB/E014445/1) to S. K. W., a Medical Research Council Strategic grant (G0301153) to R. C. A., an EC Marie-Curie Excellence grant (MEXT-CT-014171) to J.R, a Wellcome Trust Senior Research fellowship (084229/Z/07/Z) to J.R. and a Wellcome Trust Programme grant (065061/Z) to R. C. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Anderson HE, 2009, MOL CELL BIOL, V29, P5158, DOI 10.1128/MCB.00698-09; Balaji S, 2009, MOL BIOSYST, V5, P269, DOI 10.1039/b816424j; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Banumathy G, 2009, MOL CELL BIOL, V29, P758, DOI 10.1128/MCB.01047-08; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Blackwell C, 2004, MOL CELL BIOL, V24, P4309, DOI 10.1128/MCB.24.10.4309-4320.2004; Bowen NJ, 2003, GENOME RES, V13, P1984, DOI 10.1101/gr.1191603; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Dekker C, 2008, EMBO J, V27, P1827, DOI 10.1038/emboj.2008.108; Durand-Dubief M, 2007, EMBO J, V26, P2477, DOI 10.1038/sj.emboj.7601690; Ekwall K, 1999, GENETICS, V153, P1153; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Greenall A, 2006, J BIOL CHEM, V281, P8732, DOI 10.1074/jbc.M512170200; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guo MJ, 2008, PLANT CELL, V20, P48, DOI 10.1105/tpc.107.056127; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kanoh J, 2000, GENETICS, V155, P623; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Kloc A, 2008, TRENDS GENET, V24, P511, DOI 10.1016/j.tig.2008.08.002; Koues OI, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-5; Malay AD, 2008, J BIOL CHEM, V283, P14022, DOI 10.1074/jbc.M800594200; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Phelps-Durr TL, 2005, PLANT CELL, V17, P2886, DOI 10.1105/tpc.105.035477; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Prochasson P, 2005, GENE DEV, V19, P2534, DOI 10.1101/gad.1341105; Qian ZJ, 1998, MOL CELL BIOL, V18, P4783, DOI 10.1128/MCB.18.8.4783; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Sulahian R, 2006, NUCLEIC ACIDS RES, V34, P1351, DOI 10.1093/nar/gkl012; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Thon G, 2000, GENETICS, V155, P551; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06	49	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13488	10.1371/journal.pone.0013488	http://dx.doi.org/10.1371/journal.pone.0013488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976105	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000283045300042
J	van der Tol, A; Van Biesen, W; Verbeke, F; De Groote, G; Vermeiren, F; Eeckhaut, K; Vanholder, R				van der Tol, Arjan; Van Biesen, Wim; Verbeke, Francis; De Groote, Guy; Vermeiren, Frans; Eeckhaut, Kathleen; Vanholder, Raymond			Towards a Rational Screening Strategy for Albuminuria: Results from the Unreferred Renal Insufficiency Trial	PLOS ONE			English	Article							HEART-RATE; GENERAL-POPULATION; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; DIABETIC NEPHROPATHY; INCREASED RISK; FOLLOW-UP; MICROALBUMINURIA; HYPERTENSION; EVENTS	Background: There remains debate about the screening strategies for albuminuria. This study evaluated whether a screening strategy in an apparently healthy population based on basic clinical and biochemical parameters could be more effective than a strategy where screening for albuminuria is performed unselectively. Methodology/Principal Findings: The Unreferred Renal Insufficiency (URI) Study is a cross-sectional study on the prevalence of metabolic risk factors in Belgian workers, volunteering to be screened during a routine yearly occupational check-up. Subjects (n = 295) with treated hypertension, known diabetes, treated dyslipidaemia, cardiovascular and renal disease were excluded. Among 1,191 apparently healthy subjects, 23% had unknown hypertension, 13% had impaired glucose tolerance, 15.4% had normoalbuminuria, 4.2% had microalbuminuria and 0.4% had macroalbuminuria. Subjects with resting heart rate >= 85 bpm, plasma glucose >= 5.6 mmol/L and blood pressure >= 140/90 mmHg were associated with albuminuria of any degree. A strategy where only subjects with at least one of these risk factors (n = 431) were screened for albuminuria, would identify all subjects with macroalbuminuria (5/5), 64% of those with microalbuminuria (32/50), and less than half of those with normoalbuminuria (81/183). An alternative strategy whereby subjects were first screened for presence of albuminuria, and additional cardiovascular risk factors were only measured in subjects positive for albuminuria (n = 238), would identify only 27% (118/431) of the subjects with additional and potentially modifiable cardiovascular risk factors. On the other hand, half of the subjects in this study with albuminuria (120/238, of which 102 had normoalbuminuria), had no additional cardiovascular risk factor at all. Conclusions: Screening an apparently healthy population directly for albuminuria will result in a high percentage of false positives, mostly measured in the normal range. Screening for microalbuminuria and macroalbuminuria based on presence of additional, potentially modifiable risk factors appears to be more beneficial.	[van der Tol, Arjan; Van Biesen, Wim; Verbeke, Francis; Vanholder, Raymond] Ghent Univ Hosp, Div Renal, Dept Internal Med, B-9000 Ghent, Belgium; [De Groote, Guy] CRI Lab, Ghent, Belgium; [Vermeiren, Frans; Eeckhaut, Kathleen] Occupat Hlth Care Adhesia, Ghent, Belgium	Ghent University; Ghent University Hospital	van der Tol, A (corresponding author), Ghent Univ Hosp, Div Renal, Dept Internal Med, B-9000 Ghent, Belgium.	Arjan.vandertol@ugent.be			Hoffman-La Roche, Basel, Switzerland	Hoffman-La Roche, Basel, Switzerland	This study was partially funded by an unrestricted grant from Hoffman-La Roche, Basel, Switzerland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, LANCET, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Bakris GL, 2004, JAMA-J AM MED ASSOC, V292, P2227, DOI 10.1001/jama.292.18.2227; Bigazzi R, 1998, J HYPERTENS, V16, P1325, DOI 10.1097/00004872-199816090-00014; Bohm M, 2008, J HYPERTENS, V26, P18; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; *ERA EDTA REG, 2009, ERA EDTA REG 2007 AN; ERA-EDTA Registry, 2003, ERA EDTA REG 1998 AN; Facchini FS, 1996, AM J HYPERTENS, V9, P1013, DOI 10.1016/0895-7061(96)87747-8; Fried L, 2009, J AM SOC NEPHROL, V20, P686, DOI 10.1681/ASN.2009020147; Genuth S, 2003, DIABETES CARE, V26, P3160; GILLMAN MW, 1993, AM HEART J, V125, P1148, DOI 10.1016/0002-8703(93)90128-V; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hallan SI, 2010, J NEPHROL, V23, P147; Heathcote KL, 2009, CLIN INVEST MED, V32, pE261; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inoue T, 2009, CLIN EXP NEPHROL, V13, P487, DOI 10.1007/s10157-009-0193-3; Jouven X, 2009, AM J CARDIOL, V103, P279, DOI 10.1016/j.amjcard.2008.08.071; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Klausen KP, 2007, J INTERN MED, V262, P470, DOI 10.1111/j.1365-2796.2007.01839.x; Klausen KP, 2006, J INTERN MED, V260, P231, DOI 10.1111/j.1365-2796.2006.01679.x; Kramer A, 2009, NEPHROL DIAL TRANSPL, V24, P3557, DOI 10.1093/ndt/gfp519; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Metcalf PA, 1997, INT J OBESITY, V21, P203, DOI 10.1038/sj.ijo.0800388; Mogensen CE, 1999, DIABETOLOGIA, V42, P263, DOI 10.1007/s001250051151; Nielen MMJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-381; Palatini P, 2009, PROG CARDIOVASC DIS, V52, P1, DOI 10.1016/j.pcad.2009.06.001; Ritz E, 2000, DIABETES METAB, V26, P54; Romundstad S, 2003, CLIN NEPHROL, V59, P241; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; STEHOUWER CDA, 1990, ARCH INTERN MED, V150, P373, DOI 10.1001/archinte.150.2.373; Turnbull F, 2003, LANCET, V362, P1527; van der Velde M, 2009, J AM SOC NEPHROL, V20, P852, DOI 10.1681/ASN.2008060655; WALKER WG, 1992, JAMA-J AM MED ASSOC, V268, P3085, DOI 10.1001/jama.268.21.3085; Warram JH, 1996, J AM SOC NEPHROL, V7, P930; Weir MR, 2010, AM J NEPHROL, V31, P469, DOI 10.1159/000292500; *WHO, WHO STEPS SURV 3; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281; Witte EC, 2009, J AM SOC NEPHROL, V20, P436, DOI 10.1681/ASN.2008030292; CONCISE 2009 ANN DAT	43	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13328	10.1371/journal.pone.0013328	http://dx.doi.org/10.1371/journal.pone.0013328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967254	Green Published, Green Submitted, gold			2022-12-25	WOS:000282869800027
J	Wang, QA; Shen, BR; Zheng, PL; Feng, H; Chen, LA; Zhang, J; Zhang, CX; Zhang, GZ; Teng, JL; Chen, JG				Wang, Qiao; Shen, Birong; Zheng, Pengli; Feng, Hui; Chen, Liang; Zhang, Jing; Zhang, Chuanxi; Zhang, Guozheng; Teng, Junlin; Chen, Jianguo			Silkworm Coatomers and Their Role in Tube Expansion of Posterior Silkgland	PLOS ONE			English	Article							BOMBYX-MORI; TARGETED DISRUPTION; INTRACELLULAR-TRANSPORT; ENDOPLASMIC-RETICULUM; MEMBRANE-TRANSPORT; SEQUENCE ALIGNMENT; PROTEIN-TRANSPORT; GOLGI TRANSPORT; COAT PROTEINS; GAMMA-COP	Background: Coat protein complex I (COPI) vesicles, coated by seven coatomer subunits, are mainly responsible for Golgito- ER transport. Silkworm posterior silkgland (PSG), a highly differentiated secretory tissue, secretes fibroin for silk production, but many physiological processes in the PSG cells await further investigation. Methodology/Principal Findings: Here, to investigate the role of silkworm COPI, we cloned six silkworm COPI subunits (alpha,beta,beta', delta, epsilon, and zeta-COP), determined their peak expression in day 2 in fifth-instar PSG, and visualized the localization of COPI, as a coat complex, with cis-Golgi. By dsRNA injection into silkworm larvae, we suppressed the expression of alpha-, beta'- and gamma-COP, and demonstrated that COPI subunits were required for PSG tube expansion. Knockdown of alpha-COP disrupted the integrity of Golgi apparatus and led to a narrower glandular lumen of the PSG, suggesting that silkworm COPI is essential for PSG tube expansion. Conclusions/Significance: The initial characterization reveals the essential roles of silkworm COPI in PSG. Although silkworm COPI resembles the previously characterized coatomers in other organisms, some surprising findings require further investigation. Therefore, our results suggest the silkworm as a model for studying intracellular transport, and would facilitate the establishment of silkworm PSG as an efficient bioreactor.	[Wang, Qiao; Shen, Birong; Zheng, Pengli; Feng, Hui; Chen, Liang; Zhang, Jing; Teng, Junlin; Chen, Jianguo] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Bioengn, Key Lab Cell Proliferat & Differentiat,Minist Edu, Beijing 100871, Peoples R China; [Chen, Jianguo] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Zhang, Chuanxi] Zhejiang Univ, Inst Insect Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Guozheng] Chinese Acad Agr Sci, Sericultural Res Inst, Hangzhou, Zhejiang, Peoples R China	Peking University; Peking University; Zhejiang University; Chinese Academy of Agricultural Sciences	Wang, QA (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Bioengn, Key Lab Cell Proliferat & Differentiat,Minist Edu, Beijing 100871, Peoples R China.	junlinteng@pku.edu.cn; chenjg@pku.edu.cn	Zhang, Chuan-Xi/K-7978-2019	Zhang, Chuan-Xi/0000-0002-7784-1188; Wang, Qiao/0000-0001-6416-1733; Shen, Birong/0000-0002-1208-506X; Zheng, Pengli/0000-0002-3797-4023	National Natural Science Foundation of China (NSFC) [30670659, 30771086, 30721064]; Major State Basic Research Development Program of China [2006CB500700, 2006CB910700, 2010CB833705]; National High Technology Research and Development Program of China [2006AA10A119]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The funders include the National Natural Science Foundation of China (NSFC) (30670659, 30771086, 30721064)(website: http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm), the Major State Basic Research Development Program of China (973 Program) (2006CB500700,2006CB910700,2010CB833705)(website: http://www.973.gov.cn/English/Index.aspx), and the National High Technology Research and Development Program of China (863 Program) (2006AA10A119)(website: http://www.863.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Chen W, 2008, PLOS BIOL, V6, P1927, DOI 10.1371/journal.pbio.0060209; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; GERICH B, 1995, P NATL ACAD SCI USA, V92, P3229, DOI 10.1073/pnas.92.8.3229; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Grieder NC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003241; Hahn Y, 2000, FEBS LETT, V482, P31, DOI 10.1016/S0014-5793(00)02033-0; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Houdebine LM, 2000, TRANSGENIC RES, V9, P305, DOI 10.1023/A:1008934912555; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.ibmb.2004.10.002; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964; Kakei M, 2005, J INSECT PHYSIOL, V51, P17, DOI 10.1016/j.jinsphys.2004.10.012; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LIPPINCOTTSCHWARTZ J, 1995, J CELL BIOL, V128, P293, DOI 10.1083/jcb.128.3.293; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuoka T, 2000, DEV GENES EVOL, V210, P120, DOI 10.1007/s004270050018; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Moelleken J, 2007, P NATL ACAD SCI USA, V104, P4425, DOI 10.1073/pnas.0611360104; Nishikawa T, 2001, EUR J BIOCHEM, V268, P5295, DOI 10.1046/j.0014-2956.2001.02461.x; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; ORCI L, 1986, CELL, V46, P171, DOI 10.1016/0092-8674(86)90734-8; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; RODEMS SM, 1995, J VIROL, V69, P5368, DOI 10.1128/JVI.69.9.5368-5375.1995; SASAKI S, 1981, J CELL SCI, V50, P19; Shi XZ, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-5; SHIMURA K, 1976, J BIOCHEM-TOKYO, V80, P693, DOI 10.1093/oxfordjournals.jbchem.a131328; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060; Tabunoki H, 2004, FEBS LETT, V567, P175, DOI 10.1016/j.febslet.2004.04.067; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; TASHIRO Y, 1968, J CELL BIOL, V38, P574, DOI 10.1083/jcb.38.3.574; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; WANG Q, FRONTIERS BIOSCIENCE; Wang QA, 2010, CELL RES, V20, P713, DOI 10.1038/cr.2010.47; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004; WHITNEY JA, 1995, CELL, V83, P703; Wurm FM, 2003, NAT BIOTECHNOL, V21, P34, DOI 10.1038/nbt0103-34; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210	56	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13252	10.1371/journal.pone.0013252	http://dx.doi.org/10.1371/journal.pone.0013252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967265	Green Submitted, Green Published, gold			2022-12-25	WOS:000282807300008
J	Nogales-Gadea, G; Mormeneo, E; Garcia-Consuegra, I; Rubio, JC; Orozco, A; Arenas, J; Martin, MA; Lucia, A; Gomez-Foix, AM; Marti, R; Andreu, AL				Nogales-Gadea, Gisela; Mormeneo, Emma; Garcia-Consuegra, Ines; Rubio, Juan C.; Orozco, Anna; Arenas, Joaquin; Martin, Miguel A.; Lucia, Alejandro; Gomez-Foix, Anna M.; Marti, Ramon; Andreu, Antoni L.			Expression of Glycogen Phosphorylase Isoforms in Cultured Muscle from Patients with McArdle's Disease Carrying the p.R771PfsX33 PYGM Mutation	PLOS ONE			English	Article							MESSENGER-RNA DECAY; MYOPHOSPHORYLASE DEFICIENCY; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; TERMINATION-CODON; GENE-EXPRESSION; IDENTIFICATION; MECHANISMS; RESPONSES; DISORDER	Background: Mutations in the PYGM gene encoding skeletal muscle glycogen phosphorylase (GP) cause a metabolic disorder known as McArdle's disease. Previous studies in muscle biopsies and cultured muscle cells from McArdle patients have shown that PYGM mutations abolish GP activity in skeletal muscle, but that the enzyme activity reappears when muscle cells are in culture. The identification of the GP isoenzyme that accounts for this activity remains controversial. Methodology/Principal Findings: In this study we present two related patients harbouring a novel PYGM mutation, p.R771PfsX33. In the patients' skeletal muscle biopsies, PYGM mRNA levels were similar to 60% lower than those observed in two matched healthy controls; biochemical analysis of a patient muscle biopsy resulted in undetectable GP protein and GP activity. A strong reduction of the PYGM mRNA was observed in cultured muscle cells from patients and controls, as compared to the levels observed in muscle tissue. In cultured cells, PYGM mRNA levels were negligible regardless of the differentiation stage. After a 12 day period of differentiation similar expression of the brain and liver isoforms were observed at the mRNA level in cells from patients and controls. Total GP activity (measured with AMP) was not different either; however, the active GP activity and immunoreactive GP protein levels were lower in patients' cell cultures. GP immunoreactivity was mainly due to brain and liver GP but muscle GP seemed to be responsible for the differences. Conclusions/Significance: These results indicate that in both patients' and controls' cell cultures, unlike in skeletal muscle tissue, most of the protein and GP activities result from the expression of brain GP and liver GP genes, although there is still some activity resulting from the expression of the muscle GP gene. More research is necessary to clarify the differential mechanisms of metabolic adaptations that McArdle cultures undergo in vitro.	[Nogales-Gadea, Gisela; Marti, Ramon; Andreu, Antoni L.] Hosp Univ Vall Hebron, Inst Recerca, Dept Patol Mitocondrial & Neuromuscular, Barcelona, Spain; [Mormeneo, Emma; Orozco, Anna; Gomez-Foix, Anna M.] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Garcia-Consuegra, Ines; Rubio, Juan C.; Arenas, Joaquin; Martin, Miguel A.] Hosp Univ 12 Octubre, Ctr Invest, Madrid, Spain; [Lucia, Alejandro] Univ Europea Madrid, Madrid, Spain; [Nogales-Gadea, Gisela; Garcia-Consuegra, Ines; Rubio, Juan C.; Martin, Miguel A.; Marti, Ramon; Andreu, Antoni L.] Inst Salud Carlos III, Spanish Network Res Rare Dis CIBERER, Madrid, Spain; [Mormeneo, Emma; Orozco, Anna; Gomez-Foix, Anna M.] Inst Salud Carlos III, Diabet & Associated Metab Disorders CIBERDEM, Madrid, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Barcelona; Hospital Universitario 12 de Octubre; European University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Nogales-Gadea, G (corresponding author), Hosp Univ Vall Hebron, Inst Recerca, Dept Patol Mitocondrial & Neuromuscular, Barcelona, Spain.	rmarti@ir.vhebron.net	Nogales-Gadea, Gisela/N-4004-2014; Martí, Ramon/Q-3442-2016; Martin, Miguel A/S-2758-2018; Lucia, Alejandro/M-2759-2014	Nogales-Gadea, Gisela/0000-0002-7414-212X; Martí, Ramon/0000-0002-8273-9540; Martin, Miguel A/0000-0003-4741-772X; Lucia, Alejandro/0000-0002-3025-2060; Arenas, Joaquin/0000-0002-2877-5049; ANDREU, antonio luis/0000-0002-3936-3234; Lucia, Alejandro/0000-0002-5565-0997	CIBER de Enfermedades Raras, Spain; MCI; FIS, Madrid, Spain [CA05/0039]; ISCIII; Comunidad de Madrid; Instituto de Salud Carlos III; Fondo de Investigacian Sanitaria (FIS) [PI0890246, PI061183, PI07/0347]; Ministerio de Ciencia y Innovacion (MCI) [SAF2009-07559]; CIBER de Enfermedades Raras; CIBER de Diabetes y Enfermedades Metabalicas Asociadas; Fundacion Isabel Gemio para la investigacion en distrofias musculares y otras enfermedades raras	CIBER de Enfermedades Raras, Spain; MCI; FIS, Madrid, Spain(Instituto de Salud Carlos III); ISCIII(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigacian Sanitaria (FIS)(Instituto de Salud Carlos III); Ministerio de Ciencia y Innovacion (MCI); CIBER de Enfermedades Raras; CIBER de Diabetes y Enfermedades Metabalicas Asociadas; Fundacion Isabel Gemio para la investigacion en distrofias musculares y otras enfermedades raras	GN was supported by a contract from CIBER de Enfermedades Raras, Spain. EM was the recipient of a FPI fellowship from the MCI. IG was supported by a contract from FIS, Madrid, Spain. JCR was supported by a contract from FIS (CA05/0039). MAM was supported by the programme 'Intensificacion de la Actividad Investigadora' from ISCIII, and Comunidad de Madrid. This work was supported by grants from Instituto de Salud Carlos III, Fondo de Investigacian Sanitaria (FIS) grant number: PI0890246, PI061183, PI07/0347; Ministerio de Ciencia y Innovacion (MCI) grant number SAF2009-07559; CIBER de Enfermedades Raras and CIBER de Diabetes y Enfermedades Metabalicas Asociadas, which is an ISCIII project, Spain; Fundacion Isabel Gemio para la investigacion en distrofias musculares y otras enfermedades raras. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTRAM C, 1993, HUM MOL GENET, V2, P1291, DOI 10.1093/hmg/2.8.1291; Buchbinder JL, 2001, ANNU REV BIOPH BIOM, V30, P191, DOI 10.1146/annurev.biophys.30.1.191; CRERAR MM, 1995, J BIOL CHEM, V270, P13748, DOI 10.1074/jbc.270.23.13748; DIMAURO S, 1979, ANN NEUROL, V5, P422, DOI 10.1002/ana.410050504; DiMauro S, 1977, Trans Am Neurol Assoc, V102, P112; DIMAURO S, 1978, ANN NEUROL, V3, P60, DOI 10.1002/ana.410030109; Ferrer-Martinez A, 2006, GENE, V384, P145, DOI 10.1016/j.gene.2006.07.042; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Garcia-Consuegra I, 2009, J MED GENET, V46, P198, DOI 10.1136/jmg.2008.059469; GILBOE DP, 1972, ANAL BIOCHEM, V47, P20, DOI 10.1016/0003-2697(72)90274-6; Haller RG, 2002, ARCH NEUROL-CHICAGO, V59, P1395, DOI 10.1001/archneur.59.9.1395; Holcik M, 2007, EMBO REP, V8, P639, DOI 10.1038/sj.embor.7400988; HUDSON JW, 1993, J MOL BIOL, V234, P700, DOI 10.1006/jmbi.1993.1621; Imamura M, 2005, HUM MOL GENET, V14, P775, DOI 10.1093/hmg/ddi072; KINNIBURGH AJ, 1982, NUCLEIC ACIDS RES, V10, P5421, DOI 10.1093/nar/10.18.5421; Kubisch C, 1998, HUM MUTAT, V12, P27, DOI 10.1002/(SICI)1098-1004(1998)12:1<27::AID-HUMU4>3.0.CO;2-#; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Lualdi S, 2006, BBA-MOL BASIS DIS, V1762, P478, DOI 10.1016/j.bbadis.2006.01.003; Lucia A, 2008, NAT CLIN PRACT NEURO, V4, P568, DOI 10.1038/ncpneuro0913; Martin M A, 2000, Hum Mutat, V15, P294, DOI 10.1002/(SICI)1098-1004(200003)15:3<294::AID-HUMU13>3.0.CO;2-H; Martinuzzi A, 1999, AM J PATHOL, V154, P1893, DOI 10.1016/S0002-9440(10)65447-8; MARTINUZZI A, 1993, J CLIN INVEST, V92, P1774, DOI 10.1172/JCI116766; Mate-Munoz JL, 2007, CLIN J SPORT MED, V17, P297; MCARDLE B, 1951, CLIN SCI, V10, P12; MEIENHOFER MC, 1977, ARCH NEUROL-CHICAGO, V34, P779, DOI 10.1001/archneur.1977.00500240067013; MOMMAERTS WFHM, 1959, P NATL ACAD SCI USA, V45, P791, DOI 10.1073/pnas.45.6.791; Montori-Grau M, 2007, BIOCHEM J, V405, P107, DOI 10.1042/BJ20061572; Montori-Grau M, 2009, EXP GERONTOL, V44, P426, DOI 10.1016/j.exger.2009.03.005; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; NEWGARD CB, 1988, J BIOL CHEM, V263, P3850; Nielsen JN, 2002, AM J PHYSIOL-ENDOC M, V282, pE1267, DOI 10.1152/ajpendo.00526.2001; Nogales-Gadea G, 2007, CURR NEUROL NEUROSCI, V7, P84, DOI 10.1007/s11910-007-0026-2; Nogales-Gadea G, 2008, HUM MUTAT, V29, P277, DOI 10.1002/humu.20649; Nunes PM, 2008, CARBOHYD RES, V343, P1486, DOI 10.1016/j.carres.2008.04.004; PAZUR JH, 1960, J BIOL CHEM, V235, P297; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Raymond F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-125; ROELOFS RI, 1972, SCIENCE, V177, P795, DOI 10.1126/science.177.4051.795; Rubio JC, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9474; SATO K, 1977, BIOCHEM BIOPH RES CO, V78, P663, DOI 10.1016/0006-291X(77)90230-3; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; SCHMID R, 1959, J CLIN INVEST, V38, P2044, DOI 10.1172/JCI103983; Sohn EH, 2008, NEUROMUSCULAR DISORD, V18, P886, DOI 10.1016/j.nmd.2008.06.384; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Thomson AM, 2005, J BIOL CHEM, V280, P30032, DOI 10.1074/jbc.M502951200; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; TSUJINO S, 1993, NEW ENGL J MED, V329, P241, DOI 10.1056/NEJM199307223290404	47	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13164	10.1371/journal.pone.0013164	http://dx.doi.org/10.1371/journal.pone.0013164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957198	Green Published, Green Submitted, gold			2022-12-25	WOS:000282506100007
J	Brodin, P; Lakshmikanth, T; Mehr, R; Johansson, MH; Duru, AD; Achour, A; Salmon-Divon, M; Karre, K; Hoglund, P; Johansson, S				Brodin, Petter; Lakshmikanth, Tadepally; Mehr, Ramit; Johansson, Maria H.; Duru, Adil Doganay; Achour, Adnane; Salmon-Divon, Mali; Karre, Klas; Hoglund, Petter; Johansson, Sofia			Natural Killer Cell Tolerance Persists Despite Significant Reduction of Self MHC Class I on Normal Target Cells in Mice	PLOS ONE			English	Article							INHIBITORY LY49 RECEPTORS; NK CELLS; NKG2D RECEPTOR; KNOCKOUT MICE; T-CELLS; EXPRESSION; EDUCATION; CIS; MOLECULES; REJECTION	Background: A major group of murine inhibitory receptors on Natural Killer (NK) cells belong to the Ly49 receptor family and recognize MHC class I molecules. Infected or transformed target cells frequently downmodulate MHC class I molecules and can thus avoid CD8(+) T cell attack, but may at the same time develop NK cell sensitivity, due to failure to express inhibitory ligands for Ly49 receptors. The extent of MHC class I downregulation needed on normal cells to trigger NK cell effector functions is not known. Methodology/Principal Findings: In this study, we show that cells expressing MHC class I to levels well below half of the host level are tolerated in an in vivo assay in mice. Hemizygous expression (expression from only one allele) of MHC class I was sufficient to induce Ly49 receptor downmodulation on NK cells to a similar degree as homozygous expression, despite a strongly reduced cell surface level of MHC class I. Co-expression of weaker MHC class I ligands in the host did not have any further effect on the degree of Ly49 downmodulation. Furthermore, a single MHC class I allele could downmodulate up to three Ly49 receptors on individual NK cells. Only when NK cells simultaneously expressed several Ly49 receptors and hemizygous MHC class I levels, a putative threshold for Ly49 downmodulation was reached. Conclusion: Collectively, our findings suggest that in interactions between NK cells and normal untransformed cells, MHC class I molecules are in most cases expressed in excess compared to what is functionally needed to ensure self tolerance and to induce maximal Ly49 downmodulation. We speculate that the reason for this is to maintain a safety margin for otherwise normal, autologous cells over a range of MHC class I expression levels, in order to ensure robustness in NK cell tolerance.	[Brodin, Petter; Lakshmikanth, Tadepally; Johansson, Maria H.; Karre, Klas; Hoglund, Petter] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Mehr, Ramit; Salmon-Divon, Mali] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Duru, Adil Doganay; Achour, Adnane] Karolinska Inst, Dept Med, Ctr Infect Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Johansson, Sofia] AlbaNova Univ Ctr, Royal Inst Technol, Dept Appl Phys Expt Biomol Phys, Stockholm, Sweden; [Salmon-Divon, Mali] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England	Karolinska Institutet; Bar Ilan University; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology; European Molecular Biology Laboratory (EMBL)	Brodin, P (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	sofj@kth.se	Johansson, Sofia/B-9043-2011; Brodin, Petter/C-3317-2011; Höglund, Petter/AAV-7443-2021; Salmon-Divon, Mali/AAG-4479-2019; Tadepally, Lakshmikanth/P-5154-2019	Johansson, Sofia/0000-0002-9295-6266; Brodin, Petter/0000-0002-8103-0046; Salmon-Divon, Mali/0000-0002-7272-0846; Tadepally, Lakshmikanth/0000-0001-7256-5770; Mehr, Ramit/0000-0002-4303-6834; Duru, Adil/0000-0002-5844-913X; Achour, Adnane/0000-0003-0432-710X	Swedish Cancer Society; Wenner-Gren Institute; Karolinska Institutet; Swedish Foundation for Strategic Research; Aake Wiberg foundation; Magnus Bergwall foundation; Royal Swedish Academy of Sciences; Swedish Research Council; Marianne and Marcus Wallenberg Foundation; Swedish Foundation for International Cooperation in Research and Higher Educationt (STINT); Mary Beves Stiftelse; Swedish National Board of Health and Welfare	Swedish Cancer Society(Swedish Cancer Society); Wenner-Gren Institute; Karolinska Institutet(Karolinska Institutet); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Aake Wiberg foundation; Magnus Bergwall foundation; Royal Swedish Academy of Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); Marianne and Marcus Wallenberg Foundation; Swedish Foundation for International Cooperation in Research and Higher Educationt (STINT); Mary Beves Stiftelse; Swedish National Board of Health and Welfare	S.J. was financed by a post-doc position from the Swedish Cancer Society (presently) and from the Wenner-Gren Institute (2006-2008). Grants were received from Karolinska Institutet to SJ, MHJ, TLK, PH, AA and KK; from the Swedish Foundation for Strategic Research and the Swedish Cancer Society to AA, KK and PH; from the Aake Wiberg foundation, the Magnus Bergwall foundation, and the Royal Swedish Academy of Sciences to MHJ and SJ; from the Swedish Research Council, the Marianne and Marcus Wallenberg Foundation and The Swedish Foundation for International Cooperation in Research and Higher Educationt (STINT) to AA and PH; from Mary Beves Stiftelse to PB; and from the Swedish National Board of Health and Welfare to AA and MHJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CR, 2006, J IMMUNOL, V177, P6904, DOI 10.4049/jimmunol.177.10.6904; Andersson KE, 2007, EUR J IMMUNOL, V37, P516, DOI 10.1002/eji.200636693; Andersson M, 1998, J IMMUNOL, V161, P6475; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Back J, 2007, P NATL ACAD SCI USA, V104, P3978, DOI 10.1073/pnas.0607418104; Back J, 2009, IMMUNITY, V31, P598, DOI 10.1016/j.immuni.2009.07.007; BIEBERICH C, 1986, MOL CELL BIOL, V6, P1339, DOI 10.1128/MCB.6.4.1339; BRODIN P, 2009, TRENDS IMMUNOL; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; CHALIFOUR A, 2009, IMMUNITY; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Dimasi N, 2005, IMMUNOL CELL BIOL, V83, P1, DOI 10.1111/j.1440-1711.2005.01301.x; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; FERNANDEZ NC, 2005, BLOOD; GIDLUND M, 1978, NATURE, V273, P759, DOI 10.1038/273759a0; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Held W, 1997, EUR J IMMUNOL, V27, P2876, DOI 10.1002/eji.1830271120; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; HOGLUND P, 1988, J EXP MED, V168, P1469, DOI 10.1084/jem.168.4.1469; Hoglund P, 1998, EUR J IMMUNOL, V28, P370, DOI 10.1002/(SICI)1521-4141(199801)28:01<370::AID-IMMU370>3.0.CO;2-W; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Johansson MH, 1998, EUR J IMMUNOL, V28, P4198, DOI 10.1002/(SICI)1521-4141(199812)28:12<4198::AID-IMMU4198>3.0.CO;2-9; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; Johansson S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006046; Joncker NT, 2008, IMMUNOL REV, V224, P85, DOI 10.1111/j.1600-065X.2008.00658.x; Jonsson AH, 2010, J IMMUNOL, V184, P3424, DOI 10.4049/jimmunol.0904057; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kase A, 1998, J IMMUNOL, V161, P6133; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Manilay JO, 1998, INT IMMUNOL, V10, P1943, DOI 10.1093/intimm/10.12.1943; Nakamura MC, 2000, J EXP MED, V192, P447, DOI 10.1084/jem.192.3.447; Oberg L, 2004, EUR J IMMUNOL, V34, P1646, DOI 10.1002/eji.200424913; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; OlssonAlheim MY, 1997, J IMMUNOL, V159, P3189; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Regunathan J, 2005, BLOOD, V105, P233, DOI 10.1182/blood-2004-03-1075; Roth C, 2000, IMMUNITY, V13, P143, DOI 10.1016/S1074-7613(00)00015-7; Scarpellino L, 2007, J IMMUNOL, V178, P1277, DOI 10.4049/jimmunol.178.3.1277; SIJTS AJAM, 1994, J VIROL, V68, P6038, DOI 10.1128/JVI.68.9.6038-6046.1994; Sjostrom A, 2001, J EXP MED, V194, P1519, DOI 10.1084/jem.194.10.1519; STORKUS WJ, 1989, P NATL ACAD SCI USA, V86, P2361, DOI 10.1073/pnas.86.7.2361; STRINGFELLOW DA, 1972, ANTIMICROB AGENTS CH, V2, P73, DOI 10.1128/AAC.2.2.73; Sundback J, 2002, J IMMUNOL, V168, P793, DOI 10.4049/jimmunol.168.2.793; Vahlne G, 2010, EUR J IMMUNOL, V40, P813, DOI 10.1002/eji.200939755; van Stipdonk MJB, 2009, CANCER RES, V69, P7784, DOI 10.1158/0008-5472.CAN-09-1724; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Zimmer J, 2001, J EXP MED, V194, P1531, DOI 10.1084/jem.194.10.1531	54	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13174	10.1371/journal.pone.0013174	http://dx.doi.org/10.1371/journal.pone.0013174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957233	Green Submitted, gold, Green Published			2022-12-25	WOS:000282423300012
J	Tomlinson, KL; Davies, GCG; Sutton, DJ; Palframan, RT				Tomlinson, Kate L.; Davies, Gareth C. G.; Sutton, Daniel J.; Palframan, Roger T.			Neutralisation of Interleukin-13 in Mice Prevents Airway Pathology Caused by Chronic Exposure to House Dust Mite	PLOS ONE			English	Article							SMOOTH-MUSCLE; ALLERGEN CHALLENGE; IL-13 EXPRESSION; EXPERIMENTAL ASTHMA; CYNOMOLGUS MONKEYS; LUNG INFLAMMATION; TGF-BETA; RECEPTOR; CELLS; RESPONSES	Background: Repeated exposure to inhaled allergen can cause airway inflammation, remodeling and dysfunction that manifests as the symptoms of allergic asthma. We have investigated the role of the cytokine interleukin-13 (IL-13) in the generation and persistence of airway cellular inflammation, bronchial remodeling and deterioration in airway function in a model of allergic asthma caused by chronic exposure to the aeroallergen House Dust Mite (HDM). Methodology/Principal Findings: Mice were exposed to HDM via the intranasal route for 4 consecutive days per week for up to 8 consecutive weeks. Mice were treated either prophylactically or therapeutically with a potent neutralising anti-IL-13 monoclonal antibody (mAb) administered subcutaneously (s.c.). Airway cellular inflammation was assessed by flow cytometry, peribronchial collagen deposition by histocytochemistry and airway hyperreactivity (AHR) by invasive measurement of lung resistance (R-L) and dynamic compliance (C-dyn). Both prophylactic and therapeutic treatment with an anti-IL-13 mAb significantly inhibited (P < 0.05) the generation and maintenance of chronic HDM-induced airway cellular inflammation, peribronchial collagen deposition, epithelial goblet cell upregulation. AHR to inhaled methacholine was reversed by prophylactic but not therapeutic treatment with anti-IL-13 mAb. Both prophylactic and therapeutic treatment with anti-IL-13 mAb significantly reversed (P < 0.05) the increase in baseline R-L and the decrease in baseline C-dyn caused by chronic exposure to inhaled HDM. Conclusions/Significance: These data demonstrate that in a model of allergic lung disease driven by chronic exposure to a clinically relevant aeroallergen, IL-13 plays a significant role in the generation and persistence of airway inflammation, remodeling and dysfunction.	[Tomlinson, Kate L.; Davies, Gareth C. G.; Sutton, Daniel J.; Palframan, Roger T.] UCB, Immunol Res, Slough, Berks, England	UCB Pharma SA	Palframan, RT (corresponding author), UCB, Immunol Res, Slough, Berks, England.	Roger.Palframan@UCB.com		Davies, Gareth/0000-0001-5180-3143	UCB	UCB(UCB Pharma SA)	This study was funded entirely by UCB (www.ucb.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors were employees of UCB at the time these studies were performed.	Batra V, 2004, CLIN EXP ALLERGY, V34, P437, DOI 10.1111/j.1365-2222.2004.01885.x; Berry LM, 2009, INT IMMUNOPHARMACOL, V9, P201, DOI 10.1016/j.intimp.2008.11.001; Berry MA, 2004, J ALLERGY CLIN IMMUN, V114, P1106, DOI 10.1016/j.jaci.2004.08.032; Blease K, 2001, J IMMUNOL, V166, P5219, DOI 10.4049/jimmunol.166.8.5219; Bree A, 2007, J ALLERGY CLIN IMMUN, V119, P1251, DOI 10.1016/j.jaci.2007.02.009; Brightling CE, 2003, CLIN EXP ALLERGY, V33, P1711, DOI 10.1111/j.1365-2222.2003.01827.x; Chiou YL, 2009, J CELL PHYSIOL, V220, P311, DOI 10.1002/jcp.21764; de Vries JE, 1998, J ALLERGY CLIN IMMUN, V102, P165, DOI 10.1016/S0091-6749(98)70080-6; Espinosa K, 2003, J ALLERGY CLIN IMMUN, V111, P1032, DOI 10.1067/mai.2003.1451; Goplen N, 2009, J ALLERGY CLIN IMMUN, V123, P925, DOI 10.1016/j.jaci.2009.02.009; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Grunstein MM, 2002, AM J PHYSIOL-LUNG C, V282, pL520, DOI 10.1152/ajplung.00343.2001; Hewitt CRA, 1998, ALLERGY, V53, P60, DOI 10.1111/j.1398-9995.1998.tb05000.x; Holgate ST, 2004, CLIN EXP ALLERGY, V34, P632, DOI 10.1111/j.1365-2222.2004.1916.x; HUANG SK, 1995, J IMMUNOL, V155, P2688; Humbert M, 1997, J ALLERGY CLIN IMMUN, V99, P657, DOI 10.1016/S0091-6749(97)70028-9; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kasaian MT, 2008, J PHARMACOL EXP THER, V325, P882, DOI 10.1124/jpet.108.136515; Kasaian MT, 2007, AM J RESP CELL MOL, V36, P368, DOI 10.1165/rcmb.2006-0244OC; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kroegel C, 1996, EUR RESPIR J, V9, P899, DOI 10.1183/09031936.96.09050899; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Langley SJ, 2003, ANN ALLERG ASTHMA IM, V91, P398, DOI 10.1016/S1081-1206(10)61688-2; Prieto J, 2000, RESP MED, V94, P806, DOI 10.1053/rmed.2000.0826; Rogers DF, 2007, RESP CARE, V52, P1134; Saha SK, 2008, J ALLERGY CLIN IMMUN, V121, P685, DOI 10.1016/j.jaci.2008.01.005; Taube C, 2002, J IMMUNOL, V169, P6482, DOI 10.4049/jimmunol.169.11.6482; Tliba O, 2003, BRIT J PHARMACOL, V140, P1159, DOI 10.1038/sj.bjp.0705558; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Rensen ELJ, 2009, ALLERGY, V64, P72, DOI 10.1111/j.1398-9995.2008.01881.x; Warner SM, 2008, CURR OPIN ALLERGY CL, V8, P44, DOI 10.1097/ACI.0b013e3282f3b5cb; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wenzel SE, 2002, J IMMUNOL, V169, P4613, DOI 10.4049/jimmunol.169.8.4613; Willart MAM, 2009, CLIN EXP ALLERGY, V39, P12, DOI 10.1111/j.1365-2222.2008.03118.x; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yang GY, 2004, CYTOKINE, V28, P224, DOI 10.1016/j.cyto.2004.08.007; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	39	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13136	10.1371/journal.pone.0013136	http://dx.doi.org/10.1371/journal.pone.0013136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957211	Green Published, Green Submitted, gold			2022-12-25	WOS:000282359300026
J	Rishavy, MA; Usubalieva, A; Hallgren, KW; Berkner, KL				Rishavy, Mark A.; Usubalieva, Aisulu; Hallgren, Kevin W.; Berkner, Kathleen L.			Novel Insight into the Mechanism of the Vitamin K Oxidoreductase (VKOR) ELECTRON RELAY THROUGH Cys(43) AND Cys(51) REDUCES VKOR TO ALLOW VITAMIN K REDUCTION AND FACILITATION OF VITAMIN K-DEPENDENT PROTEIN CARBOXYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYL-CARBOXYLASE; BLOOD-COAGULATION FACTORS; EPOXIDE-REDUCTASE; COMBINED DEFICIENCY; PHARMACODYNAMIC RESISTANCE; 2,3-EPOXIDE REDUCTASE; ENDOPLASMIC-RETICULUM; WARFARIN RESISTANCE; ACTIVE-SITE; FACTOR-IX	The vitamin K oxidoreductase (VKOR) reduces vitamin K to support the carboxylation and consequent activation of vitamin K-dependent proteins, but the mechanism of reduction is poorly understood. VKOR is an integral membrane protein that reduces vitamin K using membrane-embedded thiols (Cys-132 and Cys-135), which become oxidized with concomitant VKOR inactivation. VKOR is subsequently reactivated by an unknown redox protein that is currently thought to act directly on the Cys132-Cys135 residues. However, VKOR contains evolutionarily conserved Cys residues (Cys-43 and Cys-51) that reside in a loop outside of the membrane, raising the question of whether they mediate electron transfer from a redox protein to Cys-132/Cys-135. To assess a possible role, the activities of mutants with Ala substituted for Cys (C43A and C51A) were analyzed in intact membranes using reductants that were either membrane-permeable or -impermeable. Both reductants resulted in wild type VKOR reduction of vitamin K epoxide; however, the C43A and C51A mutants only showed activity with the membrane-permeant reductant. We obtained similar results when testing the ability of wild type and mutant VKORs to support carboxylation, using intact membranes from cells coexpressing VKOR and carboxylase. These results indicate a role for Cys-43 and Cys-51 in catalysis, suggesting a relay mechanism in which a redox protein transfers electrons to these loop residues, which in turn reduce the membrane-embedded Cys132-Cys135 disulfide bond to activate VKOR. The results have implications for the mechanism of warfarin resistance, the topology of VKOR in the membrane, and the interaction of VKOR with the carboxylase.	[Rishavy, Mark A.; Usubalieva, Aisulu; Hallgren, Kevin W.; Berkner, Kathleen L.] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Usubalieva, Aisulu; Berkner, Kathleen L.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Berkner, KL (corresponding author), Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, 9500 Euclid Ave,NB50, Cleveland, OH 44195 USA.	berknek@ccf.org		Berkner, Kathleen/0000-0001-8054-8081	National Institutes of Health [5RO1HL081093]; American Heart Association [0735317N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081093, R01HL055666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1HL081093 (to K. L. B.).; Supported by Scientist Development Grant 0735317N from the American Heart Association.	Berkner KL, 2008, VITAM HORM, V78, P131, DOI 10.1016/S0083-6729(07)00007-6; Berkner KL, 1997, METHOD ENZYMOL, V282, P313; Berkner KL, 2005, ANNU REV NUTR, V25, P127, DOI 10.1146/annurev.nutr.25.050304.092713; Bodin L, 2008, J THROMB HAEMOST, V6, P1436, DOI 10.1111/j.1538-7836.2008.03049.x; Brenner B, 1998, BLOOD, V92, P4554, DOI 10.1182/blood.V92.12.4554.424k42_4554_4559; D'Ambrosio RL, 2007, J THROMB HAEMOST, V5, P191, DOI 10.1111/j.1538-7836.2006.02261.x; Darghouth D, 2006, BLOOD, V108, P1925, DOI 10.1182/blood-2005-12-010660; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; FASCO MJ, 1982, J BIOL CHEM, V257, P4894; FASCO MJ, 1983, BIOCHEMISTRY-US, V22, P5655, DOI 10.1021/bi00293a031; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Goodstadt L, 2004, TRENDS BIOCHEM SCI, V29, P289, DOI 10.1016/j.tibs.2004.04.004; Hallgren KW, 2006, BIOCHEMISTRY-US, V45, P5587, DOI 10.1021/bi051986y; Harrington DJ, 2008, J THROMB HAEMOST, V6, P1663, DOI 10.1111/j.1538-7836.2008.03116.x; Harrington DJ, 2005, THROMB HAEMOSTASIS, V93, P23, DOI 10.1160/TH04-08-0540; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Jin DY, 2007, BIOCHEMISTRY-US, V46, P7279, DOI 10.1021/bi700527j; KATZ FN, 1977, P NATL ACAD SCI USA, V74, P3278, DOI 10.1073/pnas.74.8.3278; KREIBICH G, 1973, J CELL BIOL, V58, P436, DOI 10.1083/jcb.58.2.436; LEE JJ, 1984, BIOCHEMISTRY-US, V23, P2246, DOI 10.1021/bi00305a024; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Li WK, 2010, NATURE, V463, P507, DOI 10.1038/nature08720; Loebstein R, 2007, BLOOD, V109, P2477, DOI 10.1182/blood-2006-08-038984; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Morris DP, 1995, J BIOL CHEM, V270, P30491, DOI 10.1074/jbc.270.51.30491; Oldenburg J, 2000, THROMB HAEMOSTASIS, V84, P937; Rishavy MA, 2008, BIOCHEMISTRY-US, V47, P9836, DOI 10.1021/bi800296r; Rost S, 2005, THROMB HAEMOSTASIS, V94, P780, DOI 10.1160/TH05-02-0082; Rost S, 2004, BRIT J HAEMATOL, V126, P546, DOI 10.1111/j.1365-2141.2004.05071.x; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; ROTH DA, 1993, P NATL ACAD SCI USA, V90, P8372, DOI 10.1073/pnas.90.18.8372; Schmeits PCJ, 2010, BRIT J HAEMATOL, V148, P955, DOI 10.1111/j.1365-2141.2009.08017.x; SOUTE BAM, 1992, BIOCHEM J, V281, P255, DOI 10.1042/bj2810255; Spohn G, 2009, THROMB HAEMOSTASIS, V101, P1044, DOI 10.1160/TH09-03-0204; Spronk HMH, 2000, BLOOD, V96, P3650; Stenina O, 2001, BIOCHEMISTRY-US, V40, P10301, DOI 10.1021/bi0107039; Tie JK, 2008, VITAM HORM, V78, P103, DOI 10.1016/S0083-6729(07)00006-4; Tie JK, 2005, J BIOL CHEM, V280, P16410, DOI 10.1074/jbc.M500765200; VANHAARLEM JL, 1987, FEBS LETT, V222, P353; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Wallin R, 2002, THROMB RES, V108, P221, DOI 10.1016/S0049-3848(03)00060-4; WHITLON DS, 1978, BIOCHEMISTRY-US, V17, P1371, DOI 10.1021/bi00601a003; Wilms EB, 2008, J THROMB HAEMOST, V6, P1224, DOI 10.1111/j.1538-7836.2008.02975.x; Zhu AH, 2007, BLOOD, V109, P5270, DOI 10.1182/blood-2006-12-064188	45	64	72	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7267	7278		10.1074/jbc.M110.172213	http://dx.doi.org/10.1074/jbc.M110.172213			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	20978134	Green Published, hybrid			2022-12-25	WOS:000287737300043
J	Wu, LM; Ma, CA; Zhao, YG; Jain, A				Wu, Liming; Ma, Chi A.; Zhao, Yongge; Jain, Ashish			Aurora B Interacts with NIR-p53, Leading to p53 Phosphorylation in Its DNA-binding Domain and Subsequent Functional Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; CHROMOSOMAL PASSENGERS; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES; IN-VIVO; KINASE; ACETYLATION; ACTIVATION; APOPTOSIS; DEGRADATION	NIR (novel INHAT repressor) is a transcriptional co-repressor with inhibitor of histone acetyltransferase (INHAT) activity and has previously been shown to physically interact with and suppress p53 transcriptional activity and function. However, the mechanism by which NIR suppresses p53 is not completely understood. Using a proteomic approach, we have identified the Aurora kinase B as a novel binding partner of NIR. We show that Aurora B, NIR and p53 exist in a protein complex in which Aurora B binds to NIR, thus also indirectly associates with p53. Functionally, overexpression of Aurora B or NIR suppresses p53 transcriptional activity, and depletion of Aurora B or NIR causes p53-dependent apoptosis and cell growth arrest, due to the up-regulation of p21 and Bax. We then demonstrate that Aurora B phosphorylates multiple sites in the p53 DNA-binding domain in vitro, and this phosphorylation probably also occurs in cells. Importantly, the Aurora B-mediated phosphorylation on Ser(269) or Thr(284) significantly compromises p53 transcriptional activity. Taken together, these results provide novel insight into NIR-mediated p53 suppression and also suggest an additional way for p53 regulation.	[Wu, Liming; Ma, Chi A.; Zhao, Yongge; Jain, Ashish] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jain, A (corresponding author), NIAID, Host Def Lab, NIH, 10 Ctr Dr,CRC,Rm 5W3950, Bethesda, MD 20892 USA.	ajain@niaid.nih.gov	Wu, liming/AAH-5415-2019; Wu, Liming/C-4004-2011		National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000924] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the intramural Research Program from National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health.	Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hublitz P, 2005, GENE DEV, V19, P2912, DOI 10.1101/gad.351205; Ikezoe T, 2010, INT J HEMATOL, V91, P69, DOI 10.1007/s12185-009-0462-7; Jain A, 2004, J CLIN INVEST, V114, P1593, DOI 10.1172/JCI200421345; Katayama H, 1999, J NATL CANCER I, V91, P1160, DOI 10.1093/jnci/91.13.1160; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee EM, 2006, NEUROLOGY, V66, pA89; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wheatley SP, 2004, J BIOL CHEM, V279, P5655, DOI 10.1074/jbc.M311299200; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200	38	56	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2236	2244		10.1074/jbc.M110.174755	http://dx.doi.org/10.1074/jbc.M110.174755			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	20959462	Green Published, hybrid			2022-12-25	WOS:000286191500064
J	Machiya, Y; Hara, S; Arawaka, S; Fukushima, S; Sato, H; Sakamoto, M; Koyama, S; Kato, T				Machiya, Youhei; Hara, Susumu; Arawaka, Shigeki; Fukushima, Shingo; Sato, Hiroyasu; Sakamoto, Masahiro; Koyama, Shingo; Kato, Takeo			Phosphorylated alpha-Synuclein at Ser-129 Is Targeted to the Proteasome Pathway in a Ubiquitin-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; COUPLED RECEPTOR KINASES; PARKINSONS-DISEASE; NEURONAL CELLS; MOUSE-BRAIN; DEGRADATION; AGGREGATION; PATHOGENESIS; INCLUSIONS; BINDING	alpha-Synuclein (a-Syn) is a major component of fibrillar aggregates in Lewy bodies (LBs), a characteristic hallmark of Parkinson disease. Almost 90% of a-Syn deposited in LBs is phosphorylated at Ser-129. However, the role of Ser-129-phosphorylated a-Syn in the biogenesis of LBs remains unclear. Here, we investigated the metabolism of Ser-129-phosphorylated a-Syn. In SH-SY5Y cells, inhibition of protein phosphatase 2A/1 by okadaic acid, and inhibition of the proteasome pathway by MG132 or lactacystin accumulated Ser129-phosphorylated a-Syn. However, these inhibitions did not alter the amounts of total a-Syn within the observation time. Inhibition of the autophagy-lysosome pathway by 3-methyladenine or chloroquine accumulated Ser-129-phosphorylated a-Syn in parallel to total a-Syn during longer incubations. Experiments using cycloheximide showed that Ser-129-phosphorylated a-Syn diminished rapidly (t1/2 = 54.9 +/- 6.4 min), in contrast to the stably expressed total a-Syn. The short half-life of Ser-129-phosphorylated a-Syn was blocked by MG132 to a greater extent than okadaic acid. In rat primary cortical neurons, either MG132, lactacystin, or okadaic acid accumulated Ser-129-phosphorylated a-Syn. Additionally, we did not find that phosphorylated a-Syn was ubiquitinated in the presence of proteasome inhibitors. These data show that Ser-129-phosphorylated a-Syn is targeted to the proteasome pathway in a ubiquitin-independent manner, in addition to undergoing dephosphorylation. The proteasome pathway may play a role in the biogenesis of Ser-129-phosphorylated a-Syn-rich LBs.	[Machiya, Youhei; Hara, Susumu; Arawaka, Shigeki; Fukushima, Shingo; Sato, Hiroyasu; Sakamoto, Masahiro; Koyama, Shingo; Kato, Takeo] Yamagata Univ, Dept Neurol Hematol Metab Endocrinol & Diabetol, Fac Med, Yamagata 9909585, Japan	Yamagata University	Arawaka, S (corresponding author), 2-2-2 Iida Nishi, Yamagata 9908585, Japan.	arawaka@med.id.yamagata-u.ac.jp		Arawaka, Shigeki/0000-0002-1505-3012	Japan Society for the Promotion of Science [F03]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid from the Global COE Program (F03) of the Japan Society for the Promotion of Science (to T.K.).	Ancolio K, 2000, NEUROSCI LETT, V285, P79, DOI 10.1016/S0304-3940(00)01049-1; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Eriksen JL, 2003, NEURON, V40, P453, DOI 10.1016/S0896-6273(03)00684-6; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hirai Y, 2004, FEBS LETT, V572, P227, DOI 10.1016/j.febslet.2004.07.046; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Karube H, 2008, FEBS LETT, V582, P3693, DOI 10.1016/j.febslet.2008.10.001; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sakamoto M, 2009, BIOCHEM BIOPH RES CO, V384, P378, DOI 10.1016/j.bbrc.2009.04.130; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600	38	80	83	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40732	40744		10.1074/jbc.M110.141952	http://dx.doi.org/10.1074/jbc.M110.141952			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959456	Green Published, hybrid			2022-12-25	WOS:000285414400037
J	Jiang, WB; Hong, Y; Peng, JBA; Fu, ZQ; Feng, XG; Liu, JM; Shi, YJ; Lin, JJ				Jiang, Weibin; Hong, Yang; Peng, Jinbiao; Fu, Zhiqiang; Feng, Xingang; Liu, Jinming; Shi, Yaojun; Lin, Jiaojiao			Study on Differences in the Pathology, T Cell Subsets and Gene Expression in Susceptible and Non-Susceptible Hosts Infected with Schistosoma japonicum	PLOS ONE			English	Article							CATHEPSIN-S; PARASITE; SPLEEN; NOTCH	More than 40 kinds of mammals in China are known to be naturally infected with Schistosoma japonicum (S. japonicum); Microtus fortis (M. fortis), a species of vole, is the only mammal in which the schistosomes cannot mature or cause significant pathogenic changes. In the current study, we compared the differences in pathology by Hematoxylin-eosin staining and in changes in the T cell subsets with flow cytometry as well as gene expression using genome oligonucleotide microarrays in the lung and liver, before challenge and 10 days post-infection with schistosomes in a S. japonicum-susceptible mouse model of infection, a non-susceptible rat model and the non-permissive host, M. fortis. The results demonstrated that S. japonicum promoted a more intensive immune response and more pathological lesions in M. fortis and rats than in mice. Hematoxylin-eosin staining revealed that the immune effector cells involved were mainly eosinophilic granulocytes supplemented with heterophilic granulocytes and macrophages. The analysis of splenic T cell subsets showed that CD4(+) T cell subsets and the CD4(+)/CD8(+) ratio were increased, while the CD8(+) T cell subsets decreased remarkably in rats; whereas the CD8(+) T cell subsets were increased, but the CD4(+)/CD8(+) ratio was decreased significantly in mice. The analysis of the pattern of gene expression suggested that some immune-associated genes and apoptosis-inducing genes up-regulated, while some development-associated genes were down-regulated in the infected M. fortis compared to the uninfected controls; the three different hosts have different response mechanisms to schistosome infection. The results of this study will be helpful for identifying the key molecules in the immune response to S. japonicum in M. fortis and for understanding more about the underlying mechanism of the response, as well as for elucidating the interaction between S. japonicum and its hosts.	[Jiang, Weibin; Hong, Yang; Peng, Jinbiao; Fu, Zhiqiang; Feng, Xingang; Liu, Jinming; Shi, Yaojun; Lin, Jiaojiao] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr China, Shanghai, Peoples R China; [Jiang, Weibin] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; East China Normal University	Jiang, WB (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr China, Shanghai, Peoples R China.	JJlin@shvri.ac.cn			National Basic Research Program of China [2007CB513108]; National Science & Technology Major Project [2008ZX10004-011]; National High Technology Research and Development Program of China [2006AA10A207-1]	National Basic Research Program of China(National Basic Research Program of China); National Science & Technology Major Project; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (No. 2007CB513108), http://www.973.gov.cn/ReadItem.aspx? itemid=578; the National Science & Technology Major Project (No. 2008ZX10004-011), http://www.nmp.gov.cn/zxjs/crb/; and the National High Technology Research and Development Program of China (No. 2006AA10A207-1), http://www.863.org.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Or RL, 2000, MATH BIOSCI, V163, P35; BRIGGS MH, 1972, BIOCHIM BIOPHYS ACTA, V280, P481, DOI 10.1016/0005-2760(72)90256-1; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027; Caraher EM, 2000, J IMMUNOL METHODS, V244, P29, DOI 10.1016/S0022-1759(00)00249-0; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Dallman MJ, 2005, CURR OPIN IMMUNOL, V17, P259, DOI 10.1016/j.coi.2005.04.002; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FUKUDA K, 1993, INT J PARASITOL, V23, P757, DOI 10.1016/0020-7519(93)90072-7; HE HB, 1992, HUNAN MED, V9, P65; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; HE YX, 1989, CHIN J PARASITOL PAR, V7, P15; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; JIA RC, 2008, CHIN J BIOTECH, V24, P733; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; LI FK, 1965, ACTA PARASITOL SIN, V2, P103; Li H., 2000, CHIN J VET PARASITOL, V8, P12; Liu J, 1996, INT J IMMUNOPHARMACO, V18, P449, DOI 10.1016/S0192-0561(96)00049-5; Liu J. S., 1992, CHIN J SCHISTO CONTR, V4, P350; Liu JinMing, 2001, Acta Parasitologica et Medica Entomologica Sinica, V8, P212; Liu WM, 2004, DRUG NEWS PERSPECT, V17, P357, DOI 10.1358/dnp.2004.17.6.829027; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Saule P, 2002, J PARASITOL, V88, P849, DOI 10.1645/0022-3395(2002)088[0849:EVOHTA]2.0.CO;2; Seigneuric R, 2007, RADIOTHER ONCOL, V83, P374, DOI 10.1016/j.radonc.2007.05.002; [孙军 Sun Jun], 2004, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V40, P532; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Qinglin, 2002, Chinese Journal of Zoonoses, V18, P65; WHO, 2002, WHO TECH REP SER; Wu K., 1957, CHIN VET J, V3, P98	33	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13494	10.1371/journal.pone.0013494	http://dx.doi.org/10.1371/journal.pone.0013494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976156	Green Published, Green Submitted, gold			2022-12-25	WOS:000283045300044
J	Radoslavov, G; Jordanova, R; Teofanova, D; Georgieva, K; Hristov, P; Salomone-Stagni, M; Liebau, E; Bankov, I				Radoslavov, Georgi; Jordanova, Rositsa; Teofanova, Denitsa; Georgieva, Katya; Hristov, Petar; Salomone-Stagni, Marco; Liebau, Eva; Bankov, Ilia			A Novel Secretory Poly-Cysteine and Histidine-Tailed Metalloprotein (Ts-PCHTP) from Trichinella spiralis (Nematoda)	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; SECONDARY STRUCTURE; BINDING SITES; PROTEIN; SEQUENCE; PREDICTION; CLONING; DOMAIN; ZINC; IDENTIFICATION	Background: Trichinella spiralis is an unusual parasitic intracellular nematode causing dedifferentiation of the host myofiber. Trichinella proteomic analyses have identified proteins that act at the interface between the parasite and the host and are probably important for the infection and pathogenesis. Many parasitic proteins, including a number of metalloproteins are unique for the nematodes and trichinellids and therefore present good targets for future therapeutic developments. Furthermore, detailed information on such proteins and their function in the nematode organism would provide better understanding of the parasite-host interactions. Methodology/Principal Findings: In this study we report the identification, biochemical characterization and localization of a novel poly-cysteine and histidine-tailed metalloprotein (Ts-PCHTP). The native Ts-PCHTP was purified from T. spiralis muscle larvae that were isolated from infected rats as a model system. The sequence analysis showed no homology with other proteins. Two unique poly-cysteine domains were found in the amino acid sequence of Ts-PCHTP. This protein is also the first reported natural histidine tailed protein. It was suggested that Ts-PCHTP has metal binding properties. Total Reflection X-ray Fluorescence (TXRF) assay revealed that it binds significant concentrations of iron, nickel and zinc at protein: metal ratio of about 1:2. Immunohistochemical analysis showed that the Ts-PCHTP is localized in the cuticle and in all tissues of the larvae, but that it is not excreted outside the parasite. Conclusions/Significance: Our data suggest that Ts-PCHTP is the first described member of a novel nematode poly-cysteine protein family and its function could be metal storage and/or transport. Since this protein family is unique for parasites from Superfamily Trichinelloidea its potential applications in diagnostics and treatment could be exploited in future.	[Radoslavov, Georgi; Teofanova, Denitsa; Georgieva, Katya; Hristov, Petar; Bankov, Ilia] Bulgarian Acad Sci, Dept Biochem, Inst Expt Pathol & Parasitol, Sofia, Bulgaria; [Jordanova, Rositsa; Salomone-Stagni, Marco] DESY, European Mol Biol Lab, Hamburg Outstn, D-2000 Hamburg, Germany; [Liebau, Eva] Univ Munster, Inst Zoophysiol, Munster, Germany	Bulgarian Academy of Sciences; Medical University Sofia; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Munster	Radoslavov, G (corresponding author), Bulgarian Acad Sci, Dept Biochem, Inst Expt Pathol & Parasitol, Sofia, Bulgaria.	gradoslavov@gmail.com	Teofanova, Denitsa/AAK-3183-2021; Radoslavov, Georgi/AAO-5374-2021	Georgieva, K/0000-0003-1490-1734; Hristov, Peter/0000-0002-7756-4571; Radoslavov, Georgi/0000-0003-0550-3291; Teofanova, Denitsa/0000-0002-0467-485X	Deutsche Forschungsgemeinschaft (DFG) [LI 793/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This investigation was supported by the Deutsche Forschungsgemeinschaft (DFG) grant LI 793/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED S, 1991, BIOCHEM J, V280, P233, DOI 10.1042/bj2800233; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2004, PREDICTION N GLYCOSY; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruschi F, 2009, VET PARASITOL, V159, P258, DOI 10.1016/j.vetpar.2008.10.038; CLOS J, 1994, PROTEIN EXPRES PURIF, V5, P133, DOI 10.1006/prep.1994.1020; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Despommier D.D., 2005, PARASITIC DIS; Despommier DD, 1998, PARASITOL TODAY, V14, P318, DOI 10.1016/S0169-4758(98)01287-3; Fu BQ, 2005, VET PARASITOL, V132, P27, DOI 10.1016/j.vetpar.2005.05.059; Gare D, 2004, MOL BIOCHEM PARASIT, V134, P257, DOI 10.1016/j.molbiopara.2004.01.001; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GARRETT R, 2005, SCIENCE, V181, P1037; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gattiker A, 2002, PROTEOMICS, V2, P1435, DOI 10.1002/1615-9861(200210)2:10<1435::AID-PROT1435>3.0.CO;2-9; GREGORY DS, 1993, PROTEIN ENG, V6, P29, DOI 10.1093/protein/6.1.29; HENGEN PN, 1995, TRENDS BIOCHEM SCI, V20, P285, DOI 10.1016/S0968-0004(00)89045-3; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; Jordanova R, 2005, J BIOL CHEM, V280, P41429, DOI 10.1074/jbc.M504474200; Jordanova R, 2005, FEBS J, V272, P180, DOI 10.1111/j.1432-1033.2004.04398.x; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Liu CL, 2002, J INORG BIOCHEM, V88, P77, DOI 10.1016/S0162-0134(01)00337-3; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MATTHEWS DJ, 1995, CURR OPIN BIOTECH, V6, P419, DOI 10.1016/0958-1669(95)80071-9; Maurer-Stroh S, 2003, BIOL CHEM, V384, P977, DOI 10.1515/BC.2003.110; Mitreva Makedonka, 2006, WormBook, P1; Nagano I, 2009, PARASITOL RES, V104, P197, DOI 10.1007/s00436-008-1248-1; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettitt J, 2008, RNA, V14, P760, DOI 10.1261/rna.948008; POZIO E, 1992, J PARASITOL, V78, P647, DOI 10.2307/3283539; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; Robinson MW, 2007, MOL BIOCHEM PARASIT, V151, P9, DOI 10.1016/j.molbiopara.2006.09.008; Robinson MW, 2005, PROTEOMICS, V5, P4525, DOI 10.1002/pmic.200402057; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scott WG, 2007, CURR OPIN STRUC BIOL, V17, P280, DOI 10.1016/j.sbi.2007.05.003; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; SREERAMA N, 1994, BIOCHEMISTRY-US, V33, P10022, DOI 10.1021/bi00199a028; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; WRIGHT KA, 1979, J PARASITOL, V65, P441, DOI 10.2307/3280292; Wu WK, 2008, PARASITOL RES, V102, P251, DOI 10.1007/s00436-007-0755-9; Wu WK, 2006, PARASITOL RES, V98, P281, DOI 10.1007/s00436-005-0056-0; Wylie T, 2004, NUCLEIC ACIDS RES, V32, pD423, DOI 10.1093/nar/gkh010; YAMASHITA MM, 1990, P NATL ACAD SCI USA, V87, P5648, DOI 10.1073/pnas.87.15.5648; YILU, 2005, ENCY INORGANIC CHEM, V5, P3159; Zarlenga DS, 2009, VET PARASITOL, V159, P210, DOI 10.1016/j.vetpar.2008.10.061; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13343	10.1371/journal.pone.0013343	http://dx.doi.org/10.1371/journal.pone.0013343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967224	Green Published, Green Submitted, gold			2022-12-25	WOS:000282869800033
J	Jeyabalan, A; Powers, RW; Clifton, RG; Van Dorsten, P; Hauth, JC; Klebanoff, MA; Lindheimer, MD; Sibai, B; Landon, M; Miodovnik, M				Jeyabalan, Arun; Powers, Robert W.; Clifton, Rebecca G.; Van Dorsten, Peter; Hauth, John C.; Klebanoff, Mark A.; Lindheimer, Marshall D.; Sibai, Baha; Landon, Mark; Miodovnik, Menachem		Eunice Kennedy Shriver Natl Inst C; Human Dev Maternal-Fetal Med Units	Effect of Smoking on Circulating Angiogenic Factors in High Risk Pregnancies	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CIGARETTE-SMOKING; MATERNAL SMOKING; SOLUBLE ENDOGLIN; PREECLAMPSIA; WOMEN; HYPERTENSION; RECEPTOR; OUTCOMES; SMOKERS	Objective: Changes in maternal concentrations of the anti-angiogenic factors, soluble fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin (sEng), and the pro-angiogenic placental growth factor (PlGF) precede the development of preeclampsia in healthy women. The risk of preeclampsia is reduced in women who smoke during pregnancy. The objective of this study was to investigate whether smoking affects concentrations of angiogenic factors (sFlt1, PlGF, and sEng) in women at high risk for developing preeclampsia. Study Design: We performed a secondary analysis of serum samples from 993 high-risk women (chronic hypertension, diabetes, multifetal gestation, and previous preeclampsia) in a preeclampsia prevention trial. sFlt1, sEng and PlGF were measured in serum samples obtained at study entry, which was prior to initiation of aspirin (median 19.0 weeks' [interquartile range of 16.0-22.6 weeks']). Smoking status was determined by self-report. Results: sFlt1 was not significantly different in smokers from any high-risk groups compared to their nonsmoking counterparts. PlGF was higher among smokers compared to nonsmokers among diabetic women (142.7 [77.4-337.3] vs 95.9 [48.5-180.7] pg/ml, p = 0.005) and women with a history of preeclampsia (252.2 [137.1-486.0] vs 152.2 [73.6-253.7] pg/ml, p = 0.001). sEng was lower in smokers with multifetal gestations (5.8 [4.6-6.5] vs 6.8 [5.5-8.7] ng/ml, p = 0.002) and trended lower among smokers with diabetes (4.9 [3.8-5.6] vs 5.3 [4.3-6.3] ng/ml, p = 0.05). Smoking was not associated with a lower incidence of preeclampsia in any of these groups. Conclusions: In certain high-risk groups, smoking is associated with changes in the concentrations of these factors towards a pro-angiogenic direction during early pregnancy; however, there was no apparent association between smoking and the development of preeclampsia in our cohort.	[Jeyabalan, Arun; Powers, Robert W.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Womens Hlth, Pittsburgh, PA 15260 USA; [Clifton, Rebecca G.] George Washington Univ, Ctr Biostat, Washington, DC USA; [Van Dorsten, Peter] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA; [Hauth, John C.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Med Sch Birmingham, Birmingham, AL 35294 USA; [Klebanoff, Mark A.] Eunice Kennedy Shriver NICHHD, Bethesda, MD USA; [Lindheimer, Marshall D.] Univ Chicago, Sch Med, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Sibai, Baha] Univ Tennessee, Sch Med, Dept Obstet & Gynecol, Memphis, TN USA; [Landon, Mark] Ohio State Univ, Sch Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Miodovnik, Menachem] Univ Cincinnati, Sch Med, Dept Obstet & Gynecol, Cincinnati, OH USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; George Washington University; Medical University of South Carolina; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Chicago; University of Tennessee System; University of Tennessee Health Science Center; University System of Ohio; Ohio State University; University System of Ohio; University of Cincinnati	Jeyabalan, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Womens Hlth, Pittsburgh, PA 15260 USA.	ajeyabalan@mail.magee.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD19897, HD36801, HD21410, HD21414, HD21434, HD27860, HD27861, HD27869, HD27883, HD27889, HD27905, HD27915, HD27917, NIH-2P01-HD30367]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD027869, P01HD030367, U10HD021410, U10HD027917, UG1HD027915, UG1HD027869, U10HD036801, U10HD027915] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD036801, U10HD021434, U10HD027861, U10HD027860, U01HD021414, U01HD021434, U10HD021414, U10HD027883, U10HD027905, U01HD021410, U01HD019897, U10HD027889] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD19897, HD36801, HD21410, HD21414, HD21434, HD27860, HD27861, HD27869, HD27883, HD27889, HD27905, HD27915, and HD27917) and NIH-2P01-HD30367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgore FM, 2000, BRIT J BIOMED SCI, V57, P207; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Castles A, 1999, AM J PREV MED, V16, P208, DOI 10.1016/S0749-3797(98)00089-0; *CDCP, 2004, MMWR; Chappell LC, 2008, HYPERTENSION, V51, P1002, DOI 10.1161/HYPERTENSIONAHA.107.107565; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Contreras KR, 2010, J PERINATOL, V30, P319, DOI 10.1038/jp.2009.175; COONROD DV, 1995, OBSTET GYNECOL, V85, P645, DOI 10.1016/0029-7844(95)00049-W; Cundy T, 2002, DIABETIC MED, V19, P482, DOI 10.1046/j.1464-5491.2002.00729.x; Engel SM, 2009, AM J EPIDEMIOL, V169, P33, DOI 10.1093/aje/kwn293; England L, 2007, FRONT BIOSCI-LANDMRK, V12, P2471, DOI 10.2741/2248; England LJ, 2007, NICOTINE TOB RES, V9, P1005, DOI 10.1080/14622200701491255; Janakiraman V, 2009, NICOTINE TOB RES, V11, P679, DOI 10.1093/ntr/ntp049; Jeyabalan A, 2008, AM J HYPERTENS, V21, P943, DOI 10.1038/ajh.2008.219; Karumanchi SA, 2010, HYPERTENSION, V55, P1100, DOI 10.1161/HYPERTENSIONAHA.109.148973; Khoury J C, 2004, J Matern Fetal Neonatal Med, V15, P44, DOI 10.1080/14767050310001650716; Klebanoff MA, 1998, AM J EPIDEMIOL, V148, P259; Levine R, 2006, AM J OBSTET GYNECOL, V195, pS37, DOI 10.1016/j.ajog.2006.10.100; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Martin CL, 2000, BRIT J OBSTET GYNAEC, V107, P745, DOI 10.1111/j.1471-0528.2000.tb13335.x; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mehendale R, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.025; Ness RB, 2008, AM J EPIDEMIOL, V168, P427, DOI 10.1093/aje/kwn140; Powers RW, 2005, AM J OBSTET GYNECOL, V193, P185, DOI 10.1016/j.ajog.2004.11.038; POWERS RW, 2010, PLOS ONE IN PRESS; Schmidt-Lucke C, 2005, INT J CARDIOL, V100, P207, DOI 10.1016/j.ijcard.2004.05.046; Sinclair SH, 2006, EXPERT REV MED DEVIC, V3, P301, DOI 10.1586/17434440.3.3.301; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wikstrom AK, 2010, HYPERTENSION, V55, P1254, DOI 10.1161/HYPERTENSIONAHA.109.147082	30	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13270	10.1371/journal.pone.0013270	http://dx.doi.org/10.1371/journal.pone.0013270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967275	Green Published, gold, Green Accepted			2022-12-25	WOS:000282807300012
J	Price, GE; Soboleski, MR; Lo, CY; Misplon, JA; Quirion, MR; Houser, KV; Pearce, MB; Pappas, C; Tumpey, TM; Epstein, SL				Price, Graeme E.; Soboleski, Mark R.; Lo, Chia-Yun; Misplon, Julia A.; Quirion, Mary R.; Houser, Katherine V.; Pearce, Melissa B.; Pappas, Claudia; Tumpey, Terrence M.; Epstein, Suzanne L.			Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; A VIRUS; RECOMBINANT ADENOVIRUS; DENDRITIC CELLS; IMMUNE-RESPONSES; IN-VIVO; HETEROSUBTYPIC IMMUNITY; INTRANASAL IMMUNIZATION; MATRIX PROTEIN-2; ANTIGENIC DRIFT	Background: The sudden emergence of novel influenza viruses is a global public health concern. Conventional influenza vaccines targeting the highly variable surface glycoproteins hemagglutinin and neuraminidase must antigenically match the emerging strain to be effective. In contrast, "universal'' vaccines targeting conserved viral components could be used regardless of viral strain or subtype. Previous approaches to universal vaccination have required protracted multi-dose immunizations. Here we evaluate a single dose universal vaccine strategy using recombinant adenoviruses (rAd) expressing the conserved influenza virus antigens matrix 2 and nucleoprotein. Methodology/Principal Findings: In BALB/c mice, administration of rAd via the intranasal route was superior to intramuscular immunization for induction of mucosal responses and for protection against highly virulent H1N1, H3N2, or H5N1 influenza virus challenge. Mucosally vaccinated mice not only survived, but had little morbidity and reduced lung virus titers. Protection was observed as early as 2 weeks post-immunization, and lasted at least 10 months, as did antibodies and lung T cells with activated phenotypes. Virus-specific IgA correlated with but was not essential for protection, as demonstrated in studies with IgA-deficient animals. Conclusion/Significance: Mucosal administration of NP and M2-expressing rAd vectors provided rapid and lasting protection from influenza viruses in a subtype-independent manner. Such vaccines could be used in the interval between emergence of a new virus strain and availability of strain-matched vaccines against it. This strikingly effective single-dose vaccination thus represents a candidate off-the-shelf vaccine for emergency use during an influenza pandemic.	[Price, Graeme E.; Soboleski, Mark R.; Lo, Chia-Yun; Misplon, Julia A.; Quirion, Mary R.; Epstein, Suzanne L.] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA; [Houser, Katherine V.; Pearce, Melissa B.; Pappas, Claudia; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Price, GE (corresponding author), US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA.	suzanne.epstein@fda.hhs.gov		Misplon, Julia/0000-0001-9614-5922; Epstein, Suzanne/0000-0002-6311-6890	National Institute of Allergy and Infectious Diseases Trans-NIH/FDA; Office of Public Health Medical Emergency Counter-Measures; FDA's Center for Biologics Evaluation and Research (CBER) pandemic influenza initiative	National Institute of Allergy and Infectious Diseases Trans-NIH/FDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Public Health Medical Emergency Counter-Measures; FDA's Center for Biologics Evaluation and Research (CBER) pandemic influenza initiative	This work was supported by grants from the National Institute of Allergy and Infectious Diseases Trans-NIH/FDA Intramural Biodefense Program, the Office of Public Health Medical Emergency Counter-Measures, and the FDA's Center for Biologics Evaluation and Research (CBER) pandemic influenza initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2005, HUM GENE THER, V16, P149, DOI 10.1089/hum.2005.16.149; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Boon ACM, 2002, J VIROL, V76, P2567, DOI 10.1128/JVI.76.5.2567-2572.2002; BOZIC CR, 1995, J IMMUNOL, V154, P6048; Brown LE, 2009, IMMUNOL CELL BIOL, V87, P300, DOI 10.1038/icb.2009.16; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; CHEN KS, 1988, J GEN VIROL, V69, P2779, DOI 10.1099/0022-1317-69-11-2779; Damjanovic Daniela, 2008, Genet Vaccines Ther, V6, P5, DOI 10.1186/1479-0556-6-5; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Edelstein ML, 2007, J GENE MED, V9, P833, DOI 10.1002/jgm.1100; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein Suzanne L, 2003, Expert Rev Anti Infect Ther, V1, P627, DOI 10.1586/14787210.1.4.627; Finn JD, 2009, J VIROL, V83, P12027, DOI 10.1128/JVI.00593-09; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Harriman GR, 1999, J IMMUNOL, V162, P2521; Harvey BG, 1999, J VIROL, V73, P6729, DOI 10.1128/JVI.73.8.6729-6742.1999; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Holman DH, 2008, VACCINE, V26, P2627, DOI 10.1016/j.vaccine.2008.02.053; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Jelley-Gibbs DM, 2007, J IMMUNOL, V178, P7563, DOI 10.4049/jimmunol.178.12.7563; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Karzon DT, 1996, SEMIN VIROL, V7, P265, DOI 10.1006/smvy.1996.0033; Kim TS, 2010, J EXP MED, V207, P1161, DOI 10.1084/jem.20092017; Lalor PA, 2008, J INFECT DIS, V197, P1643, DOI 10.1086/588431; Lemiale F, 2003, J VIROL, V77, P10078, DOI 10.1128/JVI.77.18.10078-10087.2003; Leroux-Roels I, 2009, EXPERT REV VACCINES, V8, P401, DOI 10.1586/ERV.09.15; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; McKelvey T, 2004, GENE THER, V11, P791, DOI 10.1038/sj.gt.3302232; Murphy BR, 2002, VIRAL IMMUNOL, V15, P295, DOI 10.1089/08828240260066242; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Rao SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009812; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Roy S, 2007, VACCINE, V25, P6845, DOI 10.1016/j.vaccine.2007.07.035; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; SMEENK CA, 1994, J VIROL, V68, P530, DOI 10.1128/JVI.68.1.530-534.1994; Stobie L, 2000, P NATL ACAD SCI USA, V97, P8427, DOI 10.1073/pnas.160197797; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Tatsis N, 2006, GENE THER, V13, P421, DOI 10.1038/sj.gt.3302675; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Thorner AR, 2006, J VIROL, V80, P12009, DOI 10.1128/JVI.01749-06; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Xiang ZQ, 1996, VIROLOGY, V219, P220, DOI 10.1006/viro.1996.0239; Xu Q, 2009, GENE THER, V16, P367, DOI 10.1038/gt.2008.181; Yamaguchi T, 2007, HUM GENE THER, V18, P753, DOI 10.1089/hum.2007.016; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Yu JR, 2008, J VIROL, V82, P2350, DOI 10.1128/JVI.02372-07; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zhang Y, 2001, MOL THER, V3, P697, DOI 10.1006/mthe.2001.0329; Zharikova D, 2005, J VIROL, V79, P6644, DOI 10.1128/JVI.79.11.6644-6654.2005; Zhong L, 1999, EUR J IMMUNOL, V29, P964, DOI 10.1002/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO;2-P; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; 2009, MMWR MORB MORTAL WKL, V59, P44	72	105	111	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13162	10.1371/journal.pone.0013162	http://dx.doi.org/10.1371/journal.pone.0013162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20976273	Green Submitted, gold, Green Published			2022-12-25	WOS:000282423300009
J	Ferri, F; Stoianov, IP; Gianelli, C; D'Amico, L; Borghi, AM; Gallese, V				Ferri, Francesca; Stoianov, Ivilin Peev; Gianelli, Claudia; D'Amico, Luigi; Borghi, Anna M.; Gallese, Vittorio			When Action Meets Emotions: How Facial Displays of Emotion Influence Goal-Related Behavior	PLOS ONE			English	Article							MOTOR CORTEX EXCITABILITY; SOCIAL COGNITION; ARM FLEXION; EXPRESSIONS; AVOIDANCE; RECOGNITION; INFORMATION; PERCEPTION; EXTENSION; DISGUST	Many authors have proposed that facial expressions, by conveying emotional states of the person we are interacting with, influence the interaction behavior. We aimed at verifying how specific the effect is of the facial expressions of emotions of an individual (both their valence and relevance/specificity for the purpose of the action) with respect to how the action aimed at the same individual is executed. In addition, we investigated whether and how the effects of emotions on action execution are modulated by participants' empathic attitudes. We used a kinematic approach to analyze the simulation of feeding others, which consisted of recording the 'feeding trajectory'' by using a computer mouse. Actors could express different highly arousing emotions, namely happiness, disgust, anger, or a neutral expression. Response time was sensitive to the interaction between valence and relevance/specificity of emotion: disgust caused faster response. In addition, happiness induced slower feeding time and longer time to peak velocity, but only in blocks where it alternated with expressions of disgust. The kinematic profiles described how the effect of the specificity of the emotional context for feeding, namely a modulation of accuracy requirements, occurs. An early acceleration in kinematic relative-to-neutral feeding profiles occurred when actors expressed positive emotions (happiness) in blocks with specific-to-feeding negative emotions (disgust). On the other hand, the end-part of the action was slower when feeding happy with respect to neutral faces, confirming the increase of accuracy requirements and motor control. These kinematic effects were modulated by participants' empathic attitudes. In conclusion, the social dimension of emotions, that is, their ability to modulate others' action planning/execution, strictly depends on their relevance and specificity to the purpose of the action. This finding argues against a strict distinction between social and nonsocial emotions.	[Ferri, Francesca; Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gallese, Vittorio] Italian Inst Technol, Brain Ctr Motor & Social Cognit, Parma, Italy; [Borghi, Anna M.] CNR, Inst Cognit Sci & Technol, Rome, Italy; [D'Amico, Luigi] Univ G dAnnunzio, Inst Psychiat, Chieti, Italy; [Stoianov, Ivilin Peev] Univ Padua, Dept Gen Psychol, Padua, Italy; [Gianelli, Claudia; Borghi, Anna M.] Univ Bologna, Dept Psychol, Bologna, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); G d'Annunzio University of Chieti-Pescara; University of Padua; University of Bologna	Ferri, F (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	francesca.ferri@nemo.unipr.it	Stoianov, Ivilin/AAX-8528-2020; Gianelli, Claudia/AAC-1518-2019; Gallese, Vittorio/ABD-5097-2021; Stoianov, Ivilin/G-5904-2011; Ferri, Francesca/AAC-2527-2022; Ferretti, Federico/AAR-9553-2021	Gallese, Vittorio/0000-0003-4815-3607; Stoianov, Ivilin/0000-0003-0642-259X; Ferri, Francesca/0000-0003-1821-5870; Borghi, Anna M./0000-0001-9455-8408; Gianelli, Claudia/0000-0002-3970-9055; Ferretti, Federico/0000-0002-5446-6522	MUR (Ministry of University and Research); European Union [216125]	MUR (Ministry of University and Research)(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission)	This work was supported by MUR (Ministry of University and Research) and the European Union FP7 (Seventh Framework Programme) project ROSSI (Emergence of Communication in RObots through Sensorimotor and Social Interaction) grant agreement number 216125. FF and VG were also supported by the EU grant DISCOS (Disorders and Coherence of the Embodied Self). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Aviezer H, 2008, PSYCHOL SCI, V19, P724, DOI 10.1111/j.1467-9280.2008.02148.x; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; Becchio C, 2008, COGNITION, V106, P894, DOI 10.1016/j.cognition.2007.05.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BONINO S, PROCESSI CONDIVISION; Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027; CACIOPPO JT, 1993, J PERS SOC PSYCHOL, V65, P5; CARUANA F, 2008, INTRACORTICAL MICROS; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; Darwin C., 1872, EXPRESSIONS EMOTIONS; Davis M., 1996, EMPATHY SOCIAL PSYCH; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; Dumouchel P., 1995, EMOTIONS ESSAI CORPS; Ekman Paul, 1972, NEBRASKA S MOTIVATIO, V19, P207, DOI DOI 10.1037/0022-3514.53.4.712; Elliot AJ, 2001, EDUC PSYCHOL REV, V13, P73, DOI 10.1023/A:1009009018235; Ferri F, 2010, EXP BRAIN RES, V203, P637, DOI 10.1007/s00221-010-2271-x; Fichtenholtz HM, 2004, COGNITIVE BRAIN RES, V20, P67, DOI 10.1016/j.cogbrainres.2004.01.006; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Forster J, 1997, PERCEPT MOTOR SKILL, V85, P1419, DOI 10.2466/pms.1997.85.3f.1419; Freeman JB, 2009, PSYCHOL SCI, V20, P1183, DOI 10.1111/j.1467-9280.2009.02422.x; Freina L, 2009, MEM COGNITION, V37, P493, DOI 10.3758/MC.37.4.493; Fridlund A. J., 1997, PSYCHOL FACIAL EXPRE, P103, DOI [10.1017/CBO9780511659911.007, DOI 10.1017/CBO9780511659911.007]; Fridlund A.J., 1994, HUMAN FACIAL EXPRESS; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; GOELEVEN E, 2000, COGNITION EMOTION, P1; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Halberstadt J, 2009, PSYCHOL SCI, V20, P1254, DOI 10.1111/j.1467-9280.2009.02432.x; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; Heuer K, 2007, BEHAV RES THER, V45, P2990, DOI 10.1016/j.brat.2007.08.010; Horstmann G, 2003, EMOTION, V3, P150, DOI 10.1037/1528-3542.3.2.150; Izard C. E., 1997, PSYCHOL FACIAL EXPRE, V2, P57, DOI DOI 10.1017/CBO9780511659911.005; Jabbi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002939; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Marsh AA, 2005, EMOTION, V5, P119, DOI 10.1037/1528-3542.5.1.119; Mead G. H., 1934, MIND SELF SOC; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2009, J PERS SOC PSYCHOL, V96, P1120, DOI 10.1037/a0015574; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Oliveri M, 2003, EXP BRAIN RES, V149, P214, DOI 10.1007/s00221-002-1346-8; Repacholi BM, 1997, DEV PSYCHOL, V33, P12, DOI 10.1037/0012-1649.33.1.12; Rotteveel M, 2004, EMOTION, V4, P156, DOI 10.1037/1528-3542.4.2.156; Schneider W., 2002, E PRIME VERSION 20 C; Schneider W., 2002, E PRIME USERS GUIDE; Seidel EM, 2010, J EXP PSYCHOL HUMAN, V36, P500, DOI 10.1037/a0018169; van Dantzig S, 2008, Q J EXP PSYCHOL, V61, P1298, DOI 10.1080/17470210802027987; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wilkowski BM, 2010, J PERS SOC PSYCHOL, V98, P201, DOI 10.1037/a0017992	52	27	27	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13126	10.1371/journal.pone.0013126	http://dx.doi.org/10.1371/journal.pone.0013126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	656TI	20957204	Green Published, gold			2022-12-25	WOS:000282359300020
J	Standar, K; Kreikemeyer, B; Redanz, S; Munter, WL; Laue, M; Podbielski, A				Standar, Kerstin; Kreikemeyer, Bernd; Redanz, Sylvio; Muenter, Wanja L.; Laue, Michael; Podbielski, Andreas			Setup of an In Vitro Test System for Basic Studies on Biofilm Behavior of Mixed-Species Cultures with Dental and Periodontal Pathogens	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; ORAL BIOFILMS; SUBGINGIVAL PLAQUE; SURFACES; GROWTH; COLONIZATION; ADHESION; BACTERIA	Background: Caries and periodontitis are important human diseases associated with formation of multi-species biofilms. The involved bacteria are intensively studied to understand the molecular basis of the interactions in such biofilms. This study established a basic in vitro single and mixed-species culture model for oral bacteria combining three complimentary methods. The setup allows a rapid screening for effects in the mutual species interaction. Furthermore, it is easy to handle, inexpensive, and reproducible. Methods: Streptococcus mitis, S. salivarius and S. sanguinis, typical inhabitants of the healthy oral cavity, S. mutans as main carriogenic species, and Porphyromonas gingivalis, Fusobacterium nucleatum, Parvimonas micra, S. intermedius and Aggregatibacter actinomycetemcomitans as periodontitis-associated bacteria, were investigated for their biofilm forming ability. Different liquid growth media were evaluated. Safranin-staining allowed monitoring of biofilm formation under the chosen conditions. Viable counts and microscopy permitted investigation of biofilm behavior in mixed-species and transwell setups. Findings: S. mitis, F. nucleatum, P. gingivalis and P. micra failed to form biofilm structures. S. mutans, S. sanguinis, S. intermedius and S. salivarius established abundant biofilm masses in CDM/sucrose. A. actinomycetemcomitans formed patchy monolayers. For in depth analysis S. mitis, S. mutans and A. actinomycetemcomitans were chosen, because i) they are representatives of the physiological-, cariogenic and periodontitis-associated bacterial flora, respectively and ii) their difference in their biofilm forming ability. Microscopic analysis confirmed the results of safranin staining. Investigation of two species combinations of S. mitis with either S. mutans or A. actinomycetemcomitans revealed bacterial interactions influencing biofilm mass, biofilm structure and cell viability. Conclusions: This setup shows safranin staining, microscopic analysis and viable counts together are crucial for basic examination and evaluation of biofilms. Our experiment generated meaningful results, exemplified by the noted S. mitis influence, and allows a fast decision about the most important bacterial interactions which should be investigated in depth.	[Standar, Kerstin; Kreikemeyer, Bernd; Redanz, Sylvio; Muenter, Wanja L.; Podbielski, Andreas] Univ Hosp Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Laue, Michael] Univ Hosp Rostock, Inst Pathol, Electron Microscop Ctr, Rostock, Germany	University of Rostock; University of Rostock	Standar, K (corresponding author), Univ Hosp Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	bernd.kreikemeyer@med.uni-rostock.de	Redanz, Sylvio/AAH-1369-2020	Kreikemeyer, Bernd/0000-0001-9527-5098; Redanz, Sylvio/0000-0003-1541-2545	Federal Ministry of Education and Research (BMBF) [FKZ 0313801M, FKZ 0313936B]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Federal Ministry of Education and Research (BMBF) in the framework of the PathoGenoMic Plus program (FKZ 0313801M) and ERANet PathoGenoMics I program (FKZ 0313936B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe JJ, 2009, INFECT IMMUN, V77, P2896, DOI 10.1128/IAI.00126-09; Bowden GHW, 1999, METHOD ENZYMOL, V310, P216; Bowen WH, 2002, CRIT REV ORAL BIOL M, V13, P126, DOI 10.1177/154411130201300203; Bradshaw DJ, 1996, J APPL BACTERIOL, V80, P124, DOI 10.1111/j.1365-2672.1996.tb03199.x; Brown SA, 2007, J BACTERIOL, V189, P6407, DOI 10.1128/JB.00554-07; CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318, DOI 10.1128/IAI.37.1.318-326.1982; COWAN MM, 1992, J GEN MICROBIOL, V138, P2707, DOI 10.1099/00221287-138-12-2707; Dawes C, 2008, J AM DENT ASSOC, V139, p18S, DOI 10.14219/jada.archive.2008.0351; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; FESSIA SL, 1991, PERITON DIALYSIS INT, V11, P144; Fine DH, 1999, MICROBIOL-SGM, V145, P1335, DOI 10.1099/13500872-145-6-1335; Fine DH, 1999, ARCH ORAL BIOL, V44, P1063, DOI 10.1016/S0003-9969(99)00089-8; Foster JS, 2003, BIOL BULL-US, V204, P200, DOI 10.2307/1543559; GARCIAMENDOZA A, 1993, J MED MICROBIOL, V39, P434, DOI 10.1099/00222615-39-6-434; Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Haase EM, 2006, ARCH ORAL BIOL, V51, P299, DOI 10.1016/j.archoralbio.2005.09.002; Haffajee AD, 2006, PERIODONTOL 2000, V42, P219, DOI 10.1111/j.1600-0757.2006.00191.x; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Inoue T, 2003, MICROBIOL IMMUNOL, V47, P877, DOI 10.1111/j.1348-0421.2003.tb03454.x; Kaplan JB, 2003, J BACTERIOL, V185, P1399, DOI 10.1128/JB.185.4.1399-1404.2003; LARSEN T, 1995, APMIS, V103, P339, DOI 10.1111/j.1699-0463.1995.tb01117.x; LAW DJ, 1978, ANTIMICROB AGENTS CH, V13, P473, DOI 10.1128/AAC.13.3.473; Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Leriche V, 2000, J APPL MICROBIOL, V88, P594, DOI 10.1046/j.1365-2672.2000.01000.x; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Ohta H, 2001, MICROBIOL-SGM, V147, P2461, DOI 10.1099/00221287-147-9-2461; Oliveira Mara R T R, 2007, J Oral Sci, V49, P141; Oliver JD, 2005, J MICROBIOL, V43, P93; Palmer RJ, 2001, INFECT IMMUN, V69, P5794, DOI 10.1128/IAI.69.9.5794-5804.2001; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Periasamy S, 2009, INFECT IMMUN, V77, P3542, DOI 10.1128/IAI.00345-09; Perry JA, 2009, FEMS MICROBIOL LETT, V299, P261, DOI 10.1111/j.1574-6968.2009.01758.x; Petersen FC, 2005, J BACTERIOL, V187, P4392, DOI 10.1128/JB.187.13.4392-4400.2005; Riep B, 2009, J CLIN MICROBIOL, V47, P1705, DOI 10.1128/JCM.01387-08; Schlafer S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-66; SJOLLEMA J, 1990, FEMS MICROBIOL LETT, V69, P263; Sliepen I, 2008, ORAL MICROBIOL IMMUN, V23, P520, DOI 10.1111/j.1399-302X.2008.00456.x; Sliepen I, 2009, ORAL MICROBIOL IMMUN, V24, P390, DOI 10.1111/j.1399-302X.2009.00531.x; Slots J, 1999, PERIODONTOL 2000, V20, P82, DOI 10.1111/j.1600-0757.1999.tb00159.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SREENIVASAN PK, 1993, ORAL MICROBIOL IMMUN, V8, P361, DOI 10.1111/j.1399-302X.1993.tb00612.x; Stingu CS, 2008, J MED MICROBIOL, V57, P495, DOI 10.1099/jmm.0.47649-0; TALARICO TL, 1989, ANTIMICROB AGENTS CH, V33, P674, DOI 10.1128/AAC.33.5.674; Teughels W, 2007, J DENT RES, V86, P611, DOI 10.1177/154405910708600706; Vadillo-Rodriguez V, 2004, MICROBIOL-SGM, V150, P1015, DOI 10.1099/mic.0.26828-0; Van Hoogmoed CG, 2008, ORAL MICROBIOL IMMUN, V23, P43, DOI 10.1111/j.1399-302X.2007.00388.x; van Hoogmoed CG, 2000, APPL ENVIRON MICROB, V66, P659, DOI 10.1128/AEM.66.2.659-663.2000; van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; XU HS, 1982, MICROBIAL ECOL, V8, P313, DOI 10.1007/BF02010671	53	39	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13135	10.1371/journal.pone.0013135	http://dx.doi.org/10.1371/journal.pone.0013135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957048	Green Submitted, gold, Green Published			2022-12-25	WOS:000282359300025
J	Fang, L; Deng, Z; Shatseva, T; Yang, J; Peng, C; Du, WW; Yee, AJ; Ang, LC; He, C; Shan, SW; Yang, BB				Fang, L.; Deng, Z.; Shatseva, T.; Yang, J.; Peng, C.; Du, W. W.; Yee, A. J.; Ang, L. C.; He, C.; Shan, S. W.; Yang, B. B.			MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta 8	ONCOGENE			English	Article						microRNA; siRNA; integrin; angiogenesis; tumorigenesis	MIR-17-92 CLUSTER; FACTOR-BETA; ALPHA-V-BETA-8-MEDIATED ACTIVATION; CELL-SURVIVAL; LUNG CANCERS; EXPRESSION; SUPPRESSOR; ROLES; APOPTOSIS; BLOOD	It has been reported that the miR-106b similar to 25 cluster, a paralog of the miR-17 similar to 92 cluster, possesses oncogenic activities. However, the precise role of each microRNA (miRNA) in the miR-106b similar to 25 cluster is not yet known. In this study, we examined the function of miR-93, one of the microRNAs within the miR-106b similar to 25 cluster, in angiogenesis and tumor formation. We found that miR-93 enhanced cell survival, promoted sphere formation and augmented tumor growth. Most strikingly, when miR-93-overexpressing U87 cells were co-cultured with endothelial cells, they supported endothelial cell spreading, growth, migration and tube formation. In vivo studies revealed that miR-93-expressing cells induced blood vessel formation, allowing blood vessels to extend to tumor tissues in high densities. Angiogenesis promoted by miR-93 in return facilitated cell survival, resulting in enhanced tumor growth. We further showed that integrin-beta 8 is a target of miR-93. Higher levels of integrin-beta 8 are associated with cell death in tumor mass and in human glioblastoma. Silencing of integrin-beta 8 expression using small interfering RNA promoted cell proliferation, whereas ectopic expression of integrin-beta 8 decreased cell growth. These findings showed that miR-93 promotes tumor growth and angiogenesis by suppressing, at least in part, integrin-beta 8 expression. Our results suggest that inhibition of miR-93 function may be a feasible approach to suppress angiogenesis and tumor growth. Oncogene (2011) 30, 806-821; doi:10.1038/onc.2010.465; published online 18 October 2010	[Fang, L.; Deng, Z.; Shatseva, T.; Du, W. W.; Yee, A. J.; Shan, S. W.; Yang, B. B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Fang, L.; He, C.] Jilin Univ, China Japan Union Hosp, Jilin, Peoples R China; [Yang, J.; Peng, C.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Ang, L. C.] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Fang, L.; Deng, Z.; Shatseva, T.; Shan, S. W.; Yang, B. B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Jilin University; York University - Canada; Western University (University of Western Ontario); University of Toronto	Yang, BB (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	byang@sri.utoronto.ca	Yang, Bai/F-6483-2012	SHAN, SW/0000-0001-6876-9914	Heart and Stroke Foundation of Ontario [NA6282, CI5958]; Canadian Institutes of Health Research [MOP-102635]; China Scholarship Council; Ontario Women's Health Council/CIHR	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); China Scholarship Council(China Scholarship Council); Ontario Women's Health Council/CIHR(Canadian Institutes of Health Research (CIHR))	We thank the Brain Tumour Tissue Bank (London, Ontario) for glioblastoma slides. This work was supported by a grant from the Heart and Stroke Foundation of Ontario (NA6282) and a grant from Canadian Institutes of Health Research (MOP-102635) to BBY, who is the recipient of a Career Investigator Award (CI5958) from the Heart and Stroke Foundation of Ontario. LF is supported by a Scholarship from China Scholarship Council. CP is supported by a Mid-Career Award from Ontario Women's Health Council/CIHR.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bullitt E, 2007, RADIOLOGY, V245, P824, DOI 10.1148/radiol.2453061889; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Cambier S, 2000, CANCER RES, V60, P7084; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Fjellbirkeland L, 2003, AM J PATHOL, V163, P533, DOI 10.1016/S0002-9440(10)63681-4; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Hagendoorn J, 2006, CANCER RES, V66, P3360, DOI 10.1158/0008-5472.CAN-05-2655; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Novotny GW, 2007, CELL DEATH DIFFER, V14, P879, DOI 10.1038/sj.cdd.4402090; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Sharma A, 2009, P NATL ACAD SCI USA, V106, P5761, DOI 10.1073/pnas.0808743106; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	39	252	263	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	7					806	821		10.1038/onc.2010.465	http://dx.doi.org/10.1038/onc.2010.465			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	722OT	20956944				2022-12-25	WOS:000287444600005
J	Ghoshal, S; Trivedi, DB; Graf, GA; Loftin, CD				Ghoshal, Sarbani; Trivedi, Darshini B.; Graf, Gregory A.; Loftin, Charles D.			Cyclooxygenase-2 Deficiency Attenuates Adipose Tissue Differentiation and Inflammation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS ADIPOCYTE DIFFERENTIATION; ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); UP-REGULATION; 3T3-L1 CELLS; IN-VIVO; PROSTAGLANDIN; EXPRESSION; OBESITY	Obesity is associated with a variety of disorders and is a significant health problem in developed countries. One factor controlling the level of adiposity is the differentiation of cells into adipocytes. Adipocyte differentiation requires expression of peroxisome proliferator-activated receptor gamma (PPAR gamma), which is activated by ligands to regulate expression of genes involved in adipocyte differentiation. Although 15-deoxy-Delta(12,14)-prostaglandin (PG) J(2) (15d-PGJ(2)) has long been known to be a potent activator of PPAR gamma, the importance of its synthesis in adipose tissue in vivo is not clear. The current study utilized mice deficient in cyclooxygenase-2 (COX-2) to examine the role of COX-2-derived PGs as in vivo modulators of adiposity. As compared with strain- and age-matched wildtype controls, the genetic deficiency of COX-2 resulted in a significant reduction in total body weight and percent body fat. Although there were no significant differences in food consumption between groups, COX-2-deficient mice showed increased metabolic activity. Epididymal adipose tissue from wild-type mice produced a significantly greater level of 15d-PGJ(2), as compared with adipose tissue isolated from mice deficient in COX-2. Furthermore, production of the precursor required for 15d-PGJ(2) formation, PGD(2), was also significantly reduced in COX-2-deficient adipose tissue. The expression of markers for differentiated adipocytes was significantly reduced in adipose tissue from COX-2-deficient mice, whereas preadipocyte marker expression was increased. Macrophage-dependent inflammation was also significantly reduced in adipose tissue of COX-2-deficient mice. These findings suggest that reduced adiposity in COX-2-deficient mice results from attenuated PPAR gamma ligand production and adipocyte differentiation.	[Ghoshal, Sarbani; Graf, Gregory A.; Loftin, Charles D.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Trivedi, Darshini B.] NIEHS, Lab Toxicol & Pharmacol, NIH, Res Triangle Pk, NC 27709 USA	University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Loftin, CD (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Bio Pharm Complex,Rm 347,789 S Limestone St, Lexington, KY 40536 USA.	cdloft2@email.uky.edu		Graf, Gregory/0000-0002-0130-9929	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR024598] Funding Source: Medline; NIDDK NIH HHS [R01 DK080874-01A2, R01 DK080874-02, R01 DK080874-03, R01 DK080874] Funding Source: Medline; NIGMS NIH HHS [P20 GM103527] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aubert J, 2000, MOL CELL ENDOCRINOL, V160, P149, DOI 10.1016/S0303-7207(99)00210-5; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Bosetti F, 2004, J NEUROCHEM, V91, P1389, DOI 10.1111/j.1471-4159.2004.02829.x; Bosetti F, 2007, J NEUROCHEM, V102, P577, DOI 10.1111/j.1471-4159.2007.04558.x; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Casimir DA, 1996, DIFFERENTIATION, V60, P203, DOI 10.1046/j.1432-0436.1996.6040203.x; Chu X, 2010, PROSTAG OTH LIPID M, V91, P1, DOI 10.1016/j.prostaglandins.2009.10.002; Cuzzocrea S, 2002, MOL PHARMACOL, V61, P997, DOI 10.1124/mol.61.5.997; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; Fain JN, 2001, PROSTAG OTH LIPID M, V65, P199, DOI 10.1016/S0090-6980(01)00136-8; Fajas L, 2003, J LIPID RES, V44, P1652, DOI 10.1194/jlr.M300248-JLR200; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Granado M, 2009, EUR J PHARMACOL, V608, P97, DOI 10.1016/j.ejphar.2009.02.030; Hartman HB, 2002, J BIOL CHEM, V277, P19754, DOI 10.1074/jbc.M201451200; Hsieh PS, 2010, EUR J CLIN INVEST, V40, P164, DOI 10.1111/j.1365-2362.2009.02239.x; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Kageyama H, 2003, BIOCHEM BIOPH RES CO, V305, P22, DOI 10.1016/S0006-291X(03)00663-6; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kirtikara K, 1998, J EXP MED, V187, P517, DOI 10.1084/jem.187.4.517; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Lijnen HR, 2008, THROMB HAEMOSTASIS, V100, P338, DOI 10.1160/TH08-02-0114; Liu L, 2007, J CELL BIOCHEM, V100, P161, DOI 10.1002/jcb.21044; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Mazid MA, 2006, FEBS LETT, V580, P6885, DOI 10.1016/j.febslet.2006.11.049; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Negrel R, 1999, PROSTAG LEUKOTR ESS, V60, P383, DOI 10.1016/S0952-3278(99)80017-9; Nishimura S, 2008, J CLIN INVEST, V118, P710, DOI 10.1172/JCI33328; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Scher JU, 2005, CLIN IMMUNOL, V114, P100, DOI 10.1016/j.clim.2004.09.008; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Sonoda E, 2008, ENDOCRINOLOGY, V149, P4794, DOI 10.1210/en.2008-0525; SUGIHARA H, 1988, J LIPID RES, V29, P691; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsuboi H, 2004, BIOCHEM BIOPH RES CO, V322, P1066, DOI 10.1016/j.bbrc.2004.08.018; VASSAUX G, 1992, J BIOL CHEM, V267, P11092; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wang HB, 2004, J BIOL CHEM, V279, P10649, DOI 10.1074/jbc.M312203200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu DY, 2007, J IMMUNOL, V179, P4829, DOI 10.4049/jimmunol.179.7.4829; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200	51	66	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					889	898		10.1074/jbc.M110.139139	http://dx.doi.org/10.1074/jbc.M110.139139			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20961858	Green Published, hybrid			2022-12-25	WOS:000285782800088
J	Sekiya, M; Hosokawa, H; Nakanishi-Matsui, M; Al-Shawi, MK; Nakamoto, RK; Futai, M				Sekiya, Mizuki; Hosokawa, Hiroyuki; Nakanishi-Matsui, Mayumi; Al-Shawi, Marwan K.; Nakamoto, Robert K.; Futai, Masamitsu			Single Molecule Behavior of Inhibited and Active States of Escherichia coli ATP Synthase F-1 Rotation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSILON-SUBUNIT; BETA-SUBUNIT; CATALYTIC SITE; GAMMA-SUBUNIT; NUCLEOTIDE-BINDING; F0F1-ATP SYNTHASE; ROTARY MECHANISM; TRANSITION-STATE; C-RING; F-1-ATPASE	ATP hydrolysis-dependent rotation of the F-1 sector of the ATP synthase is a successive cycle of catalytic dwells (similar to 0.2 ms at 24 degrees C) and 120 degrees rotation steps (similar to 0.6 ms) when observed under V-max conditions using a low viscous drag 60-nm bead attached to the gamma subunit (Sekiya, M., Nakamoto, R. K., AlShawi, M. K., Nakanishi-Matsui, M., and Futai, M. (2009) J. Biol. Chem. 284, 22401-22410). During the normal course of observation, the gamma subunit pauses in a stochastic manner to a catalytically inhibited state that averages similar to 1 s in duration. The rotation behavior with adenosine 5'-O-(3-thiotriphosphate) as the substrate or at a low ATP concentration (4 mu M) indicates that the rotation is inhibited at the catalytic dwell when the bound ATP undergoes reversible hydrolysis/synthesis. The temperature dependence of rotation shows that F-1 requires similar to 2-fold higher activation energy for the transition from the active to the inhibited state compared with that for normal steady-state rotation during the active state. Addition of superstoichiometric gamma subunit, the inhibitor of F-1-ATPase, decreases the rotation rate and at the same time increases the duration time of the inhibited state. Arrhenius analysis shows that the gamma subunit has little effect on the transition between active and inhibited states. Rather, the gamma subunit confers lower activation energy of steady-state rotation. These results suggest that the gamma subunit plays a role in guiding the enzyme through the proper and efficient catalytic and transport rotational pathway but does not influence the transition to the inhibited state.	[Futai, Masamitsu] Iwate Med Univ, Dept Biochem, Fac Pharmaceut Sci, Yahaba, Iwate 0283694, Japan; [Futai, Masamitsu] Iwate Med Univ, Futai Special Lab, Yahaba, Iwate 0283694, Japan; [Al-Shawi, Marwan K.; Nakamoto, Robert K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	Iwate Medical University; Iwate Medical University; University of Virginia	Futai, M (corresponding author), Iwate Med Univ, Dept Biochem, Fac Pharmaceut Sci, Yahaba, Iwate 0283694, Japan.	futaim@iwate-med.ac.jp			United States Public Health Service [RO1 GM50957, RO1 GM52502]; Ministry of Science and Culture of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052502, R01GM050957] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Ministry of Science and Culture of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was support, in whole or in part, by United States Public Health Service Grants RO1 GM50957 (to R. K.N.) and RO1 GM52502 (to M. K. A.-S.). This work was also supported by a grant from Ministry of Science and Culture of Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; AlShawi MK, 1997, J BIOL CHEM, V272, P2300; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12954, DOI 10.1021/bi971477z; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; Andrews SH, 2001, BIOCHEMISTRY-US, V40, P10664, DOI 10.1021/bi0155697; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Boyer P. D., 1979, MEMBRANE BIOENERGETI, P461; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; KANAZAWA H, 1980, J BIOCHEM-TOKYO, V88, P695, DOI 10.1093/oxfordjournals.jbchem.a133022; Kashiwagi S, 2008, BIOCHEM BIOPH RES CO, V365, P227, DOI 10.1016/j.bbrc.2007.10.157; Le NP, 2000, BIOCHEMISTRY-US, V39, P2778, DOI 10.1021/bi992530h; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Monkos K, 1996, INT J BIOL MACROMOL, V18, P61, DOI 10.1016/0141-8130(95)01057-2; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Nakanishi-Matsui M, 2007, J BIOL CHEM, V282, P20698, DOI 10.1074/jbc.M700551200; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Nakanishi-Matsui M, 2010, BIOCHEM BIOPH RES CO, V395, P173, DOI 10.1016/j.bbrc.2010.03.127; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Okuno D, 2008, P NATL ACAD SCI USA, V105, P20722, DOI 10.1073/pnas.0805828106; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Peskova YB, 2000, BIOCHEMISTRY-US, V39, P11830, DOI 10.1021/bi0013694; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Scanlon JAB, 2008, J BIOL CHEM, V283, P26228, DOI 10.1074/jbc.M804858200; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; Sekiya M, 2009, J BIOL CHEM, V284, P22401, DOI 10.1074/jbc.M109.009019; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; Tanabe M, 2001, J BIOL CHEM, V276, P15269, DOI 10.1074/jbc.M100289200; Tsumuraya M, 2009, FEBS LETT, V583, P1121, DOI 10.1016/j.febslet.2009.02.038; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	43	39	40	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42058	42067		10.1074/jbc.M110.176701	http://dx.doi.org/10.1074/jbc.M110.176701			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974856	hybrid, Green Published			2022-12-25	WOS:000285622600091
J	van Lith, M; McEwen-Smith, RM; Benham, AM				van Lith, Marcel; McEwen-Smith, Rosanna M.; Benham, Adam M.			HLA-DP, HLA-DQ, and HLA-DR Have Different Requirements for Invariant Chain and HLA-DM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II HISTOCOMPATIBILITY ANTIGENS; CELL-SURFACE EXPRESSION; PEPTIDE-BINDING; INTRACELLULAR-TRANSPORT; MHC MOLECULES; HEPATITIS-B; T-CELLS; COMPLEX; HLA-DP2; ALPHA	The MHC is central to the adaptive immune response. The human MHC class II is encoded by three different isotypes, HLA-DR, -DQ, and -DP, each being highly polymorphic. In contrast to HLA-DR, the intracellular assembly and trafficking of HLA-DP molecules have not been studied extensively. However, different HLA-DP variants can be either protective or risk factors for infectious diseases (e.g. hepatitis B), immune dysfunction (e.g. berylliosis), and autoimmunity (e.g. myasthenia gravis). Here, we establish a system to analyze the chaperone requirements for HLA-DP and to compare the assembly and trafficking of HLA-DP, -DQ, and -DR directly. Unlike HLA-DR1, HLA-DQ5 and HLA-DP4 can form SDS-stable dimers supported by invariant chain (Ii) in the absence of HLA-DM. Uniquely, HLA-DP also forms dimers in the presence of HLA-DM alone. In model antigen-presenting cells, SDS-stable HLA-DP complexes are resistant to treatments that prevent formation of SDS-stable HLA-DR complexes. The unexpected properties of HLA-DP molecules may help explain why they bind to a more restricted range of peptides than other human MHC class II proteins and frequently present viral peptides.	[van Lith, Marcel; McEwen-Smith, Rosanna M.; Benham, Adam M.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England	Durham University	Benham, AM (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	adam.benham@durham.ac.uk	Benham, Adam/AAC-6606-2019	Benham, Adam/0000-0002-0919-7431; Van Lith, Marcel/0000-0003-0225-5501	Biotechnology and Biological Sciences Research Council [BBC509582]; Biotechnology and Biological Sciences Research Council [BB/C509582/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BBC509582.	ARUNACHALAM B, 1994, INT IMMUNOL, V6, P439, DOI 10.1093/intimm/6.3.439; AUSTIN P, 1985, NATURE, V313, P61, DOI 10.1038/313061a0; BIKOFF EK, 1995, IMMUNITY, V2, P301, DOI 10.1016/1074-7613(95)90054-3; Bontrop RE, 1999, IMMUNOL REV, V167, P339, DOI 10.1111/j.1600-065X.1999.tb01403.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Castelli FA, 2002, J IMMUNOL, V169, P6928, DOI 10.4049/jimmunol.169.12.6928; CELIS E, 1990, J IMMUNOL, V145, P305; Chicz RM, 1997, J IMMUNOL, V159, P4935; COTNER T, 1995, J BIOL CHEM, V270, P2379, DOI 10.1074/jbc.270.5.2379; Crotzer VL, 2009, J IMMUNOL, V182, P3335, DOI 10.4049/jimmunol.0803458; Dai SD, 2010, P NATL ACAD SCI USA, V107, P7425, DOI 10.1073/pnas.1001772107; Diaz G, 2005, IMMUNOGENETICS, V56, P754, DOI 10.1007/s00251-004-0735-5; ECKELS DD, 1983, NATURE, V301, P716, DOI 10.1038/301716a0; El Fakhry Y, 2004, J BIOL CHEM, V279, P18472, DOI 10.1074/jbc.M401159200; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; Ettinger RA, 1998, J IMMUNOL, V161, P6439; FALK K, 1994, IMMUNOGENETICS, V39, P230; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GIACOMINI P, 1989, J IMMUNOGENET, V16, P203; GORGA JC, 1987, J BIOL CHEM, V262, P16087; Gruda R, 2007, J IMMUNOL, V179, P3655, DOI 10.4049/jimmunol.179.6.3655; HAMMOND SA, 1991, J IMMUNOL, V146, P1470; Hiltbold EM, 2002, CURR OPIN IMMUNOL, V14, P30, DOI 10.1016/S0952-7915(01)00295-3; HORIKI T, 1994, AUTOIMMUNITY, V19, P49, DOI 10.3109/08916939409008008; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; Kenty G, 1999, J IMMUNOL, V163, P232; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Koonce CH, 2003, J IMMUNOL, V170, P3751, DOI 10.4049/jimmunol.170.7.3751; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; MOMBURG F, 1988, IMMUNOLOGY, V63, P551; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; Patil NS, 2001, J IMMUNOL, V167, P7157, DOI 10.4049/jimmunol.167.12.7157; Reed AM, 1997, J IMMUNOL, V159, P6260; RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; SEKALY RP, 1986, J EXP MED, V164, P1490, DOI 10.1084/jem.164.5.1490; SHACKELFORD DA, 1983, J IMMUNOL, V130, P274; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; Toussaint H, 2008, J VIROL, V82, P8373, DOI 10.1128/JVI.00670-08; van Ham M, 2000, J EXP MED, V191, P1127, DOI 10.1084/jem.191.7.1127; van Lith M, 2006, J IMMUNOL, V177, P5430, DOI 10.4049/jimmunol.177.8.5430; VIDARD L, 1991, J IMMUNOL, V147, P1786; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	49	43	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40800	40808		10.1074/jbc.M110.148155	http://dx.doi.org/10.1074/jbc.M110.148155			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959457	Green Published, hybrid			2022-12-25	WOS:000285414400045
J	Kassim, SH; Li, H; Vandenberghe, LH; Hinderer, C; Bell, P; Marchadier, D; Wilson, A; Cromley, D; Redon, V; Yu, H; Wilson, JM; Rader, DJ				Kassim, Sadik H.; Li, Hui; Vandenberghe, Luk H.; Hinderer, Christian; Bell, Peter; Marchadier, Dawn; Wilson, Aisha; Cromley, Debra; Redon, Valeska; Yu, Hongwei; Wilson, James M.; Rader, Daniel J.			Gene Therapy in a Humanized Mouse Model of Familial Hypercholesterolemia Leads to Marked Regression of Atherosclerosis	PLOS ONE			English	Article							HELPER-DEPENDENT ADENOVIRUS; ADENOASSOCIATED VIRUS; LIVER-TRANSPLANTATION; CHOLESTEROL LEVELS; HEMOPHILIA-B; T-CELLS; MICE; VECTORS; DEFICIENCY; DISEASE	Background: Familial hypercholesterolemia (FH) is an autosomal codominant disorder caused by mutations in the low-density lipoprotein receptor (LDLR) gene. Homozygous FH patients (hoFH) have severe hypercholesterolemia leading to life threatening atherosclerosis in childhood and adolescence. Mice with germ line interruptions in the Ldlr and Apobec1 genes (Ldlr(-/-)Apobec1(-/-)) simulate metabolic and clinical aspects of hoFH, including atherogenesis on a chow diet. Methods/Principal Findings: In this study, vectors based on adeno-associated virus 8 (AAV8) were used to deliver the gene for mouse Ldlr (mLDLR) to the livers of Ldlr(-/-)Apobec1(-/)-mice. A single intravenous injection of AAV8. mLDLR was found to significantly reduce plasma cholesterol and non-HDL cholesterol levels in chow-fed animals at doses as low as 3 x 10(9) genome copies/mouse. Whereas Ldlr(-/-)Apobec1(-/-) mice fed a western-type diet and injected with a control AAV8. null vector experienced a further 65% progression in atherosclerosis over 2 months compared with baseline mice, Ldlr(-/-)Apobec1(-/-) mice treated with AAV8.mLDLR realized an 87% regression of atherosclerotic lesions after 3 months compared to baseline mice. Immunohistochemical analyses revealed a substantial remodeling of atherosclerotic lesions. Conclusions/Significance: Collectively, the results presented herein suggest that AAV8-based gene therapy for FH may be feasible and support further development of this approach. The pre-clinical data from these studies will enable for the effective translation of gene therapy into the clinic for treatment of FH.	[Kassim, Sadik H.; Vandenberghe, Luk H.; Hinderer, Christian; Bell, Peter; Yu, Hongwei; Wilson, James M.] Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA 19104 USA; [Li, Hui; Marchadier, Dawn; Wilson, Aisha; Cromley, Debra; Redon, Valeska; Rader, Daniel J.] Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Kassim, SH (corresponding author), Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu	VANDENBERGHE, LUC H./ABH-1765-2020; Wilson, James M/F-9220-2011; Vandenberghe, Luk H./J-6395-2014; Vandenberghe, Luk H/B-4678-2008	VANDENBERGHE, LUC H./0000-0002-3508-4924; Wilson, James M/0000-0002-9630-3131; Vandenberghe, Luk H./0000-0002-3508-4924; Vandenberghe, Luk H/0000-0002-3508-4924	National Heart Lung and Blood Institute [P01-HL059407]; National Institute of Diabetes and Digestive and Kidney Diseases [P30-DK047757]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK047757] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Heart Lung and Blood Institute P01-HL059407 (JMW) and National Institute of Diabetes and Digestive and Kidney Diseases P30-DK047757 (JMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigel R, 2009, J CLIN APHERESIS, V24, P219, DOI 10.1002/jca.20215; BILHEIMER DW, 1984, NEW ENGL J MED, V311, P1658, DOI 10.1056/NEJM198412273112603; Borberg H, 2009, TRANSFUS APHER SCI, V41, P49, DOI 10.1016/j.transci.2009.05.013; Breous E, 2009, HEPATOLOGY, V50, P612, DOI 10.1002/hep.23043; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Chen SJ, 2000, MOL THER, V2, P256, DOI 10.1006/mthe.2000.0122; Cichon G, 2004, J GENE MED, V6, P166, DOI 10.1002/jgm.473; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; DECKELBAUM RJ, 1977, NEW ENGL J MED, V296, P465, DOI 10.1056/NEJM197703032960901; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gao GP, 2009, HUM GENE THER, V20, P930, DOI 10.1089/hum.2009.060; Garg A, 2002, J CLIN ENDOCR METAB, V87, P3019, DOI 10.1210/jc.87.7.3019; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GROSSMAN M, 1995, NAT MED, V1, P1148, DOI 10.1038/nm1195-1148; GROSSMAN M, 1994, NAT GENET, V6, P335, DOI 10.1038/ng0494-335; Hasbrouck NC, 2008, GENE THER, V15, P870, DOI 10.1038/gt.2008.71; HIBBITT OC, 2009, MOL THER; Jacobs F, 2010, AM J PATHOL, V176, P14, DOI 10.2353/ajpath.2010.090136; Kitajima K, 2006, ARTERIOSCL THROM VAS, V26, P1852, DOI 10.1161/01.ATV.0000231520.26490.54; Kozarsky KF, 1996, NAT GENET, V13, P54, DOI 10.1038/ng0596-54; KOZARSKY KF, 1994, J BIOL CHEM, V269, P13695; Lebherz C, 2004, J GENE MED, V6, P663, DOI 10.1002/jgm.554; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mays LE, 2009, J IMMUNOL, V182, P6051, DOI 10.4049/jimmunol.0803965; McCaffrey AP, 2008, MOL THER, V16, P931, DOI 10.1038/mt.2008.37; Moghadasian MH, 2001, LAB INVEST, V81, P1173, DOI 10.1038/labinvest.3780331; NESS GC, 1994, ARCH BIOCHEM BIOPHYS, V315, P199, DOI 10.1006/abbi.1994.1490; Nomura S, 2004, GENE THER, V11, P1540, DOI 10.1038/sj.gt.3302310; Powell-Braxton L, 1998, NAT MED, V4, P934, DOI 10.1038/nm0898-934; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; RELA M, 1995, TRANSPLANT INT, V8, P41, DOI 10.1007/BF00366709; RUSSELL JC, CARDIOVASCULAR PATHO, V15, P318; Sanan DA, 1998, P NATL ACAD SCI USA, V95, P4544, DOI 10.1073/pnas.95.8.4544; Sarkar R, 2004, BLOOD, V103, P1253, DOI 10.1182/blood-2003-08-2954; SCANU AM, 1988, J LIPID RES, V29, P1671; SCHALE S, 2009, REGULATORY REQUIREME, P1; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Tangirala RK, 2001, J BIOL CHEM, V276, P261, DOI 10.1074/jbc.M003324200; Thompson GR, 2003, ATHEROSCLEROSIS, V167, P1, DOI 10.1016/S0021-9150(02)00251-4; THOMPSON GR, 1995, LANCET, V345, P811, DOI 10.1016/S0140-6736(95)92961-4; Tsukamoto K, 2000, MOL THER, V1, P189, DOI 10.1006/mthe.2000.0028; Vaessen SFC, 2007, CURR GENE THER, V7, P35, DOI 10.2174/156652307779940261; Vandenberghe LH, 2006, NAT MED, V12, P967, DOI 10.1038/nm1445; WANG L, 2009, MOL THERAPY; Wang LL, 2010, MOL THER, V18, P126, DOI 10.1038/mt.2009.245; Wang LL, 2005, BLOOD, V105, P3079, DOI 10.1182/blood-2004-10-3867; Wright JF, 2008, GENE THER, V15, P840, DOI 10.1038/gt.2008.65; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009	50	54	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13424	10.1371/journal.pone.0013424	http://dx.doi.org/10.1371/journal.pone.0013424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976059	Green Published, gold, Green Submitted			2022-12-25	WOS:000283114700004
J	Anand-Apte, B; Ebrahem, Q; Cutler, A; Farage, E; Sugimoto, M; Hollyfield, J; Folkman, J				Anand-Apte, Bela; Ebrahem, Quteba; Cutler, Alecia; Farage, Eric; Sugimoto, Masahiko; Hollyfield, Joe; Folkman, Judah			Betacellulin Induces Increased Retinal Vascular Permeability in Mice	PLOS ONE			English	Article							RECOMBINANT HUMAN BETACELLULIN; EPIDERMAL-GROWTH-FACTOR; DIABETIC-RETINOPATHY; BETA-CELLS; BARRIER BREAKDOWN; FACTOR RECEPTOR; EGF FAMILY; ACTIVIN-A; GLUCOSE; ERYTHROPOIETIN	Background: Diabetic maculopathy, the leading cause of vision loss in patients with type 2 diabetes, is characterized by hyper-permeability of retinal blood vessels with subsequent formation of macular edema and hard exudates. The degree of hyperglycemia and duration of diabetes have been suggested to be good predictors of retinal complications. Intervention studies have determined that while intensive treatment of diabetes reduced the development of proliferative diabetic retinopathy it was associated with a two to three-fold increased risk of severe hypoglycemia. Thus we hypothesized the need to identify downstream glycemic targets, which induce retinal vascular permeability that could be targeted therapeutically without the additional risks associated with intensive treatment of the hyperglycemia. Betacellulin is a 32 kD member of the epidermal growth factor family with mitogenic properties for the retinal pigment epithelial cells. This led us to hypothesize a role for betacellulin in the retinal vascular complications associated with diabetes. Methods and Findings: In this study, using a mouse model of diabetes, we demonstrate that diabetic mice have accentuated retinal vascular permeability with a concomitant increased expression of a cleaved soluble form of betacellulin (s-Btc) in the retina. Intravitreal injection of soluble betacellulin induced retinal vascular permeability in normoglycemic and hyperglycemic mice. Western blot analysis of retinas from patients with diabetic retinopathy showed an increase in the active soluble form of betacellulin. In addition, an increase in the levels of A disintegrin and metalloproteinase (ADAM)-10 which plays a role in the cleavage of betacellulin was seen in the retinas of diabetic mice and humans. Conclusions: These results suggest that excessive amounts of betacellulin in the retina may contribute to the pathogenesis of diabetic macular edema.	[Anand-Apte, Bela; Ebrahem, Quteba; Cutler, Alecia; Farage, Eric; Sugimoto, Masahiko; Hollyfield, Joe] Cleveland Clin, Lerner Coll Med, Cole Eye Inst, Dept Ophthalmol, Cleveland, OH 44106 USA; [Anand-Apte, Bela; Hollyfield, Joe] Cleveland Clin, Lerner Coll Med, Lerner Res Inst, Dept Mol Med, Cleveland, OH 44106 USA; [Folkman, Judah] Childrens Hosp, Boston, MA 02115 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Harvard University; Boston Children's Hospital	Anand-Apte, B (corresponding author), Cleveland Clin, Lerner Coll Med, Cole Eye Inst, Dept Ophthalmol, Cleveland, OH 44106 USA.	anandab@ccf.org			US National Institutes of Health [EY016490, CA106415, EY015638]; Research to Prevent Blindness (RPB) Challenge Grant; RPB Lew Wasserman award; NATIONAL CANCER INSTITUTE [R01CA106415] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016490, R24EY015638, R01EY020861] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB) Challenge Grant(Research to Prevent Blindness (RPB)); RPB Lew Wasserman award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by US National Institutes of Health EY016490, CA106415, EY015638, Research to Prevent Blindness (RPB) Challenge Grant and RPB Lew Wasserman award. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aiello LP, 2008, NEW ENGL J MED, V359, P967, DOI 10.1056/NEJMcibr0804551; Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; AMER DIABET ASSOC, 1993, DIABETES, V42, P1555; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Arjamaa O, 2006, EXP EYE RES, V83, P473, DOI 10.1016/j.exer.2006.01.016; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Chew EY, N ENGL J MED, V363, P233; Funatsu H, 2003, OPHTHALMOLOGY, V110, P1690, DOI 10.1016/S0161-6420(03)00568-2; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; JOHANSEN J, 1994, ACTA OPHTHALMOL, V72, P347; Keenan HA, 2007, DIABETES CARE, V30, P1995, DOI 10.2337/dc06-2222; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; Li L, 2003, AM J PHYSIOL-ENDOC M, V285, pE577, DOI 10.1152/ajpendo.00120.2003; Manzoni P, 2005, NEW ENGL J MED, V353, P2190; Mashima H, 1996, J CLIN INVEST, V97, P1647, DOI 10.1172/JCI118591; Miyagawa J, 1999, ENDOCR J, V46, P755, DOI 10.1507/endocrj.46.755; ORCHARD TJ, 1990, DIABETES, V39, P1116, DOI 10.2337/diabetes.39.9.1116; Ponnuchamy B, 2008, CIRC RES, V102, P1139, DOI 10.1161/CIRCRESAHA.108.177394; Qaum T, 2001, INVEST OPHTH VIS SCI, V42, P2408; Riese DJ, 1996, ONCOGENE, V12, P345; Riese DJ, 1996, J BIOL CHEM, V271, P20047, DOI 10.1074/jbc.271.33.20047; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Sanderson MP, 2006, J CELL BIOCHEM, V99, P609, DOI 10.1002/jcb.20968; Sanderson MP, 2005, J BIOL CHEM, V280, P1826, DOI 10.1074/jbc.M408804200; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Seno M, 1996, GROWTH FACTORS, V13, P181, DOI 10.3109/08977199609003220; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHING Y, 1993, SCIENCE, V259, P1604, DOI 10.1126/science.8456283; Tong ZZ, 2008, P NATL ACAD SCI USA, V105, P6998, DOI 10.1073/pnas.0800454105; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; WATANABE T, 1994, J BIOL CHEM, V269, P9966; Wong TY, 2008, LANCET, V371, P736, DOI 10.1016/S0140-6736(08)60343-8; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; Yamamoto K, 2000, DIABETES, V49, P2021, DOI 10.2337/diabetes.49.12.2021	41	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13444	10.1371/journal.pone.0013444	http://dx.doi.org/10.1371/journal.pone.0013444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976146	Green Published, gold, Green Submitted			2022-12-25	WOS:000283045300019
J	Wittekindt, NE; Padhi, A; Schuster, SC; Qi, J; Zhao, FQ; Tomsho, LP; Kasson, LR; Packard, M; Cross, P; Poss, M				Wittekindt, Nicola E.; Padhi, Abinash; Schuster, Stephan C.; Qi, Ji; Zhao, Fangqing; Tomsho, Lynn P.; Kasson, Lindsay R.; Packard, Michael; Cross, Paul; Poss, Mary			Nodeomics: Pathogen Detection in Vertebrate Lymph Nodes Using Meta-Transcriptomics	PLOS ONE			English	Article							GARDNERELLA-VAGINALIS; HELICOBACTER-PYLORI; VIRAL REPLICATION; GENE-EXPRESSION; RNA; IDENTIFICATION; MICROBIOME; DIVERSITY; DISEASES; GENOME	The ongoing emergence of human infections originating from wildlife highlights the need for better knowledge of the microbial community in wildlife species where traditional diagnostic approaches are limited. Here we evaluate the microbial biota in healthy mule deer (Odocoileus hemionus) by analyses of lymph node meta-transcriptomes. cDNA libraries from five individuals and two pools of samples were prepared from retropharyngeal lymph node RNA enriched for polyadenylated RNA and sequenced using Roche-454 Life Sciences technology. Protein-coding and 16S ribosomal RNA ( rRNA) sequences were taxonomically profiled using protein and rRNA specific databases. Representatives of all bacterial phyla were detected in the seven libraries based on protein-coding transcripts indicating that viable microbiota were present in lymph nodes. Residents of skin and rumen, and those ubiquitous in mule deer habitat dominated classifiable bacterial species. Based on detection of both rRNA and protein-coding transcripts, we identified two new proteobacterial species; a Helicobacter closely related to Helicobacter cetorum in the Helicobacter pylori/Helicobacter acinonychis complex and an Acinetobacter related to Acinetobacter schindleri. Among viruses, a novel gamma retrovirus and other members of the Poxviridae and Retroviridae were identified. We additionally evaluated bacterial diversity by amplicon sequencing the hypervariable V6 region of 16S rRNA and demonstrate that overall taxonomic diversity is higher with the meta-transcriptomic approach. These data provide the most complete picture to date of the microbial diversity within a wildlife host. Our research advances the use of meta-transcriptomics to study microbiota in wildlife tissues, which will facilitate detection of novel organisms with pathogenic potential to human and animals.	[Wittekindt, Nicola E.; Schuster, Stephan C.; Qi, Ji; Zhao, Fangqing; Tomsho, Lynn P.; Kasson, Lindsay R.; Packard, Michael] Penn State Univ, Ctr Comparat Genom & Bioinformat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Padhi, Abinash; Schuster, Stephan C.; Poss, Mary] Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, University Pk, PA 16802 USA; [Cross, Paul] US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT USA; [Poss, Mary] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Wittekindt, NE (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	mposs@bx.psu.edu	Zhao, Fangqing/P-6309-2019; QI, JI/E-2797-2016; Wittekindt, Nicola/G-3469-2013	Wittekindt, Nicola/0000-0002-3310-0919; Zhao, Fangqing/0000-0002-6216-1235	United States Geological Service [06HQAG0141, 06131HS001]; Science & Technology Directorate, Department of Homeland Security,; Fogarty International Center, National Institutes of Health; Gordon and Betty Moore Foundation	United States Geological Service; Science & Technology Directorate, Department of Homeland Security,(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was supported by United States Geological Service 06HQAG0141, subcontract 06131HS001. MP was supported, in part, by the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. S. C. S. was supported by the Gordon and Betty Moore Foundation. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U. S. Government. Field data collection was partially funded by the sale of hunting and fishing licenses in Montana, and matching Federal Aid in Wildlife Restoration grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2005, J VIROL, V79, P966, DOI 10.1128/JVI.79.2.966-977.2005; ALEXANDERSEN S, 1988, J VIROL, V62, P1495, DOI 10.1128/JVI.62.5.1495-1507.1988; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; CATLIN BW, 1992, CLIN MICROBIOL REV, V5, P213, DOI 10.1128/CMR.5.3.213-237.1992; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Demma LJ, 2008, AM J TROP MED HYG, V78, P811, DOI 10.4269/ajtmh.2008.78.811; Dortet L, 2006, J CLIN MICROBIOL, V44, P4471, DOI 10.1128/JCM.01535-06; EATON KA, 1993, INT J SYST BACTERIOL, V43, P99, DOI 10.1099/00207713-43-1-99; Falagas ME, 2009, FUTURE MICROBIOL, V4, P1103, DOI 10.2217/FMB.09.84; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gundi VAKB, 2009, MICROBIOL-SGM, V155, P2333, DOI 10.1099/mic.0.026054-0; Harper CG, 2002, J CLIN MICROBIOL, V40, P4536, DOI 10.1128/JCM.40.12.4536-4543.2002; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kirby AC, 2009, J IMMUNOL, V183, P1983, DOI 10.4049/jimmunol.0901089; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; LaMere SA, 2009, J VIROL, V83, P12956, DOI 10.1128/JVI.01354-09; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Mannioui A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-106; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; MORGAN EA, 2009, AM J DERMATOPATHOL; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Munson L, 1999, J ZOO WILDLIFE MED, V30, P342; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Oliveira AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008644; OXLEY AP, 2010, ENV MICROBIOL; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rhyan JC, 2010, VET PATHOL, V47, P34, DOI 10.1177/0300985809354466; Scholz HC, 2009, VECTOR-BORNE ZOONOT, V9, P153, DOI 10.1089/vbz.2008.0036; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; St John AL, 2009, NAT MED, V15, P1259, DOI 10.1038/nm.2036; Suzuki H, 2009, GASTRIC CANCER, V12, P79, DOI 10.1007/s10120-009-0507-x; Takanashi S, 2009, J CLIN VIROL, V44, P161, DOI 10.1016/j.jcv.2008.11.011; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	63	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13432	10.1371/journal.pone.0013432	http://dx.doi.org/10.1371/journal.pone.0013432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976145	Green Published, gold			2022-12-25	WOS:000283045300015
J	Diez-Padrisa, N; Bassat, Q; Machevo, S; Quinto, L; Morais, L; Nhampossa, T; O'Callaghan-Gordo, C; Torres, A; Alonso, PL; Roca, A				Diez-Padrisa, Nuria; Bassat, Quique; Machevo, Sonia; Quinto, Llorenc; Morais, Luis; Nhampossa, Tacilta; O'Callaghan-Gordo, Cristina; Torres, Antoni; Alonso, Pedro L.; Roca, Anna			Procalcitonin and C-Reactive Protein for Invasive Bacterial Pneumonia Diagnosis among Children in Mozambique, a Malaria-Endemic Area	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; COMMUNITY-ACQUIRED PNEUMONIA; PLACEBO-CONTROLLED TRIAL; RURAL MOZAMBIQUE; STREPTOCOCCUS-PNEUMONIAE; VIRUS-INFECTION; EFFICACY; SURVEILLANCE; METAANALYSIS; MENINGITIS	Background: Pneumonia is the major cause of mortality and morbidity in children worldwide. Procalcitonin (PCT) and C-reactive protein (CRP) are used in developed countries to differentiate between viral and bacterial causes of pneumonia. Validity of these markers needs to be further explored in Africa. Methodology and Principal Findings: We assessed the utility of PCT and CRP to differentiate viral from invasive bacterial pneumonia in children <5 years hospitalized with clinical severe pneumonia (CSP) in rural Mozambique, a malaria-endemic area with high HIV prevalence. Prognostic capacity of these markers was also evaluated. Out of 835 children with CSP, 87 fulfilled definition of viral pneumonia and 89 of invasive bacterial pneumonia. In absence of malaria parasites, levels of PCT and CRP were lower in the viral group when compared to the invasive bacterial one (PCT: median = 0.21 versus 8.31 ng/ml, p < 0.001; CRP: 18.3 vs. 185.35 mg/l, p < 0.001). However, in presence of malaria parasites distribution between clinical groups overlapped (PCT: median = 23.1 vs. 21.75 ng/ml, p = 0.825; CRP: median = 96.8 vs. 217.4 mg/l, p = 0.052). None of the two markers could predict mortality. Conclusions: Presence of malaria parasites should be taken into consideration, either for clinical or epidemiological purposes, if using PCT or CRP to differentiate viral from invasive bacterial pneumonia in malaria-endemic areas.	[Diez-Padrisa, Nuria; Bassat, Quique; Quinto, Llorenc; O'Callaghan-Gordo, Cristina; Alonso, Pedro L.; Roca, Anna] Univ Barcelona, Ctr Recerca Salut Int Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Diez-Padrisa, Nuria; Bassat, Quique; Machevo, Sonia; Morais, Luis; Nhampossa, Tacilta; O'Callaghan-Gordo, Cristina; Alonso, Pedro L.; Roca, Anna] Ctr Invest Saude Manhica, Manhica, Mozambique; [Bassat, Quique] Ctr Invest Biomed Red CIBER Epidemiol & Salud Pub, Barcelona, Spain; [Machevo, Sonia] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Nhampossa, Tacilta] Inst Nacl Saude, Minist Saude, Maputo, Mozambique; [Torres, Antoni] Univ Barcelona, Serv Pneumol, Inst Clin Torax, Inst Invest Biomed August Pi & Sunyer,Hosp Clin, Barcelona, Spain; [Torres, Antoni] Ctr Invest Biomed Red CIBER Enfermedades Resp, Bunyola, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro de Investigacao em Saude de Manhica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Eduardo Mondlane University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Diez-Padrisa, N (corresponding author), Univ Barcelona, Ctr Recerca Salut Int Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.	aroca@clinic.ub.es	Bassat, Quique/P-2341-2016; Diez-Padrisa, Nuria/AAE-1000-2020; Torres, Antoni/H-6128-2017; Alonso, Pedro L/AAZ-3645-2020	Bassat, Quique/0000-0003-0875-7596; Torres, Antoni/0000-0002-8643-2167; Alonso, Pedro L/0000-0003-3292-3443; O'Callaghan-Gordo, Cristina/0000-0002-4229-2991; Quinto, Llorenc/0000-0001-9992-6951	Bill and Melinda Gates Foundation [45 452]; Spanish Agency of International Cooperation [CM05/00134, RYC-2008-02777]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Spanish Agency of International Cooperation(Spanish Government)	This study has been supported by grant of the Bill and Melinda Gates Foundation (45 452, http://www.gatesfoundation.org/Pages/home.aspx). The Centro de Investigacao em Saude da Manhica (CISM) receives major core funding from the Spanish Agency of International Cooperation (http://www.aecid.es/ation (FIS: CM05/00134 and Raman y Cajal: RYC-2008-02777, respectively; http://www.micinn.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GUID TREATM MAL; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Carrol ED, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006621; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cheung YB, 2008, TROP MED INT HEALTH, V13, P603, DOI 10.1111/j.1365-3156.2008.02050.x; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; de Andrade ALSS, 2004, INT J EPIDEMIOL, V33, P173, DOI 10.1093/ije/dyh025; Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2; Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36; HURT N, 1994, CLIN DIAGN LAB IMMUN, V1, P437, DOI 10.1128/CDLI.1.4.437-444.1994; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Loscertales MP, 2002, PEDIATR INFECT DIS J, V21, P148, DOI 10.1097/00006454-200202000-00013; Madhi SA, 2005, PLOS MED, V2, P147, DOI 10.1371/journal.pmed.0020038; Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; McGuire W, 1996, T ROY SOC TROP MED H, V90, P10, DOI 10.1016/S0035-9203(96)90461-7; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Naniche D, 2009, AM J TROP MED HYG, V80, P870, DOI 10.4269/ajtmh.2009.80.870; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; O'Callaghan-Gordo C, PEDIAT INFE IN PRESS; Roca A, 2009, CLIN INFECT DIS, V48, pS172, DOI 10.1086/596497; Roca A, 2006, TROP MED INT HEALTH, V11, P1422, DOI 10.1111/j.1365-3156.2006.01697.x; Roca A, 2010, VACCINE, V28, P4851, DOI 10.1016/j.vaccine.2010.03.060; SAZAWAL S, 1992, LANCET, V340, P528, DOI 10.1016/0140-6736(92)91720-S; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; SIGAUQUE B, 2009, J TROP PEDIAT, P11601; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x; van der Meer V, 2005, BRIT MED J, V331, P26, DOI 10.1136/bmj.38483.478183.EB	33	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13226	10.1371/journal.pone.0013226	http://dx.doi.org/10.1371/journal.pone.0013226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976241	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000282941000002
J	An, RS; Grewal, PS				An, Ruisheng; Grewal, Parwinder S.			Molecular Mechanisms of Persistence of Mutualistic Bacteria Photorhabdus in the Entomopathogenic Nematode Host	PLOS ONE			English	Article							TRANSCRIBED SEQUENCES SCOTS; ESCHERICHIA-COLI; GENE-EXPRESSION; STEINERNEMA-CARPOCAPSAE; XENORHABDUS-NEMATOPHILA; SELECTIVE CAPTURE; STATIONARY-PHASE; VIBRIO-FISCHERI; LUMINESCENS; MACROPHAGES	Symbioses between microbes and animals are ubiquitous, yet little is known about the intricate mechanisms maintaining such associations. In an emerging mutualistic model system, insect-pathogenic bacteria Photorhabdus and their insect-parasitic nematode partner Heterorhabditis, we found that the bacteria undergo major transcriptional reshaping in the nematode intestine. Besides general starvation mechanisms, the bacteria induce cellular acidification to slow down growth, switch to pentose phosphate pathway to overcome oxidative stress and nutrition limitation, and shed motility but develop biofilm to persist in the nematode intestine until being released into the insect hemolymph. These findings demonstrate how the symbiotic bacteria reduce their nutritional dependence on the enduring nematode partner to ensure successful transmission of the couple to the next insect host.	[An, Ruisheng; Grewal, Parwinder S.] Ohio State Univ, Dept Entomol, Wooster, OH USA	University System of Ohio; Ohio State University	An, RS (corresponding author), Ohio State Univ, Dept Entomol, Wooster, OH USA.	grewal.4@osu.edu	An, Ruisheng/C-9738-2009	An, Ruisheng/0000-0003-2000-3623	Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, Ohio	Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, Ohio(Ohio State University)	This project was supported by a competitive grant from the Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, Ohio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adin DA, 2008, APPL ENVIRON MICROB, V74, P633, DOI 10.1128/AEM.02138-07; An RS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-433; Andrassy I., 1976, EVOLUTION BASIS SYST; Barrios AFG, 2006, BIOTECHNOL BIOENG, V93, P188, DOI 10.1002/bit.20681; Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005; Braschler TR, 2003, APPL ENVIRON MICROB, V69, P4268, DOI 10.1128/AEM.69.7.4268-4271.2003; Buendia-Claveria AM, 2003, MICROBIOL-SGM, V149, P1807, DOI 10.1099/mic.0.26099-0; BUTLER JS, 1986, J MOL BIOL, V192, P767, DOI 10.1016/0022-2836(86)90027-6; Clarke DJ, 2008, CELL MICROBIOL, V10, P2159, DOI 10.1111/j.1462-5822.2008.01209.x; Daigle F, 2001, MOL MICROBIOL, V41, P1211, DOI 10.1046/j.1365-2958.2001.02593.x; DeLoney CR, 2002, J BACTERIOL, V184, P5121, DOI 10.1128/JB.184.18.5121-5129.2002; Derzelle S, 2004, MICROBIOL-SGM, V150, P897, DOI 10.1099/mic.0.26563-0; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Easom CA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-168; Emelianoff V, 2008, EVOLUTION, V62, P932, DOI 10.1111/j.1558-5646.2008.00319.x; FERGUSON GP, 1995, MOL MICROBIOL, V17, P1025, DOI 10.1111/j.1365-2958.1995.mmi_17061025.x; Ferguson GP, 1997, J BACTERIOL, V179, P1007, DOI 10.1128/jb.179.4.1007-1012.1997; Flores-Lara Y, 2007, J INVERTEBR PATHOL, V95, P110, DOI 10.1016/j.jip.2007.01.006; Fresquet V, 2004, BIOCHEMISTRY-US, V43, P10619, DOI 10.1021/bi048972x; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Huang Y, 2007, APPL ENVIRON MICROB, V73, P7522, DOI 10.1128/AEM.01481-07; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kaya Harry K., 1997, P281, DOI 10.1016/B978-012432555-5/50016-6; Kelly DJ, 2001, FEMS MICROBIOL REV, V25, P405, DOI 10.1111/j.1574-6976.2001.tb00584.x; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; LEE EH, 1991, P NATL ACAD SCI USA, V88, P3029, DOI 10.1073/pnas.88.8.3029; LUNAU S, 1993, NEMATOLOGICA, V39, P385, DOI 10.1163/187529293X00330; Martens EC, 2005, MOL MICROBIOL, V58, P28, DOI 10.1111/j.1365-2958.2005.04742.x; MASAI H, 1994, EMBO J, V13, P5338, DOI 10.1002/j.1460-2075.1994.tb06868.x; McFall-Ngai M, 2008, NAT REV MICROBIOL, V6, P789, DOI 10.1038/nrmicro1982; Mendz GL, 1996, MICROBIOL-UK, V142, P2959, DOI 10.1099/13500872-142-10-2959; Mitani DK, 2004, BIOL CONTROL, V29, P382, DOI 10.1016/j.biocontrol.2003.07.005; Muela A, 2008, FEMS MICROBIOL ECOL, V64, P28, DOI 10.1111/j.1574-6941.2008.00453.x; PINNER E, 1993, J BIOL CHEM, V268, P1729; Ruby EG, 2008, NAT REV MICROBIOL, V6, P752, DOI 10.1038/nrmicro1958; SELVAN S, 1993, J PARASITOL, V79, P167, DOI 10.2307/3283503; Suga K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000671; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Thaden JJ, 2000, J AM AGING ASSOC, V23, P75, DOI 10.1007/s11357-000-0008-7; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Wang YL, 2006, NUCLEIC ACIDS RES, V34, P613, DOI 10.1093/nar/gkj438; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; Yilmaz EI, 2008, J IND MICROBIOL BIOT, V35, P1, DOI 10.1007/s10295-007-0259-8; Zhu XC, 2008, MICROBES INFECT, V10, P1274, DOI 10.1016/j.micinf.2008.07.025	50	20	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13154	10.1371/journal.pone.0013154	http://dx.doi.org/10.1371/journal.pone.0013154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957199	gold, Green Published, Green Submitted			2022-12-25	WOS:000282506100005
J	Shi, T; Mazumdar, T; DeVecchio, J; Duan, ZH; Agyeman, A; Aziz, M; Houghton, JA				Shi, Ting; Mazumdar, Tapati; DeVecchio, Jennifer; Duan, Zhong-Hui; Agyeman, Akwasi; Aziz, Mohammad; Houghton, Janet A.			cDNA Microarray Gene Expression Profiling of Hedgehog Signaling Pathway Inhibition in Human Colon Cancer Cells	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; TRANSCRIPTION FACTOR; DNA-REPLICATION; TARGET GENES; GROWTH; NETWORK; ARREST; GLI2; DIFFERENTIATION; CARCINOGENESIS	Background: Hedgehog (HH) signaling plays a critical role in normal cellular processes, in normal mammalian gastrointestinal development and differentiation, and in oncogenesis and maintenance of the malignant phenotype in a variety of human cancers. Increasing evidence further implicates the involvement of HH signaling in oncogenesis and metastatic behavior of colon cancers. However, genomic approaches to elucidate the role of HH signaling in cancers in general are lacking, and data derived on HH signaling in colon cancer is extremely limited. Methodology/Principal Findings: To identify unique downstream targets of the GLI genes, the transcriptional regulators of HH signaling, in the context of colon carcinoma, we employed a small molecule inhibitor of both GLI1 and GLI2, GANT61, in two human colon cancer cell lines, HT29 and GC3/c1. Cell cycle analysis demonstrated accumulation of GANT61-treated cells at the G1/S boundary. cDNA microarray gene expression profiling of 18,401 genes identified Differentially Expressed Genes (DEGs) both common and unique to HT29 and GC3/c1. Analyses using GenomeStudio (statistics), Matlab (heat map), Ingenuity (canonical pathway analysis), or by qRT-PCR, identified p21(Cip1) (CDKN1A) and p15(Ink4b) (CDKN2B), which play a role in the G1/S checkpoint, as up-regulated genes at the G1/S boundary. Genes that determine further cell cycle progression at G1/S including E2F2, CYCLIN E2 (CCNE2), CDC25A and CDK2, and genes that regulate passage of cells through G2/M (CYCLIN A2 [CCNA2], CDC25C, CYCLIN B2 [CCNB2], CDC20 and CDC2 [CDK1], were down-regulated. In addition, novel genes involved in stress response, DNA damage response, DNA replication and DNA repair were identified following inhibition of HH signaling. Conclusions/Significance: This study identifies genes that are involved in HH-dependent cellular proliferation in colon cancer cells, and following its inhibition, genes that regulate cell cycle progression and events downstream of the G1/S boundary.	[Shi, Ting; Mazumdar, Tapati; DeVecchio, Jennifer; Agyeman, Akwasi; Aziz, Mohammad; Houghton, Janet A.] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Duan, Zhong-Hui] Univ Akron, Dept Comp Sci, Akron, OH 44325 USA	Cleveland Clinic Foundation; University System of Ohio; University of Akron	Shi, T (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	houghtj@ccf.org	Aziz, Mohammad Azhar/F-7486-2013	Aziz, Mohammad Azhar/0000-0002-0798-5063	National Cancer Institute [RO1 CA 32613, RO1 108929]; Cleveland Clinic; NATIONAL CANCER INSTITUTE [R01CA032613, R01CA108929] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cleveland Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support from National Cancer Institute awards RO1 CA 32613 (JAH), RO1 108929 (JAH), and from the Cleveland Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Alinger B, 2009, VIRCHOWS ARCH, V454, P369, DOI 10.1007/s00428-009-0753-7; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Berger JH, 2007, CURR MOL MED, V7, P63, DOI 10.2174/156652407779940477; Bian YH, 2007, WORLD J GASTROENTERO, V13, P1659, DOI 10.3748/wjg.v13.i11.1659; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Choi S, 2009, PHARM RES-DORDR, V26, P2280, DOI 10.1007/s11095-009-9944-9; Dormoy V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-123; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Gartel AL, 2002, MOL CANCER THER, V1, P639; Ge S, 2009, CELL CYCLE, V8, P167, DOI 10.4161/cc.8.1.7606; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2008, INT J ONCOL, V33, P881, DOI 10.3892/ijo_00000076; Katoh Y, 2006, INT J MOL MED, V18, P1019; Keen N, 2009, CANCER METAST REV, V28, P185, DOI 10.1007/s10555-009-9184-9; Koyama M, 2007, MOL CANCER THER, V6, P1579, DOI 10.1158/1535-7163.MCT-06-0814; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; McDonald ER, 2000, INT J ONCOL, V16, P871; Monzo M, 2006, CANCER LETT, V233, P117, DOI 10.1016/j.canlet.2005.03.001; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Oniscu A, 2004, J PATHOL, V203, P909, DOI 10.1002/path.1591; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Regl G, 2004, ONCOGENE, V23, P1263, DOI 10.1038/sj.onc.1207240; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sandhu C, 2000, ONCOGENE, V19, P5314, DOI 10.1038/sj.onc.1203908; Sarangi A, 2009, ONCOGENE, V28, P3468, DOI 10.1038/onc.2009.208; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Thiyagarajan S, 2007, CANCER RES, V67, P10642, DOI 10.1158/0008-5472.CAN-07-2015; Tillman DM, 2003, CANCER RES, V63, P5118; van den Brink GR, 2004, NAT GENET, V36, P1038, DOI 10.1038/ng1004-1038; VARNAT F, MECH DEV, V127, P73; VARNAT F, 2009, MECH DEV; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Yoshikawa K, 2009, J GASTROENTEROL, V44, P1113, DOI 10.1007/s00535-009-0110-2; Yu M, 2009, J BIOL CHEM, V284, P5620, DOI 10.1074/jbc.M809172200	56	57	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13054	10.1371/journal.pone.0013054	http://dx.doi.org/10.1371/journal.pone.0013054			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957031	Green Published, gold, Green Submitted			2022-12-25	WOS:000282359300003
J	Parnell, JJ; Rompato, G; Latta, LC; Pfrender, ME; Van Nostrand, JD; He, ZL; Zhou, JZ; Andersen, G; Champine, P; Ganesan, B; Weimer, BC				Parnell, J. Jacob; Rompato, Giovanni; Latta, Leigh C.; Pfrender, Michael E.; Van Nostrand, Joy D.; He, Zhili; Zhou, Jizhong; Andersen, Gary; Champine, Patti; Ganesan, Balasubramanian; Weimer, Bart C.			Functional Biogeography as Evidence of Gene Transfer in Hypersaline Microbial Communities	PLOS ONE			English	Article							GREAT-SALT-LAKE; CODON USAGE; DIVERSITY; EVOLUTION; GENOME; DNA; RECOMBINATION; MICROARRAY; PATTERNS; BACTERIA	Background: Horizontal gene transfer (HGT) plays a major role in speciation and evolution of bacteria and archaea by controlling gene distribution within an environment. However, information that links HGT to a natural community using relevant population-genetics parameters and spatial considerations is scarce. The Great Salt Lake (Utah, USA) provides an excellent model for studying HGT in the context of biogeography because it is a contiguous system with dispersal limitations due to a strong selective salinity gradient. We hypothesize that in spite of the barrier to phylogenetic dispersal, functional characteristics-in the form of HGT-expand beyond phylogenetic limitations due to selective pressure. Methodology and Results: To assay the functional genes and microorganisms throughout the GSL, we used a 16S rRNA oligonucleotide microarray (Phylochip) and a functional gene array (GeoChip) to measure biogeographic patterns of nine microbial communities. We found a significant difference in biogeography based on microarray analyses when comparing Sorensen similarity values for presence/absence of function and phylogeny (Student's t-test; p = 0.005). Conclusion and Significance: Biogeographic patterns exhibit behavior associated with horizontal gene transfer in that informational genes (16S rRNA) have a lower similarity than functional genes, and functional similarity is positively correlated with lake-wide selective pressure. Specifically, high concentrations of chromium throughout GSL correspond to an average similarity of chromium resistance genes that is 22% higher than taxonomic similarity. This suggests active HGT may be measured at the population level in microbial communities and these biogeographic patterns may serve as a model to study bacteria adaptation and speciation.	[Parnell, J. Jacob; Rompato, Giovanni; Champine, Patti; Ganesan, Balasubramanian; Weimer, Bart C.] Utah State Univ, Ctr Integrated BioSyst, Logan, UT 84322 USA; [Latta, Leigh C.; Pfrender, Michael E.; Weimer, Bart C.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Ganesan, Balasubramanian] Utah State Univ, Dept Nutr & Food Sci, Logan, UT 84322 USA; [Pfrender, Michael E.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Van Nostrand, Joy D.; He, Zhili; Zhou, Jizhong] Univ Oklahoma, Dept Bot & Microbiol, Inst Environm Genom, Norman, OK 73019 USA; [Andersen, Gary] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Parnell, JJ (corresponding author), Utah State Univ, Ctr Integrated BioSyst, Logan, UT 84322 USA.	jacob.parnell@usu.edu	He, Zhili/C-2879-2012; 吴, 昊/AAB-1620-2020; Weimer, Bart/AAK-8501-2021; Weimer, Bart C/G-6928-2012; Andersen, Gary/G-2792-2015; Pfrender, Micheal E./C-5065-2019; Van Nostrand, Joy D/F-1740-2016	He, Zhili/0000-0001-8225-7333; Weimer, Bart/0000-0002-7471-1978; Weimer, Bart C/0000-0002-7471-1978; Andersen, Gary/0000-0002-1618-9827; Van Nostrand, Joy D/0000-0001-9548-6450	National Science Foundation [DEB-021212487]; United States Department of Agriculture CSREES [2006-34526-17001]; Utah Agricultural Experiment Station at Utah State University	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Utah Agricultural Experiment Station at Utah State University	Funding for this project was provided by National Science Foundation grant DEB-021212487 to MEP, and a grant from the United States Department of Agriculture CSREES 2006-34526-17001. This project was supported by the Utah Agricultural Experiment Station at Utah State University as journal paper number 8091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Azad RK, 2007, NUCLEIC ACIDS RES, V35, P4629, DOI 10.1093/nar/gkm204; Bentley SD, 2004, ANNU REV GENET, V38, P771, DOI 10.1146/annurev.genet.38.072902.094318; Branco R, 2008, J BACTERIOL, V190, P6996, DOI 10.1128/JB.00289-08; Brandt KK, 2001, MICROBIAL ECOL, V41, P1; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kassen R, 2004, ANNU REV MICROBIOL, V58, P207, DOI 10.1146/annurev.micro.58.030603.123654; Kloster M, 2008, NUCLEIC ACIDS RES, V36, P3819, DOI 10.1093/nar/gkn288; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Lonergan DJ, 1996, J BACTERIOL, V178, P2402, DOI 10.1128/jb.178.8.2402-2408.1996; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Naftz D, 2008, APPL GEOCHEM, V23, P1731, DOI 10.1016/j.apgeochem.2008.03.002; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Parnell JJ, 2009, MOL ECOL, V18, P1455, DOI 10.1111/j.1365-294X.2009.04128.x; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Putonti C, 2006, MOL BIOL EVOL, V23, P1863, DOI 10.1093/molbev/msl053; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Slater FR, 2008, FEMS MICROBIOL ECOL, V66, P3, DOI 10.1111/j.1574-6941.2008.00505.x; Smets BF, 2005, NAT REV MICROBIOL, V3, P675, DOI 10.1038/nrmicro1253; Strom SL, 2008, SCIENCE, V320, P1043, DOI 10.1126/science.1153527; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Tamames J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-136; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Tsirigos A, 2005, NUCLEIC ACIDS RES, V33, P922, DOI 10.1093/nar/gki187; Van Nostrand JD, 2009, ENVIRON MICROBIOL, V11, P2611, DOI 10.1111/j.1462-2920.2009.01986.x; Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106; Wu QL, 2006, APPL ENVIRON MICROB, V72, P5478, DOI 10.1128/AEM.00767-06; Xia XH, 2002, GENETICS, V161, P1385; Yergeau E, 2007, ISME J, V1, P163, DOI 10.1038/ismej.2007.24; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	47	41	42	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12919	10.1371/journal.pone.0012919	http://dx.doi.org/10.1371/journal.pone.0012919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20957119	Green Published, gold, Green Submitted			2022-12-25	WOS:000282091100023
J	Maezawa, I; Zimin, PI; Wulff, H; Jin, LW				Maezawa, Izumi; Zimin, Pavel I.; Wulff, Heike; Jin, Lee-Way			Amyloid-beta Protein Oligomer at Low Nanomolar Concentrations Activates Microglia and Induces Microglial Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; MILD COGNITIVE IMPAIRMENT; CA2+-ACTIVATED K+ CHANNEL; SMALL-MOLECULE INHIBITORS; NECROSIS-FACTOR-ALPHA; ALZHEIMERS-DISEASE; A-BETA; POTASSIUM CHANNELS; INTERFERON-GAMMA; MOUSE MODEL	Neuroinflammation and associated neuronal dysfunction mediated by activated microglia play an important role in the pathogenesis of Alzheimer disease (AD). Microglia are activated by aggregated forms of amyloid-beta protein (A beta), usually demonstrated in vitro by stimulating microglia with micromolar concentrations of fibrillar A beta, a major component of amyloid plaques in AD brains. Here we report that amyloid-beta oligomer (A beta O), at 5-50 nM, induces a unique pattern of microglia activation that requires the activity of the scavenger receptor A and the Ca2+-activated potassium channel KCa3.1. A beta O treatment induced an activated morphological and biochemical profile of microglia, including activation of p38 MAPK and nuclear factor kappa B. Interestingly, although increasing nitric oxide (NO) production, A beta O did not increase several proinflammatory mediators commonly induced by lipopolyliposacharides or fibrillar A beta, suggesting that A beta O stimulates both common and divergent pathways of microglia activation. A beta O at low nanomolar concentrations, although not neurotoxic, induced indirect, microglia-mediated damage to neurons in dissociated cultures and in organotypic hippocampal slices. The indirect neurotoxicity was prevented by (i) doxycycline, an inhibitor of microglia activation; (ii) TRAM-34, a selective KCa3.1 blocker; and (iii) two inhibitors of inducible NO synthase, indicating that KCa3.1 activity and excessive NO release are required for A beta O-induced microglial neurotoxicity. Our results suggest that A beta O, generally considered a neurotoxin, may more potently cause neuronal damage indirectly by activating microglia in AD.	Univ Calif Davis, Med Invest Neurodev Disorders Inst, Davis, CA 95618 USA; [Maezawa, Izumi; Jin, Lee-Way] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95618 USA; [Zimin, Pavel I.; Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95618 USA; [Jin, Lee-Way] Univ Calif Davis, Alzheimers Dis Ctr, Davis, CA 95618 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Jin, LW (corresponding author), Univ Calif Davis, Med Ctr, Dept Pathol & Lab Med, 2805 50th St, Sacramento, CA 95817 USA.	Lee-Way.Jin@ucdmc.ucdavis.edu	wulff, Heike/Z-2056-2019		National Institutes of Health [AG025500, AG031362]; University of California Davis Alzheimer's Disease Center [AG010129]; NATIONAL INSTITUTE ON AGING [P30AG010129, R01AG025500, R21AG031362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Davis Alzheimer's Disease Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG025500 and AG031362. This work was also supported by University of California Davis Alzheimer's Disease Center Grant AG010129.	Bahr BA, 1998, J COMP NEUROL, V397, P139; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Bernardino ALF, 2009, J INFECT DIS, V199, P1379, DOI 10.1086/597807; Bernardino L, 2005, J NEUROSCI, V25, P6734, DOI 10.1523/JNEUROSCI.1510-05.2005; Bornemann KD, 2001, AM J PATHOL, V158, P63, DOI 10.1016/S0002-9440(10)63945-4; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CONNOR JR, 1995, EUR J PHARMACOL, V273, P15, DOI 10.1016/0014-2999(94)00672-T; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DAVIS JB, 1992, BIOCHEM BIOPH RES CO, V189, P1096, DOI 10.1016/0006-291X(92)92317-Q; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; EDER C, 1995, J MEMBRANE BIOL, V147, P137; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; ElKhoury J, 1996, NATURE, V382, P716; Forloni G, 2001, FEBS LETT, V487, P404, DOI 10.1016/S0014-5793(00)02380-2; Franciosi S, 2006, J NEUROSCI, V26, P11652, DOI 10.1523/JNEUROSCI.2490-06.2006; GALLIN EK, 1984, BIOPHYS J, V46, P821, DOI 10.1016/S0006-3495(84)84080-1; Gasic-Milenkovic J, 2003, EUR J NEUROSCI, V17, P813, DOI 10.1046/j.1460-9568.2003.02506.x; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashioka S, 2005, NEUROCHEM INT, V47, P369, DOI 10.1016/j.neuint.2005.05.001; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hong HS, 2007, BRAIN RES, V1130, P223, DOI 10.1016/j.brainres.2006.10.093; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jantzie LL, 2005, J CEREBR BLOOD F MET, V25, P314, DOI 10.1038/sj.jcbfm.9600025; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KETTENMANN H, 1990, J NEUROSCI RES, V26, P278, DOI 10.1002/jnr.490260303; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Kokubo H, 2005, BRAIN RES, V1031, P222, DOI 10.1016/j.brainres.2004.10.041; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lai AY, 2006, GLIA, V53, P809, DOI 10.1002/glia.20335; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Li M, 2004, J NEUROCHEM, V91, P623, DOI 10.1111/j.1471-4159.2004.02765.x; Lindberg C, 2005, J MOL NEUROSCI, V27, P1, DOI 10.1385/JMN:27:1:001; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Maezawa I, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-10; Maezawa I, 2006, FASEB J, V20, P797, DOI 10.1096/fj.05-5423fje; Maezawa I, 2006, J NEUROCHEM, V98, P57, DOI 10.1111/j.1471-4159.2006.03862.x; Mauler F, 2004, EUR J NEUROSCI, V20, P1761, DOI 10.1111/j.1460-9568.2004.03615.x; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Muehlhauser F, 2001, CLIN CHEM LAB MED, V39, P313, DOI 10.1515/CCLM.2001.048; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Ohana L, 2009, CHANNELS, V3, P129, DOI 10.4161/chan.3.2.8609; Okello A, 2009, NEUROLOGY, V72, P56, DOI 10.1212/01.wnl.0000338622.27876.0d; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Parvathy S, 2009, NEUROBIOL AGING, V30, P1792, DOI 10.1016/j.neurobiolaging.2008.01.011; Reich EP, 2005, EUR J IMMUNOL, V35, P1027, DOI 10.1002/eji.200425954; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Schilling T, 2004, EUR J NEUROSCI, V19, P1469, DOI 10.1111/j.1460-9568.2004.03265.x; Schilling T, 2003, PFLUG ARCH EUR J PHY, V447, P312, DOI 10.1007/s00424-003-1155-3; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shie FS, 2002, NEUROREPORT, V13, P455, DOI 10.1097/00001756-200203250-00019; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Stenh C, 2005, ANN NEUROL, V58, P147, DOI 10.1002/ana.20524; Takata K, 2003, J PHARMACOL SCI, V91, P330; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; van Helmond Z, 2010, BRAIN PATHOL, V20, P468, DOI 10.1111/j.1750-3639.2009.00321.x; Veerhuis R, 2003, ACTA NEUROPATHOL, V105, P135, DOI 10.1007/s00401-002-0624-7; VORNOV JJ, 1991, EXP NEUROL, V114, P11, DOI 10.1016/0014-4886(91)90079-R; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Xiang H, 1998, J NEUROSCI, V18, P1363; Xie Z, 2002, J NEUROSCI, V22, P3484; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	88	198	204	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3693	3706		10.1074/jbc.M110.135244	http://dx.doi.org/10.1074/jbc.M110.135244			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	20971854	Green Published, hybrid			2022-12-25	WOS:000286653200052
J	Holloway, CJ; Montgomery, HE; Murray, AJ; Cochlin, LE; Codreanu, I; Hopwood, N; Johnson, AW; Rider, OJ; Levett, DZH; Tyler, DJ; Francis, JM; Neubauer, S; Grocott, MPW; Clarke, K				Holloway, Cameron J.; Montgomery, Hugh E.; Murray, Andrew J.; Cochlin, Lowri E.; Codreanu, Ion; Hopwood, Naomi; Johnson, Andrew W.; Rider, Oliver J.; Levett, Denny Z. H.; Tyler, Damian J.; Francis, Jane M.; Neubauer, Stefan; Grocott, Michael P. W.; Clarke, Kieran		Caudwell Xtreme Everest Res Grp	Cardiac response to hypobaric hypoxia: persistent changes in cardiac mass, function, and energy metabolism after a trek to Mt. Everest Base Camp	FASEB JOURNAL			English	Article						cardiac function; cardiac energy metabolism	MAGNETIC-RESONANCE-SPECTROSCOPY; PULMONARY-ARTERY PRESSURE; HIGH-ALTITUDE; HEART-FAILURE; DOPPLER; DISEASE	We postulated that changes in cardiac high-energy phosphate metabolism may underlie the myocardial dysfunction caused by hypobaric hypoxia. Healthy volunteers (n=14) were studied immediately before, and within 4 d of return from, a 17-d trek to Mt. Everest Base Camp (5300 m). (31)P magnetic resonance (MR) spectroscopy was used to measure cardiac phosphocreatine (PCr)/ATP, and MR imaging and echocardiography were used to assess cardiac volumes, mass, and function. Immediately after returning from Mt. Everest, total body weight had fallen by 3% (P<0.05), but left ventricular mass, adjusted for changes in body surface area, had disproportionately decreased by 11% (P<0.05). Alterations in diastolic function were also observed, with a reduction in peak left ventricular filling rates and mitral inflow E/A, by 17% (P<0.05) and 24% (P<0.01), respectively, with no change in hydration status. Compared with pretrek, cardiac PCr/ATP ratio had decreased by 18% (P<0.01). Whether the abnormalities were even greater at altitude is unknown, but all had returned to pretrek levels after 6 mo. The alterations in cardiac morphology, function, and energetics are similar to findings in patients with chronic hypoxia. Thus, a decrease in cardiac PCr/ATP may be a universal response to periods of sustained low oxygen availability, underlying hypoxia-induced cardiac dysfunction in healthy human heart and in patients with cardiopulmonary diseases.-Holloway, C. J., Montgomery, H. U., Murray, A. J., Cochlin, L. E., Codreanu, I. Hopwood, N., Johnson, A. W., Rider, O. J., Levett, D. Z. H., Tyler, D. J., Francis, J. M., Neubauer, S., Grocott, M. P. W., Clarke, K., for the Caudwell Xtreme Everest Research Group. Cardiac response to hypobaric hypoxia: persistent changes in cardiac mass, function, and energy metabolism after a trek to Mt. Everest Base Camp. FASEB J. 25, 792-796 (2011). www.fasebj.org	[Holloway, Cameron J.; Murray, Andrew J.; Cochlin, Lowri E.; Hopwood, Naomi; Johnson, Andrew W.; Tyler, Damian J.; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Holloway, Cameron J.; Murray, Andrew J.; Cochlin, Lowri E.; Codreanu, Ion; Johnson, Andrew W.; Rider, Oliver J.; Tyler, Damian J.; Francis, Jane M.; Neubauer, Stefan] Univ Oxford, Ctr Clin Magnet Resonance Res, Oxford OX1 3PT, England; [Montgomery, Hugh E.; Levett, Denny Z. H.; Grocott, Michael P. W.] UCL, Ctr Altitude Space & Extreme Environm Med, London, England	University of Oxford; University of Oxford; University of London; University College London	Holloway, CJ (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg, Oxford OX1 3PT, England.	cameron.holloway@dpag.ox.ac.uk	Grocott, Michael/C-4394-2008; Levett, Denny/F-4474-2011; Mythen, Michael G/G-8682-2011; Levett, Denny Zelda Hope/AAY-4627-2021; Codreanu, Ion/AAS-4378-2020; Levett, Denny/D-2239-2017; Tyler, Damian/E-6296-2011; Neubauer, Stefan/B-8448-2011; Montgomery, Hugh/L-1229-2019; Murray, Andrew/B-3130-2010; Montgomery, Hugh/C-2592-2008	Grocott, Michael/0000-0002-9484-7581; Levett, Denny/0000-0002-8418-1675; Levett, Denny Zelda Hope/0000-0002-8418-1675; Codreanu, Ion/0000-0002-2644-5572; Levett, Denny/0000-0002-8418-1675; Tyler, Damian/0000-0002-0780-8905; Murray, Andrew/0000-0002-0929-9315; Neubauer, Stefan/0000-0001-9017-5645; Montgomery, Hugh/0000-0001-8797-5019; Harvey, John Julian/0000-0001-5866-5847; O'Dwyer, Michael J/0000-0003-4038-5745	British Heart Foundation; Medical Research Council [Medical Research Council, grant G0601490]; Rolex Foundation; Association of Anesthetists of Great Britain; Association of Anesthetists of Ireland; UK Intensive Care Foundation; Sir Halley Stuart Trust; British Heart Foundation [PS/02/002/14893, RG/07/004/22659, FS/10/002/28078] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rolex Foundation; Association of Anesthetists of Great Britain; Association of Anesthetists of Ireland; UK Intensive Care Foundation; Sir Halley Stuart Trust; British Heart Foundation(British Heart Foundation)	The authors thank the Caudwell Xtreme Everest Project Manager, Kay Mitchell, for her tireless work that made the expedition possible and particularly her invaluable assistance with subject recruitment. The authors thank everyone involved with blood sample collection and plasma preparation in the field. Emma Carter is thanked for plasma metabolite analyses. The British Heart Foundation supported this study. D.J.T. was funded by the Medical Research Council, grant G0601490. Caudwell Xtreme Everest (CXE) is a research project coordinated by the UCL Centre for Altitude, Space, and Extreme Environment Medicine. The aim of CXE is to conduct research into hypoxia and human performance at high altitude in order to improve understanding of hypoxia in critical illness. Membership, roles, and responsibilities of the CXE Research Group can be found online (http://www.caudwell-xtreme-everest.co.uk/team). The research was funded from a variety of sources, none of which are public. The entrepreneur John Caudwell, whose name the expedition carries, donated 500,000 pound specifically to support the research. BOC Medical, now part of Linde Gas Therapeutics, generously supported the early research and continues to do so. Lilly Critical Care, The London Clinic (a private hospital), Smiths Medical, Deltex Medical, and The Rolex Foundation have also donated money to support the research and logistics. All monies were given as unrestricted grants. Specific research grants were awarded by the Association of Anesthetists of Great Britain and Ireland, the UK Intensive Care Foundation, and the Sir Halley Stuart Trust. The CXE volunteers who trekked to Mt. Everest Base Camp also kindly donated to support the research.	Allemann Y, 2000, AM J PHYSIOL-HEART C, V279, pH2013, DOI 10.1152/ajpheart.2000.279.4.H2013; Boussuges A, 2000, AM J RESP CRIT CARE, V161, P264, DOI 10.1164/ajrccm.161.1.9902096; Dubowitz G, 2007, WILD ENVIRON MED, V18, P305, DOI 10.1580/07-WEME-OR-094R1.1; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5921; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P1215, DOI 10.1073/pnas.93.3.1215; HOON RS, 1977, J APPL PHYSIOL, V42, P722, DOI 10.1152/jappl.1977.42.5.722; Howald H, 2003, EUR J APPL PHYSIOL, V90, P360, DOI 10.1007/s00421-003-0872-9; Hudsmith LE, 2006, J MAGN RESON IMAGING, V24, P312, DOI 10.1002/jmri.20638; Kelly DP, 2008, NAT GENET, V40, P132, DOI 10.1038/ng0208-132; Kjaergaard J, 2006, EUR J APPL PHYSIOL, V98, P411, DOI 10.1007/s00421-006-0299-1; Maeder MT, 2009, J AM COLL CARDIOL, V53, P905, DOI 10.1016/j.jacc.2008.12.007; Murray AJ, 2009, GENOME MED, V1, DOI 10.1186/gm117; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Portman MA, 1996, AM J PHYSIOL-HEART C, V270, pH216, DOI 10.1152/ajpheart.1996.270.1.H216; Tian R, 1997, CIRCULATION, V96, P1313, DOI 10.1161/01.CIR.96.4.1313; Tyler DJ, 2009, NMR BIOMED, V22, P405, DOI 10.1002/nbm.1350; WEISS RG, 1990, NEW ENGL J MED, V323, P1593, DOI 10.1056/NEJM199012063232304; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	19	73	77	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2011	25	2					792	796		10.1096/fj.10-172999	http://dx.doi.org/10.1096/fj.10-172999			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20978235				2022-12-25	WOS:000286724800036
J	Gorostiaga, EM; Navarro-Amezqueta, I; Cusso, R; Hellsten, Y; Calbet, JAL; Guerrero, M; Granados, C; Gonzalez-Izal, M; Ibanez, J; Izquierdo, M				Gorostiaga, Esteban M.; Navarro-Amezqueta, Ion; Cusso, Roser; Hellsten, Ylva; Calbet, Jose A. L.; Guerrero, Mario; Granados, Cristina; Gonzalez-Izal, Miriam; Ibanez, Javier; Izquierdo, Mikel			Anaerobic Energy Expenditure and Mechanical Efficiency during Exhaustive Leg Press Exercise	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ELECTRICAL-STIMULATION; INTERMITTENT EXERCISE; QUADRICEPS MUSCLE; HEAT-PRODUCTION; ISOMETRIC CONTRACTIONS; GLYCOGEN-PHOSPHORYLASE; INTENSE EXERCISE; DYNAMIC EXERCISE; POWER OUTPUT	Information about anaerobic energy production and mechanical efficiency that occurs over time during short-lasting maximal exercise is scarce and controversial. Bilateral leg press is an interesting muscle contraction model to estimate anaerobic energy production and mechanical efficiency during maximal exercise because it largely differs from the models used until now. This study examined the changes in muscle metabolite concentration and power output production during the first and the second half of a set of 10 repetitions to failure (10RM) of bilateral leg press exercise. On two separate days, muscle biopsies were obtained from vastus lateralis prior and immediately after a set of 5 or a set of 10 repetitions. During the second set of 5 repetitions, mean power production decreased by 19% and the average ATP utilisation accounted for by phosphagen decreased from 54% to 19%, whereas ATP utilisation from anaerobic glycolysis increased from 46 to 81%. Changes in contraction time and power output were correlated to the changes in muscle Phosphocreatine (PCr; r = -0.76; P < 0.01) and lactate (r = -0.91; P < 0.01), respectively, and were accompanied by parallel decreases (P < 0.01-0.05) in muscle energy charge (0.6%), muscle ATP/ADP (8%) and ATP/AMP (19%) ratios, as well as by increases in ADP content (7%). The estimated average rate of ATP utilisation from anaerobic sources during the final 5 repetitions fell to 83% whereas total anaerobic ATP production increased by 9% due to a 30% longer average duration of exercise (18.4 +/- 4.0 vs 14.2 +/- 2.1 s). These data indicate that during a set of 10RM of bilateral leg press exercise there is a decrease in power output which is associated with a decrease in the contribution of PCr and/or an increase in muscle lactate. The higher energy cost per repetition during the second 5 repetitions is suggestive of decreased mechanical efficiency.	[Gorostiaga, Esteban M.; Navarro-Amezqueta, Ion; Granados, Cristina; Gonzalez-Izal, Miriam; Ibanez, Javier; Izquierdo, Mikel] Govt Navarre, Studies Res & Sport Med Ctr, Navarra, Spain; [Cusso, Roser; Guerrero, Mario] Univ Barcelona, Dept Physiol Sci 1, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Hellsten, Ylva] Univ Copenhagen, Copenhagen Muscle Res Ctr, Mol Physiol Grp, Sect Human Physiol,Dept Exercise & Sport Sci, Copenhagen, Denmark; [Calbet, Jose A. L.] Univ Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Copenhagen; Universidad de Las Palmas de Gran Canaria	Gorostiaga, EM (corresponding author), Govt Navarre, Studies Res & Sport Med Ctr, Navarra, Spain.	egorosta@cfnavarra.es	Izquierdo, Mikel/O-8049-2019; Calbet, Jose A L/H-6693-2015; Izquierdo, Mikel/A-4894-2010; Hellsten, Ylva/B-3420-2015	Calbet, Jose A L/0000-0002-9215-6234; Izquierdo, Mikel/0000-0002-1506-4272; Hellsten, Ylva/0000-0002-2435-9558; Granados, Cristina/0000-0002-8366-8932; Guerrero, Mario/0000-0002-9912-661X; antunez, Ariel/0000-0002-2548-7885	Spanish Ministry of Education [DEP200656076]	Spanish Ministry of Education(Spanish Government)	This study was supported by the Spanish Ministry of Education (National Plan of R&D+I 2004-2007, Key action "Sport and Physical Activity'' DEP200656076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson DE, 1977, CELLULAR ENERGY META, DOI DOI 10.1016/C2009-0-03136-5; AWAN MZ, 1970, BIOCHIM BIOPHYS ACTA, V216, P229, DOI 10.1016/0005-2728(70)90176-3; Bangsbo J, 2001, AM J PHYSIOL-ENDOC M, V280, pE956, DOI 10.1152/ajpendo.2001.280.6.E956; BANGSBO J, 1990, J PHYSIOL-LONDON, V422, P539, DOI 10.1113/jphysiol.1990.sp018000; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; BERGSTROM M, 1988, J APPL PHYSIOL, V65, P1500, DOI 10.1152/jappl.1988.65.4.1500; BOGDANIS GC, 1995, J PHYSIOL-LONDON, V482, P467, DOI 10.1113/jphysiol.1995.sp020533; Bogdanis GC, 1998, ACTA PHYSIOL SCAND, V163, P261, DOI 10.1046/j.1365-201x.1998.00378.x; Bolgla LA, 2008, J SPORT REHABIL, V17, P1, DOI 10.1123/jsr.17.1.1; Boobis LH, 1987, EXERCISE BENEFITS LI, P116; CHASIOTIS D, 1987, J APPL PHYSIOL, V63, P167, DOI 10.1152/jappl.1987.63.1.167; CHASIOTIS D, 1983, J PHYSIOL-LONDON, V335, P197, DOI 10.1113/jphysiol.1983.sp014528; CHEETHAM ME, 1986, J APPL PHYSIOL, V61, P54, DOI 10.1152/jappl.1986.61.1.54; DAWSON MJ, 1978, NATURE, V274, P861, DOI 10.1038/274861a0; DUDLEY GA, 1985, AM J PHYSIOL, V248, pC43, DOI 10.1152/ajpcell.1985.248.1.C43; DUDLEY GA, 1991, AVIAT SPACE ENVIR MD, V62, P543; EDWARDS RHT, 1975, J PHYSIOL-LONDON, V251, P303, DOI 10.1113/jphysiol.1975.sp011094; EDWARDS RHT, 1972, J PHYSIOL-LONDON, V220, P335, DOI 10.1113/jphysiol.1972.sp009710; ESSEN B, 1977, J PHYSIOL-LONDON, V265, P489, DOI 10.1113/jphysiol.1977.sp011726; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Gonzalez-Alonso J, 2000, J PHYSIOL-LONDON, V524, P603, DOI 10.1111/j.1469-7793.2000.00603.x; Gonzalez-Izal M, 2010, J ELECTROMYOGR KINES, V20, P233, DOI 10.1016/j.jelekin.2009.03.011; HULTMAN E, 1983, J PHYSIOL-LONDON, V345, P525, DOI 10.1113/jphysiol.1983.sp014994; HULTMAN E, 1986, J PHYSIOL-LONDON, V374, P493, DOI 10.1113/jphysiol.1986.sp016093; HULTMAN E, 1991, SCI PROG, V75, P361; JONES NL, 1985, J APPL PHYSIOL, V59, P132, DOI 10.1152/jappl.1985.59.1.132; Karatzaferi C, 2003, AM J PHYSIOL-CELL PH, V284, pC816, DOI 10.1152/ajpcell.00291.2002; KARLSSON J, 1970, J APPL PHYSIOL, V29, P598, DOI 10.1152/jappl.1970.29.5.598; KARLSSON J, 1971, ACTA PHYSIOL SCAND, V82, P115, DOI 10.1111/j.1748-1716.1971.tb04948.x; Krustrup P, 2003, J PHYSIOL-LONDON, V549, P255, DOI 10.1113/jphysiol.2002.035089; Krustrup P, 2009, J PHYSIOL-LONDON, V587, P1843, DOI 10.1113/jphysiol.2008.166397; KUSHMERICK MJ, 1985, J EXP BIOL, V115, P165; Lowry O H, 1971, Curr Probl Clin Biochem, V3, P63; MEDBO JI, 1993, J APPL PHYSIOL, V75, P1654, DOI 10.1152/jappl.1993.75.4.1654; NORMAN B, 1991, CLIN PHYSIOL, V11, P375, DOI 10.1111/j.1475-097X.1991.tb00666.x; Parolin ML, 1999, AM J PHYSIOL-ENDOC M, V277, pE890, DOI 10.1152/ajpendo.1999.277.5.E890; REN JM, 1988, ACTA PHYSIOL SCAND, V133, P101, DOI 10.1111/j.1748-1716.1988.tb08386.x; SAHLIN K, 1989, J APPL PHYSIOL, V67, P648, DOI 10.1152/jappl.1989.67.2.648; SAHLIN K, 1978, PFLUG ARCH EUR J PHY, V374, P193, DOI 10.1007/BF00581301; SAHLIN K, 1975, BIOCHEM J, V152, P173, DOI 10.1042/bj1520173; SELLEVOLD OFM, 1986, J MOL CELL CARDIOL, V18, P517, DOI 10.1016/S0022-2828(86)80917-8; SPRIET LL, 1987, J APPL PHYSIOL, V62, P611, DOI 10.1152/jappl.1987.62.2.611; STORER TW, 1990, MED SCI SPORT EXER, V22, P704, DOI 10.1249/00005768-199010000-00024; TULLSON PC, 1995, J APPL PHYSIOL, V78, P146, DOI 10.1152/jappl.1995.78.1.146; Westerblad H, 1998, ACTA PHYSIOL SCAND, V162, P253, DOI 10.1046/j.1365-201X.1998.0301f.x	45	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13486	10.1371/journal.pone.0013486	http://dx.doi.org/10.1371/journal.pone.0013486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976067	gold, Green Published			2022-12-25	WOS:000283114700016
J	Matthews, TD; Edwards, R; Maloy, S				Matthews, T. David; Edwards, Robert; Maloy, Stanley			Chromosomal Rearrangements Formed by rrn Recombination Do Not Improve Replichore Balance in Host-Specific Salmonella enterica Serovars	PLOS ONE			English	Article							ESCHERICHIA-COLI-CHROMOSOME; RIBOSOMAL-RNA GENES; NADPH PHAGOCYTE OXIDASE; REPLICATION FORK TRAP; GENOME SEQUENCE; YERSINIA-PESTIS; INTRACELLULAR SALMONELLA; HOMOLOGOUS RECOMBINATION; ANTIMICROBIAL ACTIONS; TERMINUS REGION	Background: Most of the,2,600 serovars of Salmonella enterica have a broad host range as well as a conserved gene order. In contrast, some Salmonella serovars are host-specific and frequently exhibit large chromosomal rearrangements from recombination between rrn operons. One hypothesis explaining these rearrangements suggests that replichore imbalance introduced from horizontal transfer of pathogenicity islands and prophages drives chromosomal rearrangements in an attempt to improve balance. Methodology/Principal Findings: This hypothesis was directly tested by comparing the naturally-occurring chromosomal arrangement types to the theoretically possible arrangement types, and estimating their replichore balance using a calculator. In addition to previously characterized strains belonging to host-specific serovars, the arrangement types of 22 serovar Gallinarum strains was also determined. Only 48 out of 1,440 possible arrangement types were identified in 212 host-specific strains. While the replichores of most naturally-occurring arrangement types were well-balanced, most theoretical arrangement types had imbalanced replichores. Furthermore, the most common types of rearrangements did not change replichore balance. Conclusions/Significance: The results did not support the hypothesis that replichore imbalance causes these rearrangements, and suggest that the rearrangements could be explained by aspects of a host-specific lifestyle.	[Matthews, T. David; Edwards, Robert; Maloy, Stanley] San Diego State Univ, Dept Biol, Ctr Microbial Sci, San Diego, CA 92182 USA; [Edwards, Robert] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Edwards, Robert] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA	California State University System; San Diego State University; California State University System; San Diego State University; United States Department of Energy (DOE); Argonne National Laboratory	Matthews, TD (corresponding author), San Diego State Univ, Dept Biol, Ctr Microbial Sci, San Diego, CA 92182 USA.	smaloy@sciences.sdsu.edu	Maloy, Stanley/AAA-7095-2019; Edwards, Robert/Q-1691-2019	Maloy, Stanley/0000-0001-9900-4367; Edwards, Robert/0000-0001-8383-8949	Natioinal Institute of Health [1U54CA132384, 1U54CA132379]; NATIONAL CANCER INSTITUTE [U54CA132384, U54CA132379] Funding Source: NIH RePORTER	Natioinal Institute of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant from the National Institute of Health (# 1U54CA132384 and # 1U54CA132379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alokam S, 2002, J BACTERIOL, V184, P6190, DOI 10.1128/JB.184.22.6190-6197.2002; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Carpentier AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-84; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clegg S, 2002, J BACTERIOL, V184, P1209, DOI 10.1128/jb.184.4.1209-1213.2002; Colwell R. K., 2006, ESTIMATES VERSION 8; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Couturier E, 2006, MOL MICROBIOL, V59, P1506, DOI 10.1111/j.1365-2958.2006.05046.x; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; DESAI UJ, 1995, BIOTECHNIQUES, V19, P780; Duggin IG, 2009, J MOL BIOL, V387, P532, DOI 10.1016/j.jmb.2009.02.027; Duggin IG, 2008, MOL MICROBIOL, V70, P1323, DOI 10.1111/j.1365-2958.2008.06500.x; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Esnault E, 2007, PLOS GENET, V3, P2486, DOI 10.1371/journal.pgen.0030226; Espeli O, 2008, MOL MICROBIOL, V68, P1418, DOI 10.1111/j.1365-2958.2008.06239.x; EWING WH, 1986, GENUS SALMONELLA EDW, P181; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; Guijo MI, 2001, GENETICS, V157, P1413; HAACK KR, 1995, GENETICS, V141, P1245; Helm RA, 2003, GENETICS, V165, P951; Helm RA, 2001, APPL ENVIRON MICROB, V67, P3295, DOI 10.1128/AEM.67.7.3295-3298.2001; HELM RA, 2003, ANAL CHROMOSOMAL REA; HILL CW, 1981, P NATL ACAD SCI-BIOL, V78, P7069, DOI 10.1073/pnas.78.11.7069; HILL CW, 1988, GENETICS, V119, P771; HILL CW, 1977, J MOL BIOL, V116, P407, DOI 10.1016/0022-2836(77)90077-8; HILL CW, 1982, J BACTERIOL, V149, P449, DOI 10.1128/JB.149.2.449-457.1982; HILL TM, 1996, ESCHERICHIA COLI SAL, P1602; Iguchi A, 2006, GENE, V372, P199, DOI 10.1016/j.gene.2006.01.005; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; Jumas-Bilak E, 1998, MOL MICROBIOL, V27, P99, DOI 10.1046/j.1365-2958.1998.00661.x; Kothapalli S, 2005, J BACTERIOL, V187, P2638, DOI 10.1128/JB.187.8.2638-2650.2005; KUEMPEL PL, 1991, NEW BIOL, V3, P799; LI J, 1993, J MED MICROBIOL, V38, P129, DOI 10.1099/00222615-38-2-129; Lindroos H, 2006, J BACTERIOL, V188, P7426, DOI 10.1128/JB.00472-06; Liu GR, 2006, MOL BIOL EVOL, V23, P365, DOI 10.1093/molbev/msj042; Liu GR, 2002, J BACTERIOL, V184, P2626, DOI 10.1128/JB.184.10.2626-2633.2002; Liu SL, 1998, FEMS MICROBIOL LETT, V164, P275, DOI 10.1016/S0378-1097(98)00225-0; LIU SL, 1995, J BACTERIOL, V177, P6585, DOI 10.1128/jb.177.22.6585-6592.1995; LIU SL, 1994, J BACTERIOL, V176, P1014, DOI 10.1128/JB.176.4.1014-1024.1994; LIU SL, 1995, P NATL ACAD SCI USA, V92, P1018, DOI 10.1073/pnas.92.4.1018; Liu SL, 1996, P NATL ACAD SCI USA, V93, P10303, DOI 10.1073/pnas.93.19.10303; Liu WQ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-290; Liu WQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004510; LOUARN JM, 1985, MOL GEN GENET, V201, P467, DOI 10.1007/BF00331341; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Morton RA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-369; Niki H, 2000, GENE DEV, V14, P212; Olsen JE, 1996, J MED MICROBIOL, V45, P413, DOI 10.1099/00222615-45-6-413; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; Pomeroy B. S., 1984, DISEASES POULTRY, P79; POPOFF M.Y., 2005, BERGEYS MANUAL SYSTE, V2, P764; SCHMID MB, 1987, J BACTERIOL, V169, P2872, DOI 10.1128/jb.169.6.2872-2875.1987; Shu SE, 2000, FEMS MICROBIOL LETT, V182, P93, DOI 10.1111/j.1574-6968.2000.tb08880.x; SNOEYENBOS GH, 1984, DISEASES POULTRY, P66; Song JZ, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-17; Sousa C, 1997, MICROBIOL-SGM, V143, P2071, DOI 10.1099/00221287-143-6-2071; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Valens M, 2004, EMBO J, V23, P4330, DOI 10.1038/sj.emboj.7600434; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Vazquez-Torres A, 2001, TRENDS MICROBIOL, V9, P29, DOI 10.1016/S0966-842X(00)01897-7; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Wu KY, 2005, J BACTERIOL, V187, P4720, DOI 10.1128/JB.187.14.4720-4727.2005; [No title captured]	74	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13503	10.1371/journal.pone.0013503	http://dx.doi.org/10.1371/journal.pone.0013503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976060	gold, Green Submitted, Green Published			2022-12-25	WOS:000283114700022
J	Canault, M; Certel, K; Schatzberg, D; Wagner, DD; Hynes, RO				Canault, Matthias; Certel, Kaan; Schatzberg, Daphne; Wagner, Denisa D.; Hynes, Richard O.			The Lack of ADAM17 Activity during Embryonic Development Causes Hemorrhage and Impairs Vessel Formation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; JUNCTIONAL ADHESION MOLECULE; CONVERTING-ENZYME; IN-VITRO; INFLAMMATORY RESPONSES; TUMOR ANGIOGENESIS; ENDOTHELIAL-CELLS; DEFICIENT MICE; GROWTH-FACTOR; NOTCH	Background: ADAM17/TACE activity is important during embryonic development. We wished to investigate possible roles of this metalloprotease, focusing on vascular development. Methodology/Principal Findings: Mice mutant in the enzymatic activity of ADAM17 were examined at various stages of embryonic development for vascular pattern and integrity using markers for vessel wall cells. We observed hemorrhage and edema starting at embryonic day E14.5 and becoming more severe as development proceeded; prior to embryonic day E14.5, embryos appeared normal. Staining for PECAM-1/CD31 revealed abnormalities in the patterns of branching of the embryonic vasculature at E14.5. Conclusions/Significance: These abnormalities preceded association of pericytes or monocyte/macrophage cells with the affected vessels and, therefore, presumably arise from defects in endothelial function consequent upon failure of ADAM17 to cleave one or more substrates involved in vascular development, such as Notch, Delta, VEGFR2 or JAM-A. Our study demonstrates a role for ADAM17 in modulating embryonic vessel development and function.	[Canault, Matthias; Schatzberg, Daphne; Wagner, Denisa D.] Immune Dis Inst, Boston, MA USA; [Canault, Matthias; Schatzberg, Daphne; Wagner, Denisa D.] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Canault, Matthias; Wagner, Denisa D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Certel, Kaan; Hynes, Richard O.] Howard Hughes Med Inst, Chevy Chase, MA USA; [Certel, Kaan; Hynes, Richard O.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Canault, M (corresponding author), Immune Dis Inst, Boston, MA USA.	wagner@idi.harvard.edu; rohynes@mit.edu	Canault, Matthias/H-5128-2013	Canault, Matthias/0000-0002-7880-5250	National Heart, Lung, and Blood Institute of the National Institutes of Health [P01 HL066105, P01 HL056949]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949, P01HL066105] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health grants P01 HL066105 (D. D. W. and R.O.H.) and P01 HL056949 (D. D. W.) and support from the Howard Hughes Medical Institute, of which R.O.H. is an investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Bergmeier W, 2004, CIRC RES, V95, P677, DOI 10.1161/01.RES.0000143899.73453.11; Berkowitz EA, 1996, CELL GROWTH DIFFER, V7, P1271; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Cooke VG, 2006, ARTERIOSCL THROM VAS, V26, P2005, DOI 10.1161/01.ATV.0000234923.79173.99; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gooz P, 2009, BIOCHEM BIOPH RES CO, V380, P33, DOI 10.1016/j.bbrc.2009.01.013; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233; Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103; Koenen RR, 2009, BLOOD, V113, P4799, DOI 10.1182/blood-2008-04-152330; Kwak HI, 2009, MATRIX BIOL, V28, P470, DOI 10.1016/j.matbio.2009.07.007; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Li JL, 2009, FRONT BIOSCI-LANDMRK, V14, P3094, DOI 10.2741/3438; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Reiss K, 2006, PHARMACOL THERAPEUT, V111, P985, DOI 10.1016/j.pharmthera.2006.02.009; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Schmitt FC, 1999, AM J SURG PATHOL, V23, P358, DOI 10.1097/00000478-199903000-00023; Shi W, 2003, DEV BIOL, V261, P371, DOI 10.1016/S0012-1606(03)00315-4; Siekmann AF, 2008, BIOESSAYS, V30, P303, DOI 10.1002/bies.20736; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Thurston G, 2008, BRIT J CANCER, V99, P1204, DOI 10.1038/sj.bjc.6604484; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Willuweit A, 2001, J IMMUNOL, V167, P3944, DOI 10.4049/jimmunol.167.7.3944; Zhao JS, 2001, DEV BIOL, V232, P204, DOI 10.1006/dbio.2001.0176	31	24	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13433	10.1371/journal.pone.0013433	http://dx.doi.org/10.1371/journal.pone.0013433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976179	Green Published, Green Submitted, gold			2022-12-25	WOS:000283043700022
J	Yatsushiro, S; Yamamura, S; Yamaguchi, Y; Shinohara, Y; Tamiya, E; Horii, T; Baba, Y; Kataoka, M				Yatsushiro, Shouki; Yamamura, Shohei; Yamaguchi, Yuka; Shinohara, Yasuo; Tamiya, Eiichi; Horii, Toshihiro; Baba, Yoshinobu; Kataoka, Masatoshi			Rapid and Highly Sensitive Detection of Malaria-Infected Erythrocytes Using a Cell Microarray Chip	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; LABORATORY DIAGNOSIS; FLOW-CYTOMETRY; MICROSCOPY; TESTS	Background: Malaria is one of the major human infectious diseases in many endemic countries. For prevention of the spread of malaria, it is necessary to develop an early, sensitive, accurate and conventional diagnosis system. Methods and Findings: A cell microarray chip was used to detect for malaria-infected erythrocytes. The chip, with 20,944 microchambers (105 mu m width and 50 mu m depth), was made from polystyrene, and the formation of monolayers of erythrocytes in the microchambers was observed. Cultured Plasmodium falciparum strain 3D7 was used to examine the potential of the cell microarray chip for malaria diagnosis. An erythrocyte suspension in a nuclear staining dye, SYTO 59, was dispersed on the chip surface, followed by 10 min standing to allow the erythrocytes to settle down into the microchambers. About 130 erythrocytes were accommodated in each microchamber, there being over 2,700,000 erythrocytes in total on a chip. A microarray scanner was employed to detect any fluorescence-positive erythrocytes within 5 min, and 0.0001% parasitemia could be detected. To examine the contamination by leukocytes of purified erythrocytes from human blood, 20 mu l of whole blood was mixed with 10 ml of RPMI 1640, and the mixture was passed through a leukocyte isolation filter. The eluted portion was centrifuged at 1,000xg for 2 min, and the pellet was dispersed in 1.0 ml of medium. SYTO 59 was added to the erythrocyte suspension, followed by analysis on a cell microarray chip. Similar accommodation of cells in the microchambers was observed. The number of contaminating leukocytes was less than 1 on a cell microarray chip. Conclusion: The potential of the cell microarray chip for the detection of malaria-infected erythrocytes was shown, it offering 10-100 times higher sensitivity than that of conventional light microscopy and easy operation in 15 min with purified erythrocytes.	[Yatsushiro, Shouki; Yamamura, Shohei; Yamaguchi, Yuka; Baba, Yoshinobu; Kataoka, Masatoshi] Natl Inst Adv Ind Sci & Technol, Hlth Technol Res Ctr, Takamatsu, Kagawa, Japan; [Shinohara, Yasuo] Univ Tokushima, Grad Sch Pharmaceut Sci, Dept Mol & Pharmaceut Biotechnol, Tokushima 770, Japan; [Shinohara, Yasuo] Univ Tokushima, Div Prot Express, Inst Genome Res, Tokushima 770, Japan; [Tamiya, Eiichi] Osaka Univ, Dept Appl Phys, Grad Sch Engn, Suita, Osaka 565, Japan; [Horii, Toshihiro] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 565, Japan; [Baba, Yoshinobu] Nagoya Univ, Dept Appl Chem, Grad Sch Engn, Nagoya, Aichi 46401, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tokushima University; Tokushima University; Osaka University; Osaka University; Nagoya University	Yatsushiro, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Hlth Technol Res Ctr, Takamatsu, Kagawa, Japan.	m-kataoka@aist.go.jp	Kataoka, Masatoshi/M-6925-2018; yamamura, shohei/M-8071-2018; YATSUSHIRO, shouki/M-8155-2018; Tamiya, Eiichi/M-6111-2018	Kataoka, Masatoshi/0000-0001-9779-8319; yamamura, shohei/0000-0002-4971-4560; YATSUSHIRO, shouki/0000-0002-6123-1561; Tamiya, Eiichi/0000-0002-7646-4827; Horii, Toshihiro/0000-0002-3000-2045	Japan Society for the Promotion of Science [20790094]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants in aid (20790094) for young scientists from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlo D.D., 2006, ANAL CHEM, V78, P7918, DOI [DOI 10.1021/AC069490P, 10.1021/ac069490p]; Cheng Q, 1997, AM J TROP MED HYG, V57, P495, DOI 10.4269/ajtmh.1997.57.495; Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011; Guy R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-89; Jimenez-Diaz MB, 2005, CYTOM PART A, V67A, P27, DOI 10.1002/cyto.a.20169; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Li QG, 2007, CYTOM PART A, V71A, P297, DOI 10.1002/cyto.a.20380; Mason DP, 2002, ACTA TROP, V82, P51, DOI 10.1016/S0001-706X(02)00031-1; MILNE LM, 1994, J CLIN PATHOL, V47, P740, DOI 10.1136/jcp.47.8.740; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; PAYNE D, 1988, B WORLD HEALTH ORGAN, V66, P621; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Steketee RW, 1996, AM J TROP MED HYG, V55, P50, DOI 10.4269/ajtmh.1996.55.50; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; VANDERHEYDE HC, 1995, CLIN DIAGN LAB IMMUN, V2, P417, DOI 10.1128/CDLI.2.4.417-425.1995; Warhurst DC, 1996, J CLIN PATHOL, V49, P533, DOI 10.1136/jcp.49.7.533; *WHO, 2006, GUID WHOS ROL SECT W, P8; *WHO, 2000, NEW PERSP MAL DIAGN, P11; *WHO, 2008, WORLD MAL REP 2008, pR8; Yamamura S, 2005, ANAL CHEM, V77, P8050, DOI 10.1021/ac0515632	21	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13179	10.1371/journal.pone.0013179	http://dx.doi.org/10.1371/journal.pone.0013179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967248	Green Submitted, gold, Green Published			2022-12-25	WOS:000282869800003
J	Shi, G; Sohn, KC; Choi, DK; Kim, YJ; Kim, SJ; Ou, BS; Piao, YJ; Lee, YH; Yoon, TJ; Lee, Y; Seo, YJ; Kim, CD; Lee, JH				Shi, Ge; Sohn, Kyung-Cheol; Choi, Dae-Kyoung; Kim, Yu-Jin; Kim, Seong-Jin; Ou, Bai-Sheng; Piao, Yong-Jun; Lee, Young Ho; Yoon, Tae-Jin; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon			Brn2 Is a Transcription Factor Regulating Keratinocyte Differentiation with a Possible Role in the Pathogenesis of Lichen Planus	PLOS ONE			English	Article							T-CELL SUBSETS; POU-DOMAIN; EXPRESSION; APOPTOSIS; INVOLUCRIN; MELANOMA; GENE; HYPOTHALAMUS; PROTEIN-1; ACTIVATOR	Terminal differentiation of skin keratinocytes is a vertically directed multi-step process that is tightly controlled by the sequential expression of a variety of genes. In this study, we investigated the role of the POU domain-containing transcription factor Brn2 in keratinocyte differentiation. Immunohistochemical analysis showed that Brn2 is expressed primarily in the upper granular layer. Consistent with its epidermal localization, Brn2 expression was highly induced at 14 days after calcium treatment of cultured normal human epidermal keratinocytes. When Brn2 was overexpressed by adenoviral transduction, Brn2 led to increased expression of the differentiation-related genes involucrin, filaggrin, and loricrin in addition to inhibition of their proliferation. Chromatin immunoprecipitation demonstrated that Brn2 bound to the promoter regions of these differentiation-related genes. We injected the purified Brn2 adenovirus into rat skin, which led to a thickened epidermis with increased amounts of differentiation related markers. The histopathologic features of adenovirus-Brn2 injected skin tissues looked similar to the features of lichen planus, a human skin disease showing chronic inflammation and well-differentiated epidermal changes. Moreover, Brn2 is shown to be expressed in almost all cell nuclei of the thickened epidermis of lichen planus, and Brn2 also attracts T lymphocytes. Our results demonstrate that Brn2 is probably a transcriptional factor playing an important role in keratinocyte differentiation and probably also in the pathogenesis of lichen planus lesions.	[Shi, Ge; Sohn, Kyung-Cheol; Choi, Dae-Kyoung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon] Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon, South Korea; [Shi, Ge; Sohn, Kyung-Cheol; Choi, Dae-Kyoung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon] Chungnam Natl Univ, Sch Med, Res Inst Med Sci, Taejon, South Korea; [Kim, Seong-Jin] Chonnam Natl Univ, Sch Med, Dept Dermatol, Kwangju, South Korea; [Shi, Ge; Ou, Bai-Sheng] Guangxi Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Dermatol, Nanning, Peoples R China; [Piao, Yong-Jun] Dalian Med Univ, Affiliated Hosp 1, Dept Dermatol, Dalian, Peoples R China; [Lee, Young Ho] Chungnam Natl Univ, Dept Anat, Sch Med, Taejon, South Korea; [Yoon, Tae-Jin] Gyeongsang Natl Univ, Sch Med, Dept Dermatol, Jinju, South Korea; [Yoon, Tae-Jin] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju, South Korea	Chungnam National University; Chungnam National University; Chonnam National University; Guangxi University of Chinese Medicine; Dalian Medical University; Chungnam National University; Gyeongsang National University; Gyeongsang National University	Shi, G (corresponding author), Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon, South Korea.	jhoon@cnu.ac.kr		Lee, Young/0000-0001-9205-1785; Kim, Chang Deok/0000-0001-9341-6491; Seo, Young-Joon/0000-0002-4955-590X	National Research Foundation of Korea [KRF-2008-314-E00152]; Korea Ministry of Health, Welfare and Family Affairs [01-PJ3-PG6-01GN12-0001]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Ministry of Health, Welfare and Family Affairs	This study was supported by a grant of the National Research Foundation of Korea (KRF-2008-314-E00152), and a grant of the Korea Health 21 R&D Project from the Korea Ministry of Health, Welfare and Family Affairs (01-PJ3-PG6-01GN12-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bloor BK, 1999, ORAL SURG ORAL MED O, V88, P187, DOI 10.1016/S1079-2104(99)70116-2; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; Cook AL, 2008, PIGM CELL MELANOMA R, V21, P611, DOI 10.1111/j.1755-148X.2008.00510.x; de Boer OJ, 2007, J HISTOCHEM CYTOCHEM, V55, P891, DOI 10.1369/jhc.6A7119.2007; Dekker NP, 1997, J ORAL PATHOL MED, V26, P170, DOI 10.1111/j.1600-0714.1997.tb00453.x; Delhase M, 1996, J BIOL CHEM, V271, P32349, DOI 10.1074/jbc.271.50.32349; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; EISEN T, 1995, ONCOGENE, V11, P2157; EISENBERG E, 1987, ORAL SURG ORAL MED O, V64, P313, DOI 10.1016/0030-4220(87)90011-9; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; FUJII H, 1993, NEURON, V11, P1197, DOI 10.1016/0896-6273(93)90231-F; Goodall J, 2004, MOL CELL BIOL, V24, P2923, DOI 10.1128/MCB.24.7.2923-2931.2004; Goodall J, 2004, MOL CELL BIOL, V24, P2915, DOI 10.1128/MCB.24.7.2915-2922.2004; HASHIMOTO K, 1976, ACTA DERM-VENEREOL, V56, P187; HOHL D, 1993, AM J DERMATOPATH, V15, P20, DOI 10.1097/00000372-199302000-00004; Ichikawa E, 1997, ARCH DERMATOL RES, V289, P519, DOI 10.1007/s004030050233; ISHII T, 1987, J ORAL PATHOL MED, V16, P356, DOI 10.1111/j.1600-0714.1987.tb00708.x; Jang SI, 2000, J BIOL CHEM, V275, P15295, DOI 10.1074/jbc.275.20.15295; JUNGELL P, 1989, SCAND J DENT RES, V97, P361; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kikuchi Arata, 1992, Journal of Dermatological Science, V4, P83, DOI 10.1016/0923-1811(92)90063-H; KILPI AM, 1987, SCAND J DENT RES, V95, P174; KILPI AM, 1988, P FINN DENT SOC, V84, P5; Lee JJ, 2005, ORAL SURG ORAL MED O, V99, P471, DOI 10.1016/j.tripleo.2004.10.018; LI P, 1993, GENE DEV, V7, P2483, DOI 10.1101/gad.7.12b.2483; MATTHEWS JB, 1984, BRIT J DERMATOL, V111, P587, DOI 10.1111/j.1365-2133.1984.tb06629.x; MEDENICA M, 1977, ACTA DERM-VENEREOL, V57, P55; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; Neppleberg E, 2001, EUR J ORAL SCI, V109, P361, DOI 10.1034/j.1600-0722.2001.00081.x; Piao YJ, 2005, EXP DERMATOL, V14, P356, DOI 10.1111/j.0906-6705.2005.00272.x; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Schonemann MD, 1995, GENE DEV, V9, P3122, DOI 10.1101/gad.9.24.3122; Seo EY, 2005, GENOMICS, V86, P528, DOI 10.1016/j.ygeno.2005.06.013; Shimizu M, 1997, ARCH DERMATOL RES, V289, P527, DOI 10.1007/s004030050234; Sohn KC, 2009, J DERMATOL SCI, V54, P6, DOI 10.1016/j.jdermsci.2008.11.006; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; STURM RA, 1994, PIGM CELL RES, V7, P235, DOI 10.1111/j.1600-0749.1994.tb00055.x; Tollefson Ann E, 2007, Methods Mol Med, V130, P223; VERRIJZER CP, 1993, BIOCHIM BIOPHYS ACTA, V1173, P1, DOI 10.1016/0167-4781(93)90237-8; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; WEEDON D, 1980, CLIN EXP DERMATOL, V5, P425, DOI 10.1111/j.1365-2230.1980.tb01728.x; Wegner M, 1993, CURR OPIN CELL BIOL, V5, P488, DOI 10.1016/0955-0674(93)90015-I; Welter JF, 1996, J BIOL CHEM, V271, P14727, DOI 10.1074/jbc.271.25.14727; Yoon HK, 2008, BIOCHEM BIOPH RES CO, V377, P662, DOI 10.1016/j.bbrc.2008.10.051	44	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13216	10.1371/journal.pone.0013216	http://dx.doi.org/10.1371/journal.pone.0013216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967260	Green Published, Green Submitted, gold			2022-12-25	WOS:000282807300005
J	Millard, M; Pathania, D; Shabaik, Y; Taheri, L; Deng, JX; Neamati, N				Millard, Melissa; Pathania, Divya; Shabaik, Yumna; Taheri, Laleh; Deng, Jinxia; Neamati, Nouri			Preclinical Evaluation of Novel Triphenylphosphonium Salts with Broad-Spectrum Activity	PLOS ONE			English	Article							PHOSPHONIUM SALTS; CELL-GROWTH; CU-64-LABELED TRIPHENYLPHOSPHONIUM; LIPOPHILIC CATIONS; BREAST-CANCER; IN-VITRO; CARCINOMA; PROLIFERATION; BIOLOGY; DNA	Background: Recently, there has been a surge of interest in developing compounds selectively targeting mitochondria for the treatment of neoplasms. The critical role of mitochondria in cellular metabolism and respiration supports this therapeutic rationale. Dysfunction in the processes of energy production and metabolism contributes to attenuation of response to pro-apoptotic stimuli and increased ROS production both of which are implicated in the initiation and progression of most human cancers. Methodology/Principal Findings: A high-throughput MTT-based screen of over 10,000 drug-like small molecules for antiproliferative activity identified the phosphonium salts TP187, 197 and 421 as having IC50 concentrations in the submicromolar range. TP treatment induced cell cycle arrest independent of p53 status, as determined by analysis of DNA content in propidium iodide stained cells. In a mouse model of human breast cancer, TP-treated mice showed significantly decreased tumor growth compared to vehicle or paclitaxel treated mice. No toxicities or organ damage were observed following TP treatment. Immunohistochemical staining of tissue sections from TP187-treated tumors demonstrated a decrease in cellular proliferation and increased caspase-3 cleavage. The fluorescent properties of analog TP421 were exploited to assess subcellular uptake of TP compounds, demonstrating mitochondrial localization. Following mitochondrial uptake cells exhibited decreased oxygen consumption and concomittant increase in mitochondrial superoxide production. Proteomics analysis of results from a 600 target antibody microarray demonstrated that TP compounds significantly affected signaling pathways relevant to growth and proliferation. Conclusions/Significance: Through our continued interest in designing compounds targeting cancer-cell metabolism, the Warburg effect, and mitochondria we recently discovered a series of novel, small-molecule compounds containing a triphenylphosphine moiety that show remarkable activity in a panel of cancer cell lines as well as in a mouse model of human breast cancer. The mechanism of action includes mitochondrial localization causing decreased oxygen consumption, increased superoxide production and attenuated growth factor signaling.	[Millard, Melissa; Pathania, Divya; Shabaik, Yumna; Taheri, Laleh; Deng, Jinxia; Neamati, Nouri] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA	University of Southern California	Millard, M (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.	neamati@usc.edu			Congressionally Directed Medical Research Program (CDMRP); Sharon and William Cockrell Endowed Cancer Research Fund	Congressionally Directed Medical Research Program (CDMRP)(United States Department of Defense); Sharon and William Cockrell Endowed Cancer Research Fund	This study was supported in part by funds from the Congressionally Directed Medical Research Program (CDMRP) Breast Cancer Concept Award and the Sharon and William Cockrell Endowed Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron KL, 2009, MUTAT RES-GEN TOX EN, V673, P141, DOI 10.1016/j.mrgentox.2009.01.002; BLANK B, 1975, J MED CHEM, V18, P952, DOI 10.1021/jm00243a021; CARMICHAEL J, 1987, CANCER RES, V47, P936; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Cooper WA, 2001, MAGNET RESON MED, V45, P1001, DOI 10.1002/mrm.1133; CROMLISH JA, 1989, J BIOL CHEM, V264, P18100; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DEBY C, 1990, BIOCHEM PHARMACOL, V39, P399, DOI 10.1016/0006-2952(90)90043-K; DUBOIS RJ, 1978, J MED CHEM, V21, P303, DOI 10.1021/jm00201a016; Filomeni G, 2005, CELL DEATH DIFFER, V12, P1555, DOI 10.1038/sj.cdd.4401754; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; GRINIUS LL, 1970, BIOCHIM BIOPHYS ACTA, V216, P1, DOI 10.1016/0005-2728(70)90153-2; Haga N, 2010, CANC SCI; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; ISOLA JJ, 1990, CANCER, V65, P1180, DOI 10.1002/1097-0142(19900301)65:5<1180::AID-CNCR2820650525>3.0.CO;2-7; Kim YS, 2008, J MED CHEM, V51, P2971, DOI 10.1021/jm7015045; KINNAMON KE, 1977, J MED CHEM, V20, P741, DOI 10.1021/jm00216a001; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Manetta A, 1996, GYNECOL ONCOL, V60, P203, DOI 10.1006/gyno.1996.0026; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Munshi A, 2005, METH MOLEC MED, V110, P21; Murphy MP, 2008, BBA-BIOENERGETICS, V1777, P1028, DOI 10.1016/j.bbabio.2008.03.029; Pathania D, 2009, ADV DRUG DELIVER REV, V61, P1250, DOI 10.1016/j.addr.2009.05.010; RIDEOUT D, 1994, INT J CANCER, V57, P247, DOI 10.1002/ijc.2910570220; RIDEOUT DC, 1989, ANTI-CANCER DRUG DES, V4, P265; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Smolkova K, 2010, J BIOENERG BIOMEMBR, V42, P55, DOI 10.1007/s10863-009-9267-x; STEINBECK MJ, 1993, J BIOL CHEM, V268, P15649; VERONESE SM, 1993, CANCER, V71, P3926, DOI 10.1002/1097-0142(19930615)71:12<3926::AID-CNCR2820711221>3.0.CO;2-2; Wang JJ, 2007, J MED CHEM, V50, P5057, DOI 10.1021/jm0704088; WARBURG O, 1956, SCIENCE, V123, P310; WITTIG G, 1980, SCIENCE, V210, P600, DOI 10.1126/science.210.4470.600	35	94	97	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13131	10.1371/journal.pone.0013131	http://dx.doi.org/10.1371/journal.pone.0013131			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957228	Green Submitted, gold, Green Published			2022-12-25	WOS:000282423300003
J	Revel, M; Dejean, A; Cereghino, R; Roux, O				Revel, Messika; Dejean, Alain; Cereghino, Regis; Roux, Olivier			An Assassin among Predators: The Relationship between Plant-Ants, Their Host Myrmecophytes and the Reduviidae Zelus annulosus	PLOS ONE			English	Article							HETEROPTERA; ALEYRODIDAE; HERBIVORES; HEMIPTERA; PARASITE; BEHAVIOR; BUG	Tropical plants frequently live in association with ants that protect their foliage from defoliators. Among them, myrmecophytes have evolved mutualisms with a limited number of plant-ants that they shelter and feed, and, in return, benefit from some protection. Hirtella physophora (Chrysobalanaceae), for example, houses Allomerus decemarticulatus (Myrmicinae) that build gallery-shaped traps to catch large prey. In French Guiana, we frequently observed the assassin bug Zelus annulosus (Reduviidae, Harpactorinae) on the leaves of H. physophora. Here, we studied the distribution of Zelus annulosus among understory plants in the Guianese rainforest and found it only on pubescent plants, including H. Physophora, whether or not it was sheltering an A. decemarticulatus colony, but only rarely on other myrmecophytes. The relationship between Z. annulosus and its host plants is, then, also mutualistic, as the plant trichomes act as an enemy-free space protecting the nymphs from large predatory ants, while the nymphs protect their host-plants from herbivorous insects. Through their relationship with A. decemarticulatus colonies, Z. annulosus individuals are protected from army ants, while furnishing nothing in return. In those cases where H. physophora sheltered both an A. decemarticulatus colony and Z. annulosus nymphs, certain plant individuals repeatedly sheltered nymphs, indicating that female bugs may select not only pubescent plants but also particular H. physophora treelets having characteristics more favourable to the development of their progeny.	[Revel, Messika; Dejean, Alain; Roux, Olivier] Ecofog Ecol Forets Guyane, CNRS, UMR 8172, Kourou, France; [Cereghino, Regis] CNRS, UMR 5245, EcoLab Lab Ecol Fonct, Toulouse, France; [Cereghino, Regis] Univ Toulouse, UPS, INPT, EcoLab, Toulouse, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Revel, M (corresponding author), Ecofog Ecol Forets Guyane, CNRS, UMR 8172, Campus Agron,BP 709, Kourou, France.	olivier.roux@ecofog.gf	CEREGHINO, Regis/G-9500-2011; Roux, Olivier/A-1181-2011; Roux, Olivier/I-5675-2016	Cereghino, Regis/0000-0003-3981-3159; Revel, Messika/0000-0002-8000-8170; Roux, Olivier/0000-0001-5440-0219; Dejean, Alain/0000-0002-3561-2248	French Centre National de la Recherche Scientifique; European Community	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Community(European Commission)	This study was funded by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID) and the Programme Convergence 2007-2013, Region Guyane from the European Community (project DEGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berenger JM, 1997, CR ACAD SCI III-VIE, V320, P1007, DOI 10.1016/S0764-4469(97)82474-2; Bernays EA, 1994, HOST PLANT SELECTION; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Cetintas R, 2009, FLA ENTOMOL, V92, P538, DOI 10.1653/024.092.0402; Cobben R. H., 1978, EVOLUTIONARY TREND 2, V78-5; Corbara B, 2009, CR BIOL, V332, P470, DOI 10.1016/j.crvi.2009.01.003; DAVIDSON DW, 1989, BIOTROPICA, V21, P64, DOI 10.2307/2388444; Dejean A, 2005, NATURE, V434, P973, DOI 10.1038/434973a; Dejean A, 2001, SOCIOBIOLOGY, V37, P571; Dejean A, 2006, BIOL J LINN SOC, V89, P91, DOI 10.1111/j.1095-8312.2006.00660.x; Fowler Harold G., 1996, Revista Brasileira de Entomologia, V40, P71; Gaume L, 1998, CR ACAD SCI III-VIE, V321, P593, DOI 10.1016/S0764-4469(98)80462-9; Grangier J, 2008, NATURWISSENSCHAFTEN, V95, P909, DOI 10.1007/s00114-008-0398-4; HARIDASS ET, 1987, P INDIAN AS-ANIM SCI, V96, P485, DOI 10.1007/BF03179603; HAVILAND MAUD D., 1931, ZOOLOGICA [NEW YORK], V7, P129; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heil M, 2009, P NATL ACAD SCI USA, V106, P18091, DOI 10.1073/pnas.0904304106; Holldobler B., 1990, pi; JOLIVET P, 1996, ANTS PLANTS EXAMPLE, P304; Kautz S, 2009, EVOLUTION, V63, P839, DOI 10.1111/j.1558-5646.2008.00594.x; LaPierre L, 2007, NATURWISSENSCHAFTEN, V94, P997, DOI 10.1007/s00114-007-0270-y; LETOURNEAU DK, 1983, OECOLOGIA, V60, P122, DOI 10.1007/BF00379331; LETOURNEAU DK, 1990, SCIENCE, V248, P215, DOI 10.1126/science.248.4952.215; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; MCAUSLANE HJ, 1995, ENVIRON ENTOMOL, V24, P1135, DOI 10.1093/ee/24.5.1135; MILLER N. C. E., 1953, TRANS ZOOL SOC LONDON, V27, P541; Miller N. C. E., 1942, Proceedings of the Royal Entomological Society of London (A), V17, P49; Osses F, 2007, P ENTOMOL SOC WASH, V109, P331; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rico-Gray V., 2007, ECOLOGY EVOLUTION AN; Ruiz-Gonzalez MX, 2010, BIOTROPICA, V42, P402, DOI 10.1111/j.1744-7429.2010.00645.x; Schuh R.T., 1995, TRUE BUGS WORLD HEMI; Solano PJ, 2003, SOCIOBIOLOGY, V41, P605; STONER A, 1975, Journal of the Kansas Entomological Society, V48, P185; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Tallamy DW, 2004, J INSECT BEHAV, V17, P431, DOI 10.1023/B:JOIR.0000042532.50112.0c; USINGER R. L., 1958, PAN PACIFIC ENT, V34, P52; VANLENTEREN JC, 1995, J APPL ENTOMOL, V119, P553, DOI 10.1111/j.1439-0418.1995.tb01335.x; Yu DW, 1998, P ROY SOC B-BIOL SCI, V265, P375, DOI 10.1098/rspb.1998.0305	40	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13110	10.1371/journal.pone.0013110	http://dx.doi.org/10.1371/journal.pone.0013110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957040	Green Published, Green Submitted, gold			2022-12-25	WOS:000282359300014
J	Lakhal, S; Schodel, J; Townsend, ARM; Pugh, CW; Ratcliffe, PJ; Mole, DR				Lakhal, Samira; Schoedel, Johannes; Townsend, Alain R. M.; Pugh, Christopher W.; Ratcliffe, Peter J.; Mole, David R.			Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors NEW LINK BETWEEN HYPOXIA SIGNALING AND IRON HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE MATRIPTASE-2 TMPRSS6; TRANSFERRIN RECEPTOR; HEPCIDIN EXPRESSION; MUTATIONS; ANEMIA; GENE; HFE; BINDING; HEMOJUVELIN; INHIBITION	Hepcidin is a liver-derived hormone with a key role in iron homeostasis. In addition to iron, it is regulated by inflammation and hypoxia, although mechanisms of hypoxic regulation remain unclear. In hepatocytes, hepcidin is induced by bone morphogenetic proteins (BMPs) through a receptor complex requiring hemojuvelin (HJV) as a co-receptor. Type II transmembrane serine proteinase (TMPRSS6) antagonizes hepcidin induction by BMPs by cleaving HJV from the cell membrane. Inactivating mutations in TMPRSS6 lead to elevated hepcidin levels and consequent iron deficiency anemia. Here we demonstrate that TMPRSS6 is up-regulated in hepatic cell lines by hypoxia and by other activators of hypoxia-inducible factor (HIF). We show that TMPRSS6 expression is regulated by both HIF-1 alpha and HIF-2 alpha. This HIF-dependent up-regulation of TMPRSS6 increases membrane HJV shedding and decreases hepcidin promoter responsiveness to BMP signaling in hepatocytes. Our results reveal a potential role for TMPRSS6 in hepcidin regulation by hypoxia and provide a new molecular link between oxygen sensing and iron homeostasis.	[Lakhal, Samira; Schoedel, Johannes; Pugh, Christopher W.; Ratcliffe, Peter J.; Mole, David R.] Univ Oxford, Oxford OX3 7BN, England; [Townsend, Alain R. M.] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX4 9DS, England	University of Oxford; University of Oxford	Lakhal, S (corresponding author), Univ Oxford, Henry Wellcome Bldg Mol Physiol, Oxford OX3 7BN, England.	samira.lakhal@well.ox.ac.uk; drmole@well.ox.ac.uk		Schodel, Johannes/0000-0002-3587-8839; Mole, David/0000-0002-0984-300X; Townsend, Alain/0000-0002-3702-0107; Pugh, Chris/0000-0002-5170-1662; Ratcliffe, Peter/0000-0002-2853-806X				Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Beutler E, 2010, BLOOD CELL MOL DIS, V44, P16, DOI 10.1016/j.bcmd.2009.09.001; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Giannetti AM, 2004, J BIOL CHEM, V279, P25866, DOI 10.1074/jbc.M401467200; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; Island ML, 2009, HAEMATOL-HEMATOL J, V94, P720, DOI 10.3324/haematol.2008.001784; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Leung PS, 2005, GUT, V54, P1391, DOI 10.1136/gut.2004.062083; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; McMahon S, 2005, J BIOL CHEM, V280, P6561, DOI 10.1074/jbc.M413248200; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Parr C, 2007, CLIN CANCER RES, V13, P3568, DOI 10.1158/1078-0432.CCR-06-2357; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Sanders AJ, 2008, J CELL PHYSIOL, V216, P780, DOI 10.1002/jcp.21460; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Silvestri L, 2009, BLOOD, V113, P5605, DOI 10.1182/blood-2008-12-195594; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Volke M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007875; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Xiao YT, 2007, BIOCHEM BIOPH RES CO, V362, P550, DOI 10.1016/j.bbrc.2007.08.045; Yamaji S, 2004, BLOOD, V104, P2178, DOI 10.1182/blood-2004-03-0829	41	79	88	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4090	4097		10.1074/jbc.M110.173096	http://dx.doi.org/10.1074/jbc.M110.173096			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	20966077	Green Published, hybrid			2022-12-25	WOS:000286975700007
J	Wang, XF; Gulhati, P; Li, J; Dobner, PR; Weiss, H; Townsend, CM; Evers, BM				Wang, Xiaofu; Gulhati, Pat; Li, Jing; Dobner, Paul R.; Weiss, Heidi; Townsend, Courtney M., Jr.; Evers, B. Mark			Characterization of Promoter Elements Regulating the Expression of the Human Neurotensin/Neuromedin N Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SMALL-INTESTINE; TYROSINE-HYDROXYLASE GENE; ORPHAN NUCLEAR RECEPTOR; ENDOCRINE CELL-LINE; NEUROMEDIN-N; PANCREATIC-SECRETION; NEOPLASTIC TISSUES; STIMULATES GROWTH; MESSENGER-RNA; TRANSCRIPTION	Expression of the gene encoding neurotensin/neuromedin N (NT/N) is mostly limited to the brain and specialized enteroendocrine N cells in the distal small intestine. We have identified key regulatory elements in the promoter region that are involved in human NT/N (hNT/N) gene expression in the novel human endocrine cell line, BON, which resembles intestinal N cells in several important aspects including NT/N precursor protein processing, ratios of different NT/N mRNA isoforms, and high levels of constitutive expression of the NT/N gene. In this study, we demonstrated multiple cis-regulatory elements including a proximal region containing a cAMP-responsive element (CRE)/AP-1-like element that binds both the AP-1 and CRE-binding protein (CREB)/ATF proteins (c-Jun, ATF-1, ATF-2, JunD, and CREB). Similar to the rat NT/N gene, this region is critical for constitutive hNT/N gene expression. Moreover, we identified a novel region that binds the orphan hormone receptor, NR2F2. We have demonstrated that the C terminus of NR2F2 strongly represses hNT/N transcription, whereas an N-terminal domain antagonizes this repressive effect. Regulation of NT/N expression by NR2F2 may have important consequences for lipid metabolism. We speculate that a complex interplay between the proximal CRE/AP-1-like motif and NR2F2 binding region exists to regulate hNT/N expression, which is critical for the high level of constitutive expression of NT/N in enteroendocrine cells. Finally, the BON cell line provides a unique model to characterize the factors regulating expression of the hNT/N gene and to better understand the mechanisms responsible for terminal differentiation of the N cell lineage in the gut.	[Gulhati, Pat; Li, Jing; Weiss, Heidi; Evers, B. Mark] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Gulhati, Pat; Li, Jing; Weiss, Heidi; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY 40536 USA; [Gulhati, Pat] Univ Texas Galveston, Med Branch, MD PhD Program, Galveston, TX 77555 USA; [Wang, Xiaofu; Townsend, Courtney M., Jr.] Univ Texas Galveston, Med Branch, Dept Surg, Galveston, TX 77555 USA; [Dobner, Paul R.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; [Dobner, Paul R.] Univ Massachusetts, Sch Med, Program Neurosci, Worcester, MA 01655 USA	University of Kentucky; University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Evers, BM (corresponding author), Univ Kentucky, Lucille P Markey Canc Ctr, 800 Rose St,CC140, Lexington, KY 40536 USA.	mark.evers@uky.edu			National Institutes of Health [R37 AG10855, R01 DK48489]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK048489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG010885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 AG10855 and R01 DK48489.	Achatz G, 1997, MOL CELL BIOL, V17, P4914, DOI 10.1128/MCB.17.9.4914; ANDERSSON S, 1977, ACTA PHYSIOL SCAND, V100, P231, DOI 10.1111/j.1748-1716.1977.tb05941.x; ARMSTRONG MJ, 1986, AM J PHYSIOL, V251, pG823, DOI 10.1152/ajpgi.1986.251.6.G823; BACA I, 1982, DIGESTION, V23, P174, DOI 10.1159/000198725; BEAN AJ, 1992, NEUROSCIENCE, V50, P259, DOI 10.1016/0306-4522(92)90421-W; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; CARRAWAY RE, 1994, REGUL PEPTIDES, V53, P17, DOI 10.1016/0167-0115(94)90155-4; CHUNG DH, 1992, GASTROENTEROLOGY, V103, P1254, DOI 10.1016/0016-5085(92)91512-3; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; Everett LM, 1999, J STEROID BIOCHEM, V70, P197, DOI 10.1016/S0960-0760(99)00109-0; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; EVERS BM, 1995, J CLIN INVEST, V95, P2822, DOI 10.1172/JCI117987; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; EVERS BM, 1994, AM J PHYSIOL, V267, pG180, DOI 10.1152/ajpgi.1994.267.2.G180; EVERS BM, 1991, ANN SURG, V214, P448, DOI 10.1097/00000658-199110000-00009; EVERS BM, 1994, AM J PHYSIOL-GASTR L, V267, pG875, DOI 10.1152/ajpgi.1994.267.5.G875; EVERS BM, 1993, AM J PHYSIOL, V265, pG482, DOI 10.1152/ajpgi.1993.265.3.G482; EVERS BM, 1992, GASTROENTEROLOGY, V103, P86, DOI 10.1016/0016-5085(92)91099-P; EVERS BM, 1992, DIGEST DIS SCI, V37, P426, DOI 10.1007/BF01307738; EVERS BM, 1995, MOL CELL BIOL, V15, P3870; FERRIS CF, 1985, REGUL PEPTIDES, V12, P101, DOI 10.1016/0167-0115(85)90191-0; FEURLE GE, 1987, GUT, V28, P19, DOI 10.1136/gut.28.Suppl.19; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; Hatzis P, 2001, MOL CELL BIOL, V21, P7320, DOI 10.1128/MCB.21.21.7320-7330.2001; Haus-Seuffert P, 2000, MOL CELL BIOCHEM, V212, P5, DOI 10.1023/A:1007111818628; Jin H, 2006, J CELL PHYSIOL, V207, P49, DOI 10.1002/jcp.20534; Jordan EM, 2003, BIOCHEMISTRY-US, V42, P2656, DOI 10.1021/bi0268347; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim KS, 2003, J NEUROCHEM, V85, P622, DOI 10.1046/j.1471-4159.2003.01671.x; KIMURA A, 1993, J BIOL CHEM, V268, P11125; KISLAUSKIS E, 1990, NEURON, V4, P783, DOI 10.1016/0896-6273(90)90205-T; KISLAUSKIS E, 1988, J BIOL CHEM, V263, P4963; Kitabgi P, 2002, CURR OPIN DRUG DI DE, V5, P764; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE KAW, 1992, J CELL SCI, V103, P9; Li J, 2008, J BIOL CHEM, V283, P2614, DOI 10.1074/jbc.M707513200; Li J, 2007, MOL ENDOCRINOL, V21, P159, DOI 10.1210/me.2006-0340; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; MURAKI K, 1993, PEPTIDES, V14, P1095, DOI 10.1016/0196-9781(93)90161-9; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; POLAK JM, 1977, NATURE, V270, P183, DOI 10.1038/270183a0; ROTTMAN JN, 1993, J BIOL CHEM, V268, P11994; SAKAMOTO T, 1984, SURGERY, V96, P146; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; Slogoff M., 2003, ENCY HORMONES, P19; Thomas RP, 2003, ENDOCR REV, V24, P571, DOI 10.1210/er.2002-0028; THOR K, 1986, GASTROENTEROLOGY, V90, P27, DOI 10.1016/0016-5085(86)90070-3; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; WOOD JG, 1988, AM J PHYSIOL, V255, pG813, DOI 10.1152/ajpgi.1988.255.6.G813; WOOD JG, 1988, PANCREAS, V3, P332, DOI 10.1097/00006676-198805000-00015; Zetterstrom R. H., 1997, SCIENCE, V276, P248	54	9	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					542	554		10.1074/jbc.M110.145664	http://dx.doi.org/10.1074/jbc.M110.145664			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21030593	Green Published, hybrid			2022-12-25	WOS:000285782800057
J	Belyaev, ND; Kellett, KAB; Beckett, C; Makova, NZ; Revett, TJ; Nalivaeva, NN; Hooper, NM; Turner, AJ				Belyaev, Nikolai D.; Kellett, Katherine A. B.; Beckett, Caroline; Makova, Natalia Z.; Revett, Timothy J.; Nalivaeva, Natalia N.; Hooper, Nigel M.; Turner, Anthony J.			The Transcriptionally Active Amyloid Precursor Protein (APP) Intracellular Domain Is Preferentially Produced from the 695 Isoform of APP in a beta-Secretase-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; DEGRADING ENZYME NEPRILYSIN; ALZHEIMERS-DISEASE; ALPHA-SECRETASE; LIPID RAFTS; GENE-EXPRESSION; TARGET GENES; HUMAN-BRAIN; INHIBITOR; NEURONS	Amyloidogenic processing of the amyloid precursor protein (APP) by beta- and gamma-secretases generates several biologically active products, including amyloid-beta (A beta) and the APP intracellular domain (AICD). AICD regulates transcription of several neuronal genes, especially the A beta-degrading enzyme, neprilysin (NEP). APP exists in several alternatively spliced isoforms, APP(695), APP(751), and APP(770). We have examined whether each isoform can contribute to AICD generation and hence up-regulation of NEP expression. Using SH-SY5Y neuronal cells stably expressing each of the APP isoforms, we observed that only APP(695) up-regulated nuclear AICD levels (9-fold) and NEP expression (6-fold). Increased NEP expression was abolished by a beta- or gamma-secretase inhibitor but not an alpha-secretase inhibitor. This correlated with a marked increase in both A beta(1-40) and A beta(1-42) in APP(695) cells as compared with APP(751) or APP(770) cells. Similar phenomena were observed in Neuro2a but not HEK293 cells. SH-SY5Y cells expressing the Swedish mutant of APP(695) also showed an increase in A beta levels and NEP expression as compared with wild-type APP(695) cells. Chromatin immunoprecipitation revealed that AICD was associated with the NEP promoter in APP(695), Neuro2a, and APP(Swe) cells but not APP(751) nor APP(770) cells where AICD was replaced by histone deacetylase 1 (HDAC1). AICD occupancy of the NEP promoter was replaced by HDAC1 after treatment of the APP(695) cells with a beta- but not an alpha-secretase inhibitor. The increased AICD and NEP levels were significantly reduced in cholesterol-depleted APP(695) cells. In conclusion, A beta and functional AICD appear to be preferentially synthesized through beta-secretase action on APP(695).	[Belyaev, Nikolai D.; Kellett, Katherine A. B.; Beckett, Caroline; Makova, Natalia Z.; Revett, Timothy J.; Nalivaeva, Natalia N.; Hooper, Nigel M.; Turner, Anthony J.] Univ Leeds, Proteolysis Res Grp, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Hooper, NM (corresponding author), Univ Leeds, Proteolysis Res Grp, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	n.m.hooper@leeds.ac.uk; a.j.turner@leeds.ac.uk	Nalivaeva, Natalia/K-6522-2018	Nalivaeva, Natalia/0000-0002-7134-3540; Hooper, Nigel/0000-0002-5811-3484; Kellett, Katherine/0000-0002-2802-0615	United Kingdom Medical Research Council [G9824728, G0501565, G0802189]; Alzheimer's Research Trust [ART/PG2008/2, ART/PhD2009/4]; Alzheimers Research UK [ART-PG2008-2, ART-PhD2009-4] Funding Source: researchfish; Medical Research Council [G0802189, G9824728, G0000701, G0501565] Funding Source: researchfish; MRC [G0802189, G0501565, G9824728] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research Trust; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the United Kingdom Medical Research Council (Grants G9824728, G0501565, and G0802189) and the Alzheimer's Research Trust (Grants ART/PG2008/2 and ART/PhD2009/4).	Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; BEYREUTHER K, 1993, ANN NY ACAD SCI, V695, P91, DOI 10.1111/j.1749-6632.1993.tb23035.x; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chen AC, 2007, NEURON, V53, P479, DOI 10.1016/j.neuron.2007.01.023; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Cousins SL, 2009, J NEUROCHEM, V111, P1501, DOI 10.1111/j.1471-4159.2009.06424.x; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Forman MS, 1997, J BIOL CHEM, V272, P32247, DOI 10.1074/jbc.272.51.32247; Frigerio CS, 2010, FEBS J, V277, P1503, DOI 10.1111/j.1742-4658.2010.07579.x; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Goto JJ, 2002, J MOL NEUROSCI, V19, P37, DOI 10.1007/s12031-002-0008-4; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Haugabook SJ, 2001, J NEUROSCI METH, V108, P171, DOI 10.1016/S0165-0270(01)00388-0; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Henriques AG, 2007, J ALZHEIMERS DIS, V11, P85; Hersh LB, 2008, CURR ALZHEIMER RES, V5, P225, DOI 10.2174/156720508783954703; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hunt CE, 2009, FEBS J, V276, P1845, DOI 10.1111/j.1742-4658.2009.06929.x; ISHIMARU F, 1995, BLOOD, V85, P3199, DOI 10.1182/blood.V85.11.3199.bloodjournal85113199; KAMETANI F, 1993, BIOCHEM BIOPH RES CO, V191, P392, DOI 10.1006/bbrc.1993.1230; Kennedy Hilary, 1992, Neurodegeneration, V1, P59; Knauer MF, 1996, BRAIN RES, V740, P6, DOI 10.1016/S0006-8993(96)00711-1; Konietzko U, 2010, NEUROBIOL AGING, V31, P58, DOI 10.1016/j.neurobiolaging.2008.03.001; Lathia JD, 2008, J NEUROCHEM, V107, P1471, DOI 10.1111/j.1471-4159.2008.05715.x; Lefranc-Jullien S, 2006, J NEUROCHEM, V97, P807, DOI 10.1111/j.1471-4159.2006.03748.x; LI CW, 1995, GENE, V164, P363, DOI 10.1016/0378-1119(95)00464-H; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Moir RD, 1998, J BIOL CHEM, V273, P5013, DOI 10.1074/jbc.273.9.5013; MUCKE L, 1995, J EXP MED, V181, P1551, DOI 10.1084/jem.181.4.1551; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Nalivaeva NN, 2008, CURR ALZHEIMER RES, V5, P212, DOI 10.2174/156720508783954785; Nalivaeva NN, 2009, TRENDS PHARMACOL SCI, V30, P509, DOI 10.1016/j.tips.2009.07.002; Nili E, 2001, J CELL SCI, V114, P3297; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Panegyres PK, 1998, J NEURAL TRANSM, V105, P463, DOI 10.1007/s007020050070; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Parvathy S, 1998, BIOCHEMISTRY-US, V37, P1680, DOI 10.1021/bi972034y; Postuma RB, 1998, FEBS LETT, V428, P13, DOI 10.1016/S0014-5793(98)00475-X; Sandbrink R, 1996, ANN NY ACAD SCI, V777, P281, DOI 10.1111/j.1749-6632.1996.tb34433.x; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; SPILLANTINI MG, 1989, MOL BRAIN RES, V6, P143, DOI 10.1016/0169-328X(89)90048-X; TANAKA S, 1989, BIOCHEM BIOPH RES CO, V165, P1406, DOI 10.1016/0006-291X(89)92760-5; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Willoughby DA, 1995, J MOL NEUROSCI, V6, P257, DOI 10.1007/BF02736785; Zhang XZ, 2010, BRAIN RES BULL, V81, P3, DOI 10.1016/j.brainresbull.2009.09.003; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	55	144	146	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41443	41454		10.1074/jbc.M110.141390	http://dx.doi.org/10.1074/jbc.M110.141390			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20961856	Green Published, hybrid			2022-12-25	WOS:000285622600030
J	Westphal, D; Sytnyk, V; Schachner, M; Leshchyns'ka, I				Westphal, Doreen; Sytnyk, Vladimir; Schachner, Melitta; Leshchyns'ka, Iryna			Clustering of the Neural Cell Adhesion Molecule (NCAM) at the Neuronal Cell Surface Induces Caspase-8- and -3-dependent Changes of the Spectrin Meshwork Required for NCAM-mediated Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-CAM; BETA-SPECTRIN; LIPID RAFTS; RPTP-ALPHA; ACTIVATION; MEMBRANE; RECEPTOR; DEGRADATION; ASSOCIATION; MECHANISMS	Changes in neuronal morphology underlying neuronal differentiation depend on rapid and sustained cytoskeleton rearrangements in the growing neurites. Whereas cell adhesion molecules are well established as regulators of neuronal differentiation, less is known about the signaling mechanisms by which they influence the cytoskeleton. Here we show that the neural cell adhesion molecule (NCAM) associates with the active form of caspase-8 and that clustering of NCAM at the neuronal cell surface leads to activation of caspase-8 and -3 followed by the cleavage of the sub-membranous brain spectrin meshwork, but not of the actin or tubulin cytoskeleton. Inhibitors of caspase-8 and -3 specifically block the NCAM-dependent spectrin cleavage and abolish NCAM-dependent neurite outgrowth. NCAM-dependent rearrangements of the membrane associated spectrin meshwork via caspase-8 dependent caspase-3 activation are thus indispensable for NCAM-mediated neurite outgrowth.	[Sytnyk, Vladimir; Leshchyns'ka, Iryna] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Westphal, Doreen; Sytnyk, Vladimir; Schachner, Melitta; Leshchyns'ka, Iryna] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	University of New South Wales Sydney; University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Leshchyns'ka, I (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	iryna.leshchynska@unsw.edu.au	Sytnyk, Vladimir/A-3878-2010	Leshchyns'ka, Iryna/0000-0002-2025-5831; Sytnyk, Vladimir/0000-0003-1927-2199	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (to I. L.,V.S., and M.S.).	Acarin L, 2007, GLIA, V55, P954, DOI 10.1002/glia.20518; Barbero S, 2008, J BIOL CHEM, V283, P13031, DOI 10.1074/jbc.M800549200; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Berg CP, 2001, CELL DEATH DIFFER, V8, P1197, DOI 10.1038/sj.cdd.4400905; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Bukalo O, 2004, J NEUROSCI, V24, P1565, DOI 10.1523/JNEUROSCI.3298-03.2004; Buttner B, 2003, BIOCHEM BIOPH RES CO, V310, P967, DOI 10.1016/j.bbrc.2003.09.105; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Christensen C, 2006, FEBS LETT, V580, P3386, DOI 10.1016/j.febslet.2006.05.008; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Dash PK, 2000, NEUROREPORT, V11, P2811, DOI 10.1097/00001756-200008210-00040; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; GENNARINI G, 1984, EUR J BIOCHEM, V142, P57, DOI 10.1111/j.1432-1033.1984.tb08250.x; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; Gulyaeva NV, 2003, J NEUROSCI RES, V73, P853, DOI 10.1002/jnr.10730; Hammarlund M, 2000, J CELL BIOL, V149, P931, DOI 10.1083/jcb.149.4.931; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hulsmeier J, 2007, DEVELOPMENT, V134, P713, DOI 10.1242/dev.02758; Kiryushko D, 2006, MOL BIOL CELL, V17, P2278, DOI 10.1091/mbc.E05-10-0987; Korshunova I, 2007, J NEUROCHEM, V100, P1599, DOI 10.1111/j.1471-4159.2006.04316.x; Lee A, 2001, J BIOL CHEM, V276, P20735, DOI 10.1074/jbc.M009723200; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MILEV P, 1995, J BIOL CHEM, V270, P24650, DOI 10.1074/jbc.270.42.24650; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; PFENNINGER KH, 1983, CELL, V35, P573, DOI 10.1016/0092-8674(83)90191-5; POLLERBERG GE, 1986, NATURE, V324, P462, DOI 10.1038/324462a0; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Rolf B, 2003, J NEUROSCI RES, V71, P835, DOI 10.1002/jnr.10533; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; SOBUE K, 1989, NEURON, V3, P311, DOI 10.1016/0896-6273(89)90255-9; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Stepanichev MY, 2005, NEUROSCIENCE, V136, P579, DOI 10.1016/j.neuroscience.2005.08.010; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Sytnyk V, 2006, J CELL BIOL, V174, P1071, DOI 10.1083/jcb.200604145; THOR G, 1986, NEUROSCI LETT, V66, P121, DOI 10.1016/0304-3940(86)90176-X; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490	56	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42046	42057		10.1074/jbc.M110.177147	http://dx.doi.org/10.1074/jbc.M110.177147			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20961848	Green Published, hybrid			2022-12-25	WOS:000285622600090
J	Yao, SH; Qian, ML; Deng, SY; Xie, LF; Yang, HS; Xiao, C; Zhang, T; Xu, H; Zhao, X; Wei, YQ; Mo, XM				Yao, Shaohua; Qian, Meilin; Deng, Senyi; Xie, Lifang; Yang, Hanshuo; Xiao, Chun; Zhang, Ting; Xu, Hong; Zhao, Xia; Wei, Yu-quan; Mo, Xianming			Kzp Controls Canonical wnt8 Signaling to Modulate Dorsoventral Patterning during Zebrafish Gastrulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-BOX GENES; TRANSCRIPTIONAL REPRESSOR; MESODERM FORMATION; AXIS FORMATION; PARTNER KAISO; DNA-BINDING; EXTENSION; PROTEINS; CATENIN; CONVERGENCE	During vertebrate embryonic development, the body axis formation requires the action of Wnt signals and their antagonists. Zygotic canonical wnt8 expression appears exclusively at the ventrolateral margin and mediates Wnt/beta-catenin activities to promote posterior and ventral cell fate. However, the mechanisms involved in the initiation of zygotic wnt8 signals are poorly understood. Here, we identify a novel, maternally derived transcription factor, Kzp ((K) under bar aiso (z) under bar inc finger-containing protein), as an important determinant for the initiation of zygotic Wnt signals in zebrafish. Kzp is a DNA-binding transcription factor that recognizes specific consensus DNA sequences, 5'-(t/a/g)t(a/t/g)nctgcca-3', through zinc fingers and controls the initiation of zygotic wnt8 expression by directly binding to the wnt8 promoter during zebrafish embryonic development. Depletion of Kzp strongly dorsalized embryos, which was characterized by the expansion of dorsal gene expression. Overexpression of Kzp caused posteriorization. These phenotypes were highly similar to ones induced by wnt8 depletion or overexpression and were rescued by alteration of wnt8 activity. Thus, our results provide the first insight into the mechanism involved in the initiation of zygotic canonical Wnt signals by a maternally derived transcription factor.	[Wei, Yu-quan] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; Sichuan Univ, Ctr Canc, W China Hosp, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University	Wei, YQ (corresponding author), Sichuan Univ, State Key Lab Biotherapy, Keyuan 4 Lu, Chengdu 610041, Peoples R China.	yuquawei@sina.vip.com; xmingmo@yahoo.cn	Mo, Xianming/AAM-2167-2021	Wei, Yu-quan/0000-0002-6211-3217; Yao, Shaohua/0000-0002-0191-4889	National Basic Research Program of China [2009CB941200, 2010CB529900]; Nature Science Foundation of China [30771228, 30771227]	National Basic Research Program of China(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2009CB941200 and 2010CB529900 and Nature Science Foundation of China Grants 30771228 (to H. X.) and 30771227 (to X. M.).	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Coombs GS, 2008, CURR DRUG TARGETS, V9, P513, DOI 10.2174/138945008784911796; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Erter CE, 2001, DEVELOPMENT, V128, P3571; Goering LM, 2003, P NATL ACAD SCI USA, V100, P9410, DOI 10.1073/pnas.1633548100; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hild M, 1999, DEVELOPMENT, V126, P2149; Hong CS, 2008, DEVELOPMENT, V135, P3903, DOI 10.1242/dev.026229; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Li HY, 2006, DEV BIOL, V290, P470, DOI 10.1016/j.ydbio.2005.11.020; Little SC, 2004, DEVELOPMENT, V131, P5825, DOI 10.1242/dev.01464; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; Myers DC, 2002, TRENDS GENET, V18, P447, DOI 10.1016/S0168-9525(02)02725-7; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Ragland JW, 2004, DEV BIOL, V276, P16, DOI 10.1016/j.ydbio.2004.08.017; Ramel MC, 2004, DEV DYNAM, V231, P441, DOI 10.1002/dvdy.20141; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506; Yamamoto Y, 2004, NATURWISSENSCHAFTEN, V91, P519, DOI 10.1007/s00114-004-0575-z; Yao J, 2001, DEVELOPMENT, V128, P2975; Yao SH, 2008, FEBS LETT, V582, P2325, DOI 10.1016/j.febslet.2008.05.036	37	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42086	42096		10.1074/jbc.M110.161554	http://dx.doi.org/10.1074/jbc.M110.161554			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20978132	hybrid, Green Published			2022-12-25	WOS:000285622600093
J	Maasch, C; Vater, A; Buchner, K; Purschke, WG; Eulberg, D; Vonhoff, S; Klussmann, S				Maasch, Christian; Vater, Axel; Buchner, Klaus; Purschke, Werner G.; Eulberg, Dirk; Vonhoff, Stefan; Klussmann, Sven			Polyetheylenimine-Polyplexes of Spiegelmer NOX-A50 Directed against Intracellular High Mobility Group Protein A1 (HMGA1) Reduce Tumor Growth in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE DELIVERY-SYSTEMS; POLYETHYLENIMINE/DNA COMPLEXES; PANCREATIC ADENOCARCINOMA; POLY(ETHYLENE IMINE); CHROMOSOMAL-PROTEINS; MOLECULAR-WEIGHT; C-MYC; EXPRESSION; MICE; RNA	High mobility group A1 (HMGA1) proteins belong to a group of architectural transcription factors that are overexpressed in a range of human malignancies, including pancreatic adenocarcinoma. They promote anchorage-independent growth and epithelial-mesenchymal transition and are therefore suggested as potential therapeutic targets. Employing in vitro selection techniques against a chosen fragment of HMGA1, we have generated biostable L-RNA oligonucleotides, so-called Spiegelmers, that specifically bind HMGA1b with low nanomolar affinity. We demonstrate that the best binding Spiegelmers, NOX-A50 and NOX-f33, compete HMGA1b from binding to its natural binding partner, AT-rich double-stranded DNA. We describe a formulation method based on polyplex formation with branched polyethylenimine for efficient delivery of polyethylene glycol-modified Spiegelmers and show improved tissue distribution and persistence in mice. In a xenograft mouse study using the pancreatic cancer cell line PSN-1, subcutaneous administration of 2 mg/kg per day NOX-A50 formulated in polyplexes showed an enhanced delivery of NOX-A50 to the tumor and a significant reduction of tumor volume. Our results demonstrate that intracellular targets can be successfully addressed with a Spiegelmer using polyethylenimine-based delivery and underline the importance of HMGA1 as a therapeutic target in pancreatic cancer.	[Maasch, Christian; Vater, Axel; Buchner, Klaus; Purschke, Werner G.; Eulberg, Dirk; Vonhoff, Stefan; Klussmann, Sven] NOXXON Pharma AG, D-10589 Berlin, Germany	NOXXON Pharma	Klussmann, S (corresponding author), NOXXON Pharma AG, Max Dohrn Str 8-10, D-10589 Berlin, Germany.	sklussmann@noxxon.com		Vater, Axel/0000-0003-4166-982X	State of Berlin/Investitionsbank Berlin [10018314]	State of Berlin/Investitionsbank Berlin	This work was supported by the State of Berlin/Investitionsbank Berlin Grant 10018314. All authors are employees of NOXXON Pharma AG, a company that has a commercial interest in Spiegelmers.	Battista S, 2003, FASEB J, V17, P1496, DOI 10.1096/fj.02-0977fje; Eulberg D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni044; EULBERG D, 2006, APTAMER HDB, P417; Evans A, 2004, J SURG ONCOL, V88, P86, DOI 10.1002/jso.20136; Famulok M, 2001, CHEM BIOL, V8, P931, DOI 10.1016/S1074-5521(01)00070-9; FASHENA SJ, 1992, MOL CELL BIOL, V12, P894, DOI 10.1128/MCB.12.2.894; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Fedele M, 2010, BBA-GENE REGUL MECH, V1799, P48, DOI 10.1016/j.bbagrm.2009.11.007; Fischer D, 2004, DRUG METAB DISPOS, V32, P983; GIANCOTTI V, 1987, EMBO J, V6, P1981, DOI 10.1002/j.1460-2075.1987.tb02461.x; Goula D, 2000, GENE THER, V7, P499, DOI 10.1038/sj.gt.3301113; Helmling S, 2004, P NATL ACAD SCI USA, V101, P13174, DOI 10.1073/pnas.0404175101; Hoyos JM, 2004, CANCER RES, V64, P5728, DOI 10.1158/0008-5472.CAN-04-1410; Jeong JH, 2003, J CONTROL RELEASE, V93, P183, DOI 10.1016/j.jconrel.2003.07.002; JOHNSON KR, 1990, EXP CELL RES, V187, P69, DOI 10.1016/0014-4827(90)90118-T; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; JOHNSON KR, 1988, J BIOL CHEM, V263, P18338; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kulkarni O, 2007, J AM SOC NEPHROL, V18, P2350, DOI 10.1681/ASN.2006121348; Kunath K, 2002, PHARMACEUT RES, V19, P810, DOI 10.1023/A:1016152831963; Liau SS, 2008, CANCER-AM CANCER SOC, V113, P302, DOI 10.1002/cncr.23560; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Masciullo V, 2003, CARCINOGENESIS, V24, P1191, DOI 10.1093/carcin/bgg075; Neu M, 2005, J GENE MED, V7, P992, DOI 10.1002/jgm.773; Ogris M, 2002, DRUG DISCOV TODAY, V7, P479, DOI 10.1016/S1359-6446(02)02243-2; Ogris M, 2001, AAPS PHARMSCI, V3, part. no.; Ogris M, 2003, J CONTROL RELEASE, V91, P173, DOI 10.1016/S0168-3659(03)00230-X; Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Petersen H, 2002, BIOMACROMOLECULES, V3, P926, DOI 10.1021/bm025539z; Proske D, 2002, CHEMBIOCHEM, V3, P717, DOI 10.1002/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C; Purschke WG, 2006, P NATL ACAD SCI USA, V103, P5173, DOI 10.1073/pnas.0509663103; Reeves R, 2005, DNA REPAIR, V4, P926, DOI 10.1016/j.dnarep.2005.04.010; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; REEVES R, 1990, J BIOL CHEM, V265, P8573; Reeves Raymond, 2003, Prog Cell Cycle Res, V5, P279; Sarhadi V, 2006, J PATHOL, V209, P206, DOI 10.1002/path.1960; Sayyed SG, 2009, DIABETOLOGIA, V52, P2445, DOI 10.1007/s00125-009-1493-6; Scala S, 2000, P NATL ACAD SCI USA, V97, P4256, DOI 10.1073/pnas.070029997; Sirsi SR, 2005, HUM GENE THER, V16, P1307, DOI 10.1089/hum.2005.16.1307; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; Trapasso F, 2004, CANCER GENE THER, V11, P633, DOI 10.1038/sj.cgt.7700745; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; TUKEY JW, 1977, SCIENCE, V198, P679, DOI 10.1126/science.333584; Wlotzka B, 2002, P NATL ACAD SCI USA, V99, P8898, DOI 10.1073/pnas.132067399; Xu W, 1996, P NATL ACAD SCI USA, V93, P7475, DOI 10.1073/pnas.93.15.7475; YAMADA H, 1986, BIOCHEM BIOPH RES CO, V140, P167, DOI 10.1016/0006-291X(86)91072-7; Zou SM, 2000, J GENE MED, V2, P128, DOI 10.1002/(SICI)1521-2254(200003/04)2:2<128::AID-JGM95>3.0.CO;2-W; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	28	33	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40012	40018		10.1074/jbc.M110.178533	http://dx.doi.org/10.1074/jbc.M110.178533			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20961861	Green Published, hybrid			2022-12-25	WOS:000285185500046
J	Vallenback, P; Ghatnekar, L; Bengtsson, BO				Vallenback, Pernilla; Ghatnekar, Lena; Bengtsson, Bengt O.			Structure of the Natural Transgene PgiC2 in the Common Grass Festuca ovina	PLOS ONE			English	Article							HORIZONTAL TRANSFER; GENE-TRANSFER; NUCLEAR; PLANT; POA	Background: A horizontal gene transfer has brought an active nuclear gene, PgiC2, from a polyploid Poa species (P. palustris or a close relative) into the common grass sheep's fescue (Festuca ovina). The donor and the receptor species are strictly reproductively separated, and PgiC2 occurs in a polymorphic state within F. ovina. The active gene copy is normally closely linked to a very similar pseudogene. Methodology/Principal Findings: By genome walking we have obtained the up-and downstream sequences of PgiC2 and of corresponding genes in the donor and recipient species. Comparisons of these sequences show that the complete upstream region necessary for the gene's expression is included in the transferred segment. About 1 kb upstream of PgiC2 a fragment with transposition associated properties has been found (TAF). It is present in P. palustris and its polyploid relatives, though not at the homologous position, and is absent from many other grasses, including non-transgenic F. ovina plants. It is possible that it is a part of a transposing element involved in getting the gene into a transferring agent and/or into the recipient chromosome. Conclusions/Significance: The close similarity of the up-and downstream regions with the corresponding regions in P. palustris excludes all suggestions that PgiC2 is not a HGT but the result of a duplication within the F. ovina lineage. The small size of the genetic material transferred, the complex nature of the PgiC2 locus, and the associated fragment with transposition associated properties suggest that the horizontal transfer occurred via a vector and not via illegitimate pollination.	[Vallenback, Pernilla; Ghatnekar, Lena; Bengtsson, Bengt O.] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Vallenback, P (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	pernilla.vallenback@cob.lu.se			Nilsson-Ehle Foundation; Lindstrom Foundation; Erik Philip-Sorensen Foundation; Trygger Foundation	Nilsson-Ehle Foundation; Lindstrom Foundation; Erik Philip-Sorensen Foundation; Trygger Foundation	This work was supported by the Nilsson-Ehle, Lindstrom, Erik Philip-Sorensen and Trygger Funds and Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; DAVIES DR, 1974, HEREDITY, V32, P267, DOI 10.1038/hdy.1974.30; Davis CC, 2005, P ROY SOC B-BIOL SCI, V272, P2237, DOI 10.1098/rspb.2005.3226; Davis CC, 2004, SCIENCE, V305, P676, DOI 10.1126/science.1100671; Diao XM, 2006, PLOS BIOL, V4, P119, DOI 10.1371/journal.pbio.0040005; Gaut BS, 2000, PLANT SYST EVOL, V224, P33, DOI 10.1007/BF00985265; Ghatnekar L, 2006, P ROY SOC B-BIOL SCI, V273, P395, DOI 10.1098/rspb.2005.3355; Ghatnekar L, 1999, HEREDITY, V83, P451, DOI 10.1038/sj.hdy.6885750; GRIME JP, 1982, NATURE, V299, P151, DOI 10.1038/299151a0; HEGI G, ILLUSTRIERTE FLORA M, V1; KNOBLOCH IW, CHECK LIST CROSSES G; LAURIE DA, 1990, STADLER GEN, P95; Richardson AO, 2007, J EXP BOT, V58, P1, DOI 10.1093/jxb/erl148; Torrecilla P, 2002, SYST BOT, V27, P241; VALLENBACK P, THESIS LUND U LUND; Vallenback P, 2008, MOL PHYLOGENET EVOL, V46, P890, DOI 10.1016/j.ympev.2007.11.031; Vallenback P, 2010, GENETICA, V138, P355, DOI 10.1007/s10709-009-9425-4	18	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13529	10.1371/journal.pone.0013529	http://dx.doi.org/10.1371/journal.pone.0013529			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976007	Green Published, gold			2022-12-25	WOS:000283216400029
J	Cedile, O; Popa, N; Pollet-Villard, F; Garmy, N; Ibrahim, EC; Boucraut, J				Cedile, Oriane; Popa, Natalia; Pollet-Villard, Frederic; Garmy, Nicolas; Ibrahim, El Cherif; Boucraut, Jose			The NKG2D Ligands RAE-1 delta and RAE-1 epsilon Differ with Respect to Their Receptor Affinity, Expression Profiles and Transcriptional Regulation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CELL-SURFACE PROTEINS; CLASS-I; CUTTING EDGE; NK CELLS; TUMOR-CELLS; FAMILY; MACROPHAGES; MOLECULES; MICE	Background: RAE-1 is a ligand of the activating receptor NKG2D expressed by NK cells, NKT, gamma delta T and some CD8(+)T lymphocytes. RAE-1 is overexpressed in tumor cell lines and its expression is induced after viral infection and genotoxic stress. We have recently demonstrated that RAE-1 is expressed in the adult subventricular zone (SVZ) from C57BL/6 mice. RAE-1 is also expressed in vitro by neural stem/progenitor cells (NSPCs) and plays a non-immune role in cell proliferation. The C57BL/6 mouse genome contains two rae-1 genes, rae-1 delta and rae-1 epsilon encoding two different proteins. The goals of this study are first to characterize the in vivo and in vitro expression of each gene and secondly to elucidate the mechanisms underlying their respective expression, which are far from known. Principal Findings: We observed that Rae-1 delta and Rae-1 epsilon transcripts are differentially expressed according to tissues, pathological conditions and cell lines. Embryonic tissue and the adult SVZ mainly expressed Rae-1 delta transcripts. The NSPCs derived from the SVZ also mainly expressed RAE-1 delta. The interest of this result is especially related to the observation that RAE-1 delta is a weak NKG2D ligand compared to RAE-1 epsilon. On the contrary, cell lines expressed either similar levels of RAE-1 delta and RAE-1 epsilon proteins or only RAE-1 epsilon. Since the protein expression correlated with the level of transcripts for each rae-1 gene, we postulated that transcriptional regulation is one of the main processes explaining the difference between RAE-1 delta and RAE-1 epsilon expression. We indeed identified two different promoter regions for each gene: one mainly involved in the control of rae-1 delta gene expression and the other in the control of rae-1 epsilon expression. Conclusions/Significance: RAE-1 delta and RAE-1 epsilon differ with respect to their function and the control of their expression. Immune function would be mainly exerted by RAE-1 epsilon and non-immune function by RAE-1 delta.	[Cedile, Oriane; Popa, Natalia; Pollet-Villard, Frederic; Garmy, Nicolas; Boucraut, Jose] Univ Paul Cezanne, Fac Med, Univ Mediterranee, CRN2M,CNRS,UMR 6231, Marseille, France; [Ibrahim, El Cherif] Univ Aix Marseille 2, Fac Med, NICN, CNRS,UMR 6184, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cedile, O (corresponding author), Univ Paul Cezanne, Fac Med, Univ Mediterranee, CRN2M,CNRS,UMR 6231, Marseille, France.	jose.boucraut@univmed.fr	IBRAHIM, El Chérif/K-3899-2016	IBRAHIM, El Chérif/0000-0003-3973-7862; Boucraut, Jose/0000-0002-3471-7769	CNRS (Centre National de la Recherche Scientifique); AFM (Association Francaise contre la Myopathie); LFSEP (Ligue Francaise contre la Sclerose en Plaques)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); AFM (Association Francaise contre la Myopathie)(Association Francaise contre les Myopathies); LFSEP (Ligue Francaise contre la Sclerose en Plaques)	Our research is supported by CNRS (Centre National de la Recherche Scientifique) funding, and grants from the AFM (Association Francaise contre la Myopathie, OC (fellowship), JB), the LFSEP (Ligue Francaise contre la Sclerose en Plaques, OC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arapovic J, 2009, J VIROL, V83, P8198, DOI 10.1128/JVI.02549-08; Backstrom E, 2007, SCAND J IMMUNOL, V65, P353, DOI 10.1111/j.1365-3083.2007.01912.x; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cheng HYM, 2007, CELL CYCLE, V6, P3034, DOI 10.4161/cc.6.24.5106; Cho MK, 2002, NITRIC OXIDE-BIOL CH, V6, P319, DOI 10.1006/niox.2001.0415; Danilov AI, 2006, EUR J NEUROSCI, V23, P394, DOI 10.1111/j.1460-9568.2005.04563.x; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Ehrlich R, 2000, IMMUNITY, V13, P585, DOI 10.1016/S1074-7613(00)00058-3; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Hamerman JA, 2004, J IMMUNOL, V172, P2001, DOI 10.4049/jimmunol.172.4.2001; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Li PW, 2002, IMMUNITY, V16, P77, DOI 10.1016/S1074-7613(02)00258-3; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Mammolenti M, 2004, STEM CELLS, V22, P1101, DOI 10.1634/stemcells.22-6-1101; Mandairon N, 2003, NEUROSCIENCE, V119, P507, DOI 10.1016/S0306-4522(03)00172-6; Nausch N, 2006, J IMMUNOL, V176, P7, DOI 10.4049/jimmunol.176.1.7; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; Ogasawara K, 2005, J CLIN IMMUNOL, V25, P534, DOI 10.1007/s10875-005-8786-4; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Peng W, 2007, MOL MEMBR BIOL, V24, P475, DOI 10.1080/09687680701359408; Poimenidi E, 2009, ANTICANCER RES, V29, P349; POPA N, GLIA IN PRESS; Rabinovich BA, 2008, IMMUNOL CELL BIOL, V86, P489, DOI 10.1038/icb.2008.41; Samarakoon A, 2009, MOL IMMUNOL, V46, P1011, DOI 10.1016/j.molimm.2008.09.035; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Strong RK, 2002, MOL IMMUNOL, V38, P1029, DOI 10.1016/S0161-5890(02)00032-9; Takada A, 2008, J IMMUNOL, V180, P1678, DOI 10.4049/jimmunol.180.3.1678; Winkler-Pickett R, 2008, J IMMUNOL, V180, P4495, DOI 10.4049/jimmunol.180.7.4495; Yadav D, 2009, J IMMUNOL, V182, P39, DOI 10.4049/jimmunol.182.1.39; ZHI L, BIOCHEMISTRY, V49, P2443; Zou ZH, 1996, J BIOCHEM-TOKYO, V119, P319	37	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13466	10.1371/journal.pone.0013466	http://dx.doi.org/10.1371/journal.pone.0013466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976056	Green Submitted, Green Published, gold			2022-12-25	WOS:000283114700006
J	Del Giacco, L; Pistocchi, A; Ghilardi, A				Del Giacco, Luca; Pistocchi, Anna; Ghilardi, Anna			prox1b Activity Is Essential in Zebrafish Lymphangiogenesis	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; VASCULAR DEVELOPMENT; LYMPHATIC-SYSTEM; EXPRESSION; GENE; MODEL	Background: The lymphatic vascular system, draining interstitial fluids from most tissues and organs, exerts crucial functions in several physiological and pathological processes. Lymphatic system development depends on Prox1, the first marker to be expressed in the endothelial cells of the cardinal vein from where lymph vessels originate. Prox1 ortholog in the optically clear, easily manipulated zebrafish model has been previously isolated and its contribution to lymphangiogenesis has been clarified. Because of a round of genome duplication occurred at the base of teleosts radiation, several zebrafish genes have been retained in duplicate through evolution. We investigated for the presence of additional prox1 genes and determined their role in zebrafish lymphangiogenesis. Methodology/Principal Findings: We isolated a second ortholog, named prox1b, and analyzed its expression during development by whole mount in situ hybridization ( WISH). We detected strong prox1b expression in the endothelium of the posterior cardinal vein ( PCV) from where lymphatic precursors originate. To analyze prox1b involvement in lymphangiogenesis we utilized the fli1:GFP transgenics and followed the formation of the toracic duct (TD), the primary lymph vessel in fish, after prox1b knockdown. Our findings clearly demonstrated that the absence of prox1b activity severely hampers the formation of the TD. Conclusions/Significance: This work provides substantial progress toward the understanding of zebrafish lymphangiogenesis. In light of the features shared by the lymphatic systems of zebrafish and higher vertebrates, the establishment of such lymphatic model will provide a powerful tool to study, for instance, disorders of body fluid homeostasis, inflammation and cancer metastasis, and may ultimately contribute to novel therapies.	[Del Giacco, Luca; Ghilardi, Anna] Univ Milan, Dept Biol, Milan, Italy; [Pistocchi, Anna] Ist Sci San Raffaele, Div Regenerat Med, I-20132 Milan, Italy	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Del Giacco, L (corresponding author), Univ Milan, Dept Biol, Milan, Italy.	luca.delgiacco@unimi.it	Del Giacco, Luca P C/A-5812-2014; GHILARDI, ANNA/AAI-9596-2020; Pistocchi, Anna/A-6228-2014	GHILARDI, ANNA/0000-0002-8830-5997; Pistocchi, Anna/0000-0001-9467-2542	Fondo per gli Investimenti nella Ricerca Scientifica e Tecnologica (FIRST)	Fondo per gli Investimenti nella Ricerca Scientifica e Tecnologica (FIRST)	The study was financed by the Fondo per gli Investimenti nella Ricerca Scientifica e Tecnologica (FIRST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bixel MG, 2008, GENE DEV, V22, P3232, DOI 10.1101/gad.1751908; Deguchi T, 2009, GENE EXPR PATTERNS, V9, P341, DOI 10.1016/j.gep.2009.02.004; Flores MV, 2010, DEV DYNAM, V239, P2128, DOI 10.1002/dvdy.22328; Glasgow E, 1998, MECH DEVELOP, V76, P175, DOI 10.1016/S0925-4773(98)00121-X; Hassan B, 1997, P NATL ACAD SCI USA, V94, P10991, DOI 10.1073/pnas.94.20.10991; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liu YW, 2003, MOL CELL BIOL, V23, P7243, DOI 10.1128/MCB.23.20.7243-7255.2003; Makinena T, 2007, CELL MOL LIFE SCI, V64, P1915, DOI 10.1007/s00018-007-7040-z; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; Pistocchi A, 2008, DEV DYNAM, V237, P3916, DOI 10.1002/dvdy.21798; Pistocchi A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-27; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V248, P684, DOI 10.1006/bbrc.1998.8989; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	21	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13170	10.1371/journal.pone.0013170	http://dx.doi.org/10.1371/journal.pone.0013170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976189	Green Published, Green Submitted, gold			2022-12-25	WOS:000283045300006
J	Frech, C; Chen, N				Frech, Christian; Chen, Nansheng			Genome-Wide Comparative Gene Family Classification	PLOS ONE			English	Article							CLUSTERING PROTEIN SEQUENCES; CAENORHABDITIS-ELEGANS; MODULAR ARCHITECTURE; CHEMORECEPTOR GENES; PHYLOGENETIC TREES; IDENTIFICATION; DATABASE; EVOLUTION; DUPLICATION; RECEPTORS	Correct classification of genes into gene families is important for understanding gene function and evolution. Although gene families of many species have been resolved both computationally and experimentally with high accuracy, gene family classification in most newly sequenced genomes has not been done with the same high standard. This project has been designed to develop a strategy to effectively and accurately classify gene families across genomes. We first examine and compare the performance of computer programs developed for automated gene family classification. We demonstrate that some programs, including the hierarchical average-linkage clustering algorithm MC-UPGMA and the popular Markov clustering algorithm TRIBE-MCL, can reconstruct manual curation of gene families accurately. However, their performance is highly sensitive to parameter setting, i.e. different gene families require different program parameters for correct resolution. To circumvent the problem of parameterization, we have developed a comparative strategy for gene family classification. This strategy takes advantage of existing curated gene families of reference species to find suitable parameters for classifying genes in related genomes. To demonstrate the effectiveness of this novel strategy, we use TRIBE-MCL to classify chemosensory and ABC transporter gene families in C. elegans and its four sister species. We conclude that fully automated programs can establish biologically accurate gene families if parameterized accordingly. Comparative gene family classification finds optimal parameters automatically, thus allowing rapid insights into gene families of newly sequenced species.	[Frech, Christian; Chen, Nansheng] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Frech, C (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	chenn@sfu.ca	Chen, Nansheng/E-6450-2012		NSERC (Canada)	NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study is supported by a NSERC (Canada) Discovery Grant (to NC). NC is a Michael Smith Foundation for Health Research (MSFHR) Scholar and a Canadian Institutes of Health Research (CIHR) New Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2002, BIOINFORMATICS, V18, P908, DOI 10.1093/bioinformatics/18.7.908; Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Barriere A, 2009, GENOME RES, V19, P470, DOI 10.1101/gr.081851.108; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bolten E, 2001, BIOINFORMATICS, V17, P935, DOI 10.1093/bioinformatics/17.10.935; Chen CY, 2006, PATTERN RECOGN, V39, P2356, DOI 10.1016/j.patcog.2005.12.008; Chen NS, 2005, P NATL ACAD SCI USA, V102, P146, DOI 10.1073/pnas.0408307102; Chen YH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S10; DAYHOFF MO, 1976, FED PROC, V35, P2132; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Enright AJ, 2000, BIOINFORMATICS, V16, P451, DOI 10.1093/bioinformatics/16.5.451; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Harlow TJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-45; Heger A, 2001, BIOINFORMATICS, V17, P272, DOI 10.1093/bioinformatics/17.3.272; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Huerta-Cepas J, 2008, NUCLEIC ACIDS RES, V36, pD491, DOI 10.1093/nar/gkm899; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; JACCARD A, 2008, B SOC VAUDOISES SCI, V44; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kaplan N, 2005, NUCLEIC ACIDS RES, V33, pD216, DOI 10.1093/nar/gki007; Kelil A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-286; Kim S, 2006, INT J DATA MIN BIOIN, V1, P178, DOI 10.1504/IJDMB.2006.010855; Krause A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-15; Krause A, 1998, BIOINFORMATICS, V14, P430, DOI 10.1093/bioinformatics/14.5.430; Kriventseva E. V., 2005, ENCY GENETICS GENOMI, V6, P92; Kriventseva EV, 2001, CURR OPIN STRUC BIOL, V11, P334, DOI 10.1016/S0959-440X(00)00211-6; Kriventseva EV, 2001, NUCLEIC ACIDS RES, V29, P33, DOI 10.1093/nar/29.1.33; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee D, 2005, PROTEINS, V59, P603, DOI 10.1002/prot.20409; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Loewenstein Y, 2008, BIOINFORMATICS, V24, pI41, DOI 10.1093/bioinformatics/btn174; Ma QC, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-242; Meinel T, 2005, NUCLEIC ACIDS RES, V33, pD226; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; *NCBI, 2008, BLASTCLUST V2 2 19; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Pipenbacher P, 2002, BIOINFORMATICS, V18, pS182, DOI 10.1093/bioinformatics/18.suppl_2.S182; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; RAHMAN SA, 2008, REV PROTEIN SEQUENCE; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Robertson HM, 2001, CHEM SENSES, V26, P151, DOI 10.1093/chemse/26.2.151; ROBERTSON HM, 2006, PUTATIVE CHEMORECEPT, P1; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Sperisen P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-216; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tekaia F, 2005, CURR OPIN MICROBIOL, V8, P385, DOI 10.1016/j.mib.2005.06.017; Tetko IV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-82; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; Thomas JH, 2006, GENETICS, V172, P127, DOI 10.1534/genetics.104.040030; Thomas JH, 2005, P NATL ACAD SCI USA, V102, P4476, DOI 10.1073/pnas.0406469102; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wall PK, 2008, NUCLEIC ACIDS RES, V36, pD970, DOI 10.1093/nar/gkm972; Wittkop T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-396; Wu CH, 2003, COMPUT BIOL CHEM, V27, P37, DOI 10.1016/S1476-9271(02)00098-1; Yona G, 1999, PROTEINS, V37, P360, DOI 10.1002/(SICI)1097-0134(19991115)37:3<360::AID-PROT5>3.0.CO;2-Z; Zhao ZY, 2007, GENETICS, V175, P1407, DOI 10.1534/genetics.106.066720	62	23	24	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13409	10.1371/journal.pone.0013409	http://dx.doi.org/10.1371/journal.pone.0013409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976221	Green Published, Green Submitted, gold			2022-12-25	WOS:000283043700011
J	Giampa, C; Laurenti, D; Anizilotti, S; Bernardi, G; Menniti, FS; Fusco, FR				Giampa, Carmela; Laurenti, Daunia; Anizilotti, Serenella; Bernardi, Giorgio; Menniti, Frank S.; Fusco, Francesca Romana			Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							CREB-BINDING PROTEIN; ENRICHED PHOSPHODIESTERASE; MEDIATED TRANSCRIPTION; NEUROTROPHIC FACTOR; IMMUNOHISTOCHEMICAL LOCALIZATION; NEURONAL VULNERABILITY; CAG REPEAT; CELL-DEATH; RAT-BRAIN; MICE	Background: Huntington's disease is a devastating neurodegenerative condition for which there is no therapy to slow disease progression. The particular vulnerability of striatal medium spiny neurons to Huntington's pathology is hypothesized to result from transcriptional dysregulation within the cAMP and CREB signaling cascades in these neurons. To test this hypothesis, and a potential therapeutic approach, we investigated whether inhibition of the striatal-specific cyclic nucleotide phosphodiesterase PDE10A would alleviate neurological deficits and brain pathology in a highly utilized model system, the R6/2 mouse. Methodology/Principal Findings: R6/2 mice were treated with the highly selective PDE10A inhibitor TP-10 from 4 weeks of age until euthanasia. TP-10 treatment significantly reduced and delayed the development of the hind paw clasping response during tail suspension, deficits in rotarod performance, and decrease in locomotor activity in an open field. Treatment prolonged time to loss of righting reflex. These effects of PDE10A inhibition on neurological function were reflected in a significant amelioration in brain pathology, including reduction in striatal and cortical cell loss, the formation of striatal neuronal intranuclear inclusions, and the degree of microglial activation that occurs in response to the mutant huntingtin-induced brain damage. Striatal and cortical levels of phosphorylated CREB and BDNF were significantly elevated. Conclusions/Significance: Our findings provide experimental support for targeting the cAMP and CREB signaling pathways and more broadly transcriptional dysregulation as a therapeutic approach to Huntington's disease. It is noteworthy that PDE10A inhibition in the R6/2 mice reduces striatal pathology, consistent with the localization of the enzyme in medium spiny neurons, and also cortical pathology and the formation of neuronal nuclear inclusions. These latter findings suggest that striatal pathology may be a primary driver of these secondary pathological events. More significantly, our studies point directly to an accessible new therapeutic approach to slow Huntington's disease progression, namely, PDE10A inhibition. There is considerable activity throughout the pharmaceutical industry to develop PDE10A inhibitors for the treatment of basal ganglia disorders. The present results strongly support the investigation of PDE10A inhibitors as a much needed new treatment approach to Huntington's disease.	[Giampa, Carmela; Laurenti, Daunia; Anizilotti, Serenella; Bernardi, Giorgio; Fusco, Francesca Romana] European Ctr Brain Res, Santa Lucia Fdn IRCCS Hosp, Lab Neuroanat, Rome, Italy; [Bernardi, Giorgio] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Menniti, Frank S.] Mnemosyne Pharmaceut Inc, Providence, RI USA	IRCCS Santa Lucia; University of Rome Tor Vergata	Giampa, C (corresponding author), European Ctr Brain Res, Santa Lucia Fdn IRCCS Hosp, Lab Neuroanat, Rome, Italy.	f.fusco@hsantalucia.it	anzilotti, Serenella/I-8686-2018; Fusco, Francesca R/K-1080-2018	Fusco, Francesca R/0000-0003-2226-523X; Menniti, Frank/0000-0003-2612-9534; anzilotti, serenella/0000-0002-8729-0009; , Giampa/0000-0002-1763-5665	Pfizer Inc., Groton [CT 06355]; Pfizer Inc.	Pfizer Inc., Groton(Pfizer); Pfizer Inc.(Pfizer)	This work was funded by a grant from Pfizer Inc., Groton, CT 06355. Dr. F. Menniti was involved in the initial design, analysis and manuscript preparation while an employee of Pfizer Inc.; This work was funded through a grant from Pfizer Inc. and Pfizer Inc. supplied the compound, TP-10, used in these studies. This work was initiated while Dr. Menniti was an employee of the company; however, Dr. Menniti is no longer with Pfizer. The purpose of the grant was to fund the basic research presented in the manuscript with the full acknowledgment that the results would be published. In this way, all of the organizations interested in developing new therapies for Huntington's disease would have access to the published results. It is the hope of the authors that the work encourages further research into the potential therapeutic benefit of PDE10A inhibition in the treatment of Huntington's disease, regardless of whether such further research is for profit or not for profit. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chappie T, 2009, CURR OPIN DRUG DISC, V12, P458; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Coskran TM, 2006, J HISTOCHEM CYTOCHEM, V54, P1205, DOI 10.1369/JHC.6A6930.2006; Cramer H, 1984, Adv Neurol, V40, P431; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; DeMarch Z, 2008, NEUROBIOL DIS, V30, P375, DOI 10.1016/j.nbd.2008.02.010; DeMarch Z, 2007, NEUROBIOL DIS, V25, P266, DOI 10.1016/j.nbd.2006.09.006; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fusco FR, 1999, J NEUROSCI, V19, P1189; Fusco FR, 2003, EUR J NEUROSCI, V18, P1093, DOI 10.1046/j.1460-9568.2003.02844.x; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Giampa C, 2006, EUR J NEUROSCI, V23, P11, DOI 10.1111/j.1460-9568.2005.04545.x; GIAMPA C, 2009, NEUROBIOLOG IN PRESS; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hansson O, 2003, BRAIN RES, V970, P47, DOI 10.1016/S0006-8993(02)04275-0; Hersch Steven M, 2004, NeuroRx, V1, P298, DOI 10.1007/BF03206614; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kehler J, 2009, EXPERT OPIN THER PAT, V19, P1715, DOI 10.1517/13543770903431050; KLEIMAN RJ, 2010, NEUROSCIENC IN PRESS; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MacKenzie SJ, 2000, BIOCHEM J, V347, P571, DOI 10.1042/0264-6021:3470571; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Perrin V, 2009, EXP NEUROL, V215, P191, DOI 10.1016/j.expneurol.2008.10.008; Sano H, 2008, J NEUROCHEM, V105, P546, DOI 10.1111/j.1471-4159.2007.05152.x; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P374, DOI 10.1016/j.neuropharm.2006.01.012; Stack EC, 2006, BBA-MOL BASIS DIS, V1762, P373, DOI 10.1016/j.bbadis.2005.11.002; Stack EC, 2007, EXPERT OPIN INV DRUG, V16, P1933, DOI 10.1517/13543784.16.12.1933; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Strick CA, 2010, NEUROPHARMACOLOGY, V58, P444, DOI 10.1016/j.neuropharm.2009.09.008; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Sugars KL, 2004, J BIOL CHEM, V279, P4988, DOI 10.1074/jbc.M310226200; Verhoest PR, 2009, J MED CHEM, V52, P7946, DOI 10.1021/jm9015334; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Xie Z, 2006, NEUROSCIENCE, V139, P597, DOI 10.1016/j.neuroscience.2005.12.042; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2008, BRAIN PATHOL, V18, P225, DOI 10.1111/j.1750-3639.2007.00111.x; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	56	145	149	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13417	10.1371/journal.pone.0013417	http://dx.doi.org/10.1371/journal.pone.0013417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976216	gold, Green Published, Green Submitted			2022-12-25	WOS:000283043700016
J	Kao, PF; Davis, DA; Banigan, MG; Vanderburg, CR; Seshadri, S; Delalle, I				Kao, Patricia F.; Davis, David A.; Banigan, Meredith G.; Vanderburg, Charles R.; Seshadri, Sudha; Delalle, Ivana			Modulators of Cytoskeletal Reorganization in CA1 Hippocampal Neurons Show Increased Expression in Patients at Mid-Stage Alzheimer's Disease	PLOS ONE			English	Article							BDNF MESSENGER-RNA; LONG-TERM-MEMORY; NEUROTROPHIC FACTOR; GROWTH CONES; HUMAN BRAIN; IN-VITRO; F-ACTIN; PROTEIN; TRKB; RAT	During the progression of Alzheimer's disease (AD), hippocampal neurons undergo cytoskeletal reorganization, resulting in degenerative as well as regenerative changes. As neurofibrillary tangles form and dystrophic neurites appear, sprouting neuronal processes with growth cones emerge. Actin and tubulin are indispensable for normal neurite development and regenerative responses to injury and neurodegenerative stimuli. We have previously shown that actin capping protein beta2 subunit, Capzb2, binds tubulin and, in the presence of tau, affects microtubule polymerization necessary for neurite outgrowth and normal growth cone morphology. Accordingly, Capzb2 silencing in hippocampal neurons resulted in short, dystrophic neurites, seen in neurodegenerative diseases including AD. Here we demonstrate the statistically significant increase in the Capzb2 expression in the postmortem hippocampi in persons at mid-stage, Braak and Braak stage (BB) III-IV, non-familial AD in comparison to controls. The dynamics of Capzb2 expression in progressive AD stages cannot be attributed to reactive astrocytosis. Moreover, the increased expression of Capzb2 mRNA in CA1 pyramidal neurons in AD BB III-IV is accompanied by an increased mRNA expression of brain derived neurotrophic factor (BDNF) receptor tyrosine kinase B (TrkB), mediator of synaptic plasticity in hippocampal neurons. Thus, the up-regulation of Capzb2 and TrkB may reflect cytoskeletal reorganization and/or regenerative response occurring in hippocampal CA1 neurons at a specific stage of AD progression.	[Kao, Patricia F.; Davis, David A.; Delalle, Ivana] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Banigan, Meredith G.; Vanderburg, Charles R.] Massachusetts Gen Hosp, Harvard NeuroDiscovery Ctr, Adv Tissue Res Ctr, Charlestown, MA USA; [Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Boston University; Harvard University; Massachusetts General Hospital; Boston University	Kao, PF (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA.	idelalle@bu.edu	Vanderburg, Charles/C-4516-2013	Vanderburg, Charles/0000-0001-8979-5054; Delalle, Ivana/0000-0002-1873-3064; Seshadri, Sudha/0000-0001-6135-2622	National Institutes of Health [T32 AG00015-21]; NATIONAL INSTITUTE ON AGING [Z01AG000015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Patricia Kao and David Davis were supported by the National Institutes of Health grant T32 AG00015-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Angelucci F, 2010, CURR ALZHEIMER RES, V7, P15, DOI 10.2174/156720510790274473; Arendt T, 1997, J NEUROSCI, V17, P516; Avwenagha O, 2003, J NEUROCYTOL, V32, P1077, DOI 10.1023/B:NEUR.0000021903.24849.6c; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Connor B, 1996, MOL BRAIN RES, V42, P1, DOI 10.1016/S0169-328X(96)00040-X; Croll SD, 1998, BRAIN RES, V812, P200, DOI 10.1016/S0006-8993(98)00993-7; Davis DA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000208; Duan WZ, 2001, J MOL NEUROSCI, V16, P1, DOI 10.1385/JMN:16:1:1; Durrenberger PF, 2010, J NEUROPATH EXP NEUR, V69, P70, DOI 10.1097/NEN.0b013e3181c7e32f; FUJIMURA RK, J ALZHEIMERS DIS, V19, P97; Goutan E, 1998, MOL BRAIN RES, V59, P154, DOI 10.1016/S0169-328X(98)00156-9; Gutala RV, 2004, J NEUROSCI METH, V132, P101, DOI 10.1016/j.jneumeth.2003.09.005; Kitanishi T, 2010, GENES CELLS, V15, P737, DOI 10.1111/j.1365-2443.2010.01411.x; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Kuzumaki N, 2010, SYNAPSE, V64, P611, DOI 10.1002/syn.20768; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Laske C, 2006, J NEURAL TRANSM, V113, P1217, DOI 10.1007/s00702-005-0397-y; Li Y, 2007, PHARMACOGENOMICS, V8, P1747, DOI 10.2217/14622416.8.12.1747; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MCKEE AC, 1989, ANN NEUROL, V26, P652, DOI 10.1002/ana.410260511; McMurray CT, 2000, CELL DEATH DIFFER, V7, P861, DOI 10.1038/sj.cdd.4400764; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; NATHAN BP, 1995, J BIOL CHEM, V270, P19791, DOI 10.1074/jbc.270.34.19791; Nelson TJ, 2004, HIPPOCAMPUS, V14, P46, DOI 10.1002/hipo.10152; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; Pasinetti Giulio Maria, 2007, V35, P159; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Poon WW, 2011, NEUROBIOL AGING, V32, P821, DOI 10.1016/j.neurobiolaging.2009.05.012; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Sabo SL, 2003, J NEUROSCI, V23, P5407; Schaaf MJM, 2001, BRAIN RES, V915, P227, DOI 10.1016/S0006-8993(01)02855-4; SCHAFER DA, 1994, J CELL BIOL, V127, P453, DOI 10.1083/jcb.127.2.453; Scheibel A B, 1979, Res Publ Assoc Res Nerv Ment Dis, V57, P107; Spira ME, 2003, J COMP NEUROL, V457, P293, DOI 10.1002/cne.10569; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061	48	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13337	10.1371/journal.pone.0013337	http://dx.doi.org/10.1371/journal.pone.0013337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967212	Green Published, gold			2022-12-25	WOS:000282869800032
J	Saharay, M; Guo, H; Smith, JC				Saharay, Moumita; Guo, Hong; Smith, Jeremy C.			Catalytic Mechanism of Cellulose Degradation by a Cellobiohydrolase, CelS	PLOS ONE			English	Article							FREE-ENERGY LANDSCAPE; TRICHODERMA-REESEI; ACTIVE-SITE; MOLECULAR-DYNAMICS; GLYCOSYL HYDROLASES; CLOSTRIDIUM-CELLULOLYTICUM; ANGSTROM RESOLUTION; QM/MM SIMULATIONS; PROCESSIVE ACTION; CRYSTAL-STRUCTURE	The hydrolysis of cellulose is the bottleneck in cellulosic ethanol production. The cellobiohydrolase CelS from Clostridium thermocellum catalyzes the hydrolysis of cello-oligosaccharides via inversion of the anomeric carbon. Here, to examine key features of the CelS-catalyzed reaction, QM/MM (SCCDFTB/MM) simulations are performed. The calculated free energy profile for the reaction possesses a 19 kcal/mol barrier. The results confirm the role of active site residue Glu87 as the general acid catalyst in the cleavage reaction and show that Asp255 may act as the general base. A feasible position in the reactant state of the water molecule responsible for nucleophilic attack is identified. Sugar ring distortion as the reaction progresses is quantified. The results provide a computational approach that may complement the experimental design of more efficient enzymes for biofuel production.	[Saharay, Moumita; Guo, Hong; Smith, Jeremy C.] Univ Tennessee, Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN USA; [Guo, Hong; Smith, Jeremy C.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Saharay, M (corresponding author), Univ Tennessee, Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN USA.	smithjc@ornl.gov	saharay, moumita/K-7397-2012; smith, jeremy c/B-7287-2012	smith, jeremy c/0000-0002-2978-3227	BioEnergy Science Center (BESC); Office of Biological and Environmental Research in the DOE Office of Science; National Science Foundation	BioEnergy Science Center (BESC)(United States Department of Energy (DOE)); Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation(National Science Foundation (NSF))	The authors acknowledge funding from the BioEnergy Science Center (BESC). BESC is a U. S. Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science. This research was supported in part by the National Science Foundation through TeraGrid (64) resources provided by NICS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; BEGUIN P, 1994, FEMS MICROBIOL REV, V13, P25, DOI 10.1016/0168-6445(94)90099-X; Beguin P, 1996, CRIT REV BIOCHEM MOL, V31, P201, DOI 10.3109/10409239609106584; Biarnes X, 2006, J BIOL CHEM, V281, P1432, DOI 10.1074/jbc.M507643200; Biarnes X, 2007, J AM CHEM SOC, V129, P10686, DOI 10.1021/ja068411o; Bondar AN, 2004, STRUCTURE, V12, P1281, DOI 10.1016/j.str.2004.04.016; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROOKS CL, 1985, BIOPOLYMERS, V24, P843, DOI 10.1002/bip.360240509; Clarke A J, 1997, BIODEGRADATION CELLU; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; CREUZET N, 1983, FEMS MICROBIOL LETT, V20, P347, DOI 10.1111/j.1574-6968.1983.tb00145.x; Cui Q, 2001, J PHYS CHEM B, V105, P569, DOI 10.1021/jp0029109; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Elstner M, 2003, J MOL STRUC-THEOCHEM, V632, P29, DOI 10.1016/S0166-1280(03)00286-0; Ensing B, 2005, P NATL ACAD SCI USA, V102, P6755, DOI 10.1073/pnas.0408094102; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Formaneck M.S, 2002, J THEOR COMPUT CHEM, V1, P53, DOI [10.1142/s0219633602000075, DOI 10.1142/S0219633602000075]; Greig IR, 2007, CHEM COMMUN, P3747, DOI 10.1039/b705607a; Guerin DMA, 2002, J MOL BIOL, V316, P1061, DOI 10.1006/jmbi.2001.5404; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Guo H, 2001, P NATL ACAD SCI USA, V98, P9032, DOI 10.1073/pnas.141230998; Harjunpaa V, 1996, EUR J BIOCHEM, V240, P584, DOI 10.1111/j.1432-1033.1996.0584h.x; HARRIS EMS, 1993, BIOCHEMISTRY-US, V32, P1618, DOI 10.1021/bi00057a028; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Henrissat B, 1997, MOL MICROBIOL, V23, P848, DOI 10.1046/j.1365-2958.1997.2661629.x; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Koivula A, 1996, PROTEIN ENG, V9, P691, DOI 10.1093/protein/9.8.691; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Li GH, 2003, J AM CHEM SOC, V125, P15028, DOI 10.1021/ja0367851; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Meyer JEW, 1997, PROTEIN SCI, V6, P1084, DOI 10.1002/pro.5560060515; Parsiegla G, 2000, BIOCHEMISTRY-US, V39, P11238, DOI 10.1021/bi001139p; Parsiegla G, 1998, EMBO J, V17, P5551, DOI 10.1093/emboj/17.19.5551; Parsiegla G, 2008, J MOL BIOL, V375, P499, DOI 10.1016/j.jmb.2007.10.039; Petersen L, 2009, J PHYS CHEM B, V113, P7331, DOI 10.1021/jp811470d; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Riccardi D, 2008, BIOCHEMISTRY-US, V47, P2369, DOI 10.1021/bi701950j; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Sattelmeyer KW, 2006, J PHYS CHEM A, V110, P13551, DOI 10.1021/jp064544k; SCHINDLER M, 1977, BIOCHEMISTRY-US, V16, P423, DOI 10.1021/bi00622a013; Sheppard AN, 2009, J AM CHEM SOC, V131, P2530, DOI 10.1021/ja803879k; Shoham Y, 1999, TRENDS MICROBIOL, V7, P275, DOI 10.1016/S0966-842X(99)01533-4; SINGH UC, 1986, J COMPUT CHEM, V7, P718, DOI 10.1002/jcc.540070604; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; STRYNADKA NCJ, 1991, J MOL BIOL, V220, P401, DOI 10.1016/0022-2836(91)90021-W; SWOPE WC, 1982, J CHEM PHYS, V76, P637, DOI 10.1063/1.442716; TORRIE GM, 1974, CHEM PHYS LETT, V28, P578, DOI 10.1016/0009-2614(74)80109-0; Varrot A, 2003, STRUCTURE, V11, P855, DOI 10.1016/S0969-2126(03)00124-2; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Watson JN, 2003, BIOCHEMISTRY-US, V42, P12682, DOI 10.1021/bi035396g; Zhang YK, 2000, J CHEM PHYS, V112, P3483, DOI 10.1063/1.480503	65	27	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e12947	10.1371/journal.pone.0012947	http://dx.doi.org/10.1371/journal.pone.0012947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967294	Green Published, gold			2022-12-25	WOS:000282807300002
J	Mee, JA; Rowe, L				Mee, Jonathan A.; Rowe, Locke			Distribution of Phoxinus eos, Phoxinus neogaeus, and Their Asexually-Reproducing Hybrids (Pisces: Cyprinidae) in Algonquin Provincial Park, Ontario	PLOS ONE			English	Article							NORTHERN REDBELLY DACE; FINESCALE DACE; MORPHOLOGY; AGREEMENT; FISH	Hybrid Phoxinus are one of the few asexually reproducing vertebrates species. The distribution of hybrid Phoxinus among lakes in Algonquin Park, Ontario, was evaluated relative to the distribution of parental species and relative to physiochemical lake characteristics. No association between the distribution of hybrids and the distribution of parental species was found, suggesting that the hybrids can successfully coexist with either parental species. In addition, we found no association between hybrid distribution and the physiochemical characteristics of lakes, suggesting that the hybrids are generalists with respect to the ecological niches available in Algonquin Park. There was a difference between the physiochemical characteristics of lakes with and without the parental species P. neogaeus. The lakes containing P. neogaeus were lower elevation than the lakes containing the other parental species, P. eos. The difference in distribution between the parental species may therefore be due to different dispersal abilities, to later arrival following post-glacial dispersal, or to differences in ecology. These results suggest that asexual reproduction is a successful strategy for hybrid Phoxinus in Algonquin Park because these sperm-dependent asexual hybrids are able to survive and persist regardless of which parental species is present, and regardless of the physiochemical characteristics of their habitat.	[Mee, Jonathan A.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Rowe, Locke] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of British Columbia; University of Toronto	Mee, JA (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	mee@zoology.ubc.ca		Mee, Jonathan/0000-0003-0688-1390	National Science and Engineering Research Council of Canada [A - 266071 - 2003]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by the National Science and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) - Postgraduate Scholarship A - 266071 - 2003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2006, CURR BIOL, V16, pR696, DOI 10.1016/j.cub.2006.07.063; Angers B, 2007, MOL ECOL, V16, P4562, DOI 10.1111/j.1365-294X.2007.03511.x; Avise J., 2008, CLONALITY GENETICS E; Bell G., 1982, MASTERPIECE NATURE E; Binet MC, 2005, J FISH BIOL, V67, P1169, DOI 10.1111/j.1095-8649.2005.00802.x; COCHRAN PA, 1988, ENVIRON BIOL FISH, V22, P235, DOI 10.1007/BF00005384; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Darwin CH., 1962, J P LINNEAN SOC BOT, V6, P77; Dawley R. M, 1989, EVOLUTION ECOLOGY UN; DAWLEY RM, 1987, COPEIA, P275, DOI 10.2307/1445762; Doeringsfeld MR, 2004, EVOLUTION, V58, P1261; ELDER JF, 1995, P NATL ACAD SCI USA, V92, P5001, DOI 10.1073/pnas.92.11.5001; FELSENSTEIN J, 1974, GENETICS, V78, P737; Goddard K. A., 1989, EVOLUTION ECOLOGY UN, P269; Goddard KA, 1998, J HERED, V89, P151, DOI 10.1093/jhered/89.2.151; Massicotte R, 2008, CAN J FISH AQUAT SCI, V65, P2016, DOI 10.1139/F08-114; Mee JA, 2006, CAN J ZOOL, V84, P808, DOI 10.1139/Z06-064; MEE JA, 2010, EVOLUTION IN PRESS; NEW JG, 1962, COPEIA, P147; PHILLIPS GL, 1969, COPEIA, P501; Quinlan R, 2003, FRESHWATER BIOL, V48, P1676, DOI 10.1046/j.1365-2427.2003.01105.x; Schlosser IJ, 1998, ECOLOGY, V79, P953, DOI 10.1890/0012-9658(1998)079[0953:NROCAS]2.0.CO;2; Schlupp I, 2005, ANNU REV ECOL EVOL S, V36, P399, DOI 10.1146/annurev.ecolsys.36.102003.152629; SMITH JM, 1971, J THEOR BIOL, V30, P319, DOI 10.1016/0022-5193(71)90058-0; STASIAK RH, 1977, COPEIA, P771; TITUS K, 1984, AM MIDL NAT, V111, P1, DOI 10.2307/2425535; WILLIAMS GC, 1973, J THEOR BIOL, V39, P545, DOI 10.1016/0022-5193(73)90067-2; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	29	2	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13185	10.1371/journal.pone.0013185	http://dx.doi.org/10.1371/journal.pone.0013185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957232	Green Submitted, Green Published, gold			2022-12-25	WOS:000282423300017
J	Wilkie, KTR; Mertl, AL; Traniello, JFA				Wilkie, Kari T. Ryder; Mertl, Amy L.; Traniello, James F. A.			Species Diversity and Distribution Patterns of the Ants of Amazonian Ecuador	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; VERTICAL STRATIFICATION; ELEVATIONAL GRADIENT; FUNCTIONAL-GROUPS; WORLD ANTS; HYMENOPTERA; BIODIVERSITY; COMMUNITIES; FORMICIDAE; ASSEMBLAGES	Ants are among the most diverse, abundant and ecologically significant organisms on earth. Although their species richness appears to be greatest in the New World tropics, global patterns of ant diversity and distribution are not well understood. We comprehensively surveyed ant diversity in a lowland primary rainforest in Western Amazonia, Ecuador using canopy fogging, pitfall traps, baits, hand collecting, mini-Winkler devices and subterranean probes to sample ants. A total of 489 ant species comprising 64 genera in nine subfamilies were identified from samples collected in only 0.16 square kilometers. The most species-rich genera were Camponotus, Pheidole, Pseudomyrmex, Pachycondyla, Brachymyrmex, and Crematogaster. Camponotus and Pseudomyrmex were most diverse in the canopy, while Pheidole was most diverse on the ground. The three most abundant ground-dwelling ant genera were Pheidole, Solenopsis and Pyramica. Crematogaster carinata was the most abundant ant species in the canopy; Wasmannia auropunctata was most abundant on the ground, and the army ant Labidus coecus was the most abundant subterranean species. Ant species composition among strata was significantly different: 80% of species were found in only one stratum, 17% in two strata, and 3% in all three strata. Elevation and the number of logs and twigs available as nest sites were significant predictors of ground-dwelling ant species richness. Canopy species richness was not correlated with any ecological variable measured. Subterranean species richness was negatively correlated with depth in the soil. When ant species were categorized using a functional group matrix based on diet, nest-site preference and foraging ecology, the greatest diversity was found in Omnivorous Canopy Nesters. Our study indicates ant species richness is exceptionally high at Tiputini. We project 647-736 ant species in this global hotspot of biodiversity. Considering the relatively small area surveyed, this region of western Amazonia appears to support the most diverse ant fauna yet recorded.	[Wilkie, Kari T. Ryder; Mertl, Amy L.; Traniello, James F. A.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Wilkie, KTR (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	kryderwilkie@gmail.com			NSF [IOB 0725013]	NSF(National Science Foundation (NSF))	This research was partially supported by NSF Grant IOB 0725013 to J. Traniello and W. Gronenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti D., 2000, ANTS STANDARD METHOD; ALONSO L, 2001, URUBAMBA BIODIVERSIT; Andersen A.N., 2000, GLOBAL ECOLOGY RAINF, P25; Andersen AN, 1997, J BIOGEOGR, V24, P433, DOI 10.1111/j.1365-2699.1997.00137.x; ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; Armbrecht I, 2004, SCIENCE, V304, P284, DOI 10.1126/science.1094981; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Basset Y, 2003, ARTHROPODS OF TROPICAL FORESTS, P17; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Bernard E, 2001, J TROP ECOL, V17, P115, DOI 10.1017/S0266467401001079; BRANDAO C R F, 1990, Arquivos de Zoologia (Sao Paulo), V31, P411; Brown N, 2000, J APPL ECOL, V37, P1044, DOI 10.1046/j.1365-2664.2000.00573.x; BROWN W L JR, 1978, Studia Entomologica, V20, P549; BROWN W L JR, 1976, Studia Entomologica, V19, P67; BROWN WILLIAM L., 1958, BULL MUS COMP ZOOL HARVARD UNIV, V118, P173; Bruhl CA, 1998, J TROP ECOL, V14, P285, DOI 10.1017/S0266467498000224; Bruhl CA, 1999, J TROP ECOL, V15, P265, DOI 10.1017/S0266467499000802; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Colwell RK, 2013, ESTIMATES STAT ESTIM; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; DAVIDSON DW, 1988, ECOLOGY, V69, P1138, DOI 10.2307/1941268; DELABIE JHC, 1995, PEDOBIOLOGIA, V39, P423; DINIZ J L M, 1990, Revista Brasileira de Entomologia, V34, P277; Erwin Terry L., 2005, Proceedings of the California Academy of Sciences, V56, P72; Fernandez F, 2003, SOCIOBIOLOGY, V41, P633; Fernandez F, 2006, REV COLOMB ENTOMOL, V32, P97; Fisher BL, 1999, FIELD ZOOL, P129; Fisher BL, 1999, ECOL APPL, V9, P714, DOI 10.1890/1051-0761(1999)009[0714:IIEACS]2.0.CO;2; Fisher Brian L., 1996, Fieldiana Zoology, V85, P93; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; Floren A, 2000, OECOLOGIA, V123, P129, DOI 10.1007/s004420050998; Floren A, 2002, OECOLOGIA, V131, P137, DOI 10.1007/s00442-002-0874-z; Fowler Harold G., 2000, Tropical Ecology, V41, P73; GUNADI B, 1993, EUR J SOIL BIOL, V29, P133; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hoffmann BD, 2003, AUSTRAL ECOL, V28, P444, DOI 10.1046/j.1442-9993.2003.01301.x; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Kaspari M, 2000, P ROY SOC B-BIOL SCI, V267, P485, DOI 10.1098/rspb.2000.1026; KEMPF W W, 1973, Studia Entomologica, V16, P225; KUGLER C, 1982, SEARCH AGR ITHACA, V24, P1; KUSNEZOV N, 1957, EVOLUTION, V11, P298, DOI 10.1111/j.1558-5646.1957.tb02898.x; Lattke John E., 1995, Journal of Hymenoptera Research, V4, P137; LEVEY DJ, 1993, ECOLOGY, V74, P1802, DOI 10.2307/1939938; LONGINO J T, 1990, Psyche (Cambridge), V97, P81, DOI 10.1155/1990/36505; Longino John T., 2003, Zootaxa, V151, P1; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; MACKAY WP, 1989, SOCIOBIOLOGY, V16, P3; MACKAY WP, 1993, SOCIOBIOLOGY, V22, P1; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MAJER JD, 1994, BIOTROPICA, V26, P73, DOI 10.2307/2389112; Majer JD, 1996, J TROP ECOL, V12, P257, DOI 10.1017/S0266467400009445; MAJER JD, 1994, INSECT SOC, V41, P343, DOI 10.1007/BF01240639; Melo A. S., 2004, Community Ecology, V5, P149, DOI 10.1556/ComEc.5.2004.2.1; Mertl AL, 2010, INSECT SOC, V57, P441, DOI 10.1007/s00040-010-0102-5; Mertl AL, 2009, BIOTROPICA, V41, P633, DOI 10.1111/j.1744-7429.2009.00520.x; Mittermeier RA, 2000, NATURE, V405, p254B; Orivel J, 1997, BEHAV ECOL SOCIOBIOL, V40, P87, DOI 10.1007/s002650050319; PEARSON DL, 1971, CONDOR, V73, P46, DOI 10.2307/1366123; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; RISCH S, 1977, AM MIDLAND NATURALIS, V98; ROCKWOOD LL, 1979, BIOTROPICA, V11, P1, DOI 10.2307/2388163; Rodgers DJ, 1998, ECOGRAPHY, V21, P392, DOI 10.1111/j.1600-0587.1998.tb00404.x; Roisin Y, 2006, OECOLOGIA, V149, P301, DOI 10.1007/s00442-006-0449-5; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Sabu TK, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.0101; Samson DA, 1997, BIOTROPICA, V29, P349, DOI 10.1111/j.1744-7429.1997.tb00436.x; Silva RR, 2007, FOREST ECOL MANAG, V240, P61, DOI 10.1016/j.foreco.2006.12.002; SMITH AP, 1973, AM NAT, V107, P671, DOI 10.1086/282866; Tobin JE, 1997, J NEW YORK ENTOMOL S, V105, P105; TOBIN JE, 1995, ECOLOGY DIVERSITY NE; Vantaux A, 2007, INSECT SOC, V54, P95, DOI 10.1007/s00040-007-0914-0; Vasconcelos HL, 2006, BIOTROPICA, V38, P100, DOI 10.1111/j.1744-7429.2006.00113.x; Vasconcelos HL, 2000, J APPL ECOL, V37, P508, DOI 10.1046/j.1365-2664.2000.00512.x; Verhaagh M., 1990, P217; Vieira EM, 2003, J TROP ECOL, V19, P501, DOI 10.1017/S0266467403003559; WATKINS JF, 1985, J KANSAS ENTOMOL SOC, V58, P479; WERNEGREEN J, 2009, ONE NUTR SYMBIOSIS B; Wilkie KTR, 2007, NATURWISSENSCHAFTEN, V94, P725, DOI 10.1007/s00114-007-0250-2; Wilkie KTR, 2009, MYRMECOL NEWS, V12, P139; WILSON E O, 1976, Studia Entomologica, V19, P187; Wilson E.O., 2003, PHEIDOLE NEW WORLD D, V1; Yanoviak SP, 2000, OIKOS, V89, P259, DOI 10.1034/j.1600-0706.2000.890206.x	85	78	82	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13146	10.1371/journal.pone.0013146	http://dx.doi.org/10.1371/journal.pone.0013146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957208	gold, Green Published			2022-12-25	WOS:000282359300030
J	Tanaka, T; Sewell, H; Waters, S; Phillips, SEV; Rabbitts, TH				Tanaka, Tomoyuki; Sewell, Helen; Waters, Simon; Phillips, Simon E. V.; Rabbitts, Terence H.			Single Domain Intracellular Antibodies from Diverse Libraries EMPHASIZING DUAL FUNCTIONS OF LMO2 PROTEIN INTERACTIONS USING A SINGLE VH DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIM-PROTEIN LMO2; T-CELL LEUKEMIA; ERYTHROLEUKEMIA CELLS; MEMBRANE-PROTEINS; MAMMALIAN-CELLS; SELECTION; COMPLEX; DIFFERENTIATION; CAPTURE; CRYSTALLIZATION	Interfering intracellular antibodies are valuable for biological studies as drug surrogates and as potential macromolecular drugs per se. Their application is still limited because of the difficulty of acquisition of functional intracellular antibodies. We describe the use of the new intracellular antibody capture procedure (IAC(3)) to facilitate direct isolation of functional single domain antibody fragments using four independent target molecules (LMO2, TP53, CRAF1, and Hoxa9) from a set of diverse libraries. Initially, these have variability in only one of the three antigen-binding CDR regions of VH or VL and first round single domains are affinity matured by iterative randomization of the two other CDRs and reselection. We highlight the approach using a single domain binding to LMO2 protein. Our results show that interfering with LMO2 protein function demonstrates a role specifically in erythroid differentiation, confirm a necessary and sufficient function for LMO2 as a cancer therapy target in T-cell neoplasia and allowed for the first time production of soluble recombinant LMO2 protein by co-expression with intracellular domain antibodies. Cocrystallization of LMO2 and the anti-LMO2 VH protein was successful. These results demonstrate that this third generation IAC3 offers a robust toolbox for various biomedical applications and consolidates functional features of the LMO2 protein complex, which includes the importance of Lmo2-Ldb1 protein interaction.	[Rabbitts, Terence H.] Univ Leeds, Leeds Inst Mol Med, Sect Expt Therapeut, St Jamess Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Phillips, Simon E. V.] Rutherford Appleton Lab, Didcot OX11 0FA, Oxon, England	Saint James's University Hospital; University of Leeds; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Rabbitts, TH (corresponding author), Univ Leeds, Leeds Inst Mol Med, Sect Expt Therapeut, St Jamess Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.	thr@leeds.ac.uk	Rabbitts, Terence/D-6262-2016	Rabbitts, Terence/0000-0002-4982-2609	Medical Research Council; Leukemia and Lymphoma Research; Leeds Institute of Molecular Medicine (University of Leeds); Bramall clinical studentship; MRC [G0600914, G0901686] Funding Source: UKRI; Medical Research Council [G0901686, G0600914] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukemia and Lymphoma Research; Leeds Institute of Molecular Medicine (University of Leeds); Bramall clinical studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Medical Research Council, from Leukemia and Lymphoma Research, and from the Leeds Institute of Molecular Medicine (University of Leeds).; Supported by a Leukemia and Lymphoma Research Gordon Pillar studentship and by the Medical Research Council.; Supported by a Bramall clinical studentship and by a Leukemia and Lymphoma Research clinical fellowship.	Appert A, 2009, CANCER RES, V69, P4784, DOI 10.1158/0008-5472.CAN-08-4774; ARCHER VEV, 1994, P NATL ACAD SCI USA, V91, P316, DOI 10.1073/pnas.91.1.316; Begay-Muller V, 2002, FEBS LETT, V521, P36, DOI 10.1016/S0014-5793(02)02814-4; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Deane JE, 2003, ACTA CRYSTALLOGR D, V59, P1484, DOI 10.1107/S0907444903011843; Deane JE, 2003, EMBO J, V22, P2224, DOI 10.1093/emboj/cdg196; Deane JE, 2001, PROTEIN ENG, V14, P493, DOI 10.1093/protein/14.7.493; DEISSEROTH A, 1978, CELL, V15, P55, DOI 10.1016/0092-8674(78)90082-X; FEARON ER, 1992, P NATL ACAD SCI USA, V89, P7958, DOI 10.1073/pnas.89.17.7958; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Grutz GG, 1998, EMBO J, V17, P4594, DOI 10.1093/emboj/17.16.4594; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mao SF, 1997, ONCOGENE, V14, P1531, DOI 10.1038/sj.onc.1200988; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nam CH, 2008, ONCOGENE, V27, P4962, DOI 10.1038/onc.2008.130; Natkunam Y, 2007, BLOOD, V109, P1636, DOI 10.1182/blood-2006-08-039024; OSTERMEIER C, 1995, NAT STRUCT BIOL, V2, P842, DOI 10.1038/nsb1095-842; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Perez-Martinez D, 2010, BIOESSAYS, V32, P589, DOI 10.1002/bies.201000009; Ramsland PA, 2002, J MOL RECOGNIT, V15, P248, DOI 10.1002/jmr.585; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; REUBEN RC, 1976, P NATL ACAD SCI USA, V73, P862, DOI 10.1073/pnas.73.3.862; Rothlisberger D, 2004, FEBS LETT, V564, P340, DOI 10.1016/S0014-5793(04)00359-X; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Ruiz M, 2002, IMMUNOGENETICS, V53, P857, DOI 10.1007/s00251-001-0408-6; Ryan DP, 2008, PROTEINS, V70, P1461, DOI 10.1002/prot.21638; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; Tanaka T, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng023; Tanaka T, 2003, J MOL BIOL, V331, P1109, DOI 10.1016/S0022-2836(03)00836-2; Tanaka T, 2003, EMBO J, V22, P1025, DOI 10.1093/emboj/cdg106; Tanaka T, 2008, J MOL BIOL, V376, P749, DOI 10.1016/j.jmb.2007.11.085; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; Tanaka T, 2010, NAT PROTOC, V5, P67, DOI 10.1038/nprot.2009.199; Tanaka T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp069; Tse E, 2002, J MOL BIOL, V317, P85, DOI 10.1006/jmbi.2002.5403; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Visintin M, 2004, J IMMUNOL METHODS, V290, P135, DOI 10.1016/j.jim.2004.04.014; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yu GW, 2009, J MOL BIOL, V385, P1578, DOI 10.1016/j.jmb.2008.11.043	46	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3707	3716		10.1074/jbc.M110.188193	http://dx.doi.org/10.1074/jbc.M110.188193			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	20980262	hybrid, Green Published			2022-12-25	WOS:000286653200053
J	George, J; Motshwene, PG; Wang, H; Kubarenko, AV; Rautanen, A; Mills, TC; Hill, AVS; Gay, NJ; Weber, ANR				George, Julie; Motshwene, Precious G.; Wang, Hui; Kubarenko, Andriy V.; Rautanen, Anna; Mills, Tara C.; Hill, Adrian V. S.; Gay, Nicholas J.; Weber, Alexander N. R.			Two Human MYD88 Variants, S34Y and R98C, Interfere with MyD88-IRAK4-Myddosome Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; PYOGENIC BACTERIAL-INFECTIONS; IRAK-4; COMPLEX; DEFICIENCY; ADAPTER; KINASE; SUPERFAMILY; RESPONSES; NETWORK	Innate immune receptors detect microbial pathogens and subsequently activate adaptive immune responses to combat pathogen invasion. MyD88 is a key adaptor molecule in both Toll-like receptor (TLR) and IL-1 receptor superfamily signaling pathways. This is illustrated by the fact that human individuals carrying rare, naturally occurring MYD88 point mutations suffer from reoccurring life-threatening infections. Here we analyzed the functional properties of six reported non-synonymous single nucleotide polymorphisms of MYD88 in an in vitro cellular system. Two variants found in the MyD88 death domain, S34Y and R98C, showed severely reduced NF-kappa B activation due to reduced homo-oligomerization and IRAK4 interaction. Structural modeling highlights Ser-34 and Arg-98 as residues important for the assembly of the Myddosome, a death domain (DD) post-receptor complex involving the DD of MyD88, IRAK4, and IRAK2 or IRAK1. Using S34Y and R98C as functional probes, our data show that MyD88 homo-oligomerization and IRAK4 interaction is modulated by the MyD88 TIR and IRAK4 kinase domain, demonstrating the functional importance of non-DD regions not observed in a recent Myddosome crystal structure. The differential interference of S34Y and R98C with some (IL-1 receptor, TLR2, TLR4, TLR5, and TLR7) but not all (TLR9) MyD88-dependent signaling pathways also suggests that receptor specificities exist at the level of the Myddosome. Given their detrimental effect on signaling, it is not surprising that our epidemiological analysis in several case-control studies confirms that S34Y and R98C are rare variants that may drastically contribute to susceptibility to infection in only few individuals.	[Weber, Alexander N. R.] German Canc Res Ctr, Div Toll Like Receptors & Canc, D-69120 Heidelberg, Germany; [Motshwene, Precious G.; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1SG, England; [Rautanen, Anna; Mills, Tara C.; Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	Helmholtz Association; German Cancer Research Center (DKFZ); University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics	Weber, ANR (corresponding author), German Canc Res Ctr, Div Toll Like Receptors & Canc, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	alexander.weber@dkfz.de		Weber, Alexander/0000-0002-8627-7056; Motshwene, Precious/0000-0002-0230-9410	Deutsche Forschungsgemeinschaft [We4195-1]; German Cancer Research Centre; UK Medical Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council; European Union; Academy of Finland; BBSRC [BB/G002797/1] Funding Source: UKRI; MRC [G1000133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G002797/1] Funding Source: researchfish; Medical Research Council [G1000133] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Research Centre; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Academy of Finland(Academy of Finland); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Deutsche Forschungsgemeinschaft Grant We4195-1 (to A. N. R. W.) and by the German Cancer Research Centre.; Funded by grants from the UK Medical Research Council, the Wellcome Trust, and the Biotechnology and Biological Sciences Research Council.; Funded by the European Union FP6 GRACE grant and the Academy of Finland.	[Anonymous], 2003, NATURE, V426, P789; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Conner JR, 2009, J EXP MED, V206, P1615, DOI 10.1084/jem.20090490; George J, 2010, J IMMUNOL, V184, P3025, DOI 10.4049/jimmunol.0901156; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kubarenko A, 2007, BIOCHEM SOC T, V35, P1515, DOI 10.1042/BST0351515; Kubarenko AV, 2010, PROTEIN SCI, V19, P558, DOI 10.1002/pro.333; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 1999, MOL CELL BIOL, V19, P4643; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Loiarro M, 2009, J BIOL CHEM, V284, P28093, DOI 10.1074/jbc.M109.004465; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Park HH, 2007, ACTA CRYSTALLOGR F, V63, P229, DOI 10.1107/S1744309107007889; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pothlichet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007582; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	40	49	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1341	1353		10.1074/jbc.M110.159996	http://dx.doi.org/10.1074/jbc.M110.159996			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20966070	Green Published, hybrid			2022-12-25	WOS:000286005000046
J	Huang, YP; Ratovitski, EA				Huang, Yiping; Ratovitski, Edward A.			Phosphorylated TP63 Induces Transcription of RPN13, Leading to NOS2 Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CELL CARCINOMA-CELLS; DEUBIQUITINATING ENZYME; PROTEASOME DEGRADATION; INDUCED APOPTOSIS; DRUG-RESISTANCE; P53 ACTIVATION; CANCER; CISPLATIN; DELTA-NP63-ALPHA	Head and neck squamous cell carcinoma cells exposed to cisplatin display ATM-dependent phosphorylation of the most predominant TP63 isoform (Delta Np63 alpha), leading to its activation as a transcription factor. Here, we found that the phospho-Delta Np63 alpha protein binds to the genomic promoter of RPN13 through the TP63-responsive element. We further found that the phospho-Delta Np63 alpha protein associates with other transcription factors (DDIT3 (also known as CHOP), NF-Y, and NF-kappa B), activating RPN13 gene transcription. Furthermore, cisplatin-induced and phospho-Delta Np63 kappa-dependent RPN13 gene transcription leads to NOS2 degradation. Finally, we show that RPN13 knockdown by siRNA essentially rescues NOS2 from cisplatin-dependent inactivation. These data provide a novel mechanism for the phospho-Delta Np63 alpha-dependent regulation of NOS2 function in cells upon cisplatin treatment, contributing to the cell death pathway of tumor cells.	[Huang, Yiping; Ratovitski, Edward A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21231 USA	Johns Hopkins University	Ratovitski, EA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Dermatol, Canc Res Bldg 2,Rm 2M05,1550 Orleans St, Baltimore, MD 21231 USA.	eratovi1@jhmi.edu			NIAID [R01-AI47224]; NIDCR [R01-DE13561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013561] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI47224 from NIAID and R01-DE13561 from NIDCR (to E.A.R.).	Abrams SL, 2010, CELL CYCLE, V9, P1781, DOI 10.4161/cc.9.9.11483; Ambs S, 1998, BRIT J CANCER, V78, P233, DOI 10.1038/bjc.1998.470; Ambs S, 1997, FASEB J, V11, P443, DOI 10.1096/fasebj.11.6.9194524; Borst P, 2008, CELL CYCLE, V7, P1353, DOI 10.4161/cc.7.10.5930; Brune B, 2003, CELL DEATH DIFFER, V10, P864, DOI 10.1038/sj.cdd.4401261; Damia G, 2004, CELL CYCLE, V3, P46; Di Agostino S, 2008, CELL CYCLE, V7, P3440, DOI 10.4161/cc.7.21.6995; Fomenkov A, 2004, CELL CYCLE, V3, P1285, DOI 10.4161/cc.3.10.1155; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Gordon C, 2002, CURR TOP MICROBIOL, V268, P175; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Helmbach H, 2002, J INVEST DERMATOL, V118, P923, DOI 10.1046/j.1523-1747.2002.01786.x; Hemish J, 2003, J BIOL CHEM, V278, P42321, DOI 10.1074/jbc.M308192200; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; Huang YP, 2008, CELL CYCLE, V7, P2846, DOI 10.4161/cc.7.18.6627; Huang YP, 2010, CELL CYCLE, V9, P328, DOI 10.4161/cc.9.2.10432; Huang YP, 2005, CELL CYCLE, V4, P1440, DOI 10.4161/cc.4.10.2086; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Hussain SP, 2008, CANCER RES, V68, P7130, DOI 10.1158/0008-5472.CAN-08-0410; Hussain SP, 2004, CANCER RES, V64, P6849, DOI 10.1158/0008-5472.CAN-04-2201; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kolodziejska KE, 2005, P NATL ACAD SCI USA, V102, P4854, DOI 10.1073/pnas.0500485102; Kolodziejski PJ, 2002, P NATL ACAD SCI USA, V99, P12315, DOI 10.1073/pnas.192345199; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kroncke KD, 2003, BIOL CHEM, V384, P1365, DOI 10.1515/BC.2003.153; Leung EL, 2008, BRIT J CANCER, V98, P1803, DOI 10.1038/sj.bjc.6604375; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P4297, DOI 10.4161/cc.9.21.13817; Mazumdar T, 2010, P NATL ACAD SCI USA, V107, P13854, DOI 10.1073/pnas.0913495107; Melino G, 2000, CELL MOL LIFE SCI, V57, P612, DOI 10.1007/PL00000723; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; Musial A, 2001, J BIOL CHEM, V276, P24268, DOI 10.1074/jbc.M100725200; Nakaya N, 2000, ONCOGENE, V19, P6369, DOI 10.1038/sj.onc.1204100; Navarro-Lerida I, 2004, J BIOL CHEM, V279, P55682, DOI 10.1074/jbc.M406621200; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; Nicotera P, 1999, CELL DEATH DIFFER, V6, P931, DOI 10.1038/sj.cdd.4400583; Nott A, 2009, CELL CYCLE, V8, P725, DOI 10.4161/cc.8.5.7805; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Pandit L, 2009, P NATL ACAD SCI USA, V106, P1211, DOI 10.1073/pnas.0810968106; Pani E, 2007, CELL CYCLE, V6, P1796, DOI 10.4161/cc.6.14.4472; Peunova N, 2007, CELL CYCLE, V6, P3132, DOI 10.4161/cc.6.24.5146; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Ratovitski EA, 1999, J BIOL CHEM, V274, P30250, DOI 10.1074/jbc.274.42.30250; Ratovitski EA, 1999, J BIOL CHEM, V274, P993, DOI 10.1074/jbc.274.2.993; Richardson PG, 2005, CELL CYCLE, V4, P290; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Seminara AR, 2007, CELL CYCLE, V6, P1772, DOI 10.4161/cc.6.14.4438; SHAPOSHNIKOV JD, 1978, INT J CANCER, V21, P395, DOI 10.1002/ijc.2910210322; SHIMADA S, 1994, CANCER RES, V54, P3831; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sikora AG, 2010, CLIN CANCER RES, V16, P1834, DOI 10.1158/1078-0432.CCR-09-3123; Sos ML, 2009, CELL CYCLE, V8, P3652, DOI 10.4161/cc.8.22.9936; Staib F, 2005, CANCER RES, V65, P10255, DOI 10.1158/0008-5472.CAN-05-1714; Tanaka T, 2008, CELL CYCLE, V7, P1569, DOI 10.4161/cc.7.11.6061; Tang CH, 2004, J BIOL CHEM, V279, P288, DOI 10.1074/jbc.M310821200; Wang X, 2003, CELL DEATH DIFFER, V10, P468, DOI 10.1038/sj.cdd.4401181; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zangen R, 2005, CELL CYCLE, V4, P1313, DOI 10.4161/cc.4.10.2066	58	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41422	41431		10.1074/jbc.M110.158642	http://dx.doi.org/10.1074/jbc.M110.158642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959455	Green Published, hybrid			2022-12-25	WOS:000285622600028
J	Lu, HL; Kennedy, GG; Warshaw, DM; Trybus, KM				Lu, Hailong; Kennedy, Guy G.; Warshaw, David M.; Trybus, Kathleen M.			Simultaneous Observation of Tail and Head Movements of Myosin V during Processive Motion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; LEUCINE-RICH PROTEOGLYCANS; DECORIN-DEFICIENT MICE; CYCLIN-DEPENDENT KINASES; HUMAN COLON-CANCER; C-MYC PROTEIN; FACTOR RECEPTOR; IN-VIVO; DOWN-REGULATION; MET RECEPTOR	Processive stepping of myosin Va (myoV) has been tracked by monitoring either the tail position (center of mass) or the position of one or both heads. Here, we combine these two approaches by attaching a quantum dot to one of the motor domains and a bead to the tail. Using laser trapping and total internal reflection microscopy, the position of one head and the tail are observed simultaneously as myoV moves processively on an actin filament bundle against the resistive load of the laser trap. The head moves one step (73 +/- 10 nm) for every two steps of the tail (35 +/- 9 nm). One tail step occurs concurrently with quantum dot-labeled head movement, whereas the other occurs with movement of the unlabeled head, consistent with a hand-over-hand model. Load increases the probability of the motor taking a back step. The back step is triggered by the motor taking a shorter forward step (head step, 68 +/- 11 nm; tail step, 32 +/- 10 nm), likely one actin monomer short of its preferred binding site. During a back step, the motor reverses its hand-over-hand motion, with the leading head detaching and reattaching to one of multiple actin sites behind the trailing head. After a back step, the motor can correct its mistake and step processively forward at resistive loads <0.7 piconewton or stall or detach at higher loads. Back stepping may provide a mechanism to ensure efficient cargo delivery even when myoV encounters obstacles within the actin cytoskeletal meshwork or when other motors are attached to the same cargo.	[Warshaw, David M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Kennedy, Guy G.] Univ Vermont, Instrumentat & Model Facil, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Warshaw, DM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, 149 Beaumont Ave, Burlington, VT 05405 USA.	david.warshaw@uvm.edu; kathleen.trybus@uvm.edu	lu, hailong/C-7754-2009		National Institutes of Health [GM078097, HL059408, GM094229]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078097, R01GM094229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078097 (to K. M. T.) and HL059408 and GM094229 (to D.M.W.).	ADANY R, 1991, BIOCHEM J, V276, P301, DOI 10.1042/bj2760301; ADANY R, 1990, J BIOL CHEM, V265, P11389; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brown EL, 2001, J CLIN INVEST, V107, P845, DOI 10.1172/JCI11692; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Danilkovitch-Miagkova A, 2001, MOL CELL BIOL, V21, P5857, DOI 10.1128/MCB.21.17.5857-5868.2001; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ferdous Z, 2010, J BIOMED MATER RES A, V93A, P419, DOI 10.1002/jbm.a.32545; Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200; Foveau B, 2009, MOL BIOL CELL, V20, P2495, DOI 10.1091/mbc.E08-09-0969; Fust A, 2005, AM J PHYSIOL-LUNG C, V288, pL159, DOI 10.1152/ajplung.00089.2004; Goldberg M, 2005, CALCIFIED TISSUE INT, V77, P297, DOI 10.1007/s00223-005-0026-7; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hakkinen L, 2000, LAB INVEST, V80, P1869, DOI 10.1038/labinvest.3780197; Haruyama N, 2009, MATRIX BIOL, V28, P129, DOI 10.1016/j.matbio.2009.01.005; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kamei J, 2003, BIOCHEM BIOPH RES CO, V312, P380, DOI 10.1016/j.bbrc.2003.10.129; KRUMDIECK R, 1992, J IMMUNOL, V149, P3695; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Li X, 2008, BLOOD, V112, P159, DOI 10.1182/blood-2007-11-124164; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Merline R, 2009, J PHYSIOL PHARMACOL, V60, P5; Migliore C, 2008, EUR J CANCER, V44, P641, DOI 10.1016/j.ejca.2008.01.022; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Patel S, 1998, J BIOL CHEM, V273, P3121, DOI 10.1074/jbc.273.6.3121; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Ramirez F, 2003, MATRIX BIOL, V22, P101, DOI 10.1016/S0945-053X(03)00002-7; Rasola A, 2007, ONCOGENE, V26, P1078, DOI 10.1038/sj.onc.1209859; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; Robinson PS, 2004, ANN BIOMED ENG, V32, P924, DOI 10.1023/B:ABME.0000032455.78459.56; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sanches JCT, 2010, J ANAT, V216, P144, DOI 10.1111/j.1469-7580.2009.01170.x; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; SANTRA M, 1995, P NATL ACAD SCI USA, V92, P7016, DOI 10.1073/pnas.92.15.7016; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2004, AM J PATHOL, V165, P383, DOI 10.1016/S0002-9440(10)63305-6; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; SCHMIDT G, 1987, J CELL BIOL, V104, P1683, DOI 10.1083/jcb.104.6.1683; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Schonherr E, 2004, J VASC RES, V41, P499, DOI 10.1159/000081806; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sims K, 2009, DEV BIOL, V327, P410, DOI 10.1016/j.ydbio.2008.12.027; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Weis SM, 2005, MATRIX BIOL, V24, P313, DOI 10.1016/j.matbio.2005.05.003; Williams KJ, 2007, AM J PATHOL, V171, P1441, DOI 10.2353/ajpath.2007.070079; WINNEMOLLER M, 1992, EUR J CELL BIOL, V59, P47; Zafiropoulos A, 2008, MOL CANCER RES, V6, P785, DOI 10.1158/1541-7786.MCR-07-0165; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022; Zoeller JJ, 2009, J BIOL CHEM, V284, P11728, DOI 10.1074/jbc.M808991200	102	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42068	42085		10.1074/jbc.M110.180265	http://dx.doi.org/10.1074/jbc.M110.180265			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974847	Green Published, hybrid			2022-12-25	WOS:000285622600092
J	Munch, D; Baker, N; Kreibich, CD; Braten, AT; Amdam, GV				Munch, Daniel; Baker, Nicholas; Kreibich, Claus D.; Braten, Anders T.; Amdam, Gro V.			In the Laboratory and during Free-Flight: Old Honey Bees Reveal Learning and Extinction Deficits that Mirror Mammalian Functional Decline	PLOS ONE			English	Article							PROBOSCIS-EXTENSION RESPONSE; APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; SPONTANEOUS-RECOVERY; SPATIAL MEMORY; WATER MAZE; LIFE-SPAN; NESTMATE RECOGNITION; SOCIAL-ROLE; ACQUISITION	Loss of brain function is one of the most negative and feared aspects of aging. Studies of invertebrates have taught us much about the physiology of aging and how this progression may be slowed. Yet, how aging affects complex brain functions, e.g., the ability to acquire new memory when previous experience is no longer valid, is an almost exclusive question of studies in humans and mammalian models. In these systems, age related cognitive disorders are assessed through composite paradigms that test different performance tasks in the same individual. Such studies could demonstrate that afflicted individuals show the loss of several and often-diverse memory faculties, and that performance usually varies more between aged individuals, as compared to conspecifics from younger groups. No comparable composite surveying approaches are established yet for invertebrate models in aging research. Here we test whether an insect can share patterns of decline similar to those that are commonly observed during mammalian brain aging. Using honey bees, we combine restrained learning with free-flight assays. We demonstrate that reduced olfactory learning performance correlates with a reduced ability to extinguish the spatial memory of an abandoned nest location ( spatial memory extinction). Adding to this, we show that learning performance is more variable in old honey bees. Taken together, our findings point to generic features of brain aging and provide the prerequisites to model individual aspects of learning dysfunction with insect models.	[Munch, Daniel; Kreibich, Claus D.; Braten, Anders T.; Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Baker, Nicholas; Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Norwegian University of Life Sciences; Arizona State University; Arizona State University-Tempe	Munch, D (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	daniel.munch@umb.no			Research Council of Norway [175413, 180504, 185306, 191699]; U.S. National Science Foundation [0615502]; PEW Foundation	Research Council of Norway(Research Council of Norway); U.S. National Science Foundation(National Science Foundation (NSF)); PEW Foundation	G.V.A. was supported by the Research Council of Norway (# 175413, 180504, 185306 and 191699; http://www.forskningsradet.no), the U.S. National Science Foundation (# 0615502; http://www.nsf.gov), and the PEW Foundation (http://www.pewtrusts.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009740; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Behrends A, 2007, EXP GERONTOL, V42, P1146, DOI 10.1016/j.exger.2007.09.003; Bevilaqua Lia R. M., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/595282; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; BREED MD, 1992, J CHEM ECOL, V18, P1633, DOI 10.1007/BF00993235; Breed MD, 1998, ANIM BEHAV, V55, P13, DOI 10.1006/anbe.1997.0581; BRIGUI N, 1990, J COMP PSYCHOL, V104, P289, DOI 10.1037/0735-7036.104.3.289; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Brown S, 2009, LEARN MEMORY, V16, P210, DOI 10.1101/lm.1241909; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Downs SG, 1999, ANIM BEHAV, V58, P643, DOI 10.1006/anbe.1999.1177; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Dukas R, 2008, INSECT SOC, V55, P252, DOI 10.1007/s00040-008-0995-4; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; EBADI R, 1980, ENVIRON ENTOMOL, V9, P144, DOI 10.1093/ee/9.1.144; Fresquet N, 1999, PHYSIOL BEHAV, V67, P205, DOI 10.1016/S0031-9384(99)00058-X; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Huston JP, 2009, J NEURAL TRANSM, V116, P1029, DOI 10.1007/s00702-009-0210-4; Iliadi KG, 2009, EXP GERONTOL, V44, P546, DOI 10.1016/j.exger.2009.05.008; Kirkwood TBL, 2005, MECH AGEING DEV, V126, P439, DOI 10.1016/j.mad.2004.09.008; Lattal KM, 2003, BEHAV NEUROSCI, V117, P1017, DOI 10.1037/0735-7044.117.5.1017; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 2001, LEARN MEMORY, V8, P198, DOI 10.1101/lm.40001; Menzel Randolf, 2006, Behav Cogn Neurosci Rev, V5, P24, DOI 10.1177/1534582306289522; Mery F, 2007, EXP GERONTOL, V42, P99, DOI 10.1016/j.exger.2006.06.004; Munch D, 2010, FEBS LETT, V584, P2496, DOI 10.1016/j.febslet.2010.04.007; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Pankiw T, 2003, J COMP PHYSIOL A, V189, P675, DOI 10.1007/s00359-003-0442-y; Pavlov I.P., 1927, CONDITIONED REFLEXES; Piper MDW, 2005, EXP GERONTOL, V40, P857, DOI 10.1016/j.exger.2005.06.013; RAPP PR, 1992, TRENDS NEUROSCI, V15, P340, DOI 10.1016/0166-2236(92)90051-9; ROBINSON GE, 1993, ANIM BEHAV, V46, P311, DOI 10.1006/anbe.1993.1192; Rueppell O, 2007, CURR BIOL, V17, pR274, DOI 10.1016/j.cub.2007.02.015; Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91; Sandoz JC, 2004, LEARN MEMORY, V11, P586, DOI 10.1101/lm.81504; Scheiner R, 2005, LEARN MEMORY, V12, P626, DOI 10.1101/lm.98105; Scheiner R, 2009, J EXP BIOL, V212, P994, DOI 10.1242/jeb.021188; SCHMIDT JO, 1994, J CHEM ECOL, V20; Schubert M, 2002, ANIM BEHAV, V64, P175, DOI 10.1006/anbe.2002.3055; Schulz D, 2007, NEUROBIOL LEARN MEM, V87, P309, DOI 10.1016/j.nlm.2006.09.006; Small SA, 2001, ARCH NEUROL-CHICAGO, V58, P360, DOI 10.1001/archneur.58.3.360; Stollhoff N, 2005, J NEUROSCI, V25, P4485, DOI 10.1523/JNEUROSCI.0117-05.2005; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Wolschin F, 2009, J EXP BIOL, V212, P4027, DOI 10.1242/jeb.033845; Ylikoski R, 1999, EUR J NEUROL, V6, P645, DOI 10.1046/j.1468-1331.1999.660645.x; Zhang SW, 2006, J EXP BIOL, V209, P4420, DOI 10.1242/jeb.02522; Zhang SW, 2005, P NATL ACAD SCI USA, V102, P5250, DOI 10.1073/pnas.0501440102	54	13	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13504	10.1371/journal.pone.0013504	http://dx.doi.org/10.1371/journal.pone.0013504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976061	Green Published, gold, Green Submitted			2022-12-25	WOS:000283114700023
J	Zavizion, B; Zhao, ZH; Nittayajarn, A; Rieder, RJ				Zavizion, Boris; Zhao, Zhihui; Nittayajarn, Aphakorn; Rieder, Ronald J.			Rapid Microbiological Testing: Monitoring the Development of Bacterial Stress	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; RESPONSES	The ability to respond to adverse environments effectively along with the ability to reproduce are sine qua non conditions for all sustainable cellular forms of life. Given the availability of an appropriate sensing modality, the ubiquity and immediacy of the stress response could form the basis for a new approach for rapid biological testing. We have found that measuring the dielectric permittivity of a cellular suspension, an easily measurable electronic property, is an effective way to monitor the response of bacterial cells to adverse conditions continuously. The dielectric permittivity of susceptible and resistant strains of Escherichia coli and Staphylococcus aureus, treated with gentamicin and vancomycin, were measured directly using differential impedance sensing methods and expressed as the Normalized Impedance Response (NIR). These same strains were also heat-shocked and chemically stressed with Triton X-100 or H2O2. The NIR profiles obtained for antibiotic-treated susceptible organisms showed a strong and continuous decrease in value. In addition, the intensity of the NIR value decrease for susceptible cells varied in proportion to the amount of antibiotic added. Qualitatively similar profiles were found for the chemically treated and heat-shocked bacteria. In contrast, antibiotic-resistant cells showed no change in the NIR values in the presence of the drug to which it is resistant. The data presented here show that changes in the dielectric permittivity of a cell suspension are directly correlated with the development of a stress response as well as bacterial recovery from stressful conditions. The availability of a practical sensing modality capable of monitoring changes in the dielectric properties of stressed cells could have wide applications in areas ranging from the detection of bacterial infections in clinical specimens to antibiotic susceptibility testing and drug discovery.	[Zavizion, Boris; Zhao, Zhihui; Nittayajarn, Aphakorn; Rieder, Ronald J.] BioSense Technol Inc, Woburn, MA USA		Zavizion, B (corresponding author), BioSense Technol Inc, Woburn, MA USA.	rieder@biosensetech.com		Zavizion, Boris/0000-0001-7246-4179	National Institutes of Health [5R44DK075198]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK075198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this work was provided by the National Institutes of Health through grant 5R44DK075198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bore E, 2007, MICROBIOL-SGM, V153, P2289, DOI 10.1099/mic.0.2007/005942-0; Chang W, 2006, J BACTERIOL, V188, P1648, DOI 10.1128/JB.188.4.1648-1659.2006; COLVIN HJ, 1977, ANTIMICROB AGENTS CH, V12, P61, DOI 10.1128/AAC.12.1.61; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fleury B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-76; Giuliodori AM, 2007, ANN NY ACAD SCI, V1113, P95, DOI 10.1196/annals.1391.008; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Marles-Wright J, 2007, CURR OPIN STRUC BIOL, V17, P755, DOI 10.1016/j.sbi.2007.08.004; Michan C, 1999, J BACTERIOL, V181, P2759; MILIOTIS MD, 1991, J CLIN MICROBIOL, V29, P830, DOI 10.1128/JCM.29.4.830-831.1991; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Rieder R, 2008, TRANSFUSION, V48, P2596, DOI 10.1111/j.1537-2995.2008.01880.x; Rieder RJ, 2009, ANTIMICROB AGENTS CH, V53, P4598, DOI 10.1128/AAC.00643-09; Umakoshi H, 1998, BIOTECHNOL PROGR, V14, P909, DOI 10.1021/bp980091s; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365; Wu JJ, 1997, J CLIN MICROBIOL, V35, P1460, DOI 10.1128/JCM.35.6.1460-1464.1997	17	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13374	10.1371/journal.pone.0013374	http://dx.doi.org/10.1371/journal.pone.0013374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976282	gold, Green Submitted, Green Published			2022-12-25	WOS:000282941000013
J	Goni, F; Prelli, F; Ji, Y; Scholtzova, H; Yang, J; Sun, YJ; Liang, FX; Kascsak, R; Kascsak, R; Mehta, P; Wisniewski, T				Goni, Fernando; Prelli, Frances; Ji, Yong; Scholtzova, Henrieta; Yang, Jing; Sun, Yanjie; Liang, Feng-Xia; Kascsak, Regina; Kascsak, Richard; Mehta, Pankaj; Wisniewski, Thomas			Immunomodulation Targeting Abnormal Protein Conformation Reduces Pathology in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							FAMILIAL BRITISH DEMENTIA; AMYLOID BETA-PROTEIN; TRANSGENIC MICE; PRECURSOR-PROTEIN; PRESENILIN-1 TRANSGENES; FIBRIL FORMATION; PEPTIDE; IMMUNIZATION; OLIGOMERS; VACCINATION	Many neurodegenerative diseases are characterized by the conformational change of normal self-proteins into amyloidogenic, pathological conformers, which share structural properties such as high beta-sheet content and resistance to degradation. The most common is Alzheimer's disease (AD) where the normal soluble amyloid beta (sA beta) peptide is converted into highly toxic oligomeric A beta and fibrillar A beta that deposits as neuritic plaques and congophilic angiopathy. Currently, there is no highly effective treatment for AD, but immunotherapy is emerging as a potential disease modifying intervention. A major problem with most active and passive immunization approaches for AD is that both the normal sA beta and pathogenic forms are equally targeted with the potential of autoimmune inflammation. In order to avoid this pitfall, we have developed a novel immunomodulatory method that specifically targets the pathological conformations, by immunizing with polymerized British amyloidosis (pABri) related peptide which has no sequence homology to A beta or other human proteins. We show that the pA beta ri peptide through conformational mimicry induces a humoral immune response not only to the toxic A beta in APP/PS1 AD transgenic mice but also to paired helical filaments as shown on AD human tissue samples. Treated APP/PS1 mice had a cognitive benefit compared to controls (p<0.0001), associated with a reduction in the amyloid burden (p = 0.0001) and A beta 40/42 levels, as well as reduced A beta oligomer levels. This type of immunomodulation has the potential to be a universal beta-sheet disrupter, which could be useful for the prevention or treatment of a wide range of neurodegenerative diseases.	[Goni, Fernando; Prelli, Frances; Ji, Yong; Scholtzova, Henrieta; Yang, Jing; Sun, Yanjie; Wisniewski, Thomas] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Pathol, New York, NY USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Liang, Feng-Xia] NYU, Sch Med, Image Core Facil, New York, NY USA; [Kascsak, Regina; Kascsak, Richard; Mehta, Pankaj] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA; [Goni, Fernando] Univ Uruguay, Sch Chem, Dept Immunol, Montevideo, Uruguay	New York University; New York University; New York University; New York University; Institute for Basic Research in Developmental Disabilities; Universidad de la Republica, Uruguay	Goni, F (corresponding author), NYU, Sch Med, Dept Neurol, New York, NY 10016 USA.	Thomas.wisniewski@nyumc.org	Wisniewski, Thomas/Q-6525-2019	Wisniewski, Thomas/0000-0002-3379-8966; Prelli, Frances/0000-0002-8744-4151; Liang, Fengxia/0000-0003-0037-4590	National Institutes of Health [AG20245, AG08051, AG15408]; NATIONAL INSTITUTE ON AGING [P30AG008051, R01AG020245, R01AG015408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants: AG20245, AG08051 and AG15408. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Asuni AA, 2006, EUR J NEUROSCI, V24, P2530, DOI 10.1111/j.1460-9568.2006.05149.x; Dhenain M, 2006, MAGN RESON MED, V55, P687, DOI 10.1002/mrm.20810; Ghiso J, 2000, ANN NY ACAD SCI, V920, P84; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goni F, 2005, NEUROSCIENCE, V133, P413, DOI 10.1016/j.neuroscience.2005.02.031; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Ito K, 2009, CURR ALZHEIMER RES, V6, P132, DOI 10.2174/156720509787602889; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y; Josephs KA, 2008, NEUROLOGY, V70, P1850, DOI 10.1212/01.wnl.0000304041.09418.b1; KASCSAK RJ, 1993, DEV BIOL STAND, V80, P141; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert MP, 2009, CNS NEUROL DISORD-DR, V8, P65, DOI 10.2174/187152709787601876; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lublin AL, 2010, MT SINAI J MED, V77, P43, DOI 10.1002/msj.20160; Mamikonyan G, 2007, J BIOL CHEM, V282, P22376, DOI 10.1074/jbc.M700088200; McGowan E, 1999, NEUROBIOL DIS, V6, P231, DOI 10.1006/nbdi.1999.0243; Moretto N, 2007, J BIOL CHEM, V282, P11436, DOI 10.1074/jbc.M609690200; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morgan D, 2005, J NEUROPATH EXP NEUR, V64, P743, DOI 10.1097/01.jnen.0000178444.33972.e0; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Rostagno A, 2005, CELL MOL LIFE SCI, V62, P1814, DOI 10.1007/s00018-005-5092-5; Rostagno A, 2010, CELL MOL LIFE SCI, V67, P581, DOI 10.1007/s00018-009-0182-4; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Scholtzova H, 2008, J NEUROSCI RES, V86, P2784, DOI 10.1002/jnr.21713; Scholtzova H, 2009, J NEUROSCI, V29, P1846, DOI 10.1523/JNEUROSCI.5715-08.2009; Sigurdsson EM, 2004, J NEUROSCI, V24, P6277, DOI 10.1523/JNEUROSCI.1344-04.2004; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Srinivasan R, 2003, J MOL BIOL, V333, P1003, DOI 10.1016/j.jmb.2003.09.001; TOUMADJE A, 1992, ANAL BIOCHEM, V200, P321, DOI 10.1016/0003-2697(92)90473-K; van der Zee J, 2008, NEUROLOGY, V71, P1191, DOI 10.1212/01.wnl.0000327523.52537.86; Vidal R, 1999, NATURE, V399, P776; Vidal R, 2009, BRAIN PATHOL, V19, P58, DOI 10.1111/j.1750-3639.2008.00164.x; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wisniewski T, 2007, REV SCI TECH OIE, V26, P243, DOI 10.20506/rst.26.1.1739; WISNIEWSKI T, 1995, AM J PATHOL, V147, P238; Wisniewski T, 2010, BBA-MOL BASIS DIS, V1802, P847, DOI 10.1016/j.bbadis.2010.05.004; Wisniewski T, 2010, BRAIN STRUCT FUNCT, V214, P201, DOI 10.1007/s00429-009-0236-2	52	39	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13391	10.1371/journal.pone.0013391	http://dx.doi.org/10.1371/journal.pone.0013391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967130	Green Published, Green Submitted, gold			2022-12-25	WOS:000282869800050
J	Han, JA; Kubota, S; Uchida, H; Stanley, GD; Yao, XY; Shu, DG; Li, Y; Yasui, K				Han, Jian; Kubota, Shin; Uchida, Hiro-omi; Stanley, George D., Jr.; Yao, Xiaoyong; Shu, Degan; Li, Yong; Yasui, Kinya			Tiny Sea Anemone from the Lower Cambrian of China	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; PALEOZOIC CORALS; SOFT-TISSUE; CNIDARIA; EVOLUTION; ORIGINS; EXPRESSION; BIOTA; FOSSILIZATION; BILATERALITY	Background: Abundant fossils from the Ediacaran and Cambrian showing cnidarian grade grossly suggest that cnidarian diversification occurred earlier than that of other eumetazoans. However, fossils of possible soft-bodied polyps are scanty and modern corals are dated back only to the Middle Triassic, although molecular phylogenetic results support the idea that anthozoans represent the first major branch of the Cnidaria. Because of difficulties in taxonomic assignments owing to imperfect preservation of fossil cnidarian candidates, little is known about forms ancestral to those of living groups. Methods and Findings: We have analyzed the soft-bodied polypoid microfossils Eolympia pediculata gen. et sp. nov. from the lowest Cambrian Kuanchuanpu Formation in southern China by scanning electron microscopy and computer-aided microtomography after isolating fossils from sedimentary rocks by acetic acid maceration. The fossils, about a half mm in body size, are preserved with 18 mesenteries including directives bilaterally arranged, 18 tentacles and a stalk-like pedicle. The pedicle suggests a sexual life cycle, while asexual reproduction by transverse fission also is inferred by circumferential grooves on the body column. Conclusions: The features found in the present fossils fall within the morphological spectrum of modern Hexacorallia excluding Ceriantharia, and thus Eolympia pediculata could be a stem member for this group. The fossils also demonstrate that basic features characterizing modern hexacorallians such as bilateral symmetry and the reproductive system have deep roots in the Early Cambrian.	[Han, Jian; Yao, Xiaoyong; Shu, Degan] NW Univ Xian, State Key Lab Continental Dynam, Dept Geol, Early Life Inst, Xian 710069, Shaanxi, Peoples R China; [Kubota, Shin] Kyoto Univ, Seto Marine Biol Lab, Field Sci Educ & Res Ctr, Wakayama, Japan; [Uchida, Hiro-omi] Kushimoto Marine Pk Ctr, Wakayama, Japan; [Stanley, George D., Jr.] Univ Montana, Dept Geosci, Missoula, MT 59812 USA; [Li, Yong] Changan Univ, Key Lab Western Chinas Mineral Resources & Geol E, Sch Earth Sci & Land Resources, Xian, Shaanxi, Peoples R China; [Yasui, Kinya] Hiroshima Univ, Marine Biol Lab, Grad Sch Sci, Hiroshima, Japan	Northwest University Xi'an; Kyoto University; University of Montana System; University of Montana; Chang'an University; Hiroshima University	Han, JA (corresponding author), NW Univ Xian, State Key Lab Continental Dynam, Dept Geol, Early Life Inst, Xian 710069, Shaanxi, Peoples R China.	furaha@sci.hiroshima-u.ac.jp	Han, Jian/AAU-4500-2021	Han, Jian/0000-0002-2134-4078; yao, xiaoyong/0000-0002-9329-8955	National Science Foundation of China [40830208, 40602003, 50702005]; State Key Laboratory of Continental Dynamics, Northwest University, China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Continental Dynamics, Northwest University, China	Funding was provided by the National Science Foundation of China (http://www.nsfc.gov.cn/) grants 40830208, 40602003, 50702005 to J. Han and D. G. Shu, and by MOST Special Fund from the State Key Laboratory of Continental Dynamics, Northwest University, China (http://sklcd.nwu.edu.cn/) to J. Han and D. G. Shu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball EE, 2007, INTEGR COMP BIOL, V47, P701, DOI 10.1093/icb/icm028; Bengtson S, 2004, SCIENCE, V306; Bengtson S, 1997, SCIENCE, V277, P1645, DOI 10.1126/science.277.5332.1645; Berntson EA, 1999, MOL PHYLOGENET EVOL, V13, P417, DOI 10.1006/mpev.1999.0649; Berntson EA, 2001, MAR BIOL, V138, P235, DOI 10.1007/s002270000457; Briggs DEG, 2005, PALEOBIOLOGY, V31, P94, DOI 10.1666/0094-8373(2005)031[0094:WSSSGA]2.0.CO;2; BRIGGS DEG, 1993, SCIENCE, V259, P1439, DOI 10.1126/science.259.5100.1439; Cappola VA, 2000, J MAR BIOL ASSOC UK, V80, P995, DOI 10.1017/S0025315400003064; CARLGREN O, 1921, DAN INGOLF EXPED, V5, P3; Cartwright P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001121; CHEN CA, 1995, MOL PHYLOGENET EVOL, V4, P175, DOI 10.1006/mpev.1995.1017; Chen J.-y., 1991, P57; Chen JY, 2002, DEV BIOL, V248, P182, DOI 10.1006/dbio.2002.0714; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; Daly M, 2007, ZOOTAXA, P127, DOI 10.11646/zootaxa.1668.1.11; England K.W., 1987, B BR MUS NAT HIS Z, V53, P205; Ezaki Y, 1997, PALAEONTOLOGY, V40, P1; Fautin DG, 2002, CAN J ZOOL, V80, P1735, DOI 10.1139/Z02-133; Fedonkin M.A., 1981, T GEOLOGICHESKIY INS, V342, P1; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P15; Gudo M, 2002, LETHAIA, V35, P328, DOI 10.1080/002411602320790643; Hahn G., 1980, Senckenbergiana Lethaea, V60, P449; Hayward DC, 2002, P NATL ACAD SCI USA, V99, P8106, DOI 10.1073/pnas.112021499; Hicks M, 2006, J PALEONTOL, V80, P609, DOI 10.1666/0022-3360(2006)80[609:ANGOEC]2.0.CO;2; HILL D., 1981, TREATISE INVERTE F S, VI- XL, P1; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou XG, 2005, LETHAIA, V38, P193, DOI 10.1080/00241160510013295; Hyman L.H., 1940, INVERTEBRATES, V1; Jenkins RJF, 2002, J GEOL SOC LONDON, V159, P645, DOI 10.1144/0016-764901-127; Kayal E, 2008, GENE, V410, P177, DOI 10.1016/j.gene.2007.12.002; Liu AG, 2010, GEOLOGY, V38, P123, DOI 10.1130/G30368.1; Marques AC, 2004, INVERTEBR BIOL, V123, P23; Martindale MQ, 2009, DEV CELL, V17, P162, DOI 10.1016/j.devcel.2009.07.024; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103; MORRIS SC, 1993, PALAEONTOLOGY, V36, P593; NARBONNE GM, 1987, PALAEONTOLOGY, V30, P647; OLIVER JWA, 1996, PALAEONTOLOGY BIOL C, V1, P107; PETERSEN JJ, 1979, J NEMATOL, V11, P105; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Raff EC, 2006, P NATL ACAD SCI USA, V103, P5846, DOI 10.1073/pnas.0601536103; Raff EC, 2008, P NATL ACAD SCI USA, V105, P19360, DOI 10.1073/pnas.0810106105; ROBSON EA, 1971, J EXP BIOL, V55, P611; RUPPERT EE, 2004, INVERTEBRATE ZOOLOGY, P111; Saina M, 2009, P NATL ACAD SCI USA, V106, P18592, DOI 10.1073/pnas.0900151106; SCHCHERT P, 1993, Z ZOOLOGISCHE SYSTEM, V31, P161; Schmidt H., 1974, P 2 INT S COR REEFS, P533; Scrutton Colin, 1999, Geology Today, V15, P184, DOI 10.1046/j.1365-2451.1999.1505005.x; SCRUTTON CT, 1991, PALAEONTOLOGY, V34, P179; Scrutton CT, 1997, P YORKS GEOL SOC, V51, P177, DOI 10.1144/pygs.51.3.177; Seilacher Adolf, 2003, Paleontological Research, V7, P43, DOI 10.2517/prpsj.7.43; SHICK J. M., 1991, FUNCTIONAL BIOL SEA; Shu DG, 2006, SCIENCE, V312, P731, DOI 10.1126/science.1124565; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Steiner M, 2004, GEOBIOS-LYON, V37, P259, DOI 10.1016/j.geobios.2003.08.001; Steiner M, 2007, PALAEOGEOGR PALAEOCL, V254, P67, DOI 10.1016/j.palaeo.2007.03.046; Won JH, 2001, CORAL REEFS, V20, P39; Wood R., 1999, REEF EVOLUTION; Xiao SH, 2000, P NATL ACAD SCI USA, V97, P13684, DOI 10.1073/pnas.250491697	61	36	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13276	10.1371/journal.pone.0013276	http://dx.doi.org/10.1371/journal.pone.0013276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967244	gold, Green Published, Green Submitted			2022-12-25	WOS:000282869800010
J	Magri, C; Sacchetti, E; Traversa, M; Valsecchi, P; Gardella, R; Bonvicini, C; Minelli, A; Gennarelli, M; Barlati, S				Magri, Chiara; Sacchetti, Emilio; Traversa, Michele; Valsecchi, Paolo; Gardella, Rita; Bonvicini, Cristian; Minelli, Alessandra; Gennarelli, Massimo; Barlati, Sergio			New Copy Number Variations in Schizophrenia	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; SYNAPTIC PLASTICITY; MENTAL-RETARDATION; CANDIDATE GENE; HUMAN GENOME; ASSOCIATION; POLYMORPHISM; DISRUPTION; DELETIONS; VARIANTS	Genome-wide screenings for copy number variations (CNVs) in patients with schizophrenia have demonstrated the presence of several CNVs that increase the risk of developing the disease and a growing number of large rare CNVs; the contribution of these rare CNVs to schizophrenia remains unknown. Using Affymetrix 6.0 arrays, we undertook a systematic search for CNVs in 172 patients with schizophrenia and 160 healthy controls, all of Italian origin, with the aim of confirming previously identified loci and identifying novel schizophrenia susceptibility genes. We found five patients with a CNV occurring in one of the regions most convincingly implicated as risk factors for schizophrenia: NRXN1 and the 16p13.1 regions were found to be deleted in single patients and 15q11.2 in 2 patients, whereas the 15q13.3 region was duplicated in one patient. Furthermore, we found three distinct patients with CNVs in 2q12.2, 3q29 and 17p12 loci, respectively. These loci were previously reported to be deleted or duplicated in patients with schizophrenia but were never formally associated with the disease. We found 5 large CNVs (>900 kb) in 4q32, 5q14.3, 8q23.3, 11q25 and 17q12 in five different patients that could include some new candidate schizophrenia susceptibility genes. In conclusion, the identification of previously reported CNVs and of new, rare, large CNVs further supports a model of schizophrenia that includes the effect of multiple, rare, highly penetrant variants.	[Magri, Chiara; Traversa, Michele; Gardella, Rita; Gennarelli, Massimo; Barlati, Sergio] Univ Brescia, Sch Med, Dept Biomed Sci & Technol, Div Biol & Genet, Brescia, Italy; [Sacchetti, Emilio; Valsecchi, Paolo] Brescia Spedali Civili, Dept Mental Hlth, Brescia, Italy; [Sacchetti, Emilio; Valsecchi, Paolo] Univ Brescia, Sch Med, Univ Psychiat Unit, Brescia, Italy; [Sacchetti, Emilio; Barlati, Sergio] Univ Brescia, Ctr Behav & Neurodegenerat Disorders, Brescia, Italy; [Sacchetti, Emilio; Barlati, Sergio] EULO, Brescia, Italy; [Bonvicini, Cristian; Minelli, Alessandra; Gennarelli, Massimo] IRCCS San Giovanni di Dio, Genet Unit, Brescia, Italy	University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; University of Brescia; IRCCS Fatebenefratelli	Magri, C (corresponding author), Univ Brescia, Sch Med, Dept Biomed Sci & Technol, Div Biol & Genet, Brescia, Italy.	sacchett@med.unibs.it; barlati@med.unibs.it	Gennarelli, Massimo/B-1377-2010; Bonvicini, Cristian/G-4427-2011; Magri, Chiara/I-4691-2017; Gennarelli, Massimo/AAL-3542-2020; Barlati, Sergio/A-2666-2010; Minelli, Alessandra/ABI-2890-2020	Bonvicini, Cristian/0000-0003-1577-2823; Magri, Chiara/0000-0001-9933-8666; Minelli, Alessandra/0000-0002-9463-7808; SACCHETTI, EMILIO/0000-0003-0700-5173; GENNARELLI, Massimo/0000-0003-4192-945X	Health Authority of the Lombardia Region [153]; Center of Behavioural and Neurodegenerative Disordes; IDET Centre of Excellence	Health Authority of the Lombardia Region; Center of Behavioural and Neurodegenerative Disordes; IDET Centre of Excellence	The study was supported by the Health Authority of the Lombardia Region (Project 153) (www.sanita.regione.lombardia.it) together with grants from the Center of Behavioural and Neurodegenerative Disordes and IDET Centre of Excellence (www.unibs.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; *APS, 2000, DIAGN STAT MAN DIS; Barlati S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-49; Bassett AS, 2010, AM J PSYCHIAT, V167, P899, DOI 10.1176/appi.ajp.2009.09071016; Bonvicini C, 2010, PSYCHIAT GENET, V20, P44, DOI 10.1097/YPG.0b013e3283351167; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; FIRST MB, 1996, STRUCTURAL CLIN INTE; Floris C, 2008, EUR J HUM GENET, V16, P696, DOI 10.1038/ejhg.2008.7; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Ikeda M, 2010, BIOL PSYCHIAT, V67, P283, DOI 10.1016/j.biopsych.2009.08.034; Jeffries AR, 2003, MOL PSYCHIATR, V8, P654, DOI 10.1038/sj.mp.4001382; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kirov G, 2010, EXPERT REV NEUROTHER, V10, P25, DOI [10.1586/ern.09.133, 10.1586/ERN.09.133]; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Lau WL, 2003, GENOMICS, V82, P412, DOI 10.1016/S0888-7543(03)00149-6; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Masuda T, 2009, BRAIN RES, V1249, P61, DOI 10.1016/j.brainres.2008.10.028; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Sacchetti E, 2007, BRAIN BEHAV IMMUN, V21, P450, DOI 10.1016/j.bbi.2006.11.009; Sato J, 2008, J NEURAL TRANSM, V115, P1355, DOI 10.1007/s00702-008-0085-9; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shimizu A, 2003, BIOCHEM BIOPH RES CO, V309, P143, DOI 10.1016/S0006-291X(03)01555-9; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tam GWC, 2009, BIOL PSYCHIAT, V66, P1005, DOI 10.1016/j.biopsych.2009.07.027; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wagenstaller J, 2007, AM J HUM GENET, V81, P768, DOI 10.1086/521274; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200	37	71	73	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13422	10.1371/journal.pone.0013422	http://dx.doi.org/10.1371/journal.pone.0013422			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967226	gold, Green Published, Green Submitted			2022-12-25	WOS:000282869800052
J	Hiratsuka, T; Matsuzaki, S; Miyata, S; Kinoshita, M; Kakehi, K; Nishida, S; Katayama, T; Tohyama, M				Hiratsuka, Toru; Matsuzaki, Shinsuke; Miyata, Shingo; Kinoshita, Mitsuhiro; Kakehi, Kazuaki; Nishida, Shinji; Katayama, Taiichi; Tohyama, Masaya			Yokukansan Inhibits Neuronal Death during ER Stress by Regulating the Unfolded Protein Response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRADITIONAL JAPANESE MEDICINE; ALZHEIMERS-DISEASE; FERULIC ACID; PSYCHOLOGICAL SYMPTOMS; SIGNALING PATHWAY; CHOLINESTERASE-INHIBITORS; OXIDATIVE STRESS; MESSENGER-RNA; IMMUNOTHERAPY	Background: Recently, several studies have reported Yokukansan (Tsumura TJ-54), a traditional Japanese medicine, as a potential new drug for the treatment of Alzheimer's disease (AD). Endoplasmic reticulum (ER) stress is known to play an important role in the pathogenesis of AD, particularly in neuronal death. Therefore, we examined the effect of Yokukansan on ER stress-induced neurotoxicity and on familial AD-linked presenilin-1 mutation-associated cell death. Methods: We employed the WST-1 assay and monitored morphological changes to evaluate cell viability following Yokukansan treatment or treatment with its components. Western blotting and PCR were used to observe the expression levels of GRP78/BiP, caspase-4 and C/EBP homologous protein. Results: Yokukansan inhibited neuronal death during ER stress, with Cnidii Rhizoma (Senkyu), a component of Yokukansan, being particularly effective. We also showed that Yokukansan and Senkyu affect the unfolded protein response following ER stress and that these drugs inhibit the activation of caspase-4, resulting in the inhibition of ER stress-induced neuronal death. Furthermore, we found that the protective effect of Yokukansan and Senkyu against ER stress could be attributed to the ferulic acid content of these two drugs. Conclusions: Our results indicate that Yokukansan, Senkyu and ferulic acid are protective against ER stress-induced neuronal cell death and may provide a possible new treatment for AD.	[Hiratsuka, Toru; Matsuzaki, Shinsuke; Miyata, Shingo; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka, Japan; [Matsuzaki, Shinsuke; Katayama, Taiichi; Tohyama, Masaya] Hamamatsu Univ Sch Med, Suita, Osaka, Japan; [Matsuzaki, Shinsuke; Katayama, Taiichi; Tohyama, Masaya] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Suita, Osaka, Japan; [Matsuzaki, Shinsuke; Miyata, Shingo; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Suita, Osaka, Japan; [Kinoshita, Mitsuhiro; Kakehi, Kazuaki] Kinki Univ, Sch Pharmaceut Sci, Lab Biopharmaco Informat, Higashiosaka, Osaka 577, Japan; [Nishida, Shinji] Osaka Univ, Grad Sch Med, Dept Kampo Med, Suita, Osaka, Japan	Osaka University; Kanazawa University; Osaka University; Osaka University; Kindai University (Kinki University); Osaka University	Hiratsuka, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka, Japan.	s-matsuzaki@anat2.med.osaka-u.ac.jp		Hiratsuka, Toru/0000-0002-5359-2690	Health Labour Sciences Research Grant; Ministry of Education, Science, Sports and Culture; Global COE project	Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by the Global COE project, by Health Labour Sciences Research Grant, by Grant-in-Aid for Young Scientists(B) and by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid KAKENHI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbel M, 2007, CURR ALZHEIMER RES, V4, P437, DOI 10.2174/156720507781788792; Balasubashini MS, 2004, PHYTOTHER RES, V18, P310, DOI 10.1002/ptr.1440; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Getsios D, 2007, PHARMACOECONOMICS, V25, P997, DOI 10.2165/00019053-200725120-00003; Giacobini E, 2007, J ALZHEIMERS DIS, V12, P37; Hayashi H, 2005, BIOL PHARM BULL, V28, P744, DOI 10.1248/bpb.28.744; He LM, 2002, BRAIN RES, V939, P65, DOI 10.1016/S0006-8993(02)02549-0; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hutton M, 2004, NEURON, V43, P293, DOI 10.1016/j.neuron.2004.07.023; IIZUKA S, 2010, NEUROPATHOL IN PRESS; Ikarashi Y, 2009, BIOL PHARM BULL, V32, P1701, DOI 10.1248/bpb.32.1701; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; Katayama T, 2001, J BIOL CHEM, V276, P43446, DOI 10.1074/jbc.M104096200; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kawabata K, 2000, CANCER LETT, V157, P15, DOI 10.1016/S0304-3835(00)00461-4; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Manabe T, 2003, CELL DEATH DIFFER, V10, P698, DOI 10.1038/sj.cdd.4401221; Matsuzaki S, 2004, J NEUROCHEM, V88, P1345, DOI 10.1111/j.1471-4159.2004.02290.x; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Mizukami K, 2009, INT J NEUROPSYCHOPH, V12, P191, DOI 10.1017/S146114570800970X; Monji A, 2009, PROG NEURO-PSYCHOPH, V33, P308, DOI 10.1016/j.pnpbp.2008.12.008; MUKHOPADHYAY A, 1982, AGENTS ACTIONS, V12, P508, DOI 10.1007/BF01965935; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Pereira C, 2004, J MOL NEUROSCI, V23, P97, DOI 10.1385/JMN:23:1-2:097; Picone P, 2009, FREE RADICAL RES, V43, P1133, DOI 10.1080/10715760903214454; Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Sato N, 1999, J NEUROCHEM, V72, P2498, DOI 10.1046/j.1471-4159.1999.0722498.x; Sato N, 2001, J BIOL CHEM, V276, P2108, DOI 10.1074/jbc.M006886200; Sekiguchi K, 2009, PHYTOTHER RES, V23, P1175, DOI 10.1002/ptr.2777; Seltzer B, 2007, DRUG AGING, V24, P881, DOI 10.2165/00002512-200724110-00001; Shinno H, 2008, PROG NEURO-PSYCHOPH, V32, P1749, DOI 10.1016/j.pnpbp.2008.06.015; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Sigurdsson EM, 2008, J ALZHEIMERS DIS, V15, P157; Solomon B, 2007, CURR OPIN MOL THER, V9, P79; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Sultana R, 2005, J NEUROCHEM, V92, P749, DOI 10.1111/j.1471-4159.2004.02899.x; Sun XD, 2003, NEUROBIOL DIS, V14, P567, DOI 10.1016/j.nbd.2003.08.007; Tateno M, 2008, PROG NEURO-PSYCHOPH, V32, P1704, DOI 10.1016/j.pnpbp.2008.07.006; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Wang X, 2007, NEUROSCIENCE, V144, P1045, DOI 10.1016/j.neuroscience.2006.10.008; Yan JJ, 2001, BRIT J PHARMACOL, V133, P89, DOI 10.1038/sj.bjp.0704047; Yogeeta SK, 2006, BASIC CLIN PHARMACOL, V98, P467, DOI 10.1111/j.1742-7843.2006.pto_335.x; Yu MS, 2006, APOPTOSIS, V11, P687, DOI 10.1007/s10495-006-5540-1; Yukioka F, 2008, NEUROCHEM INT, V52, P683, DOI 10.1016/j.neuint.2007.08.017	49	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13280	10.1371/journal.pone.0013280	http://dx.doi.org/10.1371/journal.pone.0013280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967273	Green Submitted, Green Published, gold			2022-12-25	WOS:000282807300015
J	Pecarevic, M; Danoff-Burg, J; Dunn, RR				Pecarevic, Marko; Danoff-Burg, James; Dunn, Robert R.			Biodiversity on Broadway - Enigmatic Diversity of the Societies of Ants (Formicidae) on the Streets of New York City	PLOS ONE			English	Article							HYMENOPTERA; ECOLOGY; URBANIZATION; HABITAT; FRAGMENTATION; CONSERVATION; COMMUNITIES; ASSEMBLAGES	Each year, a larger proportion of the Earth's surface is urbanized, and a larger proportion of the people on Earth lives in those urban areas. The everyday nature, however, that humans encounter in cities remains poorly understood. Here, we consider perhaps the most urban green habitat, street medians. We sampled ants from forty-four medians along three boulevards in New York City and examined how median properties affect the abundance and species richness of native and introduced ants found on them. Ant species richness varied among streets and increased with area but was independent of the other median attributes measured. Ant assemblages were highly nested, with three numerically dominant species present at all medians and additional species present at a subset of medians. The most common ant species were the introduced Pavement ant (Tetramorium caespitum) and the native Thief ant (Solenopsis molesta) and Cornfield ant (Lasius neoniger). The common introduced species on the medians responded differently to natural and disturbed elements of medians. Tetramorium caespitum was most abundant in small medians, with the greatest edge/area ratio, particularly if those medians had few trees, whereas Nylanderia flavipes was most abundant in the largest medians, particularly if they had more trees. Many of the species encountered in Manhattan were similar to those found in other large North American cities, such that a relatively small subset of ant species probably represent most of the encounters humans have with ants in North America.	[Pecarevic, Marko; Danoff-Burg, James] Columbia Univ, Dept Ecol Evolut & Environm Biol E3B, New York, NY 10027 USA; [Pecarevic, Marko] State Inst Nat Protect, Zagreb, Croatia; [Danoff-Burg, James] Columbia Univ, CEES, New York, NY USA; [Dunn, Robert R.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Dunn, Robert R.] N Carolina State Univ, Keck Behav Biol Ctr, Raleigh, NC 27695 USA	Columbia University; Columbia University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Pecarevic, M (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol E3B, New York, NY 10027 USA.	marko.pecarevic@gmail.com	Dunn, Robert/B-1360-2013	Danoff-Burg, James/0000-0002-0685-6948; Dunn, Robert/0000-0002-6030-4837	United States Department of Energy (DOE) National Institute for Climatic Change Research (DOE-NICCR); DOE [DE-FG02-08ER64510]; National Science Foundation (NSF); National Aeronautics and Space Administration (NASA) [NNX09AK22G]; Office Of The Director [0809267] Funding Source: National Science Foundation	United States Department of Energy (DOE) National Institute for Climatic Change Research (DOE-NICCR)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	RRD was supported by a United States Department of Energy (DOE) National Institute for Climatic Change Research (DOE-NICCR) grant, DOE Program for Ecosystem Research (DOE-PER) grant (DE-FG02-08ER64510), a National Science Foundation (NSF) Career grant and a National Aeronautics and Space Administration (NASA) Biodiversity grant (NNX09AK22G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso Leeanne E., 2000, P80; Andersen AN, 2002, J APPL ECOL, V39, P8, DOI 10.1046/j.1365-2664.2002.00704.x; Anderson D.R., 2008, MODEL BASED INFERENC; Angold PG, 2006, SCI TOTAL ENVIRON, V360, P196, DOI 10.1016/j.scitotenv.2005.08.035; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; ATMAR W, 1995, NESTEDNESS TEMPERATU; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Bestelmeyer Brandon T., 2000, P122; BIERREGAARD RO, 1992, BIOSCIENCE, V42, P859, DOI 10.2307/1312085; Bruhl CA, 2003, BIODIVERS CONSERV, V12, P1371, DOI 10.1023/A:1023621609102; BUCZKOWSKI G, 2010, BIOL INVASIONS, P1387; Chawla L., 1998, J ENVIRON EDUC, V29, P11, DOI [DOI 10.1080/00958969809599114, 10.1080/00958969809599114]; Chawla L., 1999, J ENVIRON EDUC, V31, P15, DOI [10.1080/00958969909598628, DOI 10.1080/00958969909598628]; Clarke Kevin M., 2008, Urban Ecosystems, V11, P317, DOI 10.1007/s11252-008-0065-8; Cohn JP, 2005, BIOSCIENCE, V55, P201, DOI 10.1641/0006-3568(2005)055[0201:UW]2.0.CO;2; Collingwood CA, 1997, J ARID ENVIRON, V37, P505, DOI 10.1006/jare.1997.0309; Colwell R.K., 2009, ESTIMATE S STAT ESTI; COPE R, 2006, UNDERSTANDING SPREAD; Crawley M. J, 2002, STAT COMPUTING INTRO; de Bruyn LAL, 1999, AGR ECOSYST ENVIRON, V74, P425, DOI 10.1016/S0167-8809(99)00047-X; Dunn RR, 2010, ANT ECOLOGY, P38; Dunn RR, 2006, CONSERV BIOL, V20, P1814, DOI 10.1111/j.1523-1739.2006.00533.x; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; FRANKIE GW, 1978, ANNU REV ENTOMOL, V23, P367, DOI 10.1146/annurev.en.23.010178.002055; Friedrich R, 2009, ENVIRON ENTOMOL, V38, P600, DOI 10.1603/022.038.0311; Guenard B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011614; HERBERT RA, 1965, AUK, V82, P62; Holldobler B., 1990, pi; Holldobler B, 1994, JOURNEY ANTS; Ivanov K, 2008, P ENTOMOL SOC WASH, V110, P439, DOI 10.4289/07-046.1; Kaspari M, 2000, AM NAT, V155, P280, DOI 10.1086/303313; Klotz J., 2008, URBAN ANTS N AM EURO; KLOTZ JH, 1995, FLA ENTOMOL, V78, P109, DOI 10.2307/3495674; KONDOH M, 1984, Journal of UOEH, V6, P221; LaPolla JS, 2010, SYST ENTOMOL, V35, P118, DOI 10.1111/j.1365-3113.2009.00492.x; Lassau SA, 2004, ECOGRAPHY, V27, P157, DOI 10.1111/j.0906-7590.2004.03675.x; Lessard JP, 2009, INSECT SOC, V56, P149, DOI 10.1007/s00040-009-0006-4; Lessard JP, 2005, CAN ENTOMOL, V137, P215, DOI 10.4039/N04-055; Louv R, 2008, LAST CHILD WOODS SAV; MAC ARTHUR ROBERT H., 1967; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McIntyre NE., 2000, URBAN ECOSYST, V4, P5, DOI [10.1023/A:1009540018553, DOI 10.1023/A:1009540018553]; Mehtala J, 2006, TRENDS ECOL EVOL, V21, P116, DOI 10.1016/j.tree.2005.12.001; Menke SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009194; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Na Julie P.S., 2001, Tropical Biomedicine, V18, P1; Nelder MP, 2006, J MED ENTOMOL, V43, P1094, DOI 10.1603/0022-2585(2006)43[1094:EOTIAP]2.0.CO;2; Niemela J, 1999, BIODIVERS CONSERV, V8, P119, DOI 10.1023/A:1008817325994; NUHN TP, 1979, AM MIDL NAT, V102, P353, DOI 10.2307/2424662; Pauchard A, 2006, BIOL CONSERV, V127, P272, DOI 10.1016/j.biocon.2005.05.015; Peck SL, 1998, ENVIRON ENTOMOL, V27, P1102, DOI 10.1093/ee/27.5.1102; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; PLOWES N, 2008, SELF ORG CONFLICT TE; Plowes RM, 2007, BIOL INVASIONS, V9, P825, DOI 10.1007/s10530-006-9084-7; REBELE F, 1994, GLOBAL ECOL BIOGEOGR, V4, P173, DOI 10.2307/2997649; Sanford MP, 2009, CONSERV BIOL, V23, P131, DOI 10.1111/j.1523-1739.2008.01040.x; *SAS I INC, 1989, JMP 7; Savard JPL, 2000, LANDSCAPE URBAN PLAN, V48, P131, DOI 10.1016/S0169-2046(00)00037-2; Schaefer V., 2003, GREEN LINKS URBAN BI; Schultz Ted R., 2000, P35; SIMBERLOFF D, 1976, ECOLOGY, V57, P629, DOI 10.2307/1936179; Small EC, 2002, J INSECT CONSERV, V6, P233, DOI 10.1023/A:1024491111572; Smith RM, 2006, BIODIVERS CONSERV, V15, P2415, DOI 10.1007/s10531-004-5014-0; Sokal R. R, 1981, BIOMETRY; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Talbot M, 1934, ECOLOGY, V15, P416, DOI 10.2307/1932358; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; Thompson Bill, 2007, Urban Ecosystems, V10, P43, DOI 10.1007/s11252-006-0013-4; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P76, DOI 10.1093/aesa/81.1.76; UN, 2008, WORLD URB PROSP 2007; Weisman A., 2008, WORLD US; WERNER FG, 1994, INSECTS SW IDENTIFY; Whittaker R. J., 1998, ISLAND BIOGEOGRAPHY; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Yamaguchi T, 2005, ENTOMOL SCI, V8, P17, DOI 10.1111/j.1479-8298.2005.00096.x	75	43	47	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13222	10.1371/journal.pone.0013222	http://dx.doi.org/10.1371/journal.pone.0013222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957156	Green Published, Green Submitted, gold			2022-12-25	WOS:000282506100016
J	Seinen, E; Burgerhof, JGM; Jansen, RC; Sibon, OCM				Seinen, Erwin; Burgerhof, Johannes G. M.; Jansen, Ritsert C.; Sibon, Ody C. M.			RNAi Experiments in D. melanogaster: Solutions to the Overlooked Problem of Off-Targets Shared by Independent dsRNAs	PLOS ONE			English	Article							MESSENGER-RNA; LONG DSRNAS; HUMAN-CELLS; INTERFERENCE; DROSOPHILA; MICRORNAS; NUCLEUS; SCREENS; SIRNA; MIRNA	Background: RNAi technology is widely used to downregulate specific gene products. Investigating the phenotype induced by downregulation of gene products provides essential information about the function of the specific gene of interest. When RNAi is applied in Drosophila melanogaster or Caenorhabditis elegans, often large dsRNAs are used. One of the drawbacks of RNAi technology is that unwanted gene products with sequence similarity to the gene of interest can be down regulated too. To verify the outcome of an RNAi experiment and to avoid these unwanted off-target effects, an additional non-overlapping dsRNA can be used to down-regulate the same gene. However it has never been tested whether this approach is sufficient to reduce the risk of off-targets. Methodology: We created a novel tool to analyse the occurance of off-target effects in Drosophila and we analyzed 99 randomly chosen genes. Principal Findings: Here we show that nearly all genes contain non-overlapping internal sequences that do show overlap in a common off-target gene. Conclusion: Based on our in silico findings, off-target effects should not be ignored and our presented on-line tool enables the identification of two RNA interference constructs, free of overlapping off-targets, from any gene of interest.	[Seinen, Erwin; Sibon, Ody C. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Radiat & Stress Cell Biol, Groningen, Netherlands; [Burgerhof, Johannes G. M.] Univ Groningen, Univ Med Ctr Groningen, Fac Med Sci, Groningen, Netherlands; [Jansen, Ritsert C.] Univ Groningen, Groningen Bioinformat Ctr, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands	University of Groningen; University of Groningen; University of Groningen	Seinen, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Radiat & Stress Cell Biol, Groningen, Netherlands.	o.c.m.sibon@med.umcg.nl	Jansen, Ritsert C/C-1160-2013; Burgerhof, Johannes G/B-2455-2013	Jansen, Ritsert C/0000-0003-2977-9110; Burgerhof, Johannes G/0000-0003-3827-9601; Sibon, Ody/0000-0002-6836-6063	Netherlands Organization for Scientific Research (NWO) [971-36-400]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a VIDI grant from the Netherlands Organization for Scientific Research (NWO; 971-36-400) to O.C.M.S. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosher JM, 1999, GENETICS, V153, P1245; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Langlois MA, 2005, J BIOL CHEM, V280, P16949, DOI 10.1074/jbc.M501591200; Lin SL, 2008, FRONT BIOSCI-LANDMRK, V13, P2216, DOI 10.2741/2836; Lin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/26818; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Moffat J, 2007, TRENDS PHARMACOL SCI, V28, P149, DOI 10.1016/j.tips.2007.02.009; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Qiu S, 2005, NUCLEIC ACIDS RES, V33, P1834, DOI 10.1093/nar/gki324; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Weinberg MS, 2007, NUCLEIC ACIDS RES, V35, P7303, DOI 10.1093/nar/gkm847	25	13	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13119	10.1371/journal.pone.0013119	http://dx.doi.org/10.1371/journal.pone.0013119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957038	Green Submitted, Green Published, gold			2022-12-25	WOS:000282359300017
J	Bakhti, M; Winter, C; Simons, M				Bakhti, Mostafa; Winter, Christine; Simons, Mikael			Inhibition of Myelin Membrane Sheath Formation by Oligodendrocyte-derived Exosome-like Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; FYN TYROSINE KINASE; CNS MYELINATION; PREMYELINATING OLIGODENDROCYTES; PRECURSOR DIFFERENTIATION; MAMMALIAN TARGET; CELL; REMYELINATION; ACTIVATION; BIOLOGY	Myelin formation is a multistep process that is controlled by a number of different extracellular factors. During the development of the central nervous system (CNS), oligodendrocyte progenitor cells differentiate into mature oligodendrocytes that start to enwrap axons with myelin membrane sheaths after receiving the appropriate signal(s) from the axon or its microenvironment. The signals required to initiate this process are unknown. Here, we show that oligodendrocytes secrete small membrane vesicles, exosome-like vesicles, into the extracellular space that inhibit both the morphological differentiation of oligodendrocytes and myelin formation. The inhibitory effects of exosome-like vesicles were prevented by treatment with inhibitors of actomyosin contractility. Importantly, secretion of exosome-like vesicles from oligodendrocytes was dramatically reduced when cells were incubated by conditioned neuronal medium. In conclusion, our results provide new evidence for small and diffusible oligodendroglial-derived vesicular carriers within the extracellular space that have inhibitory properties on cellular growth. We propose that neurons control the secretion of autoinhibitory oligodendroglial-derived exosomes to coordinate myelin membrane biogenesis.	Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Winter, Christine; Simons, Mikael] Univ Gottingen, Dept Neurol, D-37075 Gottingen, Germany	Max Planck Society; University of Gottingen	Simons, M (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37073 Gottingen, Germany.	msimons@gwdg.de		Bakhti, Mostafa/0000-0002-2307-1122; Simons, Mikael/0000-0001-5329-192X	European Research Council; EMBO; Deutsche Forschungsgemeinshaft through the DFG-Research Center for Molecular Physiology of the Brain, CMPB [FZT 103]	European Research Council(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinshaft through the DFG-Research Center for Molecular Physiology of the Brain, CMPB(German Research Foundation (DFG))	This work was supported by an European Research Council starting grant, the EMBO Young Investigator Program YIP and by the Deutsche Forschungsgemeinshaft through the DFG-Research Center for Molecular Physiology of the Brain, CMPB (FZT 103) (to M. S.).	Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Camara J, 2009, J CELL BIOL, V185, P699, DOI 10.1083/jcb.200807010; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Charles P, 2000, P NATL ACAD SCI USA, V97, P7585, DOI 10.1073/pnas.100076197; Chong SYC, 2010, J CELL BIOL, V188, P305, DOI 10.1083/jcb.200905111; Dugas JC, 2007, J NEUROSCI, V27, P6185, DOI 10.1523/JNEUROSCI.0628-07.2007; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Fitzner D, 2006, EMBO J, V25, P5037, DOI 10.1038/sj.emboj.7601376; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Forrest AD, 2009, J NEUROSCI RES, V87, P3456, DOI 10.1002/jnr.22022; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Goto J, 2008, MOL CELL NEUROSCI, V38, P203, DOI 10.1016/j.mcn.2008.02.009; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Kippert A, 2007, J NEUROSCI, V27, P3560, DOI 10.1523/JNEUROSCI.4926-06.2007; Kippert A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-71; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kramer-Albers EM, 2007, PROTEOM CLIN APPL, V1, P1446, DOI 10.1002/prca.200700522; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Rajasekharan S, 2009, DEVELOPMENT, V136, P415, DOI 10.1242/dev.018234; Relucio J, 2009, J NEUROSCI, V29, P11794, DOI 10.1523/JNEUROSCI.0888-09.2009; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Robinson S, 1999, DEV BIOL, V216, P359, DOI 10.1006/dbio.1999.9466; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Thery C., 2009, NAT REV IMMUNOL; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Wang PS, 2009, J BIOL CHEM, V284, P33692, DOI 10.1074/jbc.M109.061770; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19162, DOI 10.1073/pnas.0902834106	48	160	168	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					787	796		10.1074/jbc.M110.190009	http://dx.doi.org/10.1074/jbc.M110.190009			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978131	Green Published, hybrid			2022-12-25	WOS:000285782800078
J	Jiang, XH; Bai, Y; Rider, P; Kim, K; Zhang, CY; Lu, SW; Liu, FY				Jiang, Xiaohong; Bai, Yong; Rider, Paul; Kim, Kihoon; Zhang, Chen-Yu; Lu, Sangwei; Liu, Fenyong			Engineered External Guide Sequences Effectively Block Viral Gene Expression and Replication in Cultured Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SEQUENCES; HUMAN RIBONUCLEASE-P; IN-VITRO SELECTION; HUMAN CYTOMEGALOVIRUS; EFFECTIVE INHIBITION; ESCHERICHIA-COLI; MESSENGER-RNA; HAIRPIN RIBOZYME; ENZYME; CLEAVAGE	Ribonuclease P (RNase P) complexed with external guide sequence (EGS) represents a novel nucleic acid-based gene interference approach to modulate gene expression. We have previously used an in vitro selection procedure to generate EGS variants that efficiently direct human RNase P to cleave a target mRNA in vitro. In this study, a variant was used to target the mRNA encoding the protease of human cytomegalovirus (HCMV), which is essential for viral capsid formation and replication. The EGS variant was about 35-fold more active in inducing human RNase P to cleave the mRNA in vitro than the EGS derived from a natural tRNA. Moreover, a reduction of 95% in the expression of the protease and a reduction of 4,000-fold in viral growth were observed in HCMV-infected cells that expressed the EGS variant, whereas a reduction of 80% in the protease expression and an inhibition of 150-fold in viral growth were detected in cells that expressed the EGS derived from a natural tRNA sequence. No significant reduction in viral protease expression or viral growth was observed in cells that either did not express an EGS or produced a "disabled" EGS, which carried nucleotide mutations that precluded RNase P recognition. Our results provide direct evidence that engineered EGS variant is highly effective in blocking HCMV expression and growth by targeting the viral protease. Furthermore, these results demonstrate the utility of engineered EGS RNAs in gene targeting applications, including the inhibition of HCMV infection by blocking the expression of virus-encoded essential proteins.	[Jiang, Xiaohong; Rider, Paul; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Bai, Yong; Kim, Kihoon; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA; [Jiang, Xiaohong; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Nanjing University	Lu, SW (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	sangwei@berkeley.edu; liu_fy@uclink4.berkeley.edu			National Institutes of Health [AI041927, DE014842]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants AI041927 and DE014842.	Bai Y, 2010, P NATL ACAD SCI USA, V107, P7269, DOI 10.1073/pnas.0912813107; Bertrand E, 1997, RNA, V3, P75; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Daftarian PM, 1996, J IMMUNOL, V157, P12; Donahue CP, 1997, RNA, V3, P961; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Fedor MJ, 2000, J MOL BIOL, V297, P269, DOI 10.1006/jmbi.2000.3560; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gopalan V, 2002, J BIOL CHEM, V277, P6759, DOI 10.1074/jbc.R100067200; Gopalan V., 2006, RNA WORLD, V277; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kawa D, 1998, RNA, V4, P1397, DOI 10.1017/S1355838298980918; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Kraus G, 2002, P NATL ACAD SCI USA, V99, P3406, DOI 10.1073/pnas.052651199; Li HJ, 2006, RNA, V12, P63, DOI 10.1261/rna.2184706; Liu FY, 2010, PROTEIN REV, V10, P257, DOI 10.1007/978-1-4419-1142-1_14; LIU FY, 1994, CELL, V77, P1093, DOI 10.1016/0092-8674(94)90448-0; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; Marvin MC, 2009, J CELL BIOCHEM, V108, P1244, DOI 10.1002/jcb.22367; MATUSICKKUMAR L, 1994, J VIROL, V68, P5384, DOI 10.1128/JVI.68.9.5384-5394.1994; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Plehn-Dujowich D, 1998, P NATL ACAD SCI USA, V95, P7327, DOI 10.1073/pnas.95.13.7327; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; Robbins PD, 1998, PHARMACOL THERAPEUT, V80, P35, DOI 10.1016/S0163-7258(98)00020-5; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; Trang P, 2000, P NATL ACAD SCI USA, V97, P5812, DOI 10.1073/pnas.100101797; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Wang J, 2000, RNA, V6, P571, DOI 10.1017/S1355838200992215; WELCH AR, 1991, P NATL ACAD SCI USA, V88, P10792, DOI 10.1073/pnas.88.23.10792; Yadava RS, 2004, RNA, V10, P863, DOI 10.1261/rna.5234204; Yu XK, 2005, P NATL ACAD SCI USA, V102, P7103, DOI 10.1073/pnas.0408826102; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; ZAUG AJ, 1995, RNA, V1, P363; Zhou TH, 2002, J BIOL CHEM, V277, P30112, DOI 10.1074/jbc.M200183200; Zhu JM, 2004, P NATL ACAD SCI USA, V101, P9073, DOI 10.1073/pnas.0403164101	45	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					322	330		10.1074/jbc.M110.158857	http://dx.doi.org/10.1074/jbc.M110.158857			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980254	Green Published, hybrid			2022-12-25	WOS:000285782800035
J	Offman, MN; Krol, M; Silman, I; Sussman, JL; Futerman, AH				Offman, Marc N.; Krol, Marcin; Silman, Israel; Sussman, Joel L.; Futerman, Anthony H.			Molecular Basis of Reduced Glucosylceramidase Activity in the Most Common Gaucher Disease Mutant, N370S	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BETA-GLUCOSIDASE; LYSOSOMAL STORAGE DISORDERS; X-RAY-STRUCTURE; PHARMACOLOGICAL CHAPERONES; ENZYME THERAPY; IMINOSUGAR ISOFAGOMINE; REPLACEMENT THERAPY; DEFECTIVE ENZYME; GLUCOCEREBROSIDASE; MUTATIONS	Gaucher disease is caused by the defective activity of the lysosomal hydrolase, glucosylceramidase. Although the x-ray structure of wild type glucosylceramidase has been resolved, little is known about the structural features of any of the > 200 mutations. Various treatments for Gaucher disease are available, including enzyme replacement and chaperone therapies. The latter involves binding of competitive inhibitors at the active site to enable correct folding and transport of the mutant enzyme to the lysosome. We now use molecular dynamics, a set of structural analysis tools, and several statistical methods to determine the flexible behavior of the N370S Gaucher mutant at various pH values, with and without binding the chaperone, N-butyl-deoxynojirimycin. We focus on the effect of the chaperone on the whole protein, on the active site, and on three important structural loops, and we demonstrate how the chaperone modifies the behavior of N370S in such a way that it becomes more active at lysosomal pH. Our results suggest a mechanism whereby the binding of N-butyl-deoxynojirimycin helps target correctly folded glucosylceramidase to the lysosome, contributes to binding with saposin C, and explains the initiation of the substrate-enzyme complex. Such analysis provides a new framework for determination of the structure of other Gaucher disease mutants and suggests new approaches for rational drug design.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Silman, Israel] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sussman, Joel L.] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Krol, Marcin] Jagiellonian Univ, Dept Bioinformat & Telemed, Coll Med, PL-31531 Krakow, Poland	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Jagiellonian University; Collegium Medicum Jagiellonian University		tony.futerman@weizmann.ac.il		Sussman, Joel/0000-0003-0306-3878; Futerman, Anthony/0000-0003-0013-0115	Minerva postdoctoral fellowship	Minerva postdoctoral fellowship	Supported by a Minerva postdoctoral fellowship.	Alfonso P, 2005, BLOOD CELL MOL DIS, V35, P268, DOI 10.1016/j.bcmd.2005.05.007; Alfonso P, 2004, BLOOD CELL MOL DIS, V32, P218, DOI 10.1016/j.bcmd.2003.10.010; Atrian S, 2008, PROTEINS, V70, P882, DOI 10.1002/prot.21554; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Beutler E, 2004, PLOS MED, V1, P118, DOI 10.1371/journal.pmed.0010021; Brumshtein B, 2007, J BIOL CHEM, V282, P29052, DOI 10.1074/jbc.M705005200; Brumshtein B, 2006, ACTA CRYSTALLOGR D, V62, P1458, DOI 10.1107/S0907444906038303; Brumshtein B, 2010, GLYCOBIOLOGY, V20, P24, DOI 10.1093/glycob/cwp138; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Case D.A., 2006, AMBER VERSION 9, V9; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Chang HH, 2006, FEBS J, V273, P4082, DOI 10.1111/j.1742-4658.2006.05410.x; Damborsky Jiri, 2007, Biotechnology Journal, V2, P62, DOI 10.1002/biot.200600208; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; de Fost M, 2006, BLOOD CELL MOL DIS, V36, P53, DOI 10.1016/j.bcmd.2005.08.004; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Frisch M., 2016, GAUSSIAN 16 REVISION; Futerman A.H., 2006, GAUCHER DIS; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Grabowski GA, 2003, ANNU REV GENOM HUM G, V4, P403, DOI 10.1146/annurev.genom.4.070802.110415; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; GRABOWSKI GA, 1993, ADV HUM GENET, V21, P377; Hodanova K, 2003, EUR J HUM GENET, V11, P369, DOI 10.1038/sj.ejhg.5200974; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kacher Y, 2008, BIOL CHEM, V389, P1361, DOI 10.1515/BC.2008.163; Kornhaber GJ, 2008, CHEMBIOCHEM, V9, P2643, DOI 10.1002/cbic.200800249; Lee R E, 1982, Prog Clin Biol Res, V95, P177; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Lieberman RL, 2009, BIOCHEMISTRY-US, V48, P4816, DOI 10.1021/bi9002265; Lin H, 2004, BBA-MOL BASIS DIS, V1689, P219, DOI 10.1016/j.bbadis.2004.03.007; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; Liou B, 2009, MOL GENET METAB, V97, P65, DOI 10.1016/j.ymgme.2009.01.006; Luan Z, 2009, CHEMBIOCHEM, V10, P2780, DOI 10.1002/cbic.200900442; Mezei M, 1997, J COMPUT CHEM, V18, P812, DOI 10.1002/(SICI)1096-987X(19970430)18:6<812::AID-JCC6>3.0.CO;2-V; Mitsui J, 2009, ARCH NEUROL-CHICAGO, V66, P571, DOI 10.1001/archneurol.2009.72; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Montfort M, 2004, HUM MUTAT, V23, P567, DOI 10.1002/humu.20043; Offman MN, 2006, BIOINFORMATICS, V22, P1838, DOI 10.1093/bioinformatics/btl192; Pastores GM, 2003, EXPERT OPIN INV DRUG, V12, P273, DOI 10.1517/13543784.12.2.273; PASTORES GM, 1993, BLOOD, V82, P408; Platt FM, 2005, ADV EXP MED BIOL, V564, P117; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Rosenbloom BE, 2005, BLOOD, V105, P4569, DOI 10.1182/blood-2004-12-4672; Salvioli R, 2005, BIOCHEM J, V390, P95, DOI 10.1042/BJ20050325; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; SHIRAN A, 1993, CANCER, V72, P219, DOI 10.1002/1097-0142(19930701)72:1<219::AID-CNCR2820720139>3.0.CO;2-Y; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Steet R, 2007, BIOCHEM PHARMACOL, V73, P1376, DOI 10.1016/j.bcp.2006.12.015; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Vaccaro AM, 1997, J BIOL CHEM, V272, P16862, DOI 10.1074/jbc.272.27.16862; Wang GN, 2009, J MED CHEM, V52, P3146, DOI 10.1021/jm801506m; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wilkening G, 1998, J BIOL CHEM, V273, P30271, DOI 10.1074/jbc.273.46.30271; Yu ZQ, 2007, J MED CHEM, V50, P94, DOI 10.1021/jm060677i; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104; Zimran A, 2005, BLOOD CELL MOL DIS, V34, P197, DOI 10.1016/j.bcmd.2005.03.004	65	30	32	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42105	42114		10.1074/jbc.M110.172098	http://dx.doi.org/10.1074/jbc.M110.172098			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20980259	hybrid, Green Published			2022-12-25	WOS:000285622600095
J	Ryu, MH; Moskvin, OV; Siltberg-Liberles, J; Gomelsky, M				Ryu, Min-Hyung; Moskvin, Oleg V.; Siltberg-Liberles, Jessica; Gomelsky, Mark			Natural and Engineered Photoactivated Nucleotidyl Cyclases for Optogenetic Applications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANYLYL CYCLASE; SWISS-MODEL; ADENYLYL; DOMAIN; LIGHT; ENVIRONMENT; INHIBITION; MECHANISMS; NEURONS; GENES	Cyclic nucleotides, cAMP and cGMP, are ubiquitous second messengers that regulate metabolic and behavioral responses in diverse organisms. We describe purification, engineering, and characterization of photoactivated nucleotidyl cyclases that can be used to manipulate cAMP and cGMP levels in vivo. We identified the blaC gene encoding a putative photoactivated adenylyl cyclase in the Beggiatoa sp. PS genome. BlaC contains a BLUF domain involved in blue-light sensing using FAD and a nucleotidyl cyclase domain. The blaC gene was overexpressed in Escherichia coli, and its product was purified. Irradiation of BlaC in vitro resulted in a small red shift in flavin absorbance, typical of BLUF photoreceptors. BlaC had adenylyl cyclase activity that was negligible in the dark and upregulated by light by 2 orders of magnitude. To convert BlaC into a guanylyl cyclase, we constructed a model of the nucleotidyl cyclase domain and mutagenized several residues predicted to be involved in substrate binding. One triple mutant, designated BlgC, was found to have photoactivated guanylyl cyclase in vitro. Irradiation with blue light of the E. coli cya mutant expressing BlaC or BlgC resulted in the significant increases in cAMP or cGMP synthesis, respectively. BlaC, but not BlgC, restored cAMP-dependent growth of the mutant in the presence of light. Small protein sizes, negligible activities in the dark, high light-to-dark activation ratios, functionality at broad temperature range and physiological pH, as well as utilization of the naturally occurring flavins as chromophores make BlaC and BlgC attractive for optogenetic applications in various animal and microbial models.	[Ryu, Min-Hyung; Moskvin, Oleg V.; Siltberg-Liberles, Jessica; Gomelsky, Mark] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Wyoming	Siltberg-Liberles, J (corresponding author), Univ Wyoming, Dept Mol Biol, 1000 E Univ Ave,Dept 3944, Laramie, WY 82071 USA.	jliberle@uwyo.edu; gomelsky@uwyo.edu	gomelsky, mark/F-6209-2010; Moskvin, Oleg/C-5916-2015	Moskvin, Oleg/0000-0003-1499-8900; Gomelsky, Mark/0000-0003-4077-3932	National Institutes of Health [RR016474-09]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by National Institutes of Health 2P20 Grant RR016474-09.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Briggs WR, 2007, J BIOMED SCI, V14, P499, DOI 10.1007/s11373-007-9162-6; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gille A, 2004, J BIOL CHEM, V279, P19955, DOI 10.1074/jbc.M312560200; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Liu X, 2010, CELL, V141, P22, DOI 10.1016/j.cell.2010.03.019; Losi A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1168, DOI 10.1039/b802472c; Lucas KA, 2000, PHARMACOL REV, V52, P375; Masuda S, 2005, FEBS LETT, V579, P4329, DOI 10.1016/j.febslet.2005.06.069; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; Nagahama T, 2007, NEUROSCI RES, V59, P81, DOI 10.1016/j.neures.2007.05.015; Ntefidou M, 2006, PHOTOCHEM PHOTOBIOL, V82, P1601, DOI 10.1562/2006-04-06-RA-867; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603; Sjulson L, 2008, CHEM REV, V108, P1588, DOI 10.1021/cr078221b; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993	44	154	162	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41501	41508		10.1074/jbc.M110.177600	http://dx.doi.org/10.1074/jbc.M110.177600			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21030591	Green Published, hybrid			2022-12-25	WOS:000285622600036
J	Sudiarta, IP; Fukushima, T; Sekiguchi, J				Sudiarta, I. Putu; Fukushima, Tatsuya; Sekiguchi, Junichi			Bacillus subtilis CwlP of the SP-beta Prophage Has Two Novel Peptidoglycan Hydrolase Domains, Muramidase and Cross-linkage Digesting DD-Endopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG-WHITE LYSOZYME; GLYCYLGLYCINE ENDOPEPTIDASE; STAPHYLOCOCCUS-AUREUS; CELL-SEPARATION; CRYSTAL-STRUCTURES; GOOSE LYSOZYME; GENE-PRODUCT; COMPLEX; LYSOSTAPHIN; RESOLUTION	For bacteria and bacteriophages, cell wall digestion by hydrolases is a very important event. We investigated one of the proteins involved in cell wall digestion, the yomI gene product (renamed CwlP). The gene is located in the SP-beta prophage region of the Bacillus subtilis chromosome. Inspection of the Pfam database indicates that CwlP contains soluble lytic transglycosylase (SLT) and peptidase M23 domains, which are similar to Escherichia coli lytic transglycosylase Slt70, and the Staphylococcus aureus Gly-Gly endopeptidase LytM, respectively. The SLT domain of CwlP exhibits hydrolytic activity toward the B. subtilis cell wall; however, reverse phase (RP)HPLC and mass spectrometry revealed that the CwlP-SLT domain has only muramidase activity. In addition, the peptidase M23 domain of CwlP exhibited hydrolytic activity and could cleave D-Ala-diaminopimelic acid cross-linkage, a property associated with DD-endopeptidases. Remarkably, the M23 domain of CwlP possessed a unique Zn2+ -independent endopeptidase activity; this contrasts with all other characterized M23 peptidases (and enzymes similar to CwlP), which are Zn2+ dependent. Both domains of CwlP could hydrolyze the peptidoglycan and cell wall of B. subtilis. However, the M23 domain digested neither the peptidoglycans nor the cell walls of S. aureus or Streptococcus thermophilus. The effect of defined point mutations in conserved amino acid residues of CwlP is also determined.	[Sudiarta, I. Putu] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Ueda, Nagano 3868567, Japan; [Fukushima, Tatsuya; Sekiguchi, Junichi] Shinshu Univ, Res Ctr Human & Environm Sci, Dept Life Sci, Div Gene Res, Ueda, Nagano 3868567, Japan	Shinshu University; Shinshu University	Sekiguchi, J (corresponding author), Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, 3-15-1 Tokida, Ueda, Nagano 3868567, Japan.	jsekigu@shinshu-u.ac.jp		Sudiarta, I Putu/0000-0003-1381-388X	New Energy and Industrial Technology Department Organization (NEDO); Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [19380047];  [22248008];  [21780067]	New Energy and Industrial Technology Department Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; 	This work was supported by Grants-in-Aid for Scientific Research (B) (19380047) and (A) (22248008), and grants from the New Energy and Industrial Technology Department Organization (NEDO) (to J.S.), a Grant-in-Aid for Young Scientists (21780067) (to T.F.), and the Global COE programs (to J.S., T.F., and I.P.S.) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bochtler M, 2004, PROTEIN SCI, V13, P854, DOI 10.1110/ps.03515704; Cohen DN, 2009, J MOL BIOL, V387, P607, DOI 10.1016/j.jmb.2009.02.001; DEHART HP, 1995, APPL ENVIRON MICROB, V61, P1475, DOI 10.1128/AEM.61.4.1475-1479.1995; FEIN JE, 1976, J BACTERIOL, V127, P1427, DOI 10.1128/JB.127.3.1427-1442.1976; Firczuk M, 2005, J MOL BIOL, V354, P578, DOI 10.1016/j.jmb.2005.09.082; Foster S.J., 2002, BACILLUS SUBTILIS IT, P21; Fujiwara T, 2005, J BACTERIOL, V187, P480, DOI 10.1128/JB.187.2.480-487.2005; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; Fukushima T, 2008, J BIOL CHEM, V283, P11117, DOI 10.1074/jbc.M706626200; Fukushima T, 2007, MOL GENET GENOMICS, V278, P371, DOI 10.1007/s00438-007-0255-8; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; GRUTTER MG, 1983, NATURE, V303, P828, DOI 10.1038/303828a0; Hirakawa H, 2008, J BIOCHEM, V144, P753, DOI 10.1093/jb/mvn133; Horsburgh GJ, 2003, J BACTERIOL, V185, P3813, DOI 10.1128/JB.185.13.3813-3820.2003; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Kumar JK, 2008, APPL MICROBIOL BIOT, V80, P555, DOI 10.1007/s00253-008-1579-y; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; Layec S, 2009, MOL MICROBIOL, V71, P1205, DOI 10.1111/j.1365-2958.2009.06595.x; LECLERC D, 1989, CAN J MICROBIOL, V35, P749, DOI 10.1139/m89-125; MALCOLM BA, 1989, P NATL ACAD SCI USA, V86, P133, DOI 10.1073/pnas.86.1.133; Matsumura I, 1996, BIOCHEMISTRY-US, V35, P1881, DOI 10.1021/bi951671q; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Ramadurai L, 1999, MICROBIOL-UK, V145, P801, DOI 10.1099/13500872-145-4-801; Regamey A, 1998, MICROBIOL-UK, V144, P885, DOI 10.1099/00221287-144-4-885; Sambrook J., 2002, MOL CLONING LAB MANU; Shida T, 2001, J BIOL CHEM, V276, P28140, DOI 10.1074/jbc.M103903200; Sugai M, 1997, J BACTERIOL, V179, P1193, DOI 10.1128/jb.179.4.1193-1202.1997; THUNNISSEN AMWH, 1995, PROTEINS, V22, P245, DOI 10.1002/prot.340220305; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; Tong G, 1997, BIOCHEMISTRY-US, V36, P9859, DOI 10.1021/bi970495d; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7	36	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41232	41243		10.1074/jbc.M110.156273	http://dx.doi.org/10.1074/jbc.M110.156273			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20980266	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000285622600009
J	Chow, JY; Xue, B; Lee, KH; Tung, A; Wu, L; Robinson, RC; Yew, WS				Chow, Jeng Yeong; Xue, Bo; Lee, Kang Hao; Tung, Alvin; Wu, Long; Robinson, Robert C.; Yew, Wen Shan			Directed Evolution of a Thermostable Quorum-quenching Lactonase from the Amidohydrolase Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE; PROTON RELAY SYSTEM; ENZYMATIC-ACTIVITIES; STRUCTURAL BASIS; ACTIVE-SITE; 5-MONOPHOSPHATE DECARBOXYLASE; SUPRAFAMILY; PHOSPHOTRIESTERASE; PROMISCUITY; EXPRESSION	A thermostable quorum-quenching lactonase from Geobacillus kaustophilus HTA426 (GI: 56420041) was used as an initial template for in vitro directed evolution experiments. This enzyme belongs to the phosphotriesterase-like lactonase (PLL) group of enzymes within the amidohydrolase superfamily that hydrolyze N-acylhomoserine lactones (AHLs) that are involved in virulence pathways of quorum-sensing pathogenic bacteria. Here we have determined the N-butyryl-L-homoserine lactone-liganded structure of the catalytically inactive D266N mutant of this enzyme to a resolution of 1.6 angstrom. Using a tunable, bioluminescence-based quorum-quenching molecular circuit, the catalytic efficiency was enhanced, and the AHL substrate range increased through two point mutations on the loops at the C-terminal ends of the third and seventh beta-strands. This E101N/R230I mutant had an increased value of k(cat)/K-m of 72-fold toward 3-oxo-N-dodecanoyl-L-homoserine lactone. The evolved mutant also exhibited lactonase activity toward N-butyryl-L-homoserine lactone, an AHL that was previously not hydrolyzed by the wild-type enzyme. Both the purified wild-type and mutant enzymes contain a mixture of zinc and iron and are colored purple and brown, respectively, at high concentrations. The origin of this coloration is suggested to be because of a charge transfer complex involving the beta-cation and Tyr-99 within the enzyme active site. Modulation of the charge transfer complex alters the lactonase activity of the mutant enzymes and is reflected in enzyme coloration changes. We attribute the observed enhancement in catalytic reactivity of the evolved enzyme to favorable modulations of the active site architecture toward productive geometries required for chemical catalysis.	[Xue, Bo; Tung, Alvin; Robinson, Robert C.] Inst Mol & Cell Biol, Singapore 138673, Singapore; Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Robinson, RC (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	rrobinson@imcb.a-star.edu.sg; bchyws@nus.edu.sg	Robinson, Robert/G-9702-2011	Robinson, Robert/0000-0001-6367-6903; Xue, Bo/0000-0002-5172-2519	National Medical Research Council; National Research Foundation; Biomedical Research Council of A*STAR; National Research Program for Genomic Medicine	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation; Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR)); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Medical Research Council, the National Research Foundation, and the Biomedical Research Council of A*STAR.; We thank Professor Herbert Schweizer for providing the Tn7-based transposition materials. We thank the National Synchrotron Radiation Research Center, a facility supported by the National Science Council of Taiwan for provision of beam time and assistance in data collection. The Synchrotron Radiation Protein Crystallography Facility is supported by the National Research Program for Genomic Medicine.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Chapman E, 2002, BIOORGAN MED CHEM, V10, P551, DOI 10.1016/S0968-0896(01)00306-6; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Chow JY, 2009, BIOCHEMISTRY-US, V48, P4344, DOI 10.1021/bi9004045; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DAVIS JC, 1982, P NATL ACAD SCI-BIOL, V79, P4623, DOI 10.1073/pnas.79.15.4623; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Elias M, 2008, J MOL BIOL, V379, P1017, DOI 10.1016/j.jmb.2008.04.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X; Gerlt JA, 2009, CURR OPIN CHEM BIOL, V13, P10, DOI 10.1016/j.cbpa.2009.01.014; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hawwa R, 2009, ARCH BIOCHEM BIOPHYS, V488, P109, DOI 10.1016/j.abb.2009.06.005; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lindsay A, 2005, J BACTERIOL, V187, P5054, DOI 10.1128/JB.187.14.5054-5058.2005; Marti-Arbona R, 2005, BIOCHEMISTRY-US, V44, P7115, DOI 10.1021/bi050008r; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; PYRZ JW, 1986, J BIOL CHEM, V261, P1015; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Tawfik DS, 2006, SCIENCE, V311, P475, DOI 10.1126/science.1123883; Thoden JB, 2001, BIOCHEMISTRY-US, V40, P6989, DOI 10.1021/bi010682i; Vick JE, 2005, BIOCHEMISTRY-US, V44, P11722, DOI 10.1021/bi050963g; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wise EL, 2005, BIOCHEMISTRY-US, V44, P1816, DOI 10.1021/bi0478143; Wise EL, 2004, BIOCHEMISTRY-US, V43, P6438, DOI 10.1021/bi0497392; Xiang DF, 2009, BIOCHEMISTRY-US, V48, P2237, DOI 10.1021/bi802274f; Yew WS, 2005, BIOCHEMISTRY-US, V44, P1807, DOI 10.1021/bi047815v; Yew WS, 2002, J BACTERIOL, V184, P302, DOI 10.1128/JB.184.1.302-306.2002; Yew WS, 2004, BIOCHEMISTRY-US, V43, P6427, DOI 10.1021/bi049741t	36	60	61	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40911	40920		10.1074/jbc.M110.177139	http://dx.doi.org/10.1074/jbc.M110.177139			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20980257	hybrid, Green Published			2022-12-25	WOS:000285414400055
J	Davis, BM; Jensen, R; Williams, P; O'Shea, P				Davis, Benjamin Michael; Jensen, Rasmus; Williams, Paul; O'Shea, Paul			The Interaction of N-Acylhomoserine Lactone Quorum Sensing Signaling Molecules with Biological Membranes: Implications for Inter-Kingdom Signaling	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA AUTOINDUCER; N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; PHOSPHOLIPID-MEMBRANES; GENE-EXPRESSION; CELL-ACTIVATION; LIPID RAFTS; IN-VIVO; RECEPTORS	Background: The long chain N-acylhomoserine lactone (AHL) quorum sensing signal molecules released by Pseudomonas aeruginosa have long been known to elicit immunomodulatory effects through a process termed inter-kingdom signaling. However, to date very little is known regarding the exact mechanism of action of these compounds on their eukaryotic targets. Methodology/Principal Findings: The use of the membrane dipole fluorescent sensor di-8-ANEPPS to characterise the interactions of AHL quorum sensing signal molecules, N-(3-oxotetradecanoyl)-L-homoserine lactone (3-oxo-C14-HSL), N-(3-oxododecanoyl) homoserine-L-lactone (3-oxo-C12-HSL) and N-(3-oxodecanoyl) homoserine-L-lactone (3-oxo-C10 HSL) produced by Pseudomonas aeruginosa with model and cellular membranes is reported. The interactions of these AHLs with artificial membranes reveal that each of the compounds is capable of membrane interaction in the micromolar concentration range causing significant modulation of the membrane dipole potential. These interactions fit simple hyperbolic binding models with membrane affinity increasing with acyl chain length. Similar results were obtained with T-lymphocytes providing the evidence that AHLs are capable of direct interaction with the plasma membrane. 3-oxo-C12-HSL interacts with lymphocytes via a cooperative binding model therefore implying the existence of an AHL membrane receptor. The role of cholesterol in the interactions of AHLs with membranes, the significance of modulating cellular dipole potential for receptor conformation and the implications for immune modulation are discussed. Conclusions/Significance: Our observations support previous findings that increasing AHL lipophilicity increases the immunomodulatory activity of these quorum compounds, while providing evidence to suggest membrane interaction plays an important role in quorum sensing and implies a role for membrane microdomains in this process. Finally, our results suggest the existence of a eukaryotic membrane-located system that acts as an AHL receptor.	[Davis, Benjamin Michael; O'Shea, Paul] Univ Nottingham, Inst Biophys Imaging & Opt Sci, Cell Biophys Grp, Nottingham NG7 2RD, England; [Jensen, Rasmus; Williams, Paul] Univ Nottingham, Ctr Biomol Sci, Sch Mol Med Sci, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Davis, BM (corresponding author), Univ Nottingham, Inst Biophys Imaging & Opt Sci, Cell Biophys Grp, Nottingham NG7 2RD, England.	paul.oshea@nottingham.ac.uk	Williams, Paul/A-5629-2011; Williams, Paul/P-5224-2019	Williams, Paul/0000-0002-1920-5036; Davis, Benjamin/0000-0001-6121-1635; O'Shea, paul/0000-0001-9313-8313	Engineering and Physical Sciences Research Council (EPSRC) [C534697]; UK national research council organizations; Medical Research Council (MRC) [G9219778]; MRC [G9219778] Funding Source: UKRI; Medical Research Council [G9219778] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK national research council organizations; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are grateful to the UK national research council organizations, the Engineering and Physical Sciences Research Council (EPSRC) [URL:www.EPSRC.ac.uk] (reference C534697) and the Medical Research Council (MRC) [URL: www.mrc.ac.uk] (reference G9219778) for support for much of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asawakarn T, 2001, J BIOL CHEM, V276, P38457, DOI 10.1074/jbc.M103269200; Balbis A, 2010, J CELL BIOCHEM, V109, P1103, DOI 10.1002/jcb.22505; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Charlton TS, 2000, ENVIRON MICROBIOL, V2, P530, DOI 10.1046/j.1462-2920.2000.00136.x; CHHABRA SR, 1993, J ANTIBIOT, V46, P441, DOI 10.7164/antibiotics.46.441; Chhabra SR, 2003, J MED CHEM, V46, P97, DOI 10.1021/jm020909n; Cladera J, 1998, BIOPHYS J, V74, P2434, DOI 10.1016/S0006-3495(98)77951-2; Cladera J, 1999, J BIOL CHEM, V274, P29951, DOI 10.1074/jbc.274.42.29951; Clarke RJ, 2001, ADV COLLOID INTERFAC, V89, P263, DOI 10.1016/S0001-8686(00)00061-0; Cooley M, 2008, CHEM BIOL, V15, P1141, DOI 10.1016/j.chembiol.2008.10.010; Demeule M, 2000, FEBS LETT, V466, P219, DOI 10.1016/S0014-5793(00)01087-5; Duggan J, 2008, EUR BIOPHYS J BIOPHY, V37, P1279, DOI 10.1007/s00249-008-0349-1; Ferte J, 2000, EUR J BIOCHEM, V267, P277, DOI 10.1046/j.1432-1327.2000.01046.x; Filipp D, 2004, MOL IMMUNOL, V41, P645, DOI 10.1016/j.molimm.2004.04.011; Gardiner SM, 2001, BRIT J PHARMACOL, V133, P1047, DOI 10.1038/sj.bjp.0704174; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Jahoor A, 2008, J BACTERIOL, V190, P4408, DOI 10.1128/JB.01444-07; Kaufmann GF, 2005, P NATL ACAD SCI USA, V102, P309, DOI 10.1073/pnas.0408639102; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Kravchenko VV, 2006, J BIOL CHEM, V281, P28822, DOI 10.1074/jbc.M606613200; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lowery CA, 2009, J AM CHEM SOC, V131, P14473, DOI 10.1021/ja9056079; Luker GD, 2001, J BIOL CHEM, V276, P49053, DOI 10.1074/jbc.M105192200; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; McKeegan KS, 2004, CURR OPIN PHARMACOL, V4, P479, DOI 10.1016/j.coph.2004.07.002; Middleton B, 2002, FEMS MICROBIOL LETT, V207, P1; O'Shea P, 2005, PHILOS T R SOC A, V363, P575, DOI 10.1098/rsta.2004.1509; O'Shea P, 2004, BIOELECTROCHEM P & P, V6, P23; O'Shea P, 2003, BIOCHEM SOC T, V31, P990; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Pritchard DI, 2006, INT J MED MICROBIOL, V296, P111, DOI 10.1016/j.ijmm.2006.01.037; Qazi S, 2006, INFECT IMMUN, V74, P910, DOI 10.1128/IAI.74.2.910-919.2006; Richardson G, 2007, BIOPHYS J, V92, P4145, DOI 10.1529/biophysj.106.090233; Ritchie AJ, 2007, IMMUNOL CELL BIOL, V85, P596, DOI 10.1038/sj.icb.7100090; Ritchie AJ, 2005, INFECT IMMUN, V73, P1648, DOI 10.1128/IAI.73.3.1648-1655.2005; Ritchie AJ, 2003, INFECT IMMUN, V71, P4421, DOI 10.1128/IAI.71.8.4421-4431.2003; Robert J, 2003, J MED CHEM, V46, P4805, DOI 10.1021/jm030183a; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; SEABRA R, 2008, CALCIUM BINDING PROT, V3, P31; Shiner EK, 2006, CELL MICROBIOL, V8, P1601, DOI 10.1111/j.1462-5822.2006.00734.x; Shiner Erin K, 2004, Biol Proced Online, V6, P268, DOI 10.1251/bpo98; Smith RS, 2002, J BACTERIOL, V184, P1132, DOI 10.1128/jb.184.4.1132-1139.2002; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003; Telford G, 1998, INFECT IMMUN, V66, P36, DOI 10.1128/IAI.66.1.36-42.1998; TEPLITSKI M, 2010, PERCEPTION DEGRADATI; Vikstrom E, 2009, EXP CELL RES, V315, P313, DOI 10.1016/j.yexcr.2008.10.044; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002; Zegers MMP, 1998, BIOCHEM J, V336, P257, DOI 10.1042/bj3360257	52	60	63	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13522	10.1371/journal.pone.0013522	http://dx.doi.org/10.1371/journal.pone.0013522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975958	Green Published, gold, Green Submitted			2022-12-25	WOS:000283216400026
J	Ramirez-Villegas, J; Khoury, C; Jarvis, A; Debouck, DG; Guarino, L				Ramirez-Villegas, Julian; Khoury, Colin; Jarvis, Andy; Gabriel Debouck, Daniel; Guarino, Luigi			A Gap Analysis Methodology for Collecting Crop Genepools: A Case Study with Phaseolus Beans	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; WILD RELATIVES; CLIMATE-CHANGE; SAMPLE-SIZE; CONSERVATION; DISTRIBUTIONS; PERFORMANCE; DIVERSITY; BIAS; PREDICTION	Background: The wild relatives of crops represent a major source of valuable traits for crop improvement. These resources are threatened by habitat destruction, land use changes, and other factors, requiring their urgent collection and long-term availability for research and breeding from ex situ collections. We propose a method to identify gaps in ex situ collections (i.e. gap analysis) of crop wild relatives as a means to guide efficient and effective collecting activities. Methodology/Principal Findings: The methodology prioritizes among taxa based on a combination of sampling, geographic, and environmental gaps. We apply the gap analysis methodology to wild taxa of the Phaseolus genepool. Of 85 taxa, 48 (56.5%) are assigned high priority for collecting due to lack of, or under-representation, in genebanks, 17 taxa are given medium priority for collecting, 15 low priority, and 5 species are assessed as adequately represented in ex situ collections. Gap "hotspots'', representing priority target areas for collecting, are concentrated in central Mexico, although the narrow endemic nature of a suite of priority species adds a number of specific additional regions to spatial collecting priorities. Conclusions/Significance: Results of the gap analysis method mostly align very well with expert opinion of gaps in ex situ collections, with only a few exceptions. A more detailed prioritization of taxa and geographic areas for collection can be achieved by including in the analysis predictive threat factors, such as climate change or habitat destruction, or by adding additional prioritization filters, such as the degree of relatedness to cultivated species (i.e. ease of use in crop breeding). Furthermore, results for multiple crop genepools may be overlaid, which would allow a global analysis of gaps in ex situ collections of the world's plant genetic resources.	[Ramirez-Villegas, Julian; Jarvis, Andy] Int Ctr Trop Agr CIAT, Decis & Policy Anal Program, Cali, Colombia; [Khoury, Colin; Guarino, Luigi] Global Crop Divers Trust, Rome, Italy; [Jarvis, Andy] Agr & Food Secur CCAFS, Challenge Program Climate Change, Copenhagen, Denmark; [Jarvis, Andy] Reg Off Amer, Cali, Colombia; [Gabriel Debouck, Daniel] Int Ctr Trop Agr CIAT, Genet Resources Unit, Cali, Colombia	Alliance; International Center for Tropical Agriculture - CIAT; Alliance; International Center for Tropical Agriculture - CIAT	Ramirez-Villegas, J (corresponding author), Int Ctr Trop Agr CIAT, Decis & Policy Anal Program, Cali, Colombia.	j.r.villegas@cgiar.org	Khoury, Colin K./AAA-1864-2020; Ramirez-Villegas, Julian/AAY-8073-2020; Jarvis, Andy/K-5516-2013	Khoury, Colin K./0000-0001-7893-5744; Ramirez-Villegas, Julian/0000-0002-8044-583X; Jarvis, Andy/0000-0001-6543-0798	Grains Research and Development Corporation (GRDC); System-wide Genetic Resources Program (SGRP) of Bioversity International; World Bank	Grains Research and Development Corporation (GRDC)(Grains R&D Corp); System-wide Genetic Resources Program (SGRP) of Bioversity International; World Bank(The World Bank India)	The Grains Research and Development Corporation (GRDC, http://www.grdc.com.au/), provided the initial funding that allowed the development of the methodology, and the gathering of input data. Global Public Goods Phase 2 of the System-wide Genetic Resources Program (SGRP) of Bioversity International (http://www.sgrp.cgiar.org/), provided part of the funding for the final phase of the project. The World Bank (http://www.worldbank.org/), likewise, provided part of the funding for the final phase of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gallegos JA, 2007, CROP SCI, V47, pS44, DOI 10.2135/cropsci2007.04.0008IPBS; [Anonymous], 2007, IPCC 4 ASS REP CLIM; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Burke MB, 2009, GLOBAL ENVIRON CHANG, V19, P317, DOI 10.1016/j.gloenvcha.2009.04.003; BURLE ML, 2003, PLANT GENETIC RESOUR, V135, P1; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Munoz LC, 2006, CROP SCI, V46, P1744, DOI 10.2135/cropsci2005-12-0475; Challinor AJ, 2007, AGR ECOSYST ENVIRON, V119, P190, DOI 10.1016/j.agee.2006.07.009; Costa GC, 2010, BIODIVERS CONSERV, V19, P883, DOI 10.1007/s10531-009-9746-8; Debouck D. G., 2000, The Seventh Ministry of Agriculture, Forestry and Fisheries (MAFF), Japan, International Workshop on Genetic Resources, Ibaraki, Japan, 13-15 October, 1999: Part 1, wild legumes., P95; Debouck D. G., 1995, EVOLUTION CROP PLANT, P287; Debouck D.G., 1999, COMMON BEAN IMPROVEM, P25, DOI DOI 10.1007/978-94-015-9211-6_2; DEBOUCK DG, 2009, CAHIERS PHASEOLOGIE; Delgado-Salinas A, 1999, SYST BOT, V24, P438, DOI 10.2307/2419699; Delgado-Salinas Alfonso, 2007, Lundellia, V10, P11; DELGADOSALINAS A, 1985, THESIS U TEXAS AUSTI, P363; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Food and Agriculture Organization of the United Nations (FAO), 1997, STAT WORLDS PLANT GE; Freytag G.F., 2002, TAXONOMY DISTRIBUTIO; GARVIN DF, 1994, CROP SCI, V34, P1390, DOI 10.2135/cropsci1994.0011183X003400050045x; Gepts P., 2001, ENCY GENET, P1444; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guralnick RP, 2006, PLOS BIOL, V4, P1908, DOI 10.1371/journal.pbio.0040381; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Hawkins B., 2008, PLANTS CLIMATE CHANG; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans R., 2002, ATLAS WILD POTATOES; Hijmans R.J., 2001, PLANT GENETIC RESOUR, V127, P15, DOI DOI 10.1016/j.compositesa.2008.10.018; Hijmans R.J., 2005, DIVAGIS VERSION 5 2; Hijmans RJ, 2001, AM J BOT, V88, P2101, DOI 10.2307/3558435; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Jarvis A, 2003, CROP SCI, V43, P1100, DOI 10.2135/cropsci2003.1100; JARVIS A, 2005, MOL EVOLUTION PROD B; JARVIS A, 2002, PLANT GENET RES NEWS, V131, P29; Jesus Salcedo C., 2009, Journal of the Botanical Research Institute of Texas, V3, P751; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jones PG, 1997, BIODIVERS CONSERV, V6, P947, DOI 10.1023/A:1018311513176; Khoury C, 2010, GENET RESOUR CROP EV, V57, P625, DOI 10.1007/s10722-010-9534-z; KIPENOLT JA, 1992, NEW PHYTOL, V120, P489, DOI 10.1111/j.1469-8137.1992.tb01797.x; Kornegay J., 1991, Common beans: research for crop improvement., P619; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Maxted N, 2009, 39 FAO UN COMM GEN R; Maxted N, 2008, DIVERS DISTRIB, V14, P1018, DOI 10.1111/j.1472-4642.2008.00512.x; Maxted N, 2006, BIODIVERS CONSERV, V15, P2673, DOI 10.1007/s10531-005-5409-6; McClean P, 2004, LEGUME CROP GENOMICS, P60; Meilleur BA, 2004, BIODIVERS CONSERV, V13, P663, DOI 10.1023/B:BIOC.0000011719.03230.17; Nabhan GP., 1990, SYSTEMATIC ECOGEOGRA, V5; PARTHASARATHY U, 2006, CURRENT SCI, V91; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Prescott-Allen C., 1986, 1 RESOURCE WILD SPEC; Salcedo J, 2006, NOVON, V16, P105, DOI 10.3417/1055-3177(2006)16[105:PNANSL]2.0.CO;2; SCHINKEL C, 1988, PLANT BREEDING, V101, P292, DOI 10.1111/j.1439-0523.1988.tb00301.x; Shellie-Dessert K. C., 1991, Common beans: research for crop improvement., P649; Singh RJ, 2005, GEN RESOUR CHROM ENG, V1, P1; Singh SP, 2001, CROP SCI, V41, P1659, DOI 10.2135/cropsci2001.1659; SMARTT J, 1981, EUPHYTICA, V30, P445, DOI 10.1007/BF00034009; Smolik MG, 2010, J BIOGEOGR, V37, P411, DOI 10.1111/j.1365-2699.2009.02227.x; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Termansen M, 2006, ECOL MODEL, V192, P410, DOI 10.1016/j.ecolmodel.2005.07.009; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; *UN FAO, 2009, 2 FAO UN; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	75	114	119	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13497	10.1371/journal.pone.0013497	http://dx.doi.org/10.1371/journal.pone.0013497			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976009	Green Published, Green Submitted, gold			2022-12-25	WOS:000283216400012
J	Liao, FL; Wang, L; Yang, LB; Peng, XB; Sun, MX				Liao, Fanglei; Wang, Lu; Yang, Li-Bo; Peng, Xiongbo; Sun, Mengxiang			NtGNL1 Plays an Essential Role in Pollen Tube Tip Growth and Orientation Likely via Regulation of Post-Golgi Trafficking	PLOS ONE			English	Article							LOCALIZED F-ACTIN; GNOM ARF-GEF; BREFELDIN-A; MEMBRANE TRAFFICKING; PLANT-CELLS; PREVACUOLAR COMPARTMENTS; ENDOPLASMIC-RETICULUM; VESICLE TRAFFICKING; AUXIN TRANSPORT; EXCHANGE FACTOR	Background: Tobacco GNOM LIKE 1 (NtGNL1), a new member of the Big/GBF family, is characterized by a sec 7 domain. Thus, we proposed that NtGNL1 may function in regulating pollen tube growth for vesicle trafficking. Methodology/Principal Findings: To test this hypothesis, we used an RNAi technique to down-regulate NtGNL1 expression and found that pollen tube growth and orientation were clearly inhibited. Cytological observations revealed that both timing and behavior of endocytosis was disrupted, and endosome trafficking to prevacuolar compartments (PVC) or multivesicular bodies (MVB) was altered in pollen tube tips. Moreover, NtGNL1 seemed to partially overlap with Golgi bodies, but clearly colocalized with putative late endosome compartments. We also observed that in such pollen tubes, the Golgi apparatus disassembled and fused with the endoplasmic reticulum, indicating abnormal post-Golgi trafficking. During this process, actin organization was also remodeled. Conclusions/Significance: Thus, we revealed that NtGNL1 is essential for pollen tube growth and orientation and it likely functions via stabilizing the structure of the Golgi apparatus and ensuring post-Golgi trafficking.	[Liao, Fanglei; Wang, Lu; Yang, Li-Bo; Peng, Xiongbo; Sun, Mengxiang] Wuhan Univ, Coll Life Sci, Key Lab Minist Educ Plant Dev Biol, Wuhan 430072, Peoples R China; [Liao, Fanglei] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China; [Wang, Lu] Chinese Acad Agr Sci, Tobacco Res Inst, Dept Biotechnol, Qingdao, Peoples R China	Wuhan University; Zhejiang Normal University; Chinese Academy of Agricultural Sciences; Tobacco Research Institute, CAAS	Liao, FL (corresponding author), Wuhan Univ, Coll Life Sci, Key Lab Minist Educ Plant Dev Biol, Wuhan 430072, Peoples R China.	mxsun@whu.edu.cn			Ministry of Science and Technology of China [2007CB947600, 2007CB108700]; NSFC [30821064, 31000139]; "111" project	Ministry of Science and Technology of China(Ministry of Science and Technology, China); NSFC(National Natural Science Foundation of China (NSFC)); "111" project(Ministry of Education, China - 111 Project)	This work was supported by the fund of Key Basic Theory Research of Ministry of Science and Technology of China (2007CB947600; 2007CB108700), NSFC (30821064,31000139) and the "111" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; Anders N, 2008, PLANT CELL, V20, P142, DOI 10.1105/tpc.107.056515; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; Bove J, 2008, PLANT PHYSIOL, V147, P1646, DOI 10.1104/pp.108.120212; Campanoni P, 2007, J EXP BOT, V58, P65, DOI 10.1093/jxb/erl059; Cardenas L, 2008, PLANT PHYSIOL, V146, P1611, DOI 10.1104/pp.107.113035; Chen T, 2007, PLANT CELL PHYSIOL, V48, P19, DOI 10.1093/pcp/pcl036; Cheung AY, 1996, TRENDS PLANT SCI, V1, P45, DOI 10.1016/S1360-1385(96)80028-8; Franklin-Tong VE, 2002, CURR OPIN PLANT BIOL, V5, P14, DOI 10.1016/S1369-5266(01)00217-5; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; GALWAY ME, 1993, J CELL SCI, V106, P847; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Gu Y, 2003, J EXP BOT, V54, P93, DOI 10.1093/jxb/54.380.93; Hanton SL, 2007, PLANT CELL REP, V26, P1431, DOI 10.1007/s00299-007-0390-z; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Kleine-Vehn J, 2008, CURR BIOL, V18, P526, DOI 10.1016/j.cub.2008.03.021; Lam SK, 2007, TRENDS PLANT SCI, V12, P497, DOI 10.1016/j.tplants.2007.09.001; Lowe SL, 1996, J CELL SCI, V109, P209; MAYER U, 1993, DEVELOPMENT, V117, P149; Moscatelli A, 2007, J CELL SCI, V120, P3804, DOI 10.1242/jcs.012138; Nakano RT, 2009, PLANT CELL, V21, P3672, DOI 10.1105/tpc.109.068270; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Parton RM, 2003, J CELL SCI, V116, P2707, DOI 10.1242/jcs.00468; Parton RM, 2001, J CELL SCI, V114, P2685; Richter S, 2007, NATURE, V448, P488, DOI 10.1038/nature05967; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Rockel N, 2008, PLANT J, V53, P133, DOI 10.1111/j.1365-313X.2007.03325.x; Saint-Jore CM, 2002, PLANT J, V29, P661, DOI 10.1046/j.0960-7412.2002.01252.x; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Sun MX, 2000, SEX PLANT REPROD, V12, P267; Tanaka H, 2009, CURR BIOL, V19, P391, DOI 10.1016/j.cub.2009.01.057; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Tse YC, 2004, PLANT CELL, V16, P672, DOI 10.1105/tpc.019703; Tse YC, 2006, PLANT PHYSIOL, V142, P1442, DOI 10.1104/pp.106.090423; TWELL D, 1990, DEVELOPMENT, V109, P705; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang L, 2008, NEW PHYTOL, V179, P81, DOI 10.1111/j.1469-8137.2008.02444.x; Wang QL, 2005, PLANT PHYSIOL, V139, P1692, DOI 10.1104/pp.105.069765; Wu G, 2000, PLANT PHYSIOL, V124, P1625, DOI 10.1104/pp.124.4.1625; Xiang Y, 2007, PLANT CELL, V19, P1930, DOI 10.1105/tpc.106.048413; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007	44	11	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13401	10.1371/journal.pone.0013401	http://dx.doi.org/10.1371/journal.pone.0013401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976165	Green Submitted, Green Published, gold			2022-12-25	WOS:000283043700007
J	Bornmann, L; Daniel, HD				Bornmann, Lutz; Daniel, Hans-Dieter			Do Author-Suggested Reviewers Rate Submissions More Favorably than Editor-Suggested Reviewers? A Study on Atmospheric Chemistry and Physics	PLOS ONE			English	Article							MODELING APPROACH; QUALITY; SCIENCE; CHOSEN; RECOMMENDATIONS; ARTICLES	Background: Ratings in journal peer review can be affected by sources of bias. The bias variable investigated here was the information on whether authors had suggested a possible reviewer for their manuscript, and whether the editor had taken up that suggestion or had chosen a reviewer that had not been suggested by the authors. Studies have shown that author-suggested reviewers rate manuscripts more favorably than editor-suggested reviewers do. Methodology/Principal Findings: Reviewers' ratings on three evaluation criteria and the reviewers' final publication recommendations were available for 552 manuscripts (in total 1145 reviews) that were submitted to Atmospheric Chemistry and Physics, an interactive open access journal using public peer review (authors' and reviewers' comments are publicly exchanged). Public peer review is supposed to bring a new openness to the reviewing process that will enhance its objectivity. In the statistical analysis the quality of a manuscript was controlled for to prevent favorable reviewers' ratings from being attributable to quality instead of to the bias variable. Conclusions/Significance: Our results agree with those from other studies that editor-suggested reviewers rated manuscripts between 30% and 42% less favorably than author-suggested reviewers. Against this backdrop journal editors should consider either doing without the use of author-suggested reviewers or, if they are used, bringing in more than one editor-suggested reviewer for the review process (so that the review by author-suggested reviewers can be put in perspective).	[Bornmann, Lutz] Max Planck Gesell, Off Res Anal & Foresight, Munich, Germany; [Daniel, Hans-Dieter] ETH, Zurich, Switzerland; [Daniel, Hans-Dieter] Univ Zurich, Evaluat Off, Zurich, Switzerland	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Bornmann, L (corresponding author), Max Planck Gesell, Off Res Anal & Foresight, Munich, Germany.	bornmann@gv.mpg.de	Daniel, Hans-Dieter/A-2419-2013; Bornmann, Lutz/A-3926-2008	Bornmann, Lutz/0000-0003-0810-7091	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The study was funded by the Max Planck Society. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Arkes HR, 2003, PSYCHOL SCI, V14, P1, DOI 10.1111/1467-9280.01410; BAILEY CW, 2005, OPEN ACCESS BIBLIO; Bingham CM, 1998, LANCET, V352, P441, DOI 10.1016/S0140-6736(97)11510-0; Bornmann L, 2010, LEARN PUBL, V23, P124, DOI 10.1087/20100207; BORNMANN L, 2010, RES EVALUAT, V19, P81; BORNMANN L, SCIENTOMETR IN PRESS; Bornmann L, 2008, J INFORMETR, V2, P280, DOI 10.1016/j.joi.2008.09.003; Bornmann L, 2009, RES EVALUAT, V18, P262, DOI 10.3152/095820209X477520; Bornmann L, 2009, LEARN PUBL, V22, P117, DOI 10.1087/2009207; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Budden AE, 2008, TRENDS ECOL EVOL, V23, P480, DOI 10.1016/j.tree.2008.06.004; Cole Stephen., 1991, OUTER CIRCLE WOMEN S, P205; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Craig ID, 2007, J INFORMETR, V1, P239, DOI 10.1016/j.joi.2007.04.001; *CYT SOFTW CORP, 2010, STATXACT VERS 9; Earnshaw JJ, 2000, ANN ROY COLL SURG, V82, P133; European Association for Chemical and Molecular Sciences (EuCheMS), 2006, ETH GUID PUBL J REV; Giesler E, 2001, SCIENTIST, V15, P35; Godlee F., 2003, PEER REV HLTH SCI, P91; GOLDSMITH LA, 2005, 5 INT C PEER REV BIO; Grimm D, 2005, SCIENCE, V309, P1974, DOI 10.1126/science.309.5743.1974; Hojat M, 2003, ADV HEALTH SCI EDUC, V8, P75, DOI 10.1023/A:1022670432373; Jayasinghe U. W., 2003, PEER REV ASSESSMENT; Jayasinghe UW, 2003, J R STAT SOC A STAT, V166, P279, DOI 10.1111/1467-985X.00278; Jayasinghe UW, 2001, EDUC EVAL POLICY AN, V23, P343, DOI 10.3102/01623737023004343; KOOP T, 2006, SYSTEMS OPEN 2 STAGE; LABAND DN, 1994, J POLIT ECON, V102, P194, DOI 10.1086/261927; LEE K, 2004, LOOK INSIDE BLACK BO; LINDSEY D, 1989, SCIENTOMETRICS, V15, P189, DOI 10.1007/BF02017198; Long J.S., 2006, REGRESSION MODELS CA; Long JS, 1997, REGRESSION MODELS CA; Nichols A, 2007, STATA J, V7, P507, DOI 10.1177/1536867X0700700403; Perlman D., 1987, SCI EXCELLENCE ORIGI, P204; PETERS DP, 1982, BEHAV BRAIN SCI, V5, P187, DOI 10.1017/S0140525X00011183; Poschl U, 2004, LEARN PUBL, V17, P105, DOI 10.1087/095315104322958481; Poschl Ulrich, 2010, LIBER Quarterly, V19, P293; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; RIVARA FP, 2007, J PEDIAT, V151; SCHARSCHMIDT BF, 1994, J CLIN INVEST, V93, P1877, DOI 10.1172/JCI117177; Schroter S, 2006, JAMA-J AM MED ASSOC, V295, P314, DOI 10.1001/jama.295.3.314; Smart Scott, 1996, 5460 NBER; StataCorp, 2019, STATA STAT SOFTWARE; Thorngate W, 2009, JUDGING MERIT, P1; TONKS A, 1995, BRIT MED J, V311, P210, DOI 10.1136/bmj.311.6999.210; vanRaan AFJ, 1996, SCIENTOMETRICS, V36, P397, DOI 10.1007/BF02129602; Wager E, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-13; Weller A, 2002, EDITORIAL PEER REV I; Ziman J, 1996, NATURE, V382, P751, DOI 10.1038/382751a0; 2007, BIF FUTURA, V22, P14	50	20	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13345	10.1371/journal.pone.0013345	http://dx.doi.org/10.1371/journal.pone.0013345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976226	Green Submitted, Green Published, gold			2022-12-25	WOS:000282941000005
J	Dupuis, L; Spreux-Varoquaux, O; Bensimon, G; Jullien, P; Lacomblez, L; Salachas, F; Bruneteau, GL; Pradat, PF; Loeffler, JP; Meininger, V				Dupuis, Luc; Spreux-Varoquaux, Odile; Bensimon, Gilbert; Jullien, Philippe; Lacomblez, Lucette; Salachas, Francois; Bruneteau, Gaelle; Pradat, Pierre-Francois; Loeffler, Jean-Philippe; Meininger, Vincent			Platelet Serotonin Level Predicts Survival in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							VIOLENT SUICIDE ATTEMPTERS; SPINAL-CORD; PROGNOSTIC-FACTORS; DEPRESSION; DISEASE; ALS; TRANSPORTER; FLUOXETINE; EXPRESSION; 5-HT1A	Background: Amyotrophic lateral sclerosis (ALS) is a life-threatening neurodegenerative disease involving upper and lower motor neurons loss. Clinical features are highly variable among patients and there are currently few known disease-modifying factors underlying this heterogeneity. Serotonin is involved in a range of functions altered in ALS, including motor neuron excitability and energy metabolism. However, whether serotoninergic activity represents a disease modifier of ALS natural history remains unknown. Methodology: Platelet and plasma unconjugated concentrations of serotonin and plasma 5-HIAA, the major serotonin metabolite, levels were measured using HPLC with coulometric detection in a cohort of 85 patients with ALS all followed-up until death and compared to a control group of 29 subjects. Principal Findings: Platelet serotonin levels were significantly decreased in ALS patients. Platelet serotonin levels did not correlate with disease duration but were positively correlated with survival of the patients. Univariate Cox model analysis showed a 57% decreased risk of death for patients with platelet serotonin levels in the normal range relative to patients with abnormally low platelet serotonin (p = 0.0195). This protective effect remained significant after adjustment with age, gender or site of onset in multivariate analysis. Plasma unconjugated serotonin and 5-HIAA levels were unchanged in ALS patients compared to controls and did not correlate with clinical parameters. Conclusions/Significance: The positive correlation between platelet serotonin levels and survival strongly suggests that serotonin influences the course of ALS disease.	[Dupuis, Luc; Loeffler, Jean-Philippe] INSERM, U692, Strasbourg, France; [Dupuis, Luc; Loeffler, Jean-Philippe] Univ Strasbourg, Strasbourg, France; [Spreux-Varoquaux, Odile] Fac Med Paris Ile France Ouest, Paris, France; [Spreux-Varoquaux, Odile] Univ Versailles St Quentin En Yvelines, Versailles, France; [Spreux-Varoquaux, Odile; Jullien, Philippe] Ctr Hosp Versailles, Le Chesnay, France; [Bensimon, Gilbert; Lacomblez, Lucette; Meininger, Vincent] Univ Paris 06, Paris, France; [Bensimon, Gilbert] CNRS, UMR 7211, Paris, France; [Bensimon, Gilbert] Hosp Pitie Salpetriere, AP HP, Serv Pharmacol Clin, Paris, France; [Lacomblez, Lucette; Salachas, Francois; Bruneteau, Gaelle; Pradat, Pierre-Francois; Meininger, Vincent] Ctr Referent Malad Rare SLA Hosp Pitie Salpetrier, AP HP, Dept Malad Syst Nerveux, Paris, France; [Lacomblez, Lucette] INSERM, U678, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Dupuis, L (corresponding author), INSERM, U692, Strasbourg, France.	ldupuis@unistra.fr	LOEFFLER, Jean-Philippe/AAS-4401-2020; Dupuis, Luc/A-6981-2012	Dupuis, Luc/0000-0002-0902-5824; BRUNETEAU, GAELLE/0000-0002-1905-7985	Amyotrophic Lateral Sclerosis Association [1698]; association pour la recherche sur la sclerose laterale amyotrophique (ARSla); Association Francaise contre les Myopathies (AFM); Teva Pharma; GSK; Trophos; Eisai; Novartis; Janssen-Cilag	Amyotrophic Lateral Sclerosis Association; association pour la recherche sur la sclerose laterale amyotrophique (ARSla); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Teva Pharma(Teva Pharmaceutical Industries); GSK(GlaxoSmithKline); Trophos; Eisai(Eisai Co Ltd); Novartis(Novartis); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Dr. Dupuis received research support from the Amyotrophic Lateral Sclerosis Association (Grant 1698, ALSA). Drs. Dupuis, Lacomblez, Pradat and Pr Meininger received support from the association pour la recherche sur la sclerose laterale amyotrophique (ARSla). Drs. Loeffler, Lacomblez and Pradat received research support from the Association Francaise contre les Myopathies (AFM). Pr Meininger received research support from Teva Pharma, GSK and Trophos. Dr. Lacomblez received research support from Trophos, Eisai, GSK, Novartis and Janssen-Cilag. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JC, 1999, BIOL PSYCHIAT, V45, P1066, DOI 10.1016/S0006-3223(98)00160-7; Alvarez JC, 1999, CLIN PHARMACOL THER, V66, P617; Alvarez JC, 1999, PSYCHOPHARMACOLOGY, V143, P97, DOI 10.1007/s002130050924; BERTEL O, 1991, BRAIN RES, V566, P54, DOI 10.1016/0006-8993(91)91680-Y; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Csernansky J G, 1993, Ann Clin Psychiatry, V5, P275, DOI 10.3109/10401239309148828; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Dunkley EJC, 2003, QJM-INT J MED, V96, P635, DOI 10.1093/qjmed/hcg109; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; FLACHAIRE E, 1990, CLIN CHEM, V36, P2117; Forrest V, 1996, J NEUROL SCI, V139, P83, DOI 10.1016/0022-510X(96)00109-8; FUNALOT B, 2008, AMYOTROPH LATERAL SC, P1; GUICHENEY P, 1988, METHOD FIND EXP CLIN, V10, P253; HECKMAN CJ, 2009, CLIN NEUROPHYSIOL; Hillemacher T, 2004, AMYOTROPH LATERAL SC, V5, P245, DOI 10.1080/14660820410021294; Huey ED, 2006, NEUROLOGY, V66, P17, DOI 10.1212/01.wnl.0000191304.55196.4d; Lacomblez L, 2002, NEUROLOGY, V58, P1112, DOI 10.1212/WNL.58.7.1112; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; LESCH KP, 1993, J NEUROCHEM, V60, P2319, DOI 10.1111/j.1471-4159.1993.tb03522.x; MCDONALD ER, 1994, ARCH NEUROL-CHICAGO, V51, P17, DOI 10.1001/archneur.1994.00540130027010; Muck-Seler D, 2009, PROG NEURO-PSYCHOPH, V33, P1226, DOI 10.1016/j.pnpbp.2009.07.004; OWENS MJ, 1994, CLIN CHEM, V40, P288; Paillisse C, 2005, AMYOTROPH LATERAL SC, V6, P37, DOI 10.1080/14660820510027035; PRADAT PF, 2009, AMYOTROPH LATERAL SC, P1; Radat F, 1996, PSYCHOPHARMACOLOGY, V127, P370, DOI 10.1007/BF02806017; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Sandyk R, 2006, INT J NEUROSCI, V116, P775, DOI 10.1080/00207450600754087; Sneddon J M, 1973, Prog Neurobiol, V1, P151, DOI 10.1016/0301-0082(73)90019-1; SOFIC E, 1991, J NEURAL TRANSM-PARK, V3, P133, DOI 10.1007/BF02260888; Spreux-Varoquaux O, 2001, LIFE SCI, V69, P647, DOI 10.1016/S0024-3205(01)01158-4; Strong MJ, 2008, AMYOTROPH LATERAL SC, V9, P323, DOI 10.1080/17482960802372371; SUSSMUTH SD, NEUROLOGY, V74, P982; Tecott LH, 2007, CELL METAB, V6, P352, DOI 10.1016/j.cmet.2007.09.012; Turner BJ, 2003, AMYOTROPH LATERAL SC, V4, P171, DOI 10.1080/14660820310009389; Turner MR, 2005, BRAIN, V128, P896, DOI 10.1093/brain/awh428; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051	40	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13346	10.1371/journal.pone.0013346	http://dx.doi.org/10.1371/journal.pone.0013346			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967129	Green Published, Green Submitted, gold			2022-12-25	WOS:000282869800035
J	Gardiner, BS; Smith, DW; Coote, M; Crowston, JG				Gardiner, Bruce S.; Smith, David W.; Coote, Michael; Crowston, Jonathan G.			Computational Modeling of Fluid Flow and Intra-Ocular Pressure following Glaucoma Surgery	PLOS ONE			English	Article							EPISCLERAL VENOUS-PRESSURE; FILTERING BLEBS; INTERSTITIAL FLOW; DRAINAGE DEVICES; AQUEOUS DYNAMICS; MITOMYCIN-C; TRABECULECTOMY	Background: Glaucoma surgery is the most effective means for lowering intraocular pressure by providing a new route for fluid to exit the eye. This new pathway is through the sclera of the eye into sub-conjunctival tissue, where a fluid filled bleb typically forms under the conjunctiva. The long-term success of the procedure relies on the capacity of the sub-conjunctival tissue to absorb the excess fluid presented to it, without generating excessive scar tissue during tissue remodeling that will shut-down fluid flow. The role of inflammatory factors that promote scarring are well researched yet little is known regarding the impact of physical forces on the healing response. Methodology: To help elucidate the interplay of physical factors controlling the distribution and absorption of aqueous humor in sub-conjunctival tissue, and tissue remodeling, we have developed a computational model of fluid production in the eye and removal via the trabecular/uveoscleral pathways and the surgical pathway. This surgical pathway is then linked to a porous media computational model of a fluid bleb positioned within the sub-conjunctival tissue. The computational analysis is centered on typical functioning bleb geometry found in a human eye following glaucoma surgery. A parametric study is conducted of changes in fluid absorption by the sub-conjunctival blood vessels, changes in hydraulic conductivity due to scarring, and changes in bleb size and shape, and eye outflow facility. Conclusions: This study is motivated by the fact that some blebs are known to have 'successful' characteristics that are generally described by clinicians as being low, diffuse and large without the formation of a distinct sub-conjunctival encapsulation. The model predictions are shown to accord with clinical observations in a number of key ways, specifically the variation of intra-ocular pressure with bleb size and shape and the correspondence between sites of predicted maximum interstitial fluid pressure and key features observed in blebs, which gives validity to the model described here. This model should contribute to a more complete explanation of the physical processes behind successful bleb characteristics and provide a new basis for clinically grading blebs.	[Gardiner, Bruce S.; Smith, David W.] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia; [Coote, Michael; Crowston, Jonathan G.] Univ Melbourne, CERA, Melbourne, Vic, Australia; [Coote, Michael; Crowston, Jonathan G.] Royal Victorian Eye & Ear Hosp, Melbourne, Vic 3002, Australia	University of Western Australia; University of Melbourne; Royal Victorian Eye & Ear Hospital	Gardiner, BS (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia.	bruce.gardiner@uwa.edu.au	Gardiner, Bruce/C-8593-2012; Smith, David W/H-5856-2014	Smith, David W/0000-0003-4864-0288; Gardiner, Bruce/0000-0001-8770-5908	Australian National Health and Medical Research Council (NHMRC) [529918]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Australian National Health and Medical Research Council (NHMRC Project Grant # 529918) http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuara-Blanco A, 1998, SURV OPHTHALMOL, V43, P93, DOI 10.1016/S0039-6257(98)00025-3; Bill A, 1989, Prog Clin Biol Res, V312, P417; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Brubaker RF, 2004, EXP EYE RES, V78, P633, DOI 10.1016/j.exer.2003.07.002; Casillan AJ, 2003, J APPL PHYSIOL, V94, P2313, DOI 10.1152/japplphysiol.00047.2002; Chang L, 2000, SURV OPHTHALMOL, V45, P49, DOI 10.1016/S0039-6257(00)00135-1; Ethier CR, 2004, ANNU REV BIOMED ENG, V6, P249, DOI 10.1146/annurev.bioeng.6.040803.140055; Filippopoulos Theodoros, 2009, Int Ophthalmol Clin, V49, P71, DOI 10.1097/IIO.0b013e3181924d55; FUNG YC, 1996, BIOMECHANICS CIRCULA, P214; GUYTON AC, 1966, CIRC RES, V19, P412, DOI 10.1161/01.RES.19.2.412; HARRIS NR, 1993, AM J PHYSIOL-HEART C, V34, pH1623; He PN, 2006, AM J PHYSIOL-HEART C, V291, pH591, DOI 10.1152/ajpheart.01228.2005; Hong CH, 2005, SURV OPHTHALMOL, V50, P48, DOI 10.1016/j.survophthal.2004.10.006; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Kumar S, 2006, ANN BIOMED ENG, V34, P530, DOI 10.1007/s10439-005-9048-6; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Lim KS, 1998, BRIT J OPHTHALMOL, V82, P1083, DOI 10.1136/bjo.82.9.1083; McWhae JA, 1996, CAN J OPHTHALMOL, V31, P187; MELLANDER S, 1994, J PHYSIOL-LONDON, V481, P163, DOI 10.1113/jphysiol.1994.sp020427; *MOLT OPHTH LTD, 2010, MOLTENO3 TECHN INF; MOLTENO ACB, 1969, BRIT J OPHTHALMOL, V53, P606, DOI 10.1136/bjo.53.9.606; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202; Ng CP, 2006, ANN BIOMED ENG, V34, P446, DOI 10.1007/s10439-005-9067-3; Ng CP, 2003, AM J PHYSIOL-HEART C, V284, pH1771, DOI 10.1152/ajpheart.01008.2002; Nilsson SFE, 1997, EYE, V11, P149, DOI 10.1038/eye.1997.43; Olsen TW, 1998, AM J OPHTHALMOL, V125, P237, DOI 10.1016/S0002-9394(99)80096-8; PALLIKARIS IG, 2005, INVEST OPHTHALMOL, V46; PHELPS CD, 1978, AM J OPHTHALMOL, V85, P35, DOI 10.1016/S0002-9394(14)76662-0; Picht G, 1998, Curr Opin Ophthalmol, V9, P2, DOI 10.1097/00055735-199804000-00002; Sacu S, 2003, J GLAUCOMA, V12, P430, DOI 10.1097/00061198-200310000-00006; Selbach JM, 2005, OPHTHALMOLOGICA, V219, P357, DOI 10.1159/000088378; Singh M, 2007, OPHTHALMOLOGY, V114, P47, DOI 10.1016/j.ophtha.2006.05.078; Sit AJ, 2008, INVEST OPHTH VIS SCI, V49, P1473, DOI 10.1167/iovs.07-1139; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Terzaghi K., 1943, THEORETICAL SOIL MEC; VANBUSKIRK EM, 1982, AM J OPHTHALMOL, V94, P522, DOI 10.1016/0002-9394(82)90248-3; Waite L., 2007, APPL BIOFLUID MECH; Wells AP, 2006, OPHTHALMOLOGY, V113, P77, DOI 10.1016/j.ophtha.2005.06.037; Williams DA, 2007, MICROVASC RES, V73, P48, DOI 10.1016/j.mvr.2006.08.003; Yamamoto T, 1995, OPHTHALMOLOGY, V102, P1770, DOI 10.1016/S0161-6420(95)30795-6; Yamanaka O, 2008, JPN J OPHTHALMOL, V52, P8, DOI 10.1007/s10384-007-0497-3	41	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13178	10.1371/journal.pone.0013178	http://dx.doi.org/10.1371/journal.pone.0013178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957178	Green Published, Green Submitted, gold			2022-12-25	WOS:000282423300015
J	Baltzer, JL; Thomas, SC				Baltzer, Jennifer L.; Thomas, Sean C.			A Second Dimension to the Leaf Economics Spectrum Predicts Edaphic Habitat Association in a Tropical Forest	PLOS ONE			English	Article							FUNCTIONAL TRAITS; SOIL NUTRIENTS; PHOSPHORUS; NITROGEN; SPECIALIZATION; TREES; PHOTOSYNTHESIS; DISTRIBUTIONS; PHOSPHATE; GROWTH	Background: Strong patterns of habitat association are frequent among tropical forest trees and contribute to the maintenance of biodiversity. The relation of edaphic differentiation to tradeoffs among leaf functional traits is less clear, but may provide insights into mechanisms of habitat partitioning in these species rich assemblages. Methodology/Principal Findings: We quantify the leaf economics spectrum (LES) for 16 tree species within a Bornean forest characterized by highly pronounced habitat specialization. Our findings suggest that the primary axis of trait variation in light-limited, lowland tropical forests was identical to the LES and corresponds with the shade tolerance continuum. There was no separation with respect to edaphic variation along this primary axis of trait variation. However, a second orthogonal axis determined largely by foliar P concentrations resulted in a near-perfect separation of species occupying distinct soil types within the forest. Conclusions/Significance: We suggest that this second axis of leaf trait variation represents a "leaf edaphic habitat spectrum'' related to foliar P and potentially other nutrients closely linked to geological substrate, and may generally occur in plant communities characterized by strong edaphic resource gradients.	[Baltzer, Jennifer L.] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada; [Baltzer, Jennifer L.; Thomas, Sean C.] Univ Toronto, Fac Forestry, Toronto, ON, Canada	Mount Allison University; University of Toronto	Baltzer, JL (corresponding author), Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada.	jbaltzer@mta.ca	THOMAS, Sean C./B-6089-2008	THOMAS, Sean C./0000-0002-0686-2483	Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research was funded by the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S.E., 1974, CHEM ANAL ECOLOGICAL; ASHTON PS, 1964, OXFORD FORESTRY MEMO, V8; Baker TR, 2003, J TROP ECOL, V19, P109, DOI 10.1017/S0266467403003146; Baltzer JL, 2007, J ECOL, V95, P1208, DOI 10.1111/j.1365-2745.2007.01286.x; Baltzer JL, 2005, ECOLOGY, V86, P3063, DOI 10.1890/04-0598; BIELESKI RL, 1973, ANNU REV PLANT PHYS, V24, P225, DOI 10.1146/annurev.pp.24.060173.001301; CALDWELL MM, 1992, OECOLOGIA, V89, P305, DOI 10.1007/BF00317406; Campbell CD, 2006, PLANT CELL ENVIRON, V29, P844, DOI 10.1111/j.1365-3040.2005.01464.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Craine JM, 2002, FUNCT ECOL, V16, P563, DOI 10.1046/j.1365-2435.2002.00660.x; Davies SJ, 1998, J ECOL, V86, P662, DOI 10.1046/j.1365-2745.1998.00299.x; DeWalt SJ, 2006, PLANT ECOL, V186, P203, DOI 10.1007/s11258-006-9123-6; Espeleta JF, 2009, ECOLOGY, V90, P1773, DOI 10.1890/08-0056.1; Fox J. E. D., 1973, KABILI SEPILOK FORES; Gleason SM, 2009, FUNCT ECOL, V23, P1157, DOI 10.1111/j.1365-2435.2009.01575.x; Gusewell S, 2005, PLANT ECOL, V176, P35, DOI 10.1007/s11258-004-0010-8; IMSANDE J, 1994, PLANT PHYSIOL, V105, P3, DOI 10.1104/pp.105.1.3; Jackson RB, 1996, J ECOL, V84, P891, DOI 10.2307/2960560; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Kitajima K., 2008, TROPICAL FOREST COMM, P160; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Mirmanto E, 1999, PHILOS T ROY SOC B, V354, P1825, DOI 10.1098/rstb.1999.0524; Nilus, 2004, EFFECT EDAPHIC VARIA; Palmiotto PA, 2004, J ECOL, V92, P609, DOI 10.1111/j.0022-0477.2004.00894.x; Paoli GD, 2006, J TROP ECOL, V22, P397, DOI 10.1017/S0266467406003208; Paoli GD, 2006, J ECOL, V94, P157, DOI 10.1111/j.1365-2745.2005.01077.x; Paz-Rivera C, 2009, BIOTROPICA, V41, P665, DOI 10.1111/j.1744-7429.2009.00521.x; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Poorter L, 2009, NEW PHYTOL, V181, P890, DOI 10.1111/j.1469-8137.2008.02715.x; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Potts MD, 2002, ECOLOGY, V83, P2782, DOI 10.1890/0012-9658(2002)083[2782:HPITRF]2.0.CO;2; RAAIMAKERS D, 1995, OECOLOGIA, V102, P120, DOI 10.1007/BF00333319; Reich PB, 2009, OECOLOGIA, V160, P207, DOI 10.1007/s00442-009-1291-3; RYAN MG, 1995, PLANT CELL ENVIRON, V18, P765, DOI 10.1111/j.1365-3040.1995.tb00579.x; Santiago LS, 2007, FUNCT ECOL, V21, P19, DOI 10.1111/j.1365-2435.2006.01218.x; Santiago LS, 2004, OECOLOGIA, V139, P495, DOI 10.1007/s00442-004-1542-2; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; SCHUMAN GE, 1973, SOIL SCI SOC AM J, V37, P480, DOI 10.2136/sssaj1973.03615995003700030045x; Sterck FJ, 2006, AM NAT, V167, P758, DOI 10.1086/503056; VANTIENDEREN PH, 1991, EVOLUTION, V45, P1317, DOI [10.1111/j.1558-5646.1991.tb02638.x, 10.2307/2409882]; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; WILLIAMS K, 1989, AM NAT, V133, P198, DOI 10.1086/284910; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; [No title captured]	50	27	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13163	10.1371/journal.pone.0013163	http://dx.doi.org/10.1371/journal.pone.0013163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957212	Green Published, Green Submitted, gold			2022-12-25	WOS:000282359300033
J	de Carvalho, FD; Quick, M				de Carvalho, Fernanda Delmondes; Quick, Matthias			Surprising Substrate Versatility in SLC5A6 Na+-COUPLEDI- TRANSPORT BY THE HUMAN Na+/MULTIVITAMIN TRANSPORTER (hSMVT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT MULTIVITAMIN TRANSPORTER; NA+/GLUCOSE COTRANSPORTER SGLT1; SYMPORTER NIS; NEUROTRANSMITTER TRANSPORTERS; FUNCTIONAL EXPRESSION; IODIDE TRANSPORTER; BACTERIAL HOMOLOG; ESCHERICHIA-COLI; BINDING-SITE; MECHANISM	Iodide (I-) is an essential constituent of the thyroid hormones triiodothyronine and thyroxine, which are required for the development of the central nervous system in the fetus and newborn. I- uptake in the thyroid is mediated by the Na+/I- symporter (NIS). NIS has gained particular medical interest due to its sensitivity to the environmental pollutant perchlorate (ClO4-) and its implication in radioiodide cancer treatment. Recently, others have shown that I- absorption in the intestine is mediated by NIS (Nicola, J. P., Basquin, C., Portulano, C., Reyna-Neyra, A., Paroder, M., and Carrasco, N. (2009) Am. J. Physiol. Cell Physiol. 296, C654-662). However, their data suggest the participation of other systems in the homeostasis of I-, in particular because in vivo uptake studies revealed a ClO4--insensitive transport component. Here, we describe Na+-coupled I- uptake by the human Na+/multivitamin transporter (hSMVT), a related protein isolated from the placenta, where it was suggested to supply the fetus with the water-soluble vitamins biotin and pantothenic acid, and alpha-lipoic acid. hSMVT-mediated Na+/I- symport is inhibited by the other three organic hSMVT substrates but not by NIS substrates; notably, hSMVT is insensitive to ClO4-. Because hSMVT is found in the intestine and in many other tissues, we propose that hSMVT may play an important role in the homeostasis of I- in the body.	[de Carvalho, Fernanda Delmondes; Quick, Matthias] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Quick, M (corresponding author), 650 W 168th St,BB1119, New York, NY 10032 USA.	mq2102@columbia.edu		Carvalho Poyraz, Fernanda/0000-0003-2488-6849				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ACLAND JD, 1959, J PHYSIOL-LONDON, V147, P260, DOI 10.1113/jphysiol.1959.sp006241; Balamurugan K, 2003, AM J PHYSIOL-GASTR L, V285, pG73, DOI 10.1152/ajpgi.00059.2003; Ball G. F., 2005, VITAMINS FOODS ANAL; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Coady MJ, 2004, J PHYSIOL-LONDON, V557, P719, DOI 10.1113/jphysiol.2004.063859; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Dohan O, 2003, MOL CELL ENDOCRINOL, V213, P59, DOI 10.1016/j.mce.2003.10.059; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Dohan O, 2007, P NATL ACAD SCI USA, V104, P20250, DOI 10.1073/pnas.0707207104; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HIRAYAMA BA, 1992, BIOCHIM BIOPHYS ACTA, V1103, P37, DOI 10.1016/0005-2736(92)90054-P; Hirayama BA, 1997, J BIOL CHEM, V272, P2110; Longpre JP, 2010, BIOPHYS J, V98, P231, DOI 10.1016/j.bpj.2009.10.015; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Loo DDF, 1999, J PHYSIOL-LONDON, V518, P195, DOI 10.1111/j.1469-7793.1999.0195r.x; Mackenzie B, 1998, J MEMBRANE BIOL, V162, P101, DOI 10.1007/s002329900347; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; Nabokina SM, 2003, AM J PHYSIOL-RENAL, V284, pF737, DOI 10.1152/ajprenal.00364.2002; Nicola JP, 2009, AM J PHYSIOL-CELL PH, V296, pC654, DOI 10.1152/ajpcell.00509.2008; PANAYOTOVAHEIERMANN M, 1995, J BIOL CHEM, V270, P27099, DOI 10.1074/jbc.270.45.27099; PASTAN I, 1957, ENDOCRINOLOGY, V61, P93, DOI 10.1210/endo-61-1-93; Prasad PD, 1999, ARCH BIOCHEM BIOPHYS, V366, P95, DOI 10.1006/abbi.1999.1213; Prasad PD, 1998, J BIOL CHEM, V273, P7501, DOI 10.1074/jbc.273.13.7501; Quick M, 1998, BIOCHEMISTRY-US, V37, P13800, DOI 10.1021/bi980562j; Quick M, 2001, J BIOL CHEM, V276, P1728, DOI 10.1074/jbc.M005521200; Rodriguez AM, 2002, J CLIN ENDOCR METAB, V87, P3500, DOI 10.1210/jc.87.7.3500; Said HM, 1999, J NUTR, V129, p490S, DOI 10.1093/jn/129.2.490S; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; Wang HP, 1999, J BIOL CHEM, V274, P14875, DOI 10.1074/jbc.274.21.14875; Wright EM, 1996, CURR OPIN CELL BIOL, V8, P468, DOI 10.1016/S0955-0674(96)80022-6; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	41	47	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					131	137		10.1074/jbc.M110.167197	http://dx.doi.org/10.1074/jbc.M110.167197			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980265	Green Published, hybrid			2022-12-25	WOS:000285782800014
J	Shkreta, L; Michelle, L; Toutant, J; Tremblay, ML; Chabot, B				Shkreta, Lulzim; Michelle, Laetitia; Toutant, Johanne; Tremblay, Michel L.; Chabot, Benoit			The DNA Damage Response Pathway Regulates the Alternative Splicing of the Apoptotic Mediator Bcl-x	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; PROGRAMMED CELL-DEATH; PROTEIN-PHOSPHORYLATION; TOPOISOMERASE-I; HISTONE H2AX; SR PROTEINS; HNRNP A1; INHIBITION; CANCER; STRESS	Alternative splicing often produces effectors with opposite functions in apoptosis. Splicing decisions must therefore be tightly connected to stresses, stimuli, and pathways that control cell survival and cell growth. We have shown previously that PKC signaling prevents the production of proapoptotic Bcl-x(S) to favor the accumulation of the larger antiapoptotic Bcl-x(L) splice variant in 293 cells. Here we show that the genotoxic stress induced by oxaliplatin elicits an ATM-, CHK2-, and p53-dependent splicing switch that favors the production of the proapoptotic Bcl-xS variant. This DNA damage-induced splicing shift requires the activity of protein-tyrosine phosphatases. Interestingly, the ATM/CHK2/p53/tyrosine phosphatases pathway activated by oxaliplatin regulates Bcl-x splicing through the same regulatory sequence element (SB1) that receives signals from the PKC pathway. Convergence of the PKC and DNA damage signaling routes may control the abundance of a key splicing repressor because SB1-mediated repression is lost when protein synthesis is impaired but is rescued by blocking proteasome-mediated protein degradation. The SB1 splicing regulatory module therefore receives antagonistic signals from the PKC and the p53-dependent DNA damage response pathways to control the balance of pro-and antiapoptotic Bcl-x splice variants.	[Shkreta, Lulzim; Michelle, Laetitia; Toutant, Johanne; Chabot, Benoit] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA RNP Grp, Sherbrooke, PQ J1H 5N4, Canada; [Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Tremblay, Michel L.] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada	University of Sherbrooke; McGill University; McGill University	Chabot, B (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA RNP Grp, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	benoit.chabot@usherbrooke.ca		Chabot, Benoit/0000-0003-0994-0042	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-93791 from the Canadian Institutes of Health Research.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Barbier J, 2007, MOL CELL BIOL, V27, P7315, DOI 10.1128/MCB.00272-07; Blaustein M, 2007, INT J BIOCHEM CELL B, V39, P2031, DOI 10.1016/j.biocel.2007.04.004; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Boon-Unge K, 2007, CHEM BIOL, V14, P1386, DOI 10.1016/j.chembiol.2007.11.004; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; CLARKE MF, 1995, P NATL ACAD SCI USA, V92, P11024, DOI 10.1073/pnas.92.24.11024; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; Du YCN, 2007, PLOS BIOL, V5, P2255, DOI 10.1371/journal.pbio.0050276; Feng Y, 2008, NAT STRUCT MOL BIOL, V15, P1040, DOI 10.1038/nsmb.1485; Filippov V, 2007, CANCER RES, V67, P7621, DOI 10.1158/0008-5472.CAN-07-0145; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jiang ZH, 1999, P SOC EXP BIOL MED, V220, P64, DOI 10.1046/j.1525-1373.1999.d01-11.x; Katzenberger RJ, 2006, MOL CELL BIOL, V26, P9256, DOI 10.1128/MCB.01125-06; Katzenberger RJ, 2009, J BIOL CHEM, V284, P10737, DOI 10.1074/jbc.M809506200; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Marengo MS, 2008, RNA, V14, P1681, DOI 10.1261/rna.1048808; Mercatante DR, 2002, J BIOL CHEM, V277, P49374, DOI 10.1074/jbc.M209236200; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Nehme A, 1999, BRIT J CANCER, V79, P1104, DOI 10.1038/sj.bjc.6690176; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; Olopade OI, 1997, CANCER J SCI AM, V3, P230; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Pilch B, 2001, CANCER RES, V61, P6876; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Revil T, 2007, MOL CELL BIOL, V27, P8431, DOI 10.1128/MCB.00565-07; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shi J, 2008, MOL CELL BIOL, V28, P883, DOI 10.1128/MCB.01345-07; Shin C, 2004, NATURE, V427, P553, DOI 10.1038/nature02288; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; Shkreta L, 2008, MOL CANCER THER, V7, P1398, DOI 10.1158/1535-7163.MCT-08-0192; Solier S, 2004, MOL CANCER RES, V2, P53; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stuible M, 2007, CHEMBIOCHEM, V8, P179, DOI 10.1002/cbic.200600287; Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Venables JP, 2004, HUM MOL GENET, V13, P1525, DOI 10.1093/hmg/ddh165; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Won JJ, 2006, NAT CHEM BIOL, V2, P369, DOI 10.1038/nchembio800; Wu J Y, 2003, Prog Mol Subcell Biol, V31, P153; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; Yuan ZM, 1998, ONCOGENE, V16, P1643, DOI 10.1038/sj.onc.1201698; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109	52	37	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					331	340		10.1074/jbc.M110.162644	http://dx.doi.org/10.1074/jbc.M110.162644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980256	Green Published, hybrid			2022-12-25	WOS:000285782800036
J	Melani, R; Tomati, V; Galietta, LJV; Zegarra-Moran, O				Melani, Raffaella; Tomati, Valeria; Galietta, Luis J. V.; Zegarra-Moran, Olga			Modulation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity and Genistein Binding by Cytosolic pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CL-CHANNEL ACTIVITY; CHLORIDE-CHANNEL; AFFINITY ACTIVATORS; DELTA-F508 CFTR; ATP-BINDING; WILD-TYPE; INHIBITION; DOMAINS; POTENTIATORS; SENSITIVITY	Potentiators are molecules that increase the activity of the cystic fibrosis transmembrane conductance regulator (CFTR). Some potentiators can also inhibit CFTR at higher concentrations. The activating binding site is thought to be located at the interface of the dimer formed by the two nucleotide-binding domains. We have hypothesized that if binding of potentiators involves titratable residues forming salt bridges, then modifications of cytosolic pH (pH(i)) would alter the binding affinity. Here, we analyzed the effect of pH(i) on CFTR activation and on the binding of genistein, a well known CFTR potentiator. We found that pH(i) does modify CFTR maximum current (I-m) and half-activation concentration (K-d): I-m = 127.7, 185.5, and 231.8 mu A/cm(2) and K-d = 32.7, 56.6 and 71.9 mu M at pH 6, 7.35, and 8, respectively. We also found that the genistein apparent dissociation constant for activation (K-a) increased at alkaline pH(i), near cysteine pK (K-a = 1.83, 1.81 and 4.99 mu M at pH(i) 6, 7.35, and 8, respectively), suggesting the involvement of cysteines in the binding site. Mutations of cysteine residues predicted to be within (Cys-491) or outside (Cys-1344) the potentiator-binding site showed that Cys-491 is responsible for the sensitivity of potentiator binding to alkaline pH(i). Effects of pH(i) on inhibition by high genistein doses were also analyzed. Our results extend previous data about multiple effects of pH(i) on CFTR activity and demonstrate that binding of potentiators involves salt bridge formation with amino acids of nucleotide-binding domain 1.	[Melani, Raffaella; Tomati, Valeria; Galietta, Luis J. V.; Zegarra-Moran, Olga] Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini	Zegarra-Moran, O (corresponding author), Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy.	ozegarra@unige.it	Tomati, Valeria/AAB-4543-2021; Galietta, Luis JV/HCG-8692-2022	Tomati, Valeria/0000-0003-3761-1916; Galietta, Luis/0000-0001-8686-3461	Italian Cystic Fibrosis Foundation [FFC2/2008]; Mille Bambini a Via Margutta Onlus, Blunotte; Lega Italiana Fibrosi Cistica-Associazione Toscana	Italian Cystic Fibrosis Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Mille Bambini a Via Margutta Onlus, Blunotte; Lega Italiana Fibrosi Cistica-Associazione Toscana	This work was supported by Italian Cystic Fibrosis Foundation Grant FFC2/2008, Mille Bambini a Via Margutta Onlus, Blunotte, and Lega Italiana Fibrosi Cistica-Associazione Toscana.	Ai T, 2004, MOL PHARMACOL, V65, P1415, DOI 10.1124/mol.65.6.1415; Al-Nakkash L, 2001, J PHARMACOL EXP THER, V296, P464; ALBERTY RA, 1951, J BIOL CHEM, V193, P425; ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; Berger AL, 2005, J BIOL CHEM, V280, P5221, DOI 10.1074/jbc.M412972200; Caci E, 2003, AM J PHYSIOL-LUNG C, V285, pL180, DOI 10.1152/ajplung.00351.2002; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; Chen JH, 2009, J BIOL CHEM, V284, P35495, DOI 10.1074/jbc.M109.072678; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; GREEN WN, 1991, ANNU REV PHYSIOL, V53, P341, DOI 10.1146/annurev.ph.53.030191.002013; GRIBKOFF VK, 1994, J BIOL CHEM, V269, P10983; Harrington MA, 2002, BIOPHYS J, V82, P1278, DOI 10.1016/S0006-3495(02)75484-2; Huang SY, 2009, J MOL GRAPH MODEL, V27, P822, DOI 10.1016/j.jmgm.2008.12.005; Kurth M. J., 2005, MOL PHARM, V67, P1797; Lansdell KA, 2000, J PHYSIOL-LONDON, V524, P317, DOI 10.1111/j.1469-7793.2000.t01-1-00317.x; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; Melin P, 2005, J MEMBRANE BIOL, V208, P203, DOI 10.1007/s00232-005-7001-0; Moran O, 2005, FEBS LETT, V579, P3979, DOI 10.1016/j.febslet.2005.06.026; Moran O, 2005, CELL MOL LIFE SCI, V62, P446, DOI 10.1007/s00018-004-4422-3; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Murthy M, 2005, EUR J PHARMACOL, V516, P118, DOI 10.1016/j.ejphar.2005.04.037; Noel S, 2006, J PHARMACOL EXP THER, V319, P349, DOI 10.1124/jpet.106.104521; Pedemonte N, 2005, MOL PHARMACOL, V68, P1736, DOI 10.1124/mol.105.015149; Reddy MM, 1998, AM J PHYSIOL-CELL PH, V275, pC1040, DOI 10.1152/ajpcell.1998.275.4.C1040; Sheppard DN, 1999, PHYSIOL REV, V79, P23; SHERRY AM, 1994, AM J PHYSIOL, V266, pC870, DOI 10.1152/ajpcell.1994.266.3.C870; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang F, 1998, J GEN PHYSIOL, V111, P477, DOI 10.1085/jgp.111.3.477; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882; Zegarra-Moran O, 2007, J BIOL CHEM, V282, P9098, DOI 10.1074/jbc.M611411200; Zielonka J, 2003, FREE RADICAL BIO MED, V35, P958, DOI 10.1016/S0891-5849(03)00472-6	37	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41591	41596		10.1074/jbc.M110.166850	http://dx.doi.org/10.1074/jbc.M110.166850			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974851	Green Published, hybrid			2022-12-25	WOS:000285622600046
J	Pike, JE; Henry, RA; Burgers, PMJ; Campbell, JL; Bambara, RA				Pike, Jason E.; Henry, Ryan A.; Burgers, Peter M. J.; Campbell, Judith L.; Bambara, Robert A.			An Alternative Pathway for Okazaki Fragment Processing RESOLUTION OF FOLD-BACK FLAPS BY Pif1 HELICASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; DNA-POLYMERASE-DELTA; SINGLE-STRANDED-DNA; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; FLAP ENDONUCLEASE-1; PRIMER REMOVAL; LIGATABLE NICK; YEAST; MATURATION	Two pathways have been proposed for eukaryotic Okazaki fragment RNA primer removal. Results presented here provide evidence for an alternative pathway. Primer extension by DNA polymerase delta (pol delta) displaces the downstream fragment into an RNA-initiated flap. Most flaps are cleaved by flap endonuclease 1 (FEN1) while short, and the remaining nicks joined in the first pathway. A small fraction escapes immediate FEN1 cleavage and is further lengthened by Pif1 helicase. Long flaps are bound by replication protein A (RPA), which inhibits FEN1. In the second pathway, Dna2 nuclease cleaves an RPA-bound flap and displaces RPA, leaving a short flap for FEN1. Pif1 flap lengthening creates a requirement for Dna2. This relationship should not have evolved unless Pif1 had an important role in fragment processing. In this study, biochemical reconstitution experiments were used to gain insight into this role. Pif1 did not promote synthesis through GC-rich sequences, which impede strand displacement. Pif1 was also unable to open fold-back flaps that are immune to cleavage by either FEN1 or Dna2 and cannot be bound by RPA. However, Pif1 working with pol delta readily unwound a full-length Okazaki fragment initiated by a fold-back flap. Additionally, a fold-back in the template slowed pol delta synthesis, so that the fragment could be removed before ligation to the lagging strand. These results suggest an alternative pathway in which Pif1 removes Okazaki fragments initiated by fold-back flaps in vivo.	[Pike, Jason E.; Henry, Ryan A.; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Burgers, Peter M. J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; Washington University (WUSTL); California Institute of Technology	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu	Burgers, Peter M/AAW-6621-2021		National Institutes of Health [GM024441, GM078666, GM032431]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431, R01GM024441, R01GM078666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM024441 (to R. A. B.), GM078666 (to J. L. C.), and GM032431 (to P. M. J. B.).	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Balakrishnan L, 2010, J BIOL CHEM, V285, P4398, DOI 10.1074/jbc.M109.086397; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Bartos JD, 2008, J BIOL CHEM, V283, P21758, DOI 10.1074/jbc.M800856200; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gerik KJ, 1997, J BIOL CHEM, V272, P1256, DOI 10.1074/jbc.272.2.1256; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kornberg A., 1992, DNA REPLICATION, VSecond, P113; LAHAYE A, 1993, J BIOL CHEM, V268, P26155; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Pike JE, 2009, J BIOL CHEM, V284, P25170, DOI 10.1074/jbc.M109.023325; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Ryu GH, 2004, NUCLEIC ACIDS RES, V32, P4205, DOI 10.1093/nar/gkh720; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200	37	38	39	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41712	41723		10.1074/jbc.M110.146894	http://dx.doi.org/10.1074/jbc.M110.146894			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959454	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000285622600058
J	Bryde, S; Hennrich, H; Verhulst, PM; Devaux, PF; Lenoir, G; Holthuis, JCM				Bryde, Susanne; Hennrich, Hanka; Verhulst, Patricia M.; Devaux, Philippe F.; Lenoir, Guillaume; Holthuis, Joost C. M.			CDC50 Proteins Are Critical Components of the Human Class-1 P-4-ATPase Transport Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; PUTATIVE AMINOPHOSPHOLIPID TRANSLOCASES; YEAST PLASMA-MEMBRANE; SODIUM-POTASSIUM PUMP; LIPID ASYMMETRY; PHOSPHOLIPID TRANSLOCATION; CRYSTAL-STRUCTURE; PHOSPHATIDYLSERINE ASYMMETRY; SACCHAROMYCES-CEREVISIAE; HEREDITARY CHOLESTASIS	Members of the P4 subfamily of P-type ATPases catalyze phospholipid transport and create membrane lipid asymmetry in late secretory and endocytic compartments. P-type ATPases usually pump small cations and the transport mechanism involved appears conserved throughout the family. How this mechanism is adapted to flip phospholipids remains to be established. P4-ATPases form heteromeric complexes with CDC50 proteins. Dissociation of the yeast P-4-ATPase Drs2p from its binding partner Cdc50p disrupts catalytic activity (Lenoir, G., Williamson, P., Puts, C. F., and Holthuis, J. C. (2009) J. Biol. Chem. 284, 17956-17967), suggesting that CDC50 subunits play an intimate role in the mechanism of transport by P4-ATPases. The human genome encodes 14 P4-ATPases while only three human CDC50 homologues have been identified. This implies that each human CDC50 protein interacts with multiple P4-ATPases or, alternatively, that some human P4-ATPases function without a CDC50 binding partner. Here we show that human CDC50 proteins each bind multiple class-1 P4-ATPases, and that in all cases examined, association with a CDC50 subunit is required for P4-ATPase export from the ER. Moreover, we find that phosphorylation of the catalytically important Asp residue in human P4-ATPases ATP8B1 and ATP8B2 is critically dependent on their CDC50 subunit. These results indicate that CDC50 proteins are integral part of the P4-ATPase flippase machinery.	[Bryde, Susanne; Hennrich, Hanka; Verhulst, Patricia M.; Holthuis, Joost C. M.] Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr, NL-3584 CH Utrecht, Netherlands; [Bryde, Susanne; Hennrich, Hanka; Verhulst, Patricia M.; Holthuis, Joost C. M.] Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands; [Bryde, Susanne; Devaux, Philippe F.] Inst Biol Physicochim, CNRS, UMR 7099, F-75005 Paris, France; [Lenoir, Guillaume] CEA, iBiTecS Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France; [Lenoir, Guillaume] CNRS, URA Syst Membranaires Photobiol Stress & Detoxica, F-91191 Gif Sur Yvette, France; [Lenoir, Guillaume] Univ Paris 11, F-91405 Orsay, France	Utrecht University; Utrecht University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Holthuis, JCM (corresponding author), Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	j.c.holthuis@uu.nl	Lenoir, Guillaume/I-4002-2019; Holthuis, Joost/AAL-9157-2020	Lenoir, Guillaume/0000-0002-8759-5179; Holthuis, Joost/0000-0001-8912-1586	Dutch Organization of Sciences (NWO-CW); Utrecht High Potential Program; European Union	Dutch Organization of Sciences (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); Utrecht High Potential Program; European Union(European Commission)	This work was supported by grants from the Dutch Organization of Sciences (NWO-CW), the Utrecht High Potential Program (to J. C. M. H.).; Supported by the European Union Framework V Program (the Flippase Project).	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Devaux PF, 2000, BIOCHIMIE, V82, P497, DOI 10.1016/S0300-9084(00)00209-1; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; Eppens EF, 2001, J HEPATOL, V35, P436, DOI 10.1016/S0168-8278(01)00158-1; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gomes E, 2000, PLANT CELL, V12, P2441, DOI 10.1105/tpc.12.12.2441; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Katoh Y, 2004, ONCOL REP, V12, P939; Kinnunen PKJ, 2000, BIOSCIENCE REP, V20, P465, DOI 10.1023/A:1010402819509; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Paulusma CC, 2005, BBA-MOL BASIS DIS, V1741, P11, DOI 10.1016/j.bbadis.2005.04.006; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Pomorski T, 1999, BIOCHEMISTRY-US, V38, P142, DOI 10.1021/bi981244n; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; SARKADI B, 1986, J BIOL CHEM, V261, P9552; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SMITH RL, 1980, J BIOL CHEM, V255, P9852; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Van Mil SWC, 2004, PEDIATR RES, V56, P981, DOI 10.1203/01.PDR.0000145564.06791.D1; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	49	91	96	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40562	40572		10.1074/jbc.M110.139543	http://dx.doi.org/10.1074/jbc.M110.139543			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20961850	hybrid, Green Published			2022-12-25	WOS:000285414400019
J	Jones, MK; Zhang, L; Catte, A; Li, L; Oda, MN; Ren, G; Segrest, JP				Jones, Martin K.; Zhang, Lei; Catte, Andrea; Li, Ling; Oda, Michael N.; Ren, Gang; Segrest, Jere P.			Assessment of the Validity of the Double Superhelix Model for Reconstituted High Density Lipoproteins A COMBINED COMPUTATIONAL-EXPERIMENTAL APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRON-SCATTERING; FORCE-FIELD; APOA-I; HDL; CHOLESTEROL; STABILITY; PHOSPHATIDYLCHOLINE; RECOMBINANTS; SIMULATION; MORPHOLOGY	For several decades, the standard model for high density lipoprotein (HDL) particles reconstituted from apolipoprotein A-I (apoA-I) and phospholipid (apoA-I/HDL) has been a discoidal particle similar to 100 angstrom in diameter and the thickness of a phospholipid bilayer. Recently, Wu et al. (Wu, Z., Gogonea, V., Lee, X., Wagner, M. A., Li, X. M., Huang, Y., Undurti, A., May, R. P., Haertlein, M., Moulin, M., Gutsche, I., Zaccai, G., Didonato, J. A., and Hazen, S. L. (2009) J. Biol. Chem. 284, 3660536619) used small angle neutron scattering to develop a new model they termed double superhelix (DSH) apoA-I that is dramatically different from the standard model. Their model possesses an open helical shape that wraps around a prolate ellipsoidal type I hexagonal lyotropic liquid crystalline phase. Here, we used three independent approaches, molecular dynamics, EM tomography, and fluorescence resonance energy transfer spectroscopy (FRET) to assess the validity of the DSH model. (i) By using molecular dynamics, two different approaches, all-atom simulated annealing and coarse-grained simulation, show that initial ellipsoidal DSH particles rapidly collapse to discoidal bilayer structures. These results suggest that, compatible with current knowledge of lipid phase diagrams, apoA-I cannot stabilize hexagonal I phase particles of phospholipid. (ii) By using EM, two different approaches, negative stain and cryo-EM tomography, show that reconstituted apoA-I/HDL particles are discoidal in shape. (iii) By using FRET, reconstituted apoA-I/HDL particles show a 28 -34-angstrom intermolecular separation between terminal domain residues 40 and 240, a distance that is incompatible with the dimensions of the DSH model. Therefore, we suggest that, although novel, the DSH model is energetically unfavorable and not likely to be correct. Rather, we conclude that all evidence supports the likelihood that reconstituted apoA-I/HDL particles, in general, are discoidal in shape.	[Jones, Martin K.; Catte, Andrea; Li, Ling; Segrest, Jere P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Jones, Martin K.; Catte, Andrea; Li, Ling; Segrest, Jere P.] Univ Alabama Birmingham, Atherosclerosis Res Unit, Birmingham, AL 35294 USA; [Jones, Martin K.; Catte, Andrea; Segrest, Jere P.] Univ Alabama Birmingham, Ctr Computat & Struct Dynam, Birmingham, AL 35294 USA; [Zhang, Lei; Ren, Gang] Univ Calif Berkeley, Lawrence Berkeley Lab, Mol Foundry, Berkeley, CA 94720 USA; [Zhang, Lei; Ren, Gang] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Oda, Michael N.] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Segrest, JP (corresponding author), 1808 7th Ave S,BDB 630, Birmingham, AL 35294 USA.	segrest@uab.edu	Zhang, Lei/G-6427-2012; Ren, Gang/B-1567-2012	Zhang, Lei/0000-0002-4880-824X; Ren, Gang/0000-0002-8036-2321; Li, Ling/0000-0002-9245-7387; Catte, Andrea/0000-0002-1124-1788	National Institutes of Health [P01 HL-34343]; W. M. Keck Foundation [011808]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL-34343 (to J. P. S.). This work was also supported by W. M. Keck Foundation (No. 011808, to G. R.).	Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248; Atkinson D, 1980, Ann N Y Acad Sci, V348, P284, DOI 10.1111/j.1749-6632.1980.tb21308.x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROUILLETTE CG, 1984, BIOCHEMISTRY-US, V23, P359, DOI 10.1021/bi00297a027; Catte A, 2008, BIOPHYS J, V94, P2306, DOI 10.1529/biophysj.107.115857; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Cavigiolio G, 2010, J BIOL CHEM, V285, P18847, DOI 10.1074/jbc.M109.098434; Chen B, 2009, PROTEIN SCI, V18, P921, DOI 10.1002/pro.101; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Feller S E, 1997, Pac Symp Biocomput, P142; FORTE T, 1971, J CLIN INVEST, V50, P1141, DOI 10.1172/JCI106586; FORTE TM, 1971, BIOCHIM BIOPHYS ACTA, V248, P381, DOI 10.1016/0005-2760(71)90026-9; Gogonea V, 2010, BIOCHEMISTRY-US, V49, P7323, DOI 10.1021/bi100588a; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones MK, 2009, BIOCHEMISTRY-US, V48, P11196, DOI 10.1021/bi901242k; Jones MK, 2009, BIOPHYS J, V96, P354, DOI 10.1016/j.bpj.2008.09.041; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; MASSEY JB, 1981, BIOCHEMISTRY-US, V20, P1575, DOI 10.1021/bi00509a026; MASSEY JB, 1985, BIOCHEMISTRY-US, V24, P7110, DOI 10.1021/bi00346a014; Massey JB, 2008, BBA-MOL CELL BIOL L, V1781, P245, DOI 10.1016/j.bbalip.2008.03.003; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; NICHOLS AV, 1983, BIOCHIM BIOPHYS ACTA, V750, P353, DOI 10.1016/0005-2760(83)90040-1; NICHOLS AV, 1987, J LIPID RES, V28, P719; Ren G, 2010, P NATL ACAD SCI USA, V107, P1059, DOI 10.1073/pnas.0908004107; Schlenkrich Michael, 1996, P31; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Segrest JP, 2000, CURR OPIN LIPIDOL, V11, P105, DOI 10.1097/00041433-200004000-00002; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Shih AY, 2008, BIOPHYS J, V94, pL87, DOI 10.1529/biophysj.108.131581; SLOOP CH, 1983, J LIPID RES, V24, P1429; TALL AR, 1977, BIOCHIM BIOPHYS ACTA, V487, P145, DOI 10.1016/0005-2760(77)90051-0; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; WLODAWER A, 1979, FEBS LETT, V104, P231, DOI 10.1016/0014-5793(79)80821-2; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; YEAGLE PL, 1987, MEMBRANES CELLS, P68; Zhang L, 2010, J LIPID RES, V51, P1228, DOI 10.1194/jlr.D002493; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005	48	48	48	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41161	41171		10.1074/jbc.M110.187799	http://dx.doi.org/10.1074/jbc.M110.187799			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20974855	Green Published, hybrid			2022-12-25	WOS:000285414400078
J	Yamamoto, Y; Mochida, S; Miyazaki, N; Kawai, K; Fujikura, K; Kurooka, T; Iwasaki, K; Sakisaka, T				Yamamoto, Yasunori; Mochida, Sumiko; Miyazaki, Naoyuki; Kawai, Katsuhisa; Fujikura, Kohei; Kurooka, Takao; Iwasaki, Kenji; Sakisaka, Toshiaki			Tomosyn Inhibits Synaptotagmin-1-mediated Step of Ca2+- dependent Neurotransmitter Release through Its N-terminal WD40 Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SYMPATHETIC NEURONS; CERVICAL GANGLION NEURONS; SNARE COMPLEX-FORMATION; SYNAPTIC VESICLE CYCLE; MEMBRANE-FUSION; C2B DOMAIN; TRANSMITTER RELEASE; CALCIUM SENSOR; CELL-CULTURE; I FUNCTIONS	Neurotransmitter release is triggered by Ca2+ binding to a low affinity Ca2+ sensor, mostly synaptotagmin-1, which catalyzes SNARE-mediated synaptic vesicle fusion. Tomosyn negatively regulates Ca2+ -dependent neurotransmitter release by sequestering target SNAREs through the C-terminal VAMP-like domain. In addition to the C terminus, the N-terminal WD40 repeats of tomosyn also have potent inhibitory activity toward Ca2+ -dependent neurotransmitter release, although the molecular mechanism underlying this effect remains elusive. Here, we show that through its N-terminal WD40 repeats tomosyn directly binds to synaptotagmin-1 in a Ca2+ -dependent manner. The N-terminal WD40 repeats impaired the activities of synaptotagmin-1 to promote SNARE complex-mediated membrane fusion and to bend the lipid bilayers. Decreased acetylcholine release from N-terminal WD40 repeat-microinjected superior cervical ganglion neurons was relieved by microinjection of the cytoplasmic domain of synaptotagmin-1. These results indicate that, upon direct binding, the N-terminal WD40 repeats negatively regulate the synaptotagmin-1-mediated step of Ca2+ -dependent neurotransmitter release. Furthermore, we show that synaptotagmin-1 binding enhances the target SNARE-sequestering activity of tomosyn. These results suggest that the interplay between tomosyn and synaptotagmin-1 underlies inhibitory control of Ca2+ -dependent neurotransmitter release.	[Yamamoto, Yasunori; Kawai, Katsuhisa; Fujikura, Kohei; Kurooka, Takao; Sakisaka, Toshiaki] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 6500017, Japan; [Mochida, Sumiko] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan; [Miyazaki, Naoyuki; Iwasaki, Kenji] Osaka Univ, Inst Prot Res, Res Ctr Struct & Funct Prote, Suita, Osaka 5650871, Japan; [Miyazaki, Naoyuki; Iwasaki, Kenji] Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan	Kobe University; Tokyo Medical University; Osaka University; Japan Science & Technology Agency (JST)	Sakisaka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 6500017, Japan.	sakisaka@med.kobe-u.ac.jp	Miyazaki, Naoyuki/P-3436-2018; Miyazaki, Naoyuki/D-7435-2012	Miyazaki, Naoyuki/0000-0002-4880-7300; Miyazaki, Naoyuki/0000-0002-4880-7300	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ichiro Kanehara Foundation; Uehara Memorial Foundation; Core Research for Evolutional Science and Technology; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ichiro Kanehara Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants-in-aid for the national project on Targeted Proteins Research Program (to T. S.), for scientific research C (to T. S.), for scientific research on priority areas (to T. S. and S. M.), for scientific research on innovative areas (to Y. Y.), and for the Global Center of Excellence Program F11 (to T. S.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, by a grant provided by The Ichiro Kanehara Foundation (to T. S.), and by a grant provided by The Uehara Memorial Foundation (to T. S.). Part of this work was also supported by Core Research for Evolutional Science and Technology, the Japan Science and Technology Agency (to N. M. and K. I.).	Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; de Lange RPJ, 2003, J NEUROSCI, V23, P10164; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; JOHNSON M, 1976, NATURE, V262, P308, DOI 10.1038/262308a0; KO CP, 1976, BRAIN RES, V117, P437, DOI 10.1016/0006-8993(76)90752-6; KO CP, 1976, BRAIN RES, V117, P461, DOI 10.1016/0006-8993(76)90753-8; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Ma H, 2007, NEUROSCI RES, V57, P491, DOI 10.1016/j.neures.2006.12.015; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; MIZOGUCHI A, 1989, MOL BRAIN RES, V5, P31, DOI 10.1016/0169-328X(89)90015-6; MOCHIDA S, 1994, MICROSC RES TECHNIQ, V29, P94, DOI 10.1002/jemt.1070290206; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; MOCHIDA S, 1995, J PHYSIOLOGY-PARIS, V89, P83, DOI 10.1016/0928-4257(96)80555-9; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; OLAGUE PH, 1978, DEV BIOL, V67, P424, DOI 10.1016/0012-1606(78)90210-5; OLAGUE PH, 1974, P NATL ACAD SCI USA, V71, P3602, DOI 10.1073/pnas.71.9.3602; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; REES R, 1974, J COMP NEUROL, V157, P1, DOI 10.1002/cne.901570102; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Sakaba T, 2002, NEUROSCI RES, V44, P343, DOI 10.1016/S0168-0102(02)00174-8; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; WAKSHULL E, 1979, J NEUROPHYSIOL, V42, P1426, DOI 10.1152/jn.1979.42.5.1426; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; Yamamoto Y, 2010, BIOCHEM BIOPH RES CO, V399, P24, DOI 10.1016/j.bbrc.2010.07.026; Yamamoto Y, 2009, J BIOL CHEM, V284, P12480, DOI 10.1074/jbc.M807182200; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028	58	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40943	40955		10.1074/jbc.M110.156893	http://dx.doi.org/10.1074/jbc.M110.156893			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20978127	Green Published, hybrid			2022-12-25	WOS:000285414400058
J	Looke, M; Reimand, J; Sedman, T; Sedman, J; Jarvinen, L; Varv, S; Peil, K; Kristjuhan, K; Vilo, J; Kristjuhan, A				Looke, Marko; Reimand, Jueri; Sedman, Tiina; Sedman, Juhan; Jaervinen, Lari; Vaerv, Signe; Peil, Kadri; Kristjuhan, Kersti; Vilo, Jaak; Kristjuhan, Arnold			Relicensing of Transcriptionally Inactivated Replication Origins in Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; BIDIRECTIONAL PROMOTERS; PERVASIVE TRANSCRIPTION; MCM PROTEINS; GENOME; COMPLEX; CDC45P	DNA replication origins are licensed in early G(1) phase of the cell cycle where the origin recognition complex (ORC) recruits the minichromosome maintenance (MCM) helicase to origins. These pre-replicative complexes (pre-RCs) remain inactive until replication is initiated in the S phase. However, transcriptional activity in the regions of origins can eliminate their functionality by displacing the components of pre-RC from DNA. We analyzed genome-wide data of mRNA and cryptic unstable transcripts in the context of locations of replication origins in yeast genome and found that at least one-third of the origins are transcribed and therefore might be inactivated by transcription. When investigating the fate of transcriptionally inactivated origins, we found that replication origins were repetitively licensed in G(1) to reestablish their functionality after transcription. We propose that reloading of pre-RC components in G(1) might be utilized for the maintenance of sufficient number of competent origins for efficient initiation of DNA replication in S phase.	[Kristjuhan, Kersti; Kristjuhan, Arnold] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Reimand, Jueri; Vilo, Jaak] Univ Tartu, Inst Comp Sci, EE-51010 Tartu, Estonia	University of Tartu; University of Tartu	Kristjuhan, A (corresponding author), Riia 23, EE-51010 Tartu, Estonia.	arnoldk@ut.ee	Vilo, Jaak/AAK-2228-2020; Sedman, Juhan/H-1820-2011; Vilo, Jaak/A-7183-2008; Reimand, Jüri/U-9264-2019	Vilo, Jaak/0000-0001-5604-4107; Vilo, Jaak/0000-0001-5604-4107; Reimand, Jüri/0000-0002-2299-2309; Sedman, Juhan/0000-0003-2081-1452; Kristjuhan, Arnold/0000-0002-5842-4952	Wellcome Trust [081756]; European Molecular Biology Organization [1454]	Wellcome Trust(Wellcome TrustEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by the Wellcome Trust International Senior Research Fellowship Grant 081756 and European Molecular Biology Organization Installation Grant 1454.	Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Berbenetz NM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001092; Blow JJ, 2009, EMBO REP, V10, P406, DOI 10.1038/embor.2009.5; BREWER BJ, 1991, BIOESSAYS, V13, P317, DOI 10.1002/bies.950130702; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Donato JJ, 2006, PLOS GENET, V2, P1328, DOI 10.1371/journal.pgen.0020141; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Mori S, 2007, J BIOL CHEM, V282, P4447, DOI 10.1074/jbc.M609671200; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nieduszynski CA, 2005, NUCLEIC ACIDS RES, V33, P2410, DOI 10.1093/nar/gki539; Nieduszynski CA, 2007, NUCLEIC ACIDS RES, V35, pD40, DOI 10.1093/nar/gkl758; Pryde F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005882; SNYDER M, 1988, MOL CELL BIOL, V8, P2184, DOI 10.1128/MCB.8.5.2184; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	25	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40004	40011		10.1074/jbc.M110.148924	http://dx.doi.org/10.1074/jbc.M110.148924			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20962350	hybrid, Green Published			2022-12-25	WOS:000285185500045
J	Corbett, HJ; Fernando, GJP; Chen, XF; Frazer, IH; Kendall, MAF				Corbett, Holly J.; Fernando, Germain J. P.; Chen, Xianfeng; Frazer, Ian H.; Kendall, Mark A. F.			Skin Vaccination against Cervical Cancer Associated Human Papillomavirus with a Novel Micro-Projection Array in a Mouse Model	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; EPIDERMAL POWDER IMMUNIZATION; DENDRITIC CELLS; UNSAFE INJECTIONS; IMMUNE-RESPONSES; TYPE-16 L1; INFECTION; VACCINES; IMMUNOGENICITY; CERVARIX(TM)	Background: Better delivery systems are needed for routinely used vaccines, to improve vaccine uptake. Many vaccines contain alum or alum based adjuvants. Here we investigate a novel dry-coated densely-packed micro-projection array skin patch (Nanopatch (TM)) as an alternate delivery system to intramuscular injection for delivering an alum adjuvanted human papillomavirus (HPV) vaccine (Gardasil (R)) commonly used as a prophylactic vaccine against cervical cancer. Methodology/ Principal Findings: Micro-projection arrays dry-coated with vaccine material (Gardasil (R)) delivered to C57BL/6 mouse ear skin released vaccine within 5 minutes. To assess vaccine immunogenicity, doses of corresponding to HPV-16 component of the vaccine between 0.43 +/- 0.084 ng and 300 +/- 120 ng (mean +/- SD) were administered to mice at day 0 and day 14. A dose of 55 +/- 6.0 ng delivered intracutaneously by micro-projection array was sufficient to produce a maximal virus neutralizing serum antibody response at day 28 post vaccination. Neutralizing antibody titres were sustained out to 16 weeks post vaccination, and, for comparable doses of vaccine, somewhat higher titres were observed with intracutaneous patch delivery than with intramuscular delivery with the needle and syringe at this time point. Conclusions/ Significance: Use of dry micro-projection arrays (Nanopatch (TM)) has the potential to overcome the need for a vaccine cold chain for common vaccines currently delivered by needle and syringe, and to reduce risk of needle-stick injury and vaccine avoidance due to the fear of the needle especially among children.	[Corbett, Holly J.; Fernando, Germain J. P.; Chen, Xianfeng; Kendall, Mark A. F.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Frazer, Ian H.; Kendall, Mark A. F.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Woolloongabba, Qld, Australia	University of Queensland; University of Queensland	Corbett, HJ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.	m.kendall@uq.edu.au	Fernando, Germain JP/C-3733-2009; Chen, Xianfeng/D-1709-2010; Kendall, Mark/M-4122-2017; Chen, Xianfeng/O-3359-2019; Frazer, Ian/A-1137-2007	Fernando, Germain JP/0000-0003-3260-0548; Chen, Xianfeng/0000-0002-3189-2756; Chen, Xianfeng/0000-0002-3189-2756; Frazer, Ian/0000-0002-8002-4680	Cancer Council of Queensland; University of Queensland; National Health and Medical Research Council (Australia) [569726, 456150]; Australian Research Council [DP077464]; Queensland Smart State Scheme; Queensland Government	Cancer Council of Queensland(Cancer Council Queensland); University of Queensland(University of Queensland); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Queensland Smart State Scheme; Queensland Government	Cancer Council of Queensland, the University of Queensland, National Health and Medical Research Council (Australia) Grants ID# 569726, ID# 456150, Australian Research Council Grant ID# DP077464 and the Queensland Smart State Scheme funded this research. Professor Mark A. F. Kendall was the recipient of an Australian Research Council Future Fellowship. Professor Ian H. Frazer was the recipient of a Queensland Government Premier's Fellowship. The University of Queensland and Professor Ian H. Frazer derive royalty income from the sale of HPV VLP vaccines. The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	[Anonymous], WHO M STAND HPV ASS; BAKER TS, 1991, BIOPHYS J, V60, P1445, DOI 10.1016/S0006-3495(91)82181-6; Baylor NW, 2002, VACCINE, V20, pS18, DOI 10.1016/S0264-410X(02)00166-4; BREITBURD F, 1995, J VIROL, V69, P3959, DOI 10.1128/JVI.69.6.3959-3963.1995; BUCK CB, 2006, GENERATION HPV PSEUD, P445; Chen XF, 2009, J CONTROL RELEASE, V139, P212, DOI 10.1016/j.jconrel.2009.06.029; Crichton ML, 2010, BIOMATERIALS, V31, P4562, DOI 10.1016/j.biomaterials.2010.02.022; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; Fernando GJP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010266; Fieller E., 1940, J ROYAL STAT SOC S, V7, P1, DOI [10.2307/2983630, DOI 10.2307/2983630]; FINCH JT, 1965, J MOL BIOL, V13, P1, DOI 10.1016/S0022-2836(65)80075-4; Ghim S, 2000, EXP MOL PATHOL, V68, P147, DOI 10.1006/exmp.1999.2298; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; HAMILTON JG, 1995, J FAM PRACTICE, V41, P169; HILLARD W, 2004, PERSPECT SEX REPRO H, V36, P6; JAN MMW, 1999, J PATHOL, V189, P12; Kendall M. A. F., 2005, WIPO Patent, Patent No. [2005072630, WO 2005/072630]; Kendall M, 2006, VACCINE, V24, P4651, DOI 10.1016/j.vaccine.2005.08.066; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; Kundi M, 2007, EXPERT REV VACCINES, V6, P133, DOI 10.1586/14760584.6.2.133; Le Tallec D, 2009, HUM VACCINES, V5, P467, DOI 10.4161/hv.8485; Lenz P, 2001, J IMMUNOL, V166, P5346, DOI 10.4049/jimmunol.166.9.5346; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Maa YF, 2003, PHARMACEUT RES, V20, P969, DOI 10.1023/A:1024493719236; Maa YF, 2003, J PHARM SCI-US, V92, P319, DOI 10.1002/jps.10294; McCarthy MP, 1998, J VIROL, V72, P32, DOI 10.1128/JVI.72.1.32-41.1998; Miller MA, 1999, B WORLD HEALTH ORGAN, V77, P808; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; MIZUNO K, 1989, Patent No. 0130619; Nir Y, 2003, AM J TROP MED HYG, V68, P341, DOI 10.4269/ajtmh.2003.68.341; Nokleby H, 2006, CURR ALLERGY ASTHM R, V6, P9, DOI 10.1007/s11882-006-0003-x; O'Connor K, 2007, AUST FAM PHYSICIAN, V36, P677; Osorio JE, 2003, IMMUNOL CELL BIOL, V81, P52, DOI 10.1046/j.1440-1711.2003.01134.x; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Shank-Retzlaff ML, 2006, HUM VACCINES, V2, P147, DOI 10.4161/hv.2.4.2989; SHINJE G, 1991, INT J CANCER, V49, P285; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; SUZICH JA, 1995, P NATL ACAD SCI USA, V92, P11553, DOI 10.1073/pnas.92.25.11553; Thones N, 2008, J VIROL, V82, P5472, DOI 10.1128/JVI.02482-07; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; *WHO EXP COMM BIOL, 2006, GUID ASS QUAL SAF EF; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Yuan H, 2001, J VIROL, V75, P7848, DOI 10.1128/JVI.75.17.7848-7853.2001; ZHOU J, 1991, VIROLOGY, V185, P251, DOI 10.1016/0042-6822(91)90772-4	53	82	85	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13460	10.1371/journal.pone.0013460	http://dx.doi.org/10.1371/journal.pone.0013460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976136	Green Published, gold			2022-12-25	WOS:000283045300029
J	Lifjeld, JT; Laskemoen, T; Kleven, O; Albrecht, T; Robertson, RJ				Lifjeld, Jan T.; Laskemoen, Terje; Kleven, Oddmund; Albrecht, Tomas; Robertson, Raleigh J.			Sperm Length Variation as a Predictor of Extrapair Paternity in Passerine Birds	PLOS ONE			English	Article							POSTCOPULATORY SEXUAL SELECTION; BLUETHROAT LUSCINIA-SVECICA; WARBLER PHYLLOSCOPUS-TROCHILUS; PAIR PATERNITY; TESTES SIZE; INTRASPECIFIC VARIATION; MOLECULAR PHYLOGENY; MATING SYSTEMS; ZEBRA FINCH; COMPETITION	Background: The rate of extrapair paternity is a commonly used index for the risk of sperm competition in birds, but paternity data exist for only a few percent of the approximately 10400 extant species. As paternity analyses require extensive field sampling and costly lab work, species coverage in this field will probably not improve much in the foreseeable future. Recent findings from passerine birds, which constitute the largest avian order (, 5 900 species), suggest that sperm phenotypes carry a signature of sperm competition. Here we examine how well standardized measures of sperm length variation can predict the rate of extrapair paternity in passerine birds. Methodology/Principal Findings: We collected sperm samples from 55 passerine species in Canada and Europe for which extrapair paternity rates were already available from either the same (n = 24) or a different (n = 31) study population. We measured the total length of individual spermatozoa and found that both the coefficient of between-male variation (CVbm) and within-male variation (CVwm) in sperm length were strong predictors of the rate of extrapair paternity, explaining as much as 65% and 58%, respectively, of the variation in extrapair paternity among species. However, only the CVbm predictor was independent of phylogeny, which implies that it can readily be converted into a currency of extrapair paternity without the need for phylogenetic correction. Conclusion/Significance: We propose the CVbm index as an alternative measure to extrapair paternity for passerine birds. Given the ease of sperm extraction from male birds in breeding condition, and a modest number of sampled males required for a robust estimate, this new index holds a great potential for mapping the risk of sperm competition across a wide range of passerine birds.	[Lifjeld, Jan T.; Laskemoen, Terje; Kleven, Oddmund] Univ Oslo, Nat Hist Museum, Natl Ctr Biosystemat, Oslo, Norway; [Albrecht, Tomas] Acad Sci Czech Republic, Dept Populat Biol, Inst Vertebrate Biol, Brno, Czech Republic; [Albrecht, Tomas] Charles Univ Prague, Fac Sci, Dept Zool, Brno, Czech Republic; [Robertson, Raleigh J.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	University of Oslo; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Charles University Prague; Queens University - Canada	Lifjeld, JT (corresponding author), Univ Oslo, Nat Hist Museum, Natl Ctr Biosystemat, Oslo, Norway.	j.t.lifjeld@nhm.uio.no	Kleven, Oddmund/A-6116-2009; Albrecht, Tomas/A-1130-2011; ASCR, IVB/A-9883-2011; Lifjeld, Jan T/B-1978-2008	Kleven, Oddmund/0000-0003-0267-6795; Lifjeld, Jan T/0000-0002-9172-9985; Albrecht, Tomas/0000-0002-9213-0034	Research Council of Norway [170853/V40, 196554/V40]; Ministry of Education, Youth and Sport of the Czech Republic [0021620828]; Academy of Sciences of the Czech Republic [AV0Z60930519]; Research Centrum Project [LC06073]; National Sciences and Engineering Research Council of Canada	Research Council of Norway(Research Council of Norway); Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Research Centrum Project; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The project was funded by two grants (170853/V40 and 196554/V40) from the Research Council of Norway to JTL, the Ministry of Education, Youth and Sport of the Czech Republic (0021620828), the Academy of Sciences of the Czech Republic (AV0Z60930519) and the Research Centrum Project (LC06073) to TA, and the National Sciences and Engineering Research Council of Canada (operational grant) to RJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom P, 2006, MOL PHYLOGENET EVOL, V38, P381, DOI 10.1016/j.ympev.2005.05.015; Alstrom P, 2008, MOL PHYLOGENET EVOL, V47, P960, DOI 10.1016/j.ympev.2007.12.007; [Anonymous], 2010, R LANG ENV STAT COMP; Arnold KE, 2002, P ROY SOC B-BIOL SCI, V269, P1263, DOI 10.1098/rspb.2002.2013; Birkhead TR, 2010, EMU, V110, P189, DOI 10.1071/MU09086; Birkhead TR, 2005, NATURE, V434, P383, DOI 10.1038/nature03374; Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Birkhead TR, 1998, SPERM COMPETITION SE; Breed WG, 2007, J ZOOL, V272, P299, DOI 10.1111/j.1469-7998.2006.00269.x; Briskie JV, 1997, EVOLUTION, V51, P937, DOI 10.1111/j.1558-5646.1997.tb03674.x; Calhim S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000413; Calhim S, 2007, BEHAV ECOL, V18, P271, DOI 10.1093/beheco/arl076; Cornwallis CK, 2010, NATURE, V466, P969, DOI 10.1038/nature09335; Dunn PO, 2001, EVOLUTION, V55, P161; Evans ML, 2009, J FIELD ORNITHOL, V80, P146, DOI 10.1111/j.1557-9263.2009.00216.x; Fitzpatrick JL, 2009, BIOL LETTERS, V5, P320, DOI 10.1098/rsbl.2008.0734; Fossoy F, 2006, BEHAV ECOL SOCIOBIOL, V60, P255, DOI 10.1007/s00265-006-0163-7; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gill FB, 2005, AUK, V122, P121, DOI 10.1642/0004-8038(2005)122[0121:POTPIS]2.0.CO;2; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; Griffith SC, 2009, J AVIAN BIOL, V40, P97, DOI 10.1111/j.1600-048X.2009.04562.x; HARCOURT AH, 1991, EVOLUTION, V45, P314, DOI [10.2307/2409666, 10.1111/j.1558-5646.1991.tb04406.x]; Immler S, 2008, EVOLUTION, V62, P1538, DOI 10.1111/j.1558-5646.2008.00393.x; Johnsen A, 2003, OECOLOGIA, V136, P476, DOI 10.1007/s00442-003-1286-4; Jonsson KA, 2006, ZOOL SCR, V35, P149, DOI 10.1111/j.1463-6409.2006.00221.x; Kleven O, 2008, EVOLUTION, V62, P494, DOI 10.1111/j.1558-5646.2007.00287.x; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Klicka J, 2007, MOL PHYLOGENET EVOL, V45, P1014, DOI 10.1016/j.ympev.2007.07.006; Kvist L, 2005, MOL PHYLOGENET EVOL, V34, P501, DOI 10.1016/j.ympev.2004.11.017; Laskemoen T, 2008, J AVIAN BIOL, V39, P322, DOI 10.1111/j.0908-8857.2008.04178.x; Laskemoen T, 2007, ORNIS FENNICA, V84, P131; Laskemoen T, 2010, BEHAV ECOL SOCIOBIOL, V64, P1473, DOI 10.1007/s00265-010-0962-8; Lifjeld JT, 2007, J AVIAN BIOL, V38, P267, DOI 10.1111/j.2007.0908-8857.04126.x; Lovette IJ, 2010, MOL PHYLOGENET EVOL, V57, P753, DOI 10.1016/j.ympev.2010.07.018; Lupold S, 2009, BEHAV ECOL SOCIOBIOL, V63, P899, DOI 10.1007/s00265-009-0733-6; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Lupold S, 2009, EVOLUTION, V63, P391, DOI 10.1111/j.1558-5646.2008.00571.x; Macedo RH, 2008, AUK, V125, P769, DOI 10.1525/auk.2008.11008; Michalczyk L, 2010, P ROY SOC B-BIOL SCI, V277, P3483, DOI 10.1098/rspb.2010.0514; MOLLER AP, 1995, BEHAV ECOL SOCIOBIOL, V36, P357, DOI 10.1007/BF00167797; Nguembock B, 2009, MOL PHYLOGENET EVOL, V51, P169, DOI 10.1016/j.ympev.2008.10.022; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parapanov RN, 2009, ANIM REPROD SCI, V114, P269, DOI 10.1016/j.anireprosci.2008.09.013; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; Reale D, 2003, EVOLUTION, V57, P597, DOI 10.1111/j.0014-3820.2003.tb01551.x; Salzburger W, 2002, MOL PHYLOGENET EVOL, V24, P19, DOI 10.1016/S1055-7903(02)00265-8; Sangster G, 2010, MOL PHYLOGENET EVOL, V57, P380, DOI 10.1016/j.ympev.2010.07.008; SEUANEZ HN, 1977, NATURE, V270, P345, DOI 10.1038/270345a0; Sheldon FH, 2005, MOL PHYLOGENET EVOL, V35, P254, DOI 10.1016/j.ympev.2004.11.008; Sibley CG, 1990, PHYLOGENY CLASSIFICA; Simmons LW, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P405, DOI 10.1016/B978-0-12-372568-4.00010-0; Sokal R. R, 1981, BIOMETRY; Treplin S, 2008, CLADISTICS, V24, P328, DOI 10.1111/j.1096-0031.2007.00178.x; Voelker G, 2008, MOL PHYLOGENET EVOL, V49, P377, DOI 10.1016/j.ympev.2008.06.014; Voelker G, 2007, MOL PHYLOGENET EVOL, V42, P422, DOI 10.1016/j.ympev.2006.07.016; White-Cooper H, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P151, DOI 10.1016/B978-0-12-372568-4.00004-5; Zuccon D, 2010, ZOOL SCR, V39, P213, DOI 10.1111/j.1463-6409.2010.00423.x; [No title captured]; [No title captured]	66	70	72	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13456	10.1371/journal.pone.0013456	http://dx.doi.org/10.1371/journal.pone.0013456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976147	Green Published, Green Submitted, gold			2022-12-25	WOS:000283045300026
J	Lucio, M; Fekete, A; Weigert, C; Wagele, B; Zhao, XJ; Chen, J; Fritsche, A; Haring, HU; Schleicher, ED; Xu, GW; Schmitt-Kopplin, P; Lehmann, R				Lucio, Marianna; Fekete, Agnes; Weigert, Cora; Waegele, Brigitte; Zhao, Xinjie; Chen, Jing; Fritsche, Andreas; Haering, Hans-Ulrich; Schleicher, Erwin D.; Xu, Guowang; Schmitt-Kopplin, Philippe; Lehmann, Rainer			Insulin Sensitivity Is Reflected by Characteristic Metabolic Fingerprints - A Fourier Transform Mass Spectrometric Non-Targeted Metabolomics Approach	PLOS ONE			English	Article							GLUCOSE-TOLERANCE TEST; BIOMARKERS; ACIDS; PROFILES; BLOOD; OBESE	Background: A decline in body insulin sensitivity in apparently healthy individuals indicates a high risk to develop type 2 diabetes. Investigating the metabolic fingerprints of individuals with different whole body insulin sensitivity according to the formula of Matsuda, et al. (ISIMatsuda) by a non-targeted metabolomics approach we aimed a) to figure out an unsuspicious and altered metabolic pattern, b) to estimate a threshold related to these changes based on the ISI, and c) to identify the metabolic pathways responsible for the discrimination of the two patterns. Methodology and Principal Findings: By applying infusion ion cyclotron resonance Fourier transform mass spectrometry, we analyzed plasma of 46 non-diabetic subjects exhibiting high to low insulin sensitivities. The orthogonal partial least square model revealed a cluster of 28 individuals with alterations in their metabolic fingerprints associated with a decline in insulin sensitivity. This group could be separated from 18 subjects with an unsuspicious metabolite pattern. The orthogonal signal correction score scatter plot suggests a threshold of an ISIMatsuda of 15 for the discrimination of these two groups. Of note, a potential subgroup represented by eight individuals (ISIMatsuda value between 8.5 and 15) was identified in different models. This subgroup may indicate a metabolic transition state, since it is already located within the cluster of individuals with declined insulin sensitivity but the metabolic fingerprints still show some similarities with unaffected individuals (ISI > 15). Moreover, the highest number of metabolite intensity differences between unsuspicious and altered metabolic fingerprints was detected in lipid metabolic pathways (arachidonic acid metabolism, metabolism of essential fatty acids and biosynthesis of unsaturated fatty acids), steroid hormone biosyntheses and bile acid metabolism, based on data evaluation using the metabolic annotation interface MassTRIX. Conclusions: Our results suggest that altered metabolite patterns that reflect changes in insulin sensitivity respectively the ISIMatsuda are dominated by lipid-related pathways. Furthermore, a metabolic transition state reflected by heterogeneous metabolite fingerprints may precede severe alterations of metabolism. Our findings offer future prospects for novel insights in the pathogenesis of the pre-diabetic phase.	[Lucio, Marianna; Fekete, Agnes; Schmitt-Kopplin, Philippe] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Ecol Chem, Dept BioGeoChem & Analyt, Neuherberg, Germany; [Weigert, Cora; Schleicher, Erwin D.; Lehmann, Rainer] Univ Hosp Tuebingen, Div Clin Chem & Pathobiochem, Cent Lab, Tubingen, Germany; [Weigert, Cora; Fritsche, Andreas; Haering, Hans-Ulrich; Schleicher, Erwin D.; Lehmann, Rainer] Univ Tubingen, Paul Langerhans Inst Tubingen, Tubingen, Germany; [Waegele, Brigitte] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Waegele, Brigitte; Xu, Guowang] Tech Univ Munich, Life & Food Sci Ctr Weihenstephan, Dept Genome Oriented Bioinformat, D-8050 Freising Weihenstephan, Germany; [Zhao, Xinjie; Chen, Jing] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Fritsche, Andreas; Haering, Hans-Ulrich] Univ Hosp Tuebingen, Dept Internal Med 4, Tubingen, Germany; [Schmitt-Kopplin, Philippe] Tech Univ Munich, Dept Chem Tech Anal Res Ctr Weihenstephan Brewing, D-8050 Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technical University of Munich	Lucio, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Ecol Chem, Dept BioGeoChem & Analyt, Neuherberg, Germany.	schmitt-kopplin@helmholtz-muenchen.de; Rainer.Lehmann@med.uni-tuebingen.de	Xu, Guowang/L-6910-2014; Fekete, Agnes/C-8048-2019; Lehmann, Rainer/AAF-4281-2019; Schmitt-Kopplin, Philippe/H-6271-2011	Xu, Guowang/0000-0003-4298-3554; Fekete, Agnes/0000-0003-3058-7570; Lehmann, Rainer/0000-0003-1218-6810; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Lucio, Marianna/0000-0002-5844-0098	Federal Ministry of Education and Research [FKZ 01GI0803-04]; German Federal Ministry of Education and Research; Foundation for Distinguished Young Scholars [20425516]; Foundation from National Natural Science Foundation of China [20675082]; Sino-German Center for Research Promotion (DFG) [GZ 364]; Sino-German Center for Research Promotion (NSFC); National Basic Research Program of China [2006CB503902]; State Ministry of Science & Technology of China [2006BAK02A12]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Foundation for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Foundation from National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-German Center for Research Promotion (DFG)(German Research Foundation (DFG)); Sino-German Center for Research Promotion (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); State Ministry of Science & Technology of China(Ministry of Science and Technology, China)	This work was supported in part by the Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the Federal Ministry of Education and Research (FKZ 01GI0803-04), a grant from the German Federal Ministry of Education and Research to the German Center for Diabetes Research (DZD eV), the Foundation for Distinguished Young Scholars (No. 20425516), the Foundation from National Natural Science Foundation of China (No. 20675082), the Sino-German Center for Research Promotion (DFG and NSFC, GZ 364), the National Basic Research Program of China (No. 2006CB503902) and National Key Project of Scientific and Technical Supporting Programs (No. 2006BAK02A12) from State Ministry of Science & Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Gougeon RD, 2009, P NATL ACAD SCI USA, V106, P9174, DOI 10.1073/pnas.0901100106; Han J, 2008, METABOLOMICS, V4, P128, DOI 10.1007/s11306-008-0104-8; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Huo TG, 2009, J PHARMACEUT BIOMED, V49, P976, DOI 10.1016/j.jpba.2009.01.008; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Kernan WN, 2003, STROKE, V34, P1431, DOI 10.1161/01.STR.0000071108.00234.0E; Kind T, 2007, ANAL BIOCHEM, V363, P185, DOI 10.1016/j.ab.2007.01.028; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Makinen VP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100205; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; Matsuda M, 2010, NUTR METAB CARDIOVAS, V20, P79, DOI 10.1016/j.numecd.2009.07.007; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MIHALIK SJ, 2010, OBESITY SILVER SPRIN; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Ohta D, 2010, CURR OPIN BIOTECH, V21, P35, DOI 10.1016/j.copbio.2010.01.012; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Shah SH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.11; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; TAI ES, 2010, DIABETOLOGIA; Van der Greef J, 2006, PHARMACOGENOMICS, V7, P1087, DOI 10.2217/14622416.7.7.1087; van Doorn M, 2007, BRIT J CLIN PHARMACO, V63, P562, DOI 10.1111/j.1365-2125.2006.02816.x; VANDERVOET H, 1994, CHEMOMETR INTELL LAB, V25, P313, DOI 10.1016/0169-7439(94)85050-X; Wang C, 2005, ANAL CHEM, V77, P4108, DOI 10.1021/ac0481001; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525; World Health Organization, 2006, DEF DIAGN DIAB MELL, P1; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yuan KL, 2007, J CHROMATOGR B, V850, P236, DOI 10.1016/j.jchromb.2006.11.035; ZHAO X, 2010, METABOLOMICS, P6; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	44	58	59	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13317	10.1371/journal.pone.0013317	http://dx.doi.org/10.1371/journal.pone.0013317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976215	Green Published, gold, Green Submitted			2022-12-25	WOS:000283043700002
J	Lau, JY; Oliver, BG; Baraket, M; Beckett, EL; Hansbro, NG; Moir, LM; Wilton, SD; Williams, C; Foster, PS; Hansbro, PM; Black, JL; Burgess, JK				Lau, Justine Y.; Oliver, Brian G.; Baraket, Melissa; Beckett, Emma L.; Hansbro, Nicole G.; Moir, Lyn M.; Wilton, Steve D.; Williams, Carolyn; Foster, Paul S.; Hansbro, Philip M.; Black, Judith L.; Burgess, Janette K.			Fibulin-1 Is Increased in Asthma - A Novel Mediator of Airway Remodeling?	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEINS; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; GENE-EXPRESSION; MESSENGER-RNA; PROLIFERATION; ROLES; PATHOGENESIS; ASSOCIATION; FIBROBLASTS	Background: The extracellular matrix is a dynamic and complex network of macromolecules responsible for maintaining and influencing cellular functions of the airway. The role of fibronectin, an extracellular matrix protein, is well documented in asthma. However, the expression and function of fibulin-1, a secreted glycoprotein which interacts with fibronectin, has not been reported. Fibulin-1 is widely expressed in basement membranes in many organs including the lung. There are four isoforms in humans (A-D) of which fibulin-1C and 1D predominate. The objective of this study was to study the expression of fibulin-1 in volunteers with and without asthma, and to examine its function in vitro. Methodology/Principal Findings: We used immunohistochemistry and dot-blots to examine fibulin-1 levels in bronchial biopsies, bronchoalveolar lavage fluid and serum. Real-time PCR for fibulin-1C and 1D, and ELISA and western blotting for fibulin-1 were used to study the levels in airway smooth muscle cells. The function of fibulin-1C was determined by assessing its role, using an antisense oligonucleotide, in cell proliferation, migration and wound healing. A murine model of airway hyperresponsiveness (AHR) was used to explore the biological significance of fibulin-1. Levels of fibulin-1 were significantly increased in the serum and bronchoalveolar lavage fluid of 21 asthmatics compared with 11 healthy volunteers. In addition fibulin-1 was increased in asthma derived airway smooth muscle cells and fibulin-1C contributed to the enhanced proliferation and wound repair in these cells. These features were reversed when fibulin-1C was suppressed using an antisense oligomer. In a mouse model of AHR, treatment with an AO inhibited the development of AHR to methacholine. Conclusions: Our data collectively suggest fibulin-1C may be worthy of further investigation as a target for airway remodeling in asthma.	[Lau, Justine Y.; Oliver, Brian G.; Hansbro, Nicole G.; Moir, Lyn M.; Wilton, Steve D.; Williams, Carolyn; Foster, Paul S.; Hansbro, Philip M.; Black, Judith L.; Burgess, Janette K.] Cooperat Res Ctr Asthma & Airways, Sydney, NSW, Australia; [Lau, Justine Y.; Oliver, Brian G.; Baraket, Melissa; Moir, Lyn M.; Black, Judith L.; Burgess, Janette K.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Oliver, Brian G.; Baraket, Melissa; Moir, Lyn M.; Black, Judith L.; Burgess, Janette K.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Beckett, Emma L.; Hansbro, Nicole G.; Foster, Paul S.; Hansbro, Philip M.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2308, Australia; [Beckett, Emma L.; Hansbro, Nicole G.; Foster, Paul S.; Hansbro, Philip M.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2308, Australia; [Wilton, Steve D.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; [Wilton, Steve D.; Williams, Carolyn] Univ Western Australia, Lung Inst Western Australia, Perth, WA 6009, Australia; [Wilton, Steve D.; Williams, Carolyn] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia	University of Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Western Australia; University of Western Australia; University of Western Australia	Lau, JY (corresponding author), Cooperat Res Ctr Asthma & Airways, Sydney, NSW, Australia.	janette.burgess@sydney.edu.au	Burgess, Janette K/A-3597-2010; Foster, Paul/G-5057-2013; Beckett, Emma/AAU-8537-2021; Oliver, Brian/E-7939-2010; Black, Judith L/C-6559-2008; Hansbro, Phil/G-7486-2013; Moir, Lyn/A-8967-2011; Burgess, Janette/M-7117-2019	Beckett, Emma/0000-0002-8888-3789; Oliver, Brian/0000-0002-7122-9262; Hansbro, Phil/0000-0002-4741-3035; , Paul/0000-0002-0827-8299; Wilton, Steve/0000-0002-9400-893X; Burgess, Janette/0000-0001-9868-9966	Cooperative Research Centre for Asthma and Airways; National Health and Medical Research Council, Australia [512301]; Asthma Foundation of NSW; CRC for Asthma and Airways; National Health and Medical Research Council Australia [402835]; NHMRC [571098]	Cooperative Research Centre for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Asthma Foundation of NSW; CRC for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Cooperative Research Centre for Asthma and Airways (http://www.asthma.crc.org.au/), and the National Health and Medical Research Council Project Grant #512301, Australia (http://www.nhmrc.gov.au/). J.Y. Lau was supported by The Asthma Foundation of NSW (http://www.asthmansw.org.au/content.cfm?id=1996), and the CRC for Asthma and Airways. J.K. Burgess is supported by a National Health and Medical Research Council Australia R. Douglas Wright Fellowship #402835 and J.L. Black by an NH&MRC Senior Principal Research Fellowship #571098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Burgess JK, 2003, AM J RESP CRIT CARE, V167, P71, DOI 10.1164/rccm.200205-416OC; Ducros E, 2007, CURR EYE RES, V32, P481, DOI 10.1080/02713680701411269; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X; GINA, 2002, GLOB STRAT ASTHM MAN; Hassan M, 2010, J ALLERGY CLIN IMMUN, V125, P1037, DOI 10.1016/j.jaci.2010.02.031; Hergeth SP, 2008, EXP HEMATOL, V36, P1022, DOI 10.1016/j.exphem.2008.03.013; Hesselson D, 2004, CURR BIOL, V14, P2005, DOI 10.1016/j.cub.2004.11.006; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; HIRST SJ, 1992, AM J RESP CELL MOL, V7, P574, DOI 10.1165/ajrcmb/7.6.574; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; JEFFERY PK, 1992, BRIT MED BULL, V48, P23, DOI 10.1093/oxfordjournals.bmb.a072537; Johnson PRA, 2000, AM J RESP CRIT CARE, V162, P2145, DOI 10.1164/ajrccm.162.6.9909111; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Johnson PRA, 2001, CLIN EXP PHARMACOL P, V28, P233, DOI 10.1046/j.1440-1681.2001.03426.x; Kenyon NJ, 2003, THORAX, V58, P772, DOI 10.1136/thorax.58.9.772; Kostka G, 2001, MOL CELL BIOL, V21, P7025, DOI 10.1128/MCB.21.20.7025-7034.2001; LAITINEN LA, 1995, INT ARCH ALLERGY IMM, V107, P215, DOI 10.1159/000236981; Laprise C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-21; Mitrpant Chalermchai, 2009, Curr Mol Pharmacol, V2, P110; Moll F, 2002, ONCOGENE, V21, P1097, DOI 10.1038/sj.onc.1205171; Parameswaran K, 2004, EUR RESPIR J, V24, P545, DOI 10.1183/09031936.04.00113103; Pupa SM, 2004, ONCOGENE, V23, P2153, DOI 10.1038/sj.onc.1207323; Qing J, 1997, ONCOGENE, V15, P2159, DOI 10.1038/sj.onc.1201385; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; ROARK EF, 1995, J HISTOCHEM CYTOCHEM, V43, P401, DOI 10.1177/43.4.7534784; ROMBERGER DJ, 1992, AM J RESP CELL MOL, V7, P149, DOI 10.1165/ajrcmb/7.2.149; Syed F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-9; Tran H, 1997, J BIOL CHEM, V272, P22600, DOI 10.1074/jbc.272.36.22600; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Twal WO, 2001, J CELL SCI, V114, P4587; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Westergren-Thorsson G, 2002, INT J BIOCHEM CELL B, V34, P1256, DOI 10.1016/S1357-2725(02)00058-4; Woodruff PG, 2004, AM J RESP CRIT CARE, V169, P1001, DOI 10.1164/rccm.200311-1529OC; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	39	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13360	10.1371/journal.pone.0013360	http://dx.doi.org/10.1371/journal.pone.0013360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967215	gold, Green Published			2022-12-25	WOS:000282869800040
J	Finlay, D; Richardson, RD; Landberg, LK; Howes, AL; Vuori, K				Finlay, Darren; Richardson, Robyn D.; Landberg, Lisa K.; Howes, Amy L.; Vuori, Kristiina			Novel HTS Strategy Identifies TRAIL-Sensitizing Compounds Acting Specifically Through the Caspase-8 Apoptotic Axis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; DEATH; TUMOR; REEXPRESSION; LINE	Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) is potentially a very important therapeutic as it shows selectivity for inducing apoptosis in cancer cells whilst normal cells are refractory. TRAIL binding to its cognate receptors, Death Receptors-4 and -5, leads to recruitment of caspase-8 and classical activation of downstream effector caspases, leading to apoptosis. As with many drugs however, TRAIL's usefulness is limited by resistance, either innate or acquired. We describe here the development of a novel 384-well high-throughput screening (HTS) strategy for identifying potential TRAIL-sensitizing agents that act solely in a caspase-8 dependent manner. By utilizing a TRAIL resistant cell line lacking caspase-8 (NB7) compared to the same cells reconstituted with the wild-type protein, or with a catalytically inactive point mutant of caspase-8, we are able to identify compounds that act specifically through the caspase-8 axis, rather than through general toxicity. In addition, false positive hits can easily be "weeded out" in this assay due to their activity in cells lacking caspase-8-inducible activity. Screening of the library of pharmacologically active compounds (LOPAC) was performed as both proof-of-concept and to discover potential unknown TRAIL sensitizers whose mechanism is caspase-8 mediated. We identified known TRAIL sensitizers from the library and identified new compounds that appear to sensitize specifically through caspase-8. In sum, we demonstrate proof-of-concept and discovery of novel compounds with a screening strategy optimized for the detection of caspase-8 pathway-specific TRAIL sensitizers. This screen was performed in the 384-well format, but could easily be further miniaturized, allows easy identification of artifactual false positives, and is highly scalable to accommodate diverse libraries.	[Finlay, Darren; Richardson, Robyn D.; Landberg, Lisa K.; Howes, Amy L.; Vuori, Kristiina] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Finlay, D (corresponding author), Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA.	kvuori@sanfordburnham.org			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants (to KV) from the National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Booth NL, 2009, CANCER IMMUNOL IMMUN, V58, P1229, DOI 10.1007/s00262-008-0637-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cuello M, 2001, GYNECOL ONCOL, V81, P380, DOI 10.1006/gyno.2001.6194; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; Finlay D, 2009, CANCER RES, V69, P5023, DOI 10.1158/0008-5472.CAN-08-3731; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Huang L, 2004, BONE, V34, P971, DOI 10.1016/j.bone.2004.02.005; Jin CY, 2009, ANTI-CANCER DRUG, V20, P713, DOI 10.1097/CAD.0b013e32832e8998; Koehler BC, 2009, WORLD J GASTROENTERO, V15, P5924, DOI 10.3748/wjg.15.5924; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Mellier G, 2010, MOL ASPECTS MED, V31, P93, DOI 10.1016/j.mam.2009.12.002; Moxley KM, 2009, GYNECOL ONCOL, V115, P438, DOI 10.1016/j.ygyno.2009.09.007; Muhlethaler-Mottet A, 2003, ANN NY ACAD SCI, V1010, P195, DOI 10.1196/annals.1299.033; Rokhlin OW, 2002, PROSTATE, V52, P1, DOI 10.1002/pros.10074; Song JH, 2003, BRAIN PATHOL, V13, P539; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang YQ, 2009, CANCER BIOL THER, V8, P917, DOI 10.4161/cbt.8.10.8141	23	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13375	10.1371/journal.pone.0013375	http://dx.doi.org/10.1371/journal.pone.0013375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967281	Green Submitted, Green Published, gold			2022-12-25	WOS:000282807300032
J	Liao, QY; Cowling, B; Lam, WT; Ng, MW; Fielding, R				Liao, Qiuyan; Cowling, Benjamin; Lam, Wing Tak; Ng, Man Wai; Fielding, Richard			Situational Awareness and Health Protective Responses to Pandemic Influenza A (H1N1) in Hong Kong: A Cross-Sectional Study	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; SELF-EFFICACY; AVIAN INFLUENZA; RISK PERCEPTIONS; PLANNED BEHAVIOR; OUTBREAK; PREDICTORS; PREVENTION; KNOWLEDGE; ATTITUDES	Background: Whether information sources influence health protective behaviours during influenza pandemics or other emerging infectious disease epidemics is uncertain. Methodology: Data from cross-sectional telephone interviews of 1,001 Hong Kong adults in June, 2009 were tested against theory and data-derived hypothesized associations between trust in (formal/informal) information, understanding, self-efficacy, perceived susceptibility and worry, and hand hygiene and social distancing using Structural Equation Modelling with multigroup comparisons. Principal Findings: Trust in formal (government/media) information about influenza was associated with greater reported understanding of A/H1N1 cause (beta = 0.36) and A/H1N1 prevention self-efficacy (beta = 0.25), which in turn were associated with more hand hygiene (beta = 0.19 and beta = 0.23, respectively). Trust in informal (interpersonal) information was negatively associated with perceived personal A/H1N1 susceptibility (beta = -0.21), which was negatively associated with perceived self-efficacy (beta = -0.42) but positively associated with influenza worry (beta = 0.44). Trust in informal information was positively associated with influenza worry (beta = 0.16) which was in turn associated with greater social distancing (beta = 0.36). Multigroup comparisons showed gender differences regarding paths from trust in formal information to understanding of A/H1N1 cause, trust in informal information to understanding of A/H1N1 cause, and understanding of A/H1N1 cause to perceived self-efficacy. Conclusions/Significance: Trust in government/media information was more strongly associated with greater self-efficacy and handwashing, whereas trust in informal information was strongly associated with perceived health threat and avoidance behaviour. Risk communication should consider the effect of gender differences.	[Liao, Qiuyan; Lam, Wing Tak; Fielding, Richard] Univ Hong Kong, Hlth Behav Res Grp, Dept Community Med, Sch Publ Hlth,Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China; [Cowling, Benjamin; Ng, Man Wai] Univ Hong Kong, Infect Dis Grp, Dept Community Med,Sch Publ Hlth, Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Liao, QY (corresponding author), Univ Hong Kong, Hlth Behav Res Grp, Dept Community Med, Sch Publ Hlth,Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China.	fielding@hkusua.hku.hk	Cowling, Benjamin John/C-4263-2009; Lam, Wendy Wing Tak/C-4319-2009	Cowling, Benjamin John/0000-0002-6297-7154; Liao, Qiuyan/0000-0002-1105-6857; Lam, Wendy Wing Tak/0000-0003-2383-0149	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region [PHE-01]; Harvard Center for Communicable Disease Dynamics, United States National Institutes of Health (NIH) [1 U54 GM088558]; Area of Excellence Scheme of the Hong Kong University Grants Committee [AoE/M-12/06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region; Harvard Center for Communicable Disease Dynamics, United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Area of Excellence Scheme of the Hong Kong University Grants Committee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received financial support from the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (SAR) (grant number PHE-01), the Harvard Center for Communicable Disease Dynamics from the United States National Institutes of Health (NIH) Models of Infectious Disease Agent Study program (grant number 1 U54 GM088558), and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant number AoE/M-12/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A, 1997, SELF EFFICACY EXERCI; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Beier ME, 2003, J PERS SOC PSYCHOL, V84, P439, DOI 10.1037/0022-3514.84.2.439; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brahmbhatt M., 2008, SARS TYPE EC EFFECTS; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Calman KC, 2002, LANCET, V360, P166, DOI 10.1016/S0140-6736(02)09421-7; *CDCP, 2010, CDC SAYS TAK 3 ACT F; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; *CTR HLTH PROT HON, 2005, PREV AV INFL; *CTR HLTH PROT HON, 2009, HUM SWIN INFL; *ED ENC STATEUNIVE, 2010, HONG KONG HIST BACKG; ENDSLEY MR, 1995, HUM FACTORS, V37, P32, DOI 10.1518/001872095779049543; FISHBEIN M, 1974, PSYCHOL REV, V81, P59, DOI 10.1037/h0035872; FRESCO DM, 2004, COGNITIVE THER RES, V26, P179; GATTUSO SM, 1992, J CONSULT CLIN PSYCH, V60, P133, DOI 10.1037/0022-006X.60.1.133; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Grayson ML, 2009, CLIN INFECT DIS, V48, P285, DOI 10.1086/595845; Helweg-Larsen M, 2001, PERS SOC PSYCHOL REV, V5, P74, DOI 10.1207/S15327957PSPR0501_5; *HONG KONG CENS ST, 2006, MAIN TABL 2006 POP C; Jerant A, 2008, CHRONIC ILLN, V4, P173, DOI 10.1177/1742395308089057; Kalichman SC, 1996, ANN BEHAV MED, V18, P6, DOI 10.1007/BF02903934; Katz Sara, 2005, BMC Med Educ, V5, P4, DOI 10.1186/1472-6920-5-4; King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Kraft P, 2005, BRIT J SOC PSYCHOL, V44, P479, DOI 10.1348/014466604X17533; Leppin A, 2009, INT J BEHAV MED, V16, P7, DOI 10.1007/s12529-008-9002-8; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; LIAO Q, 2010, INT J BEHAV IN PRESS; Liao QY, 2009, J PUBLIC HEALTH-UK, V31, P573, DOI 10.1093/pubmed/fdp043; Liao QY, 2009, RISK ANAL, V29, P416, DOI 10.1111/j.1539-6924.2008.01157.x; Mahler HIM, 1998, ANN BEHAV MED, V20, P39, DOI 10.1007/BF02893808; Munro S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-104; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; OLIVER J, 2002, NZ J PSYCHOL; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rhodes RE, 2003, PSYCHOL HEALTH, V18, P79, DOI 10.1080/0887044031000080665; Rubin GJ, 2010, HEALTH TECHNOL ASSES, V14, P183, DOI 10.3310/hta14340-03; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Sekirime W K, 2001, Afr Health Sci, V1, P16; Sessa A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-171; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; SHEPPARD BH, 1988, J CONSUM RES, V15, P325, DOI 10.1086/209170; Slaughter L, 2005, J BIOMED INFORM, V38, P298, DOI 10.1016/j.jbi.2004.12.006; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Tang CSK, 2005, J AGING HEALTH, V17, P490, DOI 10.1177/0898264305277966; Tang CSK, 2003, AM J PUBLIC HEALTH, V93, P1887, DOI 10.2105/AJPH.93.11.1887; Voeten HACM, 2009, INT J BEHAV MED, V16, P49, DOI 10.1007/s12529-008-9006-4; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; World Health Organization, 2009, PAND INFL PREV MIT L; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216	57	101	101	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13350	10.1371/journal.pone.0013350	http://dx.doi.org/10.1371/journal.pone.0013350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	662KX	20967280	gold, Green Submitted, Green Published			2022-12-25	WOS:000282807300028
J	Wu, H; Min, JR; Lunin, VV; Antoshenko, T; Dombrovski, L; Zeng, H; Allali-Hassani, A; Campagna-Slater, V; Vedadi, M; Arrowsmith, CH; Plotnikov, AN; Schapira, M				Wu, Hong; Min, Jinrong; Lunin, Vladimir V.; Antoshenko, Tatiana; Dombrovski, Ludmila; Zeng, Hong; Allali-Hassani, Abdellah; Campagna-Slater, Valerie; Vedadi, Masoud; Arrowsmith, Cheryl H.; Plotnikov, Alexander N.; Schapira, Matthieu			Structural Biology of Human H3K9 Methyltransferases	PLOS ONE			English	Article							HISTONE LYSINE METHYLTRANSFERASES; PRODUCT SPECIFICITY; PROTEIN METHYLTRANSFERASES; MOLECULAR REPLACEMENT; METHYLATION; DOMAIN; RECOGNITION; MECHANISM; CATALYSIS; CHROMATIN	SET domain methyltransferases deposit methyl marks on specific histone tail lysine residues and play a major role in epigenetic regulation of gene transcription. We solved the structures of the catalytic domains of GLP, G9a, Suv39H2 and PRDM2, four of the eight known human H3K9 methyltransferases in their apo conformation or in complex with the methyl donating cofactor, and peptide substrates. We analyzed the structural determinants for methylation state specificity, and designed a G9a mutant able to tri-methylate H3K9. We show that the I-SET domain acts as a rigid docking platform, while induced-fit of the Post-SET domain is necessary to achieve a catalytically competent conformation. We also propose a model where long-range electrostatics bring enzyme and histone substrate together, while the presence of an arginine upstream of the target lysine is critical for binding and specificity.	[Wu, Hong; Min, Jinrong; Lunin, Vladimir V.; Antoshenko, Tatiana; Dombrovski, Ludmila; Zeng, Hong; Allali-Hassani, Abdellah; Campagna-Slater, Valerie; Vedadi, Masoud; Arrowsmith, Cheryl H.; Plotnikov, Alexander N.; Schapira, Matthieu] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Wu, H (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	alexander.plotnikov@mssm.edu; matthieu.schapira@utoronto.ca	Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; Arrowsmith, Cheryl/0000-0002-4971-3250	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	This work is supported by the Structural Genomics Consortium (SGC), a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Collazo E, 2005, ANAL BIOCHEM, V342, P86, DOI 10.1016/j.ab.2005.04.007; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonzalez ME, 2009, ONCOGENE, V28, P843, DOI 10.1038/onc.2008.433; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Rathert P, 2008, CHEM BIOL, V15, P5, DOI 10.1016/j.chembiol.2007.11.013; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Spannhoff A, 2009, CHEMMEDCHEM, V4, P1568, DOI 10.1002/cmdc.200900301; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	39	206	217	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8570	10.1371/journal.pone.0008570	http://dx.doi.org/10.1371/journal.pone.0008570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20967253	gold, Green Published			2022-12-25	WOS:000273456300003
J	Hu, CX; Hoene, M; Zhao, XJ; Haring, HU; Schleicher, E; Lehmann, R; Han, XL; Xu, GW; Weigert, C				Hu, Chunxiu; Hoene, Miriam; Zhao, Xinjie; Haering, Hans U.; Schleicher, Erwin; Lehmann, Rainer; Han, Xianlin; Xu, Guowang; Weigert, Cora			Lipidomics Analysis Reveals Efficient Storage of Hepatic Triacylglycerides Enriched in Unsaturated Fatty Acids after One Bout of Exercise in Mice	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; POSTPRANDIAL LIPEMIA; ENDURANCE EXERCISE; PROLONGED EXERCISE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; SINGLE BOUT; TRIGLYCERIDE SECRETION; INSULIN SENSITIVITY; VLDL-TRIGLYCERIDE	Background: Endurance exercise induces lipolysis, increases circulating concentrations of free fatty acids (FFA) and the uptake and oxidation of fatty acids in the working muscle. Less is known about the regulation of lipid metabolism in the liver during and post-exercise. Methodology/Principal Findings: We performed an ultra fast liquid chromatography-mass spectrometry (UFLC-MS) based lipidomics analysis of liver tissue samples obtained from C57Bl/6J mice immediately after a 60 min treadmill run of moderate intensity, and after 3 h of recovery. The PLS-DA scores plot for 115 quantified lipid molecular species revealed a clear separation of the hepatic lipid profile of sedentary from recovering mice, but not from mice immediately after running. 21 lipid species were considered to be most responsible for the difference in the hepatic lipid profiles, including 17 triacylglycerides (TG), one lysophosphatidylcholine (LPC) and three phosphatidylcholines (PC). TG species were found to be more abundant in the recovery phase, while PC species were decreased. The degree of accumulation of individual TG species correlated well with the amount of theoretical energy stored whereas no increase was found for TG species containing only saturated or one monounsaturated fatty acid. Total liver TG content as assayed by an enzymatic method was increased to 163% in the recovery phase, while it was significantly decreased in skeletal muscle by the exercise bout and remained less in the recovery phase. Results from fasted and refed mice indicate that fasting-induced lipolysis was associated with a pronounced accumulation of hepatic TG, which is reversed by refeeding for 5 h. Thus food intake per se did not elevate hepatic TG. Conclusion: These data indicate that high availability of FFA induced by endurance exercise or fasting resulted in a transient hepatic TG accumulation, while muscle TG content was decreased during exercise presumably due to increased muscle fatty acid oxidation.	[Hu, Chunxiu; Zhao, Xinjie; Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Hoene, Miriam; Haering, Hans U.; Schleicher, Erwin; Lehmann, Rainer; Weigert, Cora] Univ Hosp Tuebingen, Div Endocrinol, Dept Internal Med, Tubingen, Germany; [Han, Xianlin] Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Hoene, Miriam; Haering, Hans U.; Schleicher, Erwin; Lehmann, Rainer; Weigert, Cora] Paul Langerhans Inst Tuebingen, Tubingen, Germany	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Washington University (WUSTL)	Hu, CX (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China.	xugw@dicp.ac.cn; Cora.Weigert@med.uni-tuebingen.de	Lehmann, Rainer/AAF-4281-2019; Xu, Guowang/L-6910-2014; Wang, Congrong/HDM-0959-2022	Lehmann, Rainer/0000-0003-1218-6810; Xu, Guowang/0000-0003-4298-3554; Hu, Cheng/0000-0003-4314-2386; Wang, Congrong/0000-0002-8645-1114	Deutsche Forschungsgemeinschaft [WE 4176, GRK 1302/1]; Federal Ministry of Education and Research [FKZ 01GI0803-04]; German Federal Ministry of Education and Research (BMBF); Sino-German Center for Research Promotion [GZ 364]; State Ministry of Science and Technology of China [2006CB503902]; National Natural Science Foundation of China [20835006]; Chinese Academy of Sciences [KSCX1-YW-02]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Sino-German Center for Research Promotion; State Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from the Deutsche Forschungsgemeinschaft to C. W. (WE 4176) and to E. S. (GRK 1302/1), by the Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the Federal Ministry of Education and Research to R. L. and H. U. H. (FKZ 01GI0803-04), by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.), the Sino-German Center for Research Promotion to R. L. and G. X. (DFG and NSFC, GZ 364), the 973 Project of the State Ministry of Science and Technology of China to G. X. (No. 2006CB503902), the National Natural Science Foundation of China to G. X. (No. 20835006), and the Knowledge Innovation Program of the Chinese Academy of Sciences to G. X. (KSCX1-YW-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBORG G, 1974, J CLIN INVEST, V53, P1080, DOI 10.1172/JCI107645; ALDRED HE, 1994, METABOLISM, V43, P836, DOI 10.1016/0026-0495(94)90263-1; Andersson A, 1998, AM J PHYSIOL-ENDOC M, V274, pE432, DOI 10.1152/ajpendo.1998.274.3.E432; ANNUZZI G, 1987, METABOLISM, V36, P438, DOI 10.1016/0026-0495(87)90040-0; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Borsheim E, 1999, MED SCI SPORT EXER, V31, P522; Burguera B, 2000, AM J PHYSIOL-ENDOC M, V278, pE113, DOI 10.1152/ajpendo.2000.278.1.E113; CHEN ZY, 1992, AM J PHYSIOL, V263, pR233, DOI 10.1152/ajpregu.1992.263.2.R233; CULLINANE E, 1982, METABOLISM, V31, P844, DOI 10.1016/0026-0495(82)90085-3; Eriksson L, 2001, MULTI AND MEGAVARIAT; Fernandez C, 2008, AM J PHYSIOL-ENDOC M, V295, pE179, DOI 10.1152/ajpendo.00282.2007; Gauthier MS, 2004, INT J OBESITY, V28, P1064, DOI 10.1038/sj.ijo.0802628; Gill JMR, 2001, EUR J CLIN INVEST, V31, P201, DOI 10.1046/j.1365-2362.2001.00799.x; GORSKI J, 1988, EUR J APPL PHYSIOL, V57, P554, DOI 10.1007/BF00418461; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; Herd SL, 1998, BRIT J NUTR, V80, P57, DOI 10.1017/S0007114598001779; Hoene M, 2009, J PHYSIOL-LONDON, V587, P241, DOI 10.1113/jphysiol.2008.160275; HOLLOSZY JO, 1964, AM J CARDIOL, V14, P753, DOI 10.1016/0002-9149(64)90004-9; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Jensen MD, 2003, ACTA PHYSIOL SCAND, V178, P385, DOI 10.1046/j.1365-201X.2003.01167.x; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Magkos F, 2006, AM J PHYSIOL-ENDOC M, V290, pE355, DOI 10.1152/ajpendo.00259.2005; Magkos F, 2008, J APPL PHYSIOL, V105, P1228, DOI 10.1152/japplphysiol.90761.2008; Magkos F, 2007, AM J PHYSIOL-ENDOC M, V292, pE1568, DOI 10.1152/ajpendo.00636.2006; Mitchell TW, 2004, J APPL PHYSIOL, V97, P1823, DOI 10.1152/japplphysiol.00344.2004; MONDON CE, 1984, J APPL PHYSIOL, V57, P1466, DOI 10.1152/jappl.1984.57.5.1466; Nielsen HB, 2007, J APPL PHYSIOL, V103, P1227, DOI 10.1152/japplphysiol.00027.2007; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Petridou A, 2005, EUR J APPL PHYSIOL, V94, P84, DOI 10.1007/s00421-004-1294-z; Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; SADY SP, 1988, METABOLISM, V37, P568, DOI 10.1016/0026-0495(88)90173-4; Schafer S, 2007, EUR J CLIN INVEST, V37, P535, DOI 10.1111/j.1365-2362.2007.01820.x; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; SIMONELLI C, 1978, AM J PHYSIOL, V234, pE221, DOI 10.1152/ajpendo.1978.234.3.E221; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; Thamer C, 2007, OBESITY, V15, P531, DOI 10.1038/oby.2007.568; TRISCARI J, 1980, METABOLISM, V29, P377, DOI 10.1016/0026-0495(80)90013-X; Tsekouras YE, 2008, AM J PHYSIOL-ENDOC M, V295, pE851, DOI 10.1152/ajpendo.90545.2008; Tsekouras YE, 2009, CLIN SCI, V116, P147, DOI 10.1042/CS20080078; van Ginneken V, 2007, BBA-MOL CELL BIOL L, V1771, P1263, DOI 10.1016/j.bbalip.2007.07.007; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935; Vieira VJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1164, DOI 10.1152/ajpendo.00054.2009; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Ziogas GG, 1997, MED SCI SPORT EXER, V29, P986, DOI 10.1097/00005768-199708000-00002	49	71	72	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13318	10.1371/journal.pone.0013318	http://dx.doi.org/10.1371/journal.pone.0013318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967198	Green Published, gold			2022-12-25	WOS:000282869800021
J	Kiebala, M; Polesskaya, O; Yao, ZQ; Perry, SW; Maggirwar, SB				Kiebala, Michelle; Polesskaya, Oksana; Yao, Zhenqiang; Perry, Seth W.; Maggirwar, Sanjay B.			Nuclear Factor-Kappa B Family Member RelB Inhibits Human Immunodeficiency Virus-1 Tat-Induced Tumor Necrosis Factor-Alpha Production	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-1 ASSOCIATED DEMENTIA; UP-REGULATES EXPRESSION; TYPE-1 GENE-EXPRESSION; HUMAN FETAL MICROGLIA; TNF-ALPHA; TRANSCRIPTION FACTORS; CHEMOKINE EXPRESSION; RECEPTOR ACTIVATION; NEURONAL INJURY	Human Immunodeficiency Virus-1 (HIV-1)-associated neurocognitive disorder (HAND) is likely neuroinflammatory in origin, believed to be triggered by inflammatory and oxidative stress responses to cytokines and HIV protein gene products such as the HIV transactivator of transcription (Tat). Here we demonstrate increased messenger RNA for nuclear factor- kappa B (NF-kappa B) family member, transcription factor RelB, in the brain of doxycycline-induced Tat transgenic mice, and increased RelB synthesis in Tat-exposed microglial cells. Since genetic ablation of RelB in mice leads to multi-organ inflammation, we hypothesized that Tat-induced, newly synthesized RelB inhibits cytokine production by microglial cells, possibly through the formation of transcriptionally inactive RelB/RelA complexes. Indeed, tumor necrosis factor-alpha (TNF alpha) production in monocytes isolated from RelB deficient mice was significantly higher than in monocytes isolated from RelB expressing controls. Moreover, RelB overexpression in microglial cells inhibited Tat-induced TNF alpha synthesis in a manner that involved transcriptional repression of the TNF alpha promoter, and increased phosphorylation of RelA at serine 276, a prerequisite for increased RelB/RelA protein interactions. The Rel-homology-domain within RelB was necessary for this interaction. Overexpression of RelA itself, in turn, significantly increased TNF alpha promoter activity, an effect that was completely blocked by RelB overexpression. We conclude that RelB regulates TNF alpha cytokine synthesis by competitive interference binding with RelA, which leads to downregulation of TNF alpha production. Moreover, because Tat activates both RelB and TNF alpha in microglia, and because Tat induces inflammatory TNF alpha synthesis via NF-kappa B, we posit that RelB serves as a cryoprotective, anti-inflammatory, counter-regulatory mechanism for pathogenic NF-kappa B activation. These findings identify a novel regulatory pathway for controlling HIV-induced microglial activation and cytokine production that may have important therapeutic implications for the management of HAND.	[Kiebala, Michelle; Polesskaya, Oksana; Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Yao, Zhenqiang] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Perry, Seth W.] Univ Rochester, Sch Med & Dent, Dept Neurol, Ctr Neural Dev & Dis, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Kiebala, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	sanjay_maggirwar@urmc.rochester.edu	Polesskaya, Oksana/AAX-9283-2021; Zhu, Yingjie/W-3315-2017	Perry, Seth W/0000-0002-1503-6634; Zhu, Yingjie/0000-0003-1849-6019; Xu, Hongxi/0000-0001-6238-4511	National Institutes of Health [RO1 NS054578, RO1 NS066801, R21 MH084718, T32 AI49105]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH084718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054578, R01NS066801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the following National Institutes of Health grants: RO1 NS054578 and RO1 NS066801 (to SBM); R21 MH084718 (to SWP); T32 AI49105 (to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony IC, 2008, INT REV PSYCHIATR, V20, P15, DOI 10.1080/09540260701862037; Archibald SL, 2004, ARCH NEUROL-CHICAGO, V61, P369, DOI 10.1001/archneur.61.3.369; Avison MJ, 2004, J NEUROVIROL, V10, P223, DOI 10.1080/13550280490463532; Beauparlant P, 1996, J VIROL, V70, P5777, DOI 10.1128/JVI.70.9.5777-5785.1996; BIDDISON WE, 2001, CURR PROTOC CELL BIO, pCH2; *BIO RAD LAB I LIF, B BIO RAD LAB I LIF, V2890; Bissel SJ, 2002, AM J PATHOL, V160, P927, DOI 10.1016/S0002-9440(10)64915-2; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bossi P, 1998, CLIN INFECT DIS, V26, P1072, DOI 10.1086/520301; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; BRAKE DA, 1990, J CELL BIOL, V111, P1275, DOI 10.1083/jcb.111.3.1275; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; CARDENAS V, 2009, J NEUROVIROL, P1; CHANAKYA HN, 1997, BIOENERGY NEWS, V1, P11; Chen PQ, 1997, J BIOL CHEM, V272, P22385, DOI 10.1074/jbc.272.36.22385; Chen YS, 2009, NEUROIMAGE, V47, P1154, DOI 10.1016/j.neuroimage.2009.04.030; D'Aversa TG, 2004, J NEUROVIROL, V10, P86, DOI 10.1080/13550280490279807; D'Aversa TG, 2002, AM J PATHOL, V160, P559, DOI 10.1016/S0002-9440(10)64875-4; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; Devadas K, 2004, J IMMUNOL, V173, P6735, DOI 10.4049/jimmunol.173.11.6735; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; DOBRZANSKI P, 1993, MOL CELL BIOL, V13, P1572, DOI 10.1128/MCB.13.3.1572; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; Everall IP, 1999, BRAIN PATHOL, V9, P209; EVERALL IP, 1994, ACTA NEUROPATHOL, V88, P538; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; GELBARD HA, 1993, DEV NEUROSCI-BASEL, V15, P417, DOI 10.1159/000111367; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gongvatana A, 2009, J NEUROVIROL, V15, P187, DOI 10.1080/13550280902769756; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Guillemard E, 2004, VIROLOGY, V329, P371, DOI 10.1016/j.virol.2004.08.030; Harhaj E, 1996, VIROLOGY, V216, P284, DOI 10.1006/viro.1996.0062; Hayashi K, 2006, J CEREBR BLOOD F MET, V26, P1052, DOI 10.1038/sj.jcbfm.9600254; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Herbein G, 2008, CURR HIV RES, V6, P117, DOI 10.2174/157016208783884985; HOWARD OMZ, 1993, P NATL ACAD SCI USA, V90, P2335, DOI 10.1073/pnas.90.6.2335; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Ju SM, 2009, EXP MOL MED, V41, P86, DOI 10.3858/emm.2009.41.2.011; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Langford TD, 2002, AIDS, V16, P1019, DOI 10.1097/00002030-200205030-00008; Langford TD, 2003, BRAIN PATHOL, V13, P195; LERNBECHER T, 1994, EMBO J, V13, P4060, DOI 10.1002/j.1460-2075.1994.tb06723.x; Letendre Scott L, 2009, Top HIV Med, V17, P46; Li WX, 2008, J NEUROSCI, V28, P12190, DOI 10.1523/JNEUROSCI.3019-08.2008; Maggirwar SB, 2000, J NEUROCHEM, V74, P527, DOI 10.1046/j.1471-4159.2000.740527.x; Maggirwar SB, 1998, J NEUROSCI, V18, P10356; MAJOR EO, 2009, ANN REV MED; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Masliah E, 2000, AIDS, V14, P69, DOI 10.1097/00002030-200001070-00008; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Mayne M, 1998, NEUROIMMUNOMODULAT, V5, P184, DOI 10.1159/000026336; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Melrose RJ, 2008, BEHAV BRAIN RES, V188, P337, DOI 10.1016/j.bbr.2007.11.021; MERRILL JE, 1991, FASEB J, V5, P2391, DOI 10.1096/fasebj.5.10.2065887; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; MULLEROEHRING EM, 2009, NEUROPSYCHOLOGIA; Nath A, 2000, ANN NEUROL, V47, P186, DOI 10.1002/1531-8249(200002)47:2<186::AID-ANA8>3.3.CO;2-V; Nath A, 1998, PROG NEUROBIOL, V54, P19, DOI 10.1016/S0301-0082(97)00053-1; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Nath A, 2006, CURR OPIN NEUROL, V19, P358, DOI 10.1097/01.wco.0000236614.51592.ca; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; NGUYEN TP, 2009, AM J PATHOL; Nichol KE, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-13; Oberdorfer P, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/348507; Perry SW, 2002, J NEUROVIROL, V8, P611, DOI 10.1080/13550280290101021; Perry SW, 1998, J BIOL CHEM, V273, P17660, DOI 10.1074/jbc.273.28.17660; Pfefferbaum A, 2009, AIDS, V23, P1977, DOI 10.1097/QAD.0b013e32832e77fe; Quiterio S, 2003, BIOMED PHARMACOTHER, V57, P49, DOI 10.1016/S0753-3322(02)00332-3; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; RESNICK L, 1988, NEUROLOGY, V38, P9, DOI 10.1212/WNL.38.1.9; Rezaie P, 1999, DEV BRAIN RES, V115, P71, DOI 10.1016/S0165-3806(99)00043-7; RUBEN S, 1989, J VIROL, V63, P1; Rumbaugh JA, 2006, CURR PHARM DESIGN, V12, P1023, DOI 10.2174/138161206776055877; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; SCHUTZE S, 1995, IMMUNOBIOLOGY, V193, P193, DOI 10.1016/S0171-2985(11)80543-7; Shatrov VA, 1997, EUR CYTOKINE NETW, V8, P37; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Sui Z, 2006, J IMMUNOL, V177, P702, DOI 10.4049/jimmunol.177.1.702; SWINGLER S, 1994, BIOCHEM BIOPH RES CO, V203, P623, DOI 10.1006/bbrc.1994.2228; TORNATORE C, 1991, J VIROL, V65, P6094, DOI 10.1128/JVI.65.11.6094-6100.1991; Tozzi V, 2007, JAIDS-J ACQ IMM DEF, V45, P174, DOI 10.1097/QAI.0b013e318042e1ee; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Weih F, 1997, J IMMUNOL, V158, P5211; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; WILEY CA, 1991, ANN NEUROL, V29, P651, DOI 10.1002/ana.410290613; Wohlschlaeger J, 2009, CLIN NEUROL NEUROSUR, V111, P422, DOI 10.1016/j.clineuro.2008.12.006; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Xia YY, 1997, AM J PATHOL, V151, P375; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080	109	278	329	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11875	10.1371/journal.pone.0011875	http://dx.doi.org/10.1371/journal.pone.0011875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20957043	Green Submitted, Green Published, gold			2022-12-25	WOS:000280520200037
J	Sato, Y; Poynter, G; Huss, D; Filla, MB; Czirok, A; Rongish, BJ; Little, CD; Fraser, SE; Lansford, R				Sato, Yuki; Poynter, Greg; Huss, David; Filla, Michael B.; Czirok, Andras; Rongish, Brenda J.; Little, Charles D.; Fraser, Scott E.; Lansford, Rusty			Dynamic Analysis of Vascular Morphogenesis Using Transgenic Quail Embryos	PLOS ONE			English	Article							BLOOD-VESSEL FORMATION; LENTIVIRAL VECTORS; CHICK EMBRYO; CELL-MIGRATION; VASCULOGENESIS; MECHANISMS; EXPRESSION; EFFICIENT; EMBRYOGENESIS; ANGIOGENESIS	Background: One of the least understood and most central questions confronting biologists is how initially simple clusters or sheet-like cell collectives can assemble into highly complex three-dimensional functional tissues and organs. Due to the limits of oxygen diffusion, blood vessels are an essential and ubiquitous presence in all amniote tissues and organs. Vasculogenesis, the de novo self-assembly of endothelial cell (EC) precursors into endothelial tubes, is the first step in blood vessel formation [1]. Static imaging and in vitro models are wholly inadequate to capture many aspects of vascular pattern formation in vivo, because vasculogenesis involves dynamic changes of the endothelial cells and of the forming blood vessels, in an embryo that is changing size and shape. Methodology/Principal Findings: We have generated Tie1 transgenic quail lines Tg(tie1:H2B-eYFP) that express H2B-eYFP in all of their endothelial cells which permit investigations into early embryonic vascular morphogenesis with unprecedented clarity and insight. By combining the power of molecular genetics with the elegance of dynamic imaging, we follow the precise patterning of endothelial cells in space and time. We show that during vasculogenesis within the vascular plexus, ECs move independently to form the rudiments of blood vessels, all while collectively moving with gastrulating tissues that flow toward the embryo midline. The aortae are a composite of somatic derived ECs forming its dorsal regions and the splanchnic derived ECs forming its ventral region. The ECs in the dorsal regions of the forming aortae exhibit variable mediolateral motions as they move rostrally; those in more ventral regions show significant lateral-to-medial movement as they course rostrally. Conclusions/Significance: The present results offer a powerful approach to the major challenge of studying the relative role(s) of the mechanical, molecular, and cellular mechanisms of vascular development. In past studies, the advantages of the molecular genetic tools available in mouse were counterbalanced by the limited experimental accessibility needed for imaging and perturbation studies. Avian embryos provide the needed accessibility, but few genetic resources. The creation of transgenic quail with labeled endothelia builds upon the important roles that avian embryos have played in previous studies of vascular development.	[Sato, Yuki; Poynter, Greg; Huss, David; Fraser, Scott E.; Lansford, Rusty] CALTECH, Beckman Inst, Biol Imaging Ctr, Div Biol, Pasadena, CA 91125 USA; [Filla, Michael B.; Czirok, Andras; Rongish, Brenda J.; Little, Charles D.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	California Institute of Technology; University of Kansas; University of Kansas Medical Center	Sato, Y (corresponding author), CALTECH, Beckman Inst, Biol Imaging Ctr, Div Biol, Pasadena, CA 91125 USA.	rusty@caltech.edu	Fraser, Scott/Y-3406-2019; Czirok, Andras/E-4253-2014; Rongish, Brenda/G-7637-2016; Lansford, Rusty/C-6956-2014; Rochel, Natacha/A-5718-2016; Sato, Yoshinori/J-2497-2015	Fraser, Scott/0000-0002-5377-0223; Czirok, Andras/0000-0002-2694-5163; Rongish, Brenda/0000-0002-1559-2876; Lansford, Rusty/0000-0002-2159-3699; Ueno, Takamasa/0000-0003-4852-4236; Poussin-Courmontagne, Pierre/0000-0003-4813-6882; POTIER, Noelle/0000-0002-6381-4365; Rochel, Natacha/0000-0002-3573-5889; Takata, Hiroshi/0000-0003-1457-6919; Nakagata, Naomi/0000-0002-5737-9993; Sato, Yoshinori/0000-0001-8250-6598	National Institutes of Health (NIH) National Center for Research Resources [R21HD047347-01]; NIH National Heart, Lung, and Blood Institute [(R01) HL085694, HL068855, HL87136]; NIH Center of Excellence in Genomic Science [P50 HG004071]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD047347] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085694, R01HL087136, R01HL068855] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Center of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Grants by the National Institutes of Health (NIH) National Center for Research Resources (R21HD047347-01), NIH National Heart, Lung, and Blood Institute (R01) HL085694 (BJR), HL068855 (CDL), HL87136 (AC), and NIH Center of Excellence in Genomic Science (P50 HG004071) supported the work. Y.S. was a postdoctoral fellow for research abroad of the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Blomer U, 1997, J VIROL, V71, P6641; Cleaver O, 1998, DEVELOPMENT, V125, P3905; COFFIN JD, 1991, ANAT REC, V231, P383; Czirok A, 2002, J MICROSC-OXFORD, V206, P209, DOI 10.1046/j.1365-2818.2002.01032.x; DE PALMA M, 2003, HUM GENE THER, V14, P1193; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DERUITER MC, 1993, ANAT RECORD, V235, P261, DOI 10.1002/ar.1092350210; DRAKE CJ, 1992, DEV DYNAM, V193, P83, DOI 10.1002/aja.1001930111; Drake CJ, 1997, DEV BIOL, V192, P17, DOI 10.1006/dbio.1997.8751; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; Eichmann A, 2005, INT J DEV BIOL, V49, P259, DOI 10.1387/ijdb.041941ae; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GONZALEZCRUSSI F, 1971, AM J ANAT, V130, P441, DOI 10.1002/aja.1001300406; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Huss D, 2008, LAB ANIMAL, V37, P513, DOI 10.1038/laban1108-513; Iljin K, 2002, FASEB J, V16, P1764, DOI 10.1096/fj.01-1043com; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257; Kulesa PM, 2000, DEVELOPMENT, V127, P1161; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; PARDANAUD L, 1987, CELL DIFFER DEV, V22, P47, DOI 10.1016/0045-6039(87)90412-X; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Perryn ED, 2008, DEV BIOL, V313, P545, DOI 10.1016/j.ydbio.2007.10.036; Pinter E, 1997, AM J PATHOL, V150, P1523; POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210; POYNTER G, 2009, COLD SPRING HARBOR P; Pudliszewski M, 2005, INT J DEV BIOL, V49, P355, DOI 10.1387/ijdb.041956mp; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; ROMANOFF A, 1960, HEMATOPOIETIC VASCUL, P571; Rupp PA, 2004, DEVELOPMENT, V131, P2887, DOI 10.1242/dev.01160; Sabin FR, 1920, CONTRIB EMBRYOL, V9, P215; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; Sedmera D, 2006, ANAT REC PART A, V288A, P933, DOI 10.1002/ar.a.20383; STALSBERG H, 1969, DEV BIOL, V19, P128, DOI 10.1016/0012-1606(69)90052-9; Trinkaus J.P., 1969, CELLS ORGANS FORCES, Vfirst; Zamir EA, 2005, ANN BIOMED ENG, V33, P854, DOI 10.1007/s10439-005-3037-7; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952	50	104	105	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12674	10.1371/journal.pone.0012674	http://dx.doi.org/10.1371/journal.pone.0012674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	21152046	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000281815700006
